data_2kpn_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kpn _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 664' ' ' ASP . . . . . . . . . . . . . 10.6 t70 . . . . . 0 N--CA 1.468 0.432 0 CA-C-O 121.098 0.475 . . . . 72.219999999999999 111.022 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 665' ' ' LEU . . . . . . . . . . . . . 86.0 mt -80.77 136.52 36.15 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.033 -0.53 . . . . 75.549999999999997 110.448 174.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 666' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -70.25 140.67 88.02 Favored Pre-proline 0 CA--C 1.538 0.486 0 CA-C-N 116.322 -0.399 . . . . 73.530000000000001 110.575 177.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 667' ' ' PRO . . . . . 0.486 ' HB3' HD13 ' A' ' 699' ' ' LEU . 19.1 Cg_endo -56.64 135.94 73.27 Favored 'Trans proline' 0 CA--C 1.537 0.668 0 C-N-CA 122.7 2.267 . . . . 74.450000000000003 113.593 -171.167 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 668' ' ' LYS . . . . . . . . . . . . . 27.4 tptp -82.8 105.09 13.53 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.048 -0.524 . . . . 73.209999999999994 110.527 176.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 669' ' ' LEU . . . . . . . . . . . . . 56.8 tp -91.65 128.38 37.46 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.957 -0.565 . . . . 74.040000000000006 110.045 175.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 670' ' ' THR . . . . . . . . . . . . . 89.5 m -113.93 110.78 20.62 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.122 0.487 . . . . 55.109999999999999 111.151 178.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 671' ' ' VAL . . . . . 0.429 HG22 HG12 ' A' ' 689' ' ' VAL . 97.8 t -135.09 131.98 20.02 Favored Pre-proline 0 CA--C 1.54 0.586 0 CA-C-N 115.63 -0.713 . . . . 65.299999999999997 110.759 -177.303 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 672' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -73.62 121.76 7.32 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 122.239 1.959 . . . . 75.25 111.997 176.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 673' ' ' VAL . . . . . . . . . . . . . 14.7 p -64.15 -26.51 40.62 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 N-CA-C 112.286 0.476 . . . . 54.539999999999999 112.286 -175.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 674' ' ' GLY . . . . . . . . . . . . . . . -148.94 139.35 7.46 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 120.864 -0.684 . . . . 55.399999999999999 113.653 -179.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 675' ' ' ALA . . . . . . . . . . . . . . . -137.29 151.48 48.71 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 122.799 0.44 . . . . 74.349999999999994 110.937 178.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 676' ' ' THR . . . . . . . . . . . . . 88.4 m -138.84 119.16 13.67 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 122.155 -0.341 . . . . 71.400000000000006 111.48 179.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 677' ' ' ILE . . . . . . . . . . . . . 33.6 pt -131.04 176.55 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 CA-C-O 120.91 0.386 . . . . 72.340000000000003 111.323 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 678' ' ' HIS . . . . . . . . . . . . . 60.4 m80 -109.22 163.71 13.11 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.337 0.589 . . . . 54.240000000000002 112.502 -178.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 679' ' ' VAL . . . . . . . . . . . . . 91.4 t -63.55 115.77 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-N 115.753 -0.658 . . . . 75.420000000000002 111.031 174.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 99.74 0.52 56.43 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 121.472 -0.394 . . . . 52.240000000000002 112.935 -177.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 681' ' ' ASP . . . . . . . . . . . . . 35.3 t0 -88.8 157.48 18.47 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-O 121.17 0.509 . . . . 72.340000000000003 111.759 -178.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 682' ' ' SER . . . . . . . . . . . . . 91.3 p -82.37 144.84 30.25 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 116.099 -0.5 . . . . 62.310000000000002 112.0 -177.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 683' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -148.58 114.16 5.64 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 116.605 -0.27 . . . . 71.340000000000003 111.016 177.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 684' ' ' VAL . . . . . . . . . . . . . 58.0 t -116.19 99.82 52.99 Favored Pre-proline 0 CA--C 1.545 0.764 0 CA-C-O 120.689 0.28 . . . . 71.230000000000004 111.653 -179.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -59.89 -37.18 87.56 Favored 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 122.928 2.419 . . . . 74.010000000000005 113.7 -177.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 686' ' ' MET . . . . . 0.498 ' HE1' ' HA ' ' A' ' 686' ' ' MET . 1.1 mmt -79.09 -2.91 42.79 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 112.634 0.605 . . . . 75.140000000000001 112.634 -177.243 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 687' ' ' ALA . . . . . . . . . . . . . . . -97.25 -32.18 12.05 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 120.918 0.39 . . . . 63.130000000000003 111.657 176.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 688' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -98.4 -2.57 38.86 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 112.471 0.545 . . . . 71.019999999999996 112.471 -175.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 689' ' ' VAL . . . . . 0.429 HG12 HG22 ' A' ' 671' ' ' VAL . 95.1 t -123.31 124.83 70.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-O 120.832 0.348 . . . . 71.120000000000005 111.643 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 690' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -123.92 162.31 23.62 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 116.432 -0.349 . . . . 74.329999999999998 111.41 -179.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 691' ' ' ALA . . . . . . . . . . . . . . . -149.35 121.57 8.37 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 120.788 0.327 . . . . 61.329999999999998 111.271 175.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 692' ' ' ILE . . . . . . . . . . . . . 35.3 mm -127.56 130.03 70.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 N-CA-C 112.285 0.476 . . . . 74.25 112.285 -175.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -115.82 145.26 42.99 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 120.866 0.365 . . . . 72.549999999999997 110.161 172.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 694' ' ' LYS . . . . . 0.469 ' NZ ' ' HB2' ' A' ' 694' ' ' LYS . 2.1 ttmp? -72.57 -45.55 58.65 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 112.125 0.416 . . . . 64.349999999999994 112.125 -178.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 32.2 mp0 -83.48 -49.43 9.28 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.245 -0.434 . . . . 75.430000000000007 112.166 -172.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 696' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -82.95 -33.51 26.72 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 120.869 0.366 . . . . 75.319999999999993 111.229 -175.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . 116.01 -150.61 18.59 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 121.174 -0.536 . . . . 71.340000000000003 113.407 176.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -70.65 118.94 14.08 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 120.87 0.367 . . . . 74.329999999999998 110.976 179.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 699' ' ' LEU . . . . . 0.486 HD13 ' HB3' ' A' ' 667' ' ' PRO . 24.3 mt -109.19 13.38 24.45 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 111.709 0.263 . . . . 72.040000000000006 111.709 -178.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 25.3 m -57.33 -38.95 74.88 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 121.071 0.462 . . . . 64.219999999999999 111.635 -178.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 701' ' ' SER . . . . . . . . . . . . . 35.3 m -66.63 -23.98 66.24 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.01 0.433 . . . . 74.099999999999994 111.65 178.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 702' ' ' LYS . . . . . 0.463 ' HD2' HD22 ' A' ' 699' ' ' LEU . 94.9 mttt -84.82 -6.42 59.35 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 112.156 0.428 . . . . 73.019999999999996 112.156 -176.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 703' ' ' ILE . . . . . 0.427 HD11 HG13 ' A' ' 689' ' ' VAL . 69.7 mt -63.57 123.2 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-O 121.213 0.53 . . . . 75.439999999999998 112.168 -178.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 704' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? -88.77 117.93 28.1 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.029 -0.532 . . . . 75.239999999999995 110.197 176.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 54.1 t -103.14 105.93 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-O 120.926 0.393 . . . . 74.040000000000006 111.512 -176.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 706' ' ' ASP . . . . . 0.464 ' HB3' ' HB ' ' A' ' 720' ' ' THR . 18.6 t70 -108.25 148.03 30.56 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 120.893 0.378 . . . . 73.120000000000005 111.411 -178.388 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 99.91 179.13 30.52 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 121.176 -0.535 . . . . 64.209999999999994 112.77 -177.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 708' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -150.33 133.78 16.46 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 122.393 -0.475 . . . . 63.409999999999997 112.166 -178.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 709' ' ' VAL . . . . . 0.489 HG23 ' HB2' ' A' ' 717' ' ' TYR . 93.7 t -111.37 120.82 62.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 CA-C-N 116.135 -0.484 . . . . 75.049999999999997 111.085 176.387 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 710' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -99.39 139.34 35.19 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 120.783 0.325 . . . . 65.349999999999994 111.053 177.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 711' ' ' THR . . . . . . . . . . . . . 75.8 p -111.36 13.4 21.59 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 112.476 0.547 . . . . 64.109999999999999 112.476 -179.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 712' ' ' THR . . . . . . . . . . . . . 71.3 p -102.57 -26.63 13.15 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-O 121.321 0.581 . . . . 75.420000000000002 111.253 175.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 713' ' ' LYS . . . . . 0.522 ' HZ1' ' HB2' ' A' ' 713' ' ' LYS . 0.1 OUTLIER -116.54 135.9 53.43 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 115.869 -0.605 . . . . 64.510000000000005 110.786 178.156 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 714' ' ' ALA . . . . . . . . . . . . . . . -74.89 137.56 41.82 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.485 -0.325 . . . . 63.100000000000001 111.595 179.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 160.71 -179.7 36.02 Favored Glycine 0 CA--C 1.523 0.567 0 C-N-CA 120.973 -0.632 . . . . 55.240000000000002 113.242 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 716' ' ' THR . . . . . . . . . . . . . 84.3 m -103.36 130.75 50.74 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.097 0.475 . . . . 75.150000000000006 111.619 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 717' ' ' TYR . . . . . 0.489 ' HB2' HG23 ' A' ' 709' ' ' VAL . 18.5 m-85 -129.12 125.1 36.38 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 116.061 -0.518 . . . . 71.420000000000002 110.154 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 718' ' ' VAL . . . . . . . . . . . . . 61.8 t -102.41 121.8 53.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-O 121.126 0.489 . . . . 72.510000000000005 112.189 -176.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 719' ' ' LEU . . . . . 0.488 HD22 HG22 ' A' ' 709' ' ' VAL . 95.4 mt -99.94 144.45 28.98 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.454 -0.339 . . . . 64.450000000000003 111.534 178.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 720' ' ' THR . . . . . 0.464 ' HB ' ' HB3' ' A' ' 706' ' ' ASP . 64.2 m -113.48 134.33 54.73 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.832 0.349 . . . . 71.140000000000001 111.164 178.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 721' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -125.32 114.36 18.81 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.563 -0.29 . . . . 74.230000000000004 110.89 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 60.6 m -121.54 127.1 50.62 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 120.637 0.256 . . . . 73.140000000000001 111.372 -179.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 11.1 p -129.44 137.55 56.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-O 121.047 0.451 . . . . 75.420000000000002 111.625 -179.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 23.7 m -119.92 134.87 55.1 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.049 0.452 . . . . 74.019999999999996 112.071 -177.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -82.8 149.11 27.39 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 115.956 -0.565 . . . . 72.219999999999999 110.028 173.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 726' ' ' SER . . . . . . . . . . . . . 38.3 t -66.84 -20.39 65.92 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.058 0.456 . . . . 64.140000000000001 110.915 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 727' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -81.9 -4.03 55.6 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 115.893 -0.594 . . . . 75.409999999999997 111.971 178.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 728' ' ' GLY . . . . . . . . . . . . . . . 108.2 -5.68 34.01 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 115.023 0.769 . . . . 43.240000000000002 115.023 173.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 36.1 m80 -84.28 122.61 29.14 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 117.848 0.824 . . . . 64.340000000000003 111.402 178.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 730' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -121.52 132.43 54.7 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 120.868 0.365 . . . . 71.109999999999999 111.707 -178.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 27.4 m -131.15 149.9 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-O 120.82 0.343 . . . . 72.219999999999999 111.374 177.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 7.2 t -144.36 147.64 33.69 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 121.088 0.47 . . . . 73.140000000000001 112.264 -178.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -148.99 161.38 42.03 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 116.083 -0.508 . . . . 53.329999999999998 110.927 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 734' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -121.95 160.29 25.16 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 112.567 0.58 . . . . 74.140000000000001 112.567 -178.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 735' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -129.37 122.13 28.83 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.554 -0.748 . . . . 71.340000000000003 110.464 179.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 736' ' ' THR . . . . . . . . . . . . . 20.9 m -94.11 103.4 15.46 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.629 0.252 . . . . 74.549999999999997 111.262 -179.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 43.2 t -96.85 133.49 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-O 120.724 0.297 . . . . 72.019999999999996 111.316 -179.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 738' ' ' THR . . . . . . . . . . . . . 93.8 m -121.29 112.38 18.53 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.05 0.452 . . . . 72.219999999999999 110.875 177.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 739' ' ' VAL . . . . . . . . . . . . . 54.4 t -93.16 133.58 33.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-N 116.167 -0.469 . . . . 53.25 110.941 178.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 740' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -127.74 162.16 27.25 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 120.844 0.354 . . . . 75.510000000000005 111.62 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 741' ' ' VAL . . . . . . . . . . . . . 5.7 t . . . . . 0 CA--C 1.541 0.601 0 CA-C-O 120.974 0.416 . . . . 72.400000000000006 111.245 -176.42 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 664' ' ' ASP . . . . . . . . . . . . . 7.1 t70 . . . . . 0 N--CA 1.468 0.459 0 CA-C-O 120.85 0.357 . . . . 70.140000000000001 110.788 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 665' ' ' LEU . . . . . 0.493 HD13 ' HD3' ' A' ' 694' ' ' LYS . 78.3 mt -95.4 137.69 34.11 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 121.097 0.475 . . . . 73.420000000000002 110.673 174.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 666' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -70.52 152.95 95.3 Favored Pre-proline 0 CA--C 1.541 0.631 0 CA-C-N 115.941 -0.572 . . . . 71.209999999999994 111.887 -177.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 667' ' ' PRO . . . . . 0.514 ' HD3' ' HB2' ' A' ' 725' ' ' ASP . 52.5 Cg_endo -67.3 138.81 47.9 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.843 2.362 . . . . 75.109999999999999 114.428 -170.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 668' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -83.27 102.18 11.78 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.678 -0.692 . . . . 73.420000000000002 110.269 175.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 669' ' ' LEU . . . . . 0.507 ' HG ' HG21 ' A' ' 671' ' ' VAL . 65.3 tp -89.14 114.05 25.29 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.371 -0.377 . . . . 74.019999999999996 111.069 -177.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 670' ' ' THR . . . . . . . . . . . . . 41.5 m -89.57 110.47 21.32 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.859 0.362 . . . . 73.230000000000004 110.931 -179.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 671' ' ' VAL . . . . . 0.507 HG21 ' HG ' ' A' ' 669' ' ' LEU . 96.4 t -135.89 123.97 15.2 Favored Pre-proline 0 N--CA 1.468 0.455 0 CA-C-N 116.379 -0.373 . . . . 71.239999999999995 110.968 -178.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 672' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -70.75 137.43 32.57 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 122.172 1.915 . . . . 75.349999999999994 112.223 178.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 673' ' ' VAL . . . . . . . . . . . . . 12.2 p -64.31 -36.72 77.97 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 N-CA-C 112.012 0.375 . . . . 75.299999999999997 112.012 -177.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 674' ' ' GLY . . . . . . . . . . . . . . . -154.83 154.86 25.82 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 121.025 -0.607 . . . . 74.030000000000001 113.435 -178.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 675' ' ' ALA . . . . . . . . . . . . . . . -150.63 143.61 24.71 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 122.669 0.387 . . . . 71.420000000000002 110.839 178.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 676' ' ' THR . . . . . . . . . . . . . 90.3 m -119.46 121.33 39.22 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 120.936 0.398 . . . . 72.5 111.833 -178.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 677' ' ' ILE . . . . . . . . . . . . . 33.9 pt -126.68 176.98 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-N 116.209 -0.451 . . . . 72.439999999999998 110.457 175.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 678' ' ' HIS . . . . . 0.485 ' HA ' ' O ' ' A' ' 740' ' ' LYS . 46.7 m80 -123.09 159.38 28.63 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 112.583 0.586 . . . . 73.209999999999994 112.583 -177.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 679' ' ' VAL . . . . . . . . . . . . . 84.2 t -59.6 112.15 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-N 115.814 -0.63 . . . . 74.140000000000001 110.556 172.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 115.12 -20.22 14.43 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 121.423 -0.417 . . . . 60.25 112.708 -174.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 681' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -78.01 -165.09 0.6 Allowed 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 121.227 0.537 . . . . 64.310000000000002 111.433 178.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 682' ' ' SER . . . . . . . . . . . . . 21.4 p -142.75 155.54 44.87 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.966 0.412 . . . . 71.239999999999995 111.557 179.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 683' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -143.4 135.86 27.22 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.383 -0.371 . . . . 74.120000000000005 110.577 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 684' ' ' VAL . . . . . . . . . . . . . 25.1 t -124.75 95.64 42.14 Favored Pre-proline 0 CA--C 1.544 0.737 0 CA-C-O 120.931 0.396 . . . . 73.400000000000006 111.848 -175.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -62.87 -31.1 77.86 Favored 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 122.687 2.258 . . . . 75.019999999999996 113.719 -177.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 686' ' ' MET . . . . . 0.5 ' HE1' ' HB ' ' A' ' 703' ' ' ILE . 1.7 mmt -81.51 0.36 38.37 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.32 0.489 . . . . 74.230000000000004 112.32 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 687' ' ' ALA . . . . . . . . . . . . . . . -120.55 -42.62 2.53 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 120.863 0.363 . . . . 74.299999999999997 111.972 179.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 688' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -79.88 2.7 22.29 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-O 120.954 0.407 . . . . 75.120000000000005 111.871 -179.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 689' ' ' VAL . . . . . 0.412 HG23 ' CZ ' ' A' ' 721' ' ' TYR . 64.7 t -124.53 151.97 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 122.996 0.519 . . . . 75.530000000000001 110.415 175.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 690' ' ' LEU . . . . . 0.614 HD23 HG12 ' A' ' 692' ' ' ILE . 8.8 tt -145.12 152.31 39.85 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 120.567 0.222 . . . . 75.409999999999997 111.427 -174.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 691' ' ' ALA . . . . . . . . . . . . . . . -146.43 126.64 13.86 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 122.341 -0.224 . . . . 52.32 111.502 177.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 692' ' ' ILE . . . . . 0.614 HG12 HD23 ' A' ' 690' ' ' LEU . 41.1 mm -129.66 132.72 65.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 CA-C-O 121.207 0.527 . . . . 70.420000000000002 112.317 -178.109 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 693' ' ' ASP . . . . . 0.471 ' HB2' HD11 ' A' ' 699' ' ' LEU . 25.6 t70 -114.72 145.23 42.3 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.031 -0.532 . . . . 73.430000000000007 109.832 172.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 694' ' ' LYS . . . . . 0.493 ' HD3' HD13 ' A' ' 665' ' ' LEU . 50.8 mtpt -71.1 -39.19 72.24 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.814 0.34 . . . . 73.129999999999995 111.854 -177.342 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 35.2 mp0 -83.15 -54.02 5.35 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 112.054 0.39 . . . . 65.400000000000006 112.054 -175.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 696' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -76.35 -48.74 18.89 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 122.149 -0.345 . . . . 73.439999999999998 111.598 -177.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . 124.2 -131.56 7.98 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 121.279 -0.486 . . . . 75.450000000000003 113.052 -179.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -75.63 119.67 19.99 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 122.442 -0.446 . . . . 61.509999999999998 111.273 -179.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 699' ' ' LEU . . . . . 0.543 HD22 ' HD2' ' A' ' 702' ' ' LYS . 35.5 mt -111.44 11.21 21.44 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.397 -0.365 . . . . 74.329999999999998 111.3 178.318 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 33.8 m -59.74 -36.07 75.86 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.302 0.572 . . . . 75.430000000000007 111.551 -177.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 701' ' ' SER . . . . . . . . . . . . . 49.4 m -76.22 -14.49 60.14 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 116.282 -0.417 . . . . 72.340000000000003 111.85 177.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 702' ' ' LYS . . . . . 0.543 ' HD2' HD22 ' A' ' 699' ' ' LEU . 96.5 mttt -97.67 11.59 36.55 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.177 0.436 . . . . 74.109999999999999 112.177 -177.216 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 703' ' ' ILE . . . . . 0.5 ' HB ' ' HE1' ' A' ' 686' ' ' MET . 67.7 mt -83.76 118.76 31.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-O 120.873 0.368 . . . . 75.049999999999997 111.766 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 704' ' ' LYS . . . . . . . . . . . . . 4.9 tppp? -84.99 125.89 33.08 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 110.168 -0.308 . . . . 72.299999999999997 110.168 174.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 49.0 t -105.88 117.39 51.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 CA-C-O 121.004 0.43 . . . . 62.340000000000003 112.013 -176.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 706' ' ' ASP . . . . . 0.57 ' HB3' ' HB ' ' A' ' 720' ' ' THR . 12.8 t70 -100.32 141.2 33.5 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.294 -0.412 . . . . 73.239999999999995 111.03 175.183 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 102.35 177.74 27.46 Favored Glycine 0 CA--C 1.523 0.54 0 C-N-CA 121.201 -0.523 . . . . 72.439999999999998 112.97 -179.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 708' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -152.48 130.48 11.82 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 120.863 0.363 . . . . 74.439999999999998 111.491 -177.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 709' ' ' VAL . . . . . 0.521 HG22 ' HB2' ' A' ' 717' ' ' TYR . 96.3 t -107.93 114.6 46.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 116.494 -0.321 . . . . 64.030000000000001 110.655 176.483 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 710' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -95.39 143.65 26.56 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 120.905 0.383 . . . . 65.040000000000006 111.039 177.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 711' ' ' THR . . . . . . . . . . . . . 75.6 p -108.08 6.54 27.04 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.666 0.617 . . . . 75.140000000000001 112.666 -176.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 712' ' ' THR . . . . . . . . . . . . . 64.1 p -101.37 -24.24 14.23 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 121.157 0.503 . . . . 73.420000000000002 111.145 175.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 713' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -116.17 122.42 44.99 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 116.294 -0.412 . . . . 73.319999999999993 110.95 178.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 714' ' ' ALA . . . . . . . . . . . . . . . -69.42 143.99 53.47 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 120.982 0.42 . . . . 74.409999999999997 111.796 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 155.77 168.92 19.48 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-N 116.255 -0.43 . . . . 74.200000000000003 112.826 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 716' ' ' THR . . . . . . . . . . . . . 99.2 m -97.71 123.07 41.48 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 122.51 -0.406 . . . . 73.420000000000002 111.812 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 717' ' ' TYR . . . . . 0.521 ' HB2' HG22 ' A' ' 709' ' ' VAL . 40.7 m-85 -115.83 125.9 53.29 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 116.2 -0.455 . . . . 75.209999999999994 110.78 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 718' ' ' VAL . . . . . . . . . . . . . 56.1 t -96.25 118.55 42.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 120.901 0.381 . . . . 74.129999999999995 111.452 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 719' ' ' LEU . . . . . . . . . . . . . 76.6 mt -103.12 135.31 45.02 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.78 0.324 . . . . 72.010000000000005 111.611 -179.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 720' ' ' THR . . . . . 0.57 ' HB ' ' HB3' ' A' ' 706' ' ' ASP . 32.9 m -103.27 131.98 49.89 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 120.943 0.401 . . . . 74.439999999999998 110.895 176.545 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 721' ' ' TYR . . . . . 0.412 ' CZ ' HG23 ' A' ' 689' ' ' VAL . 77.8 m-85 -118.34 117.73 29.88 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.471 -0.331 . . . . 75.319999999999993 110.926 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 87.3 m -120.72 126.83 51.17 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.626 -0.261 . . . . 75.530000000000001 111.263 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 13.1 p -125.23 142.18 42.87 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-O 120.869 0.366 . . . . 75.549999999999997 111.878 -177.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 26.7 m -110.23 133.6 53.07 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.144 0.497 . . . . 73.420000000000002 112.181 -176.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 725' ' ' ASP . . . . . 0.514 ' HB2' ' HD3' ' A' ' 667' ' ' PRO . 14.0 t0 -91.59 151.57 20.66 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 115.912 -0.586 . . . . 72.0 111.049 178.08 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 726' ' ' SER . . . . . . . . . . . . . 38.6 t -59.46 -29.7 68.0 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.403 0.52 . . . . 71.140000000000001 112.403 -175.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 727' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -91.63 7.35 41.96 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 112.313 0.486 . . . . 75.25 112.313 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 728' ' ' GLY . . . . . . . . . . . . . . . 100.2 8.37 50.47 Favored Glycine 0 CA--C 1.534 1.237 0 N-CA-C 115.294 0.878 . . . . 72.319999999999993 115.294 173.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 37.6 m80 -86.67 115.11 23.91 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 117.865 0.833 . . . . 74.310000000000002 111.094 177.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 730' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -120.25 117.09 26.92 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 122.133 -0.355 . . . . 75.030000000000001 111.717 -177.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 35.7 m -117.83 157.76 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-O 120.727 0.299 . . . . 65.25 111.762 -177.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 8.6 t -142.56 144.37 32.86 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.682 0.623 . . . . 72.510000000000005 112.682 -177.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -146.68 159.45 43.46 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.024 -0.534 . . . . 73.010000000000005 111.059 178.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 734' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -118.1 155.54 30.21 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 113.009 0.744 . . . . 71.5 113.009 -176.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 735' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -129.79 135.48 48.47 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 115.703 -0.681 . . . . 73.519999999999996 110.558 177.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 736' ' ' THR . . . . . . . . . . . . . 90.1 m -95.15 104.35 16.23 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 120.675 0.274 . . . . 73.109999999999999 111.39 178.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 46.5 t -100.07 104.5 16.21 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 CA-C-O 120.772 0.32 . . . . 73.540000000000006 111.295 179.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 738' ' ' THR . . . . . . . . . . . . . 44.6 m -94.54 117.4 30.06 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.119 0.485 . . . . 72.219999999999999 111.471 179.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 739' ' ' VAL . . . . . . . . . . . . . 43.6 t -98.28 117.95 44.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-O 121.113 0.482 . . . . 74.219999999999999 111.584 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 740' ' ' LYS . . . . . 0.485 ' O ' ' HA ' ' A' ' 678' ' ' HIS . 96.1 mttt -102.93 176.05 5.28 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.265 -0.425 . . . . 73.140000000000001 110.492 174.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 741' ' ' VAL . . . . . . . . . . . . . 36.3 t . . . . . 0 N--CA 1.471 0.58 0 O-C-N 121.881 -0.512 . . . . 70.209999999999994 111.734 -178.359 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 664' ' ' ASP . . . . . . . . . . . . . 5.5 t70 . . . . . 0 CA--C 1.538 0.509 0 CA-C-O 120.895 0.378 . . . . 75.530000000000001 110.847 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 665' ' ' LEU . . . . . . . . . . . . . 76.6 mt -80.82 119.76 23.8 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.404 -0.362 . . . . 71.439999999999998 110.644 177.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 666' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -56.69 144.22 66.15 Favored Pre-proline 0 CA--C 1.537 0.472 0 C-N-CA 121.131 -0.228 . . . . 64.329999999999998 110.483 177.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 667' ' ' PRO . . . . . 0.527 ' HD3' ' HB2' ' A' ' 725' ' ' ASP . 18.8 Cg_endo -56.5 133.92 61.07 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.725 2.284 . . . . 73.109999999999999 112.736 -174.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 668' ' ' LYS . . . . . . . . . . . . . 52.2 tptt -82.71 110.66 17.96 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 120.942 0.401 . . . . 72.420000000000002 110.343 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 669' ' ' LEU . . . . . 0.507 ' HG ' HG21 ' A' ' 671' ' ' VAL . 55.8 tp -98.06 112.58 24.48 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 116.067 -0.515 . . . . 71.540000000000006 111.271 -177.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 670' ' ' THR . . . . . . . . . . . . . 85.8 m -87.75 110.62 20.6 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 120.856 0.36 . . . . 73.120000000000005 111.121 177.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 671' ' ' VAL . . . . . 0.507 HG21 ' HG ' ' A' ' 669' ' ' LEU . 81.0 t -136.34 129.68 17.85 Favored Pre-proline 0 N--CA 1.47 0.575 0 CA-C-N 116.211 -0.45 . . . . 71.549999999999997 110.803 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 672' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -77.9 141.48 19.11 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 122.193 1.929 . . . . 73.409999999999997 112.791 179.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 673' ' ' VAL . . . . . . . . . . . . . 10.6 p -66.27 -35.03 73.99 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 N-CA-C 112.007 0.373 . . . . 75.230000000000004 112.007 -177.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 674' ' ' GLY . . . . . . . . . . . . . . . -146.22 161.19 28.3 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 120.879 -0.676 . . . . 60.219999999999999 113.565 -177.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 675' ' ' ALA . . . . . . . . . . . . . . . -150.5 154.85 38.38 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 122.608 0.363 . . . . 74.450000000000003 110.928 -179.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 676' ' ' THR . . . . . . . . . . . . . 91.8 m -139.04 119.56 13.93 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 120.964 0.411 . . . . 74.230000000000004 111.791 178.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 677' ' ' ILE . . . . . . . . . . . . . 28.7 pt -131.28 175.22 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-N 116.459 -0.337 . . . . 74.400000000000006 110.678 176.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 678' ' ' HIS . . . . . 0.407 ' HA ' ' O ' ' A' ' 740' ' ' LYS . 75.5 m80 -119.49 164.79 15.27 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.305 0.574 . . . . 75.129999999999995 111.912 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 679' ' ' VAL . . . . . 0.415 HG21 ' HA ' ' A' ' 741' ' ' VAL . 78.3 t -56.68 137.01 19.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-N 115.891 -0.595 . . . . 73.049999999999997 110.504 172.06 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 93.03 -18.31 56.39 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 121.052 -0.594 . . . . 55.530000000000001 113.406 -179.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 681' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -79.52 -172.47 3.27 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 121.12 0.486 . . . . 61.32 111.548 178.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 682' ' ' SER . . . . . . . . . . . . . 69.0 m -141.77 145.72 35.1 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 116.435 -0.348 . . . . 74.200000000000003 111.06 177.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 683' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -118.7 134.18 55.32 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 116.453 -0.34 . . . . 74.450000000000003 110.46 178.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 684' ' ' VAL . . . . . . . . . . . . . 53.7 t -122.17 93.09 48.75 Favored Pre-proline 0 CA--C 1.54 0.573 0 CA-C-O 120.962 0.41 . . . . 71.450000000000003 111.429 -177.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -61.69 -27.76 81.52 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 122.83 2.353 . . . . 61.140000000000001 113.347 -177.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 686' ' ' MET . . . . . 0.527 ' HE1' ' HA ' ' A' ' 686' ' ' MET . 1.9 mmt -78.91 -12.14 60.02 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 112.313 0.486 . . . . 73.329999999999998 112.313 -178.137 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 687' ' ' ALA . . . . . . . . . . . . . . . -109.02 -36.34 6.1 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.915 0.388 . . . . 52.409999999999997 111.539 178.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 688' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -85.92 -1.08 56.95 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 116.295 -0.411 . . . . 74.430000000000007 112.05 -178.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 689' ' ' VAL . . . . . 0.424 HG22 ' CZ ' ' A' ' 721' ' ' TYR . 74.5 t -125.57 150.81 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 122.59 0.356 . . . . 75.219999999999999 110.577 174.227 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 690' ' ' LEU . . . . . 0.464 HD22 HG12 ' A' ' 692' ' ' ILE . 9.6 tt -143.3 150.03 38.65 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-O 120.592 0.234 . . . . 74.349999999999994 111.537 -173.4 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 691' ' ' ALA . . . . . . . . . . . . . . . -147.3 125.35 12.08 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 112.19 0.441 . . . . 73.109999999999999 112.19 179.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 692' ' ' ILE . . . . . 0.509 HD11 ' HA ' ' A' ' 698' ' ' ASP . 43.6 mm -129.68 141.52 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 N-CA-C 111.803 0.297 . . . . 75.329999999999998 111.803 -178.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 693' ' ' ASP . . . . . 0.473 ' OD1' ' HG2' ' A' ' 695' ' ' GLU . 12.5 t70 -125.95 143.97 50.88 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 110.138 -0.319 . . . . 65.140000000000001 110.138 173.015 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 28.6 ttpp -64.79 -34.05 77.42 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 112.5 0.556 . . . . 71.319999999999993 112.5 -175.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 695' ' ' GLU . . . . . 0.473 ' HG2' ' OD1' ' A' ' 693' ' ' ASP . 9.5 pt-20 -81.89 -43.42 18.19 Favored 'General case' 0 N--CA 1.473 0.694 0 O-C-N 122.02 -0.425 . . . . 72.329999999999998 111.976 -175.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 696' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -94.85 -42.44 8.7 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 120.883 0.373 . . . . 73.349999999999994 111.773 -172.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . 118.57 -115.68 3.18 Favored Glycine 0 CA--C 1.523 0.569 0 C-N-CA 121.14 -0.552 . . . . 64.019999999999996 112.291 -177.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 698' ' ' ASP . . . . . 0.509 ' HA ' HD11 ' A' ' 692' ' ' ILE . 16.1 t70 -88.62 119.98 29.59 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 122.195 -0.591 . . . . 71.099999999999994 111.247 178.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 699' ' ' LEU . . . . . 0.456 HD13 ' HB3' ' A' ' 667' ' ' PRO . 51.0 mt -111.97 18.45 18.79 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 116.364 -0.38 . . . . 74.430000000000007 111.603 177.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 37.1 m -58.36 -30.65 66.92 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.009 0.433 . . . . 74.439999999999998 111.105 178.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 701' ' ' SER . . . . . . . . . . . . . 29.7 t -68.15 -24.48 64.99 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 120.868 0.366 . . . . 74.420000000000002 111.971 175.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 702' ' ' LYS . . . . . 0.458 ' HB2' HG21 ' A' ' 723' ' ' VAL . 73.4 mmtt -77.4 -19.84 55.55 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 111.895 0.331 . . . . 75.25 111.895 -178.34 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 703' ' ' ILE . . . . . 0.44 ' HB ' ' HE2' ' A' ' 686' ' ' MET . 63.9 mt -60.74 112.76 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 N-CA-C 112.515 0.561 . . . . 75.219999999999999 112.515 -174.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 704' ' ' LYS . . . . . . . . . . . . . 8.1 tmtm? -87.04 120.08 27.93 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.017 -0.538 . . . . 70.230000000000004 109.729 172.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 50.3 t -95.71 118.06 41.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-O 121.113 0.482 . . . . 73.109999999999999 111.063 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 706' ' ' ASP . . . . . 0.521 ' HB3' ' HB ' ' A' ' 720' ' ' THR . 11.7 t70 -108.11 118.44 36.76 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.413 -0.358 . . . . 71.340000000000003 110.249 176.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 113.42 167.82 16.7 Favored Glycine 0 CA--C 1.524 0.643 0 C-N-CA 121.344 -0.455 . . . . 71.319999999999993 112.392 -176.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 708' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -155.04 138.56 15.96 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 122.316 -0.52 . . . . 71.409999999999997 111.843 -177.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 709' ' ' VAL . . . . . . . . . . . . . 72.5 t -99.59 127.87 51.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-N 116.341 -0.39 . . . . 62.140000000000001 111.352 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 710' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -96.15 137.09 35.72 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 120.732 0.301 . . . . 74.439999999999998 110.578 175.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 711' ' ' THR . . . . . . . . . . . . . 82.5 p -110.43 23.7 13.92 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 112.416 0.525 . . . . 75.040000000000006 112.416 -177.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 712' ' ' THR . . . . . . . . . . . . . 48.8 p -113.03 -26.46 8.47 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 121.015 0.436 . . . . 73.209999999999994 110.746 173.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 713' ' ' LYS . . . . . 0.571 ' HZ1' ' HB2' ' A' ' 713' ' ' LYS . 0.1 OUTLIER -116.72 130.96 57.04 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.001 -0.545 . . . . 73.519999999999996 110.53 175.318 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 714' ' ' ALA . . . . . . . . . . . . . . . -80.9 134.88 35.82 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.067 0.46 . . . . 71.420000000000002 112.182 -178.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 169.32 171.67 35.22 Favored Glycine 0 CA--C 1.523 0.58 0 CA-C-N 116.042 -0.526 . . . . 70.450000000000003 112.582 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 716' ' ' THR . . . . . . . . . . . . . 39.9 m -90.09 123.06 33.63 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.188 0.518 . . . . 74.230000000000004 111.568 177.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 717' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 -114.43 138.23 50.84 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 116.074 -0.512 . . . . 75.0 110.234 177.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 718' ' ' VAL . . . . . . . . . . . . . 62.0 t -103.65 116.62 47.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-O 120.929 0.395 . . . . 74.200000000000003 111.54 -178.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 719' ' ' LEU . . . . . . . . . . . . . 83.0 mt -102.13 129.16 48.4 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 116.348 -0.387 . . . . 75.109999999999999 111.286 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 720' ' ' THR . . . . . 0.521 ' HB ' ' HB3' ' A' ' 706' ' ' ASP . 92.7 m -106.55 134.9 48.98 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.839 0.352 . . . . 75.409999999999997 111.12 178.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 721' ' ' TYR . . . . . 0.448 ' HH ' ' NE2' ' A' ' 735' ' ' GLN . 60.7 m-85 -123.41 120.81 34.07 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.54 -0.3 . . . . 72.129999999999995 110.795 -179.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 56.6 m -123.16 133.42 54.25 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 120.797 0.332 . . . . 60.399999999999999 111.4 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 723' ' ' VAL . . . . . 0.458 HG21 ' HB2' ' A' ' 702' ' ' LYS . 7.5 p -130.93 134.89 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-O 121.154 0.502 . . . . 73.0 111.788 -178.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 34.3 m -109.47 142.95 39.75 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.252 0.549 . . . . 75.239999999999995 111.625 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 725' ' ' ASP . . . . . 0.527 ' HB2' ' HD3' ' A' ' 667' ' ' PRO . 10.3 t70 -102.63 160.29 14.71 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 115.814 -0.63 . . . . 74.439999999999998 111.82 -178.444 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 726' ' ' SER . . . . . . . . . . . . . 48.9 m -61.52 -33.5 73.92 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.637 0.606 . . . . 73.109999999999999 112.637 -177.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 727' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -82.01 4.96 20.83 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 120.751 0.31 . . . . 74.030000000000001 111.447 177.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 728' ' ' GLY . . . . . . . . . . . . . . . 91.07 15.01 56.89 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 121.35 -0.452 . . . . 73.109999999999999 114.03 177.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 36.3 m80 -88.49 121.33 30.75 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 117.235 0.517 . . . . 74.340000000000003 111.111 178.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 730' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -124.78 122.29 37.01 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.792 0.33 . . . . 74.140000000000001 111.873 -176.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 31.9 m -121.94 159.3 24.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 116.423 -0.353 . . . . 63.329999999999998 111.029 177.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 10.3 t -143.33 154.82 44.15 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.839 0.352 . . . . 73.219999999999999 111.801 -178.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -148.5 161.35 41.81 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 122.631 0.372 . . . . 73.140000000000001 111.211 179.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 734' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -125.66 154.56 42.17 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 121.057 0.455 . . . . 72.420000000000002 112.108 -177.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 735' ' ' GLN . . . . . 0.448 ' NE2' ' HH ' ' A' ' 721' ' ' TYR . 6.8 tt0 -130.8 137.96 49.67 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.991 -0.549 . . . . 63.409999999999997 111.299 179.432 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 736' ' ' THR . . . . . . . . . . . . . 89.5 m -97.19 103.82 15.78 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.534 -0.303 . . . . 71.409999999999997 111.151 176.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 45.6 t -101.48 105.16 17.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-O 120.841 0.353 . . . . 74.329999999999998 111.649 -179.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 738' ' ' THR . . . . . . . . . . . . . 65.8 m -95.95 118.21 32.14 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.911 0.386 . . . . 61.130000000000003 111.493 179.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 739' ' ' VAL . . . . . . . . . . . . . 41.0 t -97.89 139.4 20.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-N 116.393 -0.367 . . . . 74.219999999999999 111.496 178.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 740' ' ' LYS . . . . . 0.407 ' O ' ' HA ' ' A' ' 678' ' ' HIS . 97.4 mttt -122.17 155.84 34.95 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 120.841 0.353 . . . . 71.230000000000004 110.711 176.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 741' ' ' VAL . . . . . 0.415 ' HA ' HG21 ' A' ' 679' ' ' VAL . 40.9 t . . . . . 0 N--CA 1.47 0.542 0 CA-C-O 121.04 0.448 . . . . 61.539999999999999 112.152 -175.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 664' ' ' ASP . . . . . . . . . . . . . 14.4 t70 . . . . . 0 N--CA 1.471 0.586 0 CA-C-O 120.871 0.367 . . . . 73.519999999999996 111.134 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 665' ' ' LEU . . . . . 0.421 HD13 ' HD3' ' A' ' 694' ' ' LYS . 89.4 mt -90.55 136.62 32.94 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 116.305 -0.407 . . . . 75.140000000000001 110.505 174.237 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 666' ' ' GLU . . . . . 0.473 ' HB3' ' HB3' ' A' ' 729' ' ' HIS . 2.3 pm0 -65.5 140.63 97.67 Favored Pre-proline 0 CA--C 1.543 0.701 0 CA-C-O 120.921 0.391 . . . . 73.400000000000006 111.543 177.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 667' ' ' PRO . . . . . 0.567 ' HD3' ' HB2' ' A' ' 725' ' ' ASP . 12.8 Cg_endo -55.36 145.85 65.16 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 123.378 2.719 . . . . 75.400000000000006 114.745 -169.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 668' ' ' LYS . . . . . . . . . . . . . 7.4 tmtm? -85.06 104.14 14.71 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.287 -0.87 . . . . 73.329999999999998 110.404 177.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 669' ' ' LEU . . . . . . . . . . . . . 57.5 tp -100.05 111.72 24.02 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 116.119 -0.491 . . . . 74.230000000000004 111.564 -177.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 670' ' ' THR . . . . . . . . . . . . . 86.2 m -89.11 111.53 22.31 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.9 0.381 . . . . 64.540000000000006 111.502 178.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 671' ' ' VAL . . . . . . . . . . . . . 90.6 t -134.0 129.16 19.95 Favored Pre-proline 0 N--CA 1.47 0.529 0 CA-C-N 116.194 -0.457 . . . . 72.519999999999996 110.807 176.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 672' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -74.29 128.88 12.45 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 122.161 1.907 . . . . 73.340000000000003 112.084 176.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 673' ' ' VAL . . . . . . . . . . . . . 9.6 p -64.6 -19.27 24.9 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 N-CA-C 112.423 0.527 . . . . 75.019999999999996 112.423 -175.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 674' ' ' GLY . . . . . . . . . . . . . . . -156.8 155.59 26.48 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 120.809 -0.71 . . . . 44.030000000000001 113.501 -179.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 675' ' ' ALA . . . . . 0.462 ' HB1' HG23 ' A' ' 737' ' ' VAL . . . -151.1 145.66 25.62 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 120.691 0.281 . . . . 74.519999999999996 111.148 178.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 676' ' ' THR . . . . . . . . . . . . . 88.9 m -120.65 124.79 46.09 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.031 0.443 . . . . 73.230000000000004 112.096 -179.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 677' ' ' ILE . . . . . . . . . . . . . 28.8 pt -135.4 177.24 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 CA-C-N 116.244 -0.435 . . . . 72.430000000000007 111.029 176.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 678' ' ' HIS . . . . . . . . . . . . . 65.8 m80 -124.46 168.07 13.56 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.295 0.569 . . . . 72.129999999999995 112.188 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 679' ' ' VAL . . . . . . . . . . . . . 85.5 t -63.31 111.55 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-N 115.777 -0.647 . . . . 65.310000000000002 109.871 170.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 107.59 -4.33 34.69 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 121.297 -0.478 . . . . 64.230000000000004 113.29 -175.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 681' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -86.18 170.93 11.7 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 121.223 0.535 . . . . 74.129999999999995 111.508 176.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 682' ' ' SER . . . . . . . . . . . . . 77.3 p -114.58 153.21 30.5 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 116.349 -0.387 . . . . 73.319999999999993 111.121 178.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 683' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -159.19 114.06 2.45 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 120.745 0.307 . . . . 74.340000000000003 111.453 -178.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 684' ' ' VAL . . . . . 0.428 ' HA ' ' HD2' ' A' ' 685' ' ' PRO . 84.0 t -105.47 103.98 45.72 Favored Pre-proline 0 CA--C 1.543 0.677 0 CA-C-N 116.551 -0.295 . . . . 72.010000000000005 110.982 176.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 685' ' ' PRO . . . . . 0.428 ' HD2' ' HA ' ' A' ' 684' ' ' VAL . 14.4 Cg_endo -57.12 -35.55 98.94 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 122.606 2.204 . . . . 74.209999999999994 113.484 -179.059 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 686' ' ' MET . . . . . 0.469 ' HA ' ' HE1' ' A' ' 686' ' ' MET . 0.6 OUTLIER -78.35 -6.19 54.4 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 112.314 0.487 . . . . 72.150000000000006 112.314 -179.224 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 687' ' ' ALA . . . . . . . . . . . . . . . -94.51 -27.42 15.98 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 121.039 0.447 . . . . 73.310000000000002 111.259 175.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 688' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -86.08 -9.99 55.73 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 116.158 -0.474 . . . . 75.200000000000003 111.753 -179.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 689' ' ' VAL . . . . . 0.432 HG13 HD13 ' A' ' 703' ' ' ILE . 95.5 t -118.63 133.93 63.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 CA-C-O 120.937 0.398 . . . . 74.400000000000006 111.613 -177.194 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 690' ' ' LEU . . . . . 0.529 HD22 ' N ' ' A' ' 691' ' ' ALA . 4.1 tt -141.73 136.68 31.02 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 116.188 -0.46 . . . . 73.450000000000003 110.138 -177.309 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 691' ' ' ALA . . . . . 0.529 ' N ' HD22 ' A' ' 690' ' ' LEU . . . -122.48 122.09 38.11 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.345 0.498 . . . . 71.299999999999997 112.345 -178.016 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 692' ' ' ILE . . . . . . . . . . . . . 45.0 mm -122.25 124.23 70.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-N 116.183 -0.462 . . . . 73.340000000000003 111.483 178.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -113.6 144.99 41.96 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.726 0.298 . . . . 74.439999999999998 110.294 173.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 694' ' ' LYS . . . . . 0.611 ' HB3' ' HZ3' ' A' ' 694' ' ' LYS . 7.9 mtpm? -71.72 -43.08 66.5 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 112.105 0.409 . . . . 72.450000000000003 112.105 -175.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 44.7 mp0 -83.88 -54.35 4.94 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 121.144 0.497 . . . . 75.409999999999997 112.142 -178.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 696' ' ' ASP . . . . . . . . . . . . . 32.7 t0 -79.38 -28.62 41.92 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 116.083 -0.508 . . . . 51.200000000000003 112.133 -172.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . 105.64 -155.53 16.85 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 121.186 -0.53 . . . . 72.150000000000006 113.595 176.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -68.22 118.19 11.02 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 122.55 -0.383 . . . . 75.209999999999994 110.48 176.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 699' ' ' LEU . . . . . 0.501 HD23 ' HE2' ' A' ' 702' ' ' LYS . 19.9 mt -113.31 19.89 16.63 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.46 -0.336 . . . . 75.200000000000003 111.511 -176.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 77.6 m -56.11 -37.92 70.07 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 112.313 0.486 . . . . 73.310000000000002 112.313 -176.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 701' ' ' SER . . . . . . . . . . . . . 73.3 m -70.83 -19.52 62.65 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 112.063 0.394 . . . . 74.140000000000001 112.063 178.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 702' ' ' LYS . . . . . 0.501 ' HE2' HD23 ' A' ' 699' ' ' LEU . 54.5 mtmt -92.59 11.24 27.2 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.777 0.323 . . . . 71.200000000000003 111.625 178.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 703' ' ' ILE . . . . . 0.519 HG12 ' HB ' ' A' ' 723' ' ' VAL . 54.0 mt -87.49 120.43 36.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 116.712 -0.222 . . . . 74.329999999999998 110.728 174.137 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 704' ' ' LYS . . . . . . . . . . . . . 53.6 tttm -93.11 146.32 23.74 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 120.801 0.334 . . . . 74.420000000000002 110.892 173.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 44.5 t -104.3 146.33 11.83 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-O 120.952 0.406 . . . . 74.430000000000007 110.887 176.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 706' ' ' ASP . . . . . 0.487 ' HB3' ' HB ' ' A' ' 720' ' ' THR . 32.3 t70 -135.01 129.96 34.96 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 120.899 0.38 . . . . 73.239999999999995 110.738 174.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 101.34 175.88 28.76 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 121.439 -0.41 . . . . 71.540000000000006 112.404 -176.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 708' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -151.86 144.7 24.39 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 117.076 0.438 . . . . 71.209999999999994 111.908 -178.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 709' ' ' VAL . . . . . 0.49 HG22 ' HB2' ' A' ' 717' ' ' TYR . 97.1 t -114.07 111.45 36.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-N 116.437 -0.347 . . . . 71.129999999999995 111.305 178.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 710' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -70.01 136.11 50.06 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 120.946 0.403 . . . . 73.349999999999994 111.264 176.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 711' ' ' THR . . . . . . . . . . . . . 70.7 p -106.36 -6.73 18.1 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 112.131 0.419 . . . . 74.340000000000003 112.131 -178.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 712' ' ' THR . . . . . . . . . . . . . 11.7 t -100.25 0.28 39.96 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 111.973 0.36 . . . . 75.439999999999998 111.973 177.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 713' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -144.03 134.06 24.12 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 120.692 0.282 . . . . 74.319999999999993 111.279 -177.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 714' ' ' ALA . . . . . . . . . . . . . . . -76.62 144.55 39.47 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 112.359 0.503 . . . . 72.120000000000005 112.359 -176.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 158.03 168.3 20.15 Favored Glycine 0 CA--C 1.525 0.718 0 CA-C-N 116.025 -0.534 . . . . 74.209999999999994 112.487 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 716' ' ' THR . . . . . . . . . . . . . 91.3 m -96.39 123.48 40.06 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 122.295 -0.532 . . . . 74.420000000000002 111.477 178.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 717' ' ' TYR . . . . . 0.49 ' HB2' HG22 ' A' ' 709' ' ' VAL . 33.3 m-85 -119.52 141.51 49.14 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 116.404 -0.362 . . . . 75.340000000000003 110.755 -178.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 718' ' ' VAL . . . . . . . . . . . . . 72.9 t -113.26 131.35 65.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 CA-C-O 120.893 0.378 . . . . 72.409999999999997 111.383 178.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 719' ' ' LEU . . . . . 0.421 HD23 HG21 ' A' ' 709' ' ' VAL . 69.4 mt -116.4 142.15 47.23 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 116.444 -0.344 . . . . 73.120000000000005 111.433 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 720' ' ' THR . . . . . 0.487 ' HB ' ' HB3' ' A' ' 706' ' ' ASP . 93.2 m -114.89 136.13 53.44 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 120.876 0.37 . . . . 71.349999999999994 111.356 178.035 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 721' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -124.71 135.03 52.68 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 116.346 -0.388 . . . . 73.450000000000003 110.947 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 94.6 m -138.21 134.88 35.02 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 111.813 0.301 . . . . 72.25 111.813 -177.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 723' ' ' VAL . . . . . 0.519 ' HB ' HG12 ' A' ' 703' ' ' ILE . 8.7 p -132.25 146.24 33.39 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 CA-C-O 120.879 0.371 . . . . 75.109999999999999 111.422 179.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 56.5 m -119.6 130.29 55.04 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 112.734 0.642 . . . . 71.439999999999998 112.734 -175.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 725' ' ' ASP . . . . . 0.567 ' HB2' ' HD3' ' A' ' 667' ' ' PRO . 12.0 t70 -76.68 155.58 33.24 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.983 -0.553 . . . . 74.209999999999994 110.516 174.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 726' ' ' SER . . . . . . . . . . . . . 46.4 t -54.51 -33.65 60.29 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 112.407 0.521 . . . . 75.129999999999995 112.407 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 727' ' ' LYS . . . . . . . . . . . . . 46.7 mmtm -75.96 -14.82 60.24 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 112.239 0.459 . . . . 74.200000000000003 112.239 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 728' ' ' GLY . . . . . . . . . . . . . . . 109.94 4.71 29.49 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 121.112 -0.566 . . . . 52.140000000000001 113.625 -177.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 729' ' ' HIS . . . . . 0.473 ' HB3' ' HB3' ' A' ' 666' ' ' GLU . 24.8 m170 -70.67 102.13 2.22 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 117.519 0.659 . . . . 75.219999999999999 111.353 176.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 730' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -98.0 125.26 42.86 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 120.984 0.421 . . . . 74.540000000000006 111.503 179.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 731' ' ' VAL . . . . . 0.431 HG23 ' HG2' ' A' ' 667' ' ' PRO . 30.2 m -126.65 154.18 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-O 120.84 0.352 . . . . 63.240000000000002 111.113 176.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 8.8 t -144.42 147.89 33.93 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 121.386 0.612 . . . . 72.209999999999994 112.431 -173.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -147.49 153.67 39.81 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.862 -0.608 . . . . 63.140000000000001 110.576 177.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 734' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -123.47 152.04 42.09 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 112.625 0.602 . . . . 64.219999999999999 112.625 -173.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 735' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -130.24 128.34 41.43 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 115.798 -0.637 . . . . 75.310000000000002 111.133 -177.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 736' ' ' THR . . . . . . . . . . . . . 93.9 m -100.26 109.64 21.87 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.848 0.356 . . . . 64.120000000000005 111.428 179.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 737' ' ' VAL . . . . . 0.462 HG23 ' HB1' ' A' ' 675' ' ' ALA . 41.0 t -105.33 117.72 51.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-O 120.952 0.406 . . . . 70.439999999999998 111.554 -178.111 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 738' ' ' THR . . . . . . . . . . . . . 91.8 m -102.23 131.1 49.0 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 120.906 0.384 . . . . 74.310000000000002 111.545 178.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 739' ' ' VAL . . . . . . . . . . . . . 43.1 t -104.45 131.12 54.13 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-N 116.348 -0.387 . . . . 70.340000000000003 111.535 179.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 740' ' ' LYS . . . . . 0.641 ' HZ2' ' HB3' ' A' ' 740' ' ' LYS . 7.7 mtpm? -116.08 155.77 27.56 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 120.902 0.382 . . . . 73.329999999999998 111.305 177.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 741' ' ' VAL . . . . . . . . . . . . . 43.9 t . . . . . 0 N--CA 1.47 0.573 0 N-CA-C 112.093 0.405 . . . . 74.400000000000006 112.093 -177.418 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 664' ' ' ASP . . . . . 0.51 ' CG ' ' HG3' ' A' ' 727' ' ' LYS . 12.3 t70 . . . . . 0 CA--C 1.539 0.555 0 CA-C-O 120.927 0.394 . . . . 74.420000000000002 111.291 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 665' ' ' LEU . . . . . 0.497 HD11 ' HD2' ' A' ' 694' ' ' LYS . 73.2 mt -102.84 137.74 40.65 Favored 'General case' 0 C--O 1.242 0.678 0 N-CA-C 112.268 0.47 . . . . 73.129999999999995 112.268 -176.191 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 666' ' ' GLU . . . . . 0.502 ' HG3' ' HB3' ' A' ' 729' ' ' HIS . 3.5 mp0 -67.58 151.62 97.0 Favored Pre-proline 0 CA--C 1.544 0.719 0 CA-C-N 115.957 -0.565 . . . . 74.230000000000004 111.005 176.513 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 667' ' ' PRO . . . . . 0.609 ' HD3' ' HB2' ' A' ' 725' ' ' ASP . 61.3 Cg_endo -72.7 153.72 54.14 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 122.659 2.239 . . . . 74.129999999999995 113.429 -178.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 668' ' ' LYS . . . . . . . . . . . . . 13.0 tmtt? -92.3 105.15 17.41 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.104 0.478 . . . . 75.409999999999997 110.496 178.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 669' ' ' LEU . . . . . . . . . . . . . 57.9 tp -94.88 120.04 34.44 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 116.173 -0.467 . . . . 73.540000000000006 111.29 -179.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 670' ' ' THR . . . . . . . . . . . . . 90.2 m -102.22 110.79 22.84 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 120.832 0.349 . . . . 75.129999999999995 111.151 -179.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 671' ' ' VAL . . . . . 0.431 HG22 HG13 ' A' ' 689' ' ' VAL . 87.6 t -135.42 126.54 17.3 Favored Pre-proline 0 N--CA 1.472 0.673 0 CA-C-N 116.072 -0.513 . . . . 72.310000000000002 111.065 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 672' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -73.21 145.41 38.91 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 122.241 1.961 . . . . 74.010000000000005 112.19 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 673' ' ' VAL . . . . . . . . . . . . . 13.9 p -65.14 -32.8 59.84 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 N-CA-C 112.098 0.407 . . . . 70.030000000000001 112.098 -178.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 674' ' ' GLY . . . . . . . . . . . . . . . -162.05 147.54 13.87 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 120.77 -0.729 . . . . 45.240000000000002 113.408 -179.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 675' ' ' ALA . . . . . . . . . . . . . . . -136.09 139.62 43.14 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 122.647 0.379 . . . . 61.219999999999999 110.802 179.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 676' ' ' THR . . . . . . . . . . . . . 92.1 m -117.36 124.13 48.16 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.547 0.573 . . . . 73.530000000000001 112.547 -175.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 677' ' ' ILE . . . . . . . . . . . . . 33.7 pt -130.46 177.09 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 CA-C-N 116.292 -0.413 . . . . 75.120000000000005 110.517 175.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 678' ' ' HIS . . . . . . . . . . . . . 76.5 m80 -114.31 168.76 9.57 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 121.232 0.539 . . . . 74.430000000000007 111.787 175.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 679' ' ' VAL . . . . . . . . . . . . . 96.6 t -63.55 117.93 5.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 116.182 -0.463 . . . . 71.329999999999998 110.654 175.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 95.32 8.21 58.86 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 121.419 -0.42 . . . . 64.400000000000006 113.135 -178.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 681' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -94.03 166.1 12.31 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.073 0.463 . . . . 63.109999999999999 111.43 178.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 682' ' ' SER . . . . . . . . . . . . . 47.2 m -93.54 149.42 21.25 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.22 -0.445 . . . . 75.219999999999999 111.421 -179.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 683' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -151.6 116.41 5.18 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.722 0.296 . . . . 72.120000000000005 110.761 178.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 684' ' ' VAL . . . . . . . . . . . . . 28.8 t -117.01 92.57 39.57 Favored Pre-proline 0 CA--C 1.544 0.727 0 CA-C-O 121.126 0.489 . . . . 75.510000000000005 111.522 -178.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -62.27 -31.89 82.07 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 122.606 2.204 . . . . 73.420000000000002 112.963 -177.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 686' ' ' MET . . . . . 0.508 ' HE1' ' HB ' ' A' ' 703' ' ' ILE . 0.7 OUTLIER -78.85 -1.39 34.75 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 112.248 0.462 . . . . 73.120000000000005 112.248 -178.403 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 687' ' ' ALA . . . . . . . . . . . . . . . -104.61 -30.14 10.17 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.088 0.47 . . . . 71.319999999999993 111.31 175.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 688' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -91.19 -28.17 18.02 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 116.343 -0.39 . . . . 74.329999999999998 111.85 -179.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 689' ' ' VAL . . . . . 0.444 HG11 HD13 ' A' ' 703' ' ' ILE . 80.2 t -98.15 124.7 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-O 120.922 0.391 . . . . 72.420000000000002 111.413 178.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 690' ' ' LEU . . . . . 0.426 HD13 ' C ' ' A' ' 689' ' ' VAL . 7.3 mp -126.04 154.46 42.96 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 116.234 -0.439 . . . . 75.239999999999995 111.619 -178.467 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 691' ' ' ALA . . . . . . . . . . . . . . . -137.39 122.26 18.85 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.796 0.331 . . . . 71.140000000000001 111.058 177.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 692' ' ' ILE . . . . . . . . . . . . . 50.2 mm -129.09 117.27 43.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 CA-C-O 120.842 0.353 . . . . 71.150000000000006 111.653 -176.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 693' ' ' ASP . . . . . 0.458 ' HB2' ' HB3' ' A' ' 667' ' ' PRO . 34.4 t70 -95.19 149.66 21.07 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.535 -0.302 . . . . 71.319999999999993 110.481 176.184 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 694' ' ' LYS . . . . . 0.497 ' HD2' HD11 ' A' ' 665' ' ' LEU . 30.9 ttmt -72.41 -43.29 64.09 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 112.837 0.68 . . . . 74.409999999999997 112.837 -171.121 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -84.09 -45.9 12.53 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 121.696 -0.627 . . . . 72.030000000000001 111.278 177.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 696' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -74.43 -48.99 24.21 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 112.206 0.447 . . . . 71.230000000000004 112.206 -175.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . 112.14 -117.79 4.51 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 121.0 -0.619 . . . . 72.450000000000003 112.647 -176.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -78.09 117.52 19.46 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 122.118 -0.636 . . . . 74.349999999999994 111.935 -179.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 699' ' ' LEU . . . . . 0.464 HD13 ' HB3' ' A' ' 667' ' ' PRO . 73.5 mt -117.24 14.05 14.74 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.126 -0.488 . . . . 73.5 110.726 172.246 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 33.5 m -58.66 -34.58 71.39 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.017 0.437 . . . . 71.430000000000007 111.251 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 701' ' ' SER . . . . . . . . . . . . . 80.2 p -70.31 -17.82 63.09 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 116.504 -0.316 . . . . 75.019999999999996 111.757 177.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 702' ' ' LYS . . . . . . . . . . . . . 45.3 mmtm -91.22 3.29 55.21 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 111.814 0.302 . . . . 71.239999999999995 111.814 -178.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 703' ' ' ILE . . . . . 0.508 ' HB ' ' HE1' ' A' ' 686' ' ' MET . 67.3 mt -76.36 125.73 36.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-O 121.195 0.522 . . . . 74.439999999999998 111.754 -179.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 704' ' ' LYS . . . . . . . . . . . . . 58.4 mttp -92.9 123.93 36.52 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.191 -0.459 . . . . 73.019999999999996 110.741 172.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 51.9 t -95.85 106.94 18.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.935 -0.575 . . . . 72.409999999999997 110.808 179.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 706' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -100.04 134.0 43.6 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 120.912 0.387 . . . . 71.319999999999993 111.456 -178.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 118.24 -168.96 13.23 Favored Glycine 0 CA--C 1.525 0.659 0 CA-C-N 116.293 -0.412 . . . . 62.32 112.68 -178.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 708' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -158.05 137.61 11.98 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.967 0.413 . . . . 72.129999999999995 111.72 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 709' ' ' VAL . . . . . 0.422 HG21 ' HB2' ' A' ' 717' ' ' TYR . 62.7 t -126.34 123.11 62.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-N 116.459 -0.337 . . . . 74.319999999999993 111.127 179.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 710' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -93.47 142.22 27.58 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 121.202 0.525 . . . . 71.329999999999998 111.332 177.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 711' ' ' THR . . . . . . . . . . . . . 47.6 p -101.54 -9.44 21.01 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.806 -0.634 . . . . 74.349999999999994 112.278 -178.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 712' ' ' THR . . . . . . . . . . . . . 59.6 p -103.05 -0.09 31.27 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 113.099 0.777 . . . . 74.409999999999997 113.099 -177.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 713' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -144.14 136.57 26.74 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 122.067 -0.396 . . . . 74.439999999999998 111.332 175.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 714' ' ' ALA . . . . . . . . . . . . . . . -70.08 144.48 52.12 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 112.393 0.516 . . . . 74.219999999999999 112.393 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 161.28 166.7 20.52 Favored Glycine 0 CA--C 1.525 0.679 0 CA-C-N 116.108 -0.497 . . . . 74.409999999999997 112.729 -179.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 716' ' ' THR . . . . . . . . . . . . . 53.2 m -101.12 124.52 46.96 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 122.357 -0.496 . . . . 73.519999999999996 111.182 178.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 717' ' ' TYR . . . . . 0.422 ' HB2' HG21 ' A' ' 709' ' ' VAL . 30.2 m-85 -121.75 133.47 54.93 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 116.198 -0.456 . . . . 75.209999999999994 110.762 -177.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 718' ' ' VAL . . . . . . . . . . . . . 58.8 t -94.96 133.06 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-O 120.82 0.343 . . . . 72.129999999999995 111.614 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 719' ' ' LEU . . . . . . . . . . . . . 96.4 mt -119.79 127.66 53.0 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.802 0.334 . . . . 75.340000000000003 111.116 177.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 91.8 m -111.68 120.67 42.83 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 120.752 0.311 . . . . 73.329999999999998 110.912 178.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 721' ' ' TYR . . . . . 0.449 ' HH ' ' NE2' ' A' ' 735' ' ' GLN . 57.1 m-85 -104.78 120.04 40.43 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.591 -0.277 . . . . 74.329999999999998 111.186 -178.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 59.9 m -122.55 123.46 41.29 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 120.674 0.273 . . . . 73.310000000000002 111.168 178.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 10.4 p -119.14 147.18 22.85 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 CA-C-O 121.008 0.432 . . . . 72.340000000000003 111.906 -177.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 76.2 m -110.21 133.57 53.1 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 112.303 0.482 . . . . 74.299999999999997 112.303 -177.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 725' ' ' ASP . . . . . 0.609 ' HB2' ' HD3' ' A' ' 667' ' ' PRO . 50.2 t0 -73.62 154.64 39.67 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 115.888 -0.597 . . . . 62.240000000000002 111.216 176.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 726' ' ' SER . . . . . . . . . . . . . 40.4 t -58.24 -28.58 65.02 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.036 0.446 . . . . 52.25 111.178 176.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 727' ' ' LYS . . . . . 0.51 ' HG3' ' CG ' ' A' ' 664' ' ' ASP . 36.8 mmtm -90.28 -11.01 42.08 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 111.97 0.359 . . . . 75.030000000000001 111.97 177.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 728' ' ' GLY . . . . . . . . . . . . . . . 112.4 -1.23 26.51 Favored Glycine 0 CA--C 1.533 1.171 0 N-CA-C 114.688 0.635 . . . . 71.409999999999997 114.688 179.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 729' ' ' HIS . . . . . 0.511 ' N ' ' HB3' ' A' ' 725' ' ' ASP . 34.7 m80 -68.54 105.21 2.16 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 118.12 0.96 . . . . 74.310000000000002 110.989 176.121 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 730' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -96.32 125.88 41.13 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 120.802 0.334 . . . . 75.430000000000007 110.942 -179.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 35.9 m -127.02 158.11 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-O 120.699 0.285 . . . . 72.420000000000002 111.079 178.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 5.3 t -143.52 149.76 37.95 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 112.755 0.65 . . . . 62.299999999999997 112.755 -174.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -148.37 154.59 40.15 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.771 -0.65 . . . . 73.299999999999997 110.343 176.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 734' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -119.86 154.86 33.71 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 113.159 0.8 . . . . 74.25 113.159 -174.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 735' ' ' GLN . . . . . 0.449 ' NE2' ' HH ' ' A' ' 721' ' ' TYR . 7.0 tt0 -136.67 124.12 22.09 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.5 -0.773 . . . . 62.310000000000002 110.652 177.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 736' ' ' THR . . . . . . . . . . . . . 99.8 m -93.93 105.78 17.78 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.104 0.478 . . . . 75.109999999999999 111.055 176.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 45.6 t -96.77 141.33 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-O 120.709 0.29 . . . . 71.299999999999997 111.59 -176.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 738' ' ' THR . . . . . . . . . . . . . 88.8 m -128.7 122.91 31.79 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.25 0.548 . . . . 71.400000000000006 112.269 -179.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 739' ' ' VAL . . . . . . . . . . . . . 47.2 t -95.57 124.57 48.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-N 115.754 -0.657 . . . . 75.400000000000006 110.788 176.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 740' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -102.95 151.67 22.21 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.417 0.627 . . . . 73.409999999999997 112.079 -176.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 741' ' ' VAL . . . . . . . . . . . . . 93.9 t . . . . . 0 CA--C 1.54 0.561 0 CA-C-N 115.77 -0.65 . . . . 75.010000000000005 112.264 -179.735 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 664' ' ' ASP . . . . . 0.703 ' HB2' ' HE2' ' A' ' 727' ' ' LYS . 16.1 t70 . . . . . 0 CA--C 1.537 0.462 0 CA-C-O 121.123 0.487 . . . . 73.109999999999999 111.818 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 665' ' ' LEU . . . . . . . . . . . . . 70.1 mt -85.39 119.01 25.27 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.135 -0.484 . . . . 72.540000000000006 109.697 173.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 666' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -67.68 145.33 98.09 Favored Pre-proline 0 CA--C 1.54 0.56 0 CA-C-O 120.671 0.272 . . . . 71.349999999999994 111.308 -177.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 667' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -75.8 146.26 29.7 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.405 2.07 . . . . 62.350000000000001 113.193 -173.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 668' ' ' LYS . . . . . . . . . . . . . 4.9 tmtm? -88.28 109.18 19.75 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 109.89 -0.411 . . . . 74.019999999999996 109.89 177.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 669' ' ' LEU . . . . . 0.405 ' HG ' HG22 ' A' ' 671' ' ' VAL . 58.0 tp -93.01 106.16 18.15 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.071 0.463 . . . . 74.129999999999995 110.543 176.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 670' ' ' THR . . . . . . . . . . . . . 86.9 m -86.62 110.7 20.01 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.263 -0.426 . . . . 72.129999999999995 111.391 -178.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 671' ' ' VAL . . . . . 0.405 HG22 ' HG ' ' A' ' 669' ' ' LEU . 95.0 t -137.95 128.34 15.48 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 122.629 0.372 . . . . 75.420000000000002 111.091 -178.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 672' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -77.84 132.28 11.76 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 122.212 1.941 . . . . 74.239999999999995 111.809 177.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 673' ' ' VAL . . . . . . . . . . . . . 14.3 p -64.76 -30.61 50.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 N-CA-C 112.496 0.554 . . . . 62.439999999999998 112.496 -175.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 674' ' ' GLY . . . . . . . . . . . . . . . -151.81 142.6 9.57 Favored Glycine 0 CA--C 1.525 0.666 0 C-N-CA 120.811 -0.709 . . . . 71.25 113.571 -177.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 675' ' ' ALA . . . . . . . . . . . . . . . -140.48 157.69 45.12 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 122.49 0.316 . . . . 70.0 110.922 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 676' ' ' THR . . . . . . . . . . . . . 54.9 m -136.05 128.81 30.96 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.103 0.477 . . . . 73.329999999999998 111.797 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 677' ' ' ILE . . . . . . . . . . . . . 39.8 pt -132.49 177.64 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-N 116.085 -0.507 . . . . 72.030000000000001 110.987 177.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 678' ' ' HIS . . . . . . . . . . . . . 58.4 m80 -122.44 156.75 33.4 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.151 0.501 . . . . 73.340000000000003 112.276 178.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 679' ' ' VAL . . . . . . . . . . . . . 89.4 t -61.5 128.74 23.42 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 115.824 -0.626 . . . . 53.420000000000002 111.39 176.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 99.81 -17.04 57.95 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 121.356 -0.45 . . . . 73.0 113.031 -178.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 681' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -79.08 177.26 8.94 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 121.224 0.535 . . . . 72.099999999999994 112.248 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 682' ' ' SER . . . . . . . . . . . . . 48.5 m -104.46 145.23 30.57 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.913 -0.585 . . . . 52.399999999999999 110.516 176.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 683' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -148.7 113.05 5.27 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.913 0.387 . . . . 75.140000000000001 111.557 179.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 684' ' ' VAL . . . . . . . . . . . . . 63.6 t -111.61 102.33 53.1 Favored Pre-proline 0 CA--C 1.543 0.675 0 CA-C-N 116.257 -0.429 . . . . 70.030000000000001 110.616 176.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -56.91 -42.62 62.52 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 122.731 2.287 . . . . 74.120000000000005 113.658 -177.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 686' ' ' MET . . . . . 0.411 ' HE3' ' HB3' ' A' ' 686' ' ' MET . 15.8 mtp -79.17 -12.29 59.98 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 113.06 0.763 . . . . 73.109999999999999 113.06 -176.132 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 687' ' ' ALA . . . . . . . . . . . . . . . -79.17 -18.47 53.02 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 122.017 -0.427 . . . . 73.340000000000003 111.207 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 688' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -114.34 9.74 16.97 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 112.178 0.436 . . . . 52.509999999999998 112.178 -178.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 689' ' ' VAL . . . . . 0.427 HG21 ' CZ ' ' A' ' 721' ' ' TYR . 86.8 t -123.0 124.72 70.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-O 120.879 0.371 . . . . 73.310000000000002 110.939 178.106 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 690' ' ' LEU . . . . . 0.405 HD13 ' N ' ' A' ' 690' ' ' LEU . 6.4 mp -119.7 157.63 28.14 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.165 0.507 . . . . 72.409999999999997 111.534 -177.176 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 691' ' ' ALA . . . . . . . . . . . . . . . -148.54 123.48 10.01 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.963 -0.562 . . . . 64.530000000000001 110.557 176.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 692' ' ' ILE . . . . . . . . . . . . . 41.5 mm -131.91 131.4 61.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 N-CA-C 112.404 0.52 . . . . 74.209999999999994 112.404 -174.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -115.33 130.94 57.05 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.121 -0.491 . . . . 71.530000000000001 109.741 168.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -61.76 -32.35 72.6 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.113 0.482 . . . . 63.409999999999997 111.403 -177.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -83.72 -54.32 5.0 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 112.504 0.557 . . . . 74.299999999999997 112.504 -176.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 696' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -77.57 -42.98 33.26 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 120.811 0.339 . . . . 70.310000000000002 111.59 -178.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . 121.07 -139.79 13.59 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 121.544 -0.36 . . . . 73.510000000000005 113.001 -178.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -71.73 111.85 7.35 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.052 0.453 . . . . 72.120000000000005 111.102 178.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 699' ' ' LEU . . . . . 0.475 HD21 ' HG3' ' A' ' 702' ' ' LYS . 67.0 mt -100.72 9.12 42.83 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.446 -0.343 . . . . 74.299999999999997 111.319 176.155 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 31.2 m -59.7 -36.88 77.41 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.108 0.48 . . . . 71.010000000000005 111.247 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 701' ' ' SER . . . . . . . . . . . . . 47.1 m -81.99 3.13 27.72 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 116.328 -0.396 . . . . 73.25 111.738 176.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 702' ' ' LYS . . . . . 0.475 ' HG3' HD21 ' A' ' 699' ' ' LEU . 33.5 mmtp -103.48 3.96 35.47 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 120.816 0.341 . . . . 75.299999999999997 110.914 179.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 70.2 mt -84.42 116.77 28.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 N-CA-C 112.235 0.457 . . . . 74.120000000000005 112.235 -174.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 704' ' ' LYS . . . . . . . . . . . . . 61.2 tttp -84.83 122.53 29.28 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 120.689 0.28 . . . . 62.439999999999998 110.581 172.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 47.8 t -99.28 141.15 17.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-O 121.235 0.541 . . . . 72.200000000000003 112.024 -177.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 706' ' ' ASP . . . . . 0.584 ' HB3' ' HB ' ' A' ' 720' ' ' THR . 23.7 t70 -130.31 151.82 50.4 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.77 -0.65 . . . . 74.319999999999993 110.073 176.271 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 93.42 167.05 38.15 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 120.974 -0.631 . . . . 61.219999999999999 112.37 -174.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 708' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -144.5 142.8 30.5 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 122.346 -0.502 . . . . 72.120000000000005 111.997 -176.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 709' ' ' VAL . . . . . 0.516 HG22 HD23 ' A' ' 719' ' ' LEU . 95.7 t -122.09 132.52 70.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 CA-C-O 120.885 0.374 . . . . 72.319999999999993 111.158 176.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 710' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -98.32 138.12 36.04 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.002 0.43 . . . . 53.340000000000003 111.367 176.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 711' ' ' THR . . . . . . . . . . . . . 68.0 p -94.01 -25.45 17.22 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.937 0.398 . . . . 75.439999999999998 111.236 177.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 712' ' ' THR . . . . . . . . . . . . . 12.5 t -90.7 -7.04 53.65 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.0 0.429 . . . . 75.209999999999994 111.994 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 713' ' ' LYS . . . . . . . . . . . . . 28.2 tptp -130.42 125.79 35.37 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.704 0.288 . . . . 75.430000000000007 111.259 -177.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 714' ' ' ALA . . . . . . . . . . . . . . . -74.9 144.18 43.44 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 120.826 0.346 . . . . 74.319999999999993 111.466 178.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 159.03 164.4 14.38 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 121.073 -0.584 . . . . 75.319999999999993 113.313 -179.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 716' ' ' THR . . . . . . . . . . . . . 99.2 m -96.04 128.85 43.3 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 122.495 -0.415 . . . . 64.430000000000007 111.216 178.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 717' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -126.76 149.59 49.55 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.027 0.442 . . . . 74.109999999999999 111.574 -179.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 718' ' ' VAL . . . . . . . . . . . . . 40.6 t -117.07 114.0 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 121.079 0.466 . . . . 75.420000000000002 111.264 178.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 719' ' ' LEU . . . . . 0.516 HD23 HG22 ' A' ' 709' ' ' VAL . 81.2 mt -96.26 143.01 27.73 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.09 -0.505 . . . . 74.420000000000002 111.179 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 720' ' ' THR . . . . . 0.584 ' HB ' ' HB3' ' A' ' 706' ' ' ASP . 78.0 m -118.82 136.1 54.19 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.913 0.387 . . . . 71.109999999999999 111.154 177.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 721' ' ' TYR . . . . . 0.436 ' HH ' ' NE2' ' A' ' 735' ' ' GLN . 72.6 m-85 -120.57 134.36 55.29 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.491 -0.322 . . . . 73.040000000000006 110.906 179.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 25.5 m -134.46 126.22 29.03 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 116.626 -0.261 . . . . 72.439999999999998 110.914 -178.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 8.8 p -132.49 135.78 57.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 CA-C-O 120.929 0.395 . . . . 74.310000000000002 111.611 -179.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 43.0 m -107.96 131.68 54.29 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 120.983 0.421 . . . . 74.230000000000004 111.924 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -73.35 166.39 23.28 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.967 -0.56 . . . . 70.109999999999999 111.131 178.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 726' ' ' SER . . . . . . . . . . . . . 45.3 t -63.17 -40.74 98.4 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 116.372 -0.376 . . . . 74.329999999999998 111.854 178.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 727' ' ' LYS . . . . . 0.703 ' HE2' ' HB2' ' A' ' 664' ' ' ASP . 30.8 mtmm -107.23 25.53 11.29 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 113.773 1.027 . . . . 73.150000000000006 113.773 -177.325 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 728' ' ' GLY . . . . . . . . . . . . . . . 110.16 -5.97 30.44 Favored Glycine 0 CA--C 1.536 1.376 0 N-CA-C 116.645 1.418 . . . . 74.510000000000005 116.645 165.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 18.9 m80 -80.31 104.21 10.7 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 118.936 1.368 . . . . 75.010000000000005 111.958 179.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 730' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -103.28 115.74 31.14 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.986 0.422 . . . . 75.420000000000002 111.718 -178.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 48.0 t -108.74 149.58 11.92 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 CA-C-N 116.414 -0.357 . . . . 65.310000000000002 111.512 -176.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 7.7 t -143.32 143.97 31.91 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 112.502 0.556 . . . . 74.430000000000007 112.502 -178.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -148.7 161.57 41.5 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 116.414 -0.357 . . . . 70.109999999999999 111.234 178.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 734' ' ' LYS . . . . . . . . . . . . . 99.9 mttt -127.22 152.63 47.14 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 112.728 0.64 . . . . 75.200000000000003 112.728 -177.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 735' ' ' GLN . . . . . 0.436 ' NE2' ' HH ' ' A' ' 721' ' ' TYR . 6.7 tt0 -130.49 128.48 41.31 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 115.911 -0.586 . . . . 74.230000000000004 111.13 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 736' ' ' THR . . . . . . . . . . . . . 86.8 m -97.41 109.14 21.95 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.117 0.484 . . . . 73.329999999999998 111.23 176.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 45.4 t -101.16 129.07 52.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-O 120.972 0.415 . . . . 74.430000000000007 111.538 -179.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 738' ' ' THR . . . . . . . . . . . . . 40.4 m -108.94 113.75 26.92 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.521 -0.309 . . . . 73.140000000000001 111.255 179.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 739' ' ' VAL . . . . . . . . . . . . . 21.8 t -93.07 118.89 39.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-O 120.564 0.221 . . . . 63.329999999999998 110.577 177.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 740' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -112.46 158.97 19.22 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 120.994 0.426 . . . . 72.420000000000002 111.618 -176.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 741' ' ' VAL . . . . . . . . . . . . . 38.3 t . . . . . 0 CA--C 1.544 0.746 0 N-CA-C 113.248 0.833 . . . . 73.230000000000004 113.248 -170.632 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 664' ' ' ASP . . . . . . . . . . . . . 27.4 t0 . . . . . 0 CA--C 1.534 0.358 0 CA-C-O 121.126 0.489 . . . . 74.319999999999993 111.649 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 665' ' ' LEU . . . . . 0.46 HD13 ' HD3' ' A' ' 694' ' ' LYS . 84.0 mt -80.65 117.11 21.05 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.846 -0.615 . . . . 72.400000000000006 109.621 173.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 666' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -60.09 142.54 89.34 Favored Pre-proline 0 CA--C 1.542 0.663 0 CA-C-N 116.247 -0.433 . . . . 75.430000000000007 111.6 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 667' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -75.54 155.11 40.43 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 122.536 2.157 . . . . 73.420000000000002 113.795 -169.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 668' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -86.23 102.55 14.04 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.94 -0.573 . . . . 75.329999999999998 110.845 176.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 669' ' ' LEU . . . . . . . . . . . . . 55.2 tp -93.47 105.9 17.91 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 120.958 0.408 . . . . 75.129999999999995 110.64 177.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 670' ' ' THR . . . . . . . . . . . . . 87.4 m -89.18 110.98 21.66 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.361 -0.381 . . . . 72.120000000000005 111.616 -177.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 671' ' ' VAL . . . . . 0.506 HG22 HG12 ' A' ' 689' ' ' VAL . 88.6 t -138.16 134.52 17.85 Favored Pre-proline 0 CA--C 1.539 0.555 0 CA-C-N 116.259 -0.428 . . . . 74.420000000000002 110.672 179.359 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 672' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.62 120.78 5.68 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 122.058 1.838 . . . . 75.310000000000002 111.62 175.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 673' ' ' VAL . . . . . . . . . . . . . 14.8 p -67.08 -23.2 30.3 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 N-CA-C 112.761 0.652 . . . . 74.340000000000003 112.761 -174.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 674' ' ' GLY . . . . . . . . . . . . . . . -142.93 148.33 20.03 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 120.952 -0.642 . . . . 55.5 114.041 -177.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 675' ' ' ALA . . . . . . . . . . . . . . . -157.15 151.84 25.55 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.275 0.63 . . . . 73.120000000000005 110.35 178.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 676' ' ' THR . . . . . . . . . . . . . 91.1 m -139.34 124.9 19.34 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 111.897 0.332 . . . . 70.439999999999998 111.897 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 677' ' ' ILE . . . . . . . . . . . . . 25.2 pt -128.67 172.51 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-O 121.225 0.536 . . . . 74.430000000000007 111.689 179.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 678' ' ' HIS . . . . . 0.513 ' CD2' ' HG3' ' A' ' 740' ' ' LYS . 69.5 m80 -110.96 165.4 11.9 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.267 0.556 . . . . 75.230000000000004 111.713 177.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 679' ' ' VAL . . . . . . . . . . . . . 95.2 t -63.28 126.33 21.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 116.113 -0.494 . . . . 75.25 110.696 173.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 89.35 1.09 78.99 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 121.425 -0.417 . . . . 72.310000000000002 113.126 -176.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 681' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -84.74 177.94 7.84 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 120.937 0.399 . . . . 75.209999999999994 110.713 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 682' ' ' SER . . . . . . . . . . . . . 54.9 m -114.51 150.23 35.2 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 120.972 0.415 . . . . 52.109999999999999 111.365 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 683' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -151.36 131.1 13.18 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 116.129 -0.487 . . . . 72.030000000000001 110.904 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 684' ' ' VAL . . . . . . . . . . . . . 48.6 t -122.37 103.27 38.71 Favored Pre-proline 0 CA--C 1.543 0.677 0 CA-C-O 120.851 0.357 . . . . 70.430000000000007 111.312 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -60.33 -46.97 15.8 Favored 'Trans proline' 0 CA--C 1.545 1.027 0 C-N-CA 122.819 2.346 . . . . 73.209999999999994 113.974 -175.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 686' ' ' MET . . . . . . . . . . . . . 91.2 mmm -78.48 -11.85 59.98 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 112.925 0.713 . . . . 74.209999999999994 112.925 -174.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 687' ' ' ALA . . . . . . . . . . . . . . . -77.22 -30.19 54.54 Favored 'General case' 0 N--CA 1.467 0.419 0 O-C-N 122.038 -0.414 . . . . 74.409999999999997 111.397 177.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 688' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -97.04 1.74 50.51 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 112.203 0.446 . . . . 61.329999999999998 112.203 -178.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 689' ' ' VAL . . . . . 0.506 HG12 HG22 ' A' ' 671' ' ' VAL . 95.4 t -120.67 125.08 73.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-O 120.97 0.414 . . . . 74.150000000000006 112.076 -176.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 690' ' ' LEU . . . . . 0.403 HD23 ' C ' ' A' ' 689' ' ' VAL . 2.7 mm? -127.38 164.01 22.77 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 116.115 -0.493 . . . . 75.510000000000005 110.815 178.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 691' ' ' ALA . . . . . . . . . . . . . . . -153.11 122.46 6.68 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.799 0.333 . . . . 72.25 111.345 175.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 692' ' ' ILE . . . . . . . . . . . . . 46.8 mm -130.85 132.3 64.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-O 120.996 0.427 . . . . 72.230000000000004 112.02 -176.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -113.13 150.53 32.04 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 120.969 0.414 . . . . 71.450000000000003 111.004 174.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 694' ' ' LYS . . . . . 0.46 ' HD3' HD13 ' A' ' 665' ' ' LEU . 64.3 tttp -70.89 -38.26 73.02 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 111.967 0.358 . . . . 62.310000000000002 111.967 -178.026 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -82.66 -53.79 5.65 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 122.019 -0.425 . . . . 73.409999999999997 111.894 -178.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 696' ' ' ASP . . . . . 0.487 ' HB2' ' HB2' ' A' ' 726' ' ' SER . 15.0 t70 -80.39 -42.03 23.56 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 112.595 0.591 . . . . 71.219999999999999 112.595 -174.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . 109.74 -107.4 2.34 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 120.947 -0.644 . . . . 64.310000000000002 112.993 -178.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -81.67 115.95 21.17 Favored 'General case' 0 N--CA 1.466 0.339 0 O-C-N 122.201 -0.588 . . . . 70.209999999999994 111.773 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 699' ' ' LEU . . . . . 0.444 HD22 ' HD2' ' A' ' 702' ' ' LYS . 75.5 mt -111.95 1.11 16.29 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.845 0.355 . . . . 61.43 110.443 170.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 22.4 m -56.27 -37.49 69.88 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.272 0.558 . . . . 74.409999999999997 111.158 177.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 701' ' ' SER . . . . . . . . . . . . . 65.5 p -72.33 -9.91 59.1 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 115.979 -0.555 . . . . 75.450000000000003 112.315 179.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 702' ' ' LYS . . . . . 0.444 ' HD2' HD22 ' A' ' 699' ' ' LEU . 62.1 mttp -101.34 1.47 38.63 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 112.446 0.535 . . . . 73.530000000000001 112.446 178.066 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 703' ' ' ILE . . . . . 0.421 HD13 HG13 ' A' ' 689' ' ' VAL . 67.7 mt -72.24 135.14 28.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 N-CA-C 112.081 0.4 . . . . 74.400000000000006 112.081 -178.014 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 704' ' ' LYS . . . . . . . . . . . . . 56.4 tttm -102.11 137.15 40.76 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.574 -0.285 . . . . 74.400000000000006 111.013 173.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 49.4 t -96.04 141.77 14.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-O 120.988 0.423 . . . . 75.420000000000002 111.065 176.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 706' ' ' ASP . . . . . 0.515 ' HB3' ' HB ' ' A' ' 720' ' ' THR . 27.3 t70 -136.56 138.2 41.03 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 120.728 0.299 . . . . 74.140000000000001 111.205 178.019 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 104.29 -173.07 21.05 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 121.391 -0.433 . . . . 64.239999999999995 113.246 -179.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 708' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -157.95 141.73 15.64 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 120.863 0.363 . . . . 74.310000000000002 111.306 179.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 709' ' ' VAL . . . . . 0.475 HG22 HD22 ' A' ' 719' ' ' LEU . 99.5 t -122.97 121.95 64.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-O 120.785 0.326 . . . . 73.010000000000005 111.217 -179.425 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 710' ' ' ASP . . . . . 0.421 ' O ' HG23 ' A' ' 739' ' ' VAL . 8.2 m-20 -84.95 136.08 33.77 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 121.104 0.478 . . . . 65.040000000000006 111.932 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 711' ' ' THR . . . . . . . . . . . . . 46.2 p -101.63 -3.57 28.1 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.232 0.539 . . . . 62.43 110.37 172.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 712' ' ' THR . . . . . . . . . . . . . 30.1 p -96.06 -27.67 14.98 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 115.749 -0.66 . . . . 61.299999999999997 112.314 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 713' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -121.86 141.04 51.67 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 120.628 0.251 . . . . 74.409999999999997 111.135 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 714' ' ' ALA . . . . . . . . . . . . . . . -81.11 127.24 32.42 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 120.957 0.408 . . . . 75.120000000000005 112.089 -179.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 170.14 158.62 14.33 Favored Glycine 0 CA--C 1.525 0.666 0 C-N-CA 121.447 -0.406 . . . . 74.209999999999994 112.788 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 716' ' ' THR . . . . . . . . . . . . . 51.8 m -87.91 126.44 35.05 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.049 0.452 . . . . 73.420000000000002 111.627 178.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 717' ' ' TYR . . . . . 0.438 ' HB2' HG23 ' A' ' 709' ' ' VAL . 72.5 m-85 -125.92 135.9 52.42 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.186 -0.461 . . . . 75.200000000000003 110.411 176.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 718' ' ' VAL . . . . . . . . . . . . . 59.0 t -108.29 113.69 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 CA-C-O 120.915 0.388 . . . . 75.030000000000001 111.856 -176.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 719' ' ' LEU . . . . . 0.475 HD22 HG22 ' A' ' 709' ' ' VAL . 88.1 mt -89.23 141.08 28.84 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 116.477 -0.329 . . . . 72.329999999999998 111.543 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 720' ' ' THR . . . . . 0.515 ' HB ' ' HB3' ' A' ' 706' ' ' ASP . 62.1 m -111.15 132.54 54.22 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.936 0.398 . . . . 65.239999999999995 111.315 178.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 721' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -122.09 131.03 53.76 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.329 -0.396 . . . . 74.140000000000001 110.365 178.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 86.4 m -138.0 135.71 36.21 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 120.917 0.389 . . . . 61.350000000000001 111.964 -176.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 12.7 p -136.64 146.45 28.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-O 120.996 0.427 . . . . 74.319999999999993 111.42 -179.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 26.4 m -104.5 140.2 38.3 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.439 -0.346 . . . . 75.530000000000001 111.198 178.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -73.32 169.01 18.02 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 121.09 0.471 . . . . 71.209999999999994 111.275 178.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 726' ' ' SER . . . . . 0.487 ' HB2' ' HB2' ' A' ' 696' ' ' ASP . 46.8 t -63.8 -38.47 91.2 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 120.903 0.382 . . . . 74.439999999999998 111.234 176.009 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 727' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -98.25 7.17 46.62 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 112.494 0.554 . . . . 74.140000000000001 112.494 179.296 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 728' ' ' GLY . . . . . . . . . . . . . . . 112.4 -6.24 26.59 Favored Glycine 0 CA--C 1.538 1.469 0 N-CA-C 116.688 1.435 . . . . 72.140000000000001 116.688 166.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 17.6 m80 -69.15 109.22 3.94 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 119.292 1.546 . . . . 75.420000000000002 111.368 176.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 730' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -97.43 124.1 41.51 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 116.589 -0.278 . . . . 75.120000000000005 111.159 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 31.6 m -122.82 154.19 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-O 120.801 0.334 . . . . 72.299999999999997 111.388 -178.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 9.3 t -138.28 148.25 44.48 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 121.437 0.637 . . . . 73.140000000000001 112.524 -177.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -148.41 150.12 32.94 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.838 -0.619 . . . . 72.349999999999994 110.483 178.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 734' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -120.15 160.02 23.71 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 112.67 0.619 . . . . 75.319999999999993 112.67 -174.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 735' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -130.6 119.58 22.7 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 115.478 -0.783 . . . . 71.430000000000007 110.8 -179.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 736' ' ' THR . . . . . . . . . . . . . 23.8 m -90.02 103.79 16.42 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 116.496 -0.32 . . . . 54.450000000000003 111.266 -178.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 32.5 t -102.19 113.56 39.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 CA-C-O 120.952 0.406 . . . . 63.340000000000003 111.665 -177.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 738' ' ' THR . . . . . . . . . . . . . 87.7 m -100.29 112.06 24.37 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.855 0.359 . . . . 61.119999999999997 111.464 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 739' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 710' ' ' ASP . 22.4 t -93.22 133.58 33.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-O 120.778 0.323 . . . . 75.319999999999993 110.676 177.371 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 740' ' ' LYS . . . . . 0.513 ' HG3' ' CD2' ' A' ' 678' ' ' HIS . 19.1 ptmt -132.81 152.34 51.82 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.236 0.541 . . . . 74.409999999999997 111.929 -178.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 741' ' ' VAL . . . . . . . . . . . . . 20.0 t . . . . . 0 CA--C 1.542 0.636 0 CA-C-N 116.057 -0.519 . . . . 74.140000000000001 111.987 -174.634 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 664' ' ' ASP . . . . . . . . . . . . . 24.5 t0 . . . . . 0 CA--C 1.535 0.369 0 CA-C-O 121.272 0.558 . . . . 73.420000000000002 111.249 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 665' ' ' LEU . . . . . . . . . . . . . 84.3 mt -95.44 138.07 33.63 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 115.685 -0.689 . . . . 73.310000000000002 111.261 -179.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 666' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -78.32 142.33 62.9 Favored Pre-proline 0 CA--C 1.54 0.596 0 CA-C-N 116.439 -0.346 . . . . 70.439999999999998 110.189 170.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 667' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -59.7 144.25 99.48 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 122.83 2.353 . . . . 74.120000000000005 114.467 -171.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 668' ' ' LYS . . . . . . . . . . . . . 49.9 tptt -82.3 97.37 8.26 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.658 -0.701 . . . . 72.239999999999995 109.745 171.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 669' ' ' LEU . . . . . . . . . . . . . 56.7 tp -90.19 105.86 18.09 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.002 -0.544 . . . . 65.530000000000001 110.527 179.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 670' ' ' THR . . . . . . . . . . . . . 96.8 m -88.58 110.22 20.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.265 0.555 . . . . 74.519999999999996 111.366 -178.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 671' ' ' VAL . . . . . . . . . . . . . 72.4 t -129.6 131.72 23.76 Favored Pre-proline 0 CA--C 1.535 0.396 0 CA-C-N 115.753 -0.658 . . . . 75.540000000000006 110.285 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 672' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -69.07 123.96 10.87 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 121.829 1.686 . . . . 75.340000000000003 111.693 176.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 673' ' ' VAL . . . . . . . . . . . . . 14.8 p -63.53 -29.52 47.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 N-CA-C 112.357 0.503 . . . . 73.329999999999998 112.357 -174.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 674' ' ' GLY . . . . . . . . . . . . . . . -150.88 143.9 11.14 Favored Glycine 0 CA--C 1.525 0.657 0 C-N-CA 120.741 -0.742 . . . . 72.329999999999998 113.177 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 675' ' ' ALA . . . . . 0.427 ' O ' ' HA ' ' A' ' 737' ' ' VAL . . . -148.63 143.89 26.84 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.729 0.299 . . . . 74.439999999999998 110.981 179.496 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 676' ' ' THR . . . . . . . . . . . . . 49.7 m -130.07 131.03 45.61 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.761 0.315 . . . . 70.519999999999996 111.509 -179.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 677' ' ' ILE . . . . . . . . . . . . . 25.6 pt -133.71 176.5 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 CA-C-O 120.882 0.373 . . . . 74.510000000000005 110.945 179.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 678' ' ' HIS . . . . . . . . . . . . . 76.2 m80 -118.67 158.82 24.77 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 121.08 0.467 . . . . 63.240000000000002 111.879 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 679' ' ' VAL . . . . . . . . . . . . . 98.8 t -60.45 112.1 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-N 116.142 -0.481 . . . . 75.530000000000001 111.172 176.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 114.49 -16.65 19.24 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 121.379 -0.438 . . . . 43.350000000000001 113.03 -175.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 681' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -73.96 -172.18 1.27 Allowed 'General case' 0 CA--C 1.546 0.809 0 CA-C-O 121.033 0.444 . . . . 74.5 111.723 178.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 682' ' ' SER . . . . . . . . . . . . . 25.4 m -129.07 155.12 45.95 Favored 'General case' 0 N--CA 1.478 0.94 0 O-C-N 122.211 -0.305 . . . . 74.519999999999996 111.007 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 683' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -159.2 120.35 3.28 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 120.821 0.343 . . . . 72.150000000000006 111.69 -179.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 684' ' ' VAL . . . . . . . . . . . . . 80.9 t -113.97 110.11 49.14 Favored Pre-proline 0 N--CA 1.471 0.588 0 CA-C-O 120.843 0.354 . . . . 62.299999999999997 111.544 177.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -58.09 -36.79 97.66 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 122.77 2.314 . . . . 75.519999999999996 113.665 -177.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 686' ' ' MET . . . . . 0.493 ' HE3' ' HA ' ' A' ' 686' ' ' MET . 1.0 OUTLIER -79.26 -11.78 59.95 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.424 0.527 . . . . 73.540000000000006 112.424 -177.374 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 687' ' ' ALA . . . . . . . . . . . . . . . -89.61 -32.68 16.99 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.215 0.531 . . . . 71.25 110.972 176.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 688' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -84.74 -17.54 38.0 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 116.137 -0.483 . . . . 72.310000000000002 111.683 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 76.0 t -116.76 131.38 69.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 N-CA-C 112.695 0.628 . . . . 74.099999999999994 112.695 -175.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 690' ' ' LEU . . . . . 0.411 HD13 ' N ' ' A' ' 690' ' ' LEU . 5.2 mp -125.42 166.64 16.23 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 116.309 -0.405 . . . . 74.450000000000003 111.036 177.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 691' ' ' ALA . . . . . . . . . . . . . . . -148.97 122.7 9.25 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 120.905 0.384 . . . . 72.420000000000002 111.58 176.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 692' ' ' ILE . . . . . 0.504 HD11 ' HA ' ' A' ' 698' ' ' ASP . 37.2 mm -133.03 131.75 58.84 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 CA-C-N 116.475 -0.329 . . . . 72.209999999999994 111.481 -177.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 58.6 t0 -111.36 129.03 56.13 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 109.627 -0.508 . . . . 74.219999999999999 109.627 171.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -57.69 -28.05 63.47 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 112.619 0.6 . . . . 72.530000000000001 112.619 -173.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 695' ' ' GLU . . . . . 0.432 ' HG3' ' N ' ' A' ' 696' ' ' ASP . 12.6 pt-20 -82.91 -44.48 15.32 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 111.998 0.37 . . . . 54.219999999999999 111.998 -179.418 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 696' ' ' ASP . . . . . 0.432 ' N ' ' HG3' ' A' ' 695' ' ' GLU . 10.5 t70 -95.12 -48.86 5.77 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 121.181 0.515 . . . . 74.299999999999997 111.596 -170.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . 124.32 -137.46 10.68 Favored Glycine 0 CA--C 1.526 0.722 0 CA-C-N 116.179 -0.464 . . . . 72.400000000000006 112.352 -176.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 698' ' ' ASP . . . . . 0.504 ' HA ' HD11 ' A' ' 692' ' ' ILE . 18.0 t70 -70.92 118.21 13.4 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.339 0.59 . . . . 75.310000000000002 111.619 179.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 699' ' ' LEU . . . . . . . . . . . . . 80.3 mt -116.4 18.28 15.22 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 115.882 -0.599 . . . . 73.219999999999999 110.7 173.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 54.1 m -60.78 -27.56 68.09 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.114 0.483 . . . . 74.049999999999997 111.868 -178.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 701' ' ' SER . . . . . . . . . . . . . 25.3 t -78.55 -13.54 59.78 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.071 0.462 . . . . 74.510000000000005 111.513 178.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 702' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -90.03 7.64 36.59 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 116.42 -0.355 . . . . 74.540000000000006 111.436 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 703' ' ' ILE . . . . . 0.472 HG12 ' HB ' ' A' ' 723' ' ' VAL . 62.5 mt -85.39 138.41 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-O 121.336 0.589 . . . . 75.019999999999996 112.209 -177.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 704' ' ' LYS . . . . . . . . . . . . . 67.1 tttt -100.47 140.72 34.32 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.943 -0.571 . . . . 74.150000000000006 109.772 171.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 59.9 t -111.69 112.43 40.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-O 121.146 0.498 . . . . 74.219999999999999 111.807 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 706' ' ' ASP . . . . . 0.529 ' HB2' ' HB ' ' A' ' 720' ' ' THR . 9.2 m-20 -106.08 137.83 43.32 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 116.12 -0.491 . . . . 63.439999999999998 111.388 177.344 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 101.6 -177.93 27.23 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 121.35 -0.452 . . . . 71.230000000000004 113.509 177.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 708' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -161.79 145.94 12.67 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.959 0.409 . . . . 70.349999999999994 111.415 179.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 709' ' ' VAL . . . . . 0.487 HG23 ' HB2' ' A' ' 717' ' ' TYR . 96.5 t -117.56 120.12 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-N 116.283 -0.417 . . . . 53.399999999999999 110.882 177.016 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 710' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -77.66 135.92 38.15 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 120.912 0.387 . . . . 72.420000000000002 111.574 177.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 711' ' ' THR . . . . . . . . . . . . . 76.2 p -97.66 -1.35 43.83 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.911 0.386 . . . . 73.239999999999995 110.958 173.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 712' ' ' THR . . . . . . . . . . . . . 7.2 t -105.43 -13.47 15.63 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 116.219 -0.446 . . . . 73.439999999999998 111.952 178.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 713' ' ' LYS . . . . . 0.627 ' HZ1' ' HB3' ' A' ' 713' ' ' LYS . 7.8 ttpm? -129.46 127.6 41.2 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.827 0.346 . . . . 63.240000000000002 111.662 -178.254 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 714' ' ' ALA . . . . . 0.427 ' HB1' HG21 ' A' ' 741' ' ' VAL . . . -72.0 144.89 48.67 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.199 -0.455 . . . . 75.239999999999995 111.735 177.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 152.76 171.87 20.62 Favored Glycine 0 CA--C 1.523 0.574 0 C-N-CA 121.027 -0.606 . . . . 63.329999999999998 113.029 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 716' ' ' THR . . . . . . . . . . . . . 56.3 m -100.3 122.23 42.76 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 122.36 -0.494 . . . . 74.109999999999999 111.327 179.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 717' ' ' TYR . . . . . 0.487 ' HB2' HG23 ' A' ' 709' ' ' VAL . 42.2 m-85 -118.92 134.94 54.84 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.139 -0.482 . . . . 75.340000000000003 110.582 -178.397 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 718' ' ' VAL . . . . . . . . . . . . . 49.5 t -101.27 113.97 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 CA-C-O 121.072 0.463 . . . . 72.530000000000001 111.58 -178.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 719' ' ' LEU . . . . . 0.446 HD23 HG22 ' A' ' 709' ' ' VAL . 92.3 mt -94.9 130.94 41.3 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.331 -0.395 . . . . 75.040000000000006 111.196 178.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 720' ' ' THR . . . . . 0.529 ' HB ' ' HB2' ' A' ' 706' ' ' ASP . 25.0 m -113.29 132.71 55.44 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.753 0.311 . . . . 74.0 111.196 -178.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 721' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -124.58 140.69 52.71 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.664 0.269 . . . . 74.299999999999997 110.968 -179.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 56.8 m -140.61 123.5 16.39 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 120.513 0.197 . . . . 73.430000000000007 111.179 -179.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 723' ' ' VAL . . . . . 0.472 ' HB ' HG12 ' A' ' 703' ' ' ILE . 7.5 p -114.54 140.94 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 CA-C-O 121.056 0.455 . . . . 60.049999999999997 112.142 -176.42 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 27.3 m -102.44 144.93 30.27 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 116.136 -0.484 . . . . 70.140000000000001 111.798 -179.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -103.63 150.77 23.67 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.323 0.649 . . . . 53.0 111.088 179.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 726' ' ' SER . . . . . . . . . . . . . 66.9 p -66.03 -14.65 62.04 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 112.522 0.564 . . . . 71.329999999999998 112.522 -175.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 727' ' ' LYS . . . . . . . . . . . . . 41.1 mmtm -105.36 -2.73 23.54 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 112.497 0.554 . . . . 73.239999999999995 112.497 -179.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 728' ' ' GLY . . . . . . . . . . . . . . . 112.21 12.42 13.77 Favored Glycine 0 CA--C 1.535 1.317 0 N-CA-C 115.384 0.914 . . . . 74.540000000000006 115.384 176.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 18.3 m80 -93.93 133.56 37.23 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 118.351 1.076 . . . . 74.040000000000006 111.241 173.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 730' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -134.24 112.54 11.15 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 122.075 -0.39 . . . . 72.340000000000003 111.263 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 34.1 m -112.47 160.44 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 N-CA-C 112.071 0.397 . . . . 74.400000000000006 112.071 -177.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 9.6 t -136.32 150.34 48.82 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 112.55 0.574 . . . . 75.319999999999993 112.55 -176.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -147.81 161.61 40.9 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.849 -0.614 . . . . 75.430000000000007 110.353 177.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 734' ' ' LYS . . . . . . . . . . . . . 33.2 mtmm -129.32 158.53 38.85 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 113.151 0.797 . . . . 73.209999999999994 113.151 -176.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 735' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -130.76 128.95 41.81 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 114.957 -1.019 . . . . 73.239999999999995 110.7 179.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 736' ' ' THR . . . . . . . . . . . . . 86.7 m -96.03 104.38 16.32 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.887 0.375 . . . . 74.430000000000007 111.205 178.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 737' ' ' VAL . . . . . 0.427 ' HA ' ' O ' ' A' ' 675' ' ' ALA . 46.7 t -97.69 140.84 17.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-O 120.821 0.343 . . . . 65.5 111.223 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 738' ' ' THR . . . . . . . . . . . . . 64.3 m -130.03 120.83 25.35 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 120.777 0.322 . . . . 64.099999999999994 111.147 179.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 739' ' ' VAL . . . . . . . . . . . . . 41.9 t -99.51 133.0 43.9 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-O 120.759 0.314 . . . . 73.409999999999997 111.355 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 740' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -121.97 151.84 40.34 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.39 -0.368 . . . . 75.150000000000006 111.571 -179.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 741' ' ' VAL . . . . . 0.427 HG21 ' HB1' ' A' ' 714' ' ' ALA . 25.1 t . . . . . 0 N--CA 1.47 0.539 0 CA-C-O 120.771 0.32 . . . . 62.219999999999999 111.635 -179.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 664' ' ' ASP . . . . . 0.431 ' OD2' ' HB2' ' A' ' 727' ' ' LYS . 18.7 t0 . . . . . 0 C--O 1.236 0.354 0 CA-C-O 121.255 0.55 . . . . 70.150000000000006 111.729 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 665' ' ' LEU . . . . . . . . . . . . . 73.0 mt -91.08 133.47 35.31 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 115.866 -0.606 . . . . 74.219999999999999 109.814 173.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 666' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -64.7 144.96 98.86 Favored Pre-proline 0 CA--C 1.539 0.545 0 CA-C-N 116.218 -0.446 . . . . 65.319999999999993 111.47 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 667' ' ' PRO . . . . . 0.514 ' HD3' ' HB2' ' A' ' 725' ' ' ASP . 25.8 Cg_endo -60.91 145.12 99.51 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 122.785 2.323 . . . . 64.019999999999996 113.149 -174.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 668' ' ' LYS . . . . . . . . . . . . . 9.2 tmtm? -82.58 99.12 9.35 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.33 0.586 . . . . 73.420000000000002 110.384 179.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 669' ' ' LEU . . . . . . . . . . . . . 62.8 tp -89.8 109.27 20.27 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.726 -0.67 . . . . 73.519999999999996 110.736 179.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 670' ' ' THR . . . . . . . . . . . . . 60.7 m -87.08 110.42 20.09 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.827 0.346 . . . . 64.0 111.492 -178.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 671' ' ' VAL . . . . . 0.479 HG23 ' HB3' ' A' ' 733' ' ' ALA . 67.3 t -132.89 124.82 18.88 Favored Pre-proline 0 CA--C 1.542 0.668 0 CA-C-N 116.263 -0.426 . . . . 72.140000000000001 110.831 176.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 672' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.75 154.06 43.55 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.358 2.039 . . . . 71.439999999999998 112.537 178.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 673' ' ' VAL . . . . . . . . . . . . . 12.9 p -63.6 -32.25 56.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 N-CA-C 112.062 0.393 . . . . 71.439999999999998 112.062 -176.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 674' ' ' GLY . . . . . . . . . . . . . . . -170.4 173.14 44.3 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 120.685 -0.769 . . . . 73.299999999999997 114.204 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 675' ' ' ALA . . . . . . . . . . . . . . . -152.95 122.95 6.98 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.876 0.37 . . . . 74.209999999999994 111.308 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 676' ' ' THR . . . . . . . . . . . . . 82.7 m -102.29 124.93 48.74 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 112.158 0.429 . . . . 75.120000000000005 112.158 -177.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 677' ' ' ILE . . . . . . . . . . . . . 29.3 pt -126.4 177.0 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 CA-C-N 116.38 -0.373 . . . . 74.439999999999998 111.1 176.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 678' ' ' HIS . . . . . 0.427 ' CD2' ' HG3' ' A' ' 740' ' ' LYS . 68.6 m80 -117.02 156.16 27.97 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.732 0.641 . . . . 73.040000000000006 112.732 -178.085 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 679' ' ' VAL . . . . . 0.523 HG11 ' HA ' ' A' ' 712' ' ' THR . 85.0 t -61.53 121.27 9.32 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-N 115.536 -0.756 . . . . 73.349999999999994 111.375 175.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 110.94 -23.65 18.68 Favored Glycine 0 CA--C 1.526 0.751 0 CA-C-N 116.132 -0.485 . . . . 65.120000000000005 112.185 -177.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 681' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -83.38 -162.8 0.66 Allowed 'General case' 0 CA--C 1.543 0.707 0 CA-C-O 120.984 0.421 . . . . 70.230000000000004 111.687 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 682' ' ' SER . . . . . . . . . . . . . 74.0 m -141.47 173.97 11.0 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 122.156 -0.34 . . . . 74.120000000000005 111.703 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 683' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -150.9 140.4 21.52 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.855 0.36 . . . . 65.329999999999998 111.759 -177.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 684' ' ' VAL . . . . . . . . . . . . . 99.0 t -118.12 105.78 46.36 Favored Pre-proline 0 CA--C 1.545 0.784 0 CA-C-O 120.728 0.299 . . . . 73.530000000000001 111.605 178.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.93 -38.43 78.96 Favored 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 122.745 2.297 . . . . 73.319999999999993 113.505 -178.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 686' ' ' MET . . . . . 0.491 ' HE2' ' HB ' ' A' ' 703' ' ' ILE . 0.3 OUTLIER -78.79 -9.46 59.45 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.759 0.651 . . . . 73.329999999999998 112.759 -175.977 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 687' ' ' ALA . . . . . . . . . . . . . . . -79.96 -44.9 19.46 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 120.9 0.381 . . . . 74.340000000000003 111.923 -179.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 688' ' ' GLU . . . . . . . . . . . . . 45.7 mm-40 -86.6 -8.22 57.68 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 113.0 0.741 . . . . 64.019999999999996 113.0 -174.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 689' ' ' VAL . . . . . 0.544 HG13 HD13 ' A' ' 703' ' ' ILE . 87.6 t -118.58 124.71 73.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-O 120.938 0.399 . . . . 75.030000000000001 111.956 -177.403 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 690' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -125.41 162.93 23.72 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 116.266 -0.425 . . . . 75.140000000000001 111.062 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 691' ' ' ALA . . . . . . . . . . . . . . . -142.69 121.71 12.86 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.057 0.456 . . . . 74.329999999999998 111.63 176.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 692' ' ' ILE . . . . . . . . . . . . . 45.6 mm -128.69 124.46 61.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-N 116.395 -0.366 . . . . 64.150000000000006 111.55 -178.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 693' ' ' ASP . . . . . 0.492 ' HB2' ' HB3' ' A' ' 667' ' ' PRO . 36.2 t70 -108.35 149.87 28.11 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 120.916 0.389 . . . . 64.420000000000002 110.883 173.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 694' ' ' LYS . . . . . 0.613 ' HZ1' ' HB3' ' A' ' 694' ' ' LYS . 8.3 mtpm? -65.84 -56.68 10.62 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 116.319 -0.401 . . . . 74.019999999999996 111.999 -176.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -84.44 -51.76 6.68 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 112.149 0.426 . . . . 75.230000000000004 112.149 -174.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 696' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -72.23 -28.68 63.32 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-O 120.933 0.397 . . . . 64.150000000000006 111.397 -173.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . 103.73 -147.09 16.56 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 121.477 -0.392 . . . . 73.510000000000005 113.066 178.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -69.56 131.62 44.97 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 120.982 0.42 . . . . 75.420000000000002 110.995 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 699' ' ' LEU . . . . . . . . . . . . . 98.0 mt -125.45 15.76 8.25 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 120.973 0.416 . . . . 62.229999999999997 111.164 178.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 34.9 m -58.75 -38.34 78.21 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 121.064 0.459 . . . . 75.239999999999995 111.455 -178.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 701' ' ' SER . . . . . . . . . . . . . 33.7 m -61.44 -21.95 64.6 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 116.2 -0.454 . . . . 62.039999999999999 111.814 178.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 702' ' ' LYS . . . . . . . . . . . . . 64.0 mttm -91.31 1.28 57.22 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 112.607 0.595 . . . . 74.299999999999997 112.607 -178.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 703' ' ' ILE . . . . . 0.544 HD13 HG13 ' A' ' 689' ' ' VAL . 74.5 mt -69.46 111.91 3.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-O 121.238 0.542 . . . . 74.400000000000006 111.559 -178.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 704' ' ' LYS . . . . . . . . . . . . . 24.3 tptm -85.02 118.91 24.87 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 115.549 -0.751 . . . . 73.549999999999997 110.508 178.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 51.7 t -96.42 138.25 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 CA-C-O 120.963 0.411 . . . . 71.239999999999995 111.823 -177.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 706' ' ' ASP . . . . . 0.56 ' HB3' ' HB ' ' A' ' 720' ' ' THR . 24.1 t70 -132.08 140.8 48.97 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 116.291 -0.413 . . . . 74.519999999999996 111.014 177.342 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 107.23 -176.79 21.27 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 121.331 -0.461 . . . . 73.109999999999999 113.067 -179.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 708' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -163.49 137.1 5.7 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.182 0.515 . . . . 74.439999999999998 111.734 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 709' ' ' VAL . . . . . 0.515 HG23 ' HB2' ' A' ' 717' ' ' TYR . 46.8 t -112.02 146.18 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-N 116.1 -0.5 . . . . 75.109999999999999 111.309 -178.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 710' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -83.81 156.79 22.32 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 121.396 0.617 . . . . 73.420000000000002 111.832 175.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 711' ' ' THR . . . . . 0.42 ' O ' ' HA ' ' A' ' 679' ' ' VAL . 47.2 p -117.75 -22.84 7.81 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.578 -0.737 . . . . 73.430000000000007 110.796 172.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 712' ' ' THR . . . . . 0.523 ' HA ' HG11 ' A' ' 679' ' ' VAL . 70.2 p -108.11 13.14 26.2 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 111.923 0.342 . . . . 63.43 111.923 178.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 713' ' ' LYS . . . . . 0.545 ' HZ2' ' HB2' ' A' ' 713' ' ' LYS . 3.8 ttmp? -140.08 131.71 27.22 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.664 0.268 . . . . 74.040000000000006 111.132 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 714' ' ' ALA . . . . . . . . . . . . . . . -77.66 143.44 38.16 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 120.81 0.338 . . . . 63.450000000000003 111.284 177.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 155.47 -174.94 33.51 Favored Glycine 0 CA--C 1.525 0.657 0 C-N-CA 121.316 -0.469 . . . . 61.109999999999999 112.843 -178.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 716' ' ' THR . . . . . . . . . . . . . 38.7 m -123.55 123.02 39.68 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 117.097 0.449 . . . . 74.439999999999998 111.589 -178.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 717' ' ' TYR . . . . . 0.515 ' HB2' HG23 ' A' ' 709' ' ' VAL . 61.4 m-85 -128.03 128.95 45.91 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.185 -0.461 . . . . 75.439999999999998 110.778 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 718' ' ' VAL . . . . . . . . . . . . . 61.6 t -97.78 118.67 44.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-O 121.172 0.511 . . . . 71.450000000000003 111.942 -176.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 719' ' ' LEU . . . . . . . . . . . . . 91.0 mt -93.07 133.64 36.03 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.31 -0.404 . . . . 75.230000000000004 111.076 178.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 720' ' ' THR . . . . . 0.56 ' HB ' ' HB3' ' A' ' 706' ' ' ASP . 17.0 m -100.96 144.75 29.53 Favored 'General case' 0 N--CA 1.473 0.714 0 O-C-N 122.214 -0.304 . . . . 73.120000000000005 111.101 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 721' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -134.86 113.85 11.98 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 122.449 0.3 . . . . 72.549999999999997 111.0 -178.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 60.4 m -114.23 137.92 51.15 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 111.7 0.259 . . . . 74.209999999999994 111.7 -179.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 8.2 p -138.13 136.17 44.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 CA-C-O 121.011 0.434 . . . . 73.230000000000004 111.446 177.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 42.4 m -113.13 129.58 56.46 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 120.864 0.364 . . . . 72.430000000000007 111.728 -178.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 725' ' ' ASP . . . . . 0.514 ' HB2' ' HD3' ' A' ' 667' ' ' PRO . 17.6 t0 -73.84 150.03 41.24 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-N 116.225 -0.443 . . . . 74.040000000000006 110.081 174.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 726' ' ' SER . . . . . . . . . . . . . 48.8 m -69.01 -27.24 65.5 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.692 0.282 . . . . 64.310000000000002 111.645 -178.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 727' ' ' LYS . . . . . 0.431 ' HB2' ' OD2' ' A' ' 664' ' ' ASP . 1.3 mptp? -89.19 5.22 45.73 Favored 'General case' 0 CA--C 1.546 0.827 0 N-CA-C 112.258 0.466 . . . . 71.409999999999997 112.258 -177.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 728' ' ' GLY . . . . . . . . . . . . . . . 113.31 -2.99 25.19 Favored Glycine 0 CA--C 1.537 1.409 0 N-CA-C 116.463 1.345 . . . . 54.520000000000003 116.463 169.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 63.0 m80 -94.72 119.54 33.51 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 118.941 1.37 . . . . 74.420000000000002 112.05 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 730' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -112.65 138.91 48.76 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 122.038 -0.414 . . . . 72.239999999999995 111.775 -178.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 29.4 m -138.54 152.36 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-O 120.786 0.327 . . . . 54.219999999999999 111.39 178.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 9.0 t -140.3 154.08 46.68 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.038 0.447 . . . . 71.540000000000006 111.653 179.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 733' ' ' ALA . . . . . 0.479 ' HB3' HG23 ' A' ' 671' ' ' VAL . . . -148.86 162.15 40.42 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 116.25 -0.432 . . . . 73.140000000000001 111.342 -179.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 734' ' ' LYS . . . . . 0.595 ' HB2' ' HZ3' ' A' ' 734' ' ' LYS . 10.7 mtmp? -125.96 154.44 42.85 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 112.446 0.536 . . . . 73.219999999999999 112.446 -179.27 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 735' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -129.7 124.54 33.82 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.858 -0.61 . . . . 74.030000000000001 110.585 178.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 736' ' ' THR . . . . . . . . . . . . . 88.1 m -90.91 103.9 16.56 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.841 0.353 . . . . 74.430000000000007 111.633 -177.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 50.3 t -96.55 131.76 42.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 O-C-N 122.124 -0.36 . . . . 74.510000000000005 111.299 -178.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 738' ' ' THR . . . . . . . . . . . . . 88.5 m -122.68 122.75 39.51 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.028 0.442 . . . . 73.239999999999995 111.651 -178.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 739' ' ' VAL . . . . . . . . . . . . . 21.5 t -100.85 131.51 48.33 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 116.143 -0.48 . . . . 74.230000000000004 110.812 178.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 740' ' ' LYS . . . . . 0.427 ' HG3' ' CD2' ' A' ' 678' ' ' HIS . 16.9 ptpt -124.32 160.38 28.2 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.233 0.539 . . . . 74.230000000000004 111.705 177.226 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 741' ' ' VAL . . . . . 0.459 HG22 HG23 ' A' ' 679' ' ' VAL . 37.8 t . . . . . 0 CA--C 1.537 0.479 0 N-CA-C 112.507 0.558 . . . . 72.140000000000001 112.507 -172.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 664' ' ' ASP . . . . . 0.443 ' HB3' ' HE1' ' A' ' 729' ' ' HIS . 12.8 t70 . . . . . 0 CA--C 1.538 0.505 0 CA-C-O 120.928 0.394 . . . . 74.219999999999999 111.89 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 665' ' ' LEU . . . . . . . . . . . . . 80.7 mt -88.03 117.41 26.89 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 116.337 -0.392 . . . . 74.120000000000005 110.122 173.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 666' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -54.31 149.07 21.01 Favored Pre-proline 0 CA--C 1.54 0.559 0 CA-C-O 120.796 0.331 . . . . 64.129999999999995 111.444 178.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 667' ' ' PRO . . . . . 0.485 ' HA ' ' HA ' ' A' ' 693' ' ' ASP . 38.2 Cg_exo -57.77 140.48 93.77 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 122.422 2.081 . . . . 74.209999999999994 112.95 -173.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 668' ' ' LYS . . . . . 0.7 ' HA ' ' HE2' ' A' ' 668' ' ' LYS . 0.6 OUTLIER -82.88 102.96 12.0 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 120.932 0.396 . . . . 75.430000000000007 110.363 175.403 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 669' ' ' LEU . . . . . 0.484 ' HG ' HG21 ' A' ' 671' ' ' VAL . 61.9 tp -90.01 118.61 29.69 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.195 -0.457 . . . . 75.109999999999999 111.354 -179.387 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 670' ' ' THR . . . . . . . . . . . . . 89.3 m -93.85 109.85 21.53 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.732 0.301 . . . . 73.540000000000006 110.986 177.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 671' ' ' VAL . . . . . 0.484 HG21 ' HG ' ' A' ' 669' ' ' LEU . 95.7 t -139.74 122.19 10.13 Favored Pre-proline 0 CA--C 1.538 0.51 0 CA-C-N 116.151 -0.477 . . . . 72.230000000000004 110.583 177.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 672' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -76.37 151.88 33.96 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 122.119 1.879 . . . . 75.340000000000003 112.177 177.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 673' ' ' VAL . . . . . . . . . . . . . 8.0 p -64.27 -31.89 55.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 N-CA-C 112.325 0.491 . . . . 74.349999999999994 112.325 -175.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 674' ' ' GLY . . . . . . . . . . . . . . . -160.51 166.72 35.47 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 120.469 -0.872 . . . . 39.060000000000002 114.3 -177.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 675' ' ' ALA . . . . . . . . . . . . . . . -142.77 151.06 40.83 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.312 0.645 . . . . 71.129999999999995 109.849 177.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 676' ' ' THR . . . . . . . . . . . . . 91.5 m -137.93 119.23 14.66 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.105 0.479 . . . . 74.409999999999997 111.883 -177.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 677' ' ' ILE . . . . . . . . . . . . . 33.5 pt -130.75 176.48 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-N 116.032 -0.531 . . . . 75.150000000000006 111.097 -179.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 678' ' ' HIS . . . . . 0.527 ' HA ' ' O ' ' A' ' 740' ' ' LYS . 65.3 m80 -110.78 156.7 20.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.279 0.561 . . . . 75.230000000000004 111.815 177.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 679' ' ' VAL . . . . . 0.526 HG13 ' HA ' ' A' ' 712' ' ' THR . 85.2 t -58.31 126.16 15.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-N 115.899 -0.591 . . . . 62.109999999999999 110.98 174.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 94.82 4.6 61.69 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 121.153 -0.546 . . . . 54.299999999999997 113.568 -179.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 681' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -97.7 165.35 12.0 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.366 0.603 . . . . 71.129999999999995 112.152 178.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 682' ' ' SER . . . . . . . . . . . . . 46.5 m -93.9 137.14 33.45 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.887 -0.597 . . . . 65.420000000000002 111.739 -179.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 683' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -135.09 128.7 32.71 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 120.928 0.394 . . . . 72.219999999999999 111.531 -179.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 684' ' ' VAL . . . . . . . . . . . . . 48.9 t -125.07 97.99 36.9 Favored Pre-proline 0 CA--C 1.542 0.656 0 CA-C-O 120.856 0.36 . . . . 73.129999999999995 111.444 177.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -63.7 -34.19 63.44 Favored 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 122.491 2.127 . . . . 64.040000000000006 113.571 -178.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 686' ' ' MET . . . . . 0.478 ' HE1' ' HA ' ' A' ' 686' ' ' MET . 0.7 OUTLIER -79.34 -6.32 56.49 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.782 0.66 . . . . 62.409999999999997 112.782 -176.902 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 687' ' ' ALA . . . . . . . . . . . . . . . -92.37 -38.19 12.16 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.869 0.366 . . . . 74.439999999999998 111.924 179.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 688' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -98.69 13.08 33.42 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 112.384 0.513 . . . . 75.299999999999997 112.384 -176.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 689' ' ' VAL . . . . . 0.404 HG13 HG22 ' A' ' 671' ' ' VAL . 85.2 t -125.04 140.04 49.33 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-N 116.301 -0.409 . . . . 73.129999999999995 110.086 173.252 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 690' ' ' LEU . . . . . 0.516 HD23 HG12 ' A' ' 692' ' ' ILE . 9.2 tt -145.17 153.85 41.8 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 111.574 0.213 . . . . 74.239999999999995 111.574 -172.152 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 691' ' ' ALA . . . . . . . . . . . . . . . -147.4 125.12 11.83 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 112.049 0.389 . . . . 61.409999999999997 112.049 179.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 692' ' ' ILE . . . . . 0.516 HG12 HD23 ' A' ' 690' ' ' LEU . 47.5 mm -127.93 119.05 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 N-CA-C 112.032 0.382 . . . . 65.430000000000007 112.032 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 693' ' ' ASP . . . . . 0.485 ' HA ' ' HA ' ' A' ' 667' ' ' PRO . 14.6 t70 -94.81 147.7 23.07 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 109.789 -0.449 . . . . 70.299999999999997 109.789 171.135 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 64.9 tttm -58.31 -61.91 2.23 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.373 0.508 . . . . 75.040000000000006 112.373 -174.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -88.5 -39.77 13.94 Favored 'General case' 0 N--CA 1.479 1.002 0 O-C-N 121.846 -0.534 . . . . 74.099999999999994 112.242 -176.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 696' ' ' ASP . . . . . . . . . . . . . 34.3 t0 -70.99 -23.52 62.21 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.257 0.551 . . . . 61.109999999999999 110.826 -176.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . 90.3 -147.32 19.1 Favored Glycine 0 CA--C 1.525 0.665 0 CA-C-N 116.043 -0.526 . . . . 62.409999999999997 113.87 173.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 698' ' ' ASP . . . . . 0.431 ' HA ' HD12 ' A' ' 692' ' ' ILE . 14.4 t70 -67.9 123.03 19.46 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.058 0.456 . . . . 73.409999999999997 111.189 -179.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 699' ' ' LEU . . . . . . . . . . . . . 80.8 mt -122.25 24.95 9.2 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.993 -0.549 . . . . 75.430000000000007 110.782 178.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 88.4 m -61.96 -40.32 95.17 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.044 0.45 . . . . 75.010000000000005 112.032 -177.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 701' ' ' SER . . . . . . . . . . . . . 15.6 t -79.86 -3.69 49.01 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 121.048 0.451 . . . . 75.510000000000005 111.246 179.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 702' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -84.9 -11.43 55.6 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 120.988 0.423 . . . . 74.329999999999998 110.822 175.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 703' ' ' ILE . . . . . 0.423 ' HB ' ' HE2' ' A' ' 686' ' ' MET . 74.6 mt -68.57 117.71 11.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-O 121.588 0.709 . . . . 72.510000000000005 112.82 -173.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 704' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -83.67 121.58 27.46 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.397 -0.819 . . . . 74.019999999999996 110.627 174.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 41.7 t -99.61 116.38 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-O 120.82 0.343 . . . . 75.239999999999995 111.077 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 706' ' ' ASP . . . . . 0.534 ' HB3' ' HB ' ' A' ' 720' ' ' THR . 32.9 t70 -109.96 123.21 49.24 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 120.74 0.305 . . . . 70.25 110.993 179.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 130.11 173.92 13.54 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 121.397 -0.43 . . . . 75.099999999999994 113.07 -178.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 708' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -135.27 142.23 45.86 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 122.447 -0.443 . . . . 74.450000000000003 111.518 -178.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 709' ' ' VAL . . . . . 0.467 HG22 HD21 ' A' ' 719' ' ' LEU . 98.9 t -126.32 128.25 71.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-O 120.872 0.367 . . . . 74.329999999999998 111.424 -179.094 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 710' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -109.38 137.4 47.3 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 116.73 -0.214 . . . . 60.409999999999997 110.552 177.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 711' ' ' THR . . . . . . . . . . . . . 67.3 p -111.7 4.21 18.37 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 112.85 0.685 . . . . 73.129999999999995 112.85 -175.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 712' ' ' THR . . . . . 0.526 ' HA ' HG13 ' A' ' 679' ' ' VAL . 12.9 t -111.99 -10.47 13.94 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 112.163 0.431 . . . . 74.420000000000002 112.163 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 713' ' ' LYS . . . . . 0.414 ' HD3' ' N ' ' A' ' 714' ' ' ALA . 8.8 tmtt? -128.8 129.91 46.28 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 109.861 -0.422 . . . . 74.319999999999993 109.861 176.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 714' ' ' ALA . . . . . 0.414 ' N ' ' HD3' ' A' ' 713' ' ' LYS . . . -69.81 127.6 33.48 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 112.426 0.528 . . . . 74.129999999999995 112.426 -176.418 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 177.8 174.33 44.03 Favored Glycine 0 CA--C 1.524 0.6 0 CA-C-N 116.098 -0.501 . . . . 64.140000000000001 112.772 -179.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 716' ' ' THR . . . . . . . . . . . . . 38.6 m -100.01 121.9 42.08 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 122.532 -0.393 . . . . 63.310000000000002 111.056 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 717' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -122.39 109.58 14.58 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 120.646 0.26 . . . . 72.409999999999997 110.783 -177.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 718' ' ' VAL . . . . . 0.403 ' HA ' ' HA ' ' A' ' 736' ' ' THR . 42.6 t -93.79 126.96 46.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-O 120.941 0.4 . . . . 73.030000000000001 111.845 -175.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 719' ' ' LEU . . . . . 0.467 HD21 HG22 ' A' ' 709' ' ' VAL . 97.2 mt -105.32 153.01 22.2 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.955 0.407 . . . . 75.299999999999997 111.277 177.095 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 720' ' ' THR . . . . . 0.534 ' HB ' ' HB3' ' A' ' 706' ' ' ASP . 28.8 m -120.82 129.74 53.68 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.487 -0.324 . . . . 74.219999999999999 110.809 177.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 721' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -115.18 119.79 37.58 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 120.824 0.345 . . . . 75.230000000000004 111.371 -178.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 87.0 m -124.05 140.41 53.0 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 116.54 -0.3 . . . . 71.239999999999995 111.209 -179.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 10.4 p -141.01 143.47 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 CA-C-O 120.866 0.365 . . . . 63.409999999999997 111.924 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 724' ' ' THR . . . . . 0.452 ' HA ' ' O ' ' A' ' 729' ' ' HIS . 23.7 m -123.01 142.2 51.11 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 116.392 -0.367 . . . . 64.129999999999995 111.603 -179.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -100.51 178.61 4.68 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.251 0.548 . . . . 75.420000000000002 112.316 -177.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 726' ' ' SER . . . . . . . . . . . . . 38.0 t -54.51 -31.92 57.03 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 113.323 0.86 . . . . 75.200000000000003 113.323 -179.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 727' ' ' LYS . . . . . . . . . . . . . 44.8 mmtm -86.63 -14.76 41.75 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 121.877 -0.514 . . . . 74.329999999999998 111.913 -179.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 728' ' ' GLY . . . . . . . . . . . . . . . 103.23 13.43 28.78 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 121.023 -0.608 . . . . 63.420000000000002 113.792 -178.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 729' ' ' HIS . . . . . 0.452 ' O ' ' HA ' ' A' ' 724' ' ' THR . 58.7 m80 -72.01 123.93 23.85 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 117.283 0.541 . . . . 75.120000000000005 110.54 174.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 730' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -122.25 108.47 13.32 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.137 0.494 . . . . 72.519999999999996 112.179 -174.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 34.9 m -107.72 155.67 8.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-N 116.036 -0.529 . . . . 65.109999999999999 110.737 176.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 5.4 t -152.51 136.86 16.67 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 112.819 0.674 . . . . 75.040000000000006 112.819 -175.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -141.87 146.87 36.28 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.09 -0.505 . . . . 75.120000000000005 111.214 -179.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 734' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -105.09 158.29 16.67 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.213 0.53 . . . . 74.439999999999998 112.188 -176.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 735' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -141.85 118.0 10.69 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.687 -0.688 . . . . 75.230000000000004 110.665 175.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 736' ' ' THR . . . . . 0.403 ' HA ' ' HA ' ' A' ' 718' ' ' VAL . 6.5 t -84.37 111.94 19.89 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.227 0.536 . . . . 72.510000000000005 111.73 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 43.5 t -96.63 103.84 15.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-O 121.282 0.563 . . . . 74.329999999999998 111.382 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 738' ' ' THR . . . . . . . . . . . . . 30.8 m -93.61 113.45 25.56 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.984 0.421 . . . . 74.209999999999994 111.344 -177.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 739' ' ' VAL . . . . . . . . . . . . . 45.8 t -96.41 116.4 38.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-N 116.297 -0.411 . . . . 72.120000000000005 111.037 178.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 740' ' ' LYS . . . . . 0.527 ' O ' ' HA ' ' A' ' 678' ' ' HIS . 11.7 ptmm? -111.59 159.11 18.47 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.027 0.442 . . . . 74.319999999999993 111.144 178.2 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 741' ' ' VAL . . . . . . . . . . . . . 38.3 t . . . . . 0 CA--C 1.54 0.588 0 CA-C-O 120.798 0.333 . . . . 63.420000000000002 111.829 -175.3 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 664' ' ' ASP . . . . . . . . . . . . . 22.2 t0 . . . . . 0 CA--C 1.538 0.492 0 CA-C-O 121.633 0.73 . . . . 72.439999999999998 112.356 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 665' ' ' LEU . . . . . . . . . . . . . 44.8 mt -113.64 138.02 50.79 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.086 -0.961 . . . . 75.219999999999999 110.59 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 666' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -54.01 139.23 54.15 Favored Pre-proline 0 CA--C 1.545 0.752 0 CA-C-O 120.762 0.315 . . . . 75.049999999999997 111.309 176.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 667' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -68.95 160.27 50.54 Favored 'Trans proline' 0 CA--C 1.545 1.045 0 C-N-CA 122.963 2.442 . . . . 64.099999999999994 115.124 -166.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 668' ' ' LYS . . . . . 0.417 ' HA ' ' HE3' ' A' ' 668' ' ' LYS . 0.2 OUTLIER -83.22 102.23 11.77 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 114.948 -1.024 . . . . 71.120000000000005 111.022 177.896 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 669' ' ' LEU . . . . . . . . . . . . . 57.9 tp -103.49 114.64 29.08 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 120.783 0.325 . . . . 71.409999999999997 111.096 176.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 670' ' ' THR . . . . . . . . . . . . . 99.4 m -101.67 112.1 24.56 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.875 0.369 . . . . 75.439999999999998 111.425 178.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 671' ' ' VAL . . . . . . . . . . . . . 90.2 t -125.98 132.84 24.45 Favored Pre-proline 0 CA--C 1.538 0.492 0 CA-C-N 116.3 -0.409 . . . . 75.319999999999993 110.776 177.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 672' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -66.47 138.43 50.25 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 122.128 1.886 . . . . 74.099999999999994 112.363 178.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 673' ' ' VAL . . . . . . . . . . . . . 11.7 p -73.17 -34.09 43.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 N-CA-C 112.326 0.491 . . . . 72.519999999999996 112.326 -175.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 674' ' ' GLY . . . . . . . . . . . . . . . -150.74 151.12 23.18 Favored Glycine 0 CA--C 1.523 0.533 0 C-N-CA 120.557 -0.83 . . . . 74.319999999999993 113.674 -176.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 675' ' ' ALA . . . . . 0.488 ' HB1' HG23 ' A' ' 737' ' ' VAL . . . -138.92 144.42 39.08 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 122.476 0.31 . . . . 70.019999999999996 110.978 179.136 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 676' ' ' THR . . . . . . . . . . . . . 36.5 m -131.42 118.61 20.48 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 120.596 0.236 . . . . 61.520000000000003 111.103 -178.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 677' ' ' ILE . . . . . . . . . . . . . 42.9 pt -136.67 177.58 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-O 121.091 0.472 . . . . 74.349999999999994 111.695 179.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 678' ' ' HIS . . . . . . . . . . . . . 79.2 m80 -129.57 140.29 51.25 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 111.924 0.342 . . . . 72.400000000000006 111.924 -178.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 679' ' ' VAL . . . . . . . . . . . . . 89.7 t -46.87 122.18 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 CA-C-N 115.753 -0.658 . . . . 75.430000000000007 112.558 -178.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 104.14 14.97 23.09 Favored Glycine 0 CA--C 1.528 0.883 0 CA-C-N 116.246 -0.433 . . . . 74.239999999999995 113.533 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 681' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -101.25 -161.94 0.9 Allowed 'General case' 0 CA--C 1.545 0.788 0 CA-C-O 121.407 0.622 . . . . 64.409999999999997 112.044 -179.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 682' ' ' SER . . . . . . . . . . . . . 40.1 m -134.62 111.1 9.75 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 115.938 -0.574 . . . . 73.329999999999998 110.394 175.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 683' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -118.7 136.24 54.04 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.582 0.23 . . . . 74.409999999999997 111.474 -177.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 684' ' ' VAL . . . . . . . . . . . . . 86.5 t -121.38 111.8 33.23 Favored Pre-proline 0 CA--C 1.54 0.561 0 CA-C-O 120.553 0.216 . . . . 72.510000000000005 111.104 177.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -59.46 -50.62 7.89 Favored 'Trans proline' 0 CA--C 1.543 0.968 0 C-N-CA 122.723 2.282 . . . . 74.430000000000007 114.105 -176.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 686' ' ' MET . . . . . 0.442 ' HE1' ' HB3' ' A' ' 686' ' ' MET . 53.9 mtp -79.73 -12.62 59.79 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 113.439 0.903 . . . . 74.340000000000003 113.439 -175.046 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 687' ' ' ALA . . . . . . . . . . . . . . . -65.54 -21.17 66.58 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.845 0.355 . . . . 73.140000000000001 111.553 -178.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 688' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -107.37 0.73 23.2 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 112.346 0.498 . . . . 74.430000000000007 112.346 -178.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 25.4 t -99.55 151.11 4.94 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 O-C-N 122.098 -0.376 . . . . 74.120000000000005 111.528 -177.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 690' ' ' LEU . . . . . . . . . . . . . 9.1 tt -148.08 146.78 28.97 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 122.347 0.259 . . . . 72.519999999999996 111.025 -177.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 691' ' ' ALA . . . . . . . . . . . . . . . -145.73 128.46 16.24 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 111.994 0.368 . . . . 52.420000000000002 111.994 179.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 692' ' ' ILE . . . . . 0.516 HD11 ' HA ' ' A' ' 698' ' ' ASP . 45.4 mm -134.01 134.21 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 122.72 0.408 . . . . 75.25 111.737 -177.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 693' ' ' ASP . . . . . 0.436 ' HB2' ' CD1' ' A' ' 699' ' ' LEU . 35.0 t70 -106.95 144.77 33.1 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 122.077 -0.39 . . . . 63.420000000000002 111.01 173.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -59.33 -39.89 84.56 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 116.128 -0.487 . . . . 75.099999999999994 112.11 -177.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -83.01 -55.78 4.18 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 112.462 0.541 . . . . 74.109999999999999 112.462 -178.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 696' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -79.41 -48.27 14.27 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 112.445 0.535 . . . . 74.349999999999994 112.445 -169.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . 122.31 -112.26 1.96 Allowed Glycine 0 CA--C 1.522 0.47 0 C-N-CA 120.913 -0.66 . . . . 65.310000000000002 112.613 -176.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 698' ' ' ASP . . . . . 0.516 ' HA ' HD11 ' A' ' 692' ' ' ILE . 13.0 t70 -87.65 116.92 26.11 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 122.179 -0.601 . . . . 71.209999999999994 112.064 -176.271 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 699' ' ' LEU . . . . . 0.436 ' CD1' ' HB2' ' A' ' 693' ' ' ASP . 56.9 mt -112.37 21.2 15.98 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 116.287 -0.415 . . . . 75.420000000000002 111.32 175.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 29.6 m -60.14 -25.94 65.88 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 120.952 0.406 . . . . 73.540000000000006 111.603 -178.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 701' ' ' SER . . . . . . . . . . . . . 40.0 t -82.02 -18.21 44.06 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 121.163 0.506 . . . . 71.510000000000005 111.412 177.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 702' ' ' LYS . . . . . . . . . . . . . 48.6 mmtm -82.42 3.08 29.5 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 116.293 -0.412 . . . . 65.519999999999996 111.873 179.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 72.1 mt -78.37 138.98 19.24 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 CA-C-O 121.326 0.584 . . . . 74.129999999999995 112.438 -177.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 704' ' ' LYS . . . . . 0.459 ' O ' ' HA ' ' A' ' 721' ' ' TYR . 22.5 ttmm -104.84 139.33 39.76 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.783 -0.644 . . . . 74.25 110.267 178.149 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 60.8 t -115.59 111.09 34.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 N-CA-C 112.392 0.515 . . . . 73.450000000000003 112.392 -177.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 706' ' ' ASP . . . . . 0.55 ' HB3' ' HB ' ' A' ' 720' ' ' THR . 28.7 t70 -107.41 133.14 52.36 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.122 -0.49 . . . . 73.219999999999999 110.568 174.09 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 86.86 165.74 41.63 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 120.894 -0.67 . . . . 75.420000000000002 112.441 -176.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 708' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -159.37 148.78 18.44 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 122.283 -0.54 . . . . 64.510000000000005 111.153 -179.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 709' ' ' VAL . . . . . 0.429 HG22 HD13 ' A' ' 719' ' ' LEU . 58.7 t -96.45 137.58 23.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-N 116.094 -0.503 . . . . 64.450000000000003 111.665 -178.452 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 710' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -105.03 136.76 43.9 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 116.188 -0.46 . . . . 74.25 110.225 175.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 711' ' ' THR . . . . . . . . . . . . . 73.4 p -107.91 8.77 28.69 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 112.814 0.672 . . . . 75.209999999999994 112.814 -174.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 712' ' ' THR . . . . . . . . . . . . . 7.2 t -111.83 -9.73 14.05 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 122.078 -0.389 . . . . 75.329999999999998 111.61 176.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 713' ' ' LYS . . . . . . . . . . . . . 37.8 tttp -129.3 133.19 47.35 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 120.653 0.263 . . . . 75.239999999999995 110.885 177.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 714' ' ' ALA . . . . . . . . . . . . . . . -77.73 134.01 38.18 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 112.18 0.437 . . . . 74.129999999999995 112.18 -178.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 168.27 179.81 40.91 Favored Glycine 0 CA--C 1.524 0.625 0 CA-C-N 116.123 -0.49 . . . . 72.340000000000003 112.854 -179.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 716' ' ' THR . . . . . . . . . . . . . 41.0 m -108.64 122.67 47.59 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 120.999 0.428 . . . . 73.109999999999999 111.384 -178.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 717' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -114.06 124.09 51.28 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 116.284 -0.416 . . . . 73.420000000000002 111.036 -177.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 718' ' ' VAL . . . . . . . . . . . . . 49.3 t -97.36 114.65 35.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-O 121.111 0.481 . . . . 73.400000000000006 111.124 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 719' ' ' LEU . . . . . 0.429 HD13 HG22 ' A' ' 709' ' ' VAL . 47.4 mt -101.51 132.75 46.97 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 116.292 -0.413 . . . . 74.420000000000002 111.41 -177.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 720' ' ' THR . . . . . 0.55 ' HB ' ' HB3' ' A' ' 706' ' ' ASP . 34.9 m -110.06 128.02 55.18 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 120.958 0.409 . . . . 74.219999999999999 111.501 178.083 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 721' ' ' TYR . . . . . 0.459 ' HA ' ' O ' ' A' ' 704' ' ' LYS . 75.3 m-85 -117.97 126.36 52.18 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.524 -0.307 . . . . 72.310000000000002 110.84 178.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 56.1 m -127.98 122.27 31.89 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 116.853 -0.158 . . . . 74.219999999999999 111.266 -178.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 12.9 p -111.11 142.14 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-O 120.903 0.382 . . . . 62.409999999999997 111.372 -179.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 52.3 m -113.79 126.5 55.28 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.083 0.468 . . . . 75.299999999999997 112.099 -178.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 725' ' ' ASP . . . . . 0.503 ' HB3' ' HB2' ' A' ' 729' ' ' HIS . 0.2 OUTLIER -84.5 158.81 20.88 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 115.953 -0.567 . . . . 75.319999999999993 111.483 176.22 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 726' ' ' SER . . . . . . . . . . . . . 49.8 m -58.21 -34.74 70.73 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.872 0.693 . . . . 73.109999999999999 112.872 -176.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 727' ' ' LYS . . . . . 0.475 ' HD2' ' N ' ' A' ' 727' ' ' LYS . 3.4 mptp? -90.45 13.45 15.62 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 122.09 -0.381 . . . . 74.349999999999994 111.59 -177.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 728' ' ' GLY . . . . . . . . . . . . . . . 91.54 10.84 61.46 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 121.118 -0.563 . . . . 61.329999999999998 114.224 174.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 729' ' ' HIS . . . . . 0.503 ' HB2' ' HB3' ' A' ' 725' ' ' ASP . 46.7 m80 -80.79 107.24 13.43 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 117.397 0.598 . . . . 74.109999999999999 111.203 178.36 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 730' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -111.39 124.69 52.77 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.982 -0.554 . . . . 62.450000000000003 111.271 -175.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 28.8 m -131.16 152.6 37.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 CA-C-O 120.739 0.304 . . . . 73.409999999999997 111.283 179.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 10.2 t -136.25 153.81 51.09 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 112.727 0.639 . . . . 64.510000000000005 112.727 -176.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -148.35 161.6 41.22 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.079 0.551 . . . . 53.229999999999997 110.704 177.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 734' ' ' LYS . . . . . . . . . . . . . 41.3 mttp -122.72 156.6 34.08 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 113.246 0.832 . . . . 74.120000000000005 113.246 -176.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 735' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -130.56 128.56 41.35 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 115.141 -0.936 . . . . 74.420000000000002 110.542 176.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 736' ' ' THR . . . . . . . . . . . . . 85.3 m -96.96 104.01 15.99 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.825 0.345 . . . . 71.510000000000005 111.37 178.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 737' ' ' VAL . . . . . 0.488 HG23 ' HB1' ' A' ' 675' ' ' ALA . 48.7 t -98.76 131.9 45.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-O 120.638 0.256 . . . . 73.140000000000001 111.414 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 738' ' ' THR . . . . . . . . . . . . . 90.7 m -121.36 117.9 28.12 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.042 0.449 . . . . 74.409999999999997 111.574 179.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 739' ' ' VAL . . . . . . . . . . . . . 27.4 t -98.94 125.14 52.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-N 116.244 -0.435 . . . . 73.340000000000003 111.043 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 740' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -114.1 152.34 31.23 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 112.142 0.423 . . . . 74.310000000000002 112.142 -177.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 741' ' ' VAL . . . . . . . . . . . . . 23.7 t . . . . . 0 CA--C 1.544 0.717 0 CA-C-O 121.191 0.519 . . . . 74.409999999999997 112.307 -176.599 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 664' ' ' ASP . . . . . 0.441 ' OD2' ' HB2' ' A' ' 727' ' ' LYS . 35.4 t0 . . . . . 0 CA--C 1.532 0.265 0 CA-C-O 120.988 0.423 . . . . 74.030000000000001 109.916 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 665' ' ' LEU . . . . . 0.421 HD11 ' HD3' ' A' ' 694' ' ' LYS . 88.2 mt -90.6 137.32 32.45 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.165 -0.47 . . . . 73.219999999999999 110.463 175.764 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 666' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -57.01 131.96 80.05 Favored Pre-proline 0 CA--C 1.54 0.586 0 CA-C-N 116.496 -0.32 . . . . 71.129999999999995 110.557 172.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 667' ' ' PRO . . . . . 0.505 ' HB3' HD13 ' A' ' 699' ' ' LEU . 26.9 Cg_endo -60.37 148.61 89.8 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 122.433 2.089 . . . . 72.230000000000004 113.36 -172.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 668' ' ' LYS . . . . . . . . . . . . . 56.9 tptt -83.22 108.61 16.58 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.095 0.474 . . . . 72.219999999999999 111.213 177.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 669' ' ' LEU . . . . . 0.514 ' HG ' HG22 ' A' ' 671' ' ' VAL . 56.6 tp -96.65 111.97 23.9 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 116.281 -0.418 . . . . 71.439999999999998 111.335 -179.585 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 670' ' ' THR . . . . . . . . . . . . . 72.6 m -87.87 109.69 19.96 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.657 0.265 . . . . 52.140000000000001 110.927 179.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 671' ' ' VAL . . . . . 0.514 HG22 ' HG ' ' A' ' 669' ' ' LEU . 95.2 t -136.23 130.1 18.13 Favored Pre-proline 0 N--CA 1.472 0.663 0 CA-C-N 116.455 -0.339 . . . . 74.019999999999996 111.065 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 672' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -76.2 156.09 37.64 Favored 'Trans proline' 0 CA--C 1.542 0.882 0 C-N-CA 122.622 2.215 . . . . 74.140000000000001 112.759 176.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 673' ' ' VAL . . . . . . . . . . . . . 13.5 p -81.66 -33.59 12.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 N-CA-C 112.94 0.719 . . . . 71.040000000000006 112.94 -174.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 674' ' ' GLY . . . . . . . . . . . . . . . -175.08 139.55 4.85 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 119.926 -1.131 . . . . 55.049999999999997 114.35 -176.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 675' ' ' ALA . . . . . . . . . . . . . . . -139.96 151.33 45.45 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 122.654 0.382 . . . . 72.099999999999994 110.965 178.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 676' ' ' THR . . . . . . . . . . . . . 97.6 m -131.62 123.17 27.32 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-O 120.719 0.295 . . . . 74.510000000000005 111.576 -179.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 677' ' ' ILE . . . . . . . . . . . . . 29.8 pt -123.14 177.44 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 122.699 0.4 . . . . 75.140000000000001 111.405 -179.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 678' ' ' HIS . . . . . . . . . . . . . 74.2 m80 -107.37 161.66 14.61 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 121.326 0.584 . . . . 72.409999999999997 112.368 178.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 679' ' ' VAL . . . . . 0.552 HG13 ' HA ' ' A' ' 712' ' ' THR . 76.6 t -60.44 126.37 18.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-N 115.747 -0.661 . . . . 72.239999999999995 111.837 176.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 103.52 -2.69 46.15 Favored Glycine 0 CA--C 1.528 0.906 0 CA-C-N 116.129 -0.487 . . . . 64.209999999999994 113.389 -178.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 681' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -88.8 -175.74 4.99 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 116.91 0.355 . . . . 74.099999999999994 110.979 178.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 682' ' ' SER . . . . . . . . . . . . . 74.9 m -134.69 137.68 43.76 Favored 'General case' 0 N--CA 1.477 0.898 0 O-C-N 121.993 -0.442 . . . . 74.099999999999994 111.877 -178.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 683' ' ' PHE . . . . . . . . . . . . . 47.2 t80 -125.89 133.81 51.79 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 116.35 -0.386 . . . . 74.340000000000003 110.655 -178.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 684' ' ' VAL . . . . . . . . . . . . . 46.4 t -123.77 93.77 46.9 Favored Pre-proline 0 CA--C 1.546 0.791 0 CA-C-O 121.108 0.48 . . . . 72.109999999999999 112.089 -174.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -64.02 -29.58 66.26 Favored 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 122.706 2.271 . . . . 75.530000000000001 113.805 -178.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 686' ' ' MET . . . . . 0.468 ' HE1' ' HA ' ' A' ' 686' ' ' MET . 0.7 OUTLIER -79.3 -7.57 58.4 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.547 0.573 . . . . 72.140000000000001 112.547 -177.854 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 687' ' ' ALA . . . . . . . . . . . . . . . -110.26 -39.1 5.08 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.866 0.365 . . . . 71.239999999999995 111.655 177.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 688' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -77.38 -10.47 59.47 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 112.43 0.53 . . . . 74.049999999999997 112.43 -177.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 689' ' ' VAL . . . . . 0.483 HG11 HD13 ' A' ' 703' ' ' ILE . 88.7 t -119.03 125.01 74.13 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 CA-C-O 120.865 0.364 . . . . 75.129999999999995 111.565 178.089 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 690' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -122.36 161.77 22.81 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 120.863 0.364 . . . . 74.510000000000005 111.375 -177.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 691' ' ' ALA . . . . . . . . . . . . . . . -147.46 122.62 10.18 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 120.966 0.412 . . . . 74.400000000000006 111.896 177.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 692' ' ' ILE . . . . . . . . . . . . . 45.4 mm -123.9 135.01 64.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-N 116.349 -0.387 . . . . 74.239999999999995 111.25 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -120.44 149.91 41.64 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 120.823 0.344 . . . . 70.430000000000007 111.63 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 694' ' ' LYS . . . . . 0.421 ' HD3' HD11 ' A' ' 665' ' ' LEU . 37.8 ttpt -62.49 -61.2 2.6 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 112.314 0.487 . . . . 73.510000000000005 112.314 -177.465 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -85.09 -53.11 5.48 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 111.868 0.321 . . . . 64.409999999999997 111.868 -174.664 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 696' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -66.52 -48.91 68.26 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 121.063 0.459 . . . . 71.140000000000001 111.052 -173.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . 122.49 -146.95 16.88 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 121.224 -0.513 . . . . 72.109999999999999 113.11 178.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -70.94 111.36 6.27 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.955 0.407 . . . . 75.200000000000003 110.921 179.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 699' ' ' LEU . . . . . 0.505 HD13 ' HB3' ' A' ' 667' ' ' PRO . 79.0 mt -104.77 17.41 24.18 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 120.85 0.357 . . . . 74.340000000000003 111.503 179.517 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 42.4 m -56.77 -37.12 70.65 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.177 0.513 . . . . 73.349999999999994 111.268 178.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 701' ' ' SER . . . . . . . . . . . . . 27.5 m -68.55 -12.48 61.33 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 116.207 -0.451 . . . . 73.150000000000006 111.982 178.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 702' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -100.69 3.18 42.18 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 111.813 0.301 . . . . 74.0 111.813 -176.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 703' ' ' ILE . . . . . 0.483 HD13 HG11 ' A' ' 689' ' ' VAL . 72.2 mt -73.7 118.5 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 120.964 0.411 . . . . 73.420000000000002 111.718 -178.72 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 704' ' ' LYS . . . . . 0.709 ' HZ1' ' HB2' ' A' ' 704' ' ' LYS . 5.2 ttmp? -84.33 115.59 22.58 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 116.169 -0.469 . . . . 74.430000000000007 110.329 176.277 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 67.8 t -95.87 106.57 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 121.161 0.505 . . . . 74.219999999999999 111.595 -178.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 706' ' ' ASP . . . . . 0.537 ' HB3' ' HB ' ' A' ' 720' ' ' THR . 25.2 t70 -101.82 125.57 48.52 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 116.177 -0.465 . . . . 74.450000000000003 111.099 179.378 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 112.04 163.81 17.02 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 121.067 -0.587 . . . . 52.409999999999997 113.335 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 708' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -149.62 145.72 26.92 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.019 0.438 . . . . 74.310000000000002 111.655 -177.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 709' ' ' VAL . . . . . 0.518 HG23 ' HB2' ' A' ' 717' ' ' TYR . 55.4 t -120.45 122.04 67.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 CA-C-N 116.28 -0.418 . . . . 72.019999999999996 111.607 -177.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 710' ' ' ASP . . . . . 0.505 ' HB2' ' HB3' ' A' ' 713' ' ' LYS . 10.1 m-20 -73.94 136.34 43.28 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 120.74 0.305 . . . . 70.010000000000005 110.816 174.35 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 711' ' ' THR . . . . . . . . . . . . . 81.2 p -96.48 0.99 51.1 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 120.932 0.396 . . . . 75.430000000000007 111.237 175.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 712' ' ' THR . . . . . 0.552 ' HA ' HG13 ' A' ' 679' ' ' VAL . 74.5 p -115.71 3.46 13.89 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 116.163 -0.472 . . . . 73.430000000000007 111.912 178.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 713' ' ' LYS . . . . . 0.505 ' HB3' ' HB2' ' A' ' 710' ' ' ASP . 5.6 tppp? -125.37 122.17 36.02 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 120.731 0.3 . . . . 74.430000000000007 111.586 -175.411 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 714' ' ' ALA . . . . . . . . . . . . . . . -70.36 112.46 6.68 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.928 0.394 . . . . 71.209999999999994 111.688 175.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 175.24 168.41 35.73 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 121.112 -0.566 . . . . 41.229999999999997 112.986 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 716' ' ' THR . . . . . . . . . . . . . 86.3 m -104.04 123.11 46.63 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 122.701 -0.293 . . . . 73.140000000000001 111.699 179.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 717' ' ' TYR . . . . . 0.518 ' HB2' HG23 ' A' ' 709' ' ' VAL . 86.0 m-85 -119.93 122.7 41.81 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.005 0.431 . . . . 75.25 111.164 177.012 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 718' ' ' VAL . . . . . . . . . . . . . 59.0 t -92.37 117.91 36.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-O 120.738 0.304 . . . . 73.340000000000003 111.139 177.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 719' ' ' LEU . . . . . 0.413 HD23 HG22 ' A' ' 709' ' ' VAL . 58.1 mt -94.45 148.26 22.42 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 116.671 -0.24 . . . . 75.430000000000007 111.111 -179.436 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 720' ' ' THR . . . . . 0.537 ' HB ' ' HB3' ' A' ' 706' ' ' ASP . 25.0 m -114.98 133.15 56.28 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 120.615 0.245 . . . . 53.509999999999998 111.072 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 721' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -122.91 115.87 22.66 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.835 0.35 . . . . 74.430000000000007 111.07 179.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 46.2 m -123.95 123.1 39.67 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 120.654 0.264 . . . . 74.299999999999997 111.474 -178.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 8.7 p -119.0 136.88 54.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 CA-C-O 120.963 0.411 . . . . 73.109999999999999 111.529 179.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 18.0 m -117.58 128.49 55.0 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.144 0.424 . . . . 72.430000000000007 112.144 -175.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 725' ' ' ASP . . . . . 0.426 ' HB3' ' H ' ' A' ' 729' ' ' HIS . 9.9 t70 -74.59 152.14 39.31 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 116.334 -0.394 . . . . 74.219999999999999 110.624 176.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 726' ' ' SER . . . . . . . . . . . . . 48.7 m -62.52 -27.41 69.14 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 112.624 0.601 . . . . 63.229999999999997 112.624 -177.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 727' ' ' LYS . . . . . 0.488 ' N ' ' HD3' ' A' ' 727' ' ' LYS . 3.5 mppt? -95.04 4.01 54.22 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 112.19 0.441 . . . . 73.340000000000003 112.19 179.399 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 728' ' ' GLY . . . . . . . . . . . . . . . 101.84 34.27 4.4 Favored Glycine 0 CA--C 1.533 1.161 0 N-CA-C 115.563 0.985 . . . . 51.350000000000001 115.563 171.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 729' ' ' HIS . . . . . 0.426 ' H ' ' HB3' ' A' ' 725' ' ' ASP . 31.2 m80 -109.53 111.08 22.39 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 118.077 0.938 . . . . 74.319999999999993 110.926 170.704 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 730' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -113.82 118.45 34.28 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 112.004 0.372 . . . . 61.219999999999999 112.004 -174.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 30.7 m -117.17 155.11 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-O 120.671 0.272 . . . . 72.349999999999994 111.171 178.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 10.0 t -147.52 145.38 29.08 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 112.792 0.664 . . . . 75.310000000000002 112.792 -175.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -148.72 143.65 26.57 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.962 -0.563 . . . . 74.209999999999994 111.144 178.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 734' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -106.92 159.52 16.2 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.343 0.592 . . . . 74.129999999999995 112.41 -178.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 735' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -132.77 130.08 39.46 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.707 -0.679 . . . . 75.519999999999996 110.837 -179.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 736' ' ' THR . . . . . . . . . . . . . 90.5 m -94.13 103.89 15.93 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 120.919 0.39 . . . . 74.340000000000003 111.865 -179.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 44.3 t -102.6 135.17 41.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-O 120.719 0.295 . . . . 65.209999999999994 111.473 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 738' ' ' THR . . . . . . . . . . . . . 92.5 m -125.36 131.6 52.96 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 120.723 0.297 . . . . 74.219999999999999 111.378 178.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 739' ' ' VAL . . . . . . . . . . . . . 51.6 t -109.73 128.03 66.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-O 120.829 0.347 . . . . 64.349999999999994 111.011 177.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 740' ' ' LYS . . . . . 0.682 ' HB3' ' HZ1' ' A' ' 740' ' ' LYS . 7.3 mtpm? -116.18 152.6 33.39 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.973 0.416 . . . . 74.239999999999995 111.374 179.141 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 741' ' ' VAL . . . . . . . . . . . . . 18.1 t . . . . . 0 CA--C 1.539 0.556 0 CA-C-O 120.704 0.288 . . . . 74.0 111.033 -178.561 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 664' ' ' ASP . . . . . . . . . . . . . 8.6 t70 . . . . . 0 CA--C 1.533 0.316 0 CA-C-O 121.406 0.622 . . . . 71.219999999999999 111.552 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 665' ' ' LEU . . . . . . . . . . . . . 86.9 mt -87.33 126.0 34.58 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.648 -0.706 . . . . 73.230000000000004 110.387 176.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 666' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -62.1 145.59 93.15 Favored Pre-proline 0 CA--C 1.542 0.661 0 CA-C-N 116.116 -0.493 . . . . 73.030000000000001 111.3 178.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 667' ' ' PRO . . . . . 0.457 ' HB3' ' HB2' ' A' ' 693' ' ' ASP . 80.4 Cg_endo -76.94 147.14 26.64 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 122.365 2.043 . . . . 75.549999999999997 112.872 -176.189 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 668' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -83.15 104.05 13.04 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.127 0.489 . . . . 74.549999999999997 110.901 179.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 669' ' ' LEU . . . . . 0.413 ' HG ' HG21 ' A' ' 671' ' ' VAL . 58.1 tp -89.91 105.87 18.09 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.065 -0.516 . . . . 74.510000000000005 110.707 177.392 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 670' ' ' THR . . . . . . . . . . . . . 73.5 m -88.18 110.97 21.11 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.162 -0.472 . . . . 74.430000000000007 111.273 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 671' ' ' VAL . . . . . 0.486 HG22 HG13 ' A' ' 689' ' ' VAL . 85.7 t -132.08 126.27 20.49 Favored Pre-proline 0 N--CA 1.47 0.53 0 CA-C-N 116.146 -0.479 . . . . 73.120000000000005 110.768 179.275 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 672' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -69.73 137.48 35.64 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 122.27 1.98 . . . . 71.530000000000001 112.297 179.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 673' ' ' VAL . . . . . . . . . . . . . 12.5 p -64.54 -35.89 75.83 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 N-CA-C 112.279 0.474 . . . . 70.230000000000004 112.279 -175.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 674' ' ' GLY . . . . . . . . . . . . . . . -162.22 161.62 33.63 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 120.647 -0.787 . . . . 71.099999999999994 113.699 -178.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 675' ' ' ALA . . . . . . . . . . . . . . . -151.17 157.82 43.17 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 122.299 0.24 . . . . 73.209999999999994 110.955 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 676' ' ' THR . . . . . . . . . . . . . 60.7 m -133.38 126.39 31.18 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 122.347 -0.221 . . . . 72.549999999999997 111.394 179.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 677' ' ' ILE . . . . . . . . . . . . . 23.9 pt -130.33 174.56 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-O 120.976 0.417 . . . . 72.019999999999996 111.311 177.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 678' ' ' HIS . . . . . 0.512 ' O ' ' HB2' ' A' ' 681' ' ' ASP . 72.3 m80 -121.3 171.35 8.8 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.324 0.583 . . . . 64.510000000000005 112.378 -178.1 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 679' ' ' VAL . . . . . 0.448 HG22 ' HA ' ' A' ' 741' ' ' VAL . 84.5 t -63.71 120.01 9.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-N 116.023 -0.535 . . . . 73.329999999999998 111.254 175.499 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 97.2 0.84 59.65 Favored Glycine 0 CA--C 1.528 0.895 0 CA-C-N 116.185 -0.461 . . . . 63.439999999999998 113.211 -175.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 681' ' ' ASP . . . . . 0.512 ' HB2' ' O ' ' A' ' 678' ' ' HIS . 0.9 OUTLIER -77.05 178.58 6.87 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-O 121.101 0.477 . . . . 53.039999999999999 111.116 -179.561 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 682' ' ' SER . . . . . . . . . . . . . 87.2 p -134.94 126.21 28.19 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 116.511 -0.313 . . . . 75.120000000000005 110.831 177.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 683' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -127.53 134.38 49.77 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.931 0.396 . . . . 73.450000000000003 111.647 -176.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 684' ' ' VAL . . . . . 0.419 ' HA ' ' HD2' ' A' ' 685' ' ' PRO . 61.8 t -124.26 101.6 34.52 Favored Pre-proline 0 CA--C 1.545 0.766 0 CA-C-O 121.089 0.471 . . . . 73.329999999999998 111.943 -179.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 685' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 684' ' ' VAL . 21.6 Cg_endo -60.99 -36.58 82.1 Favored 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 122.871 2.381 . . . . 72.409999999999997 113.843 -178.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 686' ' ' MET . . . . . 0.457 ' HE1' ' HA ' ' A' ' 686' ' ' MET . 0.5 OUTLIER -78.64 -1.75 35.77 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 112.237 0.458 . . . . 73.310000000000002 112.237 -177.791 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 687' ' ' ALA . . . . . . . . . . . . . . . -95.27 -48.08 6.05 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.078 0.466 . . . . 72.120000000000005 110.808 174.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 688' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -66.01 -38.31 88.12 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.605 0.594 . . . . 71.310000000000002 112.605 179.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 689' ' ' VAL . . . . . 0.486 HG13 HG22 ' A' ' 671' ' ' VAL . 98.9 t -86.67 143.1 12.08 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-O 120.934 0.397 . . . . 73.439999999999998 111.884 -178.118 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 690' ' ' LEU . . . . . 0.42 HD12 ' OG1' ' A' ' 700' ' ' THR . 45.9 tp -141.97 151.87 42.94 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.058 -0.519 . . . . 73.019999999999996 110.683 -177.092 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 691' ' ' ALA . . . . . 0.489 ' HB1' HD12 ' A' ' 703' ' ' ILE . . . -139.78 121.53 15.39 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.235 0.541 . . . . 72.530000000000001 111.439 174.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 692' ' ' ILE . . . . . . . . . . . . . 46.7 mm -128.93 120.53 52.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-N 116.219 -0.446 . . . . 65.540000000000006 111.716 -177.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 693' ' ' ASP . . . . . 0.457 ' HB2' ' HB3' ' A' ' 667' ' ' PRO . 31.9 t70 -102.88 149.24 24.7 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 120.787 0.327 . . . . 63.329999999999998 110.611 174.255 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -67.33 -55.41 13.98 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 112.367 0.506 . . . . 73.129999999999995 112.367 -176.075 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -83.8 -52.03 6.73 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 112.433 0.531 . . . . 63.530000000000001 112.433 -176.415 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 696' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -72.12 -32.79 67.27 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 120.874 0.368 . . . . 75.450000000000003 111.697 -172.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . 109.57 -144.69 16.72 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 120.973 -0.632 . . . . 55.530000000000001 113.515 177.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -71.06 122.47 20.13 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 120.85 0.357 . . . . 74.150000000000006 111.459 -178.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 699' ' ' LEU . . . . . . . . . . . . . 90.3 mt -118.85 20.89 12.69 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 120.998 0.428 . . . . 75.519999999999996 111.348 178.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 700' ' ' THR . . . . . 0.42 ' OG1' HD12 ' A' ' 690' ' ' LEU . 26.3 m -62.18 -39.22 91.94 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 121.169 0.509 . . . . 74.25 111.611 -179.339 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 701' ' ' SER . . . . . . . . . . . . . 63.3 m -71.07 -9.51 58.17 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 116.211 -0.449 . . . . 71.530000000000001 111.637 177.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 702' ' ' LYS . . . . . 0.466 ' HB3' ' HZ2' ' A' ' 702' ' ' LYS . 2.4 mmmp? -87.01 -9.66 55.01 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 120.668 0.271 . . . . 72.450000000000003 111.049 176.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 703' ' ' ILE . . . . . 0.489 HD12 ' HB1' ' A' ' 691' ' ' ALA . 67.7 mt -74.76 115.57 16.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-O 120.743 0.306 . . . . 63.200000000000003 111.531 -178.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 704' ' ' LYS . . . . . . . . . . . . . 30.2 ttpt -89.95 119.47 30.34 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 120.872 0.368 . . . . 63.100000000000001 110.375 174.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 45.2 t -97.3 137.59 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 112.238 0.459 . . . . 63.240000000000002 112.238 -174.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 706' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -131.78 134.63 46.04 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 120.932 0.396 . . . . 63.450000000000003 110.962 175.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 128.07 178.87 15.55 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 121.373 -0.442 . . . . 73.219999999999999 112.987 179.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 708' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -166.28 130.71 2.17 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.046 0.45 . . . . 72.349999999999994 111.721 179.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 709' ' ' VAL . . . . . . . . . . . . . 60.1 t -107.54 131.2 58.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-N 116.222 -0.444 . . . . 73.120000000000005 111.652 -178.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 710' ' ' ASP . . . . . 0.434 ' O ' HG23 ' A' ' 739' ' ' VAL . 7.4 m-20 -85.68 141.86 29.45 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.037 0.446 . . . . 73.120000000000005 111.757 178.518 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 711' ' ' THR . . . . . 0.444 ' O ' ' HA ' ' A' ' 679' ' ' VAL . 80.5 p -111.29 2.36 17.64 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.476 -0.329 . . . . 75.150000000000006 111.648 177.361 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 712' ' ' THR . . . . . . . . . . . . . 31.2 p -103.84 -28.68 11.46 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 120.951 0.405 . . . . 61.439999999999998 111.883 178.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 713' ' ' LYS . . . . . 0.657 ' HZ2' ' HB2' ' A' ' 713' ' ' LYS . 4.8 ttmp? -119.64 133.33 55.69 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.505 -0.316 . . . . 73.310000000000002 111.174 -178.404 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 714' ' ' ALA . . . . . . . . . . . . . . . -69.56 142.98 53.5 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 120.868 0.366 . . . . 74.540000000000006 111.435 178.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 160.84 157.83 8.95 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 120.995 -0.621 . . . . 73.430000000000007 113.107 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 716' ' ' THR . . . . . . . . . . . . . 86.3 m -99.07 123.26 43.23 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 122.496 -0.414 . . . . 74.5 111.67 -178.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 717' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -122.19 150.33 42.4 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 122.579 0.352 . . . . 65.239999999999995 111.204 -178.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 718' ' ' VAL . . . . . . . . . . . . . 57.6 t -113.7 125.44 70.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 CA-C-O 121.003 0.43 . . . . 73.019999999999996 111.642 178.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 719' ' ' LEU . . . . . . . . . . . . . 81.4 mt -102.41 141.69 34.83 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.444 -0.344 . . . . 72.349999999999994 110.95 179.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 86.5 m -112.29 139.68 47.64 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-O 120.994 0.426 . . . . 61.100000000000001 111.71 -178.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 721' ' ' TYR . . . . . . . . . . . . . 50.1 m-85 -132.56 122.38 24.7 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 116.191 -0.459 . . . . 74.430000000000007 110.937 -179.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 95.3 m -125.69 125.32 42.86 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 120.873 0.368 . . . . 74.0 111.883 -179.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 723' ' ' VAL . . . . . 0.466 ' HB ' HG12 ' A' ' 703' ' ' ILE . 14.9 p -121.56 152.14 25.11 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-N 116.297 -0.411 . . . . 72.140000000000001 111.005 178.312 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 87.0 m -133.08 132.11 41.37 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.058 0.456 . . . . 72.519999999999996 111.938 177.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 725' ' ' ASP . . . . . 0.453 ' HB2' ' HD3' ' A' ' 667' ' ' PRO . 9.9 t0 -73.41 151.05 41.29 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 115.714 -0.676 . . . . 64.519999999999996 110.608 177.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 726' ' ' SER . . . . . . . . . . . . . 44.0 t -59.57 -31.66 69.65 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.328 -0.396 . . . . 74.0 111.786 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 727' ' ' LYS . . . . . . . . . . . . . 10.3 mptt -86.71 1.05 53.41 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 112.237 0.458 . . . . 71.349999999999994 112.237 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 728' ' ' GLY . . . . . . . . . . . . . . . 100.55 33.77 4.96 Favored Glycine 0 CA--C 1.534 1.23 0 N-CA-C 115.49 0.956 . . . . 71.530000000000001 115.49 171.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 52.3 m80 -109.45 112.08 23.98 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 118.062 0.931 . . . . 74.530000000000001 111.571 173.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 730' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -99.51 129.05 45.65 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 121.028 0.442 . . . . 73.329999999999998 111.825 -176.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 48.8 t -127.51 136.1 61.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-N 116.22 -0.445 . . . . 71.209999999999994 110.591 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 10.3 t -135.13 144.95 47.39 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 112.364 0.505 . . . . 74.209999999999994 112.364 -178.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 733' ' ' ALA . . . . . 0.477 ' HB1' HG23 ' A' ' 671' ' ' VAL . . . -148.86 162.1 40.5 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 116.222 -0.445 . . . . 64.400000000000006 111.71 -178.53 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 734' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -123.72 155.35 38.01 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 112.356 0.502 . . . . 74.140000000000001 112.356 -178.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 735' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -130.04 126.36 37.5 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 116.021 -0.536 . . . . 74.25 110.746 177.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 736' ' ' THR . . . . . . . . . . . . . 97.8 m -95.1 109.54 21.59 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 120.992 0.425 . . . . 73.319999999999993 111.726 -179.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 47.7 t -106.5 121.67 59.4 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 CA-C-O 120.897 0.379 . . . . 63.350000000000001 111.505 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 738' ' ' THR . . . . . . . . . . . . . 54.2 m -104.77 121.81 44.4 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.091 0.472 . . . . 75.239999999999995 111.986 179.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 739' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 710' ' ' ASP . 24.4 t -98.09 136.3 29.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-N 116.063 -0.517 . . . . 74.530000000000001 111.047 178.11 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 740' ' ' LYS . . . . . 0.408 ' O ' ' HA ' ' A' ' 678' ' ' HIS . 96.0 mttt -131.38 156.01 46.29 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.259 0.552 . . . . 75.329999999999998 111.957 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 741' ' ' VAL . . . . . 0.448 ' HA ' HG22 ' A' ' 679' ' ' VAL . 28.2 t . . . . . 0 CA--C 1.54 0.559 0 CA-C-N 116.266 -0.425 . . . . 75.129999999999995 111.485 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 664' ' ' ASP . . . . . . . . . . . . . 27.3 t0 . . . . . 0 CA--C 1.534 0.344 0 CA-C-O 121.096 0.474 . . . . 70.450000000000003 110.979 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 665' ' ' LEU . . . . . . . . . . . . . 86.2 mt -96.94 136.89 36.86 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.117 -0.492 . . . . 74.019999999999996 110.768 175.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 666' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -56.83 139.59 77.21 Favored Pre-proline 0 CA--C 1.544 0.712 0 CA-C-O 120.79 0.329 . . . . 73.340000000000003 111.16 175.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 667' ' ' PRO . . . . . 0.523 ' HB3' HD13 ' A' ' 699' ' ' LEU . 58.3 Cg_endo -68.97 156.77 64.32 Favored 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 122.618 2.212 . . . . 73.409999999999997 113.737 -172.614 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 668' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -87.76 105.18 17.21 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.99 -0.55 . . . . 65.540000000000006 111.226 177.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 669' ' ' LEU . . . . . 0.502 ' HG ' HG22 ' A' ' 671' ' ' VAL . 62.1 tp -95.09 108.13 20.21 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 116.011 -0.54 . . . . 74.230000000000004 110.658 177.151 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 670' ' ' THR . . . . . . . . . . . . . 88.2 m -86.34 111.31 20.36 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.858 0.361 . . . . 73.109999999999999 111.244 179.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 671' ' ' VAL . . . . . 0.502 HG22 ' HG ' ' A' ' 669' ' ' LEU . 94.6 t -136.31 130.93 18.39 Favored Pre-proline 0 N--CA 1.47 0.555 0 CA-C-N 116.301 -0.409 . . . . 73.319999999999993 110.983 -179.668 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 672' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -76.24 143.73 25.58 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 122.248 1.965 . . . . 72.510000000000005 111.995 175.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 673' ' ' VAL . . . . . . . . . . . . . 15.0 p -77.87 -28.06 15.34 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 CA-C-O 120.874 0.369 . . . . 72.340000000000003 111.403 -176.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 674' ' ' GLY . . . . . . . . . . . . . . . -156.16 136.61 5.1 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 120.934 -0.65 . . . . 63.32 113.584 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 675' ' ' ALA . . . . . . . . . . . . . . . -131.29 158.91 39.39 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 122.68 0.392 . . . . 71.340000000000003 110.528 177.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 676' ' ' THR . . . . . . . . . . . . . 13.6 m -135.0 129.04 33.53 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 112.018 0.377 . . . . 72.549999999999997 112.018 -177.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 677' ' ' ILE . . . . . . . . . . . . . 24.4 pt -138.97 176.43 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 122.465 0.306 . . . . 73.219999999999999 111.032 177.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 678' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -124.73 165.46 17.92 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.976 0.417 . . . . 75.319999999999993 111.511 178.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 679' ' ' VAL . . . . . . . . . . . . . 63.6 t -60.01 112.58 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 CA-C-N 116.211 -0.449 . . . . 71.409999999999997 110.668 175.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 118.3 -26.13 7.92 Favored Glycine 0 CA--C 1.528 0.89 0 CA-C-N 116.164 -0.471 . . . . 44.43 112.808 -175.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 681' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -69.11 163.91 23.71 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.248 0.547 . . . . 74.540000000000006 112.058 178.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 682' ' ' SER . . . . . . . . . . . . . 67.2 m -120.69 121.67 38.77 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.13 -0.487 . . . . 72.439999999999998 111.246 -178.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 683' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -118.42 126.89 53.02 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.334 -0.394 . . . . 73.340000000000003 110.809 -177.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 684' ' ' VAL . . . . . . . . . . . . . 60.8 t -115.4 100.67 53.88 Favored Pre-proline 0 N--CA 1.47 0.572 0 CA-C-O 120.789 0.328 . . . . 71.25 111.429 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -54.53 -47.14 28.43 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 122.802 2.334 . . . . 64.219999999999999 113.692 -177.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 686' ' ' MET . . . . . 0.479 ' HE2' ' HB ' ' A' ' 703' ' ' ILE . 88.2 mmm -78.24 0.56 24.7 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.898 0.703 . . . . 74.329999999999998 112.898 -175.398 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 687' ' ' ALA . . . . . . . . . . . . . . . -94.02 -47.79 6.53 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 120.943 0.401 . . . . 75.430000000000007 110.907 175.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 688' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -80.84 -18.22 48.15 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 112.373 0.508 . . . . 74.040000000000006 112.373 -178.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 689' ' ' VAL . . . . . 0.485 HG22 ' CZ ' ' A' ' 721' ' ' TYR . 89.3 t -97.54 142.43 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-O 120.888 0.375 . . . . 74.310000000000002 111.227 177.031 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 690' ' ' LEU . . . . . 0.572 HD23 HG12 ' A' ' 692' ' ' ILE . 7.9 tt -146.02 150.69 36.47 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.385 -0.371 . . . . 75.209999999999994 111.357 -173.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 691' ' ' ALA . . . . . . . . . . . . . . . -142.44 120.93 12.45 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.091 0.472 . . . . 64.450000000000003 111.885 176.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 692' ' ' ILE . . . . . 0.572 HG12 HD23 ' A' ' 690' ' ' LEU . 39.3 mm -127.46 144.15 38.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-N 116.166 -0.47 . . . . 72.340000000000003 110.761 178.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 693' ' ' ASP . . . . . 0.445 ' HB2' ' HB3' ' A' ' 667' ' ' PRO . 36.5 t70 -125.02 149.3 47.9 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 120.949 0.404 . . . . 71.019999999999996 111.582 -178.137 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -57.99 -60.09 4.25 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 116.003 -0.544 . . . . 72.200000000000003 112.428 -177.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -85.07 -53.58 5.19 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 112.096 0.406 . . . . 73.109999999999999 112.096 -176.283 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 696' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -70.23 -42.13 72.68 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.793 0.33 . . . . 73.0 111.863 -171.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . 108.56 -131.89 10.81 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 120.96 -0.638 . . . . 75.040000000000006 113.399 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -70.93 113.36 7.9 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 121.064 0.459 . . . . 74.409999999999997 111.523 -177.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 699' ' ' LEU . . . . . 0.523 HD13 ' HB3' ' A' ' 667' ' ' PRO . 89.6 mt -110.73 11.8 22.59 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.316 0.579 . . . . 72.219999999999999 110.397 172.532 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 21.1 m -59.89 -28.68 67.77 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.937 -0.574 . . . . 73.040000000000006 110.888 177.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 701' ' ' SER . . . . . . . . . . . . . 34.2 t -71.13 -24.42 62.27 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 116.244 -0.434 . . . . 73.140000000000001 111.456 175.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 702' ' ' LYS . . . . . 0.478 ' HB2' HG21 ' A' ' 723' ' ' VAL . 8.4 mmpt? -81.32 -13.75 58.05 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 111.87 0.322 . . . . 65.010000000000005 111.87 -178.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 703' ' ' ILE . . . . . 0.479 ' HB ' ' HE2' ' A' ' 686' ' ' MET . 69.8 mt -65.44 115.48 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 N-CA-C 112.076 0.398 . . . . 73.200000000000003 112.076 -177.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 704' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -98.42 124.76 43.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.112 0.482 . . . . 74.030000000000001 110.797 172.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 61.5 t -96.2 111.35 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-N 115.813 -0.63 . . . . 73.109999999999999 111.852 -177.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 706' ' ' ASP . . . . . 0.441 ' HB3' ' HB ' ' A' ' 720' ' ' THR . 38.6 t70 -99.23 134.6 41.85 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.455 -0.339 . . . . 74.409999999999997 110.748 177.211 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 108.42 171.77 21.39 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 121.148 -0.548 . . . . 65.239999999999995 112.678 -176.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 708' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -144.34 148.33 34.6 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 122.58 -0.365 . . . . 74.230000000000004 111.572 -176.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 709' ' ' VAL . . . . . 0.504 HG21 HD23 ' A' ' 719' ' ' LEU . 84.5 t -126.56 118.14 50.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 CA-C-O 120.806 0.336 . . . . 75.540000000000006 111.298 178.428 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 710' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -87.19 136.57 32.88 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 121.101 0.477 . . . . 70.420000000000002 111.361 177.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 711' ' ' THR . . . . . . . . . . . . . 73.9 p -98.63 -13.47 20.33 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.927 0.394 . . . . 73.519999999999996 111.437 177.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 712' ' ' THR . . . . . . . . . . . . . 71.7 p -93.31 -27.68 16.66 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 116.271 -0.422 . . . . 74.310000000000002 111.535 178.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 713' ' ' LYS . . . . . . . . . . . . . 50.2 tptt -116.53 132.43 56.68 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.563 -0.29 . . . . 75.439999999999998 110.526 178.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 714' ' ' ALA . . . . . . . . . . . . . . . -86.59 144.93 26.95 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 112.786 0.662 . . . . 72.030000000000001 112.786 -176.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 163.41 176.31 35.27 Favored Glycine 0 CA--C 1.522 0.482 0 CA-C-N 115.424 -0.807 . . . . 63.0 111.959 -179.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 716' ' ' THR . . . . . . . . . . . . . 95.7 m -94.68 122.21 37.05 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 117.222 0.511 . . . . 71.329999999999998 110.978 177.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 717' ' ' TYR . . . . . 0.46 ' HB2' HG22 ' A' ' 709' ' ' VAL . 57.6 m-85 -121.95 119.45 31.54 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.463 -0.335 . . . . 75.200000000000003 110.94 -178.213 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 718' ' ' VAL . . . . . . . . . . . . . 60.3 t -91.42 123.23 43.48 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-O 120.809 0.338 . . . . 72.420000000000002 111.182 179.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 719' ' ' LEU . . . . . 0.504 HD23 HG21 ' A' ' 709' ' ' VAL . 88.0 mt -104.82 126.15 51.6 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.418 -0.356 . . . . 75.430000000000007 111.241 177.587 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 720' ' ' THR . . . . . 0.441 ' HB ' ' HB3' ' A' ' 706' ' ' ASP . 95.1 m -101.08 127.48 47.59 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.988 0.423 . . . . 74.450000000000003 111.33 178.314 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 721' ' ' TYR . . . . . 0.495 ' HH ' ' NE2' ' A' ' 735' ' ' GLN . 57.7 m-85 -113.47 113.91 25.81 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.685 0.279 . . . . 74.5 110.76 179.466 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 72.0 m -113.85 125.34 53.95 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.762 0.315 . . . . 70.150000000000006 111.469 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 723' ' ' VAL . . . . . 0.478 HG21 ' HB2' ' A' ' 702' ' ' LYS . 8.3 p -129.42 133.98 64.44 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-O 120.995 0.426 . . . . 75.519999999999996 111.224 179.015 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 73.5 m -116.44 136.25 53.15 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 120.934 0.397 . . . . 73.400000000000006 111.887 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 725' ' ' ASP . . . . . 0.407 ' HB2' ' HD3' ' A' ' 667' ' ' PRO . 10.7 t0 -73.28 150.9 41.59 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 109.675 -0.491 . . . . 73.439999999999998 109.675 174.297 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 726' ' ' SER . . . . . . . . . . . . . 34.9 t -56.15 -33.24 65.02 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.348 -0.387 . . . . 74.140000000000001 111.753 -179.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 727' ' ' LYS . . . . . 0.471 ' N ' ' HD3' ' A' ' 727' ' ' LYS . 3.6 mppt? -91.42 6.85 43.84 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 112.712 0.634 . . . . 74.010000000000005 112.712 -178.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 728' ' ' GLY . . . . . . . . . . . . . . . 101.69 35.2 4.13 Favored Glycine 0 CA--C 1.534 1.279 0 N-CA-C 116.122 1.209 . . . . 73.329999999999998 116.122 169.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 40.7 m80 -109.3 110.68 21.92 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 118.178 0.989 . . . . 73.400000000000006 111.49 172.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 730' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -96.89 128.5 43.91 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.277 0.56 . . . . 75.109999999999999 112.121 -177.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 57.6 t -126.4 129.48 71.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 CA-C-N 115.97 -0.559 . . . . 71.310000000000002 110.109 176.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 7.5 t -137.12 128.86 28.84 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.167 0.508 . . . . 65.349999999999994 112.296 -177.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -135.56 157.65 46.34 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 122.804 0.442 . . . . 73.230000000000004 110.863 -178.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 734' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -121.3 158.69 27.62 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.994 0.739 . . . . 73.200000000000003 112.994 -175.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 735' ' ' GLN . . . . . 0.495 ' NE2' ' HH ' ' A' ' 721' ' ' TYR . 6.7 tt0 -130.57 128.51 41.25 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.839 -0.619 . . . . 72.420000000000002 111.161 179.645 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 736' ' ' THR . . . . . . . . . . . . . 86.6 m -87.93 103.89 16.1 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 120.751 0.31 . . . . 64.230000000000004 110.991 175.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 47.8 t -96.73 108.39 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-O 120.924 0.392 . . . . 73.530000000000001 111.188 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 738' ' ' THR . . . . . . . . . . . . . 27.3 m -94.84 108.96 20.99 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.79 0.328 . . . . 75.209999999999994 111.342 -179.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 739' ' ' VAL . . . . . . . . . . . . . 43.0 t -94.22 125.34 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-O 120.729 0.3 . . . . 72.010000000000005 110.793 176.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 740' ' ' LYS . . . . . 0.637 ' HZ3' ' HB3' ' A' ' 740' ' ' LYS . 7.8 mtpm? -115.38 146.55 41.47 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.048 0.451 . . . . 73.310000000000002 111.979 -175.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 741' ' ' VAL . . . . . . . . . . . . . 24.3 t . . . . . 0 N--CA 1.473 0.715 0 CA-C-O 120.88 0.371 . . . . 73.200000000000003 111.914 -179.142 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 664' ' ' ASP . . . . . . . . . . . . . 41.5 t0 . . . . . 0 CA--C 1.532 0.257 0 CA-C-O 121.154 0.502 . . . . 65.230000000000004 110.094 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 665' ' ' LEU . . . . . 0.507 HD11 ' HB2' ' A' ' 694' ' ' LYS . 86.6 mt -91.98 137.87 32.01 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.937 -0.574 . . . . 71.140000000000001 111.038 179.191 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 666' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -80.68 142.2 52.83 Favored Pre-proline 0 CA--C 1.541 0.612 0 CA-C-N 116.223 -0.444 . . . . 73.109999999999999 110.406 173.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 667' ' ' PRO . . . . . 0.527 ' HB3' HD11 ' A' ' 699' ' ' LEU . 64.4 Cg_endo -70.86 146.2 52.75 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 122.231 1.954 . . . . 72.430000000000007 113.734 -173.002 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 668' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -83.3 103.86 13.01 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.975 -0.557 . . . . 73.140000000000001 110.576 173.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 669' ' ' LEU . . . . . . . . . . . . . 52.3 tp -89.79 132.65 35.12 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.153 -0.476 . . . . 72.319999999999993 109.95 176.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 670' ' ' THR . . . . . . . . . . . . . 91.1 m -121.61 111.31 17.07 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.025 0.441 . . . . 74.140000000000001 111.124 -179.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 671' ' ' VAL . . . . . . . . . . . . . 88.8 t -128.77 134.55 26.42 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-N 115.82 -0.627 . . . . 64.099999999999994 110.628 -179.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 672' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.57 127.82 17.94 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 121.964 1.776 . . . . 63.439999999999998 111.903 177.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 673' ' ' VAL . . . . . 0.434 ' O ' HG22 ' A' ' 736' ' ' THR . 12.5 p -64.4 -23.78 34.17 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 N-CA-C 112.414 0.524 . . . . 74.450000000000003 112.414 -174.179 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 674' ' ' GLY . . . . . . . . . . . . . . . -169.02 154.27 23.73 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 120.61 -0.805 . . . . 63.140000000000001 113.591 179.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 675' ' ' ALA . . . . . . . . . . . . . . . -150.38 156.29 41.22 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 122.502 0.321 . . . . 72.340000000000003 110.859 177.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 676' ' ' THR . . . . . . . . . . . . . 70.4 m -134.42 127.43 31.55 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.784 0.326 . . . . 72.340000000000003 111.269 -179.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 677' ' ' ILE . . . . . . . . . . . . . 28.4 pt -130.33 176.62 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-O 120.824 0.345 . . . . 61.549999999999997 111.124 179.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 678' ' ' HIS . . . . . 0.496 ' O ' ' HB2' ' A' ' 681' ' ' ASP . 69.9 m80 -116.67 166.67 11.85 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 121.581 0.705 . . . . 75.5 112.311 -179.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 679' ' ' VAL . . . . . 0.432 HG11 ' HA ' ' A' ' 712' ' ' THR . 82.4 t -67.16 112.18 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-N 115.972 -0.558 . . . . 74.129999999999995 110.494 174.334 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 109.24 -2.48 31.22 Favored Glycine 0 CA--C 1.529 0.957 0 CA-C-N 115.891 -0.595 . . . . 73.329999999999998 112.41 -172.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 681' ' ' ASP . . . . . 0.496 ' HB2' ' O ' ' A' ' 678' ' ' HIS . 1.1 t70 -75.62 -168.43 0.85 Allowed 'General case' 0 CA--C 1.547 0.835 0 CA-C-O 120.954 0.407 . . . . 71.319999999999993 110.955 178.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 682' ' ' SER . . . . . . . . . . . . . 73.7 m -150.18 136.74 19.05 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 122.159 -0.338 . . . . 75.439999999999998 110.553 176.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 683' ' ' PHE . . . . . . . . . . . . . 36.0 t80 -138.66 127.38 23.51 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 120.614 0.245 . . . . 71.340000000000003 111.652 -174.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 684' ' ' VAL . . . . . . . . . . . . . 63.8 t -111.73 101.45 51.27 Favored Pre-proline 0 N--CA 1.476 0.85 0 CA-C-O 120.726 0.298 . . . . 71.219999999999999 111.771 179.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -52.82 -42.81 60.91 Favored 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 122.975 2.45 . . . . 70.209999999999994 113.772 179.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 686' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -78.13 3.84 14.04 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 112.79 0.663 . . . . 74.010000000000005 112.79 -176.083 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 687' ' ' ALA . . . . . . . . . . . . . . . -109.35 -14.77 14.39 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 122.2 -0.313 . . . . 74.239999999999995 111.82 176.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 688' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -97.62 -6.5 33.17 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 112.722 0.638 . . . . 74.140000000000001 112.722 -175.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 49.7 t -121.67 154.83 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 N-CA-C 112.025 0.38 . . . . 72.25 112.025 -174.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 690' ' ' LEU . . . . . 0.548 HD23 ' N ' ' A' ' 691' ' ' ALA . 6.4 tt -150.57 143.82 24.9 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 116.509 -0.314 . . . . 71.319999999999993 110.827 -178.307 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 691' ' ' ALA . . . . . 0.548 ' N ' HD23 ' A' ' 690' ' ' LEU . . . -144.08 132.05 21.57 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 112.416 0.525 . . . . 71.430000000000007 112.416 -179.132 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 692' ' ' ILE . . . . . 0.455 HD11 ' HA ' ' A' ' 698' ' ' ASP . 38.6 mm -135.77 136.89 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 N-CA-C 112.116 0.413 . . . . 75.329999999999998 112.116 -179.289 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -115.68 141.82 47.56 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 109.005 -0.739 . . . . 73.140000000000001 109.005 167.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 694' ' ' LYS . . . . . 0.507 ' HB2' HD11 ' A' ' 665' ' ' LEU . 54.5 mttp -71.33 -28.97 64.46 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.289 0.478 . . . . 74.400000000000006 112.289 -177.408 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -83.38 -44.75 14.48 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-O 120.916 0.389 . . . . 75.329999999999998 111.974 -179.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 696' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -92.87 -30.3 15.5 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 120.851 0.358 . . . . 65.299999999999997 111.325 -173.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . 105.86 -135.17 12.48 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 121.325 -0.464 . . . . 73.209999999999994 112.769 179.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 698' ' ' ASP . . . . . 0.455 ' HA ' HD11 ' A' ' 692' ' ' ILE . 12.1 t70 -71.83 125.09 26.29 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 122.534 -0.392 . . . . 71.299999999999997 111.497 179.05 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 699' ' ' LEU . . . . . 0.565 HD21 ' HD2' ' A' ' 702' ' ' LYS . 45.7 mt -119.83 6.65 10.92 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.493 -0.321 . . . . 72.540000000000006 111.584 177.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 49.6 m -58.6 -40.13 82.36 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.201 0.524 . . . . 73.340000000000003 111.464 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 701' ' ' SER . . . . . . . . . . . . . 37.2 t -66.03 -13.78 60.54 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 121.072 0.463 . . . . 72.25 111.817 176.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 702' ' ' LYS . . . . . 0.565 ' HD2' HD21 ' A' ' 699' ' ' LEU . 97.4 mttt -99.11 6.62 46.43 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.217 0.451 . . . . 74.109999999999999 112.217 -178.643 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 73.9 mt -80.02 117.45 25.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-O 121.044 0.45 . . . . 72.140000000000001 111.541 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 704' ' ' LYS . . . . . 0.406 ' HE3' ' HB2' ' A' ' 704' ' ' LYS . 35.9 ttmt -91.34 136.64 32.96 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.212 -0.449 . . . . 72.209999999999994 111.039 176.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 46.6 t -109.27 140.55 27.6 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-O 121.129 0.49 . . . . 75.409999999999997 111.889 -177.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 706' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -132.36 126.02 32.26 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 116.273 -0.421 . . . . 64.519999999999996 110.253 174.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 102.97 152.94 24.1 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 121.141 -0.552 . . . . 53.25 112.404 -173.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 708' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -153.59 143.62 22.1 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 122.19 -0.594 . . . . 74.150000000000006 111.566 -176.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 709' ' ' VAL . . . . . 0.519 HG23 ' HB2' ' A' ' 717' ' ' TYR . 71.7 t -99.52 134.35 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-N 116.067 -0.515 . . . . 75.409999999999997 111.842 -177.231 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 710' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -100.54 150.78 22.32 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 121.027 0.442 . . . . 71.099999999999994 110.431 170.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 711' ' ' THR . . . . . . . . . . . . . 80.7 p -107.39 28.2 8.34 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.444 -0.344 . . . . 73.349999999999994 111.494 -178.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 712' ' ' THR . . . . . 0.432 ' HA ' HG11 ' A' ' 679' ' ' VAL . 7.5 t -115.9 -28.48 6.66 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 112.385 0.513 . . . . 74.230000000000004 112.385 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 713' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -115.67 122.37 45.35 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 120.733 0.301 . . . . 73.25 111.095 -176.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 714' ' ' ALA . . . . . 0.454 ' HB1' HG23 ' A' ' 741' ' ' VAL . . . -70.43 101.96 2.08 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 121.199 0.523 . . . . 71.239999999999995 111.718 -178.268 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . -164.18 168.45 38.61 Favored Glycine 0 CA--C 1.52 0.355 0 CA-C-N 115.99 -0.55 . . . . 71.349999999999994 112.843 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 716' ' ' THR . . . . . . . . . . . . . 73.2 m -95.52 122.7 38.54 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.05 0.452 . . . . 74.150000000000006 111.612 178.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 717' ' ' TYR . . . . . 0.519 ' HB2' HG23 ' A' ' 709' ' ' VAL . 57.6 m-85 -116.86 124.45 49.54 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 116.106 -0.497 . . . . 70.310000000000002 110.418 179.158 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 718' ' ' VAL . . . . . . . . . . . . . 45.6 t -96.28 110.88 25.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-O 121.09 0.471 . . . . 74.120000000000005 111.613 -178.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 719' ' ' LEU . . . . . 0.498 HD23 HG22 ' A' ' 709' ' ' VAL . 58.9 mt -88.41 130.5 35.16 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.131 -0.486 . . . . 75.450000000000003 111.227 -178.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 84.5 m -99.72 132.29 45.16 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.903 0.382 . . . . 75.150000000000006 111.496 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 721' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -122.01 134.27 54.8 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.838 0.351 . . . . 73.439999999999998 110.937 177.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 24.7 m -135.82 130.27 33.7 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 111.625 0.231 . . . . 73.5 111.625 -176.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 8.7 p -125.0 132.47 71.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-O 121.031 0.443 . . . . 73.200000000000003 111.286 178.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 22.7 m -108.4 120.5 42.57 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.945 0.403 . . . . 63.329999999999998 111.991 -176.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 725' ' ' ASP . . . . . 0.476 ' HB2' ' HD3' ' A' ' 667' ' ' PRO . 3.6 t70 -73.19 149.71 42.69 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 116.197 -0.456 . . . . 75.349999999999994 110.734 175.216 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 726' ' ' SER . . . . . . . . . . . . . 56.8 p -65.43 -26.3 67.91 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 112.287 0.477 . . . . 73.120000000000005 112.287 -174.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 727' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -93.76 -3.7 51.68 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 112.715 0.635 . . . . 72.129999999999995 112.715 178.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 728' ' ' GLY . . . . . . . . . . . . . . . 111.72 19.88 7.16 Favored Glycine 0 CA--C 1.532 1.096 0 N-CA-C 115.529 0.972 . . . . 72.349999999999994 115.529 172.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 27.7 m80 -97.13 104.96 17.02 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 118.241 1.02 . . . . 74.010000000000005 111.025 172.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 730' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -112.19 114.63 27.54 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 120.933 0.397 . . . . 73.400000000000006 111.665 -177.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 32.8 m -109.83 158.73 9.82 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-O 121.084 0.469 . . . . 71.439999999999998 111.582 179.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 5.6 t -135.56 145.39 46.92 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 121.204 0.526 . . . . 72.439999999999998 112.163 -176.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -148.59 161.12 42.34 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.997 -0.547 . . . . 64.239999999999995 110.791 176.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 734' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -133.52 157.49 45.51 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 112.509 0.559 . . . . 74.219999999999999 112.509 -176.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 735' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -130.61 125.98 35.48 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 115.623 -0.717 . . . . 72.099999999999994 110.794 178.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 736' ' ' THR . . . . . 0.434 HG22 ' O ' ' A' ' 673' ' ' VAL . 8.3 t -93.36 110.27 21.82 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.254 0.55 . . . . 74.040000000000006 111.588 178.298 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 46.8 t -106.69 115.69 48.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-N 116.474 -0.33 . . . . 74.109999999999999 111.339 -179.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 738' ' ' THR . . . . . . . . . . . . . 88.8 m -99.62 124.72 45.1 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 120.778 0.323 . . . . 75.420000000000002 111.503 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 739' ' ' VAL . . . . . . . . . . . . . 49.7 t -96.76 134.25 35.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-O 120.916 0.389 . . . . 74.129999999999995 111.429 178.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 740' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -121.55 144.96 48.43 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.4 -0.363 . . . . 62.109999999999999 111.188 178.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 741' ' ' VAL . . . . . 0.454 HG23 ' HB1' ' A' ' 714' ' ' ALA . 25.6 t . . . . . 0 N--CA 1.469 0.485 0 O-C-N 121.639 -0.663 . . . . 64.430000000000007 111.638 -178.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 664' ' ' ASP . . . . . 0.472 ' CG ' ' HB2' ' A' ' 727' ' ' LYS . 45.0 t0 . . . . . 0 CA--C 1.535 0.399 0 CA-C-O 121.132 0.491 . . . . 74.019999999999996 111.676 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 665' ' ' LEU . . . . . . . . . . . . . 85.2 mt -81.57 116.86 21.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.007 -0.542 . . . . 74.219999999999999 109.78 175.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 666' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -77.37 137.74 64.02 Favored Pre-proline 0 CA--C 1.541 0.616 0 CA-C-O 120.898 0.38 . . . . 75.209999999999994 111.433 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 667' ' ' PRO . . . . . 0.505 ' HB3' HD13 ' A' ' 699' ' ' LEU . 65.8 Cg_endo -71.46 140.46 36.56 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 122.596 2.197 . . . . 71.219999999999999 113.182 -174.085 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 668' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -83.58 106.9 15.68 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.302 -0.408 . . . . 74.340000000000003 110.631 176.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 669' ' ' LEU . . . . . 0.446 ' HG ' HG23 ' A' ' 671' ' ' VAL . 58.7 tp -90.04 110.14 21.15 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 116.275 -0.421 . . . . 74.349999999999994 110.523 178.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 670' ' ' THR . . . . . . . . . . . . . 67.6 m -86.38 109.4 18.99 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.854 0.359 . . . . 73.209999999999994 111.126 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 671' ' ' VAL . . . . . 0.446 HG23 ' HG ' ' A' ' 669' ' ' LEU . 91.0 t -141.78 120.83 7.95 Favored Pre-proline 0 N--CA 1.473 0.684 0 CA-C-N 116.257 -0.429 . . . . 75.439999999999998 110.774 179.178 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 672' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -73.8 150.1 43.86 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 122.366 2.044 . . . . 74.409999999999997 112.529 -179.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 673' ' ' VAL . . . . . . . . . . . . . 7.7 p -64.36 -38.2 81.94 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 N-CA-C 112.16 0.43 . . . . 74.310000000000002 112.16 -178.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 674' ' ' GLY . . . . . . . . . . . . . . . -156.46 157.67 28.1 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 120.805 -0.712 . . . . 72.540000000000006 114.031 -177.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 675' ' ' ALA . . . . . 0.434 ' O ' ' HA ' ' A' ' 737' ' ' VAL . . . -151.88 135.09 15.89 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 122.831 0.453 . . . . 74.150000000000006 110.668 178.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 676' ' ' THR . . . . . . . . . . . . . 62.5 m -115.23 123.63 49.32 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 121.993 -0.442 . . . . 74.129999999999995 112.025 -178.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 677' ' ' ILE . . . . . . . . . . . . . 17.5 pt -127.36 176.55 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 CA-C-N 116.254 -0.43 . . . . 71.109999999999999 110.865 177.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 678' ' ' HIS . . . . . . . . . . . . . 63.1 m80 -117.05 157.74 25.34 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.429 0.633 . . . . 75.439999999999998 112.182 -178.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 679' ' ' VAL . . . . . . . . . . . . . 92.0 t -54.63 113.02 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-N 115.513 -0.767 . . . . 52.299999999999997 111.401 175.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 116.3 -18.79 13.58 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 121.162 -0.542 . . . . 73.209999999999994 113.705 -179.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 681' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -74.43 -179.77 4.18 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 121.495 0.664 . . . . 64.030000000000001 112.502 -179.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 682' ' ' SER . . . . . . . . . . . . . 57.5 m -122.67 151.27 41.68 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.754 -0.657 . . . . 72.319999999999993 111.401 -178.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 683' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -158.88 116.04 2.77 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 116.546 -0.297 . . . . 73.329999999999998 110.801 -178.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 684' ' ' VAL . . . . . . . . . . . . . 41.7 t -113.57 98.3 46.52 Favored Pre-proline 0 CA--C 1.54 0.564 0 CA-C-O 120.949 0.404 . . . . 62.109999999999999 111.333 -178.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -51.52 -43.68 48.7 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 122.873 2.382 . . . . 72.140000000000001 113.615 -178.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 686' ' ' MET . . . . . 0.529 ' HE2' ' HB ' ' A' ' 703' ' ' ILE . 0.4 OUTLIER -78.25 -1.3 32.3 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 112.758 0.651 . . . . 75.400000000000006 112.758 -177.13 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 687' ' ' ALA . . . . . . . . . . . . . . . -112.32 -8.35 13.94 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.788 0.328 . . . . 74.439999999999998 111.634 176.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 688' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -121.35 -22.54 5.96 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 112.119 0.414 . . . . 75.239999999999995 112.119 -177.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 96.4 t -95.82 148.23 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-O 120.626 0.251 . . . . 74.420000000000002 110.681 175.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 690' ' ' LEU . . . . . 0.613 HD22 HG12 ' A' ' 692' ' ' ILE . 9.6 tt -144.81 152.1 39.8 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 112.037 0.384 . . . . 72.329999999999998 112.037 -171.441 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 691' ' ' ALA . . . . . . . . . . . . . . . -150.33 123.04 8.61 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 120.813 0.339 . . . . 74.310000000000002 111.371 176.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 692' ' ' ILE . . . . . 0.613 HG12 HD22 ' A' ' 690' ' ' LEU . 46.5 mm -123.62 134.65 65.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 N-CA-C 112.467 0.543 . . . . 60.130000000000003 112.467 -178.299 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 693' ' ' ASP . . . . . 0.472 ' HB2' ' HB3' ' A' ' 667' ' ' PRO . 67.7 t0 -117.43 128.34 54.91 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 109.216 -0.661 . . . . 72.040000000000006 109.216 170.588 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -65.63 -26.7 67.94 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 112.96 0.726 . . . . 73.120000000000005 112.96 -173.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -82.8 -40.65 20.12 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 120.824 0.345 . . . . 72.200000000000003 111.526 -177.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 696' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -95.65 -49.31 5.43 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 121.253 0.549 . . . . 55.119999999999997 111.702 -176.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . 129.01 -131.51 6.82 Favored Glycine 0 CA--C 1.528 0.855 0 CA-C-N 116.34 -0.391 . . . . 63.299999999999997 112.654 -177.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 698' ' ' ASP . . . . . 0.444 ' HA ' HD11 ' A' ' 692' ' ' ILE . 20.7 t70 -75.5 109.15 8.82 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 121.055 0.455 . . . . 75.239999999999995 111.464 178.422 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 699' ' ' LEU . . . . . 0.505 HD13 ' HB3' ' A' ' 667' ' ' PRO . 23.3 mt -99.42 4.41 46.2 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 120.839 0.352 . . . . 74.219999999999999 110.787 173.044 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 25.1 m -55.39 -40.06 70.92 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.686 0.755 . . . . 74.099999999999994 109.972 171.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 701' ' ' SER . . . . . . . . . . . . . 21.6 m -66.91 -7.76 24.37 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 115.218 -0.901 . . . . 73.209999999999994 112.146 177.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 702' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -104.05 -7.73 20.06 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 111.884 0.328 . . . . 72.129999999999995 111.884 -179.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 703' ' ' ILE . . . . . 0.529 ' HB ' ' HE2' ' A' ' 686' ' ' MET . 63.2 mt -70.66 140.8 17.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-O 120.835 0.35 . . . . 74.0 111.707 -178.233 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 704' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -110.51 133.42 53.31 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 110.247 -0.279 . . . . 75.299999999999997 110.247 170.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 50.5 t -96.7 107.23 19.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-O 120.956 0.407 . . . . 63.420000000000002 110.831 178.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 706' ' ' ASP . . . . . 0.502 ' HB3' ' HB ' ' A' ' 720' ' ' THR . 13.2 t70 -100.1 127.52 46.33 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 116.283 -0.417 . . . . 74.349999999999994 110.392 179.44 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 123.11 -175.86 16.6 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 121.173 -0.537 . . . . 55.119999999999997 113.132 -178.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 708' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -155.63 141.33 17.97 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 120.783 0.325 . . . . 73.430000000000007 111.237 -178.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 709' ' ' VAL . . . . . 0.447 HG22 ' HB2' ' A' ' 717' ' ' TYR . 93.9 t -124.87 111.53 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-O 120.887 0.375 . . . . 63.32 111.184 178.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 710' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -69.19 134.86 49.8 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 121.054 0.454 . . . . 63.549999999999997 110.669 176.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 711' ' ' THR . . . . . . . . . . . . . 35.9 p -113.54 -0.76 14.29 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.883 0.373 . . . . 74.310000000000002 110.98 178.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 712' ' ' THR . . . . . . . . . . . . . 81.9 p -98.15 -17.81 18.83 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.15 -0.477 . . . . 70.150000000000006 111.505 178.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 713' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -138.52 139.36 38.7 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 120.864 0.364 . . . . 64.209999999999994 111.271 -178.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 714' ' ' ALA . . . . . . . . . . . . . . . -70.18 144.4 51.95 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 112.662 0.616 . . . . 73.140000000000001 112.662 -176.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 159.25 161.54 11.28 Favored Glycine 0 CA--C 1.525 0.683 0 CA-C-N 115.689 -0.687 . . . . 75.409999999999997 112.262 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 716' ' ' THR . . . . . . . . . . . . . 97.4 m -96.88 122.53 39.95 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 117.312 0.556 . . . . 74.5 111.419 178.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 717' ' ' TYR . . . . . 0.447 ' HB2' HG22 ' A' ' 709' ' ' VAL . 22.6 m-85 -123.8 150.2 44.77 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 116.193 -0.458 . . . . 72.450000000000003 110.304 -178.714 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 718' ' ' VAL . . . . . . . . . . . . . 58.4 t -115.57 133.94 60.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 CA-C-O 121.002 0.43 . . . . 72.239999999999995 111.918 -176.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 719' ' ' LEU . . . . . . . . . . . . . 88.6 mt -112.09 125.95 54.65 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.304 -0.407 . . . . 73.230000000000004 111.416 178.043 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 720' ' ' THR . . . . . 0.502 ' HB ' ' HB3' ' A' ' 706' ' ' ASP . 68.8 m -99.52 129.12 45.66 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.156 -0.474 . . . . 75.129999999999995 111.253 178.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 721' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -115.7 114.25 24.59 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.751 0.31 . . . . 74.530000000000001 111.002 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 45.7 m -117.22 131.92 56.74 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.57 -0.286 . . . . 75.230000000000004 111.517 -178.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 723' ' ' VAL . . . . . 0.452 ' HB ' HG12 ' A' ' 703' ' ' ILE . 7.1 p -137.16 137.25 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-O 121.066 0.46 . . . . 74.120000000000005 111.424 178.213 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 724' ' ' THR . . . . . 0.444 ' HA ' ' HA ' ' A' ' 730' ' ' GLU . 33.5 m -107.27 135.3 49.01 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.248 0.547 . . . . 72.329999999999998 112.059 -178.254 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 725' ' ' ASP . . . . . 0.493 ' HB3' ' H ' ' A' ' 729' ' ' HIS . 11.0 t0 -73.61 154.09 39.9 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 115.853 -0.612 . . . . 70.340000000000003 110.617 177.553 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 726' ' ' SER . . . . . . . . . . . . . 74.6 m -65.78 -21.98 66.54 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 116.626 -0.261 . . . . 63.140000000000001 111.572 177.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 727' ' ' LYS . . . . . 0.472 ' HB2' ' CG ' ' A' ' 664' ' ' ASP . 73.8 mmtt -106.81 4.67 27.77 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 112.495 0.554 . . . . 75.120000000000005 112.495 178.725 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 728' ' ' GLY . . . . . . . . . . . . . . . 114.1 -5.67 23.65 Favored Glycine 0 CA--C 1.54 1.624 0 N-CA-C 116.739 1.455 . . . . 70.439999999999998 116.739 171.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 729' ' ' HIS . . . . . 0.493 ' H ' ' HB3' ' A' ' 725' ' ' ASP . 15.1 m80 -73.16 98.17 2.55 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 119.414 1.607 . . . . 75.409999999999997 111.389 174.661 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 730' ' ' GLU . . . . . 0.444 ' HA ' ' HA ' ' A' ' 724' ' ' THR . 34.7 tt0 -98.63 106.96 19.3 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 122.188 -0.32 . . . . 73.030000000000001 111.095 179.325 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 26.9 m -111.71 152.23 13.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-O 120.942 0.401 . . . . 75.409999999999997 111.582 -176.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 7.2 t -146.57 151.87 38.02 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.065 0.459 . . . . 75.040000000000006 112.124 -179.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -148.35 154.29 39.75 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 115.996 -0.547 . . . . 73.109999999999999 110.722 178.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 734' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -114.95 155.3 27.17 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 112.389 0.515 . . . . 75.200000000000003 112.389 -176.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 735' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -131.36 125.98 34.07 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.081 -0.508 . . . . 75.329999999999998 110.977 178.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 736' ' ' THR . . . . . . . . . . . . . 87.7 m -90.73 104.11 16.73 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 116.475 -0.329 . . . . 63.509999999999998 111.287 178.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 737' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 675' ' ' ALA . 48.3 t -99.99 110.2 26.56 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-O 120.872 0.368 . . . . 74.549999999999997 111.756 -179.512 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 738' ' ' THR . . . . . . . . . . . . . 51.8 m -95.57 123.74 39.27 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 121.036 0.446 . . . . 64.319999999999993 111.627 178.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 739' ' ' VAL . . . . . . . . . . . . . 48.1 t -104.26 128.61 57.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 CA-C-O 120.835 0.35 . . . . 75.510000000000005 111.404 178.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 740' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -116.56 160.78 20.15 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 120.858 0.361 . . . . 71.230000000000004 111.553 177.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 741' ' ' VAL . . . . . . . . . . . . . 43.6 t . . . . . 0 N--CA 1.473 0.724 0 CA-C-O 120.817 0.341 . . . . 75.450000000000003 111.582 -179.884 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 664' ' ' ASP . . . . . . . . . . . . . 42.6 t0 . . . . . 0 CA--C 1.536 0.412 0 CA-C-O 121.607 0.718 . . . . 73.209999999999994 112.017 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 665' ' ' LEU . . . . . . . . . . . . . 87.8 mt -101.82 138.72 38.42 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.266 -0.879 . . . . 72.219999999999999 110.779 175.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 666' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -70.73 137.52 85.56 Favored Pre-proline 0 CA--C 1.542 0.638 0 N-CA-C 110.222 -0.288 . . . . 74.209999999999994 110.222 170.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 667' ' ' PRO . . . . . 0.535 ' HB3' ' HB2' ' A' ' 693' ' ' ASP . 59.9 Cg_endo -70.59 150.3 62.97 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 122.569 2.179 . . . . 74.540000000000006 113.769 -174.189 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 668' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -83.53 107.88 16.29 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 121.178 0.513 . . . . 62.549999999999997 110.635 175.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 669' ' ' LEU . . . . . . . . . . . . . 48.5 tp -90.62 112.47 24.2 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.95 -0.568 . . . . 70.439999999999998 109.828 175.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 670' ' ' THR . . . . . . . . . . . . . 83.6 m -95.11 110.48 22.42 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.175 0.512 . . . . 74.25 111.73 -176.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 671' ' ' VAL . . . . . 0.424 HG22 HG13 ' A' ' 689' ' ' VAL . 82.1 t -133.25 134.2 23.81 Favored Pre-proline 0 CA--C 1.542 0.638 0 CA-C-N 115.599 -0.728 . . . . 71.239999999999995 110.758 -178.106 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 672' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.42 136.66 26.69 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 122.201 1.934 . . . . 73.400000000000006 111.807 175.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 673' ' ' VAL . . . . . . . . . . . . . 14.3 p -64.5 -33.63 64.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 N-CA-C 112.093 0.405 . . . . 72.420000000000002 112.093 -176.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 674' ' ' GLY . . . . . 0.422 ' HA2' ' O ' ' A' ' 736' ' ' THR . . . -157.31 153.3 24.55 Favored Glycine 0 CA--C 1.523 0.554 0 C-N-CA 120.894 -0.67 . . . . 63.299999999999997 113.416 -178.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 675' ' ' ALA . . . . . . . . . . . . . . . -144.51 121.0 11.03 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.752 0.311 . . . . 73.140000000000001 111.169 179.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 676' ' ' THR . . . . . . . . . . . . . 84.8 m -96.98 121.6 39.04 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.92 0.39 . . . . 62.520000000000003 111.446 -179.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 677' ' ' ILE . . . . . . . . . . . . . 32.0 pt -130.79 176.68 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 CA-C-N 116.5 -0.318 . . . . 74.310000000000002 110.984 178.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 678' ' ' HIS . . . . . . . . . . . . . 78.0 m80 -121.55 153.72 37.64 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.231 0.538 . . . . 72.230000000000004 112.394 -179.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 679' ' ' VAL . . . . . . . . . . . . . 92.6 t -55.32 115.28 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 115.68 -0.691 . . . . 72.329999999999998 111.733 179.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 100.33 24.42 9.56 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 121.313 -0.47 . . . . 72.340000000000003 113.341 -177.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 681' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -108.59 176.03 5.26 Favored 'General case' 0 CA--C 1.546 0.826 0 O-C-N 122.516 -0.402 . . . . 52.350000000000001 110.883 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 682' ' ' SER . . . . . . . . . . . . . 84.4 p -114.94 129.57 56.74 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 122.334 0.254 . . . . 74.349999999999994 111.237 -179.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 683' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -139.4 126.1 20.68 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 120.821 0.343 . . . . 70.010000000000005 111.224 -178.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 684' ' ' VAL . . . . . . . . . . . . . 81.6 t -114.17 105.19 54.39 Favored Pre-proline 0 N--CA 1.474 0.753 0 N-CA-C 111.989 0.366 . . . . 72.349999999999994 111.989 -179.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_exo -53.37 -40.55 77.78 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 123.041 2.494 . . . . 71.120000000000005 113.727 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 686' ' ' MET . . . . . 0.551 ' HE2' ' HB ' ' A' ' 703' ' ' ILE . 1.0 OUTLIER -78.24 -4.0 45.56 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 112.636 0.606 . . . . 73.439999999999998 112.636 -177.994 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 687' ' ' ALA . . . . . . . . . . . . . . . -98.74 -17.68 18.39 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.954 0.407 . . . . 64.349999999999994 111.385 177.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 688' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -98.67 -13.94 20.07 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 112.446 0.535 . . . . 74.420000000000002 112.446 -175.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 689' ' ' VAL . . . . . 0.554 HG11 HD12 ' A' ' 703' ' ' ILE . 94.9 t -122.49 132.93 70.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 N-CA-C 112.919 0.711 . . . . 75.140000000000001 112.919 -173.23 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 690' ' ' LEU . . . . . 0.494 ' HA ' HG22 ' A' ' 700' ' ' THR . 6.5 mp -124.93 165.0 18.87 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 116.274 -0.421 . . . . 73.310000000000002 111.021 177.392 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 691' ' ' ALA . . . . . . . . . . . . . . . -152.19 127.41 9.84 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 120.915 0.388 . . . . 44.340000000000003 111.909 178.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 692' ' ' ILE . . . . . . . . . . . . . 45.6 mm -135.28 139.07 47.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 N-CA-C 112.097 0.406 . . . . 75.040000000000006 112.097 -177.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 693' ' ' ASP . . . . . 0.535 ' HB2' ' HB3' ' A' ' 667' ' ' PRO . 45.5 t0 -120.29 137.93 53.98 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 109.589 -0.523 . . . . 75.519999999999996 109.589 171.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 52.9 tttp -57.33 -35.25 69.66 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 121.06 0.457 . . . . 74.129999999999995 112.1 -178.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -82.52 -46.16 13.76 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 112.294 0.479 . . . . 72.219999999999999 112.294 -176.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 696' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -94.33 -34.79 12.67 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 112.361 0.504 . . . . 64.299999999999997 112.361 -170.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . 105.26 -123.3 7.55 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 121.44 -0.409 . . . . 54.140000000000001 113.018 -178.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -75.96 118.41 18.7 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 121.272 0.558 . . . . 71.540000000000006 112.142 -178.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 699' ' ' LEU . . . . . 0.405 HD13 ' HB3' ' A' ' 667' ' ' PRO . 81.4 mt -118.33 8.13 12.15 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 115.719 -0.673 . . . . 72.219999999999999 110.408 171.742 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 700' ' ' THR . . . . . 0.494 HG22 ' HA ' ' A' ' 690' ' ' LEU . 37.8 m -59.1 -37.77 77.96 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.48 0.657 . . . . 74.209999999999994 110.568 175.343 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 701' ' ' SER . . . . . . . . . . . . . 54.8 p -73.4 -2.75 23.62 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 115.588 -0.733 . . . . 62.200000000000003 111.865 176.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 702' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -110.74 2.01 18.18 Favored 'General case' 0 CA--C 1.541 0.596 0 N-CA-C 111.859 0.318 . . . . 74.019999999999996 111.859 -179.067 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 703' ' ' ILE . . . . . 0.554 HD12 HG11 ' A' ' 689' ' ' VAL . 66.9 mt -71.12 129.67 34.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-O 121.179 0.514 . . . . 72.319999999999993 111.695 -179.169 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 704' ' ' LYS . . . . . . . . . . . . . 2.4 tppp? -104.88 127.26 52.64 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.192 -0.458 . . . . 74.549999999999997 110.244 177.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 50.1 t -97.94 134.8 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-O 120.825 0.345 . . . . 74.420000000000002 111.893 -177.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 706' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -128.56 147.63 50.71 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 116.133 -0.485 . . . . 74.349999999999994 110.351 175.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 106.13 -172.44 18.84 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 121.185 -0.531 . . . . 75.349999999999994 112.658 -177.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 708' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -165.18 130.62 2.61 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 116.925 0.363 . . . . 74.310000000000002 111.542 179.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 709' ' ' VAL . . . . . 0.518 HG23 ' HB2' ' A' ' 717' ' ' TYR . 98.8 t -110.63 116.6 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-O 120.792 0.329 . . . . 73.150000000000006 111.431 177.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 710' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -73.26 134.8 44.37 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 120.979 0.419 . . . . 72.129999999999995 110.584 175.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 711' ' ' THR . . . . . . . . . . . . . 75.8 p -105.97 -0.11 25.28 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 111.913 0.338 . . . . 75.329999999999998 111.913 -179.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 712' ' ' THR . . . . . . . . . . . . . 14.9 t -107.34 -1.86 21.21 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 112.47 0.544 . . . . 72.299999999999997 112.47 -177.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 713' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -143.58 134.94 26.0 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 122.021 -0.424 . . . . 73.010000000000005 111.174 -179.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 714' ' ' ALA . . . . . . . . . . . . . . . -70.23 140.79 52.49 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 112.343 0.498 . . . . 72.299999999999997 112.343 -176.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 153.39 167.08 15.31 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 121.124 -0.56 . . . . 61.439999999999998 112.856 -179.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 716' ' ' THR . . . . . . . . . . . . . 34.7 m -96.56 122.92 40.0 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 122.461 -0.435 . . . . 74.010000000000005 111.908 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 717' ' ' TYR . . . . . 0.518 ' HB2' HG23 ' A' ' 709' ' ' VAL . 27.3 m-85 -121.89 143.02 49.68 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 116.122 -0.49 . . . . 74.200000000000003 110.142 178.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 718' ' ' VAL . . . . . . . . . . . . . 53.8 t -109.75 127.49 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 N-CA-C 112.645 0.609 . . . . 60.340000000000003 112.645 -174.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 719' ' ' LEU . . . . . . . . . . . . . 96.3 mt -106.72 132.25 52.91 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 116.068 -0.515 . . . . 64.430000000000007 111.424 176.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 58.4 m -109.87 124.65 51.71 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 120.791 0.329 . . . . 74.040000000000006 111.261 179.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 721' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -110.94 129.63 55.82 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.507 -0.315 . . . . 74.219999999999999 110.718 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 99.5 m -132.65 125.37 30.19 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.554 0.216 . . . . 73.340000000000003 111.286 -179.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 8.1 p -117.62 142.53 31.42 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 CA-C-O 120.933 0.397 . . . . 73.409999999999997 111.773 -178.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 44.1 m -105.07 118.96 37.84 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.238 0.542 . . . . 74.439999999999998 112.429 -176.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 725' ' ' ASP . . . . . 0.509 ' HB2' ' HD3' ' A' ' 667' ' ' PRO . 5.7 t0 -73.79 150.94 40.76 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 115.798 -0.637 . . . . 75.209999999999994 110.804 174.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 726' ' ' SER . . . . . . . . . . . . . 59.8 p -74.19 -15.27 61.02 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 112.459 0.541 . . . . 74.120000000000005 112.459 -175.021 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 727' ' ' LYS . . . . . . . . . . . . . 65.2 mmtt -103.66 6.14 36.84 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 112.266 0.469 . . . . 72.120000000000005 112.266 177.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 728' ' ' GLY . . . . . . . . . . . . . . . 102.83 27.96 6.44 Favored Glycine 0 CA--C 1.532 1.103 0 N-CA-C 115.269 0.868 . . . . 54.219999999999999 115.269 173.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 21.1 m80 -109.14 104.01 13.11 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 117.897 0.849 . . . . 74.549999999999997 111.6 173.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 730' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -98.83 105.58 17.74 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 120.807 0.337 . . . . 72.109999999999999 110.867 177.172 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 33.9 m -106.79 153.59 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-O 120.822 0.344 . . . . 74.140000000000001 111.624 -178.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 9.8 t -134.94 147.86 49.88 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 112.415 0.524 . . . . 75.310000000000002 112.415 -176.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -148.56 149.6 31.87 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.08 0.552 . . . . 73.150000000000006 109.989 176.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 734' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -120.44 158.46 27.17 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 113.03 0.752 . . . . 73.420000000000002 113.03 -173.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 735' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -130.34 123.44 29.97 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.374 -0.83 . . . . 74.25 110.708 179.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 736' ' ' THR . . . . . 0.422 ' O ' ' HA2' ' A' ' 674' ' ' GLY . 62.2 m -92.49 103.67 16.07 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 121.056 0.455 . . . . 75.129999999999995 111.122 178.178 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 50.0 t -96.58 128.93 47.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-O 120.85 0.357 . . . . 74.409999999999997 111.411 -177.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 738' ' ' THR . . . . . . . . . . . . . 97.0 m -114.58 114.6 25.94 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.092 0.472 . . . . 75.120000000000005 111.642 -178.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 739' ' ' VAL . . . . . . . . . . . . . 39.3 t -93.06 135.14 28.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 CA-C-N 116.162 -0.472 . . . . 74.219999999999999 111.155 178.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 740' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -122.71 155.53 36.27 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.74 0.305 . . . . 74.430000000000007 111.594 -178.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 741' ' ' VAL . . . . . . . . . . . . . 24.1 t . . . . . 0 CA--C 1.541 0.605 0 CA-C-O 120.69 0.281 . . . . 74.409999999999997 111.586 -178.65 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 664' ' ' ASP . . . . . 0.45 ' OD2' ' HB2' ' A' ' 727' ' ' LYS . 16.2 t0 . . . . . 0 N--CA 1.467 0.376 0 CA-C-O 121.266 0.555 . . . . 75.519999999999996 111.112 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 665' ' ' LEU . . . . . . . . . . . . . 67.7 mt -99.52 126.35 45.46 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.812 -0.631 . . . . 74.329999999999998 110.412 176.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 666' ' ' GLU . . . . . 0.438 ' H ' ' CD ' ' A' ' 666' ' ' GLU . 0.7 OUTLIER -58.69 156.33 24.81 Favored Pre-proline 0 CA--C 1.544 0.722 0 CA-C-N 115.872 -0.604 . . . . 71.409999999999997 112.28 -179.283 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 667' ' ' PRO . . . . . 0.413 ' HD3' ' HB2' ' A' ' 725' ' ' ASP . 72.0 Cg_endo -75.17 145.29 30.71 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.276 1.984 . . . . 75.349999999999994 112.861 -175.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 668' ' ' LYS . . . . . . . . . . . . . 52.6 tptt -82.37 104.3 12.57 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.105 0.478 . . . . 74.310000000000002 111.001 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 669' ' ' LEU . . . . . . . . . . . . . 51.2 tp -89.91 106.58 18.57 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.271 0.557 . . . . 74.140000000000001 110.762 177.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 670' ' ' THR . . . . . . . . . . . . . 33.0 m -91.75 110.92 22.27 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.089 -0.505 . . . . 72.019999999999996 111.246 -177.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 671' ' ' VAL . . . . . 0.433 HG23 ' HB1' ' A' ' 733' ' ' ALA . 84.7 t -131.66 139.72 36.1 Favored Pre-proline 0 N--CA 1.473 0.691 0 CA-C-N 116.092 -0.504 . . . . 74.409999999999997 111.161 -176.369 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 672' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -76.74 149.34 29.72 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 122.418 2.079 . . . . 75.319999999999993 112.595 175.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 673' ' ' VAL . . . . . . . . . . . . . 12.5 p -69.57 -34.75 63.02 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 N-CA-C 112.468 0.544 . . . . 75.030000000000001 112.468 -176.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 674' ' ' GLY . . . . . . . . . . . . . . . 179.85 169.39 40.04 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 120.396 -0.907 . . . . 64.209999999999994 113.949 -178.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 675' ' ' ALA . . . . . . . . . . . . . . . -154.99 140.2 17.56 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 122.625 0.37 . . . . 62.229999999999997 111.107 179.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 676' ' ' THR . . . . . . . . . . . . . 86.2 m -118.71 121.22 39.6 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-O 120.713 0.292 . . . . 72.140000000000001 111.398 -179.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 677' ' ' ILE . . . . . . . . . . . . . 30.0 pt -129.3 174.3 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-O 120.986 0.422 . . . . 74.040000000000006 111.886 -177.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 678' ' ' HIS . . . . . . . . . . . . . 53.0 m80 -115.84 166.3 12.11 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.312 0.577 . . . . 38.740000000000002 111.933 178.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 679' ' ' VAL . . . . . 0.547 HG11 ' HA ' ' A' ' 712' ' ' THR . 63.2 t -56.95 111.88 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-N 115.628 -0.714 . . . . 73.329999999999998 110.643 174.003 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 123.05 -33.2 4.13 Favored Glycine 0 CA--C 1.526 0.736 0 CA-C-N 116.256 -0.429 . . . . 44.439999999999998 112.815 -175.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 681' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -73.48 128.26 35.01 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.095 0.474 . . . . 74.329999999999998 111.659 179.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 682' ' ' SER . . . . . . . . . . . . . 50.4 m -85.34 144.42 28.06 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 120.849 0.357 . . . . 73.530000000000001 110.871 176.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 683' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -118.08 132.38 56.36 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 120.809 0.338 . . . . 74.450000000000003 111.263 -178.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 684' ' ' VAL . . . . . . . . . . . . . 52.4 t -116.84 96.98 49.89 Favored Pre-proline 0 CA--C 1.544 0.72 0 CA-C-N 116.461 -0.336 . . . . 63.5 111.326 -178.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -77.28 -31.62 3.48 Favored 'Trans proline' 0 CA--C 1.545 1.07 0 C-N-CA 122.783 2.322 . . . . 72.549999999999997 114.461 -174.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 686' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.35 -12.17 59.99 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 112.303 0.482 . . . . 74.209999999999994 112.303 -174.515 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 687' ' ' ALA . . . . . . . . . . . . . . . -94.22 -27.39 16.2 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 111.91 0.337 . . . . 62.130000000000003 111.91 178.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 688' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -91.35 -8.22 48.7 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 112.133 0.42 . . . . 75.109999999999999 112.133 -177.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 689' ' ' VAL . . . . . 0.509 HG13 HD13 ' A' ' 703' ' ' ILE . 62.7 t -114.21 127.64 71.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-O 120.987 0.422 . . . . 75.439999999999998 111.559 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 690' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -123.66 155.82 37.04 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 116.247 -0.433 . . . . 71.439999999999998 111.125 179.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 691' ' ' ALA . . . . . . . . . . . . . . . -141.5 122.86 14.9 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 120.659 0.266 . . . . 73.150000000000006 110.865 174.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 692' ' ' ILE . . . . . 0.421 HD12 ' HA ' ' A' ' 698' ' ' ASP . 48.1 mm -128.68 120.48 52.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 N-CA-C 112.087 0.403 . . . . 73.209999999999994 112.087 -177.034 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -95.05 149.94 20.71 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.09 0.472 . . . . 62.25 110.692 172.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 694' ' ' LYS . . . . . 0.53 ' HZ2' ' HB3' ' A' ' 694' ' ' LYS . 7.5 mtpm? -77.42 -34.56 54.68 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 112.665 0.617 . . . . 63.140000000000001 112.665 -173.651 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -84.86 -54.98 4.32 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 121.828 -0.545 . . . . 73.430000000000007 112.095 177.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 696' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -75.93 -50.48 14.85 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 112.125 0.417 . . . . 74.400000000000006 112.125 -173.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . 123.94 -139.44 12.03 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 121.37 -0.443 . . . . 74.25 112.65 -175.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 698' ' ' ASP . . . . . 0.421 ' HA ' HD12 ' A' ' 692' ' ' ILE . 14.3 t70 -67.53 122.57 18.28 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 122.369 -0.489 . . . . 73.329999999999998 111.961 -178.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 699' ' ' LEU . . . . . . . . . . . . . 83.5 mt -118.49 19.44 13.33 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 116.097 -0.502 . . . . 73.510000000000005 111.1 176.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 89.3 m -59.52 -31.96 69.87 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 120.954 0.407 . . . . 74.209999999999994 112.067 -176.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 701' ' ' SER . . . . . . . . . . . . . 46.7 m -72.03 -13.58 61.64 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 120.763 0.316 . . . . 63.509999999999998 111.833 179.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 702' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -92.98 -2.74 55.48 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 112.09 0.404 . . . . 71.230000000000004 112.09 179.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 703' ' ' ILE . . . . . 0.509 HD13 HG13 ' A' ' 689' ' ' VAL . 69.8 mt -68.67 119.48 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-O 121.09 0.471 . . . . 74.409999999999997 111.763 -179.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 704' ' ' LYS . . . . . . . . . . . . . 51.1 tptt -89.76 126.62 35.74 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.246 -0.434 . . . . 54.039999999999999 110.177 175.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 51.7 t -95.99 130.07 45.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-O 121.046 0.451 . . . . 72.299999999999997 112.004 -177.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 706' ' ' ASP . . . . . 0.554 ' HB3' ' HB ' ' A' ' 720' ' ' THR . 14.4 t70 -123.29 145.69 48.49 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.185 -0.462 . . . . 64.329999999999998 110.484 176.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 119.96 -153.98 16.59 Favored Glycine 0 CA--C 1.524 0.651 0 C-N-CA 121.079 -0.582 . . . . 72.439999999999998 113.32 178.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 708' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -166.96 141.42 3.94 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.762 0.315 . . . . 71.530000000000001 111.118 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 709' ' ' VAL . . . . . . . . . . . . . 59.9 t -127.1 110.89 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-O 120.583 0.23 . . . . 75.230000000000004 110.918 174.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 710' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -94.29 135.77 35.32 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 109.882 -0.414 . . . . 63.109999999999999 109.882 176.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 711' ' ' THR . . . . . 0.426 ' O ' ' HA ' ' A' ' 679' ' ' VAL . 71.8 p -105.77 0.04 25.79 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 122.105 -0.372 . . . . 62.509999999999998 111.98 -177.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 712' ' ' THR . . . . . 0.547 ' HA ' HG11 ' A' ' 679' ' ' VAL . 72.0 p -116.24 -24.25 8.05 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 116.426 -0.352 . . . . 74.129999999999995 111.777 178.29 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 713' ' ' LYS . . . . . . . . . . . . . 61.2 tttm -111.9 121.29 44.62 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 120.899 0.381 . . . . 74.329999999999998 111.119 -178.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 714' ' ' ALA . . . . . . . . . . . . . . . -70.21 143.88 52.08 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 112.542 0.571 . . . . 72.349999999999994 112.542 -177.017 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 156.39 162.24 11.3 Favored Glycine 0 CA--C 1.526 0.722 0 CA-C-N 115.938 -0.574 . . . . 63.240000000000002 112.509 179.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 716' ' ' THR . . . . . . . . . . . . . 51.6 m -98.34 122.57 41.68 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 117.311 0.556 . . . . 73.129999999999995 111.093 177.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 717' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -119.49 137.33 53.87 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.431 -0.35 . . . . 73.5 110.71 -178.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 718' ' ' VAL . . . . . . . . . . . . . 48.4 t -95.15 131.36 42.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-O 121.079 0.466 . . . . 74.409999999999997 111.606 179.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 719' ' ' LEU . . . . . . . . . . . . . 86.6 mt -108.53 133.67 52.35 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.055 -0.52 . . . . 65.400000000000006 110.814 177.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 720' ' ' THR . . . . . 0.554 ' HB ' ' HB3' ' A' ' 706' ' ' ASP . 77.3 m -117.53 130.92 56.72 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-O 120.634 0.254 . . . . 71.420000000000002 110.934 178.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 721' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -119.23 132.26 55.91 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 120.672 0.272 . . . . 71.019999999999996 111.118 -178.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 97.8 m -128.33 139.47 52.39 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 111.686 0.254 . . . . 63.450000000000003 111.686 -179.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 13.8 p -141.27 147.2 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 CA-C-O 120.937 0.399 . . . . 75.349999999999994 111.244 178.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 18.7 m -110.97 144.95 39.26 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.035 0.445 . . . . 73.510000000000005 111.999 -176.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 725' ' ' ASP . . . . . 0.658 ' HB3' ' H ' ' A' ' 729' ' ' HIS . 7.5 t70 -74.11 168.46 19.52 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.041 0.536 . . . . 53.340000000000003 111.222 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 726' ' ' SER . . . . . . . . . . . . . 34.1 t -68.65 -30.83 69.62 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 120.78 0.324 . . . . 74.019999999999996 110.985 174.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 727' ' ' LYS . . . . . 0.45 ' HB2' ' OD2' ' A' ' 664' ' ' ASP . 4.1 mptp? -96.47 -9.44 29.7 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 112.62 0.6 . . . . 72.219999999999999 112.62 177.423 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 728' ' ' GLY . . . . . . . . . . . . . . . 113.15 22.38 5.6 Favored Glycine 0 CA--C 1.535 1.332 0 N-CA-C 116.111 1.204 . . . . 50.140000000000001 116.111 173.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 729' ' ' HIS . . . . . 0.658 ' H ' ' HB3' ' A' ' 725' ' ' ASP . 46.5 m80 -83.67 119.98 25.43 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 118.117 0.958 . . . . 74.230000000000004 110.949 169.411 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 730' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -103.56 119.76 39.54 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 120.823 0.344 . . . . 75.450000000000003 111.692 -179.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 35.1 m -120.65 157.43 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-O 120.733 0.301 . . . . 74.430000000000007 111.234 179.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 9.6 t -146.91 147.88 31.22 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.545 0.572 . . . . 74.439999999999998 112.545 -177.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 733' ' ' ALA . . . . . 0.433 ' HB1' HG23 ' A' ' 671' ' ' VAL . . . -141.73 161.9 36.8 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 116.042 -0.527 . . . . 65.329999999999998 110.91 -179.677 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 734' ' ' LYS . . . . . . . . . . . . . 42.8 mtmt -128.9 150.8 50.2 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 112.872 0.693 . . . . 72.400000000000006 112.872 -173.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 735' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -130.75 140.65 50.33 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 115.423 -0.808 . . . . 74.340000000000003 110.662 177.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 736' ' ' THR . . . . . . . . . . . . . 92.4 m -109.85 107.76 17.83 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 112.221 0.452 . . . . 72.329999999999998 112.221 -178.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 57.5 t -102.47 131.67 50.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 O-C-N 122.16 -0.338 . . . . 75.310000000000002 111.787 -178.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 738' ' ' THR . . . . . . . . . . . . . 91.7 m -119.13 118.46 31.44 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 120.788 0.327 . . . . 65.329999999999998 111.522 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 739' ' ' VAL . . . . . . . . . . . . . 41.7 t -102.88 139.1 24.73 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 CA-C-O 120.67 0.271 . . . . 73.120000000000005 111.418 178.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 740' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -128.91 157.68 40.91 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 120.931 0.396 . . . . 73.450000000000003 111.76 179.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 741' ' ' VAL . . . . . . . . . . . . . 9.6 t . . . . . 0 N--CA 1.472 0.654 0 CA-C-N 116.551 -0.295 . . . . 73.0 111.585 -176.489 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 664' ' ' ASP . . . . . . . . . . . . . 16.6 t70 . . . . . 0 N--CA 1.467 0.381 0 CA-C-O 121.644 0.735 . . . . 73.430000000000007 112.504 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 665' ' ' LEU . . . . . . . . . . . . . 72.6 mt -101.49 137.68 39.49 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-N 115.019 -0.991 . . . . 55.109999999999999 110.876 177.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 666' ' ' GLU . . . . . 0.492 ' HG3' ' HB3' ' A' ' 729' ' ' HIS . 19.7 mp0 -71.11 150.09 94.64 Favored Pre-proline 0 CA--C 1.538 0.497 0 CA-C-N 116.121 -0.491 . . . . 74.219999999999999 110.505 177.427 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 667' ' ' PRO . . . . . 0.517 ' HB3' HD11 ' A' ' 699' ' ' LEU . 37.5 Cg_endo -65.1 133.19 34.55 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 122.103 1.869 . . . . 74.420000000000002 112.345 179.092 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 668' ' ' LYS . . . . . . . . . . . . . 56.1 tptt -82.18 106.98 14.51 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 121.173 0.511 . . . . 73.340000000000003 110.56 179.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 669' ' ' LEU . . . . . 0.505 ' HG ' HG21 ' A' ' 671' ' ' VAL . 60.0 tp -89.39 106.04 18.19 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.709 -0.678 . . . . 73.530000000000001 110.912 -178.614 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 670' ' ' THR . . . . . . . . . . . . . 86.3 m -86.37 110.4 19.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.034 0.445 . . . . 74.25 110.828 179.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 671' ' ' VAL . . . . . 0.505 HG21 ' HG ' ' A' ' 669' ' ' LEU . 94.8 t -127.55 127.94 24.03 Favored Pre-proline 0 CA--C 1.536 0.418 0 CA-C-N 116.032 -0.531 . . . . 74.329999999999998 111.021 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 672' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -64.48 154.2 73.03 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 122.305 2.003 . . . . 72.420000000000002 111.929 178.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 673' ' ' VAL . . . . . . . . . . . . . 10.1 p -81.5 -34.39 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 O-C-N 122.145 -0.347 . . . . 74.239999999999995 111.89 -176.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 674' ' ' GLY . . . . . 0.404 ' HA2' ' O ' ' A' ' 736' ' ' THR . . . -162.54 163.88 35.36 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 121.094 -0.574 . . . . 65.319999999999993 113.579 -178.173 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 675' ' ' ALA . . . . . . . . . . . . . . . -156.3 118.28 3.97 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 120.694 0.283 . . . . 71.209999999999994 111.747 179.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 676' ' ' THR . . . . . . . . . . . . . 88.7 m -97.43 126.14 42.5 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 120.648 0.261 . . . . 73.049999999999997 111.591 178.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 677' ' ' ILE . . . . . 0.414 HG13 HG21 ' A' ' 739' ' ' VAL . 20.1 pt -138.52 176.44 6.62 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 C-N-CA 122.514 0.325 . . . . 74.230000000000004 111.288 179.391 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 678' ' ' HIS . . . . . 0.524 ' O ' ' HB2' ' A' ' 681' ' ' ASP . 72.1 m80 -114.93 177.21 4.73 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 121.396 0.617 . . . . 61.450000000000003 112.574 -179.6 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 679' ' ' VAL . . . . . 0.437 HG21 ' HA ' ' A' ' 741' ' ' VAL . 96.1 t -66.45 122.13 16.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-N 116.004 -0.544 . . . . 75.209999999999994 110.957 174.154 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 86.1 18.31 59.55 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 121.218 -0.515 . . . . 75.420000000000002 112.825 -176.028 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 681' ' ' ASP . . . . . 0.524 ' HB2' ' O ' ' A' ' 678' ' ' HIS . 1.1 t70 -83.09 -175.32 5.78 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-O 120.882 0.373 . . . . 73.019999999999996 111.295 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 682' ' ' SER . . . . . . . . . . . . . 69.7 m -123.12 140.66 52.8 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 122.418 0.287 . . . . 72.329999999999998 111.314 179.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 683' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -154.61 125.38 7.07 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 116.494 -0.321 . . . . 73.530000000000001 110.87 -178.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 684' ' ' VAL . . . . . . . . . . . . . 38.6 t -125.38 93.57 44.77 Favored Pre-proline 0 CA--C 1.546 0.789 0 CA-C-O 121.022 0.439 . . . . 65.510000000000005 111.926 -177.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -61.27 -36.81 77.78 Favored 'Trans proline' 0 CA--C 1.545 1.028 0 C-N-CA 122.725 2.283 . . . . 53.109999999999999 113.576 -177.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 686' ' ' MET . . . . . 0.525 ' HE1' ' HA ' ' A' ' 686' ' ' MET . 1.9 mmt -78.82 4.08 14.98 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 112.573 0.582 . . . . 71.230000000000004 112.573 -176.766 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 687' ' ' ALA . . . . . . . . . . . . . . . -119.21 -40.65 2.8 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.18 0.514 . . . . 54.450000000000003 111.211 174.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 688' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -71.93 -24.91 61.71 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 116.2 -0.455 . . . . 75.540000000000006 111.998 179.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 689' ' ' VAL . . . . . 0.419 HG13 HG22 ' A' ' 671' ' ' VAL . 63.7 t -96.91 144.48 10.49 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 CA-C-O 120.677 0.275 . . . . 73.230000000000004 110.802 174.258 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 690' ' ' LEU . . . . . 0.443 HD21 ' N ' ' A' ' 691' ' ' ALA . 10.5 tt -142.66 149.55 39.04 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 120.475 0.178 . . . . 64.200000000000003 111.105 -174.302 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 691' ' ' ALA . . . . . 0.443 ' N ' HD21 ' A' ' 690' ' ' LEU . . . -144.22 132.78 22.21 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 112.085 0.402 . . . . 44.109999999999999 112.085 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 692' ' ' ILE . . . . . 0.548 HD13 ' HA ' ' A' ' 698' ' ' ASP . 43.7 mm -133.97 132.91 56.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 N-CA-C 112.039 0.385 . . . . 72.030000000000001 112.039 -178.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 693' ' ' ASP . . . . . 0.462 ' OD1' ' HG2' ' A' ' 695' ' ' GLU . 7.7 t70 -110.68 149.21 30.79 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 109.714 -0.476 . . . . 65.530000000000001 109.714 171.162 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -69.41 -29.3 67.0 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 111.894 0.331 . . . . 73.340000000000003 111.894 -177.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 695' ' ' GLU . . . . . 0.462 ' HG2' ' OD1' ' A' ' 693' ' ' ASP . 12.2 pt-20 -81.72 -46.37 14.38 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 112.189 0.441 . . . . 74.040000000000006 112.189 -175.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 696' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -95.53 -48.85 5.66 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.138 0.494 . . . . 73.349999999999994 111.683 -174.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . 119.22 -119.28 4.25 Favored Glycine 0 CA--C 1.525 0.658 0 CA-C-N 116.006 -0.543 . . . . 64.439999999999998 112.423 -175.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 698' ' ' ASP . . . . . 0.548 ' HA ' HD13 ' A' ' 692' ' ' ILE . 12.9 t70 -74.88 116.36 15.51 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 122.372 -0.487 . . . . 74.0 111.757 -178.082 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 699' ' ' LEU . . . . . 0.517 HD11 ' HB3' ' A' ' 667' ' ' PRO . 57.8 mt -114.54 22.95 13.17 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 116.108 -0.497 . . . . 74.420000000000002 110.944 174.25 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 37.7 m -60.54 -37.39 81.05 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 120.979 0.419 . . . . 73.519999999999996 111.823 -176.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 701' ' ' SER . . . . . . . . . . . . . 70.6 m -74.51 -10.9 60.0 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 120.848 0.356 . . . . 71.430000000000007 111.794 177.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 702' ' ' LYS . . . . . 0.439 ' HG3' HD21 ' A' ' 699' ' ' LEU . 48.0 mmtm -90.88 7.22 41.08 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 120.831 0.348 . . . . 72.340000000000003 111.433 -178.413 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 703' ' ' ILE . . . . . 0.472 ' HB ' ' HE2' ' A' ' 686' ' ' MET . 66.4 mt -87.24 117.73 31.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 CA-C-O 121.234 0.54 . . . . 75.329999999999998 112.421 -177.37 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 704' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -84.68 135.39 34.18 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.959 -0.564 . . . . 72.099999999999994 110.546 173.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 56.2 t -107.98 143.58 18.19 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-O 120.844 0.354 . . . . 74.299999999999997 111.954 -177.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 706' ' ' ASP . . . . . 0.481 ' HB3' ' HB ' ' A' ' 720' ' ' THR . 24.7 t70 -129.05 143.5 50.89 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 122.713 0.405 . . . . 75.349999999999994 110.673 175.103 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 93.36 174.38 40.36 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 121.315 -0.469 . . . . 71.439999999999998 112.516 -174.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 708' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -152.07 137.9 18.01 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 122.259 -0.554 . . . . 73.140000000000001 112.157 -179.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 709' ' ' VAL . . . . . . . . . . . . . 89.3 t -106.68 114.97 47.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-O 120.94 0.4 . . . . 73.439999999999998 111.466 178.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 710' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -82.43 136.87 34.84 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 116.472 -0.331 . . . . 73.510000000000005 110.881 176.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 711' ' ' THR . . . . . . . . . . . . . 78.9 p -97.4 -31.88 12.15 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 112.326 0.491 . . . . 64.040000000000006 112.326 -176.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 712' ' ' THR . . . . . . . . . . . . . 51.0 p -85.42 -0.16 54.03 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.547 0.573 . . . . 60.100000000000001 112.547 -177.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 713' ' ' LYS . . . . . . . . . . . . . 23.0 tptp -140.3 132.4 27.97 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.705 0.288 . . . . 75.310000000000002 110.964 -178.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 714' ' ' ALA . . . . . . . . . . . . . . . -75.65 144.69 41.53 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 112.046 0.388 . . . . 63.229999999999997 112.046 -177.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 162.09 164.35 16.85 Favored Glycine 0 CA--C 1.523 0.591 0 C-N-CA 121.219 -0.515 . . . . 52.009999999999998 112.828 179.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 716' ' ' THR . . . . . . . . . . . . . 54.8 m -95.73 123.23 39.2 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.119 0.485 . . . . 63.43 111.434 178.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 717' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -120.75 110.59 16.56 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 116.109 -0.496 . . . . 75.219999999999999 110.659 -179.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 718' ' ' VAL . . . . . . . . . . . . . 48.8 t -90.58 107.82 18.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-O 121.082 0.467 . . . . 75.230000000000004 111.059 179.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 719' ' ' LEU . . . . . . . . . . . . . 59.9 mt -89.52 150.43 22.45 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.128 -0.487 . . . . 75.239999999999995 111.968 -176.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 720' ' ' THR . . . . . 0.481 ' HB ' ' HB3' ' A' ' 706' ' ' ASP . 92.2 m -121.87 135.85 54.91 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 116.412 -0.358 . . . . 64.140000000000001 110.902 177.276 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 721' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -122.08 142.72 50.08 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.929 0.395 . . . . 74.099999999999994 111.463 -178.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 69.9 m -138.71 135.12 34.43 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 122.399 0.28 . . . . 74.430000000000007 111.138 -179.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 10.9 p -128.3 144.27 38.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 O-C-N 122.233 -0.292 . . . . 71.510000000000005 111.14 178.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 28.8 m -110.7 144.01 40.29 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.434 0.635 . . . . 73.239999999999995 112.214 -177.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 725' ' ' ASP . . . . . 0.407 ' HB3' ' N ' ' A' ' 729' ' ' HIS . 45.2 t0 -91.74 151.74 20.49 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.916 0.886 . . . . 74.450000000000003 110.25 -179.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 726' ' ' SER . . . . . 0.434 ' HB3' ' OE2' ' A' ' 695' ' ' GLU . 48.0 t -64.95 -22.71 67.04 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.161 0.505 . . . . 74.329999999999998 110.846 177.602 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 727' ' ' LYS . . . . . . . . . . . . . 27.5 mmtp -90.29 -6.33 55.26 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 116.187 -0.461 . . . . 73.329999999999998 111.885 177.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 728' ' ' GLY . . . . . . . . . . . . . . . 109.25 -5.84 31.94 Favored Glycine 0 CA--C 1.531 1.044 0 N-CA-C 114.776 0.671 . . . . 63.520000000000003 114.776 176.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 729' ' ' HIS . . . . . 0.492 ' HB3' ' HG3' ' A' ' 666' ' ' GLU . 39.7 m80 -68.91 138.35 54.57 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 117.933 0.866 . . . . 74.200000000000003 111.028 179.284 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 730' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -133.65 130.92 38.92 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 120.832 0.349 . . . . 75.219999999999999 111.77 -178.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 26.9 m -131.48 160.87 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-N 116.342 -0.39 . . . . 74.400000000000006 111.625 -179.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 2.8 t -142.64 146.91 34.96 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 112.771 0.656 . . . . 73.319999999999993 112.771 -174.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -148.66 154.45 39.68 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 116.103 -0.499 . . . . 65.010000000000005 110.741 178.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 734' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -123.02 159.66 27.93 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 113.367 0.877 . . . . 74.430000000000007 113.367 -174.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 735' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -138.25 137.7 37.76 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 115.326 -0.852 . . . . 72.209999999999994 110.988 179.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 736' ' ' THR . . . . . 0.404 ' O ' ' HA2' ' A' ' 674' ' ' GLY . 99.0 m -103.36 106.48 17.0 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 121.01 0.433 . . . . 73.329999999999998 111.934 178.619 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 45.1 t -96.64 140.91 16.41 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 116.626 -0.261 . . . . 74.329999999999998 110.643 177.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 738' ' ' THR . . . . . . . . . . . . . 87.5 m -132.88 114.14 13.7 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 122.001 -0.437 . . . . 73.140000000000001 111.645 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 739' ' ' VAL . . . . . 0.414 HG21 HG13 ' A' ' 677' ' ' ILE . 52.8 t -93.28 137.07 23.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-N 116.212 -0.449 . . . . 73.349999999999994 110.829 177.504 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 740' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -123.01 149.45 44.3 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.117 0.484 . . . . 73.319999999999993 111.559 179.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 741' ' ' VAL . . . . . 0.437 ' HA ' HG21 ' A' ' 679' ' ' VAL . 26.9 t . . . . . 0 CA--C 1.539 0.542 0 CA-C-N 116.288 -0.415 . . . . 60.009999999999998 111.419 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 664' ' ' ASP . . . . . . . . . . . . . 26.1 t0 . . . . . 0 N--CA 1.473 0.706 0 CA-C-O 121.456 0.646 . . . . 73.200000000000003 111.995 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 665' ' ' LEU . . . . . . . . . . . . . 89.2 mt -96.04 138.32 33.83 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.749 -0.66 . . . . 75.340000000000003 111.196 178.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 666' ' ' GLU . . . . . 0.435 ' H ' ' CD ' ' A' ' 666' ' ' GLU . 0.8 OUTLIER -82.22 140.11 45.62 Favored Pre-proline 0 CA--C 1.541 0.625 0 CA-C-N 116.01 -0.541 . . . . 71.030000000000001 110.872 174.974 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 667' ' ' PRO . . . . . 0.506 ' HB3' HD11 ' A' ' 699' ' ' LEU . 42.3 Cg_endo -65.79 138.3 52.87 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 122.715 2.277 . . . . 71.239999999999995 113.869 -171.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 668' ' ' LYS . . . . . . . . . . . . . 28.9 ttpp -82.9 107.68 15.69 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.905 -0.588 . . . . 72.439999999999998 110.747 177.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 669' ' ' LEU . . . . . 0.422 ' HG ' HG22 ' A' ' 671' ' ' VAL . 55.3 tp -100.78 112.48 24.9 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 121.146 0.498 . . . . 74.530000000000001 111.176 -178.633 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 670' ' ' THR . . . . . . . . . . . . . 94.7 m -93.47 111.48 23.16 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.962 0.41 . . . . 73.099999999999994 111.115 179.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 671' ' ' VAL . . . . . 0.422 HG22 ' HG ' ' A' ' 669' ' ' LEU . 73.8 t -137.49 137.24 21.64 Favored Pre-proline 0 CA--C 1.54 0.569 0 CA-C-N 115.767 -0.651 . . . . 65.109999999999999 110.843 -178.237 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 672' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -73.93 139.56 27.48 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 122.098 1.865 . . . . 70.150000000000006 112.015 174.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 673' ' ' VAL . . . . . . . . . . . . . 10.9 p -79.9 -29.64 12.9 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 CA-C-O 120.955 0.407 . . . . 73.329999999999998 112.017 -177.058 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 674' ' ' GLY . . . . . . . . . . . . . . . -158.89 142.65 8.53 Favored Glycine 0 CA--C 1.523 0.563 0 C-N-CA 120.804 -0.713 . . . . 72.120000000000005 113.263 179.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 675' ' ' ALA . . . . . . . . . . . . . . . -142.7 121.14 12.41 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 120.844 0.354 . . . . 74.120000000000005 111.709 -178.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 676' ' ' THR . . . . . . . . . . . . . 62.4 m -101.41 119.0 38.1 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.701 0.286 . . . . 74.140000000000001 110.923 179.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 677' ' ' ILE . . . . . . . . . . . . . 32.1 pt -125.36 177.01 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-O 121.095 0.474 . . . . 73.319999999999993 111.333 -179.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 678' ' ' HIS . . . . . . . . . . . . . 65.6 m80 -116.99 157.94 24.94 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 121.133 0.492 . . . . 65.140000000000001 111.754 179.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 679' ' ' VAL . . . . . 0.436 HG13 ' HA ' ' A' ' 712' ' ' THR . 95.9 t -57.37 116.35 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 116.093 -0.503 . . . . 72.319999999999993 110.526 174.307 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 117.44 -22.36 10.24 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 121.294 -0.479 . . . . 55.43 112.682 -175.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 681' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -62.79 150.26 41.95 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.537 0.684 . . . . 74.420000000000002 112.697 178.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 682' ' ' SER . . . . . . . . . . . . . 99.9 p -90.64 146.07 24.33 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 115.373 -0.83 . . . . 53.219999999999999 110.162 171.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 683' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -150.1 112.26 4.63 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 120.974 0.416 . . . . 74.530000000000001 111.628 -178.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 684' ' ' VAL . . . . . . . . . . . . . 58.5 t -115.33 98.93 51.7 Favored Pre-proline 0 CA--C 1.543 0.679 0 CA-C-O 120.953 0.406 . . . . 73.150000000000006 111.198 178.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -63.44 -25.89 70.65 Favored 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 122.673 2.249 . . . . 74.340000000000003 113.144 -177.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 686' ' ' MET . . . . . 0.428 ' HA ' ' HE2' ' A' ' 686' ' ' MET . 0.0 OUTLIER -87.29 11.32 14.59 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.265 0.469 . . . . 74.219999999999999 112.265 179.57 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 687' ' ' ALA . . . . . . . . . . . . . . . -119.43 -32.43 4.35 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.908 0.385 . . . . 73.439999999999998 111.396 175.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 688' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -90.92 9.72 29.35 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 112.289 0.477 . . . . 75.140000000000001 112.289 -178.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 94.2 t -125.76 139.19 52.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 122.56 0.344 . . . . 73.420000000000002 110.93 177.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 690' ' ' LEU . . . . . 0.453 HD23 ' N ' ' A' ' 691' ' ' ALA . 2.3 tt -142.73 133.06 24.77 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-O 120.691 0.281 . . . . 75.340000000000003 111.121 -176.06 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 691' ' ' ALA . . . . . 0.453 ' N ' HD23 ' A' ' 690' ' ' LEU . . . -126.63 125.52 42.05 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 112.465 0.543 . . . . 71.120000000000005 112.465 -178.042 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 692' ' ' ILE . . . . . 0.501 HD11 ' HA ' ' A' ' 698' ' ' ASP . 43.4 mm -134.36 132.11 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 CA-C-N 116.418 -0.356 . . . . 75.209999999999994 111.813 -179.083 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -107.98 129.63 55.1 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 109.194 -0.669 . . . . 75.120000000000005 109.194 168.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -60.24 -29.12 68.57 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 112.362 0.504 . . . . 75.409999999999997 112.362 -173.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -78.84 -45.87 19.86 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 120.999 0.428 . . . . 74.400000000000006 111.909 -179.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 696' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -94.07 -48.57 6.17 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.993 0.425 . . . . 74.109999999999999 111.455 -171.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . 124.02 -131.98 8.19 Favored Glycine 0 CA--C 1.524 0.614 0 CA-C-N 116.263 -0.426 . . . . 71.439999999999998 112.977 -178.086 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 698' ' ' ASP . . . . . 0.501 ' HA ' HD11 ' A' ' 692' ' ' ILE . 32.0 t70 -72.33 119.8 17.04 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 112.301 0.482 . . . . 75.230000000000004 112.301 -178.577 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 699' ' ' LEU . . . . . 0.52 HD22 ' HD2' ' A' ' 702' ' ' LYS . 62.4 mt -118.06 14.59 14.09 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 120.981 0.42 . . . . 75.099999999999994 110.873 175.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 81.2 m -60.01 -33.77 72.44 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.293 0.479 . . . . 70.450000000000003 112.293 -178.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 701' ' ' SER . . . . . . . . . . . . . 32.2 t -70.29 -16.7 63.05 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.196 0.522 . . . . 73.099999999999994 111.377 177.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 702' ' ' LYS . . . . . 0.52 ' HD2' HD22 ' A' ' 699' ' ' LEU . 67.5 mttm -91.88 6.38 46.38 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.197 -0.456 . . . . 73.129999999999995 111.769 179.592 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 703' ' ' ILE . . . . . 0.42 HG12 ' HB ' ' A' ' 723' ' ' VAL . 67.0 mt -82.3 133.87 28.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-O 120.946 0.403 . . . . 71.519999999999996 111.326 177.361 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 704' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -112.74 126.93 55.95 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.474 -0.33 . . . . 74.530000000000001 110.534 174.189 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 61.7 t -98.66 124.29 51.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-O 120.914 0.388 . . . . 72.140000000000001 111.605 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 706' ' ' ASP . . . . . 0.443 ' HB3' ' HB ' ' A' ' 720' ' ' THR . 37.3 t70 -109.95 143.25 40.16 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 116.26 -0.427 . . . . 74.25 110.658 174.4 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 94.16 166.76 37.02 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 121.015 -0.612 . . . . 62.310000000000002 113.102 -178.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 708' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -149.52 152.61 35.85 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 120.925 0.393 . . . . 72.519999999999996 111.473 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 709' ' ' VAL . . . . . 0.441 HG23 ' HB2' ' A' ' 717' ' ' TYR . 67.2 t -121.63 135.71 60.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 CA-C-N 116.498 -0.319 . . . . 74.030000000000001 111.608 -177.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 710' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -86.82 136.13 33.09 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.805 0.336 . . . . 74.519999999999996 110.824 173.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 711' ' ' THR . . . . . . . . . . . . . 68.3 p -106.4 4.04 28.03 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.124 0.488 . . . . 64.349999999999994 110.758 176.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 712' ' ' THR . . . . . 0.436 ' HA ' HG13 ' A' ' 679' ' ' VAL . 71.2 p -112.2 -11.76 13.72 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.91 -0.586 . . . . 72.25 112.255 -178.152 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 713' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -132.63 132.57 42.61 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.619 -0.264 . . . . 72.409999999999997 110.711 -178.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 714' ' ' ALA . . . . . 0.467 ' HB2' HG22 ' A' ' 741' ' ' VAL . . . -70.38 141.78 52.16 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 112.244 0.461 . . . . 74.319999999999993 112.244 -178.429 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 152.56 170.38 18.93 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 121.072 -0.585 . . . . 74.319999999999993 113.452 179.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 716' ' ' THR . . . . . . . . . . . . . 91.8 m -93.5 130.47 39.33 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 120.961 0.41 . . . . 55.229999999999997 111.668 177.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 717' ' ' TYR . . . . . 0.441 ' HB2' HG23 ' A' ' 709' ' ' VAL . 45.2 m-85 -128.16 139.74 52.31 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 122.763 0.425 . . . . 73.510000000000005 110.398 179.693 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 718' ' ' VAL . . . . . . . . . . . . . 45.3 t -105.86 140.59 23.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 N-CA-C 112.316 0.488 . . . . 74.219999999999999 112.316 -175.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 719' ' ' LEU . . . . . 0.402 HD23 HG22 ' A' ' 709' ' ' VAL . 85.3 mt -128.22 139.33 52.51 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 116.126 -0.488 . . . . 73.319999999999993 111.536 178.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 720' ' ' THR . . . . . 0.443 ' HB ' ' HB3' ' A' ' 706' ' ' ASP . 96.5 m -120.51 139.26 53.16 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 120.814 0.34 . . . . 71.129999999999995 111.218 178.003 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 721' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -128.13 126.77 41.75 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 116.676 -0.238 . . . . 74.400000000000006 110.825 -178.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 85.0 m -132.13 135.09 46.15 Favored 'General case' 0 N--CA 1.475 0.818 0 O-C-N 122.416 -0.178 . . . . 74.099999999999994 111.476 -178.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 723' ' ' VAL . . . . . 0.42 ' HB ' HG12 ' A' ' 703' ' ' ILE . 7.5 p -130.45 137.64 55.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-O 121.032 0.444 . . . . 75.120000000000005 111.529 179.771 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 24.1 m -106.56 127.91 53.7 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.129 0.418 . . . . 75.299999999999997 112.129 -177.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 725' ' ' ASP . . . . . 0.478 ' HB2' ' HD3' ' A' ' 667' ' ' PRO . 1.1 t70 -81.59 150.95 27.91 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 122.945 0.498 . . . . 73.010000000000005 111.569 176.373 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 726' ' ' SER . . . . . . . . . . . . . 48.9 m -58.24 -34.08 70.05 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 112.57 0.581 . . . . 72.010000000000005 112.57 -176.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 727' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -85.76 -8.54 58.08 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 112.501 0.556 . . . . 73.120000000000005 112.501 -178.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 728' ' ' GLY . . . . . . . . . . . . . . . 113.1 14.3 10.09 Favored Glycine 0 CA--C 1.535 1.294 0 N-CA-C 115.255 0.862 . . . . 74.310000000000002 115.255 175.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 729' ' ' HIS . . . . . 0.409 ' O ' ' HB3' ' A' ' 725' ' ' ASP . 13.5 m80 -89.79 108.51 19.74 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 117.908 0.854 . . . . 74.319999999999993 111.229 172.518 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 730' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -108.17 113.88 27.35 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 120.811 0.338 . . . . 72.329999999999998 111.292 -178.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 731' ' ' VAL . . . . . 0.435 HG21 ' HG2' ' A' ' 667' ' ' PRO . 17.8 m -112.45 159.15 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 CA-C-O 120.624 0.249 . . . . 70.349999999999994 111.517 -177.675 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 8.8 t -147.14 151.94 37.62 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 112.746 0.647 . . . . 71.030000000000001 112.746 -177.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -148.25 161.34 41.69 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.933 -0.576 . . . . 74.549999999999997 110.424 178.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 734' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -130.64 159.59 36.74 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 112.901 0.704 . . . . 72.310000000000002 112.901 -175.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 735' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -134.03 128.41 34.27 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.581 -0.736 . . . . 73.019999999999996 111.075 178.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 736' ' ' THR . . . . . . . . . . . . . 74.3 m -99.52 107.41 19.58 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 120.918 0.39 . . . . 72.239999999999995 111.108 175.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 47.4 t -97.04 141.11 16.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-O 120.71 0.291 . . . . 72.239999999999995 111.414 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 738' ' ' THR . . . . . . . . . . . . . 85.9 m -131.32 120.91 23.82 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 122.093 -0.379 . . . . 71.430000000000007 110.917 177.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 739' ' ' VAL . . . . . . . . . . . . . 38.4 t -101.18 133.6 43.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 N-CA-C 111.831 0.308 . . . . 75.5 111.831 -177.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 740' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -120.89 149.93 41.85 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 120.811 0.339 . . . . 70.239999999999995 111.509 177.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 741' ' ' VAL . . . . . 0.467 HG22 ' HB2' ' A' ' 714' ' ' ALA . 21.2 t . . . . . 0 CA--C 1.541 0.626 0 O-C-N 122.277 -0.264 . . . . 72.450000000000003 110.72 176.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 657' ' ' MET . . . . . 0.577 ' N ' ' SD ' ' A' ' 657' ' ' MET . 3.1 mpp? . . . . . 0 N--CA 1.492 1.65 0 N-CA-C 110.584 -0.154 . . . . 74.439999999999998 110.584 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 658' ' ' GLY . . . . . . . . . . . . . . . 160.15 178.43 34.14 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 120.709 -0.758 . . . . 53.420000000000002 113.482 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 659' ' ' ASN . . . . . . . . . . . . . 38.1 m-80 -133.05 155.82 48.51 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.953 0.406 . . . . 73.510000000000005 111.524 -178.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 660' ' ' GLY . . . . . . . . . . . . . . . -117.45 135.07 11.56 Favored Glycine 0 CA--C 1.526 0.771 0 CA-C-N 116.315 -0.402 . . . . 62.140000000000001 112.157 175.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -70.34 83.48 0.56 Allowed 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.131 0.491 . . . . 71.140000000000001 111.926 -179.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 662' ' ' THR . . . . . . . . . . . . . 73.3 p -92.6 131.59 37.58 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.297 -0.41 . . . . 65.409999999999997 110.804 174.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 663' ' ' SER . . . . . . . . . . . . . 49.9 m -65.67 94.02 0.19 Allowed 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 111.755 0.28 . . . . 75.25 111.755 -178.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 664' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -73.49 124.52 26.0 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.098 0.475 . . . . 72.219999999999999 111.022 178.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 665' ' ' LEU . . . . . . . . . . . . . 86.0 mt -80.77 136.52 36.15 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.033 -0.53 . . . . 75.549999999999997 110.448 174.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 666' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -70.25 140.67 88.02 Favored Pre-proline 0 CA--C 1.538 0.486 0 CA-C-N 116.322 -0.399 . . . . 73.530000000000001 110.575 177.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 667' ' ' PRO . . . . . 0.486 ' HB3' HD13 ' A' ' 699' ' ' LEU . 19.1 Cg_endo -56.64 135.94 73.27 Favored 'Trans proline' 0 CA--C 1.537 0.668 0 C-N-CA 122.7 2.267 . . . . 74.450000000000003 113.593 -171.167 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 668' ' ' LYS . . . . . . . . . . . . . 27.4 tptp -82.8 105.09 13.53 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.048 -0.524 . . . . 73.209999999999994 110.527 176.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 669' ' ' LEU . . . . . . . . . . . . . 56.8 tp -91.65 128.38 37.46 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.957 -0.565 . . . . 74.040000000000006 110.045 175.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 670' ' ' THR . . . . . . . . . . . . . 89.5 m -113.93 110.78 20.62 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.122 0.487 . . . . 55.109999999999999 111.151 178.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 671' ' ' VAL . . . . . 0.429 HG22 HG12 ' A' ' 689' ' ' VAL . 97.8 t -135.09 131.98 20.02 Favored Pre-proline 0 CA--C 1.54 0.586 0 CA-C-N 115.63 -0.713 . . . . 65.299999999999997 110.759 -177.303 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 672' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -73.62 121.76 7.32 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 122.239 1.959 . . . . 75.25 111.997 176.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 673' ' ' VAL . . . . . . . . . . . . . 14.7 p -64.15 -26.51 40.62 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 N-CA-C 112.286 0.476 . . . . 54.539999999999999 112.286 -175.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 674' ' ' GLY . . . . . . . . . . . . . . . -148.94 139.35 7.46 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 120.864 -0.684 . . . . 55.399999999999999 113.653 -179.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 675' ' ' ALA . . . . . . . . . . . . . . . -137.29 151.48 48.71 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 122.799 0.44 . . . . 74.349999999999994 110.937 178.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 676' ' ' THR . . . . . . . . . . . . . 88.4 m -138.84 119.16 13.67 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 122.155 -0.341 . . . . 71.400000000000006 111.48 179.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 677' ' ' ILE . . . . . . . . . . . . . 33.6 pt -131.04 176.55 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 CA-C-O 120.91 0.386 . . . . 72.340000000000003 111.323 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 678' ' ' HIS . . . . . . . . . . . . . 60.4 m80 -109.22 163.71 13.11 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.337 0.589 . . . . 54.240000000000002 112.502 -178.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 679' ' ' VAL . . . . . . . . . . . . . 91.4 t -63.55 115.77 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-N 115.753 -0.658 . . . . 75.420000000000002 111.031 174.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 99.74 0.52 56.43 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 121.472 -0.394 . . . . 52.240000000000002 112.935 -177.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 681' ' ' ASP . . . . . . . . . . . . . 35.3 t0 -88.8 157.48 18.47 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-O 121.17 0.509 . . . . 72.340000000000003 111.759 -178.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 682' ' ' SER . . . . . . . . . . . . . 91.3 p -82.37 144.84 30.25 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 116.099 -0.5 . . . . 62.310000000000002 112.0 -177.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 683' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -148.58 114.16 5.64 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 116.605 -0.27 . . . . 71.340000000000003 111.016 177.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 684' ' ' VAL . . . . . . . . . . . . . 58.0 t -116.19 99.82 52.99 Favored Pre-proline 0 CA--C 1.545 0.764 0 CA-C-O 120.689 0.28 . . . . 71.230000000000004 111.653 -179.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -59.89 -37.18 87.56 Favored 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 122.928 2.419 . . . . 74.010000000000005 113.7 -177.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 686' ' ' MET . . . . . 0.498 ' HE1' ' HA ' ' A' ' 686' ' ' MET . 1.1 mmt -79.09 -2.91 42.79 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 112.634 0.605 . . . . 75.140000000000001 112.634 -177.243 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 687' ' ' ALA . . . . . . . . . . . . . . . -97.25 -32.18 12.05 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 120.918 0.39 . . . . 63.130000000000003 111.657 176.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 688' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -98.4 -2.57 38.86 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 112.471 0.545 . . . . 71.019999999999996 112.471 -175.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . 0.429 HG12 HG22 ' A' ' 671' ' ' VAL . 95.1 t -123.31 124.83 70.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-O 120.832 0.348 . . . . 71.120000000000005 111.643 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 690' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -123.92 162.31 23.62 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 116.432 -0.349 . . . . 74.329999999999998 111.41 -179.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 691' ' ' ALA . . . . . . . . . . . . . . . -149.35 121.57 8.37 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 120.788 0.327 . . . . 61.329999999999998 111.271 175.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 692' ' ' ILE . . . . . . . . . . . . . 35.3 mm -127.56 130.03 70.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 N-CA-C 112.285 0.476 . . . . 74.25 112.285 -175.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -115.82 145.26 42.99 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 120.866 0.365 . . . . 72.549999999999997 110.161 172.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 694' ' ' LYS . . . . . 0.469 ' NZ ' ' HB2' ' A' ' 694' ' ' LYS . 2.1 ttmp? -72.57 -45.55 58.65 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 112.125 0.416 . . . . 64.349999999999994 112.125 -178.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 32.2 mp0 -83.48 -49.43 9.28 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.245 -0.434 . . . . 75.430000000000007 112.166 -172.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 696' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -82.95 -33.51 26.72 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 120.869 0.366 . . . . 75.319999999999993 111.229 -175.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . 116.01 -150.61 18.59 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 121.174 -0.536 . . . . 71.340000000000003 113.407 176.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -70.65 118.94 14.08 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 120.87 0.367 . . . . 74.329999999999998 110.976 179.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 699' ' ' LEU . . . . . 0.486 HD13 ' HB3' ' A' ' 667' ' ' PRO . 24.3 mt -109.19 13.38 24.45 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 111.709 0.263 . . . . 72.040000000000006 111.709 -178.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 25.3 m -57.33 -38.95 74.88 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 121.071 0.462 . . . . 64.219999999999999 111.635 -178.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 701' ' ' SER . . . . . . . . . . . . . 35.3 m -66.63 -23.98 66.24 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.01 0.433 . . . . 74.099999999999994 111.65 178.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 702' ' ' LYS . . . . . 0.463 ' HD2' HD22 ' A' ' 699' ' ' LEU . 94.9 mttt -84.82 -6.42 59.35 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 112.156 0.428 . . . . 73.019999999999996 112.156 -176.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 703' ' ' ILE . . . . . 0.427 HD11 HG13 ' A' ' 689' ' ' VAL . 69.7 mt -63.57 123.2 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-O 121.213 0.53 . . . . 75.439999999999998 112.168 -178.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 704' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? -88.77 117.93 28.1 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.029 -0.532 . . . . 75.239999999999995 110.197 176.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 54.1 t -103.14 105.93 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-O 120.926 0.393 . . . . 74.040000000000006 111.512 -176.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 706' ' ' ASP . . . . . 0.464 ' HB3' ' HB ' ' A' ' 720' ' ' THR . 18.6 t70 -108.25 148.03 30.56 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 120.893 0.378 . . . . 73.120000000000005 111.411 -178.388 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 99.91 179.13 30.52 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 121.176 -0.535 . . . . 64.209999999999994 112.77 -177.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 708' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -150.33 133.78 16.46 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 122.393 -0.475 . . . . 63.409999999999997 112.166 -178.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 709' ' ' VAL . . . . . 0.489 HG23 ' HB2' ' A' ' 717' ' ' TYR . 93.7 t -111.37 120.82 62.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 CA-C-N 116.135 -0.484 . . . . 75.049999999999997 111.085 176.387 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 710' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -99.39 139.34 35.19 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 120.783 0.325 . . . . 65.349999999999994 111.053 177.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 711' ' ' THR . . . . . . . . . . . . . 75.8 p -111.36 13.4 21.59 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 112.476 0.547 . . . . 64.109999999999999 112.476 -179.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 712' ' ' THR . . . . . . . . . . . . . 71.3 p -102.57 -26.63 13.15 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-O 121.321 0.581 . . . . 75.420000000000002 111.253 175.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 713' ' ' LYS . . . . . 0.522 ' HZ1' ' HB2' ' A' ' 713' ' ' LYS . 0.1 OUTLIER -116.54 135.9 53.43 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 115.869 -0.605 . . . . 64.510000000000005 110.786 178.156 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 714' ' ' ALA . . . . . . . . . . . . . . . -74.89 137.56 41.82 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.485 -0.325 . . . . 63.100000000000001 111.595 179.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 160.71 -179.7 36.02 Favored Glycine 0 CA--C 1.523 0.567 0 C-N-CA 120.973 -0.632 . . . . 55.240000000000002 113.242 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 716' ' ' THR . . . . . . . . . . . . . 84.3 m -103.36 130.75 50.74 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.097 0.475 . . . . 75.150000000000006 111.619 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 717' ' ' TYR . . . . . 0.489 ' HB2' HG23 ' A' ' 709' ' ' VAL . 18.5 m-85 -129.12 125.1 36.38 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 116.061 -0.518 . . . . 71.420000000000002 110.154 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 718' ' ' VAL . . . . . . . . . . . . . 61.8 t -102.41 121.8 53.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-O 121.126 0.489 . . . . 72.510000000000005 112.189 -176.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 719' ' ' LEU . . . . . 0.488 HD22 HG22 ' A' ' 709' ' ' VAL . 95.4 mt -99.94 144.45 28.98 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.454 -0.339 . . . . 64.450000000000003 111.534 178.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 720' ' ' THR . . . . . 0.464 ' HB ' ' HB3' ' A' ' 706' ' ' ASP . 64.2 m -113.48 134.33 54.73 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.832 0.349 . . . . 71.140000000000001 111.164 178.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 721' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -125.32 114.36 18.81 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.563 -0.29 . . . . 74.230000000000004 110.89 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 60.6 m -121.54 127.1 50.62 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 120.637 0.256 . . . . 73.140000000000001 111.372 -179.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 11.1 p -129.44 137.55 56.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-O 121.047 0.451 . . . . 75.420000000000002 111.625 -179.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 23.7 m -119.92 134.87 55.1 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.049 0.452 . . . . 74.019999999999996 112.071 -177.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -82.8 149.11 27.39 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 115.956 -0.565 . . . . 72.219999999999999 110.028 173.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 726' ' ' SER . . . . . . . . . . . . . 38.3 t -66.84 -20.39 65.92 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.058 0.456 . . . . 64.140000000000001 110.915 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 727' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -81.9 -4.03 55.6 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 115.893 -0.594 . . . . 75.409999999999997 111.971 178.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 728' ' ' GLY . . . . . . . . . . . . . . . 108.2 -5.68 34.01 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 115.023 0.769 . . . . 43.240000000000002 115.023 173.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 36.1 m80 -84.28 122.61 29.14 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 117.848 0.824 . . . . 64.340000000000003 111.402 178.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 730' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -121.52 132.43 54.7 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 120.868 0.365 . . . . 71.109999999999999 111.707 -178.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 27.4 m -131.15 149.9 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-O 120.82 0.343 . . . . 72.219999999999999 111.374 177.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 7.2 t -144.36 147.64 33.69 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 121.088 0.47 . . . . 73.140000000000001 112.264 -178.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -148.99 161.38 42.03 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 116.083 -0.508 . . . . 53.329999999999998 110.927 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 734' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -121.95 160.29 25.16 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 112.567 0.58 . . . . 74.140000000000001 112.567 -178.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 735' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -129.37 122.13 28.83 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.554 -0.748 . . . . 71.340000000000003 110.464 179.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 736' ' ' THR . . . . . . . . . . . . . 20.9 m -94.11 103.4 15.46 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.629 0.252 . . . . 74.549999999999997 111.262 -179.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 43.2 t -96.85 133.49 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-O 120.724 0.297 . . . . 72.019999999999996 111.316 -179.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 738' ' ' THR . . . . . . . . . . . . . 93.8 m -121.29 112.38 18.53 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.05 0.452 . . . . 72.219999999999999 110.875 177.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 739' ' ' VAL . . . . . . . . . . . . . 54.4 t -93.16 133.58 33.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-N 116.167 -0.469 . . . . 53.25 110.941 178.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 740' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -127.74 162.16 27.25 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 120.844 0.354 . . . . 75.510000000000005 111.62 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 741' ' ' VAL . . . . . 0.425 HG12 ' H ' ' A' ' 743' ' ' GLU . 5.7 t -81.59 146.63 7.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-O 120.974 0.416 . . . . 72.400000000000006 111.245 -176.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 742' ' ' ARG . . . . . . . . . . . . . 38.0 ptt180 -91.42 3.47 54.86 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.448 0.536 . . . . 73.219999999999999 112.448 -177.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 743' ' ' GLU . . . . . 0.425 ' H ' HG12 ' A' ' 741' ' ' VAL . 51.7 mt-10 -145.4 175.27 10.44 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 122.705 0.402 . . . . 74.409999999999997 110.756 179.058 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 744' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -89.12 100.54 13.3 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.076 0.465 . . . . 73.400000000000006 111.612 177.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 13.3 m -116.4 95.95 4.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-O 121.304 0.573 . . . . 71.540000000000006 109.997 171.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 38.4 pttt -71.46 165.37 23.96 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 121.446 0.641 . . . . 75.530000000000001 112.126 -175.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 747' ' ' ASN . . . . . . . . . . . . . 10.3 p-10 -118.66 119.38 34.3 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.696 -0.684 . . . . 71.420000000000002 110.727 178.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -102.63 45.96 0.94 Allowed 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.8 0.333 . . . . 50.5 111.112 -178.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 749' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm 61.64 95.75 0.05 OUTLIER Pre-proline 0 N--CA 1.471 0.611 0 CA-C-N 115.966 -0.561 . . . . 75.219999999999999 112.272 -176.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 750' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -55.75 100.61 0.08 OUTLIER 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 122.39 2.06 . . . . 72.200000000000003 112.069 173.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 751' ' ' ILE . . . . . . . . . . . . . 33.4 pt -79.69 1.41 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 112.428 0.529 . . . . 75.040000000000006 112.428 -177.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 752' ' ' LEU . . . . . . . . . . . . . 65.6 tp -75.3 104.33 5.82 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 120.992 0.425 . . . . 71.230000000000004 110.854 177.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 753' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 . . . . . 0 C--O 1.237 0.415 0 CA-C-O 121.033 0.444 . . . . 75.209999999999994 111.115 -179.259 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 762' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 657' ' ' MET . . . . . . . . . . . . . 26.0 ttt . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 120.772 0.32 . . . . 74.430000000000007 110.666 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 658' ' ' GLY . . . . . . . . . . . . . . . -80.44 92.02 1.39 Allowed Glycine 0 CA--C 1.528 0.853 0 C-N-CA 121.122 -0.561 . . . . 74.209999999999994 112.155 173.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 659' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -63.8 120.1 11.24 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 112.705 0.632 . . . . 74.420000000000002 112.705 -174.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 660' ' ' GLY . . . . . . . . . . . . . . . -102.94 88.41 0.65 Allowed Glycine 0 CA--C 1.526 0.771 0 CA-C-N 115.817 -0.629 . . . . 74.340000000000003 111.644 172.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -76.36 123.36 25.84 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 112.146 0.424 . . . . 50.509999999999998 112.146 -176.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 662' ' ' THR . . . . . . . . . . . . . 76.7 p -79.04 107.39 11.76 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.012 0.434 . . . . 75.239999999999995 110.807 175.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 663' ' ' SER . . . . . . . . . . . . . 23.6 m -72.3 121.78 20.03 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.217 0.451 . . . . 73.519999999999996 112.217 -175.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 664' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -84.44 133.45 34.49 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.85 0.357 . . . . 70.140000000000001 110.788 173.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 665' ' ' LEU . . . . . 0.493 HD13 ' HD3' ' A' ' 694' ' ' LYS . 78.3 mt -95.4 137.69 34.11 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 121.097 0.475 . . . . 73.420000000000002 110.673 174.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 666' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -70.52 152.95 95.3 Favored Pre-proline 0 CA--C 1.541 0.631 0 CA-C-N 115.941 -0.572 . . . . 71.209999999999994 111.887 -177.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 667' ' ' PRO . . . . . 0.514 ' HD3' ' HB2' ' A' ' 725' ' ' ASP . 52.5 Cg_endo -67.3 138.81 47.9 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.843 2.362 . . . . 75.109999999999999 114.428 -170.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 668' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -83.27 102.18 11.78 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.678 -0.692 . . . . 73.420000000000002 110.269 175.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 669' ' ' LEU . . . . . 0.507 ' HG ' HG21 ' A' ' 671' ' ' VAL . 65.3 tp -89.14 114.05 25.29 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.371 -0.377 . . . . 74.019999999999996 111.069 -177.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 670' ' ' THR . . . . . . . . . . . . . 41.5 m -89.57 110.47 21.32 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.859 0.362 . . . . 73.230000000000004 110.931 -179.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 671' ' ' VAL . . . . . 0.507 HG21 ' HG ' ' A' ' 669' ' ' LEU . 96.4 t -135.89 123.97 15.2 Favored Pre-proline 0 N--CA 1.468 0.455 0 CA-C-N 116.379 -0.373 . . . . 71.239999999999995 110.968 -178.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 672' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -70.75 137.43 32.57 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 122.172 1.915 . . . . 75.349999999999994 112.223 178.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 673' ' ' VAL . . . . . . . . . . . . . 12.2 p -64.31 -36.72 77.97 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 N-CA-C 112.012 0.375 . . . . 75.299999999999997 112.012 -177.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 674' ' ' GLY . . . . . . . . . . . . . . . -154.83 154.86 25.82 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 121.025 -0.607 . . . . 74.030000000000001 113.435 -178.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 675' ' ' ALA . . . . . . . . . . . . . . . -150.63 143.61 24.71 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 122.669 0.387 . . . . 71.420000000000002 110.839 178.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 676' ' ' THR . . . . . . . . . . . . . 90.3 m -119.46 121.33 39.22 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 120.936 0.398 . . . . 72.5 111.833 -178.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 677' ' ' ILE . . . . . . . . . . . . . 33.9 pt -126.68 176.98 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-N 116.209 -0.451 . . . . 72.439999999999998 110.457 175.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 678' ' ' HIS . . . . . 0.485 ' HA ' ' O ' ' A' ' 740' ' ' LYS . 46.7 m80 -123.09 159.38 28.63 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 112.583 0.586 . . . . 73.209999999999994 112.583 -177.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 679' ' ' VAL . . . . . 0.454 ' O ' ' HG2' ' A' ' 742' ' ' ARG . 84.2 t -59.6 112.15 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-N 115.814 -0.63 . . . . 74.140000000000001 110.556 172.276 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 115.12 -20.22 14.43 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 121.423 -0.417 . . . . 60.25 112.708 -174.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 681' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -78.01 -165.09 0.6 Allowed 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 121.227 0.537 . . . . 64.310000000000002 111.433 178.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 682' ' ' SER . . . . . . . . . . . . . 21.4 p -142.75 155.54 44.87 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.966 0.412 . . . . 71.239999999999995 111.557 179.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 683' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -143.4 135.86 27.22 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.383 -0.371 . . . . 74.120000000000005 110.577 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 684' ' ' VAL . . . . . . . . . . . . . 25.1 t -124.75 95.64 42.14 Favored Pre-proline 0 CA--C 1.544 0.737 0 CA-C-O 120.931 0.396 . . . . 73.400000000000006 111.848 -175.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -62.87 -31.1 77.86 Favored 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 122.687 2.258 . . . . 75.019999999999996 113.719 -177.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 686' ' ' MET . . . . . 0.5 ' HE1' ' HB ' ' A' ' 703' ' ' ILE . 1.7 mmt -81.51 0.36 38.37 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.32 0.489 . . . . 74.230000000000004 112.32 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 687' ' ' ALA . . . . . . . . . . . . . . . -120.55 -42.62 2.53 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 120.863 0.363 . . . . 74.299999999999997 111.972 179.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 688' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -79.88 2.7 22.29 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-O 120.954 0.407 . . . . 75.120000000000005 111.871 -179.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . 0.412 HG23 ' CZ ' ' A' ' 721' ' ' TYR . 64.7 t -124.53 151.97 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 122.996 0.519 . . . . 75.530000000000001 110.415 175.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 690' ' ' LEU . . . . . 0.614 HD23 HG12 ' A' ' 692' ' ' ILE . 8.8 tt -145.12 152.31 39.85 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 120.567 0.222 . . . . 75.409999999999997 111.427 -174.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 691' ' ' ALA . . . . . . . . . . . . . . . -146.43 126.64 13.86 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 122.341 -0.224 . . . . 52.32 111.502 177.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 692' ' ' ILE . . . . . 0.614 HG12 HD23 ' A' ' 690' ' ' LEU . 41.1 mm -129.66 132.72 65.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 CA-C-O 121.207 0.527 . . . . 70.420000000000002 112.317 -178.109 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 693' ' ' ASP . . . . . 0.471 ' HB2' HD11 ' A' ' 699' ' ' LEU . 25.6 t70 -114.72 145.23 42.3 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.031 -0.532 . . . . 73.430000000000007 109.832 172.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 694' ' ' LYS . . . . . 0.493 ' HD3' HD13 ' A' ' 665' ' ' LEU . 50.8 mtpt -71.1 -39.19 72.24 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.814 0.34 . . . . 73.129999999999995 111.854 -177.342 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 35.2 mp0 -83.15 -54.02 5.35 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 112.054 0.39 . . . . 65.400000000000006 112.054 -175.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 696' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -76.35 -48.74 18.89 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 122.149 -0.345 . . . . 73.439999999999998 111.598 -177.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . 124.2 -131.56 7.98 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 121.279 -0.486 . . . . 75.450000000000003 113.052 -179.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -75.63 119.67 19.99 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 122.442 -0.446 . . . . 61.509999999999998 111.273 -179.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 699' ' ' LEU . . . . . 0.543 HD22 ' HD2' ' A' ' 702' ' ' LYS . 35.5 mt -111.44 11.21 21.44 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.397 -0.365 . . . . 74.329999999999998 111.3 178.318 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 33.8 m -59.74 -36.07 75.86 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.302 0.572 . . . . 75.430000000000007 111.551 -177.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 701' ' ' SER . . . . . . . . . . . . . 49.4 m -76.22 -14.49 60.14 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 116.282 -0.417 . . . . 72.340000000000003 111.85 177.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 702' ' ' LYS . . . . . 0.543 ' HD2' HD22 ' A' ' 699' ' ' LEU . 96.5 mttt -97.67 11.59 36.55 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.177 0.436 . . . . 74.109999999999999 112.177 -177.216 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 703' ' ' ILE . . . . . 0.5 ' HB ' ' HE1' ' A' ' 686' ' ' MET . 67.7 mt -83.76 118.76 31.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-O 120.873 0.368 . . . . 75.049999999999997 111.766 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 704' ' ' LYS . . . . . . . . . . . . . 4.9 tppp? -84.99 125.89 33.08 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 110.168 -0.308 . . . . 72.299999999999997 110.168 174.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 49.0 t -105.88 117.39 51.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 CA-C-O 121.004 0.43 . . . . 62.340000000000003 112.013 -176.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 706' ' ' ASP . . . . . 0.57 ' HB3' ' HB ' ' A' ' 720' ' ' THR . 12.8 t70 -100.32 141.2 33.5 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.294 -0.412 . . . . 73.239999999999995 111.03 175.183 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 102.35 177.74 27.46 Favored Glycine 0 CA--C 1.523 0.54 0 C-N-CA 121.201 -0.523 . . . . 72.439999999999998 112.97 -179.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 708' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -152.48 130.48 11.82 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 120.863 0.363 . . . . 74.439999999999998 111.491 -177.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 709' ' ' VAL . . . . . 0.521 HG22 ' HB2' ' A' ' 717' ' ' TYR . 96.3 t -107.93 114.6 46.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 116.494 -0.321 . . . . 64.030000000000001 110.655 176.483 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 710' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -95.39 143.65 26.56 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 120.905 0.383 . . . . 65.040000000000006 111.039 177.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 711' ' ' THR . . . . . . . . . . . . . 75.6 p -108.08 6.54 27.04 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.666 0.617 . . . . 75.140000000000001 112.666 -176.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 712' ' ' THR . . . . . . . . . . . . . 64.1 p -101.37 -24.24 14.23 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 121.157 0.503 . . . . 73.420000000000002 111.145 175.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 713' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -116.17 122.42 44.99 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 116.294 -0.412 . . . . 73.319999999999993 110.95 178.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 714' ' ' ALA . . . . . . . . . . . . . . . -69.42 143.99 53.47 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 120.982 0.42 . . . . 74.409999999999997 111.796 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 155.77 168.92 19.48 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-N 116.255 -0.43 . . . . 74.200000000000003 112.826 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 716' ' ' THR . . . . . . . . . . . . . 99.2 m -97.71 123.07 41.48 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 122.51 -0.406 . . . . 73.420000000000002 111.812 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 717' ' ' TYR . . . . . 0.521 ' HB2' HG22 ' A' ' 709' ' ' VAL . 40.7 m-85 -115.83 125.9 53.29 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 116.2 -0.455 . . . . 75.209999999999994 110.78 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 718' ' ' VAL . . . . . . . . . . . . . 56.1 t -96.25 118.55 42.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 120.901 0.381 . . . . 74.129999999999995 111.452 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 719' ' ' LEU . . . . . . . . . . . . . 76.6 mt -103.12 135.31 45.02 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.78 0.324 . . . . 72.010000000000005 111.611 -179.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 720' ' ' THR . . . . . 0.57 ' HB ' ' HB3' ' A' ' 706' ' ' ASP . 32.9 m -103.27 131.98 49.89 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 120.943 0.401 . . . . 74.439999999999998 110.895 176.545 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 721' ' ' TYR . . . . . 0.412 ' CZ ' HG23 ' A' ' 689' ' ' VAL . 77.8 m-85 -118.34 117.73 29.88 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.471 -0.331 . . . . 75.319999999999993 110.926 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 87.3 m -120.72 126.83 51.17 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.626 -0.261 . . . . 75.530000000000001 111.263 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 13.1 p -125.23 142.18 42.87 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-O 120.869 0.366 . . . . 75.549999999999997 111.878 -177.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 26.7 m -110.23 133.6 53.07 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.144 0.497 . . . . 73.420000000000002 112.181 -176.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 725' ' ' ASP . . . . . 0.514 ' HB2' ' HD3' ' A' ' 667' ' ' PRO . 14.0 t0 -91.59 151.57 20.66 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 115.912 -0.586 . . . . 72.0 111.049 178.08 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 726' ' ' SER . . . . . . . . . . . . . 38.6 t -59.46 -29.7 68.0 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.403 0.52 . . . . 71.140000000000001 112.403 -175.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 727' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -91.63 7.35 41.96 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 112.313 0.486 . . . . 75.25 112.313 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 728' ' ' GLY . . . . . . . . . . . . . . . 100.2 8.37 50.47 Favored Glycine 0 CA--C 1.534 1.237 0 N-CA-C 115.294 0.878 . . . . 72.319999999999993 115.294 173.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 37.6 m80 -86.67 115.11 23.91 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 117.865 0.833 . . . . 74.310000000000002 111.094 177.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 730' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -120.25 117.09 26.92 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 122.133 -0.355 . . . . 75.030000000000001 111.717 -177.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 35.7 m -117.83 157.76 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-O 120.727 0.299 . . . . 65.25 111.762 -177.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 8.6 t -142.56 144.37 32.86 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.682 0.623 . . . . 72.510000000000005 112.682 -177.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -146.68 159.45 43.46 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.024 -0.534 . . . . 73.010000000000005 111.059 178.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 734' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -118.1 155.54 30.21 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 113.009 0.744 . . . . 71.5 113.009 -176.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 735' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -129.79 135.48 48.47 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 115.703 -0.681 . . . . 73.519999999999996 110.558 177.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 736' ' ' THR . . . . . . . . . . . . . 90.1 m -95.15 104.35 16.23 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 120.675 0.274 . . . . 73.109999999999999 111.39 178.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 46.5 t -100.07 104.5 16.21 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 CA-C-O 120.772 0.32 . . . . 73.540000000000006 111.295 179.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 738' ' ' THR . . . . . . . . . . . . . 44.6 m -94.54 117.4 30.06 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.119 0.485 . . . . 72.219999999999999 111.471 179.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 739' ' ' VAL . . . . . . . . . . . . . 43.6 t -98.28 117.95 44.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-O 121.113 0.482 . . . . 74.219999999999999 111.584 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 740' ' ' LYS . . . . . 0.485 ' O ' ' HA ' ' A' ' 678' ' ' HIS . 96.1 mttt -102.93 176.05 5.28 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.265 -0.425 . . . . 73.140000000000001 110.492 174.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 741' ' ' VAL . . . . . . . . . . . . . 36.3 t -100.5 122.11 52.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 O-C-N 121.881 -0.512 . . . . 70.209999999999994 111.734 -178.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 742' ' ' ARG . . . . . 0.738 ' HG3' ' HG3' ' A' ' 743' ' ' GLU . 20.7 ptt180 -92.04 -46.25 7.89 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.088 0.471 . . . . 73.129999999999995 110.766 175.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 743' ' ' GLU . . . . . 0.738 ' HG3' ' HG3' ' A' ' 742' ' ' ARG . 45.7 mt-10 -123.93 96.09 4.81 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.971 -0.559 . . . . 65.239999999999995 110.212 -178.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 744' ' ' GLU . . . . . 0.413 ' H ' ' CD ' ' A' ' 744' ' ' GLU . 0.5 OUTLIER -59.66 134.55 57.13 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.664 -0.698 . . . . 74.530000000000001 112.568 -175.703 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 745' ' ' VAL . . . . . 0.569 HG12 ' H ' ' A' ' 747' ' ' ASN . 47.3 t -82.03 131.41 33.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-N 115.935 -0.575 . . . . 71.310000000000002 111.175 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -83.09 12.09 5.52 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.414 0.524 . . . . 73.030000000000001 112.414 -177.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 747' ' ' ASN . . . . . 0.569 ' H ' HG12 ' A' ' 745' ' ' VAL . 9.5 m120 -122.6 99.02 6.18 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 120.929 0.395 . . . . 71.25 111.884 -175.377 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -91.73 -4.65 54.8 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-O 121.369 0.604 . . . . 71.519999999999996 111.206 177.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 749' ' ' LYS . . . . . 0.41 ' HD2' ' N ' ' A' ' 749' ' ' LYS . 12.6 mptt -68.96 159.58 82.12 Favored Pre-proline 0 CA--C 1.54 0.583 0 CA-C-N 116.314 -0.403 . . . . 75.140000000000001 111.078 177.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 750' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -68.05 73.47 0.75 Allowed 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 122.335 2.023 . . . . 72.120000000000005 112.826 179.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 751' ' ' ILE . . . . . . . . . . . . . 56.9 mt -97.13 109.2 22.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-O 121.136 0.493 . . . . 62.200000000000003 110.566 177.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 752' ' ' LEU . . . . . . . . . . . . . 50.3 tp -106.32 140.97 38.42 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 116.118 -0.492 . . . . 73.400000000000006 111.361 -176.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 753' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 . . . . . 0 N--CA 1.471 0.6 0 CA-C-N 116.278 -0.419 . . . . 74.349999999999994 111.039 178.501 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 762' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 657' ' ' MET . . . . . . . . . . . . . 25.7 ptt? . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 120.466 0.174 . . . . 74.519999999999996 110.861 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 658' ' ' GLY . . . . . . . . . . . . . . . 71.67 -78.88 0.59 Allowed Glycine 0 CA--C 1.528 0.854 0 C-N-CA 120.82 -0.705 . . . . 72.420000000000002 113.046 179.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 659' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -144.72 156.1 43.9 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 120.806 0.336 . . . . 71.099999999999994 110.94 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 660' ' ' GLY . . . . . . . . . . . . . . . 113.24 85.93 1.47 Allowed Glycine 0 CA--C 1.526 0.745 0 C-N-CA 121.44 -0.41 . . . . 70.25 113.081 178.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -84.9 120.57 26.63 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 121.023 0.44 . . . . 70.140000000000001 110.743 177.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 662' ' ' THR . . . . . . . . . . . . . 74.1 p -111.4 131.2 55.37 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.029 0.442 . . . . 74.420000000000002 111.774 -175.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 663' ' ' SER . . . . . . . . . . . . . 40.7 m -102.4 126.02 49.3 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.129 -0.487 . . . . 74.150000000000006 111.989 -177.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 664' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -76.78 143.01 40.14 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 120.895 0.378 . . . . 75.530000000000001 110.847 173.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 665' ' ' LEU . . . . . . . . . . . . . 76.6 mt -80.82 119.76 23.8 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.404 -0.362 . . . . 71.439999999999998 110.644 177.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 666' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -56.69 144.22 66.15 Favored Pre-proline 0 CA--C 1.537 0.472 0 C-N-CA 121.131 -0.228 . . . . 64.329999999999998 110.483 177.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 667' ' ' PRO . . . . . 0.527 ' HD3' ' HB2' ' A' ' 725' ' ' ASP . 18.8 Cg_endo -56.5 133.92 61.07 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.725 2.284 . . . . 73.109999999999999 112.736 -174.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 668' ' ' LYS . . . . . . . . . . . . . 52.2 tptt -82.71 110.66 17.96 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 120.942 0.401 . . . . 72.420000000000002 110.343 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 669' ' ' LEU . . . . . 0.507 ' HG ' HG21 ' A' ' 671' ' ' VAL . 55.8 tp -98.06 112.58 24.48 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 116.067 -0.515 . . . . 71.540000000000006 111.271 -177.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 670' ' ' THR . . . . . . . . . . . . . 85.8 m -87.75 110.62 20.6 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 120.856 0.36 . . . . 73.120000000000005 111.121 177.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 671' ' ' VAL . . . . . 0.507 HG21 ' HG ' ' A' ' 669' ' ' LEU . 81.0 t -136.34 129.68 17.85 Favored Pre-proline 0 N--CA 1.47 0.575 0 CA-C-N 116.211 -0.45 . . . . 71.549999999999997 110.803 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 672' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -77.9 141.48 19.11 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 122.193 1.929 . . . . 73.409999999999997 112.791 179.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 673' ' ' VAL . . . . . . . . . . . . . 10.6 p -66.27 -35.03 73.99 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 N-CA-C 112.007 0.373 . . . . 75.230000000000004 112.007 -177.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 674' ' ' GLY . . . . . . . . . . . . . . . -146.22 161.19 28.3 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 120.879 -0.676 . . . . 60.219999999999999 113.565 -177.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 675' ' ' ALA . . . . . . . . . . . . . . . -150.5 154.85 38.38 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 122.608 0.363 . . . . 74.450000000000003 110.928 -179.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 676' ' ' THR . . . . . . . . . . . . . 91.8 m -139.04 119.56 13.93 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 120.964 0.411 . . . . 74.230000000000004 111.791 178.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 677' ' ' ILE . . . . . . . . . . . . . 28.7 pt -131.28 175.22 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-N 116.459 -0.337 . . . . 74.400000000000006 110.678 176.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 678' ' ' HIS . . . . . 0.407 ' HA ' ' O ' ' A' ' 740' ' ' LYS . 75.5 m80 -119.49 164.79 15.27 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.305 0.574 . . . . 75.129999999999995 111.912 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 679' ' ' VAL . . . . . 0.415 HG21 ' HA ' ' A' ' 741' ' ' VAL . 78.3 t -56.68 137.01 19.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-N 115.891 -0.595 . . . . 73.049999999999997 110.504 172.06 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 93.03 -18.31 56.39 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 121.052 -0.594 . . . . 55.530000000000001 113.406 -179.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 681' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -79.52 -172.47 3.27 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 121.12 0.486 . . . . 61.32 111.548 178.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 682' ' ' SER . . . . . . . . . . . . . 69.0 m -141.77 145.72 35.1 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 116.435 -0.348 . . . . 74.200000000000003 111.06 177.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 683' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -118.7 134.18 55.32 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 116.453 -0.34 . . . . 74.450000000000003 110.46 178.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 684' ' ' VAL . . . . . . . . . . . . . 53.7 t -122.17 93.09 48.75 Favored Pre-proline 0 CA--C 1.54 0.573 0 CA-C-O 120.962 0.41 . . . . 71.450000000000003 111.429 -177.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -61.69 -27.76 81.52 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 122.83 2.353 . . . . 61.140000000000001 113.347 -177.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 686' ' ' MET . . . . . 0.527 ' HE1' ' HA ' ' A' ' 686' ' ' MET . 1.9 mmt -78.91 -12.14 60.02 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 112.313 0.486 . . . . 73.329999999999998 112.313 -178.137 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 687' ' ' ALA . . . . . . . . . . . . . . . -109.02 -36.34 6.1 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.915 0.388 . . . . 52.409999999999997 111.539 178.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 688' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -85.92 -1.08 56.95 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 116.295 -0.411 . . . . 74.430000000000007 112.05 -178.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . 0.424 HG22 ' CZ ' ' A' ' 721' ' ' TYR . 74.5 t -125.57 150.81 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 122.59 0.356 . . . . 75.219999999999999 110.577 174.227 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 690' ' ' LEU . . . . . 0.464 HD22 HG12 ' A' ' 692' ' ' ILE . 9.6 tt -143.3 150.03 38.65 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-O 120.592 0.234 . . . . 74.349999999999994 111.537 -173.4 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 691' ' ' ALA . . . . . . . . . . . . . . . -147.3 125.35 12.08 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 112.19 0.441 . . . . 73.109999999999999 112.19 179.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 692' ' ' ILE . . . . . 0.509 HD11 ' HA ' ' A' ' 698' ' ' ASP . 43.6 mm -129.68 141.52 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 N-CA-C 111.803 0.297 . . . . 75.329999999999998 111.803 -178.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 693' ' ' ASP . . . . . 0.473 ' OD1' ' HG2' ' A' ' 695' ' ' GLU . 12.5 t70 -125.95 143.97 50.88 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 110.138 -0.319 . . . . 65.140000000000001 110.138 173.015 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 28.6 ttpp -64.79 -34.05 77.42 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 112.5 0.556 . . . . 71.319999999999993 112.5 -175.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 695' ' ' GLU . . . . . 0.473 ' HG2' ' OD1' ' A' ' 693' ' ' ASP . 9.5 pt-20 -81.89 -43.42 18.19 Favored 'General case' 0 N--CA 1.473 0.694 0 O-C-N 122.02 -0.425 . . . . 72.329999999999998 111.976 -175.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 696' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -94.85 -42.44 8.7 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 120.883 0.373 . . . . 73.349999999999994 111.773 -172.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . 118.57 -115.68 3.18 Favored Glycine 0 CA--C 1.523 0.569 0 C-N-CA 121.14 -0.552 . . . . 64.019999999999996 112.291 -177.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 698' ' ' ASP . . . . . 0.509 ' HA ' HD11 ' A' ' 692' ' ' ILE . 16.1 t70 -88.62 119.98 29.59 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 122.195 -0.591 . . . . 71.099999999999994 111.247 178.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 699' ' ' LEU . . . . . 0.456 HD13 ' HB3' ' A' ' 667' ' ' PRO . 51.0 mt -111.97 18.45 18.79 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 116.364 -0.38 . . . . 74.430000000000007 111.603 177.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 37.1 m -58.36 -30.65 66.92 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.009 0.433 . . . . 74.439999999999998 111.105 178.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 701' ' ' SER . . . . . . . . . . . . . 29.7 t -68.15 -24.48 64.99 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 120.868 0.366 . . . . 74.420000000000002 111.971 175.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 702' ' ' LYS . . . . . 0.458 ' HB2' HG21 ' A' ' 723' ' ' VAL . 73.4 mmtt -77.4 -19.84 55.55 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 111.895 0.331 . . . . 75.25 111.895 -178.34 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 703' ' ' ILE . . . . . 0.44 ' HB ' ' HE2' ' A' ' 686' ' ' MET . 63.9 mt -60.74 112.76 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 N-CA-C 112.515 0.561 . . . . 75.219999999999999 112.515 -174.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 704' ' ' LYS . . . . . . . . . . . . . 8.1 tmtm? -87.04 120.08 27.93 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.017 -0.538 . . . . 70.230000000000004 109.729 172.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 50.3 t -95.71 118.06 41.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-O 121.113 0.482 . . . . 73.109999999999999 111.063 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 706' ' ' ASP . . . . . 0.521 ' HB3' ' HB ' ' A' ' 720' ' ' THR . 11.7 t70 -108.11 118.44 36.76 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.413 -0.358 . . . . 71.340000000000003 110.249 176.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 113.42 167.82 16.7 Favored Glycine 0 CA--C 1.524 0.643 0 C-N-CA 121.344 -0.455 . . . . 71.319999999999993 112.392 -176.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 708' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -155.04 138.56 15.96 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 122.316 -0.52 . . . . 71.409999999999997 111.843 -177.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 709' ' ' VAL . . . . . . . . . . . . . 72.5 t -99.59 127.87 51.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-N 116.341 -0.39 . . . . 62.140000000000001 111.352 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 710' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -96.15 137.09 35.72 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 120.732 0.301 . . . . 74.439999999999998 110.578 175.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 711' ' ' THR . . . . . . . . . . . . . 82.5 p -110.43 23.7 13.92 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 112.416 0.525 . . . . 75.040000000000006 112.416 -177.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 712' ' ' THR . . . . . . . . . . . . . 48.8 p -113.03 -26.46 8.47 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 121.015 0.436 . . . . 73.209999999999994 110.746 173.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 713' ' ' LYS . . . . . 0.571 ' HZ1' ' HB2' ' A' ' 713' ' ' LYS . 0.1 OUTLIER -116.72 130.96 57.04 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.001 -0.545 . . . . 73.519999999999996 110.53 175.318 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 714' ' ' ALA . . . . . . . . . . . . . . . -80.9 134.88 35.82 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.067 0.46 . . . . 71.420000000000002 112.182 -178.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 169.32 171.67 35.22 Favored Glycine 0 CA--C 1.523 0.58 0 CA-C-N 116.042 -0.526 . . . . 70.450000000000003 112.582 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 716' ' ' THR . . . . . . . . . . . . . 39.9 m -90.09 123.06 33.63 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.188 0.518 . . . . 74.230000000000004 111.568 177.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 717' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 -114.43 138.23 50.84 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 116.074 -0.512 . . . . 75.0 110.234 177.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 718' ' ' VAL . . . . . . . . . . . . . 62.0 t -103.65 116.62 47.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-O 120.929 0.395 . . . . 74.200000000000003 111.54 -178.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 719' ' ' LEU . . . . . . . . . . . . . 83.0 mt -102.13 129.16 48.4 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 116.348 -0.387 . . . . 75.109999999999999 111.286 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 720' ' ' THR . . . . . 0.521 ' HB ' ' HB3' ' A' ' 706' ' ' ASP . 92.7 m -106.55 134.9 48.98 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.839 0.352 . . . . 75.409999999999997 111.12 178.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 721' ' ' TYR . . . . . 0.448 ' HH ' ' NE2' ' A' ' 735' ' ' GLN . 60.7 m-85 -123.41 120.81 34.07 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.54 -0.3 . . . . 72.129999999999995 110.795 -179.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 56.6 m -123.16 133.42 54.25 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 120.797 0.332 . . . . 60.399999999999999 111.4 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 723' ' ' VAL . . . . . 0.458 HG21 ' HB2' ' A' ' 702' ' ' LYS . 7.5 p -130.93 134.89 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-O 121.154 0.502 . . . . 73.0 111.788 -178.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 34.3 m -109.47 142.95 39.75 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.252 0.549 . . . . 75.239999999999995 111.625 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 725' ' ' ASP . . . . . 0.527 ' HB2' ' HD3' ' A' ' 667' ' ' PRO . 10.3 t70 -102.63 160.29 14.71 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 115.814 -0.63 . . . . 74.439999999999998 111.82 -178.444 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 726' ' ' SER . . . . . . . . . . . . . 48.9 m -61.52 -33.5 73.92 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.637 0.606 . . . . 73.109999999999999 112.637 -177.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 727' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -82.01 4.96 20.83 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 120.751 0.31 . . . . 74.030000000000001 111.447 177.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 728' ' ' GLY . . . . . . . . . . . . . . . 91.07 15.01 56.89 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 121.35 -0.452 . . . . 73.109999999999999 114.03 177.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 36.3 m80 -88.49 121.33 30.75 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 117.235 0.517 . . . . 74.340000000000003 111.111 178.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 730' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -124.78 122.29 37.01 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.792 0.33 . . . . 74.140000000000001 111.873 -176.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 31.9 m -121.94 159.3 24.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 116.423 -0.353 . . . . 63.329999999999998 111.029 177.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 10.3 t -143.33 154.82 44.15 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.839 0.352 . . . . 73.219999999999999 111.801 -178.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -148.5 161.35 41.81 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 122.631 0.372 . . . . 73.140000000000001 111.211 179.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 734' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -125.66 154.56 42.17 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 121.057 0.455 . . . . 72.420000000000002 112.108 -177.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 735' ' ' GLN . . . . . 0.448 ' NE2' ' HH ' ' A' ' 721' ' ' TYR . 6.8 tt0 -130.8 137.96 49.67 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.991 -0.549 . . . . 63.409999999999997 111.299 179.432 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 736' ' ' THR . . . . . . . . . . . . . 89.5 m -97.19 103.82 15.78 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.534 -0.303 . . . . 71.409999999999997 111.151 176.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 45.6 t -101.48 105.16 17.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-O 120.841 0.353 . . . . 74.329999999999998 111.649 -179.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 738' ' ' THR . . . . . . . . . . . . . 65.8 m -95.95 118.21 32.14 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.911 0.386 . . . . 61.130000000000003 111.493 179.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 739' ' ' VAL . . . . . . . . . . . . . 41.0 t -97.89 139.4 20.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-N 116.393 -0.367 . . . . 74.219999999999999 111.496 178.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 740' ' ' LYS . . . . . 0.407 ' O ' ' HA ' ' A' ' 678' ' ' HIS . 97.4 mttt -122.17 155.84 34.95 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 120.841 0.353 . . . . 71.230000000000004 110.711 176.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 741' ' ' VAL . . . . . 0.415 ' HA ' HG21 ' A' ' 679' ' ' VAL . 40.9 t -82.47 145.66 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-O 121.04 0.448 . . . . 61.539999999999999 112.152 -175.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 742' ' ' ARG . . . . . 0.508 ' HG3' ' HG3' ' A' ' 744' ' ' GLU . 32.2 ptt180 -103.28 140.0 37.98 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.001 -0.545 . . . . 74.019999999999996 110.287 172.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 743' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -69.63 89.04 0.53 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.235 0.541 . . . . 72.310000000000002 111.686 179.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 744' ' ' GLU . . . . . 0.508 ' HG3' ' HG3' ' A' ' 742' ' ' ARG . 48.3 mt-10 -85.81 96.0 9.61 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.073 -0.512 . . . . 54.119999999999997 111.152 177.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 7.7 p -68.96 138.89 21.43 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 121.146 0.498 . . . . 63.32 111.366 178.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 18.5 ptmt -63.89 86.31 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.821 0 CA-C-O 121.675 0.75 . . . . 73.019999999999996 112.275 -178.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 747' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -89.4 129.66 35.88 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.933 -0.576 . . . . 70.530000000000001 110.965 176.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -73.97 100.14 3.47 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 120.98 0.419 . . . . 71.310000000000002 110.044 175.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 749' ' ' LYS . . . . . . . . . . . . . 18.6 ptmt -149.28 66.88 8.74 Favored Pre-proline 0 CA--C 1.542 0.666 0 CA-C-O 121.24 0.543 . . . . 74.030000000000001 111.813 -177.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 750' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -92.15 90.35 0.21 Allowed 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 122.966 2.444 . . . . 72.349999999999994 112.535 176.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 751' ' ' ILE . . . . . . . . . . . . . 48.4 mm -84.08 93.06 3.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-N 116.378 -0.374 . . . . 74.129999999999995 111.245 -178.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 752' ' ' LEU . . . . . . . . . . . . . 53.8 tp -72.67 86.17 1.21 Allowed 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.37 0.605 . . . . 73.409999999999997 110.71 177.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 753' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 . . . . . 0 C--O 1.238 0.46 0 CA-C-O 121.465 0.65 . . . . 74.230000000000004 111.753 -177.867 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 762' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 657' ' ' MET . . . . . . . . . . . . . 58.5 tpp . . . . . 0 N--CA 1.489 1.51 0 CA-C-O 120.726 0.298 . . . . 72.420000000000002 111.149 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 658' ' ' GLY . . . . . . . . . . . . . . . 147.16 -114.32 0.7 Allowed Glycine 0 CA--C 1.525 0.706 0 C-N-CA 120.968 -0.634 . . . . 74.319999999999993 112.74 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 659' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -103.69 -177.82 3.48 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 120.893 0.377 . . . . 74.420000000000002 111.146 178.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 660' ' ' GLY . . . . . . . . . . . . . . . -126.65 120.9 3.81 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 121.382 -0.437 . . . . 74.439999999999998 112.866 176.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -71.68 131.12 42.71 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 120.856 0.36 . . . . 75.420000000000002 111.965 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 662' ' ' THR . . . . . . . . . . . . . 35.6 m -89.08 140.11 29.77 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 120.908 0.385 . . . . 74.209999999999994 111.707 -178.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 663' ' ' SER . . . . . . . . . . . . . 45.2 m -86.98 114.58 23.72 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 116.562 -0.29 . . . . 71.219999999999999 111.689 -179.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 664' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -75.46 136.49 40.68 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.871 0.367 . . . . 73.519999999999996 111.134 176.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 665' ' ' LEU . . . . . 0.421 HD13 ' HD3' ' A' ' 694' ' ' LYS . 89.4 mt -90.55 136.62 32.94 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 116.305 -0.407 . . . . 75.140000000000001 110.505 174.237 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 666' ' ' GLU . . . . . 0.473 ' HB3' ' HB3' ' A' ' 729' ' ' HIS . 2.3 pm0 -65.5 140.63 97.67 Favored Pre-proline 0 CA--C 1.543 0.701 0 CA-C-O 120.921 0.391 . . . . 73.400000000000006 111.543 177.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 667' ' ' PRO . . . . . 0.567 ' HD3' ' HB2' ' A' ' 725' ' ' ASP . 12.8 Cg_endo -55.36 145.85 65.16 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 123.378 2.719 . . . . 75.400000000000006 114.745 -169.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 668' ' ' LYS . . . . . . . . . . . . . 7.4 tmtm? -85.06 104.14 14.71 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.287 -0.87 . . . . 73.329999999999998 110.404 177.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 669' ' ' LEU . . . . . . . . . . . . . 57.5 tp -100.05 111.72 24.02 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 116.119 -0.491 . . . . 74.230000000000004 111.564 -177.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 670' ' ' THR . . . . . . . . . . . . . 86.2 m -89.11 111.53 22.31 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.9 0.381 . . . . 64.540000000000006 111.502 178.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 671' ' ' VAL . . . . . . . . . . . . . 90.6 t -134.0 129.16 19.95 Favored Pre-proline 0 N--CA 1.47 0.529 0 CA-C-N 116.194 -0.457 . . . . 72.519999999999996 110.807 176.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 672' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -74.29 128.88 12.45 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 122.161 1.907 . . . . 73.340000000000003 112.084 176.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 673' ' ' VAL . . . . . . . . . . . . . 9.6 p -64.6 -19.27 24.9 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 N-CA-C 112.423 0.527 . . . . 75.019999999999996 112.423 -175.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 674' ' ' GLY . . . . . . . . . . . . . . . -156.8 155.59 26.48 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 120.809 -0.71 . . . . 44.030000000000001 113.501 -179.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 675' ' ' ALA . . . . . 0.462 ' HB1' HG23 ' A' ' 737' ' ' VAL . . . -151.1 145.66 25.62 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 120.691 0.281 . . . . 74.519999999999996 111.148 178.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 676' ' ' THR . . . . . . . . . . . . . 88.9 m -120.65 124.79 46.09 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.031 0.443 . . . . 73.230000000000004 112.096 -179.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 677' ' ' ILE . . . . . . . . . . . . . 28.8 pt -135.4 177.24 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 CA-C-N 116.244 -0.435 . . . . 72.430000000000007 111.029 176.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 678' ' ' HIS . . . . . . . . . . . . . 65.8 m80 -124.46 168.07 13.56 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.295 0.569 . . . . 72.129999999999995 112.188 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 679' ' ' VAL . . . . . . . . . . . . . 85.5 t -63.31 111.55 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-N 115.777 -0.647 . . . . 65.310000000000002 109.871 170.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 107.59 -4.33 34.69 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 121.297 -0.478 . . . . 64.230000000000004 113.29 -175.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 681' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -86.18 170.93 11.7 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 121.223 0.535 . . . . 74.129999999999995 111.508 176.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 682' ' ' SER . . . . . . . . . . . . . 77.3 p -114.58 153.21 30.5 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 116.349 -0.387 . . . . 73.319999999999993 111.121 178.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 683' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -159.19 114.06 2.45 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 120.745 0.307 . . . . 74.340000000000003 111.453 -178.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 684' ' ' VAL . . . . . 0.428 ' HA ' ' HD2' ' A' ' 685' ' ' PRO . 84.0 t -105.47 103.98 45.72 Favored Pre-proline 0 CA--C 1.543 0.677 0 CA-C-N 116.551 -0.295 . . . . 72.010000000000005 110.982 176.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 685' ' ' PRO . . . . . 0.428 ' HD2' ' HA ' ' A' ' 684' ' ' VAL . 14.4 Cg_endo -57.12 -35.55 98.94 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 122.606 2.204 . . . . 74.209999999999994 113.484 -179.059 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 686' ' ' MET . . . . . 0.469 ' HA ' ' HE1' ' A' ' 686' ' ' MET . 0.6 OUTLIER -78.35 -6.19 54.4 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 112.314 0.487 . . . . 72.150000000000006 112.314 -179.224 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 687' ' ' ALA . . . . . . . . . . . . . . . -94.51 -27.42 15.98 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 121.039 0.447 . . . . 73.310000000000002 111.259 175.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 688' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -86.08 -9.99 55.73 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 116.158 -0.474 . . . . 75.200000000000003 111.753 -179.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . 0.432 HG13 HD13 ' A' ' 703' ' ' ILE . 95.5 t -118.63 133.93 63.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 CA-C-O 120.937 0.398 . . . . 74.400000000000006 111.613 -177.194 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 690' ' ' LEU . . . . . 0.529 HD22 ' N ' ' A' ' 691' ' ' ALA . 4.1 tt -141.73 136.68 31.02 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 116.188 -0.46 . . . . 73.450000000000003 110.138 -177.309 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 691' ' ' ALA . . . . . 0.529 ' N ' HD22 ' A' ' 690' ' ' LEU . . . -122.48 122.09 38.11 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.345 0.498 . . . . 71.299999999999997 112.345 -178.016 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 692' ' ' ILE . . . . . . . . . . . . . 45.0 mm -122.25 124.23 70.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-N 116.183 -0.462 . . . . 73.340000000000003 111.483 178.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -113.6 144.99 41.96 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.726 0.298 . . . . 74.439999999999998 110.294 173.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 694' ' ' LYS . . . . . 0.611 ' HB3' ' HZ3' ' A' ' 694' ' ' LYS . 7.9 mtpm? -71.72 -43.08 66.5 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 112.105 0.409 . . . . 72.450000000000003 112.105 -175.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 44.7 mp0 -83.88 -54.35 4.94 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 121.144 0.497 . . . . 75.409999999999997 112.142 -178.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 696' ' ' ASP . . . . . . . . . . . . . 32.7 t0 -79.38 -28.62 41.92 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 116.083 -0.508 . . . . 51.200000000000003 112.133 -172.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . 105.64 -155.53 16.85 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 121.186 -0.53 . . . . 72.150000000000006 113.595 176.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -68.22 118.19 11.02 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 122.55 -0.383 . . . . 75.209999999999994 110.48 176.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 699' ' ' LEU . . . . . 0.501 HD23 ' HE2' ' A' ' 702' ' ' LYS . 19.9 mt -113.31 19.89 16.63 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.46 -0.336 . . . . 75.200000000000003 111.511 -176.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 77.6 m -56.11 -37.92 70.07 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 112.313 0.486 . . . . 73.310000000000002 112.313 -176.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 701' ' ' SER . . . . . . . . . . . . . 73.3 m -70.83 -19.52 62.65 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 112.063 0.394 . . . . 74.140000000000001 112.063 178.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 702' ' ' LYS . . . . . 0.501 ' HE2' HD23 ' A' ' 699' ' ' LEU . 54.5 mtmt -92.59 11.24 27.2 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.777 0.323 . . . . 71.200000000000003 111.625 178.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 703' ' ' ILE . . . . . 0.519 HG12 ' HB ' ' A' ' 723' ' ' VAL . 54.0 mt -87.49 120.43 36.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 116.712 -0.222 . . . . 74.329999999999998 110.728 174.137 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 704' ' ' LYS . . . . . . . . . . . . . 53.6 tttm -93.11 146.32 23.74 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 120.801 0.334 . . . . 74.420000000000002 110.892 173.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 44.5 t -104.3 146.33 11.83 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-O 120.952 0.406 . . . . 74.430000000000007 110.887 176.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 706' ' ' ASP . . . . . 0.487 ' HB3' ' HB ' ' A' ' 720' ' ' THR . 32.3 t70 -135.01 129.96 34.96 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 120.899 0.38 . . . . 73.239999999999995 110.738 174.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 101.34 175.88 28.76 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 121.439 -0.41 . . . . 71.540000000000006 112.404 -176.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 708' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -151.86 144.7 24.39 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 117.076 0.438 . . . . 71.209999999999994 111.908 -178.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 709' ' ' VAL . . . . . 0.49 HG22 ' HB2' ' A' ' 717' ' ' TYR . 97.1 t -114.07 111.45 36.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-N 116.437 -0.347 . . . . 71.129999999999995 111.305 178.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 710' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -70.01 136.11 50.06 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 120.946 0.403 . . . . 73.349999999999994 111.264 176.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 711' ' ' THR . . . . . . . . . . . . . 70.7 p -106.36 -6.73 18.1 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 112.131 0.419 . . . . 74.340000000000003 112.131 -178.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 712' ' ' THR . . . . . . . . . . . . . 11.7 t -100.25 0.28 39.96 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 111.973 0.36 . . . . 75.439999999999998 111.973 177.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 713' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -144.03 134.06 24.12 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 120.692 0.282 . . . . 74.319999999999993 111.279 -177.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 714' ' ' ALA . . . . . . . . . . . . . . . -76.62 144.55 39.47 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 112.359 0.503 . . . . 72.120000000000005 112.359 -176.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 158.03 168.3 20.15 Favored Glycine 0 CA--C 1.525 0.718 0 CA-C-N 116.025 -0.534 . . . . 74.209999999999994 112.487 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 716' ' ' THR . . . . . . . . . . . . . 91.3 m -96.39 123.48 40.06 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 122.295 -0.532 . . . . 74.420000000000002 111.477 178.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 717' ' ' TYR . . . . . 0.49 ' HB2' HG22 ' A' ' 709' ' ' VAL . 33.3 m-85 -119.52 141.51 49.14 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 116.404 -0.362 . . . . 75.340000000000003 110.755 -178.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 718' ' ' VAL . . . . . . . . . . . . . 72.9 t -113.26 131.35 65.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 CA-C-O 120.893 0.378 . . . . 72.409999999999997 111.383 178.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 719' ' ' LEU . . . . . 0.421 HD23 HG21 ' A' ' 709' ' ' VAL . 69.4 mt -116.4 142.15 47.23 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 116.444 -0.344 . . . . 73.120000000000005 111.433 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 720' ' ' THR . . . . . 0.487 ' HB ' ' HB3' ' A' ' 706' ' ' ASP . 93.2 m -114.89 136.13 53.44 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 120.876 0.37 . . . . 71.349999999999994 111.356 178.035 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 721' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -124.71 135.03 52.68 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 116.346 -0.388 . . . . 73.450000000000003 110.947 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 94.6 m -138.21 134.88 35.02 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 111.813 0.301 . . . . 72.25 111.813 -177.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 723' ' ' VAL . . . . . 0.519 ' HB ' HG12 ' A' ' 703' ' ' ILE . 8.7 p -132.25 146.24 33.39 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 CA-C-O 120.879 0.371 . . . . 75.109999999999999 111.422 179.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 56.5 m -119.6 130.29 55.04 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 112.734 0.642 . . . . 71.439999999999998 112.734 -175.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 725' ' ' ASP . . . . . 0.567 ' HB2' ' HD3' ' A' ' 667' ' ' PRO . 12.0 t70 -76.68 155.58 33.24 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.983 -0.553 . . . . 74.209999999999994 110.516 174.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 726' ' ' SER . . . . . . . . . . . . . 46.4 t -54.51 -33.65 60.29 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 112.407 0.521 . . . . 75.129999999999995 112.407 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 727' ' ' LYS . . . . . . . . . . . . . 46.7 mmtm -75.96 -14.82 60.24 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 112.239 0.459 . . . . 74.200000000000003 112.239 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 728' ' ' GLY . . . . . . . . . . . . . . . 109.94 4.71 29.49 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 121.112 -0.566 . . . . 52.140000000000001 113.625 -177.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 729' ' ' HIS . . . . . 0.473 ' HB3' ' HB3' ' A' ' 666' ' ' GLU . 24.8 m170 -70.67 102.13 2.22 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 117.519 0.659 . . . . 75.219999999999999 111.353 176.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 730' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -98.0 125.26 42.86 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 120.984 0.421 . . . . 74.540000000000006 111.503 179.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 731' ' ' VAL . . . . . 0.431 HG23 ' HG2' ' A' ' 667' ' ' PRO . 30.2 m -126.65 154.18 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-O 120.84 0.352 . . . . 63.240000000000002 111.113 176.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 8.8 t -144.42 147.89 33.93 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 121.386 0.612 . . . . 72.209999999999994 112.431 -173.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -147.49 153.67 39.81 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.862 -0.608 . . . . 63.140000000000001 110.576 177.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 734' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -123.47 152.04 42.09 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 112.625 0.602 . . . . 64.219999999999999 112.625 -173.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 735' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -130.24 128.34 41.43 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 115.798 -0.637 . . . . 75.310000000000002 111.133 -177.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 736' ' ' THR . . . . . . . . . . . . . 93.9 m -100.26 109.64 21.87 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.848 0.356 . . . . 64.120000000000005 111.428 179.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 737' ' ' VAL . . . . . 0.462 HG23 ' HB1' ' A' ' 675' ' ' ALA . 41.0 t -105.33 117.72 51.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-O 120.952 0.406 . . . . 70.439999999999998 111.554 -178.111 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 738' ' ' THR . . . . . . . . . . . . . 91.8 m -102.23 131.1 49.0 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 120.906 0.384 . . . . 74.310000000000002 111.545 178.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 739' ' ' VAL . . . . . . . . . . . . . 43.1 t -104.45 131.12 54.13 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-N 116.348 -0.387 . . . . 70.340000000000003 111.535 179.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 740' ' ' LYS . . . . . 0.641 ' HZ2' ' HB3' ' A' ' 740' ' ' LYS . 7.7 mtpm? -116.08 155.77 27.56 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 120.902 0.382 . . . . 73.329999999999998 111.305 177.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 741' ' ' VAL . . . . . . . . . . . . . 43.9 t -90.32 140.07 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 N-CA-C 112.093 0.405 . . . . 74.400000000000006 112.093 -177.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 742' ' ' ARG . . . . . . . . . . . . . 60.0 mtp85 -88.51 -80.39 0.28 Allowed 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 121.001 0.429 . . . . 74.409999999999997 110.961 174.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 743' ' ' GLU . . . . . . . . . . . . . 10.4 mp0 -87.71 116.94 26.2 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 116.522 -0.308 . . . . 74.430000000000007 110.765 177.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 744' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -92.73 -179.31 5.12 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 120.942 0.401 . . . . 75.319999999999993 111.941 -177.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 745' ' ' VAL . . . . . 0.668 HG13 ' H ' ' A' ' 747' ' ' ASN . 47.2 t -85.46 140.34 16.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 116.476 -0.329 . . . . 75.129999999999995 111.009 178.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -68.84 -25.92 64.9 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.503 0.557 . . . . 71.430000000000007 112.503 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 747' ' ' ASN . . . . . 0.668 ' H ' HG13 ' A' ' 745' ' ' VAL . 18.6 m120 -105.4 153.23 21.96 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 112.483 0.549 . . . . 72.140000000000001 112.483 -174.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -71.51 115.14 10.34 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.636 -0.711 . . . . 75.140000000000001 111.862 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 749' ' ' LYS . . . . . . . . . . . . . 20.3 tttp -167.91 74.38 0.92 Allowed Pre-proline 0 CA--C 1.542 0.647 0 CA-C-O 120.914 0.388 . . . . 74.299999999999997 111.462 176.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 750' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.31 86.48 1.45 Allowed 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 122.327 2.018 . . . . 71.25 112.232 178.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 751' ' ' ILE . . . . . . . . . . . . . 22.6 pt -79.57 4.35 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 N-CA-C 112.553 0.575 . . . . 73.450000000000003 112.553 -178.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 752' ' ' LEU . . . . . . . . . . . . . 89.7 mt -104.79 179.33 4.3 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 120.901 0.382 . . . . 74.030000000000001 111.093 175.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 753' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 . . . . . 0 N--CA 1.468 0.467 0 CA-C-O 120.922 0.391 . . . . 75.120000000000005 111.333 179.013 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 762' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 657' ' ' MET . . . . . . . . . . . . . 23.5 ptm . . . . . 0 N--CA 1.488 1.471 0 CA-C-O 120.84 0.352 . . . . 72.230000000000004 111.418 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 658' ' ' GLY . . . . . . . . . . . . . . . 151.33 127.06 1.34 Allowed Glycine 0 CA--C 1.53 0.992 0 C-N-CA 120.919 -0.658 . . . . 63.520000000000003 113.308 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 659' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -154.97 169.44 24.07 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.924 0.392 . . . . 72.340000000000003 111.452 177.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 660' ' ' GLY . . . . . . . . . . . . . . . 159.04 -173.95 35.95 Favored Glycine 0 CA--C 1.524 0.644 0 C-N-CA 121.263 -0.494 . . . . 53.149999999999999 113.029 178.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -135.24 138.13 43.26 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.664 0.269 . . . . 74.129999999999995 110.94 178.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 662' ' ' THR . . . . . . . . . . . . . 7.3 t -133.49 146.9 51.53 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 111.897 0.332 . . . . 43.219999999999999 111.897 -178.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 663' ' ' SER . . . . . . . . . . . . . 50.7 m -86.56 136.92 32.89 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 120.788 0.327 . . . . 72.239999999999995 111.597 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 664' ' ' ASP . . . . . 0.51 ' CG ' ' HG3' ' A' ' 727' ' ' LYS . 12.3 t70 -85.75 155.68 20.94 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 120.927 0.394 . . . . 74.420000000000002 111.291 177.507 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 665' ' ' LEU . . . . . 0.497 HD11 ' HD2' ' A' ' 694' ' ' LYS . 73.2 mt -102.84 137.74 40.65 Favored 'General case' 0 C--O 1.242 0.678 0 N-CA-C 112.268 0.47 . . . . 73.129999999999995 112.268 -176.191 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 666' ' ' GLU . . . . . 0.502 ' HG3' ' HB3' ' A' ' 729' ' ' HIS . 3.5 mp0 -67.58 151.62 97.0 Favored Pre-proline 0 CA--C 1.544 0.719 0 CA-C-N 115.957 -0.565 . . . . 74.230000000000004 111.005 176.513 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 667' ' ' PRO . . . . . 0.609 ' HD3' ' HB2' ' A' ' 725' ' ' ASP . 61.3 Cg_endo -72.7 153.72 54.14 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 122.659 2.239 . . . . 74.129999999999995 113.429 -178.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 668' ' ' LYS . . . . . . . . . . . . . 13.0 tmtt? -92.3 105.15 17.41 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.104 0.478 . . . . 75.409999999999997 110.496 178.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 669' ' ' LEU . . . . . . . . . . . . . 57.9 tp -94.88 120.04 34.44 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 116.173 -0.467 . . . . 73.540000000000006 111.29 -179.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 670' ' ' THR . . . . . . . . . . . . . 90.2 m -102.22 110.79 22.84 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 120.832 0.349 . . . . 75.129999999999995 111.151 -179.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 671' ' ' VAL . . . . . 0.431 HG22 HG13 ' A' ' 689' ' ' VAL . 87.6 t -135.42 126.54 17.3 Favored Pre-proline 0 N--CA 1.472 0.673 0 CA-C-N 116.072 -0.513 . . . . 72.310000000000002 111.065 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 672' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -73.21 145.41 38.91 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 122.241 1.961 . . . . 74.010000000000005 112.19 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 673' ' ' VAL . . . . . . . . . . . . . 13.9 p -65.14 -32.8 59.84 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 N-CA-C 112.098 0.407 . . . . 70.030000000000001 112.098 -178.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 674' ' ' GLY . . . . . . . . . . . . . . . -162.05 147.54 13.87 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 120.77 -0.729 . . . . 45.240000000000002 113.408 -179.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 675' ' ' ALA . . . . . . . . . . . . . . . -136.09 139.62 43.14 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 122.647 0.379 . . . . 61.219999999999999 110.802 179.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 676' ' ' THR . . . . . . . . . . . . . 92.1 m -117.36 124.13 48.16 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.547 0.573 . . . . 73.530000000000001 112.547 -175.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 677' ' ' ILE . . . . . . . . . . . . . 33.7 pt -130.46 177.09 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 CA-C-N 116.292 -0.413 . . . . 75.120000000000005 110.517 175.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 678' ' ' HIS . . . . . . . . . . . . . 76.5 m80 -114.31 168.76 9.57 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 121.232 0.539 . . . . 74.430000000000007 111.787 175.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 679' ' ' VAL . . . . . . . . . . . . . 96.6 t -63.55 117.93 5.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 116.182 -0.463 . . . . 71.329999999999998 110.654 175.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 95.32 8.21 58.86 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 121.419 -0.42 . . . . 64.400000000000006 113.135 -178.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 681' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -94.03 166.1 12.31 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.073 0.463 . . . . 63.109999999999999 111.43 178.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 682' ' ' SER . . . . . . . . . . . . . 47.2 m -93.54 149.42 21.25 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.22 -0.445 . . . . 75.219999999999999 111.421 -179.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 683' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -151.6 116.41 5.18 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.722 0.296 . . . . 72.120000000000005 110.761 178.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 684' ' ' VAL . . . . . . . . . . . . . 28.8 t -117.01 92.57 39.57 Favored Pre-proline 0 CA--C 1.544 0.727 0 CA-C-O 121.126 0.489 . . . . 75.510000000000005 111.522 -178.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -62.27 -31.89 82.07 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 122.606 2.204 . . . . 73.420000000000002 112.963 -177.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 686' ' ' MET . . . . . 0.508 ' HE1' ' HB ' ' A' ' 703' ' ' ILE . 0.7 OUTLIER -78.85 -1.39 34.75 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 112.248 0.462 . . . . 73.120000000000005 112.248 -178.403 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 687' ' ' ALA . . . . . . . . . . . . . . . -104.61 -30.14 10.17 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.088 0.47 . . . . 71.319999999999993 111.31 175.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 688' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -91.19 -28.17 18.02 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 116.343 -0.39 . . . . 74.329999999999998 111.85 -179.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . 0.444 HG11 HD13 ' A' ' 703' ' ' ILE . 80.2 t -98.15 124.7 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-O 120.922 0.391 . . . . 72.420000000000002 111.413 178.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 690' ' ' LEU . . . . . 0.426 HD13 ' C ' ' A' ' 689' ' ' VAL . 7.3 mp -126.04 154.46 42.96 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 116.234 -0.439 . . . . 75.239999999999995 111.619 -178.467 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 691' ' ' ALA . . . . . . . . . . . . . . . -137.39 122.26 18.85 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.796 0.331 . . . . 71.140000000000001 111.058 177.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 692' ' ' ILE . . . . . . . . . . . . . 50.2 mm -129.09 117.27 43.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 CA-C-O 120.842 0.353 . . . . 71.150000000000006 111.653 -176.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 693' ' ' ASP . . . . . 0.458 ' HB2' ' HB3' ' A' ' 667' ' ' PRO . 34.4 t70 -95.19 149.66 21.07 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.535 -0.302 . . . . 71.319999999999993 110.481 176.184 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 694' ' ' LYS . . . . . 0.497 ' HD2' HD11 ' A' ' 665' ' ' LEU . 30.9 ttmt -72.41 -43.29 64.09 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 112.837 0.68 . . . . 74.409999999999997 112.837 -171.121 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -84.09 -45.9 12.53 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 121.696 -0.627 . . . . 72.030000000000001 111.278 177.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 696' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -74.43 -48.99 24.21 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 112.206 0.447 . . . . 71.230000000000004 112.206 -175.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . 112.14 -117.79 4.51 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 121.0 -0.619 . . . . 72.450000000000003 112.647 -176.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -78.09 117.52 19.46 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 122.118 -0.636 . . . . 74.349999999999994 111.935 -179.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 699' ' ' LEU . . . . . 0.464 HD13 ' HB3' ' A' ' 667' ' ' PRO . 73.5 mt -117.24 14.05 14.74 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.126 -0.488 . . . . 73.5 110.726 172.246 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 33.5 m -58.66 -34.58 71.39 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.017 0.437 . . . . 71.430000000000007 111.251 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 701' ' ' SER . . . . . . . . . . . . . 80.2 p -70.31 -17.82 63.09 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 116.504 -0.316 . . . . 75.019999999999996 111.757 177.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 702' ' ' LYS . . . . . . . . . . . . . 45.3 mmtm -91.22 3.29 55.21 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 111.814 0.302 . . . . 71.239999999999995 111.814 -178.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 703' ' ' ILE . . . . . 0.508 ' HB ' ' HE1' ' A' ' 686' ' ' MET . 67.3 mt -76.36 125.73 36.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-O 121.195 0.522 . . . . 74.439999999999998 111.754 -179.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 704' ' ' LYS . . . . . . . . . . . . . 58.4 mttp -92.9 123.93 36.52 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.191 -0.459 . . . . 73.019999999999996 110.741 172.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 51.9 t -95.85 106.94 18.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.935 -0.575 . . . . 72.409999999999997 110.808 179.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 706' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -100.04 134.0 43.6 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 120.912 0.387 . . . . 71.319999999999993 111.456 -178.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 118.24 -168.96 13.23 Favored Glycine 0 CA--C 1.525 0.659 0 CA-C-N 116.293 -0.412 . . . . 62.32 112.68 -178.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 708' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -158.05 137.61 11.98 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.967 0.413 . . . . 72.129999999999995 111.72 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 709' ' ' VAL . . . . . 0.422 HG21 ' HB2' ' A' ' 717' ' ' TYR . 62.7 t -126.34 123.11 62.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-N 116.459 -0.337 . . . . 74.319999999999993 111.127 179.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 710' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -93.47 142.22 27.58 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 121.202 0.525 . . . . 71.329999999999998 111.332 177.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 711' ' ' THR . . . . . . . . . . . . . 47.6 p -101.54 -9.44 21.01 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.806 -0.634 . . . . 74.349999999999994 112.278 -178.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 712' ' ' THR . . . . . . . . . . . . . 59.6 p -103.05 -0.09 31.27 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 113.099 0.777 . . . . 74.409999999999997 113.099 -177.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 713' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -144.14 136.57 26.74 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 122.067 -0.396 . . . . 74.439999999999998 111.332 175.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 714' ' ' ALA . . . . . . . . . . . . . . . -70.08 144.48 52.12 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 112.393 0.516 . . . . 74.219999999999999 112.393 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 161.28 166.7 20.52 Favored Glycine 0 CA--C 1.525 0.679 0 CA-C-N 116.108 -0.497 . . . . 74.409999999999997 112.729 -179.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 716' ' ' THR . . . . . . . . . . . . . 53.2 m -101.12 124.52 46.96 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 122.357 -0.496 . . . . 73.519999999999996 111.182 178.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 717' ' ' TYR . . . . . 0.422 ' HB2' HG21 ' A' ' 709' ' ' VAL . 30.2 m-85 -121.75 133.47 54.93 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 116.198 -0.456 . . . . 75.209999999999994 110.762 -177.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 718' ' ' VAL . . . . . . . . . . . . . 58.8 t -94.96 133.06 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-O 120.82 0.343 . . . . 72.129999999999995 111.614 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 719' ' ' LEU . . . . . . . . . . . . . 96.4 mt -119.79 127.66 53.0 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.802 0.334 . . . . 75.340000000000003 111.116 177.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 91.8 m -111.68 120.67 42.83 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 120.752 0.311 . . . . 73.329999999999998 110.912 178.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 721' ' ' TYR . . . . . 0.449 ' HH ' ' NE2' ' A' ' 735' ' ' GLN . 57.1 m-85 -104.78 120.04 40.43 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.591 -0.277 . . . . 74.329999999999998 111.186 -178.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 59.9 m -122.55 123.46 41.29 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 120.674 0.273 . . . . 73.310000000000002 111.168 178.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 10.4 p -119.14 147.18 22.85 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 CA-C-O 121.008 0.432 . . . . 72.340000000000003 111.906 -177.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 76.2 m -110.21 133.57 53.1 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 112.303 0.482 . . . . 74.299999999999997 112.303 -177.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 725' ' ' ASP . . . . . 0.609 ' HB2' ' HD3' ' A' ' 667' ' ' PRO . 50.2 t0 -73.62 154.64 39.67 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 115.888 -0.597 . . . . 62.240000000000002 111.216 176.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 726' ' ' SER . . . . . . . . . . . . . 40.4 t -58.24 -28.58 65.02 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.036 0.446 . . . . 52.25 111.178 176.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 727' ' ' LYS . . . . . 0.51 ' HG3' ' CG ' ' A' ' 664' ' ' ASP . 36.8 mmtm -90.28 -11.01 42.08 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 111.97 0.359 . . . . 75.030000000000001 111.97 177.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 728' ' ' GLY . . . . . . . . . . . . . . . 112.4 -1.23 26.51 Favored Glycine 0 CA--C 1.533 1.171 0 N-CA-C 114.688 0.635 . . . . 71.409999999999997 114.688 179.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 729' ' ' HIS . . . . . 0.511 ' N ' ' HB3' ' A' ' 725' ' ' ASP . 34.7 m80 -68.54 105.21 2.16 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 118.12 0.96 . . . . 74.310000000000002 110.989 176.121 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 730' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -96.32 125.88 41.13 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 120.802 0.334 . . . . 75.430000000000007 110.942 -179.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 35.9 m -127.02 158.11 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-O 120.699 0.285 . . . . 72.420000000000002 111.079 178.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 5.3 t -143.52 149.76 37.95 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 112.755 0.65 . . . . 62.299999999999997 112.755 -174.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -148.37 154.59 40.15 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.771 -0.65 . . . . 73.299999999999997 110.343 176.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 734' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -119.86 154.86 33.71 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 113.159 0.8 . . . . 74.25 113.159 -174.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 735' ' ' GLN . . . . . 0.449 ' NE2' ' HH ' ' A' ' 721' ' ' TYR . 7.0 tt0 -136.67 124.12 22.09 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.5 -0.773 . . . . 62.310000000000002 110.652 177.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 736' ' ' THR . . . . . . . . . . . . . 99.8 m -93.93 105.78 17.78 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.104 0.478 . . . . 75.109999999999999 111.055 176.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 45.6 t -96.77 141.33 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-O 120.709 0.29 . . . . 71.299999999999997 111.59 -176.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 738' ' ' THR . . . . . . . . . . . . . 88.8 m -128.7 122.91 31.79 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.25 0.548 . . . . 71.400000000000006 112.269 -179.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 739' ' ' VAL . . . . . . . . . . . . . 47.2 t -95.57 124.57 48.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-N 115.754 -0.657 . . . . 75.400000000000006 110.788 176.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 740' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -102.95 151.67 22.21 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.417 0.627 . . . . 73.409999999999997 112.079 -176.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 741' ' ' VAL . . . . . . . . . . . . . 93.9 t -74.51 147.65 8.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 115.77 -0.65 . . . . 75.010000000000005 112.264 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 742' ' ' ARG . . . . . 0.414 HH11 ' HD2' ' A' ' 742' ' ' ARG . 13.5 ptt85 -145.96 -33.35 0.33 Allowed 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.44 -0.345 . . . . 74.25 111.837 168.323 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 743' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -136.4 99.78 4.19 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 120.787 0.327 . . . . 72.409999999999997 111.808 178.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 744' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -89.91 19.55 4.77 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 121.125 0.488 . . . . 75.349999999999994 111.633 177.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 32.3 m -80.26 168.16 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-O 121.206 0.527 . . . . 75.239999999999995 112.07 -179.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 746' ' ' LYS . . . . . 0.426 ' O ' ' HG3' ' A' ' 746' ' ' LYS . 24.7 pttm -132.18 108.48 9.29 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.208 0.528 . . . . 74.030000000000001 110.866 174.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 747' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -69.71 120.18 15.08 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.461 -0.336 . . . . 74.150000000000006 110.672 179.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -71.86 77.69 0.88 Allowed 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 121.405 0.622 . . . . 71.420000000000002 110.797 -178.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 749' ' ' LYS . . . . . 0.751 ' HB2' ' HZ2' ' A' ' 749' ' ' LYS . 5.1 ttmp? -172.96 94.11 0.37 Allowed Pre-proline 0 CA--C 1.538 0.498 0 CA-C-N 115.361 -0.836 . . . . 73.420000000000002 110.532 179.033 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 750' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.2 133.94 16.89 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 122.302 2.001 . . . . 72.239999999999995 112.894 -178.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 751' ' ' ILE . . . . . 0.424 HD11 ' N ' ' A' ' 751' ' ' ILE . 2.3 mp -61.37 109.52 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-O 120.851 0.358 . . . . 70.140000000000001 110.235 176.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 752' ' ' LEU . . . . . . . . . . . . . 66.2 mt -68.85 111.92 5.22 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 120.896 0.379 . . . . 71.040000000000006 112.014 -174.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 753' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 . . . . . 0 C--O 1.237 0.442 0 CA-C-N 115.735 -0.666 . . . . 74.439999999999998 112.337 174.909 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 762' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 657' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 120.644 0.259 . . . . 75.439999999999998 110.686 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 658' ' ' GLY . . . . . . . . . . . . . . . 81.0 -58.63 4.81 Favored Glycine 0 CA--C 1.53 0.975 0 N-CA-C 114.382 0.513 . . . . 43.43 114.382 173.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 659' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -66.29 147.32 53.49 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.146 0.498 . . . . 75.530000000000001 112.271 -175.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 660' ' ' GLY . . . . . . . . . . . . . . . -90.02 169.59 35.22 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 121.279 -0.486 . . . . 38.890000000000001 113.358 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -108.69 175.91 5.3 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.101 0.477 . . . . 74.439999999999998 111.635 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 662' ' ' THR . . . . . . . . . . . . . 67.5 p -87.37 108.16 18.86 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 112.091 0.404 . . . . 72.209999999999994 112.091 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 663' ' ' SER . . . . . . . . . . . . . 68.6 m -84.53 132.66 34.5 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 120.717 0.294 . . . . 74.299999999999997 111.375 177.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 664' ' ' ASP . . . . . 0.703 ' HB2' ' HE2' ' A' ' 727' ' ' LYS . 16.1 t70 -74.27 141.97 45.29 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 121.123 0.487 . . . . 73.109999999999999 111.818 179.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 665' ' ' LEU . . . . . . . . . . . . . 70.1 mt -85.39 119.01 25.27 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.135 -0.484 . . . . 72.540000000000006 109.697 173.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 666' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -67.68 145.33 98.09 Favored Pre-proline 0 CA--C 1.54 0.56 0 CA-C-O 120.671 0.272 . . . . 71.349999999999994 111.308 -177.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 667' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -75.8 146.26 29.7 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.405 2.07 . . . . 62.350000000000001 113.193 -173.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 668' ' ' LYS . . . . . . . . . . . . . 4.9 tmtm? -88.28 109.18 19.75 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 109.89 -0.411 . . . . 74.019999999999996 109.89 177.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 669' ' ' LEU . . . . . 0.405 ' HG ' HG22 ' A' ' 671' ' ' VAL . 58.0 tp -93.01 106.16 18.15 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.071 0.463 . . . . 74.129999999999995 110.543 176.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 670' ' ' THR . . . . . . . . . . . . . 86.9 m -86.62 110.7 20.01 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.263 -0.426 . . . . 72.129999999999995 111.391 -178.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 671' ' ' VAL . . . . . 0.405 HG22 ' HG ' ' A' ' 669' ' ' LEU . 95.0 t -137.95 128.34 15.48 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 122.629 0.372 . . . . 75.420000000000002 111.091 -178.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 672' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -77.84 132.28 11.76 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 122.212 1.941 . . . . 74.239999999999995 111.809 177.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 673' ' ' VAL . . . . . . . . . . . . . 14.3 p -64.76 -30.61 50.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 N-CA-C 112.496 0.554 . . . . 62.439999999999998 112.496 -175.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 674' ' ' GLY . . . . . . . . . . . . . . . -151.81 142.6 9.57 Favored Glycine 0 CA--C 1.525 0.666 0 C-N-CA 120.811 -0.709 . . . . 71.25 113.571 -177.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 675' ' ' ALA . . . . . . . . . . . . . . . -140.48 157.69 45.12 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 122.49 0.316 . . . . 70.0 110.922 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 676' ' ' THR . . . . . . . . . . . . . 54.9 m -136.05 128.81 30.96 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.103 0.477 . . . . 73.329999999999998 111.797 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 677' ' ' ILE . . . . . . . . . . . . . 39.8 pt -132.49 177.64 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-N 116.085 -0.507 . . . . 72.030000000000001 110.987 177.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 678' ' ' HIS . . . . . . . . . . . . . 58.4 m80 -122.44 156.75 33.4 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.151 0.501 . . . . 73.340000000000003 112.276 178.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 679' ' ' VAL . . . . . . . . . . . . . 89.4 t -61.5 128.74 23.42 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 115.824 -0.626 . . . . 53.420000000000002 111.39 176.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 99.81 -17.04 57.95 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 121.356 -0.45 . . . . 73.0 113.031 -178.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 681' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -79.08 177.26 8.94 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 121.224 0.535 . . . . 72.099999999999994 112.248 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 682' ' ' SER . . . . . . . . . . . . . 48.5 m -104.46 145.23 30.57 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.913 -0.585 . . . . 52.399999999999999 110.516 176.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 683' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -148.7 113.05 5.27 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.913 0.387 . . . . 75.140000000000001 111.557 179.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 684' ' ' VAL . . . . . . . . . . . . . 63.6 t -111.61 102.33 53.1 Favored Pre-proline 0 CA--C 1.543 0.675 0 CA-C-N 116.257 -0.429 . . . . 70.030000000000001 110.616 176.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -56.91 -42.62 62.52 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 122.731 2.287 . . . . 74.120000000000005 113.658 -177.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 686' ' ' MET . . . . . 0.411 ' HE3' ' HB3' ' A' ' 686' ' ' MET . 15.8 mtp -79.17 -12.29 59.98 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 113.06 0.763 . . . . 73.109999999999999 113.06 -176.132 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 687' ' ' ALA . . . . . . . . . . . . . . . -79.17 -18.47 53.02 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 122.017 -0.427 . . . . 73.340000000000003 111.207 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 688' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -114.34 9.74 16.97 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 112.178 0.436 . . . . 52.509999999999998 112.178 -178.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . 0.427 HG21 ' CZ ' ' A' ' 721' ' ' TYR . 86.8 t -123.0 124.72 70.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-O 120.879 0.371 . . . . 73.310000000000002 110.939 178.106 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 690' ' ' LEU . . . . . 0.405 HD13 ' N ' ' A' ' 690' ' ' LEU . 6.4 mp -119.7 157.63 28.14 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.165 0.507 . . . . 72.409999999999997 111.534 -177.176 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 691' ' ' ALA . . . . . . . . . . . . . . . -148.54 123.48 10.01 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.963 -0.562 . . . . 64.530000000000001 110.557 176.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 692' ' ' ILE . . . . . . . . . . . . . 41.5 mm -131.91 131.4 61.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 N-CA-C 112.404 0.52 . . . . 74.209999999999994 112.404 -174.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -115.33 130.94 57.05 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.121 -0.491 . . . . 71.530000000000001 109.741 168.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -61.76 -32.35 72.6 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.113 0.482 . . . . 63.409999999999997 111.403 -177.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -83.72 -54.32 5.0 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 112.504 0.557 . . . . 74.299999999999997 112.504 -176.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 696' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -77.57 -42.98 33.26 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 120.811 0.339 . . . . 70.310000000000002 111.59 -178.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . 121.07 -139.79 13.59 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 121.544 -0.36 . . . . 73.510000000000005 113.001 -178.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -71.73 111.85 7.35 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.052 0.453 . . . . 72.120000000000005 111.102 178.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 699' ' ' LEU . . . . . 0.475 HD21 ' HG3' ' A' ' 702' ' ' LYS . 67.0 mt -100.72 9.12 42.83 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.446 -0.343 . . . . 74.299999999999997 111.319 176.155 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 31.2 m -59.7 -36.88 77.41 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.108 0.48 . . . . 71.010000000000005 111.247 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 701' ' ' SER . . . . . . . . . . . . . 47.1 m -81.99 3.13 27.72 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 116.328 -0.396 . . . . 73.25 111.738 176.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 702' ' ' LYS . . . . . 0.475 ' HG3' HD21 ' A' ' 699' ' ' LEU . 33.5 mmtp -103.48 3.96 35.47 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 120.816 0.341 . . . . 75.299999999999997 110.914 179.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 70.2 mt -84.42 116.77 28.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 N-CA-C 112.235 0.457 . . . . 74.120000000000005 112.235 -174.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 704' ' ' LYS . . . . . . . . . . . . . 61.2 tttp -84.83 122.53 29.28 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 120.689 0.28 . . . . 62.439999999999998 110.581 172.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 47.8 t -99.28 141.15 17.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-O 121.235 0.541 . . . . 72.200000000000003 112.024 -177.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 706' ' ' ASP . . . . . 0.584 ' HB3' ' HB ' ' A' ' 720' ' ' THR . 23.7 t70 -130.31 151.82 50.4 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.77 -0.65 . . . . 74.319999999999993 110.073 176.271 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 93.42 167.05 38.15 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 120.974 -0.631 . . . . 61.219999999999999 112.37 -174.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 708' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -144.5 142.8 30.5 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 122.346 -0.502 . . . . 72.120000000000005 111.997 -176.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 709' ' ' VAL . . . . . 0.516 HG22 HD23 ' A' ' 719' ' ' LEU . 95.7 t -122.09 132.52 70.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 CA-C-O 120.885 0.374 . . . . 72.319999999999993 111.158 176.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 710' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -98.32 138.12 36.04 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.002 0.43 . . . . 53.340000000000003 111.367 176.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 711' ' ' THR . . . . . . . . . . . . . 68.0 p -94.01 -25.45 17.22 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.937 0.398 . . . . 75.439999999999998 111.236 177.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 712' ' ' THR . . . . . . . . . . . . . 12.5 t -90.7 -7.04 53.65 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.0 0.429 . . . . 75.209999999999994 111.994 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 713' ' ' LYS . . . . . . . . . . . . . 28.2 tptp -130.42 125.79 35.37 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.704 0.288 . . . . 75.430000000000007 111.259 -177.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 714' ' ' ALA . . . . . . . . . . . . . . . -74.9 144.18 43.44 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 120.826 0.346 . . . . 74.319999999999993 111.466 178.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 159.03 164.4 14.38 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 121.073 -0.584 . . . . 75.319999999999993 113.313 -179.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 716' ' ' THR . . . . . . . . . . . . . 99.2 m -96.04 128.85 43.3 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 122.495 -0.415 . . . . 64.430000000000007 111.216 178.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 717' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -126.76 149.59 49.55 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.027 0.442 . . . . 74.109999999999999 111.574 -179.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 718' ' ' VAL . . . . . . . . . . . . . 40.6 t -117.07 114.0 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 121.079 0.466 . . . . 75.420000000000002 111.264 178.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 719' ' ' LEU . . . . . 0.516 HD23 HG22 ' A' ' 709' ' ' VAL . 81.2 mt -96.26 143.01 27.73 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.09 -0.505 . . . . 74.420000000000002 111.179 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 720' ' ' THR . . . . . 0.584 ' HB ' ' HB3' ' A' ' 706' ' ' ASP . 78.0 m -118.82 136.1 54.19 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.913 0.387 . . . . 71.109999999999999 111.154 177.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 721' ' ' TYR . . . . . 0.436 ' HH ' ' NE2' ' A' ' 735' ' ' GLN . 72.6 m-85 -120.57 134.36 55.29 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.491 -0.322 . . . . 73.040000000000006 110.906 179.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 25.5 m -134.46 126.22 29.03 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 116.626 -0.261 . . . . 72.439999999999998 110.914 -178.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 8.8 p -132.49 135.78 57.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 CA-C-O 120.929 0.395 . . . . 74.310000000000002 111.611 -179.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 43.0 m -107.96 131.68 54.29 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 120.983 0.421 . . . . 74.230000000000004 111.924 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -73.35 166.39 23.28 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.967 -0.56 . . . . 70.109999999999999 111.131 178.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 726' ' ' SER . . . . . . . . . . . . . 45.3 t -63.17 -40.74 98.4 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 116.372 -0.376 . . . . 74.329999999999998 111.854 178.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 727' ' ' LYS . . . . . 0.703 ' HE2' ' HB2' ' A' ' 664' ' ' ASP . 30.8 mtmm -107.23 25.53 11.29 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 113.773 1.027 . . . . 73.150000000000006 113.773 -177.325 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 728' ' ' GLY . . . . . . . . . . . . . . . 110.16 -5.97 30.44 Favored Glycine 0 CA--C 1.536 1.376 0 N-CA-C 116.645 1.418 . . . . 74.510000000000005 116.645 165.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 18.9 m80 -80.31 104.21 10.7 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 118.936 1.368 . . . . 75.010000000000005 111.958 179.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 730' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -103.28 115.74 31.14 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.986 0.422 . . . . 75.420000000000002 111.718 -178.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 48.0 t -108.74 149.58 11.92 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 CA-C-N 116.414 -0.357 . . . . 65.310000000000002 111.512 -176.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 7.7 t -143.32 143.97 31.91 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 112.502 0.556 . . . . 74.430000000000007 112.502 -178.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -148.7 161.57 41.5 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 116.414 -0.357 . . . . 70.109999999999999 111.234 178.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 734' ' ' LYS . . . . . . . . . . . . . 99.9 mttt -127.22 152.63 47.14 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 112.728 0.64 . . . . 75.200000000000003 112.728 -177.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 735' ' ' GLN . . . . . 0.436 ' NE2' ' HH ' ' A' ' 721' ' ' TYR . 6.7 tt0 -130.49 128.48 41.31 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 115.911 -0.586 . . . . 74.230000000000004 111.13 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 736' ' ' THR . . . . . . . . . . . . . 86.8 m -97.41 109.14 21.95 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.117 0.484 . . . . 73.329999999999998 111.23 176.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 45.4 t -101.16 129.07 52.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-O 120.972 0.415 . . . . 74.430000000000007 111.538 -179.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 738' ' ' THR . . . . . . . . . . . . . 40.4 m -108.94 113.75 26.92 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.521 -0.309 . . . . 73.140000000000001 111.255 179.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 739' ' ' VAL . . . . . . . . . . . . . 21.8 t -93.07 118.89 39.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-O 120.564 0.221 . . . . 63.329999999999998 110.577 177.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 740' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -112.46 158.97 19.22 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 120.994 0.426 . . . . 72.420000000000002 111.618 -176.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 741' ' ' VAL . . . . . . . . . . . . . 38.3 t -85.39 148.85 4.5 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 N-CA-C 113.248 0.833 . . . . 73.230000000000004 113.248 -170.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 742' ' ' ARG . . . . . . . . . . . . . 14.9 mmt180 -79.98 150.89 30.3 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.719 -0.673 . . . . 74.019999999999996 111.053 173.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 743' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -101.77 31.17 3.96 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.246 0.546 . . . . 75.239999999999995 110.578 175.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 744' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -119.35 18.01 12.97 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 116.193 -0.458 . . . . 71.109999999999999 111.41 -174.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 28.4 m -86.31 121.31 37.34 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 N-CA-C 112.911 0.708 . . . . 72.140000000000001 112.911 -171.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -140.7 -71.41 0.37 Allowed 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 121.176 0.513 . . . . 74.209999999999994 111.291 176.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 747' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -132.74 59.08 1.74 Allowed 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 121.514 0.673 . . . . 64.340000000000003 110.019 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -80.04 72.82 6.84 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.606 -0.725 . . . . 73.040000000000006 112.292 -171.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 749' ' ' LYS . . . . . 0.744 ' HA ' ' HE3' ' A' ' 749' ' ' LYS . 0.0 OUTLIER 46.85 84.64 0.19 Allowed Pre-proline 0 CA--C 1.545 0.765 0 N-CA-C 113.815 1.042 . . . . 72.430000000000007 113.815 176.022 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 750' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_exo -73.85 52.15 2.51 Favored 'Trans proline' 0 CA--C 1.544 1.006 0 C-N-CA 122.889 2.393 . . . . 75.310000000000002 111.72 171.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 751' ' ' ILE . . . . . . . . . . . . . 29.8 pt -97.9 169.27 1.52 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 N-CA-C 112.127 0.417 . . . . 75.439999999999998 112.127 -174.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 752' ' ' LEU . . . . . . . . . . . . . 42.9 tp -147.24 -21.03 0.39 Allowed 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 112.266 0.469 . . . . 75.230000000000004 112.266 178.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 753' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 . . . . . 0 N--CA 1.468 0.46 0 O-C-N 122.061 -0.399 . . . . 72.25 111.322 -176.438 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 762' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 657' ' ' MET . . . . . . . . . . . . . 66.7 mtt . . . . . 0 N--CA 1.488 1.445 0 CA-C-O 120.801 0.334 . . . . 74.349999999999994 110.984 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 658' ' ' GLY . . . . . . . . . . . . . . . -163.98 -155.41 8.27 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 121.299 -0.477 . . . . 71.329999999999998 112.919 179.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 659' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -117.35 -168.94 1.57 Allowed 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 121.076 0.465 . . . . 75.019999999999996 112.092 -177.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 660' ' ' GLY . . . . . . . . . . . . . . . 148.3 96.76 0.17 Allowed Glycine 0 CA--C 1.526 0.751 0 CA-C-N 115.827 -0.624 . . . . 37.5 111.816 -176.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 64.19 86.21 0.13 Allowed 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.318 0.58 . . . . 75.200000000000003 110.351 -174.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 662' ' ' THR . . . . . . . . . . . . . 49.9 m -119.97 93.65 4.13 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.437 -0.347 . . . . 74.239999999999995 111.097 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 663' ' ' SER . . . . . . . . . . . . . 70.3 m -70.53 142.36 51.83 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.92 0.391 . . . . 74.120000000000005 111.371 179.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 664' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -74.03 122.3 22.42 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 121.126 0.489 . . . . 74.319999999999993 111.649 -178.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 665' ' ' LEU . . . . . 0.46 HD13 ' HD3' ' A' ' 694' ' ' LYS . 84.0 mt -80.65 117.11 21.05 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.846 -0.615 . . . . 72.400000000000006 109.621 173.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 666' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -60.09 142.54 89.34 Favored Pre-proline 0 CA--C 1.542 0.663 0 CA-C-N 116.247 -0.433 . . . . 75.430000000000007 111.6 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 667' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -75.54 155.11 40.43 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 122.536 2.157 . . . . 73.420000000000002 113.795 -169.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 668' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -86.23 102.55 14.04 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.94 -0.573 . . . . 75.329999999999998 110.845 176.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 669' ' ' LEU . . . . . . . . . . . . . 55.2 tp -93.47 105.9 17.91 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 120.958 0.408 . . . . 75.129999999999995 110.64 177.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 670' ' ' THR . . . . . . . . . . . . . 87.4 m -89.18 110.98 21.66 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.361 -0.381 . . . . 72.120000000000005 111.616 -177.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 671' ' ' VAL . . . . . 0.506 HG22 HG12 ' A' ' 689' ' ' VAL . 88.6 t -138.16 134.52 17.85 Favored Pre-proline 0 CA--C 1.539 0.555 0 CA-C-N 116.259 -0.428 . . . . 74.420000000000002 110.672 179.359 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 672' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.62 120.78 5.68 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 122.058 1.838 . . . . 75.310000000000002 111.62 175.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 673' ' ' VAL . . . . . . . . . . . . . 14.8 p -67.08 -23.2 30.3 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 N-CA-C 112.761 0.652 . . . . 74.340000000000003 112.761 -174.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 674' ' ' GLY . . . . . . . . . . . . . . . -142.93 148.33 20.03 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 120.952 -0.642 . . . . 55.5 114.041 -177.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 675' ' ' ALA . . . . . . . . . . . . . . . -157.15 151.84 25.55 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.275 0.63 . . . . 73.120000000000005 110.35 178.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 676' ' ' THR . . . . . . . . . . . . . 91.1 m -139.34 124.9 19.34 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 111.897 0.332 . . . . 70.439999999999998 111.897 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 677' ' ' ILE . . . . . . . . . . . . . 25.2 pt -128.67 172.51 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-O 121.225 0.536 . . . . 74.430000000000007 111.689 179.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 678' ' ' HIS . . . . . 0.513 ' CD2' ' HG3' ' A' ' 740' ' ' LYS . 69.5 m80 -110.96 165.4 11.9 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.267 0.556 . . . . 75.230000000000004 111.713 177.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 679' ' ' VAL . . . . . . . . . . . . . 95.2 t -63.28 126.33 21.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 116.113 -0.494 . . . . 75.25 110.696 173.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 89.35 1.09 78.99 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 121.425 -0.417 . . . . 72.310000000000002 113.126 -176.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 681' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -84.74 177.94 7.84 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 120.937 0.399 . . . . 75.209999999999994 110.713 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 682' ' ' SER . . . . . . . . . . . . . 54.9 m -114.51 150.23 35.2 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 120.972 0.415 . . . . 52.109999999999999 111.365 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 683' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -151.36 131.1 13.18 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 116.129 -0.487 . . . . 72.030000000000001 110.904 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 684' ' ' VAL . . . . . . . . . . . . . 48.6 t -122.37 103.27 38.71 Favored Pre-proline 0 CA--C 1.543 0.677 0 CA-C-O 120.851 0.357 . . . . 70.430000000000007 111.312 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -60.33 -46.97 15.8 Favored 'Trans proline' 0 CA--C 1.545 1.027 0 C-N-CA 122.819 2.346 . . . . 73.209999999999994 113.974 -175.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 686' ' ' MET . . . . . . . . . . . . . 91.2 mmm -78.48 -11.85 59.98 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 112.925 0.713 . . . . 74.209999999999994 112.925 -174.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 687' ' ' ALA . . . . . . . . . . . . . . . -77.22 -30.19 54.54 Favored 'General case' 0 N--CA 1.467 0.419 0 O-C-N 122.038 -0.414 . . . . 74.409999999999997 111.397 177.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 688' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -97.04 1.74 50.51 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 112.203 0.446 . . . . 61.329999999999998 112.203 -178.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . 0.506 HG12 HG22 ' A' ' 671' ' ' VAL . 95.4 t -120.67 125.08 73.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-O 120.97 0.414 . . . . 74.150000000000006 112.076 -176.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 690' ' ' LEU . . . . . 0.403 HD23 ' C ' ' A' ' 689' ' ' VAL . 2.7 mm? -127.38 164.01 22.77 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 116.115 -0.493 . . . . 75.510000000000005 110.815 178.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 691' ' ' ALA . . . . . . . . . . . . . . . -153.11 122.46 6.68 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.799 0.333 . . . . 72.25 111.345 175.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 692' ' ' ILE . . . . . . . . . . . . . 46.8 mm -130.85 132.3 64.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-O 120.996 0.427 . . . . 72.230000000000004 112.02 -176.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -113.13 150.53 32.04 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 120.969 0.414 . . . . 71.450000000000003 111.004 174.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 694' ' ' LYS . . . . . 0.46 ' HD3' HD13 ' A' ' 665' ' ' LEU . 64.3 tttp -70.89 -38.26 73.02 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 111.967 0.358 . . . . 62.310000000000002 111.967 -178.026 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -82.66 -53.79 5.65 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 122.019 -0.425 . . . . 73.409999999999997 111.894 -178.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 696' ' ' ASP . . . . . 0.487 ' HB2' ' HB2' ' A' ' 726' ' ' SER . 15.0 t70 -80.39 -42.03 23.56 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 112.595 0.591 . . . . 71.219999999999999 112.595 -174.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . 109.74 -107.4 2.34 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 120.947 -0.644 . . . . 64.310000000000002 112.993 -178.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -81.67 115.95 21.17 Favored 'General case' 0 N--CA 1.466 0.339 0 O-C-N 122.201 -0.588 . . . . 70.209999999999994 111.773 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 699' ' ' LEU . . . . . 0.444 HD22 ' HD2' ' A' ' 702' ' ' LYS . 75.5 mt -111.95 1.11 16.29 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.845 0.355 . . . . 61.43 110.443 170.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 22.4 m -56.27 -37.49 69.88 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.272 0.558 . . . . 74.409999999999997 111.158 177.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 701' ' ' SER . . . . . . . . . . . . . 65.5 p -72.33 -9.91 59.1 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 115.979 -0.555 . . . . 75.450000000000003 112.315 179.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 702' ' ' LYS . . . . . 0.444 ' HD2' HD22 ' A' ' 699' ' ' LEU . 62.1 mttp -101.34 1.47 38.63 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 112.446 0.535 . . . . 73.530000000000001 112.446 178.066 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 703' ' ' ILE . . . . . 0.421 HD13 HG13 ' A' ' 689' ' ' VAL . 67.7 mt -72.24 135.14 28.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 N-CA-C 112.081 0.4 . . . . 74.400000000000006 112.081 -178.014 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 704' ' ' LYS . . . . . . . . . . . . . 56.4 tttm -102.11 137.15 40.76 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.574 -0.285 . . . . 74.400000000000006 111.013 173.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 49.4 t -96.04 141.77 14.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-O 120.988 0.423 . . . . 75.420000000000002 111.065 176.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 706' ' ' ASP . . . . . 0.515 ' HB3' ' HB ' ' A' ' 720' ' ' THR . 27.3 t70 -136.56 138.2 41.03 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 120.728 0.299 . . . . 74.140000000000001 111.205 178.019 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 104.29 -173.07 21.05 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 121.391 -0.433 . . . . 64.239999999999995 113.246 -179.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 708' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -157.95 141.73 15.64 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 120.863 0.363 . . . . 74.310000000000002 111.306 179.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 709' ' ' VAL . . . . . 0.475 HG22 HD22 ' A' ' 719' ' ' LEU . 99.5 t -122.97 121.95 64.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-O 120.785 0.326 . . . . 73.010000000000005 111.217 -179.425 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 710' ' ' ASP . . . . . 0.421 ' O ' HG23 ' A' ' 739' ' ' VAL . 8.2 m-20 -84.95 136.08 33.77 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 121.104 0.478 . . . . 65.040000000000006 111.932 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 711' ' ' THR . . . . . . . . . . . . . 46.2 p -101.63 -3.57 28.1 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.232 0.539 . . . . 62.43 110.37 172.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 712' ' ' THR . . . . . . . . . . . . . 30.1 p -96.06 -27.67 14.98 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 115.749 -0.66 . . . . 61.299999999999997 112.314 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 713' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -121.86 141.04 51.67 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 120.628 0.251 . . . . 74.409999999999997 111.135 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 714' ' ' ALA . . . . . . . . . . . . . . . -81.11 127.24 32.42 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 120.957 0.408 . . . . 75.120000000000005 112.089 -179.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 170.14 158.62 14.33 Favored Glycine 0 CA--C 1.525 0.666 0 C-N-CA 121.447 -0.406 . . . . 74.209999999999994 112.788 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 716' ' ' THR . . . . . . . . . . . . . 51.8 m -87.91 126.44 35.05 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.049 0.452 . . . . 73.420000000000002 111.627 178.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 717' ' ' TYR . . . . . 0.438 ' HB2' HG23 ' A' ' 709' ' ' VAL . 72.5 m-85 -125.92 135.9 52.42 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.186 -0.461 . . . . 75.200000000000003 110.411 176.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 718' ' ' VAL . . . . . . . . . . . . . 59.0 t -108.29 113.69 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 CA-C-O 120.915 0.388 . . . . 75.030000000000001 111.856 -176.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 719' ' ' LEU . . . . . 0.475 HD22 HG22 ' A' ' 709' ' ' VAL . 88.1 mt -89.23 141.08 28.84 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 116.477 -0.329 . . . . 72.329999999999998 111.543 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 720' ' ' THR . . . . . 0.515 ' HB ' ' HB3' ' A' ' 706' ' ' ASP . 62.1 m -111.15 132.54 54.22 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.936 0.398 . . . . 65.239999999999995 111.315 178.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 721' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -122.09 131.03 53.76 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.329 -0.396 . . . . 74.140000000000001 110.365 178.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 86.4 m -138.0 135.71 36.21 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 120.917 0.389 . . . . 61.350000000000001 111.964 -176.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 12.7 p -136.64 146.45 28.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-O 120.996 0.427 . . . . 74.319999999999993 111.42 -179.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 26.4 m -104.5 140.2 38.3 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.439 -0.346 . . . . 75.530000000000001 111.198 178.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -73.32 169.01 18.02 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 121.09 0.471 . . . . 71.209999999999994 111.275 178.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 726' ' ' SER . . . . . 0.487 ' HB2' ' HB2' ' A' ' 696' ' ' ASP . 46.8 t -63.8 -38.47 91.2 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 120.903 0.382 . . . . 74.439999999999998 111.234 176.009 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 727' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -98.25 7.17 46.62 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 112.494 0.554 . . . . 74.140000000000001 112.494 179.296 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 728' ' ' GLY . . . . . . . . . . . . . . . 112.4 -6.24 26.59 Favored Glycine 0 CA--C 1.538 1.469 0 N-CA-C 116.688 1.435 . . . . 72.140000000000001 116.688 166.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 17.6 m80 -69.15 109.22 3.94 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 119.292 1.546 . . . . 75.420000000000002 111.368 176.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 730' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -97.43 124.1 41.51 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 116.589 -0.278 . . . . 75.120000000000005 111.159 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 31.6 m -122.82 154.19 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-O 120.801 0.334 . . . . 72.299999999999997 111.388 -178.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 9.3 t -138.28 148.25 44.48 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 121.437 0.637 . . . . 73.140000000000001 112.524 -177.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -148.41 150.12 32.94 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.838 -0.619 . . . . 72.349999999999994 110.483 178.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 734' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -120.15 160.02 23.71 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 112.67 0.619 . . . . 75.319999999999993 112.67 -174.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 735' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -130.6 119.58 22.7 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 115.478 -0.783 . . . . 71.430000000000007 110.8 -179.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 736' ' ' THR . . . . . . . . . . . . . 23.8 m -90.02 103.79 16.42 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 116.496 -0.32 . . . . 54.450000000000003 111.266 -178.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 32.5 t -102.19 113.56 39.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 CA-C-O 120.952 0.406 . . . . 63.340000000000003 111.665 -177.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 738' ' ' THR . . . . . . . . . . . . . 87.7 m -100.29 112.06 24.37 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.855 0.359 . . . . 61.119999999999997 111.464 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 739' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 710' ' ' ASP . 22.4 t -93.22 133.58 33.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-O 120.778 0.323 . . . . 75.319999999999993 110.676 177.371 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 740' ' ' LYS . . . . . 0.513 ' HG3' ' CD2' ' A' ' 678' ' ' HIS . 19.1 ptmt -132.81 152.34 51.82 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.236 0.541 . . . . 74.409999999999997 111.929 -178.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 741' ' ' VAL . . . . . . . . . . . . . 20.0 t -75.08 149.65 7.1 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-N 116.057 -0.519 . . . . 74.140000000000001 111.987 -174.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 742' ' ' ARG . . . . . 0.555 ' HG3' ' HG3' ' A' ' 743' ' ' GLU . 4.2 ptp180 -80.66 -41.83 23.1 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 116.27 -0.423 . . . . 72.209999999999994 111.439 176.316 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 743' ' ' GLU . . . . . 0.555 ' HG3' ' HG3' ' A' ' 742' ' ' ARG . 39.8 mt-10 -102.68 117.25 34.25 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 116.465 -0.334 . . . . 75.200000000000003 110.617 178.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 744' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -74.84 84.63 2.19 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-O 121.765 0.793 . . . . 74.319999999999993 111.755 -177.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 48.9 t -69.82 99.09 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-N 115.914 -0.585 . . . . 75.5 111.309 178.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -108.28 14.8 24.63 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.989 -0.55 . . . . 74.299999999999997 111.178 178.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 747' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -79.65 4.22 16.74 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 112.715 0.635 . . . . 72.530000000000001 112.715 -174.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 38.9 t70 72.15 -9.8 0.97 Allowed 'General case' 0 CA--C 1.549 0.938 0 N-CA-C 113.041 0.756 . . . . 74.219999999999999 113.041 176.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 749' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -61.21 120.51 55.42 Favored Pre-proline 0 N--CA 1.473 0.701 0 O-C-N 121.905 -0.497 . . . . 74.209999999999994 111.067 175.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 750' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -55.63 145.41 70.48 Favored 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 122.819 2.346 . . . . 63.350000000000001 113.144 -177.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 751' ' ' ILE . . . . . . . . . . . . . 36.2 pt -88.02 164.74 2.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-O 120.858 0.361 . . . . 73.239999999999995 111.959 -177.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 752' ' ' LEU . . . . . . . . . . . . . 29.8 tp 70.39 0.23 3.13 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 112.681 0.623 . . . . 74.109999999999999 112.681 175.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 753' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 . . . . . 0 C--O 1.237 0.426 0 CA-C-O 121.292 0.568 . . . . 74.519999999999996 111.13 178.955 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 762' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 657' ' ' MET . . . . . . . . . . . . . 64.3 mtt . . . . . 0 N--CA 1.488 1.472 0 CA-C-O 121.02 0.438 . . . . 63.32 110.991 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 658' ' ' GLY . . . . . . . . . . . . . . . 120.28 -51.66 0.76 Allowed Glycine 0 CA--C 1.523 0.538 0 N-CA-C 110.448 -1.061 . . . . 61.030000000000001 110.448 -169.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 659' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -110.4 98.51 7.71 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 109.582 -0.525 . . . . 74.200000000000003 109.582 168.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 660' ' ' GLY . . . . . . . . . . . . . . . -119.8 -129.78 3.9 Favored Glycine 0 CA--C 1.524 0.603 0 C-N-CA 121.011 -0.614 . . . . 74.349999999999994 113.333 -178.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 64.33 17.35 10.71 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.092 0.557 . . . . 72.310000000000002 112.184 -178.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 662' ' ' THR . . . . . . . . . . . . . 48.1 p -81.51 92.13 6.45 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 121.181 0.515 . . . . 74.540000000000006 110.169 174.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 663' ' ' SER . . . . . . . . . . . . . 41.1 t -55.3 134.28 49.93 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 115.735 -0.666 . . . . 64.109999999999999 112.558 -174.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 664' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -74.65 122.94 23.97 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 121.272 0.558 . . . . 73.420000000000002 111.249 178.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 665' ' ' LEU . . . . . . . . . . . . . 84.3 mt -95.44 138.07 33.63 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 115.685 -0.689 . . . . 73.310000000000002 111.261 -179.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 666' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -78.32 142.33 62.9 Favored Pre-proline 0 CA--C 1.54 0.596 0 CA-C-N 116.439 -0.346 . . . . 70.439999999999998 110.189 170.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 667' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -59.7 144.25 99.48 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 122.83 2.353 . . . . 74.120000000000005 114.467 -171.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 668' ' ' LYS . . . . . . . . . . . . . 49.9 tptt -82.3 97.37 8.26 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.658 -0.701 . . . . 72.239999999999995 109.745 171.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 669' ' ' LEU . . . . . . . . . . . . . 56.7 tp -90.19 105.86 18.09 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.002 -0.544 . . . . 65.530000000000001 110.527 179.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 670' ' ' THR . . . . . . . . . . . . . 96.8 m -88.58 110.22 20.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.265 0.555 . . . . 74.519999999999996 111.366 -178.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 671' ' ' VAL . . . . . . . . . . . . . 72.4 t -129.6 131.72 23.76 Favored Pre-proline 0 CA--C 1.535 0.396 0 CA-C-N 115.753 -0.658 . . . . 75.540000000000006 110.285 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 672' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -69.07 123.96 10.87 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 121.829 1.686 . . . . 75.340000000000003 111.693 176.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 673' ' ' VAL . . . . . . . . . . . . . 14.8 p -63.53 -29.52 47.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 N-CA-C 112.357 0.503 . . . . 73.329999999999998 112.357 -174.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 674' ' ' GLY . . . . . . . . . . . . . . . -150.88 143.9 11.14 Favored Glycine 0 CA--C 1.525 0.657 0 C-N-CA 120.741 -0.742 . . . . 72.329999999999998 113.177 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 675' ' ' ALA . . . . . 0.427 ' O ' ' HA ' ' A' ' 737' ' ' VAL . . . -148.63 143.89 26.84 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.729 0.299 . . . . 74.439999999999998 110.981 179.496 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 676' ' ' THR . . . . . . . . . . . . . 49.7 m -130.07 131.03 45.61 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.761 0.315 . . . . 70.519999999999996 111.509 -179.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 677' ' ' ILE . . . . . . . . . . . . . 25.6 pt -133.71 176.5 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 CA-C-O 120.882 0.373 . . . . 74.510000000000005 110.945 179.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 678' ' ' HIS . . . . . . . . . . . . . 76.2 m80 -118.67 158.82 24.77 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 121.08 0.467 . . . . 63.240000000000002 111.879 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 679' ' ' VAL . . . . . . . . . . . . . 98.8 t -60.45 112.1 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-N 116.142 -0.481 . . . . 75.530000000000001 111.172 176.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 114.49 -16.65 19.24 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 121.379 -0.438 . . . . 43.350000000000001 113.03 -175.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 681' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -73.96 -172.18 1.27 Allowed 'General case' 0 CA--C 1.546 0.809 0 CA-C-O 121.033 0.444 . . . . 74.5 111.723 178.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 682' ' ' SER . . . . . . . . . . . . . 25.4 m -129.07 155.12 45.95 Favored 'General case' 0 N--CA 1.478 0.94 0 O-C-N 122.211 -0.305 . . . . 74.519999999999996 111.007 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 683' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -159.2 120.35 3.28 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 120.821 0.343 . . . . 72.150000000000006 111.69 -179.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 684' ' ' VAL . . . . . . . . . . . . . 80.9 t -113.97 110.11 49.14 Favored Pre-proline 0 N--CA 1.471 0.588 0 CA-C-O 120.843 0.354 . . . . 62.299999999999997 111.544 177.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -58.09 -36.79 97.66 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 122.77 2.314 . . . . 75.519999999999996 113.665 -177.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 686' ' ' MET . . . . . 0.493 ' HE3' ' HA ' ' A' ' 686' ' ' MET . 1.0 OUTLIER -79.26 -11.78 59.95 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.424 0.527 . . . . 73.540000000000006 112.424 -177.374 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 687' ' ' ALA . . . . . . . . . . . . . . . -89.61 -32.68 16.99 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.215 0.531 . . . . 71.25 110.972 176.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 688' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -84.74 -17.54 38.0 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 116.137 -0.483 . . . . 72.310000000000002 111.683 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 76.0 t -116.76 131.38 69.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 N-CA-C 112.695 0.628 . . . . 74.099999999999994 112.695 -175.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 690' ' ' LEU . . . . . 0.411 HD13 ' N ' ' A' ' 690' ' ' LEU . 5.2 mp -125.42 166.64 16.23 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 116.309 -0.405 . . . . 74.450000000000003 111.036 177.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 691' ' ' ALA . . . . . . . . . . . . . . . -148.97 122.7 9.25 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 120.905 0.384 . . . . 72.420000000000002 111.58 176.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 692' ' ' ILE . . . . . 0.504 HD11 ' HA ' ' A' ' 698' ' ' ASP . 37.2 mm -133.03 131.75 58.84 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 CA-C-N 116.475 -0.329 . . . . 72.209999999999994 111.481 -177.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 58.6 t0 -111.36 129.03 56.13 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 109.627 -0.508 . . . . 74.219999999999999 109.627 171.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -57.69 -28.05 63.47 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 112.619 0.6 . . . . 72.530000000000001 112.619 -173.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 695' ' ' GLU . . . . . 0.432 ' HG3' ' N ' ' A' ' 696' ' ' ASP . 12.6 pt-20 -82.91 -44.48 15.32 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 111.998 0.37 . . . . 54.219999999999999 111.998 -179.418 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 696' ' ' ASP . . . . . 0.432 ' N ' ' HG3' ' A' ' 695' ' ' GLU . 10.5 t70 -95.12 -48.86 5.77 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 121.181 0.515 . . . . 74.299999999999997 111.596 -170.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . 124.32 -137.46 10.68 Favored Glycine 0 CA--C 1.526 0.722 0 CA-C-N 116.179 -0.464 . . . . 72.400000000000006 112.352 -176.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 698' ' ' ASP . . . . . 0.504 ' HA ' HD11 ' A' ' 692' ' ' ILE . 18.0 t70 -70.92 118.21 13.4 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.339 0.59 . . . . 75.310000000000002 111.619 179.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 699' ' ' LEU . . . . . . . . . . . . . 80.3 mt -116.4 18.28 15.22 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 115.882 -0.599 . . . . 73.219999999999999 110.7 173.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 54.1 m -60.78 -27.56 68.09 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.114 0.483 . . . . 74.049999999999997 111.868 -178.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 701' ' ' SER . . . . . . . . . . . . . 25.3 t -78.55 -13.54 59.78 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.071 0.462 . . . . 74.510000000000005 111.513 178.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 702' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -90.03 7.64 36.59 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 116.42 -0.355 . . . . 74.540000000000006 111.436 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 703' ' ' ILE . . . . . 0.472 HG12 ' HB ' ' A' ' 723' ' ' VAL . 62.5 mt -85.39 138.41 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-O 121.336 0.589 . . . . 75.019999999999996 112.209 -177.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 704' ' ' LYS . . . . . . . . . . . . . 67.1 tttt -100.47 140.72 34.32 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.943 -0.571 . . . . 74.150000000000006 109.772 171.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 59.9 t -111.69 112.43 40.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-O 121.146 0.498 . . . . 74.219999999999999 111.807 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 706' ' ' ASP . . . . . 0.529 ' HB2' ' HB ' ' A' ' 720' ' ' THR . 9.2 m-20 -106.08 137.83 43.32 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 116.12 -0.491 . . . . 63.439999999999998 111.388 177.344 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 101.6 -177.93 27.23 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 121.35 -0.452 . . . . 71.230000000000004 113.509 177.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 708' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -161.79 145.94 12.67 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.959 0.409 . . . . 70.349999999999994 111.415 179.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 709' ' ' VAL . . . . . 0.487 HG23 ' HB2' ' A' ' 717' ' ' TYR . 96.5 t -117.56 120.12 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-N 116.283 -0.417 . . . . 53.399999999999999 110.882 177.016 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 710' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -77.66 135.92 38.15 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 120.912 0.387 . . . . 72.420000000000002 111.574 177.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 711' ' ' THR . . . . . . . . . . . . . 76.2 p -97.66 -1.35 43.83 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.911 0.386 . . . . 73.239999999999995 110.958 173.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 712' ' ' THR . . . . . . . . . . . . . 7.2 t -105.43 -13.47 15.63 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 116.219 -0.446 . . . . 73.439999999999998 111.952 178.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 713' ' ' LYS . . . . . 0.627 ' HZ1' ' HB3' ' A' ' 713' ' ' LYS . 7.8 ttpm? -129.46 127.6 41.2 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.827 0.346 . . . . 63.240000000000002 111.662 -178.254 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 714' ' ' ALA . . . . . 0.427 ' HB1' HG21 ' A' ' 741' ' ' VAL . . . -72.0 144.89 48.67 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.199 -0.455 . . . . 75.239999999999995 111.735 177.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 152.76 171.87 20.62 Favored Glycine 0 CA--C 1.523 0.574 0 C-N-CA 121.027 -0.606 . . . . 63.329999999999998 113.029 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 716' ' ' THR . . . . . . . . . . . . . 56.3 m -100.3 122.23 42.76 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 122.36 -0.494 . . . . 74.109999999999999 111.327 179.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 717' ' ' TYR . . . . . 0.487 ' HB2' HG23 ' A' ' 709' ' ' VAL . 42.2 m-85 -118.92 134.94 54.84 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.139 -0.482 . . . . 75.340000000000003 110.582 -178.397 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 718' ' ' VAL . . . . . . . . . . . . . 49.5 t -101.27 113.97 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 CA-C-O 121.072 0.463 . . . . 72.530000000000001 111.58 -178.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 719' ' ' LEU . . . . . 0.446 HD23 HG22 ' A' ' 709' ' ' VAL . 92.3 mt -94.9 130.94 41.3 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.331 -0.395 . . . . 75.040000000000006 111.196 178.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 720' ' ' THR . . . . . 0.529 ' HB ' ' HB2' ' A' ' 706' ' ' ASP . 25.0 m -113.29 132.71 55.44 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.753 0.311 . . . . 74.0 111.196 -178.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 721' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -124.58 140.69 52.71 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.664 0.269 . . . . 74.299999999999997 110.968 -179.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 56.8 m -140.61 123.5 16.39 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 120.513 0.197 . . . . 73.430000000000007 111.179 -179.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 723' ' ' VAL . . . . . 0.472 ' HB ' HG12 ' A' ' 703' ' ' ILE . 7.5 p -114.54 140.94 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 CA-C-O 121.056 0.455 . . . . 60.049999999999997 112.142 -176.42 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 27.3 m -102.44 144.93 30.27 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 116.136 -0.484 . . . . 70.140000000000001 111.798 -179.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -103.63 150.77 23.67 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.323 0.649 . . . . 53.0 111.088 179.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 726' ' ' SER . . . . . . . . . . . . . 66.9 p -66.03 -14.65 62.04 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 112.522 0.564 . . . . 71.329999999999998 112.522 -175.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 727' ' ' LYS . . . . . . . . . . . . . 41.1 mmtm -105.36 -2.73 23.54 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 112.497 0.554 . . . . 73.239999999999995 112.497 -179.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 728' ' ' GLY . . . . . . . . . . . . . . . 112.21 12.42 13.77 Favored Glycine 0 CA--C 1.535 1.317 0 N-CA-C 115.384 0.914 . . . . 74.540000000000006 115.384 176.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 18.3 m80 -93.93 133.56 37.23 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 118.351 1.076 . . . . 74.040000000000006 111.241 173.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 730' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -134.24 112.54 11.15 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 122.075 -0.39 . . . . 72.340000000000003 111.263 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 34.1 m -112.47 160.44 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 N-CA-C 112.071 0.397 . . . . 74.400000000000006 112.071 -177.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 9.6 t -136.32 150.34 48.82 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 112.55 0.574 . . . . 75.319999999999993 112.55 -176.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -147.81 161.61 40.9 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.849 -0.614 . . . . 75.430000000000007 110.353 177.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 734' ' ' LYS . . . . . . . . . . . . . 33.2 mtmm -129.32 158.53 38.85 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 113.151 0.797 . . . . 73.209999999999994 113.151 -176.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 735' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -130.76 128.95 41.81 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 114.957 -1.019 . . . . 73.239999999999995 110.7 179.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 736' ' ' THR . . . . . . . . . . . . . 86.7 m -96.03 104.38 16.32 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.887 0.375 . . . . 74.430000000000007 111.205 178.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 737' ' ' VAL . . . . . 0.427 ' HA ' ' O ' ' A' ' 675' ' ' ALA . 46.7 t -97.69 140.84 17.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-O 120.821 0.343 . . . . 65.5 111.223 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 738' ' ' THR . . . . . . . . . . . . . 64.3 m -130.03 120.83 25.35 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 120.777 0.322 . . . . 64.099999999999994 111.147 179.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 739' ' ' VAL . . . . . . . . . . . . . 41.9 t -99.51 133.0 43.9 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-O 120.759 0.314 . . . . 73.409999999999997 111.355 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 740' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -121.97 151.84 40.34 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.39 -0.368 . . . . 75.150000000000006 111.571 -179.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 741' ' ' VAL . . . . . 0.427 HG21 ' HB1' ' A' ' 714' ' ' ALA . 25.1 t -100.47 121.35 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-O 120.771 0.32 . . . . 62.219999999999999 111.635 -179.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 742' ' ' ARG . . . . . 0.432 ' HG2' ' HG3' ' A' ' 743' ' ' GLU . 0.0 OUTLIER -89.09 -21.02 23.6 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.135 0.493 . . . . 73.219999999999999 110.539 176.665 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 743' ' ' GLU . . . . . 0.432 ' HG3' ' HG2' ' A' ' 742' ' ' ARG . 25.3 mt-10 -91.61 -174.09 3.76 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.927 -0.578 . . . . 75.329999999999998 111.406 -179.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 744' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -157.53 138.23 13.11 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.003 -0.544 . . . . 75.329999999999998 110.597 174.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 14.5 p -103.52 134.07 45.7 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 CA-C-O 121.008 0.432 . . . . 72.239999999999995 111.966 -174.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -97.09 -36.42 10.49 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.033 0.444 . . . . 71.430000000000007 110.778 176.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 747' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -113.37 108.71 17.6 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.166 -0.47 . . . . 64.420000000000002 110.123 174.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -53.26 102.3 0.05 Allowed 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 121.456 0.646 . . . . 75.129999999999995 111.947 -175.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 749' ' ' LYS . . . . . . . . . . . . . 53.1 mttp -57.81 143.87 75.59 Favored Pre-proline 0 CA--C 1.539 0.535 0 CA-C-N 115.891 -0.595 . . . . 74.349999999999994 111.491 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 750' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.6 93.61 0.68 Allowed 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 121.735 1.623 . . . . 75.400000000000006 110.54 168.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 751' ' ' ILE . . . . . . . . . . . . . 60.6 mt -65.56 88.37 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-O 121.392 0.615 . . . . 74.420000000000002 112.109 -173.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 752' ' ' LEU . . . . . . . . . . . . . 90.4 mt -83.22 99.04 9.71 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.889 -0.596 . . . . 74.409999999999997 110.83 176.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 753' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 . . . . . 0 C--O 1.239 0.515 0 CA-C-O 120.854 0.359 . . . . 71.150000000000006 111.433 -179.829 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 762' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 657' ' ' MET . . . . . 0.483 ' C ' ' SD ' ' A' ' 657' ' ' MET . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 120.953 0.406 . . . . 74.310000000000002 110.996 . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 658' ' ' GLY . . . . . . . . . . . . . . . 111.54 -148.55 18.01 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 121.438 -0.41 . . . . 73.219999999999999 112.399 -177.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 659' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -149.31 165.89 30.62 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 122.457 -0.437 . . . . 73.409999999999997 111.025 177.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 660' ' ' GLY . . . . . . . . . . . . . . . 123.66 -73.59 0.4 Allowed Glycine 0 CA--C 1.522 0.497 0 C-N-CA 121.383 -0.437 . . . . 65.430000000000007 112.343 -178.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 50.8 mm-40 -76.8 129.61 36.51 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 122.593 -0.357 . . . . 73.420000000000002 110.765 176.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 662' ' ' THR . . . . . . . . . . . . . 94.1 m 61.27 88.15 0.09 Allowed 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 121.444 0.64 . . . . 64.329999999999998 111.186 -173.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 663' ' ' SER . . . . . . . . . . . . . 67.8 m -113.23 124.63 52.98 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 116.111 -0.495 . . . . 74.530000000000001 111.213 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 664' ' ' ASP . . . . . 0.431 ' OD2' ' HB2' ' A' ' 727' ' ' LYS . 18.7 t0 -93.31 124.49 37.33 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 121.255 0.55 . . . . 70.150000000000006 111.729 -179.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 665' ' ' LEU . . . . . . . . . . . . . 73.0 mt -91.08 133.47 35.31 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 115.866 -0.606 . . . . 74.219999999999999 109.814 173.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 666' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -64.7 144.96 98.86 Favored Pre-proline 0 CA--C 1.539 0.545 0 CA-C-N 116.218 -0.446 . . . . 65.319999999999993 111.47 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 667' ' ' PRO . . . . . 0.514 ' HD3' ' HB2' ' A' ' 725' ' ' ASP . 25.8 Cg_endo -60.91 145.12 99.51 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 122.785 2.323 . . . . 64.019999999999996 113.149 -174.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 668' ' ' LYS . . . . . . . . . . . . . 9.2 tmtm? -82.58 99.12 9.35 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.33 0.586 . . . . 73.420000000000002 110.384 179.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 669' ' ' LEU . . . . . . . . . . . . . 62.8 tp -89.8 109.27 20.27 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.726 -0.67 . . . . 73.519999999999996 110.736 179.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 670' ' ' THR . . . . . . . . . . . . . 60.7 m -87.08 110.42 20.09 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.827 0.346 . . . . 64.0 111.492 -178.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 671' ' ' VAL . . . . . 0.479 HG23 ' HB3' ' A' ' 733' ' ' ALA . 67.3 t -132.89 124.82 18.88 Favored Pre-proline 0 CA--C 1.542 0.668 0 CA-C-N 116.263 -0.426 . . . . 72.140000000000001 110.831 176.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 672' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.75 154.06 43.55 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.358 2.039 . . . . 71.439999999999998 112.537 178.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 673' ' ' VAL . . . . . . . . . . . . . 12.9 p -63.6 -32.25 56.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 N-CA-C 112.062 0.393 . . . . 71.439999999999998 112.062 -176.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 674' ' ' GLY . . . . . . . . . . . . . . . -170.4 173.14 44.3 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 120.685 -0.769 . . . . 73.299999999999997 114.204 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 675' ' ' ALA . . . . . . . . . . . . . . . -152.95 122.95 6.98 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.876 0.37 . . . . 74.209999999999994 111.308 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 676' ' ' THR . . . . . . . . . . . . . 82.7 m -102.29 124.93 48.74 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 112.158 0.429 . . . . 75.120000000000005 112.158 -177.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 677' ' ' ILE . . . . . . . . . . . . . 29.3 pt -126.4 177.0 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 CA-C-N 116.38 -0.373 . . . . 74.439999999999998 111.1 176.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 678' ' ' HIS . . . . . 0.427 ' CD2' ' HG3' ' A' ' 740' ' ' LYS . 68.6 m80 -117.02 156.16 27.97 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.732 0.641 . . . . 73.040000000000006 112.732 -178.085 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 679' ' ' VAL . . . . . 0.523 HG11 ' HA ' ' A' ' 712' ' ' THR . 85.0 t -61.53 121.27 9.32 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-N 115.536 -0.756 . . . . 73.349999999999994 111.375 175.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 110.94 -23.65 18.68 Favored Glycine 0 CA--C 1.526 0.751 0 CA-C-N 116.132 -0.485 . . . . 65.120000000000005 112.185 -177.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 681' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -83.38 -162.8 0.66 Allowed 'General case' 0 CA--C 1.543 0.707 0 CA-C-O 120.984 0.421 . . . . 70.230000000000004 111.687 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 682' ' ' SER . . . . . . . . . . . . . 74.0 m -141.47 173.97 11.0 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 122.156 -0.34 . . . . 74.120000000000005 111.703 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 683' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -150.9 140.4 21.52 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.855 0.36 . . . . 65.329999999999998 111.759 -177.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 684' ' ' VAL . . . . . . . . . . . . . 99.0 t -118.12 105.78 46.36 Favored Pre-proline 0 CA--C 1.545 0.784 0 CA-C-O 120.728 0.299 . . . . 73.530000000000001 111.605 178.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.93 -38.43 78.96 Favored 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 122.745 2.297 . . . . 73.319999999999993 113.505 -178.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 686' ' ' MET . . . . . 0.491 ' HE2' ' HB ' ' A' ' 703' ' ' ILE . 0.3 OUTLIER -78.79 -9.46 59.45 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.759 0.651 . . . . 73.329999999999998 112.759 -175.977 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 687' ' ' ALA . . . . . . . . . . . . . . . -79.96 -44.9 19.46 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 120.9 0.381 . . . . 74.340000000000003 111.923 -179.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 688' ' ' GLU . . . . . . . . . . . . . 45.7 mm-40 -86.6 -8.22 57.68 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 113.0 0.741 . . . . 64.019999999999996 113.0 -174.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . 0.544 HG13 HD13 ' A' ' 703' ' ' ILE . 87.6 t -118.58 124.71 73.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-O 120.938 0.399 . . . . 75.030000000000001 111.956 -177.403 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 690' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -125.41 162.93 23.72 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 116.266 -0.425 . . . . 75.140000000000001 111.062 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 691' ' ' ALA . . . . . . . . . . . . . . . -142.69 121.71 12.86 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.057 0.456 . . . . 74.329999999999998 111.63 176.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 692' ' ' ILE . . . . . . . . . . . . . 45.6 mm -128.69 124.46 61.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-N 116.395 -0.366 . . . . 64.150000000000006 111.55 -178.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 693' ' ' ASP . . . . . 0.492 ' HB2' ' HB3' ' A' ' 667' ' ' PRO . 36.2 t70 -108.35 149.87 28.11 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 120.916 0.389 . . . . 64.420000000000002 110.883 173.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 694' ' ' LYS . . . . . 0.613 ' HB3' ' HZ1' ' A' ' 694' ' ' LYS . 8.3 mtpm? -65.84 -56.68 10.62 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 116.319 -0.401 . . . . 74.019999999999996 111.999 -176.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -84.44 -51.76 6.68 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 112.149 0.426 . . . . 75.230000000000004 112.149 -174.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 696' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -72.23 -28.68 63.32 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-O 120.933 0.397 . . . . 64.150000000000006 111.397 -173.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . 103.73 -147.09 16.56 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 121.477 -0.392 . . . . 73.510000000000005 113.066 178.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -69.56 131.62 44.97 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 120.982 0.42 . . . . 75.420000000000002 110.995 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 699' ' ' LEU . . . . . . . . . . . . . 98.0 mt -125.45 15.76 8.25 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 120.973 0.416 . . . . 62.229999999999997 111.164 178.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 34.9 m -58.75 -38.34 78.21 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 121.064 0.459 . . . . 75.239999999999995 111.455 -178.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 701' ' ' SER . . . . . . . . . . . . . 33.7 m -61.44 -21.95 64.6 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 116.2 -0.454 . . . . 62.039999999999999 111.814 178.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 702' ' ' LYS . . . . . . . . . . . . . 64.0 mttm -91.31 1.28 57.22 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 112.607 0.595 . . . . 74.299999999999997 112.607 -178.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 703' ' ' ILE . . . . . 0.544 HD13 HG13 ' A' ' 689' ' ' VAL . 74.5 mt -69.46 111.91 3.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-O 121.238 0.542 . . . . 74.400000000000006 111.559 -178.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 704' ' ' LYS . . . . . . . . . . . . . 24.3 tptm -85.02 118.91 24.87 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 115.549 -0.751 . . . . 73.549999999999997 110.508 178.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 51.7 t -96.42 138.25 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 CA-C-O 120.963 0.411 . . . . 71.239999999999995 111.823 -177.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 706' ' ' ASP . . . . . 0.56 ' HB3' ' HB ' ' A' ' 720' ' ' THR . 24.1 t70 -132.08 140.8 48.97 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 116.291 -0.413 . . . . 74.519999999999996 111.014 177.342 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 107.23 -176.79 21.27 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 121.331 -0.461 . . . . 73.109999999999999 113.067 -179.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 708' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -163.49 137.1 5.7 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.182 0.515 . . . . 74.439999999999998 111.734 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 709' ' ' VAL . . . . . 0.515 HG23 ' HB2' ' A' ' 717' ' ' TYR . 46.8 t -112.02 146.18 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-N 116.1 -0.5 . . . . 75.109999999999999 111.309 -178.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 710' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -83.81 156.79 22.32 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 121.396 0.617 . . . . 73.420000000000002 111.832 175.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 711' ' ' THR . . . . . 0.42 ' O ' ' HA ' ' A' ' 679' ' ' VAL . 47.2 p -117.75 -22.84 7.81 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.578 -0.737 . . . . 73.430000000000007 110.796 172.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 712' ' ' THR . . . . . 0.523 ' HA ' HG11 ' A' ' 679' ' ' VAL . 70.2 p -108.11 13.14 26.2 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 111.923 0.342 . . . . 63.43 111.923 178.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 713' ' ' LYS . . . . . 0.545 ' HB2' ' HZ2' ' A' ' 713' ' ' LYS . 3.8 ttmp? -140.08 131.71 27.22 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.664 0.268 . . . . 74.040000000000006 111.132 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 714' ' ' ALA . . . . . . . . . . . . . . . -77.66 143.44 38.16 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 120.81 0.338 . . . . 63.450000000000003 111.284 177.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 155.47 -174.94 33.51 Favored Glycine 0 CA--C 1.525 0.657 0 C-N-CA 121.316 -0.469 . . . . 61.109999999999999 112.843 -178.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 716' ' ' THR . . . . . . . . . . . . . 38.7 m -123.55 123.02 39.68 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 117.097 0.449 . . . . 74.439999999999998 111.589 -178.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 717' ' ' TYR . . . . . 0.515 ' HB2' HG23 ' A' ' 709' ' ' VAL . 61.4 m-85 -128.03 128.95 45.91 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.185 -0.461 . . . . 75.439999999999998 110.778 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 718' ' ' VAL . . . . . . . . . . . . . 61.6 t -97.78 118.67 44.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-O 121.172 0.511 . . . . 71.450000000000003 111.942 -176.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 719' ' ' LEU . . . . . . . . . . . . . 91.0 mt -93.07 133.64 36.03 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.31 -0.404 . . . . 75.230000000000004 111.076 178.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 720' ' ' THR . . . . . 0.56 ' HB ' ' HB3' ' A' ' 706' ' ' ASP . 17.0 m -100.96 144.75 29.53 Favored 'General case' 0 N--CA 1.473 0.714 0 O-C-N 122.214 -0.304 . . . . 73.120000000000005 111.101 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 721' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -134.86 113.85 11.98 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 122.449 0.3 . . . . 72.549999999999997 111.0 -178.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 60.4 m -114.23 137.92 51.15 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 111.7 0.259 . . . . 74.209999999999994 111.7 -179.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 8.2 p -138.13 136.17 44.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 CA-C-O 121.011 0.434 . . . . 73.230000000000004 111.446 177.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 42.4 m -113.13 129.58 56.46 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 120.864 0.364 . . . . 72.430000000000007 111.728 -178.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 725' ' ' ASP . . . . . 0.514 ' HB2' ' HD3' ' A' ' 667' ' ' PRO . 17.6 t0 -73.84 150.03 41.24 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-N 116.225 -0.443 . . . . 74.040000000000006 110.081 174.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 726' ' ' SER . . . . . . . . . . . . . 48.8 m -69.01 -27.24 65.5 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.692 0.282 . . . . 64.310000000000002 111.645 -178.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 727' ' ' LYS . . . . . 0.431 ' HB2' ' OD2' ' A' ' 664' ' ' ASP . 1.3 mptp? -89.19 5.22 45.73 Favored 'General case' 0 CA--C 1.546 0.827 0 N-CA-C 112.258 0.466 . . . . 71.409999999999997 112.258 -177.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 728' ' ' GLY . . . . . . . . . . . . . . . 113.31 -2.99 25.19 Favored Glycine 0 CA--C 1.537 1.409 0 N-CA-C 116.463 1.345 . . . . 54.520000000000003 116.463 169.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 63.0 m80 -94.72 119.54 33.51 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 118.941 1.37 . . . . 74.420000000000002 112.05 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 730' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -112.65 138.91 48.76 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 122.038 -0.414 . . . . 72.239999999999995 111.775 -178.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 29.4 m -138.54 152.36 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-O 120.786 0.327 . . . . 54.219999999999999 111.39 178.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 9.0 t -140.3 154.08 46.68 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.038 0.447 . . . . 71.540000000000006 111.653 179.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 733' ' ' ALA . . . . . 0.479 ' HB3' HG23 ' A' ' 671' ' ' VAL . . . -148.86 162.15 40.42 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 116.25 -0.432 . . . . 73.140000000000001 111.342 -179.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 734' ' ' LYS . . . . . 0.595 ' HB2' ' HZ3' ' A' ' 734' ' ' LYS . 10.7 mtmp? -125.96 154.44 42.85 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 112.446 0.536 . . . . 73.219999999999999 112.446 -179.27 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 735' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -129.7 124.54 33.82 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.858 -0.61 . . . . 74.030000000000001 110.585 178.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 736' ' ' THR . . . . . . . . . . . . . 88.1 m -90.91 103.9 16.56 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.841 0.353 . . . . 74.430000000000007 111.633 -177.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 50.3 t -96.55 131.76 42.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 O-C-N 122.124 -0.36 . . . . 74.510000000000005 111.299 -178.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 738' ' ' THR . . . . . . . . . . . . . 88.5 m -122.68 122.75 39.51 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.028 0.442 . . . . 73.239999999999995 111.651 -178.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 739' ' ' VAL . . . . . . . . . . . . . 21.5 t -100.85 131.51 48.33 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 116.143 -0.48 . . . . 74.230000000000004 110.812 178.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 740' ' ' LYS . . . . . 0.427 ' HG3' ' CD2' ' A' ' 678' ' ' HIS . 16.9 ptpt -124.32 160.38 28.2 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.233 0.539 . . . . 74.230000000000004 111.705 177.226 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 741' ' ' VAL . . . . . 0.459 HG22 HG23 ' A' ' 679' ' ' VAL . 37.8 t -93.46 124.5 45.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 N-CA-C 112.507 0.558 . . . . 72.140000000000001 112.507 -172.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 742' ' ' ARG . . . . . . . . . . . . . 11.5 ptt85 -94.3 -48.42 6.18 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 120.994 0.426 . . . . 74.420000000000002 110.935 172.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 743' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -104.73 117.49 34.2 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.328 -0.396 . . . . 63.130000000000003 110.64 176.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 744' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -63.26 156.99 23.86 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 112.514 0.561 . . . . 63.109999999999999 112.514 -175.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 25.5 m -62.44 141.03 18.45 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-N 115.87 -0.605 . . . . 75.430000000000007 112.307 178.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -82.55 -177.64 6.77 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 121.31 0.576 . . . . 72.109999999999999 112.412 -173.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 747' ' ' ASN . . . . . 0.473 ' ND2' ' HG2' ' A' ' 749' ' ' LYS . 59.5 t30 -161.67 151.7 16.99 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 115.812 -0.631 . . . . 62.240000000000002 110.391 176.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -77.96 10.33 2.94 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 113.153 0.797 . . . . 75.420000000000002 113.153 -172.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 749' ' ' LYS . . . . . 0.473 ' HG2' ' ND2' ' A' ' 747' ' ' ASN . 19.8 ptmt -98.91 163.14 19.37 Favored Pre-proline 0 CA--C 1.542 0.652 0 O-C-N 122.307 -0.246 . . . . 74.310000000000002 110.637 175.364 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 750' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -65.37 97.78 0.31 Allowed 'Trans proline' 0 CA--C 1.543 0.972 0 C-N-CA 121.703 1.602 . . . . 74.549999999999997 111.347 170.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 751' ' ' ILE . . . . . . . . . . . . . 38.8 pt -90.1 173.95 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-O 121.21 0.528 . . . . 75.129999999999995 112.397 -175.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 752' ' ' LEU . . . . . . . . . . . . . 35.1 tp -102.1 127.01 49.19 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 116.122 -0.49 . . . . 74.340000000000003 111.033 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 753' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 . . . . . 0 C--O 1.24 0.567 0 CA-C-O 121.042 0.448 . . . . 70.430000000000007 111.879 -177.143 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 762' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 657' ' ' MET . . . . . . . . . . . . . 64.6 mtt . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 120.674 0.273 . . . . 74.010000000000005 111.348 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 658' ' ' GLY . . . . . . . . . . . . . . . 92.7 100.25 1.43 Allowed Glycine 0 CA--C 1.529 0.919 0 C-N-CA 121.051 -0.595 . . . . 61.210000000000001 113.734 175.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 659' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -94.63 -177.05 4.09 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 122.581 -0.364 . . . . 71.239999999999995 111.278 175.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 660' ' ' GLY . . . . . . . . . . . . . . . -147.36 160.09 28.19 Favored Glycine 0 CA--C 1.524 0.61 0 C-N-CA 120.7 -0.762 . . . . 71.230000000000004 113.292 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -81.16 90.34 6.05 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.155 0.502 . . . . 72.540000000000006 110.868 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 662' ' ' THR . . . . . . . . . . . . . 80.8 p -78.4 -173.52 3.35 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 116.019 -0.537 . . . . 73.219999999999999 112.082 -178.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 663' ' ' SER . . . . . . . . . . . . . 49.1 m -63.92 104.51 0.71 Allowed 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.078 0.466 . . . . 72.140000000000001 111.094 177.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 664' ' ' ASP . . . . . 0.443 ' HB3' ' HE1' ' A' ' 729' ' ' HIS . 12.8 t70 -86.02 126.75 34.38 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 116.061 -0.518 . . . . 74.219999999999999 111.89 -174.376 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 665' ' ' LEU . . . . . . . . . . . . . 80.7 mt -88.03 117.41 26.89 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 116.337 -0.392 . . . . 74.120000000000005 110.122 173.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 666' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -54.31 149.07 21.01 Favored Pre-proline 0 CA--C 1.54 0.559 0 CA-C-O 120.796 0.331 . . . . 64.129999999999995 111.444 178.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 667' ' ' PRO . . . . . 0.485 ' HA ' ' HA ' ' A' ' 693' ' ' ASP . 38.2 Cg_exo -57.77 140.48 93.77 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 122.422 2.081 . . . . 74.209999999999994 112.95 -173.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 668' ' ' LYS . . . . . 0.7 ' HA ' ' HE2' ' A' ' 668' ' ' LYS . 0.6 OUTLIER -82.88 102.96 12.0 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 120.932 0.396 . . . . 75.430000000000007 110.363 175.403 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 669' ' ' LEU . . . . . 0.484 ' HG ' HG21 ' A' ' 671' ' ' VAL . 61.9 tp -90.01 118.61 29.69 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.195 -0.457 . . . . 75.109999999999999 111.354 -179.387 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 670' ' ' THR . . . . . . . . . . . . . 89.3 m -93.85 109.85 21.53 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.732 0.301 . . . . 73.540000000000006 110.986 177.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 671' ' ' VAL . . . . . 0.484 HG21 ' HG ' ' A' ' 669' ' ' LEU . 95.7 t -139.74 122.19 10.13 Favored Pre-proline 0 CA--C 1.538 0.51 0 CA-C-N 116.151 -0.477 . . . . 72.230000000000004 110.583 177.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 672' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -76.37 151.88 33.96 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 122.119 1.879 . . . . 75.340000000000003 112.177 177.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 673' ' ' VAL . . . . . . . . . . . . . 8.0 p -64.27 -31.89 55.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 N-CA-C 112.325 0.491 . . . . 74.349999999999994 112.325 -175.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 674' ' ' GLY . . . . . . . . . . . . . . . -160.51 166.72 35.47 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 120.469 -0.872 . . . . 39.060000000000002 114.3 -177.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 675' ' ' ALA . . . . . . . . . . . . . . . -142.77 151.06 40.83 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.312 0.645 . . . . 71.129999999999995 109.849 177.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 676' ' ' THR . . . . . . . . . . . . . 91.5 m -137.93 119.23 14.66 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.105 0.479 . . . . 74.409999999999997 111.883 -177.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 677' ' ' ILE . . . . . . . . . . . . . 33.5 pt -130.75 176.48 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-N 116.032 -0.531 . . . . 75.150000000000006 111.097 -179.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 678' ' ' HIS . . . . . 0.527 ' HA ' ' O ' ' A' ' 740' ' ' LYS . 65.3 m80 -110.78 156.7 20.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.279 0.561 . . . . 75.230000000000004 111.815 177.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 679' ' ' VAL . . . . . 0.526 HG13 ' HA ' ' A' ' 712' ' ' THR . 85.2 t -58.31 126.16 15.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-N 115.899 -0.591 . . . . 62.109999999999999 110.98 174.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 94.82 4.6 61.69 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 121.153 -0.546 . . . . 54.299999999999997 113.568 -179.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 681' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -97.7 165.35 12.0 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.366 0.603 . . . . 71.129999999999995 112.152 178.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 682' ' ' SER . . . . . . . . . . . . . 46.5 m -93.9 137.14 33.45 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.887 -0.597 . . . . 65.420000000000002 111.739 -179.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 683' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -135.09 128.7 32.71 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 120.928 0.394 . . . . 72.219999999999999 111.531 -179.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 684' ' ' VAL . . . . . . . . . . . . . 48.9 t -125.07 97.99 36.9 Favored Pre-proline 0 CA--C 1.542 0.656 0 CA-C-O 120.856 0.36 . . . . 73.129999999999995 111.444 177.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -63.7 -34.19 63.44 Favored 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 122.491 2.127 . . . . 64.040000000000006 113.571 -178.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 686' ' ' MET . . . . . 0.478 ' HE1' ' HA ' ' A' ' 686' ' ' MET . 0.7 OUTLIER -79.34 -6.32 56.49 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.782 0.66 . . . . 62.409999999999997 112.782 -176.902 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 687' ' ' ALA . . . . . . . . . . . . . . . -92.37 -38.19 12.16 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.869 0.366 . . . . 74.439999999999998 111.924 179.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 688' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -98.69 13.08 33.42 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 112.384 0.513 . . . . 75.299999999999997 112.384 -176.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . 0.404 HG13 HG22 ' A' ' 671' ' ' VAL . 85.2 t -125.04 140.04 49.33 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-N 116.301 -0.409 . . . . 73.129999999999995 110.086 173.252 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 690' ' ' LEU . . . . . 0.516 HD23 HG12 ' A' ' 692' ' ' ILE . 9.2 tt -145.17 153.85 41.8 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 111.574 0.213 . . . . 74.239999999999995 111.574 -172.152 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 691' ' ' ALA . . . . . . . . . . . . . . . -147.4 125.12 11.83 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 112.049 0.389 . . . . 61.409999999999997 112.049 179.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 692' ' ' ILE . . . . . 0.516 HG12 HD23 ' A' ' 690' ' ' LEU . 47.5 mm -127.93 119.05 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 N-CA-C 112.032 0.382 . . . . 65.430000000000007 112.032 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 693' ' ' ASP . . . . . 0.485 ' HA ' ' HA ' ' A' ' 667' ' ' PRO . 14.6 t70 -94.81 147.7 23.07 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 109.789 -0.449 . . . . 70.299999999999997 109.789 171.135 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 64.9 tttm -58.31 -61.91 2.23 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.373 0.508 . . . . 75.040000000000006 112.373 -174.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -88.5 -39.77 13.94 Favored 'General case' 0 N--CA 1.479 1.002 0 O-C-N 121.846 -0.534 . . . . 74.099999999999994 112.242 -176.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 696' ' ' ASP . . . . . . . . . . . . . 34.3 t0 -70.99 -23.52 62.21 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.257 0.551 . . . . 61.109999999999999 110.826 -176.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . 90.3 -147.32 19.1 Favored Glycine 0 CA--C 1.525 0.665 0 CA-C-N 116.043 -0.526 . . . . 62.409999999999997 113.87 173.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 698' ' ' ASP . . . . . 0.431 ' HA ' HD12 ' A' ' 692' ' ' ILE . 14.4 t70 -67.9 123.03 19.46 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.058 0.456 . . . . 73.409999999999997 111.189 -179.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 699' ' ' LEU . . . . . . . . . . . . . 80.8 mt -122.25 24.95 9.2 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.993 -0.549 . . . . 75.430000000000007 110.782 178.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 88.4 m -61.96 -40.32 95.17 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.044 0.45 . . . . 75.010000000000005 112.032 -177.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 701' ' ' SER . . . . . . . . . . . . . 15.6 t -79.86 -3.69 49.01 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 121.048 0.451 . . . . 75.510000000000005 111.246 179.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 702' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -84.9 -11.43 55.6 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 120.988 0.423 . . . . 74.329999999999998 110.822 175.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 703' ' ' ILE . . . . . 0.423 ' HB ' ' HE2' ' A' ' 686' ' ' MET . 74.6 mt -68.57 117.71 11.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-O 121.588 0.709 . . . . 72.510000000000005 112.82 -173.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 704' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -83.67 121.58 27.46 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.397 -0.819 . . . . 74.019999999999996 110.627 174.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 41.7 t -99.61 116.38 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-O 120.82 0.343 . . . . 75.239999999999995 111.077 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 706' ' ' ASP . . . . . 0.534 ' HB3' ' HB ' ' A' ' 720' ' ' THR . 32.9 t70 -109.96 123.21 49.24 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 120.74 0.305 . . . . 70.25 110.993 179.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 130.11 173.92 13.54 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 121.397 -0.43 . . . . 75.099999999999994 113.07 -178.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 708' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -135.27 142.23 45.86 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 122.447 -0.443 . . . . 74.450000000000003 111.518 -178.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 709' ' ' VAL . . . . . 0.467 HG22 HD21 ' A' ' 719' ' ' LEU . 98.9 t -126.32 128.25 71.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-O 120.872 0.367 . . . . 74.329999999999998 111.424 -179.094 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 710' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -109.38 137.4 47.3 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 116.73 -0.214 . . . . 60.409999999999997 110.552 177.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 711' ' ' THR . . . . . . . . . . . . . 67.3 p -111.7 4.21 18.37 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 112.85 0.685 . . . . 73.129999999999995 112.85 -175.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 712' ' ' THR . . . . . 0.526 ' HA ' HG13 ' A' ' 679' ' ' VAL . 12.9 t -111.99 -10.47 13.94 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 112.163 0.431 . . . . 74.420000000000002 112.163 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 713' ' ' LYS . . . . . 0.414 ' HD3' ' N ' ' A' ' 714' ' ' ALA . 8.8 tmtt? -128.8 129.91 46.28 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 109.861 -0.422 . . . . 74.319999999999993 109.861 176.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 714' ' ' ALA . . . . . 0.414 ' N ' ' HD3' ' A' ' 713' ' ' LYS . . . -69.81 127.6 33.48 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 112.426 0.528 . . . . 74.129999999999995 112.426 -176.418 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 177.8 174.33 44.03 Favored Glycine 0 CA--C 1.524 0.6 0 CA-C-N 116.098 -0.501 . . . . 64.140000000000001 112.772 -179.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 716' ' ' THR . . . . . . . . . . . . . 38.6 m -100.01 121.9 42.08 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 122.532 -0.393 . . . . 63.310000000000002 111.056 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 717' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -122.39 109.58 14.58 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 120.646 0.26 . . . . 72.409999999999997 110.783 -177.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 718' ' ' VAL . . . . . 0.403 ' HA ' ' HA ' ' A' ' 736' ' ' THR . 42.6 t -93.79 126.96 46.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-O 120.941 0.4 . . . . 73.030000000000001 111.845 -175.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 719' ' ' LEU . . . . . 0.467 HD21 HG22 ' A' ' 709' ' ' VAL . 97.2 mt -105.32 153.01 22.2 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.955 0.407 . . . . 75.299999999999997 111.277 177.095 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 720' ' ' THR . . . . . 0.534 ' HB ' ' HB3' ' A' ' 706' ' ' ASP . 28.8 m -120.82 129.74 53.68 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.487 -0.324 . . . . 74.219999999999999 110.809 177.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 721' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -115.18 119.79 37.58 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 120.824 0.345 . . . . 75.230000000000004 111.371 -178.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 87.0 m -124.05 140.41 53.0 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 116.54 -0.3 . . . . 71.239999999999995 111.209 -179.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 10.4 p -141.01 143.47 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 CA-C-O 120.866 0.365 . . . . 63.409999999999997 111.924 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 724' ' ' THR . . . . . 0.452 ' HA ' ' O ' ' A' ' 729' ' ' HIS . 23.7 m -123.01 142.2 51.11 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 116.392 -0.367 . . . . 64.129999999999995 111.603 -179.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -100.51 178.61 4.68 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.251 0.548 . . . . 75.420000000000002 112.316 -177.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 726' ' ' SER . . . . . . . . . . . . . 38.0 t -54.51 -31.92 57.03 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 113.323 0.86 . . . . 75.200000000000003 113.323 -179.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 727' ' ' LYS . . . . . . . . . . . . . 44.8 mmtm -86.63 -14.76 41.75 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 121.877 -0.514 . . . . 74.329999999999998 111.913 -179.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 728' ' ' GLY . . . . . . . . . . . . . . . 103.23 13.43 28.78 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 121.023 -0.608 . . . . 63.420000000000002 113.792 -178.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 729' ' ' HIS . . . . . 0.452 ' O ' ' HA ' ' A' ' 724' ' ' THR . 58.7 m80 -72.01 123.93 23.85 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 117.283 0.541 . . . . 75.120000000000005 110.54 174.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 730' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -122.25 108.47 13.32 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.137 0.494 . . . . 72.519999999999996 112.179 -174.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 34.9 m -107.72 155.67 8.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-N 116.036 -0.529 . . . . 65.109999999999999 110.737 176.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 5.4 t -152.51 136.86 16.67 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 112.819 0.674 . . . . 75.040000000000006 112.819 -175.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -141.87 146.87 36.28 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.09 -0.505 . . . . 75.120000000000005 111.214 -179.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 734' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -105.09 158.29 16.67 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.213 0.53 . . . . 74.439999999999998 112.188 -176.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 735' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -141.85 118.0 10.69 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.687 -0.688 . . . . 75.230000000000004 110.665 175.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 736' ' ' THR . . . . . 0.403 ' HA ' ' HA ' ' A' ' 718' ' ' VAL . 6.5 t -84.37 111.94 19.89 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.227 0.536 . . . . 72.510000000000005 111.73 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 43.5 t -96.63 103.84 15.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-O 121.282 0.563 . . . . 74.329999999999998 111.382 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 738' ' ' THR . . . . . . . . . . . . . 30.8 m -93.61 113.45 25.56 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.984 0.421 . . . . 74.209999999999994 111.344 -177.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 739' ' ' VAL . . . . . . . . . . . . . 45.8 t -96.41 116.4 38.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-N 116.297 -0.411 . . . . 72.120000000000005 111.037 178.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 740' ' ' LYS . . . . . 0.527 ' O ' ' HA ' ' A' ' 678' ' ' HIS . 11.7 ptmm? -111.59 159.11 18.47 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.027 0.442 . . . . 74.319999999999993 111.144 178.2 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 741' ' ' VAL . . . . . . . . . . . . . 38.3 t -70.72 154.69 7.91 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-O 120.798 0.333 . . . . 63.420000000000002 111.829 -175.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 742' ' ' ARG . . . . . . . . . . . . . 14.9 ptp180 -96.28 137.97 34.57 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 120.847 0.356 . . . . 74.430000000000007 110.423 174.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 743' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -83.1 92.38 7.4 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 120.767 0.318 . . . . 75.140000000000001 111.164 -177.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 744' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -131.58 172.94 11.64 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 112.44 0.533 . . . . 64.200000000000003 112.44 -177.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 31.1 m -134.17 29.31 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-N 115.817 -0.629 . . . . 74.420000000000002 110.747 178.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -81.1 19.86 0.86 Allowed 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 112.397 0.517 . . . . 74.0 112.397 -173.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 747' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -76.09 84.93 2.95 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.104 0.478 . . . . 73.310000000000002 110.904 179.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 -80.66 63.65 5.16 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 121.28 0.562 . . . . 74.230000000000004 112.088 -176.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 749' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm 48.53 66.46 5.68 Favored Pre-proline 0 CA--C 1.545 0.768 0 N-CA-C 113.116 0.784 . . . . 75.430000000000007 113.116 178.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 750' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -71.31 111.29 3.05 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 122.476 2.117 . . . . 65.239999999999995 111.804 175.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 751' ' ' ILE . . . . . . . . . . . . . 2.4 pp -92.35 13.26 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 N-CA-C 112.238 0.459 . . . . 75.319999999999993 112.238 -178.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 752' ' ' LEU . . . . . 0.466 HD11 ' N ' ' A' ' 753' ' ' GLU . 2.6 tm? -53.49 133.94 40.73 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-O 120.904 0.383 . . . . 73.340000000000003 110.749 176.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 753' ' ' GLU . . . . . 0.466 ' N ' HD11 ' A' ' 752' ' ' LEU . 42.3 mt-10 . . . . . 0 C--O 1.238 0.47 0 CA-C-O 120.768 0.318 . . . . 71.420000000000002 111.515 -177.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 762' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 657' ' ' MET . . . . . . . . . . . . . 22.0 ptt? . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 120.741 0.305 . . . . 73.420000000000002 111.111 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 658' ' ' GLY . . . . . . . . . . . . . . . 70.48 61.97 3.9 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 121.079 -0.581 . . . . 72.540000000000006 112.155 -175.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 659' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -60.02 106.51 0.51 Allowed 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 112.403 0.52 . . . . 75.299999999999997 112.403 -178.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 660' ' ' GLY . . . . . . . . . . . . . . . -96.44 62.23 1.2 Allowed Glycine 0 CA--C 1.525 0.689 0 N-CA-C 111.386 -0.686 . . . . 61.310000000000002 111.386 173.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -101.8 138.27 38.99 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 112.439 0.533 . . . . 75.109999999999999 112.439 -173.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 662' ' ' THR . . . . . . . . . . . . . 31.0 m -92.86 152.85 19.18 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 115.976 -0.556 . . . . 75.019999999999996 111.205 178.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 663' ' ' SER . . . . . . . . . . . . . 28.8 t -93.32 143.64 26.08 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 122.348 -0.22 . . . . 75.329999999999998 110.838 176.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 664' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -88.78 154.32 20.37 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 121.633 0.73 . . . . 72.439999999999998 112.356 -178.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 665' ' ' LEU . . . . . . . . . . . . . 44.8 mt -113.64 138.02 50.79 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.086 -0.961 . . . . 75.219999999999999 110.59 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 666' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -54.01 139.23 54.15 Favored Pre-proline 0 CA--C 1.545 0.752 0 CA-C-O 120.762 0.315 . . . . 75.049999999999997 111.309 176.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 667' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -68.95 160.27 50.54 Favored 'Trans proline' 0 CA--C 1.545 1.045 0 C-N-CA 122.963 2.442 . . . . 64.099999999999994 115.124 -166.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 668' ' ' LYS . . . . . 0.417 ' HA ' ' HE3' ' A' ' 668' ' ' LYS . 0.2 OUTLIER -83.22 102.23 11.77 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 114.948 -1.024 . . . . 71.120000000000005 111.022 177.896 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 669' ' ' LEU . . . . . . . . . . . . . 57.9 tp -103.49 114.64 29.08 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 120.783 0.325 . . . . 71.409999999999997 111.096 176.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 670' ' ' THR . . . . . . . . . . . . . 99.4 m -101.67 112.1 24.56 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.875 0.369 . . . . 75.439999999999998 111.425 178.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 671' ' ' VAL . . . . . . . . . . . . . 90.2 t -125.98 132.84 24.45 Favored Pre-proline 0 CA--C 1.538 0.492 0 CA-C-N 116.3 -0.409 . . . . 75.319999999999993 110.776 177.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 672' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -66.47 138.43 50.25 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 122.128 1.886 . . . . 74.099999999999994 112.363 178.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 673' ' ' VAL . . . . . . . . . . . . . 11.7 p -73.17 -34.09 43.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 N-CA-C 112.326 0.491 . . . . 72.519999999999996 112.326 -175.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 674' ' ' GLY . . . . . . . . . . . . . . . -150.74 151.12 23.18 Favored Glycine 0 CA--C 1.523 0.533 0 C-N-CA 120.557 -0.83 . . . . 74.319999999999993 113.674 -176.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 675' ' ' ALA . . . . . 0.488 ' HB1' HG23 ' A' ' 737' ' ' VAL . . . -138.92 144.42 39.08 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 122.476 0.31 . . . . 70.019999999999996 110.978 179.136 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 676' ' ' THR . . . . . . . . . . . . . 36.5 m -131.42 118.61 20.48 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 120.596 0.236 . . . . 61.520000000000003 111.103 -178.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 677' ' ' ILE . . . . . . . . . . . . . 42.9 pt -136.67 177.58 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-O 121.091 0.472 . . . . 74.349999999999994 111.695 179.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 678' ' ' HIS . . . . . . . . . . . . . 79.2 m80 -129.57 140.29 51.25 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 111.924 0.342 . . . . 72.400000000000006 111.924 -178.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 679' ' ' VAL . . . . . . . . . . . . . 89.7 t -46.87 122.18 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 CA-C-N 115.753 -0.658 . . . . 75.430000000000007 112.558 -178.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 104.14 14.97 23.09 Favored Glycine 0 CA--C 1.528 0.883 0 CA-C-N 116.246 -0.433 . . . . 74.239999999999995 113.533 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 681' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -101.25 -161.94 0.9 Allowed 'General case' 0 CA--C 1.545 0.788 0 CA-C-O 121.407 0.622 . . . . 64.409999999999997 112.044 -179.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 682' ' ' SER . . . . . . . . . . . . . 40.1 m -134.62 111.1 9.75 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 115.938 -0.574 . . . . 73.329999999999998 110.394 175.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 683' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -118.7 136.24 54.04 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.582 0.23 . . . . 74.409999999999997 111.474 -177.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 684' ' ' VAL . . . . . . . . . . . . . 86.5 t -121.38 111.8 33.23 Favored Pre-proline 0 CA--C 1.54 0.561 0 CA-C-O 120.553 0.216 . . . . 72.510000000000005 111.104 177.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -59.46 -50.62 7.89 Favored 'Trans proline' 0 CA--C 1.543 0.968 0 C-N-CA 122.723 2.282 . . . . 74.430000000000007 114.105 -176.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 686' ' ' MET . . . . . 0.442 ' HE1' ' HB3' ' A' ' 686' ' ' MET . 53.9 mtp -79.73 -12.62 59.79 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 113.439 0.903 . . . . 74.340000000000003 113.439 -175.046 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 687' ' ' ALA . . . . . . . . . . . . . . . -65.54 -21.17 66.58 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.845 0.355 . . . . 73.140000000000001 111.553 -178.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 688' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -107.37 0.73 23.2 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 112.346 0.498 . . . . 74.430000000000007 112.346 -178.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 25.4 t -99.55 151.11 4.94 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 O-C-N 122.098 -0.376 . . . . 74.120000000000005 111.528 -177.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 690' ' ' LEU . . . . . . . . . . . . . 9.1 tt -148.08 146.78 28.97 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 122.347 0.259 . . . . 72.519999999999996 111.025 -177.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 691' ' ' ALA . . . . . . . . . . . . . . . -145.73 128.46 16.24 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 111.994 0.368 . . . . 52.420000000000002 111.994 179.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 692' ' ' ILE . . . . . 0.516 HD11 ' HA ' ' A' ' 698' ' ' ASP . 45.4 mm -134.01 134.21 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 122.72 0.408 . . . . 75.25 111.737 -177.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 693' ' ' ASP . . . . . 0.436 ' HB2' ' CD1' ' A' ' 699' ' ' LEU . 35.0 t70 -106.95 144.77 33.1 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 122.077 -0.39 . . . . 63.420000000000002 111.01 173.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -59.33 -39.89 84.56 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 116.128 -0.487 . . . . 75.099999999999994 112.11 -177.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -83.01 -55.78 4.18 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 112.462 0.541 . . . . 74.109999999999999 112.462 -178.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 696' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -79.41 -48.27 14.27 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 112.445 0.535 . . . . 74.349999999999994 112.445 -169.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . 122.31 -112.26 1.96 Allowed Glycine 0 CA--C 1.522 0.47 0 C-N-CA 120.913 -0.66 . . . . 65.310000000000002 112.613 -176.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 698' ' ' ASP . . . . . 0.516 ' HA ' HD11 ' A' ' 692' ' ' ILE . 13.0 t70 -87.65 116.92 26.11 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 122.179 -0.601 . . . . 71.209999999999994 112.064 -176.271 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 699' ' ' LEU . . . . . 0.436 ' CD1' ' HB2' ' A' ' 693' ' ' ASP . 56.9 mt -112.37 21.2 15.98 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 116.287 -0.415 . . . . 75.420000000000002 111.32 175.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 29.6 m -60.14 -25.94 65.88 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 120.952 0.406 . . . . 73.540000000000006 111.603 -178.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 701' ' ' SER . . . . . . . . . . . . . 40.0 t -82.02 -18.21 44.06 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 121.163 0.506 . . . . 71.510000000000005 111.412 177.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 702' ' ' LYS . . . . . . . . . . . . . 48.6 mmtm -82.42 3.08 29.5 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 116.293 -0.412 . . . . 65.519999999999996 111.873 179.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 72.1 mt -78.37 138.98 19.24 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 CA-C-O 121.326 0.584 . . . . 74.129999999999995 112.438 -177.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 704' ' ' LYS . . . . . 0.459 ' O ' ' HA ' ' A' ' 721' ' ' TYR . 22.5 ttmm -104.84 139.33 39.76 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.783 -0.644 . . . . 74.25 110.267 178.149 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 60.8 t -115.59 111.09 34.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 N-CA-C 112.392 0.515 . . . . 73.450000000000003 112.392 -177.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 706' ' ' ASP . . . . . 0.55 ' HB3' ' HB ' ' A' ' 720' ' ' THR . 28.7 t70 -107.41 133.14 52.36 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.122 -0.49 . . . . 73.219999999999999 110.568 174.09 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 86.86 165.74 41.63 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 120.894 -0.67 . . . . 75.420000000000002 112.441 -176.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 708' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -159.37 148.78 18.44 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 122.283 -0.54 . . . . 64.510000000000005 111.153 -179.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 709' ' ' VAL . . . . . 0.429 HG22 HD13 ' A' ' 719' ' ' LEU . 58.7 t -96.45 137.58 23.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-N 116.094 -0.503 . . . . 64.450000000000003 111.665 -178.452 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 710' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -105.03 136.76 43.9 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 116.188 -0.46 . . . . 74.25 110.225 175.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 711' ' ' THR . . . . . . . . . . . . . 73.4 p -107.91 8.77 28.69 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 112.814 0.672 . . . . 75.209999999999994 112.814 -174.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 712' ' ' THR . . . . . . . . . . . . . 7.2 t -111.83 -9.73 14.05 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 122.078 -0.389 . . . . 75.329999999999998 111.61 176.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 713' ' ' LYS . . . . . . . . . . . . . 37.8 tttp -129.3 133.19 47.35 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 120.653 0.263 . . . . 75.239999999999995 110.885 177.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 714' ' ' ALA . . . . . . . . . . . . . . . -77.73 134.01 38.18 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 112.18 0.437 . . . . 74.129999999999995 112.18 -178.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 168.27 179.81 40.91 Favored Glycine 0 CA--C 1.524 0.625 0 CA-C-N 116.123 -0.49 . . . . 72.340000000000003 112.854 -179.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 716' ' ' THR . . . . . . . . . . . . . 41.0 m -108.64 122.67 47.59 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 120.999 0.428 . . . . 73.109999999999999 111.384 -178.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 717' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -114.06 124.09 51.28 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 116.284 -0.416 . . . . 73.420000000000002 111.036 -177.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 718' ' ' VAL . . . . . . . . . . . . . 49.3 t -97.36 114.65 35.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-O 121.111 0.481 . . . . 73.400000000000006 111.124 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 719' ' ' LEU . . . . . 0.429 HD13 HG22 ' A' ' 709' ' ' VAL . 47.4 mt -101.51 132.75 46.97 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 116.292 -0.413 . . . . 74.420000000000002 111.41 -177.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 720' ' ' THR . . . . . 0.55 ' HB ' ' HB3' ' A' ' 706' ' ' ASP . 34.9 m -110.06 128.02 55.18 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 120.958 0.409 . . . . 74.219999999999999 111.501 178.083 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 721' ' ' TYR . . . . . 0.459 ' HA ' ' O ' ' A' ' 704' ' ' LYS . 75.3 m-85 -117.97 126.36 52.18 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.524 -0.307 . . . . 72.310000000000002 110.84 178.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 56.1 m -127.98 122.27 31.89 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 116.853 -0.158 . . . . 74.219999999999999 111.266 -178.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 12.9 p -111.11 142.14 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-O 120.903 0.382 . . . . 62.409999999999997 111.372 -179.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 52.3 m -113.79 126.5 55.28 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.083 0.468 . . . . 75.299999999999997 112.099 -178.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 725' ' ' ASP . . . . . 0.503 ' HB3' ' HB2' ' A' ' 729' ' ' HIS . 0.2 OUTLIER -84.5 158.81 20.88 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 115.953 -0.567 . . . . 75.319999999999993 111.483 176.22 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 726' ' ' SER . . . . . . . . . . . . . 49.8 m -58.21 -34.74 70.73 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.872 0.693 . . . . 73.109999999999999 112.872 -176.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 727' ' ' LYS . . . . . 0.475 ' HD2' ' N ' ' A' ' 727' ' ' LYS . 3.4 mptp? -90.45 13.45 15.62 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 122.09 -0.381 . . . . 74.349999999999994 111.59 -177.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 728' ' ' GLY . . . . . . . . . . . . . . . 91.54 10.84 61.46 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 121.118 -0.563 . . . . 61.329999999999998 114.224 174.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 729' ' ' HIS . . . . . 0.503 ' HB2' ' HB3' ' A' ' 725' ' ' ASP . 46.7 m80 -80.79 107.24 13.43 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 117.397 0.598 . . . . 74.109999999999999 111.203 178.36 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 730' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -111.39 124.69 52.77 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.982 -0.554 . . . . 62.450000000000003 111.271 -175.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 28.8 m -131.16 152.6 37.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 CA-C-O 120.739 0.304 . . . . 73.409999999999997 111.283 179.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 10.2 t -136.25 153.81 51.09 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 112.727 0.639 . . . . 64.510000000000005 112.727 -176.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -148.35 161.6 41.22 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.079 0.551 . . . . 53.229999999999997 110.704 177.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 734' ' ' LYS . . . . . . . . . . . . . 41.3 mttp -122.72 156.6 34.08 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 113.246 0.832 . . . . 74.120000000000005 113.246 -176.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 735' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -130.56 128.56 41.35 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 115.141 -0.936 . . . . 74.420000000000002 110.542 176.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 736' ' ' THR . . . . . . . . . . . . . 85.3 m -96.96 104.01 15.99 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.825 0.345 . . . . 71.510000000000005 111.37 178.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 737' ' ' VAL . . . . . 0.488 HG23 ' HB1' ' A' ' 675' ' ' ALA . 48.7 t -98.76 131.9 45.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-O 120.638 0.256 . . . . 73.140000000000001 111.414 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 738' ' ' THR . . . . . . . . . . . . . 90.7 m -121.36 117.9 28.12 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.042 0.449 . . . . 74.409999999999997 111.574 179.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 739' ' ' VAL . . . . . . . . . . . . . 27.4 t -98.94 125.14 52.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-N 116.244 -0.435 . . . . 73.340000000000003 111.043 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 740' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -114.1 152.34 31.23 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 112.142 0.423 . . . . 74.310000000000002 112.142 -177.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 741' ' ' VAL . . . . . 0.418 HG12 ' N ' ' A' ' 742' ' ' ARG . 23.7 t -79.94 156.4 4.56 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 CA-C-O 121.191 0.519 . . . . 74.409999999999997 112.307 -176.599 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 742' ' ' ARG . . . . . 0.418 ' N ' HG12 ' A' ' 741' ' ' VAL . 23.1 mmm180 -88.27 -177.37 5.66 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.032 0.444 . . . . 75.219999999999999 111.345 173.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 743' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -105.52 -15.52 14.98 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.859 0.362 . . . . 72.010000000000005 111.367 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 744' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -91.36 138.35 31.65 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.401 -0.363 . . . . 62.43 111.577 -176.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 4.0 p -75.83 106.03 5.29 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 CA-C-O 121.425 0.631 . . . . 62.25 111.713 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -103.86 130.08 51.4 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.117 0.484 . . . . 75.109999999999999 111.999 179.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 747' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 -102.35 12.17 36.99 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 115.926 -0.579 . . . . 73.340000000000003 110.166 173.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -67.66 83.48 0.18 Allowed 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.709 -0.678 . . . . 74.420000000000002 112.463 -177.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 749' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.04 131.93 24.33 Favored Pre-proline 0 N--CA 1.468 0.466 0 CA-C-N 116.177 -0.465 . . . . 74.530000000000001 110.117 171.456 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 750' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -63.89 118.51 5.45 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 122.407 2.072 . . . . 72.299999999999997 113.24 -178.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 751' ' ' ILE . . . . . . . . . . . . . 35.5 pt -77.34 24.39 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 N-CA-C 112.377 0.51 . . . . 75.140000000000001 112.377 -178.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 752' ' ' LEU . . . . . . . . . . . . . 2.7 pp -113.92 178.08 4.41 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 120.836 0.35 . . . . 75.340000000000003 111.424 -179.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 753' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 . . . . . 0 N--CA 1.469 0.504 0 CA-C-O 120.734 0.302 . . . . 75.409999999999997 111.782 -177.486 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 762' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 657' ' ' MET . . . . . . . . . . . . . 67.1 mtt . . . . . 0 N--CA 1.493 1.687 0 CA-C-O 120.912 0.387 . . . . 70.420000000000002 111.568 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 658' ' ' GLY . . . . . . . . . . . . . . . -93.43 -62.4 1.1 Allowed Glycine 0 CA--C 1.526 0.725 0 C-N-CA 121.286 -0.483 . . . . 52.240000000000002 112.026 176.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 659' ' ' ASN . . . . . . . . . . . . . 37.8 t30 -134.79 106.22 6.8 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 122.809 0.444 . . . . 73.310000000000002 109.871 173.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 660' ' ' GLY . . . . . . . . . . . . . . . -72.63 67.19 1.31 Allowed Glycine 0 CA--C 1.528 0.877 0 C-N-CA 121.226 -0.511 . . . . 71.209999999999994 113.179 -179.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -81.15 103.14 10.75 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.156 0.503 . . . . 72.420000000000002 110.623 178.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 662' ' ' THR . . . . . . . . . . . . . 4.4 t -144.8 173.05 12.18 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.886 -0.597 . . . . 73.209999999999994 110.374 -178.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 663' ' ' SER . . . . . . . . . . . . . 98.1 p -155.8 98.88 1.95 Allowed 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 112.896 0.702 . . . . 74.530000000000001 112.896 -176.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 664' ' ' ASP . . . . . 0.441 ' OD2' ' HB2' ' A' ' 727' ' ' LYS . 35.4 t0 -88.36 114.28 24.81 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 120.988 0.423 . . . . 74.030000000000001 109.916 169.448 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 665' ' ' LEU . . . . . 0.421 HD11 ' HD3' ' A' ' 694' ' ' LYS . 88.2 mt -90.6 137.32 32.45 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.165 -0.47 . . . . 73.219999999999999 110.463 175.764 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 666' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -57.01 131.96 80.05 Favored Pre-proline 0 CA--C 1.54 0.586 0 CA-C-N 116.496 -0.32 . . . . 71.129999999999995 110.557 172.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 667' ' ' PRO . . . . . 0.505 ' HB3' HD13 ' A' ' 699' ' ' LEU . 26.9 Cg_endo -60.37 148.61 89.8 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 122.433 2.089 . . . . 72.230000000000004 113.36 -172.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 668' ' ' LYS . . . . . . . . . . . . . 56.9 tptt -83.22 108.61 16.58 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.095 0.474 . . . . 72.219999999999999 111.213 177.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 669' ' ' LEU . . . . . 0.514 ' HG ' HG22 ' A' ' 671' ' ' VAL . 56.6 tp -96.65 111.97 23.9 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 116.281 -0.418 . . . . 71.439999999999998 111.335 -179.585 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 670' ' ' THR . . . . . . . . . . . . . 72.6 m -87.87 109.69 19.96 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.657 0.265 . . . . 52.140000000000001 110.927 179.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 671' ' ' VAL . . . . . 0.514 HG22 ' HG ' ' A' ' 669' ' ' LEU . 95.2 t -136.23 130.1 18.13 Favored Pre-proline 0 N--CA 1.472 0.663 0 CA-C-N 116.455 -0.339 . . . . 74.019999999999996 111.065 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 672' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -76.2 156.09 37.64 Favored 'Trans proline' 0 CA--C 1.542 0.882 0 C-N-CA 122.622 2.215 . . . . 74.140000000000001 112.759 176.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 673' ' ' VAL . . . . . . . . . . . . . 13.5 p -81.66 -33.59 12.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 N-CA-C 112.94 0.719 . . . . 71.040000000000006 112.94 -174.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 674' ' ' GLY . . . . . . . . . . . . . . . -175.08 139.55 4.85 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 119.926 -1.131 . . . . 55.049999999999997 114.35 -176.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 675' ' ' ALA . . . . . . . . . . . . . . . -139.96 151.33 45.45 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 122.654 0.382 . . . . 72.099999999999994 110.965 178.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 676' ' ' THR . . . . . . . . . . . . . 97.6 m -131.62 123.17 27.32 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-O 120.719 0.295 . . . . 74.510000000000005 111.576 -179.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 677' ' ' ILE . . . . . . . . . . . . . 29.8 pt -123.14 177.44 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 122.699 0.4 . . . . 75.140000000000001 111.405 -179.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 678' ' ' HIS . . . . . . . . . . . . . 74.2 m80 -107.37 161.66 14.61 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 121.326 0.584 . . . . 72.409999999999997 112.368 178.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 679' ' ' VAL . . . . . 0.552 HG13 ' HA ' ' A' ' 712' ' ' THR . 76.6 t -60.44 126.37 18.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-N 115.747 -0.661 . . . . 72.239999999999995 111.837 176.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 103.52 -2.69 46.15 Favored Glycine 0 CA--C 1.528 0.906 0 CA-C-N 116.129 -0.487 . . . . 64.209999999999994 113.389 -178.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 681' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -88.8 -175.74 4.99 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 116.91 0.355 . . . . 74.099999999999994 110.979 178.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 682' ' ' SER . . . . . . . . . . . . . 74.9 m -134.69 137.68 43.76 Favored 'General case' 0 N--CA 1.477 0.898 0 O-C-N 121.993 -0.442 . . . . 74.099999999999994 111.877 -178.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 683' ' ' PHE . . . . . . . . . . . . . 47.2 t80 -125.89 133.81 51.79 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 116.35 -0.386 . . . . 74.340000000000003 110.655 -178.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 684' ' ' VAL . . . . . . . . . . . . . 46.4 t -123.77 93.77 46.9 Favored Pre-proline 0 CA--C 1.546 0.791 0 CA-C-O 121.108 0.48 . . . . 72.109999999999999 112.089 -174.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -64.02 -29.58 66.26 Favored 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 122.706 2.271 . . . . 75.530000000000001 113.805 -178.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 686' ' ' MET . . . . . 0.468 ' HE1' ' HA ' ' A' ' 686' ' ' MET . 0.7 OUTLIER -79.3 -7.57 58.4 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.547 0.573 . . . . 72.140000000000001 112.547 -177.854 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 687' ' ' ALA . . . . . . . . . . . . . . . -110.26 -39.1 5.08 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.866 0.365 . . . . 71.239999999999995 111.655 177.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 688' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -77.38 -10.47 59.47 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 112.43 0.53 . . . . 74.049999999999997 112.43 -177.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . 0.483 HG11 HD13 ' A' ' 703' ' ' ILE . 88.7 t -119.03 125.01 74.13 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 CA-C-O 120.865 0.364 . . . . 75.129999999999995 111.565 178.089 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 690' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -122.36 161.77 22.81 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 120.863 0.364 . . . . 74.510000000000005 111.375 -177.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 691' ' ' ALA . . . . . . . . . . . . . . . -147.46 122.62 10.18 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 120.966 0.412 . . . . 74.400000000000006 111.896 177.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 692' ' ' ILE . . . . . . . . . . . . . 45.4 mm -123.9 135.01 64.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-N 116.349 -0.387 . . . . 74.239999999999995 111.25 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -120.44 149.91 41.64 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 120.823 0.344 . . . . 70.430000000000007 111.63 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 694' ' ' LYS . . . . . 0.421 ' HD3' HD11 ' A' ' 665' ' ' LEU . 37.8 ttpt -62.49 -61.2 2.6 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 112.314 0.487 . . . . 73.510000000000005 112.314 -177.465 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -85.09 -53.11 5.48 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 111.868 0.321 . . . . 64.409999999999997 111.868 -174.664 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 696' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -66.52 -48.91 68.26 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 121.063 0.459 . . . . 71.140000000000001 111.052 -173.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . 122.49 -146.95 16.88 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 121.224 -0.513 . . . . 72.109999999999999 113.11 178.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -70.94 111.36 6.27 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.955 0.407 . . . . 75.200000000000003 110.921 179.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 699' ' ' LEU . . . . . 0.505 HD13 ' HB3' ' A' ' 667' ' ' PRO . 79.0 mt -104.77 17.41 24.18 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 120.85 0.357 . . . . 74.340000000000003 111.503 179.517 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 42.4 m -56.77 -37.12 70.65 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.177 0.513 . . . . 73.349999999999994 111.268 178.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 701' ' ' SER . . . . . . . . . . . . . 27.5 m -68.55 -12.48 61.33 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 116.207 -0.451 . . . . 73.150000000000006 111.982 178.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 702' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -100.69 3.18 42.18 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 111.813 0.301 . . . . 74.0 111.813 -176.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 703' ' ' ILE . . . . . 0.483 HD13 HG11 ' A' ' 689' ' ' VAL . 72.2 mt -73.7 118.5 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 120.964 0.411 . . . . 73.420000000000002 111.718 -178.72 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 704' ' ' LYS . . . . . 0.709 ' HZ1' ' HB2' ' A' ' 704' ' ' LYS . 5.2 ttmp? -84.33 115.59 22.58 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 116.169 -0.469 . . . . 74.430000000000007 110.329 176.277 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 67.8 t -95.87 106.57 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 121.161 0.505 . . . . 74.219999999999999 111.595 -178.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 706' ' ' ASP . . . . . 0.537 ' HB3' ' HB ' ' A' ' 720' ' ' THR . 25.2 t70 -101.82 125.57 48.52 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 116.177 -0.465 . . . . 74.450000000000003 111.099 179.378 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 112.04 163.81 17.02 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 121.067 -0.587 . . . . 52.409999999999997 113.335 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 708' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -149.62 145.72 26.92 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.019 0.438 . . . . 74.310000000000002 111.655 -177.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 709' ' ' VAL . . . . . 0.518 HG23 ' HB2' ' A' ' 717' ' ' TYR . 55.4 t -120.45 122.04 67.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 CA-C-N 116.28 -0.418 . . . . 72.019999999999996 111.607 -177.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 710' ' ' ASP . . . . . 0.505 ' HB2' ' HB3' ' A' ' 713' ' ' LYS . 10.1 m-20 -73.94 136.34 43.28 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 120.74 0.305 . . . . 70.010000000000005 110.816 174.35 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 711' ' ' THR . . . . . . . . . . . . . 81.2 p -96.48 0.99 51.1 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 120.932 0.396 . . . . 75.430000000000007 111.237 175.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 712' ' ' THR . . . . . 0.552 ' HA ' HG13 ' A' ' 679' ' ' VAL . 74.5 p -115.71 3.46 13.89 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 116.163 -0.472 . . . . 73.430000000000007 111.912 178.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 713' ' ' LYS . . . . . 0.505 ' HB3' ' HB2' ' A' ' 710' ' ' ASP . 5.6 tppp? -125.37 122.17 36.02 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 120.731 0.3 . . . . 74.430000000000007 111.586 -175.411 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 714' ' ' ALA . . . . . . . . . . . . . . . -70.36 112.46 6.68 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.928 0.394 . . . . 71.209999999999994 111.688 175.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 175.24 168.41 35.73 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 121.112 -0.566 . . . . 41.229999999999997 112.986 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 716' ' ' THR . . . . . . . . . . . . . 86.3 m -104.04 123.11 46.63 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 122.701 -0.293 . . . . 73.140000000000001 111.699 179.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 717' ' ' TYR . . . . . 0.518 ' HB2' HG23 ' A' ' 709' ' ' VAL . 86.0 m-85 -119.93 122.7 41.81 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.005 0.431 . . . . 75.25 111.164 177.012 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 718' ' ' VAL . . . . . . . . . . . . . 59.0 t -92.37 117.91 36.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-O 120.738 0.304 . . . . 73.340000000000003 111.139 177.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 719' ' ' LEU . . . . . 0.413 HD23 HG22 ' A' ' 709' ' ' VAL . 58.1 mt -94.45 148.26 22.42 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 116.671 -0.24 . . . . 75.430000000000007 111.111 -179.436 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 720' ' ' THR . . . . . 0.537 ' HB ' ' HB3' ' A' ' 706' ' ' ASP . 25.0 m -114.98 133.15 56.28 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 120.615 0.245 . . . . 53.509999999999998 111.072 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 721' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -122.91 115.87 22.66 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.835 0.35 . . . . 74.430000000000007 111.07 179.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 46.2 m -123.95 123.1 39.67 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 120.654 0.264 . . . . 74.299999999999997 111.474 -178.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 8.7 p -119.0 136.88 54.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 CA-C-O 120.963 0.411 . . . . 73.109999999999999 111.529 179.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 18.0 m -117.58 128.49 55.0 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.144 0.424 . . . . 72.430000000000007 112.144 -175.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 725' ' ' ASP . . . . . 0.426 ' HB3' ' H ' ' A' ' 729' ' ' HIS . 9.9 t70 -74.59 152.14 39.31 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 116.334 -0.394 . . . . 74.219999999999999 110.624 176.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 726' ' ' SER . . . . . . . . . . . . . 48.7 m -62.52 -27.41 69.14 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 112.624 0.601 . . . . 63.229999999999997 112.624 -177.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 727' ' ' LYS . . . . . 0.488 ' N ' ' HD3' ' A' ' 727' ' ' LYS . 3.5 mppt? -95.04 4.01 54.22 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 112.19 0.441 . . . . 73.340000000000003 112.19 179.399 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 728' ' ' GLY . . . . . . . . . . . . . . . 101.84 34.27 4.4 Favored Glycine 0 CA--C 1.533 1.161 0 N-CA-C 115.563 0.985 . . . . 51.350000000000001 115.563 171.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 729' ' ' HIS . . . . . 0.426 ' H ' ' HB3' ' A' ' 725' ' ' ASP . 31.2 m80 -109.53 111.08 22.39 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 118.077 0.938 . . . . 74.319999999999993 110.926 170.704 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 730' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -113.82 118.45 34.28 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 112.004 0.372 . . . . 61.219999999999999 112.004 -174.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 30.7 m -117.17 155.11 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-O 120.671 0.272 . . . . 72.349999999999994 111.171 178.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 10.0 t -147.52 145.38 29.08 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 112.792 0.664 . . . . 75.310000000000002 112.792 -175.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -148.72 143.65 26.57 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.962 -0.563 . . . . 74.209999999999994 111.144 178.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 734' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -106.92 159.52 16.2 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.343 0.592 . . . . 74.129999999999995 112.41 -178.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 735' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -132.77 130.08 39.46 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.707 -0.679 . . . . 75.519999999999996 110.837 -179.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 736' ' ' THR . . . . . . . . . . . . . 90.5 m -94.13 103.89 15.93 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 120.919 0.39 . . . . 74.340000000000003 111.865 -179.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 44.3 t -102.6 135.17 41.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-O 120.719 0.295 . . . . 65.209999999999994 111.473 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 738' ' ' THR . . . . . . . . . . . . . 92.5 m -125.36 131.6 52.96 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 120.723 0.297 . . . . 74.219999999999999 111.378 178.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 739' ' ' VAL . . . . . . . . . . . . . 51.6 t -109.73 128.03 66.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-O 120.829 0.347 . . . . 64.349999999999994 111.011 177.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 740' ' ' LYS . . . . . 0.682 ' HB3' ' HZ1' ' A' ' 740' ' ' LYS . 7.3 mtpm? -116.18 152.6 33.39 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.973 0.416 . . . . 74.239999999999995 111.374 179.141 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 741' ' ' VAL . . . . . . . . . . . . . 18.1 t -81.48 145.9 8.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-O 120.704 0.288 . . . . 74.0 111.033 -178.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 742' ' ' ARG . . . . . . . . . . . . . 4.0 ppt_? -83.43 158.88 21.91 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.151 0.5 . . . . 74.239999999999995 112.143 178.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 743' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -69.41 143.89 53.5 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.8 -0.636 . . . . 74.430000000000007 112.5 -177.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 744' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -109.4 135.62 50.15 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 116.164 -0.471 . . . . 75.409999999999997 110.017 172.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 30.3 m -84.23 177.42 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 N-CA-C 112.136 0.421 . . . . 74.420000000000002 112.136 -177.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -61.95 90.4 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.025 0.44 . . . . 71.450000000000003 111.86 179.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 747' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -93.8 170.53 9.5 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 121.275 0.56 . . . . 71.530000000000001 111.693 178.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -83.23 32.24 0.45 Allowed 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 115.971 -0.559 . . . . 70.519999999999996 111.62 -178.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 749' ' ' LYS . . . . . . . . . . . . . 46.4 tptt 54.87 73.74 0.84 Allowed Pre-proline 0 CA--C 1.543 0.678 0 C-N-CA 123.145 0.578 . . . . 75.540000000000006 111.281 -175.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 750' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -70.27 105.34 1.55 Allowed 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 122.662 2.241 . . . . 71.209999999999994 112.705 -178.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 751' ' ' ILE . . . . . . . . . . . . . 58.3 mt -75.59 78.12 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-O 121.356 0.598 . . . . 72.439999999999998 110.297 177.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 752' ' ' LEU . . . . . . . . . . . . . 39.1 tp -74.39 90.56 2.17 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.917 -0.583 . . . . 74.230000000000004 111.91 -173.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 753' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 . . . . . 0 C--O 1.239 0.51 0 CA-C-N 116.148 -0.478 . . . . 61.520000000000003 111.186 177.103 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 762' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 657' ' ' MET . . . . . . . . . . . . . 9.7 tpt . . . . . 0 N--CA 1.488 1.437 0 CA-C-O 121.077 0.465 . . . . 75.530000000000001 111.802 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 658' ' ' GLY . . . . . . . . . . . . . . . -156.42 29.44 0.57 Allowed Glycine 0 CA--C 1.527 0.805 0 CA-C-N 116.145 -0.48 . . . . 53.420000000000002 112.582 176.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 659' ' ' ASN . . . . . . . . . . . . . 60.6 m-20 -69.72 106.63 3.16 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 120.795 0.331 . . . . 73.140000000000001 111.522 -177.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 660' ' ' GLY . . . . . . . . . . . . . . . -80.74 56.71 4.78 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 121.129 -0.557 . . . . 71.510000000000005 113.279 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 37.3 mm-40 -105.26 142.76 34.47 Favored 'General case' 0 N--CA 1.468 0.456 0 O-C-N 122.65 -0.323 . . . . 62.329999999999998 111.337 -179.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 662' ' ' THR . . . . . . . . . . . . . 9.1 t -92.79 172.59 8.24 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.211 0.529 . . . . 64.329999999999998 112.097 -177.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 663' ' ' SER . . . . . . . . . . . . . 62.8 m -89.93 122.8 33.3 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 116.328 -0.396 . . . . 62.439999999999998 111.559 -178.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 664' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -73.55 143.86 46.32 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 121.406 0.622 . . . . 71.219999999999999 111.552 177.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 665' ' ' LEU . . . . . . . . . . . . . 86.9 mt -87.33 126.0 34.58 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.648 -0.706 . . . . 73.230000000000004 110.387 176.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 666' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -62.1 145.59 93.15 Favored Pre-proline 0 CA--C 1.542 0.661 0 CA-C-N 116.116 -0.493 . . . . 73.030000000000001 111.3 178.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 667' ' ' PRO . . . . . 0.457 ' HB3' ' HB2' ' A' ' 693' ' ' ASP . 80.4 Cg_endo -76.94 147.14 26.64 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 122.365 2.043 . . . . 75.549999999999997 112.872 -176.189 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 668' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -83.15 104.05 13.04 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.127 0.489 . . . . 74.549999999999997 110.901 179.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 669' ' ' LEU . . . . . 0.413 ' HG ' HG21 ' A' ' 671' ' ' VAL . 58.1 tp -89.91 105.87 18.09 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.065 -0.516 . . . . 74.510000000000005 110.707 177.392 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 670' ' ' THR . . . . . . . . . . . . . 73.5 m -88.18 110.97 21.11 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.162 -0.472 . . . . 74.430000000000007 111.273 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 671' ' ' VAL . . . . . 0.486 HG22 HG13 ' A' ' 689' ' ' VAL . 85.7 t -132.08 126.27 20.49 Favored Pre-proline 0 N--CA 1.47 0.53 0 CA-C-N 116.146 -0.479 . . . . 73.120000000000005 110.768 179.275 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 672' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -69.73 137.48 35.64 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 122.27 1.98 . . . . 71.530000000000001 112.297 179.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 673' ' ' VAL . . . . . . . . . . . . . 12.5 p -64.54 -35.89 75.83 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 N-CA-C 112.279 0.474 . . . . 70.230000000000004 112.279 -175.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 674' ' ' GLY . . . . . . . . . . . . . . . -162.22 161.62 33.63 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 120.647 -0.787 . . . . 71.099999999999994 113.699 -178.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 675' ' ' ALA . . . . . . . . . . . . . . . -151.17 157.82 43.17 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 122.299 0.24 . . . . 73.209999999999994 110.955 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 676' ' ' THR . . . . . . . . . . . . . 60.7 m -133.38 126.39 31.18 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 122.347 -0.221 . . . . 72.549999999999997 111.394 179.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 677' ' ' ILE . . . . . . . . . . . . . 23.9 pt -130.33 174.56 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-O 120.976 0.417 . . . . 72.019999999999996 111.311 177.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 678' ' ' HIS . . . . . 0.512 ' O ' ' HB2' ' A' ' 681' ' ' ASP . 72.3 m80 -121.3 171.35 8.8 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.324 0.583 . . . . 64.510000000000005 112.378 -178.1 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 679' ' ' VAL . . . . . 0.448 HG22 ' HA ' ' A' ' 741' ' ' VAL . 84.5 t -63.71 120.01 9.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-N 116.023 -0.535 . . . . 73.329999999999998 111.254 175.499 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 97.2 0.84 59.65 Favored Glycine 0 CA--C 1.528 0.895 0 CA-C-N 116.185 -0.461 . . . . 63.439999999999998 113.211 -175.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 681' ' ' ASP . . . . . 0.512 ' HB2' ' O ' ' A' ' 678' ' ' HIS . 0.9 OUTLIER -77.05 178.58 6.87 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-O 121.101 0.477 . . . . 53.039999999999999 111.116 -179.561 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 682' ' ' SER . . . . . . . . . . . . . 87.2 p -134.94 126.21 28.19 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 116.511 -0.313 . . . . 75.120000000000005 110.831 177.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 683' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -127.53 134.38 49.77 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.931 0.396 . . . . 73.450000000000003 111.647 -176.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 684' ' ' VAL . . . . . 0.419 ' HA ' ' HD2' ' A' ' 685' ' ' PRO . 61.8 t -124.26 101.6 34.52 Favored Pre-proline 0 CA--C 1.545 0.766 0 CA-C-O 121.089 0.471 . . . . 73.329999999999998 111.943 -179.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 685' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 684' ' ' VAL . 21.6 Cg_endo -60.99 -36.58 82.1 Favored 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 122.871 2.381 . . . . 72.409999999999997 113.843 -178.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 686' ' ' MET . . . . . 0.457 ' HE1' ' HA ' ' A' ' 686' ' ' MET . 0.5 OUTLIER -78.64 -1.75 35.77 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 112.237 0.458 . . . . 73.310000000000002 112.237 -177.791 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 687' ' ' ALA . . . . . . . . . . . . . . . -95.27 -48.08 6.05 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.078 0.466 . . . . 72.120000000000005 110.808 174.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 688' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -66.01 -38.31 88.12 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.605 0.594 . . . . 71.310000000000002 112.605 179.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . 0.486 HG13 HG22 ' A' ' 671' ' ' VAL . 98.9 t -86.67 143.1 12.08 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-O 120.934 0.397 . . . . 73.439999999999998 111.884 -178.118 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 690' ' ' LEU . . . . . 0.42 HD12 ' OG1' ' A' ' 700' ' ' THR . 45.9 tp -141.97 151.87 42.94 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.058 -0.519 . . . . 73.019999999999996 110.683 -177.092 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 691' ' ' ALA . . . . . 0.489 ' HB1' HD12 ' A' ' 703' ' ' ILE . . . -139.78 121.53 15.39 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.235 0.541 . . . . 72.530000000000001 111.439 174.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 692' ' ' ILE . . . . . . . . . . . . . 46.7 mm -128.93 120.53 52.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-N 116.219 -0.446 . . . . 65.540000000000006 111.716 -177.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 693' ' ' ASP . . . . . 0.457 ' HB2' ' HB3' ' A' ' 667' ' ' PRO . 31.9 t70 -102.88 149.24 24.7 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 120.787 0.327 . . . . 63.329999999999998 110.611 174.255 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -67.33 -55.41 13.98 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 112.367 0.506 . . . . 73.129999999999995 112.367 -176.075 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -83.8 -52.03 6.73 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 112.433 0.531 . . . . 63.530000000000001 112.433 -176.415 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 696' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -72.12 -32.79 67.27 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 120.874 0.368 . . . . 75.450000000000003 111.697 -172.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . 109.57 -144.69 16.72 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 120.973 -0.632 . . . . 55.530000000000001 113.515 177.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -71.06 122.47 20.13 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 120.85 0.357 . . . . 74.150000000000006 111.459 -178.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 699' ' ' LEU . . . . . . . . . . . . . 90.3 mt -118.85 20.89 12.69 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 120.998 0.428 . . . . 75.519999999999996 111.348 178.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 700' ' ' THR . . . . . 0.42 ' OG1' HD12 ' A' ' 690' ' ' LEU . 26.3 m -62.18 -39.22 91.94 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 121.169 0.509 . . . . 74.25 111.611 -179.339 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 701' ' ' SER . . . . . . . . . . . . . 63.3 m -71.07 -9.51 58.17 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 116.211 -0.449 . . . . 71.530000000000001 111.637 177.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 702' ' ' LYS . . . . . 0.466 ' HB3' ' HZ2' ' A' ' 702' ' ' LYS . 2.4 mmmp? -87.01 -9.66 55.01 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 120.668 0.271 . . . . 72.450000000000003 111.049 176.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 703' ' ' ILE . . . . . 0.489 HD12 ' HB1' ' A' ' 691' ' ' ALA . 67.7 mt -74.76 115.57 16.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-O 120.743 0.306 . . . . 63.200000000000003 111.531 -178.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 704' ' ' LYS . . . . . . . . . . . . . 30.2 ttpt -89.95 119.47 30.34 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 120.872 0.368 . . . . 63.100000000000001 110.375 174.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 45.2 t -97.3 137.59 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 112.238 0.459 . . . . 63.240000000000002 112.238 -174.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 706' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -131.78 134.63 46.04 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 120.932 0.396 . . . . 63.450000000000003 110.962 175.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 128.07 178.87 15.55 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 121.373 -0.442 . . . . 73.219999999999999 112.987 179.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 708' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -166.28 130.71 2.17 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.046 0.45 . . . . 72.349999999999994 111.721 179.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 709' ' ' VAL . . . . . . . . . . . . . 60.1 t -107.54 131.2 58.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-N 116.222 -0.444 . . . . 73.120000000000005 111.652 -178.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 710' ' ' ASP . . . . . 0.434 ' O ' HG23 ' A' ' 739' ' ' VAL . 7.4 m-20 -85.68 141.86 29.45 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.037 0.446 . . . . 73.120000000000005 111.757 178.518 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 711' ' ' THR . . . . . 0.444 ' O ' ' HA ' ' A' ' 679' ' ' VAL . 80.5 p -111.29 2.36 17.64 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.476 -0.329 . . . . 75.150000000000006 111.648 177.361 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 712' ' ' THR . . . . . . . . . . . . . 31.2 p -103.84 -28.68 11.46 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 120.951 0.405 . . . . 61.439999999999998 111.883 178.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 713' ' ' LYS . . . . . 0.657 ' HZ2' ' HB2' ' A' ' 713' ' ' LYS . 4.8 ttmp? -119.64 133.33 55.69 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.505 -0.316 . . . . 73.310000000000002 111.174 -178.404 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 714' ' ' ALA . . . . . . . . . . . . . . . -69.56 142.98 53.5 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 120.868 0.366 . . . . 74.540000000000006 111.435 178.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 160.84 157.83 8.95 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 120.995 -0.621 . . . . 73.430000000000007 113.107 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 716' ' ' THR . . . . . . . . . . . . . 86.3 m -99.07 123.26 43.23 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 122.496 -0.414 . . . . 74.5 111.67 -178.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 717' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -122.19 150.33 42.4 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 122.579 0.352 . . . . 65.239999999999995 111.204 -178.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 718' ' ' VAL . . . . . . . . . . . . . 57.6 t -113.7 125.44 70.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 CA-C-O 121.003 0.43 . . . . 73.019999999999996 111.642 178.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 719' ' ' LEU . . . . . . . . . . . . . 81.4 mt -102.41 141.69 34.83 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.444 -0.344 . . . . 72.349999999999994 110.95 179.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 86.5 m -112.29 139.68 47.64 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-O 120.994 0.426 . . . . 61.100000000000001 111.71 -178.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 721' ' ' TYR . . . . . . . . . . . . . 50.1 m-85 -132.56 122.38 24.7 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 116.191 -0.459 . . . . 74.430000000000007 110.937 -179.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 95.3 m -125.69 125.32 42.86 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 120.873 0.368 . . . . 74.0 111.883 -179.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 723' ' ' VAL . . . . . 0.466 ' HB ' HG12 ' A' ' 703' ' ' ILE . 14.9 p -121.56 152.14 25.11 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-N 116.297 -0.411 . . . . 72.140000000000001 111.005 178.312 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 87.0 m -133.08 132.11 41.37 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.058 0.456 . . . . 72.519999999999996 111.938 177.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 725' ' ' ASP . . . . . 0.453 ' HB2' ' HD3' ' A' ' 667' ' ' PRO . 9.9 t0 -73.41 151.05 41.29 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 115.714 -0.676 . . . . 64.519999999999996 110.608 177.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 726' ' ' SER . . . . . . . . . . . . . 44.0 t -59.57 -31.66 69.65 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.328 -0.396 . . . . 74.0 111.786 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 727' ' ' LYS . . . . . . . . . . . . . 10.3 mptt -86.71 1.05 53.41 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 112.237 0.458 . . . . 71.349999999999994 112.237 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 728' ' ' GLY . . . . . . . . . . . . . . . 100.55 33.77 4.96 Favored Glycine 0 CA--C 1.534 1.23 0 N-CA-C 115.49 0.956 . . . . 71.530000000000001 115.49 171.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 52.3 m80 -109.45 112.08 23.98 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 118.062 0.931 . . . . 74.530000000000001 111.571 173.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 730' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -99.51 129.05 45.65 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 121.028 0.442 . . . . 73.329999999999998 111.825 -176.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 48.8 t -127.51 136.1 61.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-N 116.22 -0.445 . . . . 71.209999999999994 110.591 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 10.3 t -135.13 144.95 47.39 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 112.364 0.505 . . . . 74.209999999999994 112.364 -178.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 733' ' ' ALA . . . . . 0.477 ' HB1' HG23 ' A' ' 671' ' ' VAL . . . -148.86 162.1 40.5 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 116.222 -0.445 . . . . 64.400000000000006 111.71 -178.53 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 734' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -123.72 155.35 38.01 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 112.356 0.502 . . . . 74.140000000000001 112.356 -178.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 735' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -130.04 126.36 37.5 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 116.021 -0.536 . . . . 74.25 110.746 177.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 736' ' ' THR . . . . . . . . . . . . . 97.8 m -95.1 109.54 21.59 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 120.992 0.425 . . . . 73.319999999999993 111.726 -179.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 47.7 t -106.5 121.67 59.4 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 CA-C-O 120.897 0.379 . . . . 63.350000000000001 111.505 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 738' ' ' THR . . . . . . . . . . . . . 54.2 m -104.77 121.81 44.4 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.091 0.472 . . . . 75.239999999999995 111.986 179.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 739' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 710' ' ' ASP . 24.4 t -98.09 136.3 29.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-N 116.063 -0.517 . . . . 74.530000000000001 111.047 178.11 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 740' ' ' LYS . . . . . 0.408 ' O ' ' HA ' ' A' ' 678' ' ' HIS . 96.0 mttt -131.38 156.01 46.29 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.259 0.552 . . . . 75.329999999999998 111.957 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 741' ' ' VAL . . . . . 0.448 ' HA ' HG22 ' A' ' 679' ' ' VAL . 28.2 t -80.86 146.43 7.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-N 116.266 -0.425 . . . . 75.129999999999995 111.485 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 742' ' ' ARG . . . . . 0.402 HH11 ' HD3' ' A' ' 742' ' ' ARG . 13.7 ptt180 -84.35 179.42 7.45 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 120.707 0.289 . . . . 75.209999999999994 111.081 179.147 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 743' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -69.52 101.92 1.7 Allowed 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 112.888 0.699 . . . . 74.310000000000002 112.888 -175.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 744' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -100.78 153.18 19.67 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 120.77 0.319 . . . . 73.109999999999999 110.397 174.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 31.9 m -93.23 -175.24 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 N-CA-C 112.826 0.676 . . . . 75.430000000000007 112.826 -173.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -60.85 125.24 22.97 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.221 0.534 . . . . 75.519999999999996 111.811 178.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 747' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -84.53 65.05 8.78 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-O 121.513 0.673 . . . . 72.219999999999999 110.33 175.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -87.52 -28.33 22.08 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 112.553 0.575 . . . . 72.430000000000007 112.553 -176.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 749' ' ' LYS . . . . . 0.522 ' HB3' ' HZ1' ' A' ' 749' ' ' LYS . 0.1 OUTLIER -48.73 111.16 1.73 Allowed Pre-proline 0 CA--C 1.549 0.937 0 CA-C-O 121.25 0.547 . . . . 74.239999999999995 112.321 -175.389 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 750' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -85.47 146.37 9.61 Favored 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 123.133 2.555 . . . . 74.340000000000003 114.838 -171.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 751' ' ' ILE . . . . . . . . . . . . . 57.9 mt 59.67 86.0 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 CA-C-N 115.589 -0.732 . . . . 74.230000000000004 112.59 175.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 752' ' ' LEU . . . . . . . . . . . . . 43.2 tp -177.57 146.83 0.47 Allowed 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 116.167 -0.47 . . . . 72.019999999999996 111.235 178.126 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 753' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 . . . . . 0 N--CA 1.47 0.565 0 CA-C-O 121.112 0.482 . . . . 72.549999999999997 111.447 175.951 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 762' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 657' ' ' MET . . . . . . . . . . . . . 86.9 mtp . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.026 0.441 . . . . 71.0 111.532 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 658' ' ' GLY . . . . . . . . . . . . . . . 84.53 -67.92 3.61 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 121.316 -0.468 . . . . 72.319999999999993 112.962 178.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 659' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -91.42 149.28 21.78 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 122.462 -0.434 . . . . 61.340000000000003 111.475 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 660' ' ' GLY . . . . . . . . . . . . . . . -156.3 -110.44 0.33 Allowed Glycine 0 CA--C 1.525 0.673 0 C-N-CA 121.124 -0.56 . . . . 71.409999999999997 112.877 177.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 70.16 -11.46 0.57 Allowed 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 113.042 0.756 . . . . 74.340000000000003 113.042 176.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 662' ' ' THR . . . . . . . . . . . . . 82.3 m -70.39 104.77 2.81 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.13 0.49 . . . . 74.430000000000007 111.928 -174.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 663' ' ' SER . . . . . . . . . . . . . 68.2 m -132.23 158.18 42.45 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 116.167 -0.469 . . . . 72.310000000000002 111.236 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 664' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -84.84 122.53 29.29 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 121.096 0.474 . . . . 70.450000000000003 110.979 176.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 665' ' ' LEU . . . . . . . . . . . . . 86.2 mt -96.94 136.89 36.86 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.117 -0.492 . . . . 74.019999999999996 110.768 175.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 666' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -56.83 139.59 77.21 Favored Pre-proline 0 CA--C 1.544 0.712 0 CA-C-O 120.79 0.329 . . . . 73.340000000000003 111.16 175.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 667' ' ' PRO . . . . . 0.523 ' HB3' HD13 ' A' ' 699' ' ' LEU . 58.3 Cg_endo -68.97 156.77 64.32 Favored 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 122.618 2.212 . . . . 73.409999999999997 113.737 -172.614 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 668' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -87.76 105.18 17.21 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.99 -0.55 . . . . 65.540000000000006 111.226 177.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 669' ' ' LEU . . . . . 0.502 ' HG ' HG22 ' A' ' 671' ' ' VAL . 62.1 tp -95.09 108.13 20.21 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 116.011 -0.54 . . . . 74.230000000000004 110.658 177.151 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 670' ' ' THR . . . . . . . . . . . . . 88.2 m -86.34 111.31 20.36 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.858 0.361 . . . . 73.109999999999999 111.244 179.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 671' ' ' VAL . . . . . 0.502 HG22 ' HG ' ' A' ' 669' ' ' LEU . 94.6 t -136.31 130.93 18.39 Favored Pre-proline 0 N--CA 1.47 0.555 0 CA-C-N 116.301 -0.409 . . . . 73.319999999999993 110.983 -179.668 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 672' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -76.24 143.73 25.58 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 122.248 1.965 . . . . 72.510000000000005 111.995 175.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 673' ' ' VAL . . . . . . . . . . . . . 15.0 p -77.87 -28.06 15.34 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 CA-C-O 120.874 0.369 . . . . 72.340000000000003 111.403 -176.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 674' ' ' GLY . . . . . . . . . . . . . . . -156.16 136.61 5.1 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 120.934 -0.65 . . . . 63.32 113.584 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 675' ' ' ALA . . . . . . . . . . . . . . . -131.29 158.91 39.39 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 122.68 0.392 . . . . 71.340000000000003 110.528 177.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 676' ' ' THR . . . . . . . . . . . . . 13.6 m -135.0 129.04 33.53 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 112.018 0.377 . . . . 72.549999999999997 112.018 -177.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 677' ' ' ILE . . . . . . . . . . . . . 24.4 pt -138.97 176.43 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 122.465 0.306 . . . . 73.219999999999999 111.032 177.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 678' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -124.73 165.46 17.92 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.976 0.417 . . . . 75.319999999999993 111.511 178.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 679' ' ' VAL . . . . . . . . . . . . . 63.6 t -60.01 112.58 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 CA-C-N 116.211 -0.449 . . . . 71.409999999999997 110.668 175.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 118.3 -26.13 7.92 Favored Glycine 0 CA--C 1.528 0.89 0 CA-C-N 116.164 -0.471 . . . . 44.43 112.808 -175.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 681' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -69.11 163.91 23.71 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.248 0.547 . . . . 74.540000000000006 112.058 178.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 682' ' ' SER . . . . . . . . . . . . . 67.2 m -120.69 121.67 38.77 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.13 -0.487 . . . . 72.439999999999998 111.246 -178.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 683' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -118.42 126.89 53.02 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.334 -0.394 . . . . 73.340000000000003 110.809 -177.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 684' ' ' VAL . . . . . . . . . . . . . 60.8 t -115.4 100.67 53.88 Favored Pre-proline 0 N--CA 1.47 0.572 0 CA-C-O 120.789 0.328 . . . . 71.25 111.429 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -54.53 -47.14 28.43 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 122.802 2.334 . . . . 64.219999999999999 113.692 -177.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 686' ' ' MET . . . . . 0.479 ' HE2' ' HB ' ' A' ' 703' ' ' ILE . 88.2 mmm -78.24 0.56 24.7 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.898 0.703 . . . . 74.329999999999998 112.898 -175.398 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 687' ' ' ALA . . . . . . . . . . . . . . . -94.02 -47.79 6.53 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 120.943 0.401 . . . . 75.430000000000007 110.907 175.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 688' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -80.84 -18.22 48.15 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 112.373 0.508 . . . . 74.040000000000006 112.373 -178.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . 0.485 HG22 ' CZ ' ' A' ' 721' ' ' TYR . 89.3 t -97.54 142.43 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-O 120.888 0.375 . . . . 74.310000000000002 111.227 177.031 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 690' ' ' LEU . . . . . 0.572 HD23 HG12 ' A' ' 692' ' ' ILE . 7.9 tt -146.02 150.69 36.47 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.385 -0.371 . . . . 75.209999999999994 111.357 -173.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 691' ' ' ALA . . . . . . . . . . . . . . . -142.44 120.93 12.45 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.091 0.472 . . . . 64.450000000000003 111.885 176.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 692' ' ' ILE . . . . . 0.572 HG12 HD23 ' A' ' 690' ' ' LEU . 39.3 mm -127.46 144.15 38.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-N 116.166 -0.47 . . . . 72.340000000000003 110.761 178.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 693' ' ' ASP . . . . . 0.445 ' HB2' ' HB3' ' A' ' 667' ' ' PRO . 36.5 t70 -125.02 149.3 47.9 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 120.949 0.404 . . . . 71.019999999999996 111.582 -178.137 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -57.99 -60.09 4.25 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 116.003 -0.544 . . . . 72.200000000000003 112.428 -177.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -85.07 -53.58 5.19 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 112.096 0.406 . . . . 73.109999999999999 112.096 -176.283 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 696' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -70.23 -42.13 72.68 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.793 0.33 . . . . 73.0 111.863 -171.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . 108.56 -131.89 10.81 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 120.96 -0.638 . . . . 75.040000000000006 113.399 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -70.93 113.36 7.9 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 121.064 0.459 . . . . 74.409999999999997 111.523 -177.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 699' ' ' LEU . . . . . 0.523 HD13 ' HB3' ' A' ' 667' ' ' PRO . 89.6 mt -110.73 11.8 22.59 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.316 0.579 . . . . 72.219999999999999 110.397 172.532 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 21.1 m -59.89 -28.68 67.77 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.937 -0.574 . . . . 73.040000000000006 110.888 177.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 701' ' ' SER . . . . . . . . . . . . . 34.2 t -71.13 -24.42 62.27 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 116.244 -0.434 . . . . 73.140000000000001 111.456 175.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 702' ' ' LYS . . . . . 0.478 ' HB2' HG21 ' A' ' 723' ' ' VAL . 8.4 mmpt? -81.32 -13.75 58.05 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 111.87 0.322 . . . . 65.010000000000005 111.87 -178.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 703' ' ' ILE . . . . . 0.479 ' HB ' ' HE2' ' A' ' 686' ' ' MET . 69.8 mt -65.44 115.48 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 N-CA-C 112.076 0.398 . . . . 73.200000000000003 112.076 -177.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 704' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -98.42 124.76 43.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.112 0.482 . . . . 74.030000000000001 110.797 172.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 61.5 t -96.2 111.35 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-N 115.813 -0.63 . . . . 73.109999999999999 111.852 -177.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 706' ' ' ASP . . . . . 0.441 ' HB3' ' HB ' ' A' ' 720' ' ' THR . 38.6 t70 -99.23 134.6 41.85 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.455 -0.339 . . . . 74.409999999999997 110.748 177.211 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 108.42 171.77 21.39 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 121.148 -0.548 . . . . 65.239999999999995 112.678 -176.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 708' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -144.34 148.33 34.6 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 122.58 -0.365 . . . . 74.230000000000004 111.572 -176.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 709' ' ' VAL . . . . . 0.504 HG21 HD23 ' A' ' 719' ' ' LEU . 84.5 t -126.56 118.14 50.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 CA-C-O 120.806 0.336 . . . . 75.540000000000006 111.298 178.428 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 710' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -87.19 136.57 32.88 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 121.101 0.477 . . . . 70.420000000000002 111.361 177.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 711' ' ' THR . . . . . . . . . . . . . 73.9 p -98.63 -13.47 20.33 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.927 0.394 . . . . 73.519999999999996 111.437 177.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 712' ' ' THR . . . . . . . . . . . . . 71.7 p -93.31 -27.68 16.66 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 116.271 -0.422 . . . . 74.310000000000002 111.535 178.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 713' ' ' LYS . . . . . . . . . . . . . 50.2 tptt -116.53 132.43 56.68 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.563 -0.29 . . . . 75.439999999999998 110.526 178.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 714' ' ' ALA . . . . . . . . . . . . . . . -86.59 144.93 26.95 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 112.786 0.662 . . . . 72.030000000000001 112.786 -176.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 163.41 176.31 35.27 Favored Glycine 0 CA--C 1.522 0.482 0 CA-C-N 115.424 -0.807 . . . . 63.0 111.959 -179.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 716' ' ' THR . . . . . . . . . . . . . 95.7 m -94.68 122.21 37.05 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 117.222 0.511 . . . . 71.329999999999998 110.978 177.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 717' ' ' TYR . . . . . 0.46 ' HB2' HG22 ' A' ' 709' ' ' VAL . 57.6 m-85 -121.95 119.45 31.54 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.463 -0.335 . . . . 75.200000000000003 110.94 -178.213 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 718' ' ' VAL . . . . . . . . . . . . . 60.3 t -91.42 123.23 43.48 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-O 120.809 0.338 . . . . 72.420000000000002 111.182 179.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 719' ' ' LEU . . . . . 0.504 HD23 HG21 ' A' ' 709' ' ' VAL . 88.0 mt -104.82 126.15 51.6 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.418 -0.356 . . . . 75.430000000000007 111.241 177.587 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 720' ' ' THR . . . . . 0.441 ' HB ' ' HB3' ' A' ' 706' ' ' ASP . 95.1 m -101.08 127.48 47.59 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.988 0.423 . . . . 74.450000000000003 111.33 178.314 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 721' ' ' TYR . . . . . 0.495 ' HH ' ' NE2' ' A' ' 735' ' ' GLN . 57.7 m-85 -113.47 113.91 25.81 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.685 0.279 . . . . 74.5 110.76 179.466 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 72.0 m -113.85 125.34 53.95 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.762 0.315 . . . . 70.150000000000006 111.469 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 723' ' ' VAL . . . . . 0.478 HG21 ' HB2' ' A' ' 702' ' ' LYS . 8.3 p -129.42 133.98 64.44 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-O 120.995 0.426 . . . . 75.519999999999996 111.224 179.015 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 73.5 m -116.44 136.25 53.15 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 120.934 0.397 . . . . 73.400000000000006 111.887 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 725' ' ' ASP . . . . . 0.407 ' HB2' ' HD3' ' A' ' 667' ' ' PRO . 10.7 t0 -73.28 150.9 41.59 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 109.675 -0.491 . . . . 73.439999999999998 109.675 174.297 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 726' ' ' SER . . . . . . . . . . . . . 34.9 t -56.15 -33.24 65.02 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.348 -0.387 . . . . 74.140000000000001 111.753 -179.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 727' ' ' LYS . . . . . 0.471 ' HD3' ' N ' ' A' ' 727' ' ' LYS . 3.6 mppt? -91.42 6.85 43.84 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 112.712 0.634 . . . . 74.010000000000005 112.712 -178.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 728' ' ' GLY . . . . . . . . . . . . . . . 101.69 35.2 4.13 Favored Glycine 0 CA--C 1.534 1.279 0 N-CA-C 116.122 1.209 . . . . 73.329999999999998 116.122 169.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 40.7 m80 -109.3 110.68 21.92 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 118.178 0.989 . . . . 73.400000000000006 111.49 172.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 730' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -96.89 128.5 43.91 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.277 0.56 . . . . 75.109999999999999 112.121 -177.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 57.6 t -126.4 129.48 71.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 CA-C-N 115.97 -0.559 . . . . 71.310000000000002 110.109 176.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 7.5 t -137.12 128.86 28.84 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.167 0.508 . . . . 65.349999999999994 112.296 -177.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -135.56 157.65 46.34 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 122.804 0.442 . . . . 73.230000000000004 110.863 -178.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 734' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -121.3 158.69 27.62 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.994 0.739 . . . . 73.200000000000003 112.994 -175.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 735' ' ' GLN . . . . . 0.495 ' NE2' ' HH ' ' A' ' 721' ' ' TYR . 6.7 tt0 -130.57 128.51 41.25 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.839 -0.619 . . . . 72.420000000000002 111.161 179.645 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 736' ' ' THR . . . . . . . . . . . . . 86.6 m -87.93 103.89 16.1 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 120.751 0.31 . . . . 64.230000000000004 110.991 175.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 47.8 t -96.73 108.39 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-O 120.924 0.392 . . . . 73.530000000000001 111.188 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 738' ' ' THR . . . . . . . . . . . . . 27.3 m -94.84 108.96 20.99 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.79 0.328 . . . . 75.209999999999994 111.342 -179.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 739' ' ' VAL . . . . . . . . . . . . . 43.0 t -94.22 125.34 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-O 120.729 0.3 . . . . 72.010000000000005 110.793 176.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 740' ' ' LYS . . . . . 0.637 ' HB3' ' HZ3' ' A' ' 740' ' ' LYS . 7.8 mtpm? -115.38 146.55 41.47 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.048 0.451 . . . . 73.310000000000002 111.979 -175.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 741' ' ' VAL . . . . . . . . . . . . . 24.3 t -85.29 144.75 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 CA-C-O 120.88 0.371 . . . . 73.200000000000003 111.914 -179.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 742' ' ' ARG . . . . . . . . . . . . . 21.9 mmm180 -94.08 137.33 33.4 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 109.731 -0.47 . . . . 74.420000000000002 109.731 168.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 743' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -77.83 36.0 0.21 Allowed 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 121.042 0.448 . . . . 73.140000000000001 111.891 -176.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 744' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -125.5 97.8 5.33 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 116.252 -0.431 . . . . 71.0 110.714 -179.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 15.8 m -72.04 75.56 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 CA-C-O 121.832 0.825 . . . . 73.140000000000001 111.323 179.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 64.7 pttt -143.29 131.66 22.15 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.739 -0.664 . . . . 75.549999999999997 111.95 -174.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 747' ' ' ASN . . . . . 0.495 ' N ' HD21 ' A' ' 747' ' ' ASN . 0.9 OUTLIER -113.44 151.78 30.95 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 109.505 -0.554 . . . . 75.510000000000005 109.505 168.294 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -77.86 35.42 0.2 Allowed 'General case' 0 CA--C 1.545 0.772 0 CA-C-O 121.175 0.512 . . . . 72.319999999999993 111.514 177.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 749' ' ' LYS . . . . . 0.418 ' H ' ' C ' ' A' ' 747' ' ' ASN . 49.9 mtpt 65.93 149.7 0.12 Allowed Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 123.867 0.867 . . . . 74.219999999999999 112.348 -179.013 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 750' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -57.83 160.64 14.52 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 122.489 2.126 . . . . 74.409999999999997 112.791 179.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 751' ' ' ILE . . . . . . . . . . . . . 60.0 mt -64.18 93.37 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-O 121.016 0.436 . . . . 72.540000000000006 110.994 -179.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 752' ' ' LEU . . . . . . . . . . . . . 87.4 mt -75.69 139.47 41.95 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.171 -0.468 . . . . 71.5 111.292 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 753' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 . . . . . 0 C--O 1.241 0.615 0 CA-C-O 121.118 0.485 . . . . 65.140000000000001 110.687 -177.542 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 762' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 657' ' ' MET . . . . . 0.52 ' N ' ' SD ' ' A' ' 657' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.473 0 CA-C-O 120.623 0.249 . . . . 75.099999999999994 111.336 . . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 658' ' ' GLY . . . . . . . . . . . . . . . 82.97 172.05 48.11 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 121.332 -0.461 . . . . 73.409999999999997 113.197 178.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 659' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -116.62 107.86 15.23 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.937 0.398 . . . . 52.43 111.17 177.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 660' ' ' GLY . . . . . . . . . . . . . . . -74.59 110.48 3.09 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 120.895 -0.669 . . . . 44.439999999999998 112.598 175.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -60.6 116.88 4.69 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.025 0.441 . . . . 75.040000000000006 111.57 -179.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 662' ' ' THR . . . . . . . . . . . . . 80.7 p -90.33 178.9 6.02 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 115.993 -0.549 . . . . 73.129999999999995 110.811 175.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 663' ' ' SER . . . . . . . . . . . . . 47.0 m -137.13 134.57 36.53 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 122.28 -0.263 . . . . 72.340000000000003 111.483 -178.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 664' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -98.19 112.68 24.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.154 0.502 . . . . 65.230000000000004 110.094 169.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 665' ' ' LEU . . . . . 0.507 HD11 ' HB2' ' A' ' 694' ' ' LYS . 86.6 mt -91.98 137.87 32.01 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.937 -0.574 . . . . 71.140000000000001 111.038 179.191 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 666' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -80.68 142.2 52.83 Favored Pre-proline 0 CA--C 1.541 0.612 0 CA-C-N 116.223 -0.444 . . . . 73.109999999999999 110.406 173.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 667' ' ' PRO . . . . . 0.527 ' HB3' HD11 ' A' ' 699' ' ' LEU . 64.4 Cg_endo -70.86 146.2 52.75 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 122.231 1.954 . . . . 72.430000000000007 113.734 -173.002 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 668' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -83.3 103.86 13.01 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.975 -0.557 . . . . 73.140000000000001 110.576 173.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 669' ' ' LEU . . . . . . . . . . . . . 52.3 tp -89.79 132.65 35.12 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.153 -0.476 . . . . 72.319999999999993 109.95 176.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 670' ' ' THR . . . . . . . . . . . . . 91.1 m -121.61 111.31 17.07 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.025 0.441 . . . . 74.140000000000001 111.124 -179.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 671' ' ' VAL . . . . . . . . . . . . . 88.8 t -128.77 134.55 26.42 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-N 115.82 -0.627 . . . . 64.099999999999994 110.628 -179.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 672' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.57 127.82 17.94 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 121.964 1.776 . . . . 63.439999999999998 111.903 177.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 673' ' ' VAL . . . . . 0.434 ' O ' HG22 ' A' ' 736' ' ' THR . 12.5 p -64.4 -23.78 34.17 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 N-CA-C 112.414 0.524 . . . . 74.450000000000003 112.414 -174.179 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 674' ' ' GLY . . . . . . . . . . . . . . . -169.02 154.27 23.73 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 120.61 -0.805 . . . . 63.140000000000001 113.591 179.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 675' ' ' ALA . . . . . . . . . . . . . . . -150.38 156.29 41.22 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 122.502 0.321 . . . . 72.340000000000003 110.859 177.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 676' ' ' THR . . . . . . . . . . . . . 70.4 m -134.42 127.43 31.55 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.784 0.326 . . . . 72.340000000000003 111.269 -179.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 677' ' ' ILE . . . . . . . . . . . . . 28.4 pt -130.33 176.62 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-O 120.824 0.345 . . . . 61.549999999999997 111.124 179.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 678' ' ' HIS . . . . . 0.496 ' O ' ' HB2' ' A' ' 681' ' ' ASP . 69.9 m80 -116.67 166.67 11.85 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 121.581 0.705 . . . . 75.5 112.311 -179.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 679' ' ' VAL . . . . . 0.432 HG11 ' HA ' ' A' ' 712' ' ' THR . 82.4 t -67.16 112.18 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-N 115.972 -0.558 . . . . 74.129999999999995 110.494 174.334 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 109.24 -2.48 31.22 Favored Glycine 0 CA--C 1.529 0.957 0 CA-C-N 115.891 -0.595 . . . . 73.329999999999998 112.41 -172.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 681' ' ' ASP . . . . . 0.496 ' HB2' ' O ' ' A' ' 678' ' ' HIS . 1.1 t70 -75.62 -168.43 0.85 Allowed 'General case' 0 CA--C 1.547 0.835 0 CA-C-O 120.954 0.407 . . . . 71.319999999999993 110.955 178.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 682' ' ' SER . . . . . . . . . . . . . 73.7 m -150.18 136.74 19.05 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 122.159 -0.338 . . . . 75.439999999999998 110.553 176.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 683' ' ' PHE . . . . . . . . . . . . . 36.0 t80 -138.66 127.38 23.51 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 120.614 0.245 . . . . 71.340000000000003 111.652 -174.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 684' ' ' VAL . . . . . . . . . . . . . 63.8 t -111.73 101.45 51.27 Favored Pre-proline 0 N--CA 1.476 0.85 0 CA-C-O 120.726 0.298 . . . . 71.219999999999999 111.771 179.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -52.82 -42.81 60.91 Favored 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 122.975 2.45 . . . . 70.209999999999994 113.772 179.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 686' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -78.13 3.84 14.04 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 112.79 0.663 . . . . 74.010000000000005 112.79 -176.083 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 687' ' ' ALA . . . . . . . . . . . . . . . -109.35 -14.77 14.39 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 122.2 -0.313 . . . . 74.239999999999995 111.82 176.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 688' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -97.62 -6.5 33.17 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 112.722 0.638 . . . . 74.140000000000001 112.722 -175.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 49.7 t -121.67 154.83 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 N-CA-C 112.025 0.38 . . . . 72.25 112.025 -174.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 690' ' ' LEU . . . . . 0.548 HD23 ' N ' ' A' ' 691' ' ' ALA . 6.4 tt -150.57 143.82 24.9 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 116.509 -0.314 . . . . 71.319999999999993 110.827 -178.307 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 691' ' ' ALA . . . . . 0.548 ' N ' HD23 ' A' ' 690' ' ' LEU . . . -144.08 132.05 21.57 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 112.416 0.525 . . . . 71.430000000000007 112.416 -179.132 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 692' ' ' ILE . . . . . 0.455 HD11 ' HA ' ' A' ' 698' ' ' ASP . 38.6 mm -135.77 136.89 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 N-CA-C 112.116 0.413 . . . . 75.329999999999998 112.116 -179.289 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -115.68 141.82 47.56 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 109.005 -0.739 . . . . 73.140000000000001 109.005 167.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 694' ' ' LYS . . . . . 0.507 ' HB2' HD11 ' A' ' 665' ' ' LEU . 54.5 mttp -71.33 -28.97 64.46 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.289 0.478 . . . . 74.400000000000006 112.289 -177.408 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -83.38 -44.75 14.48 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-O 120.916 0.389 . . . . 75.329999999999998 111.974 -179.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 696' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -92.87 -30.3 15.5 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 120.851 0.358 . . . . 65.299999999999997 111.325 -173.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . 105.86 -135.17 12.48 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 121.325 -0.464 . . . . 73.209999999999994 112.769 179.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 698' ' ' ASP . . . . . 0.455 ' HA ' HD11 ' A' ' 692' ' ' ILE . 12.1 t70 -71.83 125.09 26.29 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 122.534 -0.392 . . . . 71.299999999999997 111.497 179.05 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 699' ' ' LEU . . . . . 0.565 HD21 ' HD2' ' A' ' 702' ' ' LYS . 45.7 mt -119.83 6.65 10.92 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.493 -0.321 . . . . 72.540000000000006 111.584 177.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 49.6 m -58.6 -40.13 82.36 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.201 0.524 . . . . 73.340000000000003 111.464 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 701' ' ' SER . . . . . . . . . . . . . 37.2 t -66.03 -13.78 60.54 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 121.072 0.463 . . . . 72.25 111.817 176.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 702' ' ' LYS . . . . . 0.565 ' HD2' HD21 ' A' ' 699' ' ' LEU . 97.4 mttt -99.11 6.62 46.43 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.217 0.451 . . . . 74.109999999999999 112.217 -178.643 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 73.9 mt -80.02 117.45 25.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-O 121.044 0.45 . . . . 72.140000000000001 111.541 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 704' ' ' LYS . . . . . 0.406 ' HE3' ' HB2' ' A' ' 704' ' ' LYS . 35.9 ttmt -91.34 136.64 32.96 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.212 -0.449 . . . . 72.209999999999994 111.039 176.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 46.6 t -109.27 140.55 27.6 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-O 121.129 0.49 . . . . 75.409999999999997 111.889 -177.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 706' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -132.36 126.02 32.26 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 116.273 -0.421 . . . . 64.519999999999996 110.253 174.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 102.97 152.94 24.1 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 121.141 -0.552 . . . . 53.25 112.404 -173.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 708' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -153.59 143.62 22.1 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 122.19 -0.594 . . . . 74.150000000000006 111.566 -176.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 709' ' ' VAL . . . . . 0.519 HG23 ' HB2' ' A' ' 717' ' ' TYR . 71.7 t -99.52 134.35 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-N 116.067 -0.515 . . . . 75.409999999999997 111.842 -177.231 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 710' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -100.54 150.78 22.32 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 121.027 0.442 . . . . 71.099999999999994 110.431 170.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 711' ' ' THR . . . . . . . . . . . . . 80.7 p -107.39 28.2 8.34 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.444 -0.344 . . . . 73.349999999999994 111.494 -178.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 712' ' ' THR . . . . . 0.432 ' HA ' HG11 ' A' ' 679' ' ' VAL . 7.5 t -115.9 -28.48 6.66 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 112.385 0.513 . . . . 74.230000000000004 112.385 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 713' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -115.67 122.37 45.35 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 120.733 0.301 . . . . 73.25 111.095 -176.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 714' ' ' ALA . . . . . 0.454 ' HB1' HG23 ' A' ' 741' ' ' VAL . . . -70.43 101.96 2.08 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 121.199 0.523 . . . . 71.239999999999995 111.718 -178.268 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . -164.18 168.45 38.61 Favored Glycine 0 CA--C 1.52 0.355 0 CA-C-N 115.99 -0.55 . . . . 71.349999999999994 112.843 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 716' ' ' THR . . . . . . . . . . . . . 73.2 m -95.52 122.7 38.54 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.05 0.452 . . . . 74.150000000000006 111.612 178.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 717' ' ' TYR . . . . . 0.519 ' HB2' HG23 ' A' ' 709' ' ' VAL . 57.6 m-85 -116.86 124.45 49.54 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 116.106 -0.497 . . . . 70.310000000000002 110.418 179.158 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 718' ' ' VAL . . . . . . . . . . . . . 45.6 t -96.28 110.88 25.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-O 121.09 0.471 . . . . 74.120000000000005 111.613 -178.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 719' ' ' LEU . . . . . 0.498 HD23 HG22 ' A' ' 709' ' ' VAL . 58.9 mt -88.41 130.5 35.16 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.131 -0.486 . . . . 75.450000000000003 111.227 -178.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 84.5 m -99.72 132.29 45.16 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.903 0.382 . . . . 75.150000000000006 111.496 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 721' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -122.01 134.27 54.8 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.838 0.351 . . . . 73.439999999999998 110.937 177.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 24.7 m -135.82 130.27 33.7 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 111.625 0.231 . . . . 73.5 111.625 -176.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 8.7 p -125.0 132.47 71.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-O 121.031 0.443 . . . . 73.200000000000003 111.286 178.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 22.7 m -108.4 120.5 42.57 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.945 0.403 . . . . 63.329999999999998 111.991 -176.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 725' ' ' ASP . . . . . 0.476 ' HB2' ' HD3' ' A' ' 667' ' ' PRO . 3.6 t70 -73.19 149.71 42.69 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 116.197 -0.456 . . . . 75.349999999999994 110.734 175.216 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 726' ' ' SER . . . . . . . . . . . . . 56.8 p -65.43 -26.3 67.91 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 112.287 0.477 . . . . 73.120000000000005 112.287 -174.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 727' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -93.76 -3.7 51.68 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 112.715 0.635 . . . . 72.129999999999995 112.715 178.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 728' ' ' GLY . . . . . . . . . . . . . . . 111.72 19.88 7.16 Favored Glycine 0 CA--C 1.532 1.096 0 N-CA-C 115.529 0.972 . . . . 72.349999999999994 115.529 172.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 27.7 m80 -97.13 104.96 17.02 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 118.241 1.02 . . . . 74.010000000000005 111.025 172.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 730' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -112.19 114.63 27.54 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 120.933 0.397 . . . . 73.400000000000006 111.665 -177.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 32.8 m -109.83 158.73 9.82 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-O 121.084 0.469 . . . . 71.439999999999998 111.582 179.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 5.6 t -135.56 145.39 46.92 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 121.204 0.526 . . . . 72.439999999999998 112.163 -176.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -148.59 161.12 42.34 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.997 -0.547 . . . . 64.239999999999995 110.791 176.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 734' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -133.52 157.49 45.51 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 112.509 0.559 . . . . 74.219999999999999 112.509 -176.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 735' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -130.61 125.98 35.48 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 115.623 -0.717 . . . . 72.099999999999994 110.794 178.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 736' ' ' THR . . . . . 0.434 HG22 ' O ' ' A' ' 673' ' ' VAL . 8.3 t -93.36 110.27 21.82 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.254 0.55 . . . . 74.040000000000006 111.588 178.298 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 46.8 t -106.69 115.69 48.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-N 116.474 -0.33 . . . . 74.109999999999999 111.339 -179.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 738' ' ' THR . . . . . . . . . . . . . 88.8 m -99.62 124.72 45.1 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 120.778 0.323 . . . . 75.420000000000002 111.503 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 739' ' ' VAL . . . . . . . . . . . . . 49.7 t -96.76 134.25 35.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-O 120.916 0.389 . . . . 74.129999999999995 111.429 178.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 740' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -121.55 144.96 48.43 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.4 -0.363 . . . . 62.109999999999999 111.188 178.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 741' ' ' VAL . . . . . 0.454 HG23 ' HB1' ' A' ' 714' ' ' ALA . 25.6 t -80.07 143.17 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 O-C-N 121.639 -0.663 . . . . 64.430000000000007 111.638 -178.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 742' ' ' ARG . . . . . . . . . . . . . 86.1 mtm180 -71.18 127.81 33.81 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 116.32 -0.4 . . . . 75.200000000000003 110.851 175.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 743' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -52.66 139.39 26.24 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 121.497 0.665 . . . . 73.299999999999997 112.293 -177.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 744' ' ' GLU . . . . . 0.402 ' CD ' ' H ' ' A' ' 744' ' ' GLU . 0.6 OUTLIER -88.53 137.02 32.69 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.664 -0.698 . . . . 72.109999999999999 112.404 -173.347 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 35.9 m -129.11 168.05 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-N 116.164 -0.471 . . . . 73.439999999999998 110.716 176.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -65.08 124.89 23.3 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 122.112 -0.367 . . . . 72.329999999999998 110.214 175.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 747' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -65.65 107.31 1.71 Allowed 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 120.996 0.427 . . . . 75.540000000000006 110.929 -175.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -108.73 130.17 55.36 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.123 -0.489 . . . . 73.299999999999997 111.129 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 749' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -110.75 99.01 40.24 Favored Pre-proline 0 CA--C 1.541 0.625 0 CA-C-O 120.858 0.361 . . . . 74.340000000000003 110.999 179.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 750' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -78.24 -164.83 0.29 Allowed 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 122.769 2.313 . . . . 74.409999999999997 112.536 179.07 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 751' ' ' ILE . . . . . . . . . . . . . 52.8 mt -97.37 89.32 1.99 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-O 120.955 0.407 . . . . 63.439999999999998 110.687 177.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 752' ' ' LEU . . . . . . . . . . . . . 82.6 mt -66.64 99.86 0.63 Allowed 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.072 0.463 . . . . 74.150000000000006 110.518 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 753' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 . . . . . 0 C--O 1.238 0.449 0 CA-C-O 121.282 0.563 . . . . 73.319999999999993 111.999 -173.52 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 762' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 657' ' ' MET . . . . . . . . . . . . . 84.1 mtp . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 120.583 0.23 . . . . 74.129999999999995 111.261 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 658' ' ' GLY . . . . . . . . . . . . . . . -133.07 -75.55 0.1 Allowed Glycine 0 CA--C 1.527 0.839 0 C-N-CA 121.04 -0.6 . . . . 71.030000000000001 112.926 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 659' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -151.91 -65.41 0.17 Allowed 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 111.971 0.36 . . . . 52.240000000000002 111.971 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 660' ' ' GLY . . . . . . . . . . . . . . . 73.35 174.24 27.73 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 121.217 -0.516 . . . . 43.130000000000003 113.255 -178.077 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -135.22 -71.01 0.48 Allowed 'General case' 0 N--CA 1.469 0.488 0 O-C-N 122.503 -0.41 . . . . 62.450000000000003 111.058 178.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 662' ' ' THR . . . . . . . . . . . . . 99.8 m 61.21 88.51 0.08 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.899 -0.591 . . . . 64.420000000000002 111.604 -175.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 663' ' ' SER . . . . . . . . . . . . . 74.0 m -92.61 120.49 33.09 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.172 -0.467 . . . . 72.519999999999996 110.312 173.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 664' ' ' ASP . . . . . 0.472 ' CG ' ' HB2' ' A' ' 727' ' ' LYS . 45.0 t0 -73.45 117.5 15.28 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 121.132 0.491 . . . . 74.019999999999996 111.676 -176.115 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 665' ' ' LEU . . . . . . . . . . . . . 85.2 mt -81.57 116.86 21.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.007 -0.542 . . . . 74.219999999999999 109.78 175.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 666' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -77.37 137.74 64.02 Favored Pre-proline 0 CA--C 1.541 0.616 0 CA-C-O 120.898 0.38 . . . . 75.209999999999994 111.433 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 667' ' ' PRO . . . . . 0.505 ' HB3' HD13 ' A' ' 699' ' ' LEU . 65.8 Cg_endo -71.46 140.46 36.56 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 122.596 2.197 . . . . 71.219999999999999 113.182 -174.085 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 668' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -83.58 106.9 15.68 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.302 -0.408 . . . . 74.340000000000003 110.631 176.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 669' ' ' LEU . . . . . 0.446 ' HG ' HG23 ' A' ' 671' ' ' VAL . 58.7 tp -90.04 110.14 21.15 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 116.275 -0.421 . . . . 74.349999999999994 110.523 178.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 670' ' ' THR . . . . . . . . . . . . . 67.6 m -86.38 109.4 18.99 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.854 0.359 . . . . 73.209999999999994 111.126 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 671' ' ' VAL . . . . . 0.446 HG23 ' HG ' ' A' ' 669' ' ' LEU . 91.0 t -141.78 120.83 7.95 Favored Pre-proline 0 N--CA 1.473 0.684 0 CA-C-N 116.257 -0.429 . . . . 75.439999999999998 110.774 179.178 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 672' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -73.8 150.1 43.86 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 122.366 2.044 . . . . 74.409999999999997 112.529 -179.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 673' ' ' VAL . . . . . . . . . . . . . 7.7 p -64.36 -38.2 81.94 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 N-CA-C 112.16 0.43 . . . . 74.310000000000002 112.16 -178.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 674' ' ' GLY . . . . . . . . . . . . . . . -156.46 157.67 28.1 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 120.805 -0.712 . . . . 72.540000000000006 114.031 -177.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 675' ' ' ALA . . . . . 0.434 ' O ' ' HA ' ' A' ' 737' ' ' VAL . . . -151.88 135.09 15.89 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 122.831 0.453 . . . . 74.150000000000006 110.668 178.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 676' ' ' THR . . . . . . . . . . . . . 62.5 m -115.23 123.63 49.32 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 121.993 -0.442 . . . . 74.129999999999995 112.025 -178.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 677' ' ' ILE . . . . . . . . . . . . . 17.5 pt -127.36 176.55 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 CA-C-N 116.254 -0.43 . . . . 71.109999999999999 110.865 177.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 678' ' ' HIS . . . . . . . . . . . . . 63.1 m80 -117.05 157.74 25.34 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.429 0.633 . . . . 75.439999999999998 112.182 -178.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 679' ' ' VAL . . . . . . . . . . . . . 92.0 t -54.63 113.02 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-N 115.513 -0.767 . . . . 52.299999999999997 111.401 175.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 116.3 -18.79 13.58 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 121.162 -0.542 . . . . 73.209999999999994 113.705 -179.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 681' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -74.43 -179.77 4.18 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 121.495 0.664 . . . . 64.030000000000001 112.502 -179.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 682' ' ' SER . . . . . . . . . . . . . 57.5 m -122.67 151.27 41.68 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.754 -0.657 . . . . 72.319999999999993 111.401 -178.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 683' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -158.88 116.04 2.77 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 116.546 -0.297 . . . . 73.329999999999998 110.801 -178.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 684' ' ' VAL . . . . . . . . . . . . . 41.7 t -113.57 98.3 46.52 Favored Pre-proline 0 CA--C 1.54 0.564 0 CA-C-O 120.949 0.404 . . . . 62.109999999999999 111.333 -178.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -51.52 -43.68 48.7 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 122.873 2.382 . . . . 72.140000000000001 113.615 -178.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 686' ' ' MET . . . . . 0.529 ' HE2' ' HB ' ' A' ' 703' ' ' ILE . 0.4 OUTLIER -78.25 -1.3 32.3 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 112.758 0.651 . . . . 75.400000000000006 112.758 -177.13 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 687' ' ' ALA . . . . . . . . . . . . . . . -112.32 -8.35 13.94 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.788 0.328 . . . . 74.439999999999998 111.634 176.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 688' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -121.35 -22.54 5.96 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 112.119 0.414 . . . . 75.239999999999995 112.119 -177.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 96.4 t -95.82 148.23 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-O 120.626 0.251 . . . . 74.420000000000002 110.681 175.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 690' ' ' LEU . . . . . 0.613 HD22 HG12 ' A' ' 692' ' ' ILE . 9.6 tt -144.81 152.1 39.8 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 112.037 0.384 . . . . 72.329999999999998 112.037 -171.441 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 691' ' ' ALA . . . . . . . . . . . . . . . -150.33 123.04 8.61 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 120.813 0.339 . . . . 74.310000000000002 111.371 176.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 692' ' ' ILE . . . . . 0.613 HG12 HD22 ' A' ' 690' ' ' LEU . 46.5 mm -123.62 134.65 65.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 N-CA-C 112.467 0.543 . . . . 60.130000000000003 112.467 -178.299 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 693' ' ' ASP . . . . . 0.472 ' HB2' ' HB3' ' A' ' 667' ' ' PRO . 67.7 t0 -117.43 128.34 54.91 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 109.216 -0.661 . . . . 72.040000000000006 109.216 170.588 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -65.63 -26.7 67.94 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 112.96 0.726 . . . . 73.120000000000005 112.96 -173.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -82.8 -40.65 20.12 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 120.824 0.345 . . . . 72.200000000000003 111.526 -177.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 696' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -95.65 -49.31 5.43 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 121.253 0.549 . . . . 55.119999999999997 111.702 -176.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . 129.01 -131.51 6.82 Favored Glycine 0 CA--C 1.528 0.855 0 CA-C-N 116.34 -0.391 . . . . 63.299999999999997 112.654 -177.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 698' ' ' ASP . . . . . 0.444 ' HA ' HD11 ' A' ' 692' ' ' ILE . 20.7 t70 -75.5 109.15 8.82 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 121.055 0.455 . . . . 75.239999999999995 111.464 178.422 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 699' ' ' LEU . . . . . 0.505 HD13 ' HB3' ' A' ' 667' ' ' PRO . 23.3 mt -99.42 4.41 46.2 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 120.839 0.352 . . . . 74.219999999999999 110.787 173.044 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 25.1 m -55.39 -40.06 70.92 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.686 0.755 . . . . 74.099999999999994 109.972 171.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 701' ' ' SER . . . . . . . . . . . . . 21.6 m -66.91 -7.76 24.37 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 115.218 -0.901 . . . . 73.209999999999994 112.146 177.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 702' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -104.05 -7.73 20.06 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 111.884 0.328 . . . . 72.129999999999995 111.884 -179.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 703' ' ' ILE . . . . . 0.529 ' HB ' ' HE2' ' A' ' 686' ' ' MET . 63.2 mt -70.66 140.8 17.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-O 120.835 0.35 . . . . 74.0 111.707 -178.233 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 704' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -110.51 133.42 53.31 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 110.247 -0.279 . . . . 75.299999999999997 110.247 170.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 50.5 t -96.7 107.23 19.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-O 120.956 0.407 . . . . 63.420000000000002 110.831 178.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 706' ' ' ASP . . . . . 0.502 ' HB3' ' HB ' ' A' ' 720' ' ' THR . 13.2 t70 -100.1 127.52 46.33 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 116.283 -0.417 . . . . 74.349999999999994 110.392 179.44 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 123.11 -175.86 16.6 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 121.173 -0.537 . . . . 55.119999999999997 113.132 -178.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 708' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -155.63 141.33 17.97 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 120.783 0.325 . . . . 73.430000000000007 111.237 -178.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 709' ' ' VAL . . . . . 0.447 HG22 ' HB2' ' A' ' 717' ' ' TYR . 93.9 t -124.87 111.53 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-O 120.887 0.375 . . . . 63.32 111.184 178.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 710' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -69.19 134.86 49.8 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 121.054 0.454 . . . . 63.549999999999997 110.669 176.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 711' ' ' THR . . . . . . . . . . . . . 35.9 p -113.54 -0.76 14.29 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.883 0.373 . . . . 74.310000000000002 110.98 178.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 712' ' ' THR . . . . . . . . . . . . . 81.9 p -98.15 -17.81 18.83 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.15 -0.477 . . . . 70.150000000000006 111.505 178.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 713' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -138.52 139.36 38.7 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 120.864 0.364 . . . . 64.209999999999994 111.271 -178.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 714' ' ' ALA . . . . . . . . . . . . . . . -70.18 144.4 51.95 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 112.662 0.616 . . . . 73.140000000000001 112.662 -176.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 159.25 161.54 11.28 Favored Glycine 0 CA--C 1.525 0.683 0 CA-C-N 115.689 -0.687 . . . . 75.409999999999997 112.262 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 716' ' ' THR . . . . . . . . . . . . . 97.4 m -96.88 122.53 39.95 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 117.312 0.556 . . . . 74.5 111.419 178.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 717' ' ' TYR . . . . . 0.447 ' HB2' HG22 ' A' ' 709' ' ' VAL . 22.6 m-85 -123.8 150.2 44.77 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 116.193 -0.458 . . . . 72.450000000000003 110.304 -178.714 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 718' ' ' VAL . . . . . . . . . . . . . 58.4 t -115.57 133.94 60.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 CA-C-O 121.002 0.43 . . . . 72.239999999999995 111.918 -176.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 719' ' ' LEU . . . . . . . . . . . . . 88.6 mt -112.09 125.95 54.65 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.304 -0.407 . . . . 73.230000000000004 111.416 178.043 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 720' ' ' THR . . . . . 0.502 ' HB ' ' HB3' ' A' ' 706' ' ' ASP . 68.8 m -99.52 129.12 45.66 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.156 -0.474 . . . . 75.129999999999995 111.253 178.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 721' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -115.7 114.25 24.59 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.751 0.31 . . . . 74.530000000000001 111.002 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 45.7 m -117.22 131.92 56.74 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.57 -0.286 . . . . 75.230000000000004 111.517 -178.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 723' ' ' VAL . . . . . 0.452 ' HB ' HG12 ' A' ' 703' ' ' ILE . 7.1 p -137.16 137.25 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-O 121.066 0.46 . . . . 74.120000000000005 111.424 178.213 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 724' ' ' THR . . . . . 0.444 ' HA ' ' HA ' ' A' ' 730' ' ' GLU . 33.5 m -107.27 135.3 49.01 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.248 0.547 . . . . 72.329999999999998 112.059 -178.254 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 725' ' ' ASP . . . . . 0.493 ' HB3' ' H ' ' A' ' 729' ' ' HIS . 11.0 t0 -73.61 154.09 39.9 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 115.853 -0.612 . . . . 70.340000000000003 110.617 177.553 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 726' ' ' SER . . . . . . . . . . . . . 74.6 m -65.78 -21.98 66.54 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 116.626 -0.261 . . . . 63.140000000000001 111.572 177.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 727' ' ' LYS . . . . . 0.472 ' HB2' ' CG ' ' A' ' 664' ' ' ASP . 73.8 mmtt -106.81 4.67 27.77 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 112.495 0.554 . . . . 75.120000000000005 112.495 178.725 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 728' ' ' GLY . . . . . . . . . . . . . . . 114.1 -5.67 23.65 Favored Glycine 0 CA--C 1.54 1.624 0 N-CA-C 116.739 1.455 . . . . 70.439999999999998 116.739 171.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 729' ' ' HIS . . . . . 0.493 ' H ' ' HB3' ' A' ' 725' ' ' ASP . 15.1 m80 -73.16 98.17 2.55 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 119.414 1.607 . . . . 75.409999999999997 111.389 174.661 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 730' ' ' GLU . . . . . 0.444 ' HA ' ' HA ' ' A' ' 724' ' ' THR . 34.7 tt0 -98.63 106.96 19.3 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 122.188 -0.32 . . . . 73.030000000000001 111.095 179.325 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 26.9 m -111.71 152.23 13.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-O 120.942 0.401 . . . . 75.409999999999997 111.582 -176.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 7.2 t -146.57 151.87 38.02 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.065 0.459 . . . . 75.040000000000006 112.124 -179.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -148.35 154.29 39.75 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 115.996 -0.547 . . . . 73.109999999999999 110.722 178.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 734' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -114.95 155.3 27.17 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 112.389 0.515 . . . . 75.200000000000003 112.389 -176.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 735' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -131.36 125.98 34.07 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.081 -0.508 . . . . 75.329999999999998 110.977 178.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 736' ' ' THR . . . . . . . . . . . . . 87.7 m -90.73 104.11 16.73 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 116.475 -0.329 . . . . 63.509999999999998 111.287 178.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 737' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 675' ' ' ALA . 48.3 t -99.99 110.2 26.56 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-O 120.872 0.368 . . . . 74.549999999999997 111.756 -179.512 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 738' ' ' THR . . . . . . . . . . . . . 51.8 m -95.57 123.74 39.27 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 121.036 0.446 . . . . 64.319999999999993 111.627 178.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 739' ' ' VAL . . . . . . . . . . . . . 48.1 t -104.26 128.61 57.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 CA-C-O 120.835 0.35 . . . . 75.510000000000005 111.404 178.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 740' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -116.56 160.78 20.15 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 120.858 0.361 . . . . 71.230000000000004 111.553 177.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 741' ' ' VAL . . . . . . . . . . . . . 43.6 t -84.62 156.02 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 CA-C-O 120.817 0.341 . . . . 75.450000000000003 111.582 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 742' ' ' ARG . . . . . . . . . . . . . 12.9 ptp180 -95.6 136.0 36.55 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 120.913 0.387 . . . . 75.219999999999999 110.661 175.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 743' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -94.47 152.93 18.19 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 121.144 0.497 . . . . 75.200000000000003 111.674 -178.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 744' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -108.7 173.52 6.28 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 112.557 0.577 . . . . 75.120000000000005 112.557 -173.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 33.7 m -125.53 160.05 32.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-N 115.749 -0.659 . . . . 75.25 110.916 176.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 49.4 mttp -133.27 143.16 48.9 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.075 0.464 . . . . 72.230000000000004 111.756 177.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 747' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -96.69 -6.51 36.3 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 121.349 0.595 . . . . 62.119999999999997 111.04 -178.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -77.65 62.83 2.63 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 116.037 -0.529 . . . . 71.530000000000001 111.237 -178.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 749' ' ' LYS . . . . . 0.412 ' HA ' ' HD3' ' A' ' 750' ' ' PRO . 95.6 mttt 65.38 143.2 0.08 OUTLIER Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 123.049 0.539 . . . . 72.430000000000007 111.568 -175.323 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 750' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 749' ' ' LYS . 31.4 Cg_exo -59.67 92.04 0.08 OUTLIER 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 122.58 2.186 . . . . 74.049999999999997 113.992 -175.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 751' ' ' ILE . . . . . . . . . . . . . 60.7 mt -79.36 82.39 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 CA-C-O 121.602 0.715 . . . . 72.019999999999996 109.789 171.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 752' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -87.07 25.91 1.26 Allowed 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 113.128 0.788 . . . . 64.519999999999996 113.128 -170.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 753' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 . . . . . 0 N--CA 1.47 0.565 0 CA-C-O 121.284 0.564 . . . . 74.109999999999999 111.707 176.381 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 762' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 657' ' ' MET . . . . . . . . . . . . . 26.3 ptt? . . . . . 0 N--CA 1.487 1.412 0 CA-C-O 120.997 0.427 . . . . 65.540000000000006 111.2 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 658' ' ' GLY . . . . . . . . . . . . . . . -139.99 157.47 25.4 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 121.373 -0.442 . . . . 75.239999999999995 112.722 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 659' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -86.9 62.66 7.52 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.409 0.623 . . . . 72.329999999999998 111.45 -178.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 660' ' ' GLY . . . . . . . . . . . . . . . -111.54 133.09 11.26 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-N 115.828 -0.623 . . . . 64.439999999999998 112.486 178.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -151.5 165.85 32.94 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 122.463 -0.434 . . . . 74.25 110.815 -179.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 662' ' ' THR . . . . . . . . . . . . . 80.9 p -60.05 143.31 52.3 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 120.956 0.408 . . . . 55.32 111.955 -179.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 663' ' ' SER . . . . . . . . . . . . . 31.6 m -69.77 104.45 2.45 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 116.208 -0.451 . . . . 74.010000000000005 110.533 177.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 664' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -73.99 117.18 15.48 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.607 0.718 . . . . 73.209999999999994 112.017 -176.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 665' ' ' LEU . . . . . . . . . . . . . 87.8 mt -101.82 138.72 38.42 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.266 -0.879 . . . . 72.219999999999999 110.779 175.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 666' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -70.73 137.52 85.56 Favored Pre-proline 0 CA--C 1.542 0.638 0 N-CA-C 110.222 -0.288 . . . . 74.209999999999994 110.222 170.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 667' ' ' PRO . . . . . 0.535 ' HB3' ' HB2' ' A' ' 693' ' ' ASP . 59.9 Cg_endo -70.59 150.3 62.97 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 122.569 2.179 . . . . 74.540000000000006 113.769 -174.189 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 668' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -83.53 107.88 16.29 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 121.178 0.513 . . . . 62.549999999999997 110.635 175.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 669' ' ' LEU . . . . . . . . . . . . . 48.5 tp -90.62 112.47 24.2 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.95 -0.568 . . . . 70.439999999999998 109.828 175.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 670' ' ' THR . . . . . . . . . . . . . 83.6 m -95.11 110.48 22.42 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.175 0.512 . . . . 74.25 111.73 -176.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 671' ' ' VAL . . . . . 0.424 HG22 HG13 ' A' ' 689' ' ' VAL . 82.1 t -133.25 134.2 23.81 Favored Pre-proline 0 CA--C 1.542 0.638 0 CA-C-N 115.599 -0.728 . . . . 71.239999999999995 110.758 -178.106 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 672' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.42 136.66 26.69 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 122.201 1.934 . . . . 73.400000000000006 111.807 175.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 673' ' ' VAL . . . . . . . . . . . . . 14.3 p -64.5 -33.63 64.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 N-CA-C 112.093 0.405 . . . . 72.420000000000002 112.093 -176.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 674' ' ' GLY . . . . . 0.422 ' HA2' ' O ' ' A' ' 736' ' ' THR . . . -157.31 153.3 24.55 Favored Glycine 0 CA--C 1.523 0.554 0 C-N-CA 120.894 -0.67 . . . . 63.299999999999997 113.416 -178.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 675' ' ' ALA . . . . . . . . . . . . . . . -144.51 121.0 11.03 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.752 0.311 . . . . 73.140000000000001 111.169 179.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 676' ' ' THR . . . . . . . . . . . . . 84.8 m -96.98 121.6 39.04 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.92 0.39 . . . . 62.520000000000003 111.446 -179.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 677' ' ' ILE . . . . . . . . . . . . . 32.0 pt -130.79 176.68 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 CA-C-N 116.5 -0.318 . . . . 74.310000000000002 110.984 178.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 678' ' ' HIS . . . . . . . . . . . . . 78.0 m80 -121.55 153.72 37.64 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.231 0.538 . . . . 72.230000000000004 112.394 -179.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 679' ' ' VAL . . . . . . . . . . . . . 92.6 t -55.32 115.28 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 115.68 -0.691 . . . . 72.329999999999998 111.733 179.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 100.33 24.42 9.56 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 121.313 -0.47 . . . . 72.340000000000003 113.341 -177.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 681' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -108.59 176.03 5.26 Favored 'General case' 0 CA--C 1.546 0.826 0 O-C-N 122.516 -0.402 . . . . 52.350000000000001 110.883 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 682' ' ' SER . . . . . . . . . . . . . 84.4 p -114.94 129.57 56.74 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 122.334 0.254 . . . . 74.349999999999994 111.237 -179.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 683' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -139.4 126.1 20.68 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 120.821 0.343 . . . . 70.010000000000005 111.224 -178.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 684' ' ' VAL . . . . . . . . . . . . . 81.6 t -114.17 105.19 54.39 Favored Pre-proline 0 N--CA 1.474 0.753 0 N-CA-C 111.989 0.366 . . . . 72.349999999999994 111.989 -179.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_exo -53.37 -40.55 77.78 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 123.041 2.494 . . . . 71.120000000000005 113.727 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 686' ' ' MET . . . . . 0.551 ' HE2' ' HB ' ' A' ' 703' ' ' ILE . 1.0 OUTLIER -78.24 -4.0 45.56 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 112.636 0.606 . . . . 73.439999999999998 112.636 -177.994 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 687' ' ' ALA . . . . . . . . . . . . . . . -98.74 -17.68 18.39 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.954 0.407 . . . . 64.349999999999994 111.385 177.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 688' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -98.67 -13.94 20.07 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 112.446 0.535 . . . . 74.420000000000002 112.446 -175.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . 0.554 HG11 HD12 ' A' ' 703' ' ' ILE . 94.9 t -122.49 132.93 70.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 N-CA-C 112.919 0.711 . . . . 75.140000000000001 112.919 -173.23 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 690' ' ' LEU . . . . . 0.494 ' HA ' HG22 ' A' ' 700' ' ' THR . 6.5 mp -124.93 165.0 18.87 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 116.274 -0.421 . . . . 73.310000000000002 111.021 177.392 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 691' ' ' ALA . . . . . . . . . . . . . . . -152.19 127.41 9.84 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 120.915 0.388 . . . . 44.340000000000003 111.909 178.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 692' ' ' ILE . . . . . . . . . . . . . 45.6 mm -135.28 139.07 47.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 N-CA-C 112.097 0.406 . . . . 75.040000000000006 112.097 -177.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 693' ' ' ASP . . . . . 0.535 ' HB2' ' HB3' ' A' ' 667' ' ' PRO . 45.5 t0 -120.29 137.93 53.98 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 109.589 -0.523 . . . . 75.519999999999996 109.589 171.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 52.9 tttp -57.33 -35.25 69.66 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 121.06 0.457 . . . . 74.129999999999995 112.1 -178.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -82.52 -46.16 13.76 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 112.294 0.479 . . . . 72.219999999999999 112.294 -176.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 696' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -94.33 -34.79 12.67 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 112.361 0.504 . . . . 64.299999999999997 112.361 -170.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . 105.26 -123.3 7.55 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 121.44 -0.409 . . . . 54.140000000000001 113.018 -178.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -75.96 118.41 18.7 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 121.272 0.558 . . . . 71.540000000000006 112.142 -178.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 699' ' ' LEU . . . . . 0.405 HD13 ' HB3' ' A' ' 667' ' ' PRO . 81.4 mt -118.33 8.13 12.15 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 115.719 -0.673 . . . . 72.219999999999999 110.408 171.742 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 700' ' ' THR . . . . . 0.494 HG22 ' HA ' ' A' ' 690' ' ' LEU . 37.8 m -59.1 -37.77 77.96 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.48 0.657 . . . . 74.209999999999994 110.568 175.343 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 701' ' ' SER . . . . . . . . . . . . . 54.8 p -73.4 -2.75 23.62 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 115.588 -0.733 . . . . 62.200000000000003 111.865 176.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 702' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -110.74 2.01 18.18 Favored 'General case' 0 CA--C 1.541 0.596 0 N-CA-C 111.859 0.318 . . . . 74.019999999999996 111.859 -179.067 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 703' ' ' ILE . . . . . 0.554 HD12 HG11 ' A' ' 689' ' ' VAL . 66.9 mt -71.12 129.67 34.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-O 121.179 0.514 . . . . 72.319999999999993 111.695 -179.169 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 704' ' ' LYS . . . . . . . . . . . . . 2.4 tppp? -104.88 127.26 52.64 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.192 -0.458 . . . . 74.549999999999997 110.244 177.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 50.1 t -97.94 134.8 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-O 120.825 0.345 . . . . 74.420000000000002 111.893 -177.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 706' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -128.56 147.63 50.71 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 116.133 -0.485 . . . . 74.349999999999994 110.351 175.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 106.13 -172.44 18.84 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 121.185 -0.531 . . . . 75.349999999999994 112.658 -177.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 708' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -165.18 130.62 2.61 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 116.925 0.363 . . . . 74.310000000000002 111.542 179.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 709' ' ' VAL . . . . . 0.518 HG23 ' HB2' ' A' ' 717' ' ' TYR . 98.8 t -110.63 116.6 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-O 120.792 0.329 . . . . 73.150000000000006 111.431 177.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 710' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -73.26 134.8 44.37 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 120.979 0.419 . . . . 72.129999999999995 110.584 175.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 711' ' ' THR . . . . . . . . . . . . . 75.8 p -105.97 -0.11 25.28 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 111.913 0.338 . . . . 75.329999999999998 111.913 -179.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 712' ' ' THR . . . . . . . . . . . . . 14.9 t -107.34 -1.86 21.21 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 112.47 0.544 . . . . 72.299999999999997 112.47 -177.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 713' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -143.58 134.94 26.0 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 122.021 -0.424 . . . . 73.010000000000005 111.174 -179.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 714' ' ' ALA . . . . . . . . . . . . . . . -70.23 140.79 52.49 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 112.343 0.498 . . . . 72.299999999999997 112.343 -176.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 153.39 167.08 15.31 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 121.124 -0.56 . . . . 61.439999999999998 112.856 -179.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 716' ' ' THR . . . . . . . . . . . . . 34.7 m -96.56 122.92 40.0 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 122.461 -0.435 . . . . 74.010000000000005 111.908 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 717' ' ' TYR . . . . . 0.518 ' HB2' HG23 ' A' ' 709' ' ' VAL . 27.3 m-85 -121.89 143.02 49.68 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 116.122 -0.49 . . . . 74.200000000000003 110.142 178.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 718' ' ' VAL . . . . . . . . . . . . . 53.8 t -109.75 127.49 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 N-CA-C 112.645 0.609 . . . . 60.340000000000003 112.645 -174.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 719' ' ' LEU . . . . . . . . . . . . . 96.3 mt -106.72 132.25 52.91 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 116.068 -0.515 . . . . 64.430000000000007 111.424 176.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 58.4 m -109.87 124.65 51.71 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 120.791 0.329 . . . . 74.040000000000006 111.261 179.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 721' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -110.94 129.63 55.82 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.507 -0.315 . . . . 74.219999999999999 110.718 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 99.5 m -132.65 125.37 30.19 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.554 0.216 . . . . 73.340000000000003 111.286 -179.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 8.1 p -117.62 142.53 31.42 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 CA-C-O 120.933 0.397 . . . . 73.409999999999997 111.773 -178.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 44.1 m -105.07 118.96 37.84 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.238 0.542 . . . . 74.439999999999998 112.429 -176.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 725' ' ' ASP . . . . . 0.509 ' HB2' ' HD3' ' A' ' 667' ' ' PRO . 5.7 t0 -73.79 150.94 40.76 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 115.798 -0.637 . . . . 75.209999999999994 110.804 174.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 726' ' ' SER . . . . . . . . . . . . . 59.8 p -74.19 -15.27 61.02 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 112.459 0.541 . . . . 74.120000000000005 112.459 -175.021 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 727' ' ' LYS . . . . . . . . . . . . . 65.2 mmtt -103.66 6.14 36.84 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 112.266 0.469 . . . . 72.120000000000005 112.266 177.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 728' ' ' GLY . . . . . . . . . . . . . . . 102.83 27.96 6.44 Favored Glycine 0 CA--C 1.532 1.103 0 N-CA-C 115.269 0.868 . . . . 54.219999999999999 115.269 173.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 21.1 m80 -109.14 104.01 13.11 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 117.897 0.849 . . . . 74.549999999999997 111.6 173.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 730' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -98.83 105.58 17.74 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 120.807 0.337 . . . . 72.109999999999999 110.867 177.172 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 33.9 m -106.79 153.59 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-O 120.822 0.344 . . . . 74.140000000000001 111.624 -178.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 9.8 t -134.94 147.86 49.88 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 112.415 0.524 . . . . 75.310000000000002 112.415 -176.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -148.56 149.6 31.87 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.08 0.552 . . . . 73.150000000000006 109.989 176.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 734' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -120.44 158.46 27.17 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 113.03 0.752 . . . . 73.420000000000002 113.03 -173.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 735' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -130.34 123.44 29.97 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.374 -0.83 . . . . 74.25 110.708 179.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 736' ' ' THR . . . . . 0.422 ' O ' ' HA2' ' A' ' 674' ' ' GLY . 62.2 m -92.49 103.67 16.07 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 121.056 0.455 . . . . 75.129999999999995 111.122 178.178 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 50.0 t -96.58 128.93 47.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-O 120.85 0.357 . . . . 74.409999999999997 111.411 -177.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 738' ' ' THR . . . . . . . . . . . . . 97.0 m -114.58 114.6 25.94 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.092 0.472 . . . . 75.120000000000005 111.642 -178.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 739' ' ' VAL . . . . . . . . . . . . . 39.3 t -93.06 135.14 28.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 CA-C-N 116.162 -0.472 . . . . 74.219999999999999 111.155 178.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 740' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -122.71 155.53 36.27 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.74 0.305 . . . . 74.430000000000007 111.594 -178.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 741' ' ' VAL . . . . . . . . . . . . . 24.1 t -75.79 148.06 7.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-O 120.69 0.281 . . . . 74.409999999999997 111.586 -178.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 742' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' A' ' 742' ' ' ARG . 51.6 mtt-85 -87.4 -169.5 2.64 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 120.702 0.286 . . . . 75.239999999999995 110.724 175.564 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 743' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -125.89 123.9 39.67 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 113.62 0.97 . . . . 74.299999999999997 113.62 -170.226 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 744' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.25 170.15 16.36 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.18 -0.918 . . . . 73.409999999999997 109.761 170.394 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 59.7 t -116.82 125.26 73.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 CA-C-O 120.853 0.359 . . . . 73.239999999999995 111.96 -177.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -67.06 95.88 0.41 Allowed 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.172 0.511 . . . . 74.329999999999998 111.159 175.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 747' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -155.83 160.97 40.66 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 116.081 -0.509 . . . . 72.310000000000002 110.427 -178.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -69.01 130.2 42.09 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 121.646 0.736 . . . . 65.239999999999995 112.024 -177.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 749' ' ' LYS . . . . . 0.541 ' HD2' ' HD2' ' A' ' 750' ' ' PRO . 22.3 tptm -103.23 125.79 34.12 Favored Pre-proline 0 CA--C 1.543 0.678 0 CA-C-N 115.64 -0.709 . . . . 75.120000000000005 110.716 -178.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 750' ' ' PRO . . . . . 0.541 ' HD2' ' HD2' ' A' ' 749' ' ' LYS . 13.0 Cg_endo -55.6 109.13 0.38 Allowed 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 122.542 2.162 . . . . 73.430000000000007 113.068 179.221 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 751' ' ' ILE . . . . . . . . . . . . . 62.9 mt 60.31 96.39 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-O 121.44 0.638 . . . . 74.219999999999999 111.722 -178.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 752' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -73.41 109.89 7.28 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 116.073 -0.512 . . . . 74.299999999999997 110.682 -178.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 753' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 . . . . . 0 N--CA 1.472 0.658 0 CA-C-O 121.407 0.622 . . . . 63.420000000000002 111.696 -178.506 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 762' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 657' ' ' MET . . . . . . . . . . . . . 96.0 mmm . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 120.768 0.318 . . . . 71.430000000000007 111.51 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 658' ' ' GLY . . . . . . . . . . . . . . . 125.64 -61.21 0.62 Allowed Glycine 0 N--CA 1.465 0.614 0 C-N-CA 121.344 -0.455 . . . . 72.120000000000005 112.62 -178.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 659' ' ' ASN . . . . . . . . . . . . . 30.2 m-80 -125.66 95.75 4.55 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 121.154 0.502 . . . . 72.349999999999994 111.184 178.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 660' ' ' GLY . . . . . . . . . . . . . . . -92.16 -46.83 3.48 Favored Glycine 0 CA--C 1.523 0.59 0 C-N-CA 121.193 -0.527 . . . . 73.519999999999996 112.815 178.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -70.63 101.4 2.04 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 120.865 0.364 . . . . 74.0 111.358 178.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 662' ' ' THR . . . . . . . . . . . . . 10.2 t -89.21 157.26 18.32 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.074 0.464 . . . . 72.120000000000005 111.239 176.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 663' ' ' SER . . . . . . . . . . . . . 63.6 m -81.32 97.81 7.86 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.044 0.387 . . . . 53.350000000000001 112.044 -178.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 664' ' ' ASP . . . . . 0.45 ' OD2' ' HB2' ' A' ' 727' ' ' LYS . 16.2 t0 -90.21 132.21 35.62 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.266 0.555 . . . . 75.519999999999996 111.112 172.593 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 665' ' ' LEU . . . . . . . . . . . . . 67.7 mt -99.52 126.35 45.46 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.812 -0.631 . . . . 74.329999999999998 110.412 176.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 666' ' ' GLU . . . . . 0.438 ' H ' ' CD ' ' A' ' 666' ' ' GLU . 0.7 OUTLIER -58.69 156.33 24.81 Favored Pre-proline 0 CA--C 1.544 0.722 0 CA-C-N 115.872 -0.604 . . . . 71.409999999999997 112.28 -179.283 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 667' ' ' PRO . . . . . 0.413 ' HD3' ' HB2' ' A' ' 725' ' ' ASP . 72.0 Cg_endo -75.17 145.29 30.71 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.276 1.984 . . . . 75.349999999999994 112.861 -175.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 668' ' ' LYS . . . . . . . . . . . . . 52.6 tptt -82.37 104.3 12.57 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.105 0.478 . . . . 74.310000000000002 111.001 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 669' ' ' LEU . . . . . . . . . . . . . 51.2 tp -89.91 106.58 18.57 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.271 0.557 . . . . 74.140000000000001 110.762 177.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 670' ' ' THR . . . . . . . . . . . . . 33.0 m -91.75 110.92 22.27 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.089 -0.505 . . . . 72.019999999999996 111.246 -177.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 671' ' ' VAL . . . . . 0.433 HG23 ' HB1' ' A' ' 733' ' ' ALA . 84.7 t -131.66 139.72 36.1 Favored Pre-proline 0 N--CA 1.473 0.691 0 CA-C-N 116.092 -0.504 . . . . 74.409999999999997 111.161 -176.369 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 672' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -76.74 149.34 29.72 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 122.418 2.079 . . . . 75.319999999999993 112.595 175.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 673' ' ' VAL . . . . . . . . . . . . . 12.5 p -69.57 -34.75 63.02 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 N-CA-C 112.468 0.544 . . . . 75.030000000000001 112.468 -176.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 674' ' ' GLY . . . . . . . . . . . . . . . 179.85 169.39 40.04 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 120.396 -0.907 . . . . 64.209999999999994 113.949 -178.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 675' ' ' ALA . . . . . . . . . . . . . . . -154.99 140.2 17.56 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 122.625 0.37 . . . . 62.229999999999997 111.107 179.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 676' ' ' THR . . . . . . . . . . . . . 86.2 m -118.71 121.22 39.6 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-O 120.713 0.292 . . . . 72.140000000000001 111.398 -179.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 677' ' ' ILE . . . . . . . . . . . . . 30.0 pt -129.3 174.3 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-O 120.986 0.422 . . . . 74.040000000000006 111.886 -177.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 678' ' ' HIS . . . . . . . . . . . . . 53.0 m80 -115.84 166.3 12.11 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.312 0.577 . . . . 38.740000000000002 111.933 178.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 679' ' ' VAL . . . . . 0.547 HG11 ' HA ' ' A' ' 712' ' ' THR . 63.2 t -56.95 111.88 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-N 115.628 -0.714 . . . . 73.329999999999998 110.643 174.003 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 123.05 -33.2 4.13 Favored Glycine 0 CA--C 1.526 0.736 0 CA-C-N 116.256 -0.429 . . . . 44.439999999999998 112.815 -175.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 681' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -73.48 128.26 35.01 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.095 0.474 . . . . 74.329999999999998 111.659 179.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 682' ' ' SER . . . . . . . . . . . . . 50.4 m -85.34 144.42 28.06 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 120.849 0.357 . . . . 73.530000000000001 110.871 176.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 683' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -118.08 132.38 56.36 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 120.809 0.338 . . . . 74.450000000000003 111.263 -178.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 684' ' ' VAL . . . . . . . . . . . . . 52.4 t -116.84 96.98 49.89 Favored Pre-proline 0 CA--C 1.544 0.72 0 CA-C-N 116.461 -0.336 . . . . 63.5 111.326 -178.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -77.28 -31.62 3.48 Favored 'Trans proline' 0 CA--C 1.545 1.07 0 C-N-CA 122.783 2.322 . . . . 72.549999999999997 114.461 -174.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 686' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.35 -12.17 59.99 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 112.303 0.482 . . . . 74.209999999999994 112.303 -174.515 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 687' ' ' ALA . . . . . . . . . . . . . . . -94.22 -27.39 16.2 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 111.91 0.337 . . . . 62.130000000000003 111.91 178.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 688' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -91.35 -8.22 48.7 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 112.133 0.42 . . . . 75.109999999999999 112.133 -177.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . 0.509 HG13 HD13 ' A' ' 703' ' ' ILE . 62.7 t -114.21 127.64 71.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-O 120.987 0.422 . . . . 75.439999999999998 111.559 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 690' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -123.66 155.82 37.04 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 116.247 -0.433 . . . . 71.439999999999998 111.125 179.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 691' ' ' ALA . . . . . . . . . . . . . . . -141.5 122.86 14.9 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 120.659 0.266 . . . . 73.150000000000006 110.865 174.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 692' ' ' ILE . . . . . 0.421 HD12 ' HA ' ' A' ' 698' ' ' ASP . 48.1 mm -128.68 120.48 52.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 N-CA-C 112.087 0.403 . . . . 73.209999999999994 112.087 -177.034 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -95.05 149.94 20.71 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.09 0.472 . . . . 62.25 110.692 172.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 694' ' ' LYS . . . . . 0.53 ' HZ2' ' HB3' ' A' ' 694' ' ' LYS . 7.5 mtpm? -77.42 -34.56 54.68 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 112.665 0.617 . . . . 63.140000000000001 112.665 -173.651 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -84.86 -54.98 4.32 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 121.828 -0.545 . . . . 73.430000000000007 112.095 177.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 696' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -75.93 -50.48 14.85 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 112.125 0.417 . . . . 74.400000000000006 112.125 -173.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . 123.94 -139.44 12.03 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 121.37 -0.443 . . . . 74.25 112.65 -175.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 698' ' ' ASP . . . . . 0.421 ' HA ' HD12 ' A' ' 692' ' ' ILE . 14.3 t70 -67.53 122.57 18.28 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 122.369 -0.489 . . . . 73.329999999999998 111.961 -178.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 699' ' ' LEU . . . . . . . . . . . . . 83.5 mt -118.49 19.44 13.33 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 116.097 -0.502 . . . . 73.510000000000005 111.1 176.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 89.3 m -59.52 -31.96 69.87 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 120.954 0.407 . . . . 74.209999999999994 112.067 -176.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 701' ' ' SER . . . . . . . . . . . . . 46.7 m -72.03 -13.58 61.64 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 120.763 0.316 . . . . 63.509999999999998 111.833 179.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 702' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -92.98 -2.74 55.48 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 112.09 0.404 . . . . 71.230000000000004 112.09 179.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 703' ' ' ILE . . . . . 0.509 HD13 HG13 ' A' ' 689' ' ' VAL . 69.8 mt -68.67 119.48 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-O 121.09 0.471 . . . . 74.409999999999997 111.763 -179.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 704' ' ' LYS . . . . . . . . . . . . . 51.1 tptt -89.76 126.62 35.74 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.246 -0.434 . . . . 54.039999999999999 110.177 175.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 51.7 t -95.99 130.07 45.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-O 121.046 0.451 . . . . 72.299999999999997 112.004 -177.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 706' ' ' ASP . . . . . 0.554 ' HB3' ' HB ' ' A' ' 720' ' ' THR . 14.4 t70 -123.29 145.69 48.49 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.185 -0.462 . . . . 64.329999999999998 110.484 176.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 119.96 -153.98 16.59 Favored Glycine 0 CA--C 1.524 0.651 0 C-N-CA 121.079 -0.582 . . . . 72.439999999999998 113.32 178.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 708' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -166.96 141.42 3.94 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.762 0.315 . . . . 71.530000000000001 111.118 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 709' ' ' VAL . . . . . . . . . . . . . 59.9 t -127.1 110.89 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-O 120.583 0.23 . . . . 75.230000000000004 110.918 174.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 710' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -94.29 135.77 35.32 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 109.882 -0.414 . . . . 63.109999999999999 109.882 176.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 711' ' ' THR . . . . . 0.426 ' O ' ' HA ' ' A' ' 679' ' ' VAL . 71.8 p -105.77 0.04 25.79 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 122.105 -0.372 . . . . 62.509999999999998 111.98 -177.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 712' ' ' THR . . . . . 0.547 ' HA ' HG11 ' A' ' 679' ' ' VAL . 72.0 p -116.24 -24.25 8.05 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 116.426 -0.352 . . . . 74.129999999999995 111.777 178.29 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 713' ' ' LYS . . . . . . . . . . . . . 61.2 tttm -111.9 121.29 44.62 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 120.899 0.381 . . . . 74.329999999999998 111.119 -178.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 714' ' ' ALA . . . . . . . . . . . . . . . -70.21 143.88 52.08 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 112.542 0.571 . . . . 72.349999999999994 112.542 -177.017 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 156.39 162.24 11.3 Favored Glycine 0 CA--C 1.526 0.722 0 CA-C-N 115.938 -0.574 . . . . 63.240000000000002 112.509 179.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 716' ' ' THR . . . . . . . . . . . . . 51.6 m -98.34 122.57 41.68 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 117.311 0.556 . . . . 73.129999999999995 111.093 177.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 717' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -119.49 137.33 53.87 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.431 -0.35 . . . . 73.5 110.71 -178.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 718' ' ' VAL . . . . . . . . . . . . . 48.4 t -95.15 131.36 42.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-O 121.079 0.466 . . . . 74.409999999999997 111.606 179.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 719' ' ' LEU . . . . . . . . . . . . . 86.6 mt -108.53 133.67 52.35 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.055 -0.52 . . . . 65.400000000000006 110.814 177.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 720' ' ' THR . . . . . 0.554 ' HB ' ' HB3' ' A' ' 706' ' ' ASP . 77.3 m -117.53 130.92 56.72 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-O 120.634 0.254 . . . . 71.420000000000002 110.934 178.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 721' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -119.23 132.26 55.91 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 120.672 0.272 . . . . 71.019999999999996 111.118 -178.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 97.8 m -128.33 139.47 52.39 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 111.686 0.254 . . . . 63.450000000000003 111.686 -179.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 13.8 p -141.27 147.2 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 CA-C-O 120.937 0.399 . . . . 75.349999999999994 111.244 178.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 18.7 m -110.97 144.95 39.26 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.035 0.445 . . . . 73.510000000000005 111.999 -176.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 725' ' ' ASP . . . . . 0.658 ' HB3' ' H ' ' A' ' 729' ' ' HIS . 7.5 t70 -74.11 168.46 19.52 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.041 0.536 . . . . 53.340000000000003 111.222 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 726' ' ' SER . . . . . . . . . . . . . 34.1 t -68.65 -30.83 69.62 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 120.78 0.324 . . . . 74.019999999999996 110.985 174.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 727' ' ' LYS . . . . . 0.45 ' HB2' ' OD2' ' A' ' 664' ' ' ASP . 4.1 mptp? -96.47 -9.44 29.7 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 112.62 0.6 . . . . 72.219999999999999 112.62 177.423 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 728' ' ' GLY . . . . . . . . . . . . . . . 113.15 22.38 5.6 Favored Glycine 0 CA--C 1.535 1.332 0 N-CA-C 116.111 1.204 . . . . 50.140000000000001 116.111 173.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 729' ' ' HIS . . . . . 0.658 ' H ' ' HB3' ' A' ' 725' ' ' ASP . 46.5 m80 -83.67 119.98 25.43 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 118.117 0.958 . . . . 74.230000000000004 110.949 169.411 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 730' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -103.56 119.76 39.54 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 120.823 0.344 . . . . 75.450000000000003 111.692 -179.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 35.1 m -120.65 157.43 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-O 120.733 0.301 . . . . 74.430000000000007 111.234 179.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 9.6 t -146.91 147.88 31.22 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.545 0.572 . . . . 74.439999999999998 112.545 -177.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 733' ' ' ALA . . . . . 0.433 ' HB1' HG23 ' A' ' 671' ' ' VAL . . . -141.73 161.9 36.8 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 116.042 -0.527 . . . . 65.329999999999998 110.91 -179.677 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 734' ' ' LYS . . . . . . . . . . . . . 42.8 mtmt -128.9 150.8 50.2 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 112.872 0.693 . . . . 72.400000000000006 112.872 -173.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 735' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -130.75 140.65 50.33 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 115.423 -0.808 . . . . 74.340000000000003 110.662 177.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 736' ' ' THR . . . . . . . . . . . . . 92.4 m -109.85 107.76 17.83 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 112.221 0.452 . . . . 72.329999999999998 112.221 -178.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 57.5 t -102.47 131.67 50.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 O-C-N 122.16 -0.338 . . . . 75.310000000000002 111.787 -178.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 738' ' ' THR . . . . . . . . . . . . . 91.7 m -119.13 118.46 31.44 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 120.788 0.327 . . . . 65.329999999999998 111.522 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 739' ' ' VAL . . . . . . . . . . . . . 41.7 t -102.88 139.1 24.73 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 CA-C-O 120.67 0.271 . . . . 73.120000000000005 111.418 178.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 740' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -128.91 157.68 40.91 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 120.931 0.396 . . . . 73.450000000000003 111.76 179.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 741' ' ' VAL . . . . . 0.416 HG13 ' H ' ' A' ' 743' ' ' GLU . 9.6 t -79.37 153.12 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-N 116.551 -0.295 . . . . 73.0 111.585 -176.489 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 742' ' ' ARG . . . . . . . . . . . . . 23.4 ptt180 -83.62 -27.82 28.9 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 112.074 0.398 . . . . 73.129999999999995 112.074 -177.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 743' ' ' GLU . . . . . 0.416 ' H ' HG13 ' A' ' 741' ' ' VAL . 12.0 pt-20 -152.86 146.76 25.29 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 120.757 0.313 . . . . 73.230000000000004 111.339 -177.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 744' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -91.16 113.16 25.34 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.818 0.342 . . . . 74.430000000000007 111.336 177.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 745' ' ' VAL . . . . . 0.447 HG13 ' H ' ' A' ' 747' ' ' ASN . 57.8 t -91.44 122.38 42.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-O 120.882 0.372 . . . . 75.129999999999995 110.92 177.136 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -93.02 7.37 44.41 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 112.107 0.41 . . . . 74.010000000000005 112.107 -176.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 747' ' ' ASN . . . . . 0.447 ' H ' HG13 ' A' ' 745' ' ' VAL . 19.4 m120 -110.03 100.5 9.43 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 120.989 0.424 . . . . 72.420000000000002 111.462 177.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -78.47 156.06 29.54 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.126 0.488 . . . . 74.219999999999999 110.881 177.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 749' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -132.45 153.66 81.27 Favored Pre-proline 0 CA--C 1.538 0.496 0 CA-C-N 116.045 -0.525 . . . . 74.310000000000002 110.89 -177.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 750' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -51.8 100.56 0.05 OUTLIER 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 122.416 2.077 . . . . 62.340000000000003 112.674 176.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 751' ' ' ILE . . . . . . . . . . . . . 22.4 pt -89.48 160.56 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-N 116.237 -0.438 . . . . 72.0 112.006 -178.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 752' ' ' LEU . . . . . . . . . . . . . 55.3 tp -83.8 125.14 31.65 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.223 -0.444 . . . . 62.210000000000001 111.871 -177.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 753' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 . . . . . 0 N--CA 1.469 0.508 0 CA-C-N 116.445 -0.343 . . . . 73.109999999999999 111.522 178.279 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 762' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 657' ' ' MET . . . . . . . . . . . . . 25.6 ptt? . . . . . 0 N--CA 1.487 1.407 0 CA-C-O 120.63 0.252 . . . . 63.340000000000003 111.028 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 658' ' ' GLY . . . . . . . . . . . . . . . 79.33 159.22 15.67 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 121.072 -0.585 . . . . 65.340000000000003 112.638 -175.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 659' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -137.68 132.36 32.79 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 122.509 -0.406 . . . . 64.120000000000005 111.51 179.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 660' ' ' GLY . . . . . . . . . . . . . . . -177.51 61.1 0.09 OUTLIER Glycine 0 CA--C 1.527 0.786 0 C-N-CA 120.741 -0.742 . . . . 62.109999999999999 113.642 -177.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -85.09 90.69 7.92 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 121.374 0.607 . . . . 75.140000000000001 110.412 176.133 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 662' ' ' THR . . . . . . . . . . . . . 68.8 p -81.07 162.59 23.68 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 113.033 0.753 . . . . 74.420000000000002 113.033 -171.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 663' ' ' SER . . . . . . . . . . . . . 46.6 t -101.31 142.45 32.71 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.297 -0.865 . . . . 75.030000000000001 109.854 171.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 664' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -73.74 149.99 41.44 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.644 0.735 . . . . 73.430000000000007 112.504 -175.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 665' ' ' LEU . . . . . . . . . . . . . 72.6 mt -101.49 137.68 39.49 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-N 115.019 -0.991 . . . . 55.109999999999999 110.876 177.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 666' ' ' GLU . . . . . 0.492 ' HG3' ' HB3' ' A' ' 729' ' ' HIS . 19.7 mp0 -71.11 150.09 94.64 Favored Pre-proline 0 CA--C 1.538 0.497 0 CA-C-N 116.121 -0.491 . . . . 74.219999999999999 110.505 177.427 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 667' ' ' PRO . . . . . 0.517 ' HB3' HD11 ' A' ' 699' ' ' LEU . 37.5 Cg_endo -65.1 133.19 34.55 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 122.103 1.869 . . . . 74.420000000000002 112.345 179.092 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 668' ' ' LYS . . . . . . . . . . . . . 56.1 tptt -82.18 106.98 14.51 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 121.173 0.511 . . . . 73.340000000000003 110.56 179.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 669' ' ' LEU . . . . . 0.505 ' HG ' HG21 ' A' ' 671' ' ' VAL . 60.0 tp -89.39 106.04 18.19 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.709 -0.678 . . . . 73.530000000000001 110.912 -178.614 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 670' ' ' THR . . . . . . . . . . . . . 86.3 m -86.37 110.4 19.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.034 0.445 . . . . 74.25 110.828 179.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 671' ' ' VAL . . . . . 0.505 HG21 ' HG ' ' A' ' 669' ' ' LEU . 94.8 t -127.55 127.94 24.03 Favored Pre-proline 0 CA--C 1.536 0.418 0 CA-C-N 116.032 -0.531 . . . . 74.329999999999998 111.021 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 672' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -64.48 154.2 73.03 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 122.305 2.003 . . . . 72.420000000000002 111.929 178.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 673' ' ' VAL . . . . . . . . . . . . . 10.1 p -81.5 -34.39 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 O-C-N 122.145 -0.347 . . . . 74.239999999999995 111.89 -176.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 674' ' ' GLY . . . . . 0.404 ' HA2' ' O ' ' A' ' 736' ' ' THR . . . -162.54 163.88 35.36 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 121.094 -0.574 . . . . 65.319999999999993 113.579 -178.173 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 675' ' ' ALA . . . . . . . . . . . . . . . -156.3 118.28 3.97 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 120.694 0.283 . . . . 71.209999999999994 111.747 179.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 676' ' ' THR . . . . . . . . . . . . . 88.7 m -97.43 126.14 42.5 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 120.648 0.261 . . . . 73.049999999999997 111.591 178.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 677' ' ' ILE . . . . . 0.414 HG13 HG21 ' A' ' 739' ' ' VAL . 20.1 pt -138.52 176.44 6.62 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 C-N-CA 122.514 0.325 . . . . 74.230000000000004 111.288 179.391 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 678' ' ' HIS . . . . . 0.524 ' O ' ' HB2' ' A' ' 681' ' ' ASP . 72.1 m80 -114.93 177.21 4.73 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 121.396 0.617 . . . . 61.450000000000003 112.574 -179.6 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 679' ' ' VAL . . . . . 0.437 HG21 ' HA ' ' A' ' 741' ' ' VAL . 96.1 t -66.45 122.13 16.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-N 116.004 -0.544 . . . . 75.209999999999994 110.957 174.154 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 86.1 18.31 59.55 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 121.218 -0.515 . . . . 75.420000000000002 112.825 -176.028 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 681' ' ' ASP . . . . . 0.524 ' HB2' ' O ' ' A' ' 678' ' ' HIS . 1.1 t70 -83.09 -175.32 5.78 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-O 120.882 0.373 . . . . 73.019999999999996 111.295 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 682' ' ' SER . . . . . . . . . . . . . 69.7 m -123.12 140.66 52.8 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 122.418 0.287 . . . . 72.329999999999998 111.314 179.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 683' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -154.61 125.38 7.07 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 116.494 -0.321 . . . . 73.530000000000001 110.87 -178.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 684' ' ' VAL . . . . . . . . . . . . . 38.6 t -125.38 93.57 44.77 Favored Pre-proline 0 CA--C 1.546 0.789 0 CA-C-O 121.022 0.439 . . . . 65.510000000000005 111.926 -177.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -61.27 -36.81 77.78 Favored 'Trans proline' 0 CA--C 1.545 1.028 0 C-N-CA 122.725 2.283 . . . . 53.109999999999999 113.576 -177.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 686' ' ' MET . . . . . 0.525 ' HA ' ' HE1' ' A' ' 686' ' ' MET . 1.9 mmt -78.82 4.08 14.98 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 112.573 0.582 . . . . 71.230000000000004 112.573 -176.766 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 687' ' ' ALA . . . . . . . . . . . . . . . -119.21 -40.65 2.8 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.18 0.514 . . . . 54.450000000000003 111.211 174.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 688' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -71.93 -24.91 61.71 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 116.2 -0.455 . . . . 75.540000000000006 111.998 179.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . 0.419 HG13 HG22 ' A' ' 671' ' ' VAL . 63.7 t -96.91 144.48 10.49 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 CA-C-O 120.677 0.275 . . . . 73.230000000000004 110.802 174.258 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 690' ' ' LEU . . . . . 0.443 HD21 ' N ' ' A' ' 691' ' ' ALA . 10.5 tt -142.66 149.55 39.04 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 120.475 0.178 . . . . 64.200000000000003 111.105 -174.302 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 691' ' ' ALA . . . . . 0.443 ' N ' HD21 ' A' ' 690' ' ' LEU . . . -144.22 132.78 22.21 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 112.085 0.402 . . . . 44.109999999999999 112.085 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 692' ' ' ILE . . . . . 0.548 HD13 ' HA ' ' A' ' 698' ' ' ASP . 43.7 mm -133.97 132.91 56.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 N-CA-C 112.039 0.385 . . . . 72.030000000000001 112.039 -178.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 693' ' ' ASP . . . . . 0.462 ' OD1' ' HG2' ' A' ' 695' ' ' GLU . 7.7 t70 -110.68 149.21 30.79 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 109.714 -0.476 . . . . 65.530000000000001 109.714 171.162 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -69.41 -29.3 67.0 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 111.894 0.331 . . . . 73.340000000000003 111.894 -177.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 695' ' ' GLU . . . . . 0.462 ' HG2' ' OD1' ' A' ' 693' ' ' ASP . 12.2 pt-20 -81.72 -46.37 14.38 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 112.189 0.441 . . . . 74.040000000000006 112.189 -175.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 696' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -95.53 -48.85 5.66 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.138 0.494 . . . . 73.349999999999994 111.683 -174.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . 119.22 -119.28 4.25 Favored Glycine 0 CA--C 1.525 0.658 0 CA-C-N 116.006 -0.543 . . . . 64.439999999999998 112.423 -175.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 698' ' ' ASP . . . . . 0.548 ' HA ' HD13 ' A' ' 692' ' ' ILE . 12.9 t70 -74.88 116.36 15.51 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 122.372 -0.487 . . . . 74.0 111.757 -178.082 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 699' ' ' LEU . . . . . 0.517 HD11 ' HB3' ' A' ' 667' ' ' PRO . 57.8 mt -114.54 22.95 13.17 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 116.108 -0.497 . . . . 74.420000000000002 110.944 174.25 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 37.7 m -60.54 -37.39 81.05 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 120.979 0.419 . . . . 73.519999999999996 111.823 -176.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 701' ' ' SER . . . . . . . . . . . . . 70.6 m -74.51 -10.9 60.0 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 120.848 0.356 . . . . 71.430000000000007 111.794 177.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 702' ' ' LYS . . . . . 0.439 ' HG3' HD21 ' A' ' 699' ' ' LEU . 48.0 mmtm -90.88 7.22 41.08 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 120.831 0.348 . . . . 72.340000000000003 111.433 -178.413 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 703' ' ' ILE . . . . . 0.472 ' HB ' ' HE2' ' A' ' 686' ' ' MET . 66.4 mt -87.24 117.73 31.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 CA-C-O 121.234 0.54 . . . . 75.329999999999998 112.421 -177.37 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 704' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -84.68 135.39 34.18 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.959 -0.564 . . . . 72.099999999999994 110.546 173.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 56.2 t -107.98 143.58 18.19 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-O 120.844 0.354 . . . . 74.299999999999997 111.954 -177.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 706' ' ' ASP . . . . . 0.481 ' HB3' ' HB ' ' A' ' 720' ' ' THR . 24.7 t70 -129.05 143.5 50.89 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 122.713 0.405 . . . . 75.349999999999994 110.673 175.103 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 93.36 174.38 40.36 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 121.315 -0.469 . . . . 71.439999999999998 112.516 -174.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 708' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -152.07 137.9 18.01 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 122.259 -0.554 . . . . 73.140000000000001 112.157 -179.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 709' ' ' VAL . . . . . . . . . . . . . 89.3 t -106.68 114.97 47.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-O 120.94 0.4 . . . . 73.439999999999998 111.466 178.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 710' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -82.43 136.87 34.84 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 116.472 -0.331 . . . . 73.510000000000005 110.881 176.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 711' ' ' THR . . . . . . . . . . . . . 78.9 p -97.4 -31.88 12.15 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 112.326 0.491 . . . . 64.040000000000006 112.326 -176.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 712' ' ' THR . . . . . . . . . . . . . 51.0 p -85.42 -0.16 54.03 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.547 0.573 . . . . 60.100000000000001 112.547 -177.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 713' ' ' LYS . . . . . . . . . . . . . 23.0 tptp -140.3 132.4 27.97 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.705 0.288 . . . . 75.310000000000002 110.964 -178.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 714' ' ' ALA . . . . . . . . . . . . . . . -75.65 144.69 41.53 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 112.046 0.388 . . . . 63.229999999999997 112.046 -177.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 162.09 164.35 16.85 Favored Glycine 0 CA--C 1.523 0.591 0 C-N-CA 121.219 -0.515 . . . . 52.009999999999998 112.828 179.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 716' ' ' THR . . . . . . . . . . . . . 54.8 m -95.73 123.23 39.2 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.119 0.485 . . . . 63.43 111.434 178.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 717' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -120.75 110.59 16.56 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 116.109 -0.496 . . . . 75.219999999999999 110.659 -179.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 718' ' ' VAL . . . . . . . . . . . . . 48.8 t -90.58 107.82 18.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-O 121.082 0.467 . . . . 75.230000000000004 111.059 179.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 719' ' ' LEU . . . . . . . . . . . . . 59.9 mt -89.52 150.43 22.45 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.128 -0.487 . . . . 75.239999999999995 111.968 -176.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 720' ' ' THR . . . . . 0.481 ' HB ' ' HB3' ' A' ' 706' ' ' ASP . 92.2 m -121.87 135.85 54.91 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 116.412 -0.358 . . . . 64.140000000000001 110.902 177.276 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 721' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -122.08 142.72 50.08 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.929 0.395 . . . . 74.099999999999994 111.463 -178.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 69.9 m -138.71 135.12 34.43 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 122.399 0.28 . . . . 74.430000000000007 111.138 -179.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 10.9 p -128.3 144.27 38.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 O-C-N 122.233 -0.292 . . . . 71.510000000000005 111.14 178.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 28.8 m -110.7 144.01 40.29 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.434 0.635 . . . . 73.239999999999995 112.214 -177.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 725' ' ' ASP . . . . . 0.407 ' HB3' ' N ' ' A' ' 729' ' ' HIS . 45.2 t0 -91.74 151.74 20.49 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.916 0.886 . . . . 74.450000000000003 110.25 -179.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 726' ' ' SER . . . . . 0.434 ' HB3' ' OE2' ' A' ' 695' ' ' GLU . 48.0 t -64.95 -22.71 67.04 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.161 0.505 . . . . 74.329999999999998 110.846 177.602 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 727' ' ' LYS . . . . . . . . . . . . . 27.5 mmtp -90.29 -6.33 55.26 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 116.187 -0.461 . . . . 73.329999999999998 111.885 177.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 728' ' ' GLY . . . . . . . . . . . . . . . 109.25 -5.84 31.94 Favored Glycine 0 CA--C 1.531 1.044 0 N-CA-C 114.776 0.671 . . . . 63.520000000000003 114.776 176.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 729' ' ' HIS . . . . . 0.492 ' HB3' ' HG3' ' A' ' 666' ' ' GLU . 39.7 m80 -68.91 138.35 54.57 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 117.933 0.866 . . . . 74.200000000000003 111.028 179.284 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 730' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -133.65 130.92 38.92 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 120.832 0.349 . . . . 75.219999999999999 111.77 -178.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 26.9 m -131.48 160.87 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-N 116.342 -0.39 . . . . 74.400000000000006 111.625 -179.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 2.8 t -142.64 146.91 34.96 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 112.771 0.656 . . . . 73.319999999999993 112.771 -174.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -148.66 154.45 39.68 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 116.103 -0.499 . . . . 65.010000000000005 110.741 178.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 734' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -123.02 159.66 27.93 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 113.367 0.877 . . . . 74.430000000000007 113.367 -174.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 735' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -138.25 137.7 37.76 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 115.326 -0.852 . . . . 72.209999999999994 110.988 179.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 736' ' ' THR . . . . . 0.404 ' O ' ' HA2' ' A' ' 674' ' ' GLY . 99.0 m -103.36 106.48 17.0 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 121.01 0.433 . . . . 73.329999999999998 111.934 178.619 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 45.1 t -96.64 140.91 16.41 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 116.626 -0.261 . . . . 74.329999999999998 110.643 177.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 738' ' ' THR . . . . . . . . . . . . . 87.5 m -132.88 114.14 13.7 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 122.001 -0.437 . . . . 73.140000000000001 111.645 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 739' ' ' VAL . . . . . 0.414 HG21 HG13 ' A' ' 677' ' ' ILE . 52.8 t -93.28 137.07 23.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-N 116.212 -0.449 . . . . 73.349999999999994 110.829 177.504 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 740' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -123.01 149.45 44.3 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.117 0.484 . . . . 73.319999999999993 111.559 179.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 741' ' ' VAL . . . . . 0.437 ' HA ' HG21 ' A' ' 679' ' ' VAL . 26.9 t -75.77 151.77 6.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 116.288 -0.415 . . . . 60.009999999999998 111.419 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 742' ' ' ARG . . . . . . . . . . . . . 16.2 ptt180 -105.38 155.27 19.28 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 121.061 0.457 . . . . 75.099999999999994 111.236 178.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 743' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -93.15 115.59 28.22 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 121.168 0.509 . . . . 70.140000000000001 110.168 171.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 744' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -117.35 173.72 6.54 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.277 0.561 . . . . 72.329999999999998 112.257 -172.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 18.8 m -109.43 -177.78 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-N 115.996 -0.547 . . . . 72.120000000000005 111.22 178.461 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 21.6 pttm -109.46 145.03 36.89 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.785 0.326 . . . . 75.310000000000002 110.485 173.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 747' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -154.65 160.23 41.29 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.449 -0.341 . . . . 75.519999999999996 111.039 -175.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -76.99 38.98 0.22 Allowed 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 112.35 0.5 . . . . 73.439999999999998 112.35 178.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 749' ' ' LYS . . . . . 0.425 ' HB3' HG12 ' A' ' 751' ' ' ILE . 53.1 mtpt 61.75 98.81 0.04 OUTLIER Pre-proline 0 CA--C 1.543 0.71 0 C-N-CA 123.063 0.545 . . . . 71.420000000000002 112.299 178.463 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 750' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -74.3 47.41 1.57 Allowed 'Trans proline' 0 CA--C 1.546 1.111 0 C-N-CA 123.134 2.556 . . . . 72.340000000000003 113.083 178.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 751' ' ' ILE . . . . . 0.425 HG12 ' HB3' ' A' ' 749' ' ' LYS . 15.5 mm -82.82 28.44 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.868 0 CA-C-O 121.652 0.739 . . . . 73.129999999999995 111.425 -177.206 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 752' ' ' LEU . . . . . 0.452 HD13 ' N ' ' A' ' 752' ' ' LEU . 6.2 mp -81.25 41.13 0.59 Allowed 'General case' 0 CA--C 1.544 0.713 0 O-C-N 121.819 -0.551 . . . . 74.010000000000005 111.357 -179.196 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 753' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 . . . . . 0 N--CA 1.468 0.465 0 CA-C-N 116.09 -0.505 . . . . 73.200000000000003 111.503 -177.727 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 762' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 657' ' ' MET . . . . . . . . . . . . . 28.1 ttt . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 120.759 0.314 . . . . 75.129999999999995 111.152 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 658' ' ' GLY . . . . . . . . . . . . . . . 74.66 -74.14 1.35 Allowed Glycine 0 CA--C 1.527 0.824 0 C-N-CA 121.201 -0.523 . . . . 73.140000000000001 113.344 178.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 659' ' ' ASN . . . . . . . . . . . . . 64.1 m-20 -75.52 130.6 39.13 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 122.594 -0.356 . . . . 75.120000000000005 111.604 -177.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 660' ' ' GLY . . . . . . . . . . . . . . . -57.03 142.98 41.27 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 121.484 -0.389 . . . . 70.540000000000006 113.641 178.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -117.88 169.11 9.89 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.312 0.577 . . . . 74.409999999999997 112.493 -177.656 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 662' ' ' THR . . . . . . . . . . . . . 62.6 p -106.82 153.68 22.12 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 115.935 -0.575 . . . . 74.310000000000002 111.677 -179.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 663' ' ' SER . . . . . . . . . . . . . 48.9 p -74.17 122.51 22.88 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 116.364 -0.38 . . . . 64.340000000000003 111.708 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 664' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -105.02 126.6 52.24 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.456 0.646 . . . . 73.200000000000003 111.995 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 665' ' ' LEU . . . . . . . . . . . . . 89.2 mt -96.04 138.32 33.83 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.749 -0.66 . . . . 75.340000000000003 111.196 178.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 666' ' ' GLU . . . . . 0.435 ' H ' ' CD ' ' A' ' 666' ' ' GLU . 0.8 OUTLIER -82.22 140.11 45.62 Favored Pre-proline 0 CA--C 1.541 0.625 0 CA-C-N 116.01 -0.541 . . . . 71.030000000000001 110.872 174.974 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 667' ' ' PRO . . . . . 0.506 ' HB3' HD11 ' A' ' 699' ' ' LEU . 42.3 Cg_endo -65.79 138.3 52.87 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 122.715 2.277 . . . . 71.239999999999995 113.869 -171.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 668' ' ' LYS . . . . . . . . . . . . . 28.9 ttpp -82.9 107.68 15.69 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.905 -0.588 . . . . 72.439999999999998 110.747 177.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 669' ' ' LEU . . . . . 0.422 ' HG ' HG22 ' A' ' 671' ' ' VAL . 55.3 tp -100.78 112.48 24.9 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 121.146 0.498 . . . . 74.530000000000001 111.176 -178.633 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 670' ' ' THR . . . . . . . . . . . . . 94.7 m -93.47 111.48 23.16 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.962 0.41 . . . . 73.099999999999994 111.115 179.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 671' ' ' VAL . . . . . 0.422 HG22 ' HG ' ' A' ' 669' ' ' LEU . 73.8 t -137.49 137.24 21.64 Favored Pre-proline 0 CA--C 1.54 0.569 0 CA-C-N 115.767 -0.651 . . . . 65.109999999999999 110.843 -178.237 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 672' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -73.93 139.56 27.48 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 122.098 1.865 . . . . 70.150000000000006 112.015 174.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 673' ' ' VAL . . . . . . . . . . . . . 10.9 p -79.9 -29.64 12.9 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 CA-C-O 120.955 0.407 . . . . 73.329999999999998 112.017 -177.058 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 674' ' ' GLY . . . . . . . . . . . . . . . -158.89 142.65 8.53 Favored Glycine 0 CA--C 1.523 0.563 0 C-N-CA 120.804 -0.713 . . . . 72.120000000000005 113.263 179.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 675' ' ' ALA . . . . . . . . . . . . . . . -142.7 121.14 12.41 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 120.844 0.354 . . . . 74.120000000000005 111.709 -178.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 676' ' ' THR . . . . . . . . . . . . . 62.4 m -101.41 119.0 38.1 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.701 0.286 . . . . 74.140000000000001 110.923 179.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 677' ' ' ILE . . . . . . . . . . . . . 32.1 pt -125.36 177.01 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-O 121.095 0.474 . . . . 73.319999999999993 111.333 -179.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 678' ' ' HIS . . . . . . . . . . . . . 65.6 m80 -116.99 157.94 24.94 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 121.133 0.492 . . . . 65.140000000000001 111.754 179.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 679' ' ' VAL . . . . . 0.436 HG13 ' HA ' ' A' ' 712' ' ' THR . 95.9 t -57.37 116.35 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 116.093 -0.503 . . . . 72.319999999999993 110.526 174.307 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 117.44 -22.36 10.24 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 121.294 -0.479 . . . . 55.43 112.682 -175.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 681' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -62.79 150.26 41.95 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.537 0.684 . . . . 74.420000000000002 112.697 178.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 682' ' ' SER . . . . . . . . . . . . . 99.9 p -90.64 146.07 24.33 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 115.373 -0.83 . . . . 53.219999999999999 110.162 171.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 683' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -150.1 112.26 4.63 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 120.974 0.416 . . . . 74.530000000000001 111.628 -178.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 684' ' ' VAL . . . . . . . . . . . . . 58.5 t -115.33 98.93 51.7 Favored Pre-proline 0 CA--C 1.543 0.679 0 CA-C-O 120.953 0.406 . . . . 73.150000000000006 111.198 178.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -63.44 -25.89 70.65 Favored 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 122.673 2.249 . . . . 74.340000000000003 113.144 -177.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 686' ' ' MET . . . . . 0.428 ' HA ' ' HE2' ' A' ' 686' ' ' MET . 0.0 OUTLIER -87.29 11.32 14.59 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.265 0.469 . . . . 74.219999999999999 112.265 179.57 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 687' ' ' ALA . . . . . . . . . . . . . . . -119.43 -32.43 4.35 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.908 0.385 . . . . 73.439999999999998 111.396 175.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 688' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -90.92 9.72 29.35 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 112.289 0.477 . . . . 75.140000000000001 112.289 -178.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 94.2 t -125.76 139.19 52.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 122.56 0.344 . . . . 73.420000000000002 110.93 177.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 690' ' ' LEU . . . . . 0.453 HD23 ' N ' ' A' ' 691' ' ' ALA . 2.3 tt -142.73 133.06 24.77 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-O 120.691 0.281 . . . . 75.340000000000003 111.121 -176.06 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 691' ' ' ALA . . . . . 0.453 ' N ' HD23 ' A' ' 690' ' ' LEU . . . -126.63 125.52 42.05 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 112.465 0.543 . . . . 71.120000000000005 112.465 -178.042 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 692' ' ' ILE . . . . . 0.501 HD11 ' HA ' ' A' ' 698' ' ' ASP . 43.4 mm -134.36 132.11 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 CA-C-N 116.418 -0.356 . . . . 75.209999999999994 111.813 -179.083 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -107.98 129.63 55.1 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 109.194 -0.669 . . . . 75.120000000000005 109.194 168.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -60.24 -29.12 68.57 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 112.362 0.504 . . . . 75.409999999999997 112.362 -173.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -78.84 -45.87 19.86 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 120.999 0.428 . . . . 74.400000000000006 111.909 -179.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 696' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -94.07 -48.57 6.17 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.993 0.425 . . . . 74.109999999999999 111.455 -171.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . 124.02 -131.98 8.19 Favored Glycine 0 CA--C 1.524 0.614 0 CA-C-N 116.263 -0.426 . . . . 71.439999999999998 112.977 -178.086 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 698' ' ' ASP . . . . . 0.501 ' HA ' HD11 ' A' ' 692' ' ' ILE . 32.0 t70 -72.33 119.8 17.04 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 112.301 0.482 . . . . 75.230000000000004 112.301 -178.577 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 699' ' ' LEU . . . . . 0.52 HD22 ' HD2' ' A' ' 702' ' ' LYS . 62.4 mt -118.06 14.59 14.09 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 120.981 0.42 . . . . 75.099999999999994 110.873 175.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 81.2 m -60.01 -33.77 72.44 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.293 0.479 . . . . 70.450000000000003 112.293 -178.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 701' ' ' SER . . . . . . . . . . . . . 32.2 t -70.29 -16.7 63.05 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.196 0.522 . . . . 73.099999999999994 111.377 177.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 702' ' ' LYS . . . . . 0.52 ' HD2' HD22 ' A' ' 699' ' ' LEU . 67.5 mttm -91.88 6.38 46.38 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.197 -0.456 . . . . 73.129999999999995 111.769 179.592 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 703' ' ' ILE . . . . . 0.42 HG12 ' HB ' ' A' ' 723' ' ' VAL . 67.0 mt -82.3 133.87 28.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-O 120.946 0.403 . . . . 71.519999999999996 111.326 177.361 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 704' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -112.74 126.93 55.95 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.474 -0.33 . . . . 74.530000000000001 110.534 174.189 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 61.7 t -98.66 124.29 51.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-O 120.914 0.388 . . . . 72.140000000000001 111.605 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 706' ' ' ASP . . . . . 0.443 ' HB3' ' HB ' ' A' ' 720' ' ' THR . 37.3 t70 -109.95 143.25 40.16 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 116.26 -0.427 . . . . 74.25 110.658 174.4 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 94.16 166.76 37.02 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 121.015 -0.612 . . . . 62.310000000000002 113.102 -178.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 708' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -149.52 152.61 35.85 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 120.925 0.393 . . . . 72.519999999999996 111.473 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 709' ' ' VAL . . . . . 0.441 HG23 ' HB2' ' A' ' 717' ' ' TYR . 67.2 t -121.63 135.71 60.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 CA-C-N 116.498 -0.319 . . . . 74.030000000000001 111.608 -177.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 710' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -86.82 136.13 33.09 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.805 0.336 . . . . 74.519999999999996 110.824 173.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 711' ' ' THR . . . . . . . . . . . . . 68.3 p -106.4 4.04 28.03 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.124 0.488 . . . . 64.349999999999994 110.758 176.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 712' ' ' THR . . . . . 0.436 ' HA ' HG13 ' A' ' 679' ' ' VAL . 71.2 p -112.2 -11.76 13.72 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.91 -0.586 . . . . 72.25 112.255 -178.152 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 713' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -132.63 132.57 42.61 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.619 -0.264 . . . . 72.409999999999997 110.711 -178.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 714' ' ' ALA . . . . . 0.467 ' HB2' HG22 ' A' ' 741' ' ' VAL . . . -70.38 141.78 52.16 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 112.244 0.461 . . . . 74.319999999999993 112.244 -178.429 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 152.56 170.38 18.93 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 121.072 -0.585 . . . . 74.319999999999993 113.452 179.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 716' ' ' THR . . . . . . . . . . . . . 91.8 m -93.5 130.47 39.33 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 120.961 0.41 . . . . 55.229999999999997 111.668 177.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 717' ' ' TYR . . . . . 0.441 ' HB2' HG23 ' A' ' 709' ' ' VAL . 45.2 m-85 -128.16 139.74 52.31 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 122.763 0.425 . . . . 73.510000000000005 110.398 179.693 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 718' ' ' VAL . . . . . . . . . . . . . 45.3 t -105.86 140.59 23.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 N-CA-C 112.316 0.488 . . . . 74.219999999999999 112.316 -175.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 719' ' ' LEU . . . . . 0.402 HD23 HG22 ' A' ' 709' ' ' VAL . 85.3 mt -128.22 139.33 52.51 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 116.126 -0.488 . . . . 73.319999999999993 111.536 178.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 720' ' ' THR . . . . . 0.443 ' HB ' ' HB3' ' A' ' 706' ' ' ASP . 96.5 m -120.51 139.26 53.16 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 120.814 0.34 . . . . 71.129999999999995 111.218 178.003 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 721' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -128.13 126.77 41.75 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 116.676 -0.238 . . . . 74.400000000000006 110.825 -178.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 85.0 m -132.13 135.09 46.15 Favored 'General case' 0 N--CA 1.475 0.818 0 O-C-N 122.416 -0.178 . . . . 74.099999999999994 111.476 -178.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 723' ' ' VAL . . . . . 0.42 ' HB ' HG12 ' A' ' 703' ' ' ILE . 7.5 p -130.45 137.64 55.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-O 121.032 0.444 . . . . 75.120000000000005 111.529 179.771 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 24.1 m -106.56 127.91 53.7 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.129 0.418 . . . . 75.299999999999997 112.129 -177.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 725' ' ' ASP . . . . . 0.478 ' HB2' ' HD3' ' A' ' 667' ' ' PRO . 1.1 t70 -81.59 150.95 27.91 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 122.945 0.498 . . . . 73.010000000000005 111.569 176.373 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 726' ' ' SER . . . . . . . . . . . . . 48.9 m -58.24 -34.08 70.05 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 112.57 0.581 . . . . 72.010000000000005 112.57 -176.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 727' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -85.76 -8.54 58.08 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 112.501 0.556 . . . . 73.120000000000005 112.501 -178.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 728' ' ' GLY . . . . . . . . . . . . . . . 113.1 14.3 10.09 Favored Glycine 0 CA--C 1.535 1.294 0 N-CA-C 115.255 0.862 . . . . 74.310000000000002 115.255 175.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 729' ' ' HIS . . . . . 0.409 ' O ' ' HB3' ' A' ' 725' ' ' ASP . 13.5 m80 -89.79 108.51 19.74 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 117.908 0.854 . . . . 74.319999999999993 111.229 172.518 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 730' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -108.17 113.88 27.35 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 120.811 0.338 . . . . 72.329999999999998 111.292 -178.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 731' ' ' VAL . . . . . 0.435 HG21 ' HG2' ' A' ' 667' ' ' PRO . 17.8 m -112.45 159.15 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 CA-C-O 120.624 0.249 . . . . 70.349999999999994 111.517 -177.675 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 8.8 t -147.14 151.94 37.62 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 112.746 0.647 . . . . 71.030000000000001 112.746 -177.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -148.25 161.34 41.69 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.933 -0.576 . . . . 74.549999999999997 110.424 178.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 734' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -130.64 159.59 36.74 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 112.901 0.704 . . . . 72.310000000000002 112.901 -175.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 735' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -134.03 128.41 34.27 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.581 -0.736 . . . . 73.019999999999996 111.075 178.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 736' ' ' THR . . . . . . . . . . . . . 74.3 m -99.52 107.41 19.58 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 120.918 0.39 . . . . 72.239999999999995 111.108 175.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 47.4 t -97.04 141.11 16.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-O 120.71 0.291 . . . . 72.239999999999995 111.414 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 738' ' ' THR . . . . . . . . . . . . . 85.9 m -131.32 120.91 23.82 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 122.093 -0.379 . . . . 71.430000000000007 110.917 177.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 739' ' ' VAL . . . . . . . . . . . . . 38.4 t -101.18 133.6 43.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 N-CA-C 111.831 0.308 . . . . 75.5 111.831 -177.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 740' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -120.89 149.93 41.85 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 120.811 0.339 . . . . 70.239999999999995 111.509 177.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 741' ' ' VAL . . . . . 0.467 HG22 ' HB2' ' A' ' 714' ' ' ALA . 21.2 t -84.68 162.2 3.02 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 O-C-N 122.277 -0.264 . . . . 72.450000000000003 110.72 176.803 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 742' ' ' ARG . . . . . 0.44 ' N ' HG12 ' A' ' 741' ' ' VAL . 5.4 mpt_? -61.17 161.78 8.3 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.235 0.541 . . . . 74.519999999999996 111.455 175.051 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 743' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -66.92 90.19 0.18 Allowed 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.011 0.434 . . . . 70.310000000000002 111.837 178.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 744' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -72.02 101.18 2.66 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.106 0.479 . . . . 64.129999999999995 110.651 174.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 73.1 t -68.99 127.98 31.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-N 116.295 -0.411 . . . . 60.32 111.074 179.562 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 746' ' ' LYS . . . . . 0.43 ' O ' ' HG3' ' A' ' 746' ' ' LYS . 52.7 pttt -68.95 95.48 0.7 Allowed 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 121.516 0.674 . . . . 73.540000000000006 111.61 179.614 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 747' ' ' ASN . . . . . . . . . . . . . 13.4 p30 -76.74 -159.46 0.12 Allowed 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.086 -0.506 . . . . 74.430000000000007 110.981 175.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -54.44 91.58 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 112.861 0.689 . . . . 55.310000000000002 112.861 -178.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 749' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt 53.41 84.1 0.22 Allowed Pre-proline 0 CA--C 1.545 0.787 0 N-CA-C 112.974 0.731 . . . . 63.420000000000002 112.974 174.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 750' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -68.18 110.6 2.25 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 122.482 2.121 . . . . 65.230000000000004 111.822 172.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 751' ' ' ILE . . . . . . . . . . . . . 60.5 mt -76.47 132.97 31.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-O 121.003 0.43 . . . . 62.229999999999997 111.788 -177.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 752' ' ' LEU . . . . . . . . . . . . . 1.9 pp -143.18 171.47 14.04 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 116.25 -0.432 . . . . 73.310000000000002 111.902 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 753' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 . . . . . 0 N--CA 1.47 0.542 0 CA-C-O 121.102 0.477 . . . . 72.239999999999995 111.401 179.685 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 762' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 664' ' ' ASP . . . . . . . . . . . . . 10.6 t70 . . . . . 0 N--CA 1.468 0.432 0 CA-C-O 121.098 0.475 . . . . 52.200000000000003 111.022 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 665' ' ' LEU . . . . . . . . . . . . . 86.0 mt -80.77 136.52 36.15 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.033 -0.53 . . . . 75.549999999999997 110.448 174.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 666' ' ' GLU . . . . . 0.473 ' H ' ' CD ' ' A' ' 666' ' ' GLU . 2.3 pm0 -70.25 140.67 88.02 Favored Pre-proline 0 CA--C 1.538 0.486 0 CA-C-N 116.322 -0.399 . . . . 73.530000000000001 110.575 177.311 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 667' ' ' PRO . . . . . 0.534 ' HB3' HD12 ' A' ' 699' ' ' LEU . 19.1 Cg_endo -56.64 135.94 73.27 Favored 'Trans proline' 0 CA--C 1.537 0.668 0 C-N-CA 122.7 2.267 . . . . 61.350000000000001 113.593 -171.167 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 668' ' ' LYS . . . . . . . . . . . . . 27.4 tptp -82.8 105.09 13.53 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.048 -0.524 . . . . 73.209999999999994 110.527 176.514 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 669' ' ' LEU . . . . . 0.421 ' HG ' HG23 ' A' ' 671' ' ' VAL . 56.8 tp -91.65 128.38 37.46 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.957 -0.565 . . . . 55.420000000000002 110.045 175.635 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 670' ' ' THR . . . . . . . . . . . . . 89.5 m -113.93 110.78 20.62 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.122 0.487 . . . . 43.340000000000003 111.151 178.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 671' ' ' VAL . . . . . 0.503 HG22 HG13 ' A' ' 689' ' ' VAL . 97.8 t -135.09 131.98 20.02 Favored Pre-proline 0 CA--C 1.54 0.586 0 CA-C-N 115.63 -0.713 . . . . 62.109999999999999 110.759 -177.303 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 672' ' ' PRO . . . . . 0.403 ' HG2' ' NE2' ' A' ' 735' ' ' GLN . 61.0 Cg_endo -73.62 121.76 7.32 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 122.239 1.959 . . . . 72.150000000000006 111.997 176.094 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 673' ' ' VAL . . . . . . . . . . . . . 14.7 p -64.15 -26.51 40.62 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 N-CA-C 112.286 0.476 . . . . 54.539999999999999 112.286 -175.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 674' ' ' GLY . . . . . . . . . . . . . . . -148.94 139.35 7.46 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 120.864 -0.684 . . . . 55.399999999999999 113.653 -179.113 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 675' ' ' ALA . . . . . . . . . . . . . . . -137.29 151.48 48.71 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 122.799 0.44 . . . . 62.409999999999997 110.937 178.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 676' ' ' THR . . . . . . . . . . . . . 88.4 m -138.84 119.16 13.67 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 122.155 -0.341 . . . . 71.400000000000006 111.48 179.675 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 677' ' ' ILE . . . . . . . . . . . . . 33.6 pt -131.04 176.55 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 CA-C-O 120.91 0.386 . . . . 72.340000000000003 111.323 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 678' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -109.22 163.71 13.11 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.337 0.589 . . . . 54.240000000000002 112.502 -178.591 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 679' ' ' VAL . . . . . . . . . . . . . 91.4 t -63.55 115.77 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-N 115.753 -0.658 . . . . 71.299999999999997 111.031 174.56 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 99.74 0.52 56.43 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 121.472 -0.394 . . . . 35.109999999999999 112.935 -177.41 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 681' ' ' ASP . . . . . . . . . . . . . 35.3 t0 -88.8 157.48 18.47 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-O 121.17 0.509 . . . . 72.340000000000003 111.759 -178.42 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 682' ' ' SER . . . . . . . . . . . . . 91.3 p -82.37 144.84 30.25 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 116.099 -0.5 . . . . 53.009999999999998 112.0 -177.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 683' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -148.58 114.16 5.64 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 116.605 -0.27 . . . . 71.340000000000003 111.016 177.11 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 684' ' ' VAL . . . . . . . . . . . . . 58.0 t -116.19 99.82 52.99 Favored Pre-proline 0 CA--C 1.545 0.764 0 CA-C-O 120.689 0.28 . . . . 54.240000000000002 111.653 -179.578 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -59.89 -37.18 87.56 Favored 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 122.928 2.419 . . . . 74.010000000000005 113.7 -177.355 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 686' ' ' MET . . . . . 0.409 ' HA ' ' CE ' ' A' ' 686' ' ' MET . 1.1 mmt -79.09 -2.91 42.79 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 112.634 0.605 . . . . 75.140000000000001 112.634 -177.243 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 687' ' ' ALA . . . . . . . . . . . . . . . -97.25 -32.18 12.05 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 120.918 0.39 . . . . 63.130000000000003 111.657 176.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 688' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -98.4 -2.57 38.86 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 112.471 0.545 . . . . 64.530000000000001 112.471 -175.702 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 689' ' ' VAL . . . . . 0.503 HG13 HG22 ' A' ' 671' ' ' VAL . 95.1 t -123.31 124.83 70.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-O 120.832 0.348 . . . . 71.120000000000005 111.643 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 690' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -123.92 162.31 23.62 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 116.432 -0.349 . . . . 63.109999999999999 111.41 -179.389 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 691' ' ' ALA . . . . . . . . . . . . . . . -149.35 121.57 8.37 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 120.788 0.327 . . . . 53.299999999999997 111.271 175.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 692' ' ' ILE . . . . . . . . . . . . . 35.3 mm -127.56 130.03 70.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 N-CA-C 112.285 0.476 . . . . 72.140000000000001 112.285 -175.133 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -115.82 145.26 42.99 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 120.866 0.365 . . . . 72.549999999999997 110.161 172.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 694' ' ' LYS . . . . . 0.466 ' NZ ' ' HB2' ' A' ' 694' ' ' LYS . 2.1 ttmp? -72.57 -45.55 58.65 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 112.125 0.416 . . . . 64.349999999999994 112.125 -178.396 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 32.2 mp0 -83.48 -49.43 9.28 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.245 -0.434 . . . . 75.430000000000007 112.166 -172.631 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 696' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -82.95 -33.51 26.72 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 120.869 0.366 . . . . 75.319999999999993 111.229 -175.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . 116.01 -150.61 18.59 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 121.174 -0.536 . . . . 71.340000000000003 113.407 176.671 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -70.65 118.94 14.08 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 120.87 0.367 . . . . 74.329999999999998 110.976 179.561 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 699' ' ' LEU . . . . . 0.534 HD12 ' HB3' ' A' ' 667' ' ' PRO . 24.3 mt -109.19 13.38 24.45 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 111.709 0.263 . . . . 71.450000000000003 111.709 -178.572 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 25.3 m -57.33 -38.95 74.88 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 121.071 0.462 . . . . 62.340000000000003 111.635 -178.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 701' ' ' SER . . . . . . . . . . . . . 35.3 m -66.63 -23.98 66.24 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.01 0.433 . . . . 74.099999999999994 111.65 178.656 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 702' ' ' LYS . . . . . 0.464 ' HD2' HD22 ' A' ' 699' ' ' LEU . 94.9 mttt -84.82 -6.42 59.35 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 112.156 0.428 . . . . 72.450000000000003 112.156 -176.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 703' ' ' ILE . . . . . 0.439 HD13 HG12 ' A' ' 689' ' ' VAL . 69.7 mt -63.57 123.2 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-O 121.213 0.53 . . . . 73.519999999999996 112.168 -178.289 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 704' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? -88.77 117.93 28.1 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.029 -0.532 . . . . 75.239999999999995 110.197 176.238 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 54.1 t -103.14 105.93 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-O 120.926 0.393 . . . . 74.040000000000006 111.512 -176.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 706' ' ' ASP . . . . . 0.479 ' HB3' ' HB ' ' A' ' 720' ' ' THR . 18.6 t70 -108.25 148.03 30.56 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 120.893 0.378 . . . . 65.409999999999997 111.411 -178.388 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 99.91 179.13 30.52 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 121.176 -0.535 . . . . 64.209999999999994 112.77 -177.504 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 708' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -150.33 133.78 16.46 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 122.393 -0.475 . . . . 63.409999999999997 112.166 -178.307 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 709' ' ' VAL . . . . . 0.517 HG22 ' HB2' ' A' ' 717' ' ' TYR . 93.7 t -111.37 120.82 62.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 CA-C-N 116.135 -0.484 . . . . 63.119999999999997 111.085 176.387 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 710' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -99.39 139.34 35.19 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 120.783 0.325 . . . . 65.349999999999994 111.053 177.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 711' ' ' THR . . . . . . . . . . . . . 75.8 p -111.36 13.4 21.59 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 112.476 0.547 . . . . 52.229999999999997 112.476 -179.3 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 712' ' ' THR . . . . . . . . . . . . . 71.3 p -102.57 -26.63 13.15 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-O 121.321 0.581 . . . . 72.010000000000005 111.253 175.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 713' ' ' LYS . . . . . 0.533 ' HB2' ' HZ3' ' A' ' 713' ' ' LYS . 0.1 OUTLIER -116.54 135.9 53.43 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 115.869 -0.605 . . . . 64.510000000000005 110.786 178.156 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 714' ' ' ALA . . . . . . . . . . . . . . . -74.89 137.56 41.82 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.485 -0.325 . . . . 32.530000000000001 111.595 179.147 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 160.71 -179.7 36.02 Favored Glycine 0 CA--C 1.523 0.567 0 C-N-CA 120.973 -0.632 . . . . 55.240000000000002 113.242 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 716' ' ' THR . . . . . . . . . . . . . 84.3 m -103.36 130.75 50.74 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.097 0.475 . . . . 75.150000000000006 111.619 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 717' ' ' TYR . . . . . 0.517 ' HB2' HG22 ' A' ' 709' ' ' VAL . 18.5 m-85 -129.12 125.1 36.38 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 116.061 -0.518 . . . . 71.420000000000002 110.154 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 718' ' ' VAL . . . . . . . . . . . . . 61.8 t -102.41 121.8 53.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-O 121.126 0.489 . . . . 72.510000000000005 112.189 -176.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 719' ' ' LEU . . . . . 0.499 HD21 HG23 ' A' ' 709' ' ' VAL . 95.4 mt -99.94 144.45 28.98 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.454 -0.339 . . . . 64.450000000000003 111.534 178.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 720' ' ' THR . . . . . 0.479 ' HB ' ' HB3' ' A' ' 706' ' ' ASP . 64.2 m -113.48 134.33 54.73 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.832 0.349 . . . . 64.540000000000006 111.164 178.375 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 721' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -125.32 114.36 18.81 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.563 -0.29 . . . . 74.230000000000004 110.89 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 60.6 m -121.54 127.1 50.62 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 120.637 0.256 . . . . 54.210000000000001 111.372 -179.273 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 11.1 p -129.44 137.55 56.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-O 121.047 0.451 . . . . 75.019999999999996 111.625 -179.407 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 23.7 m -119.92 134.87 55.1 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.049 0.452 . . . . 74.019999999999996 112.071 -177.06 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -82.8 149.11 27.39 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 115.956 -0.565 . . . . 72.219999999999999 110.028 173.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 726' ' ' SER . . . . . . . . . . . . . 38.3 t -66.84 -20.39 65.92 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.058 0.456 . . . . 43.399999999999999 110.915 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 727' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -81.9 -4.03 55.6 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 115.893 -0.594 . . . . 75.409999999999997 111.971 178.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 728' ' ' GLY . . . . . . . . . . . . . . . 108.2 -5.68 34.01 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 115.023 0.769 . . . . 43.240000000000002 115.023 173.121 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 36.1 m80 -84.28 122.61 29.14 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 117.848 0.824 . . . . 64.340000000000003 111.402 178.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 730' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -121.52 132.43 54.7 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 120.868 0.365 . . . . 71.109999999999999 111.707 -178.418 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 27.4 m -131.15 149.9 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-O 120.82 0.343 . . . . 72.219999999999999 111.374 177.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 7.2 t -144.36 147.64 33.69 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 121.088 0.47 . . . . 63.130000000000003 112.264 -178.646 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -148.99 161.38 42.03 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 116.083 -0.508 . . . . 52.530000000000001 110.927 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 734' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -121.95 160.29 25.16 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 112.567 0.58 . . . . 74.140000000000001 112.567 -178.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 735' ' ' GLN . . . . . 0.403 ' NE2' ' HG2' ' A' ' 672' ' ' PRO . 51.2 tt0 -129.37 122.13 28.83 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.554 -0.748 . . . . 71.340000000000003 110.464 179.116 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 736' ' ' THR . . . . . . . . . . . . . 20.9 m -94.11 103.4 15.46 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.629 0.252 . . . . 74.549999999999997 111.262 -179.309 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 43.2 t -96.85 133.49 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-O 120.724 0.297 . . . . 72.019999999999996 111.316 -179.236 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 738' ' ' THR . . . . . . . . . . . . . 93.8 m -121.29 112.38 18.53 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.05 0.452 . . . . 72.219999999999999 110.875 177.277 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 739' ' ' VAL . . . . . . . . . . . . . 54.4 t -93.16 133.58 33.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-N 116.167 -0.469 . . . . 51.140000000000001 110.941 178.031 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 740' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -127.74 162.16 27.25 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 120.844 0.354 . . . . 63.119999999999997 111.62 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 741' ' ' VAL . . . . . . . . . . . . . 5.7 t . . . . . 0 CA--C 1.541 0.601 0 CA-C-O 120.974 0.416 . . . . 65.549999999999997 111.245 -176.42 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 664' ' ' ASP . . . . . . . . . . . . . 7.1 t70 . . . . . 0 N--CA 1.468 0.459 0 CA-C-O 120.85 0.357 . . . . 65.540000000000006 110.788 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 665' ' ' LEU . . . . . 0.535 HD12 ' HD3' ' A' ' 694' ' ' LYS . 78.3 mt -95.4 137.69 34.11 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 121.097 0.475 . . . . 73.420000000000002 110.673 174.64 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 666' ' ' GLU . . . . . 0.41 ' HB2' ' HD2' ' A' ' 667' ' ' PRO . 9.6 pt-20 -70.52 152.95 95.3 Favored Pre-proline 0 CA--C 1.541 0.631 0 CA-C-N 115.941 -0.572 . . . . 71.209999999999994 111.887 -177.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 667' ' ' PRO . . . . . 0.527 ' HD3' ' HB2' ' A' ' 725' ' ' ASP . 52.5 Cg_endo -67.3 138.81 47.9 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.843 2.362 . . . . 75.109999999999999 114.428 -170.499 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 668' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -83.27 102.18 11.78 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.678 -0.692 . . . . 61.039999999999999 110.269 175.48 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 669' ' ' LEU . . . . . 0.529 ' HG ' HG23 ' A' ' 671' ' ' VAL . 65.3 tp -89.14 114.05 25.29 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.371 -0.377 . . . . 74.019999999999996 111.069 -177.785 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 670' ' ' THR . . . . . . . . . . . . . 41.5 m -89.57 110.47 21.32 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.859 0.362 . . . . 72.329999999999998 110.931 -179.173 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 671' ' ' VAL . . . . . 0.529 HG23 ' HG ' ' A' ' 669' ' ' LEU . 96.4 t -135.89 123.97 15.2 Favored Pre-proline 0 N--CA 1.468 0.455 0 CA-C-N 116.379 -0.373 . . . . 20.329999999999998 110.968 -178.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 672' ' ' PRO . . . . . 0.551 ' HG2' ' NE2' ' A' ' 735' ' ' GLN . 53.2 Cg_endo -70.75 137.43 32.57 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 122.172 1.915 . . . . 75.349999999999994 112.223 178.485 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 673' ' ' VAL . . . . . . . . . . . . . 12.2 p -64.31 -36.72 77.97 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 N-CA-C 112.012 0.375 . . . . 72.109999999999999 112.012 -177.093 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 674' ' ' GLY . . . . . . . . . . . . . . . -154.83 154.86 25.82 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 121.025 -0.607 . . . . 74.030000000000001 113.435 -178.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 675' ' ' ALA . . . . . . . . . . . . . . . -150.63 143.61 24.71 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 122.669 0.387 . . . . 71.420000000000002 110.839 178.263 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 676' ' ' THR . . . . . . . . . . . . . 90.3 m -119.46 121.33 39.22 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 120.936 0.398 . . . . 72.5 111.833 -178.251 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 677' ' ' ILE . . . . . . . . . . . . . 33.9 pt -126.68 176.98 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-N 116.209 -0.451 . . . . 72.439999999999998 110.457 175.778 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 678' ' ' HIS . . . . . 0.478 ' HA ' ' O ' ' A' ' 740' ' ' LYS . 46.7 m80 -123.09 159.38 28.63 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 112.583 0.586 . . . . 72.450000000000003 112.583 -177.757 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 679' ' ' VAL . . . . . . . . . . . . . 84.2 t -59.6 112.15 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-N 115.814 -0.63 . . . . 74.140000000000001 110.556 172.276 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 115.12 -20.22 14.43 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 121.423 -0.417 . . . . 60.25 112.708 -174.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 681' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -78.01 -165.09 0.6 Allowed 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 121.227 0.537 . . . . 64.310000000000002 111.433 178.278 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 682' ' ' SER . . . . . . . . . . . . . 21.4 p -142.75 155.54 44.87 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.966 0.412 . . . . 71.239999999999995 111.557 179.126 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 683' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -143.4 135.86 27.22 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.383 -0.371 . . . . 62.039999999999999 110.577 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 684' ' ' VAL . . . . . . . . . . . . . 25.1 t -124.75 95.64 42.14 Favored Pre-proline 0 CA--C 1.544 0.737 0 CA-C-O 120.931 0.396 . . . . 72.239999999999995 111.848 -175.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -62.87 -31.1 77.86 Favored 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 122.687 2.258 . . . . 75.019999999999996 113.719 -177.738 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 686' ' ' MET . . . . . 0.449 ' HE1' ' HB ' ' A' ' 703' ' ' ILE . 1.7 mmt -81.51 0.36 38.37 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.32 0.489 . . . . 74.230000000000004 112.32 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 687' ' ' ALA . . . . . . . . . . . . . . . -120.55 -42.62 2.53 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 120.863 0.363 . . . . 74.299999999999997 111.972 179.508 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 688' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -79.88 2.7 22.29 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-O 120.954 0.407 . . . . 75.120000000000005 111.871 -179.527 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 689' ' ' VAL . . . . . 0.42 HG21 ' CZ ' ' A' ' 721' ' ' TYR . 64.7 t -124.53 151.97 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 122.996 0.519 . . . . 75.530000000000001 110.415 175.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 690' ' ' LEU . . . . . 0.679 HD21 HG12 ' A' ' 692' ' ' ILE . 8.8 tt -145.12 152.31 39.85 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 120.567 0.222 . . . . 63.409999999999997 111.427 -174.36 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 691' ' ' ALA . . . . . . . . . . . . . . . -146.43 126.64 13.86 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 122.341 -0.224 . . . . 51.030000000000001 111.502 177.498 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 692' ' ' ILE . . . . . 0.679 HG12 HD21 ' A' ' 690' ' ' LEU . 41.1 mm -129.66 132.72 65.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 CA-C-O 121.207 0.527 . . . . 70.420000000000002 112.317 -178.109 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 693' ' ' ASP . . . . . 0.472 ' HB2' HD11 ' A' ' 699' ' ' LEU . 25.6 t70 -114.72 145.23 42.3 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.031 -0.532 . . . . 73.430000000000007 109.832 172.875 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 694' ' ' LYS . . . . . 0.535 ' HD3' HD12 ' A' ' 665' ' ' LEU . 50.8 mtpt -71.1 -39.19 72.24 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.814 0.34 . . . . 71.25 111.854 -177.342 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 35.2 mp0 -83.15 -54.02 5.35 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 112.054 0.39 . . . . 63.219999999999999 112.054 -175.69 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 696' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -76.35 -48.74 18.89 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 122.149 -0.345 . . . . 73.439999999999998 111.598 -177.562 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . 124.2 -131.56 7.98 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 121.279 -0.486 . . . . 75.450000000000003 113.052 -179.436 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -75.63 119.67 19.99 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 122.442 -0.446 . . . . 55.439999999999998 111.273 -179.146 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 699' ' ' LEU . . . . . 0.608 HD22 ' HD2' ' A' ' 702' ' ' LYS . 35.5 mt -111.44 11.21 21.44 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.397 -0.365 . . . . 62.140000000000001 111.3 178.318 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 33.8 m -59.74 -36.07 75.86 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.302 0.572 . . . . 75.430000000000007 111.551 -177.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 701' ' ' SER . . . . . . . . . . . . . 49.4 m -76.22 -14.49 60.14 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 116.282 -0.417 . . . . 72.340000000000003 111.85 177.354 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 702' ' ' LYS . . . . . 0.608 ' HD2' HD22 ' A' ' 699' ' ' LEU . 96.5 mttt -97.67 11.59 36.55 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.177 0.436 . . . . 74.109999999999999 112.177 -177.216 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 703' ' ' ILE . . . . . 0.449 ' HB ' ' HE1' ' A' ' 686' ' ' MET . 67.7 mt -83.76 118.76 31.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-O 120.873 0.368 . . . . 62.509999999999998 111.766 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 704' ' ' LYS . . . . . . . . . . . . . 4.9 tppp? -84.99 125.89 33.08 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 110.168 -0.308 . . . . 71.340000000000003 110.168 174.244 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 49.0 t -105.88 117.39 51.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 CA-C-O 121.004 0.43 . . . . 55.229999999999997 112.013 -176.367 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 706' ' ' ASP . . . . . 0.594 ' HB3' ' HB ' ' A' ' 720' ' ' THR . 12.8 t70 -100.32 141.2 33.5 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.294 -0.412 . . . . 61.340000000000003 111.03 175.183 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 102.35 177.74 27.46 Favored Glycine 0 CA--C 1.523 0.54 0 C-N-CA 121.201 -0.523 . . . . 72.439999999999998 112.97 -179.573 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 708' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -152.48 130.48 11.82 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 120.863 0.363 . . . . 74.439999999999998 111.491 -177.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 709' ' ' VAL . . . . . 0.546 HG22 ' HB2' ' A' ' 717' ' ' TYR . 96.3 t -107.93 114.6 46.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 116.494 -0.321 . . . . 64.030000000000001 110.655 176.483 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 710' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -95.39 143.65 26.56 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 120.905 0.383 . . . . 65.040000000000006 111.039 177.54 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 711' ' ' THR . . . . . . . . . . . . . 75.6 p -108.08 6.54 27.04 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.666 0.617 . . . . 75.140000000000001 112.666 -176.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 712' ' ' THR . . . . . . . . . . . . . 64.1 p -101.37 -24.24 14.23 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 121.157 0.503 . . . . 64.239999999999995 111.145 175.322 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 713' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -116.17 122.42 44.99 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 116.294 -0.412 . . . . 63.350000000000001 110.95 178.502 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 714' ' ' ALA . . . . . . . . . . . . . . . -69.42 143.99 53.47 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 120.982 0.42 . . . . 64.200000000000003 111.796 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 155.77 168.92 19.48 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-N 116.255 -0.43 . . . . 64.439999999999998 112.826 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 716' ' ' THR . . . . . . . . . . . . . 99.2 m -97.71 123.07 41.48 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 122.51 -0.406 . . . . 73.420000000000002 111.812 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 717' ' ' TYR . . . . . 0.546 ' HB2' HG22 ' A' ' 709' ' ' VAL . 40.7 m-85 -115.83 125.9 53.29 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 116.2 -0.455 . . . . 74.519999999999996 110.78 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 718' ' ' VAL . . . . . . . . . . . . . 56.1 t -96.25 118.55 42.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 120.901 0.381 . . . . 60.109999999999999 111.452 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 719' ' ' LEU . . . . . . . . . . . . . 76.6 mt -103.12 135.31 45.02 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.78 0.324 . . . . 63.030000000000001 111.611 -179.242 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 720' ' ' THR . . . . . 0.594 ' HB ' ' HB3' ' A' ' 706' ' ' ASP . 32.9 m -103.27 131.98 49.89 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 120.943 0.401 . . . . 74.439999999999998 110.895 176.545 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 721' ' ' TYR . . . . . 0.42 ' CZ ' HG21 ' A' ' 689' ' ' VAL . 77.8 m-85 -118.34 117.73 29.88 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.471 -0.331 . . . . 74.510000000000005 110.926 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 87.3 m -120.72 126.83 51.17 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.626 -0.261 . . . . 60.450000000000003 111.263 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 13.1 p -125.23 142.18 42.87 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-O 120.869 0.366 . . . . 75.549999999999997 111.878 -177.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 26.7 m -110.23 133.6 53.07 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.144 0.497 . . . . 65.140000000000001 112.181 -176.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 725' ' ' ASP . . . . . 0.527 ' HB2' ' HD3' ' A' ' 667' ' ' PRO . 14.0 t0 -91.59 151.57 20.66 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 115.912 -0.586 . . . . 72.0 111.049 178.08 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 726' ' ' SER . . . . . . . . . . . . . 38.6 t -59.46 -29.7 68.0 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.403 0.52 . . . . 64.140000000000001 112.403 -175.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 727' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -91.63 7.35 41.96 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 112.313 0.486 . . . . 75.25 112.313 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 728' ' ' GLY . . . . . . . . . . . . . . . 100.2 8.37 50.47 Favored Glycine 0 CA--C 1.534 1.237 0 N-CA-C 115.294 0.878 . . . . 71.5 115.294 173.603 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 37.6 m80 -86.67 115.11 23.91 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 117.865 0.833 . . . . 74.310000000000002 111.094 177.373 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 730' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -120.25 117.09 26.92 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 122.133 -0.355 . . . . 73.519999999999996 111.717 -177.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 35.7 m -117.83 157.76 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-O 120.727 0.299 . . . . 61.130000000000003 111.762 -177.69 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 8.6 t -142.56 144.37 32.86 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.682 0.623 . . . . 72.510000000000005 112.682 -177.049 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -146.68 159.45 43.46 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.024 -0.534 . . . . 61.020000000000003 111.059 178.41 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 734' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -118.1 155.54 30.21 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 113.009 0.744 . . . . 62.329999999999998 113.009 -176.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 735' ' ' GLN . . . . . 0.551 ' NE2' ' HG2' ' A' ' 672' ' ' PRO . 44.8 tt0 -129.79 135.48 48.47 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 115.703 -0.681 . . . . 73.040000000000006 110.558 177.642 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 736' ' ' THR . . . . . . . . . . . . . 90.1 m -95.15 104.35 16.23 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 120.675 0.274 . . . . 71.439999999999998 111.39 178.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 46.5 t -100.07 104.5 16.21 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 CA-C-O 120.772 0.32 . . . . 73.540000000000006 111.295 179.12 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 738' ' ' THR . . . . . . . . . . . . . 44.6 m -94.54 117.4 30.06 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.119 0.485 . . . . 71.319999999999993 111.471 179.167 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 739' ' ' VAL . . . . . . . . . . . . . 43.6 t -98.28 117.95 44.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-O 121.113 0.482 . . . . 74.219999999999999 111.584 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 740' ' ' LYS . . . . . 0.478 ' O ' ' HA ' ' A' ' 678' ' ' HIS . 96.1 mttt -102.93 176.05 5.28 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.265 -0.425 . . . . 73.120000000000005 110.492 174.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 741' ' ' VAL . . . . . . . . . . . . . 36.3 t . . . . . 0 N--CA 1.471 0.58 0 O-C-N 121.881 -0.512 . . . . 70.209999999999994 111.734 -178.359 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 664' ' ' ASP . . . . . . . . . . . . . 5.5 t70 . . . . . 0 CA--C 1.538 0.509 0 CA-C-O 120.895 0.378 . . . . 75.530000000000001 110.847 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 665' ' ' LEU . . . . . . . . . . . . . 76.6 mt -80.82 119.76 23.8 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.404 -0.362 . . . . 65.019999999999996 110.644 177.669 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 666' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -56.69 144.22 66.15 Favored Pre-proline 0 CA--C 1.537 0.472 0 C-N-CA 121.131 -0.228 . . . . 53.25 110.483 177.333 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 667' ' ' PRO . . . . . 0.545 ' HD3' ' HB2' ' A' ' 725' ' ' ASP . 18.8 Cg_endo -56.5 133.92 61.07 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.725 2.284 . . . . 70.409999999999997 112.736 -174.131 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 668' ' ' LYS . . . . . . . . . . . . . 52.2 tptt -82.71 110.66 17.96 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 120.942 0.401 . . . . 51.439999999999998 110.343 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 669' ' ' LEU . . . . . 0.521 ' HG ' HG23 ' A' ' 671' ' ' VAL . 55.8 tp -98.06 112.58 24.48 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 116.067 -0.515 . . . . 70.450000000000003 111.271 -177.616 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 670' ' ' THR . . . . . . . . . . . . . 85.8 m -87.75 110.62 20.6 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 120.856 0.36 . . . . 63.25 111.121 177.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 671' ' ' VAL . . . . . 0.521 HG23 ' HG ' ' A' ' 669' ' ' LEU . 81.0 t -136.34 129.68 17.85 Favored Pre-proline 0 N--CA 1.47 0.575 0 CA-C-N 116.211 -0.45 . . . . 71.549999999999997 110.803 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 672' ' ' PRO . . . . . 0.477 ' HG2' ' NE2' ' A' ' 735' ' ' GLN . 73.6 Cg_endo -77.9 141.48 19.11 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 122.193 1.929 . . . . 73.409999999999997 112.791 179.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 673' ' ' VAL . . . . . . . . . . . . . 10.6 p -66.27 -35.03 73.99 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 N-CA-C 112.007 0.373 . . . . 74.329999999999998 112.007 -177.571 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 674' ' ' GLY . . . . . . . . . . . . . . . -146.22 161.19 28.3 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 120.879 -0.676 . . . . 43.340000000000003 113.565 -177.52 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 675' ' ' ALA . . . . . . . . . . . . . . . -150.5 154.85 38.38 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 122.608 0.363 . . . . 72.319999999999993 110.928 -179.735 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 676' ' ' THR . . . . . . . . . . . . . 91.8 m -139.04 119.56 13.93 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 120.964 0.411 . . . . 74.019999999999996 111.791 178.491 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 677' ' ' ILE . . . . . . . . . . . . . 28.7 pt -131.28 175.22 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-N 116.459 -0.337 . . . . 74.400000000000006 110.678 176.15 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 678' ' ' HIS . . . . . 0.401 ' HA ' ' O ' ' A' ' 740' ' ' LYS . 75.5 m80 -119.49 164.79 15.27 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.305 0.574 . . . . 74.299999999999997 111.912 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 679' ' ' VAL . . . . . 0.445 HG23 ' HA ' ' A' ' 741' ' ' VAL . 78.3 t -56.68 137.01 19.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-N 115.891 -0.595 . . . . 73.049999999999997 110.504 172.06 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 93.03 -18.31 56.39 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 121.052 -0.594 . . . . 55.530000000000001 113.406 -179.034 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 681' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -79.52 -172.47 3.27 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 121.12 0.486 . . . . 51.020000000000003 111.548 178.038 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 682' ' ' SER . . . . . . . . . . . . . 69.0 m -141.77 145.72 35.1 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 116.435 -0.348 . . . . 74.200000000000003 111.06 177.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 683' ' ' PHE . . . . . 0.473 ' HZ ' HE22 ' A' ' 735' ' ' GLN . 34.2 t80 -118.7 134.18 55.32 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 116.453 -0.34 . . . . 61.509999999999998 110.46 178.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 684' ' ' VAL . . . . . 0.406 ' HA ' ' HD2' ' A' ' 685' ' ' PRO . 53.7 t -122.17 93.09 48.75 Favored Pre-proline 0 CA--C 1.54 0.573 0 CA-C-O 120.962 0.41 . . . . 60.299999999999997 111.429 -177.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 685' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 684' ' ' VAL . 28.6 Cg_endo -61.69 -27.76 81.52 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 122.83 2.353 . . . . 61.140000000000001 113.347 -177.382 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 686' ' ' MET . . . . . 0.488 ' HE1' ' HB ' ' A' ' 703' ' ' ILE . 1.9 mmt -78.91 -12.14 60.02 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 112.313 0.486 . . . . 73.109999999999999 112.313 -178.137 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 687' ' ' ALA . . . . . . . . . . . . . . . -109.02 -36.34 6.1 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.915 0.388 . . . . 52.409999999999997 111.539 178.426 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 688' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -85.92 -1.08 56.95 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 116.295 -0.411 . . . . 74.430000000000007 112.05 -178.786 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 689' ' ' VAL . . . . . 0.432 HG21 ' CZ ' ' A' ' 721' ' ' TYR . 74.5 t -125.57 150.81 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 122.59 0.356 . . . . 52.149999999999999 110.577 174.227 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 690' ' ' LEU . . . . . 0.485 HD21 HG12 ' A' ' 692' ' ' ILE . 9.6 tt -143.3 150.03 38.65 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-O 120.592 0.234 . . . . 73.430000000000007 111.537 -173.4 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 691' ' ' ALA . . . . . . . . . . . . . . . -147.3 125.35 12.08 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 112.19 0.441 . . . . 73.109999999999999 112.19 179.182 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 692' ' ' ILE . . . . . 0.538 HD13 ' HA ' ' A' ' 698' ' ' ASP . 43.6 mm -129.68 141.52 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 N-CA-C 111.803 0.297 . . . . 75.329999999999998 111.803 -178.849 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 693' ' ' ASP . . . . . 0.475 ' OD1' ' HG2' ' A' ' 695' ' ' GLU . 12.5 t70 -125.95 143.97 50.88 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 110.138 -0.319 . . . . 63.119999999999997 110.138 173.015 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 28.6 ttpp -64.79 -34.05 77.42 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 112.5 0.556 . . . . 53.219999999999999 112.5 -175.381 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 695' ' ' GLU . . . . . 0.475 ' HG2' ' OD1' ' A' ' 693' ' ' ASP . 9.5 pt-20 -81.89 -43.42 18.19 Favored 'General case' 0 N--CA 1.473 0.694 0 O-C-N 122.02 -0.425 . . . . 72.329999999999998 111.976 -175.481 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 696' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -94.85 -42.44 8.7 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 120.883 0.373 . . . . 73.349999999999994 111.773 -172.112 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . 118.57 -115.68 3.18 Favored Glycine 0 CA--C 1.523 0.569 0 C-N-CA 121.14 -0.552 . . . . 62.200000000000003 112.291 -177.204 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 698' ' ' ASP . . . . . 0.538 ' HA ' HD13 ' A' ' 692' ' ' ILE . 16.1 t70 -88.62 119.98 29.59 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 122.195 -0.591 . . . . 63.049999999999997 111.247 178.701 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 699' ' ' LEU . . . . . 0.491 HD12 ' HB3' ' A' ' 667' ' ' PRO . 51.0 mt -111.97 18.45 18.79 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 116.364 -0.38 . . . . 74.0 111.603 177.463 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 37.1 m -58.36 -30.65 66.92 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.009 0.433 . . . . 74.439999999999998 111.105 178.451 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 701' ' ' SER . . . . . . . . . . . . . 29.7 t -68.15 -24.48 64.99 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 120.868 0.366 . . . . 74.420000000000002 111.971 175.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 702' ' ' LYS . . . . . 0.488 ' HB2' HG23 ' A' ' 723' ' ' VAL . 73.4 mmtt -77.4 -19.84 55.55 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 111.895 0.331 . . . . 70.450000000000003 111.895 -178.34 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 703' ' ' ILE . . . . . 0.488 ' HB ' ' HE1' ' A' ' 686' ' ' MET . 63.9 mt -60.74 112.76 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 N-CA-C 112.515 0.561 . . . . 75.219999999999999 112.515 -174.292 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 704' ' ' LYS . . . . . . . . . . . . . 8.1 tmtm? -87.04 120.08 27.93 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.017 -0.538 . . . . 65.340000000000003 109.729 172.737 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 50.3 t -95.71 118.06 41.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-O 121.113 0.482 . . . . 64.019999999999996 111.063 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 706' ' ' ASP . . . . . 0.539 ' HB3' ' HB ' ' A' ' 720' ' ' THR . 11.7 t70 -108.11 118.44 36.76 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.413 -0.358 . . . . 71.340000000000003 110.249 176.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 113.42 167.82 16.7 Favored Glycine 0 CA--C 1.524 0.643 0 C-N-CA 121.344 -0.455 . . . . 55.240000000000002 112.392 -176.202 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 708' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -155.04 138.56 15.96 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 122.316 -0.52 . . . . 71.409999999999997 111.843 -177.676 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 709' ' ' VAL . . . . . . . . . . . . . 72.5 t -99.59 127.87 51.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-N 116.341 -0.39 . . . . 62.140000000000001 111.352 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 710' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -96.15 137.09 35.72 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 120.732 0.301 . . . . 64.530000000000001 110.578 175.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 711' ' ' THR . . . . . . . . . . . . . 82.5 p -110.43 23.7 13.92 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 112.416 0.525 . . . . 75.040000000000006 112.416 -177.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 712' ' ' THR . . . . . . . . . . . . . 48.8 p -113.03 -26.46 8.47 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 121.015 0.436 . . . . 52.25 110.746 173.05 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 713' ' ' LYS . . . . . 0.57 ' HB2' ' HZ3' ' A' ' 713' ' ' LYS . 0.1 OUTLIER -116.72 130.96 57.04 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.001 -0.545 . . . . 73.519999999999996 110.53 175.318 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 714' ' ' ALA . . . . . . . . . . . . . . . -80.9 134.88 35.82 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.067 0.46 . . . . 44.32 112.182 -178.626 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 169.32 171.67 35.22 Favored Glycine 0 CA--C 1.523 0.58 0 CA-C-N 116.042 -0.526 . . . . 70.450000000000003 112.582 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 716' ' ' THR . . . . . . . . . . . . . 39.9 m -90.09 123.06 33.63 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.188 0.518 . . . . 74.230000000000004 111.568 177.786 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 717' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 -114.43 138.23 50.84 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 116.074 -0.512 . . . . 75.0 110.234 177.241 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 718' ' ' VAL . . . . . . . . . . . . . 62.0 t -103.65 116.62 47.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-O 120.929 0.395 . . . . 62.340000000000003 111.54 -178.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 719' ' ' LEU . . . . . . . . . . . . . 83.0 mt -102.13 129.16 48.4 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 116.348 -0.387 . . . . 74.450000000000003 111.286 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 720' ' ' THR . . . . . 0.539 ' HB ' ' HB3' ' A' ' 706' ' ' ASP . 92.7 m -106.55 134.9 48.98 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.839 0.352 . . . . 64.209999999999994 111.12 178.303 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 721' ' ' TYR . . . . . 0.432 ' CZ ' HG21 ' A' ' 689' ' ' VAL . 60.7 m-85 -123.41 120.81 34.07 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.54 -0.3 . . . . 72.129999999999995 110.795 -179.559 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 56.6 m -123.16 133.42 54.25 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 120.797 0.332 . . . . 60.399999999999999 111.4 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 723' ' ' VAL . . . . . 0.488 HG23 ' HB2' ' A' ' 702' ' ' LYS . 7.5 p -130.93 134.89 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-O 121.154 0.502 . . . . 71.340000000000003 111.788 -178.623 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 34.3 m -109.47 142.95 39.75 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.252 0.549 . . . . 55.229999999999997 111.625 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 725' ' ' ASP . . . . . 0.545 ' HB2' ' HD3' ' A' ' 667' ' ' PRO . 10.3 t70 -102.63 160.29 14.71 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 115.814 -0.63 . . . . 63.409999999999997 111.82 -178.444 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 726' ' ' SER . . . . . . . . . . . . . 48.9 m -61.52 -33.5 73.92 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.637 0.606 . . . . 72.099999999999994 112.637 -177.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 727' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -82.01 4.96 20.83 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 120.751 0.31 . . . . 65.519999999999996 111.447 177.55 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 728' ' ' GLY . . . . . . . . . . . . . . . 91.07 15.01 56.89 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 121.35 -0.452 . . . . 73.109999999999999 114.03 177.219 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 36.3 m80 -88.49 121.33 30.75 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 117.235 0.517 . . . . 74.340000000000003 111.111 178.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 730' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -124.78 122.29 37.01 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.792 0.33 . . . . 72.430000000000007 111.873 -176.098 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 31.9 m -121.94 159.3 24.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 116.423 -0.353 . . . . 51.549999999999997 111.029 177.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 10.3 t -143.33 154.82 44.15 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.839 0.352 . . . . 72.219999999999999 111.801 -178.48 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -148.5 161.35 41.81 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 122.631 0.372 . . . . 73.140000000000001 111.211 179.256 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 734' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -125.66 154.56 42.17 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 121.057 0.455 . . . . 64.310000000000002 112.108 -177.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 735' ' ' GLN . . . . . 0.477 ' NE2' ' HG2' ' A' ' 672' ' ' PRO . 50.9 tt0 -130.8 137.96 49.67 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.991 -0.549 . . . . 50.100000000000001 111.299 179.432 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 736' ' ' THR . . . . . . . . . . . . . 89.5 m -97.19 103.82 15.78 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.534 -0.303 . . . . 70.409999999999997 111.151 176.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 45.6 t -101.48 105.16 17.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-O 120.841 0.353 . . . . 74.329999999999998 111.649 -179.173 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 738' ' ' THR . . . . . . . . . . . . . 65.8 m -95.95 118.21 32.14 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.911 0.386 . . . . 52.210000000000001 111.493 179.252 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 739' ' ' VAL . . . . . . . . . . . . . 41.0 t -97.89 139.4 20.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-N 116.393 -0.367 . . . . 74.219999999999999 111.496 178.341 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 740' ' ' LYS . . . . . 0.401 ' O ' ' HA ' ' A' ' 678' ' ' HIS . 97.4 mttt -122.17 155.84 34.95 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 120.841 0.353 . . . . 54.240000000000002 110.711 176.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 741' ' ' VAL . . . . . 0.445 ' HA ' HG23 ' A' ' 679' ' ' VAL . 40.9 t . . . . . 0 N--CA 1.47 0.542 0 CA-C-O 121.04 0.448 . . . . 61.539999999999999 112.152 -175.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 664' ' ' ASP . . . . . . . . . . . . . 14.4 t70 . . . . . 0 N--CA 1.471 0.586 0 CA-C-O 120.871 0.367 . . . . 64.510000000000005 111.134 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 665' ' ' LEU . . . . . 0.441 HD12 ' HD3' ' A' ' 694' ' ' LYS . 89.4 mt -90.55 136.62 32.94 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 116.305 -0.407 . . . . 70.519999999999996 110.505 174.237 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 666' ' ' GLU . . . . . 0.479 ' HB3' ' HB3' ' A' ' 729' ' ' HIS . 2.3 pm0 -65.5 140.63 97.67 Favored Pre-proline 0 CA--C 1.543 0.701 0 CA-C-O 120.921 0.391 . . . . 73.400000000000006 111.543 177.663 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 667' ' ' PRO . . . . . 0.596 ' HD3' ' HB2' ' A' ' 725' ' ' ASP . 12.8 Cg_endo -55.36 145.85 65.16 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 123.378 2.719 . . . . 75.400000000000006 114.745 -169.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 668' ' ' LYS . . . . . . . . . . . . . 7.4 tmtm? -85.06 104.14 14.71 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.287 -0.87 . . . . 51.210000000000001 110.404 177.235 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 669' ' ' LEU . . . . . . . . . . . . . 57.5 tp -100.05 111.72 24.02 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 116.119 -0.491 . . . . 63.140000000000001 111.564 -177.111 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 670' ' ' THR . . . . . . . . . . . . . 86.2 m -89.11 111.53 22.31 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.9 0.381 . . . . 61.240000000000002 111.502 178.727 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 671' ' ' VAL . . . . . 0.43 HG22 HG13 ' A' ' 689' ' ' VAL . 90.6 t -134.0 129.16 19.95 Favored Pre-proline 0 N--CA 1.47 0.529 0 CA-C-N 116.194 -0.457 . . . . 72.519999999999996 110.807 176.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 672' ' ' PRO . . . . . 0.529 ' HG2' ' NE2' ' A' ' 735' ' ' GLN . 58.6 Cg_endo -74.29 128.88 12.45 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 122.161 1.907 . . . . 65.030000000000001 112.084 176.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 673' ' ' VAL . . . . . . . . . . . . . 9.6 p -64.6 -19.27 24.9 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 N-CA-C 112.423 0.527 . . . . 75.019999999999996 112.423 -175.766 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 674' ' ' GLY . . . . . . . . . . . . . . . -156.8 155.59 26.48 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 120.809 -0.71 . . . . 44.030000000000001 113.501 -179.1 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 675' ' ' ALA . . . . . 0.486 ' HB3' HG22 ' A' ' 737' ' ' VAL . . . -151.1 145.66 25.62 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 120.691 0.281 . . . . 74.519999999999996 111.148 178.606 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 676' ' ' THR . . . . . . . . . . . . . 88.9 m -120.65 124.79 46.09 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.031 0.443 . . . . 70.150000000000006 112.096 -179.437 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 677' ' ' ILE . . . . . . . . . . . . . 28.8 pt -135.4 177.24 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 CA-C-N 116.244 -0.435 . . . . 55.520000000000003 111.029 176.203 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 678' ' ' HIS . . . . . . . . . . . . . 65.8 m80 -124.46 168.07 13.56 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.295 0.569 . . . . 62.100000000000001 112.188 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 679' ' ' VAL . . . . . . . . . . . . . 85.5 t -63.31 111.55 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-N 115.777 -0.647 . . . . 51.140000000000001 109.871 170.428 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 107.59 -4.33 34.69 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 121.297 -0.478 . . . . 40.240000000000002 113.29 -175.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 681' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -86.18 170.93 11.7 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 121.223 0.535 . . . . 74.129999999999995 111.508 176.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 682' ' ' SER . . . . . . . . . . . . . 77.3 p -114.58 153.21 30.5 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 116.349 -0.387 . . . . 71.310000000000002 111.121 178.502 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 683' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -159.19 114.06 2.45 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 120.745 0.307 . . . . 71.409999999999997 111.453 -178.032 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 684' ' ' VAL . . . . . 0.44 ' HA ' ' HD2' ' A' ' 685' ' ' PRO . 84.0 t -105.47 103.98 45.72 Favored Pre-proline 0 CA--C 1.543 0.677 0 CA-C-N 116.551 -0.295 . . . . 65.200000000000003 110.982 176.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 685' ' ' PRO . . . . . 0.44 ' HD2' ' HA ' ' A' ' 684' ' ' VAL . 14.4 Cg_endo -57.12 -35.55 98.94 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 122.606 2.204 . . . . 74.209999999999994 113.484 -179.059 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 686' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -78.35 -6.19 54.4 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 112.314 0.487 . . . . 72.150000000000006 112.314 -179.224 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 687' ' ' ALA . . . . . . . . . . . . . . . -94.51 -27.42 15.98 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 121.039 0.447 . . . . 73.310000000000002 111.259 175.04 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 688' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -86.08 -9.99 55.73 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 116.158 -0.474 . . . . 53.119999999999997 111.753 -179.214 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 689' ' ' VAL . . . . . 0.435 HG12 HD13 ' A' ' 703' ' ' ILE . 95.5 t -118.63 133.93 63.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 CA-C-O 120.937 0.398 . . . . 74.400000000000006 111.613 -177.194 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 690' ' ' LEU . . . . . 0.556 HD23 ' N ' ' A' ' 691' ' ' ALA . 4.1 tt -141.73 136.68 31.02 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 116.188 -0.46 . . . . 63.140000000000001 110.138 -177.309 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 691' ' ' ALA . . . . . 0.556 ' N ' HD23 ' A' ' 690' ' ' LEU . . . -122.48 122.09 38.11 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.345 0.498 . . . . 71.299999999999997 112.345 -178.016 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 692' ' ' ILE . . . . . . . . . . . . . 45.0 mm -122.25 124.23 70.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-N 116.183 -0.462 . . . . 73.340000000000003 111.483 178.101 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -113.6 144.99 41.96 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.726 0.298 . . . . 65.230000000000004 110.294 173.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 694' ' ' LYS . . . . . 0.441 ' HD3' HD12 ' A' ' 665' ' ' LEU . 7.9 mtpm? -71.72 -43.08 66.5 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 112.105 0.409 . . . . 72.450000000000003 112.105 -175.622 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 44.7 mp0 -83.88 -54.35 4.94 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 121.144 0.497 . . . . 75.409999999999997 112.142 -178.707 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 696' ' ' ASP . . . . . . . . . . . . . 32.7 t0 -79.38 -28.62 41.92 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 116.083 -0.508 . . . . 51.200000000000003 112.133 -172.469 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . 105.64 -155.53 16.85 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 121.186 -0.53 . . . . 55.25 113.595 176.76 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -68.22 118.19 11.02 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 122.55 -0.383 . . . . 53.240000000000002 110.48 176.671 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 699' ' ' LEU . . . . . 0.543 HD22 ' HE2' ' A' ' 702' ' ' LYS . 19.9 mt -113.31 19.89 16.63 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.46 -0.336 . . . . 74.340000000000003 111.511 -176.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 77.6 m -56.11 -37.92 70.07 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 112.313 0.486 . . . . 73.310000000000002 112.313 -176.679 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 701' ' ' SER . . . . . . . . . . . . . 73.3 m -70.83 -19.52 62.65 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 112.063 0.394 . . . . 74.140000000000001 112.063 178.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 702' ' ' LYS . . . . . 0.543 ' HE2' HD22 ' A' ' 699' ' ' LEU . 54.5 mtmt -92.59 11.24 27.2 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.777 0.323 . . . . 71.200000000000003 111.625 178.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 703' ' ' ILE . . . . . 0.547 HG12 ' HB ' ' A' ' 723' ' ' VAL . 54.0 mt -87.49 120.43 36.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 116.712 -0.222 . . . . 73.109999999999999 110.728 174.137 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 704' ' ' LYS . . . . . . . . . . . . . 53.6 tttm -93.11 146.32 23.74 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 120.801 0.334 . . . . 72.299999999999997 110.892 173.497 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 44.5 t -104.3 146.33 11.83 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-O 120.952 0.406 . . . . 74.430000000000007 110.887 176.349 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 706' ' ' ASP . . . . . 0.508 ' HB3' ' HB ' ' A' ' 720' ' ' THR . 32.3 t70 -135.01 129.96 34.96 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 120.899 0.38 . . . . 73.239999999999995 110.738 174.507 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 101.34 175.88 28.76 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 121.439 -0.41 . . . . 71.540000000000006 112.404 -176.368 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 708' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -151.86 144.7 24.39 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 117.076 0.438 . . . . 71.040000000000006 111.908 -178.6 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 709' ' ' VAL . . . . . 0.508 HG22 ' HB2' ' A' ' 717' ' ' TYR . 97.1 t -114.07 111.45 36.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-N 116.437 -0.347 . . . . 71.129999999999995 111.305 178.457 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 710' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -70.01 136.11 50.06 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 120.946 0.403 . . . . 73.349999999999994 111.264 176.34 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 711' ' ' THR . . . . . . . . . . . . . 70.7 p -106.36 -6.73 18.1 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 112.131 0.419 . . . . 74.340000000000003 112.131 -178.593 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 712' ' ' THR . . . . . . . . . . . . . 11.7 t -100.25 0.28 39.96 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 111.973 0.36 . . . . 74.239999999999995 111.973 177.468 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 713' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -144.03 134.06 24.12 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 120.692 0.282 . . . . 74.319999999999993 111.279 -177.332 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 714' ' ' ALA . . . . . . . . . . . . . . . -76.62 144.55 39.47 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 112.359 0.503 . . . . 72.120000000000005 112.359 -176.565 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 158.03 168.3 20.15 Favored Glycine 0 CA--C 1.525 0.718 0 CA-C-N 116.025 -0.534 . . . . 53.140000000000001 112.487 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 716' ' ' THR . . . . . . . . . . . . . 91.3 m -96.39 123.48 40.06 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 122.295 -0.532 . . . . 74.420000000000002 111.477 178.302 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 717' ' ' TYR . . . . . 0.508 ' HB2' HG22 ' A' ' 709' ' ' VAL . 33.3 m-85 -119.52 141.51 49.14 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 116.404 -0.362 . . . . 75.340000000000003 110.755 -178.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 718' ' ' VAL . . . . . . . . . . . . . 72.9 t -113.26 131.35 65.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 CA-C-O 120.893 0.378 . . . . 72.409999999999997 111.383 178.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 719' ' ' LEU . . . . . 0.423 HD21 HG23 ' A' ' 709' ' ' VAL . 69.4 mt -116.4 142.15 47.23 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 116.444 -0.344 . . . . 73.120000000000005 111.433 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 720' ' ' THR . . . . . 0.508 ' HB ' ' HB3' ' A' ' 706' ' ' ASP . 93.2 m -114.89 136.13 53.44 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 120.876 0.37 . . . . 52.119999999999997 111.356 178.035 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 721' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -124.71 135.03 52.68 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 116.346 -0.388 . . . . 73.450000000000003 110.947 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 94.6 m -138.21 134.88 35.02 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 111.813 0.301 . . . . 64.140000000000001 111.813 -177.715 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 723' ' ' VAL . . . . . 0.547 ' HB ' HG12 ' A' ' 703' ' ' ILE . 8.7 p -132.25 146.24 33.39 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 CA-C-O 120.879 0.371 . . . . 75.109999999999999 111.422 179.538 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 56.5 m -119.6 130.29 55.04 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 112.734 0.642 . . . . 71.439999999999998 112.734 -175.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 725' ' ' ASP . . . . . 0.596 ' HB2' ' HD3' ' A' ' 667' ' ' PRO . 12.0 t70 -76.68 155.58 33.24 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.983 -0.553 . . . . 54.240000000000002 110.516 174.492 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 726' ' ' SER . . . . . . . . . . . . . 46.4 t -54.51 -33.65 60.29 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 112.407 0.521 . . . . 75.129999999999995 112.407 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 727' ' ' LYS . . . . . . . . . . . . . 46.7 mmtm -75.96 -14.82 60.24 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 112.239 0.459 . . . . 74.200000000000003 112.239 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 728' ' ' GLY . . . . . . . . . . . . . . . 109.94 4.71 29.49 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 121.112 -0.566 . . . . 52.140000000000001 113.625 -177.532 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 729' ' ' HIS . . . . . 0.479 ' HB3' ' HB3' ' A' ' 666' ' ' GLU . 24.8 m170 -70.67 102.13 2.22 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 117.519 0.659 . . . . 52.240000000000002 111.353 176.723 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 730' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -98.0 125.26 42.86 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 120.984 0.421 . . . . 73.519999999999996 111.503 179.563 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 731' ' ' VAL . . . . . 0.436 HG22 ' HG2' ' A' ' 667' ' ' PRO . 30.2 m -126.65 154.18 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-O 120.84 0.352 . . . . 61.509999999999998 111.113 176.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 8.8 t -144.42 147.89 33.93 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 121.386 0.612 . . . . 70.230000000000004 112.431 -173.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -147.49 153.67 39.81 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.862 -0.608 . . . . 62.509999999999998 110.576 177.153 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 734' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -123.47 152.04 42.09 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 112.625 0.602 . . . . 64.219999999999999 112.625 -173.718 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 735' ' ' GLN . . . . . 0.529 ' NE2' ' HG2' ' A' ' 672' ' ' PRO . 54.1 tt0 -130.24 128.34 41.43 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 115.798 -0.637 . . . . 64.540000000000006 111.133 -177.888 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 736' ' ' THR . . . . . . . . . . . . . 93.9 m -100.26 109.64 21.87 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.848 0.356 . . . . 64.120000000000005 111.428 179.351 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 737' ' ' VAL . . . . . 0.486 HG22 ' HB3' ' A' ' 675' ' ' ALA . 41.0 t -105.33 117.72 51.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-O 120.952 0.406 . . . . 65.439999999999998 111.554 -178.111 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 738' ' ' THR . . . . . . . . . . . . . 91.8 m -102.23 131.1 49.0 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 120.906 0.384 . . . . 45.310000000000002 111.545 178.622 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 739' ' ' VAL . . . . . . . . . . . . . 43.1 t -104.45 131.12 54.13 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-N 116.348 -0.387 . . . . 60.130000000000003 111.535 179.422 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 740' ' ' LYS . . . . . 0.462 ' NZ ' ' HB3' ' A' ' 740' ' ' LYS . 7.7 mtpm? -116.08 155.77 27.56 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 120.902 0.382 . . . . 54.299999999999997 111.305 177.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 741' ' ' VAL . . . . . . . . . . . . . 43.9 t . . . . . 0 N--CA 1.47 0.573 0 N-CA-C 112.093 0.405 . . . . 73.450000000000003 112.093 -177.418 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 664' ' ' ASP . . . . . 0.528 ' CG ' ' HG3' ' A' ' 727' ' ' LYS . 12.3 t70 . . . . . 0 CA--C 1.539 0.555 0 CA-C-O 120.927 0.394 . . . . 74.420000000000002 111.291 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 665' ' ' LEU . . . . . 0.513 HD12 ' HD2' ' A' ' 694' ' ' LYS . 73.2 mt -102.84 137.74 40.65 Favored 'General case' 0 C--O 1.242 0.678 0 N-CA-C 112.268 0.47 . . . . 73.129999999999995 112.268 -176.191 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 666' ' ' GLU . . . . . 0.496 ' HG3' ' HB3' ' A' ' 729' ' ' HIS . 3.5 mp0 -67.58 151.62 97.0 Favored Pre-proline 0 CA--C 1.544 0.719 0 CA-C-N 115.957 -0.565 . . . . 71.340000000000003 111.005 176.513 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 667' ' ' PRO . . . . . 0.623 ' HD3' ' HB2' ' A' ' 725' ' ' ASP . 61.3 Cg_endo -72.7 153.72 54.14 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 122.659 2.239 . . . . 74.129999999999995 113.429 -178.81 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 668' ' ' LYS . . . . . . . . . . . . . 13.0 tmtt? -92.3 105.15 17.41 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.104 0.478 . . . . 75.409999999999997 110.496 178.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 669' ' ' LEU . . . . . . . . . . . . . 57.9 tp -94.88 120.04 34.44 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 116.173 -0.467 . . . . 71.230000000000004 111.29 -179.122 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 670' ' ' THR . . . . . . . . . . . . . 90.2 m -102.22 110.79 22.84 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 120.832 0.349 . . . . 75.129999999999995 111.151 -179.356 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 671' ' ' VAL . . . . . 0.491 HG22 HG13 ' A' ' 689' ' ' VAL . 87.6 t -135.42 126.54 17.3 Favored Pre-proline 0 N--CA 1.472 0.673 0 CA-C-N 116.072 -0.513 . . . . 63.140000000000001 111.065 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 672' ' ' PRO . . . . . 0.52 ' HG2' ' NE2' ' A' ' 735' ' ' GLN . 62.0 Cg_endo -73.21 145.41 38.91 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 122.241 1.961 . . . . 74.010000000000005 112.19 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 673' ' ' VAL . . . . . . . . . . . . . 13.9 p -65.14 -32.8 59.84 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 N-CA-C 112.098 0.407 . . . . 63.109999999999999 112.098 -178.034 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 674' ' ' GLY . . . . . . . . . . . . . . . -162.05 147.54 13.87 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 120.77 -0.729 . . . . 42.140000000000001 113.408 -179.246 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 675' ' ' ALA . . . . . . . . . . . . . . . -136.09 139.62 43.14 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 122.647 0.379 . . . . 61.219999999999999 110.802 179.326 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 676' ' ' THR . . . . . . . . . . . . . 92.1 m -117.36 124.13 48.16 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.547 0.573 . . . . 73.530000000000001 112.547 -175.207 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 677' ' ' ILE . . . . . . . . . . . . . 33.7 pt -130.46 177.09 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 CA-C-N 116.292 -0.413 . . . . 75.120000000000005 110.517 175.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 678' ' ' HIS . . . . . . . . . . . . . 76.5 m80 -114.31 168.76 9.57 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 121.232 0.539 . . . . 73.200000000000003 111.787 175.461 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 679' ' ' VAL . . . . . . . . . . . . . 96.6 t -63.55 117.93 5.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 116.182 -0.463 . . . . 65.519999999999996 110.654 175.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 95.32 8.21 58.86 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 121.419 -0.42 . . . . 64.400000000000006 113.135 -178.445 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 681' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -94.03 166.1 12.31 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.073 0.463 . . . . 63.109999999999999 111.43 178.214 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 682' ' ' SER . . . . . . . . . . . . . 47.2 m -93.54 149.42 21.25 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.22 -0.445 . . . . 75.219999999999999 111.421 -179.432 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 683' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -151.6 116.41 5.18 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.722 0.296 . . . . 65.010000000000005 110.761 178.464 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 684' ' ' VAL . . . . . 0.4 ' HA ' ' HD2' ' A' ' 685' ' ' PRO . 28.8 t -117.01 92.57 39.57 Favored Pre-proline 0 CA--C 1.544 0.727 0 CA-C-O 121.126 0.489 . . . . 74.349999999999994 111.522 -178.453 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 685' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 684' ' ' VAL . 30.6 Cg_endo -62.27 -31.89 82.07 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 122.606 2.204 . . . . 73.420000000000002 112.963 -177.692 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 686' ' ' MET . . . . . 0.428 ' HA ' ' HE3' ' A' ' 686' ' ' MET . 0.7 OUTLIER -78.85 -1.39 34.75 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 112.248 0.462 . . . . 73.120000000000005 112.248 -178.403 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 687' ' ' ALA . . . . . . . . . . . . . . . -104.61 -30.14 10.17 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.088 0.47 . . . . 71.319999999999993 111.31 175.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 688' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -91.19 -28.17 18.02 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 116.343 -0.39 . . . . 74.329999999999998 111.85 -179.115 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 689' ' ' VAL . . . . . 0.491 HG13 HG22 ' A' ' 671' ' ' VAL . 80.2 t -98.15 124.7 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-O 120.922 0.391 . . . . 64.140000000000001 111.413 178.417 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 690' ' ' LEU . . . . . 0.429 HD12 ' C ' ' A' ' 689' ' ' VAL . 7.3 mp -126.04 154.46 42.96 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 116.234 -0.439 . . . . 65.140000000000001 111.619 -178.467 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 691' ' ' ALA . . . . . . . . . . . . . . . -137.39 122.26 18.85 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.796 0.331 . . . . 71.140000000000001 111.058 177.548 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 692' ' ' ILE . . . . . . . . . . . . . 50.2 mm -129.09 117.27 43.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 CA-C-O 120.842 0.353 . . . . 71.150000000000006 111.653 -176.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 693' ' ' ASP . . . . . 0.467 ' HB2' HD12 ' A' ' 699' ' ' LEU . 34.4 t70 -95.19 149.66 21.07 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.535 -0.302 . . . . 71.319999999999993 110.481 176.184 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 694' ' ' LYS . . . . . 0.513 ' HD2' HD12 ' A' ' 665' ' ' LEU . 30.9 ttmt -72.41 -43.29 64.09 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 112.837 0.68 . . . . 74.409999999999997 112.837 -171.121 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -84.09 -45.9 12.53 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 121.696 -0.627 . . . . 72.030000000000001 111.278 177.838 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 696' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -74.43 -48.99 24.21 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 112.206 0.447 . . . . 71.230000000000004 112.206 -175.311 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . 112.14 -117.79 4.51 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 121.0 -0.619 . . . . 72.450000000000003 112.647 -176.574 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -78.09 117.52 19.46 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 122.118 -0.636 . . . . 54.140000000000001 111.935 -179.182 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 699' ' ' LEU . . . . . 0.516 HD12 ' HB3' ' A' ' 667' ' ' PRO . 73.5 mt -117.24 14.05 14.74 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.126 -0.488 . . . . 52.219999999999999 110.726 172.246 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 33.5 m -58.66 -34.58 71.39 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.017 0.437 . . . . 71.430000000000007 111.251 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 701' ' ' SER . . . . . . . . . . . . . 80.2 p -70.31 -17.82 63.09 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 116.504 -0.316 . . . . 75.019999999999996 111.757 177.544 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 702' ' ' LYS . . . . . . . . . . . . . 45.3 mmtm -91.22 3.29 55.21 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 111.814 0.302 . . . . 71.239999999999995 111.814 -178.741 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 703' ' ' ILE . . . . . 0.444 HD13 HG12 ' A' ' 689' ' ' VAL . 67.3 mt -76.36 125.73 36.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-O 121.195 0.522 . . . . 72.040000000000006 111.754 -179.491 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 704' ' ' LYS . . . . . . . . . . . . . 58.4 mttp -92.9 123.93 36.52 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.191 -0.459 . . . . 64.340000000000003 110.741 172.475 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 51.9 t -95.85 106.94 18.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.935 -0.575 . . . . 72.409999999999997 110.808 179.106 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 706' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -100.04 134.0 43.6 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 120.912 0.387 . . . . 71.319999999999993 111.456 -178.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 118.24 -168.96 13.23 Favored Glycine 0 CA--C 1.525 0.659 0 CA-C-N 116.293 -0.412 . . . . 53.109999999999999 112.68 -178.63 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 708' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -158.05 137.61 11.98 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.967 0.413 . . . . 63.229999999999997 111.72 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 709' ' ' VAL . . . . . 0.448 HG22 ' HB2' ' A' ' 717' ' ' TYR . 62.7 t -126.34 123.11 62.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-N 116.459 -0.337 . . . . 51.25 111.127 179.42 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 710' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -93.47 142.22 27.58 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 121.202 0.525 . . . . 64.329999999999998 111.332 177.295 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 711' ' ' THR . . . . . . . . . . . . . 47.6 p -101.54 -9.44 21.01 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.806 -0.634 . . . . 70.109999999999999 112.278 -178.345 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 712' ' ' THR . . . . . . . . . . . . . 59.6 p -103.05 -0.09 31.27 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 113.099 0.777 . . . . 63.509999999999998 113.099 -177.164 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 713' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -144.14 136.57 26.74 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 122.067 -0.396 . . . . 65.200000000000003 111.332 175.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 714' ' ' ALA . . . . . . . . . . . . . . . -70.08 144.48 52.12 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 112.393 0.516 . . . . 62.0 112.393 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 161.28 166.7 20.52 Favored Glycine 0 CA--C 1.525 0.679 0 CA-C-N 116.108 -0.497 . . . . 74.409999999999997 112.729 -179.686 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 716' ' ' THR . . . . . . . . . . . . . 53.2 m -101.12 124.52 46.96 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 122.357 -0.496 . . . . 71.329999999999998 111.182 178.573 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 717' ' ' TYR . . . . . 0.448 ' HB2' HG22 ' A' ' 709' ' ' VAL . 30.2 m-85 -121.75 133.47 54.93 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 116.198 -0.456 . . . . 75.209999999999994 110.762 -177.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 718' ' ' VAL . . . . . . . . . . . . . 58.8 t -94.96 133.06 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-O 120.82 0.343 . . . . 71.329999999999998 111.614 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 719' ' ' LEU . . . . . 0.404 HD21 HG23 ' A' ' 709' ' ' VAL . 96.4 mt -119.79 127.66 53.0 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.802 0.334 . . . . 75.340000000000003 111.116 177.534 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 91.8 m -111.68 120.67 42.83 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 120.752 0.311 . . . . 63.229999999999997 110.912 178.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 721' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -104.78 120.04 40.43 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.591 -0.277 . . . . 74.329999999999998 111.186 -178.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 59.9 m -122.55 123.46 41.29 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 120.674 0.273 . . . . 73.310000000000002 111.168 178.144 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 10.4 p -119.14 147.18 22.85 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 CA-C-O 121.008 0.432 . . . . 72.340000000000003 111.906 -177.392 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 76.2 m -110.21 133.57 53.1 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 112.303 0.482 . . . . 74.299999999999997 112.303 -177.491 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 725' ' ' ASP . . . . . 0.623 ' HB2' ' HD3' ' A' ' 667' ' ' PRO . 50.2 t0 -73.62 154.64 39.67 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 115.888 -0.597 . . . . 62.240000000000002 111.216 176.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 726' ' ' SER . . . . . . . . . . . . . 40.4 t -58.24 -28.58 65.02 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.036 0.446 . . . . 52.25 111.178 176.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 727' ' ' LYS . . . . . 0.528 ' HG3' ' CG ' ' A' ' 664' ' ' ASP . 36.8 mmtm -90.28 -11.01 42.08 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 111.97 0.359 . . . . 75.030000000000001 111.97 177.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 728' ' ' GLY . . . . . . . . . . . . . . . 112.4 -1.23 26.51 Favored Glycine 0 CA--C 1.533 1.171 0 N-CA-C 114.688 0.635 . . . . 71.409999999999997 114.688 179.059 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 729' ' ' HIS . . . . . 0.543 ' H ' ' HB3' ' A' ' 725' ' ' ASP . 34.7 m80 -68.54 105.21 2.16 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 118.12 0.96 . . . . 74.310000000000002 110.989 176.121 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 730' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -96.32 125.88 41.13 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 120.802 0.334 . . . . 75.209999999999994 110.942 -179.379 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 35.9 m -127.02 158.11 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-O 120.699 0.285 . . . . 63.409999999999997 111.079 178.682 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 5.3 t -143.52 149.76 37.95 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 112.755 0.65 . . . . 62.299999999999997 112.755 -174.602 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -148.37 154.59 40.15 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.771 -0.65 . . . . 60.200000000000003 110.343 176.399 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 734' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -119.86 154.86 33.71 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 113.159 0.8 . . . . 71.430000000000007 113.159 -174.149 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 735' ' ' GLN . . . . . 0.52 ' NE2' ' HG2' ' A' ' 672' ' ' PRO . 52.5 tt0 -136.67 124.12 22.09 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.5 -0.773 . . . . 62.310000000000002 110.652 177.489 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 736' ' ' THR . . . . . . . . . . . . . 99.8 m -93.93 105.78 17.78 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.104 0.478 . . . . 75.109999999999999 111.055 176.687 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 45.6 t -96.77 141.33 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-O 120.709 0.29 . . . . 71.299999999999997 111.59 -176.652 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 738' ' ' THR . . . . . . . . . . . . . 88.8 m -128.7 122.91 31.79 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.25 0.548 . . . . 43.399999999999999 112.269 -179.231 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 739' ' ' VAL . . . . . . . . . . . . . 47.2 t -95.57 124.57 48.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-N 115.754 -0.657 . . . . 75.400000000000006 110.788 176.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 740' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -102.95 151.67 22.21 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.417 0.627 . . . . 72.25 112.079 -176.38 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 741' ' ' VAL . . . . . . . . . . . . . 93.9 t . . . . . 0 CA--C 1.54 0.561 0 CA-C-N 115.77 -0.65 . . . . 74.340000000000003 112.264 -179.735 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 664' ' ' ASP . . . . . 0.699 ' HB2' ' HE2' ' A' ' 727' ' ' LYS . 16.1 t70 . . . . . 0 CA--C 1.537 0.462 0 CA-C-O 121.123 0.487 . . . . 73.109999999999999 111.818 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 665' ' ' LEU . . . . . . . . . . . . . 70.1 mt -85.39 119.01 25.27 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.135 -0.484 . . . . 63.32 109.697 173.228 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 666' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -67.68 145.33 98.09 Favored Pre-proline 0 CA--C 1.54 0.56 0 CA-C-O 120.671 0.272 . . . . 71.349999999999994 111.308 -177.281 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 667' ' ' PRO . . . . . 0.431 ' HB3' HD12 ' A' ' 699' ' ' LEU . 78.9 Cg_endo -75.8 146.26 29.7 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.405 2.07 . . . . 61.109999999999999 113.193 -173.379 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 668' ' ' LYS . . . . . . . . . . . . . 4.9 tmtm? -88.28 109.18 19.75 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 109.89 -0.411 . . . . 74.019999999999996 109.89 177.601 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 669' ' ' LEU . . . . . 0.414 ' HG ' HG23 ' A' ' 671' ' ' VAL . 58.0 tp -93.01 106.16 18.15 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.071 0.463 . . . . 74.129999999999995 110.543 176.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 670' ' ' THR . . . . . . . . . . . . . 86.9 m -86.62 110.7 20.01 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.263 -0.426 . . . . 72.129999999999995 111.391 -178.61 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 671' ' ' VAL . . . . . 0.414 HG23 ' HG ' ' A' ' 669' ' ' LEU . 95.0 t -137.95 128.34 15.48 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 122.629 0.372 . . . . 43.229999999999997 111.091 -178.76 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 672' ' ' PRO . . . . . 0.431 ' HG2' ' NE2' ' A' ' 735' ' ' GLN . 73.6 Cg_endo -77.84 132.28 11.76 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 122.212 1.941 . . . . 72.219999999999999 111.809 177.143 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 673' ' ' VAL . . . . . . . . . . . . . 14.3 p -64.76 -30.61 50.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 N-CA-C 112.496 0.554 . . . . 62.439999999999998 112.496 -175.684 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 674' ' ' GLY . . . . . . . . . . . . . . . -151.81 142.6 9.57 Favored Glycine 0 CA--C 1.525 0.666 0 C-N-CA 120.811 -0.709 . . . . 62.140000000000001 113.571 -177.268 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 675' ' ' ALA . . . . . . . . . . . . . . . -140.48 157.69 45.12 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 122.49 0.316 . . . . 70.0 110.922 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 676' ' ' THR . . . . . . . . . . . . . 54.9 m -136.05 128.81 30.96 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.103 0.477 . . . . 34.200000000000003 111.797 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 677' ' ' ILE . . . . . . . . . . . . . 39.8 pt -132.49 177.64 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-N 116.085 -0.507 . . . . 72.030000000000001 110.987 177.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 678' ' ' HIS . . . . . . . . . . . . . 58.4 m80 -122.44 156.75 33.4 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.151 0.501 . . . . 73.340000000000003 112.276 178.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 679' ' ' VAL . . . . . . . . . . . . . 89.4 t -61.5 128.74 23.42 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 115.824 -0.626 . . . . 53.420000000000002 111.39 176.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 99.81 -17.04 57.95 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 121.356 -0.45 . . . . 73.0 113.031 -178.482 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 681' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -79.08 177.26 8.94 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 121.224 0.535 . . . . 72.099999999999994 112.248 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 682' ' ' SER . . . . . . . . . . . . . 48.5 m -104.46 145.23 30.57 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.913 -0.585 . . . . 52.399999999999999 110.516 176.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 683' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -148.7 113.05 5.27 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.913 0.387 . . . . 75.140000000000001 111.557 179.068 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 684' ' ' VAL . . . . . . . . . . . . . 63.6 t -111.61 102.33 53.1 Favored Pre-proline 0 CA--C 1.543 0.675 0 CA-C-N 116.257 -0.429 . . . . 70.030000000000001 110.616 176.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -56.91 -42.62 62.52 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 122.731 2.287 . . . . 73.040000000000006 113.658 -177.06 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 686' ' ' MET . . . . . . . . . . . . . 15.8 mtp -79.17 -12.29 59.98 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 113.06 0.763 . . . . 73.109999999999999 113.06 -176.132 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 687' ' ' ALA . . . . . . . . . . . . . . . -79.17 -18.47 53.02 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 122.017 -0.427 . . . . 45.310000000000002 111.207 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 688' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -114.34 9.74 16.97 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 112.178 0.436 . . . . 45.130000000000003 112.178 -178.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 689' ' ' VAL . . . . . 0.437 HG21 ' CZ ' ' A' ' 721' ' ' TYR . 86.8 t -123.0 124.72 70.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-O 120.879 0.371 . . . . 73.310000000000002 110.939 178.106 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 690' ' ' LEU . . . . . . . . . . . . . 6.4 mp -119.7 157.63 28.14 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.165 0.507 . . . . 72.409999999999997 111.534 -177.176 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 691' ' ' ALA . . . . . . . . . . . . . . . -148.54 123.48 10.01 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.963 -0.562 . . . . 64.530000000000001 110.557 176.334 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 692' ' ' ILE . . . . . . . . . . . . . 41.5 mm -131.91 131.4 61.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 N-CA-C 112.404 0.52 . . . . 74.209999999999994 112.404 -174.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -115.33 130.94 57.05 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.121 -0.491 . . . . 61.219999999999999 109.741 168.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -61.76 -32.35 72.6 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.113 0.482 . . . . 63.409999999999997 111.403 -177.472 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -83.72 -54.32 5.0 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 112.504 0.557 . . . . 74.299999999999997 112.504 -176.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 696' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -77.57 -42.98 33.26 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 120.811 0.339 . . . . 61.32 111.59 -178.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . 121.07 -139.79 13.59 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 121.544 -0.36 . . . . 73.510000000000005 113.001 -178.482 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -71.73 111.85 7.35 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.052 0.453 . . . . 63.5 111.102 178.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 699' ' ' LEU . . . . . 0.472 HD22 ' HG3' ' A' ' 702' ' ' LYS . 67.0 mt -100.72 9.12 42.83 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.446 -0.343 . . . . 74.299999999999997 111.319 176.155 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 31.2 m -59.7 -36.88 77.41 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.108 0.48 . . . . 65.109999999999999 111.247 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 701' ' ' SER . . . . . . . . . . . . . 47.1 m -81.99 3.13 27.72 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 116.328 -0.396 . . . . 73.25 111.738 176.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 702' ' ' LYS . . . . . 0.472 ' HG3' HD22 ' A' ' 699' ' ' LEU . 33.5 mmtp -103.48 3.96 35.47 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 120.816 0.341 . . . . 71.109999999999999 110.914 179.558 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 70.2 mt -84.42 116.77 28.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 N-CA-C 112.235 0.457 . . . . 71.200000000000003 112.235 -174.214 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 704' ' ' LYS . . . . . . . . . . . . . 61.2 tttp -84.83 122.53 29.28 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 120.689 0.28 . . . . 62.32 110.581 172.221 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 47.8 t -99.28 141.15 17.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-O 121.235 0.541 . . . . 72.200000000000003 112.024 -177.392 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 706' ' ' ASP . . . . . 0.603 ' HB3' ' HB ' ' A' ' 720' ' ' THR . 23.7 t70 -130.31 151.82 50.4 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.77 -0.65 . . . . 74.319999999999993 110.073 176.271 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 93.42 167.05 38.15 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 120.974 -0.631 . . . . 61.219999999999999 112.37 -174.367 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 708' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -144.5 142.8 30.5 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 122.346 -0.502 . . . . 72.120000000000005 111.997 -176.702 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 709' ' ' VAL . . . . . 0.54 HG23 HD21 ' A' ' 719' ' ' LEU . 95.7 t -122.09 132.52 70.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 CA-C-O 120.885 0.374 . . . . 72.319999999999993 111.158 176.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 710' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -98.32 138.12 36.04 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.002 0.43 . . . . 53.329999999999998 111.367 176.271 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 711' ' ' THR . . . . . . . . . . . . . 68.0 p -94.01 -25.45 17.22 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.937 0.398 . . . . 75.439999999999998 111.236 177.547 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 712' ' ' THR . . . . . . . . . . . . . 12.5 t -90.7 -7.04 53.65 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.0 0.429 . . . . 73.310000000000002 111.994 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 713' ' ' LYS . . . . . . . . . . . . . 28.2 tptp -130.42 125.79 35.37 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.704 0.288 . . . . 74.319999999999993 111.259 -177.194 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 714' ' ' ALA . . . . . . . . . . . . . . . -74.9 144.18 43.44 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 120.826 0.346 . . . . 74.319999999999993 111.466 178.634 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 159.03 164.4 14.38 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 121.073 -0.584 . . . . 75.319999999999993 113.313 -179.533 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 716' ' ' THR . . . . . . . . . . . . . 99.2 m -96.04 128.85 43.3 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 122.495 -0.415 . . . . 64.430000000000007 111.216 178.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 717' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -126.76 149.59 49.55 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.027 0.442 . . . . 74.109999999999999 111.574 -179.513 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 718' ' ' VAL . . . . . . . . . . . . . 40.6 t -117.07 114.0 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 121.079 0.466 . . . . 75.420000000000002 111.264 178.805 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 719' ' ' LEU . . . . . 0.54 HD21 HG23 ' A' ' 709' ' ' VAL . 81.2 mt -96.26 143.01 27.73 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.09 -0.505 . . . . 64.109999999999999 111.179 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 720' ' ' THR . . . . . 0.603 ' HB ' ' HB3' ' A' ' 706' ' ' ASP . 78.0 m -118.82 136.1 54.19 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.913 0.387 . . . . 61.340000000000003 111.154 177.582 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 721' ' ' TYR . . . . . 0.437 ' CZ ' HG21 ' A' ' 689' ' ' VAL . 72.6 m-85 -120.57 134.36 55.29 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.491 -0.322 . . . . 73.040000000000006 110.906 179.55 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 25.5 m -134.46 126.22 29.03 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 116.626 -0.261 . . . . 72.439999999999998 110.914 -178.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 8.8 p -132.49 135.78 57.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 CA-C-O 120.929 0.395 . . . . 65.209999999999994 111.611 -179.217 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 43.0 m -107.96 131.68 54.29 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 120.983 0.421 . . . . 61.039999999999999 111.924 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 725' ' ' ASP . . . . . 0.424 ' HB3' ' H ' ' A' ' 729' ' ' HIS . 10.0 t70 -73.35 166.39 23.28 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.967 -0.56 . . . . 70.109999999999999 111.131 178.533 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 726' ' ' SER . . . . . . . . . . . . . 45.3 t -63.17 -40.74 98.4 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 116.372 -0.376 . . . . 61.409999999999997 111.854 178.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 727' ' ' LYS . . . . . 0.699 ' HE2' ' HB2' ' A' ' 664' ' ' ASP . 30.8 mtmm -107.23 25.53 11.29 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 113.773 1.027 . . . . 73.150000000000006 113.773 -177.325 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 728' ' ' GLY . . . . . . . . . . . . . . . 110.16 -5.97 30.44 Favored Glycine 0 CA--C 1.536 1.376 0 N-CA-C 116.645 1.418 . . . . 74.510000000000005 116.645 165.764 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 729' ' ' HIS . . . . . 0.424 ' H ' ' HB3' ' A' ' 725' ' ' ASP . 18.9 m80 -80.31 104.21 10.7 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 118.936 1.368 . . . . 75.010000000000005 111.958 179.168 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 730' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -103.28 115.74 31.14 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.986 0.422 . . . . 74.0 111.718 -178.23 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 48.0 t -108.74 149.58 11.92 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 CA-C-N 116.414 -0.357 . . . . 54.240000000000002 111.512 -176.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 7.7 t -143.32 143.97 31.91 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 112.502 0.556 . . . . 63.310000000000002 112.502 -178.686 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -148.7 161.57 41.5 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 116.414 -0.357 . . . . 70.109999999999999 111.234 178.779 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 734' ' ' LYS . . . . . . . . . . . . . 99.9 mttt -127.22 152.63 47.14 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 112.728 0.64 . . . . 75.200000000000003 112.728 -177.479 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 735' ' ' GLN . . . . . 0.431 ' NE2' ' HG2' ' A' ' 672' ' ' PRO . 50.0 tt0 -130.49 128.48 41.31 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 115.911 -0.586 . . . . 63.009999999999998 111.13 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 736' ' ' THR . . . . . . . . . . . . . 86.8 m -97.41 109.14 21.95 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.117 0.484 . . . . 73.329999999999998 111.23 176.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 45.4 t -101.16 129.07 52.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-O 120.972 0.415 . . . . 74.430000000000007 111.538 -179.096 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 738' ' ' THR . . . . . . . . . . . . . 40.4 m -108.94 113.75 26.92 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.521 -0.309 . . . . 64.120000000000005 111.255 179.038 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 739' ' ' VAL . . . . . . . . . . . . . 21.8 t -93.07 118.89 39.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-O 120.564 0.221 . . . . 63.329999999999998 110.577 177.097 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 740' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -112.46 158.97 19.22 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 120.994 0.426 . . . . 72.420000000000002 111.618 -176.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 741' ' ' VAL . . . . . . . . . . . . . 38.3 t . . . . . 0 CA--C 1.544 0.746 0 N-CA-C 113.248 0.833 . . . . 53.32 113.248 -170.632 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 664' ' ' ASP . . . . . . . . . . . . . 27.4 t0 . . . . . 0 CA--C 1.534 0.358 0 CA-C-O 121.126 0.489 . . . . 72.219999999999999 111.649 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 665' ' ' LEU . . . . . 0.48 HD12 ' HD3' ' A' ' 694' ' ' LYS . 84.0 mt -80.65 117.11 21.05 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.846 -0.615 . . . . 72.400000000000006 109.621 173.574 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 666' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -60.09 142.54 89.34 Favored Pre-proline 0 CA--C 1.542 0.663 0 CA-C-N 116.247 -0.433 . . . . 75.430000000000007 111.6 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 667' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -75.54 155.11 40.43 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 122.536 2.157 . . . . 73.420000000000002 113.795 -169.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 668' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -86.23 102.55 14.04 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.94 -0.573 . . . . 73.540000000000006 110.845 176.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 669' ' ' LEU . . . . . . . . . . . . . 55.2 tp -93.47 105.9 17.91 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 120.958 0.408 . . . . 73.430000000000007 110.64 177.356 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 670' ' ' THR . . . . . . . . . . . . . 87.4 m -89.18 110.98 21.66 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.361 -0.381 . . . . 63.299999999999997 111.616 -177.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 671' ' ' VAL . . . . . 0.573 HG22 HG13 ' A' ' 689' ' ' VAL . 88.6 t -138.16 134.52 17.85 Favored Pre-proline 0 CA--C 1.539 0.555 0 CA-C-N 116.259 -0.428 . . . . 74.400000000000006 110.672 179.359 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 672' ' ' PRO . . . . . 0.448 ' HG2' ' NE2' ' A' ' 735' ' ' GLN . 71.7 Cg_endo -76.62 120.78 5.68 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 122.058 1.838 . . . . 55.509999999999998 111.62 175.634 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 673' ' ' VAL . . . . . . . . . . . . . 14.8 p -67.08 -23.2 30.3 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 N-CA-C 112.761 0.652 . . . . 74.340000000000003 112.761 -174.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 674' ' ' GLY . . . . . . . . . . . . . . . -142.93 148.33 20.03 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 120.952 -0.642 . . . . 51.539999999999999 114.041 -177.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 675' ' ' ALA . . . . . . . . . . . . . . . -157.15 151.84 25.55 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.275 0.63 . . . . 72.109999999999999 110.35 178.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 676' ' ' THR . . . . . . . . . . . . . 91.1 m -139.34 124.9 19.34 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 111.897 0.332 . . . . 63.409999999999997 111.897 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 677' ' ' ILE . . . . . . . . . . . . . 25.2 pt -128.67 172.51 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-O 121.225 0.536 . . . . 74.430000000000007 111.689 179.394 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 678' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -110.96 165.4 11.9 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.267 0.556 . . . . 73.010000000000005 111.713 177.795 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 679' ' ' VAL . . . . . . . . . . . . . 95.2 t -63.28 126.33 21.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 116.113 -0.494 . . . . 43.43 110.696 173.419 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 89.35 1.09 78.99 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 121.425 -0.417 . . . . 72.310000000000002 113.126 -176.571 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 681' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -84.74 177.94 7.84 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 120.937 0.399 . . . . 75.209999999999994 110.713 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 682' ' ' SER . . . . . . . . . . . . . 54.9 m -114.51 150.23 35.2 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 120.972 0.415 . . . . 52.109999999999999 111.365 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 683' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -151.36 131.1 13.18 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 116.129 -0.487 . . . . 64.519999999999996 110.904 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 684' ' ' VAL . . . . . . . . . . . . . 48.6 t -122.37 103.27 38.71 Favored Pre-proline 0 CA--C 1.543 0.677 0 CA-C-O 120.851 0.357 . . . . 65.310000000000002 111.312 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -60.33 -46.97 15.8 Favored 'Trans proline' 0 CA--C 1.545 1.027 0 C-N-CA 122.819 2.346 . . . . 62.240000000000002 113.974 -175.28 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 686' ' ' MET . . . . . . . . . . . . . 91.2 mmm -78.48 -11.85 59.98 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 112.925 0.713 . . . . 74.209999999999994 112.925 -174.503 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 687' ' ' ALA . . . . . . . . . . . . . . . -77.22 -30.19 54.54 Favored 'General case' 0 N--CA 1.467 0.419 0 O-C-N 122.038 -0.414 . . . . 32.049999999999997 111.397 177.689 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 688' ' ' GLU . . . . . 0.407 ' O ' ' HD3' ' A' ' 672' ' ' PRO . 19.7 mm-40 -97.04 1.74 50.51 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 112.203 0.446 . . . . 61.329999999999998 112.203 -178.042 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 689' ' ' VAL . . . . . 0.573 HG13 HG22 ' A' ' 671' ' ' VAL . 95.4 t -120.67 125.08 73.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-O 120.97 0.414 . . . . 65.239999999999995 112.076 -176.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 690' ' ' LEU . . . . . 0.42 HD22 ' C ' ' A' ' 689' ' ' VAL . 2.7 mm? -127.38 164.01 22.77 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 116.115 -0.493 . . . . 73.349999999999994 110.815 178.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 691' ' ' ALA . . . . . . . . . . . . . . . -153.11 122.46 6.68 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.799 0.333 . . . . 72.25 111.345 175.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 692' ' ' ILE . . . . . . . . . . . . . 46.8 mm -130.85 132.3 64.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-O 120.996 0.427 . . . . 70.420000000000002 112.02 -176.695 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -113.13 150.53 32.04 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 120.969 0.414 . . . . 71.450000000000003 111.004 174.559 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 694' ' ' LYS . . . . . 0.48 ' HD3' HD12 ' A' ' 665' ' ' LEU . 64.3 tttp -70.89 -38.26 73.02 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 111.967 0.358 . . . . 62.310000000000002 111.967 -178.026 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -82.66 -53.79 5.65 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 122.019 -0.425 . . . . 73.409999999999997 111.894 -178.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 696' ' ' ASP . . . . . 0.508 ' HB2' ' HB2' ' A' ' 726' ' ' SER . 15.0 t70 -80.39 -42.03 23.56 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 112.595 0.591 . . . . 71.219999999999999 112.595 -174.671 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . 109.74 -107.4 2.34 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 120.947 -0.644 . . . . 64.310000000000002 112.993 -178.545 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -81.67 115.95 21.17 Favored 'General case' 0 N--CA 1.466 0.339 0 O-C-N 122.201 -0.588 . . . . 70.209999999999994 111.773 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 699' ' ' LEU . . . . . 0.45 HD22 ' HD2' ' A' ' 702' ' ' LYS . 75.5 mt -111.95 1.11 16.29 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.845 0.355 . . . . 61.43 110.443 170.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 22.4 m -56.27 -37.49 69.88 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.272 0.558 . . . . 73.340000000000003 111.158 177.5 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 701' ' ' SER . . . . . . . . . . . . . 65.5 p -72.33 -9.91 59.1 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 115.979 -0.555 . . . . 75.450000000000003 112.315 179.15 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 702' ' ' LYS . . . . . 0.45 ' HD2' HD22 ' A' ' 699' ' ' LEU . 62.1 mttp -101.34 1.47 38.63 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 112.446 0.535 . . . . 73.530000000000001 112.446 178.066 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 703' ' ' ILE . . . . . 0.429 HD13 HG12 ' A' ' 689' ' ' VAL . 67.7 mt -72.24 135.14 28.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 N-CA-C 112.081 0.4 . . . . 71.019999999999996 112.081 -178.014 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 704' ' ' LYS . . . . . . . . . . . . . 56.4 tttm -102.11 137.15 40.76 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.574 -0.285 . . . . 74.400000000000006 111.013 173.053 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 49.4 t -96.04 141.77 14.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-O 120.988 0.423 . . . . 75.420000000000002 111.065 176.484 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 706' ' ' ASP . . . . . 0.535 ' HB3' ' HB ' ' A' ' 720' ' ' THR . 27.3 t70 -136.56 138.2 41.03 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 120.728 0.299 . . . . 42.350000000000001 111.205 178.019 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 104.29 -173.07 21.05 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 121.391 -0.433 . . . . 64.239999999999995 113.246 -179.18 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 708' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -157.95 141.73 15.64 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 120.863 0.363 . . . . 61.149999999999999 111.306 179.345 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 709' ' ' VAL . . . . . 0.488 HG23 HD21 ' A' ' 719' ' ' LEU . 99.5 t -122.97 121.95 64.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-O 120.785 0.326 . . . . 73.010000000000005 111.217 -179.425 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 710' ' ' ASP . . . . . 0.438 ' O ' HG21 ' A' ' 739' ' ' VAL . 8.2 m-20 -84.95 136.08 33.77 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 121.104 0.478 . . . . 61.100000000000001 111.932 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 711' ' ' THR . . . . . . . . . . . . . 46.2 p -101.63 -3.57 28.1 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.232 0.539 . . . . 62.43 110.37 172.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 712' ' ' THR . . . . . . . . . . . . . 30.1 p -96.06 -27.67 14.98 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 115.749 -0.66 . . . . 60.549999999999997 112.314 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 713' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -121.86 141.04 51.67 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 120.628 0.251 . . . . 72.049999999999997 111.135 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 714' ' ' ALA . . . . . . . . . . . . . . . -81.11 127.24 32.42 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 120.957 0.408 . . . . 44.420000000000002 112.089 -179.503 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 715' ' ' GLY . . . . . 0.42 ' H ' ' HB ' ' A' ' 739' ' ' VAL . . . 170.14 158.62 14.33 Favored Glycine 0 CA--C 1.525 0.666 0 C-N-CA 121.447 -0.406 . . . . 73.040000000000006 112.788 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 716' ' ' THR . . . . . 0.403 ' HA ' ' HA ' ' A' ' 738' ' ' THR . 51.8 m -87.91 126.44 35.05 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.049 0.452 . . . . 71.109999999999999 111.627 178.133 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 717' ' ' TYR . . . . . 0.472 ' HB2' HG22 ' A' ' 709' ' ' VAL . 72.5 m-85 -125.92 135.9 52.42 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.186 -0.461 . . . . 74.219999999999999 110.411 176.614 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 718' ' ' VAL . . . . . . . . . . . . . 59.0 t -108.29 113.69 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 CA-C-O 120.915 0.388 . . . . 51.509999999999998 111.856 -176.218 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 719' ' ' LEU . . . . . 0.488 HD21 HG23 ' A' ' 709' ' ' VAL . 88.1 mt -89.23 141.08 28.84 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 116.477 -0.329 . . . . 72.329999999999998 111.543 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 720' ' ' THR . . . . . 0.535 ' HB ' ' HB3' ' A' ' 706' ' ' ASP . 62.1 m -111.15 132.54 54.22 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.936 0.398 . . . . 65.239999999999995 111.315 178.685 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 721' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -122.09 131.03 53.76 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.329 -0.396 . . . . 72.219999999999999 110.365 178.21 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 86.4 m -138.0 135.71 36.21 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 120.917 0.389 . . . . 53.420000000000002 111.964 -176.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 12.7 p -136.64 146.45 28.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-O 120.996 0.427 . . . . 74.319999999999993 111.42 -179.209 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 26.4 m -104.5 140.2 38.3 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.439 -0.346 . . . . 73.310000000000002 111.198 178.513 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -73.32 169.01 18.02 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 121.09 0.471 . . . . 62.329999999999998 111.275 178.677 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 726' ' ' SER . . . . . 0.508 ' HB2' ' HB2' ' A' ' 696' ' ' ASP . 46.8 t -63.8 -38.47 91.2 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 120.903 0.382 . . . . 60.409999999999997 111.234 176.009 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 727' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -98.25 7.17 46.62 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 112.494 0.554 . . . . 74.140000000000001 112.494 179.296 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 728' ' ' GLY . . . . . . . . . . . . . . . 112.4 -6.24 26.59 Favored Glycine 0 CA--C 1.538 1.469 0 N-CA-C 116.688 1.435 . . . . 72.140000000000001 116.688 166.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 17.6 m80 -69.15 109.22 3.94 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 119.292 1.546 . . . . 75.420000000000002 111.368 176.506 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 730' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -97.43 124.1 41.51 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 116.589 -0.278 . . . . 72.219999999999999 111.159 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 31.6 m -122.82 154.19 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-O 120.801 0.334 . . . . 62.5 111.388 -178.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 9.3 t -138.28 148.25 44.48 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 121.437 0.637 . . . . 55.32 112.524 -177.345 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -148.41 150.12 32.94 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.838 -0.619 . . . . 22.219999999999999 110.483 178.193 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 734' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -120.15 160.02 23.71 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 112.67 0.619 . . . . 75.319999999999993 112.67 -174.059 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 735' ' ' GLN . . . . . 0.448 ' NE2' ' HG2' ' A' ' 672' ' ' PRO . 59.0 tt0 -130.6 119.58 22.7 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 115.478 -0.783 . . . . 71.430000000000007 110.8 -179.259 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 736' ' ' THR . . . . . . . . . . . . . 23.8 m -90.02 103.79 16.42 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 116.496 -0.32 . . . . 44.420000000000002 111.266 -178.021 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 32.5 t -102.19 113.56 39.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 CA-C-O 120.952 0.406 . . . . 53.409999999999997 111.665 -177.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 738' ' ' THR . . . . . 0.403 ' HA ' ' HA ' ' A' ' 716' ' ' THR . 87.7 m -100.29 112.06 24.37 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.855 0.359 . . . . 53.409999999999997 111.464 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 739' ' ' VAL . . . . . 0.438 HG21 ' O ' ' A' ' 710' ' ' ASP . 22.4 t -93.22 133.58 33.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-O 120.778 0.323 . . . . 60.030000000000001 110.676 177.371 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 740' ' ' LYS . . . . . . . . . . . . . 19.1 ptmt -132.81 152.34 51.82 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.236 0.541 . . . . 74.409999999999997 111.929 -178.709 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 741' ' ' VAL . . . . . . . . . . . . . 20.0 t . . . . . 0 CA--C 1.542 0.636 0 CA-C-N 116.057 -0.519 . . . . 62.439999999999998 111.987 -174.634 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 664' ' ' ASP . . . . . 0.416 ' OD2' ' HB2' ' A' ' 727' ' ' LYS . 24.5 t0 . . . . . 0 CA--C 1.535 0.369 0 CA-C-O 121.272 0.558 . . . . 73.420000000000002 111.249 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 665' ' ' LEU . . . . . . . . . . . . . 84.3 mt -95.44 138.07 33.63 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 115.685 -0.689 . . . . 61.219999999999999 111.261 -179.143 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 666' ' ' GLU . . . . . 0.454 ' H ' ' CD ' ' A' ' 666' ' ' GLU . 1.3 pm0 -78.32 142.33 62.9 Favored Pre-proline 0 CA--C 1.54 0.596 0 CA-C-N 116.439 -0.346 . . . . 70.439999999999998 110.189 170.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 667' ' ' PRO . . . . . 0.414 ' HG3' ' HB2' ' A' ' 725' ' ' ASP . 38.2 Cg_exo -59.7 144.25 99.48 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 122.83 2.353 . . . . 33.200000000000003 114.467 -171.137 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 668' ' ' LYS . . . . . . . . . . . . . 49.9 tptt -82.3 97.37 8.26 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.658 -0.701 . . . . 72.239999999999995 109.745 171.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 669' ' ' LEU . . . . . 0.413 ' HG ' HG23 ' A' ' 671' ' ' VAL . 56.7 tp -90.19 105.86 18.09 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.002 -0.544 . . . . 65.530000000000001 110.527 179.188 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 670' ' ' THR . . . . . . . . . . . . . 96.8 m -88.58 110.22 20.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.265 0.555 . . . . 74.519999999999996 111.366 -178.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 671' ' ' VAL . . . . . 0.418 HG22 HG13 ' A' ' 689' ' ' VAL . 72.4 t -129.6 131.72 23.76 Favored Pre-proline 0 CA--C 1.535 0.396 0 CA-C-N 115.753 -0.658 . . . . 70.5 110.285 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 672' ' ' PRO . . . . . 0.477 ' HG2' ' NE2' ' A' ' 735' ' ' GLN . 47.4 Cg_endo -69.07 123.96 10.87 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 121.829 1.686 . . . . 75.340000000000003 111.693 176.471 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 673' ' ' VAL . . . . . . . . . . . . . 14.8 p -63.53 -29.52 47.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 N-CA-C 112.357 0.503 . . . . 71.530000000000001 112.357 -174.543 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 674' ' ' GLY . . . . . . . . . . . . . . . -150.88 143.9 11.14 Favored Glycine 0 CA--C 1.525 0.657 0 C-N-CA 120.741 -0.742 . . . . 72.329999999999998 113.177 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 675' ' ' ALA . . . . . 0.423 ' O ' ' HA ' ' A' ' 737' ' ' VAL . . . -148.63 143.89 26.84 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.729 0.299 . . . . 74.439999999999998 110.981 179.496 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 676' ' ' THR . . . . . . . . . . . . . 49.7 m -130.07 131.03 45.61 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.761 0.315 . . . . 70.519999999999996 111.509 -179.485 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 677' ' ' ILE . . . . . . . . . . . . . 25.6 pt -133.71 176.5 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 CA-C-O 120.882 0.373 . . . . 74.510000000000005 110.945 179.045 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 678' ' ' HIS . . . . . . . . . . . . . 76.2 m80 -118.67 158.82 24.77 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 121.08 0.467 . . . . 63.240000000000002 111.879 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 679' ' ' VAL . . . . . 0.402 HG21 HG22 ' A' ' 741' ' ' VAL . 98.8 t -60.45 112.1 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-N 116.142 -0.481 . . . . 75.530000000000001 111.172 176.295 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 114.49 -16.65 19.24 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 121.379 -0.438 . . . . 43.350000000000001 113.03 -175.263 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 681' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -73.96 -172.18 1.27 Allowed 'General case' 0 CA--C 1.546 0.809 0 CA-C-O 121.033 0.444 . . . . 70.239999999999995 111.723 178.107 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 682' ' ' SER . . . . . . . . . . . . . 25.4 m -129.07 155.12 45.95 Favored 'General case' 0 N--CA 1.478 0.94 0 O-C-N 122.211 -0.305 . . . . 62.530000000000001 111.007 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 683' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -159.2 120.35 3.28 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 120.821 0.343 . . . . 72.150000000000006 111.69 -179.383 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 684' ' ' VAL . . . . . . . . . . . . . 80.9 t -113.97 110.11 49.14 Favored Pre-proline 0 N--CA 1.471 0.588 0 CA-C-O 120.843 0.354 . . . . 62.299999999999997 111.544 177.241 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -58.09 -36.79 97.66 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 122.77 2.314 . . . . 71.409999999999997 113.665 -177.394 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 686' ' ' MET . . . . . 0.442 ' CE ' ' HA ' ' A' ' 686' ' ' MET . 1.0 OUTLIER -79.26 -11.78 59.95 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.424 0.527 . . . . 72.510000000000005 112.424 -177.374 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 687' ' ' ALA . . . . . . . . . . . . . . . -89.61 -32.68 16.99 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.215 0.531 . . . . 52.539999999999999 110.972 176.683 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 688' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -84.74 -17.54 38.0 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 116.137 -0.483 . . . . 72.310000000000002 111.683 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 689' ' ' VAL . . . . . 0.418 HG13 HG22 ' A' ' 671' ' ' VAL . 76.0 t -116.76 131.38 69.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 N-CA-C 112.695 0.628 . . . . 72.450000000000003 112.695 -175.331 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 690' ' ' LEU . . . . . 0.416 HD12 ' N ' ' A' ' 690' ' ' LEU . 5.2 mp -125.42 166.64 16.23 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 116.309 -0.405 . . . . 74.450000000000003 111.036 177.556 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 691' ' ' ALA . . . . . . . . . . . . . . . -148.97 122.7 9.25 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 120.905 0.384 . . . . 72.420000000000002 111.58 176.02 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 692' ' ' ILE . . . . . 0.548 HD13 ' HA ' ' A' ' 698' ' ' ASP . 37.2 mm -133.03 131.75 58.84 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 CA-C-N 116.475 -0.329 . . . . 55.340000000000003 111.481 -177.776 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 58.6 t0 -111.36 129.03 56.13 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 109.627 -0.508 . . . . 74.219999999999999 109.627 171.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -57.69 -28.05 63.47 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 112.619 0.6 . . . . 72.530000000000001 112.619 -173.708 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 695' ' ' GLU . . . . . 0.437 ' HG3' ' N ' ' A' ' 696' ' ' ASP . 12.6 pt-20 -82.91 -44.48 15.32 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 111.998 0.37 . . . . 54.020000000000003 111.998 -179.418 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 696' ' ' ASP . . . . . 0.437 ' N ' ' HG3' ' A' ' 695' ' ' GLU . 10.5 t70 -95.12 -48.86 5.77 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 121.181 0.515 . . . . 74.230000000000004 111.596 -170.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . 124.32 -137.46 10.68 Favored Glycine 0 CA--C 1.526 0.722 0 CA-C-N 116.179 -0.464 . . . . 55.420000000000002 112.352 -176.435 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 698' ' ' ASP . . . . . 0.548 ' HA ' HD13 ' A' ' 692' ' ' ILE . 18.0 t70 -70.92 118.21 13.4 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.339 0.59 . . . . 75.310000000000002 111.619 179.395 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 699' ' ' LEU . . . . . . . . . . . . . 80.3 mt -116.4 18.28 15.22 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 115.882 -0.599 . . . . 73.219999999999999 110.7 173.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 54.1 m -60.78 -27.56 68.09 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.114 0.483 . . . . 74.049999999999997 111.868 -178.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 701' ' ' SER . . . . . . . . . . . . . 25.3 t -78.55 -13.54 59.78 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.071 0.462 . . . . 72.439999999999998 111.513 178.292 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 702' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -90.03 7.64 36.59 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 116.42 -0.355 . . . . 74.540000000000006 111.436 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 703' ' ' ILE . . . . . 0.494 HG12 ' HB ' ' A' ' 723' ' ' VAL . 62.5 mt -85.39 138.41 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-O 121.336 0.589 . . . . 74.120000000000005 112.209 -177.483 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 704' ' ' LYS . . . . . . . . . . . . . 67.1 tttt -100.47 140.72 34.32 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.943 -0.571 . . . . 72.099999999999994 109.772 171.241 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 59.9 t -111.69 112.43 40.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-O 121.146 0.498 . . . . 74.099999999999994 111.807 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 706' ' ' ASP . . . . . 0.567 ' HB2' ' HB ' ' A' ' 720' ' ' THR . 9.2 m-20 -106.08 137.83 43.32 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 116.12 -0.491 . . . . 63.439999999999998 111.388 177.344 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 101.6 -177.93 27.23 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 121.35 -0.452 . . . . 71.209999999999994 113.509 177.555 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 708' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -161.79 145.94 12.67 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.959 0.409 . . . . 70.349999999999994 111.415 179.017 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 709' ' ' VAL . . . . . 0.508 HG22 ' HB2' ' A' ' 717' ' ' TYR . 96.5 t -117.56 120.12 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-N 116.283 -0.417 . . . . 53.399999999999999 110.882 177.016 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 710' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -77.66 135.92 38.15 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 120.912 0.387 . . . . 72.420000000000002 111.574 177.455 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 711' ' ' THR . . . . . . . . . . . . . 76.2 p -97.66 -1.35 43.83 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.911 0.386 . . . . 73.239999999999995 110.958 173.754 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 712' ' ' THR . . . . . . . . . . . . . 7.2 t -105.43 -13.47 15.63 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 116.219 -0.446 . . . . 63.329999999999998 111.952 178.001 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 713' ' ' LYS . . . . . . . . . . . . . 7.8 ttpm? -129.46 127.6 41.2 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.827 0.346 . . . . 62.439999999999998 111.662 -178.254 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 714' ' ' ALA . . . . . 0.462 ' HB2' HG23 ' A' ' 741' ' ' VAL . . . -72.0 144.89 48.67 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.199 -0.455 . . . . 75.239999999999995 111.735 177.701 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 152.76 171.87 20.62 Favored Glycine 0 CA--C 1.523 0.574 0 C-N-CA 121.027 -0.606 . . . . 63.329999999999998 113.029 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 716' ' ' THR . . . . . . . . . . . . . 56.3 m -100.3 122.23 42.76 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 122.36 -0.494 . . . . 72.400000000000006 111.327 179.141 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 717' ' ' TYR . . . . . 0.508 ' HB2' HG22 ' A' ' 709' ' ' VAL . 42.2 m-85 -118.92 134.94 54.84 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.139 -0.482 . . . . 73.140000000000001 110.582 -178.397 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 718' ' ' VAL . . . . . . . . . . . . . 49.5 t -101.27 113.97 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 CA-C-O 121.072 0.463 . . . . 72.530000000000001 111.58 -178.456 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 719' ' ' LEU . . . . . 0.467 HD21 HG23 ' A' ' 709' ' ' VAL . 92.3 mt -94.9 130.94 41.3 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.331 -0.395 . . . . 75.040000000000006 111.196 178.493 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 720' ' ' THR . . . . . 0.567 ' HB ' ' HB2' ' A' ' 706' ' ' ASP . 25.0 m -113.29 132.71 55.44 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.753 0.311 . . . . 64.519999999999996 111.196 -178.84 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 721' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -124.58 140.69 52.71 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.664 0.269 . . . . 74.299999999999997 110.968 -179.385 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 56.8 m -140.61 123.5 16.39 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 120.513 0.197 . . . . 73.430000000000007 111.179 -179.514 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 723' ' ' VAL . . . . . 0.494 ' HB ' HG12 ' A' ' 703' ' ' ILE . 7.5 p -114.54 140.94 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 CA-C-O 121.056 0.455 . . . . 60.049999999999997 112.142 -176.42 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 27.3 m -102.44 144.93 30.27 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 116.136 -0.484 . . . . 63.310000000000002 111.798 -179.119 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 725' ' ' ASP . . . . . 0.414 ' HB2' ' HG3' ' A' ' 667' ' ' PRO . 5.7 t70 -103.63 150.77 23.67 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.323 0.649 . . . . 53.0 111.088 179.592 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 726' ' ' SER . . . . . . . . . . . . . 66.9 p -66.03 -14.65 62.04 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 112.522 0.564 . . . . 71.329999999999998 112.522 -175.13 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 727' ' ' LYS . . . . . 0.416 ' HB2' ' OD2' ' A' ' 664' ' ' ASP . 41.1 mmtm -105.36 -2.73 23.54 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 112.497 0.554 . . . . 63.009999999999998 112.497 -179.594 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 728' ' ' GLY . . . . . . . . . . . . . . . 112.21 12.42 13.77 Favored Glycine 0 CA--C 1.535 1.317 0 N-CA-C 115.384 0.914 . . . . 71.010000000000005 115.384 176.235 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 18.3 m80 -93.93 133.56 37.23 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 118.351 1.076 . . . . 74.040000000000006 111.241 173.592 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 730' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -134.24 112.54 11.15 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 122.075 -0.39 . . . . 72.340000000000003 111.263 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 34.1 m -112.47 160.44 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 N-CA-C 112.071 0.397 . . . . 73.420000000000002 112.071 -177.039 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 9.6 t -136.32 150.34 48.82 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 112.55 0.574 . . . . 75.319999999999993 112.55 -176.638 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -147.81 161.61 40.9 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.849 -0.614 . . . . 65.450000000000003 110.353 177.005 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 734' ' ' LYS . . . . . . . . . . . . . 33.2 mtmm -129.32 158.53 38.85 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 113.151 0.797 . . . . 63.439999999999998 113.151 -176.212 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 735' ' ' GLN . . . . . 0.477 ' NE2' ' HG2' ' A' ' 672' ' ' PRO . 48.1 tt0 -130.76 128.95 41.81 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 114.957 -1.019 . . . . 73.239999999999995 110.7 179.216 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 736' ' ' THR . . . . . . . . . . . . . 86.7 m -96.03 104.38 16.32 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.887 0.375 . . . . 74.209999999999994 111.205 178.08 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 737' ' ' VAL . . . . . 0.423 ' HA ' ' O ' ' A' ' 675' ' ' ALA . 46.7 t -97.69 140.84 17.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-O 120.821 0.343 . . . . 62.32 111.223 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 738' ' ' THR . . . . . . . . . . . . . 64.3 m -130.03 120.83 25.35 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 120.777 0.322 . . . . 55.109999999999999 111.147 179.496 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 739' ' ' VAL . . . . . . . . . . . . . 41.9 t -99.51 133.0 43.9 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-O 120.759 0.314 . . . . 73.409999999999997 111.355 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 740' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -121.97 151.84 40.34 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.39 -0.368 . . . . 75.150000000000006 111.571 -179.127 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 741' ' ' VAL . . . . . 0.462 HG23 ' HB2' ' A' ' 714' ' ' ALA . 25.1 t . . . . . 0 N--CA 1.47 0.539 0 CA-C-O 120.771 0.32 . . . . 61.439999999999998 111.635 -179.54 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 664' ' ' ASP . . . . . 0.444 ' OD2' ' HB2' ' A' ' 727' ' ' LYS . 18.7 t0 . . . . . 0 C--O 1.236 0.354 0 CA-C-O 121.255 0.55 . . . . 64.200000000000003 111.729 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 665' ' ' LEU . . . . . . . . . . . . . 73.0 mt -91.08 133.47 35.31 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 115.866 -0.606 . . . . 71.049999999999997 109.814 173.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 666' ' ' GLU . . . . . 0.447 ' H ' ' CD ' ' A' ' 666' ' ' GLU . 1.5 pm0 -64.7 144.96 98.86 Favored Pre-proline 0 CA--C 1.539 0.545 0 CA-C-N 116.218 -0.446 . . . . 45.240000000000002 111.47 -179.672 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 667' ' ' PRO . . . . . 0.531 ' HD3' ' HB2' ' A' ' 725' ' ' ASP . 25.8 Cg_endo -60.91 145.12 99.51 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 122.785 2.323 . . . . 64.019999999999996 113.149 -174.545 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 668' ' ' LYS . . . . . . . . . . . . . 9.2 tmtm? -82.58 99.12 9.35 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.33 0.586 . . . . 61.420000000000002 110.384 179.176 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 669' ' ' LEU . . . . . . . . . . . . . 62.8 tp -89.8 109.27 20.27 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.726 -0.67 . . . . 64.5 110.736 179.498 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 670' ' ' THR . . . . . . . . . . . . . 60.7 m -87.08 110.42 20.09 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.827 0.346 . . . . 64.0 111.492 -178.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 671' ' ' VAL . . . . . 0.49 HG21 ' HB3' ' A' ' 733' ' ' ALA . 67.3 t -132.89 124.82 18.88 Favored Pre-proline 0 CA--C 1.542 0.668 0 CA-C-N 116.263 -0.426 . . . . 72.140000000000001 110.831 176.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 672' ' ' PRO . . . . . 0.437 ' HG2' ' NE2' ' A' ' 735' ' ' GLN . 73.2 Cg_endo -74.75 154.06 43.55 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.358 2.039 . . . . 71.439999999999998 112.537 178.33 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 673' ' ' VAL . . . . . . . . . . . . . 12.9 p -63.6 -32.25 56.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 N-CA-C 112.062 0.393 . . . . 61.450000000000003 112.062 -176.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 674' ' ' GLY . . . . . . . . . . . . . . . -170.4 173.14 44.3 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 120.685 -0.769 . . . . 73.299999999999997 114.204 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 675' ' ' ALA . . . . . . . . . . . . . . . -152.95 122.95 6.98 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.876 0.37 . . . . 74.209999999999994 111.308 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 676' ' ' THR . . . . . . . . . . . . . 82.7 m -102.29 124.93 48.74 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 112.158 0.429 . . . . 74.230000000000004 112.158 -177.514 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 677' ' ' ILE . . . . . 0.404 HD13 ' HB2' ' A' ' 683' ' ' PHE . 29.3 pt -126.4 177.0 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 CA-C-N 116.38 -0.373 . . . . 62.420000000000002 111.1 176.189 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 678' ' ' HIS . . . . . 0.411 ' HA ' ' O ' ' A' ' 740' ' ' LYS . 98.0 m-70 -117.02 156.16 27.97 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.732 0.641 . . . . 73.040000000000006 112.732 -178.085 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 679' ' ' VAL . . . . . 0.526 HG13 ' HA ' ' A' ' 712' ' ' THR . 85.0 t -61.53 121.27 9.32 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-N 115.536 -0.756 . . . . 73.349999999999994 111.375 175.321 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 110.94 -23.65 18.68 Favored Glycine 0 CA--C 1.526 0.751 0 CA-C-N 116.132 -0.485 . . . . 65.120000000000005 112.185 -177.719 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 681' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -83.38 -162.8 0.66 Allowed 'General case' 0 CA--C 1.543 0.707 0 CA-C-O 120.984 0.421 . . . . 70.230000000000004 111.687 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 682' ' ' SER . . . . . . . . . . . . . 74.0 m -141.47 173.97 11.0 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 122.156 -0.34 . . . . 74.120000000000005 111.703 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 683' ' ' PHE . . . . . 0.404 ' HB2' HD13 ' A' ' 677' ' ' ILE . 76.2 t80 -150.9 140.4 21.52 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.855 0.36 . . . . 65.329999999999998 111.759 -177.596 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 684' ' ' VAL . . . . . . . . . . . . . 99.0 t -118.12 105.78 46.36 Favored Pre-proline 0 CA--C 1.545 0.784 0 CA-C-O 120.728 0.299 . . . . 73.530000000000001 111.605 178.327 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.93 -38.43 78.96 Favored 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 122.745 2.297 . . . . 73.319999999999993 113.505 -178.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 686' ' ' MET . . . . . 0.563 ' HE1' ' HB ' ' A' ' 703' ' ' ILE . 0.3 OUTLIER -78.79 -9.46 59.45 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.759 0.651 . . . . 73.329999999999998 112.759 -175.977 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 687' ' ' ALA . . . . . . . . . . . . . . . -79.96 -44.9 19.46 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 120.9 0.381 . . . . 74.340000000000003 111.923 -179.632 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 688' ' ' GLU . . . . . . . . . . . . . 45.7 mm-40 -86.6 -8.22 57.68 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 113.0 0.741 . . . . 64.019999999999996 113.0 -174.494 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 689' ' ' VAL . . . . . 0.556 HG12 HD13 ' A' ' 703' ' ' ILE . 87.6 t -118.58 124.71 73.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-O 120.938 0.399 . . . . 72.430000000000007 111.956 -177.403 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 690' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -125.41 162.93 23.72 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 116.266 -0.425 . . . . 75.140000000000001 111.062 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 691' ' ' ALA . . . . . . . . . . . . . . . -142.69 121.71 12.86 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.057 0.456 . . . . 74.329999999999998 111.63 176.459 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 692' ' ' ILE . . . . . . . . . . . . . 45.6 mm -128.69 124.46 61.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-N 116.395 -0.366 . . . . 64.150000000000006 111.55 -178.182 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 693' ' ' ASP . . . . . 0.488 ' HB2' ' HB3' ' A' ' 667' ' ' PRO . 36.2 t70 -108.35 149.87 28.11 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 120.916 0.389 . . . . 61.43 110.883 173.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 8.3 mtpm? -65.84 -56.68 10.62 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 116.319 -0.401 . . . . 73.420000000000002 111.999 -176.76 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 695' ' ' GLU . . . . . 0.418 ' CD ' ' H ' ' A' ' 695' ' ' GLU . 0.6 OUTLIER -84.44 -51.76 6.68 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 112.149 0.426 . . . . 75.230000000000004 112.149 -174.856 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 696' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -72.23 -28.68 63.32 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-O 120.933 0.397 . . . . 64.150000000000006 111.397 -173.436 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . 103.73 -147.09 16.56 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 121.477 -0.392 . . . . 73.510000000000005 113.066 178.098 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -69.56 131.62 44.97 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 120.982 0.42 . . . . 75.420000000000002 110.995 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 699' ' ' LEU . . . . . 0.428 HD12 ' HB3' ' A' ' 667' ' ' PRO . 98.0 mt -125.45 15.76 8.25 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 120.973 0.416 . . . . 62.229999999999997 111.164 178.093 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 34.9 m -58.75 -38.34 78.21 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 121.064 0.459 . . . . 75.239999999999995 111.455 -178.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 701' ' ' SER . . . . . . . . . . . . . 33.7 m -61.44 -21.95 64.6 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 116.2 -0.454 . . . . 62.039999999999999 111.814 178.603 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 702' ' ' LYS . . . . . . . . . . . . . 64.0 mttm -91.31 1.28 57.22 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 112.607 0.595 . . . . 70.329999999999998 112.607 -178.182 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 703' ' ' ILE . . . . . 0.563 ' HB ' ' HE1' ' A' ' 686' ' ' MET . 74.5 mt -69.46 111.91 3.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-O 121.238 0.542 . . . . 72.329999999999998 111.559 -178.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 704' ' ' LYS . . . . . . . . . . . . . 24.3 tptm -85.02 118.91 24.87 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 115.549 -0.751 . . . . 70.420000000000002 110.508 178.541 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 51.7 t -96.42 138.25 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 CA-C-O 120.963 0.411 . . . . 64.040000000000006 111.823 -177.177 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 706' ' ' ASP . . . . . 0.584 ' HB3' ' HB ' ' A' ' 720' ' ' THR . 24.1 t70 -132.08 140.8 48.97 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 116.291 -0.413 . . . . 71.519999999999996 111.014 177.342 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 107.23 -176.79 21.27 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 121.331 -0.461 . . . . 73.109999999999999 113.067 -179.369 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 708' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -163.49 137.1 5.7 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.182 0.515 . . . . 72.510000000000005 111.734 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 709' ' ' VAL . . . . . 0.548 HG22 ' HB2' ' A' ' 717' ' ' TYR . 46.8 t -112.02 146.18 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-N 116.1 -0.5 . . . . 64.129999999999995 111.309 -178.816 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 710' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -83.81 156.79 22.32 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 121.396 0.617 . . . . 73.420000000000002 111.832 175.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 711' ' ' THR . . . . . 0.423 ' O ' ' HA ' ' A' ' 679' ' ' VAL . 47.2 p -117.75 -22.84 7.81 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.578 -0.737 . . . . 73.430000000000007 110.796 172.894 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 712' ' ' THR . . . . . 0.526 ' HA ' HG13 ' A' ' 679' ' ' VAL . 70.2 p -108.11 13.14 26.2 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 111.923 0.342 . . . . 63.43 111.923 178.556 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 713' ' ' LYS . . . . . . . . . . . . . 3.8 ttmp? -140.08 131.71 27.22 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.664 0.268 . . . . 74.040000000000006 111.132 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 714' ' ' ALA . . . . . . . . . . . . . . . -77.66 143.44 38.16 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 120.81 0.338 . . . . 63.329999999999998 111.284 177.368 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 155.47 -174.94 33.51 Favored Glycine 0 CA--C 1.525 0.657 0 C-N-CA 121.316 -0.469 . . . . 53.32 112.843 -178.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 716' ' ' THR . . . . . . . . . . . . . 38.7 m -123.55 123.02 39.68 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 117.097 0.449 . . . . 73.030000000000001 111.589 -178.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 717' ' ' TYR . . . . . 0.548 ' HB2' HG22 ' A' ' 709' ' ' VAL . 61.4 m-85 -128.03 128.95 45.91 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.185 -0.461 . . . . 55.240000000000002 110.778 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 718' ' ' VAL . . . . . . . . . . . . . 61.6 t -97.78 118.67 44.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-O 121.172 0.511 . . . . 65.140000000000001 111.942 -176.697 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 719' ' ' LEU . . . . . 0.407 HD21 HG23 ' A' ' 709' ' ' VAL . 91.0 mt -93.07 133.64 36.03 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.31 -0.404 . . . . 75.049999999999997 111.076 178.139 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 720' ' ' THR . . . . . 0.584 ' HB ' ' HB3' ' A' ' 706' ' ' ASP . 17.0 m -100.96 144.75 29.53 Favored 'General case' 0 N--CA 1.473 0.714 0 O-C-N 122.214 -0.304 . . . . 73.120000000000005 111.101 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 721' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -134.86 113.85 11.98 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 122.449 0.3 . . . . 72.549999999999997 111.0 -178.39 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 60.4 m -114.23 137.92 51.15 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 111.7 0.259 . . . . 72.140000000000001 111.7 -179.148 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 8.2 p -138.13 136.17 44.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 CA-C-O 121.011 0.434 . . . . 71.140000000000001 111.446 177.667 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 42.4 m -113.13 129.58 56.46 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 120.864 0.364 . . . . 72.430000000000007 111.728 -178.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 725' ' ' ASP . . . . . 0.531 ' HB2' ' HD3' ' A' ' 667' ' ' PRO . 17.6 t0 -73.84 150.03 41.24 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-N 116.225 -0.443 . . . . 73.150000000000006 110.081 174.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 726' ' ' SER . . . . . . . . . . . . . 48.8 m -69.01 -27.24 65.5 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.692 0.282 . . . . 64.310000000000002 111.645 -178.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 727' ' ' LYS . . . . . 0.444 ' HB2' ' OD2' ' A' ' 664' ' ' ASP . 1.3 mptp? -89.19 5.22 45.73 Favored 'General case' 0 CA--C 1.546 0.827 0 N-CA-C 112.258 0.466 . . . . 71.150000000000006 112.258 -177.905 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 728' ' ' GLY . . . . . . . . . . . . . . . 113.31 -2.99 25.19 Favored Glycine 0 CA--C 1.537 1.409 0 N-CA-C 116.463 1.345 . . . . 54.520000000000003 116.463 169.123 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 63.0 m80 -94.72 119.54 33.51 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 118.941 1.37 . . . . 72.129999999999995 112.05 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 730' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -112.65 138.91 48.76 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 122.038 -0.414 . . . . 72.239999999999995 111.775 -178.274 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 29.4 m -138.54 152.36 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-O 120.786 0.327 . . . . 54.219999999999999 111.39 178.22 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 9.0 t -140.3 154.08 46.68 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.038 0.447 . . . . 45.030000000000001 111.653 179.176 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 733' ' ' ALA . . . . . 0.49 ' HB3' HG21 ' A' ' 671' ' ' VAL . . . -148.86 162.15 40.42 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 116.25 -0.432 . . . . 73.140000000000001 111.342 -179.369 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 734' ' ' LYS . . . . . . . . . . . . . 10.7 mtmp? -125.96 154.44 42.85 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 112.446 0.536 . . . . 73.219999999999999 112.446 -179.27 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 735' ' ' GLN . . . . . 0.437 ' NE2' ' HG2' ' A' ' 672' ' ' PRO . 54.0 tt0 -129.7 124.54 33.82 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.858 -0.61 . . . . 65.400000000000006 110.585 178.147 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 736' ' ' THR . . . . . . . . . . . . . 88.1 m -90.91 103.9 16.56 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.841 0.353 . . . . 74.430000000000007 111.633 -177.537 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 50.3 t -96.55 131.76 42.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 O-C-N 122.124 -0.36 . . . . 74.510000000000005 111.299 -178.52 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 738' ' ' THR . . . . . . . . . . . . . 88.5 m -122.68 122.75 39.51 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.028 0.442 . . . . 73.239999999999995 111.651 -178.52 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 739' ' ' VAL . . . . . . . . . . . . . 21.5 t -100.85 131.51 48.33 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 116.143 -0.48 . . . . 70.430000000000007 110.812 178.114 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 740' ' ' LYS . . . . . 0.411 ' O ' ' HA ' ' A' ' 678' ' ' HIS . 16.9 ptpt -124.32 160.38 28.2 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.233 0.539 . . . . 74.230000000000004 111.705 177.226 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 741' ' ' VAL . . . . . 0.462 HG22 HG21 ' A' ' 679' ' ' VAL . 37.8 t . . . . . 0 CA--C 1.537 0.479 0 N-CA-C 112.507 0.558 . . . . 45.299999999999997 112.507 -172.579 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 664' ' ' ASP . . . . . 0.448 ' HB3' ' HE1' ' A' ' 729' ' ' HIS . 12.8 t70 . . . . . 0 CA--C 1.538 0.505 0 CA-C-O 120.928 0.394 . . . . 72.340000000000003 111.89 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 665' ' ' LEU . . . . . . . . . . . . . 80.7 mt -88.03 117.41 26.89 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 116.337 -0.392 . . . . 55.100000000000001 110.122 173.58 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 666' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -54.31 149.07 21.01 Favored Pre-proline 0 CA--C 1.54 0.559 0 CA-C-O 120.796 0.331 . . . . 64.129999999999995 111.444 178.805 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 667' ' ' PRO . . . . . 0.436 ' HA ' ' HA ' ' A' ' 693' ' ' ASP . 38.2 Cg_exo -57.77 140.48 93.77 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 122.422 2.081 . . . . 72.230000000000004 112.95 -173.339 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 668' ' ' LYS . . . . . 0.718 ' HA ' ' HE2' ' A' ' 668' ' ' LYS . 0.6 OUTLIER -82.88 102.96 12.0 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 120.932 0.396 . . . . 73.430000000000007 110.363 175.403 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 669' ' ' LEU . . . . . 0.502 ' HG ' HG23 ' A' ' 671' ' ' VAL . 61.9 tp -90.01 118.61 29.69 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.195 -0.457 . . . . 75.109999999999999 111.354 -179.387 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 670' ' ' THR . . . . . . . . . . . . . 89.3 m -93.85 109.85 21.53 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.732 0.301 . . . . 73.540000000000006 110.986 177.151 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 671' ' ' VAL . . . . . 0.502 HG23 ' HG ' ' A' ' 669' ' ' LEU . 95.7 t -139.74 122.19 10.13 Favored Pre-proline 0 CA--C 1.538 0.51 0 CA-C-N 116.151 -0.477 . . . . 72.230000000000004 110.583 177.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 672' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -76.37 151.88 33.96 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 122.119 1.879 . . . . 75.340000000000003 112.177 177.422 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 673' ' ' VAL . . . . . . . . . . . . . 8.0 p -64.27 -31.89 55.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 N-CA-C 112.325 0.491 . . . . 74.310000000000002 112.325 -175.729 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 674' ' ' GLY . . . . . . . . . . . . . . . -160.51 166.72 35.47 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 120.469 -0.872 . . . . 30.239999999999998 114.3 -177.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 675' ' ' ALA . . . . . . . . . . . . . . . -142.77 151.06 40.83 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.312 0.645 . . . . 71.129999999999995 109.849 177.329 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 676' ' ' THR . . . . . . . . . . . . . 91.5 m -137.93 119.23 14.66 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.105 0.479 . . . . 72.329999999999998 111.883 -177.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 677' ' ' ILE . . . . . . . . . . . . . 33.5 pt -130.75 176.48 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-N 116.032 -0.531 . . . . 75.150000000000006 111.097 -179.197 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 678' ' ' HIS . . . . . 0.524 ' HA ' ' O ' ' A' ' 740' ' ' LYS . 98.4 m-70 -110.78 156.7 20.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.279 0.561 . . . . 75.230000000000004 111.815 177.843 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 679' ' ' VAL . . . . . 0.551 HG13 ' HA ' ' A' ' 712' ' ' THR . 85.2 t -58.31 126.16 15.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-N 115.899 -0.591 . . . . 55.420000000000002 110.98 174.693 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 94.82 4.6 61.69 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 121.153 -0.546 . . . . 40.140000000000001 113.568 -179.341 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 681' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -97.7 165.35 12.0 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.366 0.603 . . . . 62.420000000000002 112.152 178.216 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 682' ' ' SER . . . . . . . . . . . . . 46.5 m -93.9 137.14 33.45 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.887 -0.597 . . . . 65.420000000000002 111.739 -179.302 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 683' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -135.09 128.7 32.71 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 120.928 0.394 . . . . 72.219999999999999 111.531 -179.206 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 684' ' ' VAL . . . . . . . . . . . . . 48.9 t -125.07 97.99 36.9 Favored Pre-proline 0 CA--C 1.542 0.656 0 CA-C-O 120.856 0.36 . . . . 63.240000000000002 111.444 177.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -63.7 -34.19 63.44 Favored 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 122.491 2.127 . . . . 64.040000000000006 113.571 -178.223 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 686' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -79.34 -6.32 56.49 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.782 0.66 . . . . 62.409999999999997 112.782 -176.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 687' ' ' ALA . . . . . . . . . . . . . . . -92.37 -38.19 12.16 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.869 0.366 . . . . 74.439999999999998 111.924 179.261 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 688' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -98.69 13.08 33.42 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 112.384 0.513 . . . . 75.230000000000004 112.384 -176.654 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 689' ' ' VAL . . . . . 0.417 HG13 HG22 ' A' ' 671' ' ' VAL . 85.2 t -125.04 140.04 49.33 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-N 116.301 -0.409 . . . . 71.019999999999996 110.086 173.252 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 690' ' ' LEU . . . . . 0.55 HD21 HG12 ' A' ' 692' ' ' ILE . 9.2 tt -145.17 153.85 41.8 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 111.574 0.213 . . . . 62.130000000000003 111.574 -172.152 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 691' ' ' ALA . . . . . . . . . . . . . . . -147.4 125.12 11.83 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 112.049 0.389 . . . . 61.32 112.049 179.081 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 692' ' ' ILE . . . . . 0.55 HG12 HD21 ' A' ' 690' ' ' LEU . 47.5 mm -127.93 119.05 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 N-CA-C 112.032 0.382 . . . . 65.430000000000007 112.032 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 693' ' ' ASP . . . . . 0.436 ' HA ' ' HA ' ' A' ' 667' ' ' PRO . 14.6 t70 -94.81 147.7 23.07 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 109.789 -0.449 . . . . 70.299999999999997 109.789 171.135 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 64.9 tttm -58.31 -61.91 2.23 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.373 0.508 . . . . 75.040000000000006 112.373 -174.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -88.5 -39.77 13.94 Favored 'General case' 0 N--CA 1.479 1.002 0 O-C-N 121.846 -0.534 . . . . 64.409999999999997 112.242 -176.537 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 696' ' ' ASP . . . . . . . . . . . . . 34.3 t0 -70.99 -23.52 62.21 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.257 0.551 . . . . 61.109999999999999 110.826 -176.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . 90.3 -147.32 19.1 Favored Glycine 0 CA--C 1.525 0.665 0 CA-C-N 116.043 -0.526 . . . . 53.119999999999997 113.87 173.214 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 698' ' ' ASP . . . . . 0.454 ' HA ' HD13 ' A' ' 692' ' ' ILE . 14.4 t70 -67.9 123.03 19.46 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.058 0.456 . . . . 73.409999999999997 111.189 -179.725 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 699' ' ' LEU . . . . . . . . . . . . . 80.8 mt -122.25 24.95 9.2 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.993 -0.549 . . . . 74.549999999999997 110.782 178.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 88.4 m -61.96 -40.32 95.17 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.044 0.45 . . . . 75.010000000000005 112.032 -177.175 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 701' ' ' SER . . . . . . . . . . . . . 15.6 t -79.86 -3.69 49.01 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 121.048 0.451 . . . . 75.510000000000005 111.246 179.483 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 702' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -84.9 -11.43 55.6 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 120.988 0.423 . . . . 73.5 110.822 175.01 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 74.6 mt -68.57 117.71 11.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-O 121.588 0.709 . . . . 72.510000000000005 112.82 -173.757 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 704' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -83.67 121.58 27.46 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.397 -0.819 . . . . 64.530000000000001 110.627 174.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 41.7 t -99.61 116.38 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-O 120.82 0.343 . . . . 72.430000000000007 111.077 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 706' ' ' ASP . . . . . 0.55 ' HB3' ' HB ' ' A' ' 720' ' ' THR . 32.9 t70 -109.96 123.21 49.24 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 120.74 0.305 . . . . 70.25 110.993 179.338 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 130.11 173.92 13.54 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 121.397 -0.43 . . . . 53.140000000000001 113.07 -178.561 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 708' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -135.27 142.23 45.86 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 122.447 -0.443 . . . . 74.450000000000003 111.518 -178.098 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 709' ' ' VAL . . . . . 0.49 HG23 HD21 ' A' ' 719' ' ' LEU . 98.9 t -126.32 128.25 71.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-O 120.872 0.367 . . . . 74.329999999999998 111.424 -179.094 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 710' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -109.38 137.4 47.3 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 116.73 -0.214 . . . . 60.409999999999997 110.552 177.543 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 711' ' ' THR . . . . . . . . . . . . . 67.3 p -111.7 4.21 18.37 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 112.85 0.685 . . . . 73.129999999999995 112.85 -175.269 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 712' ' ' THR . . . . . 0.551 ' HA ' HG13 ' A' ' 679' ' ' VAL . 12.9 t -111.99 -10.47 13.94 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 112.163 0.431 . . . . 74.420000000000002 112.163 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 713' ' ' LYS . . . . . 0.431 ' HD3' ' N ' ' A' ' 714' ' ' ALA . 8.8 tmtt? -128.8 129.91 46.28 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 109.861 -0.422 . . . . 73.099999999999994 109.861 176.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 714' ' ' ALA . . . . . 0.431 ' N ' ' HD3' ' A' ' 713' ' ' LYS . . . -69.81 127.6 33.48 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 112.426 0.528 . . . . 74.049999999999997 112.426 -176.418 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 177.8 174.33 44.03 Favored Glycine 0 CA--C 1.524 0.6 0 CA-C-N 116.098 -0.501 . . . . 64.140000000000001 112.772 -179.516 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 716' ' ' THR . . . . . . . . . . . . . 38.6 m -100.01 121.9 42.08 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 122.532 -0.393 . . . . 63.310000000000002 111.056 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 717' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -122.39 109.58 14.58 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 120.646 0.26 . . . . 60.329999999999998 110.783 -177.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 718' ' ' VAL . . . . . 0.412 ' HA ' ' HA ' ' A' ' 736' ' ' THR . 42.6 t -93.79 126.96 46.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-O 120.941 0.4 . . . . 71.239999999999995 111.845 -175.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 719' ' ' LEU . . . . . 0.49 HD21 HG23 ' A' ' 709' ' ' VAL . 97.2 mt -105.32 153.01 22.2 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.955 0.407 . . . . 71.310000000000002 111.277 177.095 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 720' ' ' THR . . . . . 0.55 ' HB ' ' HB3' ' A' ' 706' ' ' ASP . 28.8 m -120.82 129.74 53.68 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.487 -0.324 . . . . 63.340000000000003 110.809 177.718 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 721' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -115.18 119.79 37.58 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 120.824 0.345 . . . . 75.230000000000004 111.371 -178.019 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 87.0 m -124.05 140.41 53.0 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 116.54 -0.3 . . . . 70.040000000000006 111.209 -179.016 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 10.4 p -141.01 143.47 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 CA-C-O 120.866 0.365 . . . . 63.409999999999997 111.924 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 724' ' ' THR . . . . . 0.45 ' HA ' ' O ' ' A' ' 729' ' ' HIS . 23.7 m -123.01 142.2 51.11 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 116.392 -0.367 . . . . 61.119999999999997 111.603 -179.645 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -100.51 178.61 4.68 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.251 0.548 . . . . 74.239999999999995 112.316 -177.855 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 726' ' ' SER . . . . . . . . . . . . . 38.0 t -54.51 -31.92 57.03 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 113.323 0.86 . . . . 75.200000000000003 113.323 -179.165 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 727' ' ' LYS . . . . . . . . . . . . . 44.8 mmtm -86.63 -14.76 41.75 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 121.877 -0.514 . . . . 74.319999999999993 111.913 -179.452 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 728' ' ' GLY . . . . . . . . . . . . . . . 103.23 13.43 28.78 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 121.023 -0.608 . . . . 63.420000000000002 113.792 -178.244 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 729' ' ' HIS . . . . . 0.45 ' O ' ' HA ' ' A' ' 724' ' ' THR . 58.7 m80 -72.01 123.93 23.85 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 117.283 0.541 . . . . 72.109999999999999 110.54 174.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 730' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -122.25 108.47 13.32 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.137 0.494 . . . . 72.519999999999996 112.179 -174.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 34.9 m -107.72 155.67 8.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-N 116.036 -0.529 . . . . 65.109999999999999 110.737 176.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 5.4 t -152.51 136.86 16.67 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 112.819 0.674 . . . . 75.040000000000006 112.819 -175.534 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -141.87 146.87 36.28 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.09 -0.505 . . . . 75.120000000000005 111.214 -179.364 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 734' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -105.09 158.29 16.67 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.213 0.53 . . . . 74.310000000000002 112.188 -176.197 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 735' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -141.85 118.0 10.69 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.687 -0.688 . . . . 75.230000000000004 110.665 175.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 736' ' ' THR . . . . . 0.412 ' HA ' ' HA ' ' A' ' 718' ' ' VAL . 6.5 t -84.37 111.94 19.89 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.227 0.536 . . . . 53.450000000000003 111.73 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 43.5 t -96.63 103.84 15.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-O 121.282 0.563 . . . . 53.43 111.382 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 738' ' ' THR . . . . . . . . . . . . . 30.8 m -93.61 113.45 25.56 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.984 0.421 . . . . 74.209999999999994 111.344 -177.726 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 739' ' ' VAL . . . . . . . . . . . . . 45.8 t -96.41 116.4 38.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-N 116.297 -0.411 . . . . 72.120000000000005 111.037 178.064 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 740' ' ' LYS . . . . . 0.524 ' O ' ' HA ' ' A' ' 678' ' ' HIS . 11.7 ptmm? -111.59 159.11 18.47 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.027 0.442 . . . . 74.319999999999993 111.144 178.2 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 741' ' ' VAL . . . . . . . . . . . . . 38.3 t . . . . . 0 CA--C 1.54 0.588 0 CA-C-O 120.798 0.333 . . . . 62.100000000000001 111.829 -175.3 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 664' ' ' ASP . . . . . . . . . . . . . 22.2 t0 . . . . . 0 CA--C 1.538 0.492 0 CA-C-O 121.633 0.73 . . . . 72.439999999999998 112.356 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 665' ' ' LEU . . . . . . . . . . . . . 44.8 mt -113.64 138.02 50.79 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.086 -0.961 . . . . 71.400000000000006 110.59 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 666' ' ' GLU . . . . . 0.484 ' H ' ' CD ' ' A' ' 666' ' ' GLU . 1.6 pm0 -54.01 139.23 54.15 Favored Pre-proline 0 CA--C 1.545 0.752 0 CA-C-O 120.762 0.315 . . . . 51.119999999999997 111.309 176.302 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 667' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -68.95 160.27 50.54 Favored 'Trans proline' 0 CA--C 1.545 1.045 0 C-N-CA 122.963 2.442 . . . . 64.099999999999994 115.124 -166.642 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 668' ' ' LYS . . . . . 0.442 ' HA ' ' HE3' ' A' ' 668' ' ' LYS . 0.2 OUTLIER -83.22 102.23 11.77 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 114.948 -1.024 . . . . 70.099999999999994 111.022 177.896 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 669' ' ' LEU . . . . . . . . . . . . . 57.9 tp -103.49 114.64 29.08 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 120.783 0.325 . . . . 63.299999999999997 111.096 176.114 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 670' ' ' THR . . . . . . . . . . . . . 99.4 m -101.67 112.1 24.56 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.875 0.369 . . . . 75.439999999999998 111.425 178.419 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 671' ' ' VAL . . . . . . . . . . . . . 90.2 t -125.98 132.84 24.45 Favored Pre-proline 0 CA--C 1.538 0.492 0 CA-C-N 116.3 -0.409 . . . . 75.120000000000005 110.776 177.452 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 672' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -66.47 138.43 50.25 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 122.128 1.886 . . . . 74.099999999999994 112.363 178.486 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 673' ' ' VAL . . . . . . . . . . . . . 11.7 p -73.17 -34.09 43.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 N-CA-C 112.326 0.491 . . . . 63.149999999999999 112.326 -175.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 674' ' ' GLY . . . . . . . . . . . . . . . -150.74 151.12 23.18 Favored Glycine 0 CA--C 1.523 0.533 0 C-N-CA 120.557 -0.83 . . . . 74.319999999999993 113.674 -176.553 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 675' ' ' ALA . . . . . 0.524 ' HB3' HG22 ' A' ' 737' ' ' VAL . . . -138.92 144.42 39.08 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 122.476 0.31 . . . . 63.329999999999998 110.978 179.136 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 676' ' ' THR . . . . . . . . . . . . . 36.5 m -131.42 118.61 20.48 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 120.596 0.236 . . . . 42.020000000000003 111.103 -178.413 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 677' ' ' ILE . . . . . . . . . . . . . 42.9 pt -136.67 177.58 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-O 121.091 0.472 . . . . 74.349999999999994 111.695 179.354 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 678' ' ' HIS . . . . . . . . . . . . . 79.2 m80 -129.57 140.29 51.25 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 111.924 0.342 . . . . 64.120000000000005 111.924 -178.69 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 679' ' ' VAL . . . . . . . . . . . . . 89.7 t -46.87 122.18 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 CA-C-N 115.753 -0.658 . . . . 70.219999999999999 112.558 -178.619 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 104.14 14.97 23.09 Favored Glycine 0 CA--C 1.528 0.883 0 CA-C-N 116.246 -0.433 . . . . 74.209999999999994 113.533 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 681' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -101.25 -161.94 0.9 Allowed 'General case' 0 CA--C 1.545 0.788 0 CA-C-O 121.407 0.622 . . . . 64.409999999999997 112.044 -179.175 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 682' ' ' SER . . . . . . . . . . . . . 40.1 m -134.62 111.1 9.75 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 115.938 -0.574 . . . . 73.329999999999998 110.394 175.723 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 683' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -118.7 136.24 54.04 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.582 0.23 . . . . 62.409999999999997 111.474 -177.49 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 684' ' ' VAL . . . . . 0.41 HG12 ' H ' ' A' ' 687' ' ' ALA . 86.5 t -121.38 111.8 33.23 Favored Pre-proline 0 CA--C 1.54 0.561 0 CA-C-O 120.553 0.216 . . . . 71.030000000000001 111.104 177.555 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -59.46 -50.62 7.89 Favored 'Trans proline' 0 CA--C 1.543 0.968 0 C-N-CA 122.723 2.282 . . . . 63.210000000000001 114.105 -176.552 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 686' ' ' MET . . . . . . . . . . . . . 53.9 mtp -79.73 -12.62 59.79 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 113.439 0.903 . . . . 74.340000000000003 113.439 -175.046 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 687' ' ' ALA . . . . . 0.41 ' H ' HG12 ' A' ' 684' ' ' VAL . . . -65.54 -21.17 66.58 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.845 0.355 . . . . 52.43 111.553 -178.412 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 688' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -107.37 0.73 23.2 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 112.346 0.498 . . . . 74.430000000000007 112.346 -178.587 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 25.4 t -99.55 151.11 4.94 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 O-C-N 122.098 -0.376 . . . . 74.120000000000005 111.528 -177.634 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 690' ' ' LEU . . . . . 0.446 HD21 HG12 ' A' ' 692' ' ' ILE . 9.1 tt -148.08 146.78 28.97 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 122.347 0.259 . . . . 72.519999999999996 111.025 -177.802 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 691' ' ' ALA . . . . . . . . . . . . . . . -145.73 128.46 16.24 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 111.994 0.368 . . . . 52.420000000000002 111.994 179.195 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 692' ' ' ILE . . . . . 0.529 HD13 ' HA ' ' A' ' 698' ' ' ASP . 45.4 mm -134.01 134.21 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 122.72 0.408 . . . . 63.229999999999997 111.737 -177.773 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 693' ' ' ASP . . . . . 0.454 ' HB2' ' CD1' ' A' ' 699' ' ' LEU . 35.0 t70 -106.95 144.77 33.1 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 122.077 -0.39 . . . . 63.420000000000002 111.01 173.381 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -59.33 -39.89 84.56 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 116.128 -0.487 . . . . 75.099999999999994 112.11 -177.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -83.01 -55.78 4.18 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 112.462 0.541 . . . . 73.230000000000004 112.462 -178.319 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 696' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -79.41 -48.27 14.27 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 112.445 0.535 . . . . 74.349999999999994 112.445 -169.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . 122.31 -112.26 1.96 Allowed Glycine 0 CA--C 1.522 0.47 0 C-N-CA 120.913 -0.66 . . . . 41.530000000000001 112.613 -176.446 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 698' ' ' ASP . . . . . 0.529 ' HA ' HD13 ' A' ' 692' ' ' ILE . 13.0 t70 -87.65 116.92 26.11 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 122.179 -0.601 . . . . 71.209999999999994 112.064 -176.271 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 699' ' ' LEU . . . . . 0.454 ' CD1' ' HB2' ' A' ' 693' ' ' ASP . 56.9 mt -112.37 21.2 15.98 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 116.287 -0.415 . . . . 75.420000000000002 111.32 175.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 29.6 m -60.14 -25.94 65.88 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 120.952 0.406 . . . . 70.040000000000006 111.603 -178.114 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 701' ' ' SER . . . . . . . . . . . . . 40.0 t -82.02 -18.21 44.06 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 121.163 0.506 . . . . 71.510000000000005 111.412 177.211 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 702' ' ' LYS . . . . . . . . . . . . . 48.6 mmtm -82.42 3.08 29.5 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 116.293 -0.412 . . . . 65.519999999999996 111.873 179.611 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 72.1 mt -78.37 138.98 19.24 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 CA-C-O 121.326 0.584 . . . . 73.439999999999998 112.438 -177.368 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 704' ' ' LYS . . . . . 0.471 ' O ' ' HA ' ' A' ' 721' ' ' TYR . 22.5 ttmm -104.84 139.33 39.76 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.783 -0.644 . . . . 65.530000000000001 110.267 178.149 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 60.8 t -115.59 111.09 34.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 N-CA-C 112.392 0.515 . . . . 73.450000000000003 112.392 -177.601 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 706' ' ' ASP . . . . . 0.571 ' HB3' ' HB ' ' A' ' 720' ' ' THR . 28.7 t70 -107.41 133.14 52.36 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.122 -0.49 . . . . 62.32 110.568 174.09 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 86.86 165.74 41.63 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 120.894 -0.67 . . . . 75.420000000000002 112.441 -176.272 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 708' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -159.37 148.78 18.44 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 122.283 -0.54 . . . . 64.510000000000005 111.153 -179.099 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 709' ' ' VAL . . . . . 0.451 HG23 HD11 ' A' ' 719' ' ' LEU . 58.7 t -96.45 137.58 23.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-N 116.094 -0.503 . . . . 64.319999999999993 111.665 -178.452 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 710' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -105.03 136.76 43.9 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 116.188 -0.46 . . . . 74.25 110.225 175.139 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 711' ' ' THR . . . . . . . . . . . . . 73.4 p -107.91 8.77 28.69 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 112.814 0.672 . . . . 74.120000000000005 112.814 -174.24 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 712' ' ' THR . . . . . . . . . . . . . 7.2 t -111.83 -9.73 14.05 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 122.078 -0.389 . . . . 50.549999999999997 111.61 176.788 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 713' ' ' LYS . . . . . . . . . . . . . 37.8 tttp -129.3 133.19 47.35 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 120.653 0.263 . . . . 74.439999999999998 110.885 177.577 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 714' ' ' ALA . . . . . . . . . . . . . . . -77.73 134.01 38.18 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 112.18 0.437 . . . . 74.129999999999995 112.18 -178.195 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 168.27 179.81 40.91 Favored Glycine 0 CA--C 1.524 0.625 0 CA-C-N 116.123 -0.49 . . . . 72.340000000000003 112.854 -179.348 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 716' ' ' THR . . . . . . . . . . . . . 41.0 m -108.64 122.67 47.59 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 120.999 0.428 . . . . 73.109999999999999 111.384 -178.835 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 717' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -114.06 124.09 51.28 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 116.284 -0.416 . . . . 71.319999999999993 111.036 -177.422 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 718' ' ' VAL . . . . . . . . . . . . . 49.3 t -97.36 114.65 35.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-O 121.111 0.481 . . . . 65.409999999999997 111.124 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 719' ' ' LEU . . . . . 0.451 HD11 HG23 ' A' ' 709' ' ' VAL . 47.4 mt -101.51 132.75 46.97 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 116.292 -0.413 . . . . 74.109999999999999 111.41 -177.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 720' ' ' THR . . . . . 0.571 ' HB ' ' HB3' ' A' ' 706' ' ' ASP . 34.9 m -110.06 128.02 55.18 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 120.958 0.409 . . . . 60.119999999999997 111.501 178.083 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 721' ' ' TYR . . . . . 0.471 ' HA ' ' O ' ' A' ' 704' ' ' LYS . 75.3 m-85 -117.97 126.36 52.18 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.524 -0.307 . . . . 72.310000000000002 110.84 178.85 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 56.1 m -127.98 122.27 31.89 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 116.853 -0.158 . . . . 74.219999999999999 111.266 -178.143 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 12.9 p -111.11 142.14 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-O 120.903 0.382 . . . . 62.409999999999997 111.372 -179.191 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 52.3 m -113.79 126.5 55.28 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.083 0.468 . . . . 75.299999999999997 112.099 -178.368 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 725' ' ' ASP . . . . . 0.517 ' HB3' ' HB2' ' A' ' 729' ' ' HIS . 0.2 OUTLIER -84.5 158.81 20.88 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 115.953 -0.567 . . . . 75.319999999999993 111.483 176.22 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 726' ' ' SER . . . . . . . . . . . . . 49.8 m -58.21 -34.74 70.73 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.872 0.693 . . . . 71.129999999999995 112.872 -176.299 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 727' ' ' LYS . . . . . 0.489 ' HD2' ' N ' ' A' ' 727' ' ' LYS . 3.4 mptp? -90.45 13.45 15.62 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 122.09 -0.381 . . . . 72.120000000000005 111.59 -177.793 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 728' ' ' GLY . . . . . . . . . . . . . . . 91.54 10.84 61.46 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 121.118 -0.563 . . . . 52.130000000000003 114.224 174.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 729' ' ' HIS . . . . . 0.517 ' HB2' ' HB3' ' A' ' 725' ' ' ASP . 46.7 m80 -80.79 107.24 13.43 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 117.397 0.598 . . . . 74.109999999999999 111.203 178.36 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 730' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -111.39 124.69 52.77 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.982 -0.554 . . . . 43.25 111.271 -175.417 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 28.8 m -131.16 152.6 37.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 CA-C-O 120.739 0.304 . . . . 73.409999999999997 111.283 179.097 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 10.2 t -136.25 153.81 51.09 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 112.727 0.639 . . . . 63.140000000000001 112.727 -176.316 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -148.35 161.6 41.22 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.079 0.551 . . . . 52.039999999999999 110.704 177.296 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 734' ' ' LYS . . . . . . . . . . . . . 41.3 mttp -122.72 156.6 34.08 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 113.246 0.832 . . . . 74.120000000000005 113.246 -176.197 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 735' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -130.56 128.56 41.35 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 115.141 -0.936 . . . . 74.420000000000002 110.542 176.793 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 736' ' ' THR . . . . . . . . . . . . . 85.3 m -96.96 104.01 15.99 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.825 0.345 . . . . 71.510000000000005 111.37 178.779 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 737' ' ' VAL . . . . . 0.524 HG22 ' HB3' ' A' ' 675' ' ' ALA . 48.7 t -98.76 131.9 45.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-O 120.638 0.256 . . . . 44.149999999999999 111.414 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 738' ' ' THR . . . . . . . . . . . . . 90.7 m -121.36 117.9 28.12 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.042 0.449 . . . . 74.409999999999997 111.574 179.299 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 739' ' ' VAL . . . . . . . . . . . . . 27.4 t -98.94 125.14 52.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-N 116.244 -0.435 . . . . 73.340000000000003 111.043 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 740' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -114.1 152.34 31.23 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 112.142 0.423 . . . . 73.510000000000005 112.142 -177.17 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 741' ' ' VAL . . . . . . . . . . . . . 23.7 t . . . . . 0 CA--C 1.544 0.717 0 CA-C-O 121.191 0.519 . . . . 74.409999999999997 112.307 -176.599 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 664' ' ' ASP . . . . . 0.454 ' OD2' ' HB2' ' A' ' 727' ' ' LYS . 35.4 t0 . . . . . 0 CA--C 1.532 0.265 0 CA-C-O 120.988 0.423 . . . . 74.030000000000001 109.916 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 665' ' ' LEU . . . . . 0.429 HD12 ' HD3' ' A' ' 694' ' ' LYS . 88.2 mt -90.6 137.32 32.45 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.165 -0.47 . . . . 73.219999999999999 110.463 175.764 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 666' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -57.01 131.96 80.05 Favored Pre-proline 0 CA--C 1.54 0.586 0 CA-C-N 116.496 -0.32 . . . . 71.030000000000001 110.557 172.775 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 667' ' ' PRO . . . . . 0.544 ' HB3' HD12 ' A' ' 699' ' ' LEU . 26.9 Cg_endo -60.37 148.61 89.8 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 122.433 2.089 . . . . 72.230000000000004 113.36 -172.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 668' ' ' LYS . . . . . . . . . . . . . 56.9 tptt -83.22 108.61 16.58 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.095 0.474 . . . . 72.219999999999999 111.213 177.853 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 669' ' ' LEU . . . . . 0.536 ' HG ' HG23 ' A' ' 671' ' ' VAL . 56.6 tp -96.65 111.97 23.9 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 116.281 -0.418 . . . . 70.310000000000002 111.335 -179.585 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 670' ' ' THR . . . . . . . . . . . . . 72.6 m -87.87 109.69 19.96 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.657 0.265 . . . . 52.140000000000001 110.927 179.177 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 671' ' ' VAL . . . . . 0.536 HG23 ' HG ' ' A' ' 669' ' ' LEU . 95.2 t -136.23 130.1 18.13 Favored Pre-proline 0 N--CA 1.472 0.663 0 CA-C-N 116.455 -0.339 . . . . 71.010000000000005 111.065 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 672' ' ' PRO . . . . . 0.441 ' HG2' ' NE2' ' A' ' 735' ' ' GLN . 69.6 Cg_endo -76.2 156.09 37.64 Favored 'Trans proline' 0 CA--C 1.542 0.882 0 C-N-CA 122.622 2.215 . . . . 74.140000000000001 112.759 176.838 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 673' ' ' VAL . . . . . . . . . . . . . 13.5 p -81.66 -33.59 12.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 N-CA-C 112.94 0.719 . . . . 55.329999999999998 112.94 -174.651 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 674' ' ' GLY . . . . . 0.401 ' HA2' ' O ' ' A' ' 736' ' ' THR . . . -175.08 139.55 4.85 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 119.926 -1.131 . . . . 52.109999999999999 114.35 -176.078 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 675' ' ' ALA . . . . . . . . . . . . . . . -139.96 151.33 45.45 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 122.654 0.382 . . . . 52.450000000000003 110.965 178.047 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 676' ' ' THR . . . . . . . . . . . . . 97.6 m -131.62 123.17 27.32 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-O 120.719 0.295 . . . . 74.510000000000005 111.576 -179.694 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 677' ' ' ILE . . . . . . . . . . . . . 29.8 pt -123.14 177.44 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 122.699 0.4 . . . . 72.450000000000003 111.405 -179.319 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 678' ' ' HIS . . . . . . . . . . . . . 74.2 m80 -107.37 161.66 14.61 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 121.326 0.584 . . . . 72.409999999999997 112.368 178.624 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 679' ' ' VAL . . . . . 0.607 HG13 ' HA ' ' A' ' 712' ' ' THR . 76.6 t -60.44 126.37 18.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-N 115.747 -0.661 . . . . 64.040000000000006 111.837 176.513 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 103.52 -2.69 46.15 Favored Glycine 0 CA--C 1.528 0.906 0 CA-C-N 116.129 -0.487 . . . . 64.209999999999994 113.389 -178.899 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 681' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -88.8 -175.74 4.99 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 116.91 0.355 . . . . 74.099999999999994 110.979 178.741 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 682' ' ' SER . . . . . . . . . . . . . 74.9 m -134.69 137.68 43.76 Favored 'General case' 0 N--CA 1.477 0.898 0 O-C-N 121.993 -0.442 . . . . 72.400000000000006 111.877 -178.473 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 683' ' ' PHE . . . . . . . . . . . . . 47.2 t80 -125.89 133.81 51.79 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 116.35 -0.386 . . . . 62.299999999999997 110.655 -178.098 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 684' ' ' VAL . . . . . . . . . . . . . 46.4 t -123.77 93.77 46.9 Favored Pre-proline 0 CA--C 1.546 0.791 0 CA-C-O 121.108 0.48 . . . . 72.109999999999999 112.089 -174.555 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -64.02 -29.58 66.26 Favored 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 122.706 2.271 . . . . 75.530000000000001 113.805 -178.17 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 686' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -79.3 -7.57 58.4 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.547 0.573 . . . . 72.140000000000001 112.547 -177.854 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 687' ' ' ALA . . . . . . . . . . . . . . . -110.26 -39.1 5.08 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.866 0.365 . . . . 62.340000000000003 111.655 177.646 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 688' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -77.38 -10.47 59.47 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 112.43 0.53 . . . . 54.439999999999998 112.43 -177.64 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 689' ' ' VAL . . . . . 0.476 HG12 HD13 ' A' ' 703' ' ' ILE . 88.7 t -119.03 125.01 74.13 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 CA-C-O 120.865 0.364 . . . . 73.510000000000005 111.565 178.089 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 690' ' ' LEU . . . . . 0.42 HD22 ' N ' ' A' ' 690' ' ' LEU . 2.7 mm? -122.36 161.77 22.81 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 120.863 0.364 . . . . 73.120000000000005 111.375 -177.223 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 691' ' ' ALA . . . . . . . . . . . . . . . -147.46 122.62 10.18 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 120.966 0.412 . . . . 63.420000000000002 111.896 177.64 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 692' ' ' ILE . . . . . . . . . . . . . 45.4 mm -123.9 135.01 64.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-N 116.349 -0.387 . . . . 74.239999999999995 111.25 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -120.44 149.91 41.64 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 120.823 0.344 . . . . 70.430000000000007 111.63 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 694' ' ' LYS . . . . . 0.429 ' HD3' HD12 ' A' ' 665' ' ' LEU . 37.8 ttpt -62.49 -61.2 2.6 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 112.314 0.487 . . . . 73.510000000000005 112.314 -177.465 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 695' ' ' GLU . . . . . 0.468 ' CD ' ' H ' ' A' ' 695' ' ' GLU . 0.1 OUTLIER -85.09 -53.11 5.48 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 111.868 0.321 . . . . 64.409999999999997 111.868 -174.664 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 696' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -66.52 -48.91 68.26 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 121.063 0.459 . . . . 71.140000000000001 111.052 -173.434 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . 122.49 -146.95 16.88 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 121.224 -0.513 . . . . 72.109999999999999 113.11 178.629 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -70.94 111.36 6.27 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.955 0.407 . . . . 62.32 110.921 179.078 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 699' ' ' LEU . . . . . 0.544 HD12 ' HB3' ' A' ' 667' ' ' PRO . 79.0 mt -104.77 17.41 24.18 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 120.85 0.357 . . . . 52.399999999999999 111.503 179.517 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 42.4 m -56.77 -37.12 70.65 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.177 0.513 . . . . 73.349999999999994 111.268 178.762 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 701' ' ' SER . . . . . . . . . . . . . 27.5 m -68.55 -12.48 61.33 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 116.207 -0.451 . . . . 73.150000000000006 111.982 178.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 702' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -100.69 3.18 42.18 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 111.813 0.301 . . . . 71.540000000000006 111.813 -176.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 703' ' ' ILE . . . . . 0.476 HD13 HG12 ' A' ' 689' ' ' VAL . 72.2 mt -73.7 118.5 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 120.964 0.411 . . . . 73.239999999999995 111.718 -178.72 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 704' ' ' LYS . . . . . 0.422 ' HB2' ' NZ ' ' A' ' 704' ' ' LYS . 5.2 ttmp? -84.33 115.59 22.58 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 116.169 -0.469 . . . . 53.25 110.329 176.277 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 67.8 t -95.87 106.57 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 121.161 0.505 . . . . 62.310000000000002 111.595 -178.318 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 706' ' ' ASP . . . . . 0.551 ' HB3' ' HB ' ' A' ' 720' ' ' THR . 25.2 t70 -101.82 125.57 48.52 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 116.177 -0.465 . . . . 51.229999999999997 111.099 179.378 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 112.04 163.81 17.02 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 121.067 -0.587 . . . . 52.409999999999997 113.335 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 708' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -149.62 145.72 26.92 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.019 0.438 . . . . 65.109999999999999 111.655 -177.079 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 709' ' ' VAL . . . . . 0.554 HG22 ' HB2' ' A' ' 717' ' ' TYR . 55.4 t -120.45 122.04 67.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 CA-C-N 116.28 -0.418 . . . . 72.019999999999996 111.607 -177.85 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 710' ' ' ASP . . . . . 0.533 ' HB2' ' HB3' ' A' ' 713' ' ' LYS . 10.1 m-20 -73.94 136.34 43.28 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 120.74 0.305 . . . . 60.539999999999999 110.816 174.35 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 711' ' ' THR . . . . . . . . . . . . . 81.2 p -96.48 0.99 51.1 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 120.932 0.396 . . . . 75.430000000000007 111.237 175.711 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 712' ' ' THR . . . . . 0.607 ' HA ' HG13 ' A' ' 679' ' ' VAL . 74.5 p -115.71 3.46 13.89 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 116.163 -0.472 . . . . 73.430000000000007 111.912 178.804 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 713' ' ' LYS . . . . . 0.533 ' HB3' ' HB2' ' A' ' 710' ' ' ASP . 5.6 tppp? -125.37 122.17 36.02 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 120.731 0.3 . . . . 65.239999999999995 111.586 -175.411 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 714' ' ' ALA . . . . . . . . . . . . . . . -70.36 112.46 6.68 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.928 0.394 . . . . 71.209999999999994 111.688 175.494 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 175.24 168.41 35.73 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 121.112 -0.566 . . . . 41.229999999999997 112.986 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 716' ' ' THR . . . . . . . . . . . . . 86.3 m -104.04 123.11 46.63 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 122.701 -0.293 . . . . 64.109999999999999 111.699 179.217 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 717' ' ' TYR . . . . . 0.554 ' HB2' HG22 ' A' ' 709' ' ' VAL . 86.0 m-85 -119.93 122.7 41.81 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.005 0.431 . . . . 73.120000000000005 111.164 177.012 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 718' ' ' VAL . . . . . . . . . . . . . 59.0 t -92.37 117.91 36.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-O 120.738 0.304 . . . . 52.240000000000002 111.139 177.477 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 719' ' ' LEU . . . . . 0.455 HD21 HG23 ' A' ' 709' ' ' VAL . 58.1 mt -94.45 148.26 22.42 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 116.671 -0.24 . . . . 74.420000000000002 111.111 -179.436 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 720' ' ' THR . . . . . 0.551 ' HB ' ' HB3' ' A' ' 706' ' ' ASP . 25.0 m -114.98 133.15 56.28 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 120.615 0.245 . . . . 42.210000000000001 111.072 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 721' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -122.91 115.87 22.66 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.835 0.35 . . . . 61.32 111.07 179.51 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 46.2 m -123.95 123.1 39.67 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 120.654 0.264 . . . . 74.299999999999997 111.474 -178.219 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 8.7 p -119.0 136.88 54.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 CA-C-O 120.963 0.411 . . . . 73.109999999999999 111.529 179.362 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 18.0 m -117.58 128.49 55.0 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.144 0.424 . . . . 72.430000000000007 112.144 -175.787 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 725' ' ' ASP . . . . . 0.515 ' HB3' ' H ' ' A' ' 729' ' ' HIS . 9.9 t70 -74.59 152.14 39.31 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 116.334 -0.394 . . . . 74.219999999999999 110.624 176.703 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 726' ' ' SER . . . . . . . . . . . . . 48.7 m -62.52 -27.41 69.14 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 112.624 0.601 . . . . 63.109999999999999 112.624 -177.846 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 727' ' ' LYS . . . . . 0.478 ' N ' ' HD3' ' A' ' 727' ' ' LYS . 3.5 mppt? -95.04 4.01 54.22 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 112.19 0.441 . . . . 72.219999999999999 112.19 179.399 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 728' ' ' GLY . . . . . . . . . . . . . . . 101.84 34.27 4.4 Favored Glycine 0 CA--C 1.533 1.161 0 N-CA-C 115.563 0.985 . . . . 51.350000000000001 115.563 171.136 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 729' ' ' HIS . . . . . 0.515 ' H ' ' HB3' ' A' ' 725' ' ' ASP . 31.2 m80 -109.53 111.08 22.39 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 118.077 0.938 . . . . 74.319999999999993 110.926 170.704 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 730' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -113.82 118.45 34.28 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 112.004 0.372 . . . . 52.420000000000002 112.004 -174.418 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 30.7 m -117.17 155.11 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-O 120.671 0.272 . . . . 72.150000000000006 111.171 178.055 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 10.0 t -147.52 145.38 29.08 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 112.792 0.664 . . . . 72.200000000000003 112.792 -175.269 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -148.72 143.65 26.57 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.962 -0.563 . . . . 55.32 111.144 178.125 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 734' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -106.92 159.52 16.2 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.343 0.592 . . . . 74.129999999999995 112.41 -178.818 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 735' ' ' GLN . . . . . 0.441 ' NE2' ' HG2' ' A' ' 672' ' ' PRO . 47.7 tt0 -132.77 130.08 39.46 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.707 -0.679 . . . . 63.520000000000003 110.837 -179.321 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 736' ' ' THR . . . . . 0.401 ' O ' ' HA2' ' A' ' 674' ' ' GLY . 90.5 m -94.13 103.89 15.93 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 120.919 0.39 . . . . 74.340000000000003 111.865 -179.017 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 44.3 t -102.6 135.17 41.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-O 120.719 0.295 . . . . 65.209999999999994 111.473 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 738' ' ' THR . . . . . . . . . . . . . 92.5 m -125.36 131.6 52.96 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 120.723 0.297 . . . . 74.219999999999999 111.378 178.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 739' ' ' VAL . . . . . . . . . . . . . 51.6 t -109.73 128.03 66.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-O 120.829 0.347 . . . . 64.349999999999994 111.011 177.409 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 740' ' ' LYS . . . . . 0.514 ' NZ ' ' HB3' ' A' ' 740' ' ' LYS . 7.3 mtpm? -116.18 152.6 33.39 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.973 0.416 . . . . 74.239999999999995 111.374 179.141 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 741' ' ' VAL . . . . . . . . . . . . . 18.1 t . . . . . 0 CA--C 1.539 0.556 0 CA-C-O 120.704 0.288 . . . . 53.140000000000001 111.033 -178.561 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 664' ' ' ASP . . . . . . . . . . . . . 8.6 t70 . . . . . 0 CA--C 1.533 0.316 0 CA-C-O 121.406 0.622 . . . . 71.219999999999999 111.552 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 665' ' ' LEU . . . . . . . . . . . . . 86.9 mt -87.33 126.0 34.58 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.648 -0.706 . . . . 73.230000000000004 110.387 176.825 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 666' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -62.1 145.59 93.15 Favored Pre-proline 0 CA--C 1.542 0.661 0 CA-C-N 116.116 -0.493 . . . . 73.030000000000001 111.3 178.626 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 667' ' ' PRO . . . . . 0.463 ' HD3' ' HB2' ' A' ' 725' ' ' ASP . 80.4 Cg_endo -76.94 147.14 26.64 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 122.365 2.043 . . . . 72.019999999999996 112.872 -176.189 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 668' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -83.15 104.05 13.04 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.127 0.489 . . . . 74.549999999999997 110.901 179.319 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 669' ' ' LEU . . . . . 0.418 ' HG ' HG23 ' A' ' 671' ' ' VAL . 58.1 tp -89.91 105.87 18.09 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.065 -0.516 . . . . 74.510000000000005 110.707 177.392 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 670' ' ' THR . . . . . . . . . . . . . 73.5 m -88.18 110.97 21.11 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.162 -0.472 . . . . 74.430000000000007 111.273 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 671' ' ' VAL . . . . . 0.497 HG22 HG13 ' A' ' 689' ' ' VAL . 85.7 t -132.08 126.27 20.49 Favored Pre-proline 0 N--CA 1.47 0.53 0 CA-C-N 116.146 -0.479 . . . . 64.109999999999999 110.768 179.275 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 672' ' ' PRO . . . . . 0.504 ' HG2' ' NE2' ' A' ' 735' ' ' GLN . 45.4 Cg_endo -69.73 137.48 35.64 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 122.27 1.98 . . . . 71.329999999999998 112.297 179.097 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 673' ' ' VAL . . . . . . . . . . . . . 12.5 p -64.54 -35.89 75.83 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 N-CA-C 112.279 0.474 . . . . 63.329999999999998 112.279 -175.39 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 674' ' ' GLY . . . . . . . . . . . . . . . -162.22 161.62 33.63 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 120.647 -0.787 . . . . 33.310000000000002 113.699 -178.032 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 675' ' ' ALA . . . . . . . . . . . . . . . -151.17 157.82 43.17 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 122.299 0.24 . . . . 65.439999999999998 110.955 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 676' ' ' THR . . . . . . . . . . . . . 60.7 m -133.38 126.39 31.18 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 122.347 -0.221 . . . . 72.549999999999997 111.394 179.544 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 677' ' ' ILE . . . . . . . . . . . . . 23.9 pt -130.33 174.56 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-O 120.976 0.417 . . . . 72.019999999999996 111.311 177.804 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 678' ' ' HIS . . . . . 0.528 ' O ' ' HB2' ' A' ' 681' ' ' ASP . 72.3 m80 -121.3 171.35 8.8 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.324 0.583 . . . . 64.510000000000005 112.378 -178.1 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 679' ' ' VAL . . . . . 0.485 HG23 ' HA ' ' A' ' 741' ' ' VAL . 84.5 t -63.71 120.01 9.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-N 116.023 -0.535 . . . . 35.109999999999999 111.254 175.499 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 97.2 0.84 59.65 Favored Glycine 0 CA--C 1.528 0.895 0 CA-C-N 116.185 -0.461 . . . . 63.439999999999998 113.211 -175.55 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 681' ' ' ASP . . . . . 0.528 ' HB2' ' O ' ' A' ' 678' ' ' HIS . 0.9 OUTLIER -77.05 178.58 6.87 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-O 121.101 0.477 . . . . 53.039999999999999 111.116 -179.561 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 682' ' ' SER . . . . . . . . . . . . . 87.2 p -134.94 126.21 28.19 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 116.511 -0.313 . . . . 53.229999999999997 110.831 177.597 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 683' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -127.53 134.38 49.77 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.931 0.396 . . . . 71.530000000000001 111.647 -176.247 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 684' ' ' VAL . . . . . 0.435 ' HA ' ' HD2' ' A' ' 685' ' ' PRO . 61.8 t -124.26 101.6 34.52 Favored Pre-proline 0 CA--C 1.545 0.766 0 CA-C-O 121.089 0.471 . . . . 72.409999999999997 111.943 -179.665 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 685' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' A' ' 684' ' ' VAL . 21.6 Cg_endo -60.99 -36.58 82.1 Favored 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 122.871 2.381 . . . . 53.43 113.843 -178.905 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 686' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -78.64 -1.75 35.77 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 112.237 0.458 . . . . 73.310000000000002 112.237 -177.791 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 687' ' ' ALA . . . . . . . . . . . . . . . -95.27 -48.08 6.05 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.078 0.466 . . . . 72.120000000000005 110.808 174.001 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 688' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -66.01 -38.31 88.12 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.605 0.594 . . . . 71.310000000000002 112.605 179.46 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 689' ' ' VAL . . . . . 0.497 HG13 HG22 ' A' ' 671' ' ' VAL . 98.9 t -86.67 143.1 12.08 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-O 120.934 0.397 . . . . 64.430000000000007 111.884 -178.118 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 690' ' ' LEU . . . . . 0.435 HD12 ' OG1' ' A' ' 700' ' ' THR . 45.9 tp -141.97 151.87 42.94 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.058 -0.519 . . . . 64.209999999999994 110.683 -177.092 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 691' ' ' ALA . . . . . 0.488 ' HB2' HD11 ' A' ' 703' ' ' ILE . . . -139.78 121.53 15.39 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.235 0.541 . . . . 72.530000000000001 111.439 174.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 692' ' ' ILE . . . . . . . . . . . . . 46.7 mm -128.93 120.53 52.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-N 116.219 -0.446 . . . . 55.43 111.716 -177.515 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 693' ' ' ASP . . . . . 0.46 ' HB2' ' HB3' ' A' ' 667' ' ' PRO . 31.9 t70 -102.88 149.24 24.7 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 120.787 0.327 . . . . 63.240000000000002 110.611 174.255 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -67.33 -55.41 13.98 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 112.367 0.506 . . . . 73.129999999999995 112.367 -176.075 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -83.8 -52.03 6.73 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 112.433 0.531 . . . . 63.530000000000001 112.433 -176.415 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 696' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -72.12 -32.79 67.27 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 120.874 0.368 . . . . 75.450000000000003 111.697 -172.572 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . 109.57 -144.69 16.72 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 120.973 -0.632 . . . . 24.420000000000002 113.515 177.441 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -71.06 122.47 20.13 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 120.85 0.357 . . . . 74.150000000000006 111.459 -178.433 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 699' ' ' LEU . . . . . . . . . . . . . 90.3 mt -118.85 20.89 12.69 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 120.998 0.428 . . . . 75.310000000000002 111.348 178.434 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 700' ' ' THR . . . . . 0.435 ' OG1' HD12 ' A' ' 690' ' ' LEU . 26.3 m -62.18 -39.22 91.94 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 121.169 0.509 . . . . 72.430000000000007 111.611 -179.339 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 701' ' ' SER . . . . . . . . . . . . . 63.3 m -71.07 -9.51 58.17 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 116.211 -0.449 . . . . 71.530000000000001 111.637 177.687 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 702' ' ' LYS . . . . . . . . . . . . . 2.4 mmmp? -87.01 -9.66 55.01 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 120.668 0.271 . . . . 71.540000000000006 111.049 176.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 703' ' ' ILE . . . . . 0.489 HG12 ' HB ' ' A' ' 723' ' ' VAL . 67.7 mt -74.76 115.57 16.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-O 120.743 0.306 . . . . 63.200000000000003 111.531 -178.781 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 704' ' ' LYS . . . . . . . . . . . . . 30.2 ttpt -89.95 119.47 30.34 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 120.872 0.368 . . . . 55.219999999999999 110.375 174.243 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 45.2 t -97.3 137.59 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 112.238 0.459 . . . . 62.450000000000003 112.238 -174.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 706' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -131.78 134.63 46.04 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 120.932 0.396 . . . . 63.450000000000003 110.962 175.597 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 128.07 178.87 15.55 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 121.373 -0.442 . . . . 73.219999999999999 112.987 179.723 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 708' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -166.28 130.71 2.17 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.046 0.45 . . . . 72.349999999999994 111.721 179.29 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 709' ' ' VAL . . . . . . . . . . . . . 60.1 t -107.54 131.2 58.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-N 116.222 -0.444 . . . . 71.120000000000005 111.652 -178.21 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 710' ' ' ASP . . . . . 0.437 ' O ' HG21 ' A' ' 739' ' ' VAL . 7.4 m-20 -85.68 141.86 29.45 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.037 0.446 . . . . 73.120000000000005 111.757 178.518 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 711' ' ' THR . . . . . 0.446 ' O ' ' HA ' ' A' ' 679' ' ' VAL . 80.5 p -111.29 2.36 17.64 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.476 -0.329 . . . . 75.150000000000006 111.648 177.361 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 712' ' ' THR . . . . . . . . . . . . . 31.2 p -103.84 -28.68 11.46 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 120.951 0.405 . . . . 61.439999999999998 111.883 178.375 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 713' ' ' LYS . . . . . 0.403 ' HB2' ' NZ ' ' A' ' 713' ' ' LYS . 4.8 ttmp? -119.64 133.33 55.69 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.505 -0.316 . . . . 53.210000000000001 111.174 -178.404 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 714' ' ' ALA . . . . . . . . . . . . . . . -69.56 142.98 53.5 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 120.868 0.366 . . . . 71.340000000000003 111.435 178.855 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 160.84 157.83 8.95 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 120.995 -0.621 . . . . 73.430000000000007 113.107 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 716' ' ' THR . . . . . . . . . . . . . 86.3 m -99.07 123.26 43.23 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 122.496 -0.414 . . . . 74.5 111.67 -178.741 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 717' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -122.19 150.33 42.4 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 122.579 0.352 . . . . 65.239999999999995 111.204 -178.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 718' ' ' VAL . . . . . . . . . . . . . 57.6 t -113.7 125.44 70.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 CA-C-O 121.003 0.43 . . . . 73.019999999999996 111.642 178.651 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 719' ' ' LEU . . . . . . . . . . . . . 81.4 mt -102.41 141.69 34.83 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.444 -0.344 . . . . 54.119999999999997 110.95 179.193 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 86.5 m -112.29 139.68 47.64 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-O 120.994 0.426 . . . . 61.100000000000001 111.71 -178.41 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 721' ' ' TYR . . . . . . . . . . . . . 50.1 m-85 -132.56 122.38 24.7 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 116.191 -0.459 . . . . 71.109999999999999 110.937 -179.017 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 95.3 m -125.69 125.32 42.86 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 120.873 0.368 . . . . 72.129999999999995 111.883 -179.654 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 723' ' ' VAL . . . . . 0.489 ' HB ' HG12 ' A' ' 703' ' ' ILE . 14.9 p -121.56 152.14 25.11 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-N 116.297 -0.411 . . . . 71.430000000000007 111.005 178.312 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 87.0 m -133.08 132.11 41.37 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.058 0.456 . . . . 72.519999999999996 111.938 177.676 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 725' ' ' ASP . . . . . 0.475 ' HB3' ' H ' ' A' ' 729' ' ' HIS . 9.9 t0 -73.41 151.05 41.29 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 115.714 -0.676 . . . . 64.519999999999996 110.608 177.747 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 726' ' ' SER . . . . . . . . . . . . . 44.0 t -59.57 -31.66 69.65 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.328 -0.396 . . . . 44.520000000000003 111.786 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 727' ' ' LYS . . . . . . . . . . . . . 10.3 mptt -86.71 1.05 53.41 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 112.237 0.458 . . . . 54.439999999999998 112.237 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 728' ' ' GLY . . . . . . . . . . . . . . . 100.55 33.77 4.96 Favored Glycine 0 CA--C 1.534 1.23 0 N-CA-C 115.49 0.956 . . . . 71.530000000000001 115.49 171.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 729' ' ' HIS . . . . . 0.475 ' H ' ' HB3' ' A' ' 725' ' ' ASP . 52.3 m80 -109.45 112.08 23.98 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 118.062 0.931 . . . . 74.530000000000001 111.571 173.058 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 730' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -99.51 129.05 45.65 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 121.028 0.442 . . . . 71.549999999999997 111.825 -176.813 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 48.8 t -127.51 136.1 61.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-N 116.22 -0.445 . . . . 71.209999999999994 110.591 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 10.3 t -135.13 144.95 47.39 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 112.364 0.505 . . . . 74.209999999999994 112.364 -178.628 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 733' ' ' ALA . . . . . 0.489 ' HB3' HG21 ' A' ' 671' ' ' VAL . . . -148.86 162.1 40.5 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 116.222 -0.445 . . . . 64.400000000000006 111.71 -178.53 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 734' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -123.72 155.35 38.01 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 112.356 0.502 . . . . 74.140000000000001 112.356 -178.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 735' ' ' GLN . . . . . 0.504 ' NE2' ' HG2' ' A' ' 672' ' ' PRO . 49.9 tt0 -130.04 126.36 37.5 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 116.021 -0.536 . . . . 74.25 110.746 177.284 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 736' ' ' THR . . . . . . . . . . . . . 97.8 m -95.1 109.54 21.59 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 120.992 0.425 . . . . 73.319999999999993 111.726 -179.711 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 47.7 t -106.5 121.67 59.4 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 CA-C-O 120.897 0.379 . . . . 62.399999999999999 111.505 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 738' ' ' THR . . . . . . . . . . . . . 54.2 m -104.77 121.81 44.4 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.091 0.472 . . . . 71.349999999999994 111.986 179.617 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 739' ' ' VAL . . . . . 0.437 HG21 ' O ' ' A' ' 710' ' ' ASP . 24.4 t -98.09 136.3 29.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-N 116.063 -0.517 . . . . 51.25 111.047 178.11 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 740' ' ' LYS . . . . . 0.408 ' O ' ' HA ' ' A' ' 678' ' ' HIS . 96.0 mttt -131.38 156.01 46.29 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.259 0.552 . . . . 75.329999999999998 111.957 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 741' ' ' VAL . . . . . 0.485 ' HA ' HG23 ' A' ' 679' ' ' VAL . 28.2 t . . . . . 0 CA--C 1.54 0.559 0 CA-C-N 116.266 -0.425 . . . . 74.140000000000001 111.485 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 664' ' ' ASP . . . . . 0.406 ' OD2' ' HB2' ' A' ' 727' ' ' LYS . 27.3 t0 . . . . . 0 CA--C 1.534 0.344 0 CA-C-O 121.096 0.474 . . . . 70.450000000000003 110.979 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 665' ' ' LEU . . . . . . . . . . . . . 86.2 mt -96.94 136.89 36.86 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.117 -0.492 . . . . 55.030000000000001 110.768 175.701 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 666' ' ' GLU . . . . . 0.47 ' H ' ' CD ' ' A' ' 666' ' ' GLU . 1.4 pm0 -56.83 139.59 77.21 Favored Pre-proline 0 CA--C 1.544 0.712 0 CA-C-O 120.79 0.329 . . . . 73.340000000000003 111.16 175.53 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 667' ' ' PRO . . . . . 0.584 ' HB3' HD12 ' A' ' 699' ' ' LEU . 58.3 Cg_endo -68.97 156.77 64.32 Favored 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 122.618 2.212 . . . . 73.409999999999997 113.737 -172.614 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 668' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -87.76 105.18 17.21 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.99 -0.55 . . . . 65.540000000000006 111.226 177.733 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 669' ' ' LEU . . . . . 0.518 ' HG ' HG23 ' A' ' 671' ' ' VAL . 62.1 tp -95.09 108.13 20.21 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 116.011 -0.54 . . . . 72.329999999999998 110.658 177.151 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 670' ' ' THR . . . . . . . . . . . . . 88.2 m -86.34 111.31 20.36 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.858 0.361 . . . . 73.109999999999999 111.244 179.446 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 671' ' ' VAL . . . . . 0.518 HG23 ' HG ' ' A' ' 669' ' ' LEU . 94.6 t -136.31 130.93 18.39 Favored Pre-proline 0 N--CA 1.47 0.555 0 CA-C-N 116.301 -0.409 . . . . 73.319999999999993 110.983 -179.668 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 672' ' ' PRO . . . . . 0.464 ' HG2' ' NE2' ' A' ' 735' ' ' GLN . 71.9 Cg_endo -76.24 143.73 25.58 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 122.248 1.965 . . . . 72.510000000000005 111.995 175.069 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 673' ' ' VAL . . . . . . . . . . . . . 15.0 p -77.87 -28.06 15.34 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 CA-C-O 120.874 0.369 . . . . 72.340000000000003 111.403 -176.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 674' ' ' GLY . . . . . . . . . . . . . . . -156.16 136.61 5.1 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 120.934 -0.65 . . . . 63.32 113.584 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 675' ' ' ALA . . . . . . . . . . . . . . . -131.29 158.91 39.39 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 122.68 0.392 . . . . 71.340000000000003 110.528 177.676 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 676' ' ' THR . . . . . . . . . . . . . 13.6 m -135.0 129.04 33.53 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 112.018 0.377 . . . . 72.549999999999997 112.018 -177.288 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 677' ' ' ILE . . . . . . . . . . . . . 24.4 pt -138.97 176.43 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 122.465 0.306 . . . . 52.43 111.032 177.176 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 678' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -124.73 165.46 17.92 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.976 0.417 . . . . 75.319999999999993 111.511 178.525 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 679' ' ' VAL . . . . . . . . . . . . . 63.6 t -60.01 112.58 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 CA-C-N 116.211 -0.449 . . . . 65.349999999999994 110.668 175.344 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 118.3 -26.13 7.92 Favored Glycine 0 CA--C 1.528 0.89 0 CA-C-N 116.164 -0.471 . . . . 33.43 112.808 -175.841 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 681' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -69.11 163.91 23.71 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.248 0.547 . . . . 74.540000000000006 112.058 178.097 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 682' ' ' SER . . . . . . . . . . . . . 67.2 m -120.69 121.67 38.77 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.13 -0.487 . . . . 72.439999999999998 111.246 -178.52 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 683' ' ' PHE . . . . . 0.436 ' HZ ' HE22 ' A' ' 735' ' ' GLN . 56.6 t80 -118.42 126.89 53.02 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.334 -0.394 . . . . 73.340000000000003 110.809 -177.324 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 684' ' ' VAL . . . . . . . . . . . . . 60.8 t -115.4 100.67 53.88 Favored Pre-proline 0 N--CA 1.47 0.572 0 CA-C-O 120.789 0.328 . . . . 71.209999999999994 111.429 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -54.53 -47.14 28.43 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 122.802 2.334 . . . . 64.219999999999999 113.692 -177.517 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 686' ' ' MET . . . . . . . . . . . . . 88.2 mmm -78.24 0.56 24.7 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.898 0.703 . . . . 74.239999999999995 112.898 -175.398 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 687' ' ' ALA . . . . . . . . . . . . . . . -94.02 -47.79 6.53 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 120.943 0.401 . . . . 75.430000000000007 110.907 175.161 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 688' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -80.84 -18.22 48.15 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 112.373 0.508 . . . . 70.430000000000007 112.373 -178.462 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 689' ' ' VAL . . . . . 0.498 HG21 ' CZ ' ' A' ' 721' ' ' TYR . 89.3 t -97.54 142.43 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-O 120.888 0.375 . . . . 74.310000000000002 111.227 177.031 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 690' ' ' LEU . . . . . 0.633 HD21 HG12 ' A' ' 692' ' ' ILE . 7.9 tt -146.02 150.69 36.47 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.385 -0.371 . . . . 64.040000000000006 111.357 -173.837 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 691' ' ' ALA . . . . . . . . . . . . . . . -142.44 120.93 12.45 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.091 0.472 . . . . 63.439999999999998 111.885 176.02 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 692' ' ' ILE . . . . . 0.633 HG12 HD21 ' A' ' 690' ' ' LEU . 39.3 mm -127.46 144.15 38.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-N 116.166 -0.47 . . . . 71.319999999999993 110.761 178.79 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 693' ' ' ASP . . . . . 0.452 ' HB2' ' HB3' ' A' ' 667' ' ' PRO . 36.5 t70 -125.02 149.3 47.9 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 120.949 0.404 . . . . 71.019999999999996 111.582 -178.137 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -57.99 -60.09 4.25 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 116.003 -0.544 . . . . 72.200000000000003 112.428 -177.478 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 695' ' ' GLU . . . . . 0.427 ' CD ' ' H ' ' A' ' 695' ' ' GLU . 0.3 OUTLIER -85.07 -53.58 5.19 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 112.096 0.406 . . . . 72.329999999999998 112.096 -176.283 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 696' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -70.23 -42.13 72.68 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.793 0.33 . . . . 73.0 111.863 -171.68 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . 108.56 -131.89 10.81 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 120.96 -0.638 . . . . 63.340000000000003 113.399 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -70.93 113.36 7.9 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 121.064 0.459 . . . . 74.409999999999997 111.523 -177.582 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 699' ' ' LEU . . . . . 0.584 HD12 ' HB3' ' A' ' 667' ' ' PRO . 89.6 mt -110.73 11.8 22.59 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.316 0.579 . . . . 72.219999999999999 110.397 172.532 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 21.1 m -59.89 -28.68 67.77 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.937 -0.574 . . . . 73.040000000000006 110.888 177.189 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 701' ' ' SER . . . . . . . . . . . . . 34.2 t -71.13 -24.42 62.27 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 116.244 -0.434 . . . . 64.099999999999994 111.456 175.662 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 702' ' ' LYS . . . . . 0.494 ' HB2' HG23 ' A' ' 723' ' ' VAL . 8.4 mmpt? -81.32 -13.75 58.05 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 111.87 0.322 . . . . 62.420000000000002 111.87 -178.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 69.8 mt -65.44 115.48 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 N-CA-C 112.076 0.398 . . . . 54.399999999999999 112.076 -177.585 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 704' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -98.42 124.76 43.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.112 0.482 . . . . 64.450000000000003 110.797 172.468 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 61.5 t -96.2 111.35 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-N 115.813 -0.63 . . . . 73.109999999999999 111.852 -177.201 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 706' ' ' ASP . . . . . 0.454 ' HB3' ' HB ' ' A' ' 720' ' ' THR . 38.6 t70 -99.23 134.6 41.85 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.455 -0.339 . . . . 74.409999999999997 110.748 177.211 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 108.42 171.77 21.39 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 121.148 -0.548 . . . . 34.409999999999997 112.678 -176.637 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 708' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -144.34 148.33 34.6 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 122.58 -0.365 . . . . 74.120000000000005 111.572 -176.668 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 709' ' ' VAL . . . . . 0.521 HG23 HD21 ' A' ' 719' ' ' LEU . 84.5 t -126.56 118.14 50.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 CA-C-O 120.806 0.336 . . . . 64.140000000000001 111.298 178.428 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 710' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -87.19 136.57 32.88 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 121.101 0.477 . . . . 70.420000000000002 111.361 177.877 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 711' ' ' THR . . . . . . . . . . . . . 73.9 p -98.63 -13.47 20.33 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.927 0.394 . . . . 73.010000000000005 111.437 177.706 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 712' ' ' THR . . . . . . . . . . . . . 71.7 p -93.31 -27.68 16.66 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 116.271 -0.422 . . . . 64.530000000000001 111.535 178.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 713' ' ' LYS . . . . . . . . . . . . . 50.2 tptt -116.53 132.43 56.68 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.563 -0.29 . . . . 74.430000000000007 110.526 178.82 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 714' ' ' ALA . . . . . . . . . . . . . . . -86.59 144.93 26.95 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 112.786 0.662 . . . . 72.030000000000001 112.786 -176.507 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 163.41 176.31 35.27 Favored Glycine 0 CA--C 1.522 0.482 0 CA-C-N 115.424 -0.807 . . . . 63.0 111.959 -179.739 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 716' ' ' THR . . . . . . . . . . . . . 95.7 m -94.68 122.21 37.05 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 117.222 0.511 . . . . 63.039999999999999 110.978 177.528 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 717' ' ' TYR . . . . . 0.477 ' HB2' HG22 ' A' ' 709' ' ' VAL . 57.6 m-85 -121.95 119.45 31.54 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.463 -0.335 . . . . 61.32 110.94 -178.213 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 718' ' ' VAL . . . . . . . . . . . . . 60.3 t -91.42 123.23 43.48 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-O 120.809 0.338 . . . . 54.130000000000003 111.182 179.379 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 719' ' ' LEU . . . . . 0.521 HD21 HG23 ' A' ' 709' ' ' VAL . 88.0 mt -104.82 126.15 51.6 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.418 -0.356 . . . . 63.130000000000003 111.241 177.587 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 720' ' ' THR . . . . . 0.454 ' HB ' ' HB3' ' A' ' 706' ' ' ASP . 95.1 m -101.08 127.48 47.59 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.988 0.423 . . . . 70.150000000000006 111.33 178.314 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 721' ' ' TYR . . . . . 0.498 ' CZ ' HG21 ' A' ' 689' ' ' VAL . 57.7 m-85 -113.47 113.91 25.81 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.685 0.279 . . . . 74.5 110.76 179.466 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 72.0 m -113.85 125.34 53.95 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.762 0.315 . . . . 54.549999999999997 111.469 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 723' ' ' VAL . . . . . 0.494 HG23 ' HB2' ' A' ' 702' ' ' LYS . 8.3 p -129.42 133.98 64.44 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-O 120.995 0.426 . . . . 74.310000000000002 111.224 179.015 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 73.5 m -116.44 136.25 53.15 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 120.934 0.397 . . . . 62.530000000000001 111.887 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 725' ' ' ASP . . . . . 0.428 ' HB2' ' HD3' ' A' ' 667' ' ' PRO . 10.7 t0 -73.28 150.9 41.59 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 109.675 -0.491 . . . . 73.439999999999998 109.675 174.297 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 726' ' ' SER . . . . . . . . . . . . . 34.9 t -56.15 -33.24 65.02 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.348 -0.387 . . . . 73.209999999999994 111.753 -179.191 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 727' ' ' LYS . . . . . 0.464 ' HD3' ' N ' ' A' ' 727' ' ' LYS . 3.6 mppt? -91.42 6.85 43.84 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 112.712 0.634 . . . . 72.200000000000003 112.712 -178.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 728' ' ' GLY . . . . . . . . . . . . . . . 101.69 35.2 4.13 Favored Glycine 0 CA--C 1.534 1.279 0 N-CA-C 116.122 1.209 . . . . 71.409999999999997 116.122 169.173 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 729' ' ' HIS . . . . . 0.411 ' H ' ' HB3' ' A' ' 725' ' ' ASP . 40.7 m80 -109.3 110.68 21.92 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 118.178 0.989 . . . . 73.030000000000001 111.49 172.833 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 730' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -96.89 128.5 43.91 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.277 0.56 . . . . 71.209999999999994 112.121 -177.01 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 57.6 t -126.4 129.48 71.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 CA-C-N 115.97 -0.559 . . . . 53.149999999999999 110.109 176.062 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 7.5 t -137.12 128.86 28.84 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.167 0.508 . . . . 65.349999999999994 112.296 -177.611 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -135.56 157.65 46.34 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 122.804 0.442 . . . . 73.230000000000004 110.863 -178.665 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 734' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -121.3 158.69 27.62 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.994 0.739 . . . . 61.109999999999999 112.994 -175.242 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 735' ' ' GLN . . . . . 0.464 ' NE2' ' HG2' ' A' ' 672' ' ' PRO . 51.0 tt0 -130.57 128.51 41.25 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.839 -0.619 . . . . 64.319999999999993 111.161 179.645 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 736' ' ' THR . . . . . . . . . . . . . 86.6 m -87.93 103.89 16.1 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 120.751 0.31 . . . . 63.520000000000003 110.991 175.883 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 47.8 t -96.73 108.39 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-O 120.924 0.392 . . . . 73.530000000000001 111.188 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 738' ' ' THR . . . . . . . . . . . . . 27.3 m -94.84 108.96 20.99 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.79 0.328 . . . . 75.209999999999994 111.342 -179.6 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 739' ' ' VAL . . . . . . . . . . . . . 43.0 t -94.22 125.34 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-O 120.729 0.3 . . . . 71.150000000000006 110.793 176.703 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 740' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -115.38 146.55 41.47 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.048 0.451 . . . . 73.310000000000002 111.979 -175.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 741' ' ' VAL . . . . . . . . . . . . . 24.3 t . . . . . 0 N--CA 1.473 0.715 0 CA-C-O 120.88 0.371 . . . . 54.210000000000001 111.914 -179.142 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 664' ' ' ASP . . . . . . . . . . . . . 41.5 t0 . . . . . 0 CA--C 1.532 0.257 0 CA-C-O 121.154 0.502 . . . . 65.230000000000004 110.094 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 665' ' ' LEU . . . . . 0.524 HD12 ' HB2' ' A' ' 694' ' ' LYS . 86.6 mt -91.98 137.87 32.01 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.937 -0.574 . . . . 65.310000000000002 111.038 179.191 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 666' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -80.68 142.2 52.83 Favored Pre-proline 0 CA--C 1.541 0.612 0 CA-C-N 116.223 -0.444 . . . . 73.109999999999999 110.406 173.654 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 667' ' ' PRO . . . . . 0.595 ' HB3' HD12 ' A' ' 699' ' ' LEU . 64.4 Cg_endo -70.86 146.2 52.75 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 122.231 1.954 . . . . 53.409999999999997 113.734 -173.002 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 668' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -83.3 103.86 13.01 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.975 -0.557 . . . . 73.140000000000001 110.576 173.725 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 669' ' ' LEU . . . . . . . . . . . . . 52.3 tp -89.79 132.65 35.12 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.153 -0.476 . . . . 71.239999999999995 109.95 176.232 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 670' ' ' THR . . . . . . . . . . . . . 91.1 m -121.61 111.31 17.07 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.025 0.441 . . . . 74.140000000000001 111.124 -179.399 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 671' ' ' VAL . . . . . . . . . . . . . 88.8 t -128.77 134.55 26.42 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-N 115.82 -0.627 . . . . 51.43 110.628 -179.252 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 672' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.57 127.82 17.94 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 121.964 1.776 . . . . 43.32 111.903 177.536 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 673' ' ' VAL . . . . . 0.442 ' O ' HG22 ' A' ' 736' ' ' THR . 12.5 p -64.4 -23.78 34.17 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 N-CA-C 112.414 0.524 . . . . 72.430000000000007 112.414 -174.179 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 674' ' ' GLY . . . . . . . . . . . . . . . -169.02 154.27 23.73 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 120.61 -0.805 . . . . 63.140000000000001 113.591 179.506 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 675' ' ' ALA . . . . . . . . . . . . . . . -150.38 156.29 41.22 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 122.502 0.321 . . . . 72.340000000000003 110.859 177.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 676' ' ' THR . . . . . . . . . . . . . 70.4 m -134.42 127.43 31.55 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.784 0.326 . . . . 60.140000000000001 111.269 -179.535 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 677' ' ' ILE . . . . . . . . . . . . . 28.4 pt -130.33 176.62 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-O 120.824 0.345 . . . . 61.549999999999997 111.124 179.506 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 678' ' ' HIS . . . . . 0.513 ' O ' ' HB2' ' A' ' 681' ' ' ASP . 69.9 m80 -116.67 166.67 11.85 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 121.581 0.705 . . . . 75.5 112.311 -179.728 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 679' ' ' VAL . . . . . 0.473 HG13 ' HA ' ' A' ' 712' ' ' THR . 82.4 t -67.16 112.18 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-N 115.972 -0.558 . . . . 72.329999999999998 110.494 174.334 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 109.24 -2.48 31.22 Favored Glycine 0 CA--C 1.529 0.957 0 CA-C-N 115.891 -0.595 . . . . 73.329999999999998 112.41 -172.192 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 681' ' ' ASP . . . . . 0.513 ' HB2' ' O ' ' A' ' 678' ' ' HIS . 1.1 t70 -75.62 -168.43 0.85 Allowed 'General case' 0 CA--C 1.547 0.835 0 CA-C-O 120.954 0.407 . . . . 71.319999999999993 110.955 178.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 682' ' ' SER . . . . . . . . . . . . . 73.7 m -150.18 136.74 19.05 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 122.159 -0.338 . . . . 63.450000000000003 110.553 176.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 683' ' ' PHE . . . . . . . . . . . . . 36.0 t80 -138.66 127.38 23.51 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 120.614 0.245 . . . . 65.400000000000006 111.652 -174.493 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 684' ' ' VAL . . . . . . . . . . . . . 63.8 t -111.73 101.45 51.27 Favored Pre-proline 0 N--CA 1.476 0.85 0 CA-C-O 120.726 0.298 . . . . 71.150000000000006 111.771 179.025 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -52.82 -42.81 60.91 Favored 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 122.975 2.45 . . . . 70.209999999999994 113.772 179.463 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 686' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -78.13 3.84 14.04 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 112.79 0.663 . . . . 61.509999999999998 112.79 -176.083 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 687' ' ' ALA . . . . . . . . . . . . . . . -109.35 -14.77 14.39 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 122.2 -0.313 . . . . 74.239999999999995 111.82 176.853 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 688' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -97.62 -6.5 33.17 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 112.722 0.638 . . . . 71.420000000000002 112.722 -175.443 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 689' ' ' VAL . . . . . 0.413 HG12 HD13 ' A' ' 703' ' ' ILE . 49.7 t -121.67 154.83 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 N-CA-C 112.025 0.38 . . . . 43.32 112.025 -174.17 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 690' ' ' LEU . . . . . 0.563 HD23 ' N ' ' A' ' 691' ' ' ALA . 6.4 tt -150.57 143.82 24.9 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 116.509 -0.314 . . . . 71.150000000000006 110.827 -178.307 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 691' ' ' ALA . . . . . 0.563 ' N ' HD23 ' A' ' 690' ' ' LEU . . . -144.08 132.05 21.57 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 112.416 0.525 . . . . 42.439999999999998 112.416 -179.132 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 692' ' ' ILE . . . . . 0.473 HD13 ' HA ' ' A' ' 698' ' ' ASP . 38.6 mm -135.77 136.89 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 N-CA-C 112.116 0.413 . . . . 63.539999999999999 112.116 -179.289 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -115.68 141.82 47.56 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 109.005 -0.739 . . . . 73.140000000000001 109.005 167.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 694' ' ' LYS . . . . . 0.524 ' HB2' HD12 ' A' ' 665' ' ' LEU . 54.5 mttp -71.33 -28.97 64.46 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.289 0.478 . . . . 74.400000000000006 112.289 -177.408 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -83.38 -44.75 14.48 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-O 120.916 0.389 . . . . 75.329999999999998 111.974 -179.581 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 696' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -92.87 -30.3 15.5 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 120.851 0.358 . . . . 65.299999999999997 111.325 -173.622 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . 105.86 -135.17 12.48 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 121.325 -0.464 . . . . 53.5 112.769 179.096 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 698' ' ' ASP . . . . . 0.473 ' HA ' HD13 ' A' ' 692' ' ' ILE . 12.1 t70 -71.83 125.09 26.29 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 122.534 -0.392 . . . . 71.299999999999997 111.497 179.05 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 699' ' ' LEU . . . . . 0.632 HD22 ' HD2' ' A' ' 702' ' ' LYS . 45.7 mt -119.83 6.65 10.92 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.493 -0.321 . . . . 72.540000000000006 111.584 177.721 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 49.6 m -58.6 -40.13 82.36 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.201 0.524 . . . . 73.340000000000003 111.464 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 701' ' ' SER . . . . . . . . . . . . . 37.2 t -66.03 -13.78 60.54 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 121.072 0.463 . . . . 63.149999999999999 111.817 176.098 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 702' ' ' LYS . . . . . 0.632 ' HD2' HD22 ' A' ' 699' ' ' LEU . 97.4 mttt -99.11 6.62 46.43 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.217 0.451 . . . . 74.109999999999999 112.217 -178.643 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 703' ' ' ILE . . . . . 0.413 HD13 HG12 ' A' ' 689' ' ' VAL . 73.9 mt -80.02 117.45 25.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-O 121.044 0.45 . . . . 72.140000000000001 111.541 -179.74 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 704' ' ' LYS . . . . . 0.409 ' HE3' ' HB2' ' A' ' 704' ' ' LYS . 35.9 ttmt -91.34 136.64 32.96 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.212 -0.449 . . . . 72.019999999999996 111.039 176.673 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 46.6 t -109.27 140.55 27.6 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-O 121.129 0.49 . . . . 63.219999999999999 111.889 -177.319 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 706' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -132.36 126.02 32.26 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 116.273 -0.421 . . . . 64.010000000000005 110.253 174.077 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 102.97 152.94 24.1 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 121.141 -0.552 . . . . 51.420000000000002 112.404 -173.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 708' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -153.59 143.62 22.1 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 122.19 -0.594 . . . . 60.43 111.566 -176.902 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 709' ' ' VAL . . . . . 0.543 HG22 ' HB2' ' A' ' 717' ' ' TYR . 71.7 t -99.52 134.35 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-N 116.067 -0.515 . . . . 64.329999999999998 111.842 -177.231 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 710' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -100.54 150.78 22.32 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 121.027 0.442 . . . . 64.25 110.431 170.384 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 711' ' ' THR . . . . . . . . . . . . . 80.7 p -107.39 28.2 8.34 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.444 -0.344 . . . . 73.349999999999994 111.494 -178.815 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 712' ' ' THR . . . . . 0.473 ' HA ' HG13 ' A' ' 679' ' ' VAL . 7.5 t -115.9 -28.48 6.66 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 112.385 0.513 . . . . 74.230000000000004 112.385 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 713' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -115.67 122.37 45.35 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 120.733 0.301 . . . . 63.32 111.095 -176.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 714' ' ' ALA . . . . . 0.482 ' HB2' HG23 ' A' ' 741' ' ' VAL . . . -70.43 101.96 2.08 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 121.199 0.523 . . . . 71.239999999999995 111.718 -178.268 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . -164.18 168.45 38.61 Favored Glycine 0 CA--C 1.52 0.355 0 CA-C-N 115.99 -0.55 . . . . 71.349999999999994 112.843 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 716' ' ' THR . . . . . . . . . . . . . 73.2 m -95.52 122.7 38.54 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.05 0.452 . . . . 74.150000000000006 111.612 178.803 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 717' ' ' TYR . . . . . 0.543 ' HB2' HG22 ' A' ' 709' ' ' VAL . 57.6 m-85 -116.86 124.45 49.54 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 116.106 -0.497 . . . . 70.310000000000002 110.418 179.158 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 718' ' ' VAL . . . . . . . . . . . . . 45.6 t -96.28 110.88 25.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-O 121.09 0.471 . . . . 71.120000000000005 111.613 -178.523 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 719' ' ' LEU . . . . . 0.531 HD21 HG23 ' A' ' 709' ' ' VAL . 58.9 mt -88.41 130.5 35.16 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.131 -0.486 . . . . 75.450000000000003 111.227 -178.822 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 84.5 m -99.72 132.29 45.16 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.903 0.382 . . . . 75.150000000000006 111.496 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 721' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -122.01 134.27 54.8 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.838 0.351 . . . . 73.310000000000002 110.937 177.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 24.7 m -135.82 130.27 33.7 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 111.625 0.231 . . . . 73.5 111.625 -176.756 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 8.7 p -125.0 132.47 71.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-O 121.031 0.443 . . . . 73.200000000000003 111.286 178.371 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 22.7 m -108.4 120.5 42.57 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.945 0.403 . . . . 63.329999999999998 111.991 -176.751 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 725' ' ' ASP . . . . . 0.496 ' HB2' ' HD3' ' A' ' 667' ' ' PRO . 3.6 t70 -73.19 149.71 42.69 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 116.197 -0.456 . . . . 75.349999999999994 110.734 175.216 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 726' ' ' SER . . . . . . . . . . . . . 56.8 p -65.43 -26.3 67.91 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 112.287 0.477 . . . . 55.420000000000002 112.287 -174.463 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 727' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -93.76 -3.7 51.68 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 112.715 0.635 . . . . 72.129999999999995 112.715 178.58 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 728' ' ' GLY . . . . . . . . . . . . . . . 111.72 19.88 7.16 Favored Glycine 0 CA--C 1.532 1.096 0 N-CA-C 115.529 0.972 . . . . 63.329999999999998 115.529 172.071 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 27.7 m80 -97.13 104.96 17.02 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 118.241 1.02 . . . . 74.010000000000005 111.025 172.688 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 730' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -112.19 114.63 27.54 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 120.933 0.397 . . . . 64.219999999999999 111.665 -177.116 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 32.8 m -109.83 158.73 9.82 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-O 121.084 0.469 . . . . 64.530000000000001 111.582 179.671 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 5.6 t -135.56 145.39 46.92 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 121.204 0.526 . . . . 61.530000000000001 112.163 -176.331 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -148.59 161.12 42.34 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.997 -0.547 . . . . 53.149999999999999 110.791 176.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 734' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -133.52 157.49 45.51 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 112.509 0.559 . . . . 73.329999999999998 112.509 -176.416 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 735' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -130.61 125.98 35.48 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 115.623 -0.717 . . . . 71.530000000000001 110.794 178.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 736' ' ' THR . . . . . 0.442 HG22 ' O ' ' A' ' 673' ' ' VAL . 8.3 t -93.36 110.27 21.82 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.254 0.55 . . . . 74.040000000000006 111.588 178.298 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 46.8 t -106.69 115.69 48.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-N 116.474 -0.33 . . . . 74.109999999999999 111.339 -179.648 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 738' ' ' THR . . . . . . . . . . . . . 88.8 m -99.62 124.72 45.1 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 120.778 0.323 . . . . 42.399999999999999 111.503 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 739' ' ' VAL . . . . . . . . . . . . . 49.7 t -96.76 134.25 35.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-O 120.916 0.389 . . . . 74.129999999999995 111.429 178.14 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 740' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -121.55 144.96 48.43 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.4 -0.363 . . . . 60.130000000000003 111.188 178.558 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 741' ' ' VAL . . . . . 0.482 HG23 ' HB2' ' A' ' 714' ' ' ALA . 25.6 t . . . . . 0 N--CA 1.469 0.485 0 O-C-N 121.639 -0.663 . . . . 63.350000000000001 111.638 -178.633 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 664' ' ' ASP . . . . . 0.493 ' CG ' ' HB2' ' A' ' 727' ' ' LYS . 45.0 t0 . . . . . 0 CA--C 1.535 0.399 0 CA-C-O 121.132 0.491 . . . . 51.119999999999997 111.676 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 665' ' ' LEU . . . . . . . . . . . . . 85.2 mt -81.57 116.86 21.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.007 -0.542 . . . . 55.420000000000002 109.78 175.111 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 666' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -77.37 137.74 64.02 Favored Pre-proline 0 CA--C 1.541 0.616 0 CA-C-O 120.898 0.38 . . . . 75.209999999999994 111.433 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 667' ' ' PRO . . . . . 0.558 ' HB3' HD12 ' A' ' 699' ' ' LEU . 65.8 Cg_endo -71.46 140.46 36.56 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 122.596 2.197 . . . . 71.219999999999999 113.182 -174.085 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 668' ' ' LYS . . . . . 0.402 ' O ' ' HA ' ' A' ' 691' ' ' ALA . 22.7 tptm -83.58 106.9 15.68 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.302 -0.408 . . . . 74.340000000000003 110.631 176.687 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 669' ' ' LEU . . . . . 0.464 ' HG ' HG23 ' A' ' 671' ' ' VAL . 58.7 tp -90.04 110.14 21.15 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 116.275 -0.421 . . . . 74.349999999999994 110.523 178.783 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 670' ' ' THR . . . . . . . . . . . . . 67.6 m -86.38 109.4 18.99 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.854 0.359 . . . . 73.209999999999994 111.126 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 671' ' ' VAL . . . . . 0.464 HG23 ' HG ' ' A' ' 669' ' ' LEU . 91.0 t -141.78 120.83 7.95 Favored Pre-proline 0 N--CA 1.473 0.684 0 CA-C-N 116.257 -0.429 . . . . 75.299999999999997 110.774 179.178 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 672' ' ' PRO . . . . . 0.433 ' HG2' ' NE2' ' A' ' 735' ' ' GLN . 65.8 Cg_endo -73.8 150.1 43.86 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 122.366 2.044 . . . . 74.409999999999997 112.529 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 673' ' ' VAL . . . . . . . . . . . . . 7.7 p -64.36 -38.2 81.94 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 N-CA-C 112.16 0.43 . . . . 74.310000000000002 112.16 -178.625 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 674' ' ' GLY . . . . . . . . . . . . . . . -156.46 157.67 28.1 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 120.805 -0.712 . . . . 72.540000000000006 114.031 -177.787 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 675' ' ' ALA . . . . . 0.434 ' O ' ' HA ' ' A' ' 737' ' ' VAL . . . -151.88 135.09 15.89 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 122.831 0.453 . . . . 62.299999999999997 110.668 178.706 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 676' ' ' THR . . . . . . . . . . . . . 62.5 m -115.23 123.63 49.32 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 121.993 -0.442 . . . . 74.129999999999995 112.025 -178.835 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 677' ' ' ILE . . . . . . . . . . . . . 17.5 pt -127.36 176.55 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 CA-C-N 116.254 -0.43 . . . . 71.109999999999999 110.865 177.26 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 678' ' ' HIS . . . . . . . . . . . . . 63.1 m80 -117.05 157.74 25.34 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.429 0.633 . . . . 72.140000000000001 112.182 -178.879 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 679' ' ' VAL . . . . . . . . . . . . . 92.0 t -54.63 113.02 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-N 115.513 -0.767 . . . . 52.299999999999997 111.401 175.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 116.3 -18.79 13.58 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 121.162 -0.542 . . . . 63.25 113.705 -179.289 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 681' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -74.43 -179.77 4.18 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 121.495 0.664 . . . . 64.030000000000001 112.502 -179.472 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 682' ' ' SER . . . . . . . . . . . . . 57.5 m -122.67 151.27 41.68 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.754 -0.657 . . . . 72.319999999999993 111.401 -178.068 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 683' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -158.88 116.04 2.77 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 116.546 -0.297 . . . . 73.329999999999998 110.801 -178.789 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 684' ' ' VAL . . . . . . . . . . . . . 41.7 t -113.57 98.3 46.52 Favored Pre-proline 0 CA--C 1.54 0.564 0 CA-C-O 120.949 0.404 . . . . 62.109999999999999 111.333 -178.751 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 685' ' ' PRO . . . . . 0.42 ' HB3' ' HE1' ' A' ' 721' ' ' TYR . 77.7 Cg_exo -51.52 -43.68 48.7 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 122.873 2.382 . . . . 71.420000000000002 113.615 -178.472 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 686' ' ' MET . . . . . 0.554 ' HE2' ' HA ' ' A' ' 686' ' ' MET . 0.4 OUTLIER -78.25 -1.3 32.3 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 112.758 0.651 . . . . 74.530000000000001 112.758 -177.13 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 687' ' ' ALA . . . . . . . . . . . . . . . -112.32 -8.35 13.94 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.788 0.328 . . . . 74.439999999999998 111.634 176.761 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 688' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -121.35 -22.54 5.96 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 112.119 0.414 . . . . 75.239999999999995 112.119 -177.571 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 96.4 t -95.82 148.23 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-O 120.626 0.251 . . . . 71.230000000000004 110.681 175.553 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 690' ' ' LEU . . . . . 0.68 HD21 HG12 ' A' ' 692' ' ' ILE . 9.6 tt -144.81 152.1 39.8 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 112.037 0.384 . . . . 65.530000000000001 112.037 -171.441 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 691' ' ' ALA . . . . . 0.402 ' HA ' ' O ' ' A' ' 668' ' ' LYS . . . -150.33 123.04 8.61 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 120.813 0.339 . . . . 65.230000000000004 111.371 176.479 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 692' ' ' ILE . . . . . 0.68 HG12 HD21 ' A' ' 690' ' ' LEU . 46.5 mm -123.62 134.65 65.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 N-CA-C 112.467 0.543 . . . . 53.229999999999997 112.467 -178.299 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 693' ' ' ASP . . . . . 0.474 ' HB2' ' HB3' ' A' ' 667' ' ' PRO . 67.7 t0 -117.43 128.34 54.91 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 109.216 -0.661 . . . . 72.040000000000006 109.216 170.588 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -65.63 -26.7 67.94 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 112.96 0.726 . . . . 73.120000000000005 112.96 -173.625 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -82.8 -40.65 20.12 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 120.824 0.345 . . . . 71.310000000000002 111.526 -177.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 696' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -95.65 -49.31 5.43 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 121.253 0.549 . . . . 55.119999999999997 111.702 -176.867 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . 129.01 -131.51 6.82 Favored Glycine 0 CA--C 1.528 0.855 0 CA-C-N 116.34 -0.391 . . . . 63.299999999999997 112.654 -177.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 698' ' ' ASP . . . . . 0.454 ' HA ' HD13 ' A' ' 692' ' ' ILE . 20.7 t70 -75.5 109.15 8.82 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 121.055 0.455 . . . . 75.239999999999995 111.464 178.422 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 699' ' ' LEU . . . . . 0.558 HD12 ' HB3' ' A' ' 667' ' ' PRO . 23.3 mt -99.42 4.41 46.2 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 120.839 0.352 . . . . 71.25 110.787 173.044 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 25.1 m -55.39 -40.06 70.92 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.686 0.755 . . . . 74.099999999999994 109.972 171.407 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 701' ' ' SER . . . . . . . . . . . . . 21.6 m -66.91 -7.76 24.37 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 115.218 -0.901 . . . . 71.120000000000005 112.146 177.555 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 702' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -104.05 -7.73 20.06 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 111.884 0.328 . . . . 72.129999999999995 111.884 -179.565 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 703' ' ' ILE . . . . . 0.482 ' HB ' ' HE1' ' A' ' 686' ' ' MET . 63.2 mt -70.66 140.8 17.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-O 120.835 0.35 . . . . 74.0 111.707 -178.233 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 704' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -110.51 133.42 53.31 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 110.247 -0.279 . . . . 72.140000000000001 110.247 170.159 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 50.5 t -96.7 107.23 19.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-O 120.956 0.407 . . . . 63.020000000000003 110.831 178.785 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 706' ' ' ASP . . . . . 0.519 ' HB3' ' HB ' ' A' ' 720' ' ' THR . 13.2 t70 -100.1 127.52 46.33 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 116.283 -0.417 . . . . 74.349999999999994 110.392 179.44 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 123.11 -175.86 16.6 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 121.173 -0.537 . . . . 55.119999999999997 113.132 -178.814 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 708' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -155.63 141.33 17.97 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 120.783 0.325 . . . . 73.430000000000007 111.237 -178.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 709' ' ' VAL . . . . . 0.471 HG22 ' HB2' ' A' ' 717' ' ' TYR . 93.9 t -124.87 111.53 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-O 120.887 0.375 . . . . 63.32 111.184 178.871 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 710' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -69.19 134.86 49.8 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 121.054 0.454 . . . . 63.549999999999997 110.669 176.729 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 711' ' ' THR . . . . . . . . . . . . . 35.9 p -113.54 -0.76 14.29 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.883 0.373 . . . . 74.310000000000002 110.98 178.499 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 712' ' ' THR . . . . . . . . . . . . . 81.9 p -98.15 -17.81 18.83 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.15 -0.477 . . . . 62.219999999999999 111.505 178.277 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 713' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -138.52 139.36 38.7 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 120.864 0.364 . . . . 64.209999999999994 111.271 -178.318 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 714' ' ' ALA . . . . . . . . . . . . . . . -70.18 144.4 51.95 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 112.662 0.616 . . . . 65.319999999999993 112.662 -176.703 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 159.25 161.54 11.28 Favored Glycine 0 CA--C 1.525 0.683 0 CA-C-N 115.689 -0.687 . . . . 75.409999999999997 112.262 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 716' ' ' THR . . . . . 0.405 ' HA ' ' HA ' ' A' ' 738' ' ' THR . 97.4 m -96.88 122.53 39.95 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 117.312 0.556 . . . . 74.5 111.419 178.752 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 717' ' ' TYR . . . . . 0.471 ' HB2' HG22 ' A' ' 709' ' ' VAL . 22.6 m-85 -123.8 150.2 44.77 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 116.193 -0.458 . . . . 53.219999999999999 110.304 -178.714 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 718' ' ' VAL . . . . . . . . . . . . . 58.4 t -115.57 133.94 60.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 CA-C-O 121.002 0.43 . . . . 72.239999999999995 111.918 -176.576 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 719' ' ' LEU . . . . . 0.414 HD21 HG23 ' A' ' 709' ' ' VAL . 88.6 mt -112.09 125.95 54.65 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.304 -0.407 . . . . 73.230000000000004 111.416 178.043 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 720' ' ' THR . . . . . 0.519 ' HB ' ' HB3' ' A' ' 706' ' ' ASP . 68.8 m -99.52 129.12 45.66 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.156 -0.474 . . . . 74.040000000000006 111.253 178.817 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 721' ' ' TYR . . . . . 0.42 ' HE1' ' HB3' ' A' ' 685' ' ' PRO . 77.1 m-85 -115.7 114.25 24.59 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.751 0.31 . . . . 65.239999999999995 111.002 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 45.7 m -117.22 131.92 56.74 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.57 -0.286 . . . . 73.030000000000001 111.517 -178.921 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 723' ' ' VAL . . . . . 0.471 ' HB ' HG12 ' A' ' 703' ' ' ILE . 7.1 p -137.16 137.25 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-O 121.066 0.46 . . . . 74.120000000000005 111.424 178.213 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 724' ' ' THR . . . . . 0.458 ' HA ' ' HA ' ' A' ' 730' ' ' GLU . 33.5 m -107.27 135.3 49.01 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.248 0.547 . . . . 72.329999999999998 112.059 -178.254 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 725' ' ' ASP . . . . . 0.537 ' HB3' ' H ' ' A' ' 729' ' ' HIS . 11.0 t0 -73.61 154.09 39.9 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 115.853 -0.612 . . . . 70.340000000000003 110.617 177.553 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 726' ' ' SER . . . . . . . . . . . . . 74.6 m -65.78 -21.98 66.54 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 116.626 -0.261 . . . . 61.219999999999999 111.572 177.67 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 727' ' ' LYS . . . . . 0.493 ' HB2' ' CG ' ' A' ' 664' ' ' ASP . 73.8 mmtt -106.81 4.67 27.77 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 112.495 0.554 . . . . 75.120000000000005 112.495 178.725 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 728' ' ' GLY . . . . . . . . . . . . . . . 114.1 -5.67 23.65 Favored Glycine 0 CA--C 1.54 1.624 0 N-CA-C 116.739 1.455 . . . . 70.439999999999998 116.739 171.283 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 729' ' ' HIS . . . . . 0.537 ' H ' ' HB3' ' A' ' 725' ' ' ASP . 15.1 m80 -73.16 98.17 2.55 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 119.414 1.607 . . . . 75.030000000000001 111.389 174.661 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 730' ' ' GLU . . . . . 0.458 ' HA ' ' HA ' ' A' ' 724' ' ' THR . 34.7 tt0 -98.63 106.96 19.3 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 122.188 -0.32 . . . . 73.030000000000001 111.095 179.325 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 26.9 m -111.71 152.23 13.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-O 120.942 0.401 . . . . 75.409999999999997 111.582 -176.074 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 7.2 t -146.57 151.87 38.02 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.065 0.459 . . . . 75.040000000000006 112.124 -179.277 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -148.35 154.29 39.75 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 115.996 -0.547 . . . . 73.109999999999999 110.722 178.303 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 734' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -114.95 155.3 27.17 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 112.389 0.515 . . . . 74.019999999999996 112.389 -176.767 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 735' ' ' GLN . . . . . 0.433 ' NE2' ' HG2' ' A' ' 672' ' ' PRO . 56.9 tt0 -131.36 125.98 34.07 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.081 -0.508 . . . . 75.329999999999998 110.977 178.019 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 736' ' ' THR . . . . . . . . . . . . . 87.7 m -90.73 104.11 16.73 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 116.475 -0.329 . . . . 61.109999999999999 111.287 178.728 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 737' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 675' ' ' ALA . 48.3 t -99.99 110.2 26.56 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-O 120.872 0.368 . . . . 71.549999999999997 111.756 -179.512 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 738' ' ' THR . . . . . 0.405 ' HA ' ' HA ' ' A' ' 716' ' ' THR . 51.8 m -95.57 123.74 39.27 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 121.036 0.446 . . . . 54.399999999999999 111.627 178.758 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 739' ' ' VAL . . . . . . . . . . . . . 48.1 t -104.26 128.61 57.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 CA-C-O 120.835 0.35 . . . . 75.510000000000005 111.404 178.403 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 740' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -116.56 160.78 20.15 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 120.858 0.361 . . . . 60.240000000000002 111.553 177.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 741' ' ' VAL . . . . . . . . . . . . . 43.6 t . . . . . 0 N--CA 1.473 0.724 0 CA-C-O 120.817 0.341 . . . . 75.450000000000003 111.582 -179.884 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 664' ' ' ASP . . . . . . . . . . . . . 42.6 t0 . . . . . 0 CA--C 1.536 0.412 0 CA-C-O 121.607 0.718 . . . . 63.310000000000002 112.017 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 665' ' ' LEU . . . . . . . . . . . . . 87.8 mt -101.82 138.72 38.42 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.266 -0.879 . . . . 65.230000000000004 110.779 175.866 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 666' ' ' GLU . . . . . 0.419 ' H ' ' CD ' ' A' ' 666' ' ' GLU . 1.3 pm0 -70.73 137.52 85.56 Favored Pre-proline 0 CA--C 1.542 0.638 0 N-CA-C 110.222 -0.288 . . . . 74.209999999999994 110.222 170.698 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 667' ' ' PRO . . . . . 0.537 ' HB3' ' HB2' ' A' ' 693' ' ' ASP . 59.9 Cg_endo -70.59 150.3 62.97 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 122.569 2.179 . . . . 74.420000000000002 113.769 -174.189 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 668' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -83.53 107.88 16.29 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 121.178 0.513 . . . . 62.549999999999997 110.635 175.447 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 669' ' ' LEU . . . . . . . . . . . . . 48.5 tp -90.62 112.47 24.2 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.95 -0.568 . . . . 63.229999999999997 109.828 175.09 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 670' ' ' THR . . . . . . . . . . . . . 83.6 m -95.11 110.48 22.42 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.175 0.512 . . . . 74.25 111.73 -176.864 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 671' ' ' VAL . . . . . 0.41 HG22 HG13 ' A' ' 689' ' ' VAL . 82.1 t -133.25 134.2 23.81 Favored Pre-proline 0 CA--C 1.542 0.638 0 CA-C-N 115.599 -0.728 . . . . 71.239999999999995 110.758 -178.106 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 672' ' ' PRO . . . . . 0.45 ' HG2' ' NE2' ' A' ' 735' ' ' GLN . 60.8 Cg_endo -72.42 136.66 26.69 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 122.201 1.934 . . . . 63.229999999999997 111.807 175.683 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 673' ' ' VAL . . . . . . . . . . . . . 14.3 p -64.5 -33.63 64.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 N-CA-C 112.093 0.405 . . . . 60.329999999999998 112.093 -176.205 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 674' ' ' GLY . . . . . 0.437 ' HA2' ' O ' ' A' ' 736' ' ' THR . . . -157.31 153.3 24.55 Favored Glycine 0 CA--C 1.523 0.554 0 C-N-CA 120.894 -0.67 . . . . 63.299999999999997 113.416 -178.61 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 675' ' ' ALA . . . . . . . . . . . . . . . -144.51 121.0 11.03 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.752 0.311 . . . . 61.409999999999997 111.169 179.576 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 676' ' ' THR . . . . . . . . . . . . . 84.8 m -96.98 121.6 39.04 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.92 0.39 . . . . 61.130000000000003 111.446 -179.527 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 677' ' ' ILE . . . . . . . . . . . . . 32.0 pt -130.79 176.68 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 CA-C-N 116.5 -0.318 . . . . 74.310000000000002 110.984 178.366 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 678' ' ' HIS . . . . . . . . . . . . . 78.0 m80 -121.55 153.72 37.64 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.231 0.538 . . . . 52.439999999999998 112.394 -179.443 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 679' ' ' VAL . . . . . . . . . . . . . 92.6 t -55.32 115.28 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 115.68 -0.691 . . . . 64.540000000000006 111.733 179.261 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 100.33 24.42 9.56 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 121.313 -0.47 . . . . 71.129999999999995 113.341 -177.634 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 681' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -108.59 176.03 5.26 Favored 'General case' 0 CA--C 1.546 0.826 0 O-C-N 122.516 -0.402 . . . . 52.350000000000001 110.883 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 682' ' ' SER . . . . . . . . . . . . . 84.4 p -114.94 129.57 56.74 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 122.334 0.254 . . . . 64.129999999999995 111.237 -179.761 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 683' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -139.4 126.1 20.68 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 120.821 0.343 . . . . 64.310000000000002 111.224 -178.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 684' ' ' VAL . . . . . . . . . . . . . 81.6 t -114.17 105.19 54.39 Favored Pre-proline 0 N--CA 1.474 0.753 0 N-CA-C 111.989 0.366 . . . . 55.409999999999997 111.989 -179.14 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_exo -53.37 -40.55 77.78 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 123.041 2.494 . . . . 71.120000000000005 113.727 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 686' ' ' MET . . . . . 0.552 ' HE3' ' HA ' ' A' ' 686' ' ' MET . 1.0 OUTLIER -78.24 -4.0 45.56 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 112.636 0.606 . . . . 73.439999999999998 112.636 -177.994 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 687' ' ' ALA . . . . . . . . . . . . . . . -98.74 -17.68 18.39 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.954 0.407 . . . . 63.130000000000003 111.385 177.376 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 688' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -98.67 -13.94 20.07 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 112.446 0.535 . . . . 74.420000000000002 112.446 -175.231 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 689' ' ' VAL . . . . . 0.59 HG12 HD13 ' A' ' 703' ' ' ILE . 94.9 t -122.49 132.93 70.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 N-CA-C 112.919 0.711 . . . . 75.140000000000001 112.919 -173.23 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 690' ' ' LEU . . . . . 0.514 ' HA ' HG23 ' A' ' 700' ' ' THR . 6.5 mp -124.93 165.0 18.87 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 116.274 -0.421 . . . . 71.540000000000006 111.021 177.392 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 691' ' ' ALA . . . . . . . . . . . . . . . -152.19 127.41 9.84 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 120.915 0.388 . . . . 44.340000000000003 111.909 178.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 692' ' ' ILE . . . . . . . . . . . . . 45.6 mm -135.28 139.07 47.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 N-CA-C 112.097 0.406 . . . . 73.310000000000002 112.097 -177.493 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 693' ' ' ASP . . . . . 0.537 ' HB2' ' HB3' ' A' ' 667' ' ' PRO . 45.5 t0 -120.29 137.93 53.98 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 109.589 -0.523 . . . . 75.519999999999996 109.589 171.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 52.9 tttp -57.33 -35.25 69.66 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 121.06 0.457 . . . . 74.129999999999995 112.1 -178.807 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -82.52 -46.16 13.76 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 112.294 0.479 . . . . 72.219999999999999 112.294 -176.51 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 696' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -94.33 -34.79 12.67 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 112.361 0.504 . . . . 51.100000000000001 112.361 -170.601 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . 105.26 -123.3 7.55 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 121.44 -0.409 . . . . 33.530000000000001 113.018 -178.322 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -75.96 118.41 18.7 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 121.272 0.558 . . . . 71.540000000000006 112.142 -178.705 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 699' ' ' LEU . . . . . 0.449 HD12 ' HB3' ' A' ' 667' ' ' PRO . 81.4 mt -118.33 8.13 12.15 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 115.719 -0.673 . . . . 62.420000000000002 110.408 171.742 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 700' ' ' THR . . . . . 0.514 HG23 ' HA ' ' A' ' 690' ' ' LEU . 37.8 m -59.1 -37.77 77.96 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.48 0.657 . . . . 54.229999999999997 110.568 175.343 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 701' ' ' SER . . . . . . . . . . . . . 54.8 p -73.4 -2.75 23.62 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 115.588 -0.733 . . . . 62.200000000000003 111.865 176.569 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 702' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -110.74 2.01 18.18 Favored 'General case' 0 CA--C 1.541 0.596 0 N-CA-C 111.859 0.318 . . . . 72.150000000000006 111.859 -179.067 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 703' ' ' ILE . . . . . 0.59 HD13 HG12 ' A' ' 689' ' ' VAL . 66.9 mt -71.12 129.67 34.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-O 121.179 0.514 . . . . 72.319999999999993 111.695 -179.169 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 704' ' ' LYS . . . . . . . . . . . . . 2.4 tppp? -104.88 127.26 52.64 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.192 -0.458 . . . . 71.049999999999997 110.244 177.347 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 50.1 t -97.94 134.8 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-O 120.825 0.345 . . . . 74.329999999999998 111.893 -177.115 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 706' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -128.56 147.63 50.71 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 116.133 -0.485 . . . . 74.349999999999994 110.351 175.232 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 106.13 -172.44 18.84 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 121.185 -0.531 . . . . 75.349999999999994 112.658 -177.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 708' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -165.18 130.62 2.61 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 116.925 0.363 . . . . 74.310000000000002 111.542 179.65 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 709' ' ' VAL . . . . . 0.553 HG22 ' HB2' ' A' ' 717' ' ' TYR . 98.8 t -110.63 116.6 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-O 120.792 0.329 . . . . 73.150000000000006 111.431 177.818 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 710' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -73.26 134.8 44.37 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 120.979 0.419 . . . . 72.129999999999995 110.584 175.493 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 711' ' ' THR . . . . . . . . . . . . . 75.8 p -105.97 -0.11 25.28 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 111.913 0.338 . . . . 75.120000000000005 111.913 -179.04 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 712' ' ' THR . . . . . . . . . . . . . 14.9 t -107.34 -1.86 21.21 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 112.47 0.544 . . . . 72.299999999999997 112.47 -177.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 713' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -143.58 134.94 26.0 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 122.021 -0.424 . . . . 73.010000000000005 111.174 -179.378 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 714' ' ' ALA . . . . . . . . . . . . . . . -70.23 140.79 52.49 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 112.343 0.498 . . . . 72.299999999999997 112.343 -176.16 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 153.39 167.08 15.31 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 121.124 -0.56 . . . . 61.439999999999998 112.856 -179.521 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 716' ' ' THR . . . . . . . . . . . . . 34.7 m -96.56 122.92 40.0 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 122.461 -0.435 . . . . 70.219999999999999 111.908 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 717' ' ' TYR . . . . . 0.553 ' HB2' HG22 ' A' ' 709' ' ' VAL . 27.3 m-85 -121.89 143.02 49.68 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 116.122 -0.49 . . . . 73.310000000000002 110.142 178.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 718' ' ' VAL . . . . . . . . . . . . . 53.8 t -109.75 127.49 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 N-CA-C 112.645 0.609 . . . . 60.340000000000003 112.645 -174.545 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 719' ' ' LEU . . . . . . . . . . . . . 96.3 mt -106.72 132.25 52.91 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 116.068 -0.515 . . . . 50.229999999999997 111.424 176.745 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 58.4 m -109.87 124.65 51.71 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 120.791 0.329 . . . . 74.040000000000006 111.261 179.289 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 721' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -110.94 129.63 55.82 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.507 -0.315 . . . . 73.25 110.718 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 99.5 m -132.65 125.37 30.19 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.554 0.216 . . . . 73.340000000000003 111.286 -179.163 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 8.1 p -117.62 142.53 31.42 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 CA-C-O 120.933 0.397 . . . . 51.229999999999997 111.773 -178.453 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 44.1 m -105.07 118.96 37.84 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.238 0.542 . . . . 74.439999999999998 112.429 -176.748 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 725' ' ' ASP . . . . . 0.525 ' HB2' ' HD3' ' A' ' 667' ' ' PRO . 5.7 t0 -73.79 150.94 40.76 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 115.798 -0.637 . . . . 75.209999999999994 110.804 174.943 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 726' ' ' SER . . . . . . . . . . . . . 59.8 p -74.19 -15.27 61.02 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 112.459 0.541 . . . . 65.450000000000003 112.459 -175.021 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 727' ' ' LYS . . . . . . . . . . . . . 65.2 mmtt -103.66 6.14 36.84 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 112.266 0.469 . . . . 72.120000000000005 112.266 177.853 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 728' ' ' GLY . . . . . . . . . . . . . . . 102.83 27.96 6.44 Favored Glycine 0 CA--C 1.532 1.103 0 N-CA-C 115.269 0.868 . . . . 54.219999999999999 115.269 173.184 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 729' ' ' HIS . . . . . 0.42 ' H ' ' HB3' ' A' ' 725' ' ' ASP . 21.1 m80 -109.14 104.01 13.11 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 117.897 0.849 . . . . 55.399999999999999 111.6 173.19 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 730' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -98.83 105.58 17.74 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 120.807 0.337 . . . . 72.109999999999999 110.867 177.172 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 33.9 m -106.79 153.59 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-O 120.822 0.344 . . . . 74.140000000000001 111.624 -178.2 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 9.8 t -134.94 147.86 49.88 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 112.415 0.524 . . . . 75.310000000000002 112.415 -176.469 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -148.56 149.6 31.87 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.08 0.552 . . . . 63.450000000000003 109.989 176.082 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 734' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -120.44 158.46 27.17 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 113.03 0.752 . . . . 73.420000000000002 113.03 -173.134 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 735' ' ' GLN . . . . . 0.45 ' NE2' ' HG2' ' A' ' 672' ' ' PRO . 54.0 tt0 -130.34 123.44 29.97 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.374 -0.83 . . . . 63.109999999999999 110.708 179.123 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 736' ' ' THR . . . . . 0.437 ' O ' ' HA2' ' A' ' 674' ' ' GLY . 62.2 m -92.49 103.67 16.07 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 121.056 0.455 . . . . 61.340000000000003 111.122 178.178 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 50.0 t -96.58 128.93 47.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-O 120.85 0.357 . . . . 74.409999999999997 111.411 -177.295 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 738' ' ' THR . . . . . . . . . . . . . 97.0 m -114.58 114.6 25.94 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.092 0.472 . . . . 75.120000000000005 111.642 -178.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 739' ' ' VAL . . . . . . . . . . . . . 39.3 t -93.06 135.14 28.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 CA-C-N 116.162 -0.472 . . . . 55.43 111.155 178.297 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 740' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -122.71 155.53 36.27 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.74 0.305 . . . . 71.150000000000006 111.594 -178.833 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 741' ' ' VAL . . . . . . . . . . . . . 24.1 t . . . . . 0 CA--C 1.541 0.605 0 CA-C-O 120.69 0.281 . . . . 74.409999999999997 111.586 -178.65 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 664' ' ' ASP . . . . . 0.463 ' OD2' ' HB2' ' A' ' 727' ' ' LYS . 16.2 t0 . . . . . 0 N--CA 1.467 0.376 0 CA-C-O 121.266 0.555 . . . . 75.519999999999996 111.112 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 665' ' ' LEU . . . . . . . . . . . . . 67.7 mt -99.52 126.35 45.46 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.812 -0.631 . . . . 74.329999999999998 110.412 176.693 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 666' ' ' GLU . . . . . 0.519 ' H ' ' CD ' ' A' ' 666' ' ' GLU . 0.7 OUTLIER -58.69 156.33 24.81 Favored Pre-proline 0 CA--C 1.544 0.722 0 CA-C-N 115.872 -0.604 . . . . 71.409999999999997 112.28 -179.283 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 667' ' ' PRO . . . . . 0.421 ' HD3' ' HB2' ' A' ' 725' ' ' ASP . 72.0 Cg_endo -75.17 145.29 30.71 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.276 1.984 . . . . 75.349999999999994 112.861 -175.878 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 668' ' ' LYS . . . . . . . . . . . . . 52.6 tptt -82.37 104.3 12.57 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.105 0.478 . . . . 73.319999999999993 111.001 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 669' ' ' LEU . . . . . . . . . . . . . 51.2 tp -89.91 106.58 18.57 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.271 0.557 . . . . 62.109999999999999 110.762 177.749 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 670' ' ' THR . . . . . . . . . . . . . 33.0 m -91.75 110.92 22.27 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.089 -0.505 . . . . 72.019999999999996 111.246 -177.225 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 671' ' ' VAL . . . . . 0.437 HG21 ' HB3' ' A' ' 733' ' ' ALA . 84.7 t -131.66 139.72 36.1 Favored Pre-proline 0 N--CA 1.473 0.691 0 CA-C-N 116.092 -0.504 . . . . 74.409999999999997 111.161 -176.369 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 672' ' ' PRO . . . . . 0.404 ' HD2' HG13 ' A' ' 671' ' ' VAL . 74.3 Cg_endo -76.74 149.34 29.72 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 122.418 2.079 . . . . 75.319999999999993 112.595 175.129 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 673' ' ' VAL . . . . . . . . . . . . . 12.5 p -69.57 -34.75 63.02 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 N-CA-C 112.468 0.544 . . . . 72.129999999999995 112.468 -176.428 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 674' ' ' GLY . . . . . . . . . . . . . . . 179.85 169.39 40.04 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 120.396 -0.907 . . . . 64.209999999999994 113.949 -178.337 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 675' ' ' ALA . . . . . . . . . . . . . . . -154.99 140.2 17.56 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 122.625 0.37 . . . . 61.240000000000002 111.107 179.259 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 676' ' ' THR . . . . . . . . . . . . . 86.2 m -118.71 121.22 39.6 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-O 120.713 0.292 . . . . 72.140000000000001 111.398 -179.227 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 677' ' ' ILE . . . . . . . . . . . . . 30.0 pt -129.3 174.3 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-O 120.986 0.422 . . . . 74.040000000000006 111.886 -177.882 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 678' ' ' HIS . . . . . . . . . . . . . 53.0 m80 -115.84 166.3 12.11 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.312 0.577 . . . . 32.130000000000003 111.933 178.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 679' ' ' VAL . . . . . 0.585 HG13 ' HA ' ' A' ' 712' ' ' THR . 63.2 t -56.95 111.88 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-N 115.628 -0.714 . . . . 73.329999999999998 110.643 174.003 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 123.05 -33.2 4.13 Favored Glycine 0 CA--C 1.526 0.736 0 CA-C-N 116.256 -0.429 . . . . 44.439999999999998 112.815 -175.555 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 681' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -73.48 128.26 35.01 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.095 0.474 . . . . 74.329999999999998 111.659 179.184 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 682' ' ' SER . . . . . . . . . . . . . 50.4 m -85.34 144.42 28.06 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 120.849 0.357 . . . . 61.409999999999997 110.871 176.822 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 683' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -118.08 132.38 56.36 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 120.809 0.338 . . . . 74.450000000000003 111.263 -178.401 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 684' ' ' VAL . . . . . . . . . . . . . 52.4 t -116.84 96.98 49.89 Favored Pre-proline 0 CA--C 1.544 0.72 0 CA-C-N 116.461 -0.336 . . . . 61.210000000000001 111.326 -178.176 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -77.28 -31.62 3.48 Favored 'Trans proline' 0 CA--C 1.545 1.07 0 C-N-CA 122.783 2.322 . . . . 72.549999999999997 114.461 -174.814 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 686' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.35 -12.17 59.99 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 112.303 0.482 . . . . 74.209999999999994 112.303 -174.515 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 687' ' ' ALA . . . . . . . . . . . . . . . -94.22 -27.39 16.2 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 111.91 0.337 . . . . 62.130000000000003 111.91 178.602 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 688' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -91.35 -8.22 48.7 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 112.133 0.42 . . . . 75.109999999999999 112.133 -177.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 689' ' ' VAL . . . . . 0.515 HG12 HD13 ' A' ' 703' ' ' ILE . 62.7 t -114.21 127.64 71.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-O 120.987 0.422 . . . . 75.439999999999998 111.559 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 690' ' ' LEU . . . . . 0.412 HD22 ' C ' ' A' ' 689' ' ' VAL . 3.8 mm? -123.66 155.82 37.04 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 116.247 -0.433 . . . . 71.129999999999995 111.125 179.563 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 691' ' ' ALA . . . . . . . . . . . . . . . -141.5 122.86 14.9 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 120.659 0.266 . . . . 73.150000000000006 110.865 174.737 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 692' ' ' ILE . . . . . 0.431 HD13 ' HA ' ' A' ' 698' ' ' ASP . 48.1 mm -128.68 120.48 52.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 N-CA-C 112.087 0.403 . . . . 73.209999999999994 112.087 -177.034 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -95.05 149.94 20.71 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.09 0.472 . . . . 62.25 110.692 172.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 7.5 mtpm? -77.42 -34.56 54.68 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 112.665 0.617 . . . . 61.539999999999999 112.665 -173.651 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -84.86 -54.98 4.32 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 121.828 -0.545 . . . . 73.430000000000007 112.095 177.748 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 696' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -75.93 -50.48 14.85 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 112.125 0.417 . . . . 74.400000000000006 112.125 -173.904 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . 123.94 -139.44 12.03 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 121.37 -0.443 . . . . 74.25 112.65 -175.663 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 698' ' ' ASP . . . . . 0.431 ' HA ' HD13 ' A' ' 692' ' ' ILE . 14.3 t70 -67.53 122.57 18.28 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 122.369 -0.489 . . . . 73.329999999999998 111.961 -178.739 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 699' ' ' LEU . . . . . 0.405 HD22 ' HD2' ' A' ' 702' ' ' LYS . 83.5 mt -118.49 19.44 13.33 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 116.097 -0.502 . . . . 72.420000000000002 111.1 176.087 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 89.3 m -59.52 -31.96 69.87 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 120.954 0.407 . . . . 74.209999999999994 112.067 -176.63 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 701' ' ' SER . . . . . . . . . . . . . 46.7 m -72.03 -13.58 61.64 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 120.763 0.316 . . . . 40.299999999999997 111.833 179.679 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 702' ' ' LYS . . . . . 0.405 ' HD2' HD22 ' A' ' 699' ' ' LEU . 68.8 mttm -92.98 -2.74 55.48 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 112.09 0.404 . . . . 71.230000000000004 112.09 179.513 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 703' ' ' ILE . . . . . 0.515 HD13 HG12 ' A' ' 689' ' ' VAL . 69.8 mt -68.67 119.48 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-O 121.09 0.471 . . . . 71.420000000000002 111.763 -179.777 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 704' ' ' LYS . . . . . . . . . . . . . 51.1 tptt -89.76 126.62 35.74 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.246 -0.434 . . . . 54.039999999999999 110.177 175.755 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 51.7 t -95.99 130.07 45.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-O 121.046 0.451 . . . . 45.109999999999999 112.004 -177.369 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 706' ' ' ASP . . . . . 0.581 ' HB3' ' HB ' ' A' ' 720' ' ' THR . 14.4 t70 -123.29 145.69 48.49 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.185 -0.462 . . . . 64.150000000000006 110.484 176.939 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 119.96 -153.98 16.59 Favored Glycine 0 CA--C 1.524 0.651 0 C-N-CA 121.079 -0.582 . . . . 51.240000000000002 113.32 178.78 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 708' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -166.96 141.42 3.94 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.762 0.315 . . . . 71.530000000000001 111.118 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 709' ' ' VAL . . . . . . . . . . . . . 59.9 t -127.1 110.89 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-O 120.583 0.23 . . . . 75.230000000000004 110.918 174.888 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 710' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -94.29 135.77 35.32 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 109.882 -0.414 . . . . 63.109999999999999 109.882 176.356 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 711' ' ' THR . . . . . 0.431 ' O ' ' HA ' ' A' ' 679' ' ' VAL . 71.8 p -105.77 0.04 25.79 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 122.105 -0.372 . . . . 62.509999999999998 111.98 -177.779 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 712' ' ' THR . . . . . 0.585 ' HA ' HG13 ' A' ' 679' ' ' VAL . 72.0 p -116.24 -24.25 8.05 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 116.426 -0.352 . . . . 74.129999999999995 111.777 178.29 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 713' ' ' LYS . . . . . . . . . . . . . 61.2 tttm -111.9 121.29 44.62 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 120.899 0.381 . . . . 72.109999999999999 111.119 -178.25 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 714' ' ' ALA . . . . . . . . . . . . . . . -70.21 143.88 52.08 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 112.542 0.571 . . . . 71.510000000000005 112.542 -177.017 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 156.39 162.24 11.3 Favored Glycine 0 CA--C 1.526 0.722 0 CA-C-N 115.938 -0.574 . . . . 63.240000000000002 112.509 179.156 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 716' ' ' THR . . . . . . . . . . . . . 51.6 m -98.34 122.57 41.68 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 117.311 0.556 . . . . 73.129999999999995 111.093 177.794 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 717' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -119.49 137.33 53.87 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.431 -0.35 . . . . 72.329999999999998 110.71 -178.175 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 718' ' ' VAL . . . . . . . . . . . . . 48.4 t -95.15 131.36 42.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-O 121.079 0.466 . . . . 74.409999999999997 111.606 179.505 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 719' ' ' LEU . . . . . . . . . . . . . 86.6 mt -108.53 133.67 52.35 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.055 -0.52 . . . . 65.400000000000006 110.814 177.563 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 720' ' ' THR . . . . . 0.581 ' HB ' ' HB3' ' A' ' 706' ' ' ASP . 77.3 m -117.53 130.92 56.72 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-O 120.634 0.254 . . . . 63.5 110.934 178.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 721' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -119.23 132.26 55.91 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 120.672 0.272 . . . . 63.420000000000002 111.118 -178.511 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 97.8 m -128.33 139.47 52.39 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 111.686 0.254 . . . . 62.109999999999999 111.686 -179.115 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 13.8 p -141.27 147.2 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 CA-C-O 120.937 0.399 . . . . 75.239999999999995 111.244 178.103 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 18.7 m -110.97 144.95 39.26 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.035 0.445 . . . . 73.510000000000005 111.999 -176.452 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 725' ' ' ASP . . . . . 0.723 ' HB3' ' H ' ' A' ' 729' ' ' HIS . 7.5 t70 -74.11 168.46 19.52 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.041 0.536 . . . . 50.229999999999997 111.222 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 726' ' ' SER . . . . . . . . . . . . . 34.1 t -68.65 -30.83 69.62 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 120.78 0.324 . . . . 74.019999999999996 110.985 174.356 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 727' ' ' LYS . . . . . 0.463 ' HB2' ' OD2' ' A' ' 664' ' ' ASP . 4.1 mptp? -96.47 -9.44 29.7 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 112.62 0.6 . . . . 71.430000000000007 112.62 177.423 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 728' ' ' GLY . . . . . . . . . . . . . . . 113.15 22.38 5.6 Favored Glycine 0 CA--C 1.535 1.332 0 N-CA-C 116.111 1.204 . . . . 50.140000000000001 116.111 173.155 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 729' ' ' HIS . . . . . 0.723 ' H ' ' HB3' ' A' ' 725' ' ' ASP . 46.5 m80 -83.67 119.98 25.43 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 118.117 0.958 . . . . 74.230000000000004 110.949 169.411 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 730' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -103.56 119.76 39.54 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 120.823 0.344 . . . . 73.510000000000005 111.692 -179.161 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 35.1 m -120.65 157.43 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-O 120.733 0.301 . . . . 55.149999999999999 111.234 179.064 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 9.6 t -146.91 147.88 31.22 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.545 0.572 . . . . 72.420000000000002 112.545 -177.401 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 733' ' ' ALA . . . . . 0.437 ' HB3' HG21 ' A' ' 671' ' ' VAL . . . -141.73 161.9 36.8 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 116.042 -0.527 . . . . 60.140000000000001 110.91 -179.677 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 734' ' ' LYS . . . . . . . . . . . . . 42.8 mtmt -128.9 150.8 50.2 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 112.872 0.693 . . . . 44.140000000000001 112.872 -173.038 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 735' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -130.75 140.65 50.33 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 115.423 -0.808 . . . . 73.409999999999997 110.662 177.866 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 736' ' ' THR . . . . . . . . . . . . . 92.4 m -109.85 107.76 17.83 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 112.221 0.452 . . . . 72.329999999999998 112.221 -178.191 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 57.5 t -102.47 131.67 50.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 O-C-N 122.16 -0.338 . . . . 71.109999999999999 111.787 -178.679 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 738' ' ' THR . . . . . . . . . . . . . 91.7 m -119.13 118.46 31.44 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 120.788 0.327 . . . . 60.119999999999997 111.522 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 739' ' ' VAL . . . . . . . . . . . . . 41.7 t -102.88 139.1 24.73 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 CA-C-O 120.67 0.271 . . . . 73.120000000000005 111.418 178.88 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 740' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -128.91 157.68 40.91 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 120.931 0.396 . . . . 73.329999999999998 111.76 179.396 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 741' ' ' VAL . . . . . 0.404 ' HA ' HG23 ' A' ' 679' ' ' VAL . 9.6 t . . . . . 0 N--CA 1.472 0.654 0 CA-C-N 116.551 -0.295 . . . . 71.420000000000002 111.585 -176.489 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 664' ' ' ASP . . . . . . . . . . . . . 16.6 t70 . . . . . 0 N--CA 1.467 0.381 0 CA-C-O 121.644 0.735 . . . . 73.430000000000007 112.504 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 665' ' ' LEU . . . . . . . . . . . . . 72.6 mt -101.49 137.68 39.49 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-N 115.019 -0.991 . . . . 55.030000000000001 110.876 177.838 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 666' ' ' GLU . . . . . 0.502 ' HG3' ' HB3' ' A' ' 729' ' ' HIS . 19.7 mp0 -71.11 150.09 94.64 Favored Pre-proline 0 CA--C 1.538 0.497 0 CA-C-N 116.121 -0.491 . . . . 74.219999999999999 110.505 177.427 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 667' ' ' PRO . . . . . 0.559 ' HB3' HD12 ' A' ' 699' ' ' LEU . 37.5 Cg_endo -65.1 133.19 34.55 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 122.103 1.869 . . . . 73.519999999999996 112.345 179.092 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 668' ' ' LYS . . . . . . . . . . . . . 56.1 tptt -82.18 106.98 14.51 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 121.173 0.511 . . . . 73.340000000000003 110.56 179.143 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 669' ' ' LEU . . . . . 0.516 ' HG ' HG23 ' A' ' 671' ' ' VAL . 60.0 tp -89.39 106.04 18.19 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.709 -0.678 . . . . 53.409999999999997 110.912 -178.614 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 670' ' ' THR . . . . . . . . . . . . . 86.3 m -86.37 110.4 19.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.034 0.445 . . . . 74.25 110.828 179.004 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 671' ' ' VAL . . . . . 0.516 HG23 ' HG ' ' A' ' 669' ' ' LEU . 94.8 t -127.55 127.94 24.03 Favored Pre-proline 0 CA--C 1.536 0.418 0 CA-C-N 116.032 -0.531 . . . . 74.329999999999998 111.021 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 672' ' ' PRO . . . . . 0.425 ' HG2' ' NE2' ' A' ' 735' ' ' GLN . 33.4 Cg_endo -64.48 154.2 73.03 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 122.305 2.003 . . . . 72.420000000000002 111.929 178.248 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 673' ' ' VAL . . . . . . . . . . . . . 10.1 p -81.5 -34.39 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 O-C-N 122.145 -0.347 . . . . 74.239999999999995 111.89 -176.429 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 674' ' ' GLY . . . . . 0.418 ' HA2' ' O ' ' A' ' 736' ' ' THR . . . -162.54 163.88 35.36 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 121.094 -0.574 . . . . 64.430000000000007 113.579 -178.173 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 675' ' ' ALA . . . . . . . . . . . . . . . -156.3 118.28 3.97 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 120.694 0.283 . . . . 71.209999999999994 111.747 179.284 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 676' ' ' THR . . . . . . . . . . . . . 88.7 m -97.43 126.14 42.5 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 120.648 0.261 . . . . 73.049999999999997 111.591 178.895 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 677' ' ' ILE . . . . . 0.416 HG13 HG22 ' A' ' 739' ' ' VAL . 20.1 pt -138.52 176.44 6.62 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 C-N-CA 122.514 0.325 . . . . 71.430000000000007 111.288 179.391 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 678' ' ' HIS . . . . . 0.541 ' O ' ' HB2' ' A' ' 681' ' ' ASP . 72.1 m80 -114.93 177.21 4.73 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 121.396 0.617 . . . . 53.229999999999997 112.574 -179.6 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 679' ' ' VAL . . . . . 0.481 HG23 ' HA ' ' A' ' 741' ' ' VAL . 96.1 t -66.45 122.13 16.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-N 116.004 -0.544 . . . . 75.209999999999994 110.957 174.154 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 86.1 18.31 59.55 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 121.218 -0.515 . . . . 70.439999999999998 112.825 -176.028 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 681' ' ' ASP . . . . . 0.541 ' HB2' ' O ' ' A' ' 678' ' ' HIS . 1.1 t70 -83.09 -175.32 5.78 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-O 120.882 0.373 . . . . 70.109999999999999 111.295 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 682' ' ' SER . . . . . . . . . . . . . 69.7 m -123.12 140.66 52.8 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 122.418 0.287 . . . . 53.340000000000003 111.314 179.285 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 683' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -154.61 125.38 7.07 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 116.494 -0.321 . . . . 73.530000000000001 110.87 -178.339 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 684' ' ' VAL . . . . . . . . . . . . . 38.6 t -125.38 93.57 44.77 Favored Pre-proline 0 CA--C 1.546 0.789 0 CA-C-O 121.022 0.439 . . . . 65.510000000000005 111.926 -177.318 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -61.27 -36.81 77.78 Favored 'Trans proline' 0 CA--C 1.545 1.028 0 C-N-CA 122.725 2.283 . . . . 53.109999999999999 113.576 -177.869 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 686' ' ' MET . . . . . . . . . . . . . 1.9 mmt -78.82 4.08 14.98 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 112.573 0.582 . . . . 65.510000000000005 112.573 -176.766 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 687' ' ' ALA . . . . . . . . . . . . . . . -119.21 -40.65 2.8 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.18 0.514 . . . . 54.450000000000003 111.211 174.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 688' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -71.93 -24.91 61.71 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 116.2 -0.455 . . . . 75.540000000000006 111.998 179.202 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 689' ' ' VAL . . . . . 0.427 HG13 HG22 ' A' ' 671' ' ' VAL . 63.7 t -96.91 144.48 10.49 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 CA-C-O 120.677 0.275 . . . . 51.009999999999998 110.802 174.258 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 690' ' ' LEU . . . . . 0.45 HD23 ' N ' ' A' ' 691' ' ' ALA . 10.5 tt -142.66 149.55 39.04 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 120.475 0.178 . . . . 61.240000000000002 111.105 -174.302 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 691' ' ' ALA . . . . . 0.45 ' N ' HD23 ' A' ' 690' ' ' LEU . . . -144.22 132.78 22.21 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 112.085 0.402 . . . . 42.5 112.085 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 692' ' ' ILE . . . . . 0.576 HD13 ' HA ' ' A' ' 698' ' ' ASP . 43.7 mm -133.97 132.91 56.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 N-CA-C 112.039 0.385 . . . . 63.25 112.039 -178.83 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 693' ' ' ASP . . . . . 0.46 ' OD1' ' HG2' ' A' ' 695' ' ' GLU . 7.7 t70 -110.68 149.21 30.79 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 109.714 -0.476 . . . . 65.530000000000001 109.714 171.162 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -69.41 -29.3 67.0 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 111.894 0.331 . . . . 70.140000000000001 111.894 -177.432 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 695' ' ' GLU . . . . . 0.46 ' HG2' ' OD1' ' A' ' 693' ' ' ASP . 12.2 pt-20 -81.72 -46.37 14.38 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 112.189 0.441 . . . . 74.040000000000006 112.189 -175.789 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 696' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -95.53 -48.85 5.66 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.138 0.494 . . . . 73.349999999999994 111.683 -174.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . 119.22 -119.28 4.25 Favored Glycine 0 CA--C 1.525 0.658 0 CA-C-N 116.006 -0.543 . . . . 50.350000000000001 112.423 -175.334 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 698' ' ' ASP . . . . . 0.576 ' HA ' HD13 ' A' ' 692' ' ' ILE . 12.9 t70 -74.88 116.36 15.51 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 122.372 -0.487 . . . . 74.0 111.757 -178.082 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 699' ' ' LEU . . . . . 0.559 HD12 ' HB3' ' A' ' 667' ' ' PRO . 57.8 mt -114.54 22.95 13.17 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 116.108 -0.497 . . . . 63.310000000000002 110.944 174.25 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 37.7 m -60.54 -37.39 81.05 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 120.979 0.419 . . . . 55.530000000000001 111.823 -176.675 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 701' ' ' SER . . . . . . . . . . . . . 70.6 m -74.51 -10.9 60.0 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 120.848 0.356 . . . . 71.430000000000007 111.794 177.607 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 702' ' ' LYS . . . . . 0.458 ' HG3' HD22 ' A' ' 699' ' ' LEU . 48.0 mmtm -90.88 7.22 41.08 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 120.831 0.348 . . . . 72.340000000000003 111.433 -178.413 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 703' ' ' ILE . . . . . 0.423 HD13 HG12 ' A' ' 689' ' ' VAL . 66.4 mt -87.24 117.73 31.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 CA-C-O 121.234 0.54 . . . . 75.329999999999998 112.421 -177.37 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 704' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -84.68 135.39 34.18 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.959 -0.564 . . . . 55.130000000000003 110.546 173.033 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 56.2 t -107.98 143.58 18.19 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-O 120.844 0.354 . . . . 74.299999999999997 111.954 -177.352 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 706' ' ' ASP . . . . . 0.503 ' HB3' ' HB ' ' A' ' 720' ' ' THR . 24.7 t70 -129.05 143.5 50.89 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 122.713 0.405 . . . . 75.349999999999994 110.673 175.103 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 93.36 174.38 40.36 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 121.315 -0.469 . . . . 64.239999999999995 112.516 -174.945 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 708' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -152.07 137.9 18.01 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 122.259 -0.554 . . . . 73.140000000000001 112.157 -179.118 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 709' ' ' VAL . . . . . . . . . . . . . 89.3 t -106.68 114.97 47.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-O 120.94 0.4 . . . . 73.129999999999995 111.466 178.678 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 710' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -82.43 136.87 34.84 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 116.472 -0.331 . . . . 73.510000000000005 110.881 176.656 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 711' ' ' THR . . . . . . . . . . . . . 78.9 p -97.4 -31.88 12.15 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 112.326 0.491 . . . . 64.040000000000006 112.326 -176.655 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 712' ' ' THR . . . . . . . . . . . . . 51.0 p -85.42 -0.16 54.03 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.547 0.573 . . . . 60.100000000000001 112.547 -177.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 713' ' ' LYS . . . . . . . . . . . . . 23.0 tptp -140.3 132.4 27.97 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.705 0.288 . . . . 73.209999999999994 110.964 -178.065 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 714' ' ' ALA . . . . . . . . . . . . . . . -75.65 144.69 41.53 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 112.046 0.388 . . . . 63.229999999999997 112.046 -177.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 162.09 164.35 16.85 Favored Glycine 0 CA--C 1.523 0.591 0 C-N-CA 121.219 -0.515 . . . . 52.009999999999998 112.828 179.38 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 716' ' ' THR . . . . . . . . . . . . . 54.8 m -95.73 123.23 39.2 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.119 0.485 . . . . 52.229999999999997 111.434 178.228 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 717' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -120.75 110.59 16.56 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 116.109 -0.496 . . . . 75.219999999999999 110.659 -179.101 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 718' ' ' VAL . . . . . . . . . . . . . 48.8 t -90.58 107.82 18.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-O 121.082 0.467 . . . . 75.129999999999995 111.059 179.25 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 719' ' ' LEU . . . . . . . . . . . . . 59.9 mt -89.52 150.43 22.45 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.128 -0.487 . . . . 75.239999999999995 111.968 -176.643 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 720' ' ' THR . . . . . 0.503 ' HB ' ' HB3' ' A' ' 706' ' ' ASP . 92.2 m -121.87 135.85 54.91 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 116.412 -0.358 . . . . 64.140000000000001 110.902 177.276 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 721' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -122.08 142.72 50.08 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.929 0.395 . . . . 62.399999999999999 111.463 -178.157 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 69.9 m -138.71 135.12 34.43 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 122.399 0.28 . . . . 72.019999999999996 111.138 -179.691 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 10.9 p -128.3 144.27 38.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 O-C-N 122.233 -0.292 . . . . 71.510000000000005 111.14 178.481 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 28.8 m -110.7 144.01 40.29 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.434 0.635 . . . . 73.239999999999995 112.214 -177.48 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 725' ' ' ASP . . . . . 0.449 ' HB3' ' H ' ' A' ' 729' ' ' HIS . 45.2 t0 -91.74 151.74 20.49 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.916 0.886 . . . . 73.530000000000001 110.25 -179.824 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 726' ' ' SER . . . . . 0.446 ' HB3' ' OE2' ' A' ' 695' ' ' GLU . 48.0 t -64.95 -22.71 67.04 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.161 0.505 . . . . 73.310000000000002 110.846 177.602 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 727' ' ' LYS . . . . . . . . . . . . . 27.5 mmtp -90.29 -6.33 55.26 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 116.187 -0.461 . . . . 73.329999999999998 111.885 177.279 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 728' ' ' GLY . . . . . . . . . . . . . . . 109.25 -5.84 31.94 Favored Glycine 0 CA--C 1.531 1.044 0 N-CA-C 114.776 0.671 . . . . 62.530000000000001 114.776 176.647 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 729' ' ' HIS . . . . . 0.502 ' HB3' ' HG3' ' A' ' 666' ' ' GLU . 39.7 m80 -68.91 138.35 54.57 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 117.933 0.866 . . . . 62.039999999999999 111.028 179.284 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 730' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -133.65 130.92 38.92 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 120.832 0.349 . . . . 75.219999999999999 111.77 -178.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 26.9 m -131.48 160.87 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-N 116.342 -0.39 . . . . 74.400000000000006 111.625 -179.278 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 2.8 t -142.64 146.91 34.96 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 112.771 0.656 . . . . 61.119999999999997 112.771 -174.725 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -148.66 154.45 39.68 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 116.103 -0.499 . . . . 65.010000000000005 110.741 178.193 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 734' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -123.02 159.66 27.93 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 113.367 0.877 . . . . 74.430000000000007 113.367 -174.297 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 735' ' ' GLN . . . . . 0.425 ' NE2' ' HG2' ' A' ' 672' ' ' PRO . 46.9 tt0 -138.25 137.7 37.76 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 115.326 -0.852 . . . . 71.030000000000001 110.988 179.318 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 736' ' ' THR . . . . . 0.418 ' O ' ' HA2' ' A' ' 674' ' ' GLY . 99.0 m -103.36 106.48 17.0 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 121.01 0.433 . . . . 70.120000000000005 111.934 178.619 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 45.1 t -96.64 140.91 16.41 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 116.626 -0.261 . . . . 73.209999999999994 110.643 177.663 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 738' ' ' THR . . . . . . . . . . . . . 87.5 m -132.88 114.14 13.7 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 122.001 -0.437 . . . . 24.350000000000001 111.645 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 739' ' ' VAL . . . . . 0.416 HG22 HG13 ' A' ' 677' ' ' ILE . 52.8 t -93.28 137.07 23.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-N 116.212 -0.449 . . . . 61.109999999999999 110.829 177.504 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 740' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -123.01 149.45 44.3 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.117 0.484 . . . . 73.209999999999994 111.559 179.576 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 741' ' ' VAL . . . . . 0.481 ' HA ' HG23 ' A' ' 679' ' ' VAL . 26.9 t . . . . . 0 CA--C 1.539 0.542 0 CA-C-N 116.288 -0.415 . . . . 53.100000000000001 111.419 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 664' ' ' ASP . . . . . . . . . . . . . 26.1 t0 . . . . . 0 N--CA 1.473 0.706 0 CA-C-O 121.456 0.646 . . . . 73.200000000000003 111.995 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 665' ' ' LEU . . . . . . . . . . . . . 89.2 mt -96.04 138.32 33.83 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.749 -0.66 . . . . 74.319999999999993 111.196 178.877 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 666' ' ' GLU . . . . . 0.528 ' H ' ' CD ' ' A' ' 666' ' ' GLU . 0.8 OUTLIER -82.22 140.11 45.62 Favored Pre-proline 0 CA--C 1.541 0.625 0 CA-C-N 116.01 -0.541 . . . . 71.030000000000001 110.872 174.974 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 667' ' ' PRO . . . . . 0.536 ' HB3' HD12 ' A' ' 699' ' ' LEU . 42.3 Cg_endo -65.79 138.3 52.87 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 122.715 2.277 . . . . 71.239999999999995 113.869 -171.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 668' ' ' LYS . . . . . . . . . . . . . 28.9 ttpp -82.9 107.68 15.69 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.905 -0.588 . . . . 72.439999999999998 110.747 177.19 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 669' ' ' LEU . . . . . 0.443 ' HG ' HG23 ' A' ' 671' ' ' VAL . 55.3 tp -100.78 112.48 24.9 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 121.146 0.498 . . . . 74.530000000000001 111.176 -178.633 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 670' ' ' THR . . . . . . . . . . . . . 94.7 m -93.47 111.48 23.16 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.962 0.41 . . . . 53.43 111.115 179.533 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 671' ' ' VAL . . . . . 0.443 HG23 ' HG ' ' A' ' 669' ' ' LEU . 73.8 t -137.49 137.24 21.64 Favored Pre-proline 0 CA--C 1.54 0.569 0 CA-C-N 115.767 -0.651 . . . . 64.400000000000006 110.843 -178.237 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 672' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -73.93 139.56 27.48 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 122.098 1.865 . . . . 65.530000000000001 112.015 174.688 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 673' ' ' VAL . . . . . . . . . . . . . 10.9 p -79.9 -29.64 12.9 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 CA-C-O 120.955 0.407 . . . . 71.140000000000001 112.017 -177.058 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 674' ' ' GLY . . . . . . . . . . . . . . . -158.89 142.65 8.53 Favored Glycine 0 CA--C 1.523 0.563 0 C-N-CA 120.804 -0.713 . . . . 52.509999999999998 113.263 179.336 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 675' ' ' ALA . . . . . . . . . . . . . . . -142.7 121.14 12.41 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 120.844 0.354 . . . . 50.409999999999997 111.709 -178.409 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 676' ' ' THR . . . . . . . . . . . . . 62.4 m -101.41 119.0 38.1 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.701 0.286 . . . . 74.140000000000001 110.923 179.148 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 677' ' ' ILE . . . . . . . . . . . . . 32.1 pt -125.36 177.01 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-O 121.095 0.474 . . . . 54.210000000000001 111.333 -179.612 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 678' ' ' HIS . . . . . . . . . . . . . 65.6 m80 -116.99 157.94 24.94 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 121.133 0.492 . . . . 63.420000000000002 111.754 179.595 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 679' ' ' VAL . . . . . 0.478 HG13 ' HA ' ' A' ' 712' ' ' THR . 95.9 t -57.37 116.35 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 116.093 -0.503 . . . . 70.340000000000003 110.526 174.307 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 117.44 -22.36 10.24 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 121.294 -0.479 . . . . 55.43 112.682 -175.47 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 681' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -62.79 150.26 41.95 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.537 0.684 . . . . 73.340000000000003 112.697 178.791 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 682' ' ' SER . . . . . . . . . . . . . 99.9 p -90.64 146.07 24.33 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 115.373 -0.83 . . . . 50.439999999999998 110.162 171.089 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 683' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -150.1 112.26 4.63 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 120.974 0.416 . . . . 74.530000000000001 111.628 -178.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 684' ' ' VAL . . . . . . . . . . . . . 58.5 t -115.33 98.93 51.7 Favored Pre-proline 0 CA--C 1.543 0.679 0 CA-C-O 120.953 0.406 . . . . 73.150000000000006 111.198 178.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -63.44 -25.89 70.65 Favored 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 122.673 2.249 . . . . 74.340000000000003 113.144 -177.301 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 686' ' ' MET . . . . . 0.404 ' HA ' ' CE ' ' A' ' 686' ' ' MET . 0.0 OUTLIER -87.29 11.32 14.59 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.265 0.469 . . . . 74.219999999999999 112.265 179.57 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 687' ' ' ALA . . . . . . . . . . . . . . . -119.43 -32.43 4.35 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.908 0.385 . . . . 71.319999999999993 111.396 175.817 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 688' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -90.92 9.72 29.35 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 112.289 0.477 . . . . 75.140000000000001 112.289 -178.89 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 94.2 t -125.76 139.19 52.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 122.56 0.344 . . . . 73.420000000000002 110.93 177.129 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 690' ' ' LEU . . . . . 0.478 HD23 ' N ' ' A' ' 691' ' ' ALA . 2.3 tt -142.73 133.06 24.77 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-O 120.691 0.281 . . . . 73.200000000000003 111.121 -176.06 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 691' ' ' ALA . . . . . 0.478 ' N ' HD23 ' A' ' 690' ' ' LEU . . . -126.63 125.52 42.05 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 112.465 0.543 . . . . 63.329999999999998 112.465 -178.042 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 692' ' ' ILE . . . . . 0.528 HD13 ' HA ' ' A' ' 698' ' ' ASP . 43.4 mm -134.36 132.11 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 CA-C-N 116.418 -0.356 . . . . 75.209999999999994 111.813 -179.083 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -107.98 129.63 55.1 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 109.194 -0.669 . . . . 63.100000000000001 109.194 168.632 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -60.24 -29.12 68.57 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 112.362 0.504 . . . . 63.399999999999999 112.362 -173.338 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 695' ' ' GLU . . . . . 0.406 ' HG3' ' N ' ' A' ' 696' ' ' ASP . 12.1 pt-20 -78.84 -45.87 19.86 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 120.999 0.428 . . . . 74.400000000000006 111.909 -179.741 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 696' ' ' ASP . . . . . 0.406 ' N ' ' HG3' ' A' ' 695' ' ' GLU . 10.2 t70 -94.07 -48.57 6.17 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.993 0.425 . . . . 74.109999999999999 111.455 -171.769 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . 124.02 -131.98 8.19 Favored Glycine 0 CA--C 1.524 0.614 0 CA-C-N 116.263 -0.426 . . . . 71.439999999999998 112.977 -178.086 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 698' ' ' ASP . . . . . 0.528 ' HA ' HD13 ' A' ' 692' ' ' ILE . 32.0 t70 -72.33 119.8 17.04 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 112.301 0.482 . . . . 75.230000000000004 112.301 -178.577 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 699' ' ' LEU . . . . . 0.536 HD12 ' HB3' ' A' ' 667' ' ' PRO . 62.4 mt -118.06 14.59 14.09 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 120.981 0.42 . . . . 73.400000000000006 110.873 175.895 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 81.2 m -60.01 -33.77 72.44 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.293 0.479 . . . . 70.450000000000003 112.293 -178.043 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 701' ' ' SER . . . . . . . . . . . . . 32.2 t -70.29 -16.7 63.05 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.196 0.522 . . . . 73.099999999999994 111.377 177.538 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 702' ' ' LYS . . . . . 0.535 ' HD2' HD22 ' A' ' 699' ' ' LEU . 67.5 mttm -91.88 6.38 46.38 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.197 -0.456 . . . . 62.039999999999999 111.769 179.592 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 703' ' ' ILE . . . . . 0.447 HG12 ' HB ' ' A' ' 723' ' ' VAL . 67.0 mt -82.3 133.87 28.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-O 120.946 0.403 . . . . 70.329999999999998 111.326 177.361 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 704' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -112.74 126.93 55.95 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.474 -0.33 . . . . 73.239999999999995 110.534 174.189 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 61.7 t -98.66 124.29 51.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-O 120.914 0.388 . . . . 72.140000000000001 111.605 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 706' ' ' ASP . . . . . 0.46 ' HB3' ' HB ' ' A' ' 720' ' ' THR . 37.3 t70 -109.95 143.25 40.16 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 116.26 -0.427 . . . . 64.120000000000005 110.658 174.4 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 94.16 166.76 37.02 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 121.015 -0.612 . . . . 53.109999999999999 113.102 -178.87 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 708' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -149.52 152.61 35.85 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 120.925 0.393 . . . . 63.509999999999998 111.473 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 709' ' ' VAL . . . . . 0.458 HG22 ' HB2' ' A' ' 717' ' ' TYR . 67.2 t -121.63 135.71 60.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 CA-C-N 116.498 -0.319 . . . . 61.539999999999999 111.608 -177.773 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 710' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -86.82 136.13 33.09 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.805 0.336 . . . . 74.519999999999996 110.824 173.174 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 711' ' ' THR . . . . . . . . . . . . . 68.3 p -106.4 4.04 28.03 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.124 0.488 . . . . 64.349999999999994 110.758 176.535 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 712' ' ' THR . . . . . 0.478 ' HA ' HG13 ' A' ' 679' ' ' VAL . 71.2 p -112.2 -11.76 13.72 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.91 -0.586 . . . . 72.25 112.255 -178.152 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 713' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -132.63 132.57 42.61 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.619 -0.264 . . . . 72.409999999999997 110.711 -178.117 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 714' ' ' ALA . . . . . 0.471 ' HB2' HG23 ' A' ' 741' ' ' VAL . . . -70.38 141.78 52.16 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 112.244 0.461 . . . . 74.319999999999993 112.244 -178.429 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 152.56 170.38 18.93 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 121.072 -0.585 . . . . 61.200000000000003 113.452 179.272 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 716' ' ' THR . . . . . . . . . . . . . 91.8 m -93.5 130.47 39.33 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 120.961 0.41 . . . . 55.229999999999997 111.668 177.587 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 717' ' ' TYR . . . . . 0.458 ' HB2' HG22 ' A' ' 709' ' ' VAL . 45.2 m-85 -128.16 139.74 52.31 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 122.763 0.425 . . . . 73.510000000000005 110.398 179.693 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 718' ' ' VAL . . . . . . . . . . . . . 45.3 t -105.86 140.59 23.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 N-CA-C 112.316 0.488 . . . . 74.219999999999999 112.316 -175.137 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 719' ' ' LEU . . . . . 0.418 HD21 HG23 ' A' ' 709' ' ' VAL . 85.3 mt -128.22 139.33 52.51 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 116.126 -0.488 . . . . 73.319999999999993 111.536 178.742 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 720' ' ' THR . . . . . 0.46 ' HB ' ' HB3' ' A' ' 706' ' ' ASP . 96.5 m -120.51 139.26 53.16 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 120.814 0.34 . . . . 64.340000000000003 111.218 178.003 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 721' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -128.13 126.77 41.75 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 116.676 -0.238 . . . . 74.400000000000006 110.825 -178.813 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 85.0 m -132.13 135.09 46.15 Favored 'General case' 0 N--CA 1.475 0.818 0 O-C-N 122.416 -0.178 . . . . 74.099999999999994 111.476 -178.834 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 723' ' ' VAL . . . . . 0.447 ' HB ' HG12 ' A' ' 703' ' ' ILE . 7.5 p -130.45 137.64 55.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-O 121.032 0.444 . . . . 74.340000000000003 111.529 179.771 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 24.1 m -106.56 127.91 53.7 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.129 0.418 . . . . 72.230000000000004 112.129 -177.306 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 725' ' ' ASP . . . . . 0.488 ' HB2' ' HD3' ' A' ' 667' ' ' PRO . 1.1 t70 -81.59 150.95 27.91 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 122.945 0.498 . . . . 73.010000000000005 111.569 176.373 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 726' ' ' SER . . . . . . . . . . . . . 48.9 m -58.24 -34.08 70.05 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 112.57 0.581 . . . . 72.010000000000005 112.57 -176.087 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 727' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -85.76 -8.54 58.08 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 112.501 0.556 . . . . 72.230000000000004 112.501 -178.615 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 728' ' ' GLY . . . . . . . . . . . . . . . 113.1 14.3 10.09 Favored Glycine 0 CA--C 1.535 1.294 0 N-CA-C 115.255 0.862 . . . . 74.310000000000002 115.255 175.443 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 729' ' ' HIS . . . . . 0.419 ' O ' ' HB3' ' A' ' 725' ' ' ASP . 13.5 m80 -89.79 108.51 19.74 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 117.908 0.854 . . . . 74.319999999999993 111.229 172.518 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 730' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -108.17 113.88 27.35 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 120.811 0.338 . . . . 72.329999999999998 111.292 -178.554 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 731' ' ' VAL . . . . . 0.446 HG22 ' HG2' ' A' ' 667' ' ' PRO . 17.8 m -112.45 159.15 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 CA-C-O 120.624 0.249 . . . . 63.009999999999998 111.517 -177.675 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 8.8 t -147.14 151.94 37.62 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 112.746 0.647 . . . . 55.409999999999997 112.746 -177.311 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -148.25 161.34 41.69 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.933 -0.576 . . . . 74.549999999999997 110.424 178.398 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 734' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -130.64 159.59 36.74 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 112.901 0.704 . . . . 72.310000000000002 112.901 -175.547 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 735' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -134.03 128.41 34.27 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.581 -0.736 . . . . 72.340000000000003 111.075 178.788 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 736' ' ' THR . . . . . . . . . . . . . 74.3 m -99.52 107.41 19.58 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 120.918 0.39 . . . . 54.219999999999999 111.108 175.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 47.4 t -97.04 141.11 16.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-O 120.71 0.291 . . . . 72.239999999999995 111.414 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 738' ' ' THR . . . . . . . . . . . . . 85.9 m -131.32 120.91 23.82 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 122.093 -0.379 . . . . 71.430000000000007 110.917 177.205 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 739' ' ' VAL . . . . . . . . . . . . . 38.4 t -101.18 133.6 43.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 N-CA-C 111.831 0.308 . . . . 62.549999999999997 111.831 -177.321 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 740' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -120.89 149.93 41.85 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 120.811 0.339 . . . . 70.239999999999995 111.509 177.158 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 741' ' ' VAL . . . . . 0.471 HG23 ' HB2' ' A' ' 714' ' ' ALA . 21.2 t . . . . . 0 CA--C 1.541 0.626 0 O-C-N 122.277 -0.264 . . . . 53.340000000000003 110.72 176.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 657' ' ' MET . . . . . 0.577 ' N ' ' SD ' ' A' ' 657' ' ' MET . 3.1 mpp? . . . . . 0 N--CA 1.492 1.65 0 N-CA-C 110.584 -0.154 . . . . 74.439999999999998 110.584 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 658' ' ' GLY . . . . . . . . . . . . . . . 160.15 178.43 34.14 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 120.709 -0.758 . . . . 53.420000000000002 113.482 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 659' ' ' ASN . . . . . . . . . . . . . 38.1 m-80 -133.05 155.82 48.51 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.953 0.406 . . . . 73.510000000000005 111.524 -178.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 660' ' ' GLY . . . . . . . . . . . . . . . -117.45 135.07 11.56 Favored Glycine 0 CA--C 1.526 0.771 0 CA-C-N 116.315 -0.402 . . . . 62.140000000000001 112.157 175.428 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -70.34 83.48 0.56 Allowed 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.131 0.491 . . . . 71.140000000000001 111.926 -179.001 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 662' ' ' THR . . . . . . . . . . . . . 73.3 p -92.6 131.59 37.58 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.297 -0.41 . . . . 50.340000000000003 110.804 174.125 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 663' ' ' SER . . . . . . . . . . . . . 49.9 m -65.67 94.02 0.19 Allowed 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 111.755 0.28 . . . . 75.25 111.755 -178.43 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 664' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -73.49 124.52 26.0 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.098 0.475 . . . . 52.200000000000003 111.022 178.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 665' ' ' LEU . . . . . . . . . . . . . 86.0 mt -80.77 136.52 36.15 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.033 -0.53 . . . . 75.549999999999997 110.448 174.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 666' ' ' GLU . . . . . 0.473 ' H ' ' CD ' ' A' ' 666' ' ' GLU . 2.3 pm0 -70.25 140.67 88.02 Favored Pre-proline 0 CA--C 1.538 0.486 0 CA-C-N 116.322 -0.399 . . . . 73.530000000000001 110.575 177.311 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 667' ' ' PRO . . . . . 0.534 ' HB3' HD12 ' A' ' 699' ' ' LEU . 19.1 Cg_endo -56.64 135.94 73.27 Favored 'Trans proline' 0 CA--C 1.537 0.668 0 C-N-CA 122.7 2.267 . . . . 61.350000000000001 113.593 -171.167 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 668' ' ' LYS . . . . . . . . . . . . . 27.4 tptp -82.8 105.09 13.53 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.048 -0.524 . . . . 73.209999999999994 110.527 176.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 669' ' ' LEU . . . . . 0.421 ' HG ' HG23 ' A' ' 671' ' ' VAL . 56.8 tp -91.65 128.38 37.46 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.957 -0.565 . . . . 55.420000000000002 110.045 175.635 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 670' ' ' THR . . . . . . . . . . . . . 89.5 m -113.93 110.78 20.62 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.122 0.487 . . . . 43.340000000000003 111.151 178.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 671' ' ' VAL . . . . . 0.503 HG22 HG13 ' A' ' 689' ' ' VAL . 97.8 t -135.09 131.98 20.02 Favored Pre-proline 0 CA--C 1.54 0.586 0 CA-C-N 115.63 -0.713 . . . . 62.109999999999999 110.759 -177.303 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 672' ' ' PRO . . . . . 0.403 ' HG2' ' NE2' ' A' ' 735' ' ' GLN . 61.0 Cg_endo -73.62 121.76 7.32 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 122.239 1.959 . . . . 72.150000000000006 111.997 176.094 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 673' ' ' VAL . . . . . . . . . . . . . 14.7 p -64.15 -26.51 40.62 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 N-CA-C 112.286 0.476 . . . . 54.539999999999999 112.286 -175.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 674' ' ' GLY . . . . . . . . . . . . . . . -148.94 139.35 7.46 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 120.864 -0.684 . . . . 55.399999999999999 113.653 -179.113 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 675' ' ' ALA . . . . . . . . . . . . . . . -137.29 151.48 48.71 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 122.799 0.44 . . . . 62.409999999999997 110.937 178.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 676' ' ' THR . . . . . . . . . . . . . 88.4 m -138.84 119.16 13.67 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 122.155 -0.341 . . . . 71.400000000000006 111.48 179.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 677' ' ' ILE . . . . . . . . . . . . . 33.6 pt -131.04 176.55 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 CA-C-O 120.91 0.386 . . . . 72.340000000000003 111.323 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 678' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -109.22 163.71 13.11 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.337 0.589 . . . . 54.240000000000002 112.502 -178.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 679' ' ' VAL . . . . . . . . . . . . . 91.4 t -63.55 115.77 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-N 115.753 -0.658 . . . . 71.299999999999997 111.031 174.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 99.74 0.52 56.43 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 121.472 -0.394 . . . . 35.109999999999999 112.935 -177.41 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 681' ' ' ASP . . . . . . . . . . . . . 35.3 t0 -88.8 157.48 18.47 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-O 121.17 0.509 . . . . 72.340000000000003 111.759 -178.42 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 682' ' ' SER . . . . . . . . . . . . . 91.3 p -82.37 144.84 30.25 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 116.099 -0.5 . . . . 53.009999999999998 112.0 -177.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 683' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -148.58 114.16 5.64 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 116.605 -0.27 . . . . 71.340000000000003 111.016 177.11 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 684' ' ' VAL . . . . . . . . . . . . . 58.0 t -116.19 99.82 52.99 Favored Pre-proline 0 CA--C 1.545 0.764 0 CA-C-O 120.689 0.28 . . . . 54.240000000000002 111.653 -179.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -59.89 -37.18 87.56 Favored 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 122.928 2.419 . . . . 74.010000000000005 113.7 -177.355 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 686' ' ' MET . . . . . 0.409 ' HA ' ' CE ' ' A' ' 686' ' ' MET . 1.1 mmt -79.09 -2.91 42.79 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 112.634 0.605 . . . . 75.140000000000001 112.634 -177.243 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 687' ' ' ALA . . . . . . . . . . . . . . . -97.25 -32.18 12.05 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 120.918 0.39 . . . . 63.130000000000003 111.657 176.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 688' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -98.4 -2.57 38.86 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 112.471 0.545 . . . . 64.530000000000001 112.471 -175.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 689' ' ' VAL . . . . . 0.503 HG13 HG22 ' A' ' 671' ' ' VAL . 95.1 t -123.31 124.83 70.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-O 120.832 0.348 . . . . 71.120000000000005 111.643 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 690' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -123.92 162.31 23.62 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 116.432 -0.349 . . . . 63.109999999999999 111.41 -179.389 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 691' ' ' ALA . . . . . . . . . . . . . . . -149.35 121.57 8.37 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 120.788 0.327 . . . . 53.299999999999997 111.271 175.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 692' ' ' ILE . . . . . . . . . . . . . 35.3 mm -127.56 130.03 70.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 N-CA-C 112.285 0.476 . . . . 72.140000000000001 112.285 -175.133 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -115.82 145.26 42.99 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 120.866 0.365 . . . . 72.549999999999997 110.161 172.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 694' ' ' LYS . . . . . 0.466 ' NZ ' ' HB2' ' A' ' 694' ' ' LYS . 2.1 ttmp? -72.57 -45.55 58.65 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 112.125 0.416 . . . . 64.349999999999994 112.125 -178.396 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 32.2 mp0 -83.48 -49.43 9.28 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.245 -0.434 . . . . 75.430000000000007 112.166 -172.631 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 696' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -82.95 -33.51 26.72 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 120.869 0.366 . . . . 75.319999999999993 111.229 -175.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . 116.01 -150.61 18.59 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 121.174 -0.536 . . . . 71.340000000000003 113.407 176.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -70.65 118.94 14.08 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 120.87 0.367 . . . . 74.329999999999998 110.976 179.561 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 699' ' ' LEU . . . . . 0.534 HD12 ' HB3' ' A' ' 667' ' ' PRO . 24.3 mt -109.19 13.38 24.45 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 111.709 0.263 . . . . 71.450000000000003 111.709 -178.572 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 25.3 m -57.33 -38.95 74.88 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 121.071 0.462 . . . . 62.340000000000003 111.635 -178.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 701' ' ' SER . . . . . . . . . . . . . 35.3 m -66.63 -23.98 66.24 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.01 0.433 . . . . 74.099999999999994 111.65 178.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 702' ' ' LYS . . . . . 0.464 ' HD2' HD22 ' A' ' 699' ' ' LEU . 94.9 mttt -84.82 -6.42 59.35 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 112.156 0.428 . . . . 72.450000000000003 112.156 -176.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 703' ' ' ILE . . . . . 0.439 HD13 HG12 ' A' ' 689' ' ' VAL . 69.7 mt -63.57 123.2 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-O 121.213 0.53 . . . . 73.519999999999996 112.168 -178.289 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 704' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? -88.77 117.93 28.1 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.029 -0.532 . . . . 75.239999999999995 110.197 176.238 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 54.1 t -103.14 105.93 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-O 120.926 0.393 . . . . 74.040000000000006 111.512 -176.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 706' ' ' ASP . . . . . 0.479 ' HB3' ' HB ' ' A' ' 720' ' ' THR . 18.6 t70 -108.25 148.03 30.56 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 120.893 0.378 . . . . 65.409999999999997 111.411 -178.388 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 99.91 179.13 30.52 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 121.176 -0.535 . . . . 64.209999999999994 112.77 -177.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 708' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -150.33 133.78 16.46 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 122.393 -0.475 . . . . 63.409999999999997 112.166 -178.307 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 709' ' ' VAL . . . . . 0.517 HG22 ' HB2' ' A' ' 717' ' ' TYR . 93.7 t -111.37 120.82 62.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 CA-C-N 116.135 -0.484 . . . . 63.119999999999997 111.085 176.387 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 710' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -99.39 139.34 35.19 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 120.783 0.325 . . . . 65.349999999999994 111.053 177.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 711' ' ' THR . . . . . . . . . . . . . 75.8 p -111.36 13.4 21.59 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 112.476 0.547 . . . . 52.229999999999997 112.476 -179.3 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 712' ' ' THR . . . . . . . . . . . . . 71.3 p -102.57 -26.63 13.15 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-O 121.321 0.581 . . . . 72.010000000000005 111.253 175.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 713' ' ' LYS . . . . . 0.533 ' HB2' ' HZ3' ' A' ' 713' ' ' LYS . 0.1 OUTLIER -116.54 135.9 53.43 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 115.869 -0.605 . . . . 64.510000000000005 110.786 178.156 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 714' ' ' ALA . . . . . . . . . . . . . . . -74.89 137.56 41.82 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.485 -0.325 . . . . 32.530000000000001 111.595 179.147 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 160.71 -179.7 36.02 Favored Glycine 0 CA--C 1.523 0.567 0 C-N-CA 120.973 -0.632 . . . . 55.240000000000002 113.242 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 716' ' ' THR . . . . . . . . . . . . . 84.3 m -103.36 130.75 50.74 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.097 0.475 . . . . 75.150000000000006 111.619 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 717' ' ' TYR . . . . . 0.517 ' HB2' HG22 ' A' ' 709' ' ' VAL . 18.5 m-85 -129.12 125.1 36.38 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 116.061 -0.518 . . . . 71.420000000000002 110.154 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 718' ' ' VAL . . . . . . . . . . . . . 61.8 t -102.41 121.8 53.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-O 121.126 0.489 . . . . 72.510000000000005 112.189 -176.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 719' ' ' LEU . . . . . 0.499 HD21 HG23 ' A' ' 709' ' ' VAL . 95.4 mt -99.94 144.45 28.98 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.454 -0.339 . . . . 64.450000000000003 111.534 178.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 720' ' ' THR . . . . . 0.479 ' HB ' ' HB3' ' A' ' 706' ' ' ASP . 64.2 m -113.48 134.33 54.73 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.832 0.349 . . . . 64.540000000000006 111.164 178.375 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 721' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -125.32 114.36 18.81 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.563 -0.29 . . . . 74.230000000000004 110.89 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 60.6 m -121.54 127.1 50.62 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 120.637 0.256 . . . . 54.210000000000001 111.372 -179.273 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 11.1 p -129.44 137.55 56.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-O 121.047 0.451 . . . . 75.019999999999996 111.625 -179.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 23.7 m -119.92 134.87 55.1 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.049 0.452 . . . . 74.019999999999996 112.071 -177.06 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -82.8 149.11 27.39 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 115.956 -0.565 . . . . 72.219999999999999 110.028 173.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 726' ' ' SER . . . . . . . . . . . . . 38.3 t -66.84 -20.39 65.92 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.058 0.456 . . . . 43.399999999999999 110.915 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 727' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -81.9 -4.03 55.6 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 115.893 -0.594 . . . . 75.409999999999997 111.971 178.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 728' ' ' GLY . . . . . . . . . . . . . . . 108.2 -5.68 34.01 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 115.023 0.769 . . . . 43.240000000000002 115.023 173.121 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 36.1 m80 -84.28 122.61 29.14 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 117.848 0.824 . . . . 64.340000000000003 111.402 178.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 730' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -121.52 132.43 54.7 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 120.868 0.365 . . . . 71.109999999999999 111.707 -178.418 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 27.4 m -131.15 149.9 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-O 120.82 0.343 . . . . 72.219999999999999 111.374 177.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 7.2 t -144.36 147.64 33.69 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 121.088 0.47 . . . . 63.130000000000003 112.264 -178.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -148.99 161.38 42.03 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 116.083 -0.508 . . . . 52.530000000000001 110.927 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 734' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -121.95 160.29 25.16 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 112.567 0.58 . . . . 74.140000000000001 112.567 -178.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 735' ' ' GLN . . . . . 0.403 ' NE2' ' HG2' ' A' ' 672' ' ' PRO . 51.2 tt0 -129.37 122.13 28.83 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.554 -0.748 . . . . 71.340000000000003 110.464 179.116 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 736' ' ' THR . . . . . . . . . . . . . 20.9 m -94.11 103.4 15.46 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.629 0.252 . . . . 74.549999999999997 111.262 -179.309 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 43.2 t -96.85 133.49 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-O 120.724 0.297 . . . . 72.019999999999996 111.316 -179.236 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 738' ' ' THR . . . . . . . . . . . . . 93.8 m -121.29 112.38 18.53 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.05 0.452 . . . . 72.219999999999999 110.875 177.277 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 739' ' ' VAL . . . . . . . . . . . . . 54.4 t -93.16 133.58 33.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-N 116.167 -0.469 . . . . 51.140000000000001 110.941 178.031 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 740' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -127.74 162.16 27.25 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 120.844 0.354 . . . . 63.119999999999997 111.62 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 741' ' ' VAL . . . . . 0.507 HG12 ' H ' ' A' ' 743' ' ' GLU . 5.7 t -81.59 146.63 7.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-O 120.974 0.416 . . . . 65.549999999999997 111.245 -176.42 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 742' ' ' ARG . . . . . . . . . . . . . 38.0 ptt180 -91.42 3.47 54.86 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.448 0.536 . . . . 73.219999999999999 112.448 -177.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 743' ' ' GLU . . . . . 0.507 ' H ' HG12 ' A' ' 741' ' ' VAL . 51.7 mt-10 -145.4 175.27 10.44 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 122.705 0.402 . . . . 74.409999999999997 110.756 179.058 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 744' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -89.12 100.54 13.3 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.076 0.465 . . . . 73.400000000000006 111.612 177.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 13.3 m -116.4 95.95 4.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-O 121.304 0.573 . . . . 62.25 109.997 171.21 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 38.4 pttt -71.46 165.37 23.96 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 121.446 0.641 . . . . 65.120000000000005 112.126 -175.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 747' ' ' ASN . . . . . . . . . . . . . 10.3 p-10 -118.66 119.38 34.3 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.696 -0.684 . . . . 71.420000000000002 110.727 178.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -102.63 45.96 0.94 Allowed 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.8 0.333 . . . . 50.5 111.112 -178.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 749' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm 61.64 95.75 0.05 OUTLIER Pre-proline 0 N--CA 1.471 0.611 0 CA-C-N 115.966 -0.561 . . . . 75.219999999999999 112.272 -176.002 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 750' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -55.75 100.61 0.08 OUTLIER 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 122.39 2.06 . . . . 65.430000000000007 112.069 173.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 751' ' ' ILE . . . . . . . . . . . . . 33.4 pt -79.69 1.41 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 112.428 0.529 . . . . 75.040000000000006 112.428 -177.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 752' ' ' LEU . . . . . . . . . . . . . 65.6 tp -75.3 104.33 5.82 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 120.992 0.425 . . . . 55.420000000000002 110.854 177.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 753' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 . . . . . 0 C--O 1.237 0.415 0 CA-C-O 121.033 0.444 . . . . 61.310000000000002 111.115 -179.259 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 762' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 657' ' ' MET . . . . . . . . . . . . . 26.0 ttt . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 120.772 0.32 . . . . 74.430000000000007 110.666 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 658' ' ' GLY . . . . . . . . . . . . . . . -80.44 92.02 1.39 Allowed Glycine 0 CA--C 1.528 0.853 0 C-N-CA 121.122 -0.561 . . . . 74.209999999999994 112.155 173.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 659' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -63.8 120.1 11.24 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 112.705 0.632 . . . . 62.509999999999998 112.705 -174.229 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 660' ' ' GLY . . . . . . . . . . . . . . . -102.94 88.41 0.65 Allowed Glycine 0 CA--C 1.526 0.771 0 CA-C-N 115.817 -0.629 . . . . 74.340000000000003 111.644 172.455 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -76.36 123.36 25.84 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 112.146 0.424 . . . . 50.509999999999998 112.146 -176.341 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 662' ' ' THR . . . . . . . . . . . . . 76.7 p -79.04 107.39 11.76 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.012 0.434 . . . . 75.239999999999995 110.807 175.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 663' ' ' SER . . . . . . . . . . . . . 23.6 m -72.3 121.78 20.03 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.217 0.451 . . . . 73.519999999999996 112.217 -175.138 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 664' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -84.44 133.45 34.49 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.85 0.357 . . . . 65.540000000000006 110.788 173.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 665' ' ' LEU . . . . . 0.535 HD12 ' HD3' ' A' ' 694' ' ' LYS . 78.3 mt -95.4 137.69 34.11 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 121.097 0.475 . . . . 73.420000000000002 110.673 174.64 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 666' ' ' GLU . . . . . 0.41 ' HB2' ' HD2' ' A' ' 667' ' ' PRO . 9.6 pt-20 -70.52 152.95 95.3 Favored Pre-proline 0 CA--C 1.541 0.631 0 CA-C-N 115.941 -0.572 . . . . 71.209999999999994 111.887 -177.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 667' ' ' PRO . . . . . 0.527 ' HD3' ' HB2' ' A' ' 725' ' ' ASP . 52.5 Cg_endo -67.3 138.81 47.9 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.843 2.362 . . . . 75.109999999999999 114.428 -170.499 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 668' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -83.27 102.18 11.78 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.678 -0.692 . . . . 61.039999999999999 110.269 175.48 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 669' ' ' LEU . . . . . 0.529 ' HG ' HG23 ' A' ' 671' ' ' VAL . 65.3 tp -89.14 114.05 25.29 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.371 -0.377 . . . . 74.019999999999996 111.069 -177.785 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 670' ' ' THR . . . . . . . . . . . . . 41.5 m -89.57 110.47 21.32 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.859 0.362 . . . . 72.329999999999998 110.931 -179.173 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 671' ' ' VAL . . . . . 0.529 HG23 ' HG ' ' A' ' 669' ' ' LEU . 96.4 t -135.89 123.97 15.2 Favored Pre-proline 0 N--CA 1.468 0.455 0 CA-C-N 116.379 -0.373 . . . . 20.329999999999998 110.968 -178.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 672' ' ' PRO . . . . . 0.551 ' HG2' ' NE2' ' A' ' 735' ' ' GLN . 53.2 Cg_endo -70.75 137.43 32.57 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 122.172 1.915 . . . . 75.349999999999994 112.223 178.485 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 673' ' ' VAL . . . . . . . . . . . . . 12.2 p -64.31 -36.72 77.97 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 N-CA-C 112.012 0.375 . . . . 72.109999999999999 112.012 -177.093 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 674' ' ' GLY . . . . . . . . . . . . . . . -154.83 154.86 25.82 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 121.025 -0.607 . . . . 74.030000000000001 113.435 -178.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 675' ' ' ALA . . . . . . . . . . . . . . . -150.63 143.61 24.71 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 122.669 0.387 . . . . 71.420000000000002 110.839 178.263 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 676' ' ' THR . . . . . . . . . . . . . 90.3 m -119.46 121.33 39.22 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 120.936 0.398 . . . . 72.5 111.833 -178.251 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 677' ' ' ILE . . . . . . . . . . . . . 33.9 pt -126.68 176.98 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-N 116.209 -0.451 . . . . 72.439999999999998 110.457 175.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 678' ' ' HIS . . . . . 0.478 ' HA ' ' O ' ' A' ' 740' ' ' LYS . 46.7 m80 -123.09 159.38 28.63 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 112.583 0.586 . . . . 72.450000000000003 112.583 -177.757 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 679' ' ' VAL . . . . . 0.466 ' O ' ' HG2' ' A' ' 742' ' ' ARG . 84.2 t -59.6 112.15 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-N 115.814 -0.63 . . . . 74.140000000000001 110.556 172.276 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 115.12 -20.22 14.43 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 121.423 -0.417 . . . . 60.25 112.708 -174.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 681' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -78.01 -165.09 0.6 Allowed 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 121.227 0.537 . . . . 64.310000000000002 111.433 178.278 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 682' ' ' SER . . . . . . . . . . . . . 21.4 p -142.75 155.54 44.87 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.966 0.412 . . . . 71.239999999999995 111.557 179.126 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 683' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -143.4 135.86 27.22 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.383 -0.371 . . . . 62.039999999999999 110.577 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 684' ' ' VAL . . . . . . . . . . . . . 25.1 t -124.75 95.64 42.14 Favored Pre-proline 0 CA--C 1.544 0.737 0 CA-C-O 120.931 0.396 . . . . 72.239999999999995 111.848 -175.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -62.87 -31.1 77.86 Favored 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 122.687 2.258 . . . . 75.019999999999996 113.719 -177.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 686' ' ' MET . . . . . 0.449 ' HE1' ' HB ' ' A' ' 703' ' ' ILE . 1.7 mmt -81.51 0.36 38.37 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.32 0.489 . . . . 74.230000000000004 112.32 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 687' ' ' ALA . . . . . . . . . . . . . . . -120.55 -42.62 2.53 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 120.863 0.363 . . . . 74.299999999999997 111.972 179.508 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 688' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -79.88 2.7 22.29 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-O 120.954 0.407 . . . . 75.120000000000005 111.871 -179.527 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 689' ' ' VAL . . . . . 0.42 HG21 ' CZ ' ' A' ' 721' ' ' TYR . 64.7 t -124.53 151.97 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 122.996 0.519 . . . . 75.530000000000001 110.415 175.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 690' ' ' LEU . . . . . 0.679 HD21 HG12 ' A' ' 692' ' ' ILE . 8.8 tt -145.12 152.31 39.85 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 120.567 0.222 . . . . 63.409999999999997 111.427 -174.36 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 691' ' ' ALA . . . . . . . . . . . . . . . -146.43 126.64 13.86 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 122.341 -0.224 . . . . 51.030000000000001 111.502 177.498 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 692' ' ' ILE . . . . . 0.679 HG12 HD21 ' A' ' 690' ' ' LEU . 41.1 mm -129.66 132.72 65.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 CA-C-O 121.207 0.527 . . . . 70.420000000000002 112.317 -178.109 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 693' ' ' ASP . . . . . 0.472 ' HB2' HD11 ' A' ' 699' ' ' LEU . 25.6 t70 -114.72 145.23 42.3 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.031 -0.532 . . . . 73.430000000000007 109.832 172.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 694' ' ' LYS . . . . . 0.535 ' HD3' HD12 ' A' ' 665' ' ' LEU . 50.8 mtpt -71.1 -39.19 72.24 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.814 0.34 . . . . 71.25 111.854 -177.342 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 35.2 mp0 -83.15 -54.02 5.35 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 112.054 0.39 . . . . 63.219999999999999 112.054 -175.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 696' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -76.35 -48.74 18.89 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 122.149 -0.345 . . . . 73.439999999999998 111.598 -177.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . 124.2 -131.56 7.98 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 121.279 -0.486 . . . . 75.450000000000003 113.052 -179.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -75.63 119.67 19.99 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 122.442 -0.446 . . . . 55.439999999999998 111.273 -179.146 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 699' ' ' LEU . . . . . 0.608 HD22 ' HD2' ' A' ' 702' ' ' LYS . 35.5 mt -111.44 11.21 21.44 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.397 -0.365 . . . . 62.140000000000001 111.3 178.318 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 33.8 m -59.74 -36.07 75.86 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.302 0.572 . . . . 75.430000000000007 111.551 -177.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 701' ' ' SER . . . . . . . . . . . . . 49.4 m -76.22 -14.49 60.14 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 116.282 -0.417 . . . . 72.340000000000003 111.85 177.354 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 702' ' ' LYS . . . . . 0.608 ' HD2' HD22 ' A' ' 699' ' ' LEU . 96.5 mttt -97.67 11.59 36.55 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.177 0.436 . . . . 74.109999999999999 112.177 -177.216 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 703' ' ' ILE . . . . . 0.449 ' HB ' ' HE1' ' A' ' 686' ' ' MET . 67.7 mt -83.76 118.76 31.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-O 120.873 0.368 . . . . 62.509999999999998 111.766 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 704' ' ' LYS . . . . . . . . . . . . . 4.9 tppp? -84.99 125.89 33.08 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 110.168 -0.308 . . . . 71.340000000000003 110.168 174.244 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 49.0 t -105.88 117.39 51.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 CA-C-O 121.004 0.43 . . . . 55.229999999999997 112.013 -176.367 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 706' ' ' ASP . . . . . 0.594 ' HB3' ' HB ' ' A' ' 720' ' ' THR . 12.8 t70 -100.32 141.2 33.5 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.294 -0.412 . . . . 61.340000000000003 111.03 175.183 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 102.35 177.74 27.46 Favored Glycine 0 CA--C 1.523 0.54 0 C-N-CA 121.201 -0.523 . . . . 72.439999999999998 112.97 -179.573 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 708' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -152.48 130.48 11.82 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 120.863 0.363 . . . . 74.439999999999998 111.491 -177.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 709' ' ' VAL . . . . . 0.546 HG22 ' HB2' ' A' ' 717' ' ' TYR . 96.3 t -107.93 114.6 46.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 116.494 -0.321 . . . . 64.030000000000001 110.655 176.483 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 710' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -95.39 143.65 26.56 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 120.905 0.383 . . . . 65.040000000000006 111.039 177.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 711' ' ' THR . . . . . . . . . . . . . 75.6 p -108.08 6.54 27.04 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.666 0.617 . . . . 75.140000000000001 112.666 -176.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 712' ' ' THR . . . . . . . . . . . . . 64.1 p -101.37 -24.24 14.23 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 121.157 0.503 . . . . 64.239999999999995 111.145 175.322 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 713' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -116.17 122.42 44.99 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 116.294 -0.412 . . . . 63.350000000000001 110.95 178.502 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 714' ' ' ALA . . . . . . . . . . . . . . . -69.42 143.99 53.47 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 120.982 0.42 . . . . 64.200000000000003 111.796 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 155.77 168.92 19.48 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-N 116.255 -0.43 . . . . 64.439999999999998 112.826 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 716' ' ' THR . . . . . . . . . . . . . 99.2 m -97.71 123.07 41.48 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 122.51 -0.406 . . . . 73.420000000000002 111.812 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 717' ' ' TYR . . . . . 0.546 ' HB2' HG22 ' A' ' 709' ' ' VAL . 40.7 m-85 -115.83 125.9 53.29 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 116.2 -0.455 . . . . 74.519999999999996 110.78 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 718' ' ' VAL . . . . . . . . . . . . . 56.1 t -96.25 118.55 42.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 120.901 0.381 . . . . 60.109999999999999 111.452 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 719' ' ' LEU . . . . . . . . . . . . . 76.6 mt -103.12 135.31 45.02 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.78 0.324 . . . . 63.030000000000001 111.611 -179.242 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 720' ' ' THR . . . . . 0.594 ' HB ' ' HB3' ' A' ' 706' ' ' ASP . 32.9 m -103.27 131.98 49.89 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 120.943 0.401 . . . . 74.439999999999998 110.895 176.545 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 721' ' ' TYR . . . . . 0.42 ' CZ ' HG21 ' A' ' 689' ' ' VAL . 77.8 m-85 -118.34 117.73 29.88 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.471 -0.331 . . . . 74.510000000000005 110.926 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 87.3 m -120.72 126.83 51.17 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.626 -0.261 . . . . 60.450000000000003 111.263 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 13.1 p -125.23 142.18 42.87 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-O 120.869 0.366 . . . . 75.549999999999997 111.878 -177.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 26.7 m -110.23 133.6 53.07 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.144 0.497 . . . . 65.140000000000001 112.181 -176.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 725' ' ' ASP . . . . . 0.527 ' HB2' ' HD3' ' A' ' 667' ' ' PRO . 14.0 t0 -91.59 151.57 20.66 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 115.912 -0.586 . . . . 72.0 111.049 178.08 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 726' ' ' SER . . . . . . . . . . . . . 38.6 t -59.46 -29.7 68.0 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.403 0.52 . . . . 64.140000000000001 112.403 -175.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 727' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -91.63 7.35 41.96 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 112.313 0.486 . . . . 75.25 112.313 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 728' ' ' GLY . . . . . . . . . . . . . . . 100.2 8.37 50.47 Favored Glycine 0 CA--C 1.534 1.237 0 N-CA-C 115.294 0.878 . . . . 71.5 115.294 173.603 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 37.6 m80 -86.67 115.11 23.91 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 117.865 0.833 . . . . 74.310000000000002 111.094 177.373 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 730' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -120.25 117.09 26.92 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 122.133 -0.355 . . . . 73.519999999999996 111.717 -177.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 35.7 m -117.83 157.76 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-O 120.727 0.299 . . . . 61.130000000000003 111.762 -177.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 8.6 t -142.56 144.37 32.86 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.682 0.623 . . . . 72.510000000000005 112.682 -177.049 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -146.68 159.45 43.46 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.024 -0.534 . . . . 61.020000000000003 111.059 178.41 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 734' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -118.1 155.54 30.21 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 113.009 0.744 . . . . 62.329999999999998 113.009 -176.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 735' ' ' GLN . . . . . 0.551 ' NE2' ' HG2' ' A' ' 672' ' ' PRO . 44.8 tt0 -129.79 135.48 48.47 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 115.703 -0.681 . . . . 73.040000000000006 110.558 177.642 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 736' ' ' THR . . . . . . . . . . . . . 90.1 m -95.15 104.35 16.23 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 120.675 0.274 . . . . 71.439999999999998 111.39 178.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 46.5 t -100.07 104.5 16.21 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 CA-C-O 120.772 0.32 . . . . 73.540000000000006 111.295 179.12 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 738' ' ' THR . . . . . . . . . . . . . 44.6 m -94.54 117.4 30.06 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.119 0.485 . . . . 71.319999999999993 111.471 179.167 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 739' ' ' VAL . . . . . . . . . . . . . 43.6 t -98.28 117.95 44.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-O 121.113 0.482 . . . . 74.219999999999999 111.584 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 740' ' ' LYS . . . . . 0.478 ' O ' ' HA ' ' A' ' 678' ' ' HIS . 96.1 mttt -102.93 176.05 5.28 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.265 -0.425 . . . . 73.120000000000005 110.492 174.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 741' ' ' VAL . . . . . . . . . . . . . 36.3 t -100.5 122.11 52.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 O-C-N 121.881 -0.512 . . . . 70.209999999999994 111.734 -178.359 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 742' ' ' ARG . . . . . 0.736 ' HG3' ' HG3' ' A' ' 743' ' ' GLU . 20.7 ptt180 -92.04 -46.25 7.89 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.088 0.471 . . . . 73.129999999999995 110.766 175.706 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 743' ' ' GLU . . . . . 0.736 ' HG3' ' HG3' ' A' ' 742' ' ' ARG . 45.7 mt-10 -123.93 96.09 4.81 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.971 -0.559 . . . . 65.239999999999995 110.212 -178.652 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 744' ' ' GLU . . . . . 0.493 ' H ' ' CD ' ' A' ' 744' ' ' GLU . 0.5 OUTLIER -59.66 134.55 57.13 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.664 -0.698 . . . . 74.530000000000001 112.568 -175.703 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 745' ' ' VAL . . . . . 0.644 HG12 ' H ' ' A' ' 747' ' ' ASN . 47.3 t -82.03 131.41 33.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-N 115.935 -0.575 . . . . 63.509999999999998 111.175 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -83.09 12.09 5.52 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.414 0.524 . . . . 63.439999999999998 112.414 -177.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 747' ' ' ASN . . . . . 0.644 ' H ' HG12 ' A' ' 745' ' ' VAL . 9.5 m120 -122.6 99.02 6.18 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 120.929 0.395 . . . . 62.200000000000003 111.884 -175.377 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -91.73 -4.65 54.8 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-O 121.369 0.604 . . . . 65.209999999999994 111.206 177.224 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 749' ' ' LYS . . . . . 0.42 ' N ' ' HD2' ' A' ' 749' ' ' LYS . 12.6 mptt -68.96 159.58 82.12 Favored Pre-proline 0 CA--C 1.54 0.583 0 CA-C-N 116.314 -0.403 . . . . 73.409999999999997 111.078 177.542 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 750' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -68.05 73.47 0.75 Allowed 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 122.335 2.023 . . . . 55.030000000000001 112.826 179.341 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 751' ' ' ILE . . . . . 0.405 HD12 ' HB3' ' A' ' 747' ' ' ASN . 56.9 mt -97.13 109.2 22.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-O 121.136 0.493 . . . . 54.140000000000001 110.566 177.533 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 752' ' ' LEU . . . . . . . . . . . . . 50.3 tp -106.32 140.97 38.42 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 116.118 -0.492 . . . . 73.400000000000006 111.361 -176.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 753' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 . . . . . 0 N--CA 1.471 0.6 0 CA-C-N 116.278 -0.419 . . . . 74.349999999999994 111.039 178.501 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 762' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 657' ' ' MET . . . . . . . . . . . . . 25.7 ptt? . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 120.466 0.174 . . . . 73.430000000000007 110.861 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 658' ' ' GLY . . . . . . . . . . . . . . . 71.67 -78.88 0.59 Allowed Glycine 0 CA--C 1.528 0.854 0 C-N-CA 120.82 -0.705 . . . . 72.420000000000002 113.046 179.244 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 659' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -144.72 156.1 43.9 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 120.806 0.336 . . . . 64.230000000000004 110.94 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 660' ' ' GLY . . . . . . . . . . . . . . . 113.24 85.93 1.47 Allowed Glycine 0 CA--C 1.526 0.745 0 C-N-CA 121.44 -0.41 . . . . 70.25 113.081 178.415 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -84.9 120.57 26.63 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 121.023 0.44 . . . . 70.140000000000001 110.743 177.402 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 662' ' ' THR . . . . . . . . . . . . . 74.1 p -111.4 131.2 55.37 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.029 0.442 . . . . 74.420000000000002 111.774 -175.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 663' ' ' SER . . . . . . . . . . . . . 40.7 m -102.4 126.02 49.3 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.129 -0.487 . . . . 74.150000000000006 111.989 -177.524 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 664' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -76.78 143.01 40.14 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 120.895 0.378 . . . . 75.530000000000001 110.847 173.444 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 665' ' ' LEU . . . . . . . . . . . . . 76.6 mt -80.82 119.76 23.8 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.404 -0.362 . . . . 65.019999999999996 110.644 177.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 666' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -56.69 144.22 66.15 Favored Pre-proline 0 CA--C 1.537 0.472 0 C-N-CA 121.131 -0.228 . . . . 53.25 110.483 177.333 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 667' ' ' PRO . . . . . 0.545 ' HD3' ' HB2' ' A' ' 725' ' ' ASP . 18.8 Cg_endo -56.5 133.92 61.07 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.725 2.284 . . . . 70.409999999999997 112.736 -174.131 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 668' ' ' LYS . . . . . . . . . . . . . 52.2 tptt -82.71 110.66 17.96 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 120.942 0.401 . . . . 51.439999999999998 110.343 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 669' ' ' LEU . . . . . 0.521 ' HG ' HG23 ' A' ' 671' ' ' VAL . 55.8 tp -98.06 112.58 24.48 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 116.067 -0.515 . . . . 70.450000000000003 111.271 -177.616 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 670' ' ' THR . . . . . . . . . . . . . 85.8 m -87.75 110.62 20.6 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 120.856 0.36 . . . . 63.25 111.121 177.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 671' ' ' VAL . . . . . 0.521 HG23 ' HG ' ' A' ' 669' ' ' LEU . 81.0 t -136.34 129.68 17.85 Favored Pre-proline 0 N--CA 1.47 0.575 0 CA-C-N 116.211 -0.45 . . . . 71.549999999999997 110.803 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 672' ' ' PRO . . . . . 0.477 ' HG2' ' NE2' ' A' ' 735' ' ' GLN . 73.6 Cg_endo -77.9 141.48 19.11 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 122.193 1.929 . . . . 73.409999999999997 112.791 179.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 673' ' ' VAL . . . . . . . . . . . . . 10.6 p -66.27 -35.03 73.99 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 N-CA-C 112.007 0.373 . . . . 74.329999999999998 112.007 -177.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 674' ' ' GLY . . . . . . . . . . . . . . . -146.22 161.19 28.3 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 120.879 -0.676 . . . . 43.340000000000003 113.565 -177.52 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 675' ' ' ALA . . . . . . . . . . . . . . . -150.5 154.85 38.38 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 122.608 0.363 . . . . 72.319999999999993 110.928 -179.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 676' ' ' THR . . . . . . . . . . . . . 91.8 m -139.04 119.56 13.93 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 120.964 0.411 . . . . 74.019999999999996 111.791 178.491 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 677' ' ' ILE . . . . . . . . . . . . . 28.7 pt -131.28 175.22 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-N 116.459 -0.337 . . . . 74.400000000000006 110.678 176.15 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 678' ' ' HIS . . . . . 0.401 ' HA ' ' O ' ' A' ' 740' ' ' LYS . 75.5 m80 -119.49 164.79 15.27 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.305 0.574 . . . . 74.299999999999997 111.912 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 679' ' ' VAL . . . . . 0.445 HG23 ' HA ' ' A' ' 741' ' ' VAL . 78.3 t -56.68 137.01 19.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-N 115.891 -0.595 . . . . 73.049999999999997 110.504 172.06 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 93.03 -18.31 56.39 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 121.052 -0.594 . . . . 55.530000000000001 113.406 -179.034 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 681' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -79.52 -172.47 3.27 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 121.12 0.486 . . . . 51.020000000000003 111.548 178.038 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 682' ' ' SER . . . . . . . . . . . . . 69.0 m -141.77 145.72 35.1 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 116.435 -0.348 . . . . 74.200000000000003 111.06 177.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 683' ' ' PHE . . . . . 0.473 ' HZ ' HE22 ' A' ' 735' ' ' GLN . 34.2 t80 -118.7 134.18 55.32 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 116.453 -0.34 . . . . 61.509999999999998 110.46 178.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 684' ' ' VAL . . . . . 0.406 ' HA ' ' HD2' ' A' ' 685' ' ' PRO . 53.7 t -122.17 93.09 48.75 Favored Pre-proline 0 CA--C 1.54 0.573 0 CA-C-O 120.962 0.41 . . . . 60.299999999999997 111.429 -177.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 685' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 684' ' ' VAL . 28.6 Cg_endo -61.69 -27.76 81.52 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 122.83 2.353 . . . . 61.140000000000001 113.347 -177.382 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 686' ' ' MET . . . . . 0.488 ' HE1' ' HB ' ' A' ' 703' ' ' ILE . 1.9 mmt -78.91 -12.14 60.02 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 112.313 0.486 . . . . 73.109999999999999 112.313 -178.137 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 687' ' ' ALA . . . . . . . . . . . . . . . -109.02 -36.34 6.1 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.915 0.388 . . . . 52.409999999999997 111.539 178.426 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 688' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -85.92 -1.08 56.95 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 116.295 -0.411 . . . . 74.430000000000007 112.05 -178.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 689' ' ' VAL . . . . . 0.432 HG21 ' CZ ' ' A' ' 721' ' ' TYR . 74.5 t -125.57 150.81 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 122.59 0.356 . . . . 52.149999999999999 110.577 174.227 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 690' ' ' LEU . . . . . 0.485 HD21 HG12 ' A' ' 692' ' ' ILE . 9.6 tt -143.3 150.03 38.65 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-O 120.592 0.234 . . . . 73.430000000000007 111.537 -173.4 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 691' ' ' ALA . . . . . . . . . . . . . . . -147.3 125.35 12.08 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 112.19 0.441 . . . . 73.109999999999999 112.19 179.182 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 692' ' ' ILE . . . . . 0.538 HD13 ' HA ' ' A' ' 698' ' ' ASP . 43.6 mm -129.68 141.52 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 N-CA-C 111.803 0.297 . . . . 75.329999999999998 111.803 -178.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 693' ' ' ASP . . . . . 0.475 ' OD1' ' HG2' ' A' ' 695' ' ' GLU . 12.5 t70 -125.95 143.97 50.88 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 110.138 -0.319 . . . . 63.119999999999997 110.138 173.015 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 28.6 ttpp -64.79 -34.05 77.42 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 112.5 0.556 . . . . 53.219999999999999 112.5 -175.381 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 695' ' ' GLU . . . . . 0.475 ' HG2' ' OD1' ' A' ' 693' ' ' ASP . 9.5 pt-20 -81.89 -43.42 18.19 Favored 'General case' 0 N--CA 1.473 0.694 0 O-C-N 122.02 -0.425 . . . . 72.329999999999998 111.976 -175.481 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 696' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -94.85 -42.44 8.7 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 120.883 0.373 . . . . 73.349999999999994 111.773 -172.112 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . 118.57 -115.68 3.18 Favored Glycine 0 CA--C 1.523 0.569 0 C-N-CA 121.14 -0.552 . . . . 62.200000000000003 112.291 -177.204 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 698' ' ' ASP . . . . . 0.538 ' HA ' HD13 ' A' ' 692' ' ' ILE . 16.1 t70 -88.62 119.98 29.59 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 122.195 -0.591 . . . . 63.049999999999997 111.247 178.701 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 699' ' ' LEU . . . . . 0.491 HD12 ' HB3' ' A' ' 667' ' ' PRO . 51.0 mt -111.97 18.45 18.79 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 116.364 -0.38 . . . . 74.0 111.603 177.463 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 37.1 m -58.36 -30.65 66.92 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.009 0.433 . . . . 74.439999999999998 111.105 178.451 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 701' ' ' SER . . . . . . . . . . . . . 29.7 t -68.15 -24.48 64.99 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 120.868 0.366 . . . . 74.420000000000002 111.971 175.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 702' ' ' LYS . . . . . 0.488 ' HB2' HG23 ' A' ' 723' ' ' VAL . 73.4 mmtt -77.4 -19.84 55.55 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 111.895 0.331 . . . . 70.450000000000003 111.895 -178.34 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 703' ' ' ILE . . . . . 0.488 ' HB ' ' HE1' ' A' ' 686' ' ' MET . 63.9 mt -60.74 112.76 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 N-CA-C 112.515 0.561 . . . . 75.219999999999999 112.515 -174.292 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 704' ' ' LYS . . . . . . . . . . . . . 8.1 tmtm? -87.04 120.08 27.93 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.017 -0.538 . . . . 65.340000000000003 109.729 172.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 50.3 t -95.71 118.06 41.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-O 121.113 0.482 . . . . 64.019999999999996 111.063 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 706' ' ' ASP . . . . . 0.539 ' HB3' ' HB ' ' A' ' 720' ' ' THR . 11.7 t70 -108.11 118.44 36.76 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.413 -0.358 . . . . 71.340000000000003 110.249 176.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 113.42 167.82 16.7 Favored Glycine 0 CA--C 1.524 0.643 0 C-N-CA 121.344 -0.455 . . . . 55.240000000000002 112.392 -176.202 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 708' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -155.04 138.56 15.96 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 122.316 -0.52 . . . . 71.409999999999997 111.843 -177.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 709' ' ' VAL . . . . . . . . . . . . . 72.5 t -99.59 127.87 51.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-N 116.341 -0.39 . . . . 62.140000000000001 111.352 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 710' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -96.15 137.09 35.72 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 120.732 0.301 . . . . 64.530000000000001 110.578 175.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 711' ' ' THR . . . . . . . . . . . . . 82.5 p -110.43 23.7 13.92 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 112.416 0.525 . . . . 75.040000000000006 112.416 -177.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 712' ' ' THR . . . . . . . . . . . . . 48.8 p -113.03 -26.46 8.47 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 121.015 0.436 . . . . 52.25 110.746 173.05 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 713' ' ' LYS . . . . . 0.57 ' HB2' ' HZ3' ' A' ' 713' ' ' LYS . 0.1 OUTLIER -116.72 130.96 57.04 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.001 -0.545 . . . . 73.519999999999996 110.53 175.318 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 714' ' ' ALA . . . . . . . . . . . . . . . -80.9 134.88 35.82 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.067 0.46 . . . . 44.32 112.182 -178.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 169.32 171.67 35.22 Favored Glycine 0 CA--C 1.523 0.58 0 CA-C-N 116.042 -0.526 . . . . 70.450000000000003 112.582 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 716' ' ' THR . . . . . . . . . . . . . 39.9 m -90.09 123.06 33.63 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.188 0.518 . . . . 74.230000000000004 111.568 177.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 717' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 -114.43 138.23 50.84 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 116.074 -0.512 . . . . 75.0 110.234 177.241 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 718' ' ' VAL . . . . . . . . . . . . . 62.0 t -103.65 116.62 47.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-O 120.929 0.395 . . . . 62.340000000000003 111.54 -178.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 719' ' ' LEU . . . . . . . . . . . . . 83.0 mt -102.13 129.16 48.4 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 116.348 -0.387 . . . . 74.450000000000003 111.286 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 720' ' ' THR . . . . . 0.539 ' HB ' ' HB3' ' A' ' 706' ' ' ASP . 92.7 m -106.55 134.9 48.98 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.839 0.352 . . . . 64.209999999999994 111.12 178.303 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 721' ' ' TYR . . . . . 0.432 ' CZ ' HG21 ' A' ' 689' ' ' VAL . 60.7 m-85 -123.41 120.81 34.07 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.54 -0.3 . . . . 72.129999999999995 110.795 -179.559 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 56.6 m -123.16 133.42 54.25 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 120.797 0.332 . . . . 60.399999999999999 111.4 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 723' ' ' VAL . . . . . 0.488 HG23 ' HB2' ' A' ' 702' ' ' LYS . 7.5 p -130.93 134.89 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-O 121.154 0.502 . . . . 71.340000000000003 111.788 -178.623 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 34.3 m -109.47 142.95 39.75 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.252 0.549 . . . . 55.229999999999997 111.625 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 725' ' ' ASP . . . . . 0.545 ' HB2' ' HD3' ' A' ' 667' ' ' PRO . 10.3 t70 -102.63 160.29 14.71 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 115.814 -0.63 . . . . 63.409999999999997 111.82 -178.444 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 726' ' ' SER . . . . . . . . . . . . . 48.9 m -61.52 -33.5 73.92 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.637 0.606 . . . . 72.099999999999994 112.637 -177.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 727' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -82.01 4.96 20.83 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 120.751 0.31 . . . . 65.519999999999996 111.447 177.55 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 728' ' ' GLY . . . . . . . . . . . . . . . 91.07 15.01 56.89 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 121.35 -0.452 . . . . 73.109999999999999 114.03 177.219 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 36.3 m80 -88.49 121.33 30.75 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 117.235 0.517 . . . . 74.340000000000003 111.111 178.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 730' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -124.78 122.29 37.01 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.792 0.33 . . . . 72.430000000000007 111.873 -176.098 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 31.9 m -121.94 159.3 24.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 116.423 -0.353 . . . . 51.549999999999997 111.029 177.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 10.3 t -143.33 154.82 44.15 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.839 0.352 . . . . 72.219999999999999 111.801 -178.48 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -148.5 161.35 41.81 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 122.631 0.372 . . . . 73.140000000000001 111.211 179.256 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 734' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -125.66 154.56 42.17 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 121.057 0.455 . . . . 64.310000000000002 112.108 -177.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 735' ' ' GLN . . . . . 0.477 ' NE2' ' HG2' ' A' ' 672' ' ' PRO . 50.9 tt0 -130.8 137.96 49.67 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.991 -0.549 . . . . 50.100000000000001 111.299 179.432 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 736' ' ' THR . . . . . . . . . . . . . 89.5 m -97.19 103.82 15.78 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.534 -0.303 . . . . 70.409999999999997 111.151 176.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 45.6 t -101.48 105.16 17.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-O 120.841 0.353 . . . . 74.329999999999998 111.649 -179.173 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 738' ' ' THR . . . . . . . . . . . . . 65.8 m -95.95 118.21 32.14 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.911 0.386 . . . . 52.210000000000001 111.493 179.252 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 739' ' ' VAL . . . . . . . . . . . . . 41.0 t -97.89 139.4 20.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-N 116.393 -0.367 . . . . 74.219999999999999 111.496 178.341 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 740' ' ' LYS . . . . . 0.401 ' O ' ' HA ' ' A' ' 678' ' ' HIS . 97.4 mttt -122.17 155.84 34.95 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 120.841 0.353 . . . . 54.240000000000002 110.711 176.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 741' ' ' VAL . . . . . 0.445 ' HA ' HG23 ' A' ' 679' ' ' VAL . 40.9 t -82.47 145.66 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-O 121.04 0.448 . . . . 61.539999999999999 112.152 -175.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 742' ' ' ARG . . . . . 0.532 ' HG3' ' HG3' ' A' ' 744' ' ' GLU . 32.2 ptt180 -103.28 140.0 37.98 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.001 -0.545 . . . . 64.019999999999996 110.287 172.623 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 743' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -69.63 89.04 0.53 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.235 0.541 . . . . 72.310000000000002 111.686 179.383 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 744' ' ' GLU . . . . . 0.532 ' HG3' ' HG3' ' A' ' 742' ' ' ARG . 48.3 mt-10 -85.81 96.0 9.61 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.073 -0.512 . . . . 54.119999999999997 111.152 177.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 7.7 p -68.96 138.89 21.43 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 121.146 0.498 . . . . 44.219999999999999 111.366 178.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 18.5 ptmt -63.89 86.31 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.821 0 CA-C-O 121.675 0.75 . . . . 72.25 112.275 -178.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 747' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -89.4 129.66 35.88 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.933 -0.576 . . . . 70.530000000000001 110.965 176.478 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -73.97 100.14 3.47 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 120.98 0.419 . . . . 71.310000000000002 110.044 175.315 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 749' ' ' LYS . . . . . . . . . . . . . 18.6 ptmt -149.28 66.88 8.74 Favored Pre-proline 0 CA--C 1.542 0.666 0 CA-C-O 121.24 0.543 . . . . 74.030000000000001 111.813 -177.392 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 750' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -92.15 90.35 0.21 Allowed 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 122.966 2.444 . . . . 70.450000000000003 112.535 176.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 751' ' ' ILE . . . . . . . . . . . . . 48.4 mm -84.08 93.06 3.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-N 116.378 -0.374 . . . . 74.129999999999995 111.245 -178.313 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 752' ' ' LEU . . . . . . . . . . . . . 53.8 tp -72.67 86.17 1.21 Allowed 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.37 0.605 . . . . 73.409999999999997 110.71 177.394 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 753' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 . . . . . 0 C--O 1.238 0.46 0 CA-C-O 121.465 0.65 . . . . 74.230000000000004 111.753 -177.867 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 762' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 657' ' ' MET . . . . . . . . . . . . . 58.5 tpp . . . . . 0 N--CA 1.489 1.51 0 CA-C-O 120.726 0.298 . . . . 72.420000000000002 111.149 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 658' ' ' GLY . . . . . . . . . . . . . . . 147.16 -114.32 0.7 Allowed Glycine 0 CA--C 1.525 0.706 0 C-N-CA 120.968 -0.634 . . . . 74.319999999999993 112.74 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 659' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -103.69 -177.82 3.48 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 120.893 0.377 . . . . 74.420000000000002 111.146 178.03 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 660' ' ' GLY . . . . . . . . . . . . . . . -126.65 120.9 3.81 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 121.382 -0.437 . . . . 64.349999999999994 112.866 176.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -71.68 131.12 42.71 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 120.856 0.36 . . . . 72.109999999999999 111.965 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 662' ' ' THR . . . . . . . . . . . . . 35.6 m -89.08 140.11 29.77 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 120.908 0.385 . . . . 70.230000000000004 111.707 -178.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 663' ' ' SER . . . . . . . . . . . . . 45.2 m -86.98 114.58 23.72 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 116.562 -0.29 . . . . 71.219999999999999 111.689 -179.07 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 664' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -75.46 136.49 40.68 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.871 0.367 . . . . 64.510000000000005 111.134 176.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 665' ' ' LEU . . . . . 0.441 HD12 ' HD3' ' A' ' 694' ' ' LYS . 89.4 mt -90.55 136.62 32.94 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 116.305 -0.407 . . . . 70.519999999999996 110.505 174.237 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 666' ' ' GLU . . . . . 0.479 ' HB3' ' HB3' ' A' ' 729' ' ' HIS . 2.3 pm0 -65.5 140.63 97.67 Favored Pre-proline 0 CA--C 1.543 0.701 0 CA-C-O 120.921 0.391 . . . . 73.400000000000006 111.543 177.663 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 667' ' ' PRO . . . . . 0.596 ' HD3' ' HB2' ' A' ' 725' ' ' ASP . 12.8 Cg_endo -55.36 145.85 65.16 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 123.378 2.719 . . . . 75.400000000000006 114.745 -169.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 668' ' ' LYS . . . . . . . . . . . . . 7.4 tmtm? -85.06 104.14 14.71 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.287 -0.87 . . . . 51.210000000000001 110.404 177.235 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 669' ' ' LEU . . . . . . . . . . . . . 57.5 tp -100.05 111.72 24.02 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 116.119 -0.491 . . . . 63.140000000000001 111.564 -177.111 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 670' ' ' THR . . . . . . . . . . . . . 86.2 m -89.11 111.53 22.31 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.9 0.381 . . . . 61.240000000000002 111.502 178.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 671' ' ' VAL . . . . . 0.43 HG22 HG13 ' A' ' 689' ' ' VAL . 90.6 t -134.0 129.16 19.95 Favored Pre-proline 0 N--CA 1.47 0.529 0 CA-C-N 116.194 -0.457 . . . . 72.519999999999996 110.807 176.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 672' ' ' PRO . . . . . 0.529 ' HG2' ' NE2' ' A' ' 735' ' ' GLN . 58.6 Cg_endo -74.29 128.88 12.45 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 122.161 1.907 . . . . 65.030000000000001 112.084 176.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 673' ' ' VAL . . . . . . . . . . . . . 9.6 p -64.6 -19.27 24.9 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 N-CA-C 112.423 0.527 . . . . 75.019999999999996 112.423 -175.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 674' ' ' GLY . . . . . . . . . . . . . . . -156.8 155.59 26.48 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 120.809 -0.71 . . . . 44.030000000000001 113.501 -179.1 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 675' ' ' ALA . . . . . 0.486 ' HB3' HG22 ' A' ' 737' ' ' VAL . . . -151.1 145.66 25.62 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 120.691 0.281 . . . . 74.519999999999996 111.148 178.606 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 676' ' ' THR . . . . . . . . . . . . . 88.9 m -120.65 124.79 46.09 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.031 0.443 . . . . 70.150000000000006 112.096 -179.437 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 677' ' ' ILE . . . . . . . . . . . . . 28.8 pt -135.4 177.24 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 CA-C-N 116.244 -0.435 . . . . 55.520000000000003 111.029 176.203 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 678' ' ' HIS . . . . . . . . . . . . . 65.8 m80 -124.46 168.07 13.56 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.295 0.569 . . . . 62.100000000000001 112.188 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 679' ' ' VAL . . . . . . . . . . . . . 85.5 t -63.31 111.55 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-N 115.777 -0.647 . . . . 51.140000000000001 109.871 170.428 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 107.59 -4.33 34.69 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 121.297 -0.478 . . . . 40.240000000000002 113.29 -175.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 681' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -86.18 170.93 11.7 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 121.223 0.535 . . . . 74.129999999999995 111.508 176.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 682' ' ' SER . . . . . . . . . . . . . 77.3 p -114.58 153.21 30.5 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 116.349 -0.387 . . . . 71.310000000000002 111.121 178.502 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 683' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -159.19 114.06 2.45 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 120.745 0.307 . . . . 71.409999999999997 111.453 -178.032 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 684' ' ' VAL . . . . . 0.44 ' HA ' ' HD2' ' A' ' 685' ' ' PRO . 84.0 t -105.47 103.98 45.72 Favored Pre-proline 0 CA--C 1.543 0.677 0 CA-C-N 116.551 -0.295 . . . . 65.200000000000003 110.982 176.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 685' ' ' PRO . . . . . 0.44 ' HD2' ' HA ' ' A' ' 684' ' ' VAL . 14.4 Cg_endo -57.12 -35.55 98.94 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 122.606 2.204 . . . . 74.209999999999994 113.484 -179.059 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 686' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -78.35 -6.19 54.4 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 112.314 0.487 . . . . 72.150000000000006 112.314 -179.224 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 687' ' ' ALA . . . . . . . . . . . . . . . -94.51 -27.42 15.98 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 121.039 0.447 . . . . 73.310000000000002 111.259 175.04 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 688' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -86.08 -9.99 55.73 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 116.158 -0.474 . . . . 53.119999999999997 111.753 -179.214 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 689' ' ' VAL . . . . . 0.435 HG12 HD13 ' A' ' 703' ' ' ILE . 95.5 t -118.63 133.93 63.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 CA-C-O 120.937 0.398 . . . . 74.400000000000006 111.613 -177.194 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 690' ' ' LEU . . . . . 0.556 HD23 ' N ' ' A' ' 691' ' ' ALA . 4.1 tt -141.73 136.68 31.02 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 116.188 -0.46 . . . . 63.140000000000001 110.138 -177.309 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 691' ' ' ALA . . . . . 0.556 ' N ' HD23 ' A' ' 690' ' ' LEU . . . -122.48 122.09 38.11 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.345 0.498 . . . . 71.299999999999997 112.345 -178.016 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 692' ' ' ILE . . . . . . . . . . . . . 45.0 mm -122.25 124.23 70.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-N 116.183 -0.462 . . . . 73.340000000000003 111.483 178.101 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -113.6 144.99 41.96 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.726 0.298 . . . . 65.230000000000004 110.294 173.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 694' ' ' LYS . . . . . 0.441 ' HD3' HD12 ' A' ' 665' ' ' LEU . 7.9 mtpm? -71.72 -43.08 66.5 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 112.105 0.409 . . . . 72.450000000000003 112.105 -175.622 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 44.7 mp0 -83.88 -54.35 4.94 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 121.144 0.497 . . . . 75.409999999999997 112.142 -178.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 696' ' ' ASP . . . . . . . . . . . . . 32.7 t0 -79.38 -28.62 41.92 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 116.083 -0.508 . . . . 51.200000000000003 112.133 -172.469 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . 105.64 -155.53 16.85 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 121.186 -0.53 . . . . 55.25 113.595 176.76 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -68.22 118.19 11.02 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 122.55 -0.383 . . . . 53.240000000000002 110.48 176.671 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 699' ' ' LEU . . . . . 0.543 HD22 ' HE2' ' A' ' 702' ' ' LYS . 19.9 mt -113.31 19.89 16.63 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.46 -0.336 . . . . 74.340000000000003 111.511 -176.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 77.6 m -56.11 -37.92 70.07 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 112.313 0.486 . . . . 73.310000000000002 112.313 -176.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 701' ' ' SER . . . . . . . . . . . . . 73.3 m -70.83 -19.52 62.65 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 112.063 0.394 . . . . 74.140000000000001 112.063 178.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 702' ' ' LYS . . . . . 0.543 ' HE2' HD22 ' A' ' 699' ' ' LEU . 54.5 mtmt -92.59 11.24 27.2 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.777 0.323 . . . . 71.200000000000003 111.625 178.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 703' ' ' ILE . . . . . 0.547 HG12 ' HB ' ' A' ' 723' ' ' VAL . 54.0 mt -87.49 120.43 36.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 116.712 -0.222 . . . . 73.109999999999999 110.728 174.137 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 704' ' ' LYS . . . . . . . . . . . . . 53.6 tttm -93.11 146.32 23.74 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 120.801 0.334 . . . . 72.299999999999997 110.892 173.497 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 44.5 t -104.3 146.33 11.83 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-O 120.952 0.406 . . . . 74.430000000000007 110.887 176.349 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 706' ' ' ASP . . . . . 0.508 ' HB3' ' HB ' ' A' ' 720' ' ' THR . 32.3 t70 -135.01 129.96 34.96 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 120.899 0.38 . . . . 73.239999999999995 110.738 174.507 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 101.34 175.88 28.76 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 121.439 -0.41 . . . . 71.540000000000006 112.404 -176.368 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 708' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -151.86 144.7 24.39 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 117.076 0.438 . . . . 71.040000000000006 111.908 -178.6 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 709' ' ' VAL . . . . . 0.508 HG22 ' HB2' ' A' ' 717' ' ' TYR . 97.1 t -114.07 111.45 36.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-N 116.437 -0.347 . . . . 71.129999999999995 111.305 178.457 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 710' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -70.01 136.11 50.06 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 120.946 0.403 . . . . 73.349999999999994 111.264 176.34 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 711' ' ' THR . . . . . . . . . . . . . 70.7 p -106.36 -6.73 18.1 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 112.131 0.419 . . . . 74.340000000000003 112.131 -178.593 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 712' ' ' THR . . . . . . . . . . . . . 11.7 t -100.25 0.28 39.96 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 111.973 0.36 . . . . 74.239999999999995 111.973 177.468 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 713' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -144.03 134.06 24.12 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 120.692 0.282 . . . . 74.319999999999993 111.279 -177.332 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 714' ' ' ALA . . . . . . . . . . . . . . . -76.62 144.55 39.47 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 112.359 0.503 . . . . 72.120000000000005 112.359 -176.565 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 158.03 168.3 20.15 Favored Glycine 0 CA--C 1.525 0.718 0 CA-C-N 116.025 -0.534 . . . . 53.140000000000001 112.487 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 716' ' ' THR . . . . . . . . . . . . . 91.3 m -96.39 123.48 40.06 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 122.295 -0.532 . . . . 74.420000000000002 111.477 178.302 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 717' ' ' TYR . . . . . 0.508 ' HB2' HG22 ' A' ' 709' ' ' VAL . 33.3 m-85 -119.52 141.51 49.14 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 116.404 -0.362 . . . . 75.340000000000003 110.755 -178.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 718' ' ' VAL . . . . . . . . . . . . . 72.9 t -113.26 131.35 65.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 CA-C-O 120.893 0.378 . . . . 72.409999999999997 111.383 178.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 719' ' ' LEU . . . . . 0.423 HD21 HG23 ' A' ' 709' ' ' VAL . 69.4 mt -116.4 142.15 47.23 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 116.444 -0.344 . . . . 73.120000000000005 111.433 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 720' ' ' THR . . . . . 0.508 ' HB ' ' HB3' ' A' ' 706' ' ' ASP . 93.2 m -114.89 136.13 53.44 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 120.876 0.37 . . . . 52.119999999999997 111.356 178.035 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 721' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -124.71 135.03 52.68 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 116.346 -0.388 . . . . 73.450000000000003 110.947 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 94.6 m -138.21 134.88 35.02 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 111.813 0.301 . . . . 64.140000000000001 111.813 -177.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 723' ' ' VAL . . . . . 0.547 ' HB ' HG12 ' A' ' 703' ' ' ILE . 8.7 p -132.25 146.24 33.39 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 CA-C-O 120.879 0.371 . . . . 75.109999999999999 111.422 179.538 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 56.5 m -119.6 130.29 55.04 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 112.734 0.642 . . . . 71.439999999999998 112.734 -175.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 725' ' ' ASP . . . . . 0.596 ' HB2' ' HD3' ' A' ' 667' ' ' PRO . 12.0 t70 -76.68 155.58 33.24 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.983 -0.553 . . . . 54.240000000000002 110.516 174.492 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 726' ' ' SER . . . . . . . . . . . . . 46.4 t -54.51 -33.65 60.29 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 112.407 0.521 . . . . 75.129999999999995 112.407 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 727' ' ' LYS . . . . . . . . . . . . . 46.7 mmtm -75.96 -14.82 60.24 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 112.239 0.459 . . . . 74.200000000000003 112.239 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 728' ' ' GLY . . . . . . . . . . . . . . . 109.94 4.71 29.49 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 121.112 -0.566 . . . . 52.140000000000001 113.625 -177.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 729' ' ' HIS . . . . . 0.479 ' HB3' ' HB3' ' A' ' 666' ' ' GLU . 24.8 m170 -70.67 102.13 2.22 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 117.519 0.659 . . . . 52.240000000000002 111.353 176.723 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 730' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -98.0 125.26 42.86 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 120.984 0.421 . . . . 73.519999999999996 111.503 179.563 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 731' ' ' VAL . . . . . 0.436 HG22 ' HG2' ' A' ' 667' ' ' PRO . 30.2 m -126.65 154.18 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-O 120.84 0.352 . . . . 61.509999999999998 111.113 176.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 8.8 t -144.42 147.89 33.93 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 121.386 0.612 . . . . 70.230000000000004 112.431 -173.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -147.49 153.67 39.81 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.862 -0.608 . . . . 62.509999999999998 110.576 177.153 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 734' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -123.47 152.04 42.09 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 112.625 0.602 . . . . 64.219999999999999 112.625 -173.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 735' ' ' GLN . . . . . 0.529 ' NE2' ' HG2' ' A' ' 672' ' ' PRO . 54.1 tt0 -130.24 128.34 41.43 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 115.798 -0.637 . . . . 64.540000000000006 111.133 -177.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 736' ' ' THR . . . . . . . . . . . . . 93.9 m -100.26 109.64 21.87 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.848 0.356 . . . . 64.120000000000005 111.428 179.351 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 737' ' ' VAL . . . . . 0.486 HG22 ' HB3' ' A' ' 675' ' ' ALA . 41.0 t -105.33 117.72 51.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-O 120.952 0.406 . . . . 65.439999999999998 111.554 -178.111 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 738' ' ' THR . . . . . . . . . . . . . 91.8 m -102.23 131.1 49.0 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 120.906 0.384 . . . . 45.310000000000002 111.545 178.622 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 739' ' ' VAL . . . . . . . . . . . . . 43.1 t -104.45 131.12 54.13 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-N 116.348 -0.387 . . . . 60.130000000000003 111.535 179.422 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 740' ' ' LYS . . . . . 0.462 ' NZ ' ' HB3' ' A' ' 740' ' ' LYS . 7.7 mtpm? -116.08 155.77 27.56 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 120.902 0.382 . . . . 54.299999999999997 111.305 177.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 741' ' ' VAL . . . . . . . . . . . . . 43.9 t -90.32 140.07 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 N-CA-C 112.093 0.405 . . . . 73.450000000000003 112.093 -177.418 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 742' ' ' ARG . . . . . . . . . . . . . 60.0 mtp85 -88.51 -80.39 0.28 Allowed 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 121.001 0.429 . . . . 70.010000000000005 110.961 174.401 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 743' ' ' GLU . . . . . . . . . . . . . 10.4 mp0 -87.71 116.94 26.2 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 116.522 -0.308 . . . . 73.129999999999995 110.765 177.324 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 744' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -92.73 -179.31 5.12 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 120.942 0.401 . . . . 65.040000000000006 111.941 -177.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 745' ' ' VAL . . . . . 0.728 HG12 ' H ' ' A' ' 747' ' ' ASN . 47.2 t -85.46 140.34 16.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 116.476 -0.329 . . . . 75.129999999999995 111.009 178.723 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -68.84 -25.92 64.9 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.503 0.557 . . . . 63.399999999999999 112.503 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 747' ' ' ASN . . . . . 0.728 ' H ' HG12 ' A' ' 745' ' ' VAL . 18.6 m120 -105.4 153.23 21.96 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 112.483 0.549 . . . . 71.420000000000002 112.483 -174.796 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -71.51 115.14 10.34 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.636 -0.711 . . . . 75.140000000000001 111.862 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 749' ' ' LYS . . . . . . . . . . . . . 20.3 tttp -167.91 74.38 0.92 Allowed Pre-proline 0 CA--C 1.542 0.647 0 CA-C-O 120.914 0.388 . . . . 73.030000000000001 111.462 176.071 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 750' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.31 86.48 1.45 Allowed 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 122.327 2.018 . . . . 71.25 112.232 178.603 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 751' ' ' ILE . . . . . . . . . . . . . 22.6 pt -79.57 4.35 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 N-CA-C 112.553 0.575 . . . . 72.450000000000003 112.553 -178.152 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 752' ' ' LEU . . . . . . . . . . . . . 89.7 mt -104.79 179.33 4.3 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 120.901 0.382 . . . . 74.030000000000001 111.093 175.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 753' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 . . . . . 0 N--CA 1.468 0.467 0 CA-C-O 120.922 0.391 . . . . 74.450000000000003 111.333 179.013 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 762' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 657' ' ' MET . . . . . . . . . . . . . 23.5 ptm . . . . . 0 N--CA 1.488 1.471 0 CA-C-O 120.84 0.352 . . . . 72.230000000000004 111.418 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 658' ' ' GLY . . . . . . . . . . . . . . . 151.33 127.06 1.34 Allowed Glycine 0 CA--C 1.53 0.992 0 C-N-CA 120.919 -0.658 . . . . 63.520000000000003 113.308 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 659' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -154.97 169.44 24.07 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.924 0.392 . . . . 72.340000000000003 111.452 177.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 660' ' ' GLY . . . . . . . . . . . . . . . 159.04 -173.95 35.95 Favored Glycine 0 CA--C 1.524 0.644 0 C-N-CA 121.263 -0.494 . . . . 53.149999999999999 113.029 178.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -135.24 138.13 43.26 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.664 0.269 . . . . 71.420000000000002 110.94 178.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 662' ' ' THR . . . . . . . . . . . . . 7.3 t -133.49 146.9 51.53 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 111.897 0.332 . . . . 43.219999999999999 111.897 -178.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 663' ' ' SER . . . . . . . . . . . . . 50.7 m -86.56 136.92 32.89 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 120.788 0.327 . . . . 63.439999999999998 111.597 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 664' ' ' ASP . . . . . 0.528 ' CG ' ' HG3' ' A' ' 727' ' ' LYS . 12.3 t70 -85.75 155.68 20.94 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 120.927 0.394 . . . . 74.420000000000002 111.291 177.507 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 665' ' ' LEU . . . . . 0.513 HD12 ' HD2' ' A' ' 694' ' ' LYS . 73.2 mt -102.84 137.74 40.65 Favored 'General case' 0 C--O 1.242 0.678 0 N-CA-C 112.268 0.47 . . . . 73.129999999999995 112.268 -176.191 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 666' ' ' GLU . . . . . 0.496 ' HG3' ' HB3' ' A' ' 729' ' ' HIS . 3.5 mp0 -67.58 151.62 97.0 Favored Pre-proline 0 CA--C 1.544 0.719 0 CA-C-N 115.957 -0.565 . . . . 71.340000000000003 111.005 176.513 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 667' ' ' PRO . . . . . 0.623 ' HD3' ' HB2' ' A' ' 725' ' ' ASP . 61.3 Cg_endo -72.7 153.72 54.14 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 122.659 2.239 . . . . 74.129999999999995 113.429 -178.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 668' ' ' LYS . . . . . . . . . . . . . 13.0 tmtt? -92.3 105.15 17.41 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.104 0.478 . . . . 75.409999999999997 110.496 178.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 669' ' ' LEU . . . . . . . . . . . . . 57.9 tp -94.88 120.04 34.44 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 116.173 -0.467 . . . . 71.230000000000004 111.29 -179.122 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 670' ' ' THR . . . . . . . . . . . . . 90.2 m -102.22 110.79 22.84 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 120.832 0.349 . . . . 75.129999999999995 111.151 -179.356 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 671' ' ' VAL . . . . . 0.491 HG22 HG13 ' A' ' 689' ' ' VAL . 87.6 t -135.42 126.54 17.3 Favored Pre-proline 0 N--CA 1.472 0.673 0 CA-C-N 116.072 -0.513 . . . . 63.140000000000001 111.065 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 672' ' ' PRO . . . . . 0.52 ' HG2' ' NE2' ' A' ' 735' ' ' GLN . 62.0 Cg_endo -73.21 145.41 38.91 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 122.241 1.961 . . . . 74.010000000000005 112.19 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 673' ' ' VAL . . . . . . . . . . . . . 13.9 p -65.14 -32.8 59.84 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 N-CA-C 112.098 0.407 . . . . 63.109999999999999 112.098 -178.034 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 674' ' ' GLY . . . . . . . . . . . . . . . -162.05 147.54 13.87 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 120.77 -0.729 . . . . 42.140000000000001 113.408 -179.246 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 675' ' ' ALA . . . . . . . . . . . . . . . -136.09 139.62 43.14 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 122.647 0.379 . . . . 61.219999999999999 110.802 179.326 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 676' ' ' THR . . . . . . . . . . . . . 92.1 m -117.36 124.13 48.16 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.547 0.573 . . . . 73.530000000000001 112.547 -175.207 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 677' ' ' ILE . . . . . . . . . . . . . 33.7 pt -130.46 177.09 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 CA-C-N 116.292 -0.413 . . . . 75.120000000000005 110.517 175.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 678' ' ' HIS . . . . . . . . . . . . . 76.5 m80 -114.31 168.76 9.57 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 121.232 0.539 . . . . 73.200000000000003 111.787 175.461 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 679' ' ' VAL . . . . . . . . . . . . . 96.6 t -63.55 117.93 5.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 116.182 -0.463 . . . . 65.519999999999996 110.654 175.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 95.32 8.21 58.86 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 121.419 -0.42 . . . . 64.400000000000006 113.135 -178.445 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 681' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -94.03 166.1 12.31 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.073 0.463 . . . . 63.109999999999999 111.43 178.214 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 682' ' ' SER . . . . . . . . . . . . . 47.2 m -93.54 149.42 21.25 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.22 -0.445 . . . . 75.219999999999999 111.421 -179.432 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 683' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -151.6 116.41 5.18 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.722 0.296 . . . . 65.010000000000005 110.761 178.464 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 684' ' ' VAL . . . . . 0.4 ' HA ' ' HD2' ' A' ' 685' ' ' PRO . 28.8 t -117.01 92.57 39.57 Favored Pre-proline 0 CA--C 1.544 0.727 0 CA-C-O 121.126 0.489 . . . . 74.349999999999994 111.522 -178.453 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 685' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 684' ' ' VAL . 30.6 Cg_endo -62.27 -31.89 82.07 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 122.606 2.204 . . . . 73.420000000000002 112.963 -177.692 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 686' ' ' MET . . . . . 0.428 ' HA ' ' HE3' ' A' ' 686' ' ' MET . 0.7 OUTLIER -78.85 -1.39 34.75 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 112.248 0.462 . . . . 73.120000000000005 112.248 -178.403 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 687' ' ' ALA . . . . . . . . . . . . . . . -104.61 -30.14 10.17 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.088 0.47 . . . . 71.319999999999993 111.31 175.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 688' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -91.19 -28.17 18.02 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 116.343 -0.39 . . . . 74.329999999999998 111.85 -179.115 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 689' ' ' VAL . . . . . 0.491 HG13 HG22 ' A' ' 671' ' ' VAL . 80.2 t -98.15 124.7 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-O 120.922 0.391 . . . . 64.140000000000001 111.413 178.417 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 690' ' ' LEU . . . . . 0.429 HD12 ' C ' ' A' ' 689' ' ' VAL . 7.3 mp -126.04 154.46 42.96 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 116.234 -0.439 . . . . 65.140000000000001 111.619 -178.467 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 691' ' ' ALA . . . . . . . . . . . . . . . -137.39 122.26 18.85 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.796 0.331 . . . . 71.140000000000001 111.058 177.548 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 692' ' ' ILE . . . . . . . . . . . . . 50.2 mm -129.09 117.27 43.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 CA-C-O 120.842 0.353 . . . . 71.150000000000006 111.653 -176.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 693' ' ' ASP . . . . . 0.467 ' HB2' HD12 ' A' ' 699' ' ' LEU . 34.4 t70 -95.19 149.66 21.07 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.535 -0.302 . . . . 71.319999999999993 110.481 176.184 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 694' ' ' LYS . . . . . 0.513 ' HD2' HD12 ' A' ' 665' ' ' LEU . 30.9 ttmt -72.41 -43.29 64.09 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 112.837 0.68 . . . . 74.409999999999997 112.837 -171.121 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -84.09 -45.9 12.53 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 121.696 -0.627 . . . . 72.030000000000001 111.278 177.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 696' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -74.43 -48.99 24.21 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 112.206 0.447 . . . . 71.230000000000004 112.206 -175.311 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . 112.14 -117.79 4.51 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 121.0 -0.619 . . . . 72.450000000000003 112.647 -176.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -78.09 117.52 19.46 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 122.118 -0.636 . . . . 54.140000000000001 111.935 -179.182 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 699' ' ' LEU . . . . . 0.516 HD12 ' HB3' ' A' ' 667' ' ' PRO . 73.5 mt -117.24 14.05 14.74 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.126 -0.488 . . . . 52.219999999999999 110.726 172.246 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 33.5 m -58.66 -34.58 71.39 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.017 0.437 . . . . 71.430000000000007 111.251 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 701' ' ' SER . . . . . . . . . . . . . 80.2 p -70.31 -17.82 63.09 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 116.504 -0.316 . . . . 75.019999999999996 111.757 177.544 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 702' ' ' LYS . . . . . . . . . . . . . 45.3 mmtm -91.22 3.29 55.21 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 111.814 0.302 . . . . 71.239999999999995 111.814 -178.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 703' ' ' ILE . . . . . 0.444 HD13 HG12 ' A' ' 689' ' ' VAL . 67.3 mt -76.36 125.73 36.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-O 121.195 0.522 . . . . 72.040000000000006 111.754 -179.491 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 704' ' ' LYS . . . . . . . . . . . . . 58.4 mttp -92.9 123.93 36.52 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.191 -0.459 . . . . 64.340000000000003 110.741 172.475 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 51.9 t -95.85 106.94 18.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.935 -0.575 . . . . 72.409999999999997 110.808 179.106 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 706' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -100.04 134.0 43.6 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 120.912 0.387 . . . . 71.319999999999993 111.456 -178.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 118.24 -168.96 13.23 Favored Glycine 0 CA--C 1.525 0.659 0 CA-C-N 116.293 -0.412 . . . . 53.109999999999999 112.68 -178.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 708' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -158.05 137.61 11.98 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.967 0.413 . . . . 63.229999999999997 111.72 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 709' ' ' VAL . . . . . 0.448 HG22 ' HB2' ' A' ' 717' ' ' TYR . 62.7 t -126.34 123.11 62.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-N 116.459 -0.337 . . . . 51.25 111.127 179.42 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 710' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -93.47 142.22 27.58 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 121.202 0.525 . . . . 64.329999999999998 111.332 177.295 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 711' ' ' THR . . . . . . . . . . . . . 47.6 p -101.54 -9.44 21.01 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.806 -0.634 . . . . 70.109999999999999 112.278 -178.345 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 712' ' ' THR . . . . . . . . . . . . . 59.6 p -103.05 -0.09 31.27 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 113.099 0.777 . . . . 63.509999999999998 113.099 -177.164 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 713' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -144.14 136.57 26.74 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 122.067 -0.396 . . . . 65.200000000000003 111.332 175.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 714' ' ' ALA . . . . . . . . . . . . . . . -70.08 144.48 52.12 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 112.393 0.516 . . . . 62.0 112.393 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 161.28 166.7 20.52 Favored Glycine 0 CA--C 1.525 0.679 0 CA-C-N 116.108 -0.497 . . . . 74.409999999999997 112.729 -179.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 716' ' ' THR . . . . . . . . . . . . . 53.2 m -101.12 124.52 46.96 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 122.357 -0.496 . . . . 71.329999999999998 111.182 178.573 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 717' ' ' TYR . . . . . 0.448 ' HB2' HG22 ' A' ' 709' ' ' VAL . 30.2 m-85 -121.75 133.47 54.93 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 116.198 -0.456 . . . . 75.209999999999994 110.762 -177.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 718' ' ' VAL . . . . . . . . . . . . . 58.8 t -94.96 133.06 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-O 120.82 0.343 . . . . 71.329999999999998 111.614 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 719' ' ' LEU . . . . . 0.404 HD21 HG23 ' A' ' 709' ' ' VAL . 96.4 mt -119.79 127.66 53.0 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.802 0.334 . . . . 75.340000000000003 111.116 177.534 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 91.8 m -111.68 120.67 42.83 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 120.752 0.311 . . . . 63.229999999999997 110.912 178.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 721' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -104.78 120.04 40.43 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.591 -0.277 . . . . 74.329999999999998 111.186 -178.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 59.9 m -122.55 123.46 41.29 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 120.674 0.273 . . . . 73.310000000000002 111.168 178.144 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 10.4 p -119.14 147.18 22.85 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 CA-C-O 121.008 0.432 . . . . 72.340000000000003 111.906 -177.392 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 76.2 m -110.21 133.57 53.1 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 112.303 0.482 . . . . 74.299999999999997 112.303 -177.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 725' ' ' ASP . . . . . 0.623 ' HB2' ' HD3' ' A' ' 667' ' ' PRO . 50.2 t0 -73.62 154.64 39.67 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 115.888 -0.597 . . . . 62.240000000000002 111.216 176.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 726' ' ' SER . . . . . . . . . . . . . 40.4 t -58.24 -28.58 65.02 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.036 0.446 . . . . 52.25 111.178 176.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 727' ' ' LYS . . . . . 0.528 ' HG3' ' CG ' ' A' ' 664' ' ' ASP . 36.8 mmtm -90.28 -11.01 42.08 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 111.97 0.359 . . . . 75.030000000000001 111.97 177.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 728' ' ' GLY . . . . . . . . . . . . . . . 112.4 -1.23 26.51 Favored Glycine 0 CA--C 1.533 1.171 0 N-CA-C 114.688 0.635 . . . . 71.409999999999997 114.688 179.059 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 729' ' ' HIS . . . . . 0.543 ' H ' ' HB3' ' A' ' 725' ' ' ASP . 34.7 m80 -68.54 105.21 2.16 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 118.12 0.96 . . . . 74.310000000000002 110.989 176.121 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 730' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -96.32 125.88 41.13 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 120.802 0.334 . . . . 75.209999999999994 110.942 -179.379 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 35.9 m -127.02 158.11 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-O 120.699 0.285 . . . . 63.409999999999997 111.079 178.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 5.3 t -143.52 149.76 37.95 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 112.755 0.65 . . . . 62.299999999999997 112.755 -174.602 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -148.37 154.59 40.15 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.771 -0.65 . . . . 60.200000000000003 110.343 176.399 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 734' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -119.86 154.86 33.71 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 113.159 0.8 . . . . 71.430000000000007 113.159 -174.149 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 735' ' ' GLN . . . . . 0.52 ' NE2' ' HG2' ' A' ' 672' ' ' PRO . 52.5 tt0 -136.67 124.12 22.09 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.5 -0.773 . . . . 62.310000000000002 110.652 177.489 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 736' ' ' THR . . . . . . . . . . . . . 99.8 m -93.93 105.78 17.78 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.104 0.478 . . . . 75.109999999999999 111.055 176.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 45.6 t -96.77 141.33 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-O 120.709 0.29 . . . . 71.299999999999997 111.59 -176.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 738' ' ' THR . . . . . . . . . . . . . 88.8 m -128.7 122.91 31.79 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.25 0.548 . . . . 43.399999999999999 112.269 -179.231 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 739' ' ' VAL . . . . . . . . . . . . . 47.2 t -95.57 124.57 48.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-N 115.754 -0.657 . . . . 75.400000000000006 110.788 176.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 740' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -102.95 151.67 22.21 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.417 0.627 . . . . 72.25 112.079 -176.38 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 741' ' ' VAL . . . . . . . . . . . . . 93.9 t -74.51 147.65 8.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 115.77 -0.65 . . . . 74.340000000000003 112.264 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 742' ' ' ARG . . . . . 0.422 HH11 ' HD2' ' A' ' 742' ' ' ARG . 13.5 ptt85 -145.96 -33.35 0.33 Allowed 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.44 -0.345 . . . . 61.219999999999999 111.837 168.323 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 743' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -136.4 99.78 4.19 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 120.787 0.327 . . . . 44.439999999999998 111.808 178.384 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 744' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -89.91 19.55 4.77 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 121.125 0.488 . . . . 74.25 111.633 177.413 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 32.3 m -80.26 168.16 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-O 121.206 0.527 . . . . 63.240000000000002 112.07 -179.097 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 746' ' ' LYS . . . . . 0.428 ' O ' ' HG3' ' A' ' 746' ' ' LYS . 24.7 pttm -132.18 108.48 9.29 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.208 0.528 . . . . 63.340000000000003 110.866 174.422 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 747' ' ' ASN . . . . . . . . . . . . . 37.2 m-20 -69.71 120.18 15.08 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.461 -0.336 . . . . 74.150000000000006 110.672 179.065 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -71.86 77.69 0.88 Allowed 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 121.405 0.622 . . . . 71.420000000000002 110.797 -178.522 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 749' ' ' LYS . . . . . 0.478 ' NZ ' ' HB2' ' A' ' 749' ' ' LYS . 5.1 ttmp? -172.96 94.11 0.37 Allowed Pre-proline 0 CA--C 1.538 0.498 0 CA-C-N 115.361 -0.836 . . . . 72.409999999999997 110.532 179.033 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 750' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.2 133.94 16.89 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 122.302 2.001 . . . . 72.239999999999995 112.894 -178.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 751' ' ' ILE . . . . . 0.455 HD12 ' N ' ' A' ' 751' ' ' ILE . 2.3 mp -61.37 109.52 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-O 120.851 0.358 . . . . 70.140000000000001 110.235 176.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 752' ' ' LEU . . . . . . . . . . . . . 66.2 mt -68.85 111.92 5.22 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 120.896 0.379 . . . . 64.519999999999996 112.014 -174.557 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 753' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 . . . . . 0 C--O 1.237 0.442 0 CA-C-N 115.735 -0.666 . . . . 74.439999999999998 112.337 174.909 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 762' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 657' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 120.644 0.259 . . . . 75.439999999999998 110.686 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 658' ' ' GLY . . . . . . . . . . . . . . . 81.0 -58.63 4.81 Favored Glycine 0 CA--C 1.53 0.975 0 N-CA-C 114.382 0.513 . . . . 41.409999999999997 114.382 173.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 659' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -66.29 147.32 53.49 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.146 0.498 . . . . 75.530000000000001 112.271 -175.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 660' ' ' GLY . . . . . . . . . . . . . . . -90.02 169.59 35.22 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 121.279 -0.486 . . . . 32.25 113.358 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -108.69 175.91 5.3 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.101 0.477 . . . . 72.329999999999998 111.635 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 662' ' ' THR . . . . . . . . . . . . . 67.5 p -87.37 108.16 18.86 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 112.091 0.404 . . . . 72.209999999999994 112.091 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 663' ' ' SER . . . . . . . . . . . . . 68.6 m -84.53 132.66 34.5 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 120.717 0.294 . . . . 74.299999999999997 111.375 177.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 664' ' ' ASP . . . . . 0.699 ' HB2' ' HE2' ' A' ' 727' ' ' LYS . 16.1 t70 -74.27 141.97 45.29 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 121.123 0.487 . . . . 73.109999999999999 111.818 179.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 665' ' ' LEU . . . . . . . . . . . . . 70.1 mt -85.39 119.01 25.27 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.135 -0.484 . . . . 63.32 109.697 173.228 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 666' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -67.68 145.33 98.09 Favored Pre-proline 0 CA--C 1.54 0.56 0 CA-C-O 120.671 0.272 . . . . 71.349999999999994 111.308 -177.281 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 667' ' ' PRO . . . . . 0.431 ' HB3' HD12 ' A' ' 699' ' ' LEU . 78.9 Cg_endo -75.8 146.26 29.7 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.405 2.07 . . . . 61.109999999999999 113.193 -173.379 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 668' ' ' LYS . . . . . . . . . . . . . 4.9 tmtm? -88.28 109.18 19.75 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 109.89 -0.411 . . . . 74.019999999999996 109.89 177.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 669' ' ' LEU . . . . . 0.414 ' HG ' HG23 ' A' ' 671' ' ' VAL . 58.0 tp -93.01 106.16 18.15 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.071 0.463 . . . . 74.129999999999995 110.543 176.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 670' ' ' THR . . . . . . . . . . . . . 86.9 m -86.62 110.7 20.01 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.263 -0.426 . . . . 72.129999999999995 111.391 -178.61 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 671' ' ' VAL . . . . . 0.414 HG23 ' HG ' ' A' ' 669' ' ' LEU . 95.0 t -137.95 128.34 15.48 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 122.629 0.372 . . . . 43.229999999999997 111.091 -178.76 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 672' ' ' PRO . . . . . 0.431 ' HG2' ' NE2' ' A' ' 735' ' ' GLN . 73.6 Cg_endo -77.84 132.28 11.76 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 122.212 1.941 . . . . 72.219999999999999 111.809 177.143 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 673' ' ' VAL . . . . . . . . . . . . . 14.3 p -64.76 -30.61 50.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 N-CA-C 112.496 0.554 . . . . 62.439999999999998 112.496 -175.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 674' ' ' GLY . . . . . . . . . . . . . . . -151.81 142.6 9.57 Favored Glycine 0 CA--C 1.525 0.666 0 C-N-CA 120.811 -0.709 . . . . 62.140000000000001 113.571 -177.268 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 675' ' ' ALA . . . . . . . . . . . . . . . -140.48 157.69 45.12 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 122.49 0.316 . . . . 70.0 110.922 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 676' ' ' THR . . . . . . . . . . . . . 54.9 m -136.05 128.81 30.96 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.103 0.477 . . . . 34.200000000000003 111.797 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 677' ' ' ILE . . . . . . . . . . . . . 39.8 pt -132.49 177.64 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-N 116.085 -0.507 . . . . 72.030000000000001 110.987 177.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 678' ' ' HIS . . . . . . . . . . . . . 58.4 m80 -122.44 156.75 33.4 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.151 0.501 . . . . 73.340000000000003 112.276 178.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 679' ' ' VAL . . . . . . . . . . . . . 89.4 t -61.5 128.74 23.42 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 115.824 -0.626 . . . . 53.420000000000002 111.39 176.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 99.81 -17.04 57.95 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 121.356 -0.45 . . . . 73.0 113.031 -178.482 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 681' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -79.08 177.26 8.94 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 121.224 0.535 . . . . 72.099999999999994 112.248 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 682' ' ' SER . . . . . . . . . . . . . 48.5 m -104.46 145.23 30.57 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.913 -0.585 . . . . 52.399999999999999 110.516 176.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 683' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -148.7 113.05 5.27 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.913 0.387 . . . . 75.140000000000001 111.557 179.068 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 684' ' ' VAL . . . . . . . . . . . . . 63.6 t -111.61 102.33 53.1 Favored Pre-proline 0 CA--C 1.543 0.675 0 CA-C-N 116.257 -0.429 . . . . 70.030000000000001 110.616 176.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -56.91 -42.62 62.52 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 122.731 2.287 . . . . 73.040000000000006 113.658 -177.06 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 686' ' ' MET . . . . . . . . . . . . . 15.8 mtp -79.17 -12.29 59.98 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 113.06 0.763 . . . . 73.109999999999999 113.06 -176.132 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 687' ' ' ALA . . . . . . . . . . . . . . . -79.17 -18.47 53.02 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 122.017 -0.427 . . . . 45.310000000000002 111.207 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 688' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -114.34 9.74 16.97 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 112.178 0.436 . . . . 45.130000000000003 112.178 -178.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 689' ' ' VAL . . . . . 0.437 HG21 ' CZ ' ' A' ' 721' ' ' TYR . 86.8 t -123.0 124.72 70.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-O 120.879 0.371 . . . . 73.310000000000002 110.939 178.106 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 690' ' ' LEU . . . . . . . . . . . . . 6.4 mp -119.7 157.63 28.14 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.165 0.507 . . . . 72.409999999999997 111.534 -177.176 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 691' ' ' ALA . . . . . . . . . . . . . . . -148.54 123.48 10.01 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.963 -0.562 . . . . 64.530000000000001 110.557 176.334 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 692' ' ' ILE . . . . . . . . . . . . . 41.5 mm -131.91 131.4 61.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 N-CA-C 112.404 0.52 . . . . 74.209999999999994 112.404 -174.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -115.33 130.94 57.05 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.121 -0.491 . . . . 61.219999999999999 109.741 168.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -61.76 -32.35 72.6 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.113 0.482 . . . . 63.409999999999997 111.403 -177.472 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -83.72 -54.32 5.0 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 112.504 0.557 . . . . 74.299999999999997 112.504 -176.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 696' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -77.57 -42.98 33.26 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 120.811 0.339 . . . . 61.32 111.59 -178.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . 121.07 -139.79 13.59 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 121.544 -0.36 . . . . 73.510000000000005 113.001 -178.482 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -71.73 111.85 7.35 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.052 0.453 . . . . 63.5 111.102 178.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 699' ' ' LEU . . . . . 0.472 HD22 ' HG3' ' A' ' 702' ' ' LYS . 67.0 mt -100.72 9.12 42.83 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.446 -0.343 . . . . 74.299999999999997 111.319 176.155 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 31.2 m -59.7 -36.88 77.41 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.108 0.48 . . . . 65.109999999999999 111.247 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 701' ' ' SER . . . . . . . . . . . . . 47.1 m -81.99 3.13 27.72 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 116.328 -0.396 . . . . 73.25 111.738 176.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 702' ' ' LYS . . . . . 0.472 ' HG3' HD22 ' A' ' 699' ' ' LEU . 33.5 mmtp -103.48 3.96 35.47 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 120.816 0.341 . . . . 71.109999999999999 110.914 179.558 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 70.2 mt -84.42 116.77 28.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 N-CA-C 112.235 0.457 . . . . 71.200000000000003 112.235 -174.214 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 704' ' ' LYS . . . . . . . . . . . . . 61.2 tttp -84.83 122.53 29.28 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 120.689 0.28 . . . . 62.32 110.581 172.221 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 47.8 t -99.28 141.15 17.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-O 121.235 0.541 . . . . 72.200000000000003 112.024 -177.392 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 706' ' ' ASP . . . . . 0.603 ' HB3' ' HB ' ' A' ' 720' ' ' THR . 23.7 t70 -130.31 151.82 50.4 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.77 -0.65 . . . . 74.319999999999993 110.073 176.271 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 93.42 167.05 38.15 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 120.974 -0.631 . . . . 61.219999999999999 112.37 -174.367 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 708' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -144.5 142.8 30.5 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 122.346 -0.502 . . . . 72.120000000000005 111.997 -176.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 709' ' ' VAL . . . . . 0.54 HG23 HD21 ' A' ' 719' ' ' LEU . 95.7 t -122.09 132.52 70.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 CA-C-O 120.885 0.374 . . . . 72.319999999999993 111.158 176.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 710' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -98.32 138.12 36.04 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.002 0.43 . . . . 53.329999999999998 111.367 176.271 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 711' ' ' THR . . . . . . . . . . . . . 68.0 p -94.01 -25.45 17.22 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.937 0.398 . . . . 75.439999999999998 111.236 177.547 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 712' ' ' THR . . . . . . . . . . . . . 12.5 t -90.7 -7.04 53.65 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.0 0.429 . . . . 73.310000000000002 111.994 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 713' ' ' LYS . . . . . . . . . . . . . 28.2 tptp -130.42 125.79 35.37 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.704 0.288 . . . . 74.319999999999993 111.259 -177.194 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 714' ' ' ALA . . . . . . . . . . . . . . . -74.9 144.18 43.44 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 120.826 0.346 . . . . 74.319999999999993 111.466 178.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 159.03 164.4 14.38 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 121.073 -0.584 . . . . 75.319999999999993 113.313 -179.533 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 716' ' ' THR . . . . . . . . . . . . . 99.2 m -96.04 128.85 43.3 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 122.495 -0.415 . . . . 64.430000000000007 111.216 178.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 717' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -126.76 149.59 49.55 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.027 0.442 . . . . 74.109999999999999 111.574 -179.513 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 718' ' ' VAL . . . . . . . . . . . . . 40.6 t -117.07 114.0 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 121.079 0.466 . . . . 75.420000000000002 111.264 178.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 719' ' ' LEU . . . . . 0.54 HD21 HG23 ' A' ' 709' ' ' VAL . 81.2 mt -96.26 143.01 27.73 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.09 -0.505 . . . . 64.109999999999999 111.179 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 720' ' ' THR . . . . . 0.603 ' HB ' ' HB3' ' A' ' 706' ' ' ASP . 78.0 m -118.82 136.1 54.19 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.913 0.387 . . . . 61.340000000000003 111.154 177.582 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 721' ' ' TYR . . . . . 0.437 ' CZ ' HG21 ' A' ' 689' ' ' VAL . 72.6 m-85 -120.57 134.36 55.29 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.491 -0.322 . . . . 73.040000000000006 110.906 179.55 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 25.5 m -134.46 126.22 29.03 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 116.626 -0.261 . . . . 72.439999999999998 110.914 -178.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 8.8 p -132.49 135.78 57.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 CA-C-O 120.929 0.395 . . . . 65.209999999999994 111.611 -179.217 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 43.0 m -107.96 131.68 54.29 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 120.983 0.421 . . . . 61.039999999999999 111.924 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 725' ' ' ASP . . . . . 0.424 ' HB3' ' H ' ' A' ' 729' ' ' HIS . 10.0 t70 -73.35 166.39 23.28 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.967 -0.56 . . . . 70.109999999999999 111.131 178.533 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 726' ' ' SER . . . . . . . . . . . . . 45.3 t -63.17 -40.74 98.4 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 116.372 -0.376 . . . . 61.409999999999997 111.854 178.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 727' ' ' LYS . . . . . 0.699 ' HE2' ' HB2' ' A' ' 664' ' ' ASP . 30.8 mtmm -107.23 25.53 11.29 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 113.773 1.027 . . . . 73.150000000000006 113.773 -177.325 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 728' ' ' GLY . . . . . . . . . . . . . . . 110.16 -5.97 30.44 Favored Glycine 0 CA--C 1.536 1.376 0 N-CA-C 116.645 1.418 . . . . 74.510000000000005 116.645 165.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 729' ' ' HIS . . . . . 0.424 ' H ' ' HB3' ' A' ' 725' ' ' ASP . 18.9 m80 -80.31 104.21 10.7 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 118.936 1.368 . . . . 75.010000000000005 111.958 179.168 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 730' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -103.28 115.74 31.14 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.986 0.422 . . . . 74.0 111.718 -178.23 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 48.0 t -108.74 149.58 11.92 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 CA-C-N 116.414 -0.357 . . . . 54.240000000000002 111.512 -176.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 7.7 t -143.32 143.97 31.91 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 112.502 0.556 . . . . 63.310000000000002 112.502 -178.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -148.7 161.57 41.5 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 116.414 -0.357 . . . . 70.109999999999999 111.234 178.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 734' ' ' LYS . . . . . . . . . . . . . 99.9 mttt -127.22 152.63 47.14 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 112.728 0.64 . . . . 75.200000000000003 112.728 -177.479 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 735' ' ' GLN . . . . . 0.431 ' NE2' ' HG2' ' A' ' 672' ' ' PRO . 50.0 tt0 -130.49 128.48 41.31 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 115.911 -0.586 . . . . 63.009999999999998 111.13 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 736' ' ' THR . . . . . . . . . . . . . 86.8 m -97.41 109.14 21.95 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.117 0.484 . . . . 73.329999999999998 111.23 176.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 45.4 t -101.16 129.07 52.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-O 120.972 0.415 . . . . 74.430000000000007 111.538 -179.096 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 738' ' ' THR . . . . . . . . . . . . . 40.4 m -108.94 113.75 26.92 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.521 -0.309 . . . . 64.120000000000005 111.255 179.038 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 739' ' ' VAL . . . . . . . . . . . . . 21.8 t -93.07 118.89 39.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-O 120.564 0.221 . . . . 63.329999999999998 110.577 177.097 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 740' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -112.46 158.97 19.22 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 120.994 0.426 . . . . 72.420000000000002 111.618 -176.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 741' ' ' VAL . . . . . . . . . . . . . 38.3 t -85.39 148.85 4.5 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 N-CA-C 113.248 0.833 . . . . 53.32 113.248 -170.632 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 742' ' ' ARG . . . . . . . . . . . . . 14.9 mmt180 -79.98 150.89 30.3 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.719 -0.673 . . . . 74.019999999999996 111.053 173.047 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 743' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -101.77 31.17 3.96 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.246 0.546 . . . . 74.200000000000003 110.578 175.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 744' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -119.35 18.01 12.97 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 116.193 -0.458 . . . . 71.109999999999999 111.41 -174.467 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 28.4 m -86.31 121.31 37.34 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 N-CA-C 112.911 0.708 . . . . 72.140000000000001 112.911 -171.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -140.7 -71.41 0.37 Allowed 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 121.176 0.513 . . . . 74.209999999999994 111.291 176.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 747' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -132.74 59.08 1.74 Allowed 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 121.514 0.673 . . . . 64.340000000000003 110.019 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -80.04 72.82 6.84 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.606 -0.725 . . . . 73.040000000000006 112.292 -171.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 749' ' ' LYS . . . . . 0.727 ' HA ' ' HE3' ' A' ' 749' ' ' LYS . 0.0 OUTLIER 46.85 84.64 0.19 Allowed Pre-proline 0 CA--C 1.545 0.765 0 N-CA-C 113.815 1.042 . . . . 71.120000000000005 113.815 176.022 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 750' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_exo -73.85 52.15 2.51 Favored 'Trans proline' 0 CA--C 1.544 1.006 0 C-N-CA 122.889 2.393 . . . . 75.310000000000002 111.72 171.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 751' ' ' ILE . . . . . . . . . . . . . 29.8 pt -97.9 169.27 1.52 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 N-CA-C 112.127 0.417 . . . . 73.25 112.127 -174.144 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 752' ' ' LEU . . . . . . . . . . . . . 42.9 tp -147.24 -21.03 0.39 Allowed 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 112.266 0.469 . . . . 65.129999999999995 112.266 178.165 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 753' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 . . . . . 0 N--CA 1.468 0.46 0 O-C-N 122.061 -0.399 . . . . 63.240000000000002 111.322 -176.438 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 762' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 657' ' ' MET . . . . . . . . . . . . . 66.7 mtt . . . . . 0 N--CA 1.488 1.445 0 CA-C-O 120.801 0.334 . . . . 65.120000000000005 110.984 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 658' ' ' GLY . . . . . . . . . . . . . . . -163.98 -155.41 8.27 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 121.299 -0.477 . . . . 71.329999999999998 112.919 179.499 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 659' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -117.35 -168.94 1.57 Allowed 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 121.076 0.465 . . . . 75.019999999999996 112.092 -177.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 660' ' ' GLY . . . . . . . . . . . . . . . 148.3 96.76 0.17 Allowed Glycine 0 CA--C 1.526 0.751 0 CA-C-N 115.827 -0.624 . . . . 34.009999999999998 111.816 -176.129 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 64.19 86.21 0.13 Allowed 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.318 0.58 . . . . 75.200000000000003 110.351 -174.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 662' ' ' THR . . . . . . . . . . . . . 49.9 m -119.97 93.65 4.13 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.437 -0.347 . . . . 72.109999999999999 111.097 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 663' ' ' SER . . . . . . . . . . . . . 70.3 m -70.53 142.36 51.83 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.92 0.391 . . . . 74.120000000000005 111.371 179.168 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 664' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -74.03 122.3 22.42 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 121.126 0.489 . . . . 72.219999999999999 111.649 -178.397 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 665' ' ' LEU . . . . . 0.48 HD12 ' HD3' ' A' ' 694' ' ' LYS . 84.0 mt -80.65 117.11 21.05 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.846 -0.615 . . . . 72.400000000000006 109.621 173.574 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 666' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -60.09 142.54 89.34 Favored Pre-proline 0 CA--C 1.542 0.663 0 CA-C-N 116.247 -0.433 . . . . 75.430000000000007 111.6 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 667' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -75.54 155.11 40.43 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 122.536 2.157 . . . . 73.420000000000002 113.795 -169.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 668' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -86.23 102.55 14.04 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.94 -0.573 . . . . 73.540000000000006 110.845 176.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 669' ' ' LEU . . . . . . . . . . . . . 55.2 tp -93.47 105.9 17.91 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 120.958 0.408 . . . . 73.430000000000007 110.64 177.356 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 670' ' ' THR . . . . . . . . . . . . . 87.4 m -89.18 110.98 21.66 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.361 -0.381 . . . . 63.299999999999997 111.616 -177.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 671' ' ' VAL . . . . . 0.573 HG22 HG13 ' A' ' 689' ' ' VAL . 88.6 t -138.16 134.52 17.85 Favored Pre-proline 0 CA--C 1.539 0.555 0 CA-C-N 116.259 -0.428 . . . . 74.400000000000006 110.672 179.359 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 672' ' ' PRO . . . . . 0.448 ' HG2' ' NE2' ' A' ' 735' ' ' GLN . 71.7 Cg_endo -76.62 120.78 5.68 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 122.058 1.838 . . . . 55.509999999999998 111.62 175.634 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 673' ' ' VAL . . . . . . . . . . . . . 14.8 p -67.08 -23.2 30.3 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 N-CA-C 112.761 0.652 . . . . 74.340000000000003 112.761 -174.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 674' ' ' GLY . . . . . . . . . . . . . . . -142.93 148.33 20.03 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 120.952 -0.642 . . . . 51.539999999999999 114.041 -177.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 675' ' ' ALA . . . . . . . . . . . . . . . -157.15 151.84 25.55 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.275 0.63 . . . . 72.109999999999999 110.35 178.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 676' ' ' THR . . . . . . . . . . . . . 91.1 m -139.34 124.9 19.34 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 111.897 0.332 . . . . 63.409999999999997 111.897 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 677' ' ' ILE . . . . . . . . . . . . . 25.2 pt -128.67 172.51 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-O 121.225 0.536 . . . . 74.430000000000007 111.689 179.394 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 678' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -110.96 165.4 11.9 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.267 0.556 . . . . 73.010000000000005 111.713 177.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 679' ' ' VAL . . . . . . . . . . . . . 95.2 t -63.28 126.33 21.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 116.113 -0.494 . . . . 43.43 110.696 173.419 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 89.35 1.09 78.99 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 121.425 -0.417 . . . . 72.310000000000002 113.126 -176.571 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 681' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -84.74 177.94 7.84 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 120.937 0.399 . . . . 75.209999999999994 110.713 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 682' ' ' SER . . . . . . . . . . . . . 54.9 m -114.51 150.23 35.2 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 120.972 0.415 . . . . 52.109999999999999 111.365 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 683' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -151.36 131.1 13.18 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 116.129 -0.487 . . . . 64.519999999999996 110.904 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 684' ' ' VAL . . . . . . . . . . . . . 48.6 t -122.37 103.27 38.71 Favored Pre-proline 0 CA--C 1.543 0.677 0 CA-C-O 120.851 0.357 . . . . 65.310000000000002 111.312 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -60.33 -46.97 15.8 Favored 'Trans proline' 0 CA--C 1.545 1.027 0 C-N-CA 122.819 2.346 . . . . 62.240000000000002 113.974 -175.28 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 686' ' ' MET . . . . . . . . . . . . . 91.2 mmm -78.48 -11.85 59.98 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 112.925 0.713 . . . . 74.209999999999994 112.925 -174.503 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 687' ' ' ALA . . . . . . . . . . . . . . . -77.22 -30.19 54.54 Favored 'General case' 0 N--CA 1.467 0.419 0 O-C-N 122.038 -0.414 . . . . 32.049999999999997 111.397 177.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 688' ' ' GLU . . . . . 0.407 ' O ' ' HD3' ' A' ' 672' ' ' PRO . 19.7 mm-40 -97.04 1.74 50.51 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 112.203 0.446 . . . . 61.329999999999998 112.203 -178.042 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 689' ' ' VAL . . . . . 0.573 HG13 HG22 ' A' ' 671' ' ' VAL . 95.4 t -120.67 125.08 73.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-O 120.97 0.414 . . . . 65.239999999999995 112.076 -176.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 690' ' ' LEU . . . . . 0.42 HD22 ' C ' ' A' ' 689' ' ' VAL . 2.7 mm? -127.38 164.01 22.77 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 116.115 -0.493 . . . . 73.349999999999994 110.815 178.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 691' ' ' ALA . . . . . . . . . . . . . . . -153.11 122.46 6.68 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.799 0.333 . . . . 72.25 111.345 175.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 692' ' ' ILE . . . . . . . . . . . . . 46.8 mm -130.85 132.3 64.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-O 120.996 0.427 . . . . 70.420000000000002 112.02 -176.695 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -113.13 150.53 32.04 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 120.969 0.414 . . . . 71.450000000000003 111.004 174.559 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 694' ' ' LYS . . . . . 0.48 ' HD3' HD12 ' A' ' 665' ' ' LEU . 64.3 tttp -70.89 -38.26 73.02 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 111.967 0.358 . . . . 62.310000000000002 111.967 -178.026 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -82.66 -53.79 5.65 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 122.019 -0.425 . . . . 73.409999999999997 111.894 -178.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 696' ' ' ASP . . . . . 0.508 ' HB2' ' HB2' ' A' ' 726' ' ' SER . 15.0 t70 -80.39 -42.03 23.56 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 112.595 0.591 . . . . 71.219999999999999 112.595 -174.671 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . 109.74 -107.4 2.34 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 120.947 -0.644 . . . . 64.310000000000002 112.993 -178.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -81.67 115.95 21.17 Favored 'General case' 0 N--CA 1.466 0.339 0 O-C-N 122.201 -0.588 . . . . 70.209999999999994 111.773 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 699' ' ' LEU . . . . . 0.45 HD22 ' HD2' ' A' ' 702' ' ' LYS . 75.5 mt -111.95 1.11 16.29 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.845 0.355 . . . . 61.43 110.443 170.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 22.4 m -56.27 -37.49 69.88 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.272 0.558 . . . . 73.340000000000003 111.158 177.5 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 701' ' ' SER . . . . . . . . . . . . . 65.5 p -72.33 -9.91 59.1 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 115.979 -0.555 . . . . 75.450000000000003 112.315 179.15 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 702' ' ' LYS . . . . . 0.45 ' HD2' HD22 ' A' ' 699' ' ' LEU . 62.1 mttp -101.34 1.47 38.63 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 112.446 0.535 . . . . 73.530000000000001 112.446 178.066 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 703' ' ' ILE . . . . . 0.429 HD13 HG12 ' A' ' 689' ' ' VAL . 67.7 mt -72.24 135.14 28.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 N-CA-C 112.081 0.4 . . . . 71.019999999999996 112.081 -178.014 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 704' ' ' LYS . . . . . . . . . . . . . 56.4 tttm -102.11 137.15 40.76 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.574 -0.285 . . . . 74.400000000000006 111.013 173.053 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 49.4 t -96.04 141.77 14.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-O 120.988 0.423 . . . . 75.420000000000002 111.065 176.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 706' ' ' ASP . . . . . 0.535 ' HB3' ' HB ' ' A' ' 720' ' ' THR . 27.3 t70 -136.56 138.2 41.03 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 120.728 0.299 . . . . 42.350000000000001 111.205 178.019 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 104.29 -173.07 21.05 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 121.391 -0.433 . . . . 64.239999999999995 113.246 -179.18 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 708' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -157.95 141.73 15.64 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 120.863 0.363 . . . . 61.149999999999999 111.306 179.345 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 709' ' ' VAL . . . . . 0.488 HG23 HD21 ' A' ' 719' ' ' LEU . 99.5 t -122.97 121.95 64.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-O 120.785 0.326 . . . . 73.010000000000005 111.217 -179.425 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 710' ' ' ASP . . . . . 0.438 ' O ' HG21 ' A' ' 739' ' ' VAL . 8.2 m-20 -84.95 136.08 33.77 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 121.104 0.478 . . . . 61.100000000000001 111.932 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 711' ' ' THR . . . . . . . . . . . . . 46.2 p -101.63 -3.57 28.1 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.232 0.539 . . . . 62.43 110.37 172.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 712' ' ' THR . . . . . . . . . . . . . 30.1 p -96.06 -27.67 14.98 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 115.749 -0.66 . . . . 60.549999999999997 112.314 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 713' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -121.86 141.04 51.67 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 120.628 0.251 . . . . 72.049999999999997 111.135 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 714' ' ' ALA . . . . . . . . . . . . . . . -81.11 127.24 32.42 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 120.957 0.408 . . . . 44.420000000000002 112.089 -179.503 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 715' ' ' GLY . . . . . 0.42 ' H ' ' HB ' ' A' ' 739' ' ' VAL . . . 170.14 158.62 14.33 Favored Glycine 0 CA--C 1.525 0.666 0 C-N-CA 121.447 -0.406 . . . . 73.040000000000006 112.788 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 716' ' ' THR . . . . . 0.403 ' HA ' ' HA ' ' A' ' 738' ' ' THR . 51.8 m -87.91 126.44 35.05 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.049 0.452 . . . . 71.109999999999999 111.627 178.133 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 717' ' ' TYR . . . . . 0.472 ' HB2' HG22 ' A' ' 709' ' ' VAL . 72.5 m-85 -125.92 135.9 52.42 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.186 -0.461 . . . . 74.219999999999999 110.411 176.614 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 718' ' ' VAL . . . . . . . . . . . . . 59.0 t -108.29 113.69 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 CA-C-O 120.915 0.388 . . . . 51.509999999999998 111.856 -176.218 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 719' ' ' LEU . . . . . 0.488 HD21 HG23 ' A' ' 709' ' ' VAL . 88.1 mt -89.23 141.08 28.84 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 116.477 -0.329 . . . . 72.329999999999998 111.543 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 720' ' ' THR . . . . . 0.535 ' HB ' ' HB3' ' A' ' 706' ' ' ASP . 62.1 m -111.15 132.54 54.22 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.936 0.398 . . . . 65.239999999999995 111.315 178.685 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 721' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -122.09 131.03 53.76 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.329 -0.396 . . . . 72.219999999999999 110.365 178.21 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 86.4 m -138.0 135.71 36.21 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 120.917 0.389 . . . . 53.420000000000002 111.964 -176.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 12.7 p -136.64 146.45 28.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-O 120.996 0.427 . . . . 74.319999999999993 111.42 -179.209 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 26.4 m -104.5 140.2 38.3 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.439 -0.346 . . . . 73.310000000000002 111.198 178.513 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -73.32 169.01 18.02 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 121.09 0.471 . . . . 62.329999999999998 111.275 178.677 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 726' ' ' SER . . . . . 0.508 ' HB2' ' HB2' ' A' ' 696' ' ' ASP . 46.8 t -63.8 -38.47 91.2 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 120.903 0.382 . . . . 60.409999999999997 111.234 176.009 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 727' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -98.25 7.17 46.62 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 112.494 0.554 . . . . 74.140000000000001 112.494 179.296 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 728' ' ' GLY . . . . . . . . . . . . . . . 112.4 -6.24 26.59 Favored Glycine 0 CA--C 1.538 1.469 0 N-CA-C 116.688 1.435 . . . . 72.140000000000001 116.688 166.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 17.6 m80 -69.15 109.22 3.94 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 119.292 1.546 . . . . 75.420000000000002 111.368 176.506 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 730' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -97.43 124.1 41.51 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 116.589 -0.278 . . . . 72.219999999999999 111.159 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 31.6 m -122.82 154.19 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-O 120.801 0.334 . . . . 62.5 111.388 -178.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 9.3 t -138.28 148.25 44.48 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 121.437 0.637 . . . . 55.32 112.524 -177.345 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -148.41 150.12 32.94 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.838 -0.619 . . . . 22.219999999999999 110.483 178.193 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 734' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -120.15 160.02 23.71 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 112.67 0.619 . . . . 75.319999999999993 112.67 -174.059 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 735' ' ' GLN . . . . . 0.448 ' NE2' ' HG2' ' A' ' 672' ' ' PRO . 59.0 tt0 -130.6 119.58 22.7 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 115.478 -0.783 . . . . 71.430000000000007 110.8 -179.259 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 736' ' ' THR . . . . . . . . . . . . . 23.8 m -90.02 103.79 16.42 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 116.496 -0.32 . . . . 44.420000000000002 111.266 -178.021 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 32.5 t -102.19 113.56 39.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 CA-C-O 120.952 0.406 . . . . 53.409999999999997 111.665 -177.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 738' ' ' THR . . . . . 0.403 ' HA ' ' HA ' ' A' ' 716' ' ' THR . 87.7 m -100.29 112.06 24.37 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.855 0.359 . . . . 53.409999999999997 111.464 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 739' ' ' VAL . . . . . 0.438 HG21 ' O ' ' A' ' 710' ' ' ASP . 22.4 t -93.22 133.58 33.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-O 120.778 0.323 . . . . 60.030000000000001 110.676 177.371 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 740' ' ' LYS . . . . . . . . . . . . . 19.1 ptmt -132.81 152.34 51.82 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.236 0.541 . . . . 74.409999999999997 111.929 -178.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 741' ' ' VAL . . . . . . . . . . . . . 20.0 t -75.08 149.65 7.1 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-N 116.057 -0.519 . . . . 62.439999999999998 111.987 -174.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 742' ' ' ARG . . . . . 0.562 ' HG3' ' HG3' ' A' ' 743' ' ' GLU . 4.2 ptp180 -80.66 -41.83 23.1 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 116.27 -0.423 . . . . 64.329999999999998 111.439 176.316 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 743' ' ' GLU . . . . . 0.562 ' HG3' ' HG3' ' A' ' 742' ' ' ARG . 39.8 mt-10 -102.68 117.25 34.25 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 116.465 -0.334 . . . . 75.200000000000003 110.617 178.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 744' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -74.84 84.63 2.19 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-O 121.765 0.793 . . . . 74.319999999999993 111.755 -177.241 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 48.9 t -69.82 99.09 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-N 115.914 -0.585 . . . . 73.319999999999993 111.309 178.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -108.28 14.8 24.63 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.989 -0.55 . . . . 72.400000000000006 111.178 178.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 747' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -79.65 4.22 16.74 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 112.715 0.635 . . . . 72.530000000000001 112.715 -174.205 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 38.9 t70 72.15 -9.8 0.97 Allowed 'General case' 0 CA--C 1.549 0.938 0 N-CA-C 113.041 0.756 . . . . 72.519999999999996 113.041 176.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 749' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -61.21 120.51 55.42 Favored Pre-proline 0 N--CA 1.473 0.701 0 O-C-N 121.905 -0.497 . . . . 74.209999999999994 111.067 175.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 750' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -55.63 145.41 70.48 Favored 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 122.819 2.346 . . . . 63.350000000000001 113.144 -177.513 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 751' ' ' ILE . . . . . . . . . . . . . 36.2 pt -88.02 164.74 2.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-O 120.858 0.361 . . . . 73.219999999999999 111.959 -177.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 752' ' ' LEU . . . . . . . . . . . . . 29.8 tp 70.39 0.23 3.13 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 112.681 0.623 . . . . 72.409999999999997 112.681 175.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 753' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 . . . . . 0 C--O 1.237 0.426 0 CA-C-O 121.292 0.568 . . . . 74.519999999999996 111.13 178.955 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 762' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 657' ' ' MET . . . . . . . . . . . . . 64.3 mtt . . . . . 0 N--CA 1.488 1.472 0 CA-C-O 121.02 0.438 . . . . 63.32 110.991 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 658' ' ' GLY . . . . . . . . . . . . . . . 120.28 -51.66 0.76 Allowed Glycine 0 CA--C 1.523 0.538 0 N-CA-C 110.448 -1.061 . . . . 61.030000000000001 110.448 -169.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 659' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -110.4 98.51 7.71 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 109.582 -0.525 . . . . 74.200000000000003 109.582 168.461 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 660' ' ' GLY . . . . . . . . . . . . . . . -119.8 -129.78 3.9 Favored Glycine 0 CA--C 1.524 0.603 0 C-N-CA 121.011 -0.614 . . . . 74.349999999999994 113.333 -178.323 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 64.33 17.35 10.71 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.092 0.557 . . . . 65.439999999999998 112.184 -178.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 662' ' ' THR . . . . . . . . . . . . . 48.1 p -81.51 92.13 6.45 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 121.181 0.515 . . . . 74.540000000000006 110.169 174.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 663' ' ' SER . . . . . . . . . . . . . 41.1 t -55.3 134.28 49.93 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 115.735 -0.666 . . . . 64.109999999999999 112.558 -174.526 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 664' ' ' ASP . . . . . 0.416 ' OD2' ' HB2' ' A' ' 727' ' ' LYS . 24.5 t0 -74.65 122.94 23.97 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 121.272 0.558 . . . . 73.420000000000002 111.249 178.304 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 665' ' ' LEU . . . . . . . . . . . . . 84.3 mt -95.44 138.07 33.63 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 115.685 -0.689 . . . . 61.219999999999999 111.261 -179.143 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 666' ' ' GLU . . . . . 0.454 ' H ' ' CD ' ' A' ' 666' ' ' GLU . 1.3 pm0 -78.32 142.33 62.9 Favored Pre-proline 0 CA--C 1.54 0.596 0 CA-C-N 116.439 -0.346 . . . . 70.439999999999998 110.189 170.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 667' ' ' PRO . . . . . 0.414 ' HG3' ' HB2' ' A' ' 725' ' ' ASP . 38.2 Cg_exo -59.7 144.25 99.48 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 122.83 2.353 . . . . 33.200000000000003 114.467 -171.137 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 668' ' ' LYS . . . . . . . . . . . . . 49.9 tptt -82.3 97.37 8.26 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.658 -0.701 . . . . 72.239999999999995 109.745 171.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 669' ' ' LEU . . . . . 0.413 ' HG ' HG23 ' A' ' 671' ' ' VAL . 56.7 tp -90.19 105.86 18.09 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.002 -0.544 . . . . 65.530000000000001 110.527 179.188 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 670' ' ' THR . . . . . . . . . . . . . 96.8 m -88.58 110.22 20.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.265 0.555 . . . . 74.519999999999996 111.366 -178.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 671' ' ' VAL . . . . . 0.418 HG22 HG13 ' A' ' 689' ' ' VAL . 72.4 t -129.6 131.72 23.76 Favored Pre-proline 0 CA--C 1.535 0.396 0 CA-C-N 115.753 -0.658 . . . . 70.5 110.285 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 672' ' ' PRO . . . . . 0.477 ' HG2' ' NE2' ' A' ' 735' ' ' GLN . 47.4 Cg_endo -69.07 123.96 10.87 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 121.829 1.686 . . . . 75.340000000000003 111.693 176.471 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 673' ' ' VAL . . . . . . . . . . . . . 14.8 p -63.53 -29.52 47.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 N-CA-C 112.357 0.503 . . . . 71.530000000000001 112.357 -174.543 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 674' ' ' GLY . . . . . . . . . . . . . . . -150.88 143.9 11.14 Favored Glycine 0 CA--C 1.525 0.657 0 C-N-CA 120.741 -0.742 . . . . 72.329999999999998 113.177 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 675' ' ' ALA . . . . . 0.423 ' O ' ' HA ' ' A' ' 737' ' ' VAL . . . -148.63 143.89 26.84 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.729 0.299 . . . . 74.439999999999998 110.981 179.496 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 676' ' ' THR . . . . . . . . . . . . . 49.7 m -130.07 131.03 45.61 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.761 0.315 . . . . 70.519999999999996 111.509 -179.485 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 677' ' ' ILE . . . . . . . . . . . . . 25.6 pt -133.71 176.5 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 CA-C-O 120.882 0.373 . . . . 74.510000000000005 110.945 179.045 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 678' ' ' HIS . . . . . . . . . . . . . 76.2 m80 -118.67 158.82 24.77 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 121.08 0.467 . . . . 63.240000000000002 111.879 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 679' ' ' VAL . . . . . 0.402 HG21 HG22 ' A' ' 741' ' ' VAL . 98.8 t -60.45 112.1 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-N 116.142 -0.481 . . . . 75.530000000000001 111.172 176.295 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 114.49 -16.65 19.24 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 121.379 -0.438 . . . . 43.350000000000001 113.03 -175.263 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 681' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -73.96 -172.18 1.27 Allowed 'General case' 0 CA--C 1.546 0.809 0 CA-C-O 121.033 0.444 . . . . 70.239999999999995 111.723 178.107 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 682' ' ' SER . . . . . . . . . . . . . 25.4 m -129.07 155.12 45.95 Favored 'General case' 0 N--CA 1.478 0.94 0 O-C-N 122.211 -0.305 . . . . 62.530000000000001 111.007 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 683' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -159.2 120.35 3.28 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 120.821 0.343 . . . . 72.150000000000006 111.69 -179.383 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 684' ' ' VAL . . . . . . . . . . . . . 80.9 t -113.97 110.11 49.14 Favored Pre-proline 0 N--CA 1.471 0.588 0 CA-C-O 120.843 0.354 . . . . 62.299999999999997 111.544 177.241 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -58.09 -36.79 97.66 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 122.77 2.314 . . . . 71.409999999999997 113.665 -177.394 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 686' ' ' MET . . . . . 0.442 ' HA ' ' CE ' ' A' ' 686' ' ' MET . 1.0 OUTLIER -79.26 -11.78 59.95 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.424 0.527 . . . . 72.510000000000005 112.424 -177.374 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 687' ' ' ALA . . . . . . . . . . . . . . . -89.61 -32.68 16.99 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.215 0.531 . . . . 52.539999999999999 110.972 176.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 688' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -84.74 -17.54 38.0 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 116.137 -0.483 . . . . 72.310000000000002 111.683 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 689' ' ' VAL . . . . . 0.418 HG13 HG22 ' A' ' 671' ' ' VAL . 76.0 t -116.76 131.38 69.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 N-CA-C 112.695 0.628 . . . . 72.450000000000003 112.695 -175.331 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 690' ' ' LEU . . . . . 0.416 ' N ' HD12 ' A' ' 690' ' ' LEU . 5.2 mp -125.42 166.64 16.23 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 116.309 -0.405 . . . . 74.450000000000003 111.036 177.556 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 691' ' ' ALA . . . . . . . . . . . . . . . -148.97 122.7 9.25 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 120.905 0.384 . . . . 72.420000000000002 111.58 176.02 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 692' ' ' ILE . . . . . 0.548 HD13 ' HA ' ' A' ' 698' ' ' ASP . 37.2 mm -133.03 131.75 58.84 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 CA-C-N 116.475 -0.329 . . . . 55.340000000000003 111.481 -177.776 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 58.6 t0 -111.36 129.03 56.13 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 109.627 -0.508 . . . . 74.219999999999999 109.627 171.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -57.69 -28.05 63.47 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 112.619 0.6 . . . . 72.530000000000001 112.619 -173.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 695' ' ' GLU . . . . . 0.437 ' HG3' ' N ' ' A' ' 696' ' ' ASP . 12.6 pt-20 -82.91 -44.48 15.32 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 111.998 0.37 . . . . 54.020000000000003 111.998 -179.418 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 696' ' ' ASP . . . . . 0.437 ' N ' ' HG3' ' A' ' 695' ' ' GLU . 10.5 t70 -95.12 -48.86 5.77 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 121.181 0.515 . . . . 74.230000000000004 111.596 -170.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . 124.32 -137.46 10.68 Favored Glycine 0 CA--C 1.526 0.722 0 CA-C-N 116.179 -0.464 . . . . 55.420000000000002 112.352 -176.435 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 698' ' ' ASP . . . . . 0.548 ' HA ' HD13 ' A' ' 692' ' ' ILE . 18.0 t70 -70.92 118.21 13.4 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.339 0.59 . . . . 75.310000000000002 111.619 179.395 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 699' ' ' LEU . . . . . . . . . . . . . 80.3 mt -116.4 18.28 15.22 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 115.882 -0.599 . . . . 73.219999999999999 110.7 173.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 54.1 m -60.78 -27.56 68.09 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.114 0.483 . . . . 74.049999999999997 111.868 -178.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 701' ' ' SER . . . . . . . . . . . . . 25.3 t -78.55 -13.54 59.78 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.071 0.462 . . . . 72.439999999999998 111.513 178.292 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 702' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -90.03 7.64 36.59 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 116.42 -0.355 . . . . 74.540000000000006 111.436 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 703' ' ' ILE . . . . . 0.494 HG12 ' HB ' ' A' ' 723' ' ' VAL . 62.5 mt -85.39 138.41 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-O 121.336 0.589 . . . . 74.120000000000005 112.209 -177.483 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 704' ' ' LYS . . . . . . . . . . . . . 67.1 tttt -100.47 140.72 34.32 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.943 -0.571 . . . . 72.099999999999994 109.772 171.241 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 59.9 t -111.69 112.43 40.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-O 121.146 0.498 . . . . 74.099999999999994 111.807 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 706' ' ' ASP . . . . . 0.567 ' HB2' ' HB ' ' A' ' 720' ' ' THR . 9.2 m-20 -106.08 137.83 43.32 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 116.12 -0.491 . . . . 63.439999999999998 111.388 177.344 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 101.6 -177.93 27.23 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 121.35 -0.452 . . . . 71.209999999999994 113.509 177.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 708' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -161.79 145.94 12.67 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.959 0.409 . . . . 70.349999999999994 111.415 179.017 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 709' ' ' VAL . . . . . 0.508 HG22 ' HB2' ' A' ' 717' ' ' TYR . 96.5 t -117.56 120.12 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-N 116.283 -0.417 . . . . 53.399999999999999 110.882 177.016 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 710' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -77.66 135.92 38.15 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 120.912 0.387 . . . . 72.420000000000002 111.574 177.455 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 711' ' ' THR . . . . . . . . . . . . . 76.2 p -97.66 -1.35 43.83 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.911 0.386 . . . . 73.239999999999995 110.958 173.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 712' ' ' THR . . . . . . . . . . . . . 7.2 t -105.43 -13.47 15.63 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 116.219 -0.446 . . . . 63.329999999999998 111.952 178.001 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 713' ' ' LYS . . . . . . . . . . . . . 7.8 ttpm? -129.46 127.6 41.2 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.827 0.346 . . . . 62.439999999999998 111.662 -178.254 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 714' ' ' ALA . . . . . 0.462 ' HB2' HG23 ' A' ' 741' ' ' VAL . . . -72.0 144.89 48.67 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.199 -0.455 . . . . 75.239999999999995 111.735 177.701 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 152.76 171.87 20.62 Favored Glycine 0 CA--C 1.523 0.574 0 C-N-CA 121.027 -0.606 . . . . 63.329999999999998 113.029 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 716' ' ' THR . . . . . . . . . . . . . 56.3 m -100.3 122.23 42.76 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 122.36 -0.494 . . . . 72.400000000000006 111.327 179.141 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 717' ' ' TYR . . . . . 0.508 ' HB2' HG22 ' A' ' 709' ' ' VAL . 42.2 m-85 -118.92 134.94 54.84 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.139 -0.482 . . . . 73.140000000000001 110.582 -178.397 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 718' ' ' VAL . . . . . . . . . . . . . 49.5 t -101.27 113.97 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 CA-C-O 121.072 0.463 . . . . 72.530000000000001 111.58 -178.456 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 719' ' ' LEU . . . . . 0.467 HD21 HG23 ' A' ' 709' ' ' VAL . 92.3 mt -94.9 130.94 41.3 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.331 -0.395 . . . . 75.040000000000006 111.196 178.493 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 720' ' ' THR . . . . . 0.567 ' HB ' ' HB2' ' A' ' 706' ' ' ASP . 25.0 m -113.29 132.71 55.44 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.753 0.311 . . . . 64.519999999999996 111.196 -178.84 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 721' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -124.58 140.69 52.71 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.664 0.269 . . . . 74.299999999999997 110.968 -179.385 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 56.8 m -140.61 123.5 16.39 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 120.513 0.197 . . . . 73.430000000000007 111.179 -179.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 723' ' ' VAL . . . . . 0.494 ' HB ' HG12 ' A' ' 703' ' ' ILE . 7.5 p -114.54 140.94 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 CA-C-O 121.056 0.455 . . . . 60.049999999999997 112.142 -176.42 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 27.3 m -102.44 144.93 30.27 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 116.136 -0.484 . . . . 63.310000000000002 111.798 -179.119 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 725' ' ' ASP . . . . . 0.414 ' HB2' ' HG3' ' A' ' 667' ' ' PRO . 5.7 t70 -103.63 150.77 23.67 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.323 0.649 . . . . 53.0 111.088 179.592 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 726' ' ' SER . . . . . . . . . . . . . 66.9 p -66.03 -14.65 62.04 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 112.522 0.564 . . . . 71.329999999999998 112.522 -175.13 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 727' ' ' LYS . . . . . 0.416 ' HB2' ' OD2' ' A' ' 664' ' ' ASP . 41.1 mmtm -105.36 -2.73 23.54 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 112.497 0.554 . . . . 63.009999999999998 112.497 -179.594 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 728' ' ' GLY . . . . . . . . . . . . . . . 112.21 12.42 13.77 Favored Glycine 0 CA--C 1.535 1.317 0 N-CA-C 115.384 0.914 . . . . 71.010000000000005 115.384 176.235 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 18.3 m80 -93.93 133.56 37.23 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 118.351 1.076 . . . . 74.040000000000006 111.241 173.592 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 730' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -134.24 112.54 11.15 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 122.075 -0.39 . . . . 72.340000000000003 111.263 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 34.1 m -112.47 160.44 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 N-CA-C 112.071 0.397 . . . . 73.420000000000002 112.071 -177.039 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 9.6 t -136.32 150.34 48.82 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 112.55 0.574 . . . . 75.319999999999993 112.55 -176.638 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -147.81 161.61 40.9 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.849 -0.614 . . . . 65.450000000000003 110.353 177.005 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 734' ' ' LYS . . . . . . . . . . . . . 33.2 mtmm -129.32 158.53 38.85 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 113.151 0.797 . . . . 63.439999999999998 113.151 -176.212 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 735' ' ' GLN . . . . . 0.477 ' NE2' ' HG2' ' A' ' 672' ' ' PRO . 48.1 tt0 -130.76 128.95 41.81 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 114.957 -1.019 . . . . 73.239999999999995 110.7 179.216 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 736' ' ' THR . . . . . . . . . . . . . 86.7 m -96.03 104.38 16.32 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.887 0.375 . . . . 74.209999999999994 111.205 178.08 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 737' ' ' VAL . . . . . 0.423 ' HA ' ' O ' ' A' ' 675' ' ' ALA . 46.7 t -97.69 140.84 17.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-O 120.821 0.343 . . . . 62.32 111.223 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 738' ' ' THR . . . . . . . . . . . . . 64.3 m -130.03 120.83 25.35 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 120.777 0.322 . . . . 55.109999999999999 111.147 179.496 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 739' ' ' VAL . . . . . . . . . . . . . 41.9 t -99.51 133.0 43.9 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-O 120.759 0.314 . . . . 73.409999999999997 111.355 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 740' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -121.97 151.84 40.34 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.39 -0.368 . . . . 75.150000000000006 111.571 -179.127 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 741' ' ' VAL . . . . . 0.462 HG23 ' HB2' ' A' ' 714' ' ' ALA . 25.1 t -100.47 121.35 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-O 120.771 0.32 . . . . 61.439999999999998 111.635 -179.54 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 742' ' ' ARG . . . . . 0.454 ' HG2' ' HG3' ' A' ' 743' ' ' GLU . 0.0 OUTLIER -89.09 -21.02 23.6 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.135 0.493 . . . . 63.32 110.539 176.665 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 743' ' ' GLU . . . . . 0.454 ' HG3' ' HG2' ' A' ' 742' ' ' ARG . 25.3 mt-10 -91.61 -174.09 3.76 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.927 -0.578 . . . . 74.129999999999995 111.406 -179.493 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 744' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -157.53 138.23 13.11 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.003 -0.544 . . . . 72.120000000000005 110.597 174.005 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 14.5 p -103.52 134.07 45.7 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 CA-C-O 121.008 0.432 . . . . 71.439999999999998 111.966 -174.345 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 746' ' ' LYS . . . . . 0.406 ' HG3' ' OD1' ' A' ' 747' ' ' ASN . 22.5 pttp -97.09 -36.42 10.49 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.033 0.444 . . . . 71.430000000000007 110.778 176.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 747' ' ' ASN . . . . . 0.406 ' OD1' ' HG3' ' A' ' 746' ' ' LYS . 15.5 m120 -113.37 108.71 17.6 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.166 -0.47 . . . . 54.329999999999998 110.123 174.288 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -53.26 102.3 0.05 Allowed 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 121.456 0.646 . . . . 75.129999999999995 111.947 -175.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 749' ' ' LYS . . . . . . . . . . . . . 53.1 mttp -57.81 143.87 75.59 Favored Pre-proline 0 CA--C 1.539 0.535 0 CA-C-N 115.891 -0.595 . . . . 74.349999999999994 111.491 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 750' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.6 93.61 0.68 Allowed 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 121.735 1.623 . . . . 75.400000000000006 110.54 168.502 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 751' ' ' ILE . . . . . . . . . . . . . 60.6 mt -65.56 88.37 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-O 121.392 0.615 . . . . 74.420000000000002 112.109 -173.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 752' ' ' LEU . . . . . . . . . . . . . 90.4 mt -83.22 99.04 9.71 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.889 -0.596 . . . . 74.409999999999997 110.83 176.44 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 753' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 . . . . . 0 C--O 1.239 0.515 0 CA-C-O 120.854 0.359 . . . . 71.150000000000006 111.433 -179.829 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 762' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 657' ' ' MET . . . . . 0.483 ' C ' ' SD ' ' A' ' 657' ' ' MET . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 120.953 0.406 . . . . 74.310000000000002 110.996 . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 658' ' ' GLY . . . . . . . . . . . . . . . 111.54 -148.55 18.01 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 121.438 -0.41 . . . . 73.219999999999999 112.399 -177.355 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 659' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -149.31 165.89 30.62 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 122.457 -0.437 . . . . 73.310000000000002 111.025 177.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 660' ' ' GLY . . . . . . . . . . . . . . . 123.66 -73.59 0.4 Allowed Glycine 0 CA--C 1.522 0.497 0 C-N-CA 121.383 -0.437 . . . . 65.430000000000007 112.343 -178.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 50.8 mm-40 -76.8 129.61 36.51 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 122.593 -0.357 . . . . 73.420000000000002 110.765 176.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 662' ' ' THR . . . . . . . . . . . . . 94.1 m 61.27 88.15 0.09 Allowed 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 121.444 0.64 . . . . 64.329999999999998 111.186 -173.583 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 663' ' ' SER . . . . . . . . . . . . . 67.8 m -113.23 124.63 52.98 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 116.111 -0.495 . . . . 74.530000000000001 111.213 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 664' ' ' ASP . . . . . 0.444 ' OD2' ' HB2' ' A' ' 727' ' ' LYS . 18.7 t0 -93.31 124.49 37.33 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 121.255 0.55 . . . . 64.200000000000003 111.729 -179.672 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 665' ' ' LEU . . . . . . . . . . . . . 73.0 mt -91.08 133.47 35.31 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 115.866 -0.606 . . . . 71.049999999999997 109.814 173.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 666' ' ' GLU . . . . . 0.447 ' H ' ' CD ' ' A' ' 666' ' ' GLU . 1.5 pm0 -64.7 144.96 98.86 Favored Pre-proline 0 CA--C 1.539 0.545 0 CA-C-N 116.218 -0.446 . . . . 45.240000000000002 111.47 -179.672 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 667' ' ' PRO . . . . . 0.531 ' HD3' ' HB2' ' A' ' 725' ' ' ASP . 25.8 Cg_endo -60.91 145.12 99.51 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 122.785 2.323 . . . . 64.019999999999996 113.149 -174.545 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 668' ' ' LYS . . . . . . . . . . . . . 9.2 tmtm? -82.58 99.12 9.35 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.33 0.586 . . . . 61.420000000000002 110.384 179.176 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 669' ' ' LEU . . . . . . . . . . . . . 62.8 tp -89.8 109.27 20.27 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.726 -0.67 . . . . 64.5 110.736 179.498 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 670' ' ' THR . . . . . . . . . . . . . 60.7 m -87.08 110.42 20.09 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.827 0.346 . . . . 64.0 111.492 -178.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 671' ' ' VAL . . . . . 0.49 HG21 ' HB3' ' A' ' 733' ' ' ALA . 67.3 t -132.89 124.82 18.88 Favored Pre-proline 0 CA--C 1.542 0.668 0 CA-C-N 116.263 -0.426 . . . . 72.140000000000001 110.831 176.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 672' ' ' PRO . . . . . 0.437 ' HG2' ' NE2' ' A' ' 735' ' ' GLN . 73.2 Cg_endo -74.75 154.06 43.55 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.358 2.039 . . . . 71.439999999999998 112.537 178.33 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 673' ' ' VAL . . . . . . . . . . . . . 12.9 p -63.6 -32.25 56.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 N-CA-C 112.062 0.393 . . . . 61.450000000000003 112.062 -176.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 674' ' ' GLY . . . . . . . . . . . . . . . -170.4 173.14 44.3 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 120.685 -0.769 . . . . 73.299999999999997 114.204 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 675' ' ' ALA . . . . . . . . . . . . . . . -152.95 122.95 6.98 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.876 0.37 . . . . 74.209999999999994 111.308 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 676' ' ' THR . . . . . . . . . . . . . 82.7 m -102.29 124.93 48.74 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 112.158 0.429 . . . . 74.230000000000004 112.158 -177.514 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 677' ' ' ILE . . . . . 0.404 HD13 ' HB2' ' A' ' 683' ' ' PHE . 29.3 pt -126.4 177.0 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 CA-C-N 116.38 -0.373 . . . . 62.420000000000002 111.1 176.189 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 678' ' ' HIS . . . . . 0.411 ' HA ' ' O ' ' A' ' 740' ' ' LYS . 98.0 m-70 -117.02 156.16 27.97 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.732 0.641 . . . . 73.040000000000006 112.732 -178.085 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 679' ' ' VAL . . . . . 0.526 HG13 ' HA ' ' A' ' 712' ' ' THR . 85.0 t -61.53 121.27 9.32 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-N 115.536 -0.756 . . . . 73.349999999999994 111.375 175.321 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 110.94 -23.65 18.68 Favored Glycine 0 CA--C 1.526 0.751 0 CA-C-N 116.132 -0.485 . . . . 65.120000000000005 112.185 -177.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 681' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -83.38 -162.8 0.66 Allowed 'General case' 0 CA--C 1.543 0.707 0 CA-C-O 120.984 0.421 . . . . 70.230000000000004 111.687 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 682' ' ' SER . . . . . . . . . . . . . 74.0 m -141.47 173.97 11.0 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 122.156 -0.34 . . . . 74.120000000000005 111.703 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 683' ' ' PHE . . . . . 0.404 ' HB2' HD13 ' A' ' 677' ' ' ILE . 76.2 t80 -150.9 140.4 21.52 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.855 0.36 . . . . 65.329999999999998 111.759 -177.596 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 684' ' ' VAL . . . . . . . . . . . . . 99.0 t -118.12 105.78 46.36 Favored Pre-proline 0 CA--C 1.545 0.784 0 CA-C-O 120.728 0.299 . . . . 73.530000000000001 111.605 178.327 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.93 -38.43 78.96 Favored 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 122.745 2.297 . . . . 73.319999999999993 113.505 -178.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 686' ' ' MET . . . . . 0.563 ' HE1' ' HB ' ' A' ' 703' ' ' ILE . 0.3 OUTLIER -78.79 -9.46 59.45 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.759 0.651 . . . . 73.329999999999998 112.759 -175.977 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 687' ' ' ALA . . . . . . . . . . . . . . . -79.96 -44.9 19.46 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 120.9 0.381 . . . . 74.340000000000003 111.923 -179.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 688' ' ' GLU . . . . . . . . . . . . . 45.7 mm-40 -86.6 -8.22 57.68 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 113.0 0.741 . . . . 64.019999999999996 113.0 -174.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 689' ' ' VAL . . . . . 0.556 HG12 HD13 ' A' ' 703' ' ' ILE . 87.6 t -118.58 124.71 73.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-O 120.938 0.399 . . . . 72.430000000000007 111.956 -177.403 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 690' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -125.41 162.93 23.72 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 116.266 -0.425 . . . . 75.140000000000001 111.062 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 691' ' ' ALA . . . . . . . . . . . . . . . -142.69 121.71 12.86 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.057 0.456 . . . . 74.329999999999998 111.63 176.459 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 692' ' ' ILE . . . . . . . . . . . . . 45.6 mm -128.69 124.46 61.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-N 116.395 -0.366 . . . . 64.150000000000006 111.55 -178.182 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 693' ' ' ASP . . . . . 0.488 ' HB2' ' HB3' ' A' ' 667' ' ' PRO . 36.2 t70 -108.35 149.87 28.11 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 120.916 0.389 . . . . 61.43 110.883 173.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 8.3 mtpm? -65.84 -56.68 10.62 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 116.319 -0.401 . . . . 73.420000000000002 111.999 -176.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 695' ' ' GLU . . . . . 0.418 ' CD ' ' H ' ' A' ' 695' ' ' GLU . 0.6 OUTLIER -84.44 -51.76 6.68 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 112.149 0.426 . . . . 75.230000000000004 112.149 -174.856 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 696' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -72.23 -28.68 63.32 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-O 120.933 0.397 . . . . 64.150000000000006 111.397 -173.436 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . 103.73 -147.09 16.56 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 121.477 -0.392 . . . . 73.510000000000005 113.066 178.098 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -69.56 131.62 44.97 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 120.982 0.42 . . . . 75.420000000000002 110.995 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 699' ' ' LEU . . . . . 0.428 HD12 ' HB3' ' A' ' 667' ' ' PRO . 98.0 mt -125.45 15.76 8.25 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 120.973 0.416 . . . . 62.229999999999997 111.164 178.093 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 34.9 m -58.75 -38.34 78.21 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 121.064 0.459 . . . . 75.239999999999995 111.455 -178.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 701' ' ' SER . . . . . . . . . . . . . 33.7 m -61.44 -21.95 64.6 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 116.2 -0.454 . . . . 62.039999999999999 111.814 178.603 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 702' ' ' LYS . . . . . . . . . . . . . 64.0 mttm -91.31 1.28 57.22 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 112.607 0.595 . . . . 70.329999999999998 112.607 -178.182 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 703' ' ' ILE . . . . . 0.563 ' HB ' ' HE1' ' A' ' 686' ' ' MET . 74.5 mt -69.46 111.91 3.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-O 121.238 0.542 . . . . 72.329999999999998 111.559 -178.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 704' ' ' LYS . . . . . . . . . . . . . 24.3 tptm -85.02 118.91 24.87 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 115.549 -0.751 . . . . 70.420000000000002 110.508 178.541 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 51.7 t -96.42 138.25 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 CA-C-O 120.963 0.411 . . . . 64.040000000000006 111.823 -177.177 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 706' ' ' ASP . . . . . 0.584 ' HB3' ' HB ' ' A' ' 720' ' ' THR . 24.1 t70 -132.08 140.8 48.97 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 116.291 -0.413 . . . . 71.519999999999996 111.014 177.342 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 107.23 -176.79 21.27 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 121.331 -0.461 . . . . 73.109999999999999 113.067 -179.369 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 708' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -163.49 137.1 5.7 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.182 0.515 . . . . 72.510000000000005 111.734 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 709' ' ' VAL . . . . . 0.548 HG22 ' HB2' ' A' ' 717' ' ' TYR . 46.8 t -112.02 146.18 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-N 116.1 -0.5 . . . . 64.129999999999995 111.309 -178.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 710' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -83.81 156.79 22.32 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 121.396 0.617 . . . . 73.420000000000002 111.832 175.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 711' ' ' THR . . . . . 0.423 ' O ' ' HA ' ' A' ' 679' ' ' VAL . 47.2 p -117.75 -22.84 7.81 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.578 -0.737 . . . . 73.430000000000007 110.796 172.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 712' ' ' THR . . . . . 0.526 ' HA ' HG13 ' A' ' 679' ' ' VAL . 70.2 p -108.11 13.14 26.2 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 111.923 0.342 . . . . 63.43 111.923 178.556 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 713' ' ' LYS . . . . . . . . . . . . . 3.8 ttmp? -140.08 131.71 27.22 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.664 0.268 . . . . 74.040000000000006 111.132 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 714' ' ' ALA . . . . . . . . . . . . . . . -77.66 143.44 38.16 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 120.81 0.338 . . . . 63.329999999999998 111.284 177.368 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 155.47 -174.94 33.51 Favored Glycine 0 CA--C 1.525 0.657 0 C-N-CA 121.316 -0.469 . . . . 53.32 112.843 -178.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 716' ' ' THR . . . . . . . . . . . . . 38.7 m -123.55 123.02 39.68 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 117.097 0.449 . . . . 73.030000000000001 111.589 -178.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 717' ' ' TYR . . . . . 0.548 ' HB2' HG22 ' A' ' 709' ' ' VAL . 61.4 m-85 -128.03 128.95 45.91 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.185 -0.461 . . . . 55.240000000000002 110.778 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 718' ' ' VAL . . . . . . . . . . . . . 61.6 t -97.78 118.67 44.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-O 121.172 0.511 . . . . 65.140000000000001 111.942 -176.697 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 719' ' ' LEU . . . . . 0.407 HD21 HG23 ' A' ' 709' ' ' VAL . 91.0 mt -93.07 133.64 36.03 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.31 -0.404 . . . . 75.049999999999997 111.076 178.139 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 720' ' ' THR . . . . . 0.584 ' HB ' ' HB3' ' A' ' 706' ' ' ASP . 17.0 m -100.96 144.75 29.53 Favored 'General case' 0 N--CA 1.473 0.714 0 O-C-N 122.214 -0.304 . . . . 73.120000000000005 111.101 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 721' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -134.86 113.85 11.98 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 122.449 0.3 . . . . 72.549999999999997 111.0 -178.39 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 60.4 m -114.23 137.92 51.15 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 111.7 0.259 . . . . 72.140000000000001 111.7 -179.148 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 8.2 p -138.13 136.17 44.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 CA-C-O 121.011 0.434 . . . . 71.140000000000001 111.446 177.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 42.4 m -113.13 129.58 56.46 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 120.864 0.364 . . . . 72.430000000000007 111.728 -178.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 725' ' ' ASP . . . . . 0.531 ' HB2' ' HD3' ' A' ' 667' ' ' PRO . 17.6 t0 -73.84 150.03 41.24 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-N 116.225 -0.443 . . . . 73.150000000000006 110.081 174.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 726' ' ' SER . . . . . . . . . . . . . 48.8 m -69.01 -27.24 65.5 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.692 0.282 . . . . 64.310000000000002 111.645 -178.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 727' ' ' LYS . . . . . 0.444 ' HB2' ' OD2' ' A' ' 664' ' ' ASP . 1.3 mptp? -89.19 5.22 45.73 Favored 'General case' 0 CA--C 1.546 0.827 0 N-CA-C 112.258 0.466 . . . . 71.150000000000006 112.258 -177.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 728' ' ' GLY . . . . . . . . . . . . . . . 113.31 -2.99 25.19 Favored Glycine 0 CA--C 1.537 1.409 0 N-CA-C 116.463 1.345 . . . . 54.520000000000003 116.463 169.123 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 63.0 m80 -94.72 119.54 33.51 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 118.941 1.37 . . . . 72.129999999999995 112.05 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 730' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -112.65 138.91 48.76 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 122.038 -0.414 . . . . 72.239999999999995 111.775 -178.274 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 29.4 m -138.54 152.36 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-O 120.786 0.327 . . . . 54.219999999999999 111.39 178.22 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 9.0 t -140.3 154.08 46.68 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.038 0.447 . . . . 45.030000000000001 111.653 179.176 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 733' ' ' ALA . . . . . 0.49 ' HB3' HG21 ' A' ' 671' ' ' VAL . . . -148.86 162.15 40.42 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 116.25 -0.432 . . . . 73.140000000000001 111.342 -179.369 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 734' ' ' LYS . . . . . . . . . . . . . 10.7 mtmp? -125.96 154.44 42.85 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 112.446 0.536 . . . . 73.219999999999999 112.446 -179.27 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 735' ' ' GLN . . . . . 0.437 ' NE2' ' HG2' ' A' ' 672' ' ' PRO . 54.0 tt0 -129.7 124.54 33.82 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.858 -0.61 . . . . 65.400000000000006 110.585 178.147 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 736' ' ' THR . . . . . . . . . . . . . 88.1 m -90.91 103.9 16.56 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.841 0.353 . . . . 74.430000000000007 111.633 -177.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 50.3 t -96.55 131.76 42.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 O-C-N 122.124 -0.36 . . . . 74.510000000000005 111.299 -178.52 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 738' ' ' THR . . . . . . . . . . . . . 88.5 m -122.68 122.75 39.51 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.028 0.442 . . . . 73.239999999999995 111.651 -178.52 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 739' ' ' VAL . . . . . . . . . . . . . 21.5 t -100.85 131.51 48.33 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 116.143 -0.48 . . . . 70.430000000000007 110.812 178.114 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 740' ' ' LYS . . . . . 0.411 ' O ' ' HA ' ' A' ' 678' ' ' HIS . 16.9 ptpt -124.32 160.38 28.2 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.233 0.539 . . . . 74.230000000000004 111.705 177.226 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 741' ' ' VAL . . . . . 0.462 HG22 HG21 ' A' ' 679' ' ' VAL . 37.8 t -93.46 124.5 45.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 N-CA-C 112.507 0.558 . . . . 45.299999999999997 112.507 -172.579 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 742' ' ' ARG . . . . . . . . . . . . . 11.5 ptt85 -94.3 -48.42 6.18 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 120.994 0.426 . . . . 73.439999999999998 110.935 172.032 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 743' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -104.73 117.49 34.2 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.328 -0.396 . . . . 63.130000000000003 110.64 176.279 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 744' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -63.26 156.99 23.86 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 112.514 0.561 . . . . 55.399999999999999 112.514 -175.002 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 25.5 m -62.44 141.03 18.45 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-N 115.87 -0.605 . . . . 75.430000000000007 112.307 178.325 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -82.55 -177.64 6.77 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 121.31 0.576 . . . . 71.109999999999999 112.412 -173.597 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 747' ' ' ASN . . . . . 0.476 ' ND2' ' HG2' ' A' ' 749' ' ' LYS . 59.5 t30 -161.67 151.7 16.99 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 115.812 -0.631 . . . . 62.240000000000002 110.391 176.827 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -77.96 10.33 2.94 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 113.153 0.797 . . . . 75.420000000000002 113.153 -172.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 749' ' ' LYS . . . . . 0.476 ' HG2' ' ND2' ' A' ' 747' ' ' ASN . 19.8 ptmt -98.91 163.14 19.37 Favored Pre-proline 0 CA--C 1.542 0.652 0 O-C-N 122.307 -0.246 . . . . 74.230000000000004 110.637 175.364 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 750' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -65.37 97.78 0.31 Allowed 'Trans proline' 0 CA--C 1.543 0.972 0 C-N-CA 121.703 1.602 . . . . 74.430000000000007 111.347 170.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 751' ' ' ILE . . . . . . . . . . . . . 38.8 pt -90.1 173.95 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-O 121.21 0.528 . . . . 75.129999999999995 112.397 -175.119 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 752' ' ' LEU . . . . . . . . . . . . . 35.1 tp -102.1 127.01 49.19 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 116.122 -0.49 . . . . 74.340000000000003 111.033 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 753' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 . . . . . 0 C--O 1.24 0.567 0 CA-C-O 121.042 0.448 . . . . 70.430000000000007 111.879 -177.143 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 762' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 657' ' ' MET . . . . . . . . . . . . . 64.6 mtt . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 120.674 0.273 . . . . 72.400000000000006 111.348 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 658' ' ' GLY . . . . . . . . . . . . . . . 92.7 100.25 1.43 Allowed Glycine 0 CA--C 1.529 0.919 0 C-N-CA 121.051 -0.595 . . . . 61.210000000000001 113.734 175.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 659' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -94.63 -177.05 4.09 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 122.581 -0.364 . . . . 65.349999999999994 111.278 175.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 660' ' ' GLY . . . . . . . . . . . . . . . -147.36 160.09 28.19 Favored Glycine 0 CA--C 1.524 0.61 0 C-N-CA 120.7 -0.762 . . . . 70.129999999999995 113.292 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 661' ' ' GLU . . . . . 0.407 ' OE2' ' HE3' ' A' ' 727' ' ' LYS . 7.8 mm-40 -81.16 90.34 6.05 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.155 0.502 . . . . 70.219999999999999 110.868 -179.685 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 662' ' ' THR . . . . . . . . . . . . . 80.8 p -78.4 -173.52 3.35 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 116.019 -0.537 . . . . 72.510000000000005 112.082 -178.116 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 663' ' ' SER . . . . . . . . . . . . . 49.1 m -63.92 104.51 0.71 Allowed 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.078 0.466 . . . . 53.43 111.094 177.378 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 664' ' ' ASP . . . . . 0.448 ' HB3' ' HE1' ' A' ' 729' ' ' HIS . 12.8 t70 -86.02 126.75 34.38 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 116.061 -0.518 . . . . 72.340000000000003 111.89 -174.376 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 665' ' ' LEU . . . . . . . . . . . . . 80.7 mt -88.03 117.41 26.89 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 116.337 -0.392 . . . . 55.100000000000001 110.122 173.58 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 666' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -54.31 149.07 21.01 Favored Pre-proline 0 CA--C 1.54 0.559 0 CA-C-O 120.796 0.331 . . . . 64.129999999999995 111.444 178.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 667' ' ' PRO . . . . . 0.436 ' HA ' ' HA ' ' A' ' 693' ' ' ASP . 38.2 Cg_exo -57.77 140.48 93.77 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 122.422 2.081 . . . . 72.230000000000004 112.95 -173.339 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 668' ' ' LYS . . . . . 0.718 ' HA ' ' HE2' ' A' ' 668' ' ' LYS . 0.6 OUTLIER -82.88 102.96 12.0 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 120.932 0.396 . . . . 73.430000000000007 110.363 175.403 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 669' ' ' LEU . . . . . 0.502 ' HG ' HG23 ' A' ' 671' ' ' VAL . 61.9 tp -90.01 118.61 29.69 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.195 -0.457 . . . . 75.109999999999999 111.354 -179.387 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 670' ' ' THR . . . . . . . . . . . . . 89.3 m -93.85 109.85 21.53 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.732 0.301 . . . . 73.540000000000006 110.986 177.151 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 671' ' ' VAL . . . . . 0.502 HG23 ' HG ' ' A' ' 669' ' ' LEU . 95.7 t -139.74 122.19 10.13 Favored Pre-proline 0 CA--C 1.538 0.51 0 CA-C-N 116.151 -0.477 . . . . 72.230000000000004 110.583 177.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 672' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -76.37 151.88 33.96 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 122.119 1.879 . . . . 75.340000000000003 112.177 177.422 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 673' ' ' VAL . . . . . . . . . . . . . 8.0 p -64.27 -31.89 55.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 N-CA-C 112.325 0.491 . . . . 74.310000000000002 112.325 -175.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 674' ' ' GLY . . . . . . . . . . . . . . . -160.51 166.72 35.47 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 120.469 -0.872 . . . . 30.239999999999998 114.3 -177.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 675' ' ' ALA . . . . . . . . . . . . . . . -142.77 151.06 40.83 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.312 0.645 . . . . 71.129999999999995 109.849 177.329 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 676' ' ' THR . . . . . . . . . . . . . 91.5 m -137.93 119.23 14.66 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.105 0.479 . . . . 72.329999999999998 111.883 -177.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 677' ' ' ILE . . . . . . . . . . . . . 33.5 pt -130.75 176.48 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-N 116.032 -0.531 . . . . 75.150000000000006 111.097 -179.197 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 678' ' ' HIS . . . . . 0.524 ' HA ' ' O ' ' A' ' 740' ' ' LYS . 98.4 m-70 -110.78 156.7 20.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.279 0.561 . . . . 75.230000000000004 111.815 177.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 679' ' ' VAL . . . . . 0.551 HG13 ' HA ' ' A' ' 712' ' ' THR . 85.2 t -58.31 126.16 15.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-N 115.899 -0.591 . . . . 55.420000000000002 110.98 174.693 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 94.82 4.6 61.69 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 121.153 -0.546 . . . . 40.140000000000001 113.568 -179.341 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 681' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -97.7 165.35 12.0 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.366 0.603 . . . . 62.420000000000002 112.152 178.216 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 682' ' ' SER . . . . . . . . . . . . . 46.5 m -93.9 137.14 33.45 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.887 -0.597 . . . . 65.420000000000002 111.739 -179.302 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 683' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -135.09 128.7 32.71 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 120.928 0.394 . . . . 72.219999999999999 111.531 -179.206 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 684' ' ' VAL . . . . . . . . . . . . . 48.9 t -125.07 97.99 36.9 Favored Pre-proline 0 CA--C 1.542 0.656 0 CA-C-O 120.856 0.36 . . . . 63.240000000000002 111.444 177.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -63.7 -34.19 63.44 Favored 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 122.491 2.127 . . . . 64.040000000000006 113.571 -178.223 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 686' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -79.34 -6.32 56.49 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.782 0.66 . . . . 62.409999999999997 112.782 -176.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 687' ' ' ALA . . . . . . . . . . . . . . . -92.37 -38.19 12.16 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.869 0.366 . . . . 74.439999999999998 111.924 179.261 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 688' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -98.69 13.08 33.42 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 112.384 0.513 . . . . 75.230000000000004 112.384 -176.654 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 689' ' ' VAL . . . . . 0.417 HG13 HG22 ' A' ' 671' ' ' VAL . 85.2 t -125.04 140.04 49.33 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-N 116.301 -0.409 . . . . 71.019999999999996 110.086 173.252 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 690' ' ' LEU . . . . . 0.55 HD21 HG12 ' A' ' 692' ' ' ILE . 9.2 tt -145.17 153.85 41.8 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 111.574 0.213 . . . . 62.130000000000003 111.574 -172.152 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 691' ' ' ALA . . . . . . . . . . . . . . . -147.4 125.12 11.83 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 112.049 0.389 . . . . 61.32 112.049 179.081 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 692' ' ' ILE . . . . . 0.55 HG12 HD21 ' A' ' 690' ' ' LEU . 47.5 mm -127.93 119.05 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 N-CA-C 112.032 0.382 . . . . 65.430000000000007 112.032 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 693' ' ' ASP . . . . . 0.436 ' HA ' ' HA ' ' A' ' 667' ' ' PRO . 14.6 t70 -94.81 147.7 23.07 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 109.789 -0.449 . . . . 70.299999999999997 109.789 171.135 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 64.9 tttm -58.31 -61.91 2.23 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.373 0.508 . . . . 75.040000000000006 112.373 -174.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -88.5 -39.77 13.94 Favored 'General case' 0 N--CA 1.479 1.002 0 O-C-N 121.846 -0.534 . . . . 64.409999999999997 112.242 -176.537 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 696' ' ' ASP . . . . . . . . . . . . . 34.3 t0 -70.99 -23.52 62.21 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.257 0.551 . . . . 61.109999999999999 110.826 -176.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . 90.3 -147.32 19.1 Favored Glycine 0 CA--C 1.525 0.665 0 CA-C-N 116.043 -0.526 . . . . 53.119999999999997 113.87 173.214 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 698' ' ' ASP . . . . . 0.454 ' HA ' HD13 ' A' ' 692' ' ' ILE . 14.4 t70 -67.9 123.03 19.46 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.058 0.456 . . . . 73.409999999999997 111.189 -179.725 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 699' ' ' LEU . . . . . . . . . . . . . 80.8 mt -122.25 24.95 9.2 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.993 -0.549 . . . . 74.549999999999997 110.782 178.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 88.4 m -61.96 -40.32 95.17 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.044 0.45 . . . . 75.010000000000005 112.032 -177.175 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 701' ' ' SER . . . . . . . . . . . . . 15.6 t -79.86 -3.69 49.01 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 121.048 0.451 . . . . 75.510000000000005 111.246 179.483 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 702' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -84.9 -11.43 55.6 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 120.988 0.423 . . . . 73.5 110.822 175.01 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 74.6 mt -68.57 117.71 11.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-O 121.588 0.709 . . . . 72.510000000000005 112.82 -173.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 704' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -83.67 121.58 27.46 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.397 -0.819 . . . . 64.530000000000001 110.627 174.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 41.7 t -99.61 116.38 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-O 120.82 0.343 . . . . 72.430000000000007 111.077 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 706' ' ' ASP . . . . . 0.55 ' HB3' ' HB ' ' A' ' 720' ' ' THR . 32.9 t70 -109.96 123.21 49.24 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 120.74 0.305 . . . . 70.25 110.993 179.338 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 130.11 173.92 13.54 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 121.397 -0.43 . . . . 53.140000000000001 113.07 -178.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 708' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -135.27 142.23 45.86 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 122.447 -0.443 . . . . 74.450000000000003 111.518 -178.098 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 709' ' ' VAL . . . . . 0.49 HG23 HD21 ' A' ' 719' ' ' LEU . 98.9 t -126.32 128.25 71.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-O 120.872 0.367 . . . . 74.329999999999998 111.424 -179.094 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 710' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -109.38 137.4 47.3 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 116.73 -0.214 . . . . 60.409999999999997 110.552 177.543 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 711' ' ' THR . . . . . . . . . . . . . 67.3 p -111.7 4.21 18.37 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 112.85 0.685 . . . . 73.129999999999995 112.85 -175.269 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 712' ' ' THR . . . . . 0.551 ' HA ' HG13 ' A' ' 679' ' ' VAL . 12.9 t -111.99 -10.47 13.94 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 112.163 0.431 . . . . 74.420000000000002 112.163 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 713' ' ' LYS . . . . . 0.431 ' HD3' ' N ' ' A' ' 714' ' ' ALA . 8.8 tmtt? -128.8 129.91 46.28 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 109.861 -0.422 . . . . 73.099999999999994 109.861 176.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 714' ' ' ALA . . . . . 0.431 ' N ' ' HD3' ' A' ' 713' ' ' LYS . . . -69.81 127.6 33.48 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 112.426 0.528 . . . . 74.049999999999997 112.426 -176.418 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 177.8 174.33 44.03 Favored Glycine 0 CA--C 1.524 0.6 0 CA-C-N 116.098 -0.501 . . . . 64.140000000000001 112.772 -179.516 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 716' ' ' THR . . . . . . . . . . . . . 38.6 m -100.01 121.9 42.08 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 122.532 -0.393 . . . . 63.310000000000002 111.056 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 717' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -122.39 109.58 14.58 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 120.646 0.26 . . . . 60.329999999999998 110.783 -177.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 718' ' ' VAL . . . . . 0.412 ' HA ' ' HA ' ' A' ' 736' ' ' THR . 42.6 t -93.79 126.96 46.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-O 120.941 0.4 . . . . 71.239999999999995 111.845 -175.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 719' ' ' LEU . . . . . 0.49 HD21 HG23 ' A' ' 709' ' ' VAL . 97.2 mt -105.32 153.01 22.2 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.955 0.407 . . . . 71.310000000000002 111.277 177.095 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 720' ' ' THR . . . . . 0.55 ' HB ' ' HB3' ' A' ' 706' ' ' ASP . 28.8 m -120.82 129.74 53.68 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.487 -0.324 . . . . 63.340000000000003 110.809 177.718 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 721' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -115.18 119.79 37.58 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 120.824 0.345 . . . . 75.230000000000004 111.371 -178.019 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 87.0 m -124.05 140.41 53.0 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 116.54 -0.3 . . . . 70.040000000000006 111.209 -179.016 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 10.4 p -141.01 143.47 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 CA-C-O 120.866 0.365 . . . . 63.409999999999997 111.924 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 724' ' ' THR . . . . . 0.45 ' HA ' ' O ' ' A' ' 729' ' ' HIS . 23.7 m -123.01 142.2 51.11 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 116.392 -0.367 . . . . 61.119999999999997 111.603 -179.645 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -100.51 178.61 4.68 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.251 0.548 . . . . 74.239999999999995 112.316 -177.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 726' ' ' SER . . . . . . . . . . . . . 38.0 t -54.51 -31.92 57.03 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 113.323 0.86 . . . . 75.200000000000003 113.323 -179.165 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 727' ' ' LYS . . . . . 0.407 ' HE3' ' OE2' ' A' ' 661' ' ' GLU . 44.8 mmtm -86.63 -14.76 41.75 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 121.877 -0.514 . . . . 74.319999999999993 111.913 -179.452 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 728' ' ' GLY . . . . . . . . . . . . . . . 103.23 13.43 28.78 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 121.023 -0.608 . . . . 63.420000000000002 113.792 -178.244 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 729' ' ' HIS . . . . . 0.45 ' O ' ' HA ' ' A' ' 724' ' ' THR . 58.7 m80 -72.01 123.93 23.85 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 117.283 0.541 . . . . 72.109999999999999 110.54 174.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 730' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -122.25 108.47 13.32 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.137 0.494 . . . . 72.519999999999996 112.179 -174.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 34.9 m -107.72 155.67 8.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-N 116.036 -0.529 . . . . 65.109999999999999 110.737 176.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 5.4 t -152.51 136.86 16.67 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 112.819 0.674 . . . . 75.040000000000006 112.819 -175.534 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -141.87 146.87 36.28 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.09 -0.505 . . . . 75.120000000000005 111.214 -179.364 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 734' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -105.09 158.29 16.67 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.213 0.53 . . . . 74.310000000000002 112.188 -176.197 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 735' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -141.85 118.0 10.69 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.687 -0.688 . . . . 75.230000000000004 110.665 175.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 736' ' ' THR . . . . . 0.412 ' HA ' ' HA ' ' A' ' 718' ' ' VAL . 6.5 t -84.37 111.94 19.89 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.227 0.536 . . . . 53.450000000000003 111.73 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 43.5 t -96.63 103.84 15.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-O 121.282 0.563 . . . . 53.43 111.382 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 738' ' ' THR . . . . . . . . . . . . . 30.8 m -93.61 113.45 25.56 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.984 0.421 . . . . 74.209999999999994 111.344 -177.726 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 739' ' ' VAL . . . . . . . . . . . . . 45.8 t -96.41 116.4 38.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-N 116.297 -0.411 . . . . 72.120000000000005 111.037 178.064 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 740' ' ' LYS . . . . . 0.524 ' O ' ' HA ' ' A' ' 678' ' ' HIS . 11.7 ptmm? -111.59 159.11 18.47 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.027 0.442 . . . . 74.319999999999993 111.144 178.2 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 741' ' ' VAL . . . . . . . . . . . . . 38.3 t -70.72 154.69 7.91 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-O 120.798 0.333 . . . . 62.100000000000001 111.829 -175.3 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 742' ' ' ARG . . . . . . . . . . . . . 14.9 ptp180 -96.28 137.97 34.57 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 120.847 0.356 . . . . 74.430000000000007 110.423 174.255 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 743' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -83.1 92.38 7.4 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 120.767 0.318 . . . . 75.140000000000001 111.164 -177.255 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 744' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -131.58 172.94 11.64 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 112.44 0.533 . . . . 63.450000000000003 112.44 -177.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 31.1 m -134.17 29.31 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-N 115.817 -0.629 . . . . 74.420000000000002 110.747 178.636 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -81.1 19.86 0.86 Allowed 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 112.397 0.517 . . . . 51.200000000000003 112.397 -173.34 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 747' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 -76.09 84.93 2.95 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.104 0.478 . . . . 61.229999999999997 110.904 179.332 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 -80.66 63.65 5.16 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 121.28 0.562 . . . . 74.230000000000004 112.088 -176.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 749' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm 48.53 66.46 5.68 Favored Pre-proline 0 CA--C 1.545 0.768 0 N-CA-C 113.116 0.784 . . . . 73.450000000000003 113.116 178.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 750' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -71.31 111.29 3.05 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 122.476 2.117 . . . . 65.239999999999995 111.804 175.012 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 751' ' ' ILE . . . . . . . . . . . . . 2.4 pp -92.35 13.26 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 N-CA-C 112.238 0.459 . . . . 61.549999999999997 112.238 -178.465 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 752' ' ' LEU . . . . . 0.488 HD13 ' N ' ' A' ' 753' ' ' GLU . 2.6 tm? -53.49 133.94 40.73 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-O 120.904 0.383 . . . . 73.340000000000003 110.749 176.706 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 753' ' ' GLU . . . . . 0.488 ' N ' HD13 ' A' ' 752' ' ' LEU . 42.3 mt-10 . . . . . 0 C--O 1.238 0.47 0 CA-C-O 120.768 0.318 . . . . 71.420000000000002 111.515 -177.121 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 762' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 657' ' ' MET . . . . . . . . . . . . . 22.0 ptt? . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 120.741 0.305 . . . . 73.420000000000002 111.111 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 658' ' ' GLY . . . . . . . . . . . . . . . 70.48 61.97 3.9 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 121.079 -0.581 . . . . 53.439999999999998 112.155 -175.132 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 659' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -60.02 106.51 0.51 Allowed 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 112.403 0.52 . . . . 70.329999999999998 112.403 -178.269 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 660' ' ' GLY . . . . . . . . . . . . . . . -96.44 62.23 1.2 Allowed Glycine 0 CA--C 1.525 0.689 0 N-CA-C 111.386 -0.686 . . . . 61.310000000000002 111.386 173.252 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -101.8 138.27 38.99 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 112.439 0.533 . . . . 63.119999999999997 112.439 -173.085 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 662' ' ' THR . . . . . . . . . . . . . 31.0 m -92.86 152.85 19.18 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 115.976 -0.556 . . . . 75.019999999999996 111.205 178.091 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 663' ' ' SER . . . . . . . . . . . . . 28.8 t -93.32 143.64 26.08 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 122.348 -0.22 . . . . 70.439999999999998 110.838 176.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 664' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -88.78 154.32 20.37 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 121.633 0.73 . . . . 72.439999999999998 112.356 -178.592 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 665' ' ' LEU . . . . . . . . . . . . . 44.8 mt -113.64 138.02 50.79 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.086 -0.961 . . . . 71.400000000000006 110.59 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 666' ' ' GLU . . . . . 0.484 ' H ' ' CD ' ' A' ' 666' ' ' GLU . 1.6 pm0 -54.01 139.23 54.15 Favored Pre-proline 0 CA--C 1.545 0.752 0 CA-C-O 120.762 0.315 . . . . 51.119999999999997 111.309 176.302 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 667' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -68.95 160.27 50.54 Favored 'Trans proline' 0 CA--C 1.545 1.045 0 C-N-CA 122.963 2.442 . . . . 64.099999999999994 115.124 -166.642 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 668' ' ' LYS . . . . . 0.442 ' HA ' ' HE3' ' A' ' 668' ' ' LYS . 0.2 OUTLIER -83.22 102.23 11.77 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 114.948 -1.024 . . . . 70.099999999999994 111.022 177.896 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 669' ' ' LEU . . . . . . . . . . . . . 57.9 tp -103.49 114.64 29.08 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 120.783 0.325 . . . . 63.299999999999997 111.096 176.114 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 670' ' ' THR . . . . . . . . . . . . . 99.4 m -101.67 112.1 24.56 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.875 0.369 . . . . 75.439999999999998 111.425 178.419 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 671' ' ' VAL . . . . . . . . . . . . . 90.2 t -125.98 132.84 24.45 Favored Pre-proline 0 CA--C 1.538 0.492 0 CA-C-N 116.3 -0.409 . . . . 75.120000000000005 110.776 177.452 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 672' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -66.47 138.43 50.25 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 122.128 1.886 . . . . 74.099999999999994 112.363 178.486 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 673' ' ' VAL . . . . . . . . . . . . . 11.7 p -73.17 -34.09 43.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 N-CA-C 112.326 0.491 . . . . 63.149999999999999 112.326 -175.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 674' ' ' GLY . . . . . . . . . . . . . . . -150.74 151.12 23.18 Favored Glycine 0 CA--C 1.523 0.533 0 C-N-CA 120.557 -0.83 . . . . 74.319999999999993 113.674 -176.553 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 675' ' ' ALA . . . . . 0.524 ' HB3' HG22 ' A' ' 737' ' ' VAL . . . -138.92 144.42 39.08 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 122.476 0.31 . . . . 63.329999999999998 110.978 179.136 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 676' ' ' THR . . . . . . . . . . . . . 36.5 m -131.42 118.61 20.48 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 120.596 0.236 . . . . 42.020000000000003 111.103 -178.413 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 677' ' ' ILE . . . . . . . . . . . . . 42.9 pt -136.67 177.58 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-O 121.091 0.472 . . . . 74.349999999999994 111.695 179.354 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 678' ' ' HIS . . . . . . . . . . . . . 79.2 m80 -129.57 140.29 51.25 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 111.924 0.342 . . . . 64.120000000000005 111.924 -178.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 679' ' ' VAL . . . . . . . . . . . . . 89.7 t -46.87 122.18 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 CA-C-N 115.753 -0.658 . . . . 70.219999999999999 112.558 -178.619 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 104.14 14.97 23.09 Favored Glycine 0 CA--C 1.528 0.883 0 CA-C-N 116.246 -0.433 . . . . 74.209999999999994 113.533 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 681' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -101.25 -161.94 0.9 Allowed 'General case' 0 CA--C 1.545 0.788 0 CA-C-O 121.407 0.622 . . . . 64.409999999999997 112.044 -179.175 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 682' ' ' SER . . . . . . . . . . . . . 40.1 m -134.62 111.1 9.75 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 115.938 -0.574 . . . . 73.329999999999998 110.394 175.723 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 683' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -118.7 136.24 54.04 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.582 0.23 . . . . 62.409999999999997 111.474 -177.49 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 684' ' ' VAL . . . . . 0.41 HG12 ' H ' ' A' ' 687' ' ' ALA . 86.5 t -121.38 111.8 33.23 Favored Pre-proline 0 CA--C 1.54 0.561 0 CA-C-O 120.553 0.216 . . . . 71.030000000000001 111.104 177.555 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -59.46 -50.62 7.89 Favored 'Trans proline' 0 CA--C 1.543 0.968 0 C-N-CA 122.723 2.282 . . . . 63.210000000000001 114.105 -176.552 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 686' ' ' MET . . . . . . . . . . . . . 53.9 mtp -79.73 -12.62 59.79 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 113.439 0.903 . . . . 74.340000000000003 113.439 -175.046 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 687' ' ' ALA . . . . . 0.41 ' H ' HG12 ' A' ' 684' ' ' VAL . . . -65.54 -21.17 66.58 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.845 0.355 . . . . 52.43 111.553 -178.412 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 688' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -107.37 0.73 23.2 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 112.346 0.498 . . . . 74.430000000000007 112.346 -178.587 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 25.4 t -99.55 151.11 4.94 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 O-C-N 122.098 -0.376 . . . . 74.120000000000005 111.528 -177.634 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 690' ' ' LEU . . . . . 0.446 HD21 HG12 ' A' ' 692' ' ' ILE . 9.1 tt -148.08 146.78 28.97 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 122.347 0.259 . . . . 72.519999999999996 111.025 -177.802 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 691' ' ' ALA . . . . . . . . . . . . . . . -145.73 128.46 16.24 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 111.994 0.368 . . . . 52.420000000000002 111.994 179.195 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 692' ' ' ILE . . . . . 0.529 HD13 ' HA ' ' A' ' 698' ' ' ASP . 45.4 mm -134.01 134.21 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 122.72 0.408 . . . . 63.229999999999997 111.737 -177.773 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 693' ' ' ASP . . . . . 0.454 ' HB2' ' CD1' ' A' ' 699' ' ' LEU . 35.0 t70 -106.95 144.77 33.1 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 122.077 -0.39 . . . . 63.420000000000002 111.01 173.381 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -59.33 -39.89 84.56 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 116.128 -0.487 . . . . 75.099999999999994 112.11 -177.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -83.01 -55.78 4.18 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 112.462 0.541 . . . . 73.230000000000004 112.462 -178.319 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 696' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -79.41 -48.27 14.27 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 112.445 0.535 . . . . 74.349999999999994 112.445 -169.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . 122.31 -112.26 1.96 Allowed Glycine 0 CA--C 1.522 0.47 0 C-N-CA 120.913 -0.66 . . . . 41.530000000000001 112.613 -176.446 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 698' ' ' ASP . . . . . 0.529 ' HA ' HD13 ' A' ' 692' ' ' ILE . 13.0 t70 -87.65 116.92 26.11 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 122.179 -0.601 . . . . 71.209999999999994 112.064 -176.271 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 699' ' ' LEU . . . . . 0.454 ' CD1' ' HB2' ' A' ' 693' ' ' ASP . 56.9 mt -112.37 21.2 15.98 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 116.287 -0.415 . . . . 75.420000000000002 111.32 175.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 29.6 m -60.14 -25.94 65.88 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 120.952 0.406 . . . . 70.040000000000006 111.603 -178.114 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 701' ' ' SER . . . . . . . . . . . . . 40.0 t -82.02 -18.21 44.06 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 121.163 0.506 . . . . 71.510000000000005 111.412 177.211 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 702' ' ' LYS . . . . . . . . . . . . . 48.6 mmtm -82.42 3.08 29.5 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 116.293 -0.412 . . . . 65.519999999999996 111.873 179.611 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 72.1 mt -78.37 138.98 19.24 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 CA-C-O 121.326 0.584 . . . . 73.439999999999998 112.438 -177.368 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 704' ' ' LYS . . . . . 0.471 ' O ' ' HA ' ' A' ' 721' ' ' TYR . 22.5 ttmm -104.84 139.33 39.76 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.783 -0.644 . . . . 65.530000000000001 110.267 178.149 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 60.8 t -115.59 111.09 34.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 N-CA-C 112.392 0.515 . . . . 73.450000000000003 112.392 -177.601 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 706' ' ' ASP . . . . . 0.571 ' HB3' ' HB ' ' A' ' 720' ' ' THR . 28.7 t70 -107.41 133.14 52.36 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.122 -0.49 . . . . 62.32 110.568 174.09 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 86.86 165.74 41.63 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 120.894 -0.67 . . . . 75.420000000000002 112.441 -176.272 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 708' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -159.37 148.78 18.44 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 122.283 -0.54 . . . . 64.510000000000005 111.153 -179.099 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 709' ' ' VAL . . . . . 0.451 HG23 HD11 ' A' ' 719' ' ' LEU . 58.7 t -96.45 137.58 23.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-N 116.094 -0.503 . . . . 64.319999999999993 111.665 -178.452 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 710' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -105.03 136.76 43.9 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 116.188 -0.46 . . . . 74.25 110.225 175.139 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 711' ' ' THR . . . . . . . . . . . . . 73.4 p -107.91 8.77 28.69 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 112.814 0.672 . . . . 74.120000000000005 112.814 -174.24 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 712' ' ' THR . . . . . . . . . . . . . 7.2 t -111.83 -9.73 14.05 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 122.078 -0.389 . . . . 50.549999999999997 111.61 176.788 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 713' ' ' LYS . . . . . . . . . . . . . 37.8 tttp -129.3 133.19 47.35 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 120.653 0.263 . . . . 74.439999999999998 110.885 177.577 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 714' ' ' ALA . . . . . . . . . . . . . . . -77.73 134.01 38.18 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 112.18 0.437 . . . . 74.129999999999995 112.18 -178.195 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 168.27 179.81 40.91 Favored Glycine 0 CA--C 1.524 0.625 0 CA-C-N 116.123 -0.49 . . . . 72.340000000000003 112.854 -179.348 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 716' ' ' THR . . . . . . . . . . . . . 41.0 m -108.64 122.67 47.59 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 120.999 0.428 . . . . 73.109999999999999 111.384 -178.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 717' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -114.06 124.09 51.28 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 116.284 -0.416 . . . . 71.319999999999993 111.036 -177.422 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 718' ' ' VAL . . . . . . . . . . . . . 49.3 t -97.36 114.65 35.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-O 121.111 0.481 . . . . 65.409999999999997 111.124 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 719' ' ' LEU . . . . . 0.451 HD11 HG23 ' A' ' 709' ' ' VAL . 47.4 mt -101.51 132.75 46.97 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 116.292 -0.413 . . . . 74.109999999999999 111.41 -177.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 720' ' ' THR . . . . . 0.571 ' HB ' ' HB3' ' A' ' 706' ' ' ASP . 34.9 m -110.06 128.02 55.18 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 120.958 0.409 . . . . 60.119999999999997 111.501 178.083 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 721' ' ' TYR . . . . . 0.471 ' HA ' ' O ' ' A' ' 704' ' ' LYS . 75.3 m-85 -117.97 126.36 52.18 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.524 -0.307 . . . . 72.310000000000002 110.84 178.85 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 56.1 m -127.98 122.27 31.89 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 116.853 -0.158 . . . . 74.219999999999999 111.266 -178.143 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 12.9 p -111.11 142.14 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-O 120.903 0.382 . . . . 62.409999999999997 111.372 -179.191 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 52.3 m -113.79 126.5 55.28 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.083 0.468 . . . . 75.299999999999997 112.099 -178.368 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 725' ' ' ASP . . . . . 0.517 ' HB3' ' HB2' ' A' ' 729' ' ' HIS . 0.2 OUTLIER -84.5 158.81 20.88 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 115.953 -0.567 . . . . 75.319999999999993 111.483 176.22 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 726' ' ' SER . . . . . . . . . . . . . 49.8 m -58.21 -34.74 70.73 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.872 0.693 . . . . 71.129999999999995 112.872 -176.299 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 727' ' ' LYS . . . . . 0.489 ' HD2' ' N ' ' A' ' 727' ' ' LYS . 3.4 mptp? -90.45 13.45 15.62 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 122.09 -0.381 . . . . 72.120000000000005 111.59 -177.793 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 728' ' ' GLY . . . . . . . . . . . . . . . 91.54 10.84 61.46 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 121.118 -0.563 . . . . 52.130000000000003 114.224 174.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 729' ' ' HIS . . . . . 0.517 ' HB2' ' HB3' ' A' ' 725' ' ' ASP . 46.7 m80 -80.79 107.24 13.43 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 117.397 0.598 . . . . 74.109999999999999 111.203 178.36 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 730' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -111.39 124.69 52.77 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.982 -0.554 . . . . 43.25 111.271 -175.417 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 28.8 m -131.16 152.6 37.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 CA-C-O 120.739 0.304 . . . . 73.409999999999997 111.283 179.097 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 10.2 t -136.25 153.81 51.09 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 112.727 0.639 . . . . 63.140000000000001 112.727 -176.316 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -148.35 161.6 41.22 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.079 0.551 . . . . 52.039999999999999 110.704 177.296 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 734' ' ' LYS . . . . . . . . . . . . . 41.3 mttp -122.72 156.6 34.08 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 113.246 0.832 . . . . 74.120000000000005 113.246 -176.197 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 735' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -130.56 128.56 41.35 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 115.141 -0.936 . . . . 74.420000000000002 110.542 176.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 736' ' ' THR . . . . . . . . . . . . . 85.3 m -96.96 104.01 15.99 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.825 0.345 . . . . 71.510000000000005 111.37 178.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 737' ' ' VAL . . . . . 0.524 HG22 ' HB3' ' A' ' 675' ' ' ALA . 48.7 t -98.76 131.9 45.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-O 120.638 0.256 . . . . 44.149999999999999 111.414 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 738' ' ' THR . . . . . . . . . . . . . 90.7 m -121.36 117.9 28.12 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.042 0.449 . . . . 74.409999999999997 111.574 179.299 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 739' ' ' VAL . . . . . . . . . . . . . 27.4 t -98.94 125.14 52.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-N 116.244 -0.435 . . . . 73.340000000000003 111.043 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 740' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -114.1 152.34 31.23 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 112.142 0.423 . . . . 73.510000000000005 112.142 -177.17 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 741' ' ' VAL . . . . . 0.401 HG12 ' N ' ' A' ' 742' ' ' ARG . 23.7 t -79.94 156.4 4.56 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 CA-C-O 121.191 0.519 . . . . 74.409999999999997 112.307 -176.599 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 742' ' ' ARG . . . . . 0.401 ' N ' HG12 ' A' ' 741' ' ' VAL . 23.1 mmm180 -88.27 -177.37 5.66 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.032 0.444 . . . . 75.219999999999999 111.345 173.617 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 743' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -105.52 -15.52 14.98 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.859 0.362 . . . . 72.010000000000005 111.367 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 744' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -91.36 138.35 31.65 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.401 -0.363 . . . . 52.240000000000002 111.577 -176.513 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 4.0 p -75.83 106.03 5.29 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 CA-C-O 121.425 0.631 . . . . 62.25 111.713 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -103.86 130.08 51.4 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.117 0.484 . . . . 74.25 111.999 179.439 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 747' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 -102.35 12.17 36.99 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 115.926 -0.579 . . . . 63.130000000000003 110.166 173.517 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -67.66 83.48 0.18 Allowed 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.709 -0.678 . . . . 72.209999999999994 112.463 -177.45 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 749' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.04 131.93 24.33 Favored Pre-proline 0 N--CA 1.468 0.466 0 CA-C-N 116.177 -0.465 . . . . 74.530000000000001 110.117 171.456 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 750' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -63.89 118.51 5.45 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 122.407 2.072 . . . . 65.129999999999995 113.24 -178.079 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 751' ' ' ILE . . . . . . . . . . . . . 35.5 pt -77.34 24.39 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 N-CA-C 112.377 0.51 . . . . 63.329999999999998 112.377 -178.599 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 752' ' ' LEU . . . . . . . . . . . . . 2.7 pp -113.92 178.08 4.41 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 120.836 0.35 . . . . 65.209999999999994 111.424 -179.331 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 753' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 . . . . . 0 N--CA 1.469 0.504 0 CA-C-O 120.734 0.302 . . . . 75.409999999999997 111.782 -177.486 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 762' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 657' ' ' MET . . . . . . . . . . . . . 67.1 mtt . . . . . 0 N--CA 1.493 1.687 0 CA-C-O 120.912 0.387 . . . . 54.25 111.568 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 658' ' ' GLY . . . . . . . . . . . . . . . -93.43 -62.4 1.1 Allowed Glycine 0 CA--C 1.526 0.725 0 C-N-CA 121.286 -0.483 . . . . 43.229999999999997 112.026 176.68 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 659' ' ' ASN . . . . . . . . . . . . . 37.8 t30 -134.79 106.22 6.8 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 122.809 0.444 . . . . 72.030000000000001 109.871 173.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 660' ' ' GLY . . . . . . . . . . . . . . . -72.63 67.19 1.31 Allowed Glycine 0 CA--C 1.528 0.877 0 C-N-CA 121.226 -0.511 . . . . 71.209999999999994 113.179 -179.162 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -81.15 103.14 10.75 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.156 0.503 . . . . 72.420000000000002 110.623 178.557 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 662' ' ' THR . . . . . . . . . . . . . 4.4 t -144.8 173.05 12.18 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.886 -0.597 . . . . 63.340000000000003 110.374 -178.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 663' ' ' SER . . . . . . . . . . . . . 98.1 p -155.8 98.88 1.95 Allowed 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 112.896 0.702 . . . . 53.210000000000001 112.896 -176.033 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 664' ' ' ASP . . . . . 0.454 ' OD2' ' HB2' ' A' ' 727' ' ' LYS . 35.4 t0 -88.36 114.28 24.81 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 120.988 0.423 . . . . 74.030000000000001 109.916 169.448 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 665' ' ' LEU . . . . . 0.429 HD12 ' HD3' ' A' ' 694' ' ' LYS . 88.2 mt -90.6 137.32 32.45 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.165 -0.47 . . . . 73.219999999999999 110.463 175.764 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 666' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -57.01 131.96 80.05 Favored Pre-proline 0 CA--C 1.54 0.586 0 CA-C-N 116.496 -0.32 . . . . 71.030000000000001 110.557 172.775 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 667' ' ' PRO . . . . . 0.544 ' HB3' HD12 ' A' ' 699' ' ' LEU . 26.9 Cg_endo -60.37 148.61 89.8 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 122.433 2.089 . . . . 72.230000000000004 113.36 -172.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 668' ' ' LYS . . . . . . . . . . . . . 56.9 tptt -83.22 108.61 16.58 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.095 0.474 . . . . 72.219999999999999 111.213 177.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 669' ' ' LEU . . . . . 0.536 ' HG ' HG23 ' A' ' 671' ' ' VAL . 56.6 tp -96.65 111.97 23.9 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 116.281 -0.418 . . . . 70.310000000000002 111.335 -179.585 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 670' ' ' THR . . . . . . . . . . . . . 72.6 m -87.87 109.69 19.96 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.657 0.265 . . . . 52.140000000000001 110.927 179.177 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 671' ' ' VAL . . . . . 0.536 HG23 ' HG ' ' A' ' 669' ' ' LEU . 95.2 t -136.23 130.1 18.13 Favored Pre-proline 0 N--CA 1.472 0.663 0 CA-C-N 116.455 -0.339 . . . . 71.010000000000005 111.065 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 672' ' ' PRO . . . . . 0.441 ' HG2' ' NE2' ' A' ' 735' ' ' GLN . 69.6 Cg_endo -76.2 156.09 37.64 Favored 'Trans proline' 0 CA--C 1.542 0.882 0 C-N-CA 122.622 2.215 . . . . 74.140000000000001 112.759 176.838 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 673' ' ' VAL . . . . . . . . . . . . . 13.5 p -81.66 -33.59 12.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 N-CA-C 112.94 0.719 . . . . 55.329999999999998 112.94 -174.651 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 674' ' ' GLY . . . . . 0.401 ' HA2' ' O ' ' A' ' 736' ' ' THR . . . -175.08 139.55 4.85 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 119.926 -1.131 . . . . 52.109999999999999 114.35 -176.078 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 675' ' ' ALA . . . . . . . . . . . . . . . -139.96 151.33 45.45 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 122.654 0.382 . . . . 52.450000000000003 110.965 178.047 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 676' ' ' THR . . . . . . . . . . . . . 97.6 m -131.62 123.17 27.32 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-O 120.719 0.295 . . . . 74.510000000000005 111.576 -179.694 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 677' ' ' ILE . . . . . . . . . . . . . 29.8 pt -123.14 177.44 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 122.699 0.4 . . . . 72.450000000000003 111.405 -179.319 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 678' ' ' HIS . . . . . . . . . . . . . 74.2 m80 -107.37 161.66 14.61 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 121.326 0.584 . . . . 72.409999999999997 112.368 178.624 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 679' ' ' VAL . . . . . 0.607 HG13 ' HA ' ' A' ' 712' ' ' THR . 76.6 t -60.44 126.37 18.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-N 115.747 -0.661 . . . . 64.040000000000006 111.837 176.513 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 103.52 -2.69 46.15 Favored Glycine 0 CA--C 1.528 0.906 0 CA-C-N 116.129 -0.487 . . . . 64.209999999999994 113.389 -178.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 681' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -88.8 -175.74 4.99 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 116.91 0.355 . . . . 74.099999999999994 110.979 178.741 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 682' ' ' SER . . . . . . . . . . . . . 74.9 m -134.69 137.68 43.76 Favored 'General case' 0 N--CA 1.477 0.898 0 O-C-N 121.993 -0.442 . . . . 72.400000000000006 111.877 -178.473 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 683' ' ' PHE . . . . . . . . . . . . . 47.2 t80 -125.89 133.81 51.79 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 116.35 -0.386 . . . . 62.299999999999997 110.655 -178.098 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 684' ' ' VAL . . . . . . . . . . . . . 46.4 t -123.77 93.77 46.9 Favored Pre-proline 0 CA--C 1.546 0.791 0 CA-C-O 121.108 0.48 . . . . 72.109999999999999 112.089 -174.555 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -64.02 -29.58 66.26 Favored 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 122.706 2.271 . . . . 75.530000000000001 113.805 -178.17 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 686' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -79.3 -7.57 58.4 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.547 0.573 . . . . 72.140000000000001 112.547 -177.854 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 687' ' ' ALA . . . . . . . . . . . . . . . -110.26 -39.1 5.08 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.866 0.365 . . . . 62.340000000000003 111.655 177.646 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 688' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -77.38 -10.47 59.47 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 112.43 0.53 . . . . 54.439999999999998 112.43 -177.64 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 689' ' ' VAL . . . . . 0.476 HG12 HD13 ' A' ' 703' ' ' ILE . 88.7 t -119.03 125.01 74.13 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 CA-C-O 120.865 0.364 . . . . 73.510000000000005 111.565 178.089 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 690' ' ' LEU . . . . . 0.42 HD22 ' N ' ' A' ' 690' ' ' LEU . 2.7 mm? -122.36 161.77 22.81 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 120.863 0.364 . . . . 73.120000000000005 111.375 -177.223 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 691' ' ' ALA . . . . . . . . . . . . . . . -147.46 122.62 10.18 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 120.966 0.412 . . . . 63.420000000000002 111.896 177.64 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 692' ' ' ILE . . . . . . . . . . . . . 45.4 mm -123.9 135.01 64.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-N 116.349 -0.387 . . . . 74.239999999999995 111.25 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -120.44 149.91 41.64 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 120.823 0.344 . . . . 70.430000000000007 111.63 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 694' ' ' LYS . . . . . 0.429 ' HD3' HD12 ' A' ' 665' ' ' LEU . 37.8 ttpt -62.49 -61.2 2.6 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 112.314 0.487 . . . . 73.510000000000005 112.314 -177.465 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 695' ' ' GLU . . . . . 0.468 ' CD ' ' H ' ' A' ' 695' ' ' GLU . 0.1 OUTLIER -85.09 -53.11 5.48 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 111.868 0.321 . . . . 64.409999999999997 111.868 -174.664 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 696' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -66.52 -48.91 68.26 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 121.063 0.459 . . . . 71.140000000000001 111.052 -173.434 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . 122.49 -146.95 16.88 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 121.224 -0.513 . . . . 72.109999999999999 113.11 178.629 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -70.94 111.36 6.27 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.955 0.407 . . . . 62.32 110.921 179.078 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 699' ' ' LEU . . . . . 0.544 HD12 ' HB3' ' A' ' 667' ' ' PRO . 79.0 mt -104.77 17.41 24.18 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 120.85 0.357 . . . . 52.399999999999999 111.503 179.517 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 42.4 m -56.77 -37.12 70.65 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.177 0.513 . . . . 73.349999999999994 111.268 178.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 701' ' ' SER . . . . . . . . . . . . . 27.5 m -68.55 -12.48 61.33 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 116.207 -0.451 . . . . 73.150000000000006 111.982 178.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 702' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -100.69 3.18 42.18 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 111.813 0.301 . . . . 71.540000000000006 111.813 -176.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 703' ' ' ILE . . . . . 0.476 HD13 HG12 ' A' ' 689' ' ' VAL . 72.2 mt -73.7 118.5 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 120.964 0.411 . . . . 73.239999999999995 111.718 -178.72 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 704' ' ' LYS . . . . . 0.422 ' HB2' ' NZ ' ' A' ' 704' ' ' LYS . 5.2 ttmp? -84.33 115.59 22.58 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 116.169 -0.469 . . . . 53.25 110.329 176.277 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 67.8 t -95.87 106.57 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 121.161 0.505 . . . . 62.310000000000002 111.595 -178.318 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 706' ' ' ASP . . . . . 0.551 ' HB3' ' HB ' ' A' ' 720' ' ' THR . 25.2 t70 -101.82 125.57 48.52 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 116.177 -0.465 . . . . 51.229999999999997 111.099 179.378 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 112.04 163.81 17.02 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 121.067 -0.587 . . . . 52.409999999999997 113.335 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 708' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -149.62 145.72 26.92 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.019 0.438 . . . . 65.109999999999999 111.655 -177.079 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 709' ' ' VAL . . . . . 0.554 HG22 ' HB2' ' A' ' 717' ' ' TYR . 55.4 t -120.45 122.04 67.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 CA-C-N 116.28 -0.418 . . . . 72.019999999999996 111.607 -177.85 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 710' ' ' ASP . . . . . 0.533 ' HB2' ' HB3' ' A' ' 713' ' ' LYS . 10.1 m-20 -73.94 136.34 43.28 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 120.74 0.305 . . . . 60.539999999999999 110.816 174.35 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 711' ' ' THR . . . . . . . . . . . . . 81.2 p -96.48 0.99 51.1 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 120.932 0.396 . . . . 75.430000000000007 111.237 175.711 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 712' ' ' THR . . . . . 0.607 ' HA ' HG13 ' A' ' 679' ' ' VAL . 74.5 p -115.71 3.46 13.89 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 116.163 -0.472 . . . . 73.430000000000007 111.912 178.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 713' ' ' LYS . . . . . 0.533 ' HB3' ' HB2' ' A' ' 710' ' ' ASP . 5.6 tppp? -125.37 122.17 36.02 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 120.731 0.3 . . . . 65.239999999999995 111.586 -175.411 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 714' ' ' ALA . . . . . . . . . . . . . . . -70.36 112.46 6.68 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.928 0.394 . . . . 71.209999999999994 111.688 175.494 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 175.24 168.41 35.73 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 121.112 -0.566 . . . . 41.229999999999997 112.986 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 716' ' ' THR . . . . . . . . . . . . . 86.3 m -104.04 123.11 46.63 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 122.701 -0.293 . . . . 64.109999999999999 111.699 179.217 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 717' ' ' TYR . . . . . 0.554 ' HB2' HG22 ' A' ' 709' ' ' VAL . 86.0 m-85 -119.93 122.7 41.81 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.005 0.431 . . . . 73.120000000000005 111.164 177.012 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 718' ' ' VAL . . . . . . . . . . . . . 59.0 t -92.37 117.91 36.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-O 120.738 0.304 . . . . 52.240000000000002 111.139 177.477 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 719' ' ' LEU . . . . . 0.455 HD21 HG23 ' A' ' 709' ' ' VAL . 58.1 mt -94.45 148.26 22.42 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 116.671 -0.24 . . . . 74.420000000000002 111.111 -179.436 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 720' ' ' THR . . . . . 0.551 ' HB ' ' HB3' ' A' ' 706' ' ' ASP . 25.0 m -114.98 133.15 56.28 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 120.615 0.245 . . . . 42.210000000000001 111.072 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 721' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -122.91 115.87 22.66 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.835 0.35 . . . . 61.32 111.07 179.51 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 46.2 m -123.95 123.1 39.67 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 120.654 0.264 . . . . 74.299999999999997 111.474 -178.219 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 8.7 p -119.0 136.88 54.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 CA-C-O 120.963 0.411 . . . . 73.109999999999999 111.529 179.362 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 18.0 m -117.58 128.49 55.0 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.144 0.424 . . . . 72.430000000000007 112.144 -175.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 725' ' ' ASP . . . . . 0.515 ' HB3' ' H ' ' A' ' 729' ' ' HIS . 9.9 t70 -74.59 152.14 39.31 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 116.334 -0.394 . . . . 74.219999999999999 110.624 176.703 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 726' ' ' SER . . . . . . . . . . . . . 48.7 m -62.52 -27.41 69.14 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 112.624 0.601 . . . . 63.109999999999999 112.624 -177.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 727' ' ' LYS . . . . . 0.478 ' N ' ' HD3' ' A' ' 727' ' ' LYS . 3.5 mppt? -95.04 4.01 54.22 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 112.19 0.441 . . . . 72.219999999999999 112.19 179.399 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 728' ' ' GLY . . . . . . . . . . . . . . . 101.84 34.27 4.4 Favored Glycine 0 CA--C 1.533 1.161 0 N-CA-C 115.563 0.985 . . . . 51.350000000000001 115.563 171.136 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 729' ' ' HIS . . . . . 0.515 ' H ' ' HB3' ' A' ' 725' ' ' ASP . 31.2 m80 -109.53 111.08 22.39 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 118.077 0.938 . . . . 74.319999999999993 110.926 170.704 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 730' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -113.82 118.45 34.28 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 112.004 0.372 . . . . 52.420000000000002 112.004 -174.418 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 30.7 m -117.17 155.11 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-O 120.671 0.272 . . . . 72.150000000000006 111.171 178.055 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 10.0 t -147.52 145.38 29.08 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 112.792 0.664 . . . . 72.200000000000003 112.792 -175.269 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -148.72 143.65 26.57 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.962 -0.563 . . . . 55.32 111.144 178.125 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 734' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -106.92 159.52 16.2 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.343 0.592 . . . . 74.129999999999995 112.41 -178.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 735' ' ' GLN . . . . . 0.441 ' NE2' ' HG2' ' A' ' 672' ' ' PRO . 47.7 tt0 -132.77 130.08 39.46 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.707 -0.679 . . . . 63.520000000000003 110.837 -179.321 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 736' ' ' THR . . . . . 0.401 ' O ' ' HA2' ' A' ' 674' ' ' GLY . 90.5 m -94.13 103.89 15.93 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 120.919 0.39 . . . . 74.340000000000003 111.865 -179.017 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 44.3 t -102.6 135.17 41.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-O 120.719 0.295 . . . . 65.209999999999994 111.473 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 738' ' ' THR . . . . . . . . . . . . . 92.5 m -125.36 131.6 52.96 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 120.723 0.297 . . . . 74.219999999999999 111.378 178.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 739' ' ' VAL . . . . . . . . . . . . . 51.6 t -109.73 128.03 66.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-O 120.829 0.347 . . . . 64.349999999999994 111.011 177.409 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 740' ' ' LYS . . . . . 0.514 ' NZ ' ' HB3' ' A' ' 740' ' ' LYS . 7.3 mtpm? -116.18 152.6 33.39 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.973 0.416 . . . . 74.239999999999995 111.374 179.141 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 741' ' ' VAL . . . . . . . . . . . . . 18.1 t -81.48 145.9 8.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-O 120.704 0.288 . . . . 53.140000000000001 111.033 -178.561 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 742' ' ' ARG . . . . . . . . . . . . . 4.0 ppt_? -83.43 158.88 21.91 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.151 0.5 . . . . 63.539999999999999 112.143 178.239 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 743' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -69.41 143.89 53.5 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.8 -0.636 . . . . 74.430000000000007 112.5 -177.096 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 744' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -109.4 135.62 50.15 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 116.164 -0.471 . . . . 75.409999999999997 110.017 172.611 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 30.3 m -84.23 177.42 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 N-CA-C 112.136 0.421 . . . . 71.0 112.136 -177.512 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -61.95 90.4 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.025 0.44 . . . . 64.430000000000007 111.86 179.156 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 747' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -93.8 170.53 9.5 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 121.275 0.56 . . . . 55.030000000000001 111.693 178.474 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -83.23 32.24 0.45 Allowed 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 115.971 -0.559 . . . . 70.519999999999996 111.62 -178.48 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 749' ' ' LYS . . . . . . . . . . . . . 46.4 tptt 54.87 73.74 0.84 Allowed Pre-proline 0 CA--C 1.543 0.678 0 C-N-CA 123.145 0.578 . . . . 75.540000000000006 111.281 -175.526 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 750' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -70.27 105.34 1.55 Allowed 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 122.662 2.241 . . . . 55.210000000000001 112.705 -178.217 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 751' ' ' ILE . . . . . . . . . . . . . 58.3 mt -75.59 78.12 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-O 121.356 0.598 . . . . 72.439999999999998 110.297 177.563 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 752' ' ' LEU . . . . . . . . . . . . . 39.1 tp -74.39 90.56 2.17 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.917 -0.583 . . . . 74.140000000000001 111.91 -173.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 753' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 . . . . . 0 C--O 1.239 0.51 0 CA-C-N 116.148 -0.478 . . . . 53.43 111.186 177.103 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 762' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 657' ' ' MET . . . . . . . . . . . . . 9.7 tpt . . . . . 0 N--CA 1.488 1.437 0 CA-C-O 121.077 0.465 . . . . 70.420000000000002 111.802 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 658' ' ' GLY . . . . . . . . . . . . . . . -156.42 29.44 0.57 Allowed Glycine 0 CA--C 1.527 0.805 0 CA-C-N 116.145 -0.48 . . . . 53.420000000000002 112.582 176.523 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 659' ' ' ASN . . . . . . . . . . . . . 60.6 m-20 -69.72 106.63 3.16 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 120.795 0.331 . . . . 73.140000000000001 111.522 -177.164 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 660' ' ' GLY . . . . . . . . . . . . . . . -80.74 56.71 4.78 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 121.129 -0.557 . . . . 71.510000000000005 113.279 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 37.3 mm-40 -105.26 142.76 34.47 Favored 'General case' 0 N--CA 1.468 0.456 0 O-C-N 122.65 -0.323 . . . . 62.329999999999998 111.337 -179.688 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 662' ' ' THR . . . . . . . . . . . . . 9.1 t -92.79 172.59 8.24 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.211 0.529 . . . . 64.329999999999998 112.097 -177.137 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 663' ' ' SER . . . . . . . . . . . . . 62.8 m -89.93 122.8 33.3 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 116.328 -0.396 . . . . 62.439999999999998 111.559 -178.6 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 664' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -73.55 143.86 46.32 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 121.406 0.622 . . . . 71.219999999999999 111.552 177.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 665' ' ' LEU . . . . . . . . . . . . . 86.9 mt -87.33 126.0 34.58 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.648 -0.706 . . . . 73.230000000000004 110.387 176.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 666' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -62.1 145.59 93.15 Favored Pre-proline 0 CA--C 1.542 0.661 0 CA-C-N 116.116 -0.493 . . . . 73.030000000000001 111.3 178.626 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 667' ' ' PRO . . . . . 0.463 ' HD3' ' HB2' ' A' ' 725' ' ' ASP . 80.4 Cg_endo -76.94 147.14 26.64 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 122.365 2.043 . . . . 72.019999999999996 112.872 -176.189 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 668' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -83.15 104.05 13.04 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.127 0.489 . . . . 74.549999999999997 110.901 179.319 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 669' ' ' LEU . . . . . 0.418 ' HG ' HG23 ' A' ' 671' ' ' VAL . 58.1 tp -89.91 105.87 18.09 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.065 -0.516 . . . . 74.510000000000005 110.707 177.392 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 670' ' ' THR . . . . . . . . . . . . . 73.5 m -88.18 110.97 21.11 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.162 -0.472 . . . . 74.430000000000007 111.273 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 671' ' ' VAL . . . . . 0.497 HG22 HG13 ' A' ' 689' ' ' VAL . 85.7 t -132.08 126.27 20.49 Favored Pre-proline 0 N--CA 1.47 0.53 0 CA-C-N 116.146 -0.479 . . . . 64.109999999999999 110.768 179.275 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 672' ' ' PRO . . . . . 0.504 ' HG2' ' NE2' ' A' ' 735' ' ' GLN . 45.4 Cg_endo -69.73 137.48 35.64 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 122.27 1.98 . . . . 71.329999999999998 112.297 179.097 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 673' ' ' VAL . . . . . . . . . . . . . 12.5 p -64.54 -35.89 75.83 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 N-CA-C 112.279 0.474 . . . . 63.329999999999998 112.279 -175.39 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 674' ' ' GLY . . . . . . . . . . . . . . . -162.22 161.62 33.63 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 120.647 -0.787 . . . . 33.310000000000002 113.699 -178.032 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 675' ' ' ALA . . . . . . . . . . . . . . . -151.17 157.82 43.17 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 122.299 0.24 . . . . 65.439999999999998 110.955 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 676' ' ' THR . . . . . . . . . . . . . 60.7 m -133.38 126.39 31.18 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 122.347 -0.221 . . . . 72.549999999999997 111.394 179.544 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 677' ' ' ILE . . . . . . . . . . . . . 23.9 pt -130.33 174.56 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-O 120.976 0.417 . . . . 72.019999999999996 111.311 177.804 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 678' ' ' HIS . . . . . 0.528 ' O ' ' HB2' ' A' ' 681' ' ' ASP . 72.3 m80 -121.3 171.35 8.8 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.324 0.583 . . . . 64.510000000000005 112.378 -178.1 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 679' ' ' VAL . . . . . 0.485 HG23 ' HA ' ' A' ' 741' ' ' VAL . 84.5 t -63.71 120.01 9.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-N 116.023 -0.535 . . . . 35.109999999999999 111.254 175.499 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 97.2 0.84 59.65 Favored Glycine 0 CA--C 1.528 0.895 0 CA-C-N 116.185 -0.461 . . . . 63.439999999999998 113.211 -175.55 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 681' ' ' ASP . . . . . 0.528 ' HB2' ' O ' ' A' ' 678' ' ' HIS . 0.9 OUTLIER -77.05 178.58 6.87 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-O 121.101 0.477 . . . . 53.039999999999999 111.116 -179.561 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 682' ' ' SER . . . . . . . . . . . . . 87.2 p -134.94 126.21 28.19 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 116.511 -0.313 . . . . 53.229999999999997 110.831 177.597 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 683' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -127.53 134.38 49.77 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.931 0.396 . . . . 71.530000000000001 111.647 -176.247 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 684' ' ' VAL . . . . . 0.435 ' HA ' ' HD2' ' A' ' 685' ' ' PRO . 61.8 t -124.26 101.6 34.52 Favored Pre-proline 0 CA--C 1.545 0.766 0 CA-C-O 121.089 0.471 . . . . 72.409999999999997 111.943 -179.665 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 685' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' A' ' 684' ' ' VAL . 21.6 Cg_endo -60.99 -36.58 82.1 Favored 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 122.871 2.381 . . . . 53.43 113.843 -178.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 686' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -78.64 -1.75 35.77 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 112.237 0.458 . . . . 73.310000000000002 112.237 -177.791 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 687' ' ' ALA . . . . . . . . . . . . . . . -95.27 -48.08 6.05 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.078 0.466 . . . . 72.120000000000005 110.808 174.001 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 688' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -66.01 -38.31 88.12 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.605 0.594 . . . . 71.310000000000002 112.605 179.46 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 689' ' ' VAL . . . . . 0.497 HG13 HG22 ' A' ' 671' ' ' VAL . 98.9 t -86.67 143.1 12.08 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-O 120.934 0.397 . . . . 64.430000000000007 111.884 -178.118 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 690' ' ' LEU . . . . . 0.435 HD12 ' OG1' ' A' ' 700' ' ' THR . 45.9 tp -141.97 151.87 42.94 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.058 -0.519 . . . . 64.209999999999994 110.683 -177.092 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 691' ' ' ALA . . . . . 0.488 ' HB2' HD11 ' A' ' 703' ' ' ILE . . . -139.78 121.53 15.39 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.235 0.541 . . . . 72.530000000000001 111.439 174.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 692' ' ' ILE . . . . . . . . . . . . . 46.7 mm -128.93 120.53 52.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-N 116.219 -0.446 . . . . 55.43 111.716 -177.515 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 693' ' ' ASP . . . . . 0.46 ' HB2' ' HB3' ' A' ' 667' ' ' PRO . 31.9 t70 -102.88 149.24 24.7 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 120.787 0.327 . . . . 63.240000000000002 110.611 174.255 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -67.33 -55.41 13.98 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 112.367 0.506 . . . . 73.129999999999995 112.367 -176.075 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -83.8 -52.03 6.73 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 112.433 0.531 . . . . 63.530000000000001 112.433 -176.415 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 696' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -72.12 -32.79 67.27 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 120.874 0.368 . . . . 75.450000000000003 111.697 -172.572 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . 109.57 -144.69 16.72 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 120.973 -0.632 . . . . 24.420000000000002 113.515 177.441 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -71.06 122.47 20.13 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 120.85 0.357 . . . . 74.150000000000006 111.459 -178.433 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 699' ' ' LEU . . . . . . . . . . . . . 90.3 mt -118.85 20.89 12.69 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 120.998 0.428 . . . . 75.310000000000002 111.348 178.434 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 700' ' ' THR . . . . . 0.435 ' OG1' HD12 ' A' ' 690' ' ' LEU . 26.3 m -62.18 -39.22 91.94 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 121.169 0.509 . . . . 72.430000000000007 111.611 -179.339 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 701' ' ' SER . . . . . . . . . . . . . 63.3 m -71.07 -9.51 58.17 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 116.211 -0.449 . . . . 71.530000000000001 111.637 177.687 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 702' ' ' LYS . . . . . . . . . . . . . 2.4 mmmp? -87.01 -9.66 55.01 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 120.668 0.271 . . . . 71.540000000000006 111.049 176.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 703' ' ' ILE . . . . . 0.489 HG12 ' HB ' ' A' ' 723' ' ' VAL . 67.7 mt -74.76 115.57 16.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-O 120.743 0.306 . . . . 63.200000000000003 111.531 -178.781 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 704' ' ' LYS . . . . . . . . . . . . . 30.2 ttpt -89.95 119.47 30.34 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 120.872 0.368 . . . . 55.219999999999999 110.375 174.243 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 45.2 t -97.3 137.59 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 112.238 0.459 . . . . 62.450000000000003 112.238 -174.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 706' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -131.78 134.63 46.04 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 120.932 0.396 . . . . 63.450000000000003 110.962 175.597 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 128.07 178.87 15.55 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 121.373 -0.442 . . . . 73.219999999999999 112.987 179.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 708' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -166.28 130.71 2.17 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.046 0.45 . . . . 72.349999999999994 111.721 179.29 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 709' ' ' VAL . . . . . . . . . . . . . 60.1 t -107.54 131.2 58.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-N 116.222 -0.444 . . . . 71.120000000000005 111.652 -178.21 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 710' ' ' ASP . . . . . 0.437 ' O ' HG21 ' A' ' 739' ' ' VAL . 7.4 m-20 -85.68 141.86 29.45 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.037 0.446 . . . . 73.120000000000005 111.757 178.518 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 711' ' ' THR . . . . . 0.446 ' O ' ' HA ' ' A' ' 679' ' ' VAL . 80.5 p -111.29 2.36 17.64 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.476 -0.329 . . . . 75.150000000000006 111.648 177.361 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 712' ' ' THR . . . . . . . . . . . . . 31.2 p -103.84 -28.68 11.46 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 120.951 0.405 . . . . 61.439999999999998 111.883 178.375 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 713' ' ' LYS . . . . . 0.403 ' HB2' ' NZ ' ' A' ' 713' ' ' LYS . 4.8 ttmp? -119.64 133.33 55.69 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.505 -0.316 . . . . 53.210000000000001 111.174 -178.404 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 714' ' ' ALA . . . . . . . . . . . . . . . -69.56 142.98 53.5 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 120.868 0.366 . . . . 71.340000000000003 111.435 178.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 160.84 157.83 8.95 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 120.995 -0.621 . . . . 73.430000000000007 113.107 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 716' ' ' THR . . . . . . . . . . . . . 86.3 m -99.07 123.26 43.23 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 122.496 -0.414 . . . . 74.5 111.67 -178.741 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 717' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -122.19 150.33 42.4 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 122.579 0.352 . . . . 65.239999999999995 111.204 -178.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 718' ' ' VAL . . . . . . . . . . . . . 57.6 t -113.7 125.44 70.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 CA-C-O 121.003 0.43 . . . . 73.019999999999996 111.642 178.651 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 719' ' ' LEU . . . . . . . . . . . . . 81.4 mt -102.41 141.69 34.83 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.444 -0.344 . . . . 54.119999999999997 110.95 179.193 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 86.5 m -112.29 139.68 47.64 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-O 120.994 0.426 . . . . 61.100000000000001 111.71 -178.41 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 721' ' ' TYR . . . . . . . . . . . . . 50.1 m-85 -132.56 122.38 24.7 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 116.191 -0.459 . . . . 71.109999999999999 110.937 -179.017 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 95.3 m -125.69 125.32 42.86 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 120.873 0.368 . . . . 72.129999999999995 111.883 -179.654 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 723' ' ' VAL . . . . . 0.489 ' HB ' HG12 ' A' ' 703' ' ' ILE . 14.9 p -121.56 152.14 25.11 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-N 116.297 -0.411 . . . . 71.430000000000007 111.005 178.312 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 87.0 m -133.08 132.11 41.37 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.058 0.456 . . . . 72.519999999999996 111.938 177.676 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 725' ' ' ASP . . . . . 0.475 ' HB3' ' H ' ' A' ' 729' ' ' HIS . 9.9 t0 -73.41 151.05 41.29 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 115.714 -0.676 . . . . 64.519999999999996 110.608 177.747 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 726' ' ' SER . . . . . . . . . . . . . 44.0 t -59.57 -31.66 69.65 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.328 -0.396 . . . . 44.520000000000003 111.786 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 727' ' ' LYS . . . . . . . . . . . . . 10.3 mptt -86.71 1.05 53.41 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 112.237 0.458 . . . . 54.439999999999998 112.237 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 728' ' ' GLY . . . . . . . . . . . . . . . 100.55 33.77 4.96 Favored Glycine 0 CA--C 1.534 1.23 0 N-CA-C 115.49 0.956 . . . . 71.530000000000001 115.49 171.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 729' ' ' HIS . . . . . 0.475 ' H ' ' HB3' ' A' ' 725' ' ' ASP . 52.3 m80 -109.45 112.08 23.98 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 118.062 0.931 . . . . 74.530000000000001 111.571 173.058 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 730' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -99.51 129.05 45.65 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 121.028 0.442 . . . . 71.549999999999997 111.825 -176.813 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 48.8 t -127.51 136.1 61.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-N 116.22 -0.445 . . . . 71.209999999999994 110.591 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 10.3 t -135.13 144.95 47.39 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 112.364 0.505 . . . . 74.209999999999994 112.364 -178.628 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 733' ' ' ALA . . . . . 0.489 ' HB3' HG21 ' A' ' 671' ' ' VAL . . . -148.86 162.1 40.5 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 116.222 -0.445 . . . . 64.400000000000006 111.71 -178.53 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 734' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -123.72 155.35 38.01 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 112.356 0.502 . . . . 74.140000000000001 112.356 -178.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 735' ' ' GLN . . . . . 0.504 ' NE2' ' HG2' ' A' ' 672' ' ' PRO . 49.9 tt0 -130.04 126.36 37.5 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 116.021 -0.536 . . . . 74.25 110.746 177.284 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 736' ' ' THR . . . . . . . . . . . . . 97.8 m -95.1 109.54 21.59 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 120.992 0.425 . . . . 73.319999999999993 111.726 -179.711 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 47.7 t -106.5 121.67 59.4 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 CA-C-O 120.897 0.379 . . . . 62.399999999999999 111.505 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 738' ' ' THR . . . . . . . . . . . . . 54.2 m -104.77 121.81 44.4 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.091 0.472 . . . . 71.349999999999994 111.986 179.617 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 739' ' ' VAL . . . . . 0.437 HG21 ' O ' ' A' ' 710' ' ' ASP . 24.4 t -98.09 136.3 29.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-N 116.063 -0.517 . . . . 51.25 111.047 178.11 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 740' ' ' LYS . . . . . 0.408 ' O ' ' HA ' ' A' ' 678' ' ' HIS . 96.0 mttt -131.38 156.01 46.29 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.259 0.552 . . . . 75.329999999999998 111.957 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 741' ' ' VAL . . . . . 0.485 ' HA ' HG23 ' A' ' 679' ' ' VAL . 28.2 t -80.86 146.43 7.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-N 116.266 -0.425 . . . . 74.140000000000001 111.485 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 742' ' ' ARG . . . . . 0.415 HH11 ' HD3' ' A' ' 742' ' ' ARG . 13.7 ptt180 -84.35 179.42 7.45 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 120.707 0.289 . . . . 75.140000000000001 111.081 179.147 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 743' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -69.52 101.92 1.7 Allowed 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 112.888 0.699 . . . . 61.210000000000001 112.888 -175.559 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 744' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -100.78 153.18 19.67 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 120.77 0.319 . . . . 73.109999999999999 110.397 174.781 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 31.9 m -93.23 -175.24 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 N-CA-C 112.826 0.676 . . . . 73.329999999999998 112.826 -173.503 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -60.85 125.24 22.97 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.221 0.534 . . . . 75.519999999999996 111.811 178.239 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 747' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -84.53 65.05 8.78 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-O 121.513 0.673 . . . . 55.530000000000001 110.33 175.668 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -87.52 -28.33 22.08 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 112.553 0.575 . . . . 64.209999999999994 112.553 -176.502 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 749' ' ' LYS . . . . . 0.481 ' NZ ' ' HB3' ' A' ' 749' ' ' LYS . 0.1 OUTLIER -48.73 111.16 1.73 Allowed Pre-proline 0 CA--C 1.549 0.937 0 CA-C-O 121.25 0.547 . . . . 74.239999999999995 112.321 -175.389 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 750' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -85.47 146.37 9.61 Favored 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 123.133 2.555 . . . . 74.340000000000003 114.838 -171.594 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 751' ' ' ILE . . . . . . . . . . . . . 57.9 mt 59.67 86.0 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 CA-C-N 115.589 -0.732 . . . . 65.239999999999995 112.59 175.513 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 752' ' ' LEU . . . . . . . . . . . . . 43.2 tp -177.57 146.83 0.47 Allowed 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 116.167 -0.47 . . . . 64.450000000000003 111.235 178.126 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 753' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 . . . . . 0 N--CA 1.47 0.565 0 CA-C-O 121.112 0.482 . . . . 71.010000000000005 111.447 175.951 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 762' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 657' ' ' MET . . . . . . . . . . . . . 86.9 mtp . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.026 0.441 . . . . 71.0 111.532 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 658' ' ' GLY . . . . . . . . . . . . . . . 84.53 -67.92 3.61 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 121.316 -0.468 . . . . 62.310000000000002 112.962 178.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 659' ' ' ASN . . . . . . . . . . . . . 74.6 m-20 -91.42 149.28 21.78 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 122.462 -0.434 . . . . 61.340000000000003 111.475 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 660' ' ' GLY . . . . . . . . . . . . . . . -156.3 -110.44 0.33 Allowed Glycine 0 CA--C 1.525 0.673 0 C-N-CA 121.124 -0.56 . . . . 71.409999999999997 112.877 177.538 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 70.16 -11.46 0.57 Allowed 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 113.042 0.756 . . . . 72.209999999999994 113.042 176.582 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 662' ' ' THR . . . . . . . . . . . . . 82.3 m -70.39 104.77 2.81 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.13 0.49 . . . . 74.430000000000007 111.928 -174.153 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 663' ' ' SER . . . . . . . . . . . . . 68.2 m -132.23 158.18 42.45 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 116.167 -0.469 . . . . 72.310000000000002 111.236 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 664' ' ' ASP . . . . . 0.406 ' OD2' ' HB2' ' A' ' 727' ' ' LYS . 27.3 t0 -84.84 122.53 29.29 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 121.096 0.474 . . . . 70.450000000000003 110.979 176.013 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 665' ' ' LEU . . . . . . . . . . . . . 86.2 mt -96.94 136.89 36.86 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.117 -0.492 . . . . 55.030000000000001 110.768 175.701 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 666' ' ' GLU . . . . . 0.47 ' H ' ' CD ' ' A' ' 666' ' ' GLU . 1.4 pm0 -56.83 139.59 77.21 Favored Pre-proline 0 CA--C 1.544 0.712 0 CA-C-O 120.79 0.329 . . . . 73.340000000000003 111.16 175.53 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 667' ' ' PRO . . . . . 0.584 ' HB3' HD12 ' A' ' 699' ' ' LEU . 58.3 Cg_endo -68.97 156.77 64.32 Favored 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 122.618 2.212 . . . . 73.409999999999997 113.737 -172.614 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 668' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -87.76 105.18 17.21 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.99 -0.55 . . . . 65.540000000000006 111.226 177.733 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 669' ' ' LEU . . . . . 0.518 ' HG ' HG23 ' A' ' 671' ' ' VAL . 62.1 tp -95.09 108.13 20.21 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 116.011 -0.54 . . . . 72.329999999999998 110.658 177.151 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 670' ' ' THR . . . . . . . . . . . . . 88.2 m -86.34 111.31 20.36 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.858 0.361 . . . . 73.109999999999999 111.244 179.446 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 671' ' ' VAL . . . . . 0.518 HG23 ' HG ' ' A' ' 669' ' ' LEU . 94.6 t -136.31 130.93 18.39 Favored Pre-proline 0 N--CA 1.47 0.555 0 CA-C-N 116.301 -0.409 . . . . 73.319999999999993 110.983 -179.668 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 672' ' ' PRO . . . . . 0.464 ' HG2' ' NE2' ' A' ' 735' ' ' GLN . 71.9 Cg_endo -76.24 143.73 25.58 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 122.248 1.965 . . . . 72.510000000000005 111.995 175.069 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 673' ' ' VAL . . . . . . . . . . . . . 15.0 p -77.87 -28.06 15.34 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 CA-C-O 120.874 0.369 . . . . 72.340000000000003 111.403 -176.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 674' ' ' GLY . . . . . . . . . . . . . . . -156.16 136.61 5.1 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 120.934 -0.65 . . . . 63.32 113.584 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 675' ' ' ALA . . . . . . . . . . . . . . . -131.29 158.91 39.39 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 122.68 0.392 . . . . 71.340000000000003 110.528 177.676 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 676' ' ' THR . . . . . . . . . . . . . 13.6 m -135.0 129.04 33.53 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 112.018 0.377 . . . . 72.549999999999997 112.018 -177.288 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 677' ' ' ILE . . . . . . . . . . . . . 24.4 pt -138.97 176.43 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 122.465 0.306 . . . . 52.43 111.032 177.176 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 678' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -124.73 165.46 17.92 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.976 0.417 . . . . 75.319999999999993 111.511 178.525 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 679' ' ' VAL . . . . . . . . . . . . . 63.6 t -60.01 112.58 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 CA-C-N 116.211 -0.449 . . . . 65.349999999999994 110.668 175.344 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 118.3 -26.13 7.92 Favored Glycine 0 CA--C 1.528 0.89 0 CA-C-N 116.164 -0.471 . . . . 33.43 112.808 -175.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 681' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -69.11 163.91 23.71 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.248 0.547 . . . . 74.540000000000006 112.058 178.097 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 682' ' ' SER . . . . . . . . . . . . . 67.2 m -120.69 121.67 38.77 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.13 -0.487 . . . . 72.439999999999998 111.246 -178.52 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 683' ' ' PHE . . . . . 0.436 ' HZ ' HE22 ' A' ' 735' ' ' GLN . 56.6 t80 -118.42 126.89 53.02 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.334 -0.394 . . . . 73.340000000000003 110.809 -177.324 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 684' ' ' VAL . . . . . . . . . . . . . 60.8 t -115.4 100.67 53.88 Favored Pre-proline 0 N--CA 1.47 0.572 0 CA-C-O 120.789 0.328 . . . . 71.209999999999994 111.429 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -54.53 -47.14 28.43 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 122.802 2.334 . . . . 64.219999999999999 113.692 -177.517 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 686' ' ' MET . . . . . . . . . . . . . 88.2 mmm -78.24 0.56 24.7 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.898 0.703 . . . . 74.239999999999995 112.898 -175.398 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 687' ' ' ALA . . . . . . . . . . . . . . . -94.02 -47.79 6.53 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 120.943 0.401 . . . . 75.430000000000007 110.907 175.161 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 688' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -80.84 -18.22 48.15 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 112.373 0.508 . . . . 70.430000000000007 112.373 -178.462 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 689' ' ' VAL . . . . . 0.498 HG21 ' CZ ' ' A' ' 721' ' ' TYR . 89.3 t -97.54 142.43 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-O 120.888 0.375 . . . . 74.310000000000002 111.227 177.031 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 690' ' ' LEU . . . . . 0.633 HD21 HG12 ' A' ' 692' ' ' ILE . 7.9 tt -146.02 150.69 36.47 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.385 -0.371 . . . . 64.040000000000006 111.357 -173.837 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 691' ' ' ALA . . . . . . . . . . . . . . . -142.44 120.93 12.45 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.091 0.472 . . . . 63.439999999999998 111.885 176.02 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 692' ' ' ILE . . . . . 0.633 HG12 HD21 ' A' ' 690' ' ' LEU . 39.3 mm -127.46 144.15 38.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-N 116.166 -0.47 . . . . 71.319999999999993 110.761 178.79 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 693' ' ' ASP . . . . . 0.452 ' HB2' ' HB3' ' A' ' 667' ' ' PRO . 36.5 t70 -125.02 149.3 47.9 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 120.949 0.404 . . . . 71.019999999999996 111.582 -178.137 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -57.99 -60.09 4.25 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 116.003 -0.544 . . . . 72.200000000000003 112.428 -177.478 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 695' ' ' GLU . . . . . 0.427 ' CD ' ' H ' ' A' ' 695' ' ' GLU . 0.3 OUTLIER -85.07 -53.58 5.19 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 112.096 0.406 . . . . 72.329999999999998 112.096 -176.283 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 696' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -70.23 -42.13 72.68 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.793 0.33 . . . . 73.0 111.863 -171.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . 108.56 -131.89 10.81 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 120.96 -0.638 . . . . 63.340000000000003 113.399 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -70.93 113.36 7.9 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 121.064 0.459 . . . . 74.409999999999997 111.523 -177.582 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 699' ' ' LEU . . . . . 0.584 HD12 ' HB3' ' A' ' 667' ' ' PRO . 89.6 mt -110.73 11.8 22.59 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.316 0.579 . . . . 72.219999999999999 110.397 172.532 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 21.1 m -59.89 -28.68 67.77 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.937 -0.574 . . . . 73.040000000000006 110.888 177.189 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 701' ' ' SER . . . . . . . . . . . . . 34.2 t -71.13 -24.42 62.27 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 116.244 -0.434 . . . . 64.099999999999994 111.456 175.662 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 702' ' ' LYS . . . . . 0.494 ' HB2' HG23 ' A' ' 723' ' ' VAL . 8.4 mmpt? -81.32 -13.75 58.05 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 111.87 0.322 . . . . 62.420000000000002 111.87 -178.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 69.8 mt -65.44 115.48 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 N-CA-C 112.076 0.398 . . . . 54.399999999999999 112.076 -177.585 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 704' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -98.42 124.76 43.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.112 0.482 . . . . 64.450000000000003 110.797 172.468 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 61.5 t -96.2 111.35 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-N 115.813 -0.63 . . . . 73.109999999999999 111.852 -177.201 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 706' ' ' ASP . . . . . 0.454 ' HB3' ' HB ' ' A' ' 720' ' ' THR . 38.6 t70 -99.23 134.6 41.85 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.455 -0.339 . . . . 74.409999999999997 110.748 177.211 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 108.42 171.77 21.39 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 121.148 -0.548 . . . . 34.409999999999997 112.678 -176.637 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 708' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -144.34 148.33 34.6 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 122.58 -0.365 . . . . 74.120000000000005 111.572 -176.668 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 709' ' ' VAL . . . . . 0.521 HG23 HD21 ' A' ' 719' ' ' LEU . 84.5 t -126.56 118.14 50.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 CA-C-O 120.806 0.336 . . . . 64.140000000000001 111.298 178.428 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 710' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -87.19 136.57 32.88 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 121.101 0.477 . . . . 70.420000000000002 111.361 177.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 711' ' ' THR . . . . . . . . . . . . . 73.9 p -98.63 -13.47 20.33 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.927 0.394 . . . . 73.010000000000005 111.437 177.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 712' ' ' THR . . . . . . . . . . . . . 71.7 p -93.31 -27.68 16.66 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 116.271 -0.422 . . . . 64.530000000000001 111.535 178.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 713' ' ' LYS . . . . . . . . . . . . . 50.2 tptt -116.53 132.43 56.68 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.563 -0.29 . . . . 74.430000000000007 110.526 178.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 714' ' ' ALA . . . . . . . . . . . . . . . -86.59 144.93 26.95 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 112.786 0.662 . . . . 72.030000000000001 112.786 -176.507 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 163.41 176.31 35.27 Favored Glycine 0 CA--C 1.522 0.482 0 CA-C-N 115.424 -0.807 . . . . 63.0 111.959 -179.739 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 716' ' ' THR . . . . . . . . . . . . . 95.7 m -94.68 122.21 37.05 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 117.222 0.511 . . . . 63.039999999999999 110.978 177.528 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 717' ' ' TYR . . . . . 0.477 ' HB2' HG22 ' A' ' 709' ' ' VAL . 57.6 m-85 -121.95 119.45 31.54 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.463 -0.335 . . . . 61.32 110.94 -178.213 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 718' ' ' VAL . . . . . . . . . . . . . 60.3 t -91.42 123.23 43.48 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-O 120.809 0.338 . . . . 54.130000000000003 111.182 179.379 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 719' ' ' LEU . . . . . 0.521 HD21 HG23 ' A' ' 709' ' ' VAL . 88.0 mt -104.82 126.15 51.6 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.418 -0.356 . . . . 63.130000000000003 111.241 177.587 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 720' ' ' THR . . . . . 0.454 ' HB ' ' HB3' ' A' ' 706' ' ' ASP . 95.1 m -101.08 127.48 47.59 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.988 0.423 . . . . 70.150000000000006 111.33 178.314 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 721' ' ' TYR . . . . . 0.498 ' CZ ' HG21 ' A' ' 689' ' ' VAL . 57.7 m-85 -113.47 113.91 25.81 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.685 0.279 . . . . 74.5 110.76 179.466 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 72.0 m -113.85 125.34 53.95 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.762 0.315 . . . . 54.549999999999997 111.469 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 723' ' ' VAL . . . . . 0.494 HG23 ' HB2' ' A' ' 702' ' ' LYS . 8.3 p -129.42 133.98 64.44 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-O 120.995 0.426 . . . . 74.310000000000002 111.224 179.015 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 73.5 m -116.44 136.25 53.15 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 120.934 0.397 . . . . 62.530000000000001 111.887 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 725' ' ' ASP . . . . . 0.428 ' HB2' ' HD3' ' A' ' 667' ' ' PRO . 10.7 t0 -73.28 150.9 41.59 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 109.675 -0.491 . . . . 73.439999999999998 109.675 174.297 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 726' ' ' SER . . . . . . . . . . . . . 34.9 t -56.15 -33.24 65.02 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.348 -0.387 . . . . 73.209999999999994 111.753 -179.191 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 727' ' ' LYS . . . . . 0.464 ' HD3' ' N ' ' A' ' 727' ' ' LYS . 3.6 mppt? -91.42 6.85 43.84 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 112.712 0.634 . . . . 72.200000000000003 112.712 -178.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 728' ' ' GLY . . . . . . . . . . . . . . . 101.69 35.2 4.13 Favored Glycine 0 CA--C 1.534 1.279 0 N-CA-C 116.122 1.209 . . . . 71.409999999999997 116.122 169.173 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 729' ' ' HIS . . . . . 0.411 ' H ' ' HB3' ' A' ' 725' ' ' ASP . 40.7 m80 -109.3 110.68 21.92 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 118.178 0.989 . . . . 73.030000000000001 111.49 172.833 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 730' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -96.89 128.5 43.91 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.277 0.56 . . . . 71.209999999999994 112.121 -177.01 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 57.6 t -126.4 129.48 71.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 CA-C-N 115.97 -0.559 . . . . 53.149999999999999 110.109 176.062 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 7.5 t -137.12 128.86 28.84 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.167 0.508 . . . . 65.349999999999994 112.296 -177.611 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -135.56 157.65 46.34 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 122.804 0.442 . . . . 73.230000000000004 110.863 -178.665 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 734' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -121.3 158.69 27.62 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.994 0.739 . . . . 61.109999999999999 112.994 -175.242 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 735' ' ' GLN . . . . . 0.464 ' NE2' ' HG2' ' A' ' 672' ' ' PRO . 51.0 tt0 -130.57 128.51 41.25 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.839 -0.619 . . . . 64.319999999999993 111.161 179.645 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 736' ' ' THR . . . . . . . . . . . . . 86.6 m -87.93 103.89 16.1 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 120.751 0.31 . . . . 63.520000000000003 110.991 175.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 47.8 t -96.73 108.39 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-O 120.924 0.392 . . . . 73.530000000000001 111.188 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 738' ' ' THR . . . . . . . . . . . . . 27.3 m -94.84 108.96 20.99 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.79 0.328 . . . . 75.209999999999994 111.342 -179.6 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 739' ' ' VAL . . . . . . . . . . . . . 43.0 t -94.22 125.34 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-O 120.729 0.3 . . . . 71.150000000000006 110.793 176.703 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 740' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -115.38 146.55 41.47 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.048 0.451 . . . . 73.310000000000002 111.979 -175.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 741' ' ' VAL . . . . . . . . . . . . . 24.3 t -85.29 144.75 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 CA-C-O 120.88 0.371 . . . . 54.210000000000001 111.914 -179.142 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 742' ' ' ARG . . . . . . . . . . . . . 21.9 mmm180 -94.08 137.33 33.4 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 109.731 -0.47 . . . . 74.420000000000002 109.731 168.299 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 743' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -77.83 36.0 0.21 Allowed 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 121.042 0.448 . . . . 73.140000000000001 111.891 -176.228 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 744' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -125.5 97.8 5.33 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 116.252 -0.431 . . . . 71.0 110.714 -179.232 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 15.8 m -72.04 75.56 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 CA-C-O 121.832 0.825 . . . . 73.140000000000001 111.323 179.028 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 64.7 pttt -143.29 131.66 22.15 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.739 -0.664 . . . . 75.549999999999997 111.95 -174.707 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 747' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -113.44 151.78 30.95 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 109.505 -0.554 . . . . 75.510000000000005 109.505 168.294 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -77.86 35.42 0.2 Allowed 'General case' 0 CA--C 1.545 0.772 0 CA-C-O 121.175 0.512 . . . . 64.329999999999998 111.514 177.533 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 749' ' ' LYS . . . . . . . . . . . . . 49.9 mtpt 65.93 149.7 0.12 Allowed Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 123.867 0.867 . . . . 63.409999999999997 112.348 -179.013 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 750' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -57.83 160.64 14.52 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 122.489 2.126 . . . . 73.209999999999994 112.791 179.539 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 751' ' ' ILE . . . . . . . . . . . . . 60.0 mt -64.18 93.37 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-O 121.016 0.436 . . . . 71.209999999999994 110.994 -179.009 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 752' ' ' LEU . . . . . . . . . . . . . 87.4 mt -75.69 139.47 41.95 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.171 -0.468 . . . . 64.150000000000006 111.292 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 753' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 . . . . . 0 C--O 1.241 0.615 0 CA-C-O 121.118 0.485 . . . . 65.140000000000001 110.687 -177.542 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 762' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 657' ' ' MET . . . . . 0.526 ' N ' ' SD ' ' A' ' 657' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.473 0 CA-C-O 120.623 0.249 . . . . 65.219999999999999 111.336 . . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 658' ' ' GLY . . . . . . . . . . . . . . . 82.97 172.05 48.11 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 121.332 -0.461 . . . . 73.409999999999997 113.197 178.295 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 659' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -116.62 107.86 15.23 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.937 0.398 . . . . 52.43 111.17 177.616 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 660' ' ' GLY . . . . . . . . . . . . . . . -74.59 110.48 3.09 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 120.895 -0.669 . . . . 40.409999999999997 112.598 175.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -60.6 116.88 4.69 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.025 0.441 . . . . 74.439999999999998 111.57 -179.081 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 662' ' ' THR . . . . . . . . . . . . . 80.7 p -90.33 178.9 6.02 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 115.993 -0.549 . . . . 73.129999999999995 110.811 175.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 663' ' ' SER . . . . . . . . . . . . . 47.0 m -137.13 134.57 36.53 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 122.28 -0.263 . . . . 44.43 111.483 -178.415 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 664' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -98.19 112.68 24.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.154 0.502 . . . . 65.230000000000004 110.094 169.664 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 665' ' ' LEU . . . . . 0.524 HD12 ' HB2' ' A' ' 694' ' ' LYS . 86.6 mt -91.98 137.87 32.01 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.937 -0.574 . . . . 65.310000000000002 111.038 179.191 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 666' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -80.68 142.2 52.83 Favored Pre-proline 0 CA--C 1.541 0.612 0 CA-C-N 116.223 -0.444 . . . . 73.109999999999999 110.406 173.654 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 667' ' ' PRO . . . . . 0.595 ' HB3' HD12 ' A' ' 699' ' ' LEU . 64.4 Cg_endo -70.86 146.2 52.75 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 122.231 1.954 . . . . 53.409999999999997 113.734 -173.002 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 668' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -83.3 103.86 13.01 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.975 -0.557 . . . . 73.140000000000001 110.576 173.725 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 669' ' ' LEU . . . . . . . . . . . . . 52.3 tp -89.79 132.65 35.12 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.153 -0.476 . . . . 71.239999999999995 109.95 176.232 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 670' ' ' THR . . . . . . . . . . . . . 91.1 m -121.61 111.31 17.07 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.025 0.441 . . . . 74.140000000000001 111.124 -179.399 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 671' ' ' VAL . . . . . . . . . . . . . 88.8 t -128.77 134.55 26.42 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-N 115.82 -0.627 . . . . 51.43 110.628 -179.252 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 672' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.57 127.82 17.94 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 121.964 1.776 . . . . 43.32 111.903 177.536 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 673' ' ' VAL . . . . . 0.442 ' O ' HG22 ' A' ' 736' ' ' THR . 12.5 p -64.4 -23.78 34.17 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 N-CA-C 112.414 0.524 . . . . 72.430000000000007 112.414 -174.179 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 674' ' ' GLY . . . . . . . . . . . . . . . -169.02 154.27 23.73 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 120.61 -0.805 . . . . 63.140000000000001 113.591 179.506 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 675' ' ' ALA . . . . . . . . . . . . . . . -150.38 156.29 41.22 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 122.502 0.321 . . . . 72.340000000000003 110.859 177.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 676' ' ' THR . . . . . . . . . . . . . 70.4 m -134.42 127.43 31.55 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.784 0.326 . . . . 60.140000000000001 111.269 -179.535 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 677' ' ' ILE . . . . . . . . . . . . . 28.4 pt -130.33 176.62 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-O 120.824 0.345 . . . . 61.549999999999997 111.124 179.506 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 678' ' ' HIS . . . . . 0.513 ' O ' ' HB2' ' A' ' 681' ' ' ASP . 69.9 m80 -116.67 166.67 11.85 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 121.581 0.705 . . . . 75.5 112.311 -179.728 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 679' ' ' VAL . . . . . 0.473 HG13 ' HA ' ' A' ' 712' ' ' THR . 82.4 t -67.16 112.18 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-N 115.972 -0.558 . . . . 72.329999999999998 110.494 174.334 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 109.24 -2.48 31.22 Favored Glycine 0 CA--C 1.529 0.957 0 CA-C-N 115.891 -0.595 . . . . 73.329999999999998 112.41 -172.192 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 681' ' ' ASP . . . . . 0.513 ' HB2' ' O ' ' A' ' 678' ' ' HIS . 1.1 t70 -75.62 -168.43 0.85 Allowed 'General case' 0 CA--C 1.547 0.835 0 CA-C-O 120.954 0.407 . . . . 71.319999999999993 110.955 178.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 682' ' ' SER . . . . . . . . . . . . . 73.7 m -150.18 136.74 19.05 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 122.159 -0.338 . . . . 63.450000000000003 110.553 176.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 683' ' ' PHE . . . . . . . . . . . . . 36.0 t80 -138.66 127.38 23.51 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 120.614 0.245 . . . . 65.400000000000006 111.652 -174.493 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 684' ' ' VAL . . . . . . . . . . . . . 63.8 t -111.73 101.45 51.27 Favored Pre-proline 0 N--CA 1.476 0.85 0 CA-C-O 120.726 0.298 . . . . 71.150000000000006 111.771 179.025 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -52.82 -42.81 60.91 Favored 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 122.975 2.45 . . . . 70.209999999999994 113.772 179.463 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 686' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -78.13 3.84 14.04 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 112.79 0.663 . . . . 61.509999999999998 112.79 -176.083 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 687' ' ' ALA . . . . . . . . . . . . . . . -109.35 -14.77 14.39 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 122.2 -0.313 . . . . 74.239999999999995 111.82 176.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 688' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -97.62 -6.5 33.17 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 112.722 0.638 . . . . 71.420000000000002 112.722 -175.443 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 689' ' ' VAL . . . . . 0.413 HG12 HD13 ' A' ' 703' ' ' ILE . 49.7 t -121.67 154.83 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 N-CA-C 112.025 0.38 . . . . 43.32 112.025 -174.17 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 690' ' ' LEU . . . . . 0.563 HD23 ' N ' ' A' ' 691' ' ' ALA . 6.4 tt -150.57 143.82 24.9 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 116.509 -0.314 . . . . 71.150000000000006 110.827 -178.307 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 691' ' ' ALA . . . . . 0.563 ' N ' HD23 ' A' ' 690' ' ' LEU . . . -144.08 132.05 21.57 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 112.416 0.525 . . . . 42.439999999999998 112.416 -179.132 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 692' ' ' ILE . . . . . 0.473 HD13 ' HA ' ' A' ' 698' ' ' ASP . 38.6 mm -135.77 136.89 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 N-CA-C 112.116 0.413 . . . . 63.539999999999999 112.116 -179.289 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -115.68 141.82 47.56 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 109.005 -0.739 . . . . 73.140000000000001 109.005 167.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 694' ' ' LYS . . . . . 0.524 ' HB2' HD12 ' A' ' 665' ' ' LEU . 54.5 mttp -71.33 -28.97 64.46 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.289 0.478 . . . . 74.400000000000006 112.289 -177.408 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -83.38 -44.75 14.48 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-O 120.916 0.389 . . . . 75.329999999999998 111.974 -179.581 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 696' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -92.87 -30.3 15.5 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 120.851 0.358 . . . . 65.299999999999997 111.325 -173.622 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . 105.86 -135.17 12.48 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 121.325 -0.464 . . . . 53.5 112.769 179.096 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 698' ' ' ASP . . . . . 0.473 ' HA ' HD13 ' A' ' 692' ' ' ILE . 12.1 t70 -71.83 125.09 26.29 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 122.534 -0.392 . . . . 71.299999999999997 111.497 179.05 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 699' ' ' LEU . . . . . 0.632 HD22 ' HD2' ' A' ' 702' ' ' LYS . 45.7 mt -119.83 6.65 10.92 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.493 -0.321 . . . . 72.540000000000006 111.584 177.721 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 49.6 m -58.6 -40.13 82.36 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.201 0.524 . . . . 73.340000000000003 111.464 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 701' ' ' SER . . . . . . . . . . . . . 37.2 t -66.03 -13.78 60.54 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 121.072 0.463 . . . . 63.149999999999999 111.817 176.098 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 702' ' ' LYS . . . . . 0.632 ' HD2' HD22 ' A' ' 699' ' ' LEU . 97.4 mttt -99.11 6.62 46.43 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.217 0.451 . . . . 74.109999999999999 112.217 -178.643 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 703' ' ' ILE . . . . . 0.413 HD13 HG12 ' A' ' 689' ' ' VAL . 73.9 mt -80.02 117.45 25.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-O 121.044 0.45 . . . . 72.140000000000001 111.541 -179.74 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 704' ' ' LYS . . . . . 0.409 ' HE3' ' HB2' ' A' ' 704' ' ' LYS . 35.9 ttmt -91.34 136.64 32.96 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.212 -0.449 . . . . 72.019999999999996 111.039 176.673 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 46.6 t -109.27 140.55 27.6 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-O 121.129 0.49 . . . . 63.219999999999999 111.889 -177.319 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 706' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -132.36 126.02 32.26 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 116.273 -0.421 . . . . 64.010000000000005 110.253 174.077 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 102.97 152.94 24.1 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 121.141 -0.552 . . . . 51.420000000000002 112.404 -173.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 708' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -153.59 143.62 22.1 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 122.19 -0.594 . . . . 60.43 111.566 -176.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 709' ' ' VAL . . . . . 0.543 HG22 ' HB2' ' A' ' 717' ' ' TYR . 71.7 t -99.52 134.35 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-N 116.067 -0.515 . . . . 64.329999999999998 111.842 -177.231 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 710' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -100.54 150.78 22.32 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 121.027 0.442 . . . . 64.25 110.431 170.384 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 711' ' ' THR . . . . . . . . . . . . . 80.7 p -107.39 28.2 8.34 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.444 -0.344 . . . . 73.349999999999994 111.494 -178.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 712' ' ' THR . . . . . 0.473 ' HA ' HG13 ' A' ' 679' ' ' VAL . 7.5 t -115.9 -28.48 6.66 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 112.385 0.513 . . . . 74.230000000000004 112.385 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 713' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -115.67 122.37 45.35 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 120.733 0.301 . . . . 63.32 111.095 -176.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 714' ' ' ALA . . . . . 0.482 ' HB2' HG23 ' A' ' 741' ' ' VAL . . . -70.43 101.96 2.08 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 121.199 0.523 . . . . 71.239999999999995 111.718 -178.268 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . -164.18 168.45 38.61 Favored Glycine 0 CA--C 1.52 0.355 0 CA-C-N 115.99 -0.55 . . . . 71.349999999999994 112.843 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 716' ' ' THR . . . . . . . . . . . . . 73.2 m -95.52 122.7 38.54 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.05 0.452 . . . . 74.150000000000006 111.612 178.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 717' ' ' TYR . . . . . 0.543 ' HB2' HG22 ' A' ' 709' ' ' VAL . 57.6 m-85 -116.86 124.45 49.54 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 116.106 -0.497 . . . . 70.310000000000002 110.418 179.158 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 718' ' ' VAL . . . . . . . . . . . . . 45.6 t -96.28 110.88 25.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-O 121.09 0.471 . . . . 71.120000000000005 111.613 -178.523 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 719' ' ' LEU . . . . . 0.531 HD21 HG23 ' A' ' 709' ' ' VAL . 58.9 mt -88.41 130.5 35.16 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.131 -0.486 . . . . 75.450000000000003 111.227 -178.822 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 84.5 m -99.72 132.29 45.16 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.903 0.382 . . . . 75.150000000000006 111.496 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 721' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -122.01 134.27 54.8 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.838 0.351 . . . . 73.310000000000002 110.937 177.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 24.7 m -135.82 130.27 33.7 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 111.625 0.231 . . . . 73.5 111.625 -176.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 8.7 p -125.0 132.47 71.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-O 121.031 0.443 . . . . 73.200000000000003 111.286 178.371 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 22.7 m -108.4 120.5 42.57 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.945 0.403 . . . . 63.329999999999998 111.991 -176.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 725' ' ' ASP . . . . . 0.496 ' HB2' ' HD3' ' A' ' 667' ' ' PRO . 3.6 t70 -73.19 149.71 42.69 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 116.197 -0.456 . . . . 75.349999999999994 110.734 175.216 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 726' ' ' SER . . . . . . . . . . . . . 56.8 p -65.43 -26.3 67.91 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 112.287 0.477 . . . . 55.420000000000002 112.287 -174.463 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 727' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -93.76 -3.7 51.68 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 112.715 0.635 . . . . 72.129999999999995 112.715 178.58 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 728' ' ' GLY . . . . . . . . . . . . . . . 111.72 19.88 7.16 Favored Glycine 0 CA--C 1.532 1.096 0 N-CA-C 115.529 0.972 . . . . 63.329999999999998 115.529 172.071 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 27.7 m80 -97.13 104.96 17.02 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 118.241 1.02 . . . . 74.010000000000005 111.025 172.688 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 730' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -112.19 114.63 27.54 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 120.933 0.397 . . . . 64.219999999999999 111.665 -177.116 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 32.8 m -109.83 158.73 9.82 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-O 121.084 0.469 . . . . 64.530000000000001 111.582 179.671 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 5.6 t -135.56 145.39 46.92 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 121.204 0.526 . . . . 61.530000000000001 112.163 -176.331 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -148.59 161.12 42.34 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.997 -0.547 . . . . 53.149999999999999 110.791 176.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 734' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -133.52 157.49 45.51 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 112.509 0.559 . . . . 73.329999999999998 112.509 -176.416 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 735' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -130.61 125.98 35.48 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 115.623 -0.717 . . . . 71.530000000000001 110.794 178.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 736' ' ' THR . . . . . 0.442 HG22 ' O ' ' A' ' 673' ' ' VAL . 8.3 t -93.36 110.27 21.82 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.254 0.55 . . . . 74.040000000000006 111.588 178.298 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 46.8 t -106.69 115.69 48.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-N 116.474 -0.33 . . . . 74.109999999999999 111.339 -179.648 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 738' ' ' THR . . . . . . . . . . . . . 88.8 m -99.62 124.72 45.1 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 120.778 0.323 . . . . 42.399999999999999 111.503 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 739' ' ' VAL . . . . . . . . . . . . . 49.7 t -96.76 134.25 35.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-O 120.916 0.389 . . . . 74.129999999999995 111.429 178.14 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 740' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -121.55 144.96 48.43 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.4 -0.363 . . . . 60.130000000000003 111.188 178.558 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 741' ' ' VAL . . . . . 0.482 HG23 ' HB2' ' A' ' 714' ' ' ALA . 25.6 t -80.07 143.17 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 O-C-N 121.639 -0.663 . . . . 63.350000000000001 111.638 -178.633 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 742' ' ' ARG . . . . . . . . . . . . . 86.1 mtm180 -71.18 127.81 33.81 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 116.32 -0.4 . . . . 75.200000000000003 110.851 175.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 743' ' ' GLU . . . . . 0.462 ' H ' ' CD ' ' A' ' 743' ' ' GLU . 1.1 pm0 -52.66 139.39 26.24 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 121.497 0.665 . . . . 73.299999999999997 112.293 -177.025 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 744' ' ' GLU . . . . . 0.49 ' H ' ' CD ' ' A' ' 744' ' ' GLU . 0.6 OUTLIER -88.53 137.02 32.69 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.664 -0.698 . . . . 72.109999999999999 112.404 -173.347 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 35.9 m -129.11 168.05 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-N 116.164 -0.471 . . . . 73.439999999999998 110.716 176.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -65.08 124.89 23.3 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 122.112 -0.367 . . . . 72.329999999999998 110.214 175.24 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 747' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -65.65 107.31 1.71 Allowed 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 120.996 0.427 . . . . 73.239999999999995 110.929 -175.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -108.73 130.17 55.36 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.123 -0.489 . . . . 73.299999999999997 111.129 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 749' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -110.75 99.01 40.24 Favored Pre-proline 0 CA--C 1.541 0.625 0 CA-C-O 120.858 0.361 . . . . 74.340000000000003 110.999 179.012 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 750' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -78.24 -164.83 0.29 Allowed 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 122.769 2.313 . . . . 74.409999999999997 112.536 179.07 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 751' ' ' ILE . . . . . . . . . . . . . 52.8 mt -97.37 89.32 1.99 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-O 120.955 0.407 . . . . 63.439999999999998 110.687 177.265 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 752' ' ' LEU . . . . . . . . . . . . . 82.6 mt -66.64 99.86 0.63 Allowed 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.072 0.463 . . . . 74.150000000000006 110.518 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 753' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 . . . . . 0 C--O 1.238 0.449 0 CA-C-O 121.282 0.563 . . . . 64.040000000000006 111.999 -173.52 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 762' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 657' ' ' MET . . . . . . . . . . . . . 84.1 mtp . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 120.583 0.23 . . . . 63.109999999999999 111.261 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 658' ' ' GLY . . . . . . . . . . . . . . . -133.07 -75.55 0.1 Allowed Glycine 0 CA--C 1.527 0.839 0 C-N-CA 121.04 -0.6 . . . . 71.030000000000001 112.926 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 659' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -151.91 -65.41 0.17 Allowed 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 111.971 0.36 . . . . 52.240000000000002 111.971 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 660' ' ' GLY . . . . . . . . . . . . . . . 73.35 174.24 27.73 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 121.217 -0.516 . . . . 43.130000000000003 113.255 -178.077 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -135.22 -71.01 0.48 Allowed 'General case' 0 N--CA 1.469 0.488 0 O-C-N 122.503 -0.41 . . . . 62.439999999999998 111.058 178.47 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 662' ' ' THR . . . . . . . . . . . . . 99.8 m 61.21 88.51 0.08 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.899 -0.591 . . . . 64.420000000000002 111.604 -175.207 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 663' ' ' SER . . . . . . . . . . . . . 74.0 m -92.61 120.49 33.09 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.172 -0.467 . . . . 72.519999999999996 110.312 173.091 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 664' ' ' ASP . . . . . 0.493 ' CG ' ' HB2' ' A' ' 727' ' ' LYS . 45.0 t0 -73.45 117.5 15.28 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 121.132 0.491 . . . . 51.119999999999997 111.676 -176.115 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 665' ' ' LEU . . . . . . . . . . . . . 85.2 mt -81.57 116.86 21.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.007 -0.542 . . . . 55.420000000000002 109.78 175.111 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 666' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -77.37 137.74 64.02 Favored Pre-proline 0 CA--C 1.541 0.616 0 CA-C-O 120.898 0.38 . . . . 75.209999999999994 111.433 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 667' ' ' PRO . . . . . 0.558 ' HB3' HD12 ' A' ' 699' ' ' LEU . 65.8 Cg_endo -71.46 140.46 36.56 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 122.596 2.197 . . . . 71.219999999999999 113.182 -174.085 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 668' ' ' LYS . . . . . 0.402 ' O ' ' HA ' ' A' ' 691' ' ' ALA . 22.7 tptm -83.58 106.9 15.68 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.302 -0.408 . . . . 74.340000000000003 110.631 176.687 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 669' ' ' LEU . . . . . 0.464 ' HG ' HG23 ' A' ' 671' ' ' VAL . 58.7 tp -90.04 110.14 21.15 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 116.275 -0.421 . . . . 74.349999999999994 110.523 178.783 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 670' ' ' THR . . . . . . . . . . . . . 67.6 m -86.38 109.4 18.99 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.854 0.359 . . . . 73.209999999999994 111.126 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 671' ' ' VAL . . . . . 0.464 HG23 ' HG ' ' A' ' 669' ' ' LEU . 91.0 t -141.78 120.83 7.95 Favored Pre-proline 0 N--CA 1.473 0.684 0 CA-C-N 116.257 -0.429 . . . . 75.299999999999997 110.774 179.178 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 672' ' ' PRO . . . . . 0.433 ' HG2' ' NE2' ' A' ' 735' ' ' GLN . 65.8 Cg_endo -73.8 150.1 43.86 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 122.366 2.044 . . . . 74.409999999999997 112.529 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 673' ' ' VAL . . . . . . . . . . . . . 7.7 p -64.36 -38.2 81.94 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 N-CA-C 112.16 0.43 . . . . 74.310000000000002 112.16 -178.625 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 674' ' ' GLY . . . . . . . . . . . . . . . -156.46 157.67 28.1 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 120.805 -0.712 . . . . 72.540000000000006 114.031 -177.787 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 675' ' ' ALA . . . . . 0.434 ' O ' ' HA ' ' A' ' 737' ' ' VAL . . . -151.88 135.09 15.89 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 122.831 0.453 . . . . 62.299999999999997 110.668 178.706 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 676' ' ' THR . . . . . . . . . . . . . 62.5 m -115.23 123.63 49.32 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 121.993 -0.442 . . . . 74.129999999999995 112.025 -178.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 677' ' ' ILE . . . . . . . . . . . . . 17.5 pt -127.36 176.55 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 CA-C-N 116.254 -0.43 . . . . 71.109999999999999 110.865 177.26 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 678' ' ' HIS . . . . . . . . . . . . . 63.1 m80 -117.05 157.74 25.34 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.429 0.633 . . . . 72.140000000000001 112.182 -178.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 679' ' ' VAL . . . . . . . . . . . . . 92.0 t -54.63 113.02 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-N 115.513 -0.767 . . . . 52.299999999999997 111.401 175.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 116.3 -18.79 13.58 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 121.162 -0.542 . . . . 63.25 113.705 -179.289 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 681' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -74.43 -179.77 4.18 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 121.495 0.664 . . . . 64.030000000000001 112.502 -179.472 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 682' ' ' SER . . . . . . . . . . . . . 57.5 m -122.67 151.27 41.68 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.754 -0.657 . . . . 72.319999999999993 111.401 -178.068 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 683' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -158.88 116.04 2.77 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 116.546 -0.297 . . . . 73.329999999999998 110.801 -178.789 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 684' ' ' VAL . . . . . . . . . . . . . 41.7 t -113.57 98.3 46.52 Favored Pre-proline 0 CA--C 1.54 0.564 0 CA-C-O 120.949 0.404 . . . . 62.109999999999999 111.333 -178.751 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 685' ' ' PRO . . . . . 0.42 ' HB3' ' HE1' ' A' ' 721' ' ' TYR . 77.7 Cg_exo -51.52 -43.68 48.7 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 122.873 2.382 . . . . 71.420000000000002 113.615 -178.472 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 686' ' ' MET . . . . . 0.554 ' HE2' ' HA ' ' A' ' 686' ' ' MET . 0.4 OUTLIER -78.25 -1.3 32.3 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 112.758 0.651 . . . . 74.530000000000001 112.758 -177.13 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 687' ' ' ALA . . . . . . . . . . . . . . . -112.32 -8.35 13.94 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.788 0.328 . . . . 74.439999999999998 111.634 176.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 688' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -121.35 -22.54 5.96 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 112.119 0.414 . . . . 75.239999999999995 112.119 -177.571 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 96.4 t -95.82 148.23 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-O 120.626 0.251 . . . . 71.230000000000004 110.681 175.553 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 690' ' ' LEU . . . . . 0.68 HD21 HG12 ' A' ' 692' ' ' ILE . 9.6 tt -144.81 152.1 39.8 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 112.037 0.384 . . . . 65.530000000000001 112.037 -171.441 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 691' ' ' ALA . . . . . 0.402 ' HA ' ' O ' ' A' ' 668' ' ' LYS . . . -150.33 123.04 8.61 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 120.813 0.339 . . . . 65.230000000000004 111.371 176.479 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 692' ' ' ILE . . . . . 0.68 HG12 HD21 ' A' ' 690' ' ' LEU . 46.5 mm -123.62 134.65 65.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 N-CA-C 112.467 0.543 . . . . 53.229999999999997 112.467 -178.299 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 693' ' ' ASP . . . . . 0.474 ' HB2' ' HB3' ' A' ' 667' ' ' PRO . 67.7 t0 -117.43 128.34 54.91 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 109.216 -0.661 . . . . 72.040000000000006 109.216 170.588 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -65.63 -26.7 67.94 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 112.96 0.726 . . . . 73.120000000000005 112.96 -173.625 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -82.8 -40.65 20.12 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 120.824 0.345 . . . . 71.310000000000002 111.526 -177.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 696' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -95.65 -49.31 5.43 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 121.253 0.549 . . . . 55.119999999999997 111.702 -176.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . 129.01 -131.51 6.82 Favored Glycine 0 CA--C 1.528 0.855 0 CA-C-N 116.34 -0.391 . . . . 63.299999999999997 112.654 -177.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 698' ' ' ASP . . . . . 0.454 ' HA ' HD13 ' A' ' 692' ' ' ILE . 20.7 t70 -75.5 109.15 8.82 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 121.055 0.455 . . . . 75.239999999999995 111.464 178.422 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 699' ' ' LEU . . . . . 0.558 HD12 ' HB3' ' A' ' 667' ' ' PRO . 23.3 mt -99.42 4.41 46.2 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 120.839 0.352 . . . . 71.25 110.787 173.044 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 25.1 m -55.39 -40.06 70.92 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.686 0.755 . . . . 74.099999999999994 109.972 171.407 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 701' ' ' SER . . . . . . . . . . . . . 21.6 m -66.91 -7.76 24.37 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 115.218 -0.901 . . . . 71.120000000000005 112.146 177.555 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 702' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -104.05 -7.73 20.06 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 111.884 0.328 . . . . 72.129999999999995 111.884 -179.565 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 703' ' ' ILE . . . . . 0.482 ' HB ' ' HE1' ' A' ' 686' ' ' MET . 63.2 mt -70.66 140.8 17.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-O 120.835 0.35 . . . . 74.0 111.707 -178.233 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 704' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -110.51 133.42 53.31 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 110.247 -0.279 . . . . 72.140000000000001 110.247 170.159 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 50.5 t -96.7 107.23 19.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-O 120.956 0.407 . . . . 63.020000000000003 110.831 178.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 706' ' ' ASP . . . . . 0.519 ' HB3' ' HB ' ' A' ' 720' ' ' THR . 13.2 t70 -100.1 127.52 46.33 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 116.283 -0.417 . . . . 74.349999999999994 110.392 179.44 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 123.11 -175.86 16.6 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 121.173 -0.537 . . . . 55.119999999999997 113.132 -178.814 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 708' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -155.63 141.33 17.97 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 120.783 0.325 . . . . 73.430000000000007 111.237 -178.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 709' ' ' VAL . . . . . 0.471 HG22 ' HB2' ' A' ' 717' ' ' TYR . 93.9 t -124.87 111.53 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-O 120.887 0.375 . . . . 63.32 111.184 178.871 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 710' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -69.19 134.86 49.8 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 121.054 0.454 . . . . 63.549999999999997 110.669 176.729 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 711' ' ' THR . . . . . . . . . . . . . 35.9 p -113.54 -0.76 14.29 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.883 0.373 . . . . 74.310000000000002 110.98 178.499 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 712' ' ' THR . . . . . . . . . . . . . 81.9 p -98.15 -17.81 18.83 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.15 -0.477 . . . . 62.219999999999999 111.505 178.277 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 713' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -138.52 139.36 38.7 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 120.864 0.364 . . . . 64.209999999999994 111.271 -178.318 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 714' ' ' ALA . . . . . . . . . . . . . . . -70.18 144.4 51.95 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 112.662 0.616 . . . . 65.319999999999993 112.662 -176.703 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 159.25 161.54 11.28 Favored Glycine 0 CA--C 1.525 0.683 0 CA-C-N 115.689 -0.687 . . . . 75.409999999999997 112.262 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 716' ' ' THR . . . . . 0.405 ' HA ' ' HA ' ' A' ' 738' ' ' THR . 97.4 m -96.88 122.53 39.95 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 117.312 0.556 . . . . 74.5 111.419 178.752 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 717' ' ' TYR . . . . . 0.471 ' HB2' HG22 ' A' ' 709' ' ' VAL . 22.6 m-85 -123.8 150.2 44.77 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 116.193 -0.458 . . . . 53.219999999999999 110.304 -178.714 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 718' ' ' VAL . . . . . . . . . . . . . 58.4 t -115.57 133.94 60.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 CA-C-O 121.002 0.43 . . . . 72.239999999999995 111.918 -176.576 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 719' ' ' LEU . . . . . 0.414 HD21 HG23 ' A' ' 709' ' ' VAL . 88.6 mt -112.09 125.95 54.65 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.304 -0.407 . . . . 73.230000000000004 111.416 178.043 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 720' ' ' THR . . . . . 0.519 ' HB ' ' HB3' ' A' ' 706' ' ' ASP . 68.8 m -99.52 129.12 45.66 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.156 -0.474 . . . . 74.040000000000006 111.253 178.817 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 721' ' ' TYR . . . . . 0.42 ' HE1' ' HB3' ' A' ' 685' ' ' PRO . 77.1 m-85 -115.7 114.25 24.59 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.751 0.31 . . . . 65.239999999999995 111.002 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 45.7 m -117.22 131.92 56.74 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.57 -0.286 . . . . 73.030000000000001 111.517 -178.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 723' ' ' VAL . . . . . 0.471 ' HB ' HG12 ' A' ' 703' ' ' ILE . 7.1 p -137.16 137.25 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-O 121.066 0.46 . . . . 74.120000000000005 111.424 178.213 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 724' ' ' THR . . . . . 0.458 ' HA ' ' HA ' ' A' ' 730' ' ' GLU . 33.5 m -107.27 135.3 49.01 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.248 0.547 . . . . 72.329999999999998 112.059 -178.254 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 725' ' ' ASP . . . . . 0.537 ' HB3' ' H ' ' A' ' 729' ' ' HIS . 11.0 t0 -73.61 154.09 39.9 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 115.853 -0.612 . . . . 70.340000000000003 110.617 177.553 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 726' ' ' SER . . . . . . . . . . . . . 74.6 m -65.78 -21.98 66.54 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 116.626 -0.261 . . . . 61.219999999999999 111.572 177.67 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 727' ' ' LYS . . . . . 0.493 ' HB2' ' CG ' ' A' ' 664' ' ' ASP . 73.8 mmtt -106.81 4.67 27.77 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 112.495 0.554 . . . . 75.120000000000005 112.495 178.725 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 728' ' ' GLY . . . . . . . . . . . . . . . 114.1 -5.67 23.65 Favored Glycine 0 CA--C 1.54 1.624 0 N-CA-C 116.739 1.455 . . . . 70.439999999999998 116.739 171.283 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 729' ' ' HIS . . . . . 0.537 ' H ' ' HB3' ' A' ' 725' ' ' ASP . 15.1 m80 -73.16 98.17 2.55 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 119.414 1.607 . . . . 75.030000000000001 111.389 174.661 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 730' ' ' GLU . . . . . 0.458 ' HA ' ' HA ' ' A' ' 724' ' ' THR . 34.7 tt0 -98.63 106.96 19.3 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 122.188 -0.32 . . . . 73.030000000000001 111.095 179.325 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 26.9 m -111.71 152.23 13.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-O 120.942 0.401 . . . . 75.409999999999997 111.582 -176.074 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 7.2 t -146.57 151.87 38.02 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.065 0.459 . . . . 75.040000000000006 112.124 -179.277 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -148.35 154.29 39.75 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 115.996 -0.547 . . . . 73.109999999999999 110.722 178.303 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 734' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -114.95 155.3 27.17 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 112.389 0.515 . . . . 74.019999999999996 112.389 -176.767 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 735' ' ' GLN . . . . . 0.433 ' NE2' ' HG2' ' A' ' 672' ' ' PRO . 56.9 tt0 -131.36 125.98 34.07 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.081 -0.508 . . . . 75.329999999999998 110.977 178.019 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 736' ' ' THR . . . . . . . . . . . . . 87.7 m -90.73 104.11 16.73 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 116.475 -0.329 . . . . 61.109999999999999 111.287 178.728 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 737' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 675' ' ' ALA . 48.3 t -99.99 110.2 26.56 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-O 120.872 0.368 . . . . 71.549999999999997 111.756 -179.512 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 738' ' ' THR . . . . . 0.405 ' HA ' ' HA ' ' A' ' 716' ' ' THR . 51.8 m -95.57 123.74 39.27 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 121.036 0.446 . . . . 54.399999999999999 111.627 178.758 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 739' ' ' VAL . . . . . . . . . . . . . 48.1 t -104.26 128.61 57.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 CA-C-O 120.835 0.35 . . . . 75.510000000000005 111.404 178.403 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 740' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -116.56 160.78 20.15 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 120.858 0.361 . . . . 60.240000000000002 111.553 177.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 741' ' ' VAL . . . . . . . . . . . . . 43.6 t -84.62 156.02 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 CA-C-O 120.817 0.341 . . . . 75.450000000000003 111.582 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 742' ' ' ARG . . . . . . . . . . . . . 12.9 ptp180 -95.6 136.0 36.55 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 120.913 0.387 . . . . 65.420000000000002 110.661 175.138 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 743' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -94.47 152.93 18.19 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 121.144 0.497 . . . . 75.200000000000003 111.674 -178.725 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 744' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -108.7 173.52 6.28 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 112.557 0.577 . . . . 63.340000000000003 112.557 -173.076 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 33.7 m -125.53 160.05 32.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-N 115.749 -0.659 . . . . 74.400000000000006 110.916 176.467 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 49.4 mttp -133.27 143.16 48.9 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.075 0.464 . . . . 63.549999999999997 111.756 177.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 747' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -96.69 -6.51 36.3 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 121.349 0.595 . . . . 62.119999999999997 111.04 -178.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -77.65 62.83 2.63 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 116.037 -0.529 . . . . 71.530000000000001 111.237 -178.77 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 749' ' ' LYS . . . . . 0.429 ' HA ' ' HD3' ' A' ' 750' ' ' PRO . 95.6 mttt 65.38 143.2 0.08 OUTLIER Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 123.049 0.539 . . . . 72.430000000000007 111.568 -175.323 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 750' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 749' ' ' LYS . 31.4 Cg_exo -59.67 92.04 0.08 OUTLIER 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 122.58 2.186 . . . . 65.209999999999994 113.992 -175.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 751' ' ' ILE . . . . . . . . . . . . . 60.7 mt -79.36 82.39 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 CA-C-O 121.602 0.715 . . . . 71.219999999999999 109.789 171.757 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 752' ' ' LEU . . . . . 0.533 HD23 ' H ' ' A' ' 752' ' ' LEU . 2.4 pt? -87.07 25.91 1.26 Allowed 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 113.128 0.788 . . . . 64.519999999999996 113.128 -170.357 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 753' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 . . . . . 0 N--CA 1.47 0.565 0 CA-C-O 121.284 0.564 . . . . 63.399999999999999 111.707 176.381 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 762' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 657' ' ' MET . . . . . . . . . . . . . 26.3 ptt? . . . . . 0 N--CA 1.487 1.412 0 CA-C-O 120.997 0.427 . . . . 64.329999999999998 111.2 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 658' ' ' GLY . . . . . . . . . . . . . . . -139.99 157.47 25.4 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 121.373 -0.442 . . . . 75.239999999999995 112.722 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 659' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -86.9 62.66 7.52 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.409 0.623 . . . . 72.329999999999998 111.45 -178.19 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 660' ' ' GLY . . . . . . . . . . . . . . . -111.54 133.09 11.26 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-N 115.828 -0.623 . . . . 64.439999999999998 112.486 178.477 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -151.5 165.85 32.94 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 122.463 -0.434 . . . . 74.25 110.815 -179.165 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 662' ' ' THR . . . . . . . . . . . . . 80.9 p -60.05 143.31 52.3 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 120.956 0.408 . . . . 51.229999999999997 111.955 -179.681 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 663' ' ' SER . . . . . . . . . . . . . 31.6 m -69.77 104.45 2.45 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 116.208 -0.451 . . . . 74.010000000000005 110.533 177.259 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 664' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -73.99 117.18 15.48 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.607 0.718 . . . . 63.310000000000002 112.017 -176.069 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 665' ' ' LEU . . . . . . . . . . . . . 87.8 mt -101.82 138.72 38.42 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.266 -0.879 . . . . 65.230000000000004 110.779 175.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 666' ' ' GLU . . . . . 0.419 ' H ' ' CD ' ' A' ' 666' ' ' GLU . 1.3 pm0 -70.73 137.52 85.56 Favored Pre-proline 0 CA--C 1.542 0.638 0 N-CA-C 110.222 -0.288 . . . . 74.209999999999994 110.222 170.698 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 667' ' ' PRO . . . . . 0.537 ' HB3' ' HB2' ' A' ' 693' ' ' ASP . 59.9 Cg_endo -70.59 150.3 62.97 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 122.569 2.179 . . . . 74.420000000000002 113.769 -174.189 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 668' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -83.53 107.88 16.29 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 121.178 0.513 . . . . 62.549999999999997 110.635 175.447 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 669' ' ' LEU . . . . . . . . . . . . . 48.5 tp -90.62 112.47 24.2 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.95 -0.568 . . . . 63.229999999999997 109.828 175.09 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 670' ' ' THR . . . . . . . . . . . . . 83.6 m -95.11 110.48 22.42 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.175 0.512 . . . . 74.25 111.73 -176.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 671' ' ' VAL . . . . . 0.41 HG22 HG13 ' A' ' 689' ' ' VAL . 82.1 t -133.25 134.2 23.81 Favored Pre-proline 0 CA--C 1.542 0.638 0 CA-C-N 115.599 -0.728 . . . . 71.239999999999995 110.758 -178.106 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 672' ' ' PRO . . . . . 0.45 ' HG2' ' NE2' ' A' ' 735' ' ' GLN . 60.8 Cg_endo -72.42 136.66 26.69 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 122.201 1.934 . . . . 63.229999999999997 111.807 175.683 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 673' ' ' VAL . . . . . . . . . . . . . 14.3 p -64.5 -33.63 64.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 N-CA-C 112.093 0.405 . . . . 60.329999999999998 112.093 -176.205 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 674' ' ' GLY . . . . . 0.437 ' HA2' ' O ' ' A' ' 736' ' ' THR . . . -157.31 153.3 24.55 Favored Glycine 0 CA--C 1.523 0.554 0 C-N-CA 120.894 -0.67 . . . . 63.299999999999997 113.416 -178.61 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 675' ' ' ALA . . . . . . . . . . . . . . . -144.51 121.0 11.03 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.752 0.311 . . . . 61.409999999999997 111.169 179.576 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 676' ' ' THR . . . . . . . . . . . . . 84.8 m -96.98 121.6 39.04 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.92 0.39 . . . . 61.130000000000003 111.446 -179.527 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 677' ' ' ILE . . . . . . . . . . . . . 32.0 pt -130.79 176.68 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 CA-C-N 116.5 -0.318 . . . . 74.310000000000002 110.984 178.366 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 678' ' ' HIS . . . . . . . . . . . . . 78.0 m80 -121.55 153.72 37.64 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.231 0.538 . . . . 52.439999999999998 112.394 -179.443 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 679' ' ' VAL . . . . . . . . . . . . . 92.6 t -55.32 115.28 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 115.68 -0.691 . . . . 64.540000000000006 111.733 179.261 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 100.33 24.42 9.56 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 121.313 -0.47 . . . . 71.129999999999995 113.341 -177.634 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 681' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -108.59 176.03 5.26 Favored 'General case' 0 CA--C 1.546 0.826 0 O-C-N 122.516 -0.402 . . . . 52.350000000000001 110.883 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 682' ' ' SER . . . . . . . . . . . . . 84.4 p -114.94 129.57 56.74 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 122.334 0.254 . . . . 64.129999999999995 111.237 -179.761 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 683' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -139.4 126.1 20.68 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 120.821 0.343 . . . . 64.310000000000002 111.224 -178.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 684' ' ' VAL . . . . . . . . . . . . . 81.6 t -114.17 105.19 54.39 Favored Pre-proline 0 N--CA 1.474 0.753 0 N-CA-C 111.989 0.366 . . . . 55.409999999999997 111.989 -179.14 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_exo -53.37 -40.55 77.78 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 123.041 2.494 . . . . 71.120000000000005 113.727 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 686' ' ' MET . . . . . 0.552 ' HE3' ' HA ' ' A' ' 686' ' ' MET . 1.0 OUTLIER -78.24 -4.0 45.56 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 112.636 0.606 . . . . 73.439999999999998 112.636 -177.994 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 687' ' ' ALA . . . . . . . . . . . . . . . -98.74 -17.68 18.39 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.954 0.407 . . . . 63.130000000000003 111.385 177.376 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 688' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -98.67 -13.94 20.07 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 112.446 0.535 . . . . 74.420000000000002 112.446 -175.231 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 689' ' ' VAL . . . . . 0.59 HG12 HD13 ' A' ' 703' ' ' ILE . 94.9 t -122.49 132.93 70.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 N-CA-C 112.919 0.711 . . . . 75.140000000000001 112.919 -173.23 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 690' ' ' LEU . . . . . 0.514 ' HA ' HG23 ' A' ' 700' ' ' THR . 6.5 mp -124.93 165.0 18.87 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 116.274 -0.421 . . . . 71.540000000000006 111.021 177.392 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 691' ' ' ALA . . . . . . . . . . . . . . . -152.19 127.41 9.84 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 120.915 0.388 . . . . 44.340000000000003 111.909 178.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 692' ' ' ILE . . . . . . . . . . . . . 45.6 mm -135.28 139.07 47.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 N-CA-C 112.097 0.406 . . . . 73.310000000000002 112.097 -177.493 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 693' ' ' ASP . . . . . 0.537 ' HB2' ' HB3' ' A' ' 667' ' ' PRO . 45.5 t0 -120.29 137.93 53.98 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 109.589 -0.523 . . . . 75.519999999999996 109.589 171.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 52.9 tttp -57.33 -35.25 69.66 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 121.06 0.457 . . . . 74.129999999999995 112.1 -178.807 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -82.52 -46.16 13.76 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 112.294 0.479 . . . . 72.219999999999999 112.294 -176.51 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 696' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -94.33 -34.79 12.67 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 112.361 0.504 . . . . 51.100000000000001 112.361 -170.601 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . 105.26 -123.3 7.55 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 121.44 -0.409 . . . . 33.530000000000001 113.018 -178.322 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -75.96 118.41 18.7 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 121.272 0.558 . . . . 71.540000000000006 112.142 -178.705 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 699' ' ' LEU . . . . . 0.449 HD12 ' HB3' ' A' ' 667' ' ' PRO . 81.4 mt -118.33 8.13 12.15 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 115.719 -0.673 . . . . 62.420000000000002 110.408 171.742 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 700' ' ' THR . . . . . 0.514 HG23 ' HA ' ' A' ' 690' ' ' LEU . 37.8 m -59.1 -37.77 77.96 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.48 0.657 . . . . 54.229999999999997 110.568 175.343 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 701' ' ' SER . . . . . . . . . . . . . 54.8 p -73.4 -2.75 23.62 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 115.588 -0.733 . . . . 62.200000000000003 111.865 176.569 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 702' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -110.74 2.01 18.18 Favored 'General case' 0 CA--C 1.541 0.596 0 N-CA-C 111.859 0.318 . . . . 72.150000000000006 111.859 -179.067 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 703' ' ' ILE . . . . . 0.59 HD13 HG12 ' A' ' 689' ' ' VAL . 66.9 mt -71.12 129.67 34.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-O 121.179 0.514 . . . . 72.319999999999993 111.695 -179.169 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 704' ' ' LYS . . . . . . . . . . . . . 2.4 tppp? -104.88 127.26 52.64 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.192 -0.458 . . . . 71.049999999999997 110.244 177.347 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 50.1 t -97.94 134.8 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-O 120.825 0.345 . . . . 74.329999999999998 111.893 -177.115 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 706' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -128.56 147.63 50.71 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 116.133 -0.485 . . . . 74.349999999999994 110.351 175.232 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 106.13 -172.44 18.84 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 121.185 -0.531 . . . . 75.349999999999994 112.658 -177.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 708' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -165.18 130.62 2.61 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 116.925 0.363 . . . . 74.310000000000002 111.542 179.65 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 709' ' ' VAL . . . . . 0.553 HG22 ' HB2' ' A' ' 717' ' ' TYR . 98.8 t -110.63 116.6 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-O 120.792 0.329 . . . . 73.150000000000006 111.431 177.818 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 710' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -73.26 134.8 44.37 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 120.979 0.419 . . . . 72.129999999999995 110.584 175.493 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 711' ' ' THR . . . . . . . . . . . . . 75.8 p -105.97 -0.11 25.28 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 111.913 0.338 . . . . 75.120000000000005 111.913 -179.04 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 712' ' ' THR . . . . . . . . . . . . . 14.9 t -107.34 -1.86 21.21 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 112.47 0.544 . . . . 72.299999999999997 112.47 -177.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 713' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -143.58 134.94 26.0 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 122.021 -0.424 . . . . 73.010000000000005 111.174 -179.378 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 714' ' ' ALA . . . . . . . . . . . . . . . -70.23 140.79 52.49 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 112.343 0.498 . . . . 72.299999999999997 112.343 -176.16 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 153.39 167.08 15.31 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 121.124 -0.56 . . . . 61.439999999999998 112.856 -179.521 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 716' ' ' THR . . . . . . . . . . . . . 34.7 m -96.56 122.92 40.0 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 122.461 -0.435 . . . . 70.219999999999999 111.908 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 717' ' ' TYR . . . . . 0.553 ' HB2' HG22 ' A' ' 709' ' ' VAL . 27.3 m-85 -121.89 143.02 49.68 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 116.122 -0.49 . . . . 73.310000000000002 110.142 178.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 718' ' ' VAL . . . . . . . . . . . . . 53.8 t -109.75 127.49 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 N-CA-C 112.645 0.609 . . . . 60.340000000000003 112.645 -174.545 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 719' ' ' LEU . . . . . . . . . . . . . 96.3 mt -106.72 132.25 52.91 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 116.068 -0.515 . . . . 50.229999999999997 111.424 176.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 58.4 m -109.87 124.65 51.71 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 120.791 0.329 . . . . 74.040000000000006 111.261 179.289 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 721' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -110.94 129.63 55.82 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.507 -0.315 . . . . 73.25 110.718 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 99.5 m -132.65 125.37 30.19 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.554 0.216 . . . . 73.340000000000003 111.286 -179.163 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 8.1 p -117.62 142.53 31.42 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 CA-C-O 120.933 0.397 . . . . 51.229999999999997 111.773 -178.453 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 44.1 m -105.07 118.96 37.84 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.238 0.542 . . . . 74.439999999999998 112.429 -176.748 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 725' ' ' ASP . . . . . 0.525 ' HB2' ' HD3' ' A' ' 667' ' ' PRO . 5.7 t0 -73.79 150.94 40.76 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 115.798 -0.637 . . . . 75.209999999999994 110.804 174.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 726' ' ' SER . . . . . . . . . . . . . 59.8 p -74.19 -15.27 61.02 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 112.459 0.541 . . . . 65.450000000000003 112.459 -175.021 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 727' ' ' LYS . . . . . . . . . . . . . 65.2 mmtt -103.66 6.14 36.84 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 112.266 0.469 . . . . 72.120000000000005 112.266 177.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 728' ' ' GLY . . . . . . . . . . . . . . . 102.83 27.96 6.44 Favored Glycine 0 CA--C 1.532 1.103 0 N-CA-C 115.269 0.868 . . . . 54.219999999999999 115.269 173.184 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 729' ' ' HIS . . . . . 0.42 ' H ' ' HB3' ' A' ' 725' ' ' ASP . 21.1 m80 -109.14 104.01 13.11 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 117.897 0.849 . . . . 55.399999999999999 111.6 173.19 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 730' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -98.83 105.58 17.74 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 120.807 0.337 . . . . 72.109999999999999 110.867 177.172 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 33.9 m -106.79 153.59 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-O 120.822 0.344 . . . . 74.140000000000001 111.624 -178.2 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 9.8 t -134.94 147.86 49.88 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 112.415 0.524 . . . . 75.310000000000002 112.415 -176.469 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -148.56 149.6 31.87 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.08 0.552 . . . . 63.450000000000003 109.989 176.082 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 734' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -120.44 158.46 27.17 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 113.03 0.752 . . . . 73.420000000000002 113.03 -173.134 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 735' ' ' GLN . . . . . 0.45 ' NE2' ' HG2' ' A' ' 672' ' ' PRO . 54.0 tt0 -130.34 123.44 29.97 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.374 -0.83 . . . . 63.109999999999999 110.708 179.123 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 736' ' ' THR . . . . . 0.437 ' O ' ' HA2' ' A' ' 674' ' ' GLY . 62.2 m -92.49 103.67 16.07 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 121.056 0.455 . . . . 61.340000000000003 111.122 178.178 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 50.0 t -96.58 128.93 47.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-O 120.85 0.357 . . . . 74.409999999999997 111.411 -177.295 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 738' ' ' THR . . . . . . . . . . . . . 97.0 m -114.58 114.6 25.94 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.092 0.472 . . . . 75.120000000000005 111.642 -178.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 739' ' ' VAL . . . . . . . . . . . . . 39.3 t -93.06 135.14 28.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 CA-C-N 116.162 -0.472 . . . . 55.43 111.155 178.297 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 740' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -122.71 155.53 36.27 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.74 0.305 . . . . 71.150000000000006 111.594 -178.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 741' ' ' VAL . . . . . . . . . . . . . 24.1 t -75.79 148.06 7.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-O 120.69 0.281 . . . . 74.409999999999997 111.586 -178.65 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 742' ' ' ARG . . . . . 0.416 HH11 ' HD3' ' A' ' 742' ' ' ARG . 51.6 mtt-85 -87.4 -169.5 2.64 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 120.702 0.286 . . . . 74.409999999999997 110.724 175.564 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 743' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -125.89 123.9 39.67 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 113.62 0.97 . . . . 73.349999999999994 113.62 -170.226 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 744' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.25 170.15 16.36 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.18 -0.918 . . . . 73.409999999999997 109.761 170.394 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 59.7 t -116.82 125.26 73.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 CA-C-O 120.853 0.359 . . . . 73.239999999999995 111.96 -177.288 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -67.06 95.88 0.41 Allowed 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.172 0.511 . . . . 74.329999999999998 111.159 175.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 747' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -155.83 160.97 40.66 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 116.081 -0.509 . . . . 63.140000000000001 110.427 -178.129 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -69.01 130.2 42.09 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 121.646 0.736 . . . . 65.239999999999995 112.024 -177.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 749' ' ' LYS . . . . . 0.548 ' HD2' ' HD2' ' A' ' 750' ' ' PRO . 22.3 tptm -103.23 125.79 34.12 Favored Pre-proline 0 CA--C 1.543 0.678 0 CA-C-N 115.64 -0.709 . . . . 61.140000000000001 110.716 -178.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 750' ' ' PRO . . . . . 0.548 ' HD2' ' HD2' ' A' ' 749' ' ' LYS . 13.0 Cg_endo -55.6 109.13 0.38 Allowed 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 122.542 2.162 . . . . 65.430000000000007 113.068 179.221 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 751' ' ' ILE . . . . . . . . . . . . . 62.9 mt 60.31 96.39 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-O 121.44 0.638 . . . . 74.219999999999999 111.722 -178.662 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 752' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -73.41 109.89 7.28 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 116.073 -0.512 . . . . 74.299999999999997 110.682 -178.721 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 753' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 . . . . . 0 N--CA 1.472 0.658 0 CA-C-O 121.407 0.622 . . . . 63.420000000000002 111.696 -178.506 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 762' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 657' ' ' MET . . . . . . . . . . . . . 96.0 mmm . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 120.768 0.318 . . . . 71.430000000000007 111.51 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 658' ' ' GLY . . . . . . . . . . . . . . . 125.64 -61.21 0.62 Allowed Glycine 0 N--CA 1.465 0.614 0 C-N-CA 121.344 -0.455 . . . . 72.120000000000005 112.62 -178.561 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 659' ' ' ASN . . . . . . . . . . . . . 30.2 m-80 -125.66 95.75 4.55 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 121.154 0.502 . . . . 72.349999999999994 111.184 178.18 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 660' ' ' GLY . . . . . . . . . . . . . . . -92.16 -46.83 3.48 Favored Glycine 0 CA--C 1.523 0.59 0 C-N-CA 121.193 -0.527 . . . . 73.519999999999996 112.815 178.588 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -70.63 101.4 2.04 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 120.865 0.364 . . . . 74.0 111.358 178.091 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 662' ' ' THR . . . . . . . . . . . . . 10.2 t -89.21 157.26 18.32 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.074 0.464 . . . . 72.120000000000005 111.239 176.363 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 663' ' ' SER . . . . . . . . . . . . . 63.6 m -81.32 97.81 7.86 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.044 0.387 . . . . 53.350000000000001 112.044 -178.565 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 664' ' ' ASP . . . . . 0.463 ' OD2' ' HB2' ' A' ' 727' ' ' LYS . 16.2 t0 -90.21 132.21 35.62 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.266 0.555 . . . . 75.519999999999996 111.112 172.593 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 665' ' ' LEU . . . . . . . . . . . . . 67.7 mt -99.52 126.35 45.46 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.812 -0.631 . . . . 74.329999999999998 110.412 176.693 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 666' ' ' GLU . . . . . 0.519 ' H ' ' CD ' ' A' ' 666' ' ' GLU . 0.7 OUTLIER -58.69 156.33 24.81 Favored Pre-proline 0 CA--C 1.544 0.722 0 CA-C-N 115.872 -0.604 . . . . 71.409999999999997 112.28 -179.283 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 667' ' ' PRO . . . . . 0.421 ' HD3' ' HB2' ' A' ' 725' ' ' ASP . 72.0 Cg_endo -75.17 145.29 30.71 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.276 1.984 . . . . 75.349999999999994 112.861 -175.878 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 668' ' ' LYS . . . . . . . . . . . . . 52.6 tptt -82.37 104.3 12.57 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.105 0.478 . . . . 73.319999999999993 111.001 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 669' ' ' LEU . . . . . . . . . . . . . 51.2 tp -89.91 106.58 18.57 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.271 0.557 . . . . 62.109999999999999 110.762 177.749 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 670' ' ' THR . . . . . . . . . . . . . 33.0 m -91.75 110.92 22.27 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.089 -0.505 . . . . 72.019999999999996 111.246 -177.225 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 671' ' ' VAL . . . . . 0.437 HG21 ' HB3' ' A' ' 733' ' ' ALA . 84.7 t -131.66 139.72 36.1 Favored Pre-proline 0 N--CA 1.473 0.691 0 CA-C-N 116.092 -0.504 . . . . 74.409999999999997 111.161 -176.369 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 672' ' ' PRO . . . . . 0.404 ' HD2' HG13 ' A' ' 671' ' ' VAL . 74.3 Cg_endo -76.74 149.34 29.72 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 122.418 2.079 . . . . 75.319999999999993 112.595 175.129 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 673' ' ' VAL . . . . . . . . . . . . . 12.5 p -69.57 -34.75 63.02 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 N-CA-C 112.468 0.544 . . . . 72.129999999999995 112.468 -176.428 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 674' ' ' GLY . . . . . . . . . . . . . . . 179.85 169.39 40.04 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 120.396 -0.907 . . . . 64.209999999999994 113.949 -178.337 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 675' ' ' ALA . . . . . . . . . . . . . . . -154.99 140.2 17.56 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 122.625 0.37 . . . . 61.240000000000002 111.107 179.259 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 676' ' ' THR . . . . . . . . . . . . . 86.2 m -118.71 121.22 39.6 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-O 120.713 0.292 . . . . 72.140000000000001 111.398 -179.227 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 677' ' ' ILE . . . . . . . . . . . . . 30.0 pt -129.3 174.3 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-O 120.986 0.422 . . . . 74.040000000000006 111.886 -177.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 678' ' ' HIS . . . . . . . . . . . . . 53.0 m80 -115.84 166.3 12.11 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.312 0.577 . . . . 32.130000000000003 111.933 178.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 679' ' ' VAL . . . . . 0.585 HG13 ' HA ' ' A' ' 712' ' ' THR . 63.2 t -56.95 111.88 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-N 115.628 -0.714 . . . . 73.329999999999998 110.643 174.003 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 123.05 -33.2 4.13 Favored Glycine 0 CA--C 1.526 0.736 0 CA-C-N 116.256 -0.429 . . . . 44.439999999999998 112.815 -175.555 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 681' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -73.48 128.26 35.01 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.095 0.474 . . . . 74.329999999999998 111.659 179.184 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 682' ' ' SER . . . . . . . . . . . . . 50.4 m -85.34 144.42 28.06 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 120.849 0.357 . . . . 61.409999999999997 110.871 176.822 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 683' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -118.08 132.38 56.36 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 120.809 0.338 . . . . 74.450000000000003 111.263 -178.401 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 684' ' ' VAL . . . . . . . . . . . . . 52.4 t -116.84 96.98 49.89 Favored Pre-proline 0 CA--C 1.544 0.72 0 CA-C-N 116.461 -0.336 . . . . 61.210000000000001 111.326 -178.176 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -77.28 -31.62 3.48 Favored 'Trans proline' 0 CA--C 1.545 1.07 0 C-N-CA 122.783 2.322 . . . . 72.549999999999997 114.461 -174.814 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 686' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.35 -12.17 59.99 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 112.303 0.482 . . . . 74.209999999999994 112.303 -174.515 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 687' ' ' ALA . . . . . . . . . . . . . . . -94.22 -27.39 16.2 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 111.91 0.337 . . . . 62.130000000000003 111.91 178.602 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 688' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -91.35 -8.22 48.7 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 112.133 0.42 . . . . 75.109999999999999 112.133 -177.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 689' ' ' VAL . . . . . 0.515 HG12 HD13 ' A' ' 703' ' ' ILE . 62.7 t -114.21 127.64 71.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-O 120.987 0.422 . . . . 75.439999999999998 111.559 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 690' ' ' LEU . . . . . 0.412 HD22 ' C ' ' A' ' 689' ' ' VAL . 3.8 mm? -123.66 155.82 37.04 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 116.247 -0.433 . . . . 71.129999999999995 111.125 179.563 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 691' ' ' ALA . . . . . . . . . . . . . . . -141.5 122.86 14.9 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 120.659 0.266 . . . . 73.150000000000006 110.865 174.737 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 692' ' ' ILE . . . . . 0.431 HD13 ' HA ' ' A' ' 698' ' ' ASP . 48.1 mm -128.68 120.48 52.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 N-CA-C 112.087 0.403 . . . . 73.209999999999994 112.087 -177.034 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -95.05 149.94 20.71 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.09 0.472 . . . . 62.25 110.692 172.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 7.5 mtpm? -77.42 -34.56 54.68 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 112.665 0.617 . . . . 61.539999999999999 112.665 -173.651 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -84.86 -54.98 4.32 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 121.828 -0.545 . . . . 73.430000000000007 112.095 177.748 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 696' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -75.93 -50.48 14.85 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 112.125 0.417 . . . . 74.400000000000006 112.125 -173.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . 123.94 -139.44 12.03 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 121.37 -0.443 . . . . 74.25 112.65 -175.663 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 698' ' ' ASP . . . . . 0.431 ' HA ' HD13 ' A' ' 692' ' ' ILE . 14.3 t70 -67.53 122.57 18.28 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 122.369 -0.489 . . . . 73.329999999999998 111.961 -178.739 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 699' ' ' LEU . . . . . 0.405 HD22 ' HD2' ' A' ' 702' ' ' LYS . 83.5 mt -118.49 19.44 13.33 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 116.097 -0.502 . . . . 72.420000000000002 111.1 176.087 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 89.3 m -59.52 -31.96 69.87 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 120.954 0.407 . . . . 74.209999999999994 112.067 -176.63 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 701' ' ' SER . . . . . . . . . . . . . 46.7 m -72.03 -13.58 61.64 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 120.763 0.316 . . . . 40.299999999999997 111.833 179.679 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 702' ' ' LYS . . . . . 0.405 ' HD2' HD22 ' A' ' 699' ' ' LEU . 68.8 mttm -92.98 -2.74 55.48 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 112.09 0.404 . . . . 71.230000000000004 112.09 179.513 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 703' ' ' ILE . . . . . 0.515 HD13 HG12 ' A' ' 689' ' ' VAL . 69.8 mt -68.67 119.48 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-O 121.09 0.471 . . . . 71.420000000000002 111.763 -179.777 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 704' ' ' LYS . . . . . . . . . . . . . 51.1 tptt -89.76 126.62 35.74 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.246 -0.434 . . . . 54.039999999999999 110.177 175.755 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 51.7 t -95.99 130.07 45.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-O 121.046 0.451 . . . . 45.109999999999999 112.004 -177.369 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 706' ' ' ASP . . . . . 0.581 ' HB3' ' HB ' ' A' ' 720' ' ' THR . 14.4 t70 -123.29 145.69 48.49 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.185 -0.462 . . . . 64.150000000000006 110.484 176.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 119.96 -153.98 16.59 Favored Glycine 0 CA--C 1.524 0.651 0 C-N-CA 121.079 -0.582 . . . . 51.240000000000002 113.32 178.78 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 708' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -166.96 141.42 3.94 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.762 0.315 . . . . 71.530000000000001 111.118 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 709' ' ' VAL . . . . . . . . . . . . . 59.9 t -127.1 110.89 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-O 120.583 0.23 . . . . 75.230000000000004 110.918 174.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 710' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -94.29 135.77 35.32 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 109.882 -0.414 . . . . 63.109999999999999 109.882 176.356 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 711' ' ' THR . . . . . 0.431 ' O ' ' HA ' ' A' ' 679' ' ' VAL . 71.8 p -105.77 0.04 25.79 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 122.105 -0.372 . . . . 62.509999999999998 111.98 -177.779 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 712' ' ' THR . . . . . 0.585 ' HA ' HG13 ' A' ' 679' ' ' VAL . 72.0 p -116.24 -24.25 8.05 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 116.426 -0.352 . . . . 74.129999999999995 111.777 178.29 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 713' ' ' LYS . . . . . . . . . . . . . 61.2 tttm -111.9 121.29 44.62 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 120.899 0.381 . . . . 72.109999999999999 111.119 -178.25 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 714' ' ' ALA . . . . . . . . . . . . . . . -70.21 143.88 52.08 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 112.542 0.571 . . . . 71.510000000000005 112.542 -177.017 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 156.39 162.24 11.3 Favored Glycine 0 CA--C 1.526 0.722 0 CA-C-N 115.938 -0.574 . . . . 63.240000000000002 112.509 179.156 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 716' ' ' THR . . . . . . . . . . . . . 51.6 m -98.34 122.57 41.68 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 117.311 0.556 . . . . 73.129999999999995 111.093 177.794 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 717' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -119.49 137.33 53.87 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.431 -0.35 . . . . 72.329999999999998 110.71 -178.175 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 718' ' ' VAL . . . . . . . . . . . . . 48.4 t -95.15 131.36 42.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-O 121.079 0.466 . . . . 74.409999999999997 111.606 179.505 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 719' ' ' LEU . . . . . . . . . . . . . 86.6 mt -108.53 133.67 52.35 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.055 -0.52 . . . . 65.400000000000006 110.814 177.563 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 720' ' ' THR . . . . . 0.581 ' HB ' ' HB3' ' A' ' 706' ' ' ASP . 77.3 m -117.53 130.92 56.72 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-O 120.634 0.254 . . . . 63.5 110.934 178.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 721' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -119.23 132.26 55.91 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 120.672 0.272 . . . . 63.420000000000002 111.118 -178.511 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 97.8 m -128.33 139.47 52.39 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 111.686 0.254 . . . . 62.109999999999999 111.686 -179.115 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 13.8 p -141.27 147.2 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 CA-C-O 120.937 0.399 . . . . 75.239999999999995 111.244 178.103 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 18.7 m -110.97 144.95 39.26 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.035 0.445 . . . . 73.510000000000005 111.999 -176.452 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 725' ' ' ASP . . . . . 0.723 ' HB3' ' H ' ' A' ' 729' ' ' HIS . 7.5 t70 -74.11 168.46 19.52 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.041 0.536 . . . . 50.229999999999997 111.222 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 726' ' ' SER . . . . . . . . . . . . . 34.1 t -68.65 -30.83 69.62 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 120.78 0.324 . . . . 74.019999999999996 110.985 174.356 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 727' ' ' LYS . . . . . 0.463 ' HB2' ' OD2' ' A' ' 664' ' ' ASP . 4.1 mptp? -96.47 -9.44 29.7 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 112.62 0.6 . . . . 71.430000000000007 112.62 177.423 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 728' ' ' GLY . . . . . . . . . . . . . . . 113.15 22.38 5.6 Favored Glycine 0 CA--C 1.535 1.332 0 N-CA-C 116.111 1.204 . . . . 50.140000000000001 116.111 173.155 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 729' ' ' HIS . . . . . 0.723 ' H ' ' HB3' ' A' ' 725' ' ' ASP . 46.5 m80 -83.67 119.98 25.43 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 118.117 0.958 . . . . 74.230000000000004 110.949 169.411 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 730' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -103.56 119.76 39.54 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 120.823 0.344 . . . . 73.510000000000005 111.692 -179.161 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 35.1 m -120.65 157.43 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-O 120.733 0.301 . . . . 55.149999999999999 111.234 179.064 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 9.6 t -146.91 147.88 31.22 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.545 0.572 . . . . 72.420000000000002 112.545 -177.401 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 733' ' ' ALA . . . . . 0.437 ' HB3' HG21 ' A' ' 671' ' ' VAL . . . -141.73 161.9 36.8 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 116.042 -0.527 . . . . 60.140000000000001 110.91 -179.677 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 734' ' ' LYS . . . . . . . . . . . . . 42.8 mtmt -128.9 150.8 50.2 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 112.872 0.693 . . . . 44.140000000000001 112.872 -173.038 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 735' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -130.75 140.65 50.33 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 115.423 -0.808 . . . . 73.409999999999997 110.662 177.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 736' ' ' THR . . . . . . . . . . . . . 92.4 m -109.85 107.76 17.83 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 112.221 0.452 . . . . 72.329999999999998 112.221 -178.191 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 57.5 t -102.47 131.67 50.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 O-C-N 122.16 -0.338 . . . . 71.109999999999999 111.787 -178.679 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 738' ' ' THR . . . . . . . . . . . . . 91.7 m -119.13 118.46 31.44 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 120.788 0.327 . . . . 60.119999999999997 111.522 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 739' ' ' VAL . . . . . . . . . . . . . 41.7 t -102.88 139.1 24.73 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 CA-C-O 120.67 0.271 . . . . 73.120000000000005 111.418 178.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 740' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -128.91 157.68 40.91 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 120.931 0.396 . . . . 73.329999999999998 111.76 179.396 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 741' ' ' VAL . . . . . 0.464 HG12 ' H ' ' A' ' 743' ' ' GLU . 9.6 t -79.37 153.12 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-N 116.551 -0.295 . . . . 71.420000000000002 111.585 -176.489 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 742' ' ' ARG . . . . . . . . . . . . . 23.4 ptt180 -83.62 -27.82 28.9 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 112.074 0.398 . . . . 73.129999999999995 112.074 -177.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 743' ' ' GLU . . . . . 0.464 ' H ' HG12 ' A' ' 741' ' ' VAL . 12.0 pt-20 -152.86 146.76 25.29 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 120.757 0.313 . . . . 73.230000000000004 111.339 -177.758 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 744' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -91.16 113.16 25.34 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.818 0.342 . . . . 74.430000000000007 111.336 177.485 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 745' ' ' VAL . . . . . 0.521 HG12 ' H ' ' A' ' 747' ' ' ASN . 57.8 t -91.44 122.38 42.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-O 120.882 0.372 . . . . 75.129999999999995 110.92 177.136 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -93.02 7.37 44.41 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 112.107 0.41 . . . . 74.010000000000005 112.107 -176.358 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 747' ' ' ASN . . . . . 0.521 ' H ' HG12 ' A' ' 745' ' ' VAL . 19.4 m120 -110.03 100.5 9.43 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 120.989 0.424 . . . . 72.420000000000002 111.462 177.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -78.47 156.06 29.54 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.126 0.488 . . . . 74.219999999999999 110.881 177.744 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 749' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -132.45 153.66 81.27 Favored Pre-proline 0 CA--C 1.538 0.496 0 CA-C-N 116.045 -0.525 . . . . 72.219999999999999 110.89 -177.711 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 750' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -51.8 100.56 0.05 OUTLIER 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 122.416 2.077 . . . . 62.340000000000003 112.674 176.625 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 751' ' ' ILE . . . . . . . . . . . . . 22.4 pt -89.48 160.56 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-N 116.237 -0.438 . . . . 71.409999999999997 112.006 -178.37 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 752' ' ' LEU . . . . . . . . . . . . . 55.3 tp -83.8 125.14 31.65 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.223 -0.444 . . . . 62.210000000000001 111.871 -177.347 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 753' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 . . . . . 0 N--CA 1.469 0.508 0 CA-C-N 116.445 -0.343 . . . . 73.109999999999999 111.522 178.279 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 762' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 657' ' ' MET . . . . . . . . . . . . . 25.6 ptt? . . . . . 0 N--CA 1.487 1.407 0 CA-C-O 120.63 0.252 . . . . 63.340000000000003 111.028 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 658' ' ' GLY . . . . . . . . . . . . . . . 79.33 159.22 15.67 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 121.072 -0.585 . . . . 65.340000000000003 112.638 -175.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 659' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -137.68 132.36 32.79 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 122.509 -0.406 . . . . 64.120000000000005 111.51 179.314 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 660' ' ' GLY . . . . . . . . . . . . . . . -177.51 61.1 0.09 OUTLIER Glycine 0 CA--C 1.527 0.786 0 C-N-CA 120.741 -0.742 . . . . 32.229999999999997 113.642 -177.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -85.09 90.69 7.92 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 121.374 0.607 . . . . 64.200000000000003 110.412 176.133 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 662' ' ' THR . . . . . . . . . . . . . 68.8 p -81.07 162.59 23.68 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 113.033 0.753 . . . . 74.420000000000002 113.033 -171.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 663' ' ' SER . . . . . . . . . . . . . 46.6 t -101.31 142.45 32.71 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.297 -0.865 . . . . 74.129999999999995 109.854 171.578 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 664' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -73.74 149.99 41.44 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.644 0.735 . . . . 73.430000000000007 112.504 -175.716 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 665' ' ' LEU . . . . . . . . . . . . . 72.6 mt -101.49 137.68 39.49 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-N 115.019 -0.991 . . . . 55.030000000000001 110.876 177.838 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 666' ' ' GLU . . . . . 0.502 ' HG3' ' HB3' ' A' ' 729' ' ' HIS . 19.7 mp0 -71.11 150.09 94.64 Favored Pre-proline 0 CA--C 1.538 0.497 0 CA-C-N 116.121 -0.491 . . . . 74.219999999999999 110.505 177.427 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 667' ' ' PRO . . . . . 0.559 ' HB3' HD12 ' A' ' 699' ' ' LEU . 37.5 Cg_endo -65.1 133.19 34.55 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 122.103 1.869 . . . . 73.519999999999996 112.345 179.092 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 668' ' ' LYS . . . . . . . . . . . . . 56.1 tptt -82.18 106.98 14.51 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 121.173 0.511 . . . . 73.340000000000003 110.56 179.143 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 669' ' ' LEU . . . . . 0.516 ' HG ' HG23 ' A' ' 671' ' ' VAL . 60.0 tp -89.39 106.04 18.19 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.709 -0.678 . . . . 53.409999999999997 110.912 -178.614 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 670' ' ' THR . . . . . . . . . . . . . 86.3 m -86.37 110.4 19.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.034 0.445 . . . . 74.25 110.828 179.004 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 671' ' ' VAL . . . . . 0.516 HG23 ' HG ' ' A' ' 669' ' ' LEU . 94.8 t -127.55 127.94 24.03 Favored Pre-proline 0 CA--C 1.536 0.418 0 CA-C-N 116.032 -0.531 . . . . 74.329999999999998 111.021 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 672' ' ' PRO . . . . . 0.425 ' HG2' ' NE2' ' A' ' 735' ' ' GLN . 33.4 Cg_endo -64.48 154.2 73.03 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 122.305 2.003 . . . . 72.420000000000002 111.929 178.248 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 673' ' ' VAL . . . . . . . . . . . . . 10.1 p -81.5 -34.39 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 O-C-N 122.145 -0.347 . . . . 74.239999999999995 111.89 -176.429 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 674' ' ' GLY . . . . . 0.418 ' HA2' ' O ' ' A' ' 736' ' ' THR . . . -162.54 163.88 35.36 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 121.094 -0.574 . . . . 64.430000000000007 113.579 -178.173 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 675' ' ' ALA . . . . . . . . . . . . . . . -156.3 118.28 3.97 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 120.694 0.283 . . . . 71.209999999999994 111.747 179.284 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 676' ' ' THR . . . . . . . . . . . . . 88.7 m -97.43 126.14 42.5 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 120.648 0.261 . . . . 73.049999999999997 111.591 178.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 677' ' ' ILE . . . . . 0.416 HG13 HG22 ' A' ' 739' ' ' VAL . 20.1 pt -138.52 176.44 6.62 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 C-N-CA 122.514 0.325 . . . . 71.430000000000007 111.288 179.391 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 678' ' ' HIS . . . . . 0.541 ' O ' ' HB2' ' A' ' 681' ' ' ASP . 72.1 m80 -114.93 177.21 4.73 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 121.396 0.617 . . . . 53.229999999999997 112.574 -179.6 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 679' ' ' VAL . . . . . 0.481 HG23 ' HA ' ' A' ' 741' ' ' VAL . 96.1 t -66.45 122.13 16.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-N 116.004 -0.544 . . . . 75.209999999999994 110.957 174.154 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 86.1 18.31 59.55 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 121.218 -0.515 . . . . 70.439999999999998 112.825 -176.028 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 681' ' ' ASP . . . . . 0.541 ' HB2' ' O ' ' A' ' 678' ' ' HIS . 1.1 t70 -83.09 -175.32 5.78 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-O 120.882 0.373 . . . . 70.109999999999999 111.295 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 682' ' ' SER . . . . . . . . . . . . . 69.7 m -123.12 140.66 52.8 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 122.418 0.287 . . . . 53.340000000000003 111.314 179.285 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 683' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -154.61 125.38 7.07 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 116.494 -0.321 . . . . 73.530000000000001 110.87 -178.339 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 684' ' ' VAL . . . . . . . . . . . . . 38.6 t -125.38 93.57 44.77 Favored Pre-proline 0 CA--C 1.546 0.789 0 CA-C-O 121.022 0.439 . . . . 65.510000000000005 111.926 -177.318 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -61.27 -36.81 77.78 Favored 'Trans proline' 0 CA--C 1.545 1.028 0 C-N-CA 122.725 2.283 . . . . 53.109999999999999 113.576 -177.869 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 686' ' ' MET . . . . . . . . . . . . . 1.9 mmt -78.82 4.08 14.98 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 112.573 0.582 . . . . 65.510000000000005 112.573 -176.766 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 687' ' ' ALA . . . . . . . . . . . . . . . -119.21 -40.65 2.8 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.18 0.514 . . . . 54.450000000000003 111.211 174.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 688' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -71.93 -24.91 61.71 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 116.2 -0.455 . . . . 75.540000000000006 111.998 179.202 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 689' ' ' VAL . . . . . 0.427 HG13 HG22 ' A' ' 671' ' ' VAL . 63.7 t -96.91 144.48 10.49 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 CA-C-O 120.677 0.275 . . . . 51.009999999999998 110.802 174.258 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 690' ' ' LEU . . . . . 0.45 HD23 ' N ' ' A' ' 691' ' ' ALA . 10.5 tt -142.66 149.55 39.04 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 120.475 0.178 . . . . 61.240000000000002 111.105 -174.302 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 691' ' ' ALA . . . . . 0.45 ' N ' HD23 ' A' ' 690' ' ' LEU . . . -144.22 132.78 22.21 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 112.085 0.402 . . . . 42.5 112.085 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 692' ' ' ILE . . . . . 0.576 HD13 ' HA ' ' A' ' 698' ' ' ASP . 43.7 mm -133.97 132.91 56.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 N-CA-C 112.039 0.385 . . . . 63.25 112.039 -178.83 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 693' ' ' ASP . . . . . 0.46 ' OD1' ' HG2' ' A' ' 695' ' ' GLU . 7.7 t70 -110.68 149.21 30.79 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 109.714 -0.476 . . . . 65.530000000000001 109.714 171.162 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -69.41 -29.3 67.0 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 111.894 0.331 . . . . 70.140000000000001 111.894 -177.432 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 695' ' ' GLU . . . . . 0.46 ' HG2' ' OD1' ' A' ' 693' ' ' ASP . 12.2 pt-20 -81.72 -46.37 14.38 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 112.189 0.441 . . . . 74.040000000000006 112.189 -175.789 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 696' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -95.53 -48.85 5.66 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.138 0.494 . . . . 73.349999999999994 111.683 -174.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . 119.22 -119.28 4.25 Favored Glycine 0 CA--C 1.525 0.658 0 CA-C-N 116.006 -0.543 . . . . 50.350000000000001 112.423 -175.334 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 698' ' ' ASP . . . . . 0.576 ' HA ' HD13 ' A' ' 692' ' ' ILE . 12.9 t70 -74.88 116.36 15.51 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 122.372 -0.487 . . . . 74.0 111.757 -178.082 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 699' ' ' LEU . . . . . 0.559 HD12 ' HB3' ' A' ' 667' ' ' PRO . 57.8 mt -114.54 22.95 13.17 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 116.108 -0.497 . . . . 63.310000000000002 110.944 174.25 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 37.7 m -60.54 -37.39 81.05 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 120.979 0.419 . . . . 55.530000000000001 111.823 -176.675 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 701' ' ' SER . . . . . . . . . . . . . 70.6 m -74.51 -10.9 60.0 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 120.848 0.356 . . . . 71.430000000000007 111.794 177.607 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 702' ' ' LYS . . . . . 0.458 ' HG3' HD22 ' A' ' 699' ' ' LEU . 48.0 mmtm -90.88 7.22 41.08 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 120.831 0.348 . . . . 72.340000000000003 111.433 -178.413 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 703' ' ' ILE . . . . . 0.423 HD13 HG12 ' A' ' 689' ' ' VAL . 66.4 mt -87.24 117.73 31.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 CA-C-O 121.234 0.54 . . . . 75.329999999999998 112.421 -177.37 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 704' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -84.68 135.39 34.18 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.959 -0.564 . . . . 55.130000000000003 110.546 173.033 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 56.2 t -107.98 143.58 18.19 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-O 120.844 0.354 . . . . 74.299999999999997 111.954 -177.352 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 706' ' ' ASP . . . . . 0.503 ' HB3' ' HB ' ' A' ' 720' ' ' THR . 24.7 t70 -129.05 143.5 50.89 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 122.713 0.405 . . . . 75.349999999999994 110.673 175.103 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 93.36 174.38 40.36 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 121.315 -0.469 . . . . 64.239999999999995 112.516 -174.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 708' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -152.07 137.9 18.01 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 122.259 -0.554 . . . . 73.140000000000001 112.157 -179.118 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 709' ' ' VAL . . . . . . . . . . . . . 89.3 t -106.68 114.97 47.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-O 120.94 0.4 . . . . 73.129999999999995 111.466 178.678 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 710' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -82.43 136.87 34.84 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 116.472 -0.331 . . . . 73.510000000000005 110.881 176.656 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 711' ' ' THR . . . . . . . . . . . . . 78.9 p -97.4 -31.88 12.15 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 112.326 0.491 . . . . 64.040000000000006 112.326 -176.655 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 712' ' ' THR . . . . . . . . . . . . . 51.0 p -85.42 -0.16 54.03 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.547 0.573 . . . . 60.100000000000001 112.547 -177.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 713' ' ' LYS . . . . . . . . . . . . . 23.0 tptp -140.3 132.4 27.97 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.705 0.288 . . . . 73.209999999999994 110.964 -178.065 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 714' ' ' ALA . . . . . . . . . . . . . . . -75.65 144.69 41.53 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 112.046 0.388 . . . . 63.229999999999997 112.046 -177.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 162.09 164.35 16.85 Favored Glycine 0 CA--C 1.523 0.591 0 C-N-CA 121.219 -0.515 . . . . 52.009999999999998 112.828 179.38 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 716' ' ' THR . . . . . . . . . . . . . 54.8 m -95.73 123.23 39.2 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.119 0.485 . . . . 52.229999999999997 111.434 178.228 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 717' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -120.75 110.59 16.56 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 116.109 -0.496 . . . . 75.219999999999999 110.659 -179.101 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 718' ' ' VAL . . . . . . . . . . . . . 48.8 t -90.58 107.82 18.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-O 121.082 0.467 . . . . 75.129999999999995 111.059 179.25 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 719' ' ' LEU . . . . . . . . . . . . . 59.9 mt -89.52 150.43 22.45 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.128 -0.487 . . . . 75.239999999999995 111.968 -176.643 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 720' ' ' THR . . . . . 0.503 ' HB ' ' HB3' ' A' ' 706' ' ' ASP . 92.2 m -121.87 135.85 54.91 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 116.412 -0.358 . . . . 64.140000000000001 110.902 177.276 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 721' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -122.08 142.72 50.08 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.929 0.395 . . . . 62.399999999999999 111.463 -178.157 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 69.9 m -138.71 135.12 34.43 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 122.399 0.28 . . . . 72.019999999999996 111.138 -179.691 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 10.9 p -128.3 144.27 38.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 O-C-N 122.233 -0.292 . . . . 71.510000000000005 111.14 178.481 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 28.8 m -110.7 144.01 40.29 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.434 0.635 . . . . 73.239999999999995 112.214 -177.48 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 725' ' ' ASP . . . . . 0.449 ' HB3' ' H ' ' A' ' 729' ' ' HIS . 45.2 t0 -91.74 151.74 20.49 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.916 0.886 . . . . 73.530000000000001 110.25 -179.824 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 726' ' ' SER . . . . . 0.446 ' HB3' ' OE2' ' A' ' 695' ' ' GLU . 48.0 t -64.95 -22.71 67.04 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.161 0.505 . . . . 73.310000000000002 110.846 177.602 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 727' ' ' LYS . . . . . . . . . . . . . 27.5 mmtp -90.29 -6.33 55.26 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 116.187 -0.461 . . . . 73.329999999999998 111.885 177.279 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 728' ' ' GLY . . . . . . . . . . . . . . . 109.25 -5.84 31.94 Favored Glycine 0 CA--C 1.531 1.044 0 N-CA-C 114.776 0.671 . . . . 62.530000000000001 114.776 176.647 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 729' ' ' HIS . . . . . 0.502 ' HB3' ' HG3' ' A' ' 666' ' ' GLU . 39.7 m80 -68.91 138.35 54.57 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 117.933 0.866 . . . . 62.039999999999999 111.028 179.284 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 730' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -133.65 130.92 38.92 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 120.832 0.349 . . . . 75.219999999999999 111.77 -178.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 26.9 m -131.48 160.87 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-N 116.342 -0.39 . . . . 74.400000000000006 111.625 -179.278 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 2.8 t -142.64 146.91 34.96 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 112.771 0.656 . . . . 61.119999999999997 112.771 -174.725 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -148.66 154.45 39.68 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 116.103 -0.499 . . . . 65.010000000000005 110.741 178.193 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 734' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -123.02 159.66 27.93 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 113.367 0.877 . . . . 74.430000000000007 113.367 -174.297 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 735' ' ' GLN . . . . . 0.425 ' NE2' ' HG2' ' A' ' 672' ' ' PRO . 46.9 tt0 -138.25 137.7 37.76 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 115.326 -0.852 . . . . 71.030000000000001 110.988 179.318 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 736' ' ' THR . . . . . 0.418 ' O ' ' HA2' ' A' ' 674' ' ' GLY . 99.0 m -103.36 106.48 17.0 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 121.01 0.433 . . . . 70.120000000000005 111.934 178.619 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 45.1 t -96.64 140.91 16.41 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 116.626 -0.261 . . . . 73.209999999999994 110.643 177.663 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 738' ' ' THR . . . . . . . . . . . . . 87.5 m -132.88 114.14 13.7 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 122.001 -0.437 . . . . 24.350000000000001 111.645 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 739' ' ' VAL . . . . . 0.416 HG22 HG13 ' A' ' 677' ' ' ILE . 52.8 t -93.28 137.07 23.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-N 116.212 -0.449 . . . . 61.109999999999999 110.829 177.504 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 740' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -123.01 149.45 44.3 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.117 0.484 . . . . 73.209999999999994 111.559 179.576 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 741' ' ' VAL . . . . . 0.481 ' HA ' HG23 ' A' ' 679' ' ' VAL . 26.9 t -75.77 151.77 6.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 116.288 -0.415 . . . . 53.100000000000001 111.419 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 742' ' ' ARG . . . . . . . . . . . . . 16.2 ptt180 -105.38 155.27 19.28 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 121.061 0.457 . . . . 75.099999999999994 111.236 178.271 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 743' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -93.15 115.59 28.22 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 121.168 0.509 . . . . 70.140000000000001 110.168 171.113 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 744' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -117.35 173.72 6.54 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.277 0.561 . . . . 72.329999999999998 112.257 -172.865 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 18.8 m -109.43 -177.78 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-N 115.996 -0.547 . . . . 71.349999999999994 111.22 178.461 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 21.6 pttm -109.46 145.03 36.89 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.785 0.326 . . . . 53.140000000000001 110.485 173.43 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 747' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -154.65 160.23 41.29 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.449 -0.341 . . . . 71.340000000000003 111.039 -175.491 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -76.99 38.98 0.22 Allowed 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 112.35 0.5 . . . . 73.439999999999998 112.35 178.349 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 749' ' ' LYS . . . . . 0.451 ' HB3' HG12 ' A' ' 751' ' ' ILE . 53.1 mtpt 61.75 98.81 0.04 OUTLIER Pre-proline 0 CA--C 1.543 0.71 0 C-N-CA 123.063 0.545 . . . . 61.140000000000001 112.299 178.463 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 750' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -74.3 47.41 1.57 Allowed 'Trans proline' 0 CA--C 1.546 1.111 0 C-N-CA 123.134 2.556 . . . . 71.030000000000001 113.083 178.335 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 751' ' ' ILE . . . . . 0.451 HG12 ' HB3' ' A' ' 749' ' ' LYS . 15.5 mm -82.82 28.44 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.868 0 CA-C-O 121.652 0.739 . . . . 73.129999999999995 111.425 -177.206 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 752' ' ' LEU . . . . . 0.461 ' N ' HD12 ' A' ' 752' ' ' LEU . 6.2 mp -81.25 41.13 0.59 Allowed 'General case' 0 CA--C 1.544 0.713 0 O-C-N 121.819 -0.551 . . . . 74.010000000000005 111.357 -179.196 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 753' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 . . . . . 0 N--CA 1.468 0.465 0 CA-C-N 116.09 -0.505 . . . . 73.200000000000003 111.503 -177.727 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 762' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 657' ' ' MET . . . . . . . . . . . . . 28.1 ttt . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 120.759 0.314 . . . . 74.109999999999999 111.152 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 658' ' ' GLY . . . . . . . . . . . . . . . 74.66 -74.14 1.35 Allowed Glycine 0 CA--C 1.527 0.824 0 C-N-CA 121.201 -0.523 . . . . 73.140000000000001 113.344 178.111 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 659' ' ' ASN . . . . . . . . . . . . . 64.1 m-20 -75.52 130.6 39.13 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 122.594 -0.356 . . . . 75.120000000000005 111.604 -177.265 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 660' ' ' GLY . . . . . . . . . . . . . . . -57.03 142.98 41.27 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 121.484 -0.389 . . . . 70.540000000000006 113.641 178.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -117.88 169.11 9.89 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.312 0.577 . . . . 74.409999999999997 112.493 -177.656 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 662' ' ' THR . . . . . . . . . . . . . 62.6 p -106.82 153.68 22.12 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 115.935 -0.575 . . . . 74.310000000000002 111.677 -179.663 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 663' ' ' SER . . . . . . . . . . . . . 48.9 p -74.17 122.51 22.88 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 116.364 -0.38 . . . . 64.340000000000003 111.708 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 664' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -105.02 126.6 52.24 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.456 0.646 . . . . 73.200000000000003 111.995 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 665' ' ' LEU . . . . . . . . . . . . . 89.2 mt -96.04 138.32 33.83 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.749 -0.66 . . . . 74.319999999999993 111.196 178.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 666' ' ' GLU . . . . . 0.528 ' H ' ' CD ' ' A' ' 666' ' ' GLU . 0.8 OUTLIER -82.22 140.11 45.62 Favored Pre-proline 0 CA--C 1.541 0.625 0 CA-C-N 116.01 -0.541 . . . . 71.030000000000001 110.872 174.974 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 667' ' ' PRO . . . . . 0.536 ' HB3' HD12 ' A' ' 699' ' ' LEU . 42.3 Cg_endo -65.79 138.3 52.87 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 122.715 2.277 . . . . 71.239999999999995 113.869 -171.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 668' ' ' LYS . . . . . . . . . . . . . 28.9 ttpp -82.9 107.68 15.69 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.905 -0.588 . . . . 72.439999999999998 110.747 177.19 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 669' ' ' LEU . . . . . 0.443 ' HG ' HG23 ' A' ' 671' ' ' VAL . 55.3 tp -100.78 112.48 24.9 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 121.146 0.498 . . . . 74.530000000000001 111.176 -178.633 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 670' ' ' THR . . . . . . . . . . . . . 94.7 m -93.47 111.48 23.16 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.962 0.41 . . . . 53.43 111.115 179.533 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 671' ' ' VAL . . . . . 0.443 HG23 ' HG ' ' A' ' 669' ' ' LEU . 73.8 t -137.49 137.24 21.64 Favored Pre-proline 0 CA--C 1.54 0.569 0 CA-C-N 115.767 -0.651 . . . . 64.400000000000006 110.843 -178.237 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 672' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -73.93 139.56 27.48 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 122.098 1.865 . . . . 65.530000000000001 112.015 174.688 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 673' ' ' VAL . . . . . . . . . . . . . 10.9 p -79.9 -29.64 12.9 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 CA-C-O 120.955 0.407 . . . . 71.140000000000001 112.017 -177.058 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 674' ' ' GLY . . . . . . . . . . . . . . . -158.89 142.65 8.53 Favored Glycine 0 CA--C 1.523 0.563 0 C-N-CA 120.804 -0.713 . . . . 52.509999999999998 113.263 179.336 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 675' ' ' ALA . . . . . . . . . . . . . . . -142.7 121.14 12.41 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 120.844 0.354 . . . . 50.409999999999997 111.709 -178.409 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 676' ' ' THR . . . . . . . . . . . . . 62.4 m -101.41 119.0 38.1 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.701 0.286 . . . . 74.140000000000001 110.923 179.148 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 677' ' ' ILE . . . . . . . . . . . . . 32.1 pt -125.36 177.01 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-O 121.095 0.474 . . . . 54.210000000000001 111.333 -179.612 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 678' ' ' HIS . . . . . . . . . . . . . 65.6 m80 -116.99 157.94 24.94 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 121.133 0.492 . . . . 63.420000000000002 111.754 179.595 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 679' ' ' VAL . . . . . 0.478 HG13 ' HA ' ' A' ' 712' ' ' THR . 95.9 t -57.37 116.35 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 116.093 -0.503 . . . . 70.340000000000003 110.526 174.307 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 117.44 -22.36 10.24 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 121.294 -0.479 . . . . 55.43 112.682 -175.47 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 681' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -62.79 150.26 41.95 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.537 0.684 . . . . 73.340000000000003 112.697 178.791 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 682' ' ' SER . . . . . . . . . . . . . 99.9 p -90.64 146.07 24.33 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 115.373 -0.83 . . . . 50.439999999999998 110.162 171.089 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 683' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -150.1 112.26 4.63 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 120.974 0.416 . . . . 74.530000000000001 111.628 -178.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 684' ' ' VAL . . . . . . . . . . . . . 58.5 t -115.33 98.93 51.7 Favored Pre-proline 0 CA--C 1.543 0.679 0 CA-C-O 120.953 0.406 . . . . 73.150000000000006 111.198 178.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -63.44 -25.89 70.65 Favored 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 122.673 2.249 . . . . 74.340000000000003 113.144 -177.301 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 686' ' ' MET . . . . . 0.404 ' HA ' ' CE ' ' A' ' 686' ' ' MET . 0.0 OUTLIER -87.29 11.32 14.59 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.265 0.469 . . . . 74.219999999999999 112.265 179.57 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 687' ' ' ALA . . . . . . . . . . . . . . . -119.43 -32.43 4.35 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.908 0.385 . . . . 71.319999999999993 111.396 175.817 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 688' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -90.92 9.72 29.35 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 112.289 0.477 . . . . 75.140000000000001 112.289 -178.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 94.2 t -125.76 139.19 52.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 122.56 0.344 . . . . 73.420000000000002 110.93 177.129 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 690' ' ' LEU . . . . . 0.478 HD23 ' N ' ' A' ' 691' ' ' ALA . 2.3 tt -142.73 133.06 24.77 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-O 120.691 0.281 . . . . 73.200000000000003 111.121 -176.06 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 691' ' ' ALA . . . . . 0.478 ' N ' HD23 ' A' ' 690' ' ' LEU . . . -126.63 125.52 42.05 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 112.465 0.543 . . . . 63.329999999999998 112.465 -178.042 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 692' ' ' ILE . . . . . 0.528 HD13 ' HA ' ' A' ' 698' ' ' ASP . 43.4 mm -134.36 132.11 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 CA-C-N 116.418 -0.356 . . . . 75.209999999999994 111.813 -179.083 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -107.98 129.63 55.1 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 109.194 -0.669 . . . . 63.100000000000001 109.194 168.632 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -60.24 -29.12 68.57 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 112.362 0.504 . . . . 63.399999999999999 112.362 -173.338 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 695' ' ' GLU . . . . . 0.406 ' HG3' ' N ' ' A' ' 696' ' ' ASP . 12.1 pt-20 -78.84 -45.87 19.86 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 120.999 0.428 . . . . 74.400000000000006 111.909 -179.741 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 696' ' ' ASP . . . . . 0.406 ' N ' ' HG3' ' A' ' 695' ' ' GLU . 10.2 t70 -94.07 -48.57 6.17 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.993 0.425 . . . . 74.109999999999999 111.455 -171.769 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . 124.02 -131.98 8.19 Favored Glycine 0 CA--C 1.524 0.614 0 CA-C-N 116.263 -0.426 . . . . 71.439999999999998 112.977 -178.086 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 698' ' ' ASP . . . . . 0.528 ' HA ' HD13 ' A' ' 692' ' ' ILE . 32.0 t70 -72.33 119.8 17.04 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 112.301 0.482 . . . . 75.230000000000004 112.301 -178.577 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 699' ' ' LEU . . . . . 0.536 HD12 ' HB3' ' A' ' 667' ' ' PRO . 62.4 mt -118.06 14.59 14.09 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 120.981 0.42 . . . . 73.400000000000006 110.873 175.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 81.2 m -60.01 -33.77 72.44 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.293 0.479 . . . . 70.450000000000003 112.293 -178.043 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 701' ' ' SER . . . . . . . . . . . . . 32.2 t -70.29 -16.7 63.05 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.196 0.522 . . . . 73.099999999999994 111.377 177.538 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 702' ' ' LYS . . . . . 0.535 ' HD2' HD22 ' A' ' 699' ' ' LEU . 67.5 mttm -91.88 6.38 46.38 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.197 -0.456 . . . . 62.039999999999999 111.769 179.592 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 703' ' ' ILE . . . . . 0.447 HG12 ' HB ' ' A' ' 723' ' ' VAL . 67.0 mt -82.3 133.87 28.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-O 120.946 0.403 . . . . 70.329999999999998 111.326 177.361 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 704' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -112.74 126.93 55.95 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.474 -0.33 . . . . 73.239999999999995 110.534 174.189 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 61.7 t -98.66 124.29 51.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-O 120.914 0.388 . . . . 72.140000000000001 111.605 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 706' ' ' ASP . . . . . 0.46 ' HB3' ' HB ' ' A' ' 720' ' ' THR . 37.3 t70 -109.95 143.25 40.16 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 116.26 -0.427 . . . . 64.120000000000005 110.658 174.4 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 94.16 166.76 37.02 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 121.015 -0.612 . . . . 53.109999999999999 113.102 -178.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 708' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -149.52 152.61 35.85 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 120.925 0.393 . . . . 63.509999999999998 111.473 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 709' ' ' VAL . . . . . 0.458 HG22 ' HB2' ' A' ' 717' ' ' TYR . 67.2 t -121.63 135.71 60.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 CA-C-N 116.498 -0.319 . . . . 61.539999999999999 111.608 -177.773 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 710' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -86.82 136.13 33.09 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.805 0.336 . . . . 74.519999999999996 110.824 173.174 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 711' ' ' THR . . . . . . . . . . . . . 68.3 p -106.4 4.04 28.03 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.124 0.488 . . . . 64.349999999999994 110.758 176.535 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 712' ' ' THR . . . . . 0.478 ' HA ' HG13 ' A' ' 679' ' ' VAL . 71.2 p -112.2 -11.76 13.72 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.91 -0.586 . . . . 72.25 112.255 -178.152 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 713' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -132.63 132.57 42.61 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.619 -0.264 . . . . 72.409999999999997 110.711 -178.117 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 714' ' ' ALA . . . . . 0.471 ' HB2' HG23 ' A' ' 741' ' ' VAL . . . -70.38 141.78 52.16 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 112.244 0.461 . . . . 74.319999999999993 112.244 -178.429 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 152.56 170.38 18.93 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 121.072 -0.585 . . . . 61.200000000000003 113.452 179.272 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 716' ' ' THR . . . . . . . . . . . . . 91.8 m -93.5 130.47 39.33 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 120.961 0.41 . . . . 55.229999999999997 111.668 177.587 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 717' ' ' TYR . . . . . 0.458 ' HB2' HG22 ' A' ' 709' ' ' VAL . 45.2 m-85 -128.16 139.74 52.31 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 122.763 0.425 . . . . 73.510000000000005 110.398 179.693 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 718' ' ' VAL . . . . . . . . . . . . . 45.3 t -105.86 140.59 23.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 N-CA-C 112.316 0.488 . . . . 74.219999999999999 112.316 -175.137 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 719' ' ' LEU . . . . . 0.418 HD21 HG23 ' A' ' 709' ' ' VAL . 85.3 mt -128.22 139.33 52.51 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 116.126 -0.488 . . . . 73.319999999999993 111.536 178.742 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 720' ' ' THR . . . . . 0.46 ' HB ' ' HB3' ' A' ' 706' ' ' ASP . 96.5 m -120.51 139.26 53.16 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 120.814 0.34 . . . . 64.340000000000003 111.218 178.003 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 721' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -128.13 126.77 41.75 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 116.676 -0.238 . . . . 74.400000000000006 110.825 -178.813 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 85.0 m -132.13 135.09 46.15 Favored 'General case' 0 N--CA 1.475 0.818 0 O-C-N 122.416 -0.178 . . . . 74.099999999999994 111.476 -178.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 723' ' ' VAL . . . . . 0.447 ' HB ' HG12 ' A' ' 703' ' ' ILE . 7.5 p -130.45 137.64 55.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-O 121.032 0.444 . . . . 74.340000000000003 111.529 179.771 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 24.1 m -106.56 127.91 53.7 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.129 0.418 . . . . 72.230000000000004 112.129 -177.306 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 725' ' ' ASP . . . . . 0.488 ' HB2' ' HD3' ' A' ' 667' ' ' PRO . 1.1 t70 -81.59 150.95 27.91 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 122.945 0.498 . . . . 73.010000000000005 111.569 176.373 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 726' ' ' SER . . . . . . . . . . . . . 48.9 m -58.24 -34.08 70.05 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 112.57 0.581 . . . . 72.010000000000005 112.57 -176.087 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 727' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -85.76 -8.54 58.08 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 112.501 0.556 . . . . 72.230000000000004 112.501 -178.615 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 728' ' ' GLY . . . . . . . . . . . . . . . 113.1 14.3 10.09 Favored Glycine 0 CA--C 1.535 1.294 0 N-CA-C 115.255 0.862 . . . . 74.310000000000002 115.255 175.443 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 729' ' ' HIS . . . . . 0.419 ' O ' ' HB3' ' A' ' 725' ' ' ASP . 13.5 m80 -89.79 108.51 19.74 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 117.908 0.854 . . . . 74.319999999999993 111.229 172.518 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 730' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -108.17 113.88 27.35 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 120.811 0.338 . . . . 72.329999999999998 111.292 -178.554 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 731' ' ' VAL . . . . . 0.446 HG22 ' HG2' ' A' ' 667' ' ' PRO . 17.8 m -112.45 159.15 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 CA-C-O 120.624 0.249 . . . . 63.009999999999998 111.517 -177.675 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 8.8 t -147.14 151.94 37.62 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 112.746 0.647 . . . . 55.409999999999997 112.746 -177.311 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -148.25 161.34 41.69 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.933 -0.576 . . . . 74.549999999999997 110.424 178.398 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 734' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -130.64 159.59 36.74 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 112.901 0.704 . . . . 72.310000000000002 112.901 -175.547 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 735' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -134.03 128.41 34.27 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.581 -0.736 . . . . 72.340000000000003 111.075 178.788 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 736' ' ' THR . . . . . . . . . . . . . 74.3 m -99.52 107.41 19.58 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 120.918 0.39 . . . . 54.219999999999999 111.108 175.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 47.4 t -97.04 141.11 16.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-O 120.71 0.291 . . . . 72.239999999999995 111.414 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 738' ' ' THR . . . . . . . . . . . . . 85.9 m -131.32 120.91 23.82 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 122.093 -0.379 . . . . 71.430000000000007 110.917 177.205 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 739' ' ' VAL . . . . . . . . . . . . . 38.4 t -101.18 133.6 43.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 N-CA-C 111.831 0.308 . . . . 62.549999999999997 111.831 -177.321 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 740' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -120.89 149.93 41.85 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 120.811 0.339 . . . . 70.239999999999995 111.509 177.158 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 741' ' ' VAL . . . . . 0.471 HG23 ' HB2' ' A' ' 714' ' ' ALA . 21.2 t -84.68 162.2 3.02 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 O-C-N 122.277 -0.264 . . . . 53.340000000000003 110.72 176.803 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 742' ' ' ARG . . . . . 0.436 ' N ' HG12 ' A' ' 741' ' ' VAL . 5.4 mpt_? -61.17 161.78 8.3 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.235 0.541 . . . . 74.140000000000001 111.455 175.051 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 743' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -66.92 90.19 0.18 Allowed 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.011 0.434 . . . . 70.310000000000002 111.837 178.577 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 744' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -72.02 101.18 2.66 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.106 0.479 . . . . 64.129999999999995 110.651 174.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 73.1 t -68.99 127.98 31.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-N 116.295 -0.411 . . . . 60.32 111.074 179.562 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 746' ' ' LYS . . . . . 0.429 ' O ' ' HG3' ' A' ' 746' ' ' LYS . 52.7 pttt -68.95 95.48 0.7 Allowed 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 121.516 0.674 . . . . 72.219999999999999 111.61 179.614 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 747' ' ' ASN . . . . . . . . . . . . . 13.4 p30 -76.74 -159.46 0.12 Allowed 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.086 -0.506 . . . . 63.039999999999999 110.981 175.616 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -54.44 91.58 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 112.861 0.689 . . . . 55.310000000000002 112.861 -178.765 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 749' ' ' LYS . . . . . 0.424 ' HB2' ' HE3' ' A' ' 749' ' ' LYS . 38.1 ttmt 53.41 84.1 0.22 Allowed Pre-proline 0 CA--C 1.545 0.787 0 N-CA-C 112.974 0.731 . . . . 61.509999999999998 112.974 174.2 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 750' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -68.18 110.6 2.25 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 122.482 2.121 . . . . 64.340000000000003 111.822 172.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 751' ' ' ILE . . . . . . . . . . . . . 60.5 mt -76.47 132.97 31.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-O 121.003 0.43 . . . . 62.229999999999997 111.788 -177.506 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 752' ' ' LEU . . . . . . . . . . . . . 1.9 pp -143.18 171.47 14.04 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 116.25 -0.432 . . . . 73.310000000000002 111.902 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 753' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 . . . . . 0 N--CA 1.47 0.542 0 CA-C-O 121.102 0.477 . . . . 72.239999999999995 111.401 179.685 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 762' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 664' ' ' ASP . . . . . . . . . . . . . 10.6 t70 . . . . . 0 N--CA 1.468 0.432 0 CA-C-O 121.098 0.475 . . . . 52.200000000000003 111.022 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 665' ' ' LEU . . . . . . . . . . . . . 86.0 mt -80.77 136.52 36.15 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.033 -0.53 . . . . 75.549999999999997 110.448 174.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 666' ' ' GLU . . . . . 0.473 ' H ' ' CD ' ' A' ' 666' ' ' GLU . 2.3 pm0 -70.25 140.67 88.02 Favored Pre-proline 0 CA--C 1.538 0.486 0 CA-C-N 116.322 -0.399 . . . . 73.530000000000001 110.575 177.311 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 667' ' ' PRO . . . . . 0.534 ' HB3' HD12 ' A' ' 699' ' ' LEU . 19.1 Cg_endo -56.64 135.94 73.27 Favored 'Trans proline' 0 CA--C 1.537 0.668 0 C-N-CA 122.7 2.267 . . . . 61.350000000000001 113.593 -171.167 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 668' ' ' LYS . . . . . . . . . . . . . 27.4 tptp -82.8 105.09 13.53 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.048 -0.524 . . . . 73.209999999999994 110.527 176.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 669' ' ' LEU . . . . . 0.421 ' HG ' HG23 ' A' ' 671' ' ' VAL . 56.8 tp -91.65 128.38 37.46 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.957 -0.565 . . . . 55.420000000000002 110.045 175.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 670' ' ' THR . . . . . . . . . . . . . 89.5 m -113.93 110.78 20.62 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.122 0.487 . . . . 43.340000000000003 111.151 178.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 671' ' ' VAL . . . . . 0.503 HG22 HG13 ' A' ' 689' ' ' VAL . 97.8 t -135.09 131.98 20.02 Favored Pre-proline 0 CA--C 1.54 0.586 0 CA-C-N 115.63 -0.713 . . . . 62.109999999999999 110.759 -177.303 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 672' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -73.62 121.76 7.32 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 122.239 1.959 . . . . 72.150000000000006 111.997 176.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 673' ' ' VAL . . . . . . . . . . . . . 14.7 p -64.15 -26.51 40.62 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 N-CA-C 112.286 0.476 . . . . 54.539999999999999 112.286 -175.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 674' ' ' GLY . . . . . . . . . . . . . . . -148.94 139.35 7.46 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 120.864 -0.684 . . . . 55.399999999999999 113.653 -179.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 675' ' ' ALA . . . . . . . . . . . . . . . -137.29 151.48 48.71 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 122.799 0.44 . . . . 62.409999999999997 110.937 178.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 676' ' ' THR . . . . . . . . . . . . . 88.4 m -138.84 119.16 13.67 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 122.155 -0.341 . . . . 71.400000000000006 111.48 179.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 677' ' ' ILE . . . . . . . . . . . . . 33.6 pt -131.04 176.55 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 CA-C-O 120.91 0.386 . . . . 72.340000000000003 111.323 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 678' ' ' HIS . . . . . 0.405 ' CD2' ' HG3' ' A' ' 740' ' ' LYS . 60.4 m80 -109.22 163.71 13.11 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.337 0.589 . . . . 54.240000000000002 112.502 -178.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 679' ' ' VAL . . . . . . . . . . . . . 91.4 t -63.55 115.77 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-N 115.753 -0.658 . . . . 71.299999999999997 111.031 174.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 99.74 0.52 56.43 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 121.472 -0.394 . . . . 35.109999999999999 112.935 -177.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 681' ' ' ASP . . . . . . . . . . . . . 35.3 t0 -88.8 157.48 18.47 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-O 121.17 0.509 . . . . 72.340000000000003 111.759 -178.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 682' ' ' SER . . . . . . . . . . . . . 91.3 p -82.37 144.84 30.25 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 116.099 -0.5 . . . . 53.009999999999998 112.0 -177.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 683' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -148.58 114.16 5.64 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 116.605 -0.27 . . . . 71.340000000000003 111.016 177.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 684' ' ' VAL . . . . . . . . . . . . . 58.0 t -116.19 99.82 52.99 Favored Pre-proline 0 CA--C 1.545 0.764 0 CA-C-O 120.689 0.28 . . . . 54.240000000000002 111.653 -179.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -59.89 -37.18 87.56 Favored 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 122.928 2.419 . . . . 74.010000000000005 113.7 -177.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 686' ' ' MET . . . . . 0.409 ' HA ' ' CE ' ' A' ' 686' ' ' MET . 1.1 mmt -79.09 -2.91 42.79 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 112.634 0.605 . . . . 75.140000000000001 112.634 -177.243 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 687' ' ' ALA . . . . . . . . . . . . . . . -97.25 -32.18 12.05 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 120.918 0.39 . . . . 63.130000000000003 111.657 176.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 688' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -98.4 -2.57 38.86 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 112.471 0.545 . . . . 64.530000000000001 112.471 -175.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 689' ' ' VAL . . . . . 0.503 HG13 HG22 ' A' ' 671' ' ' VAL . 95.1 t -123.31 124.83 70.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-O 120.832 0.348 . . . . 71.120000000000005 111.643 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 690' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -123.92 162.31 23.62 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 116.432 -0.349 . . . . 63.109999999999999 111.41 -179.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 691' ' ' ALA . . . . . . . . . . . . . . . -149.35 121.57 8.37 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 120.788 0.327 . . . . 53.299999999999997 111.271 175.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 692' ' ' ILE . . . . . . . . . . . . . 35.3 mm -127.56 130.03 70.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 N-CA-C 112.285 0.476 . . . . 72.140000000000001 112.285 -175.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -115.82 145.26 42.99 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 120.866 0.365 . . . . 72.549999999999997 110.161 172.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 694' ' ' LYS . . . . . 0.466 ' NZ ' ' HB2' ' A' ' 694' ' ' LYS . 2.1 ttmp? -72.57 -45.55 58.65 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 112.125 0.416 . . . . 64.349999999999994 112.125 -178.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 32.2 mp0 -83.48 -49.43 9.28 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.245 -0.434 . . . . 75.430000000000007 112.166 -172.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 696' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -82.95 -33.51 26.72 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 120.869 0.366 . . . . 75.319999999999993 111.229 -175.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . 116.01 -150.61 18.59 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 121.174 -0.536 . . . . 71.340000000000003 113.407 176.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -70.65 118.94 14.08 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 120.87 0.367 . . . . 74.329999999999998 110.976 179.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 699' ' ' LEU . . . . . 0.534 HD12 ' HB3' ' A' ' 667' ' ' PRO . 24.3 mt -109.19 13.38 24.45 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 111.709 0.263 . . . . 71.450000000000003 111.709 -178.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 25.3 m -57.33 -38.95 74.88 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 121.071 0.462 . . . . 62.340000000000003 111.635 -178.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 701' ' ' SER . . . . . . . . . . . . . 35.3 m -66.63 -23.98 66.24 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.01 0.433 . . . . 74.099999999999994 111.65 178.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 702' ' ' LYS . . . . . 0.464 ' HD2' HD22 ' A' ' 699' ' ' LEU . 94.9 mttt -84.82 -6.42 59.35 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 112.156 0.428 . . . . 72.450000000000003 112.156 -176.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 703' ' ' ILE . . . . . 0.439 HD13 HG12 ' A' ' 689' ' ' VAL . 69.7 mt -63.57 123.2 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-O 121.213 0.53 . . . . 73.519999999999996 112.168 -178.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 704' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? -88.77 117.93 28.1 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.029 -0.532 . . . . 75.239999999999995 110.197 176.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 54.1 t -103.14 105.93 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-O 120.926 0.393 . . . . 74.040000000000006 111.512 -176.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 706' ' ' ASP . . . . . 0.479 ' HB3' ' HB ' ' A' ' 720' ' ' THR . 18.6 t70 -108.25 148.03 30.56 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 120.893 0.378 . . . . 65.409999999999997 111.411 -178.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 99.91 179.13 30.52 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 121.176 -0.535 . . . . 64.209999999999994 112.77 -177.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 708' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -150.33 133.78 16.46 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 122.393 -0.475 . . . . 63.409999999999997 112.166 -178.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 709' ' ' VAL . . . . . 0.517 HG22 ' HB2' ' A' ' 717' ' ' TYR . 93.7 t -111.37 120.82 62.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 CA-C-N 116.135 -0.484 . . . . 63.119999999999997 111.085 176.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 710' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -99.39 139.34 35.19 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 120.783 0.325 . . . . 65.349999999999994 111.053 177.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 711' ' ' THR . . . . . . . . . . . . . 75.8 p -111.36 13.4 21.59 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 112.476 0.547 . . . . 52.229999999999997 112.476 -179.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 712' ' ' THR . . . . . . . . . . . . . 71.3 p -102.57 -26.63 13.15 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-O 121.321 0.581 . . . . 72.010000000000005 111.253 175.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 713' ' ' LYS . . . . . 0.533 ' HB2' ' HZ3' ' A' ' 713' ' ' LYS . 0.1 OUTLIER -116.54 135.9 53.43 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 115.869 -0.605 . . . . 64.510000000000005 110.786 178.156 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 714' ' ' ALA . . . . . . . . . . . . . . . -74.89 137.56 41.82 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.485 -0.325 . . . . 32.530000000000001 111.595 179.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 160.71 -179.7 36.02 Favored Glycine 0 CA--C 1.523 0.567 0 C-N-CA 120.973 -0.632 . . . . 55.240000000000002 113.242 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 716' ' ' THR . . . . . . . . . . . . . 84.3 m -103.36 130.75 50.74 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.097 0.475 . . . . 75.150000000000006 111.619 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 717' ' ' TYR . . . . . 0.517 ' HB2' HG22 ' A' ' 709' ' ' VAL . 18.5 m-85 -129.12 125.1 36.38 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 116.061 -0.518 . . . . 71.420000000000002 110.154 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 718' ' ' VAL . . . . . . . . . . . . . 61.8 t -102.41 121.8 53.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-O 121.126 0.489 . . . . 72.510000000000005 112.189 -176.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 719' ' ' LEU . . . . . 0.499 HD21 HG23 ' A' ' 709' ' ' VAL . 95.4 mt -99.94 144.45 28.98 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.454 -0.339 . . . . 64.450000000000003 111.534 178.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 720' ' ' THR . . . . . 0.479 ' HB ' ' HB3' ' A' ' 706' ' ' ASP . 64.2 m -113.48 134.33 54.73 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.832 0.349 . . . . 64.540000000000006 111.164 178.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 721' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -125.32 114.36 18.81 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.563 -0.29 . . . . 74.230000000000004 110.89 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 60.6 m -121.54 127.1 50.62 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 120.637 0.256 . . . . 54.210000000000001 111.372 -179.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 11.1 p -129.44 137.55 56.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-O 121.047 0.451 . . . . 75.019999999999996 111.625 -179.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 23.7 m -119.92 134.87 55.1 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.049 0.452 . . . . 74.019999999999996 112.071 -177.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -82.8 149.11 27.39 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 115.956 -0.565 . . . . 72.219999999999999 110.028 173.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 726' ' ' SER . . . . . . . . . . . . . 38.3 t -66.84 -20.39 65.92 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.058 0.456 . . . . 43.399999999999999 110.915 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 727' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -81.9 -4.03 55.6 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 115.893 -0.594 . . . . 75.409999999999997 111.971 178.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 728' ' ' GLY . . . . . . . . . . . . . . . 108.2 -5.68 34.01 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 115.023 0.769 . . . . 43.240000000000002 115.023 173.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 36.1 m80 -84.28 122.61 29.14 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 117.848 0.824 . . . . 64.340000000000003 111.402 178.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 730' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -121.52 132.43 54.7 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 120.868 0.365 . . . . 71.109999999999999 111.707 -178.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 27.4 m -131.15 149.9 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-O 120.82 0.343 . . . . 72.219999999999999 111.374 177.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 7.2 t -144.36 147.64 33.69 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 121.088 0.47 . . . . 63.130000000000003 112.264 -178.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -148.99 161.38 42.03 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 116.083 -0.508 . . . . 52.530000000000001 110.927 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 734' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -121.95 160.29 25.16 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 112.567 0.58 . . . . 74.140000000000001 112.567 -178.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 735' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -129.37 122.13 28.83 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.554 -0.748 . . . . 71.340000000000003 110.464 179.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 736' ' ' THR . . . . . . . . . . . . . 20.9 m -94.11 103.4 15.46 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.629 0.252 . . . . 74.549999999999997 111.262 -179.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 43.2 t -96.85 133.49 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-O 120.724 0.297 . . . . 72.019999999999996 111.316 -179.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 738' ' ' THR . . . . . . . . . . . . . 93.8 m -121.29 112.38 18.53 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.05 0.452 . . . . 72.219999999999999 110.875 177.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 739' ' ' VAL . . . . . . . . . . . . . 54.4 t -93.16 133.58 33.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-N 116.167 -0.469 . . . . 51.140000000000001 110.941 178.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 740' ' ' LYS . . . . . 0.405 ' HG3' ' CD2' ' A' ' 678' ' ' HIS . 21.0 ptmt -127.74 162.16 27.25 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 120.844 0.354 . . . . 63.119999999999997 111.62 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 741' ' ' VAL . . . . . . . . . . . . . 5.7 t . . . . . 0 CA--C 1.541 0.601 0 CA-C-O 120.974 0.416 . . . . 65.549999999999997 111.245 -176.42 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 664' ' ' ASP . . . . . . . . . . . . . 7.1 t70 . . . . . 0 N--CA 1.468 0.459 0 CA-C-O 120.85 0.357 . . . . 65.540000000000006 110.788 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 665' ' ' LEU . . . . . 0.535 HD12 ' HD3' ' A' ' 694' ' ' LYS . 78.3 mt -95.4 137.69 34.11 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 121.097 0.475 . . . . 73.420000000000002 110.673 174.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 666' ' ' GLU . . . . . 0.41 ' HB2' ' HD2' ' A' ' 667' ' ' PRO . 9.6 pt-20 -70.52 152.95 95.3 Favored Pre-proline 0 CA--C 1.541 0.631 0 CA-C-N 115.941 -0.572 . . . . 71.209999999999994 111.887 -177.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 667' ' ' PRO . . . . . 0.527 ' HD3' ' HB2' ' A' ' 725' ' ' ASP . 52.5 Cg_endo -67.3 138.81 47.9 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.843 2.362 . . . . 75.109999999999999 114.428 -170.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 668' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -83.27 102.18 11.78 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.678 -0.692 . . . . 61.039999999999999 110.269 175.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 669' ' ' LEU . . . . . 0.529 ' HG ' HG23 ' A' ' 671' ' ' VAL . 65.3 tp -89.14 114.05 25.29 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.371 -0.377 . . . . 74.019999999999996 111.069 -177.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 670' ' ' THR . . . . . . . . . . . . . 41.5 m -89.57 110.47 21.32 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.859 0.362 . . . . 72.329999999999998 110.931 -179.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 671' ' ' VAL . . . . . 0.529 HG23 ' HG ' ' A' ' 669' ' ' LEU . 96.4 t -135.89 123.97 15.2 Favored Pre-proline 0 N--CA 1.468 0.455 0 CA-C-N 116.379 -0.373 . . . . 20.329999999999998 110.968 -178.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 672' ' ' PRO . . . . . 0.401 ' HG2' ' OE1' ' A' ' 735' ' ' GLN . 53.2 Cg_endo -70.75 137.43 32.57 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 122.172 1.915 . . . . 75.349999999999994 112.223 178.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 673' ' ' VAL . . . . . . . . . . . . . 12.2 p -64.31 -36.72 77.97 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 N-CA-C 112.012 0.375 . . . . 72.109999999999999 112.012 -177.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 674' ' ' GLY . . . . . . . . . . . . . . . -154.83 154.86 25.82 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 121.025 -0.607 . . . . 74.030000000000001 113.435 -178.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 675' ' ' ALA . . . . . . . . . . . . . . . -150.63 143.61 24.71 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 122.669 0.387 . . . . 71.420000000000002 110.839 178.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 676' ' ' THR . . . . . . . . . . . . . 90.3 m -119.46 121.33 39.22 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 120.936 0.398 . . . . 72.5 111.833 -178.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 677' ' ' ILE . . . . . . . . . . . . . 33.9 pt -126.68 176.98 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-N 116.209 -0.451 . . . . 72.439999999999998 110.457 175.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 678' ' ' HIS . . . . . 0.478 ' HA ' ' O ' ' A' ' 740' ' ' LYS . 46.7 m80 -123.09 159.38 28.63 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 112.583 0.586 . . . . 72.450000000000003 112.583 -177.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 679' ' ' VAL . . . . . . . . . . . . . 84.2 t -59.6 112.15 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-N 115.814 -0.63 . . . . 74.140000000000001 110.556 172.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 115.12 -20.22 14.43 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 121.423 -0.417 . . . . 60.25 112.708 -174.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 681' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -78.01 -165.09 0.6 Allowed 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 121.227 0.537 . . . . 64.310000000000002 111.433 178.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 682' ' ' SER . . . . . . . . . . . . . 21.4 p -142.75 155.54 44.87 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.966 0.412 . . . . 71.239999999999995 111.557 179.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 683' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -143.4 135.86 27.22 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.383 -0.371 . . . . 62.039999999999999 110.577 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 684' ' ' VAL . . . . . . . . . . . . . 25.1 t -124.75 95.64 42.14 Favored Pre-proline 0 CA--C 1.544 0.737 0 CA-C-O 120.931 0.396 . . . . 72.239999999999995 111.848 -175.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -62.87 -31.1 77.86 Favored 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 122.687 2.258 . . . . 75.019999999999996 113.719 -177.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 686' ' ' MET . . . . . 0.449 ' HE1' ' HB ' ' A' ' 703' ' ' ILE . 1.7 mmt -81.51 0.36 38.37 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.32 0.489 . . . . 74.230000000000004 112.32 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 687' ' ' ALA . . . . . . . . . . . . . . . -120.55 -42.62 2.53 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 120.863 0.363 . . . . 74.299999999999997 111.972 179.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 688' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -79.88 2.7 22.29 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-O 120.954 0.407 . . . . 75.120000000000005 111.871 -179.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 689' ' ' VAL . . . . . 0.42 HG21 ' CZ ' ' A' ' 721' ' ' TYR . 64.7 t -124.53 151.97 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 122.996 0.519 . . . . 75.530000000000001 110.415 175.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 690' ' ' LEU . . . . . 0.679 HD21 HG12 ' A' ' 692' ' ' ILE . 8.8 tt -145.12 152.31 39.85 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 120.567 0.222 . . . . 63.409999999999997 111.427 -174.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 691' ' ' ALA . . . . . . . . . . . . . . . -146.43 126.64 13.86 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 122.341 -0.224 . . . . 51.030000000000001 111.502 177.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 692' ' ' ILE . . . . . 0.679 HG12 HD21 ' A' ' 690' ' ' LEU . 41.1 mm -129.66 132.72 65.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 CA-C-O 121.207 0.527 . . . . 70.420000000000002 112.317 -178.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 693' ' ' ASP . . . . . 0.472 ' HB2' HD11 ' A' ' 699' ' ' LEU . 25.6 t70 -114.72 145.23 42.3 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.031 -0.532 . . . . 73.430000000000007 109.832 172.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 694' ' ' LYS . . . . . 0.535 ' HD3' HD12 ' A' ' 665' ' ' LEU . 50.8 mtpt -71.1 -39.19 72.24 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.814 0.34 . . . . 71.25 111.854 -177.342 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 35.2 mp0 -83.15 -54.02 5.35 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 112.054 0.39 . . . . 63.219999999999999 112.054 -175.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 696' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -76.35 -48.74 18.89 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 122.149 -0.345 . . . . 73.439999999999998 111.598 -177.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . 124.2 -131.56 7.98 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 121.279 -0.486 . . . . 75.450000000000003 113.052 -179.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -75.63 119.67 19.99 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 122.442 -0.446 . . . . 55.439999999999998 111.273 -179.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 699' ' ' LEU . . . . . 0.608 HD22 ' HD2' ' A' ' 702' ' ' LYS . 35.5 mt -111.44 11.21 21.44 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.397 -0.365 . . . . 62.140000000000001 111.3 178.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 33.8 m -59.74 -36.07 75.86 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.302 0.572 . . . . 75.430000000000007 111.551 -177.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 701' ' ' SER . . . . . . . . . . . . . 49.4 m -76.22 -14.49 60.14 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 116.282 -0.417 . . . . 72.340000000000003 111.85 177.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 702' ' ' LYS . . . . . 0.608 ' HD2' HD22 ' A' ' 699' ' ' LEU . 96.5 mttt -97.67 11.59 36.55 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.177 0.436 . . . . 74.109999999999999 112.177 -177.216 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 703' ' ' ILE . . . . . 0.449 ' HB ' ' HE1' ' A' ' 686' ' ' MET . 67.7 mt -83.76 118.76 31.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-O 120.873 0.368 . . . . 62.509999999999998 111.766 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 704' ' ' LYS . . . . . . . . . . . . . 4.9 tppp? -84.99 125.89 33.08 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 110.168 -0.308 . . . . 71.340000000000003 110.168 174.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 49.0 t -105.88 117.39 51.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 CA-C-O 121.004 0.43 . . . . 55.229999999999997 112.013 -176.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 706' ' ' ASP . . . . . 0.594 ' HB3' ' HB ' ' A' ' 720' ' ' THR . 12.8 t70 -100.32 141.2 33.5 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.294 -0.412 . . . . 61.340000000000003 111.03 175.183 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 102.35 177.74 27.46 Favored Glycine 0 CA--C 1.523 0.54 0 C-N-CA 121.201 -0.523 . . . . 72.439999999999998 112.97 -179.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 708' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -152.48 130.48 11.82 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 120.863 0.363 . . . . 74.439999999999998 111.491 -177.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 709' ' ' VAL . . . . . 0.546 HG22 ' HB2' ' A' ' 717' ' ' TYR . 96.3 t -107.93 114.6 46.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 116.494 -0.321 . . . . 64.030000000000001 110.655 176.483 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 710' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -95.39 143.65 26.56 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 120.905 0.383 . . . . 65.040000000000006 111.039 177.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 711' ' ' THR . . . . . . . . . . . . . 75.6 p -108.08 6.54 27.04 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.666 0.617 . . . . 75.140000000000001 112.666 -176.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 712' ' ' THR . . . . . . . . . . . . . 64.1 p -101.37 -24.24 14.23 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 121.157 0.503 . . . . 64.239999999999995 111.145 175.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 713' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -116.17 122.42 44.99 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 116.294 -0.412 . . . . 63.350000000000001 110.95 178.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 714' ' ' ALA . . . . . . . . . . . . . . . -69.42 143.99 53.47 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 120.982 0.42 . . . . 64.200000000000003 111.796 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 155.77 168.92 19.48 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-N 116.255 -0.43 . . . . 64.439999999999998 112.826 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 716' ' ' THR . . . . . . . . . . . . . 99.2 m -97.71 123.07 41.48 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 122.51 -0.406 . . . . 73.420000000000002 111.812 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 717' ' ' TYR . . . . . 0.546 ' HB2' HG22 ' A' ' 709' ' ' VAL . 40.7 m-85 -115.83 125.9 53.29 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 116.2 -0.455 . . . . 74.519999999999996 110.78 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 718' ' ' VAL . . . . . . . . . . . . . 56.1 t -96.25 118.55 42.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 120.901 0.381 . . . . 60.109999999999999 111.452 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 719' ' ' LEU . . . . . . . . . . . . . 76.6 mt -103.12 135.31 45.02 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.78 0.324 . . . . 63.030000000000001 111.611 -179.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 720' ' ' THR . . . . . 0.594 ' HB ' ' HB3' ' A' ' 706' ' ' ASP . 32.9 m -103.27 131.98 49.89 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 120.943 0.401 . . . . 74.439999999999998 110.895 176.545 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 721' ' ' TYR . . . . . 0.42 ' CZ ' HG21 ' A' ' 689' ' ' VAL . 77.8 m-85 -118.34 117.73 29.88 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.471 -0.331 . . . . 74.510000000000005 110.926 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 87.3 m -120.72 126.83 51.17 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.626 -0.261 . . . . 60.450000000000003 111.263 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 13.1 p -125.23 142.18 42.87 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-O 120.869 0.366 . . . . 75.549999999999997 111.878 -177.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 26.7 m -110.23 133.6 53.07 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.144 0.497 . . . . 65.140000000000001 112.181 -176.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 725' ' ' ASP . . . . . 0.527 ' HB2' ' HD3' ' A' ' 667' ' ' PRO . 14.0 t0 -91.59 151.57 20.66 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 115.912 -0.586 . . . . 72.0 111.049 178.08 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 726' ' ' SER . . . . . . . . . . . . . 38.6 t -59.46 -29.7 68.0 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.403 0.52 . . . . 64.140000000000001 112.403 -175.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 727' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -91.63 7.35 41.96 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 112.313 0.486 . . . . 75.25 112.313 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 728' ' ' GLY . . . . . . . . . . . . . . . 100.2 8.37 50.47 Favored Glycine 0 CA--C 1.534 1.237 0 N-CA-C 115.294 0.878 . . . . 71.5 115.294 173.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 37.6 m80 -86.67 115.11 23.91 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 117.865 0.833 . . . . 74.310000000000002 111.094 177.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 730' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -120.25 117.09 26.92 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 122.133 -0.355 . . . . 73.519999999999996 111.717 -177.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 35.7 m -117.83 157.76 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-O 120.727 0.299 . . . . 61.130000000000003 111.762 -177.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 8.6 t -142.56 144.37 32.86 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.682 0.623 . . . . 72.510000000000005 112.682 -177.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -146.68 159.45 43.46 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.024 -0.534 . . . . 61.020000000000003 111.059 178.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 734' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -118.1 155.54 30.21 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 113.009 0.744 . . . . 62.329999999999998 113.009 -176.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 735' ' ' GLN . . . . . 0.401 ' OE1' ' HG2' ' A' ' 672' ' ' PRO . 6.4 tt0 -129.79 135.48 48.47 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 115.703 -0.681 . . . . 73.040000000000006 110.558 177.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 736' ' ' THR . . . . . . . . . . . . . 90.1 m -95.15 104.35 16.23 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 120.675 0.274 . . . . 71.439999999999998 111.39 178.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 46.5 t -100.07 104.5 16.21 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 CA-C-O 120.772 0.32 . . . . 73.540000000000006 111.295 179.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 738' ' ' THR . . . . . . . . . . . . . 44.6 m -94.54 117.4 30.06 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.119 0.485 . . . . 71.319999999999993 111.471 179.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 739' ' ' VAL . . . . . . . . . . . . . 43.6 t -98.28 117.95 44.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-O 121.113 0.482 . . . . 74.219999999999999 111.584 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 740' ' ' LYS . . . . . 0.478 ' O ' ' HA ' ' A' ' 678' ' ' HIS . 96.1 mttt -102.93 176.05 5.28 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.265 -0.425 . . . . 73.120000000000005 110.492 174.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 741' ' ' VAL . . . . . . . . . . . . . 36.3 t . . . . . 0 N--CA 1.471 0.58 0 O-C-N 121.881 -0.512 . . . . 70.209999999999994 111.734 -178.359 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 664' ' ' ASP . . . . . . . . . . . . . 5.5 t70 . . . . . 0 CA--C 1.538 0.509 0 CA-C-O 120.895 0.378 . . . . 75.530000000000001 110.847 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 665' ' ' LEU . . . . . . . . . . . . . 76.6 mt -80.82 119.76 23.8 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.404 -0.362 . . . . 65.019999999999996 110.644 177.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 666' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -56.69 144.22 66.15 Favored Pre-proline 0 CA--C 1.537 0.472 0 C-N-CA 121.131 -0.228 . . . . 53.25 110.483 177.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 667' ' ' PRO . . . . . 0.545 ' HD3' ' HB2' ' A' ' 725' ' ' ASP . 18.8 Cg_endo -56.5 133.92 61.07 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.725 2.284 . . . . 70.409999999999997 112.736 -174.131 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 668' ' ' LYS . . . . . . . . . . . . . 52.2 tptt -82.71 110.66 17.96 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 120.942 0.401 . . . . 51.439999999999998 110.343 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 669' ' ' LEU . . . . . 0.521 ' HG ' HG23 ' A' ' 671' ' ' VAL . 55.8 tp -98.06 112.58 24.48 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 116.067 -0.515 . . . . 70.450000000000003 111.271 -177.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 670' ' ' THR . . . . . . . . . . . . . 85.8 m -87.75 110.62 20.6 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 120.856 0.36 . . . . 63.25 111.121 177.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 671' ' ' VAL . . . . . 0.521 HG23 ' HG ' ' A' ' 669' ' ' LEU . 81.0 t -136.34 129.68 17.85 Favored Pre-proline 0 N--CA 1.47 0.575 0 CA-C-N 116.211 -0.45 . . . . 71.549999999999997 110.803 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 672' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -77.9 141.48 19.11 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 122.193 1.929 . . . . 73.409999999999997 112.791 179.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 673' ' ' VAL . . . . . . . . . . . . . 10.6 p -66.27 -35.03 73.99 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 N-CA-C 112.007 0.373 . . . . 74.329999999999998 112.007 -177.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 674' ' ' GLY . . . . . . . . . . . . . . . -146.22 161.19 28.3 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 120.879 -0.676 . . . . 43.340000000000003 113.565 -177.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 675' ' ' ALA . . . . . . . . . . . . . . . -150.5 154.85 38.38 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 122.608 0.363 . . . . 72.319999999999993 110.928 -179.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 676' ' ' THR . . . . . . . . . . . . . 91.8 m -139.04 119.56 13.93 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 120.964 0.411 . . . . 74.019999999999996 111.791 178.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 677' ' ' ILE . . . . . . . . . . . . . 28.7 pt -131.28 175.22 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-N 116.459 -0.337 . . . . 74.400000000000006 110.678 176.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 678' ' ' HIS . . . . . 0.401 ' HA ' ' O ' ' A' ' 740' ' ' LYS . 75.5 m80 -119.49 164.79 15.27 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.305 0.574 . . . . 74.299999999999997 111.912 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 679' ' ' VAL . . . . . 0.445 HG23 ' HA ' ' A' ' 741' ' ' VAL . 78.3 t -56.68 137.01 19.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-N 115.891 -0.595 . . . . 73.049999999999997 110.504 172.06 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 93.03 -18.31 56.39 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 121.052 -0.594 . . . . 55.530000000000001 113.406 -179.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 681' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -79.52 -172.47 3.27 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 121.12 0.486 . . . . 51.020000000000003 111.548 178.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 682' ' ' SER . . . . . . . . . . . . . 69.0 m -141.77 145.72 35.1 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 116.435 -0.348 . . . . 74.200000000000003 111.06 177.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 683' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -118.7 134.18 55.32 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 116.453 -0.34 . . . . 61.509999999999998 110.46 178.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 684' ' ' VAL . . . . . 0.406 ' HA ' ' HD2' ' A' ' 685' ' ' PRO . 53.7 t -122.17 93.09 48.75 Favored Pre-proline 0 CA--C 1.54 0.573 0 CA-C-O 120.962 0.41 . . . . 60.299999999999997 111.429 -177.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 685' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 684' ' ' VAL . 28.6 Cg_endo -61.69 -27.76 81.52 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 122.83 2.353 . . . . 61.140000000000001 113.347 -177.382 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 686' ' ' MET . . . . . 0.488 ' HE1' ' HB ' ' A' ' 703' ' ' ILE . 1.9 mmt -78.91 -12.14 60.02 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 112.313 0.486 . . . . 73.109999999999999 112.313 -178.137 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 687' ' ' ALA . . . . . . . . . . . . . . . -109.02 -36.34 6.1 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.915 0.388 . . . . 52.409999999999997 111.539 178.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 688' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -85.92 -1.08 56.95 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 116.295 -0.411 . . . . 74.430000000000007 112.05 -178.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 689' ' ' VAL . . . . . 0.432 HG21 ' CZ ' ' A' ' 721' ' ' TYR . 74.5 t -125.57 150.81 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 122.59 0.356 . . . . 52.149999999999999 110.577 174.227 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 690' ' ' LEU . . . . . 0.485 HD21 HG12 ' A' ' 692' ' ' ILE . 9.6 tt -143.3 150.03 38.65 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-O 120.592 0.234 . . . . 73.430000000000007 111.537 -173.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 691' ' ' ALA . . . . . . . . . . . . . . . -147.3 125.35 12.08 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 112.19 0.441 . . . . 73.109999999999999 112.19 179.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 692' ' ' ILE . . . . . 0.538 HD13 ' HA ' ' A' ' 698' ' ' ASP . 43.6 mm -129.68 141.52 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 N-CA-C 111.803 0.297 . . . . 75.329999999999998 111.803 -178.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 693' ' ' ASP . . . . . 0.475 ' OD1' ' HG2' ' A' ' 695' ' ' GLU . 12.5 t70 -125.95 143.97 50.88 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 110.138 -0.319 . . . . 63.119999999999997 110.138 173.015 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 28.6 ttpp -64.79 -34.05 77.42 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 112.5 0.556 . . . . 53.219999999999999 112.5 -175.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 695' ' ' GLU . . . . . 0.475 ' HG2' ' OD1' ' A' ' 693' ' ' ASP . 9.5 pt-20 -81.89 -43.42 18.19 Favored 'General case' 0 N--CA 1.473 0.694 0 O-C-N 122.02 -0.425 . . . . 72.329999999999998 111.976 -175.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 696' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -94.85 -42.44 8.7 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 120.883 0.373 . . . . 73.349999999999994 111.773 -172.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . 118.57 -115.68 3.18 Favored Glycine 0 CA--C 1.523 0.569 0 C-N-CA 121.14 -0.552 . . . . 62.200000000000003 112.291 -177.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 698' ' ' ASP . . . . . 0.538 ' HA ' HD13 ' A' ' 692' ' ' ILE . 16.1 t70 -88.62 119.98 29.59 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 122.195 -0.591 . . . . 63.049999999999997 111.247 178.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 699' ' ' LEU . . . . . 0.491 HD12 ' HB3' ' A' ' 667' ' ' PRO . 51.0 mt -111.97 18.45 18.79 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 116.364 -0.38 . . . . 74.0 111.603 177.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 37.1 m -58.36 -30.65 66.92 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.009 0.433 . . . . 74.439999999999998 111.105 178.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 701' ' ' SER . . . . . . . . . . . . . 29.7 t -68.15 -24.48 64.99 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 120.868 0.366 . . . . 74.420000000000002 111.971 175.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 702' ' ' LYS . . . . . 0.488 ' HB2' HG23 ' A' ' 723' ' ' VAL . 73.4 mmtt -77.4 -19.84 55.55 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 111.895 0.331 . . . . 70.450000000000003 111.895 -178.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 703' ' ' ILE . . . . . 0.488 ' HB ' ' HE1' ' A' ' 686' ' ' MET . 63.9 mt -60.74 112.76 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 N-CA-C 112.515 0.561 . . . . 75.219999999999999 112.515 -174.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 704' ' ' LYS . . . . . . . . . . . . . 8.1 tmtm? -87.04 120.08 27.93 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.017 -0.538 . . . . 65.340000000000003 109.729 172.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 50.3 t -95.71 118.06 41.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-O 121.113 0.482 . . . . 64.019999999999996 111.063 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 706' ' ' ASP . . . . . 0.539 ' HB3' ' HB ' ' A' ' 720' ' ' THR . 11.7 t70 -108.11 118.44 36.76 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.413 -0.358 . . . . 71.340000000000003 110.249 176.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 113.42 167.82 16.7 Favored Glycine 0 CA--C 1.524 0.643 0 C-N-CA 121.344 -0.455 . . . . 55.240000000000002 112.392 -176.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 708' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -155.04 138.56 15.96 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 122.316 -0.52 . . . . 71.409999999999997 111.843 -177.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 709' ' ' VAL . . . . . . . . . . . . . 72.5 t -99.59 127.87 51.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-N 116.341 -0.39 . . . . 62.140000000000001 111.352 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 710' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -96.15 137.09 35.72 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 120.732 0.301 . . . . 64.530000000000001 110.578 175.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 711' ' ' THR . . . . . . . . . . . . . 82.5 p -110.43 23.7 13.92 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 112.416 0.525 . . . . 75.040000000000006 112.416 -177.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 712' ' ' THR . . . . . . . . . . . . . 48.8 p -113.03 -26.46 8.47 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 121.015 0.436 . . . . 52.25 110.746 173.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 713' ' ' LYS . . . . . 0.57 ' HB2' ' HZ3' ' A' ' 713' ' ' LYS . 0.1 OUTLIER -116.72 130.96 57.04 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.001 -0.545 . . . . 73.519999999999996 110.53 175.318 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 714' ' ' ALA . . . . . . . . . . . . . . . -80.9 134.88 35.82 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.067 0.46 . . . . 44.32 112.182 -178.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 169.32 171.67 35.22 Favored Glycine 0 CA--C 1.523 0.58 0 CA-C-N 116.042 -0.526 . . . . 70.450000000000003 112.582 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 716' ' ' THR . . . . . . . . . . . . . 39.9 m -90.09 123.06 33.63 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.188 0.518 . . . . 74.230000000000004 111.568 177.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 717' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 -114.43 138.23 50.84 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 116.074 -0.512 . . . . 75.0 110.234 177.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 718' ' ' VAL . . . . . . . . . . . . . 62.0 t -103.65 116.62 47.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-O 120.929 0.395 . . . . 62.340000000000003 111.54 -178.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 719' ' ' LEU . . . . . . . . . . . . . 83.0 mt -102.13 129.16 48.4 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 116.348 -0.387 . . . . 74.450000000000003 111.286 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 720' ' ' THR . . . . . 0.539 ' HB ' ' HB3' ' A' ' 706' ' ' ASP . 92.7 m -106.55 134.9 48.98 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.839 0.352 . . . . 64.209999999999994 111.12 178.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 721' ' ' TYR . . . . . 0.432 ' CZ ' HG21 ' A' ' 689' ' ' VAL . 60.7 m-85 -123.41 120.81 34.07 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.54 -0.3 . . . . 72.129999999999995 110.795 -179.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 56.6 m -123.16 133.42 54.25 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 120.797 0.332 . . . . 60.399999999999999 111.4 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 723' ' ' VAL . . . . . 0.488 HG23 ' HB2' ' A' ' 702' ' ' LYS . 7.5 p -130.93 134.89 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-O 121.154 0.502 . . . . 71.340000000000003 111.788 -178.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 34.3 m -109.47 142.95 39.75 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.252 0.549 . . . . 55.229999999999997 111.625 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 725' ' ' ASP . . . . . 0.545 ' HB2' ' HD3' ' A' ' 667' ' ' PRO . 10.3 t70 -102.63 160.29 14.71 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 115.814 -0.63 . . . . 63.409999999999997 111.82 -178.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 726' ' ' SER . . . . . . . . . . . . . 48.9 m -61.52 -33.5 73.92 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.637 0.606 . . . . 72.099999999999994 112.637 -177.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 727' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -82.01 4.96 20.83 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 120.751 0.31 . . . . 65.519999999999996 111.447 177.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 728' ' ' GLY . . . . . . . . . . . . . . . 91.07 15.01 56.89 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 121.35 -0.452 . . . . 73.109999999999999 114.03 177.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 36.3 m80 -88.49 121.33 30.75 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 117.235 0.517 . . . . 74.340000000000003 111.111 178.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 730' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -124.78 122.29 37.01 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.792 0.33 . . . . 72.430000000000007 111.873 -176.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 31.9 m -121.94 159.3 24.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 116.423 -0.353 . . . . 51.549999999999997 111.029 177.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 10.3 t -143.33 154.82 44.15 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.839 0.352 . . . . 72.219999999999999 111.801 -178.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -148.5 161.35 41.81 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 122.631 0.372 . . . . 73.140000000000001 111.211 179.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 734' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -125.66 154.56 42.17 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 121.057 0.455 . . . . 64.310000000000002 112.108 -177.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 735' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -130.8 137.96 49.67 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.991 -0.549 . . . . 50.100000000000001 111.299 179.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 736' ' ' THR . . . . . . . . . . . . . 89.5 m -97.19 103.82 15.78 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.534 -0.303 . . . . 70.409999999999997 111.151 176.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 45.6 t -101.48 105.16 17.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-O 120.841 0.353 . . . . 74.329999999999998 111.649 -179.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 738' ' ' THR . . . . . . . . . . . . . 65.8 m -95.95 118.21 32.14 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.911 0.386 . . . . 52.210000000000001 111.493 179.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 739' ' ' VAL . . . . . . . . . . . . . 41.0 t -97.89 139.4 20.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-N 116.393 -0.367 . . . . 74.219999999999999 111.496 178.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 740' ' ' LYS . . . . . 0.401 ' O ' ' HA ' ' A' ' 678' ' ' HIS . 97.4 mttt -122.17 155.84 34.95 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 120.841 0.353 . . . . 54.240000000000002 110.711 176.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 741' ' ' VAL . . . . . 0.445 ' HA ' HG23 ' A' ' 679' ' ' VAL . 40.9 t . . . . . 0 N--CA 1.47 0.542 0 CA-C-O 121.04 0.448 . . . . 61.539999999999999 112.152 -175.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 664' ' ' ASP . . . . . . . . . . . . . 14.4 t70 . . . . . 0 N--CA 1.471 0.586 0 CA-C-O 120.871 0.367 . . . . 64.510000000000005 111.134 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 665' ' ' LEU . . . . . 0.441 HD12 ' HD3' ' A' ' 694' ' ' LYS . 89.4 mt -90.55 136.62 32.94 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 116.305 -0.407 . . . . 70.519999999999996 110.505 174.237 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 666' ' ' GLU . . . . . 0.479 ' HB3' ' HB3' ' A' ' 729' ' ' HIS . 2.3 pm0 -65.5 140.63 97.67 Favored Pre-proline 0 CA--C 1.543 0.701 0 CA-C-O 120.921 0.391 . . . . 73.400000000000006 111.543 177.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 667' ' ' PRO . . . . . 0.596 ' HD3' ' HB2' ' A' ' 725' ' ' ASP . 12.8 Cg_endo -55.36 145.85 65.16 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 123.378 2.719 . . . . 75.400000000000006 114.745 -169.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 668' ' ' LYS . . . . . . . . . . . . . 7.4 tmtm? -85.06 104.14 14.71 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.287 -0.87 . . . . 51.210000000000001 110.404 177.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 669' ' ' LEU . . . . . . . . . . . . . 57.5 tp -100.05 111.72 24.02 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 116.119 -0.491 . . . . 63.140000000000001 111.564 -177.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 670' ' ' THR . . . . . . . . . . . . . 86.2 m -89.11 111.53 22.31 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.9 0.381 . . . . 61.240000000000002 111.502 178.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 671' ' ' VAL . . . . . 0.43 HG22 HG13 ' A' ' 689' ' ' VAL . 90.6 t -134.0 129.16 19.95 Favored Pre-proline 0 N--CA 1.47 0.529 0 CA-C-N 116.194 -0.457 . . . . 72.519999999999996 110.807 176.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 672' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -74.29 128.88 12.45 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 122.161 1.907 . . . . 65.030000000000001 112.084 176.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 673' ' ' VAL . . . . . . . . . . . . . 9.6 p -64.6 -19.27 24.9 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 N-CA-C 112.423 0.527 . . . . 75.019999999999996 112.423 -175.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 674' ' ' GLY . . . . . . . . . . . . . . . -156.8 155.59 26.48 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 120.809 -0.71 . . . . 44.030000000000001 113.501 -179.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 675' ' ' ALA . . . . . 0.486 ' HB3' HG22 ' A' ' 737' ' ' VAL . . . -151.1 145.66 25.62 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 120.691 0.281 . . . . 74.519999999999996 111.148 178.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 676' ' ' THR . . . . . . . . . . . . . 88.9 m -120.65 124.79 46.09 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.031 0.443 . . . . 70.150000000000006 112.096 -179.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 677' ' ' ILE . . . . . . . . . . . . . 28.8 pt -135.4 177.24 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 CA-C-N 116.244 -0.435 . . . . 55.520000000000003 111.029 176.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 678' ' ' HIS . . . . . . . . . . . . . 65.8 m80 -124.46 168.07 13.56 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.295 0.569 . . . . 62.100000000000001 112.188 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 679' ' ' VAL . . . . . . . . . . . . . 85.5 t -63.31 111.55 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-N 115.777 -0.647 . . . . 51.140000000000001 109.871 170.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 107.59 -4.33 34.69 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 121.297 -0.478 . . . . 40.240000000000002 113.29 -175.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 681' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -86.18 170.93 11.7 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 121.223 0.535 . . . . 74.129999999999995 111.508 176.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 682' ' ' SER . . . . . . . . . . . . . 77.3 p -114.58 153.21 30.5 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 116.349 -0.387 . . . . 71.310000000000002 111.121 178.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 683' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -159.19 114.06 2.45 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 120.745 0.307 . . . . 71.409999999999997 111.453 -178.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 684' ' ' VAL . . . . . 0.44 ' HA ' ' HD2' ' A' ' 685' ' ' PRO . 84.0 t -105.47 103.98 45.72 Favored Pre-proline 0 CA--C 1.543 0.677 0 CA-C-N 116.551 -0.295 . . . . 65.200000000000003 110.982 176.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 685' ' ' PRO . . . . . 0.44 ' HD2' ' HA ' ' A' ' 684' ' ' VAL . 14.4 Cg_endo -57.12 -35.55 98.94 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 122.606 2.204 . . . . 74.209999999999994 113.484 -179.059 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 686' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -78.35 -6.19 54.4 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 112.314 0.487 . . . . 72.150000000000006 112.314 -179.224 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 687' ' ' ALA . . . . . . . . . . . . . . . -94.51 -27.42 15.98 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 121.039 0.447 . . . . 73.310000000000002 111.259 175.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 688' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -86.08 -9.99 55.73 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 116.158 -0.474 . . . . 53.119999999999997 111.753 -179.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 689' ' ' VAL . . . . . 0.435 HG12 HD13 ' A' ' 703' ' ' ILE . 95.5 t -118.63 133.93 63.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 CA-C-O 120.937 0.398 . . . . 74.400000000000006 111.613 -177.194 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 690' ' ' LEU . . . . . 0.556 HD23 ' N ' ' A' ' 691' ' ' ALA . 4.1 tt -141.73 136.68 31.02 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 116.188 -0.46 . . . . 63.140000000000001 110.138 -177.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 691' ' ' ALA . . . . . 0.556 ' N ' HD23 ' A' ' 690' ' ' LEU . . . -122.48 122.09 38.11 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.345 0.498 . . . . 71.299999999999997 112.345 -178.016 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 692' ' ' ILE . . . . . . . . . . . . . 45.0 mm -122.25 124.23 70.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-N 116.183 -0.462 . . . . 73.340000000000003 111.483 178.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -113.6 144.99 41.96 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.726 0.298 . . . . 65.230000000000004 110.294 173.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 694' ' ' LYS . . . . . 0.441 ' HD3' HD12 ' A' ' 665' ' ' LEU . 7.9 mtpm? -71.72 -43.08 66.5 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 112.105 0.409 . . . . 72.450000000000003 112.105 -175.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 44.7 mp0 -83.88 -54.35 4.94 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 121.144 0.497 . . . . 75.409999999999997 112.142 -178.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 696' ' ' ASP . . . . . . . . . . . . . 32.7 t0 -79.38 -28.62 41.92 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 116.083 -0.508 . . . . 51.200000000000003 112.133 -172.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . 105.64 -155.53 16.85 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 121.186 -0.53 . . . . 55.25 113.595 176.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -68.22 118.19 11.02 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 122.55 -0.383 . . . . 53.240000000000002 110.48 176.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 699' ' ' LEU . . . . . 0.543 HD22 ' HE2' ' A' ' 702' ' ' LYS . 19.9 mt -113.31 19.89 16.63 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.46 -0.336 . . . . 74.340000000000003 111.511 -176.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 77.6 m -56.11 -37.92 70.07 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 112.313 0.486 . . . . 73.310000000000002 112.313 -176.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 701' ' ' SER . . . . . . . . . . . . . 73.3 m -70.83 -19.52 62.65 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 112.063 0.394 . . . . 74.140000000000001 112.063 178.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 702' ' ' LYS . . . . . 0.543 ' HE2' HD22 ' A' ' 699' ' ' LEU . 54.5 mtmt -92.59 11.24 27.2 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.777 0.323 . . . . 71.200000000000003 111.625 178.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 703' ' ' ILE . . . . . 0.547 HG12 ' HB ' ' A' ' 723' ' ' VAL . 54.0 mt -87.49 120.43 36.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 116.712 -0.222 . . . . 73.109999999999999 110.728 174.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 704' ' ' LYS . . . . . . . . . . . . . 53.6 tttm -93.11 146.32 23.74 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 120.801 0.334 . . . . 72.299999999999997 110.892 173.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 44.5 t -104.3 146.33 11.83 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-O 120.952 0.406 . . . . 74.430000000000007 110.887 176.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 706' ' ' ASP . . . . . 0.508 ' HB3' ' HB ' ' A' ' 720' ' ' THR . 32.3 t70 -135.01 129.96 34.96 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 120.899 0.38 . . . . 73.239999999999995 110.738 174.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 101.34 175.88 28.76 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 121.439 -0.41 . . . . 71.540000000000006 112.404 -176.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 708' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -151.86 144.7 24.39 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 117.076 0.438 . . . . 71.040000000000006 111.908 -178.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 709' ' ' VAL . . . . . 0.508 HG22 ' HB2' ' A' ' 717' ' ' TYR . 97.1 t -114.07 111.45 36.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-N 116.437 -0.347 . . . . 71.129999999999995 111.305 178.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 710' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -70.01 136.11 50.06 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 120.946 0.403 . . . . 73.349999999999994 111.264 176.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 711' ' ' THR . . . . . . . . . . . . . 70.7 p -106.36 -6.73 18.1 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 112.131 0.419 . . . . 74.340000000000003 112.131 -178.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 712' ' ' THR . . . . . . . . . . . . . 11.7 t -100.25 0.28 39.96 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 111.973 0.36 . . . . 74.239999999999995 111.973 177.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 713' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -144.03 134.06 24.12 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 120.692 0.282 . . . . 74.319999999999993 111.279 -177.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 714' ' ' ALA . . . . . . . . . . . . . . . -76.62 144.55 39.47 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 112.359 0.503 . . . . 72.120000000000005 112.359 -176.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 158.03 168.3 20.15 Favored Glycine 0 CA--C 1.525 0.718 0 CA-C-N 116.025 -0.534 . . . . 53.140000000000001 112.487 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 716' ' ' THR . . . . . . . . . . . . . 91.3 m -96.39 123.48 40.06 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 122.295 -0.532 . . . . 74.420000000000002 111.477 178.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 717' ' ' TYR . . . . . 0.508 ' HB2' HG22 ' A' ' 709' ' ' VAL . 33.3 m-85 -119.52 141.51 49.14 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 116.404 -0.362 . . . . 75.340000000000003 110.755 -178.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 718' ' ' VAL . . . . . . . . . . . . . 72.9 t -113.26 131.35 65.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 CA-C-O 120.893 0.378 . . . . 72.409999999999997 111.383 178.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 719' ' ' LEU . . . . . 0.423 HD21 HG23 ' A' ' 709' ' ' VAL . 69.4 mt -116.4 142.15 47.23 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 116.444 -0.344 . . . . 73.120000000000005 111.433 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 720' ' ' THR . . . . . 0.508 ' HB ' ' HB3' ' A' ' 706' ' ' ASP . 93.2 m -114.89 136.13 53.44 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 120.876 0.37 . . . . 52.119999999999997 111.356 178.035 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 721' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -124.71 135.03 52.68 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 116.346 -0.388 . . . . 73.450000000000003 110.947 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 94.6 m -138.21 134.88 35.02 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 111.813 0.301 . . . . 64.140000000000001 111.813 -177.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 723' ' ' VAL . . . . . 0.547 ' HB ' HG12 ' A' ' 703' ' ' ILE . 8.7 p -132.25 146.24 33.39 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 CA-C-O 120.879 0.371 . . . . 75.109999999999999 111.422 179.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 56.5 m -119.6 130.29 55.04 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 112.734 0.642 . . . . 71.439999999999998 112.734 -175.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 725' ' ' ASP . . . . . 0.596 ' HB2' ' HD3' ' A' ' 667' ' ' PRO . 12.0 t70 -76.68 155.58 33.24 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.983 -0.553 . . . . 54.240000000000002 110.516 174.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 726' ' ' SER . . . . . . . . . . . . . 46.4 t -54.51 -33.65 60.29 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 112.407 0.521 . . . . 75.129999999999995 112.407 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 727' ' ' LYS . . . . . . . . . . . . . 46.7 mmtm -75.96 -14.82 60.24 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 112.239 0.459 . . . . 74.200000000000003 112.239 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 728' ' ' GLY . . . . . . . . . . . . . . . 109.94 4.71 29.49 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 121.112 -0.566 . . . . 52.140000000000001 113.625 -177.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 729' ' ' HIS . . . . . 0.479 ' HB3' ' HB3' ' A' ' 666' ' ' GLU . 24.8 m170 -70.67 102.13 2.22 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 117.519 0.659 . . . . 52.240000000000002 111.353 176.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 730' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -98.0 125.26 42.86 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 120.984 0.421 . . . . 73.519999999999996 111.503 179.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 731' ' ' VAL . . . . . 0.436 HG22 ' HG2' ' A' ' 667' ' ' PRO . 30.2 m -126.65 154.18 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-O 120.84 0.352 . . . . 61.509999999999998 111.113 176.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 8.8 t -144.42 147.89 33.93 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 121.386 0.612 . . . . 70.230000000000004 112.431 -173.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -147.49 153.67 39.81 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.862 -0.608 . . . . 62.509999999999998 110.576 177.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 734' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -123.47 152.04 42.09 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 112.625 0.602 . . . . 64.219999999999999 112.625 -173.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 735' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -130.24 128.34 41.43 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 115.798 -0.637 . . . . 64.540000000000006 111.133 -177.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 736' ' ' THR . . . . . . . . . . . . . 93.9 m -100.26 109.64 21.87 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.848 0.356 . . . . 64.120000000000005 111.428 179.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 737' ' ' VAL . . . . . 0.486 HG22 ' HB3' ' A' ' 675' ' ' ALA . 41.0 t -105.33 117.72 51.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-O 120.952 0.406 . . . . 65.439999999999998 111.554 -178.111 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 738' ' ' THR . . . . . . . . . . . . . 91.8 m -102.23 131.1 49.0 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 120.906 0.384 . . . . 45.310000000000002 111.545 178.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 739' ' ' VAL . . . . . . . . . . . . . 43.1 t -104.45 131.12 54.13 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-N 116.348 -0.387 . . . . 60.130000000000003 111.535 179.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 740' ' ' LYS . . . . . 0.462 ' NZ ' ' HB3' ' A' ' 740' ' ' LYS . 7.7 mtpm? -116.08 155.77 27.56 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 120.902 0.382 . . . . 54.299999999999997 111.305 177.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 741' ' ' VAL . . . . . . . . . . . . . 43.9 t . . . . . 0 N--CA 1.47 0.573 0 N-CA-C 112.093 0.405 . . . . 73.450000000000003 112.093 -177.418 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 664' ' ' ASP . . . . . 0.528 ' CG ' ' HG3' ' A' ' 727' ' ' LYS . 12.3 t70 . . . . . 0 CA--C 1.539 0.555 0 CA-C-O 120.927 0.394 . . . . 74.420000000000002 111.291 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 665' ' ' LEU . . . . . 0.513 HD12 ' HD2' ' A' ' 694' ' ' LYS . 73.2 mt -102.84 137.74 40.65 Favored 'General case' 0 C--O 1.242 0.678 0 N-CA-C 112.268 0.47 . . . . 73.129999999999995 112.268 -176.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 666' ' ' GLU . . . . . 0.496 ' HG3' ' HB3' ' A' ' 729' ' ' HIS . 3.5 mp0 -67.58 151.62 97.0 Favored Pre-proline 0 CA--C 1.544 0.719 0 CA-C-N 115.957 -0.565 . . . . 71.340000000000003 111.005 176.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 667' ' ' PRO . . . . . 0.623 ' HD3' ' HB2' ' A' ' 725' ' ' ASP . 61.3 Cg_endo -72.7 153.72 54.14 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 122.659 2.239 . . . . 74.129999999999995 113.429 -178.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 668' ' ' LYS . . . . . . . . . . . . . 13.0 tmtt? -92.3 105.15 17.41 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.104 0.478 . . . . 75.409999999999997 110.496 178.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 669' ' ' LEU . . . . . . . . . . . . . 57.9 tp -94.88 120.04 34.44 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 116.173 -0.467 . . . . 71.230000000000004 111.29 -179.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 670' ' ' THR . . . . . . . . . . . . . 90.2 m -102.22 110.79 22.84 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 120.832 0.349 . . . . 75.129999999999995 111.151 -179.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 671' ' ' VAL . . . . . 0.491 HG22 HG13 ' A' ' 689' ' ' VAL . 87.6 t -135.42 126.54 17.3 Favored Pre-proline 0 N--CA 1.472 0.673 0 CA-C-N 116.072 -0.513 . . . . 63.140000000000001 111.065 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 672' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -73.21 145.41 38.91 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 122.241 1.961 . . . . 74.010000000000005 112.19 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 673' ' ' VAL . . . . . . . . . . . . . 13.9 p -65.14 -32.8 59.84 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 N-CA-C 112.098 0.407 . . . . 63.109999999999999 112.098 -178.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 674' ' ' GLY . . . . . . . . . . . . . . . -162.05 147.54 13.87 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 120.77 -0.729 . . . . 42.140000000000001 113.408 -179.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 675' ' ' ALA . . . . . . . . . . . . . . . -136.09 139.62 43.14 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 122.647 0.379 . . . . 61.219999999999999 110.802 179.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 676' ' ' THR . . . . . . . . . . . . . 92.1 m -117.36 124.13 48.16 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.547 0.573 . . . . 73.530000000000001 112.547 -175.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 677' ' ' ILE . . . . . . . . . . . . . 33.7 pt -130.46 177.09 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 CA-C-N 116.292 -0.413 . . . . 75.120000000000005 110.517 175.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 678' ' ' HIS . . . . . . . . . . . . . 76.5 m80 -114.31 168.76 9.57 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 121.232 0.539 . . . . 73.200000000000003 111.787 175.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 679' ' ' VAL . . . . . . . . . . . . . 96.6 t -63.55 117.93 5.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 116.182 -0.463 . . . . 65.519999999999996 110.654 175.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 95.32 8.21 58.86 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 121.419 -0.42 . . . . 64.400000000000006 113.135 -178.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 681' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -94.03 166.1 12.31 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.073 0.463 . . . . 63.109999999999999 111.43 178.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 682' ' ' SER . . . . . . . . . . . . . 47.2 m -93.54 149.42 21.25 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.22 -0.445 . . . . 75.219999999999999 111.421 -179.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 683' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -151.6 116.41 5.18 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.722 0.296 . . . . 65.010000000000005 110.761 178.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 684' ' ' VAL . . . . . 0.4 ' HA ' ' HD2' ' A' ' 685' ' ' PRO . 28.8 t -117.01 92.57 39.57 Favored Pre-proline 0 CA--C 1.544 0.727 0 CA-C-O 121.126 0.489 . . . . 74.349999999999994 111.522 -178.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 685' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 684' ' ' VAL . 30.6 Cg_endo -62.27 -31.89 82.07 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 122.606 2.204 . . . . 73.420000000000002 112.963 -177.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 686' ' ' MET . . . . . 0.428 ' HA ' ' HE3' ' A' ' 686' ' ' MET . 0.7 OUTLIER -78.85 -1.39 34.75 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 112.248 0.462 . . . . 73.120000000000005 112.248 -178.403 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 687' ' ' ALA . . . . . . . . . . . . . . . -104.61 -30.14 10.17 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.088 0.47 . . . . 71.319999999999993 111.31 175.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 688' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -91.19 -28.17 18.02 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 116.343 -0.39 . . . . 74.329999999999998 111.85 -179.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 689' ' ' VAL . . . . . 0.491 HG13 HG22 ' A' ' 671' ' ' VAL . 80.2 t -98.15 124.7 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-O 120.922 0.391 . . . . 64.140000000000001 111.413 178.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 690' ' ' LEU . . . . . 0.429 HD12 ' C ' ' A' ' 689' ' ' VAL . 7.3 mp -126.04 154.46 42.96 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 116.234 -0.439 . . . . 65.140000000000001 111.619 -178.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 691' ' ' ALA . . . . . . . . . . . . . . . -137.39 122.26 18.85 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.796 0.331 . . . . 71.140000000000001 111.058 177.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 692' ' ' ILE . . . . . . . . . . . . . 50.2 mm -129.09 117.27 43.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 CA-C-O 120.842 0.353 . . . . 71.150000000000006 111.653 -176.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 693' ' ' ASP . . . . . 0.467 ' HB2' HD12 ' A' ' 699' ' ' LEU . 34.4 t70 -95.19 149.66 21.07 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.535 -0.302 . . . . 71.319999999999993 110.481 176.184 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 694' ' ' LYS . . . . . 0.513 ' HD2' HD12 ' A' ' 665' ' ' LEU . 30.9 ttmt -72.41 -43.29 64.09 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 112.837 0.68 . . . . 74.409999999999997 112.837 -171.121 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -84.09 -45.9 12.53 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 121.696 -0.627 . . . . 72.030000000000001 111.278 177.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 696' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -74.43 -48.99 24.21 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 112.206 0.447 . . . . 71.230000000000004 112.206 -175.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . 112.14 -117.79 4.51 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 121.0 -0.619 . . . . 72.450000000000003 112.647 -176.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -78.09 117.52 19.46 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 122.118 -0.636 . . . . 54.140000000000001 111.935 -179.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 699' ' ' LEU . . . . . 0.516 HD12 ' HB3' ' A' ' 667' ' ' PRO . 73.5 mt -117.24 14.05 14.74 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.126 -0.488 . . . . 52.219999999999999 110.726 172.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 33.5 m -58.66 -34.58 71.39 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.017 0.437 . . . . 71.430000000000007 111.251 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 701' ' ' SER . . . . . . . . . . . . . 80.2 p -70.31 -17.82 63.09 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 116.504 -0.316 . . . . 75.019999999999996 111.757 177.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 702' ' ' LYS . . . . . . . . . . . . . 45.3 mmtm -91.22 3.29 55.21 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 111.814 0.302 . . . . 71.239999999999995 111.814 -178.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 703' ' ' ILE . . . . . 0.444 HD13 HG12 ' A' ' 689' ' ' VAL . 67.3 mt -76.36 125.73 36.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-O 121.195 0.522 . . . . 72.040000000000006 111.754 -179.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 704' ' ' LYS . . . . . . . . . . . . . 58.4 mttp -92.9 123.93 36.52 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.191 -0.459 . . . . 64.340000000000003 110.741 172.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 51.9 t -95.85 106.94 18.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.935 -0.575 . . . . 72.409999999999997 110.808 179.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 706' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -100.04 134.0 43.6 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 120.912 0.387 . . . . 71.319999999999993 111.456 -178.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 118.24 -168.96 13.23 Favored Glycine 0 CA--C 1.525 0.659 0 CA-C-N 116.293 -0.412 . . . . 53.109999999999999 112.68 -178.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 708' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -158.05 137.61 11.98 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.967 0.413 . . . . 63.229999999999997 111.72 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 709' ' ' VAL . . . . . 0.448 HG22 ' HB2' ' A' ' 717' ' ' TYR . 62.7 t -126.34 123.11 62.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-N 116.459 -0.337 . . . . 51.25 111.127 179.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 710' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -93.47 142.22 27.58 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 121.202 0.525 . . . . 64.329999999999998 111.332 177.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 711' ' ' THR . . . . . . . . . . . . . 47.6 p -101.54 -9.44 21.01 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.806 -0.634 . . . . 70.109999999999999 112.278 -178.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 712' ' ' THR . . . . . . . . . . . . . 59.6 p -103.05 -0.09 31.27 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 113.099 0.777 . . . . 63.509999999999998 113.099 -177.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 713' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -144.14 136.57 26.74 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 122.067 -0.396 . . . . 65.200000000000003 111.332 175.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 714' ' ' ALA . . . . . . . . . . . . . . . -70.08 144.48 52.12 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 112.393 0.516 . . . . 62.0 112.393 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 161.28 166.7 20.52 Favored Glycine 0 CA--C 1.525 0.679 0 CA-C-N 116.108 -0.497 . . . . 74.409999999999997 112.729 -179.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 716' ' ' THR . . . . . . . . . . . . . 53.2 m -101.12 124.52 46.96 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 122.357 -0.496 . . . . 71.329999999999998 111.182 178.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 717' ' ' TYR . . . . . 0.448 ' HB2' HG22 ' A' ' 709' ' ' VAL . 30.2 m-85 -121.75 133.47 54.93 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 116.198 -0.456 . . . . 75.209999999999994 110.762 -177.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 718' ' ' VAL . . . . . . . . . . . . . 58.8 t -94.96 133.06 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-O 120.82 0.343 . . . . 71.329999999999998 111.614 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 719' ' ' LEU . . . . . 0.404 HD21 HG23 ' A' ' 709' ' ' VAL . 96.4 mt -119.79 127.66 53.0 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.802 0.334 . . . . 75.340000000000003 111.116 177.534 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 91.8 m -111.68 120.67 42.83 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 120.752 0.311 . . . . 63.229999999999997 110.912 178.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 721' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -104.78 120.04 40.43 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.591 -0.277 . . . . 74.329999999999998 111.186 -178.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 59.9 m -122.55 123.46 41.29 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 120.674 0.273 . . . . 73.310000000000002 111.168 178.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 10.4 p -119.14 147.18 22.85 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 CA-C-O 121.008 0.432 . . . . 72.340000000000003 111.906 -177.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 76.2 m -110.21 133.57 53.1 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 112.303 0.482 . . . . 74.299999999999997 112.303 -177.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 725' ' ' ASP . . . . . 0.623 ' HB2' ' HD3' ' A' ' 667' ' ' PRO . 50.2 t0 -73.62 154.64 39.67 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 115.888 -0.597 . . . . 62.240000000000002 111.216 176.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 726' ' ' SER . . . . . . . . . . . . . 40.4 t -58.24 -28.58 65.02 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.036 0.446 . . . . 52.25 111.178 176.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 727' ' ' LYS . . . . . 0.528 ' HG3' ' CG ' ' A' ' 664' ' ' ASP . 36.8 mmtm -90.28 -11.01 42.08 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 111.97 0.359 . . . . 75.030000000000001 111.97 177.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 728' ' ' GLY . . . . . . . . . . . . . . . 112.4 -1.23 26.51 Favored Glycine 0 CA--C 1.533 1.171 0 N-CA-C 114.688 0.635 . . . . 71.409999999999997 114.688 179.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 729' ' ' HIS . . . . . 0.543 ' H ' ' HB3' ' A' ' 725' ' ' ASP . 34.7 m80 -68.54 105.21 2.16 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 118.12 0.96 . . . . 74.310000000000002 110.989 176.121 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 730' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -96.32 125.88 41.13 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 120.802 0.334 . . . . 75.209999999999994 110.942 -179.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 35.9 m -127.02 158.11 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-O 120.699 0.285 . . . . 63.409999999999997 111.079 178.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 5.3 t -143.52 149.76 37.95 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 112.755 0.65 . . . . 62.299999999999997 112.755 -174.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -148.37 154.59 40.15 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.771 -0.65 . . . . 60.200000000000003 110.343 176.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 734' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -119.86 154.86 33.71 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 113.159 0.8 . . . . 71.430000000000007 113.159 -174.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 735' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -136.67 124.12 22.09 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.5 -0.773 . . . . 62.310000000000002 110.652 177.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 736' ' ' THR . . . . . . . . . . . . . 99.8 m -93.93 105.78 17.78 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.104 0.478 . . . . 75.109999999999999 111.055 176.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 45.6 t -96.77 141.33 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-O 120.709 0.29 . . . . 71.299999999999997 111.59 -176.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 738' ' ' THR . . . . . . . . . . . . . 88.8 m -128.7 122.91 31.79 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.25 0.548 . . . . 43.399999999999999 112.269 -179.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 739' ' ' VAL . . . . . . . . . . . . . 47.2 t -95.57 124.57 48.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-N 115.754 -0.657 . . . . 75.400000000000006 110.788 176.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 740' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -102.95 151.67 22.21 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.417 0.627 . . . . 72.25 112.079 -176.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 741' ' ' VAL . . . . . . . . . . . . . 93.9 t . . . . . 0 CA--C 1.54 0.561 0 CA-C-N 115.77 -0.65 . . . . 74.340000000000003 112.264 -179.735 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 664' ' ' ASP . . . . . 0.699 ' HB2' ' HE2' ' A' ' 727' ' ' LYS . 16.1 t70 . . . . . 0 CA--C 1.537 0.462 0 CA-C-O 121.123 0.487 . . . . 73.109999999999999 111.818 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 665' ' ' LEU . . . . . . . . . . . . . 70.1 mt -85.39 119.01 25.27 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.135 -0.484 . . . . 63.32 109.697 173.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 666' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -67.68 145.33 98.09 Favored Pre-proline 0 CA--C 1.54 0.56 0 CA-C-O 120.671 0.272 . . . . 71.349999999999994 111.308 -177.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 667' ' ' PRO . . . . . 0.431 ' HB3' HD12 ' A' ' 699' ' ' LEU . 78.9 Cg_endo -75.8 146.26 29.7 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.405 2.07 . . . . 61.109999999999999 113.193 -173.379 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 668' ' ' LYS . . . . . . . . . . . . . 4.9 tmtm? -88.28 109.18 19.75 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 109.89 -0.411 . . . . 74.019999999999996 109.89 177.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 669' ' ' LEU . . . . . 0.414 ' HG ' HG23 ' A' ' 671' ' ' VAL . 58.0 tp -93.01 106.16 18.15 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.071 0.463 . . . . 74.129999999999995 110.543 176.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 670' ' ' THR . . . . . . . . . . . . . 86.9 m -86.62 110.7 20.01 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.263 -0.426 . . . . 72.129999999999995 111.391 -178.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 671' ' ' VAL . . . . . 0.414 HG23 ' HG ' ' A' ' 669' ' ' LEU . 95.0 t -137.95 128.34 15.48 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 122.629 0.372 . . . . 43.229999999999997 111.091 -178.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 672' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -77.84 132.28 11.76 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 122.212 1.941 . . . . 72.219999999999999 111.809 177.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 673' ' ' VAL . . . . . . . . . . . . . 14.3 p -64.76 -30.61 50.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 N-CA-C 112.496 0.554 . . . . 62.439999999999998 112.496 -175.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 674' ' ' GLY . . . . . . . . . . . . . . . -151.81 142.6 9.57 Favored Glycine 0 CA--C 1.525 0.666 0 C-N-CA 120.811 -0.709 . . . . 62.140000000000001 113.571 -177.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 675' ' ' ALA . . . . . . . . . . . . . . . -140.48 157.69 45.12 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 122.49 0.316 . . . . 70.0 110.922 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 676' ' ' THR . . . . . . . . . . . . . 54.9 m -136.05 128.81 30.96 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.103 0.477 . . . . 34.200000000000003 111.797 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 677' ' ' ILE . . . . . . . . . . . . . 39.8 pt -132.49 177.64 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-N 116.085 -0.507 . . . . 72.030000000000001 110.987 177.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 678' ' ' HIS . . . . . . . . . . . . . 58.4 m80 -122.44 156.75 33.4 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.151 0.501 . . . . 73.340000000000003 112.276 178.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 679' ' ' VAL . . . . . . . . . . . . . 89.4 t -61.5 128.74 23.42 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 115.824 -0.626 . . . . 53.420000000000002 111.39 176.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 99.81 -17.04 57.95 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 121.356 -0.45 . . . . 73.0 113.031 -178.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 681' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -79.08 177.26 8.94 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 121.224 0.535 . . . . 72.099999999999994 112.248 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 682' ' ' SER . . . . . . . . . . . . . 48.5 m -104.46 145.23 30.57 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.913 -0.585 . . . . 52.399999999999999 110.516 176.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 683' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -148.7 113.05 5.27 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.913 0.387 . . . . 75.140000000000001 111.557 179.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 684' ' ' VAL . . . . . . . . . . . . . 63.6 t -111.61 102.33 53.1 Favored Pre-proline 0 CA--C 1.543 0.675 0 CA-C-N 116.257 -0.429 . . . . 70.030000000000001 110.616 176.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -56.91 -42.62 62.52 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 122.731 2.287 . . . . 73.040000000000006 113.658 -177.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 686' ' ' MET . . . . . . . . . . . . . 15.8 mtp -79.17 -12.29 59.98 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 113.06 0.763 . . . . 73.109999999999999 113.06 -176.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 687' ' ' ALA . . . . . . . . . . . . . . . -79.17 -18.47 53.02 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 122.017 -0.427 . . . . 45.310000000000002 111.207 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 688' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -114.34 9.74 16.97 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 112.178 0.436 . . . . 45.130000000000003 112.178 -178.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 689' ' ' VAL . . . . . 0.437 HG21 ' CZ ' ' A' ' 721' ' ' TYR . 86.8 t -123.0 124.72 70.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-O 120.879 0.371 . . . . 73.310000000000002 110.939 178.106 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 690' ' ' LEU . . . . . . . . . . . . . 6.4 mp -119.7 157.63 28.14 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.165 0.507 . . . . 72.409999999999997 111.534 -177.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 691' ' ' ALA . . . . . . . . . . . . . . . -148.54 123.48 10.01 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.963 -0.562 . . . . 64.530000000000001 110.557 176.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 692' ' ' ILE . . . . . . . . . . . . . 41.5 mm -131.91 131.4 61.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 N-CA-C 112.404 0.52 . . . . 74.209999999999994 112.404 -174.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -115.33 130.94 57.05 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.121 -0.491 . . . . 61.219999999999999 109.741 168.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -61.76 -32.35 72.6 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.113 0.482 . . . . 63.409999999999997 111.403 -177.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -83.72 -54.32 5.0 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 112.504 0.557 . . . . 74.299999999999997 112.504 -176.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 696' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -77.57 -42.98 33.26 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 120.811 0.339 . . . . 61.32 111.59 -178.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . 121.07 -139.79 13.59 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 121.544 -0.36 . . . . 73.510000000000005 113.001 -178.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -71.73 111.85 7.35 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.052 0.453 . . . . 63.5 111.102 178.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 699' ' ' LEU . . . . . 0.472 HD22 ' HG3' ' A' ' 702' ' ' LYS . 67.0 mt -100.72 9.12 42.83 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.446 -0.343 . . . . 74.299999999999997 111.319 176.155 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 31.2 m -59.7 -36.88 77.41 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.108 0.48 . . . . 65.109999999999999 111.247 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 701' ' ' SER . . . . . . . . . . . . . 47.1 m -81.99 3.13 27.72 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 116.328 -0.396 . . . . 73.25 111.738 176.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 702' ' ' LYS . . . . . 0.472 ' HG3' HD22 ' A' ' 699' ' ' LEU . 33.5 mmtp -103.48 3.96 35.47 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 120.816 0.341 . . . . 71.109999999999999 110.914 179.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 70.2 mt -84.42 116.77 28.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 N-CA-C 112.235 0.457 . . . . 71.200000000000003 112.235 -174.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 704' ' ' LYS . . . . . . . . . . . . . 61.2 tttp -84.83 122.53 29.28 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 120.689 0.28 . . . . 62.32 110.581 172.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 47.8 t -99.28 141.15 17.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-O 121.235 0.541 . . . . 72.200000000000003 112.024 -177.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 706' ' ' ASP . . . . . 0.603 ' HB3' ' HB ' ' A' ' 720' ' ' THR . 23.7 t70 -130.31 151.82 50.4 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.77 -0.65 . . . . 74.319999999999993 110.073 176.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 93.42 167.05 38.15 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 120.974 -0.631 . . . . 61.219999999999999 112.37 -174.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 708' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -144.5 142.8 30.5 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 122.346 -0.502 . . . . 72.120000000000005 111.997 -176.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 709' ' ' VAL . . . . . 0.54 HG23 HD21 ' A' ' 719' ' ' LEU . 95.7 t -122.09 132.52 70.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 CA-C-O 120.885 0.374 . . . . 72.319999999999993 111.158 176.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 710' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -98.32 138.12 36.04 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.002 0.43 . . . . 53.329999999999998 111.367 176.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 711' ' ' THR . . . . . . . . . . . . . 68.0 p -94.01 -25.45 17.22 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.937 0.398 . . . . 75.439999999999998 111.236 177.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 712' ' ' THR . . . . . . . . . . . . . 12.5 t -90.7 -7.04 53.65 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.0 0.429 . . . . 73.310000000000002 111.994 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 713' ' ' LYS . . . . . . . . . . . . . 28.2 tptp -130.42 125.79 35.37 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.704 0.288 . . . . 74.319999999999993 111.259 -177.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 714' ' ' ALA . . . . . . . . . . . . . . . -74.9 144.18 43.44 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 120.826 0.346 . . . . 74.319999999999993 111.466 178.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 159.03 164.4 14.38 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 121.073 -0.584 . . . . 75.319999999999993 113.313 -179.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 716' ' ' THR . . . . . . . . . . . . . 99.2 m -96.04 128.85 43.3 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 122.495 -0.415 . . . . 64.430000000000007 111.216 178.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 717' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -126.76 149.59 49.55 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.027 0.442 . . . . 74.109999999999999 111.574 -179.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 718' ' ' VAL . . . . . . . . . . . . . 40.6 t -117.07 114.0 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 121.079 0.466 . . . . 75.420000000000002 111.264 178.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 719' ' ' LEU . . . . . 0.54 HD21 HG23 ' A' ' 709' ' ' VAL . 81.2 mt -96.26 143.01 27.73 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.09 -0.505 . . . . 64.109999999999999 111.179 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 720' ' ' THR . . . . . 0.603 ' HB ' ' HB3' ' A' ' 706' ' ' ASP . 78.0 m -118.82 136.1 54.19 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.913 0.387 . . . . 61.340000000000003 111.154 177.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 721' ' ' TYR . . . . . 0.437 ' CZ ' HG21 ' A' ' 689' ' ' VAL . 72.6 m-85 -120.57 134.36 55.29 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.491 -0.322 . . . . 73.040000000000006 110.906 179.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 25.5 m -134.46 126.22 29.03 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 116.626 -0.261 . . . . 72.439999999999998 110.914 -178.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 8.8 p -132.49 135.78 57.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 CA-C-O 120.929 0.395 . . . . 65.209999999999994 111.611 -179.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 43.0 m -107.96 131.68 54.29 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 120.983 0.421 . . . . 61.039999999999999 111.924 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 725' ' ' ASP . . . . . 0.424 ' HB3' ' H ' ' A' ' 729' ' ' HIS . 10.0 t70 -73.35 166.39 23.28 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.967 -0.56 . . . . 70.109999999999999 111.131 178.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 726' ' ' SER . . . . . . . . . . . . . 45.3 t -63.17 -40.74 98.4 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 116.372 -0.376 . . . . 61.409999999999997 111.854 178.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 727' ' ' LYS . . . . . 0.699 ' HE2' ' HB2' ' A' ' 664' ' ' ASP . 30.8 mtmm -107.23 25.53 11.29 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 113.773 1.027 . . . . 73.150000000000006 113.773 -177.325 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 728' ' ' GLY . . . . . . . . . . . . . . . 110.16 -5.97 30.44 Favored Glycine 0 CA--C 1.536 1.376 0 N-CA-C 116.645 1.418 . . . . 74.510000000000005 116.645 165.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 729' ' ' HIS . . . . . 0.424 ' H ' ' HB3' ' A' ' 725' ' ' ASP . 18.9 m80 -80.31 104.21 10.7 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 118.936 1.368 . . . . 75.010000000000005 111.958 179.168 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 730' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -103.28 115.74 31.14 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.986 0.422 . . . . 74.0 111.718 -178.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 48.0 t -108.74 149.58 11.92 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 CA-C-N 116.414 -0.357 . . . . 54.240000000000002 111.512 -176.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 7.7 t -143.32 143.97 31.91 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 112.502 0.556 . . . . 63.310000000000002 112.502 -178.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -148.7 161.57 41.5 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 116.414 -0.357 . . . . 70.109999999999999 111.234 178.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 734' ' ' LYS . . . . . . . . . . . . . 99.9 mttt -127.22 152.63 47.14 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 112.728 0.64 . . . . 75.200000000000003 112.728 -177.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 735' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -130.49 128.48 41.31 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 115.911 -0.586 . . . . 63.009999999999998 111.13 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 736' ' ' THR . . . . . . . . . . . . . 86.8 m -97.41 109.14 21.95 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.117 0.484 . . . . 73.329999999999998 111.23 176.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 45.4 t -101.16 129.07 52.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-O 120.972 0.415 . . . . 74.430000000000007 111.538 -179.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 738' ' ' THR . . . . . . . . . . . . . 40.4 m -108.94 113.75 26.92 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.521 -0.309 . . . . 64.120000000000005 111.255 179.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 739' ' ' VAL . . . . . . . . . . . . . 21.8 t -93.07 118.89 39.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-O 120.564 0.221 . . . . 63.329999999999998 110.577 177.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 740' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -112.46 158.97 19.22 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 120.994 0.426 . . . . 72.420000000000002 111.618 -176.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 741' ' ' VAL . . . . . . . . . . . . . 38.3 t . . . . . 0 CA--C 1.544 0.746 0 N-CA-C 113.248 0.833 . . . . 53.32 113.248 -170.632 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 664' ' ' ASP . . . . . . . . . . . . . 27.4 t0 . . . . . 0 CA--C 1.534 0.358 0 CA-C-O 121.126 0.489 . . . . 72.219999999999999 111.649 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 665' ' ' LEU . . . . . 0.48 HD12 ' HD3' ' A' ' 694' ' ' LYS . 84.0 mt -80.65 117.11 21.05 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.846 -0.615 . . . . 72.400000000000006 109.621 173.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 666' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -60.09 142.54 89.34 Favored Pre-proline 0 CA--C 1.542 0.663 0 CA-C-N 116.247 -0.433 . . . . 75.430000000000007 111.6 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 667' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -75.54 155.11 40.43 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 122.536 2.157 . . . . 73.420000000000002 113.795 -169.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 668' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -86.23 102.55 14.04 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.94 -0.573 . . . . 73.540000000000006 110.845 176.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 669' ' ' LEU . . . . . . . . . . . . . 55.2 tp -93.47 105.9 17.91 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 120.958 0.408 . . . . 73.430000000000007 110.64 177.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 670' ' ' THR . . . . . . . . . . . . . 87.4 m -89.18 110.98 21.66 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.361 -0.381 . . . . 63.299999999999997 111.616 -177.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 671' ' ' VAL . . . . . 0.573 HG22 HG13 ' A' ' 689' ' ' VAL . 88.6 t -138.16 134.52 17.85 Favored Pre-proline 0 CA--C 1.539 0.555 0 CA-C-N 116.259 -0.428 . . . . 74.400000000000006 110.672 179.359 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 672' ' ' PRO . . . . . 0.407 ' HD3' ' O ' ' A' ' 688' ' ' GLU . 71.7 Cg_endo -76.62 120.78 5.68 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 122.058 1.838 . . . . 55.509999999999998 111.62 175.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 673' ' ' VAL . . . . . . . . . . . . . 14.8 p -67.08 -23.2 30.3 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 N-CA-C 112.761 0.652 . . . . 74.340000000000003 112.761 -174.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 674' ' ' GLY . . . . . . . . . . . . . . . -142.93 148.33 20.03 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 120.952 -0.642 . . . . 51.539999999999999 114.041 -177.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 675' ' ' ALA . . . . . . . . . . . . . . . -157.15 151.84 25.55 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.275 0.63 . . . . 72.109999999999999 110.35 178.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 676' ' ' THR . . . . . . . . . . . . . 91.1 m -139.34 124.9 19.34 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 111.897 0.332 . . . . 63.409999999999997 111.897 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 677' ' ' ILE . . . . . . . . . . . . . 25.2 pt -128.67 172.51 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-O 121.225 0.536 . . . . 74.430000000000007 111.689 179.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 678' ' ' HIS . . . . . 0.529 ' CD2' ' HG3' ' A' ' 740' ' ' LYS . 69.5 m80 -110.96 165.4 11.9 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.267 0.556 . . . . 73.010000000000005 111.713 177.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 679' ' ' VAL . . . . . . . . . . . . . 95.2 t -63.28 126.33 21.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 116.113 -0.494 . . . . 43.43 110.696 173.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 89.35 1.09 78.99 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 121.425 -0.417 . . . . 72.310000000000002 113.126 -176.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 681' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -84.74 177.94 7.84 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 120.937 0.399 . . . . 75.209999999999994 110.713 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 682' ' ' SER . . . . . . . . . . . . . 54.9 m -114.51 150.23 35.2 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 120.972 0.415 . . . . 52.109999999999999 111.365 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 683' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -151.36 131.1 13.18 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 116.129 -0.487 . . . . 64.519999999999996 110.904 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 684' ' ' VAL . . . . . . . . . . . . . 48.6 t -122.37 103.27 38.71 Favored Pre-proline 0 CA--C 1.543 0.677 0 CA-C-O 120.851 0.357 . . . . 65.310000000000002 111.312 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -60.33 -46.97 15.8 Favored 'Trans proline' 0 CA--C 1.545 1.027 0 C-N-CA 122.819 2.346 . . . . 62.240000000000002 113.974 -175.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 686' ' ' MET . . . . . . . . . . . . . 91.2 mmm -78.48 -11.85 59.98 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 112.925 0.713 . . . . 74.209999999999994 112.925 -174.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 687' ' ' ALA . . . . . . . . . . . . . . . -77.22 -30.19 54.54 Favored 'General case' 0 N--CA 1.467 0.419 0 O-C-N 122.038 -0.414 . . . . 32.049999999999997 111.397 177.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 688' ' ' GLU . . . . . 0.407 ' O ' ' HD3' ' A' ' 672' ' ' PRO . 19.7 mm-40 -97.04 1.74 50.51 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 112.203 0.446 . . . . 61.329999999999998 112.203 -178.042 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 689' ' ' VAL . . . . . 0.573 HG13 HG22 ' A' ' 671' ' ' VAL . 95.4 t -120.67 125.08 73.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-O 120.97 0.414 . . . . 65.239999999999995 112.076 -176.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 690' ' ' LEU . . . . . 0.42 HD22 ' C ' ' A' ' 689' ' ' VAL . 2.7 mm? -127.38 164.01 22.77 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 116.115 -0.493 . . . . 73.349999999999994 110.815 178.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 691' ' ' ALA . . . . . . . . . . . . . . . -153.11 122.46 6.68 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.799 0.333 . . . . 72.25 111.345 175.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 692' ' ' ILE . . . . . . . . . . . . . 46.8 mm -130.85 132.3 64.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-O 120.996 0.427 . . . . 70.420000000000002 112.02 -176.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -113.13 150.53 32.04 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 120.969 0.414 . . . . 71.450000000000003 111.004 174.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 694' ' ' LYS . . . . . 0.48 ' HD3' HD12 ' A' ' 665' ' ' LEU . 64.3 tttp -70.89 -38.26 73.02 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 111.967 0.358 . . . . 62.310000000000002 111.967 -178.026 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -82.66 -53.79 5.65 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 122.019 -0.425 . . . . 73.409999999999997 111.894 -178.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 696' ' ' ASP . . . . . 0.508 ' HB2' ' HB2' ' A' ' 726' ' ' SER . 15.0 t70 -80.39 -42.03 23.56 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 112.595 0.591 . . . . 71.219999999999999 112.595 -174.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . 109.74 -107.4 2.34 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 120.947 -0.644 . . . . 64.310000000000002 112.993 -178.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -81.67 115.95 21.17 Favored 'General case' 0 N--CA 1.466 0.339 0 O-C-N 122.201 -0.588 . . . . 70.209999999999994 111.773 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 699' ' ' LEU . . . . . 0.45 HD22 ' HD2' ' A' ' 702' ' ' LYS . 75.5 mt -111.95 1.11 16.29 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.845 0.355 . . . . 61.43 110.443 170.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 22.4 m -56.27 -37.49 69.88 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.272 0.558 . . . . 73.340000000000003 111.158 177.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 701' ' ' SER . . . . . . . . . . . . . 65.5 p -72.33 -9.91 59.1 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 115.979 -0.555 . . . . 75.450000000000003 112.315 179.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 702' ' ' LYS . . . . . 0.45 ' HD2' HD22 ' A' ' 699' ' ' LEU . 62.1 mttp -101.34 1.47 38.63 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 112.446 0.535 . . . . 73.530000000000001 112.446 178.066 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 703' ' ' ILE . . . . . 0.429 HD13 HG12 ' A' ' 689' ' ' VAL . 67.7 mt -72.24 135.14 28.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 N-CA-C 112.081 0.4 . . . . 71.019999999999996 112.081 -178.014 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 704' ' ' LYS . . . . . . . . . . . . . 56.4 tttm -102.11 137.15 40.76 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.574 -0.285 . . . . 74.400000000000006 111.013 173.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 49.4 t -96.04 141.77 14.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-O 120.988 0.423 . . . . 75.420000000000002 111.065 176.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 706' ' ' ASP . . . . . 0.535 ' HB3' ' HB ' ' A' ' 720' ' ' THR . 27.3 t70 -136.56 138.2 41.03 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 120.728 0.299 . . . . 42.350000000000001 111.205 178.019 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 104.29 -173.07 21.05 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 121.391 -0.433 . . . . 64.239999999999995 113.246 -179.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 708' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -157.95 141.73 15.64 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 120.863 0.363 . . . . 61.149999999999999 111.306 179.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 709' ' ' VAL . . . . . 0.488 HG23 HD21 ' A' ' 719' ' ' LEU . 99.5 t -122.97 121.95 64.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-O 120.785 0.326 . . . . 73.010000000000005 111.217 -179.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 710' ' ' ASP . . . . . 0.438 ' O ' HG21 ' A' ' 739' ' ' VAL . 8.2 m-20 -84.95 136.08 33.77 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 121.104 0.478 . . . . 61.100000000000001 111.932 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 711' ' ' THR . . . . . . . . . . . . . 46.2 p -101.63 -3.57 28.1 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.232 0.539 . . . . 62.43 110.37 172.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 712' ' ' THR . . . . . . . . . . . . . 30.1 p -96.06 -27.67 14.98 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 115.749 -0.66 . . . . 60.549999999999997 112.314 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 713' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -121.86 141.04 51.67 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 120.628 0.251 . . . . 72.049999999999997 111.135 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 714' ' ' ALA . . . . . . . . . . . . . . . -81.11 127.24 32.42 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 120.957 0.408 . . . . 44.420000000000002 112.089 -179.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 715' ' ' GLY . . . . . 0.42 ' H ' ' HB ' ' A' ' 739' ' ' VAL . . . 170.14 158.62 14.33 Favored Glycine 0 CA--C 1.525 0.666 0 C-N-CA 121.447 -0.406 . . . . 73.040000000000006 112.788 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 716' ' ' THR . . . . . 0.403 ' HA ' ' HA ' ' A' ' 738' ' ' THR . 51.8 m -87.91 126.44 35.05 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.049 0.452 . . . . 71.109999999999999 111.627 178.133 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 717' ' ' TYR . . . . . 0.472 ' HB2' HG22 ' A' ' 709' ' ' VAL . 72.5 m-85 -125.92 135.9 52.42 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.186 -0.461 . . . . 74.219999999999999 110.411 176.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 718' ' ' VAL . . . . . . . . . . . . . 59.0 t -108.29 113.69 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 CA-C-O 120.915 0.388 . . . . 51.509999999999998 111.856 -176.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 719' ' ' LEU . . . . . 0.488 HD21 HG23 ' A' ' 709' ' ' VAL . 88.1 mt -89.23 141.08 28.84 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 116.477 -0.329 . . . . 72.329999999999998 111.543 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 720' ' ' THR . . . . . 0.535 ' HB ' ' HB3' ' A' ' 706' ' ' ASP . 62.1 m -111.15 132.54 54.22 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.936 0.398 . . . . 65.239999999999995 111.315 178.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 721' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -122.09 131.03 53.76 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.329 -0.396 . . . . 72.219999999999999 110.365 178.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 86.4 m -138.0 135.71 36.21 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 120.917 0.389 . . . . 53.420000000000002 111.964 -176.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 12.7 p -136.64 146.45 28.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-O 120.996 0.427 . . . . 74.319999999999993 111.42 -179.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 26.4 m -104.5 140.2 38.3 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.439 -0.346 . . . . 73.310000000000002 111.198 178.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -73.32 169.01 18.02 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 121.09 0.471 . . . . 62.329999999999998 111.275 178.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 726' ' ' SER . . . . . 0.508 ' HB2' ' HB2' ' A' ' 696' ' ' ASP . 46.8 t -63.8 -38.47 91.2 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 120.903 0.382 . . . . 60.409999999999997 111.234 176.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 727' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -98.25 7.17 46.62 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 112.494 0.554 . . . . 74.140000000000001 112.494 179.296 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 728' ' ' GLY . . . . . . . . . . . . . . . 112.4 -6.24 26.59 Favored Glycine 0 CA--C 1.538 1.469 0 N-CA-C 116.688 1.435 . . . . 72.140000000000001 116.688 166.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 17.6 m80 -69.15 109.22 3.94 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 119.292 1.546 . . . . 75.420000000000002 111.368 176.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 730' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -97.43 124.1 41.51 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 116.589 -0.278 . . . . 72.219999999999999 111.159 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 31.6 m -122.82 154.19 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-O 120.801 0.334 . . . . 62.5 111.388 -178.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 9.3 t -138.28 148.25 44.48 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 121.437 0.637 . . . . 55.32 112.524 -177.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -148.41 150.12 32.94 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.838 -0.619 . . . . 22.219999999999999 110.483 178.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 734' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -120.15 160.02 23.71 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 112.67 0.619 . . . . 75.319999999999993 112.67 -174.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 735' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -130.6 119.58 22.7 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 115.478 -0.783 . . . . 71.430000000000007 110.8 -179.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 736' ' ' THR . . . . . . . . . . . . . 23.8 m -90.02 103.79 16.42 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 116.496 -0.32 . . . . 44.420000000000002 111.266 -178.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 32.5 t -102.19 113.56 39.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 CA-C-O 120.952 0.406 . . . . 53.409999999999997 111.665 -177.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 738' ' ' THR . . . . . 0.403 ' HA ' ' HA ' ' A' ' 716' ' ' THR . 87.7 m -100.29 112.06 24.37 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.855 0.359 . . . . 53.409999999999997 111.464 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 739' ' ' VAL . . . . . 0.438 HG21 ' O ' ' A' ' 710' ' ' ASP . 22.4 t -93.22 133.58 33.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-O 120.778 0.323 . . . . 60.030000000000001 110.676 177.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 740' ' ' LYS . . . . . 0.529 ' HG3' ' CD2' ' A' ' 678' ' ' HIS . 19.1 ptmt -132.81 152.34 51.82 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.236 0.541 . . . . 74.409999999999997 111.929 -178.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 741' ' ' VAL . . . . . . . . . . . . . 20.0 t . . . . . 0 CA--C 1.542 0.636 0 CA-C-N 116.057 -0.519 . . . . 62.439999999999998 111.987 -174.634 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 664' ' ' ASP . . . . . 0.416 ' OD2' ' HB2' ' A' ' 727' ' ' LYS . 24.5 t0 . . . . . 0 CA--C 1.535 0.369 0 CA-C-O 121.272 0.558 . . . . 73.420000000000002 111.249 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 665' ' ' LEU . . . . . . . . . . . . . 84.3 mt -95.44 138.07 33.63 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 115.685 -0.689 . . . . 61.219999999999999 111.261 -179.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 666' ' ' GLU . . . . . 0.454 ' H ' ' CD ' ' A' ' 666' ' ' GLU . 1.3 pm0 -78.32 142.33 62.9 Favored Pre-proline 0 CA--C 1.54 0.596 0 CA-C-N 116.439 -0.346 . . . . 70.439999999999998 110.189 170.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 667' ' ' PRO . . . . . 0.414 ' HG3' ' HB2' ' A' ' 725' ' ' ASP . 38.2 Cg_exo -59.7 144.25 99.48 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 122.83 2.353 . . . . 33.200000000000003 114.467 -171.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 668' ' ' LYS . . . . . . . . . . . . . 49.9 tptt -82.3 97.37 8.26 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.658 -0.701 . . . . 72.239999999999995 109.745 171.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 669' ' ' LEU . . . . . 0.413 ' HG ' HG23 ' A' ' 671' ' ' VAL . 56.7 tp -90.19 105.86 18.09 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.002 -0.544 . . . . 65.530000000000001 110.527 179.188 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 670' ' ' THR . . . . . . . . . . . . . 96.8 m -88.58 110.22 20.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.265 0.555 . . . . 74.519999999999996 111.366 -178.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 671' ' ' VAL . . . . . 0.418 HG22 HG13 ' A' ' 689' ' ' VAL . 72.4 t -129.6 131.72 23.76 Favored Pre-proline 0 CA--C 1.535 0.396 0 CA-C-N 115.753 -0.658 . . . . 70.5 110.285 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 672' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -69.07 123.96 10.87 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 121.829 1.686 . . . . 75.340000000000003 111.693 176.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 673' ' ' VAL . . . . . . . . . . . . . 14.8 p -63.53 -29.52 47.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 N-CA-C 112.357 0.503 . . . . 71.530000000000001 112.357 -174.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 674' ' ' GLY . . . . . . . . . . . . . . . -150.88 143.9 11.14 Favored Glycine 0 CA--C 1.525 0.657 0 C-N-CA 120.741 -0.742 . . . . 72.329999999999998 113.177 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 675' ' ' ALA . . . . . 0.423 ' O ' ' HA ' ' A' ' 737' ' ' VAL . . . -148.63 143.89 26.84 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.729 0.299 . . . . 74.439999999999998 110.981 179.496 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 676' ' ' THR . . . . . . . . . . . . . 49.7 m -130.07 131.03 45.61 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.761 0.315 . . . . 70.519999999999996 111.509 -179.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 677' ' ' ILE . . . . . . . . . . . . . 25.6 pt -133.71 176.5 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 CA-C-O 120.882 0.373 . . . . 74.510000000000005 110.945 179.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 678' ' ' HIS . . . . . . . . . . . . . 76.2 m80 -118.67 158.82 24.77 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 121.08 0.467 . . . . 63.240000000000002 111.879 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 679' ' ' VAL . . . . . 0.402 HG21 HG22 ' A' ' 741' ' ' VAL . 98.8 t -60.45 112.1 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-N 116.142 -0.481 . . . . 75.530000000000001 111.172 176.295 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 114.49 -16.65 19.24 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 121.379 -0.438 . . . . 43.350000000000001 113.03 -175.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 681' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -73.96 -172.18 1.27 Allowed 'General case' 0 CA--C 1.546 0.809 0 CA-C-O 121.033 0.444 . . . . 70.239999999999995 111.723 178.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 682' ' ' SER . . . . . . . . . . . . . 25.4 m -129.07 155.12 45.95 Favored 'General case' 0 N--CA 1.478 0.94 0 O-C-N 122.211 -0.305 . . . . 62.530000000000001 111.007 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 683' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -159.2 120.35 3.28 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 120.821 0.343 . . . . 72.150000000000006 111.69 -179.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 684' ' ' VAL . . . . . . . . . . . . . 80.9 t -113.97 110.11 49.14 Favored Pre-proline 0 N--CA 1.471 0.588 0 CA-C-O 120.843 0.354 . . . . 62.299999999999997 111.544 177.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -58.09 -36.79 97.66 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 122.77 2.314 . . . . 71.409999999999997 113.665 -177.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 686' ' ' MET . . . . . 0.442 ' CE ' ' HA ' ' A' ' 686' ' ' MET . 1.0 OUTLIER -79.26 -11.78 59.95 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.424 0.527 . . . . 72.510000000000005 112.424 -177.374 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 687' ' ' ALA . . . . . . . . . . . . . . . -89.61 -32.68 16.99 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.215 0.531 . . . . 52.539999999999999 110.972 176.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 688' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -84.74 -17.54 38.0 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 116.137 -0.483 . . . . 72.310000000000002 111.683 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 689' ' ' VAL . . . . . 0.418 HG13 HG22 ' A' ' 671' ' ' VAL . 76.0 t -116.76 131.38 69.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 N-CA-C 112.695 0.628 . . . . 72.450000000000003 112.695 -175.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 690' ' ' LEU . . . . . 0.416 HD12 ' N ' ' A' ' 690' ' ' LEU . 5.2 mp -125.42 166.64 16.23 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 116.309 -0.405 . . . . 74.450000000000003 111.036 177.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 691' ' ' ALA . . . . . . . . . . . . . . . -148.97 122.7 9.25 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 120.905 0.384 . . . . 72.420000000000002 111.58 176.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 692' ' ' ILE . . . . . 0.548 HD13 ' HA ' ' A' ' 698' ' ' ASP . 37.2 mm -133.03 131.75 58.84 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 CA-C-N 116.475 -0.329 . . . . 55.340000000000003 111.481 -177.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 58.6 t0 -111.36 129.03 56.13 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 109.627 -0.508 . . . . 74.219999999999999 109.627 171.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -57.69 -28.05 63.47 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 112.619 0.6 . . . . 72.530000000000001 112.619 -173.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 695' ' ' GLU . . . . . 0.437 ' HG3' ' N ' ' A' ' 696' ' ' ASP . 12.6 pt-20 -82.91 -44.48 15.32 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 111.998 0.37 . . . . 54.020000000000003 111.998 -179.418 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 696' ' ' ASP . . . . . 0.437 ' N ' ' HG3' ' A' ' 695' ' ' GLU . 10.5 t70 -95.12 -48.86 5.77 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 121.181 0.515 . . . . 74.230000000000004 111.596 -170.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . 124.32 -137.46 10.68 Favored Glycine 0 CA--C 1.526 0.722 0 CA-C-N 116.179 -0.464 . . . . 55.420000000000002 112.352 -176.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 698' ' ' ASP . . . . . 0.548 ' HA ' HD13 ' A' ' 692' ' ' ILE . 18.0 t70 -70.92 118.21 13.4 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.339 0.59 . . . . 75.310000000000002 111.619 179.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 699' ' ' LEU . . . . . . . . . . . . . 80.3 mt -116.4 18.28 15.22 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 115.882 -0.599 . . . . 73.219999999999999 110.7 173.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 54.1 m -60.78 -27.56 68.09 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.114 0.483 . . . . 74.049999999999997 111.868 -178.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 701' ' ' SER . . . . . . . . . . . . . 25.3 t -78.55 -13.54 59.78 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.071 0.462 . . . . 72.439999999999998 111.513 178.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 702' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -90.03 7.64 36.59 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 116.42 -0.355 . . . . 74.540000000000006 111.436 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 703' ' ' ILE . . . . . 0.494 HG12 ' HB ' ' A' ' 723' ' ' VAL . 62.5 mt -85.39 138.41 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-O 121.336 0.589 . . . . 74.120000000000005 112.209 -177.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 704' ' ' LYS . . . . . . . . . . . . . 67.1 tttt -100.47 140.72 34.32 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.943 -0.571 . . . . 72.099999999999994 109.772 171.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 59.9 t -111.69 112.43 40.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-O 121.146 0.498 . . . . 74.099999999999994 111.807 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 706' ' ' ASP . . . . . 0.567 ' HB2' ' HB ' ' A' ' 720' ' ' THR . 9.2 m-20 -106.08 137.83 43.32 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 116.12 -0.491 . . . . 63.439999999999998 111.388 177.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 101.6 -177.93 27.23 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 121.35 -0.452 . . . . 71.209999999999994 113.509 177.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 708' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -161.79 145.94 12.67 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.959 0.409 . . . . 70.349999999999994 111.415 179.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 709' ' ' VAL . . . . . 0.508 HG22 ' HB2' ' A' ' 717' ' ' TYR . 96.5 t -117.56 120.12 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-N 116.283 -0.417 . . . . 53.399999999999999 110.882 177.016 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 710' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -77.66 135.92 38.15 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 120.912 0.387 . . . . 72.420000000000002 111.574 177.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 711' ' ' THR . . . . . . . . . . . . . 76.2 p -97.66 -1.35 43.83 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.911 0.386 . . . . 73.239999999999995 110.958 173.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 712' ' ' THR . . . . . . . . . . . . . 7.2 t -105.43 -13.47 15.63 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 116.219 -0.446 . . . . 63.329999999999998 111.952 178.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 713' ' ' LYS . . . . . . . . . . . . . 7.8 ttpm? -129.46 127.6 41.2 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.827 0.346 . . . . 62.439999999999998 111.662 -178.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 714' ' ' ALA . . . . . 0.462 ' HB2' HG23 ' A' ' 741' ' ' VAL . . . -72.0 144.89 48.67 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.199 -0.455 . . . . 75.239999999999995 111.735 177.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 152.76 171.87 20.62 Favored Glycine 0 CA--C 1.523 0.574 0 C-N-CA 121.027 -0.606 . . . . 63.329999999999998 113.029 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 716' ' ' THR . . . . . . . . . . . . . 56.3 m -100.3 122.23 42.76 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 122.36 -0.494 . . . . 72.400000000000006 111.327 179.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 717' ' ' TYR . . . . . 0.508 ' HB2' HG22 ' A' ' 709' ' ' VAL . 42.2 m-85 -118.92 134.94 54.84 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.139 -0.482 . . . . 73.140000000000001 110.582 -178.397 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 718' ' ' VAL . . . . . . . . . . . . . 49.5 t -101.27 113.97 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 CA-C-O 121.072 0.463 . . . . 72.530000000000001 111.58 -178.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 719' ' ' LEU . . . . . 0.467 HD21 HG23 ' A' ' 709' ' ' VAL . 92.3 mt -94.9 130.94 41.3 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.331 -0.395 . . . . 75.040000000000006 111.196 178.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 720' ' ' THR . . . . . 0.567 ' HB ' ' HB2' ' A' ' 706' ' ' ASP . 25.0 m -113.29 132.71 55.44 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.753 0.311 . . . . 64.519999999999996 111.196 -178.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 721' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -124.58 140.69 52.71 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.664 0.269 . . . . 74.299999999999997 110.968 -179.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 56.8 m -140.61 123.5 16.39 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 120.513 0.197 . . . . 73.430000000000007 111.179 -179.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 723' ' ' VAL . . . . . 0.494 ' HB ' HG12 ' A' ' 703' ' ' ILE . 7.5 p -114.54 140.94 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 CA-C-O 121.056 0.455 . . . . 60.049999999999997 112.142 -176.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 27.3 m -102.44 144.93 30.27 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 116.136 -0.484 . . . . 63.310000000000002 111.798 -179.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 725' ' ' ASP . . . . . 0.414 ' HB2' ' HG3' ' A' ' 667' ' ' PRO . 5.7 t70 -103.63 150.77 23.67 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.323 0.649 . . . . 53.0 111.088 179.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 726' ' ' SER . . . . . . . . . . . . . 66.9 p -66.03 -14.65 62.04 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 112.522 0.564 . . . . 71.329999999999998 112.522 -175.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 727' ' ' LYS . . . . . 0.416 ' HB2' ' OD2' ' A' ' 664' ' ' ASP . 41.1 mmtm -105.36 -2.73 23.54 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 112.497 0.554 . . . . 63.009999999999998 112.497 -179.594 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 728' ' ' GLY . . . . . . . . . . . . . . . 112.21 12.42 13.77 Favored Glycine 0 CA--C 1.535 1.317 0 N-CA-C 115.384 0.914 . . . . 71.010000000000005 115.384 176.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 18.3 m80 -93.93 133.56 37.23 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 118.351 1.076 . . . . 74.040000000000006 111.241 173.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 730' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -134.24 112.54 11.15 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 122.075 -0.39 . . . . 72.340000000000003 111.263 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 34.1 m -112.47 160.44 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 N-CA-C 112.071 0.397 . . . . 73.420000000000002 112.071 -177.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 9.6 t -136.32 150.34 48.82 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 112.55 0.574 . . . . 75.319999999999993 112.55 -176.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -147.81 161.61 40.9 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.849 -0.614 . . . . 65.450000000000003 110.353 177.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 734' ' ' LYS . . . . . . . . . . . . . 33.2 mtmm -129.32 158.53 38.85 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 113.151 0.797 . . . . 63.439999999999998 113.151 -176.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 735' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -130.76 128.95 41.81 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 114.957 -1.019 . . . . 73.239999999999995 110.7 179.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 736' ' ' THR . . . . . . . . . . . . . 86.7 m -96.03 104.38 16.32 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.887 0.375 . . . . 74.209999999999994 111.205 178.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 737' ' ' VAL . . . . . 0.423 ' HA ' ' O ' ' A' ' 675' ' ' ALA . 46.7 t -97.69 140.84 17.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-O 120.821 0.343 . . . . 62.32 111.223 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 738' ' ' THR . . . . . . . . . . . . . 64.3 m -130.03 120.83 25.35 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 120.777 0.322 . . . . 55.109999999999999 111.147 179.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 739' ' ' VAL . . . . . . . . . . . . . 41.9 t -99.51 133.0 43.9 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-O 120.759 0.314 . . . . 73.409999999999997 111.355 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 740' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -121.97 151.84 40.34 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.39 -0.368 . . . . 75.150000000000006 111.571 -179.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 741' ' ' VAL . . . . . 0.462 HG23 ' HB2' ' A' ' 714' ' ' ALA . 25.1 t . . . . . 0 N--CA 1.47 0.539 0 CA-C-O 120.771 0.32 . . . . 61.439999999999998 111.635 -179.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 664' ' ' ASP . . . . . 0.444 ' OD2' ' HB2' ' A' ' 727' ' ' LYS . 18.7 t0 . . . . . 0 C--O 1.236 0.354 0 CA-C-O 121.255 0.55 . . . . 64.200000000000003 111.729 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 665' ' ' LEU . . . . . . . . . . . . . 73.0 mt -91.08 133.47 35.31 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 115.866 -0.606 . . . . 71.049999999999997 109.814 173.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 666' ' ' GLU . . . . . 0.447 ' H ' ' CD ' ' A' ' 666' ' ' GLU . 1.5 pm0 -64.7 144.96 98.86 Favored Pre-proline 0 CA--C 1.539 0.545 0 CA-C-N 116.218 -0.446 . . . . 45.240000000000002 111.47 -179.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 667' ' ' PRO . . . . . 0.531 ' HD3' ' HB2' ' A' ' 725' ' ' ASP . 25.8 Cg_endo -60.91 145.12 99.51 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 122.785 2.323 . . . . 64.019999999999996 113.149 -174.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 668' ' ' LYS . . . . . . . . . . . . . 9.2 tmtm? -82.58 99.12 9.35 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.33 0.586 . . . . 61.420000000000002 110.384 179.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 669' ' ' LEU . . . . . . . . . . . . . 62.8 tp -89.8 109.27 20.27 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.726 -0.67 . . . . 64.5 110.736 179.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 670' ' ' THR . . . . . . . . . . . . . 60.7 m -87.08 110.42 20.09 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.827 0.346 . . . . 64.0 111.492 -178.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 671' ' ' VAL . . . . . 0.49 HG21 ' HB3' ' A' ' 733' ' ' ALA . 67.3 t -132.89 124.82 18.88 Favored Pre-proline 0 CA--C 1.542 0.668 0 CA-C-N 116.263 -0.426 . . . . 72.140000000000001 110.831 176.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 672' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.75 154.06 43.55 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.358 2.039 . . . . 71.439999999999998 112.537 178.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 673' ' ' VAL . . . . . . . . . . . . . 12.9 p -63.6 -32.25 56.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 N-CA-C 112.062 0.393 . . . . 61.450000000000003 112.062 -176.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 674' ' ' GLY . . . . . . . . . . . . . . . -170.4 173.14 44.3 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 120.685 -0.769 . . . . 73.299999999999997 114.204 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 675' ' ' ALA . . . . . . . . . . . . . . . -152.95 122.95 6.98 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.876 0.37 . . . . 74.209999999999994 111.308 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 676' ' ' THR . . . . . . . . . . . . . 82.7 m -102.29 124.93 48.74 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 112.158 0.429 . . . . 74.230000000000004 112.158 -177.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 677' ' ' ILE . . . . . 0.404 HD13 ' HB2' ' A' ' 683' ' ' PHE . 29.3 pt -126.4 177.0 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 CA-C-N 116.38 -0.373 . . . . 62.420000000000002 111.1 176.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 678' ' ' HIS . . . . . 0.443 ' CD2' ' HG3' ' A' ' 740' ' ' LYS . 68.6 m80 -117.02 156.16 27.97 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.732 0.641 . . . . 73.040000000000006 112.732 -178.085 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 679' ' ' VAL . . . . . 0.526 HG13 ' HA ' ' A' ' 712' ' ' THR . 85.0 t -61.53 121.27 9.32 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-N 115.536 -0.756 . . . . 73.349999999999994 111.375 175.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 110.94 -23.65 18.68 Favored Glycine 0 CA--C 1.526 0.751 0 CA-C-N 116.132 -0.485 . . . . 65.120000000000005 112.185 -177.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 681' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -83.38 -162.8 0.66 Allowed 'General case' 0 CA--C 1.543 0.707 0 CA-C-O 120.984 0.421 . . . . 70.230000000000004 111.687 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 682' ' ' SER . . . . . . . . . . . . . 74.0 m -141.47 173.97 11.0 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 122.156 -0.34 . . . . 74.120000000000005 111.703 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 683' ' ' PHE . . . . . 0.404 ' HB2' HD13 ' A' ' 677' ' ' ILE . 76.2 t80 -150.9 140.4 21.52 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.855 0.36 . . . . 65.329999999999998 111.759 -177.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 684' ' ' VAL . . . . . . . . . . . . . 99.0 t -118.12 105.78 46.36 Favored Pre-proline 0 CA--C 1.545 0.784 0 CA-C-O 120.728 0.299 . . . . 73.530000000000001 111.605 178.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.93 -38.43 78.96 Favored 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 122.745 2.297 . . . . 73.319999999999993 113.505 -178.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 686' ' ' MET . . . . . 0.563 ' HE1' ' HB ' ' A' ' 703' ' ' ILE . 0.3 OUTLIER -78.79 -9.46 59.45 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.759 0.651 . . . . 73.329999999999998 112.759 -175.977 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 687' ' ' ALA . . . . . . . . . . . . . . . -79.96 -44.9 19.46 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 120.9 0.381 . . . . 74.340000000000003 111.923 -179.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 688' ' ' GLU . . . . . . . . . . . . . 45.7 mm-40 -86.6 -8.22 57.68 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 113.0 0.741 . . . . 64.019999999999996 113.0 -174.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 689' ' ' VAL . . . . . 0.556 HG12 HD13 ' A' ' 703' ' ' ILE . 87.6 t -118.58 124.71 73.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-O 120.938 0.399 . . . . 72.430000000000007 111.956 -177.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 690' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -125.41 162.93 23.72 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 116.266 -0.425 . . . . 75.140000000000001 111.062 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 691' ' ' ALA . . . . . . . . . . . . . . . -142.69 121.71 12.86 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.057 0.456 . . . . 74.329999999999998 111.63 176.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 692' ' ' ILE . . . . . . . . . . . . . 45.6 mm -128.69 124.46 61.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-N 116.395 -0.366 . . . . 64.150000000000006 111.55 -178.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 693' ' ' ASP . . . . . 0.488 ' HB2' ' HB3' ' A' ' 667' ' ' PRO . 36.2 t70 -108.35 149.87 28.11 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 120.916 0.389 . . . . 61.43 110.883 173.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 8.3 mtpm? -65.84 -56.68 10.62 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 116.319 -0.401 . . . . 73.420000000000002 111.999 -176.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 695' ' ' GLU . . . . . 0.418 ' CD ' ' H ' ' A' ' 695' ' ' GLU . 0.6 OUTLIER -84.44 -51.76 6.68 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 112.149 0.426 . . . . 75.230000000000004 112.149 -174.856 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 696' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -72.23 -28.68 63.32 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-O 120.933 0.397 . . . . 64.150000000000006 111.397 -173.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . 103.73 -147.09 16.56 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 121.477 -0.392 . . . . 73.510000000000005 113.066 178.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -69.56 131.62 44.97 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 120.982 0.42 . . . . 75.420000000000002 110.995 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 699' ' ' LEU . . . . . 0.428 HD12 ' HB3' ' A' ' 667' ' ' PRO . 98.0 mt -125.45 15.76 8.25 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 120.973 0.416 . . . . 62.229999999999997 111.164 178.093 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 34.9 m -58.75 -38.34 78.21 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 121.064 0.459 . . . . 75.239999999999995 111.455 -178.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 701' ' ' SER . . . . . . . . . . . . . 33.7 m -61.44 -21.95 64.6 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 116.2 -0.454 . . . . 62.039999999999999 111.814 178.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 702' ' ' LYS . . . . . . . . . . . . . 64.0 mttm -91.31 1.28 57.22 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 112.607 0.595 . . . . 70.329999999999998 112.607 -178.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 703' ' ' ILE . . . . . 0.563 ' HB ' ' HE1' ' A' ' 686' ' ' MET . 74.5 mt -69.46 111.91 3.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-O 121.238 0.542 . . . . 72.329999999999998 111.559 -178.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 704' ' ' LYS . . . . . . . . . . . . . 24.3 tptm -85.02 118.91 24.87 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 115.549 -0.751 . . . . 70.420000000000002 110.508 178.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 51.7 t -96.42 138.25 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 CA-C-O 120.963 0.411 . . . . 64.040000000000006 111.823 -177.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 706' ' ' ASP . . . . . 0.584 ' HB3' ' HB ' ' A' ' 720' ' ' THR . 24.1 t70 -132.08 140.8 48.97 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 116.291 -0.413 . . . . 71.519999999999996 111.014 177.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 107.23 -176.79 21.27 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 121.331 -0.461 . . . . 73.109999999999999 113.067 -179.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 708' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -163.49 137.1 5.7 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.182 0.515 . . . . 72.510000000000005 111.734 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 709' ' ' VAL . . . . . 0.548 HG22 ' HB2' ' A' ' 717' ' ' TYR . 46.8 t -112.02 146.18 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-N 116.1 -0.5 . . . . 64.129999999999995 111.309 -178.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 710' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -83.81 156.79 22.32 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 121.396 0.617 . . . . 73.420000000000002 111.832 175.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 711' ' ' THR . . . . . 0.423 ' O ' ' HA ' ' A' ' 679' ' ' VAL . 47.2 p -117.75 -22.84 7.81 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.578 -0.737 . . . . 73.430000000000007 110.796 172.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 712' ' ' THR . . . . . 0.526 ' HA ' HG13 ' A' ' 679' ' ' VAL . 70.2 p -108.11 13.14 26.2 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 111.923 0.342 . . . . 63.43 111.923 178.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 713' ' ' LYS . . . . . . . . . . . . . 3.8 ttmp? -140.08 131.71 27.22 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.664 0.268 . . . . 74.040000000000006 111.132 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 714' ' ' ALA . . . . . . . . . . . . . . . -77.66 143.44 38.16 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 120.81 0.338 . . . . 63.329999999999998 111.284 177.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 155.47 -174.94 33.51 Favored Glycine 0 CA--C 1.525 0.657 0 C-N-CA 121.316 -0.469 . . . . 53.32 112.843 -178.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 716' ' ' THR . . . . . . . . . . . . . 38.7 m -123.55 123.02 39.68 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 117.097 0.449 . . . . 73.030000000000001 111.589 -178.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 717' ' ' TYR . . . . . 0.548 ' HB2' HG22 ' A' ' 709' ' ' VAL . 61.4 m-85 -128.03 128.95 45.91 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.185 -0.461 . . . . 55.240000000000002 110.778 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 718' ' ' VAL . . . . . . . . . . . . . 61.6 t -97.78 118.67 44.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-O 121.172 0.511 . . . . 65.140000000000001 111.942 -176.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 719' ' ' LEU . . . . . 0.407 HD21 HG23 ' A' ' 709' ' ' VAL . 91.0 mt -93.07 133.64 36.03 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.31 -0.404 . . . . 75.049999999999997 111.076 178.139 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 720' ' ' THR . . . . . 0.584 ' HB ' ' HB3' ' A' ' 706' ' ' ASP . 17.0 m -100.96 144.75 29.53 Favored 'General case' 0 N--CA 1.473 0.714 0 O-C-N 122.214 -0.304 . . . . 73.120000000000005 111.101 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 721' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -134.86 113.85 11.98 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 122.449 0.3 . . . . 72.549999999999997 111.0 -178.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 60.4 m -114.23 137.92 51.15 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 111.7 0.259 . . . . 72.140000000000001 111.7 -179.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 8.2 p -138.13 136.17 44.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 CA-C-O 121.011 0.434 . . . . 71.140000000000001 111.446 177.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 42.4 m -113.13 129.58 56.46 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 120.864 0.364 . . . . 72.430000000000007 111.728 -178.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 725' ' ' ASP . . . . . 0.531 ' HB2' ' HD3' ' A' ' 667' ' ' PRO . 17.6 t0 -73.84 150.03 41.24 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-N 116.225 -0.443 . . . . 73.150000000000006 110.081 174.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 726' ' ' SER . . . . . . . . . . . . . 48.8 m -69.01 -27.24 65.5 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.692 0.282 . . . . 64.310000000000002 111.645 -178.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 727' ' ' LYS . . . . . 0.444 ' HB2' ' OD2' ' A' ' 664' ' ' ASP . 1.3 mptp? -89.19 5.22 45.73 Favored 'General case' 0 CA--C 1.546 0.827 0 N-CA-C 112.258 0.466 . . . . 71.150000000000006 112.258 -177.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 728' ' ' GLY . . . . . . . . . . . . . . . 113.31 -2.99 25.19 Favored Glycine 0 CA--C 1.537 1.409 0 N-CA-C 116.463 1.345 . . . . 54.520000000000003 116.463 169.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 63.0 m80 -94.72 119.54 33.51 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 118.941 1.37 . . . . 72.129999999999995 112.05 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 730' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -112.65 138.91 48.76 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 122.038 -0.414 . . . . 72.239999999999995 111.775 -178.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 29.4 m -138.54 152.36 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-O 120.786 0.327 . . . . 54.219999999999999 111.39 178.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 9.0 t -140.3 154.08 46.68 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.038 0.447 . . . . 45.030000000000001 111.653 179.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 733' ' ' ALA . . . . . 0.49 ' HB3' HG21 ' A' ' 671' ' ' VAL . . . -148.86 162.15 40.42 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 116.25 -0.432 . . . . 73.140000000000001 111.342 -179.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 734' ' ' LYS . . . . . . . . . . . . . 10.7 mtmp? -125.96 154.44 42.85 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 112.446 0.536 . . . . 73.219999999999999 112.446 -179.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 735' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -129.7 124.54 33.82 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.858 -0.61 . . . . 65.400000000000006 110.585 178.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 736' ' ' THR . . . . . . . . . . . . . 88.1 m -90.91 103.9 16.56 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.841 0.353 . . . . 74.430000000000007 111.633 -177.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 50.3 t -96.55 131.76 42.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 O-C-N 122.124 -0.36 . . . . 74.510000000000005 111.299 -178.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 738' ' ' THR . . . . . . . . . . . . . 88.5 m -122.68 122.75 39.51 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.028 0.442 . . . . 73.239999999999995 111.651 -178.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 739' ' ' VAL . . . . . . . . . . . . . 21.5 t -100.85 131.51 48.33 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 116.143 -0.48 . . . . 70.430000000000007 110.812 178.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 740' ' ' LYS . . . . . 0.443 ' HG3' ' CD2' ' A' ' 678' ' ' HIS . 16.9 ptpt -124.32 160.38 28.2 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.233 0.539 . . . . 74.230000000000004 111.705 177.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 741' ' ' VAL . . . . . 0.462 HG22 HG21 ' A' ' 679' ' ' VAL . 37.8 t . . . . . 0 CA--C 1.537 0.479 0 N-CA-C 112.507 0.558 . . . . 45.299999999999997 112.507 -172.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 664' ' ' ASP . . . . . 0.448 ' HB3' ' HE1' ' A' ' 729' ' ' HIS . 12.8 t70 . . . . . 0 CA--C 1.538 0.505 0 CA-C-O 120.928 0.394 . . . . 72.340000000000003 111.89 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 665' ' ' LEU . . . . . . . . . . . . . 80.7 mt -88.03 117.41 26.89 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 116.337 -0.392 . . . . 55.100000000000001 110.122 173.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 666' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -54.31 149.07 21.01 Favored Pre-proline 0 CA--C 1.54 0.559 0 CA-C-O 120.796 0.331 . . . . 64.129999999999995 111.444 178.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 667' ' ' PRO . . . . . 0.436 ' HA ' ' HA ' ' A' ' 693' ' ' ASP . 38.2 Cg_exo -57.77 140.48 93.77 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 122.422 2.081 . . . . 72.230000000000004 112.95 -173.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 668' ' ' LYS . . . . . 0.718 ' HA ' ' HE2' ' A' ' 668' ' ' LYS . 0.6 OUTLIER -82.88 102.96 12.0 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 120.932 0.396 . . . . 73.430000000000007 110.363 175.403 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 669' ' ' LEU . . . . . 0.502 ' HG ' HG23 ' A' ' 671' ' ' VAL . 61.9 tp -90.01 118.61 29.69 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.195 -0.457 . . . . 75.109999999999999 111.354 -179.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 670' ' ' THR . . . . . . . . . . . . . 89.3 m -93.85 109.85 21.53 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.732 0.301 . . . . 73.540000000000006 110.986 177.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 671' ' ' VAL . . . . . 0.502 HG23 ' HG ' ' A' ' 669' ' ' LEU . 95.7 t -139.74 122.19 10.13 Favored Pre-proline 0 CA--C 1.538 0.51 0 CA-C-N 116.151 -0.477 . . . . 72.230000000000004 110.583 177.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 672' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -76.37 151.88 33.96 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 122.119 1.879 . . . . 75.340000000000003 112.177 177.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 673' ' ' VAL . . . . . . . . . . . . . 8.0 p -64.27 -31.89 55.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 N-CA-C 112.325 0.491 . . . . 74.310000000000002 112.325 -175.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 674' ' ' GLY . . . . . . . . . . . . . . . -160.51 166.72 35.47 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 120.469 -0.872 . . . . 30.239999999999998 114.3 -177.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 675' ' ' ALA . . . . . . . . . . . . . . . -142.77 151.06 40.83 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.312 0.645 . . . . 71.129999999999995 109.849 177.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 676' ' ' THR . . . . . . . . . . . . . 91.5 m -137.93 119.23 14.66 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.105 0.479 . . . . 72.329999999999998 111.883 -177.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 677' ' ' ILE . . . . . . . . . . . . . 33.5 pt -130.75 176.48 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-N 116.032 -0.531 . . . . 75.150000000000006 111.097 -179.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 678' ' ' HIS . . . . . 0.524 ' HA ' ' O ' ' A' ' 740' ' ' LYS . 65.3 m80 -110.78 156.7 20.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.279 0.561 . . . . 75.230000000000004 111.815 177.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 679' ' ' VAL . . . . . 0.551 HG13 ' HA ' ' A' ' 712' ' ' THR . 85.2 t -58.31 126.16 15.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-N 115.899 -0.591 . . . . 55.420000000000002 110.98 174.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 94.82 4.6 61.69 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 121.153 -0.546 . . . . 40.140000000000001 113.568 -179.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 681' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -97.7 165.35 12.0 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.366 0.603 . . . . 62.420000000000002 112.152 178.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 682' ' ' SER . . . . . . . . . . . . . 46.5 m -93.9 137.14 33.45 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.887 -0.597 . . . . 65.420000000000002 111.739 -179.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 683' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -135.09 128.7 32.71 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 120.928 0.394 . . . . 72.219999999999999 111.531 -179.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 684' ' ' VAL . . . . . . . . . . . . . 48.9 t -125.07 97.99 36.9 Favored Pre-proline 0 CA--C 1.542 0.656 0 CA-C-O 120.856 0.36 . . . . 63.240000000000002 111.444 177.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -63.7 -34.19 63.44 Favored 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 122.491 2.127 . . . . 64.040000000000006 113.571 -178.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 686' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -79.34 -6.32 56.49 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.782 0.66 . . . . 62.409999999999997 112.782 -176.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 687' ' ' ALA . . . . . . . . . . . . . . . -92.37 -38.19 12.16 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.869 0.366 . . . . 74.439999999999998 111.924 179.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 688' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -98.69 13.08 33.42 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 112.384 0.513 . . . . 75.230000000000004 112.384 -176.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 689' ' ' VAL . . . . . 0.417 HG13 HG22 ' A' ' 671' ' ' VAL . 85.2 t -125.04 140.04 49.33 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-N 116.301 -0.409 . . . . 71.019999999999996 110.086 173.252 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 690' ' ' LEU . . . . . 0.55 HD21 HG12 ' A' ' 692' ' ' ILE . 9.2 tt -145.17 153.85 41.8 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 111.574 0.213 . . . . 62.130000000000003 111.574 -172.152 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 691' ' ' ALA . . . . . . . . . . . . . . . -147.4 125.12 11.83 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 112.049 0.389 . . . . 61.32 112.049 179.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 692' ' ' ILE . . . . . 0.55 HG12 HD21 ' A' ' 690' ' ' LEU . 47.5 mm -127.93 119.05 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 N-CA-C 112.032 0.382 . . . . 65.430000000000007 112.032 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 693' ' ' ASP . . . . . 0.436 ' HA ' ' HA ' ' A' ' 667' ' ' PRO . 14.6 t70 -94.81 147.7 23.07 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 109.789 -0.449 . . . . 70.299999999999997 109.789 171.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 64.9 tttm -58.31 -61.91 2.23 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.373 0.508 . . . . 75.040000000000006 112.373 -174.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -88.5 -39.77 13.94 Favored 'General case' 0 N--CA 1.479 1.002 0 O-C-N 121.846 -0.534 . . . . 64.409999999999997 112.242 -176.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 696' ' ' ASP . . . . . . . . . . . . . 34.3 t0 -70.99 -23.52 62.21 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.257 0.551 . . . . 61.109999999999999 110.826 -176.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . 90.3 -147.32 19.1 Favored Glycine 0 CA--C 1.525 0.665 0 CA-C-N 116.043 -0.526 . . . . 53.119999999999997 113.87 173.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 698' ' ' ASP . . . . . 0.454 ' HA ' HD13 ' A' ' 692' ' ' ILE . 14.4 t70 -67.9 123.03 19.46 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.058 0.456 . . . . 73.409999999999997 111.189 -179.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 699' ' ' LEU . . . . . . . . . . . . . 80.8 mt -122.25 24.95 9.2 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.993 -0.549 . . . . 74.549999999999997 110.782 178.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 88.4 m -61.96 -40.32 95.17 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.044 0.45 . . . . 75.010000000000005 112.032 -177.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 701' ' ' SER . . . . . . . . . . . . . 15.6 t -79.86 -3.69 49.01 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 121.048 0.451 . . . . 75.510000000000005 111.246 179.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 702' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -84.9 -11.43 55.6 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 120.988 0.423 . . . . 73.5 110.822 175.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 74.6 mt -68.57 117.71 11.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-O 121.588 0.709 . . . . 72.510000000000005 112.82 -173.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 704' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -83.67 121.58 27.46 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.397 -0.819 . . . . 64.530000000000001 110.627 174.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 41.7 t -99.61 116.38 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-O 120.82 0.343 . . . . 72.430000000000007 111.077 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 706' ' ' ASP . . . . . 0.55 ' HB3' ' HB ' ' A' ' 720' ' ' THR . 32.9 t70 -109.96 123.21 49.24 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 120.74 0.305 . . . . 70.25 110.993 179.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 130.11 173.92 13.54 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 121.397 -0.43 . . . . 53.140000000000001 113.07 -178.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 708' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -135.27 142.23 45.86 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 122.447 -0.443 . . . . 74.450000000000003 111.518 -178.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 709' ' ' VAL . . . . . 0.49 HG23 HD21 ' A' ' 719' ' ' LEU . 98.9 t -126.32 128.25 71.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-O 120.872 0.367 . . . . 74.329999999999998 111.424 -179.094 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 710' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -109.38 137.4 47.3 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 116.73 -0.214 . . . . 60.409999999999997 110.552 177.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 711' ' ' THR . . . . . . . . . . . . . 67.3 p -111.7 4.21 18.37 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 112.85 0.685 . . . . 73.129999999999995 112.85 -175.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 712' ' ' THR . . . . . 0.551 ' HA ' HG13 ' A' ' 679' ' ' VAL . 12.9 t -111.99 -10.47 13.94 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 112.163 0.431 . . . . 74.420000000000002 112.163 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 713' ' ' LYS . . . . . 0.431 ' HD3' ' N ' ' A' ' 714' ' ' ALA . 8.8 tmtt? -128.8 129.91 46.28 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 109.861 -0.422 . . . . 73.099999999999994 109.861 176.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 714' ' ' ALA . . . . . 0.431 ' N ' ' HD3' ' A' ' 713' ' ' LYS . . . -69.81 127.6 33.48 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 112.426 0.528 . . . . 74.049999999999997 112.426 -176.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 177.8 174.33 44.03 Favored Glycine 0 CA--C 1.524 0.6 0 CA-C-N 116.098 -0.501 . . . . 64.140000000000001 112.772 -179.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 716' ' ' THR . . . . . . . . . . . . . 38.6 m -100.01 121.9 42.08 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 122.532 -0.393 . . . . 63.310000000000002 111.056 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 717' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -122.39 109.58 14.58 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 120.646 0.26 . . . . 60.329999999999998 110.783 -177.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 718' ' ' VAL . . . . . 0.412 ' HA ' ' HA ' ' A' ' 736' ' ' THR . 42.6 t -93.79 126.96 46.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-O 120.941 0.4 . . . . 71.239999999999995 111.845 -175.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 719' ' ' LEU . . . . . 0.49 HD21 HG23 ' A' ' 709' ' ' VAL . 97.2 mt -105.32 153.01 22.2 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.955 0.407 . . . . 71.310000000000002 111.277 177.095 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 720' ' ' THR . . . . . 0.55 ' HB ' ' HB3' ' A' ' 706' ' ' ASP . 28.8 m -120.82 129.74 53.68 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.487 -0.324 . . . . 63.340000000000003 110.809 177.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 721' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -115.18 119.79 37.58 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 120.824 0.345 . . . . 75.230000000000004 111.371 -178.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 87.0 m -124.05 140.41 53.0 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 116.54 -0.3 . . . . 70.040000000000006 111.209 -179.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 10.4 p -141.01 143.47 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 CA-C-O 120.866 0.365 . . . . 63.409999999999997 111.924 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 724' ' ' THR . . . . . 0.45 ' HA ' ' O ' ' A' ' 729' ' ' HIS . 23.7 m -123.01 142.2 51.11 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 116.392 -0.367 . . . . 61.119999999999997 111.603 -179.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -100.51 178.61 4.68 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.251 0.548 . . . . 74.239999999999995 112.316 -177.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 726' ' ' SER . . . . . . . . . . . . . 38.0 t -54.51 -31.92 57.03 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 113.323 0.86 . . . . 75.200000000000003 113.323 -179.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 727' ' ' LYS . . . . . . . . . . . . . 44.8 mmtm -86.63 -14.76 41.75 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 121.877 -0.514 . . . . 74.319999999999993 111.913 -179.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 728' ' ' GLY . . . . . . . . . . . . . . . 103.23 13.43 28.78 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 121.023 -0.608 . . . . 63.420000000000002 113.792 -178.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 729' ' ' HIS . . . . . 0.45 ' O ' ' HA ' ' A' ' 724' ' ' THR . 58.7 m80 -72.01 123.93 23.85 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 117.283 0.541 . . . . 72.109999999999999 110.54 174.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 730' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -122.25 108.47 13.32 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.137 0.494 . . . . 72.519999999999996 112.179 -174.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 34.9 m -107.72 155.67 8.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-N 116.036 -0.529 . . . . 65.109999999999999 110.737 176.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 5.4 t -152.51 136.86 16.67 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 112.819 0.674 . . . . 75.040000000000006 112.819 -175.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -141.87 146.87 36.28 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.09 -0.505 . . . . 75.120000000000005 111.214 -179.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 734' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -105.09 158.29 16.67 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.213 0.53 . . . . 74.310000000000002 112.188 -176.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 735' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -141.85 118.0 10.69 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.687 -0.688 . . . . 75.230000000000004 110.665 175.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 736' ' ' THR . . . . . 0.412 ' HA ' ' HA ' ' A' ' 718' ' ' VAL . 6.5 t -84.37 111.94 19.89 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.227 0.536 . . . . 53.450000000000003 111.73 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 43.5 t -96.63 103.84 15.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-O 121.282 0.563 . . . . 53.43 111.382 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 738' ' ' THR . . . . . . . . . . . . . 30.8 m -93.61 113.45 25.56 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.984 0.421 . . . . 74.209999999999994 111.344 -177.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 739' ' ' VAL . . . . . . . . . . . . . 45.8 t -96.41 116.4 38.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-N 116.297 -0.411 . . . . 72.120000000000005 111.037 178.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 740' ' ' LYS . . . . . 0.524 ' O ' ' HA ' ' A' ' 678' ' ' HIS . 11.7 ptmm? -111.59 159.11 18.47 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.027 0.442 . . . . 74.319999999999993 111.144 178.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 741' ' ' VAL . . . . . . . . . . . . . 38.3 t . . . . . 0 CA--C 1.54 0.588 0 CA-C-O 120.798 0.333 . . . . 62.100000000000001 111.829 -175.3 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 664' ' ' ASP . . . . . . . . . . . . . 22.2 t0 . . . . . 0 CA--C 1.538 0.492 0 CA-C-O 121.633 0.73 . . . . 72.439999999999998 112.356 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 665' ' ' LEU . . . . . . . . . . . . . 44.8 mt -113.64 138.02 50.79 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.086 -0.961 . . . . 71.400000000000006 110.59 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 666' ' ' GLU . . . . . 0.484 ' H ' ' CD ' ' A' ' 666' ' ' GLU . 1.6 pm0 -54.01 139.23 54.15 Favored Pre-proline 0 CA--C 1.545 0.752 0 CA-C-O 120.762 0.315 . . . . 51.119999999999997 111.309 176.302 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 667' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -68.95 160.27 50.54 Favored 'Trans proline' 0 CA--C 1.545 1.045 0 C-N-CA 122.963 2.442 . . . . 64.099999999999994 115.124 -166.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 668' ' ' LYS . . . . . 0.442 ' HA ' ' HE3' ' A' ' 668' ' ' LYS . 0.2 OUTLIER -83.22 102.23 11.77 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 114.948 -1.024 . . . . 70.099999999999994 111.022 177.896 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 669' ' ' LEU . . . . . . . . . . . . . 57.9 tp -103.49 114.64 29.08 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 120.783 0.325 . . . . 63.299999999999997 111.096 176.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 670' ' ' THR . . . . . . . . . . . . . 99.4 m -101.67 112.1 24.56 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.875 0.369 . . . . 75.439999999999998 111.425 178.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 671' ' ' VAL . . . . . . . . . . . . . 90.2 t -125.98 132.84 24.45 Favored Pre-proline 0 CA--C 1.538 0.492 0 CA-C-N 116.3 -0.409 . . . . 75.120000000000005 110.776 177.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 672' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -66.47 138.43 50.25 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 122.128 1.886 . . . . 74.099999999999994 112.363 178.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 673' ' ' VAL . . . . . . . . . . . . . 11.7 p -73.17 -34.09 43.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 N-CA-C 112.326 0.491 . . . . 63.149999999999999 112.326 -175.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 674' ' ' GLY . . . . . . . . . . . . . . . -150.74 151.12 23.18 Favored Glycine 0 CA--C 1.523 0.533 0 C-N-CA 120.557 -0.83 . . . . 74.319999999999993 113.674 -176.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 675' ' ' ALA . . . . . 0.524 ' HB3' HG22 ' A' ' 737' ' ' VAL . . . -138.92 144.42 39.08 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 122.476 0.31 . . . . 63.329999999999998 110.978 179.136 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 676' ' ' THR . . . . . . . . . . . . . 36.5 m -131.42 118.61 20.48 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 120.596 0.236 . . . . 42.020000000000003 111.103 -178.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 677' ' ' ILE . . . . . . . . . . . . . 42.9 pt -136.67 177.58 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-O 121.091 0.472 . . . . 74.349999999999994 111.695 179.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 678' ' ' HIS . . . . . . . . . . . . . 79.2 m80 -129.57 140.29 51.25 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 111.924 0.342 . . . . 64.120000000000005 111.924 -178.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 679' ' ' VAL . . . . . . . . . . . . . 89.7 t -46.87 122.18 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 CA-C-N 115.753 -0.658 . . . . 70.219999999999999 112.558 -178.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 104.14 14.97 23.09 Favored Glycine 0 CA--C 1.528 0.883 0 CA-C-N 116.246 -0.433 . . . . 74.209999999999994 113.533 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 681' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -101.25 -161.94 0.9 Allowed 'General case' 0 CA--C 1.545 0.788 0 CA-C-O 121.407 0.622 . . . . 64.409999999999997 112.044 -179.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 682' ' ' SER . . . . . . . . . . . . . 40.1 m -134.62 111.1 9.75 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 115.938 -0.574 . . . . 73.329999999999998 110.394 175.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 683' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -118.7 136.24 54.04 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.582 0.23 . . . . 62.409999999999997 111.474 -177.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 684' ' ' VAL . . . . . 0.41 HG12 ' H ' ' A' ' 687' ' ' ALA . 86.5 t -121.38 111.8 33.23 Favored Pre-proline 0 CA--C 1.54 0.561 0 CA-C-O 120.553 0.216 . . . . 71.030000000000001 111.104 177.555 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -59.46 -50.62 7.89 Favored 'Trans proline' 0 CA--C 1.543 0.968 0 C-N-CA 122.723 2.282 . . . . 63.210000000000001 114.105 -176.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 686' ' ' MET . . . . . . . . . . . . . 53.9 mtp -79.73 -12.62 59.79 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 113.439 0.903 . . . . 74.340000000000003 113.439 -175.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 687' ' ' ALA . . . . . 0.41 ' H ' HG12 ' A' ' 684' ' ' VAL . . . -65.54 -21.17 66.58 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.845 0.355 . . . . 52.43 111.553 -178.412 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 688' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -107.37 0.73 23.2 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 112.346 0.498 . . . . 74.430000000000007 112.346 -178.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 25.4 t -99.55 151.11 4.94 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 O-C-N 122.098 -0.376 . . . . 74.120000000000005 111.528 -177.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 690' ' ' LEU . . . . . 0.446 HD21 HG12 ' A' ' 692' ' ' ILE . 9.1 tt -148.08 146.78 28.97 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 122.347 0.259 . . . . 72.519999999999996 111.025 -177.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 691' ' ' ALA . . . . . . . . . . . . . . . -145.73 128.46 16.24 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 111.994 0.368 . . . . 52.420000000000002 111.994 179.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 692' ' ' ILE . . . . . 0.529 HD13 ' HA ' ' A' ' 698' ' ' ASP . 45.4 mm -134.01 134.21 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 122.72 0.408 . . . . 63.229999999999997 111.737 -177.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 693' ' ' ASP . . . . . 0.454 ' HB2' ' CD1' ' A' ' 699' ' ' LEU . 35.0 t70 -106.95 144.77 33.1 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 122.077 -0.39 . . . . 63.420000000000002 111.01 173.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -59.33 -39.89 84.56 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 116.128 -0.487 . . . . 75.099999999999994 112.11 -177.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -83.01 -55.78 4.18 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 112.462 0.541 . . . . 73.230000000000004 112.462 -178.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 696' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -79.41 -48.27 14.27 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 112.445 0.535 . . . . 74.349999999999994 112.445 -169.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . 122.31 -112.26 1.96 Allowed Glycine 0 CA--C 1.522 0.47 0 C-N-CA 120.913 -0.66 . . . . 41.530000000000001 112.613 -176.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 698' ' ' ASP . . . . . 0.529 ' HA ' HD13 ' A' ' 692' ' ' ILE . 13.0 t70 -87.65 116.92 26.11 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 122.179 -0.601 . . . . 71.209999999999994 112.064 -176.271 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 699' ' ' LEU . . . . . 0.454 ' CD1' ' HB2' ' A' ' 693' ' ' ASP . 56.9 mt -112.37 21.2 15.98 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 116.287 -0.415 . . . . 75.420000000000002 111.32 175.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 29.6 m -60.14 -25.94 65.88 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 120.952 0.406 . . . . 70.040000000000006 111.603 -178.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 701' ' ' SER . . . . . . . . . . . . . 40.0 t -82.02 -18.21 44.06 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 121.163 0.506 . . . . 71.510000000000005 111.412 177.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 702' ' ' LYS . . . . . . . . . . . . . 48.6 mmtm -82.42 3.08 29.5 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 116.293 -0.412 . . . . 65.519999999999996 111.873 179.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 72.1 mt -78.37 138.98 19.24 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 CA-C-O 121.326 0.584 . . . . 73.439999999999998 112.438 -177.368 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 704' ' ' LYS . . . . . 0.471 ' O ' ' HA ' ' A' ' 721' ' ' TYR . 22.5 ttmm -104.84 139.33 39.76 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.783 -0.644 . . . . 65.530000000000001 110.267 178.149 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 60.8 t -115.59 111.09 34.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 N-CA-C 112.392 0.515 . . . . 73.450000000000003 112.392 -177.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 706' ' ' ASP . . . . . 0.571 ' HB3' ' HB ' ' A' ' 720' ' ' THR . 28.7 t70 -107.41 133.14 52.36 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.122 -0.49 . . . . 62.32 110.568 174.09 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 86.86 165.74 41.63 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 120.894 -0.67 . . . . 75.420000000000002 112.441 -176.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 708' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -159.37 148.78 18.44 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 122.283 -0.54 . . . . 64.510000000000005 111.153 -179.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 709' ' ' VAL . . . . . 0.451 HG23 HD11 ' A' ' 719' ' ' LEU . 58.7 t -96.45 137.58 23.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-N 116.094 -0.503 . . . . 64.319999999999993 111.665 -178.452 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 710' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -105.03 136.76 43.9 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 116.188 -0.46 . . . . 74.25 110.225 175.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 711' ' ' THR . . . . . . . . . . . . . 73.4 p -107.91 8.77 28.69 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 112.814 0.672 . . . . 74.120000000000005 112.814 -174.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 712' ' ' THR . . . . . . . . . . . . . 7.2 t -111.83 -9.73 14.05 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 122.078 -0.389 . . . . 50.549999999999997 111.61 176.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 713' ' ' LYS . . . . . . . . . . . . . 37.8 tttp -129.3 133.19 47.35 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 120.653 0.263 . . . . 74.439999999999998 110.885 177.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 714' ' ' ALA . . . . . . . . . . . . . . . -77.73 134.01 38.18 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 112.18 0.437 . . . . 74.129999999999995 112.18 -178.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 168.27 179.81 40.91 Favored Glycine 0 CA--C 1.524 0.625 0 CA-C-N 116.123 -0.49 . . . . 72.340000000000003 112.854 -179.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 716' ' ' THR . . . . . . . . . . . . . 41.0 m -108.64 122.67 47.59 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 120.999 0.428 . . . . 73.109999999999999 111.384 -178.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 717' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -114.06 124.09 51.28 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 116.284 -0.416 . . . . 71.319999999999993 111.036 -177.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 718' ' ' VAL . . . . . . . . . . . . . 49.3 t -97.36 114.65 35.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-O 121.111 0.481 . . . . 65.409999999999997 111.124 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 719' ' ' LEU . . . . . 0.451 HD11 HG23 ' A' ' 709' ' ' VAL . 47.4 mt -101.51 132.75 46.97 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 116.292 -0.413 . . . . 74.109999999999999 111.41 -177.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 720' ' ' THR . . . . . 0.571 ' HB ' ' HB3' ' A' ' 706' ' ' ASP . 34.9 m -110.06 128.02 55.18 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 120.958 0.409 . . . . 60.119999999999997 111.501 178.083 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 721' ' ' TYR . . . . . 0.471 ' HA ' ' O ' ' A' ' 704' ' ' LYS . 75.3 m-85 -117.97 126.36 52.18 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.524 -0.307 . . . . 72.310000000000002 110.84 178.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 56.1 m -127.98 122.27 31.89 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 116.853 -0.158 . . . . 74.219999999999999 111.266 -178.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 12.9 p -111.11 142.14 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-O 120.903 0.382 . . . . 62.409999999999997 111.372 -179.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 52.3 m -113.79 126.5 55.28 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.083 0.468 . . . . 75.299999999999997 112.099 -178.368 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 725' ' ' ASP . . . . . 0.517 ' HB3' ' HB2' ' A' ' 729' ' ' HIS . 0.2 OUTLIER -84.5 158.81 20.88 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 115.953 -0.567 . . . . 75.319999999999993 111.483 176.22 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 726' ' ' SER . . . . . . . . . . . . . 49.8 m -58.21 -34.74 70.73 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.872 0.693 . . . . 71.129999999999995 112.872 -176.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 727' ' ' LYS . . . . . 0.489 ' HD2' ' N ' ' A' ' 727' ' ' LYS . 3.4 mptp? -90.45 13.45 15.62 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 122.09 -0.381 . . . . 72.120000000000005 111.59 -177.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 728' ' ' GLY . . . . . . . . . . . . . . . 91.54 10.84 61.46 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 121.118 -0.563 . . . . 52.130000000000003 114.224 174.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 729' ' ' HIS . . . . . 0.517 ' HB2' ' HB3' ' A' ' 725' ' ' ASP . 46.7 m80 -80.79 107.24 13.43 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 117.397 0.598 . . . . 74.109999999999999 111.203 178.36 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 730' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -111.39 124.69 52.77 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.982 -0.554 . . . . 43.25 111.271 -175.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 28.8 m -131.16 152.6 37.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 CA-C-O 120.739 0.304 . . . . 73.409999999999997 111.283 179.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 10.2 t -136.25 153.81 51.09 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 112.727 0.639 . . . . 63.140000000000001 112.727 -176.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -148.35 161.6 41.22 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.079 0.551 . . . . 52.039999999999999 110.704 177.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 734' ' ' LYS . . . . . . . . . . . . . 41.3 mttp -122.72 156.6 34.08 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 113.246 0.832 . . . . 74.120000000000005 113.246 -176.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 735' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -130.56 128.56 41.35 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 115.141 -0.936 . . . . 74.420000000000002 110.542 176.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 736' ' ' THR . . . . . . . . . . . . . 85.3 m -96.96 104.01 15.99 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.825 0.345 . . . . 71.510000000000005 111.37 178.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 737' ' ' VAL . . . . . 0.524 HG22 ' HB3' ' A' ' 675' ' ' ALA . 48.7 t -98.76 131.9 45.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-O 120.638 0.256 . . . . 44.149999999999999 111.414 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 738' ' ' THR . . . . . . . . . . . . . 90.7 m -121.36 117.9 28.12 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.042 0.449 . . . . 74.409999999999997 111.574 179.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 739' ' ' VAL . . . . . . . . . . . . . 27.4 t -98.94 125.14 52.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-N 116.244 -0.435 . . . . 73.340000000000003 111.043 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 740' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -114.1 152.34 31.23 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 112.142 0.423 . . . . 73.510000000000005 112.142 -177.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 741' ' ' VAL . . . . . . . . . . . . . 23.7 t . . . . . 0 CA--C 1.544 0.717 0 CA-C-O 121.191 0.519 . . . . 74.409999999999997 112.307 -176.599 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 664' ' ' ASP . . . . . 0.454 ' OD2' ' HB2' ' A' ' 727' ' ' LYS . 35.4 t0 . . . . . 0 CA--C 1.532 0.265 0 CA-C-O 120.988 0.423 . . . . 74.030000000000001 109.916 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 665' ' ' LEU . . . . . 0.429 HD12 ' HD3' ' A' ' 694' ' ' LYS . 88.2 mt -90.6 137.32 32.45 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.165 -0.47 . . . . 73.219999999999999 110.463 175.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 666' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -57.01 131.96 80.05 Favored Pre-proline 0 CA--C 1.54 0.586 0 CA-C-N 116.496 -0.32 . . . . 71.030000000000001 110.557 172.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 667' ' ' PRO . . . . . 0.544 ' HB3' HD12 ' A' ' 699' ' ' LEU . 26.9 Cg_endo -60.37 148.61 89.8 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 122.433 2.089 . . . . 72.230000000000004 113.36 -172.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 668' ' ' LYS . . . . . . . . . . . . . 56.9 tptt -83.22 108.61 16.58 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.095 0.474 . . . . 72.219999999999999 111.213 177.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 669' ' ' LEU . . . . . 0.536 ' HG ' HG23 ' A' ' 671' ' ' VAL . 56.6 tp -96.65 111.97 23.9 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 116.281 -0.418 . . . . 70.310000000000002 111.335 -179.585 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 670' ' ' THR . . . . . . . . . . . . . 72.6 m -87.87 109.69 19.96 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.657 0.265 . . . . 52.140000000000001 110.927 179.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 671' ' ' VAL . . . . . 0.536 HG23 ' HG ' ' A' ' 669' ' ' LEU . 95.2 t -136.23 130.1 18.13 Favored Pre-proline 0 N--CA 1.472 0.663 0 CA-C-N 116.455 -0.339 . . . . 71.010000000000005 111.065 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 672' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -76.2 156.09 37.64 Favored 'Trans proline' 0 CA--C 1.542 0.882 0 C-N-CA 122.622 2.215 . . . . 74.140000000000001 112.759 176.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 673' ' ' VAL . . . . . . . . . . . . . 13.5 p -81.66 -33.59 12.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 N-CA-C 112.94 0.719 . . . . 55.329999999999998 112.94 -174.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 674' ' ' GLY . . . . . 0.401 ' HA2' ' O ' ' A' ' 736' ' ' THR . . . -175.08 139.55 4.85 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 119.926 -1.131 . . . . 52.109999999999999 114.35 -176.078 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 675' ' ' ALA . . . . . . . . . . . . . . . -139.96 151.33 45.45 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 122.654 0.382 . . . . 52.450000000000003 110.965 178.047 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 676' ' ' THR . . . . . . . . . . . . . 97.6 m -131.62 123.17 27.32 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-O 120.719 0.295 . . . . 74.510000000000005 111.576 -179.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 677' ' ' ILE . . . . . . . . . . . . . 29.8 pt -123.14 177.44 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 122.699 0.4 . . . . 72.450000000000003 111.405 -179.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 678' ' ' HIS . . . . . . . . . . . . . 74.2 m80 -107.37 161.66 14.61 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 121.326 0.584 . . . . 72.409999999999997 112.368 178.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 679' ' ' VAL . . . . . 0.607 HG13 ' HA ' ' A' ' 712' ' ' THR . 76.6 t -60.44 126.37 18.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-N 115.747 -0.661 . . . . 64.040000000000006 111.837 176.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 103.52 -2.69 46.15 Favored Glycine 0 CA--C 1.528 0.906 0 CA-C-N 116.129 -0.487 . . . . 64.209999999999994 113.389 -178.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 681' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -88.8 -175.74 4.99 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 116.91 0.355 . . . . 74.099999999999994 110.979 178.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 682' ' ' SER . . . . . . . . . . . . . 74.9 m -134.69 137.68 43.76 Favored 'General case' 0 N--CA 1.477 0.898 0 O-C-N 121.993 -0.442 . . . . 72.400000000000006 111.877 -178.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 683' ' ' PHE . . . . . . . . . . . . . 47.2 t80 -125.89 133.81 51.79 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 116.35 -0.386 . . . . 62.299999999999997 110.655 -178.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 684' ' ' VAL . . . . . . . . . . . . . 46.4 t -123.77 93.77 46.9 Favored Pre-proline 0 CA--C 1.546 0.791 0 CA-C-O 121.108 0.48 . . . . 72.109999999999999 112.089 -174.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -64.02 -29.58 66.26 Favored 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 122.706 2.271 . . . . 75.530000000000001 113.805 -178.17 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 686' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -79.3 -7.57 58.4 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.547 0.573 . . . . 72.140000000000001 112.547 -177.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 687' ' ' ALA . . . . . . . . . . . . . . . -110.26 -39.1 5.08 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.866 0.365 . . . . 62.340000000000003 111.655 177.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 688' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -77.38 -10.47 59.47 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 112.43 0.53 . . . . 54.439999999999998 112.43 -177.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 689' ' ' VAL . . . . . 0.476 HG12 HD13 ' A' ' 703' ' ' ILE . 88.7 t -119.03 125.01 74.13 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 CA-C-O 120.865 0.364 . . . . 73.510000000000005 111.565 178.089 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 690' ' ' LEU . . . . . 0.42 HD22 ' N ' ' A' ' 690' ' ' LEU . 2.7 mm? -122.36 161.77 22.81 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 120.863 0.364 . . . . 73.120000000000005 111.375 -177.223 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 691' ' ' ALA . . . . . . . . . . . . . . . -147.46 122.62 10.18 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 120.966 0.412 . . . . 63.420000000000002 111.896 177.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 692' ' ' ILE . . . . . . . . . . . . . 45.4 mm -123.9 135.01 64.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-N 116.349 -0.387 . . . . 74.239999999999995 111.25 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -120.44 149.91 41.64 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 120.823 0.344 . . . . 70.430000000000007 111.63 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 694' ' ' LYS . . . . . 0.429 ' HD3' HD12 ' A' ' 665' ' ' LEU . 37.8 ttpt -62.49 -61.2 2.6 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 112.314 0.487 . . . . 73.510000000000005 112.314 -177.465 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 695' ' ' GLU . . . . . 0.468 ' CD ' ' H ' ' A' ' 695' ' ' GLU . 0.1 OUTLIER -85.09 -53.11 5.48 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 111.868 0.321 . . . . 64.409999999999997 111.868 -174.664 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 696' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -66.52 -48.91 68.26 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 121.063 0.459 . . . . 71.140000000000001 111.052 -173.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . 122.49 -146.95 16.88 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 121.224 -0.513 . . . . 72.109999999999999 113.11 178.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -70.94 111.36 6.27 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.955 0.407 . . . . 62.32 110.921 179.078 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 699' ' ' LEU . . . . . 0.544 HD12 ' HB3' ' A' ' 667' ' ' PRO . 79.0 mt -104.77 17.41 24.18 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 120.85 0.357 . . . . 52.399999999999999 111.503 179.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 42.4 m -56.77 -37.12 70.65 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.177 0.513 . . . . 73.349999999999994 111.268 178.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 701' ' ' SER . . . . . . . . . . . . . 27.5 m -68.55 -12.48 61.33 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 116.207 -0.451 . . . . 73.150000000000006 111.982 178.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 702' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -100.69 3.18 42.18 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 111.813 0.301 . . . . 71.540000000000006 111.813 -176.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 703' ' ' ILE . . . . . 0.476 HD13 HG12 ' A' ' 689' ' ' VAL . 72.2 mt -73.7 118.5 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 120.964 0.411 . . . . 73.239999999999995 111.718 -178.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 704' ' ' LYS . . . . . 0.422 ' HB2' ' NZ ' ' A' ' 704' ' ' LYS . 5.2 ttmp? -84.33 115.59 22.58 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 116.169 -0.469 . . . . 53.25 110.329 176.277 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 67.8 t -95.87 106.57 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 121.161 0.505 . . . . 62.310000000000002 111.595 -178.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 706' ' ' ASP . . . . . 0.551 ' HB3' ' HB ' ' A' ' 720' ' ' THR . 25.2 t70 -101.82 125.57 48.52 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 116.177 -0.465 . . . . 51.229999999999997 111.099 179.378 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 112.04 163.81 17.02 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 121.067 -0.587 . . . . 52.409999999999997 113.335 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 708' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -149.62 145.72 26.92 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.019 0.438 . . . . 65.109999999999999 111.655 -177.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 709' ' ' VAL . . . . . 0.554 HG22 ' HB2' ' A' ' 717' ' ' TYR . 55.4 t -120.45 122.04 67.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 CA-C-N 116.28 -0.418 . . . . 72.019999999999996 111.607 -177.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 710' ' ' ASP . . . . . 0.533 ' HB2' ' HB3' ' A' ' 713' ' ' LYS . 10.1 m-20 -73.94 136.34 43.28 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 120.74 0.305 . . . . 60.539999999999999 110.816 174.35 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 711' ' ' THR . . . . . . . . . . . . . 81.2 p -96.48 0.99 51.1 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 120.932 0.396 . . . . 75.430000000000007 111.237 175.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 712' ' ' THR . . . . . 0.607 ' HA ' HG13 ' A' ' 679' ' ' VAL . 74.5 p -115.71 3.46 13.89 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 116.163 -0.472 . . . . 73.430000000000007 111.912 178.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 713' ' ' LYS . . . . . 0.533 ' HB3' ' HB2' ' A' ' 710' ' ' ASP . 5.6 tppp? -125.37 122.17 36.02 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 120.731 0.3 . . . . 65.239999999999995 111.586 -175.411 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 714' ' ' ALA . . . . . . . . . . . . . . . -70.36 112.46 6.68 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.928 0.394 . . . . 71.209999999999994 111.688 175.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 175.24 168.41 35.73 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 121.112 -0.566 . . . . 41.229999999999997 112.986 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 716' ' ' THR . . . . . . . . . . . . . 86.3 m -104.04 123.11 46.63 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 122.701 -0.293 . . . . 64.109999999999999 111.699 179.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 717' ' ' TYR . . . . . 0.554 ' HB2' HG22 ' A' ' 709' ' ' VAL . 86.0 m-85 -119.93 122.7 41.81 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.005 0.431 . . . . 73.120000000000005 111.164 177.012 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 718' ' ' VAL . . . . . . . . . . . . . 59.0 t -92.37 117.91 36.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-O 120.738 0.304 . . . . 52.240000000000002 111.139 177.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 719' ' ' LEU . . . . . 0.455 HD21 HG23 ' A' ' 709' ' ' VAL . 58.1 mt -94.45 148.26 22.42 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 116.671 -0.24 . . . . 74.420000000000002 111.111 -179.436 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 720' ' ' THR . . . . . 0.551 ' HB ' ' HB3' ' A' ' 706' ' ' ASP . 25.0 m -114.98 133.15 56.28 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 120.615 0.245 . . . . 42.210000000000001 111.072 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 721' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -122.91 115.87 22.66 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.835 0.35 . . . . 61.32 111.07 179.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 46.2 m -123.95 123.1 39.67 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 120.654 0.264 . . . . 74.299999999999997 111.474 -178.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 8.7 p -119.0 136.88 54.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 CA-C-O 120.963 0.411 . . . . 73.109999999999999 111.529 179.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 18.0 m -117.58 128.49 55.0 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.144 0.424 . . . . 72.430000000000007 112.144 -175.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 725' ' ' ASP . . . . . 0.515 ' HB3' ' H ' ' A' ' 729' ' ' HIS . 9.9 t70 -74.59 152.14 39.31 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 116.334 -0.394 . . . . 74.219999999999999 110.624 176.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 726' ' ' SER . . . . . . . . . . . . . 48.7 m -62.52 -27.41 69.14 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 112.624 0.601 . . . . 63.109999999999999 112.624 -177.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 727' ' ' LYS . . . . . 0.478 ' N ' ' HD3' ' A' ' 727' ' ' LYS . 3.5 mppt? -95.04 4.01 54.22 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 112.19 0.441 . . . . 72.219999999999999 112.19 179.399 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 728' ' ' GLY . . . . . . . . . . . . . . . 101.84 34.27 4.4 Favored Glycine 0 CA--C 1.533 1.161 0 N-CA-C 115.563 0.985 . . . . 51.350000000000001 115.563 171.136 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 729' ' ' HIS . . . . . 0.515 ' H ' ' HB3' ' A' ' 725' ' ' ASP . 31.2 m80 -109.53 111.08 22.39 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 118.077 0.938 . . . . 74.319999999999993 110.926 170.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 730' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -113.82 118.45 34.28 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 112.004 0.372 . . . . 52.420000000000002 112.004 -174.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 30.7 m -117.17 155.11 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-O 120.671 0.272 . . . . 72.150000000000006 111.171 178.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 10.0 t -147.52 145.38 29.08 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 112.792 0.664 . . . . 72.200000000000003 112.792 -175.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -148.72 143.65 26.57 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.962 -0.563 . . . . 55.32 111.144 178.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 734' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -106.92 159.52 16.2 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.343 0.592 . . . . 74.129999999999995 112.41 -178.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 735' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -132.77 130.08 39.46 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.707 -0.679 . . . . 63.520000000000003 110.837 -179.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 736' ' ' THR . . . . . 0.401 ' O ' ' HA2' ' A' ' 674' ' ' GLY . 90.5 m -94.13 103.89 15.93 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 120.919 0.39 . . . . 74.340000000000003 111.865 -179.017 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 44.3 t -102.6 135.17 41.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-O 120.719 0.295 . . . . 65.209999999999994 111.473 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 738' ' ' THR . . . . . . . . . . . . . 92.5 m -125.36 131.6 52.96 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 120.723 0.297 . . . . 74.219999999999999 111.378 178.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 739' ' ' VAL . . . . . . . . . . . . . 51.6 t -109.73 128.03 66.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-O 120.829 0.347 . . . . 64.349999999999994 111.011 177.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 740' ' ' LYS . . . . . 0.514 ' NZ ' ' HB3' ' A' ' 740' ' ' LYS . 7.3 mtpm? -116.18 152.6 33.39 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.973 0.416 . . . . 74.239999999999995 111.374 179.141 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 741' ' ' VAL . . . . . . . . . . . . . 18.1 t . . . . . 0 CA--C 1.539 0.556 0 CA-C-O 120.704 0.288 . . . . 53.140000000000001 111.033 -178.561 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 664' ' ' ASP . . . . . . . . . . . . . 8.6 t70 . . . . . 0 CA--C 1.533 0.316 0 CA-C-O 121.406 0.622 . . . . 71.219999999999999 111.552 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 665' ' ' LEU . . . . . . . . . . . . . 86.9 mt -87.33 126.0 34.58 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.648 -0.706 . . . . 73.230000000000004 110.387 176.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 666' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -62.1 145.59 93.15 Favored Pre-proline 0 CA--C 1.542 0.661 0 CA-C-N 116.116 -0.493 . . . . 73.030000000000001 111.3 178.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 667' ' ' PRO . . . . . 0.463 ' HD3' ' HB2' ' A' ' 725' ' ' ASP . 80.4 Cg_endo -76.94 147.14 26.64 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 122.365 2.043 . . . . 72.019999999999996 112.872 -176.189 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 668' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -83.15 104.05 13.04 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.127 0.489 . . . . 74.549999999999997 110.901 179.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 669' ' ' LEU . . . . . 0.418 ' HG ' HG23 ' A' ' 671' ' ' VAL . 58.1 tp -89.91 105.87 18.09 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.065 -0.516 . . . . 74.510000000000005 110.707 177.392 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 670' ' ' THR . . . . . . . . . . . . . 73.5 m -88.18 110.97 21.11 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.162 -0.472 . . . . 74.430000000000007 111.273 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 671' ' ' VAL . . . . . 0.497 HG22 HG13 ' A' ' 689' ' ' VAL . 85.7 t -132.08 126.27 20.49 Favored Pre-proline 0 N--CA 1.47 0.53 0 CA-C-N 116.146 -0.479 . . . . 64.109999999999999 110.768 179.275 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 672' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -69.73 137.48 35.64 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 122.27 1.98 . . . . 71.329999999999998 112.297 179.097 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 673' ' ' VAL . . . . . . . . . . . . . 12.5 p -64.54 -35.89 75.83 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 N-CA-C 112.279 0.474 . . . . 63.329999999999998 112.279 -175.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 674' ' ' GLY . . . . . . . . . . . . . . . -162.22 161.62 33.63 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 120.647 -0.787 . . . . 33.310000000000002 113.699 -178.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 675' ' ' ALA . . . . . . . . . . . . . . . -151.17 157.82 43.17 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 122.299 0.24 . . . . 65.439999999999998 110.955 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 676' ' ' THR . . . . . . . . . . . . . 60.7 m -133.38 126.39 31.18 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 122.347 -0.221 . . . . 72.549999999999997 111.394 179.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 677' ' ' ILE . . . . . . . . . . . . . 23.9 pt -130.33 174.56 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-O 120.976 0.417 . . . . 72.019999999999996 111.311 177.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 678' ' ' HIS . . . . . 0.528 ' O ' ' HB2' ' A' ' 681' ' ' ASP . 72.3 m80 -121.3 171.35 8.8 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.324 0.583 . . . . 64.510000000000005 112.378 -178.1 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 679' ' ' VAL . . . . . 0.485 HG23 ' HA ' ' A' ' 741' ' ' VAL . 84.5 t -63.71 120.01 9.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-N 116.023 -0.535 . . . . 35.109999999999999 111.254 175.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 97.2 0.84 59.65 Favored Glycine 0 CA--C 1.528 0.895 0 CA-C-N 116.185 -0.461 . . . . 63.439999999999998 113.211 -175.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 681' ' ' ASP . . . . . 0.528 ' HB2' ' O ' ' A' ' 678' ' ' HIS . 0.9 OUTLIER -77.05 178.58 6.87 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-O 121.101 0.477 . . . . 53.039999999999999 111.116 -179.561 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 682' ' ' SER . . . . . . . . . . . . . 87.2 p -134.94 126.21 28.19 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 116.511 -0.313 . . . . 53.229999999999997 110.831 177.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 683' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -127.53 134.38 49.77 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.931 0.396 . . . . 71.530000000000001 111.647 -176.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 684' ' ' VAL . . . . . 0.435 ' HA ' ' HD2' ' A' ' 685' ' ' PRO . 61.8 t -124.26 101.6 34.52 Favored Pre-proline 0 CA--C 1.545 0.766 0 CA-C-O 121.089 0.471 . . . . 72.409999999999997 111.943 -179.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 685' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' A' ' 684' ' ' VAL . 21.6 Cg_endo -60.99 -36.58 82.1 Favored 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 122.871 2.381 . . . . 53.43 113.843 -178.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 686' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -78.64 -1.75 35.77 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 112.237 0.458 . . . . 73.310000000000002 112.237 -177.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 687' ' ' ALA . . . . . . . . . . . . . . . -95.27 -48.08 6.05 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.078 0.466 . . . . 72.120000000000005 110.808 174.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 688' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -66.01 -38.31 88.12 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.605 0.594 . . . . 71.310000000000002 112.605 179.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 689' ' ' VAL . . . . . 0.497 HG13 HG22 ' A' ' 671' ' ' VAL . 98.9 t -86.67 143.1 12.08 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-O 120.934 0.397 . . . . 64.430000000000007 111.884 -178.118 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 690' ' ' LEU . . . . . 0.435 HD12 ' OG1' ' A' ' 700' ' ' THR . 45.9 tp -141.97 151.87 42.94 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.058 -0.519 . . . . 64.209999999999994 110.683 -177.092 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 691' ' ' ALA . . . . . 0.488 ' HB2' HD11 ' A' ' 703' ' ' ILE . . . -139.78 121.53 15.39 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.235 0.541 . . . . 72.530000000000001 111.439 174.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 692' ' ' ILE . . . . . . . . . . . . . 46.7 mm -128.93 120.53 52.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-N 116.219 -0.446 . . . . 55.43 111.716 -177.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 693' ' ' ASP . . . . . 0.46 ' HB2' ' HB3' ' A' ' 667' ' ' PRO . 31.9 t70 -102.88 149.24 24.7 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 120.787 0.327 . . . . 63.240000000000002 110.611 174.255 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -67.33 -55.41 13.98 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 112.367 0.506 . . . . 73.129999999999995 112.367 -176.075 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -83.8 -52.03 6.73 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 112.433 0.531 . . . . 63.530000000000001 112.433 -176.415 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 696' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -72.12 -32.79 67.27 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 120.874 0.368 . . . . 75.450000000000003 111.697 -172.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . 109.57 -144.69 16.72 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 120.973 -0.632 . . . . 24.420000000000002 113.515 177.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -71.06 122.47 20.13 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 120.85 0.357 . . . . 74.150000000000006 111.459 -178.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 699' ' ' LEU . . . . . . . . . . . . . 90.3 mt -118.85 20.89 12.69 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 120.998 0.428 . . . . 75.310000000000002 111.348 178.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 700' ' ' THR . . . . . 0.435 ' OG1' HD12 ' A' ' 690' ' ' LEU . 26.3 m -62.18 -39.22 91.94 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 121.169 0.509 . . . . 72.430000000000007 111.611 -179.339 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 701' ' ' SER . . . . . . . . . . . . . 63.3 m -71.07 -9.51 58.17 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 116.211 -0.449 . . . . 71.530000000000001 111.637 177.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 702' ' ' LYS . . . . . . . . . . . . . 2.4 mmmp? -87.01 -9.66 55.01 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 120.668 0.271 . . . . 71.540000000000006 111.049 176.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 703' ' ' ILE . . . . . 0.489 HG12 ' HB ' ' A' ' 723' ' ' VAL . 67.7 mt -74.76 115.57 16.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-O 120.743 0.306 . . . . 63.200000000000003 111.531 -178.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 704' ' ' LYS . . . . . . . . . . . . . 30.2 ttpt -89.95 119.47 30.34 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 120.872 0.368 . . . . 55.219999999999999 110.375 174.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 45.2 t -97.3 137.59 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 112.238 0.459 . . . . 62.450000000000003 112.238 -174.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 706' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -131.78 134.63 46.04 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 120.932 0.396 . . . . 63.450000000000003 110.962 175.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 128.07 178.87 15.55 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 121.373 -0.442 . . . . 73.219999999999999 112.987 179.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 708' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -166.28 130.71 2.17 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.046 0.45 . . . . 72.349999999999994 111.721 179.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 709' ' ' VAL . . . . . . . . . . . . . 60.1 t -107.54 131.2 58.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-N 116.222 -0.444 . . . . 71.120000000000005 111.652 -178.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 710' ' ' ASP . . . . . 0.437 ' O ' HG21 ' A' ' 739' ' ' VAL . 7.4 m-20 -85.68 141.86 29.45 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.037 0.446 . . . . 73.120000000000005 111.757 178.518 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 711' ' ' THR . . . . . 0.446 ' O ' ' HA ' ' A' ' 679' ' ' VAL . 80.5 p -111.29 2.36 17.64 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.476 -0.329 . . . . 75.150000000000006 111.648 177.361 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 712' ' ' THR . . . . . . . . . . . . . 31.2 p -103.84 -28.68 11.46 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 120.951 0.405 . . . . 61.439999999999998 111.883 178.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 713' ' ' LYS . . . . . 0.403 ' HB2' ' NZ ' ' A' ' 713' ' ' LYS . 4.8 ttmp? -119.64 133.33 55.69 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.505 -0.316 . . . . 53.210000000000001 111.174 -178.404 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 714' ' ' ALA . . . . . . . . . . . . . . . -69.56 142.98 53.5 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 120.868 0.366 . . . . 71.340000000000003 111.435 178.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 160.84 157.83 8.95 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 120.995 -0.621 . . . . 73.430000000000007 113.107 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 716' ' ' THR . . . . . . . . . . . . . 86.3 m -99.07 123.26 43.23 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 122.496 -0.414 . . . . 74.5 111.67 -178.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 717' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -122.19 150.33 42.4 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 122.579 0.352 . . . . 65.239999999999995 111.204 -178.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 718' ' ' VAL . . . . . . . . . . . . . 57.6 t -113.7 125.44 70.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 CA-C-O 121.003 0.43 . . . . 73.019999999999996 111.642 178.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 719' ' ' LEU . . . . . . . . . . . . . 81.4 mt -102.41 141.69 34.83 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.444 -0.344 . . . . 54.119999999999997 110.95 179.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 86.5 m -112.29 139.68 47.64 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-O 120.994 0.426 . . . . 61.100000000000001 111.71 -178.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 721' ' ' TYR . . . . . . . . . . . . . 50.1 m-85 -132.56 122.38 24.7 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 116.191 -0.459 . . . . 71.109999999999999 110.937 -179.017 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 95.3 m -125.69 125.32 42.86 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 120.873 0.368 . . . . 72.129999999999995 111.883 -179.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 723' ' ' VAL . . . . . 0.489 ' HB ' HG12 ' A' ' 703' ' ' ILE . 14.9 p -121.56 152.14 25.11 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-N 116.297 -0.411 . . . . 71.430000000000007 111.005 178.312 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 87.0 m -133.08 132.11 41.37 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.058 0.456 . . . . 72.519999999999996 111.938 177.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 725' ' ' ASP . . . . . 0.475 ' HB3' ' H ' ' A' ' 729' ' ' HIS . 9.9 t0 -73.41 151.05 41.29 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 115.714 -0.676 . . . . 64.519999999999996 110.608 177.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 726' ' ' SER . . . . . . . . . . . . . 44.0 t -59.57 -31.66 69.65 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.328 -0.396 . . . . 44.520000000000003 111.786 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 727' ' ' LYS . . . . . . . . . . . . . 10.3 mptt -86.71 1.05 53.41 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 112.237 0.458 . . . . 54.439999999999998 112.237 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 728' ' ' GLY . . . . . . . . . . . . . . . 100.55 33.77 4.96 Favored Glycine 0 CA--C 1.534 1.23 0 N-CA-C 115.49 0.956 . . . . 71.530000000000001 115.49 171.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 729' ' ' HIS . . . . . 0.475 ' H ' ' HB3' ' A' ' 725' ' ' ASP . 52.3 m80 -109.45 112.08 23.98 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 118.062 0.931 . . . . 74.530000000000001 111.571 173.058 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 730' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -99.51 129.05 45.65 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 121.028 0.442 . . . . 71.549999999999997 111.825 -176.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 48.8 t -127.51 136.1 61.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-N 116.22 -0.445 . . . . 71.209999999999994 110.591 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 10.3 t -135.13 144.95 47.39 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 112.364 0.505 . . . . 74.209999999999994 112.364 -178.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 733' ' ' ALA . . . . . 0.489 ' HB3' HG21 ' A' ' 671' ' ' VAL . . . -148.86 162.1 40.5 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 116.222 -0.445 . . . . 64.400000000000006 111.71 -178.53 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 734' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -123.72 155.35 38.01 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 112.356 0.502 . . . . 74.140000000000001 112.356 -178.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 735' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -130.04 126.36 37.5 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 116.021 -0.536 . . . . 74.25 110.746 177.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 736' ' ' THR . . . . . . . . . . . . . 97.8 m -95.1 109.54 21.59 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 120.992 0.425 . . . . 73.319999999999993 111.726 -179.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 47.7 t -106.5 121.67 59.4 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 CA-C-O 120.897 0.379 . . . . 62.399999999999999 111.505 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 738' ' ' THR . . . . . . . . . . . . . 54.2 m -104.77 121.81 44.4 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.091 0.472 . . . . 71.349999999999994 111.986 179.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 739' ' ' VAL . . . . . 0.437 HG21 ' O ' ' A' ' 710' ' ' ASP . 24.4 t -98.09 136.3 29.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-N 116.063 -0.517 . . . . 51.25 111.047 178.11 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 740' ' ' LYS . . . . . 0.408 ' O ' ' HA ' ' A' ' 678' ' ' HIS . 96.0 mttt -131.38 156.01 46.29 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.259 0.552 . . . . 75.329999999999998 111.957 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 741' ' ' VAL . . . . . 0.485 ' HA ' HG23 ' A' ' 679' ' ' VAL . 28.2 t . . . . . 0 CA--C 1.54 0.559 0 CA-C-N 116.266 -0.425 . . . . 74.140000000000001 111.485 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 664' ' ' ASP . . . . . 0.406 ' OD2' ' HB2' ' A' ' 727' ' ' LYS . 27.3 t0 . . . . . 0 CA--C 1.534 0.344 0 CA-C-O 121.096 0.474 . . . . 70.450000000000003 110.979 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 665' ' ' LEU . . . . . . . . . . . . . 86.2 mt -96.94 136.89 36.86 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.117 -0.492 . . . . 55.030000000000001 110.768 175.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 666' ' ' GLU . . . . . 0.47 ' H ' ' CD ' ' A' ' 666' ' ' GLU . 1.4 pm0 -56.83 139.59 77.21 Favored Pre-proline 0 CA--C 1.544 0.712 0 CA-C-O 120.79 0.329 . . . . 73.340000000000003 111.16 175.53 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 667' ' ' PRO . . . . . 0.584 ' HB3' HD12 ' A' ' 699' ' ' LEU . 58.3 Cg_endo -68.97 156.77 64.32 Favored 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 122.618 2.212 . . . . 73.409999999999997 113.737 -172.614 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 668' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -87.76 105.18 17.21 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.99 -0.55 . . . . 65.540000000000006 111.226 177.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 669' ' ' LEU . . . . . 0.518 ' HG ' HG23 ' A' ' 671' ' ' VAL . 62.1 tp -95.09 108.13 20.21 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 116.011 -0.54 . . . . 72.329999999999998 110.658 177.151 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 670' ' ' THR . . . . . . . . . . . . . 88.2 m -86.34 111.31 20.36 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.858 0.361 . . . . 73.109999999999999 111.244 179.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 671' ' ' VAL . . . . . 0.518 HG23 ' HG ' ' A' ' 669' ' ' LEU . 94.6 t -136.31 130.93 18.39 Favored Pre-proline 0 N--CA 1.47 0.555 0 CA-C-N 116.301 -0.409 . . . . 73.319999999999993 110.983 -179.668 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 672' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -76.24 143.73 25.58 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 122.248 1.965 . . . . 72.510000000000005 111.995 175.069 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 673' ' ' VAL . . . . . . . . . . . . . 15.0 p -77.87 -28.06 15.34 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 CA-C-O 120.874 0.369 . . . . 72.340000000000003 111.403 -176.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 674' ' ' GLY . . . . . . . . . . . . . . . -156.16 136.61 5.1 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 120.934 -0.65 . . . . 63.32 113.584 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 675' ' ' ALA . . . . . . . . . . . . . . . -131.29 158.91 39.39 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 122.68 0.392 . . . . 71.340000000000003 110.528 177.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 676' ' ' THR . . . . . . . . . . . . . 13.6 m -135.0 129.04 33.53 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 112.018 0.377 . . . . 72.549999999999997 112.018 -177.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 677' ' ' ILE . . . . . . . . . . . . . 24.4 pt -138.97 176.43 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 122.465 0.306 . . . . 52.43 111.032 177.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 678' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -124.73 165.46 17.92 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.976 0.417 . . . . 75.319999999999993 111.511 178.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 679' ' ' VAL . . . . . . . . . . . . . 63.6 t -60.01 112.58 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 CA-C-N 116.211 -0.449 . . . . 65.349999999999994 110.668 175.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 118.3 -26.13 7.92 Favored Glycine 0 CA--C 1.528 0.89 0 CA-C-N 116.164 -0.471 . . . . 33.43 112.808 -175.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 681' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -69.11 163.91 23.71 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.248 0.547 . . . . 74.540000000000006 112.058 178.097 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 682' ' ' SER . . . . . . . . . . . . . 67.2 m -120.69 121.67 38.77 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.13 -0.487 . . . . 72.439999999999998 111.246 -178.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 683' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -118.42 126.89 53.02 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.334 -0.394 . . . . 73.340000000000003 110.809 -177.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 684' ' ' VAL . . . . . . . . . . . . . 60.8 t -115.4 100.67 53.88 Favored Pre-proline 0 N--CA 1.47 0.572 0 CA-C-O 120.789 0.328 . . . . 71.209999999999994 111.429 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -54.53 -47.14 28.43 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 122.802 2.334 . . . . 64.219999999999999 113.692 -177.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 686' ' ' MET . . . . . . . . . . . . . 88.2 mmm -78.24 0.56 24.7 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.898 0.703 . . . . 74.239999999999995 112.898 -175.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 687' ' ' ALA . . . . . . . . . . . . . . . -94.02 -47.79 6.53 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 120.943 0.401 . . . . 75.430000000000007 110.907 175.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 688' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -80.84 -18.22 48.15 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 112.373 0.508 . . . . 70.430000000000007 112.373 -178.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 689' ' ' VAL . . . . . 0.498 HG21 ' CZ ' ' A' ' 721' ' ' TYR . 89.3 t -97.54 142.43 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-O 120.888 0.375 . . . . 74.310000000000002 111.227 177.031 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 690' ' ' LEU . . . . . 0.633 HD21 HG12 ' A' ' 692' ' ' ILE . 7.9 tt -146.02 150.69 36.47 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.385 -0.371 . . . . 64.040000000000006 111.357 -173.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 691' ' ' ALA . . . . . . . . . . . . . . . -142.44 120.93 12.45 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.091 0.472 . . . . 63.439999999999998 111.885 176.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 692' ' ' ILE . . . . . 0.633 HG12 HD21 ' A' ' 690' ' ' LEU . 39.3 mm -127.46 144.15 38.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-N 116.166 -0.47 . . . . 71.319999999999993 110.761 178.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 693' ' ' ASP . . . . . 0.452 ' HB2' ' HB3' ' A' ' 667' ' ' PRO . 36.5 t70 -125.02 149.3 47.9 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 120.949 0.404 . . . . 71.019999999999996 111.582 -178.137 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -57.99 -60.09 4.25 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 116.003 -0.544 . . . . 72.200000000000003 112.428 -177.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 695' ' ' GLU . . . . . 0.427 ' CD ' ' H ' ' A' ' 695' ' ' GLU . 0.3 OUTLIER -85.07 -53.58 5.19 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 112.096 0.406 . . . . 72.329999999999998 112.096 -176.283 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 696' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -70.23 -42.13 72.68 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.793 0.33 . . . . 73.0 111.863 -171.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . 108.56 -131.89 10.81 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 120.96 -0.638 . . . . 63.340000000000003 113.399 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -70.93 113.36 7.9 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 121.064 0.459 . . . . 74.409999999999997 111.523 -177.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 699' ' ' LEU . . . . . 0.584 HD12 ' HB3' ' A' ' 667' ' ' PRO . 89.6 mt -110.73 11.8 22.59 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.316 0.579 . . . . 72.219999999999999 110.397 172.532 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 21.1 m -59.89 -28.68 67.77 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.937 -0.574 . . . . 73.040000000000006 110.888 177.189 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 701' ' ' SER . . . . . . . . . . . . . 34.2 t -71.13 -24.42 62.27 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 116.244 -0.434 . . . . 64.099999999999994 111.456 175.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 702' ' ' LYS . . . . . 0.494 ' HB2' HG23 ' A' ' 723' ' ' VAL . 8.4 mmpt? -81.32 -13.75 58.05 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 111.87 0.322 . . . . 62.420000000000002 111.87 -178.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 69.8 mt -65.44 115.48 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 N-CA-C 112.076 0.398 . . . . 54.399999999999999 112.076 -177.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 704' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -98.42 124.76 43.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.112 0.482 . . . . 64.450000000000003 110.797 172.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 61.5 t -96.2 111.35 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-N 115.813 -0.63 . . . . 73.109999999999999 111.852 -177.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 706' ' ' ASP . . . . . 0.454 ' HB3' ' HB ' ' A' ' 720' ' ' THR . 38.6 t70 -99.23 134.6 41.85 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.455 -0.339 . . . . 74.409999999999997 110.748 177.211 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 108.42 171.77 21.39 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 121.148 -0.548 . . . . 34.409999999999997 112.678 -176.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 708' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -144.34 148.33 34.6 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 122.58 -0.365 . . . . 74.120000000000005 111.572 -176.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 709' ' ' VAL . . . . . 0.521 HG23 HD21 ' A' ' 719' ' ' LEU . 84.5 t -126.56 118.14 50.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 CA-C-O 120.806 0.336 . . . . 64.140000000000001 111.298 178.428 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 710' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -87.19 136.57 32.88 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 121.101 0.477 . . . . 70.420000000000002 111.361 177.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 711' ' ' THR . . . . . . . . . . . . . 73.9 p -98.63 -13.47 20.33 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.927 0.394 . . . . 73.010000000000005 111.437 177.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 712' ' ' THR . . . . . . . . . . . . . 71.7 p -93.31 -27.68 16.66 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 116.271 -0.422 . . . . 64.530000000000001 111.535 178.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 713' ' ' LYS . . . . . . . . . . . . . 50.2 tptt -116.53 132.43 56.68 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.563 -0.29 . . . . 74.430000000000007 110.526 178.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 714' ' ' ALA . . . . . . . . . . . . . . . -86.59 144.93 26.95 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 112.786 0.662 . . . . 72.030000000000001 112.786 -176.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 163.41 176.31 35.27 Favored Glycine 0 CA--C 1.522 0.482 0 CA-C-N 115.424 -0.807 . . . . 63.0 111.959 -179.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 716' ' ' THR . . . . . . . . . . . . . 95.7 m -94.68 122.21 37.05 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 117.222 0.511 . . . . 63.039999999999999 110.978 177.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 717' ' ' TYR . . . . . 0.477 ' HB2' HG22 ' A' ' 709' ' ' VAL . 57.6 m-85 -121.95 119.45 31.54 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.463 -0.335 . . . . 61.32 110.94 -178.213 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 718' ' ' VAL . . . . . . . . . . . . . 60.3 t -91.42 123.23 43.48 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-O 120.809 0.338 . . . . 54.130000000000003 111.182 179.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 719' ' ' LEU . . . . . 0.521 HD21 HG23 ' A' ' 709' ' ' VAL . 88.0 mt -104.82 126.15 51.6 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.418 -0.356 . . . . 63.130000000000003 111.241 177.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 720' ' ' THR . . . . . 0.454 ' HB ' ' HB3' ' A' ' 706' ' ' ASP . 95.1 m -101.08 127.48 47.59 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.988 0.423 . . . . 70.150000000000006 111.33 178.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 721' ' ' TYR . . . . . 0.498 ' CZ ' HG21 ' A' ' 689' ' ' VAL . 57.7 m-85 -113.47 113.91 25.81 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.685 0.279 . . . . 74.5 110.76 179.466 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 72.0 m -113.85 125.34 53.95 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.762 0.315 . . . . 54.549999999999997 111.469 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 723' ' ' VAL . . . . . 0.494 HG23 ' HB2' ' A' ' 702' ' ' LYS . 8.3 p -129.42 133.98 64.44 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-O 120.995 0.426 . . . . 74.310000000000002 111.224 179.015 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 73.5 m -116.44 136.25 53.15 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 120.934 0.397 . . . . 62.530000000000001 111.887 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 725' ' ' ASP . . . . . 0.428 ' HB2' ' HD3' ' A' ' 667' ' ' PRO . 10.7 t0 -73.28 150.9 41.59 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 109.675 -0.491 . . . . 73.439999999999998 109.675 174.297 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 726' ' ' SER . . . . . . . . . . . . . 34.9 t -56.15 -33.24 65.02 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.348 -0.387 . . . . 73.209999999999994 111.753 -179.191 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 727' ' ' LYS . . . . . 0.464 ' N ' ' HD3' ' A' ' 727' ' ' LYS . 3.6 mppt? -91.42 6.85 43.84 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 112.712 0.634 . . . . 72.200000000000003 112.712 -178.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 728' ' ' GLY . . . . . . . . . . . . . . . 101.69 35.2 4.13 Favored Glycine 0 CA--C 1.534 1.279 0 N-CA-C 116.122 1.209 . . . . 71.409999999999997 116.122 169.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 729' ' ' HIS . . . . . 0.411 ' H ' ' HB3' ' A' ' 725' ' ' ASP . 40.7 m80 -109.3 110.68 21.92 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 118.178 0.989 . . . . 73.030000000000001 111.49 172.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 730' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -96.89 128.5 43.91 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.277 0.56 . . . . 71.209999999999994 112.121 -177.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 57.6 t -126.4 129.48 71.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 CA-C-N 115.97 -0.559 . . . . 53.149999999999999 110.109 176.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 7.5 t -137.12 128.86 28.84 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.167 0.508 . . . . 65.349999999999994 112.296 -177.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -135.56 157.65 46.34 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 122.804 0.442 . . . . 73.230000000000004 110.863 -178.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 734' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -121.3 158.69 27.62 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.994 0.739 . . . . 61.109999999999999 112.994 -175.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 735' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -130.57 128.51 41.25 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.839 -0.619 . . . . 64.319999999999993 111.161 179.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 736' ' ' THR . . . . . . . . . . . . . 86.6 m -87.93 103.89 16.1 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 120.751 0.31 . . . . 63.520000000000003 110.991 175.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 47.8 t -96.73 108.39 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-O 120.924 0.392 . . . . 73.530000000000001 111.188 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 738' ' ' THR . . . . . . . . . . . . . 27.3 m -94.84 108.96 20.99 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.79 0.328 . . . . 75.209999999999994 111.342 -179.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 739' ' ' VAL . . . . . . . . . . . . . 43.0 t -94.22 125.34 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-O 120.729 0.3 . . . . 71.150000000000006 110.793 176.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 740' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -115.38 146.55 41.47 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.048 0.451 . . . . 73.310000000000002 111.979 -175.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 741' ' ' VAL . . . . . . . . . . . . . 24.3 t . . . . . 0 N--CA 1.473 0.715 0 CA-C-O 120.88 0.371 . . . . 54.210000000000001 111.914 -179.142 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 664' ' ' ASP . . . . . . . . . . . . . 41.5 t0 . . . . . 0 CA--C 1.532 0.257 0 CA-C-O 121.154 0.502 . . . . 65.230000000000004 110.094 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 665' ' ' LEU . . . . . 0.524 HD12 ' HB2' ' A' ' 694' ' ' LYS . 86.6 mt -91.98 137.87 32.01 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.937 -0.574 . . . . 65.310000000000002 111.038 179.191 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 666' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -80.68 142.2 52.83 Favored Pre-proline 0 CA--C 1.541 0.612 0 CA-C-N 116.223 -0.444 . . . . 73.109999999999999 110.406 173.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 667' ' ' PRO . . . . . 0.595 ' HB3' HD12 ' A' ' 699' ' ' LEU . 64.4 Cg_endo -70.86 146.2 52.75 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 122.231 1.954 . . . . 53.409999999999997 113.734 -173.002 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 668' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -83.3 103.86 13.01 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.975 -0.557 . . . . 73.140000000000001 110.576 173.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 669' ' ' LEU . . . . . . . . . . . . . 52.3 tp -89.79 132.65 35.12 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.153 -0.476 . . . . 71.239999999999995 109.95 176.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 670' ' ' THR . . . . . . . . . . . . . 91.1 m -121.61 111.31 17.07 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.025 0.441 . . . . 74.140000000000001 111.124 -179.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 671' ' ' VAL . . . . . . . . . . . . . 88.8 t -128.77 134.55 26.42 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-N 115.82 -0.627 . . . . 51.43 110.628 -179.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 672' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.57 127.82 17.94 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 121.964 1.776 . . . . 43.32 111.903 177.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 673' ' ' VAL . . . . . 0.442 ' O ' HG22 ' A' ' 736' ' ' THR . 12.5 p -64.4 -23.78 34.17 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 N-CA-C 112.414 0.524 . . . . 72.430000000000007 112.414 -174.179 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 674' ' ' GLY . . . . . . . . . . . . . . . -169.02 154.27 23.73 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 120.61 -0.805 . . . . 63.140000000000001 113.591 179.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 675' ' ' ALA . . . . . . . . . . . . . . . -150.38 156.29 41.22 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 122.502 0.321 . . . . 72.340000000000003 110.859 177.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 676' ' ' THR . . . . . . . . . . . . . 70.4 m -134.42 127.43 31.55 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.784 0.326 . . . . 60.140000000000001 111.269 -179.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 677' ' ' ILE . . . . . . . . . . . . . 28.4 pt -130.33 176.62 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-O 120.824 0.345 . . . . 61.549999999999997 111.124 179.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 678' ' ' HIS . . . . . 0.513 ' O ' ' HB2' ' A' ' 681' ' ' ASP . 69.9 m80 -116.67 166.67 11.85 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 121.581 0.705 . . . . 75.5 112.311 -179.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 679' ' ' VAL . . . . . 0.473 HG13 ' HA ' ' A' ' 712' ' ' THR . 82.4 t -67.16 112.18 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-N 115.972 -0.558 . . . . 72.329999999999998 110.494 174.334 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 109.24 -2.48 31.22 Favored Glycine 0 CA--C 1.529 0.957 0 CA-C-N 115.891 -0.595 . . . . 73.329999999999998 112.41 -172.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 681' ' ' ASP . . . . . 0.513 ' HB2' ' O ' ' A' ' 678' ' ' HIS . 1.1 t70 -75.62 -168.43 0.85 Allowed 'General case' 0 CA--C 1.547 0.835 0 CA-C-O 120.954 0.407 . . . . 71.319999999999993 110.955 178.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 682' ' ' SER . . . . . . . . . . . . . 73.7 m -150.18 136.74 19.05 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 122.159 -0.338 . . . . 63.450000000000003 110.553 176.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 683' ' ' PHE . . . . . . . . . . . . . 36.0 t80 -138.66 127.38 23.51 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 120.614 0.245 . . . . 65.400000000000006 111.652 -174.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 684' ' ' VAL . . . . . . . . . . . . . 63.8 t -111.73 101.45 51.27 Favored Pre-proline 0 N--CA 1.476 0.85 0 CA-C-O 120.726 0.298 . . . . 71.150000000000006 111.771 179.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -52.82 -42.81 60.91 Favored 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 122.975 2.45 . . . . 70.209999999999994 113.772 179.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 686' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -78.13 3.84 14.04 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 112.79 0.663 . . . . 61.509999999999998 112.79 -176.083 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 687' ' ' ALA . . . . . . . . . . . . . . . -109.35 -14.77 14.39 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 122.2 -0.313 . . . . 74.239999999999995 111.82 176.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 688' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -97.62 -6.5 33.17 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 112.722 0.638 . . . . 71.420000000000002 112.722 -175.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 689' ' ' VAL . . . . . 0.413 HG12 HD13 ' A' ' 703' ' ' ILE . 49.7 t -121.67 154.83 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 N-CA-C 112.025 0.38 . . . . 43.32 112.025 -174.17 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 690' ' ' LEU . . . . . 0.563 HD23 ' N ' ' A' ' 691' ' ' ALA . 6.4 tt -150.57 143.82 24.9 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 116.509 -0.314 . . . . 71.150000000000006 110.827 -178.307 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 691' ' ' ALA . . . . . 0.563 ' N ' HD23 ' A' ' 690' ' ' LEU . . . -144.08 132.05 21.57 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 112.416 0.525 . . . . 42.439999999999998 112.416 -179.132 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 692' ' ' ILE . . . . . 0.473 HD13 ' HA ' ' A' ' 698' ' ' ASP . 38.6 mm -135.77 136.89 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 N-CA-C 112.116 0.413 . . . . 63.539999999999999 112.116 -179.289 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -115.68 141.82 47.56 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 109.005 -0.739 . . . . 73.140000000000001 109.005 167.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 694' ' ' LYS . . . . . 0.524 ' HB2' HD12 ' A' ' 665' ' ' LEU . 54.5 mttp -71.33 -28.97 64.46 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.289 0.478 . . . . 74.400000000000006 112.289 -177.408 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -83.38 -44.75 14.48 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-O 120.916 0.389 . . . . 75.329999999999998 111.974 -179.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 696' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -92.87 -30.3 15.5 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 120.851 0.358 . . . . 65.299999999999997 111.325 -173.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . 105.86 -135.17 12.48 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 121.325 -0.464 . . . . 53.5 112.769 179.096 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 698' ' ' ASP . . . . . 0.473 ' HA ' HD13 ' A' ' 692' ' ' ILE . 12.1 t70 -71.83 125.09 26.29 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 122.534 -0.392 . . . . 71.299999999999997 111.497 179.05 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 699' ' ' LEU . . . . . 0.632 HD22 ' HD2' ' A' ' 702' ' ' LYS . 45.7 mt -119.83 6.65 10.92 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.493 -0.321 . . . . 72.540000000000006 111.584 177.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 49.6 m -58.6 -40.13 82.36 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.201 0.524 . . . . 73.340000000000003 111.464 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 701' ' ' SER . . . . . . . . . . . . . 37.2 t -66.03 -13.78 60.54 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 121.072 0.463 . . . . 63.149999999999999 111.817 176.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 702' ' ' LYS . . . . . 0.632 ' HD2' HD22 ' A' ' 699' ' ' LEU . 97.4 mttt -99.11 6.62 46.43 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.217 0.451 . . . . 74.109999999999999 112.217 -178.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 703' ' ' ILE . . . . . 0.413 HD13 HG12 ' A' ' 689' ' ' VAL . 73.9 mt -80.02 117.45 25.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-O 121.044 0.45 . . . . 72.140000000000001 111.541 -179.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 704' ' ' LYS . . . . . 0.409 ' HE3' ' HB2' ' A' ' 704' ' ' LYS . 35.9 ttmt -91.34 136.64 32.96 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.212 -0.449 . . . . 72.019999999999996 111.039 176.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 46.6 t -109.27 140.55 27.6 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-O 121.129 0.49 . . . . 63.219999999999999 111.889 -177.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 706' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -132.36 126.02 32.26 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 116.273 -0.421 . . . . 64.010000000000005 110.253 174.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 102.97 152.94 24.1 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 121.141 -0.552 . . . . 51.420000000000002 112.404 -173.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 708' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -153.59 143.62 22.1 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 122.19 -0.594 . . . . 60.43 111.566 -176.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 709' ' ' VAL . . . . . 0.543 HG22 ' HB2' ' A' ' 717' ' ' TYR . 71.7 t -99.52 134.35 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-N 116.067 -0.515 . . . . 64.329999999999998 111.842 -177.231 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 710' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -100.54 150.78 22.32 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 121.027 0.442 . . . . 64.25 110.431 170.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 711' ' ' THR . . . . . . . . . . . . . 80.7 p -107.39 28.2 8.34 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.444 -0.344 . . . . 73.349999999999994 111.494 -178.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 712' ' ' THR . . . . . 0.473 ' HA ' HG13 ' A' ' 679' ' ' VAL . 7.5 t -115.9 -28.48 6.66 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 112.385 0.513 . . . . 74.230000000000004 112.385 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 713' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -115.67 122.37 45.35 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 120.733 0.301 . . . . 63.32 111.095 -176.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 714' ' ' ALA . . . . . 0.482 ' HB2' HG23 ' A' ' 741' ' ' VAL . . . -70.43 101.96 2.08 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 121.199 0.523 . . . . 71.239999999999995 111.718 -178.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . -164.18 168.45 38.61 Favored Glycine 0 CA--C 1.52 0.355 0 CA-C-N 115.99 -0.55 . . . . 71.349999999999994 112.843 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 716' ' ' THR . . . . . . . . . . . . . 73.2 m -95.52 122.7 38.54 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.05 0.452 . . . . 74.150000000000006 111.612 178.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 717' ' ' TYR . . . . . 0.543 ' HB2' HG22 ' A' ' 709' ' ' VAL . 57.6 m-85 -116.86 124.45 49.54 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 116.106 -0.497 . . . . 70.310000000000002 110.418 179.158 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 718' ' ' VAL . . . . . . . . . . . . . 45.6 t -96.28 110.88 25.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-O 121.09 0.471 . . . . 71.120000000000005 111.613 -178.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 719' ' ' LEU . . . . . 0.531 HD21 HG23 ' A' ' 709' ' ' VAL . 58.9 mt -88.41 130.5 35.16 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.131 -0.486 . . . . 75.450000000000003 111.227 -178.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 84.5 m -99.72 132.29 45.16 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.903 0.382 . . . . 75.150000000000006 111.496 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 721' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -122.01 134.27 54.8 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.838 0.351 . . . . 73.310000000000002 110.937 177.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 24.7 m -135.82 130.27 33.7 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 111.625 0.231 . . . . 73.5 111.625 -176.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 8.7 p -125.0 132.47 71.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-O 121.031 0.443 . . . . 73.200000000000003 111.286 178.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 22.7 m -108.4 120.5 42.57 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.945 0.403 . . . . 63.329999999999998 111.991 -176.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 725' ' ' ASP . . . . . 0.496 ' HB2' ' HD3' ' A' ' 667' ' ' PRO . 3.6 t70 -73.19 149.71 42.69 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 116.197 -0.456 . . . . 75.349999999999994 110.734 175.216 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 726' ' ' SER . . . . . . . . . . . . . 56.8 p -65.43 -26.3 67.91 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 112.287 0.477 . . . . 55.420000000000002 112.287 -174.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 727' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -93.76 -3.7 51.68 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 112.715 0.635 . . . . 72.129999999999995 112.715 178.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 728' ' ' GLY . . . . . . . . . . . . . . . 111.72 19.88 7.16 Favored Glycine 0 CA--C 1.532 1.096 0 N-CA-C 115.529 0.972 . . . . 63.329999999999998 115.529 172.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 27.7 m80 -97.13 104.96 17.02 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 118.241 1.02 . . . . 74.010000000000005 111.025 172.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 730' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -112.19 114.63 27.54 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 120.933 0.397 . . . . 64.219999999999999 111.665 -177.116 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 32.8 m -109.83 158.73 9.82 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-O 121.084 0.469 . . . . 64.530000000000001 111.582 179.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 5.6 t -135.56 145.39 46.92 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 121.204 0.526 . . . . 61.530000000000001 112.163 -176.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -148.59 161.12 42.34 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.997 -0.547 . . . . 53.149999999999999 110.791 176.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 734' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -133.52 157.49 45.51 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 112.509 0.559 . . . . 73.329999999999998 112.509 -176.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 735' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -130.61 125.98 35.48 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 115.623 -0.717 . . . . 71.530000000000001 110.794 178.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 736' ' ' THR . . . . . 0.442 HG22 ' O ' ' A' ' 673' ' ' VAL . 8.3 t -93.36 110.27 21.82 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.254 0.55 . . . . 74.040000000000006 111.588 178.298 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 46.8 t -106.69 115.69 48.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-N 116.474 -0.33 . . . . 74.109999999999999 111.339 -179.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 738' ' ' THR . . . . . . . . . . . . . 88.8 m -99.62 124.72 45.1 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 120.778 0.323 . . . . 42.399999999999999 111.503 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 739' ' ' VAL . . . . . . . . . . . . . 49.7 t -96.76 134.25 35.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-O 120.916 0.389 . . . . 74.129999999999995 111.429 178.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 740' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -121.55 144.96 48.43 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.4 -0.363 . . . . 60.130000000000003 111.188 178.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 741' ' ' VAL . . . . . 0.482 HG23 ' HB2' ' A' ' 714' ' ' ALA . 25.6 t . . . . . 0 N--CA 1.469 0.485 0 O-C-N 121.639 -0.663 . . . . 63.350000000000001 111.638 -178.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 664' ' ' ASP . . . . . 0.493 ' CG ' ' HB2' ' A' ' 727' ' ' LYS . 45.0 t0 . . . . . 0 CA--C 1.535 0.399 0 CA-C-O 121.132 0.491 . . . . 51.119999999999997 111.676 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 665' ' ' LEU . . . . . . . . . . . . . 85.2 mt -81.57 116.86 21.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.007 -0.542 . . . . 55.420000000000002 109.78 175.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 666' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -77.37 137.74 64.02 Favored Pre-proline 0 CA--C 1.541 0.616 0 CA-C-O 120.898 0.38 . . . . 75.209999999999994 111.433 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 667' ' ' PRO . . . . . 0.558 ' HB3' HD12 ' A' ' 699' ' ' LEU . 65.8 Cg_endo -71.46 140.46 36.56 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 122.596 2.197 . . . . 71.219999999999999 113.182 -174.085 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 668' ' ' LYS . . . . . 0.402 ' O ' ' HA ' ' A' ' 691' ' ' ALA . 22.7 tptm -83.58 106.9 15.68 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.302 -0.408 . . . . 74.340000000000003 110.631 176.687 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 669' ' ' LEU . . . . . 0.464 ' HG ' HG23 ' A' ' 671' ' ' VAL . 58.7 tp -90.04 110.14 21.15 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 116.275 -0.421 . . . . 74.349999999999994 110.523 178.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 670' ' ' THR . . . . . . . . . . . . . 67.6 m -86.38 109.4 18.99 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.854 0.359 . . . . 73.209999999999994 111.126 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 671' ' ' VAL . . . . . 0.464 HG23 ' HG ' ' A' ' 669' ' ' LEU . 91.0 t -141.78 120.83 7.95 Favored Pre-proline 0 N--CA 1.473 0.684 0 CA-C-N 116.257 -0.429 . . . . 75.299999999999997 110.774 179.178 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 672' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -73.8 150.1 43.86 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 122.366 2.044 . . . . 74.409999999999997 112.529 -179.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 673' ' ' VAL . . . . . . . . . . . . . 7.7 p -64.36 -38.2 81.94 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 N-CA-C 112.16 0.43 . . . . 74.310000000000002 112.16 -178.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 674' ' ' GLY . . . . . . . . . . . . . . . -156.46 157.67 28.1 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 120.805 -0.712 . . . . 72.540000000000006 114.031 -177.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 675' ' ' ALA . . . . . 0.434 ' O ' ' HA ' ' A' ' 737' ' ' VAL . . . -151.88 135.09 15.89 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 122.831 0.453 . . . . 62.299999999999997 110.668 178.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 676' ' ' THR . . . . . . . . . . . . . 62.5 m -115.23 123.63 49.32 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 121.993 -0.442 . . . . 74.129999999999995 112.025 -178.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 677' ' ' ILE . . . . . . . . . . . . . 17.5 pt -127.36 176.55 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 CA-C-N 116.254 -0.43 . . . . 71.109999999999999 110.865 177.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 678' ' ' HIS . . . . . . . . . . . . . 63.1 m80 -117.05 157.74 25.34 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.429 0.633 . . . . 72.140000000000001 112.182 -178.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 679' ' ' VAL . . . . . . . . . . . . . 92.0 t -54.63 113.02 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-N 115.513 -0.767 . . . . 52.299999999999997 111.401 175.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 116.3 -18.79 13.58 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 121.162 -0.542 . . . . 63.25 113.705 -179.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 681' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -74.43 -179.77 4.18 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 121.495 0.664 . . . . 64.030000000000001 112.502 -179.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 682' ' ' SER . . . . . . . . . . . . . 57.5 m -122.67 151.27 41.68 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.754 -0.657 . . . . 72.319999999999993 111.401 -178.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 683' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -158.88 116.04 2.77 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 116.546 -0.297 . . . . 73.329999999999998 110.801 -178.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 684' ' ' VAL . . . . . . . . . . . . . 41.7 t -113.57 98.3 46.52 Favored Pre-proline 0 CA--C 1.54 0.564 0 CA-C-O 120.949 0.404 . . . . 62.109999999999999 111.333 -178.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 685' ' ' PRO . . . . . 0.42 ' HB3' ' HE1' ' A' ' 721' ' ' TYR . 77.7 Cg_exo -51.52 -43.68 48.7 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 122.873 2.382 . . . . 71.420000000000002 113.615 -178.472 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 686' ' ' MET . . . . . 0.554 ' HE2' ' HA ' ' A' ' 686' ' ' MET . 0.4 OUTLIER -78.25 -1.3 32.3 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 112.758 0.651 . . . . 74.530000000000001 112.758 -177.13 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 687' ' ' ALA . . . . . . . . . . . . . . . -112.32 -8.35 13.94 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.788 0.328 . . . . 74.439999999999998 111.634 176.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 688' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -121.35 -22.54 5.96 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 112.119 0.414 . . . . 75.239999999999995 112.119 -177.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 96.4 t -95.82 148.23 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-O 120.626 0.251 . . . . 71.230000000000004 110.681 175.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 690' ' ' LEU . . . . . 0.68 HD21 HG12 ' A' ' 692' ' ' ILE . 9.6 tt -144.81 152.1 39.8 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 112.037 0.384 . . . . 65.530000000000001 112.037 -171.441 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 691' ' ' ALA . . . . . 0.402 ' HA ' ' O ' ' A' ' 668' ' ' LYS . . . -150.33 123.04 8.61 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 120.813 0.339 . . . . 65.230000000000004 111.371 176.479 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 692' ' ' ILE . . . . . 0.68 HG12 HD21 ' A' ' 690' ' ' LEU . 46.5 mm -123.62 134.65 65.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 N-CA-C 112.467 0.543 . . . . 53.229999999999997 112.467 -178.299 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 693' ' ' ASP . . . . . 0.474 ' HB2' ' HB3' ' A' ' 667' ' ' PRO . 67.7 t0 -117.43 128.34 54.91 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 109.216 -0.661 . . . . 72.040000000000006 109.216 170.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -65.63 -26.7 67.94 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 112.96 0.726 . . . . 73.120000000000005 112.96 -173.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -82.8 -40.65 20.12 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 120.824 0.345 . . . . 71.310000000000002 111.526 -177.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 696' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -95.65 -49.31 5.43 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 121.253 0.549 . . . . 55.119999999999997 111.702 -176.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . 129.01 -131.51 6.82 Favored Glycine 0 CA--C 1.528 0.855 0 CA-C-N 116.34 -0.391 . . . . 63.299999999999997 112.654 -177.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 698' ' ' ASP . . . . . 0.454 ' HA ' HD13 ' A' ' 692' ' ' ILE . 20.7 t70 -75.5 109.15 8.82 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 121.055 0.455 . . . . 75.239999999999995 111.464 178.422 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 699' ' ' LEU . . . . . 0.558 HD12 ' HB3' ' A' ' 667' ' ' PRO . 23.3 mt -99.42 4.41 46.2 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 120.839 0.352 . . . . 71.25 110.787 173.044 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 25.1 m -55.39 -40.06 70.92 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.686 0.755 . . . . 74.099999999999994 109.972 171.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 701' ' ' SER . . . . . . . . . . . . . 21.6 m -66.91 -7.76 24.37 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 115.218 -0.901 . . . . 71.120000000000005 112.146 177.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 702' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -104.05 -7.73 20.06 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 111.884 0.328 . . . . 72.129999999999995 111.884 -179.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 703' ' ' ILE . . . . . 0.482 ' HB ' ' HE1' ' A' ' 686' ' ' MET . 63.2 mt -70.66 140.8 17.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-O 120.835 0.35 . . . . 74.0 111.707 -178.233 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 704' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -110.51 133.42 53.31 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 110.247 -0.279 . . . . 72.140000000000001 110.247 170.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 50.5 t -96.7 107.23 19.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-O 120.956 0.407 . . . . 63.020000000000003 110.831 178.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 706' ' ' ASP . . . . . 0.519 ' HB3' ' HB ' ' A' ' 720' ' ' THR . 13.2 t70 -100.1 127.52 46.33 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 116.283 -0.417 . . . . 74.349999999999994 110.392 179.44 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 123.11 -175.86 16.6 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 121.173 -0.537 . . . . 55.119999999999997 113.132 -178.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 708' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -155.63 141.33 17.97 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 120.783 0.325 . . . . 73.430000000000007 111.237 -178.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 709' ' ' VAL . . . . . 0.471 HG22 ' HB2' ' A' ' 717' ' ' TYR . 93.9 t -124.87 111.53 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-O 120.887 0.375 . . . . 63.32 111.184 178.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 710' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -69.19 134.86 49.8 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 121.054 0.454 . . . . 63.549999999999997 110.669 176.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 711' ' ' THR . . . . . . . . . . . . . 35.9 p -113.54 -0.76 14.29 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.883 0.373 . . . . 74.310000000000002 110.98 178.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 712' ' ' THR . . . . . . . . . . . . . 81.9 p -98.15 -17.81 18.83 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.15 -0.477 . . . . 62.219999999999999 111.505 178.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 713' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -138.52 139.36 38.7 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 120.864 0.364 . . . . 64.209999999999994 111.271 -178.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 714' ' ' ALA . . . . . . . . . . . . . . . -70.18 144.4 51.95 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 112.662 0.616 . . . . 65.319999999999993 112.662 -176.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 159.25 161.54 11.28 Favored Glycine 0 CA--C 1.525 0.683 0 CA-C-N 115.689 -0.687 . . . . 75.409999999999997 112.262 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 716' ' ' THR . . . . . 0.405 ' HA ' ' HA ' ' A' ' 738' ' ' THR . 97.4 m -96.88 122.53 39.95 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 117.312 0.556 . . . . 74.5 111.419 178.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 717' ' ' TYR . . . . . 0.471 ' HB2' HG22 ' A' ' 709' ' ' VAL . 22.6 m-85 -123.8 150.2 44.77 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 116.193 -0.458 . . . . 53.219999999999999 110.304 -178.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 718' ' ' VAL . . . . . . . . . . . . . 58.4 t -115.57 133.94 60.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 CA-C-O 121.002 0.43 . . . . 72.239999999999995 111.918 -176.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 719' ' ' LEU . . . . . 0.414 HD21 HG23 ' A' ' 709' ' ' VAL . 88.6 mt -112.09 125.95 54.65 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.304 -0.407 . . . . 73.230000000000004 111.416 178.043 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 720' ' ' THR . . . . . 0.519 ' HB ' ' HB3' ' A' ' 706' ' ' ASP . 68.8 m -99.52 129.12 45.66 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.156 -0.474 . . . . 74.040000000000006 111.253 178.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 721' ' ' TYR . . . . . 0.42 ' HE1' ' HB3' ' A' ' 685' ' ' PRO . 77.1 m-85 -115.7 114.25 24.59 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.751 0.31 . . . . 65.239999999999995 111.002 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 45.7 m -117.22 131.92 56.74 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.57 -0.286 . . . . 73.030000000000001 111.517 -178.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 723' ' ' VAL . . . . . 0.471 ' HB ' HG12 ' A' ' 703' ' ' ILE . 7.1 p -137.16 137.25 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-O 121.066 0.46 . . . . 74.120000000000005 111.424 178.213 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 724' ' ' THR . . . . . 0.458 ' HA ' ' HA ' ' A' ' 730' ' ' GLU . 33.5 m -107.27 135.3 49.01 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.248 0.547 . . . . 72.329999999999998 112.059 -178.254 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 725' ' ' ASP . . . . . 0.537 ' HB3' ' H ' ' A' ' 729' ' ' HIS . 11.0 t0 -73.61 154.09 39.9 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 115.853 -0.612 . . . . 70.340000000000003 110.617 177.553 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 726' ' ' SER . . . . . . . . . . . . . 74.6 m -65.78 -21.98 66.54 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 116.626 -0.261 . . . . 61.219999999999999 111.572 177.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 727' ' ' LYS . . . . . 0.493 ' HB2' ' CG ' ' A' ' 664' ' ' ASP . 73.8 mmtt -106.81 4.67 27.77 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 112.495 0.554 . . . . 75.120000000000005 112.495 178.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 728' ' ' GLY . . . . . . . . . . . . . . . 114.1 -5.67 23.65 Favored Glycine 0 CA--C 1.54 1.624 0 N-CA-C 116.739 1.455 . . . . 70.439999999999998 116.739 171.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 729' ' ' HIS . . . . . 0.537 ' H ' ' HB3' ' A' ' 725' ' ' ASP . 15.1 m80 -73.16 98.17 2.55 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 119.414 1.607 . . . . 75.030000000000001 111.389 174.661 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 730' ' ' GLU . . . . . 0.458 ' HA ' ' HA ' ' A' ' 724' ' ' THR . 34.7 tt0 -98.63 106.96 19.3 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 122.188 -0.32 . . . . 73.030000000000001 111.095 179.325 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 26.9 m -111.71 152.23 13.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-O 120.942 0.401 . . . . 75.409999999999997 111.582 -176.074 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 7.2 t -146.57 151.87 38.02 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.065 0.459 . . . . 75.040000000000006 112.124 -179.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -148.35 154.29 39.75 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 115.996 -0.547 . . . . 73.109999999999999 110.722 178.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 734' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -114.95 155.3 27.17 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 112.389 0.515 . . . . 74.019999999999996 112.389 -176.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 735' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -131.36 125.98 34.07 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.081 -0.508 . . . . 75.329999999999998 110.977 178.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 736' ' ' THR . . . . . . . . . . . . . 87.7 m -90.73 104.11 16.73 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 116.475 -0.329 . . . . 61.109999999999999 111.287 178.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 737' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 675' ' ' ALA . 48.3 t -99.99 110.2 26.56 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-O 120.872 0.368 . . . . 71.549999999999997 111.756 -179.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 738' ' ' THR . . . . . 0.405 ' HA ' ' HA ' ' A' ' 716' ' ' THR . 51.8 m -95.57 123.74 39.27 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 121.036 0.446 . . . . 54.399999999999999 111.627 178.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 739' ' ' VAL . . . . . . . . . . . . . 48.1 t -104.26 128.61 57.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 CA-C-O 120.835 0.35 . . . . 75.510000000000005 111.404 178.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 740' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -116.56 160.78 20.15 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 120.858 0.361 . . . . 60.240000000000002 111.553 177.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 741' ' ' VAL . . . . . . . . . . . . . 43.6 t . . . . . 0 N--CA 1.473 0.724 0 CA-C-O 120.817 0.341 . . . . 75.450000000000003 111.582 -179.884 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 664' ' ' ASP . . . . . . . . . . . . . 42.6 t0 . . . . . 0 CA--C 1.536 0.412 0 CA-C-O 121.607 0.718 . . . . 63.310000000000002 112.017 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 665' ' ' LEU . . . . . . . . . . . . . 87.8 mt -101.82 138.72 38.42 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.266 -0.879 . . . . 65.230000000000004 110.779 175.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 666' ' ' GLU . . . . . 0.419 ' H ' ' CD ' ' A' ' 666' ' ' GLU . 1.3 pm0 -70.73 137.52 85.56 Favored Pre-proline 0 CA--C 1.542 0.638 0 N-CA-C 110.222 -0.288 . . . . 74.209999999999994 110.222 170.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 667' ' ' PRO . . . . . 0.537 ' HB3' ' HB2' ' A' ' 693' ' ' ASP . 59.9 Cg_endo -70.59 150.3 62.97 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 122.569 2.179 . . . . 74.420000000000002 113.769 -174.189 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 668' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -83.53 107.88 16.29 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 121.178 0.513 . . . . 62.549999999999997 110.635 175.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 669' ' ' LEU . . . . . . . . . . . . . 48.5 tp -90.62 112.47 24.2 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.95 -0.568 . . . . 63.229999999999997 109.828 175.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 670' ' ' THR . . . . . . . . . . . . . 83.6 m -95.11 110.48 22.42 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.175 0.512 . . . . 74.25 111.73 -176.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 671' ' ' VAL . . . . . 0.41 HG22 HG13 ' A' ' 689' ' ' VAL . 82.1 t -133.25 134.2 23.81 Favored Pre-proline 0 CA--C 1.542 0.638 0 CA-C-N 115.599 -0.728 . . . . 71.239999999999995 110.758 -178.106 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 672' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.42 136.66 26.69 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 122.201 1.934 . . . . 63.229999999999997 111.807 175.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 673' ' ' VAL . . . . . . . . . . . . . 14.3 p -64.5 -33.63 64.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 N-CA-C 112.093 0.405 . . . . 60.329999999999998 112.093 -176.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 674' ' ' GLY . . . . . 0.437 ' HA2' ' O ' ' A' ' 736' ' ' THR . . . -157.31 153.3 24.55 Favored Glycine 0 CA--C 1.523 0.554 0 C-N-CA 120.894 -0.67 . . . . 63.299999999999997 113.416 -178.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 675' ' ' ALA . . . . . . . . . . . . . . . -144.51 121.0 11.03 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.752 0.311 . . . . 61.409999999999997 111.169 179.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 676' ' ' THR . . . . . . . . . . . . . 84.8 m -96.98 121.6 39.04 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.92 0.39 . . . . 61.130000000000003 111.446 -179.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 677' ' ' ILE . . . . . . . . . . . . . 32.0 pt -130.79 176.68 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 CA-C-N 116.5 -0.318 . . . . 74.310000000000002 110.984 178.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 678' ' ' HIS . . . . . . . . . . . . . 78.0 m80 -121.55 153.72 37.64 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.231 0.538 . . . . 52.439999999999998 112.394 -179.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 679' ' ' VAL . . . . . . . . . . . . . 92.6 t -55.32 115.28 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 115.68 -0.691 . . . . 64.540000000000006 111.733 179.261 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 100.33 24.42 9.56 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 121.313 -0.47 . . . . 71.129999999999995 113.341 -177.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 681' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -108.59 176.03 5.26 Favored 'General case' 0 CA--C 1.546 0.826 0 O-C-N 122.516 -0.402 . . . . 52.350000000000001 110.883 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 682' ' ' SER . . . . . . . . . . . . . 84.4 p -114.94 129.57 56.74 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 122.334 0.254 . . . . 64.129999999999995 111.237 -179.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 683' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -139.4 126.1 20.68 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 120.821 0.343 . . . . 64.310000000000002 111.224 -178.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 684' ' ' VAL . . . . . . . . . . . . . 81.6 t -114.17 105.19 54.39 Favored Pre-proline 0 N--CA 1.474 0.753 0 N-CA-C 111.989 0.366 . . . . 55.409999999999997 111.989 -179.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_exo -53.37 -40.55 77.78 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 123.041 2.494 . . . . 71.120000000000005 113.727 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 686' ' ' MET . . . . . 0.552 ' HE3' ' HA ' ' A' ' 686' ' ' MET . 1.0 OUTLIER -78.24 -4.0 45.56 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 112.636 0.606 . . . . 73.439999999999998 112.636 -177.994 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 687' ' ' ALA . . . . . . . . . . . . . . . -98.74 -17.68 18.39 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.954 0.407 . . . . 63.130000000000003 111.385 177.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 688' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -98.67 -13.94 20.07 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 112.446 0.535 . . . . 74.420000000000002 112.446 -175.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 689' ' ' VAL . . . . . 0.59 HG12 HD13 ' A' ' 703' ' ' ILE . 94.9 t -122.49 132.93 70.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 N-CA-C 112.919 0.711 . . . . 75.140000000000001 112.919 -173.23 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 690' ' ' LEU . . . . . 0.514 ' HA ' HG23 ' A' ' 700' ' ' THR . 6.5 mp -124.93 165.0 18.87 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 116.274 -0.421 . . . . 71.540000000000006 111.021 177.392 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 691' ' ' ALA . . . . . . . . . . . . . . . -152.19 127.41 9.84 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 120.915 0.388 . . . . 44.340000000000003 111.909 178.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 692' ' ' ILE . . . . . . . . . . . . . 45.6 mm -135.28 139.07 47.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 N-CA-C 112.097 0.406 . . . . 73.310000000000002 112.097 -177.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 693' ' ' ASP . . . . . 0.537 ' HB2' ' HB3' ' A' ' 667' ' ' PRO . 45.5 t0 -120.29 137.93 53.98 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 109.589 -0.523 . . . . 75.519999999999996 109.589 171.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 52.9 tttp -57.33 -35.25 69.66 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 121.06 0.457 . . . . 74.129999999999995 112.1 -178.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -82.52 -46.16 13.76 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 112.294 0.479 . . . . 72.219999999999999 112.294 -176.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 696' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -94.33 -34.79 12.67 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 112.361 0.504 . . . . 51.100000000000001 112.361 -170.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . 105.26 -123.3 7.55 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 121.44 -0.409 . . . . 33.530000000000001 113.018 -178.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -75.96 118.41 18.7 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 121.272 0.558 . . . . 71.540000000000006 112.142 -178.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 699' ' ' LEU . . . . . 0.449 HD12 ' HB3' ' A' ' 667' ' ' PRO . 81.4 mt -118.33 8.13 12.15 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 115.719 -0.673 . . . . 62.420000000000002 110.408 171.742 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 700' ' ' THR . . . . . 0.514 HG23 ' HA ' ' A' ' 690' ' ' LEU . 37.8 m -59.1 -37.77 77.96 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.48 0.657 . . . . 54.229999999999997 110.568 175.343 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 701' ' ' SER . . . . . . . . . . . . . 54.8 p -73.4 -2.75 23.62 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 115.588 -0.733 . . . . 62.200000000000003 111.865 176.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 702' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -110.74 2.01 18.18 Favored 'General case' 0 CA--C 1.541 0.596 0 N-CA-C 111.859 0.318 . . . . 72.150000000000006 111.859 -179.067 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 703' ' ' ILE . . . . . 0.59 HD13 HG12 ' A' ' 689' ' ' VAL . 66.9 mt -71.12 129.67 34.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-O 121.179 0.514 . . . . 72.319999999999993 111.695 -179.169 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 704' ' ' LYS . . . . . . . . . . . . . 2.4 tppp? -104.88 127.26 52.64 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.192 -0.458 . . . . 71.049999999999997 110.244 177.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 50.1 t -97.94 134.8 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-O 120.825 0.345 . . . . 74.329999999999998 111.893 -177.115 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 706' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -128.56 147.63 50.71 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 116.133 -0.485 . . . . 74.349999999999994 110.351 175.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 106.13 -172.44 18.84 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 121.185 -0.531 . . . . 75.349999999999994 112.658 -177.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 708' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -165.18 130.62 2.61 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 116.925 0.363 . . . . 74.310000000000002 111.542 179.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 709' ' ' VAL . . . . . 0.553 HG22 ' HB2' ' A' ' 717' ' ' TYR . 98.8 t -110.63 116.6 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-O 120.792 0.329 . . . . 73.150000000000006 111.431 177.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 710' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -73.26 134.8 44.37 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 120.979 0.419 . . . . 72.129999999999995 110.584 175.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 711' ' ' THR . . . . . . . . . . . . . 75.8 p -105.97 -0.11 25.28 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 111.913 0.338 . . . . 75.120000000000005 111.913 -179.04 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 712' ' ' THR . . . . . . . . . . . . . 14.9 t -107.34 -1.86 21.21 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 112.47 0.544 . . . . 72.299999999999997 112.47 -177.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 713' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -143.58 134.94 26.0 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 122.021 -0.424 . . . . 73.010000000000005 111.174 -179.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 714' ' ' ALA . . . . . . . . . . . . . . . -70.23 140.79 52.49 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 112.343 0.498 . . . . 72.299999999999997 112.343 -176.16 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 153.39 167.08 15.31 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 121.124 -0.56 . . . . 61.439999999999998 112.856 -179.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 716' ' ' THR . . . . . . . . . . . . . 34.7 m -96.56 122.92 40.0 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 122.461 -0.435 . . . . 70.219999999999999 111.908 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 717' ' ' TYR . . . . . 0.553 ' HB2' HG22 ' A' ' 709' ' ' VAL . 27.3 m-85 -121.89 143.02 49.68 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 116.122 -0.49 . . . . 73.310000000000002 110.142 178.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 718' ' ' VAL . . . . . . . . . . . . . 53.8 t -109.75 127.49 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 N-CA-C 112.645 0.609 . . . . 60.340000000000003 112.645 -174.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 719' ' ' LEU . . . . . . . . . . . . . 96.3 mt -106.72 132.25 52.91 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 116.068 -0.515 . . . . 50.229999999999997 111.424 176.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 58.4 m -109.87 124.65 51.71 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 120.791 0.329 . . . . 74.040000000000006 111.261 179.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 721' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -110.94 129.63 55.82 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.507 -0.315 . . . . 73.25 110.718 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 99.5 m -132.65 125.37 30.19 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.554 0.216 . . . . 73.340000000000003 111.286 -179.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 8.1 p -117.62 142.53 31.42 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 CA-C-O 120.933 0.397 . . . . 51.229999999999997 111.773 -178.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 44.1 m -105.07 118.96 37.84 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.238 0.542 . . . . 74.439999999999998 112.429 -176.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 725' ' ' ASP . . . . . 0.525 ' HB2' ' HD3' ' A' ' 667' ' ' PRO . 5.7 t0 -73.79 150.94 40.76 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 115.798 -0.637 . . . . 75.209999999999994 110.804 174.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 726' ' ' SER . . . . . . . . . . . . . 59.8 p -74.19 -15.27 61.02 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 112.459 0.541 . . . . 65.450000000000003 112.459 -175.021 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 727' ' ' LYS . . . . . . . . . . . . . 65.2 mmtt -103.66 6.14 36.84 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 112.266 0.469 . . . . 72.120000000000005 112.266 177.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 728' ' ' GLY . . . . . . . . . . . . . . . 102.83 27.96 6.44 Favored Glycine 0 CA--C 1.532 1.103 0 N-CA-C 115.269 0.868 . . . . 54.219999999999999 115.269 173.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 729' ' ' HIS . . . . . 0.42 ' H ' ' HB3' ' A' ' 725' ' ' ASP . 21.1 m80 -109.14 104.01 13.11 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 117.897 0.849 . . . . 55.399999999999999 111.6 173.19 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 730' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -98.83 105.58 17.74 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 120.807 0.337 . . . . 72.109999999999999 110.867 177.172 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 33.9 m -106.79 153.59 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-O 120.822 0.344 . . . . 74.140000000000001 111.624 -178.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 9.8 t -134.94 147.86 49.88 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 112.415 0.524 . . . . 75.310000000000002 112.415 -176.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -148.56 149.6 31.87 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.08 0.552 . . . . 63.450000000000003 109.989 176.082 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 734' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -120.44 158.46 27.17 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 113.03 0.752 . . . . 73.420000000000002 113.03 -173.134 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 735' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -130.34 123.44 29.97 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.374 -0.83 . . . . 63.109999999999999 110.708 179.123 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 736' ' ' THR . . . . . 0.437 ' O ' ' HA2' ' A' ' 674' ' ' GLY . 62.2 m -92.49 103.67 16.07 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 121.056 0.455 . . . . 61.340000000000003 111.122 178.178 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 50.0 t -96.58 128.93 47.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-O 120.85 0.357 . . . . 74.409999999999997 111.411 -177.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 738' ' ' THR . . . . . . . . . . . . . 97.0 m -114.58 114.6 25.94 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.092 0.472 . . . . 75.120000000000005 111.642 -178.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 739' ' ' VAL . . . . . . . . . . . . . 39.3 t -93.06 135.14 28.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 CA-C-N 116.162 -0.472 . . . . 55.43 111.155 178.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 740' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -122.71 155.53 36.27 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.74 0.305 . . . . 71.150000000000006 111.594 -178.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 741' ' ' VAL . . . . . . . . . . . . . 24.1 t . . . . . 0 CA--C 1.541 0.605 0 CA-C-O 120.69 0.281 . . . . 74.409999999999997 111.586 -178.65 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 664' ' ' ASP . . . . . 0.463 ' OD2' ' HB2' ' A' ' 727' ' ' LYS . 16.2 t0 . . . . . 0 N--CA 1.467 0.376 0 CA-C-O 121.266 0.555 . . . . 75.519999999999996 111.112 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 665' ' ' LEU . . . . . . . . . . . . . 67.7 mt -99.52 126.35 45.46 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.812 -0.631 . . . . 74.329999999999998 110.412 176.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 666' ' ' GLU . . . . . 0.519 ' H ' ' CD ' ' A' ' 666' ' ' GLU . 0.7 OUTLIER -58.69 156.33 24.81 Favored Pre-proline 0 CA--C 1.544 0.722 0 CA-C-N 115.872 -0.604 . . . . 71.409999999999997 112.28 -179.283 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 667' ' ' PRO . . . . . 0.421 ' HD3' ' HB2' ' A' ' 725' ' ' ASP . 72.0 Cg_endo -75.17 145.29 30.71 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.276 1.984 . . . . 75.349999999999994 112.861 -175.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 668' ' ' LYS . . . . . . . . . . . . . 52.6 tptt -82.37 104.3 12.57 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.105 0.478 . . . . 73.319999999999993 111.001 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 669' ' ' LEU . . . . . . . . . . . . . 51.2 tp -89.91 106.58 18.57 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.271 0.557 . . . . 62.109999999999999 110.762 177.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 670' ' ' THR . . . . . . . . . . . . . 33.0 m -91.75 110.92 22.27 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.089 -0.505 . . . . 72.019999999999996 111.246 -177.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 671' ' ' VAL . . . . . 0.437 HG21 ' HB3' ' A' ' 733' ' ' ALA . 84.7 t -131.66 139.72 36.1 Favored Pre-proline 0 N--CA 1.473 0.691 0 CA-C-N 116.092 -0.504 . . . . 74.409999999999997 111.161 -176.369 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 672' ' ' PRO . . . . . 0.404 ' HD2' HG13 ' A' ' 671' ' ' VAL . 74.3 Cg_endo -76.74 149.34 29.72 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 122.418 2.079 . . . . 75.319999999999993 112.595 175.129 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 673' ' ' VAL . . . . . . . . . . . . . 12.5 p -69.57 -34.75 63.02 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 N-CA-C 112.468 0.544 . . . . 72.129999999999995 112.468 -176.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 674' ' ' GLY . . . . . . . . . . . . . . . 179.85 169.39 40.04 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 120.396 -0.907 . . . . 64.209999999999994 113.949 -178.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 675' ' ' ALA . . . . . . . . . . . . . . . -154.99 140.2 17.56 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 122.625 0.37 . . . . 61.240000000000002 111.107 179.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 676' ' ' THR . . . . . . . . . . . . . 86.2 m -118.71 121.22 39.6 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-O 120.713 0.292 . . . . 72.140000000000001 111.398 -179.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 677' ' ' ILE . . . . . . . . . . . . . 30.0 pt -129.3 174.3 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-O 120.986 0.422 . . . . 74.040000000000006 111.886 -177.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 678' ' ' HIS . . . . . . . . . . . . . 53.0 m80 -115.84 166.3 12.11 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.312 0.577 . . . . 32.130000000000003 111.933 178.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 679' ' ' VAL . . . . . 0.585 HG13 ' HA ' ' A' ' 712' ' ' THR . 63.2 t -56.95 111.88 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-N 115.628 -0.714 . . . . 73.329999999999998 110.643 174.003 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 123.05 -33.2 4.13 Favored Glycine 0 CA--C 1.526 0.736 0 CA-C-N 116.256 -0.429 . . . . 44.439999999999998 112.815 -175.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 681' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -73.48 128.26 35.01 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.095 0.474 . . . . 74.329999999999998 111.659 179.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 682' ' ' SER . . . . . . . . . . . . . 50.4 m -85.34 144.42 28.06 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 120.849 0.357 . . . . 61.409999999999997 110.871 176.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 683' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -118.08 132.38 56.36 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 120.809 0.338 . . . . 74.450000000000003 111.263 -178.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 684' ' ' VAL . . . . . . . . . . . . . 52.4 t -116.84 96.98 49.89 Favored Pre-proline 0 CA--C 1.544 0.72 0 CA-C-N 116.461 -0.336 . . . . 61.210000000000001 111.326 -178.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -77.28 -31.62 3.48 Favored 'Trans proline' 0 CA--C 1.545 1.07 0 C-N-CA 122.783 2.322 . . . . 72.549999999999997 114.461 -174.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 686' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.35 -12.17 59.99 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 112.303 0.482 . . . . 74.209999999999994 112.303 -174.515 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 687' ' ' ALA . . . . . . . . . . . . . . . -94.22 -27.39 16.2 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 111.91 0.337 . . . . 62.130000000000003 111.91 178.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 688' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -91.35 -8.22 48.7 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 112.133 0.42 . . . . 75.109999999999999 112.133 -177.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 689' ' ' VAL . . . . . 0.515 HG12 HD13 ' A' ' 703' ' ' ILE . 62.7 t -114.21 127.64 71.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-O 120.987 0.422 . . . . 75.439999999999998 111.559 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 690' ' ' LEU . . . . . 0.412 HD22 ' C ' ' A' ' 689' ' ' VAL . 3.8 mm? -123.66 155.82 37.04 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 116.247 -0.433 . . . . 71.129999999999995 111.125 179.563 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 691' ' ' ALA . . . . . . . . . . . . . . . -141.5 122.86 14.9 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 120.659 0.266 . . . . 73.150000000000006 110.865 174.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 692' ' ' ILE . . . . . 0.431 HD13 ' HA ' ' A' ' 698' ' ' ASP . 48.1 mm -128.68 120.48 52.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 N-CA-C 112.087 0.403 . . . . 73.209999999999994 112.087 -177.034 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -95.05 149.94 20.71 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.09 0.472 . . . . 62.25 110.692 172.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 7.5 mtpm? -77.42 -34.56 54.68 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 112.665 0.617 . . . . 61.539999999999999 112.665 -173.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -84.86 -54.98 4.32 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 121.828 -0.545 . . . . 73.430000000000007 112.095 177.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 696' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -75.93 -50.48 14.85 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 112.125 0.417 . . . . 74.400000000000006 112.125 -173.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . 123.94 -139.44 12.03 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 121.37 -0.443 . . . . 74.25 112.65 -175.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 698' ' ' ASP . . . . . 0.431 ' HA ' HD13 ' A' ' 692' ' ' ILE . 14.3 t70 -67.53 122.57 18.28 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 122.369 -0.489 . . . . 73.329999999999998 111.961 -178.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 699' ' ' LEU . . . . . 0.405 HD22 ' HD2' ' A' ' 702' ' ' LYS . 83.5 mt -118.49 19.44 13.33 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 116.097 -0.502 . . . . 72.420000000000002 111.1 176.087 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 89.3 m -59.52 -31.96 69.87 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 120.954 0.407 . . . . 74.209999999999994 112.067 -176.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 701' ' ' SER . . . . . . . . . . . . . 46.7 m -72.03 -13.58 61.64 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 120.763 0.316 . . . . 40.299999999999997 111.833 179.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 702' ' ' LYS . . . . . 0.405 ' HD2' HD22 ' A' ' 699' ' ' LEU . 68.8 mttm -92.98 -2.74 55.48 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 112.09 0.404 . . . . 71.230000000000004 112.09 179.513 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 703' ' ' ILE . . . . . 0.515 HD13 HG12 ' A' ' 689' ' ' VAL . 69.8 mt -68.67 119.48 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-O 121.09 0.471 . . . . 71.420000000000002 111.763 -179.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 704' ' ' LYS . . . . . . . . . . . . . 51.1 tptt -89.76 126.62 35.74 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.246 -0.434 . . . . 54.039999999999999 110.177 175.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 51.7 t -95.99 130.07 45.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-O 121.046 0.451 . . . . 45.109999999999999 112.004 -177.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 706' ' ' ASP . . . . . 0.581 ' HB3' ' HB ' ' A' ' 720' ' ' THR . 14.4 t70 -123.29 145.69 48.49 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.185 -0.462 . . . . 64.150000000000006 110.484 176.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 119.96 -153.98 16.59 Favored Glycine 0 CA--C 1.524 0.651 0 C-N-CA 121.079 -0.582 . . . . 51.240000000000002 113.32 178.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 708' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -166.96 141.42 3.94 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.762 0.315 . . . . 71.530000000000001 111.118 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 709' ' ' VAL . . . . . . . . . . . . . 59.9 t -127.1 110.89 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-O 120.583 0.23 . . . . 75.230000000000004 110.918 174.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 710' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -94.29 135.77 35.32 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 109.882 -0.414 . . . . 63.109999999999999 109.882 176.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 711' ' ' THR . . . . . 0.431 ' O ' ' HA ' ' A' ' 679' ' ' VAL . 71.8 p -105.77 0.04 25.79 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 122.105 -0.372 . . . . 62.509999999999998 111.98 -177.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 712' ' ' THR . . . . . 0.585 ' HA ' HG13 ' A' ' 679' ' ' VAL . 72.0 p -116.24 -24.25 8.05 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 116.426 -0.352 . . . . 74.129999999999995 111.777 178.29 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 713' ' ' LYS . . . . . . . . . . . . . 61.2 tttm -111.9 121.29 44.62 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 120.899 0.381 . . . . 72.109999999999999 111.119 -178.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 714' ' ' ALA . . . . . . . . . . . . . . . -70.21 143.88 52.08 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 112.542 0.571 . . . . 71.510000000000005 112.542 -177.017 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 156.39 162.24 11.3 Favored Glycine 0 CA--C 1.526 0.722 0 CA-C-N 115.938 -0.574 . . . . 63.240000000000002 112.509 179.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 716' ' ' THR . . . . . . . . . . . . . 51.6 m -98.34 122.57 41.68 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 117.311 0.556 . . . . 73.129999999999995 111.093 177.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 717' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -119.49 137.33 53.87 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.431 -0.35 . . . . 72.329999999999998 110.71 -178.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 718' ' ' VAL . . . . . . . . . . . . . 48.4 t -95.15 131.36 42.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-O 121.079 0.466 . . . . 74.409999999999997 111.606 179.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 719' ' ' LEU . . . . . . . . . . . . . 86.6 mt -108.53 133.67 52.35 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.055 -0.52 . . . . 65.400000000000006 110.814 177.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 720' ' ' THR . . . . . 0.581 ' HB ' ' HB3' ' A' ' 706' ' ' ASP . 77.3 m -117.53 130.92 56.72 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-O 120.634 0.254 . . . . 63.5 110.934 178.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 721' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -119.23 132.26 55.91 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 120.672 0.272 . . . . 63.420000000000002 111.118 -178.511 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 97.8 m -128.33 139.47 52.39 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 111.686 0.254 . . . . 62.109999999999999 111.686 -179.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 13.8 p -141.27 147.2 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 CA-C-O 120.937 0.399 . . . . 75.239999999999995 111.244 178.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 18.7 m -110.97 144.95 39.26 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.035 0.445 . . . . 73.510000000000005 111.999 -176.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 725' ' ' ASP . . . . . 0.723 ' HB3' ' H ' ' A' ' 729' ' ' HIS . 7.5 t70 -74.11 168.46 19.52 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.041 0.536 . . . . 50.229999999999997 111.222 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 726' ' ' SER . . . . . . . . . . . . . 34.1 t -68.65 -30.83 69.62 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 120.78 0.324 . . . . 74.019999999999996 110.985 174.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 727' ' ' LYS . . . . . 0.463 ' HB2' ' OD2' ' A' ' 664' ' ' ASP . 4.1 mptp? -96.47 -9.44 29.7 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 112.62 0.6 . . . . 71.430000000000007 112.62 177.423 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 728' ' ' GLY . . . . . . . . . . . . . . . 113.15 22.38 5.6 Favored Glycine 0 CA--C 1.535 1.332 0 N-CA-C 116.111 1.204 . . . . 50.140000000000001 116.111 173.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 729' ' ' HIS . . . . . 0.723 ' H ' ' HB3' ' A' ' 725' ' ' ASP . 46.5 m80 -83.67 119.98 25.43 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 118.117 0.958 . . . . 74.230000000000004 110.949 169.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 730' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -103.56 119.76 39.54 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 120.823 0.344 . . . . 73.510000000000005 111.692 -179.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 35.1 m -120.65 157.43 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-O 120.733 0.301 . . . . 55.149999999999999 111.234 179.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 9.6 t -146.91 147.88 31.22 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.545 0.572 . . . . 72.420000000000002 112.545 -177.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 733' ' ' ALA . . . . . 0.437 ' HB3' HG21 ' A' ' 671' ' ' VAL . . . -141.73 161.9 36.8 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 116.042 -0.527 . . . . 60.140000000000001 110.91 -179.677 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 734' ' ' LYS . . . . . . . . . . . . . 42.8 mtmt -128.9 150.8 50.2 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 112.872 0.693 . . . . 44.140000000000001 112.872 -173.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 735' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -130.75 140.65 50.33 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 115.423 -0.808 . . . . 73.409999999999997 110.662 177.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 736' ' ' THR . . . . . . . . . . . . . 92.4 m -109.85 107.76 17.83 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 112.221 0.452 . . . . 72.329999999999998 112.221 -178.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 57.5 t -102.47 131.67 50.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 O-C-N 122.16 -0.338 . . . . 71.109999999999999 111.787 -178.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 738' ' ' THR . . . . . . . . . . . . . 91.7 m -119.13 118.46 31.44 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 120.788 0.327 . . . . 60.119999999999997 111.522 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 739' ' ' VAL . . . . . . . . . . . . . 41.7 t -102.88 139.1 24.73 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 CA-C-O 120.67 0.271 . . . . 73.120000000000005 111.418 178.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 740' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -128.91 157.68 40.91 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 120.931 0.396 . . . . 73.329999999999998 111.76 179.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 741' ' ' VAL . . . . . 0.404 ' HA ' HG23 ' A' ' 679' ' ' VAL . 9.6 t . . . . . 0 N--CA 1.472 0.654 0 CA-C-N 116.551 -0.295 . . . . 71.420000000000002 111.585 -176.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 664' ' ' ASP . . . . . . . . . . . . . 16.6 t70 . . . . . 0 N--CA 1.467 0.381 0 CA-C-O 121.644 0.735 . . . . 73.430000000000007 112.504 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 665' ' ' LEU . . . . . . . . . . . . . 72.6 mt -101.49 137.68 39.49 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-N 115.019 -0.991 . . . . 55.030000000000001 110.876 177.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 666' ' ' GLU . . . . . 0.502 ' HG3' ' HB3' ' A' ' 729' ' ' HIS . 19.7 mp0 -71.11 150.09 94.64 Favored Pre-proline 0 CA--C 1.538 0.497 0 CA-C-N 116.121 -0.491 . . . . 74.219999999999999 110.505 177.427 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 667' ' ' PRO . . . . . 0.559 ' HB3' HD12 ' A' ' 699' ' ' LEU . 37.5 Cg_endo -65.1 133.19 34.55 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 122.103 1.869 . . . . 73.519999999999996 112.345 179.092 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 668' ' ' LYS . . . . . . . . . . . . . 56.1 tptt -82.18 106.98 14.51 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 121.173 0.511 . . . . 73.340000000000003 110.56 179.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 669' ' ' LEU . . . . . 0.516 ' HG ' HG23 ' A' ' 671' ' ' VAL . 60.0 tp -89.39 106.04 18.19 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.709 -0.678 . . . . 53.409999999999997 110.912 -178.614 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 670' ' ' THR . . . . . . . . . . . . . 86.3 m -86.37 110.4 19.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.034 0.445 . . . . 74.25 110.828 179.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 671' ' ' VAL . . . . . 0.516 HG23 ' HG ' ' A' ' 669' ' ' LEU . 94.8 t -127.55 127.94 24.03 Favored Pre-proline 0 CA--C 1.536 0.418 0 CA-C-N 116.032 -0.531 . . . . 74.329999999999998 111.021 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 672' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -64.48 154.2 73.03 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 122.305 2.003 . . . . 72.420000000000002 111.929 178.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 673' ' ' VAL . . . . . . . . . . . . . 10.1 p -81.5 -34.39 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 O-C-N 122.145 -0.347 . . . . 74.239999999999995 111.89 -176.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 674' ' ' GLY . . . . . 0.418 ' HA2' ' O ' ' A' ' 736' ' ' THR . . . -162.54 163.88 35.36 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 121.094 -0.574 . . . . 64.430000000000007 113.579 -178.173 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 675' ' ' ALA . . . . . . . . . . . . . . . -156.3 118.28 3.97 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 120.694 0.283 . . . . 71.209999999999994 111.747 179.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 676' ' ' THR . . . . . . . . . . . . . 88.7 m -97.43 126.14 42.5 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 120.648 0.261 . . . . 73.049999999999997 111.591 178.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 677' ' ' ILE . . . . . 0.416 HG13 HG22 ' A' ' 739' ' ' VAL . 20.1 pt -138.52 176.44 6.62 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 C-N-CA 122.514 0.325 . . . . 71.430000000000007 111.288 179.391 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 678' ' ' HIS . . . . . 0.541 ' O ' ' HB2' ' A' ' 681' ' ' ASP . 72.1 m80 -114.93 177.21 4.73 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 121.396 0.617 . . . . 53.229999999999997 112.574 -179.6 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 679' ' ' VAL . . . . . 0.481 HG23 ' HA ' ' A' ' 741' ' ' VAL . 96.1 t -66.45 122.13 16.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-N 116.004 -0.544 . . . . 75.209999999999994 110.957 174.154 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 86.1 18.31 59.55 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 121.218 -0.515 . . . . 70.439999999999998 112.825 -176.028 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 681' ' ' ASP . . . . . 0.541 ' HB2' ' O ' ' A' ' 678' ' ' HIS . 1.1 t70 -83.09 -175.32 5.78 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-O 120.882 0.373 . . . . 70.109999999999999 111.295 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 682' ' ' SER . . . . . . . . . . . . . 69.7 m -123.12 140.66 52.8 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 122.418 0.287 . . . . 53.340000000000003 111.314 179.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 683' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -154.61 125.38 7.07 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 116.494 -0.321 . . . . 73.530000000000001 110.87 -178.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 684' ' ' VAL . . . . . . . . . . . . . 38.6 t -125.38 93.57 44.77 Favored Pre-proline 0 CA--C 1.546 0.789 0 CA-C-O 121.022 0.439 . . . . 65.510000000000005 111.926 -177.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -61.27 -36.81 77.78 Favored 'Trans proline' 0 CA--C 1.545 1.028 0 C-N-CA 122.725 2.283 . . . . 53.109999999999999 113.576 -177.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 686' ' ' MET . . . . . . . . . . . . . 1.9 mmt -78.82 4.08 14.98 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 112.573 0.582 . . . . 65.510000000000005 112.573 -176.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 687' ' ' ALA . . . . . . . . . . . . . . . -119.21 -40.65 2.8 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.18 0.514 . . . . 54.450000000000003 111.211 174.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 688' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -71.93 -24.91 61.71 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 116.2 -0.455 . . . . 75.540000000000006 111.998 179.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 689' ' ' VAL . . . . . 0.427 HG13 HG22 ' A' ' 671' ' ' VAL . 63.7 t -96.91 144.48 10.49 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 CA-C-O 120.677 0.275 . . . . 51.009999999999998 110.802 174.258 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 690' ' ' LEU . . . . . 0.45 HD23 ' N ' ' A' ' 691' ' ' ALA . 10.5 tt -142.66 149.55 39.04 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 120.475 0.178 . . . . 61.240000000000002 111.105 -174.302 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 691' ' ' ALA . . . . . 0.45 ' N ' HD23 ' A' ' 690' ' ' LEU . . . -144.22 132.78 22.21 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 112.085 0.402 . . . . 42.5 112.085 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 692' ' ' ILE . . . . . 0.576 HD13 ' HA ' ' A' ' 698' ' ' ASP . 43.7 mm -133.97 132.91 56.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 N-CA-C 112.039 0.385 . . . . 63.25 112.039 -178.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 693' ' ' ASP . . . . . 0.46 ' OD1' ' HG2' ' A' ' 695' ' ' GLU . 7.7 t70 -110.68 149.21 30.79 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 109.714 -0.476 . . . . 65.530000000000001 109.714 171.162 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -69.41 -29.3 67.0 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 111.894 0.331 . . . . 70.140000000000001 111.894 -177.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 695' ' ' GLU . . . . . 0.46 ' HG2' ' OD1' ' A' ' 693' ' ' ASP . 12.2 pt-20 -81.72 -46.37 14.38 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 112.189 0.441 . . . . 74.040000000000006 112.189 -175.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 696' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -95.53 -48.85 5.66 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.138 0.494 . . . . 73.349999999999994 111.683 -174.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . 119.22 -119.28 4.25 Favored Glycine 0 CA--C 1.525 0.658 0 CA-C-N 116.006 -0.543 . . . . 50.350000000000001 112.423 -175.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 698' ' ' ASP . . . . . 0.576 ' HA ' HD13 ' A' ' 692' ' ' ILE . 12.9 t70 -74.88 116.36 15.51 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 122.372 -0.487 . . . . 74.0 111.757 -178.082 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 699' ' ' LEU . . . . . 0.559 HD12 ' HB3' ' A' ' 667' ' ' PRO . 57.8 mt -114.54 22.95 13.17 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 116.108 -0.497 . . . . 63.310000000000002 110.944 174.25 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 37.7 m -60.54 -37.39 81.05 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 120.979 0.419 . . . . 55.530000000000001 111.823 -176.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 701' ' ' SER . . . . . . . . . . . . . 70.6 m -74.51 -10.9 60.0 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 120.848 0.356 . . . . 71.430000000000007 111.794 177.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 702' ' ' LYS . . . . . 0.458 ' HG3' HD22 ' A' ' 699' ' ' LEU . 48.0 mmtm -90.88 7.22 41.08 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 120.831 0.348 . . . . 72.340000000000003 111.433 -178.413 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 703' ' ' ILE . . . . . 0.423 HD13 HG12 ' A' ' 689' ' ' VAL . 66.4 mt -87.24 117.73 31.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 CA-C-O 121.234 0.54 . . . . 75.329999999999998 112.421 -177.37 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 704' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -84.68 135.39 34.18 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.959 -0.564 . . . . 55.130000000000003 110.546 173.033 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 56.2 t -107.98 143.58 18.19 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-O 120.844 0.354 . . . . 74.299999999999997 111.954 -177.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 706' ' ' ASP . . . . . 0.503 ' HB3' ' HB ' ' A' ' 720' ' ' THR . 24.7 t70 -129.05 143.5 50.89 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 122.713 0.405 . . . . 75.349999999999994 110.673 175.103 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 93.36 174.38 40.36 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 121.315 -0.469 . . . . 64.239999999999995 112.516 -174.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 708' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -152.07 137.9 18.01 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 122.259 -0.554 . . . . 73.140000000000001 112.157 -179.118 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 709' ' ' VAL . . . . . . . . . . . . . 89.3 t -106.68 114.97 47.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-O 120.94 0.4 . . . . 73.129999999999995 111.466 178.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 710' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -82.43 136.87 34.84 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 116.472 -0.331 . . . . 73.510000000000005 110.881 176.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 711' ' ' THR . . . . . . . . . . . . . 78.9 p -97.4 -31.88 12.15 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 112.326 0.491 . . . . 64.040000000000006 112.326 -176.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 712' ' ' THR . . . . . . . . . . . . . 51.0 p -85.42 -0.16 54.03 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.547 0.573 . . . . 60.100000000000001 112.547 -177.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 713' ' ' LYS . . . . . . . . . . . . . 23.0 tptp -140.3 132.4 27.97 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.705 0.288 . . . . 73.209999999999994 110.964 -178.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 714' ' ' ALA . . . . . . . . . . . . . . . -75.65 144.69 41.53 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 112.046 0.388 . . . . 63.229999999999997 112.046 -177.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 162.09 164.35 16.85 Favored Glycine 0 CA--C 1.523 0.591 0 C-N-CA 121.219 -0.515 . . . . 52.009999999999998 112.828 179.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 716' ' ' THR . . . . . . . . . . . . . 54.8 m -95.73 123.23 39.2 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.119 0.485 . . . . 52.229999999999997 111.434 178.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 717' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -120.75 110.59 16.56 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 116.109 -0.496 . . . . 75.219999999999999 110.659 -179.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 718' ' ' VAL . . . . . . . . . . . . . 48.8 t -90.58 107.82 18.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-O 121.082 0.467 . . . . 75.129999999999995 111.059 179.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 719' ' ' LEU . . . . . . . . . . . . . 59.9 mt -89.52 150.43 22.45 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.128 -0.487 . . . . 75.239999999999995 111.968 -176.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 720' ' ' THR . . . . . 0.503 ' HB ' ' HB3' ' A' ' 706' ' ' ASP . 92.2 m -121.87 135.85 54.91 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 116.412 -0.358 . . . . 64.140000000000001 110.902 177.276 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 721' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -122.08 142.72 50.08 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.929 0.395 . . . . 62.399999999999999 111.463 -178.157 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 69.9 m -138.71 135.12 34.43 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 122.399 0.28 . . . . 72.019999999999996 111.138 -179.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 10.9 p -128.3 144.27 38.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 O-C-N 122.233 -0.292 . . . . 71.510000000000005 111.14 178.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 28.8 m -110.7 144.01 40.29 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.434 0.635 . . . . 73.239999999999995 112.214 -177.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 725' ' ' ASP . . . . . 0.449 ' HB3' ' H ' ' A' ' 729' ' ' HIS . 45.2 t0 -91.74 151.74 20.49 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.916 0.886 . . . . 73.530000000000001 110.25 -179.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 726' ' ' SER . . . . . 0.446 ' HB3' ' OE2' ' A' ' 695' ' ' GLU . 48.0 t -64.95 -22.71 67.04 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.161 0.505 . . . . 73.310000000000002 110.846 177.602 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 727' ' ' LYS . . . . . . . . . . . . . 27.5 mmtp -90.29 -6.33 55.26 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 116.187 -0.461 . . . . 73.329999999999998 111.885 177.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 728' ' ' GLY . . . . . . . . . . . . . . . 109.25 -5.84 31.94 Favored Glycine 0 CA--C 1.531 1.044 0 N-CA-C 114.776 0.671 . . . . 62.530000000000001 114.776 176.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 729' ' ' HIS . . . . . 0.502 ' HB3' ' HG3' ' A' ' 666' ' ' GLU . 39.7 m80 -68.91 138.35 54.57 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 117.933 0.866 . . . . 62.039999999999999 111.028 179.284 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 730' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -133.65 130.92 38.92 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 120.832 0.349 . . . . 75.219999999999999 111.77 -178.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 26.9 m -131.48 160.87 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-N 116.342 -0.39 . . . . 74.400000000000006 111.625 -179.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 2.8 t -142.64 146.91 34.96 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 112.771 0.656 . . . . 61.119999999999997 112.771 -174.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -148.66 154.45 39.68 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 116.103 -0.499 . . . . 65.010000000000005 110.741 178.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 734' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -123.02 159.66 27.93 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 113.367 0.877 . . . . 74.430000000000007 113.367 -174.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 735' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -138.25 137.7 37.76 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 115.326 -0.852 . . . . 71.030000000000001 110.988 179.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 736' ' ' THR . . . . . 0.418 ' O ' ' HA2' ' A' ' 674' ' ' GLY . 99.0 m -103.36 106.48 17.0 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 121.01 0.433 . . . . 70.120000000000005 111.934 178.619 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 45.1 t -96.64 140.91 16.41 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 116.626 -0.261 . . . . 73.209999999999994 110.643 177.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 738' ' ' THR . . . . . . . . . . . . . 87.5 m -132.88 114.14 13.7 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 122.001 -0.437 . . . . 24.350000000000001 111.645 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 739' ' ' VAL . . . . . 0.416 HG22 HG13 ' A' ' 677' ' ' ILE . 52.8 t -93.28 137.07 23.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-N 116.212 -0.449 . . . . 61.109999999999999 110.829 177.504 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 740' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -123.01 149.45 44.3 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.117 0.484 . . . . 73.209999999999994 111.559 179.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 741' ' ' VAL . . . . . 0.481 ' HA ' HG23 ' A' ' 679' ' ' VAL . 26.9 t . . . . . 0 CA--C 1.539 0.542 0 CA-C-N 116.288 -0.415 . . . . 53.100000000000001 111.419 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 664' ' ' ASP . . . . . . . . . . . . . 26.1 t0 . . . . . 0 N--CA 1.473 0.706 0 CA-C-O 121.456 0.646 . . . . 73.200000000000003 111.995 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 665' ' ' LEU . . . . . . . . . . . . . 89.2 mt -96.04 138.32 33.83 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.749 -0.66 . . . . 74.319999999999993 111.196 178.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 666' ' ' GLU . . . . . 0.528 ' H ' ' CD ' ' A' ' 666' ' ' GLU . 0.8 OUTLIER -82.22 140.11 45.62 Favored Pre-proline 0 CA--C 1.541 0.625 0 CA-C-N 116.01 -0.541 . . . . 71.030000000000001 110.872 174.974 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 667' ' ' PRO . . . . . 0.536 ' HB3' HD12 ' A' ' 699' ' ' LEU . 42.3 Cg_endo -65.79 138.3 52.87 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 122.715 2.277 . . . . 71.239999999999995 113.869 -171.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 668' ' ' LYS . . . . . . . . . . . . . 28.9 ttpp -82.9 107.68 15.69 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.905 -0.588 . . . . 72.439999999999998 110.747 177.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 669' ' ' LEU . . . . . 0.443 ' HG ' HG23 ' A' ' 671' ' ' VAL . 55.3 tp -100.78 112.48 24.9 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 121.146 0.498 . . . . 74.530000000000001 111.176 -178.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 670' ' ' THR . . . . . . . . . . . . . 94.7 m -93.47 111.48 23.16 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.962 0.41 . . . . 53.43 111.115 179.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 671' ' ' VAL . . . . . 0.443 HG23 ' HG ' ' A' ' 669' ' ' LEU . 73.8 t -137.49 137.24 21.64 Favored Pre-proline 0 CA--C 1.54 0.569 0 CA-C-N 115.767 -0.651 . . . . 64.400000000000006 110.843 -178.237 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 672' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -73.93 139.56 27.48 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 122.098 1.865 . . . . 65.530000000000001 112.015 174.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 673' ' ' VAL . . . . . . . . . . . . . 10.9 p -79.9 -29.64 12.9 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 CA-C-O 120.955 0.407 . . . . 71.140000000000001 112.017 -177.058 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 674' ' ' GLY . . . . . . . . . . . . . . . -158.89 142.65 8.53 Favored Glycine 0 CA--C 1.523 0.563 0 C-N-CA 120.804 -0.713 . . . . 52.509999999999998 113.263 179.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 675' ' ' ALA . . . . . . . . . . . . . . . -142.7 121.14 12.41 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 120.844 0.354 . . . . 50.409999999999997 111.709 -178.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 676' ' ' THR . . . . . . . . . . . . . 62.4 m -101.41 119.0 38.1 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.701 0.286 . . . . 74.140000000000001 110.923 179.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 677' ' ' ILE . . . . . . . . . . . . . 32.1 pt -125.36 177.01 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-O 121.095 0.474 . . . . 54.210000000000001 111.333 -179.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 678' ' ' HIS . . . . . . . . . . . . . 65.6 m80 -116.99 157.94 24.94 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 121.133 0.492 . . . . 63.420000000000002 111.754 179.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 679' ' ' VAL . . . . . 0.478 HG13 ' HA ' ' A' ' 712' ' ' THR . 95.9 t -57.37 116.35 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 116.093 -0.503 . . . . 70.340000000000003 110.526 174.307 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 117.44 -22.36 10.24 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 121.294 -0.479 . . . . 55.43 112.682 -175.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 681' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -62.79 150.26 41.95 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.537 0.684 . . . . 73.340000000000003 112.697 178.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 682' ' ' SER . . . . . . . . . . . . . 99.9 p -90.64 146.07 24.33 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 115.373 -0.83 . . . . 50.439999999999998 110.162 171.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 683' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -150.1 112.26 4.63 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 120.974 0.416 . . . . 74.530000000000001 111.628 -178.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 684' ' ' VAL . . . . . . . . . . . . . 58.5 t -115.33 98.93 51.7 Favored Pre-proline 0 CA--C 1.543 0.679 0 CA-C-O 120.953 0.406 . . . . 73.150000000000006 111.198 178.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -63.44 -25.89 70.65 Favored 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 122.673 2.249 . . . . 74.340000000000003 113.144 -177.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 686' ' ' MET . . . . . 0.404 ' HA ' ' CE ' ' A' ' 686' ' ' MET . 0.0 OUTLIER -87.29 11.32 14.59 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.265 0.469 . . . . 74.219999999999999 112.265 179.57 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 687' ' ' ALA . . . . . . . . . . . . . . . -119.43 -32.43 4.35 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.908 0.385 . . . . 71.319999999999993 111.396 175.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 688' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -90.92 9.72 29.35 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 112.289 0.477 . . . . 75.140000000000001 112.289 -178.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 94.2 t -125.76 139.19 52.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 122.56 0.344 . . . . 73.420000000000002 110.93 177.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 690' ' ' LEU . . . . . 0.478 HD23 ' N ' ' A' ' 691' ' ' ALA . 2.3 tt -142.73 133.06 24.77 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-O 120.691 0.281 . . . . 73.200000000000003 111.121 -176.06 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 691' ' ' ALA . . . . . 0.478 ' N ' HD23 ' A' ' 690' ' ' LEU . . . -126.63 125.52 42.05 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 112.465 0.543 . . . . 63.329999999999998 112.465 -178.042 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 692' ' ' ILE . . . . . 0.528 HD13 ' HA ' ' A' ' 698' ' ' ASP . 43.4 mm -134.36 132.11 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 CA-C-N 116.418 -0.356 . . . . 75.209999999999994 111.813 -179.083 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -107.98 129.63 55.1 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 109.194 -0.669 . . . . 63.100000000000001 109.194 168.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -60.24 -29.12 68.57 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 112.362 0.504 . . . . 63.399999999999999 112.362 -173.338 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 695' ' ' GLU . . . . . 0.406 ' HG3' ' N ' ' A' ' 696' ' ' ASP . 12.1 pt-20 -78.84 -45.87 19.86 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 120.999 0.428 . . . . 74.400000000000006 111.909 -179.741 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 696' ' ' ASP . . . . . 0.406 ' N ' ' HG3' ' A' ' 695' ' ' GLU . 10.2 t70 -94.07 -48.57 6.17 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.993 0.425 . . . . 74.109999999999999 111.455 -171.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . 124.02 -131.98 8.19 Favored Glycine 0 CA--C 1.524 0.614 0 CA-C-N 116.263 -0.426 . . . . 71.439999999999998 112.977 -178.086 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 698' ' ' ASP . . . . . 0.528 ' HA ' HD13 ' A' ' 692' ' ' ILE . 32.0 t70 -72.33 119.8 17.04 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 112.301 0.482 . . . . 75.230000000000004 112.301 -178.577 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 699' ' ' LEU . . . . . 0.536 HD12 ' HB3' ' A' ' 667' ' ' PRO . 62.4 mt -118.06 14.59 14.09 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 120.981 0.42 . . . . 73.400000000000006 110.873 175.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 81.2 m -60.01 -33.77 72.44 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.293 0.479 . . . . 70.450000000000003 112.293 -178.043 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 701' ' ' SER . . . . . . . . . . . . . 32.2 t -70.29 -16.7 63.05 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.196 0.522 . . . . 73.099999999999994 111.377 177.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 702' ' ' LYS . . . . . 0.535 ' HD2' HD22 ' A' ' 699' ' ' LEU . 67.5 mttm -91.88 6.38 46.38 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.197 -0.456 . . . . 62.039999999999999 111.769 179.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 703' ' ' ILE . . . . . 0.447 HG12 ' HB ' ' A' ' 723' ' ' VAL . 67.0 mt -82.3 133.87 28.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-O 120.946 0.403 . . . . 70.329999999999998 111.326 177.361 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 704' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -112.74 126.93 55.95 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.474 -0.33 . . . . 73.239999999999995 110.534 174.189 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 61.7 t -98.66 124.29 51.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-O 120.914 0.388 . . . . 72.140000000000001 111.605 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 706' ' ' ASP . . . . . 0.46 ' HB3' ' HB ' ' A' ' 720' ' ' THR . 37.3 t70 -109.95 143.25 40.16 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 116.26 -0.427 . . . . 64.120000000000005 110.658 174.4 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 94.16 166.76 37.02 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 121.015 -0.612 . . . . 53.109999999999999 113.102 -178.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 708' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -149.52 152.61 35.85 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 120.925 0.393 . . . . 63.509999999999998 111.473 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 709' ' ' VAL . . . . . 0.458 HG22 ' HB2' ' A' ' 717' ' ' TYR . 67.2 t -121.63 135.71 60.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 CA-C-N 116.498 -0.319 . . . . 61.539999999999999 111.608 -177.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 710' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -86.82 136.13 33.09 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.805 0.336 . . . . 74.519999999999996 110.824 173.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 711' ' ' THR . . . . . . . . . . . . . 68.3 p -106.4 4.04 28.03 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.124 0.488 . . . . 64.349999999999994 110.758 176.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 712' ' ' THR . . . . . 0.478 ' HA ' HG13 ' A' ' 679' ' ' VAL . 71.2 p -112.2 -11.76 13.72 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.91 -0.586 . . . . 72.25 112.255 -178.152 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 713' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -132.63 132.57 42.61 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.619 -0.264 . . . . 72.409999999999997 110.711 -178.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 714' ' ' ALA . . . . . 0.471 ' HB2' HG23 ' A' ' 741' ' ' VAL . . . -70.38 141.78 52.16 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 112.244 0.461 . . . . 74.319999999999993 112.244 -178.429 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 152.56 170.38 18.93 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 121.072 -0.585 . . . . 61.200000000000003 113.452 179.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 716' ' ' THR . . . . . . . . . . . . . 91.8 m -93.5 130.47 39.33 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 120.961 0.41 . . . . 55.229999999999997 111.668 177.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 717' ' ' TYR . . . . . 0.458 ' HB2' HG22 ' A' ' 709' ' ' VAL . 45.2 m-85 -128.16 139.74 52.31 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 122.763 0.425 . . . . 73.510000000000005 110.398 179.693 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 718' ' ' VAL . . . . . . . . . . . . . 45.3 t -105.86 140.59 23.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 N-CA-C 112.316 0.488 . . . . 74.219999999999999 112.316 -175.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 719' ' ' LEU . . . . . 0.418 HD21 HG23 ' A' ' 709' ' ' VAL . 85.3 mt -128.22 139.33 52.51 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 116.126 -0.488 . . . . 73.319999999999993 111.536 178.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 720' ' ' THR . . . . . 0.46 ' HB ' ' HB3' ' A' ' 706' ' ' ASP . 96.5 m -120.51 139.26 53.16 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 120.814 0.34 . . . . 64.340000000000003 111.218 178.003 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 721' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -128.13 126.77 41.75 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 116.676 -0.238 . . . . 74.400000000000006 110.825 -178.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 85.0 m -132.13 135.09 46.15 Favored 'General case' 0 N--CA 1.475 0.818 0 O-C-N 122.416 -0.178 . . . . 74.099999999999994 111.476 -178.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 723' ' ' VAL . . . . . 0.447 ' HB ' HG12 ' A' ' 703' ' ' ILE . 7.5 p -130.45 137.64 55.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-O 121.032 0.444 . . . . 74.340000000000003 111.529 179.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 24.1 m -106.56 127.91 53.7 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.129 0.418 . . . . 72.230000000000004 112.129 -177.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 725' ' ' ASP . . . . . 0.488 ' HB2' ' HD3' ' A' ' 667' ' ' PRO . 1.1 t70 -81.59 150.95 27.91 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 122.945 0.498 . . . . 73.010000000000005 111.569 176.373 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 726' ' ' SER . . . . . . . . . . . . . 48.9 m -58.24 -34.08 70.05 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 112.57 0.581 . . . . 72.010000000000005 112.57 -176.087 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 727' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -85.76 -8.54 58.08 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 112.501 0.556 . . . . 72.230000000000004 112.501 -178.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 728' ' ' GLY . . . . . . . . . . . . . . . 113.1 14.3 10.09 Favored Glycine 0 CA--C 1.535 1.294 0 N-CA-C 115.255 0.862 . . . . 74.310000000000002 115.255 175.443 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 729' ' ' HIS . . . . . 0.419 ' O ' ' HB3' ' A' ' 725' ' ' ASP . 13.5 m80 -89.79 108.51 19.74 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 117.908 0.854 . . . . 74.319999999999993 111.229 172.518 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 730' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -108.17 113.88 27.35 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 120.811 0.338 . . . . 72.329999999999998 111.292 -178.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 731' ' ' VAL . . . . . 0.446 HG22 ' HG2' ' A' ' 667' ' ' PRO . 17.8 m -112.45 159.15 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 CA-C-O 120.624 0.249 . . . . 63.009999999999998 111.517 -177.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 8.8 t -147.14 151.94 37.62 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 112.746 0.647 . . . . 55.409999999999997 112.746 -177.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -148.25 161.34 41.69 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.933 -0.576 . . . . 74.549999999999997 110.424 178.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 734' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -130.64 159.59 36.74 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 112.901 0.704 . . . . 72.310000000000002 112.901 -175.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 735' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -134.03 128.41 34.27 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.581 -0.736 . . . . 72.340000000000003 111.075 178.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 736' ' ' THR . . . . . . . . . . . . . 74.3 m -99.52 107.41 19.58 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 120.918 0.39 . . . . 54.219999999999999 111.108 175.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 47.4 t -97.04 141.11 16.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-O 120.71 0.291 . . . . 72.239999999999995 111.414 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 738' ' ' THR . . . . . . . . . . . . . 85.9 m -131.32 120.91 23.82 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 122.093 -0.379 . . . . 71.430000000000007 110.917 177.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 739' ' ' VAL . . . . . . . . . . . . . 38.4 t -101.18 133.6 43.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 N-CA-C 111.831 0.308 . . . . 62.549999999999997 111.831 -177.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 740' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -120.89 149.93 41.85 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 120.811 0.339 . . . . 70.239999999999995 111.509 177.158 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 741' ' ' VAL . . . . . 0.471 HG23 ' HB2' ' A' ' 714' ' ' ALA . 21.2 t . . . . . 0 CA--C 1.541 0.626 0 O-C-N 122.277 -0.264 . . . . 53.340000000000003 110.72 176.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 657' ' ' MET . . . . . 0.577 ' N ' ' SD ' ' A' ' 657' ' ' MET . 3.1 mpp? . . . . . 0 N--CA 1.492 1.65 0 N-CA-C 110.584 -0.154 . . . . 74.439999999999998 110.584 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 658' ' ' GLY . . . . . . . . . . . . . . . 160.15 178.43 34.14 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 120.709 -0.758 . . . . 53.420000000000002 113.482 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 659' ' ' ASN . . . . . . . . . . . . . 38.1 m-80 -133.05 155.82 48.51 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.953 0.406 . . . . 73.510000000000005 111.524 -178.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 660' ' ' GLY . . . . . . . . . . . . . . . -117.45 135.07 11.56 Favored Glycine 0 CA--C 1.526 0.771 0 CA-C-N 116.315 -0.402 . . . . 62.140000000000001 112.157 175.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -70.34 83.48 0.56 Allowed 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.131 0.491 . . . . 71.140000000000001 111.926 -179.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 662' ' ' THR . . . . . . . . . . . . . 73.3 p -92.6 131.59 37.58 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.297 -0.41 . . . . 50.340000000000003 110.804 174.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 663' ' ' SER . . . . . . . . . . . . . 49.9 m -65.67 94.02 0.19 Allowed 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 111.755 0.28 . . . . 75.25 111.755 -178.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 664' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -73.49 124.52 26.0 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.098 0.475 . . . . 52.200000000000003 111.022 178.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 665' ' ' LEU . . . . . . . . . . . . . 86.0 mt -80.77 136.52 36.15 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.033 -0.53 . . . . 75.549999999999997 110.448 174.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 666' ' ' GLU . . . . . 0.473 ' H ' ' CD ' ' A' ' 666' ' ' GLU . 2.3 pm0 -70.25 140.67 88.02 Favored Pre-proline 0 CA--C 1.538 0.486 0 CA-C-N 116.322 -0.399 . . . . 73.530000000000001 110.575 177.311 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 667' ' ' PRO . . . . . 0.534 ' HB3' HD12 ' A' ' 699' ' ' LEU . 19.1 Cg_endo -56.64 135.94 73.27 Favored 'Trans proline' 0 CA--C 1.537 0.668 0 C-N-CA 122.7 2.267 . . . . 61.350000000000001 113.593 -171.167 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 668' ' ' LYS . . . . . . . . . . . . . 27.4 tptp -82.8 105.09 13.53 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.048 -0.524 . . . . 73.209999999999994 110.527 176.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 669' ' ' LEU . . . . . 0.421 ' HG ' HG23 ' A' ' 671' ' ' VAL . 56.8 tp -91.65 128.38 37.46 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.957 -0.565 . . . . 55.420000000000002 110.045 175.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 670' ' ' THR . . . . . . . . . . . . . 89.5 m -113.93 110.78 20.62 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.122 0.487 . . . . 43.340000000000003 111.151 178.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 671' ' ' VAL . . . . . 0.503 HG22 HG13 ' A' ' 689' ' ' VAL . 97.8 t -135.09 131.98 20.02 Favored Pre-proline 0 CA--C 1.54 0.586 0 CA-C-N 115.63 -0.713 . . . . 62.109999999999999 110.759 -177.303 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 672' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -73.62 121.76 7.32 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 122.239 1.959 . . . . 72.150000000000006 111.997 176.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 673' ' ' VAL . . . . . . . . . . . . . 14.7 p -64.15 -26.51 40.62 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 N-CA-C 112.286 0.476 . . . . 54.539999999999999 112.286 -175.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 674' ' ' GLY . . . . . . . . . . . . . . . -148.94 139.35 7.46 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 120.864 -0.684 . . . . 55.399999999999999 113.653 -179.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 675' ' ' ALA . . . . . . . . . . . . . . . -137.29 151.48 48.71 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 122.799 0.44 . . . . 62.409999999999997 110.937 178.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 676' ' ' THR . . . . . . . . . . . . . 88.4 m -138.84 119.16 13.67 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 122.155 -0.341 . . . . 71.400000000000006 111.48 179.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 677' ' ' ILE . . . . . . . . . . . . . 33.6 pt -131.04 176.55 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 CA-C-O 120.91 0.386 . . . . 72.340000000000003 111.323 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 678' ' ' HIS . . . . . 0.405 ' CD2' ' HG3' ' A' ' 740' ' ' LYS . 60.4 m80 -109.22 163.71 13.11 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.337 0.589 . . . . 54.240000000000002 112.502 -178.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 679' ' ' VAL . . . . . . . . . . . . . 91.4 t -63.55 115.77 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-N 115.753 -0.658 . . . . 71.299999999999997 111.031 174.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 99.74 0.52 56.43 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 121.472 -0.394 . . . . 35.109999999999999 112.935 -177.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 681' ' ' ASP . . . . . . . . . . . . . 35.3 t0 -88.8 157.48 18.47 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-O 121.17 0.509 . . . . 72.340000000000003 111.759 -178.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 682' ' ' SER . . . . . . . . . . . . . 91.3 p -82.37 144.84 30.25 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 116.099 -0.5 . . . . 53.009999999999998 112.0 -177.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 683' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -148.58 114.16 5.64 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 116.605 -0.27 . . . . 71.340000000000003 111.016 177.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 684' ' ' VAL . . . . . . . . . . . . . 58.0 t -116.19 99.82 52.99 Favored Pre-proline 0 CA--C 1.545 0.764 0 CA-C-O 120.689 0.28 . . . . 54.240000000000002 111.653 -179.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -59.89 -37.18 87.56 Favored 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 122.928 2.419 . . . . 74.010000000000005 113.7 -177.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 686' ' ' MET . . . . . 0.409 ' HA ' ' CE ' ' A' ' 686' ' ' MET . 1.1 mmt -79.09 -2.91 42.79 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 112.634 0.605 . . . . 75.140000000000001 112.634 -177.243 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 687' ' ' ALA . . . . . . . . . . . . . . . -97.25 -32.18 12.05 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 120.918 0.39 . . . . 63.130000000000003 111.657 176.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 688' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -98.4 -2.57 38.86 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 112.471 0.545 . . . . 64.530000000000001 112.471 -175.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . 0.503 HG13 HG22 ' A' ' 671' ' ' VAL . 95.1 t -123.31 124.83 70.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-O 120.832 0.348 . . . . 71.120000000000005 111.643 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 690' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -123.92 162.31 23.62 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 116.432 -0.349 . . . . 63.109999999999999 111.41 -179.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 691' ' ' ALA . . . . . . . . . . . . . . . -149.35 121.57 8.37 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 120.788 0.327 . . . . 53.299999999999997 111.271 175.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 692' ' ' ILE . . . . . . . . . . . . . 35.3 mm -127.56 130.03 70.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 N-CA-C 112.285 0.476 . . . . 72.140000000000001 112.285 -175.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -115.82 145.26 42.99 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 120.866 0.365 . . . . 72.549999999999997 110.161 172.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 694' ' ' LYS . . . . . 0.466 ' NZ ' ' HB2' ' A' ' 694' ' ' LYS . 2.1 ttmp? -72.57 -45.55 58.65 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 112.125 0.416 . . . . 64.349999999999994 112.125 -178.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 32.2 mp0 -83.48 -49.43 9.28 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.245 -0.434 . . . . 75.430000000000007 112.166 -172.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 696' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -82.95 -33.51 26.72 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 120.869 0.366 . . . . 75.319999999999993 111.229 -175.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . 116.01 -150.61 18.59 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 121.174 -0.536 . . . . 71.340000000000003 113.407 176.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -70.65 118.94 14.08 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 120.87 0.367 . . . . 74.329999999999998 110.976 179.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 699' ' ' LEU . . . . . 0.534 HD12 ' HB3' ' A' ' 667' ' ' PRO . 24.3 mt -109.19 13.38 24.45 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 111.709 0.263 . . . . 71.450000000000003 111.709 -178.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 25.3 m -57.33 -38.95 74.88 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 121.071 0.462 . . . . 62.340000000000003 111.635 -178.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 701' ' ' SER . . . . . . . . . . . . . 35.3 m -66.63 -23.98 66.24 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.01 0.433 . . . . 74.099999999999994 111.65 178.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 702' ' ' LYS . . . . . 0.464 ' HD2' HD22 ' A' ' 699' ' ' LEU . 94.9 mttt -84.82 -6.42 59.35 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 112.156 0.428 . . . . 72.450000000000003 112.156 -176.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 703' ' ' ILE . . . . . 0.439 HD13 HG12 ' A' ' 689' ' ' VAL . 69.7 mt -63.57 123.2 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-O 121.213 0.53 . . . . 73.519999999999996 112.168 -178.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 704' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? -88.77 117.93 28.1 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.029 -0.532 . . . . 75.239999999999995 110.197 176.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 54.1 t -103.14 105.93 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-O 120.926 0.393 . . . . 74.040000000000006 111.512 -176.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 706' ' ' ASP . . . . . 0.479 ' HB3' ' HB ' ' A' ' 720' ' ' THR . 18.6 t70 -108.25 148.03 30.56 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 120.893 0.378 . . . . 65.409999999999997 111.411 -178.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 99.91 179.13 30.52 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 121.176 -0.535 . . . . 64.209999999999994 112.77 -177.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 708' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -150.33 133.78 16.46 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 122.393 -0.475 . . . . 63.409999999999997 112.166 -178.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 709' ' ' VAL . . . . . 0.517 HG22 ' HB2' ' A' ' 717' ' ' TYR . 93.7 t -111.37 120.82 62.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 CA-C-N 116.135 -0.484 . . . . 63.119999999999997 111.085 176.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 710' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -99.39 139.34 35.19 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 120.783 0.325 . . . . 65.349999999999994 111.053 177.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 711' ' ' THR . . . . . . . . . . . . . 75.8 p -111.36 13.4 21.59 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 112.476 0.547 . . . . 52.229999999999997 112.476 -179.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 712' ' ' THR . . . . . . . . . . . . . 71.3 p -102.57 -26.63 13.15 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-O 121.321 0.581 . . . . 72.010000000000005 111.253 175.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 713' ' ' LYS . . . . . 0.533 ' HB2' ' HZ3' ' A' ' 713' ' ' LYS . 0.1 OUTLIER -116.54 135.9 53.43 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 115.869 -0.605 . . . . 64.510000000000005 110.786 178.156 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 714' ' ' ALA . . . . . . . . . . . . . . . -74.89 137.56 41.82 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.485 -0.325 . . . . 32.530000000000001 111.595 179.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 160.71 -179.7 36.02 Favored Glycine 0 CA--C 1.523 0.567 0 C-N-CA 120.973 -0.632 . . . . 55.240000000000002 113.242 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 716' ' ' THR . . . . . . . . . . . . . 84.3 m -103.36 130.75 50.74 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.097 0.475 . . . . 75.150000000000006 111.619 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 717' ' ' TYR . . . . . 0.517 ' HB2' HG22 ' A' ' 709' ' ' VAL . 18.5 m-85 -129.12 125.1 36.38 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 116.061 -0.518 . . . . 71.420000000000002 110.154 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 718' ' ' VAL . . . . . . . . . . . . . 61.8 t -102.41 121.8 53.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-O 121.126 0.489 . . . . 72.510000000000005 112.189 -176.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 719' ' ' LEU . . . . . 0.499 HD21 HG23 ' A' ' 709' ' ' VAL . 95.4 mt -99.94 144.45 28.98 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.454 -0.339 . . . . 64.450000000000003 111.534 178.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . 0.479 ' HB ' ' HB3' ' A' ' 706' ' ' ASP . 64.2 m -113.48 134.33 54.73 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.832 0.349 . . . . 64.540000000000006 111.164 178.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 721' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -125.32 114.36 18.81 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.563 -0.29 . . . . 74.230000000000004 110.89 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 60.6 m -121.54 127.1 50.62 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 120.637 0.256 . . . . 54.210000000000001 111.372 -179.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 11.1 p -129.44 137.55 56.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-O 121.047 0.451 . . . . 75.019999999999996 111.625 -179.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 23.7 m -119.92 134.87 55.1 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.049 0.452 . . . . 74.019999999999996 112.071 -177.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -82.8 149.11 27.39 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 115.956 -0.565 . . . . 72.219999999999999 110.028 173.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 726' ' ' SER . . . . . . . . . . . . . 38.3 t -66.84 -20.39 65.92 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.058 0.456 . . . . 43.399999999999999 110.915 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 727' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -81.9 -4.03 55.6 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 115.893 -0.594 . . . . 75.409999999999997 111.971 178.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 728' ' ' GLY . . . . . . . . . . . . . . . 108.2 -5.68 34.01 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 115.023 0.769 . . . . 43.240000000000002 115.023 173.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 36.1 m80 -84.28 122.61 29.14 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 117.848 0.824 . . . . 64.340000000000003 111.402 178.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 730' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -121.52 132.43 54.7 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 120.868 0.365 . . . . 71.109999999999999 111.707 -178.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 27.4 m -131.15 149.9 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-O 120.82 0.343 . . . . 72.219999999999999 111.374 177.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 7.2 t -144.36 147.64 33.69 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 121.088 0.47 . . . . 63.130000000000003 112.264 -178.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -148.99 161.38 42.03 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 116.083 -0.508 . . . . 52.530000000000001 110.927 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 734' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -121.95 160.29 25.16 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 112.567 0.58 . . . . 74.140000000000001 112.567 -178.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 735' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -129.37 122.13 28.83 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.554 -0.748 . . . . 71.340000000000003 110.464 179.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 736' ' ' THR . . . . . . . . . . . . . 20.9 m -94.11 103.4 15.46 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.629 0.252 . . . . 74.549999999999997 111.262 -179.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 43.2 t -96.85 133.49 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-O 120.724 0.297 . . . . 72.019999999999996 111.316 -179.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 738' ' ' THR . . . . . . . . . . . . . 93.8 m -121.29 112.38 18.53 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.05 0.452 . . . . 72.219999999999999 110.875 177.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 739' ' ' VAL . . . . . . . . . . . . . 54.4 t -93.16 133.58 33.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-N 116.167 -0.469 . . . . 51.140000000000001 110.941 178.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 740' ' ' LYS . . . . . 0.405 ' HG3' ' CD2' ' A' ' 678' ' ' HIS . 21.0 ptmt -127.74 162.16 27.25 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 120.844 0.354 . . . . 63.119999999999997 111.62 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 741' ' ' VAL . . . . . 0.507 HG12 ' H ' ' A' ' 743' ' ' GLU . 5.7 t -81.59 146.63 7.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-O 120.974 0.416 . . . . 65.549999999999997 111.245 -176.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 742' ' ' ARG . . . . . . . . . . . . . 38.0 ptt180 -91.42 3.47 54.86 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.448 0.536 . . . . 73.219999999999999 112.448 -177.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 743' ' ' GLU . . . . . 0.507 ' H ' HG12 ' A' ' 741' ' ' VAL . 51.7 mt-10 -145.4 175.27 10.44 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 122.705 0.402 . . . . 74.409999999999997 110.756 179.058 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 744' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -89.12 100.54 13.3 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.076 0.465 . . . . 73.400000000000006 111.612 177.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 13.3 m -116.4 95.95 4.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-O 121.304 0.573 . . . . 62.25 109.997 171.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 38.4 pttt -71.46 165.37 23.96 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 121.446 0.641 . . . . 65.120000000000005 112.126 -175.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 747' ' ' ASN . . . . . . . . . . . . . 10.3 p-10 -118.66 119.38 34.3 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.696 -0.684 . . . . 71.420000000000002 110.727 178.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -102.63 45.96 0.94 Allowed 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.8 0.333 . . . . 50.5 111.112 -178.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 749' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm 61.64 95.75 0.05 OUTLIER Pre-proline 0 N--CA 1.471 0.611 0 CA-C-N 115.966 -0.561 . . . . 75.219999999999999 112.272 -176.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 750' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -55.75 100.61 0.08 OUTLIER 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 122.39 2.06 . . . . 65.430000000000007 112.069 173.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 751' ' ' ILE . . . . . . . . . . . . . 33.4 pt -79.69 1.41 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 112.428 0.529 . . . . 75.040000000000006 112.428 -177.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 752' ' ' LEU . . . . . . . . . . . . . 65.6 tp -75.3 104.33 5.82 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 120.992 0.425 . . . . 55.420000000000002 110.854 177.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 753' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 . . . . . 0 C--O 1.237 0.415 0 CA-C-O 121.033 0.444 . . . . 61.310000000000002 111.115 -179.259 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 762' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 657' ' ' MET . . . . . . . . . . . . . 26.0 ttt . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 120.772 0.32 . . . . 74.430000000000007 110.666 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 658' ' ' GLY . . . . . . . . . . . . . . . -80.44 92.02 1.39 Allowed Glycine 0 CA--C 1.528 0.853 0 C-N-CA 121.122 -0.561 . . . . 74.209999999999994 112.155 173.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 659' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -63.8 120.1 11.24 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 112.705 0.632 . . . . 62.509999999999998 112.705 -174.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 660' ' ' GLY . . . . . . . . . . . . . . . -102.94 88.41 0.65 Allowed Glycine 0 CA--C 1.526 0.771 0 CA-C-N 115.817 -0.629 . . . . 74.340000000000003 111.644 172.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -76.36 123.36 25.84 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 112.146 0.424 . . . . 50.509999999999998 112.146 -176.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 662' ' ' THR . . . . . . . . . . . . . 76.7 p -79.04 107.39 11.76 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.012 0.434 . . . . 75.239999999999995 110.807 175.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 663' ' ' SER . . . . . . . . . . . . . 23.6 m -72.3 121.78 20.03 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.217 0.451 . . . . 73.519999999999996 112.217 -175.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 664' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -84.44 133.45 34.49 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.85 0.357 . . . . 65.540000000000006 110.788 173.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 665' ' ' LEU . . . . . 0.535 HD12 ' HD3' ' A' ' 694' ' ' LYS . 78.3 mt -95.4 137.69 34.11 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 121.097 0.475 . . . . 73.420000000000002 110.673 174.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 666' ' ' GLU . . . . . 0.41 ' HB2' ' HD2' ' A' ' 667' ' ' PRO . 9.6 pt-20 -70.52 152.95 95.3 Favored Pre-proline 0 CA--C 1.541 0.631 0 CA-C-N 115.941 -0.572 . . . . 71.209999999999994 111.887 -177.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 667' ' ' PRO . . . . . 0.527 ' HD3' ' HB2' ' A' ' 725' ' ' ASP . 52.5 Cg_endo -67.3 138.81 47.9 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.843 2.362 . . . . 75.109999999999999 114.428 -170.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 668' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -83.27 102.18 11.78 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.678 -0.692 . . . . 61.039999999999999 110.269 175.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 669' ' ' LEU . . . . . 0.529 ' HG ' HG23 ' A' ' 671' ' ' VAL . 65.3 tp -89.14 114.05 25.29 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.371 -0.377 . . . . 74.019999999999996 111.069 -177.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 670' ' ' THR . . . . . . . . . . . . . 41.5 m -89.57 110.47 21.32 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.859 0.362 . . . . 72.329999999999998 110.931 -179.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 671' ' ' VAL . . . . . 0.529 HG23 ' HG ' ' A' ' 669' ' ' LEU . 96.4 t -135.89 123.97 15.2 Favored Pre-proline 0 N--CA 1.468 0.455 0 CA-C-N 116.379 -0.373 . . . . 20.329999999999998 110.968 -178.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 672' ' ' PRO . . . . . 0.401 ' HG2' ' OE1' ' A' ' 735' ' ' GLN . 53.2 Cg_endo -70.75 137.43 32.57 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 122.172 1.915 . . . . 75.349999999999994 112.223 178.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 673' ' ' VAL . . . . . . . . . . . . . 12.2 p -64.31 -36.72 77.97 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 N-CA-C 112.012 0.375 . . . . 72.109999999999999 112.012 -177.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 674' ' ' GLY . . . . . . . . . . . . . . . -154.83 154.86 25.82 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 121.025 -0.607 . . . . 74.030000000000001 113.435 -178.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 675' ' ' ALA . . . . . . . . . . . . . . . -150.63 143.61 24.71 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 122.669 0.387 . . . . 71.420000000000002 110.839 178.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 676' ' ' THR . . . . . . . . . . . . . 90.3 m -119.46 121.33 39.22 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 120.936 0.398 . . . . 72.5 111.833 -178.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 677' ' ' ILE . . . . . . . . . . . . . 33.9 pt -126.68 176.98 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-N 116.209 -0.451 . . . . 72.439999999999998 110.457 175.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 678' ' ' HIS . . . . . 0.478 ' HA ' ' O ' ' A' ' 740' ' ' LYS . 46.7 m80 -123.09 159.38 28.63 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 112.583 0.586 . . . . 72.450000000000003 112.583 -177.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 679' ' ' VAL . . . . . 0.466 ' O ' ' HG2' ' A' ' 742' ' ' ARG . 84.2 t -59.6 112.15 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-N 115.814 -0.63 . . . . 74.140000000000001 110.556 172.276 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 115.12 -20.22 14.43 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 121.423 -0.417 . . . . 60.25 112.708 -174.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 681' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -78.01 -165.09 0.6 Allowed 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 121.227 0.537 . . . . 64.310000000000002 111.433 178.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 682' ' ' SER . . . . . . . . . . . . . 21.4 p -142.75 155.54 44.87 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.966 0.412 . . . . 71.239999999999995 111.557 179.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 683' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -143.4 135.86 27.22 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.383 -0.371 . . . . 62.039999999999999 110.577 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 684' ' ' VAL . . . . . . . . . . . . . 25.1 t -124.75 95.64 42.14 Favored Pre-proline 0 CA--C 1.544 0.737 0 CA-C-O 120.931 0.396 . . . . 72.239999999999995 111.848 -175.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -62.87 -31.1 77.86 Favored 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 122.687 2.258 . . . . 75.019999999999996 113.719 -177.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 686' ' ' MET . . . . . 0.449 ' HE1' ' HB ' ' A' ' 703' ' ' ILE . 1.7 mmt -81.51 0.36 38.37 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.32 0.489 . . . . 74.230000000000004 112.32 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 687' ' ' ALA . . . . . . . . . . . . . . . -120.55 -42.62 2.53 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 120.863 0.363 . . . . 74.299999999999997 111.972 179.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 688' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -79.88 2.7 22.29 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-O 120.954 0.407 . . . . 75.120000000000005 111.871 -179.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . 0.42 HG21 ' CZ ' ' A' ' 721' ' ' TYR . 64.7 t -124.53 151.97 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 122.996 0.519 . . . . 75.530000000000001 110.415 175.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 690' ' ' LEU . . . . . 0.679 HD21 HG12 ' A' ' 692' ' ' ILE . 8.8 tt -145.12 152.31 39.85 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 120.567 0.222 . . . . 63.409999999999997 111.427 -174.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 691' ' ' ALA . . . . . . . . . . . . . . . -146.43 126.64 13.86 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 122.341 -0.224 . . . . 51.030000000000001 111.502 177.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 692' ' ' ILE . . . . . 0.679 HG12 HD21 ' A' ' 690' ' ' LEU . 41.1 mm -129.66 132.72 65.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 CA-C-O 121.207 0.527 . . . . 70.420000000000002 112.317 -178.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 693' ' ' ASP . . . . . 0.472 ' HB2' HD11 ' A' ' 699' ' ' LEU . 25.6 t70 -114.72 145.23 42.3 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.031 -0.532 . . . . 73.430000000000007 109.832 172.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 694' ' ' LYS . . . . . 0.535 ' HD3' HD12 ' A' ' 665' ' ' LEU . 50.8 mtpt -71.1 -39.19 72.24 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.814 0.34 . . . . 71.25 111.854 -177.342 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 35.2 mp0 -83.15 -54.02 5.35 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 112.054 0.39 . . . . 63.219999999999999 112.054 -175.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 696' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -76.35 -48.74 18.89 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 122.149 -0.345 . . . . 73.439999999999998 111.598 -177.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . 124.2 -131.56 7.98 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 121.279 -0.486 . . . . 75.450000000000003 113.052 -179.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -75.63 119.67 19.99 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 122.442 -0.446 . . . . 55.439999999999998 111.273 -179.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 699' ' ' LEU . . . . . 0.608 HD22 ' HD2' ' A' ' 702' ' ' LYS . 35.5 mt -111.44 11.21 21.44 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.397 -0.365 . . . . 62.140000000000001 111.3 178.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 33.8 m -59.74 -36.07 75.86 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.302 0.572 . . . . 75.430000000000007 111.551 -177.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 701' ' ' SER . . . . . . . . . . . . . 49.4 m -76.22 -14.49 60.14 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 116.282 -0.417 . . . . 72.340000000000003 111.85 177.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 702' ' ' LYS . . . . . 0.608 ' HD2' HD22 ' A' ' 699' ' ' LEU . 96.5 mttt -97.67 11.59 36.55 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.177 0.436 . . . . 74.109999999999999 112.177 -177.216 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 703' ' ' ILE . . . . . 0.449 ' HB ' ' HE1' ' A' ' 686' ' ' MET . 67.7 mt -83.76 118.76 31.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-O 120.873 0.368 . . . . 62.509999999999998 111.766 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 704' ' ' LYS . . . . . . . . . . . . . 4.9 tppp? -84.99 125.89 33.08 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 110.168 -0.308 . . . . 71.340000000000003 110.168 174.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 49.0 t -105.88 117.39 51.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 CA-C-O 121.004 0.43 . . . . 55.229999999999997 112.013 -176.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 706' ' ' ASP . . . . . 0.594 ' HB3' ' HB ' ' A' ' 720' ' ' THR . 12.8 t70 -100.32 141.2 33.5 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.294 -0.412 . . . . 61.340000000000003 111.03 175.183 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 102.35 177.74 27.46 Favored Glycine 0 CA--C 1.523 0.54 0 C-N-CA 121.201 -0.523 . . . . 72.439999999999998 112.97 -179.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 708' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -152.48 130.48 11.82 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 120.863 0.363 . . . . 74.439999999999998 111.491 -177.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 709' ' ' VAL . . . . . 0.546 HG22 ' HB2' ' A' ' 717' ' ' TYR . 96.3 t -107.93 114.6 46.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 116.494 -0.321 . . . . 64.030000000000001 110.655 176.483 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 710' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -95.39 143.65 26.56 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 120.905 0.383 . . . . 65.040000000000006 111.039 177.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 711' ' ' THR . . . . . . . . . . . . . 75.6 p -108.08 6.54 27.04 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.666 0.617 . . . . 75.140000000000001 112.666 -176.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 712' ' ' THR . . . . . . . . . . . . . 64.1 p -101.37 -24.24 14.23 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 121.157 0.503 . . . . 64.239999999999995 111.145 175.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 713' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -116.17 122.42 44.99 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 116.294 -0.412 . . . . 63.350000000000001 110.95 178.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 714' ' ' ALA . . . . . . . . . . . . . . . -69.42 143.99 53.47 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 120.982 0.42 . . . . 64.200000000000003 111.796 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 155.77 168.92 19.48 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-N 116.255 -0.43 . . . . 64.439999999999998 112.826 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 716' ' ' THR . . . . . . . . . . . . . 99.2 m -97.71 123.07 41.48 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 122.51 -0.406 . . . . 73.420000000000002 111.812 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 717' ' ' TYR . . . . . 0.546 ' HB2' HG22 ' A' ' 709' ' ' VAL . 40.7 m-85 -115.83 125.9 53.29 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 116.2 -0.455 . . . . 74.519999999999996 110.78 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 718' ' ' VAL . . . . . . . . . . . . . 56.1 t -96.25 118.55 42.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 120.901 0.381 . . . . 60.109999999999999 111.452 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 719' ' ' LEU . . . . . . . . . . . . . 76.6 mt -103.12 135.31 45.02 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.78 0.324 . . . . 63.030000000000001 111.611 -179.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . 0.594 ' HB ' ' HB3' ' A' ' 706' ' ' ASP . 32.9 m -103.27 131.98 49.89 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 120.943 0.401 . . . . 74.439999999999998 110.895 176.545 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 721' ' ' TYR . . . . . 0.42 ' CZ ' HG21 ' A' ' 689' ' ' VAL . 77.8 m-85 -118.34 117.73 29.88 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.471 -0.331 . . . . 74.510000000000005 110.926 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 87.3 m -120.72 126.83 51.17 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.626 -0.261 . . . . 60.450000000000003 111.263 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 13.1 p -125.23 142.18 42.87 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-O 120.869 0.366 . . . . 75.549999999999997 111.878 -177.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 26.7 m -110.23 133.6 53.07 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.144 0.497 . . . . 65.140000000000001 112.181 -176.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 725' ' ' ASP . . . . . 0.527 ' HB2' ' HD3' ' A' ' 667' ' ' PRO . 14.0 t0 -91.59 151.57 20.66 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 115.912 -0.586 . . . . 72.0 111.049 178.08 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 726' ' ' SER . . . . . . . . . . . . . 38.6 t -59.46 -29.7 68.0 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.403 0.52 . . . . 64.140000000000001 112.403 -175.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 727' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -91.63 7.35 41.96 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 112.313 0.486 . . . . 75.25 112.313 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 728' ' ' GLY . . . . . . . . . . . . . . . 100.2 8.37 50.47 Favored Glycine 0 CA--C 1.534 1.237 0 N-CA-C 115.294 0.878 . . . . 71.5 115.294 173.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 37.6 m80 -86.67 115.11 23.91 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 117.865 0.833 . . . . 74.310000000000002 111.094 177.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 730' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -120.25 117.09 26.92 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 122.133 -0.355 . . . . 73.519999999999996 111.717 -177.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 35.7 m -117.83 157.76 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-O 120.727 0.299 . . . . 61.130000000000003 111.762 -177.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 8.6 t -142.56 144.37 32.86 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.682 0.623 . . . . 72.510000000000005 112.682 -177.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -146.68 159.45 43.46 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.024 -0.534 . . . . 61.020000000000003 111.059 178.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 734' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -118.1 155.54 30.21 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 113.009 0.744 . . . . 62.329999999999998 113.009 -176.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 735' ' ' GLN . . . . . 0.401 ' OE1' ' HG2' ' A' ' 672' ' ' PRO . 6.4 tt0 -129.79 135.48 48.47 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 115.703 -0.681 . . . . 73.040000000000006 110.558 177.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 736' ' ' THR . . . . . . . . . . . . . 90.1 m -95.15 104.35 16.23 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 120.675 0.274 . . . . 71.439999999999998 111.39 178.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 46.5 t -100.07 104.5 16.21 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 CA-C-O 120.772 0.32 . . . . 73.540000000000006 111.295 179.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 738' ' ' THR . . . . . . . . . . . . . 44.6 m -94.54 117.4 30.06 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.119 0.485 . . . . 71.319999999999993 111.471 179.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 739' ' ' VAL . . . . . . . . . . . . . 43.6 t -98.28 117.95 44.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-O 121.113 0.482 . . . . 74.219999999999999 111.584 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 740' ' ' LYS . . . . . 0.478 ' O ' ' HA ' ' A' ' 678' ' ' HIS . 96.1 mttt -102.93 176.05 5.28 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.265 -0.425 . . . . 73.120000000000005 110.492 174.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 741' ' ' VAL . . . . . . . . . . . . . 36.3 t -100.5 122.11 52.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 O-C-N 121.881 -0.512 . . . . 70.209999999999994 111.734 -178.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 742' ' ' ARG . . . . . 0.736 ' HG3' ' HG3' ' A' ' 743' ' ' GLU . 20.7 ptt180 -92.04 -46.25 7.89 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.088 0.471 . . . . 73.129999999999995 110.766 175.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 743' ' ' GLU . . . . . 0.736 ' HG3' ' HG3' ' A' ' 742' ' ' ARG . 45.7 mt-10 -123.93 96.09 4.81 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.971 -0.559 . . . . 65.239999999999995 110.212 -178.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 744' ' ' GLU . . . . . 0.493 ' H ' ' CD ' ' A' ' 744' ' ' GLU . 0.5 OUTLIER -59.66 134.55 57.13 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.664 -0.698 . . . . 74.530000000000001 112.568 -175.703 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 745' ' ' VAL . . . . . 0.644 HG12 ' H ' ' A' ' 747' ' ' ASN . 47.3 t -82.03 131.41 33.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-N 115.935 -0.575 . . . . 63.509999999999998 111.175 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -83.09 12.09 5.52 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.414 0.524 . . . . 63.439999999999998 112.414 -177.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 747' ' ' ASN . . . . . 0.644 ' H ' HG12 ' A' ' 745' ' ' VAL . 9.5 m120 -122.6 99.02 6.18 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 120.929 0.395 . . . . 62.200000000000003 111.884 -175.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -91.73 -4.65 54.8 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-O 121.369 0.604 . . . . 65.209999999999994 111.206 177.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 749' ' ' LYS . . . . . 0.42 ' N ' ' HD2' ' A' ' 749' ' ' LYS . 12.6 mptt -68.96 159.58 82.12 Favored Pre-proline 0 CA--C 1.54 0.583 0 CA-C-N 116.314 -0.403 . . . . 73.409999999999997 111.078 177.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 750' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -68.05 73.47 0.75 Allowed 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 122.335 2.023 . . . . 55.030000000000001 112.826 179.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 751' ' ' ILE . . . . . 0.405 HD12 ' HB3' ' A' ' 747' ' ' ASN . 56.9 mt -97.13 109.2 22.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-O 121.136 0.493 . . . . 54.140000000000001 110.566 177.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 752' ' ' LEU . . . . . . . . . . . . . 50.3 tp -106.32 140.97 38.42 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 116.118 -0.492 . . . . 73.400000000000006 111.361 -176.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 753' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 . . . . . 0 N--CA 1.471 0.6 0 CA-C-N 116.278 -0.419 . . . . 74.349999999999994 111.039 178.501 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 762' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 657' ' ' MET . . . . . . . . . . . . . 25.7 ptt? . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 120.466 0.174 . . . . 73.430000000000007 110.861 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 658' ' ' GLY . . . . . . . . . . . . . . . 71.67 -78.88 0.59 Allowed Glycine 0 CA--C 1.528 0.854 0 C-N-CA 120.82 -0.705 . . . . 72.420000000000002 113.046 179.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 659' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -144.72 156.1 43.9 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 120.806 0.336 . . . . 64.230000000000004 110.94 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 660' ' ' GLY . . . . . . . . . . . . . . . 113.24 85.93 1.47 Allowed Glycine 0 CA--C 1.526 0.745 0 C-N-CA 121.44 -0.41 . . . . 70.25 113.081 178.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -84.9 120.57 26.63 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 121.023 0.44 . . . . 70.140000000000001 110.743 177.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 662' ' ' THR . . . . . . . . . . . . . 74.1 p -111.4 131.2 55.37 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.029 0.442 . . . . 74.420000000000002 111.774 -175.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 663' ' ' SER . . . . . . . . . . . . . 40.7 m -102.4 126.02 49.3 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.129 -0.487 . . . . 74.150000000000006 111.989 -177.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 664' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -76.78 143.01 40.14 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 120.895 0.378 . . . . 75.530000000000001 110.847 173.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 665' ' ' LEU . . . . . . . . . . . . . 76.6 mt -80.82 119.76 23.8 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.404 -0.362 . . . . 65.019999999999996 110.644 177.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 666' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -56.69 144.22 66.15 Favored Pre-proline 0 CA--C 1.537 0.472 0 C-N-CA 121.131 -0.228 . . . . 53.25 110.483 177.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 667' ' ' PRO . . . . . 0.545 ' HD3' ' HB2' ' A' ' 725' ' ' ASP . 18.8 Cg_endo -56.5 133.92 61.07 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.725 2.284 . . . . 70.409999999999997 112.736 -174.131 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 668' ' ' LYS . . . . . . . . . . . . . 52.2 tptt -82.71 110.66 17.96 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 120.942 0.401 . . . . 51.439999999999998 110.343 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 669' ' ' LEU . . . . . 0.521 ' HG ' HG23 ' A' ' 671' ' ' VAL . 55.8 tp -98.06 112.58 24.48 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 116.067 -0.515 . . . . 70.450000000000003 111.271 -177.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 670' ' ' THR . . . . . . . . . . . . . 85.8 m -87.75 110.62 20.6 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 120.856 0.36 . . . . 63.25 111.121 177.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 671' ' ' VAL . . . . . 0.521 HG23 ' HG ' ' A' ' 669' ' ' LEU . 81.0 t -136.34 129.68 17.85 Favored Pre-proline 0 N--CA 1.47 0.575 0 CA-C-N 116.211 -0.45 . . . . 71.549999999999997 110.803 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 672' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -77.9 141.48 19.11 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 122.193 1.929 . . . . 73.409999999999997 112.791 179.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 673' ' ' VAL . . . . . . . . . . . . . 10.6 p -66.27 -35.03 73.99 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 N-CA-C 112.007 0.373 . . . . 74.329999999999998 112.007 -177.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 674' ' ' GLY . . . . . . . . . . . . . . . -146.22 161.19 28.3 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 120.879 -0.676 . . . . 43.340000000000003 113.565 -177.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 675' ' ' ALA . . . . . . . . . . . . . . . -150.5 154.85 38.38 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 122.608 0.363 . . . . 72.319999999999993 110.928 -179.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 676' ' ' THR . . . . . . . . . . . . . 91.8 m -139.04 119.56 13.93 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 120.964 0.411 . . . . 74.019999999999996 111.791 178.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 677' ' ' ILE . . . . . . . . . . . . . 28.7 pt -131.28 175.22 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-N 116.459 -0.337 . . . . 74.400000000000006 110.678 176.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 678' ' ' HIS . . . . . 0.401 ' HA ' ' O ' ' A' ' 740' ' ' LYS . 75.5 m80 -119.49 164.79 15.27 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.305 0.574 . . . . 74.299999999999997 111.912 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 679' ' ' VAL . . . . . 0.445 HG23 ' HA ' ' A' ' 741' ' ' VAL . 78.3 t -56.68 137.01 19.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-N 115.891 -0.595 . . . . 73.049999999999997 110.504 172.06 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 93.03 -18.31 56.39 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 121.052 -0.594 . . . . 55.530000000000001 113.406 -179.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 681' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -79.52 -172.47 3.27 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 121.12 0.486 . . . . 51.020000000000003 111.548 178.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 682' ' ' SER . . . . . . . . . . . . . 69.0 m -141.77 145.72 35.1 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 116.435 -0.348 . . . . 74.200000000000003 111.06 177.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 683' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -118.7 134.18 55.32 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 116.453 -0.34 . . . . 61.509999999999998 110.46 178.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 684' ' ' VAL . . . . . 0.406 ' HA ' ' HD2' ' A' ' 685' ' ' PRO . 53.7 t -122.17 93.09 48.75 Favored Pre-proline 0 CA--C 1.54 0.573 0 CA-C-O 120.962 0.41 . . . . 60.299999999999997 111.429 -177.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 685' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 684' ' ' VAL . 28.6 Cg_endo -61.69 -27.76 81.52 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 122.83 2.353 . . . . 61.140000000000001 113.347 -177.382 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 686' ' ' MET . . . . . 0.488 ' HE1' ' HB ' ' A' ' 703' ' ' ILE . 1.9 mmt -78.91 -12.14 60.02 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 112.313 0.486 . . . . 73.109999999999999 112.313 -178.137 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 687' ' ' ALA . . . . . . . . . . . . . . . -109.02 -36.34 6.1 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.915 0.388 . . . . 52.409999999999997 111.539 178.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 688' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -85.92 -1.08 56.95 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 116.295 -0.411 . . . . 74.430000000000007 112.05 -178.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . 0.432 HG21 ' CZ ' ' A' ' 721' ' ' TYR . 74.5 t -125.57 150.81 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 122.59 0.356 . . . . 52.149999999999999 110.577 174.227 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 690' ' ' LEU . . . . . 0.485 HD21 HG12 ' A' ' 692' ' ' ILE . 9.6 tt -143.3 150.03 38.65 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-O 120.592 0.234 . . . . 73.430000000000007 111.537 -173.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 691' ' ' ALA . . . . . . . . . . . . . . . -147.3 125.35 12.08 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 112.19 0.441 . . . . 73.109999999999999 112.19 179.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 692' ' ' ILE . . . . . 0.538 HD13 ' HA ' ' A' ' 698' ' ' ASP . 43.6 mm -129.68 141.52 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 N-CA-C 111.803 0.297 . . . . 75.329999999999998 111.803 -178.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 693' ' ' ASP . . . . . 0.475 ' OD1' ' HG2' ' A' ' 695' ' ' GLU . 12.5 t70 -125.95 143.97 50.88 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 110.138 -0.319 . . . . 63.119999999999997 110.138 173.015 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 28.6 ttpp -64.79 -34.05 77.42 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 112.5 0.556 . . . . 53.219999999999999 112.5 -175.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 695' ' ' GLU . . . . . 0.475 ' HG2' ' OD1' ' A' ' 693' ' ' ASP . 9.5 pt-20 -81.89 -43.42 18.19 Favored 'General case' 0 N--CA 1.473 0.694 0 O-C-N 122.02 -0.425 . . . . 72.329999999999998 111.976 -175.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 696' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -94.85 -42.44 8.7 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 120.883 0.373 . . . . 73.349999999999994 111.773 -172.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . 118.57 -115.68 3.18 Favored Glycine 0 CA--C 1.523 0.569 0 C-N-CA 121.14 -0.552 . . . . 62.200000000000003 112.291 -177.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 698' ' ' ASP . . . . . 0.538 ' HA ' HD13 ' A' ' 692' ' ' ILE . 16.1 t70 -88.62 119.98 29.59 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 122.195 -0.591 . . . . 63.049999999999997 111.247 178.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 699' ' ' LEU . . . . . 0.491 HD12 ' HB3' ' A' ' 667' ' ' PRO . 51.0 mt -111.97 18.45 18.79 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 116.364 -0.38 . . . . 74.0 111.603 177.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 37.1 m -58.36 -30.65 66.92 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.009 0.433 . . . . 74.439999999999998 111.105 178.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 701' ' ' SER . . . . . . . . . . . . . 29.7 t -68.15 -24.48 64.99 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 120.868 0.366 . . . . 74.420000000000002 111.971 175.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 702' ' ' LYS . . . . . 0.488 ' HB2' HG23 ' A' ' 723' ' ' VAL . 73.4 mmtt -77.4 -19.84 55.55 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 111.895 0.331 . . . . 70.450000000000003 111.895 -178.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 703' ' ' ILE . . . . . 0.488 ' HB ' ' HE1' ' A' ' 686' ' ' MET . 63.9 mt -60.74 112.76 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 N-CA-C 112.515 0.561 . . . . 75.219999999999999 112.515 -174.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 704' ' ' LYS . . . . . . . . . . . . . 8.1 tmtm? -87.04 120.08 27.93 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.017 -0.538 . . . . 65.340000000000003 109.729 172.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 50.3 t -95.71 118.06 41.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-O 121.113 0.482 . . . . 64.019999999999996 111.063 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 706' ' ' ASP . . . . . 0.539 ' HB3' ' HB ' ' A' ' 720' ' ' THR . 11.7 t70 -108.11 118.44 36.76 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.413 -0.358 . . . . 71.340000000000003 110.249 176.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 113.42 167.82 16.7 Favored Glycine 0 CA--C 1.524 0.643 0 C-N-CA 121.344 -0.455 . . . . 55.240000000000002 112.392 -176.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 708' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -155.04 138.56 15.96 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 122.316 -0.52 . . . . 71.409999999999997 111.843 -177.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 709' ' ' VAL . . . . . . . . . . . . . 72.5 t -99.59 127.87 51.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-N 116.341 -0.39 . . . . 62.140000000000001 111.352 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 710' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -96.15 137.09 35.72 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 120.732 0.301 . . . . 64.530000000000001 110.578 175.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 711' ' ' THR . . . . . . . . . . . . . 82.5 p -110.43 23.7 13.92 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 112.416 0.525 . . . . 75.040000000000006 112.416 -177.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 712' ' ' THR . . . . . . . . . . . . . 48.8 p -113.03 -26.46 8.47 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 121.015 0.436 . . . . 52.25 110.746 173.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 713' ' ' LYS . . . . . 0.57 ' HB2' ' HZ3' ' A' ' 713' ' ' LYS . 0.1 OUTLIER -116.72 130.96 57.04 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.001 -0.545 . . . . 73.519999999999996 110.53 175.318 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 714' ' ' ALA . . . . . . . . . . . . . . . -80.9 134.88 35.82 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.067 0.46 . . . . 44.32 112.182 -178.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 169.32 171.67 35.22 Favored Glycine 0 CA--C 1.523 0.58 0 CA-C-N 116.042 -0.526 . . . . 70.450000000000003 112.582 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 716' ' ' THR . . . . . . . . . . . . . 39.9 m -90.09 123.06 33.63 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.188 0.518 . . . . 74.230000000000004 111.568 177.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 717' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 -114.43 138.23 50.84 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 116.074 -0.512 . . . . 75.0 110.234 177.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 718' ' ' VAL . . . . . . . . . . . . . 62.0 t -103.65 116.62 47.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-O 120.929 0.395 . . . . 62.340000000000003 111.54 -178.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 719' ' ' LEU . . . . . . . . . . . . . 83.0 mt -102.13 129.16 48.4 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 116.348 -0.387 . . . . 74.450000000000003 111.286 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . 0.539 ' HB ' ' HB3' ' A' ' 706' ' ' ASP . 92.7 m -106.55 134.9 48.98 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.839 0.352 . . . . 64.209999999999994 111.12 178.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 721' ' ' TYR . . . . . 0.432 ' CZ ' HG21 ' A' ' 689' ' ' VAL . 60.7 m-85 -123.41 120.81 34.07 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.54 -0.3 . . . . 72.129999999999995 110.795 -179.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 56.6 m -123.16 133.42 54.25 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 120.797 0.332 . . . . 60.399999999999999 111.4 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 723' ' ' VAL . . . . . 0.488 HG23 ' HB2' ' A' ' 702' ' ' LYS . 7.5 p -130.93 134.89 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-O 121.154 0.502 . . . . 71.340000000000003 111.788 -178.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 34.3 m -109.47 142.95 39.75 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.252 0.549 . . . . 55.229999999999997 111.625 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 725' ' ' ASP . . . . . 0.545 ' HB2' ' HD3' ' A' ' 667' ' ' PRO . 10.3 t70 -102.63 160.29 14.71 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 115.814 -0.63 . . . . 63.409999999999997 111.82 -178.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 726' ' ' SER . . . . . . . . . . . . . 48.9 m -61.52 -33.5 73.92 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.637 0.606 . . . . 72.099999999999994 112.637 -177.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 727' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -82.01 4.96 20.83 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 120.751 0.31 . . . . 65.519999999999996 111.447 177.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 728' ' ' GLY . . . . . . . . . . . . . . . 91.07 15.01 56.89 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 121.35 -0.452 . . . . 73.109999999999999 114.03 177.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 36.3 m80 -88.49 121.33 30.75 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 117.235 0.517 . . . . 74.340000000000003 111.111 178.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 730' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -124.78 122.29 37.01 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.792 0.33 . . . . 72.430000000000007 111.873 -176.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 31.9 m -121.94 159.3 24.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 116.423 -0.353 . . . . 51.549999999999997 111.029 177.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 10.3 t -143.33 154.82 44.15 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.839 0.352 . . . . 72.219999999999999 111.801 -178.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -148.5 161.35 41.81 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 122.631 0.372 . . . . 73.140000000000001 111.211 179.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 734' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -125.66 154.56 42.17 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 121.057 0.455 . . . . 64.310000000000002 112.108 -177.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 735' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -130.8 137.96 49.67 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.991 -0.549 . . . . 50.100000000000001 111.299 179.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 736' ' ' THR . . . . . . . . . . . . . 89.5 m -97.19 103.82 15.78 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.534 -0.303 . . . . 70.409999999999997 111.151 176.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 45.6 t -101.48 105.16 17.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-O 120.841 0.353 . . . . 74.329999999999998 111.649 -179.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 738' ' ' THR . . . . . . . . . . . . . 65.8 m -95.95 118.21 32.14 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.911 0.386 . . . . 52.210000000000001 111.493 179.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 739' ' ' VAL . . . . . . . . . . . . . 41.0 t -97.89 139.4 20.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-N 116.393 -0.367 . . . . 74.219999999999999 111.496 178.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 740' ' ' LYS . . . . . 0.401 ' O ' ' HA ' ' A' ' 678' ' ' HIS . 97.4 mttt -122.17 155.84 34.95 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 120.841 0.353 . . . . 54.240000000000002 110.711 176.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 741' ' ' VAL . . . . . 0.445 ' HA ' HG23 ' A' ' 679' ' ' VAL . 40.9 t -82.47 145.66 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-O 121.04 0.448 . . . . 61.539999999999999 112.152 -175.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 742' ' ' ARG . . . . . 0.532 ' HG3' ' HG3' ' A' ' 744' ' ' GLU . 32.2 ptt180 -103.28 140.0 37.98 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.001 -0.545 . . . . 64.019999999999996 110.287 172.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 743' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -69.63 89.04 0.53 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.235 0.541 . . . . 72.310000000000002 111.686 179.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 744' ' ' GLU . . . . . 0.532 ' HG3' ' HG3' ' A' ' 742' ' ' ARG . 48.3 mt-10 -85.81 96.0 9.61 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.073 -0.512 . . . . 54.119999999999997 111.152 177.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 7.7 p -68.96 138.89 21.43 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 121.146 0.498 . . . . 44.219999999999999 111.366 178.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 18.5 ptmt -63.89 86.31 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.821 0 CA-C-O 121.675 0.75 . . . . 72.25 112.275 -178.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 747' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -89.4 129.66 35.88 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.933 -0.576 . . . . 70.530000000000001 110.965 176.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -73.97 100.14 3.47 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 120.98 0.419 . . . . 71.310000000000002 110.044 175.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 749' ' ' LYS . . . . . . . . . . . . . 18.6 ptmt -149.28 66.88 8.74 Favored Pre-proline 0 CA--C 1.542 0.666 0 CA-C-O 121.24 0.543 . . . . 74.030000000000001 111.813 -177.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 750' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -92.15 90.35 0.21 Allowed 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 122.966 2.444 . . . . 70.450000000000003 112.535 176.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 751' ' ' ILE . . . . . . . . . . . . . 48.4 mm -84.08 93.06 3.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-N 116.378 -0.374 . . . . 74.129999999999995 111.245 -178.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 752' ' ' LEU . . . . . . . . . . . . . 53.8 tp -72.67 86.17 1.21 Allowed 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.37 0.605 . . . . 73.409999999999997 110.71 177.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 753' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 . . . . . 0 C--O 1.238 0.46 0 CA-C-O 121.465 0.65 . . . . 74.230000000000004 111.753 -177.867 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 762' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 657' ' ' MET . . . . . . . . . . . . . 58.5 tpp . . . . . 0 N--CA 1.489 1.51 0 CA-C-O 120.726 0.298 . . . . 72.420000000000002 111.149 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 658' ' ' GLY . . . . . . . . . . . . . . . 147.16 -114.32 0.7 Allowed Glycine 0 CA--C 1.525 0.706 0 C-N-CA 120.968 -0.634 . . . . 74.319999999999993 112.74 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 659' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -103.69 -177.82 3.48 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 120.893 0.377 . . . . 74.420000000000002 111.146 178.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 660' ' ' GLY . . . . . . . . . . . . . . . -126.65 120.9 3.81 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 121.382 -0.437 . . . . 64.349999999999994 112.866 176.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -71.68 131.12 42.71 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 120.856 0.36 . . . . 72.109999999999999 111.965 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 662' ' ' THR . . . . . . . . . . . . . 35.6 m -89.08 140.11 29.77 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 120.908 0.385 . . . . 70.230000000000004 111.707 -178.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 663' ' ' SER . . . . . . . . . . . . . 45.2 m -86.98 114.58 23.72 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 116.562 -0.29 . . . . 71.219999999999999 111.689 -179.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 664' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -75.46 136.49 40.68 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.871 0.367 . . . . 64.510000000000005 111.134 176.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 665' ' ' LEU . . . . . 0.441 HD12 ' HD3' ' A' ' 694' ' ' LYS . 89.4 mt -90.55 136.62 32.94 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 116.305 -0.407 . . . . 70.519999999999996 110.505 174.237 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 666' ' ' GLU . . . . . 0.479 ' HB3' ' HB3' ' A' ' 729' ' ' HIS . 2.3 pm0 -65.5 140.63 97.67 Favored Pre-proline 0 CA--C 1.543 0.701 0 CA-C-O 120.921 0.391 . . . . 73.400000000000006 111.543 177.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 667' ' ' PRO . . . . . 0.596 ' HD3' ' HB2' ' A' ' 725' ' ' ASP . 12.8 Cg_endo -55.36 145.85 65.16 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 123.378 2.719 . . . . 75.400000000000006 114.745 -169.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 668' ' ' LYS . . . . . . . . . . . . . 7.4 tmtm? -85.06 104.14 14.71 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.287 -0.87 . . . . 51.210000000000001 110.404 177.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 669' ' ' LEU . . . . . . . . . . . . . 57.5 tp -100.05 111.72 24.02 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 116.119 -0.491 . . . . 63.140000000000001 111.564 -177.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 670' ' ' THR . . . . . . . . . . . . . 86.2 m -89.11 111.53 22.31 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.9 0.381 . . . . 61.240000000000002 111.502 178.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 671' ' ' VAL . . . . . 0.43 HG22 HG13 ' A' ' 689' ' ' VAL . 90.6 t -134.0 129.16 19.95 Favored Pre-proline 0 N--CA 1.47 0.529 0 CA-C-N 116.194 -0.457 . . . . 72.519999999999996 110.807 176.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 672' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -74.29 128.88 12.45 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 122.161 1.907 . . . . 65.030000000000001 112.084 176.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 673' ' ' VAL . . . . . . . . . . . . . 9.6 p -64.6 -19.27 24.9 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 N-CA-C 112.423 0.527 . . . . 75.019999999999996 112.423 -175.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 674' ' ' GLY . . . . . . . . . . . . . . . -156.8 155.59 26.48 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 120.809 -0.71 . . . . 44.030000000000001 113.501 -179.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 675' ' ' ALA . . . . . 0.486 ' HB3' HG22 ' A' ' 737' ' ' VAL . . . -151.1 145.66 25.62 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 120.691 0.281 . . . . 74.519999999999996 111.148 178.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 676' ' ' THR . . . . . . . . . . . . . 88.9 m -120.65 124.79 46.09 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.031 0.443 . . . . 70.150000000000006 112.096 -179.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 677' ' ' ILE . . . . . . . . . . . . . 28.8 pt -135.4 177.24 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 CA-C-N 116.244 -0.435 . . . . 55.520000000000003 111.029 176.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 678' ' ' HIS . . . . . . . . . . . . . 65.8 m80 -124.46 168.07 13.56 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.295 0.569 . . . . 62.100000000000001 112.188 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 679' ' ' VAL . . . . . . . . . . . . . 85.5 t -63.31 111.55 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-N 115.777 -0.647 . . . . 51.140000000000001 109.871 170.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 107.59 -4.33 34.69 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 121.297 -0.478 . . . . 40.240000000000002 113.29 -175.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 681' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -86.18 170.93 11.7 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 121.223 0.535 . . . . 74.129999999999995 111.508 176.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 682' ' ' SER . . . . . . . . . . . . . 77.3 p -114.58 153.21 30.5 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 116.349 -0.387 . . . . 71.310000000000002 111.121 178.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 683' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -159.19 114.06 2.45 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 120.745 0.307 . . . . 71.409999999999997 111.453 -178.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 684' ' ' VAL . . . . . 0.44 ' HA ' ' HD2' ' A' ' 685' ' ' PRO . 84.0 t -105.47 103.98 45.72 Favored Pre-proline 0 CA--C 1.543 0.677 0 CA-C-N 116.551 -0.295 . . . . 65.200000000000003 110.982 176.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 685' ' ' PRO . . . . . 0.44 ' HD2' ' HA ' ' A' ' 684' ' ' VAL . 14.4 Cg_endo -57.12 -35.55 98.94 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 122.606 2.204 . . . . 74.209999999999994 113.484 -179.059 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 686' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -78.35 -6.19 54.4 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 112.314 0.487 . . . . 72.150000000000006 112.314 -179.224 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 687' ' ' ALA . . . . . . . . . . . . . . . -94.51 -27.42 15.98 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 121.039 0.447 . . . . 73.310000000000002 111.259 175.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 688' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -86.08 -9.99 55.73 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 116.158 -0.474 . . . . 53.119999999999997 111.753 -179.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . 0.435 HG12 HD13 ' A' ' 703' ' ' ILE . 95.5 t -118.63 133.93 63.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 CA-C-O 120.937 0.398 . . . . 74.400000000000006 111.613 -177.194 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 690' ' ' LEU . . . . . 0.556 HD23 ' N ' ' A' ' 691' ' ' ALA . 4.1 tt -141.73 136.68 31.02 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 116.188 -0.46 . . . . 63.140000000000001 110.138 -177.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 691' ' ' ALA . . . . . 0.556 ' N ' HD23 ' A' ' 690' ' ' LEU . . . -122.48 122.09 38.11 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.345 0.498 . . . . 71.299999999999997 112.345 -178.016 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 692' ' ' ILE . . . . . . . . . . . . . 45.0 mm -122.25 124.23 70.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-N 116.183 -0.462 . . . . 73.340000000000003 111.483 178.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -113.6 144.99 41.96 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.726 0.298 . . . . 65.230000000000004 110.294 173.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 694' ' ' LYS . . . . . 0.441 ' HD3' HD12 ' A' ' 665' ' ' LEU . 7.9 mtpm? -71.72 -43.08 66.5 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 112.105 0.409 . . . . 72.450000000000003 112.105 -175.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 44.7 mp0 -83.88 -54.35 4.94 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 121.144 0.497 . . . . 75.409999999999997 112.142 -178.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 696' ' ' ASP . . . . . . . . . . . . . 32.7 t0 -79.38 -28.62 41.92 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 116.083 -0.508 . . . . 51.200000000000003 112.133 -172.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . 105.64 -155.53 16.85 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 121.186 -0.53 . . . . 55.25 113.595 176.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -68.22 118.19 11.02 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 122.55 -0.383 . . . . 53.240000000000002 110.48 176.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 699' ' ' LEU . . . . . 0.543 HD22 ' HE2' ' A' ' 702' ' ' LYS . 19.9 mt -113.31 19.89 16.63 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.46 -0.336 . . . . 74.340000000000003 111.511 -176.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 77.6 m -56.11 -37.92 70.07 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 112.313 0.486 . . . . 73.310000000000002 112.313 -176.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 701' ' ' SER . . . . . . . . . . . . . 73.3 m -70.83 -19.52 62.65 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 112.063 0.394 . . . . 74.140000000000001 112.063 178.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 702' ' ' LYS . . . . . 0.543 ' HE2' HD22 ' A' ' 699' ' ' LEU . 54.5 mtmt -92.59 11.24 27.2 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.777 0.323 . . . . 71.200000000000003 111.625 178.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 703' ' ' ILE . . . . . 0.547 HG12 ' HB ' ' A' ' 723' ' ' VAL . 54.0 mt -87.49 120.43 36.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 116.712 -0.222 . . . . 73.109999999999999 110.728 174.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 704' ' ' LYS . . . . . . . . . . . . . 53.6 tttm -93.11 146.32 23.74 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 120.801 0.334 . . . . 72.299999999999997 110.892 173.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 44.5 t -104.3 146.33 11.83 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-O 120.952 0.406 . . . . 74.430000000000007 110.887 176.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 706' ' ' ASP . . . . . 0.508 ' HB3' ' HB ' ' A' ' 720' ' ' THR . 32.3 t70 -135.01 129.96 34.96 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 120.899 0.38 . . . . 73.239999999999995 110.738 174.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 101.34 175.88 28.76 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 121.439 -0.41 . . . . 71.540000000000006 112.404 -176.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 708' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -151.86 144.7 24.39 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 117.076 0.438 . . . . 71.040000000000006 111.908 -178.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 709' ' ' VAL . . . . . 0.508 HG22 ' HB2' ' A' ' 717' ' ' TYR . 97.1 t -114.07 111.45 36.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-N 116.437 -0.347 . . . . 71.129999999999995 111.305 178.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 710' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -70.01 136.11 50.06 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 120.946 0.403 . . . . 73.349999999999994 111.264 176.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 711' ' ' THR . . . . . . . . . . . . . 70.7 p -106.36 -6.73 18.1 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 112.131 0.419 . . . . 74.340000000000003 112.131 -178.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 712' ' ' THR . . . . . . . . . . . . . 11.7 t -100.25 0.28 39.96 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 111.973 0.36 . . . . 74.239999999999995 111.973 177.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 713' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -144.03 134.06 24.12 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 120.692 0.282 . . . . 74.319999999999993 111.279 -177.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 714' ' ' ALA . . . . . . . . . . . . . . . -76.62 144.55 39.47 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 112.359 0.503 . . . . 72.120000000000005 112.359 -176.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 158.03 168.3 20.15 Favored Glycine 0 CA--C 1.525 0.718 0 CA-C-N 116.025 -0.534 . . . . 53.140000000000001 112.487 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 716' ' ' THR . . . . . . . . . . . . . 91.3 m -96.39 123.48 40.06 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 122.295 -0.532 . . . . 74.420000000000002 111.477 178.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 717' ' ' TYR . . . . . 0.508 ' HB2' HG22 ' A' ' 709' ' ' VAL . 33.3 m-85 -119.52 141.51 49.14 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 116.404 -0.362 . . . . 75.340000000000003 110.755 -178.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 718' ' ' VAL . . . . . . . . . . . . . 72.9 t -113.26 131.35 65.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 CA-C-O 120.893 0.378 . . . . 72.409999999999997 111.383 178.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 719' ' ' LEU . . . . . 0.423 HD21 HG23 ' A' ' 709' ' ' VAL . 69.4 mt -116.4 142.15 47.23 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 116.444 -0.344 . . . . 73.120000000000005 111.433 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . 0.508 ' HB ' ' HB3' ' A' ' 706' ' ' ASP . 93.2 m -114.89 136.13 53.44 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 120.876 0.37 . . . . 52.119999999999997 111.356 178.035 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 721' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -124.71 135.03 52.68 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 116.346 -0.388 . . . . 73.450000000000003 110.947 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 94.6 m -138.21 134.88 35.02 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 111.813 0.301 . . . . 64.140000000000001 111.813 -177.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 723' ' ' VAL . . . . . 0.547 ' HB ' HG12 ' A' ' 703' ' ' ILE . 8.7 p -132.25 146.24 33.39 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 CA-C-O 120.879 0.371 . . . . 75.109999999999999 111.422 179.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 56.5 m -119.6 130.29 55.04 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 112.734 0.642 . . . . 71.439999999999998 112.734 -175.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 725' ' ' ASP . . . . . 0.596 ' HB2' ' HD3' ' A' ' 667' ' ' PRO . 12.0 t70 -76.68 155.58 33.24 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.983 -0.553 . . . . 54.240000000000002 110.516 174.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 726' ' ' SER . . . . . . . . . . . . . 46.4 t -54.51 -33.65 60.29 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 112.407 0.521 . . . . 75.129999999999995 112.407 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 727' ' ' LYS . . . . . . . . . . . . . 46.7 mmtm -75.96 -14.82 60.24 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 112.239 0.459 . . . . 74.200000000000003 112.239 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 728' ' ' GLY . . . . . . . . . . . . . . . 109.94 4.71 29.49 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 121.112 -0.566 . . . . 52.140000000000001 113.625 -177.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 729' ' ' HIS . . . . . 0.479 ' HB3' ' HB3' ' A' ' 666' ' ' GLU . 24.8 m170 -70.67 102.13 2.22 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 117.519 0.659 . . . . 52.240000000000002 111.353 176.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 730' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -98.0 125.26 42.86 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 120.984 0.421 . . . . 73.519999999999996 111.503 179.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 731' ' ' VAL . . . . . 0.436 HG22 ' HG2' ' A' ' 667' ' ' PRO . 30.2 m -126.65 154.18 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-O 120.84 0.352 . . . . 61.509999999999998 111.113 176.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 8.8 t -144.42 147.89 33.93 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 121.386 0.612 . . . . 70.230000000000004 112.431 -173.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -147.49 153.67 39.81 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.862 -0.608 . . . . 62.509999999999998 110.576 177.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 734' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -123.47 152.04 42.09 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 112.625 0.602 . . . . 64.219999999999999 112.625 -173.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 735' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -130.24 128.34 41.43 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 115.798 -0.637 . . . . 64.540000000000006 111.133 -177.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 736' ' ' THR . . . . . . . . . . . . . 93.9 m -100.26 109.64 21.87 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.848 0.356 . . . . 64.120000000000005 111.428 179.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 737' ' ' VAL . . . . . 0.486 HG22 ' HB3' ' A' ' 675' ' ' ALA . 41.0 t -105.33 117.72 51.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-O 120.952 0.406 . . . . 65.439999999999998 111.554 -178.111 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 738' ' ' THR . . . . . . . . . . . . . 91.8 m -102.23 131.1 49.0 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 120.906 0.384 . . . . 45.310000000000002 111.545 178.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 739' ' ' VAL . . . . . . . . . . . . . 43.1 t -104.45 131.12 54.13 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-N 116.348 -0.387 . . . . 60.130000000000003 111.535 179.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 740' ' ' LYS . . . . . 0.462 ' NZ ' ' HB3' ' A' ' 740' ' ' LYS . 7.7 mtpm? -116.08 155.77 27.56 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 120.902 0.382 . . . . 54.299999999999997 111.305 177.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 741' ' ' VAL . . . . . . . . . . . . . 43.9 t -90.32 140.07 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 N-CA-C 112.093 0.405 . . . . 73.450000000000003 112.093 -177.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 742' ' ' ARG . . . . . . . . . . . . . 60.0 mtp85 -88.51 -80.39 0.28 Allowed 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 121.001 0.429 . . . . 70.010000000000005 110.961 174.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 743' ' ' GLU . . . . . . . . . . . . . 10.4 mp0 -87.71 116.94 26.2 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 116.522 -0.308 . . . . 73.129999999999995 110.765 177.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 744' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -92.73 -179.31 5.12 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 120.942 0.401 . . . . 65.040000000000006 111.941 -177.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 745' ' ' VAL . . . . . 0.728 HG12 ' H ' ' A' ' 747' ' ' ASN . 47.2 t -85.46 140.34 16.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 116.476 -0.329 . . . . 75.129999999999995 111.009 178.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -68.84 -25.92 64.9 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.503 0.557 . . . . 63.399999999999999 112.503 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 747' ' ' ASN . . . . . 0.728 ' H ' HG12 ' A' ' 745' ' ' VAL . 18.6 m120 -105.4 153.23 21.96 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 112.483 0.549 . . . . 71.420000000000002 112.483 -174.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -71.51 115.14 10.34 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.636 -0.711 . . . . 75.140000000000001 111.862 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 749' ' ' LYS . . . . . . . . . . . . . 20.3 tttp -167.91 74.38 0.92 Allowed Pre-proline 0 CA--C 1.542 0.647 0 CA-C-O 120.914 0.388 . . . . 73.030000000000001 111.462 176.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 750' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.31 86.48 1.45 Allowed 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 122.327 2.018 . . . . 71.25 112.232 178.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 751' ' ' ILE . . . . . . . . . . . . . 22.6 pt -79.57 4.35 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 N-CA-C 112.553 0.575 . . . . 72.450000000000003 112.553 -178.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 752' ' ' LEU . . . . . . . . . . . . . 89.7 mt -104.79 179.33 4.3 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 120.901 0.382 . . . . 74.030000000000001 111.093 175.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 753' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 . . . . . 0 N--CA 1.468 0.467 0 CA-C-O 120.922 0.391 . . . . 74.450000000000003 111.333 179.013 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 762' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 657' ' ' MET . . . . . . . . . . . . . 23.5 ptm . . . . . 0 N--CA 1.488 1.471 0 CA-C-O 120.84 0.352 . . . . 72.230000000000004 111.418 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 658' ' ' GLY . . . . . . . . . . . . . . . 151.33 127.06 1.34 Allowed Glycine 0 CA--C 1.53 0.992 0 C-N-CA 120.919 -0.658 . . . . 63.520000000000003 113.308 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 659' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -154.97 169.44 24.07 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.924 0.392 . . . . 72.340000000000003 111.452 177.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 660' ' ' GLY . . . . . . . . . . . . . . . 159.04 -173.95 35.95 Favored Glycine 0 CA--C 1.524 0.644 0 C-N-CA 121.263 -0.494 . . . . 53.149999999999999 113.029 178.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -135.24 138.13 43.26 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.664 0.269 . . . . 71.420000000000002 110.94 178.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 662' ' ' THR . . . . . . . . . . . . . 7.3 t -133.49 146.9 51.53 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 111.897 0.332 . . . . 43.219999999999999 111.897 -178.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 663' ' ' SER . . . . . . . . . . . . . 50.7 m -86.56 136.92 32.89 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 120.788 0.327 . . . . 63.439999999999998 111.597 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 664' ' ' ASP . . . . . 0.528 ' CG ' ' HG3' ' A' ' 727' ' ' LYS . 12.3 t70 -85.75 155.68 20.94 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 120.927 0.394 . . . . 74.420000000000002 111.291 177.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 665' ' ' LEU . . . . . 0.513 HD12 ' HD2' ' A' ' 694' ' ' LYS . 73.2 mt -102.84 137.74 40.65 Favored 'General case' 0 C--O 1.242 0.678 0 N-CA-C 112.268 0.47 . . . . 73.129999999999995 112.268 -176.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 666' ' ' GLU . . . . . 0.496 ' HG3' ' HB3' ' A' ' 729' ' ' HIS . 3.5 mp0 -67.58 151.62 97.0 Favored Pre-proline 0 CA--C 1.544 0.719 0 CA-C-N 115.957 -0.565 . . . . 71.340000000000003 111.005 176.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 667' ' ' PRO . . . . . 0.623 ' HD3' ' HB2' ' A' ' 725' ' ' ASP . 61.3 Cg_endo -72.7 153.72 54.14 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 122.659 2.239 . . . . 74.129999999999995 113.429 -178.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 668' ' ' LYS . . . . . . . . . . . . . 13.0 tmtt? -92.3 105.15 17.41 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.104 0.478 . . . . 75.409999999999997 110.496 178.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 669' ' ' LEU . . . . . . . . . . . . . 57.9 tp -94.88 120.04 34.44 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 116.173 -0.467 . . . . 71.230000000000004 111.29 -179.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 670' ' ' THR . . . . . . . . . . . . . 90.2 m -102.22 110.79 22.84 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 120.832 0.349 . . . . 75.129999999999995 111.151 -179.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 671' ' ' VAL . . . . . 0.491 HG22 HG13 ' A' ' 689' ' ' VAL . 87.6 t -135.42 126.54 17.3 Favored Pre-proline 0 N--CA 1.472 0.673 0 CA-C-N 116.072 -0.513 . . . . 63.140000000000001 111.065 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 672' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -73.21 145.41 38.91 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 122.241 1.961 . . . . 74.010000000000005 112.19 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 673' ' ' VAL . . . . . . . . . . . . . 13.9 p -65.14 -32.8 59.84 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 N-CA-C 112.098 0.407 . . . . 63.109999999999999 112.098 -178.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 674' ' ' GLY . . . . . . . . . . . . . . . -162.05 147.54 13.87 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 120.77 -0.729 . . . . 42.140000000000001 113.408 -179.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 675' ' ' ALA . . . . . . . . . . . . . . . -136.09 139.62 43.14 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 122.647 0.379 . . . . 61.219999999999999 110.802 179.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 676' ' ' THR . . . . . . . . . . . . . 92.1 m -117.36 124.13 48.16 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.547 0.573 . . . . 73.530000000000001 112.547 -175.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 677' ' ' ILE . . . . . . . . . . . . . 33.7 pt -130.46 177.09 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 CA-C-N 116.292 -0.413 . . . . 75.120000000000005 110.517 175.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 678' ' ' HIS . . . . . . . . . . . . . 76.5 m80 -114.31 168.76 9.57 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 121.232 0.539 . . . . 73.200000000000003 111.787 175.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 679' ' ' VAL . . . . . . . . . . . . . 96.6 t -63.55 117.93 5.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 116.182 -0.463 . . . . 65.519999999999996 110.654 175.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 95.32 8.21 58.86 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 121.419 -0.42 . . . . 64.400000000000006 113.135 -178.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 681' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -94.03 166.1 12.31 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.073 0.463 . . . . 63.109999999999999 111.43 178.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 682' ' ' SER . . . . . . . . . . . . . 47.2 m -93.54 149.42 21.25 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.22 -0.445 . . . . 75.219999999999999 111.421 -179.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 683' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -151.6 116.41 5.18 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.722 0.296 . . . . 65.010000000000005 110.761 178.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 684' ' ' VAL . . . . . 0.4 ' HA ' ' HD2' ' A' ' 685' ' ' PRO . 28.8 t -117.01 92.57 39.57 Favored Pre-proline 0 CA--C 1.544 0.727 0 CA-C-O 121.126 0.489 . . . . 74.349999999999994 111.522 -178.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 685' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 684' ' ' VAL . 30.6 Cg_endo -62.27 -31.89 82.07 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 122.606 2.204 . . . . 73.420000000000002 112.963 -177.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 686' ' ' MET . . . . . 0.428 ' HA ' ' HE3' ' A' ' 686' ' ' MET . 0.7 OUTLIER -78.85 -1.39 34.75 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 112.248 0.462 . . . . 73.120000000000005 112.248 -178.403 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 687' ' ' ALA . . . . . . . . . . . . . . . -104.61 -30.14 10.17 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.088 0.47 . . . . 71.319999999999993 111.31 175.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 688' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -91.19 -28.17 18.02 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 116.343 -0.39 . . . . 74.329999999999998 111.85 -179.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . 0.491 HG13 HG22 ' A' ' 671' ' ' VAL . 80.2 t -98.15 124.7 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-O 120.922 0.391 . . . . 64.140000000000001 111.413 178.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 690' ' ' LEU . . . . . 0.429 HD12 ' C ' ' A' ' 689' ' ' VAL . 7.3 mp -126.04 154.46 42.96 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 116.234 -0.439 . . . . 65.140000000000001 111.619 -178.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 691' ' ' ALA . . . . . . . . . . . . . . . -137.39 122.26 18.85 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.796 0.331 . . . . 71.140000000000001 111.058 177.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 692' ' ' ILE . . . . . . . . . . . . . 50.2 mm -129.09 117.27 43.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 CA-C-O 120.842 0.353 . . . . 71.150000000000006 111.653 -176.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 693' ' ' ASP . . . . . 0.467 ' HB2' HD12 ' A' ' 699' ' ' LEU . 34.4 t70 -95.19 149.66 21.07 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.535 -0.302 . . . . 71.319999999999993 110.481 176.184 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 694' ' ' LYS . . . . . 0.513 ' HD2' HD12 ' A' ' 665' ' ' LEU . 30.9 ttmt -72.41 -43.29 64.09 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 112.837 0.68 . . . . 74.409999999999997 112.837 -171.121 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -84.09 -45.9 12.53 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 121.696 -0.627 . . . . 72.030000000000001 111.278 177.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 696' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -74.43 -48.99 24.21 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 112.206 0.447 . . . . 71.230000000000004 112.206 -175.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . 112.14 -117.79 4.51 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 121.0 -0.619 . . . . 72.450000000000003 112.647 -176.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -78.09 117.52 19.46 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 122.118 -0.636 . . . . 54.140000000000001 111.935 -179.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 699' ' ' LEU . . . . . 0.516 HD12 ' HB3' ' A' ' 667' ' ' PRO . 73.5 mt -117.24 14.05 14.74 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.126 -0.488 . . . . 52.219999999999999 110.726 172.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 33.5 m -58.66 -34.58 71.39 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.017 0.437 . . . . 71.430000000000007 111.251 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 701' ' ' SER . . . . . . . . . . . . . 80.2 p -70.31 -17.82 63.09 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 116.504 -0.316 . . . . 75.019999999999996 111.757 177.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 702' ' ' LYS . . . . . . . . . . . . . 45.3 mmtm -91.22 3.29 55.21 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 111.814 0.302 . . . . 71.239999999999995 111.814 -178.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 703' ' ' ILE . . . . . 0.444 HD13 HG12 ' A' ' 689' ' ' VAL . 67.3 mt -76.36 125.73 36.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-O 121.195 0.522 . . . . 72.040000000000006 111.754 -179.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 704' ' ' LYS . . . . . . . . . . . . . 58.4 mttp -92.9 123.93 36.52 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.191 -0.459 . . . . 64.340000000000003 110.741 172.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 51.9 t -95.85 106.94 18.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.935 -0.575 . . . . 72.409999999999997 110.808 179.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 706' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -100.04 134.0 43.6 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 120.912 0.387 . . . . 71.319999999999993 111.456 -178.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 118.24 -168.96 13.23 Favored Glycine 0 CA--C 1.525 0.659 0 CA-C-N 116.293 -0.412 . . . . 53.109999999999999 112.68 -178.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 708' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -158.05 137.61 11.98 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.967 0.413 . . . . 63.229999999999997 111.72 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 709' ' ' VAL . . . . . 0.448 HG22 ' HB2' ' A' ' 717' ' ' TYR . 62.7 t -126.34 123.11 62.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-N 116.459 -0.337 . . . . 51.25 111.127 179.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 710' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -93.47 142.22 27.58 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 121.202 0.525 . . . . 64.329999999999998 111.332 177.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 711' ' ' THR . . . . . . . . . . . . . 47.6 p -101.54 -9.44 21.01 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.806 -0.634 . . . . 70.109999999999999 112.278 -178.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 712' ' ' THR . . . . . . . . . . . . . 59.6 p -103.05 -0.09 31.27 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 113.099 0.777 . . . . 63.509999999999998 113.099 -177.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 713' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -144.14 136.57 26.74 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 122.067 -0.396 . . . . 65.200000000000003 111.332 175.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 714' ' ' ALA . . . . . . . . . . . . . . . -70.08 144.48 52.12 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 112.393 0.516 . . . . 62.0 112.393 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 161.28 166.7 20.52 Favored Glycine 0 CA--C 1.525 0.679 0 CA-C-N 116.108 -0.497 . . . . 74.409999999999997 112.729 -179.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 716' ' ' THR . . . . . . . . . . . . . 53.2 m -101.12 124.52 46.96 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 122.357 -0.496 . . . . 71.329999999999998 111.182 178.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 717' ' ' TYR . . . . . 0.448 ' HB2' HG22 ' A' ' 709' ' ' VAL . 30.2 m-85 -121.75 133.47 54.93 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 116.198 -0.456 . . . . 75.209999999999994 110.762 -177.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 718' ' ' VAL . . . . . . . . . . . . . 58.8 t -94.96 133.06 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-O 120.82 0.343 . . . . 71.329999999999998 111.614 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 719' ' ' LEU . . . . . 0.404 HD21 HG23 ' A' ' 709' ' ' VAL . 96.4 mt -119.79 127.66 53.0 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.802 0.334 . . . . 75.340000000000003 111.116 177.534 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 91.8 m -111.68 120.67 42.83 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 120.752 0.311 . . . . 63.229999999999997 110.912 178.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 721' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -104.78 120.04 40.43 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.591 -0.277 . . . . 74.329999999999998 111.186 -178.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 59.9 m -122.55 123.46 41.29 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 120.674 0.273 . . . . 73.310000000000002 111.168 178.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 10.4 p -119.14 147.18 22.85 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 CA-C-O 121.008 0.432 . . . . 72.340000000000003 111.906 -177.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 76.2 m -110.21 133.57 53.1 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 112.303 0.482 . . . . 74.299999999999997 112.303 -177.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 725' ' ' ASP . . . . . 0.623 ' HB2' ' HD3' ' A' ' 667' ' ' PRO . 50.2 t0 -73.62 154.64 39.67 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 115.888 -0.597 . . . . 62.240000000000002 111.216 176.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 726' ' ' SER . . . . . . . . . . . . . 40.4 t -58.24 -28.58 65.02 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.036 0.446 . . . . 52.25 111.178 176.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 727' ' ' LYS . . . . . 0.528 ' HG3' ' CG ' ' A' ' 664' ' ' ASP . 36.8 mmtm -90.28 -11.01 42.08 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 111.97 0.359 . . . . 75.030000000000001 111.97 177.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 728' ' ' GLY . . . . . . . . . . . . . . . 112.4 -1.23 26.51 Favored Glycine 0 CA--C 1.533 1.171 0 N-CA-C 114.688 0.635 . . . . 71.409999999999997 114.688 179.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 729' ' ' HIS . . . . . 0.543 ' H ' ' HB3' ' A' ' 725' ' ' ASP . 34.7 m80 -68.54 105.21 2.16 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 118.12 0.96 . . . . 74.310000000000002 110.989 176.121 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 730' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -96.32 125.88 41.13 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 120.802 0.334 . . . . 75.209999999999994 110.942 -179.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 35.9 m -127.02 158.11 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-O 120.699 0.285 . . . . 63.409999999999997 111.079 178.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 5.3 t -143.52 149.76 37.95 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 112.755 0.65 . . . . 62.299999999999997 112.755 -174.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -148.37 154.59 40.15 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.771 -0.65 . . . . 60.200000000000003 110.343 176.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 734' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -119.86 154.86 33.71 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 113.159 0.8 . . . . 71.430000000000007 113.159 -174.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 735' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -136.67 124.12 22.09 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.5 -0.773 . . . . 62.310000000000002 110.652 177.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 736' ' ' THR . . . . . . . . . . . . . 99.8 m -93.93 105.78 17.78 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.104 0.478 . . . . 75.109999999999999 111.055 176.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 45.6 t -96.77 141.33 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-O 120.709 0.29 . . . . 71.299999999999997 111.59 -176.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 738' ' ' THR . . . . . . . . . . . . . 88.8 m -128.7 122.91 31.79 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.25 0.548 . . . . 43.399999999999999 112.269 -179.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 739' ' ' VAL . . . . . . . . . . . . . 47.2 t -95.57 124.57 48.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-N 115.754 -0.657 . . . . 75.400000000000006 110.788 176.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 740' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -102.95 151.67 22.21 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.417 0.627 . . . . 72.25 112.079 -176.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 741' ' ' VAL . . . . . . . . . . . . . 93.9 t -74.51 147.65 8.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 115.77 -0.65 . . . . 74.340000000000003 112.264 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 742' ' ' ARG . . . . . 0.422 HH11 ' HD2' ' A' ' 742' ' ' ARG . 13.5 ptt85 -145.96 -33.35 0.33 Allowed 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.44 -0.345 . . . . 61.219999999999999 111.837 168.323 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 743' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -136.4 99.78 4.19 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 120.787 0.327 . . . . 44.439999999999998 111.808 178.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 744' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -89.91 19.55 4.77 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 121.125 0.488 . . . . 74.25 111.633 177.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 32.3 m -80.26 168.16 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-O 121.206 0.527 . . . . 63.240000000000002 112.07 -179.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 746' ' ' LYS . . . . . 0.428 ' O ' ' HG3' ' A' ' 746' ' ' LYS . 24.7 pttm -132.18 108.48 9.29 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.208 0.528 . . . . 63.340000000000003 110.866 174.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 747' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -69.71 120.18 15.08 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.461 -0.336 . . . . 74.150000000000006 110.672 179.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -71.86 77.69 0.88 Allowed 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 121.405 0.622 . . . . 71.420000000000002 110.797 -178.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 749' ' ' LYS . . . . . 0.478 ' NZ ' ' HB2' ' A' ' 749' ' ' LYS . 5.1 ttmp? -172.96 94.11 0.37 Allowed Pre-proline 0 CA--C 1.538 0.498 0 CA-C-N 115.361 -0.836 . . . . 72.409999999999997 110.532 179.033 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 750' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.2 133.94 16.89 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 122.302 2.001 . . . . 72.239999999999995 112.894 -178.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 751' ' ' ILE . . . . . 0.455 HD12 ' N ' ' A' ' 751' ' ' ILE . 2.3 mp -61.37 109.52 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-O 120.851 0.358 . . . . 70.140000000000001 110.235 176.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 752' ' ' LEU . . . . . . . . . . . . . 66.2 mt -68.85 111.92 5.22 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 120.896 0.379 . . . . 64.519999999999996 112.014 -174.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 753' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 . . . . . 0 C--O 1.237 0.442 0 CA-C-N 115.735 -0.666 . . . . 74.439999999999998 112.337 174.909 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 762' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 657' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 120.644 0.259 . . . . 75.439999999999998 110.686 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 658' ' ' GLY . . . . . . . . . . . . . . . 81.0 -58.63 4.81 Favored Glycine 0 CA--C 1.53 0.975 0 N-CA-C 114.382 0.513 . . . . 41.409999999999997 114.382 173.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 659' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -66.29 147.32 53.49 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.146 0.498 . . . . 75.530000000000001 112.271 -175.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 660' ' ' GLY . . . . . . . . . . . . . . . -90.02 169.59 35.22 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 121.279 -0.486 . . . . 32.25 113.358 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -108.69 175.91 5.3 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.101 0.477 . . . . 72.329999999999998 111.635 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 662' ' ' THR . . . . . . . . . . . . . 67.5 p -87.37 108.16 18.86 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 112.091 0.404 . . . . 72.209999999999994 112.091 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 663' ' ' SER . . . . . . . . . . . . . 68.6 m -84.53 132.66 34.5 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 120.717 0.294 . . . . 74.299999999999997 111.375 177.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 664' ' ' ASP . . . . . 0.699 ' HB2' ' HE2' ' A' ' 727' ' ' LYS . 16.1 t70 -74.27 141.97 45.29 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 121.123 0.487 . . . . 73.109999999999999 111.818 179.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 665' ' ' LEU . . . . . . . . . . . . . 70.1 mt -85.39 119.01 25.27 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.135 -0.484 . . . . 63.32 109.697 173.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 666' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -67.68 145.33 98.09 Favored Pre-proline 0 CA--C 1.54 0.56 0 CA-C-O 120.671 0.272 . . . . 71.349999999999994 111.308 -177.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 667' ' ' PRO . . . . . 0.431 ' HB3' HD12 ' A' ' 699' ' ' LEU . 78.9 Cg_endo -75.8 146.26 29.7 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.405 2.07 . . . . 61.109999999999999 113.193 -173.379 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 668' ' ' LYS . . . . . . . . . . . . . 4.9 tmtm? -88.28 109.18 19.75 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 109.89 -0.411 . . . . 74.019999999999996 109.89 177.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 669' ' ' LEU . . . . . 0.414 ' HG ' HG23 ' A' ' 671' ' ' VAL . 58.0 tp -93.01 106.16 18.15 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.071 0.463 . . . . 74.129999999999995 110.543 176.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 670' ' ' THR . . . . . . . . . . . . . 86.9 m -86.62 110.7 20.01 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.263 -0.426 . . . . 72.129999999999995 111.391 -178.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 671' ' ' VAL . . . . . 0.414 HG23 ' HG ' ' A' ' 669' ' ' LEU . 95.0 t -137.95 128.34 15.48 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 122.629 0.372 . . . . 43.229999999999997 111.091 -178.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 672' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -77.84 132.28 11.76 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 122.212 1.941 . . . . 72.219999999999999 111.809 177.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 673' ' ' VAL . . . . . . . . . . . . . 14.3 p -64.76 -30.61 50.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 N-CA-C 112.496 0.554 . . . . 62.439999999999998 112.496 -175.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 674' ' ' GLY . . . . . . . . . . . . . . . -151.81 142.6 9.57 Favored Glycine 0 CA--C 1.525 0.666 0 C-N-CA 120.811 -0.709 . . . . 62.140000000000001 113.571 -177.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 675' ' ' ALA . . . . . . . . . . . . . . . -140.48 157.69 45.12 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 122.49 0.316 . . . . 70.0 110.922 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 676' ' ' THR . . . . . . . . . . . . . 54.9 m -136.05 128.81 30.96 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.103 0.477 . . . . 34.200000000000003 111.797 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 677' ' ' ILE . . . . . . . . . . . . . 39.8 pt -132.49 177.64 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-N 116.085 -0.507 . . . . 72.030000000000001 110.987 177.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 678' ' ' HIS . . . . . . . . . . . . . 58.4 m80 -122.44 156.75 33.4 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.151 0.501 . . . . 73.340000000000003 112.276 178.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 679' ' ' VAL . . . . . . . . . . . . . 89.4 t -61.5 128.74 23.42 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 115.824 -0.626 . . . . 53.420000000000002 111.39 176.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 99.81 -17.04 57.95 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 121.356 -0.45 . . . . 73.0 113.031 -178.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 681' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -79.08 177.26 8.94 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 121.224 0.535 . . . . 72.099999999999994 112.248 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 682' ' ' SER . . . . . . . . . . . . . 48.5 m -104.46 145.23 30.57 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.913 -0.585 . . . . 52.399999999999999 110.516 176.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 683' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -148.7 113.05 5.27 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.913 0.387 . . . . 75.140000000000001 111.557 179.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 684' ' ' VAL . . . . . . . . . . . . . 63.6 t -111.61 102.33 53.1 Favored Pre-proline 0 CA--C 1.543 0.675 0 CA-C-N 116.257 -0.429 . . . . 70.030000000000001 110.616 176.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -56.91 -42.62 62.52 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 122.731 2.287 . . . . 73.040000000000006 113.658 -177.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 686' ' ' MET . . . . . . . . . . . . . 15.8 mtp -79.17 -12.29 59.98 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 113.06 0.763 . . . . 73.109999999999999 113.06 -176.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 687' ' ' ALA . . . . . . . . . . . . . . . -79.17 -18.47 53.02 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 122.017 -0.427 . . . . 45.310000000000002 111.207 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 688' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -114.34 9.74 16.97 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 112.178 0.436 . . . . 45.130000000000003 112.178 -178.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . 0.437 HG21 ' CZ ' ' A' ' 721' ' ' TYR . 86.8 t -123.0 124.72 70.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-O 120.879 0.371 . . . . 73.310000000000002 110.939 178.106 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 690' ' ' LEU . . . . . . . . . . . . . 6.4 mp -119.7 157.63 28.14 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.165 0.507 . . . . 72.409999999999997 111.534 -177.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 691' ' ' ALA . . . . . . . . . . . . . . . -148.54 123.48 10.01 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.963 -0.562 . . . . 64.530000000000001 110.557 176.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 692' ' ' ILE . . . . . . . . . . . . . 41.5 mm -131.91 131.4 61.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 N-CA-C 112.404 0.52 . . . . 74.209999999999994 112.404 -174.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -115.33 130.94 57.05 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.121 -0.491 . . . . 61.219999999999999 109.741 168.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -61.76 -32.35 72.6 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.113 0.482 . . . . 63.409999999999997 111.403 -177.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -83.72 -54.32 5.0 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 112.504 0.557 . . . . 74.299999999999997 112.504 -176.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 696' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -77.57 -42.98 33.26 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 120.811 0.339 . . . . 61.32 111.59 -178.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . 121.07 -139.79 13.59 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 121.544 -0.36 . . . . 73.510000000000005 113.001 -178.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -71.73 111.85 7.35 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.052 0.453 . . . . 63.5 111.102 178.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 699' ' ' LEU . . . . . 0.472 HD22 ' HG3' ' A' ' 702' ' ' LYS . 67.0 mt -100.72 9.12 42.83 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.446 -0.343 . . . . 74.299999999999997 111.319 176.155 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 31.2 m -59.7 -36.88 77.41 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.108 0.48 . . . . 65.109999999999999 111.247 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 701' ' ' SER . . . . . . . . . . . . . 47.1 m -81.99 3.13 27.72 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 116.328 -0.396 . . . . 73.25 111.738 176.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 702' ' ' LYS . . . . . 0.472 ' HG3' HD22 ' A' ' 699' ' ' LEU . 33.5 mmtp -103.48 3.96 35.47 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 120.816 0.341 . . . . 71.109999999999999 110.914 179.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 70.2 mt -84.42 116.77 28.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 N-CA-C 112.235 0.457 . . . . 71.200000000000003 112.235 -174.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 704' ' ' LYS . . . . . . . . . . . . . 61.2 tttp -84.83 122.53 29.28 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 120.689 0.28 . . . . 62.32 110.581 172.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 47.8 t -99.28 141.15 17.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-O 121.235 0.541 . . . . 72.200000000000003 112.024 -177.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 706' ' ' ASP . . . . . 0.603 ' HB3' ' HB ' ' A' ' 720' ' ' THR . 23.7 t70 -130.31 151.82 50.4 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.77 -0.65 . . . . 74.319999999999993 110.073 176.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 93.42 167.05 38.15 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 120.974 -0.631 . . . . 61.219999999999999 112.37 -174.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 708' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -144.5 142.8 30.5 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 122.346 -0.502 . . . . 72.120000000000005 111.997 -176.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 709' ' ' VAL . . . . . 0.54 HG23 HD21 ' A' ' 719' ' ' LEU . 95.7 t -122.09 132.52 70.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 CA-C-O 120.885 0.374 . . . . 72.319999999999993 111.158 176.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 710' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -98.32 138.12 36.04 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.002 0.43 . . . . 53.329999999999998 111.367 176.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 711' ' ' THR . . . . . . . . . . . . . 68.0 p -94.01 -25.45 17.22 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.937 0.398 . . . . 75.439999999999998 111.236 177.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 712' ' ' THR . . . . . . . . . . . . . 12.5 t -90.7 -7.04 53.65 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.0 0.429 . . . . 73.310000000000002 111.994 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 713' ' ' LYS . . . . . . . . . . . . . 28.2 tptp -130.42 125.79 35.37 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.704 0.288 . . . . 74.319999999999993 111.259 -177.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 714' ' ' ALA . . . . . . . . . . . . . . . -74.9 144.18 43.44 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 120.826 0.346 . . . . 74.319999999999993 111.466 178.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 159.03 164.4 14.38 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 121.073 -0.584 . . . . 75.319999999999993 113.313 -179.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 716' ' ' THR . . . . . . . . . . . . . 99.2 m -96.04 128.85 43.3 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 122.495 -0.415 . . . . 64.430000000000007 111.216 178.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 717' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -126.76 149.59 49.55 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.027 0.442 . . . . 74.109999999999999 111.574 -179.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 718' ' ' VAL . . . . . . . . . . . . . 40.6 t -117.07 114.0 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 121.079 0.466 . . . . 75.420000000000002 111.264 178.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 719' ' ' LEU . . . . . 0.54 HD21 HG23 ' A' ' 709' ' ' VAL . 81.2 mt -96.26 143.01 27.73 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.09 -0.505 . . . . 64.109999999999999 111.179 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . 0.603 ' HB ' ' HB3' ' A' ' 706' ' ' ASP . 78.0 m -118.82 136.1 54.19 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.913 0.387 . . . . 61.340000000000003 111.154 177.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 721' ' ' TYR . . . . . 0.437 ' CZ ' HG21 ' A' ' 689' ' ' VAL . 72.6 m-85 -120.57 134.36 55.29 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.491 -0.322 . . . . 73.040000000000006 110.906 179.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 25.5 m -134.46 126.22 29.03 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 116.626 -0.261 . . . . 72.439999999999998 110.914 -178.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 8.8 p -132.49 135.78 57.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 CA-C-O 120.929 0.395 . . . . 65.209999999999994 111.611 -179.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 43.0 m -107.96 131.68 54.29 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 120.983 0.421 . . . . 61.039999999999999 111.924 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 725' ' ' ASP . . . . . 0.424 ' HB3' ' H ' ' A' ' 729' ' ' HIS . 10.0 t70 -73.35 166.39 23.28 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.967 -0.56 . . . . 70.109999999999999 111.131 178.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 726' ' ' SER . . . . . . . . . . . . . 45.3 t -63.17 -40.74 98.4 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 116.372 -0.376 . . . . 61.409999999999997 111.854 178.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 727' ' ' LYS . . . . . 0.699 ' HE2' ' HB2' ' A' ' 664' ' ' ASP . 30.8 mtmm -107.23 25.53 11.29 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 113.773 1.027 . . . . 73.150000000000006 113.773 -177.325 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 728' ' ' GLY . . . . . . . . . . . . . . . 110.16 -5.97 30.44 Favored Glycine 0 CA--C 1.536 1.376 0 N-CA-C 116.645 1.418 . . . . 74.510000000000005 116.645 165.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 729' ' ' HIS . . . . . 0.424 ' H ' ' HB3' ' A' ' 725' ' ' ASP . 18.9 m80 -80.31 104.21 10.7 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 118.936 1.368 . . . . 75.010000000000005 111.958 179.168 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 730' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -103.28 115.74 31.14 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.986 0.422 . . . . 74.0 111.718 -178.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 48.0 t -108.74 149.58 11.92 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 CA-C-N 116.414 -0.357 . . . . 54.240000000000002 111.512 -176.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 7.7 t -143.32 143.97 31.91 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 112.502 0.556 . . . . 63.310000000000002 112.502 -178.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -148.7 161.57 41.5 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 116.414 -0.357 . . . . 70.109999999999999 111.234 178.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 734' ' ' LYS . . . . . . . . . . . . . 99.9 mttt -127.22 152.63 47.14 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 112.728 0.64 . . . . 75.200000000000003 112.728 -177.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 735' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -130.49 128.48 41.31 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 115.911 -0.586 . . . . 63.009999999999998 111.13 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 736' ' ' THR . . . . . . . . . . . . . 86.8 m -97.41 109.14 21.95 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.117 0.484 . . . . 73.329999999999998 111.23 176.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 45.4 t -101.16 129.07 52.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-O 120.972 0.415 . . . . 74.430000000000007 111.538 -179.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 738' ' ' THR . . . . . . . . . . . . . 40.4 m -108.94 113.75 26.92 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.521 -0.309 . . . . 64.120000000000005 111.255 179.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 739' ' ' VAL . . . . . . . . . . . . . 21.8 t -93.07 118.89 39.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-O 120.564 0.221 . . . . 63.329999999999998 110.577 177.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 740' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -112.46 158.97 19.22 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 120.994 0.426 . . . . 72.420000000000002 111.618 -176.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 741' ' ' VAL . . . . . . . . . . . . . 38.3 t -85.39 148.85 4.5 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 N-CA-C 113.248 0.833 . . . . 53.32 113.248 -170.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 742' ' ' ARG . . . . . . . . . . . . . 14.9 mmt180 -79.98 150.89 30.3 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.719 -0.673 . . . . 74.019999999999996 111.053 173.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 743' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -101.77 31.17 3.96 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.246 0.546 . . . . 74.200000000000003 110.578 175.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 744' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -119.35 18.01 12.97 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 116.193 -0.458 . . . . 71.109999999999999 111.41 -174.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 28.4 m -86.31 121.31 37.34 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 N-CA-C 112.911 0.708 . . . . 72.140000000000001 112.911 -171.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -140.7 -71.41 0.37 Allowed 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 121.176 0.513 . . . . 74.209999999999994 111.291 176.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 747' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -132.74 59.08 1.74 Allowed 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 121.514 0.673 . . . . 64.340000000000003 110.019 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -80.04 72.82 6.84 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.606 -0.725 . . . . 73.040000000000006 112.292 -171.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 749' ' ' LYS . . . . . 0.727 ' HA ' ' HE3' ' A' ' 749' ' ' LYS . 0.0 OUTLIER 46.85 84.64 0.19 Allowed Pre-proline 0 CA--C 1.545 0.765 0 N-CA-C 113.815 1.042 . . . . 71.120000000000005 113.815 176.022 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 750' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_exo -73.85 52.15 2.51 Favored 'Trans proline' 0 CA--C 1.544 1.006 0 C-N-CA 122.889 2.393 . . . . 75.310000000000002 111.72 171.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 751' ' ' ILE . . . . . . . . . . . . . 29.8 pt -97.9 169.27 1.52 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 N-CA-C 112.127 0.417 . . . . 73.25 112.127 -174.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 752' ' ' LEU . . . . . . . . . . . . . 42.9 tp -147.24 -21.03 0.39 Allowed 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 112.266 0.469 . . . . 65.129999999999995 112.266 178.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 753' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 . . . . . 0 N--CA 1.468 0.46 0 O-C-N 122.061 -0.399 . . . . 63.240000000000002 111.322 -176.438 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 762' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 657' ' ' MET . . . . . . . . . . . . . 66.7 mtt . . . . . 0 N--CA 1.488 1.445 0 CA-C-O 120.801 0.334 . . . . 65.120000000000005 110.984 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 658' ' ' GLY . . . . . . . . . . . . . . . -163.98 -155.41 8.27 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 121.299 -0.477 . . . . 71.329999999999998 112.919 179.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 659' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -117.35 -168.94 1.57 Allowed 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 121.076 0.465 . . . . 75.019999999999996 112.092 -177.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 660' ' ' GLY . . . . . . . . . . . . . . . 148.3 96.76 0.17 Allowed Glycine 0 CA--C 1.526 0.751 0 CA-C-N 115.827 -0.624 . . . . 34.009999999999998 111.816 -176.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 64.19 86.21 0.13 Allowed 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.318 0.58 . . . . 75.200000000000003 110.351 -174.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 662' ' ' THR . . . . . . . . . . . . . 49.9 m -119.97 93.65 4.13 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.437 -0.347 . . . . 72.109999999999999 111.097 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 663' ' ' SER . . . . . . . . . . . . . 70.3 m -70.53 142.36 51.83 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.92 0.391 . . . . 74.120000000000005 111.371 179.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 664' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -74.03 122.3 22.42 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 121.126 0.489 . . . . 72.219999999999999 111.649 -178.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 665' ' ' LEU . . . . . 0.48 HD12 ' HD3' ' A' ' 694' ' ' LYS . 84.0 mt -80.65 117.11 21.05 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.846 -0.615 . . . . 72.400000000000006 109.621 173.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 666' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -60.09 142.54 89.34 Favored Pre-proline 0 CA--C 1.542 0.663 0 CA-C-N 116.247 -0.433 . . . . 75.430000000000007 111.6 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 667' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -75.54 155.11 40.43 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 122.536 2.157 . . . . 73.420000000000002 113.795 -169.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 668' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -86.23 102.55 14.04 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.94 -0.573 . . . . 73.540000000000006 110.845 176.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 669' ' ' LEU . . . . . . . . . . . . . 55.2 tp -93.47 105.9 17.91 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 120.958 0.408 . . . . 73.430000000000007 110.64 177.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 670' ' ' THR . . . . . . . . . . . . . 87.4 m -89.18 110.98 21.66 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.361 -0.381 . . . . 63.299999999999997 111.616 -177.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 671' ' ' VAL . . . . . 0.573 HG22 HG13 ' A' ' 689' ' ' VAL . 88.6 t -138.16 134.52 17.85 Favored Pre-proline 0 CA--C 1.539 0.555 0 CA-C-N 116.259 -0.428 . . . . 74.400000000000006 110.672 179.359 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 672' ' ' PRO . . . . . 0.407 ' HD3' ' O ' ' A' ' 688' ' ' GLU . 71.7 Cg_endo -76.62 120.78 5.68 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 122.058 1.838 . . . . 55.509999999999998 111.62 175.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 673' ' ' VAL . . . . . . . . . . . . . 14.8 p -67.08 -23.2 30.3 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 N-CA-C 112.761 0.652 . . . . 74.340000000000003 112.761 -174.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 674' ' ' GLY . . . . . . . . . . . . . . . -142.93 148.33 20.03 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 120.952 -0.642 . . . . 51.539999999999999 114.041 -177.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 675' ' ' ALA . . . . . . . . . . . . . . . -157.15 151.84 25.55 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.275 0.63 . . . . 72.109999999999999 110.35 178.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 676' ' ' THR . . . . . . . . . . . . . 91.1 m -139.34 124.9 19.34 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 111.897 0.332 . . . . 63.409999999999997 111.897 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 677' ' ' ILE . . . . . . . . . . . . . 25.2 pt -128.67 172.51 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-O 121.225 0.536 . . . . 74.430000000000007 111.689 179.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 678' ' ' HIS . . . . . 0.529 ' CD2' ' HG3' ' A' ' 740' ' ' LYS . 69.5 m80 -110.96 165.4 11.9 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.267 0.556 . . . . 73.010000000000005 111.713 177.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 679' ' ' VAL . . . . . . . . . . . . . 95.2 t -63.28 126.33 21.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 116.113 -0.494 . . . . 43.43 110.696 173.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 89.35 1.09 78.99 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 121.425 -0.417 . . . . 72.310000000000002 113.126 -176.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 681' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -84.74 177.94 7.84 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 120.937 0.399 . . . . 75.209999999999994 110.713 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 682' ' ' SER . . . . . . . . . . . . . 54.9 m -114.51 150.23 35.2 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 120.972 0.415 . . . . 52.109999999999999 111.365 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 683' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -151.36 131.1 13.18 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 116.129 -0.487 . . . . 64.519999999999996 110.904 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 684' ' ' VAL . . . . . . . . . . . . . 48.6 t -122.37 103.27 38.71 Favored Pre-proline 0 CA--C 1.543 0.677 0 CA-C-O 120.851 0.357 . . . . 65.310000000000002 111.312 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -60.33 -46.97 15.8 Favored 'Trans proline' 0 CA--C 1.545 1.027 0 C-N-CA 122.819 2.346 . . . . 62.240000000000002 113.974 -175.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 686' ' ' MET . . . . . . . . . . . . . 91.2 mmm -78.48 -11.85 59.98 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 112.925 0.713 . . . . 74.209999999999994 112.925 -174.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 687' ' ' ALA . . . . . . . . . . . . . . . -77.22 -30.19 54.54 Favored 'General case' 0 N--CA 1.467 0.419 0 O-C-N 122.038 -0.414 . . . . 32.049999999999997 111.397 177.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 688' ' ' GLU . . . . . 0.407 ' O ' ' HD3' ' A' ' 672' ' ' PRO . 19.7 mm-40 -97.04 1.74 50.51 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 112.203 0.446 . . . . 61.329999999999998 112.203 -178.042 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . 0.573 HG13 HG22 ' A' ' 671' ' ' VAL . 95.4 t -120.67 125.08 73.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-O 120.97 0.414 . . . . 65.239999999999995 112.076 -176.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 690' ' ' LEU . . . . . 0.42 HD22 ' C ' ' A' ' 689' ' ' VAL . 2.7 mm? -127.38 164.01 22.77 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 116.115 -0.493 . . . . 73.349999999999994 110.815 178.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 691' ' ' ALA . . . . . . . . . . . . . . . -153.11 122.46 6.68 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.799 0.333 . . . . 72.25 111.345 175.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 692' ' ' ILE . . . . . . . . . . . . . 46.8 mm -130.85 132.3 64.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-O 120.996 0.427 . . . . 70.420000000000002 112.02 -176.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -113.13 150.53 32.04 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 120.969 0.414 . . . . 71.450000000000003 111.004 174.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 694' ' ' LYS . . . . . 0.48 ' HD3' HD12 ' A' ' 665' ' ' LEU . 64.3 tttp -70.89 -38.26 73.02 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 111.967 0.358 . . . . 62.310000000000002 111.967 -178.026 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -82.66 -53.79 5.65 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 122.019 -0.425 . . . . 73.409999999999997 111.894 -178.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 696' ' ' ASP . . . . . 0.508 ' HB2' ' HB2' ' A' ' 726' ' ' SER . 15.0 t70 -80.39 -42.03 23.56 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 112.595 0.591 . . . . 71.219999999999999 112.595 -174.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . 109.74 -107.4 2.34 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 120.947 -0.644 . . . . 64.310000000000002 112.993 -178.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -81.67 115.95 21.17 Favored 'General case' 0 N--CA 1.466 0.339 0 O-C-N 122.201 -0.588 . . . . 70.209999999999994 111.773 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 699' ' ' LEU . . . . . 0.45 HD22 ' HD2' ' A' ' 702' ' ' LYS . 75.5 mt -111.95 1.11 16.29 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.845 0.355 . . . . 61.43 110.443 170.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 22.4 m -56.27 -37.49 69.88 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.272 0.558 . . . . 73.340000000000003 111.158 177.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 701' ' ' SER . . . . . . . . . . . . . 65.5 p -72.33 -9.91 59.1 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 115.979 -0.555 . . . . 75.450000000000003 112.315 179.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 702' ' ' LYS . . . . . 0.45 ' HD2' HD22 ' A' ' 699' ' ' LEU . 62.1 mttp -101.34 1.47 38.63 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 112.446 0.535 . . . . 73.530000000000001 112.446 178.066 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 703' ' ' ILE . . . . . 0.429 HD13 HG12 ' A' ' 689' ' ' VAL . 67.7 mt -72.24 135.14 28.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 N-CA-C 112.081 0.4 . . . . 71.019999999999996 112.081 -178.014 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 704' ' ' LYS . . . . . . . . . . . . . 56.4 tttm -102.11 137.15 40.76 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.574 -0.285 . . . . 74.400000000000006 111.013 173.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 49.4 t -96.04 141.77 14.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-O 120.988 0.423 . . . . 75.420000000000002 111.065 176.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 706' ' ' ASP . . . . . 0.535 ' HB3' ' HB ' ' A' ' 720' ' ' THR . 27.3 t70 -136.56 138.2 41.03 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 120.728 0.299 . . . . 42.350000000000001 111.205 178.019 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 104.29 -173.07 21.05 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 121.391 -0.433 . . . . 64.239999999999995 113.246 -179.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 708' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -157.95 141.73 15.64 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 120.863 0.363 . . . . 61.149999999999999 111.306 179.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 709' ' ' VAL . . . . . 0.488 HG23 HD21 ' A' ' 719' ' ' LEU . 99.5 t -122.97 121.95 64.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-O 120.785 0.326 . . . . 73.010000000000005 111.217 -179.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 710' ' ' ASP . . . . . 0.438 ' O ' HG21 ' A' ' 739' ' ' VAL . 8.2 m-20 -84.95 136.08 33.77 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 121.104 0.478 . . . . 61.100000000000001 111.932 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 711' ' ' THR . . . . . . . . . . . . . 46.2 p -101.63 -3.57 28.1 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.232 0.539 . . . . 62.43 110.37 172.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 712' ' ' THR . . . . . . . . . . . . . 30.1 p -96.06 -27.67 14.98 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 115.749 -0.66 . . . . 60.549999999999997 112.314 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 713' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -121.86 141.04 51.67 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 120.628 0.251 . . . . 72.049999999999997 111.135 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 714' ' ' ALA . . . . . . . . . . . . . . . -81.11 127.24 32.42 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 120.957 0.408 . . . . 44.420000000000002 112.089 -179.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 715' ' ' GLY . . . . . 0.42 ' H ' ' HB ' ' A' ' 739' ' ' VAL . . . 170.14 158.62 14.33 Favored Glycine 0 CA--C 1.525 0.666 0 C-N-CA 121.447 -0.406 . . . . 73.040000000000006 112.788 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 716' ' ' THR . . . . . 0.403 ' HA ' ' HA ' ' A' ' 738' ' ' THR . 51.8 m -87.91 126.44 35.05 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.049 0.452 . . . . 71.109999999999999 111.627 178.133 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 717' ' ' TYR . . . . . 0.472 ' HB2' HG22 ' A' ' 709' ' ' VAL . 72.5 m-85 -125.92 135.9 52.42 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.186 -0.461 . . . . 74.219999999999999 110.411 176.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 718' ' ' VAL . . . . . . . . . . . . . 59.0 t -108.29 113.69 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 CA-C-O 120.915 0.388 . . . . 51.509999999999998 111.856 -176.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 719' ' ' LEU . . . . . 0.488 HD21 HG23 ' A' ' 709' ' ' VAL . 88.1 mt -89.23 141.08 28.84 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 116.477 -0.329 . . . . 72.329999999999998 111.543 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . 0.535 ' HB ' ' HB3' ' A' ' 706' ' ' ASP . 62.1 m -111.15 132.54 54.22 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.936 0.398 . . . . 65.239999999999995 111.315 178.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 721' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -122.09 131.03 53.76 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.329 -0.396 . . . . 72.219999999999999 110.365 178.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 86.4 m -138.0 135.71 36.21 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 120.917 0.389 . . . . 53.420000000000002 111.964 -176.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 12.7 p -136.64 146.45 28.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-O 120.996 0.427 . . . . 74.319999999999993 111.42 -179.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 26.4 m -104.5 140.2 38.3 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.439 -0.346 . . . . 73.310000000000002 111.198 178.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -73.32 169.01 18.02 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 121.09 0.471 . . . . 62.329999999999998 111.275 178.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 726' ' ' SER . . . . . 0.508 ' HB2' ' HB2' ' A' ' 696' ' ' ASP . 46.8 t -63.8 -38.47 91.2 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 120.903 0.382 . . . . 60.409999999999997 111.234 176.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 727' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -98.25 7.17 46.62 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 112.494 0.554 . . . . 74.140000000000001 112.494 179.296 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 728' ' ' GLY . . . . . . . . . . . . . . . 112.4 -6.24 26.59 Favored Glycine 0 CA--C 1.538 1.469 0 N-CA-C 116.688 1.435 . . . . 72.140000000000001 116.688 166.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 17.6 m80 -69.15 109.22 3.94 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 119.292 1.546 . . . . 75.420000000000002 111.368 176.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 730' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -97.43 124.1 41.51 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 116.589 -0.278 . . . . 72.219999999999999 111.159 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 31.6 m -122.82 154.19 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-O 120.801 0.334 . . . . 62.5 111.388 -178.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 9.3 t -138.28 148.25 44.48 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 121.437 0.637 . . . . 55.32 112.524 -177.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -148.41 150.12 32.94 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.838 -0.619 . . . . 22.219999999999999 110.483 178.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 734' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -120.15 160.02 23.71 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 112.67 0.619 . . . . 75.319999999999993 112.67 -174.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 735' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -130.6 119.58 22.7 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 115.478 -0.783 . . . . 71.430000000000007 110.8 -179.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 736' ' ' THR . . . . . . . . . . . . . 23.8 m -90.02 103.79 16.42 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 116.496 -0.32 . . . . 44.420000000000002 111.266 -178.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 32.5 t -102.19 113.56 39.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 CA-C-O 120.952 0.406 . . . . 53.409999999999997 111.665 -177.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 738' ' ' THR . . . . . 0.403 ' HA ' ' HA ' ' A' ' 716' ' ' THR . 87.7 m -100.29 112.06 24.37 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.855 0.359 . . . . 53.409999999999997 111.464 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 739' ' ' VAL . . . . . 0.438 HG21 ' O ' ' A' ' 710' ' ' ASP . 22.4 t -93.22 133.58 33.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-O 120.778 0.323 . . . . 60.030000000000001 110.676 177.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 740' ' ' LYS . . . . . 0.529 ' HG3' ' CD2' ' A' ' 678' ' ' HIS . 19.1 ptmt -132.81 152.34 51.82 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.236 0.541 . . . . 74.409999999999997 111.929 -178.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 741' ' ' VAL . . . . . . . . . . . . . 20.0 t -75.08 149.65 7.1 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-N 116.057 -0.519 . . . . 62.439999999999998 111.987 -174.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 742' ' ' ARG . . . . . 0.562 ' HG3' ' HG3' ' A' ' 743' ' ' GLU . 4.2 ptp180 -80.66 -41.83 23.1 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 116.27 -0.423 . . . . 64.329999999999998 111.439 176.316 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 743' ' ' GLU . . . . . 0.562 ' HG3' ' HG3' ' A' ' 742' ' ' ARG . 39.8 mt-10 -102.68 117.25 34.25 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 116.465 -0.334 . . . . 75.200000000000003 110.617 178.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 744' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -74.84 84.63 2.19 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-O 121.765 0.793 . . . . 74.319999999999993 111.755 -177.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 48.9 t -69.82 99.09 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-N 115.914 -0.585 . . . . 73.319999999999993 111.309 178.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -108.28 14.8 24.63 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.989 -0.55 . . . . 72.400000000000006 111.178 178.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 747' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -79.65 4.22 16.74 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 112.715 0.635 . . . . 72.530000000000001 112.715 -174.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 38.9 t70 72.15 -9.8 0.97 Allowed 'General case' 0 CA--C 1.549 0.938 0 N-CA-C 113.041 0.756 . . . . 72.519999999999996 113.041 176.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 749' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -61.21 120.51 55.42 Favored Pre-proline 0 N--CA 1.473 0.701 0 O-C-N 121.905 -0.497 . . . . 74.209999999999994 111.067 175.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 750' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -55.63 145.41 70.48 Favored 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 122.819 2.346 . . . . 63.350000000000001 113.144 -177.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 751' ' ' ILE . . . . . . . . . . . . . 36.2 pt -88.02 164.74 2.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-O 120.858 0.361 . . . . 73.219999999999999 111.959 -177.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 752' ' ' LEU . . . . . . . . . . . . . 29.8 tp 70.39 0.23 3.13 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 112.681 0.623 . . . . 72.409999999999997 112.681 175.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 753' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 . . . . . 0 C--O 1.237 0.426 0 CA-C-O 121.292 0.568 . . . . 74.519999999999996 111.13 178.955 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 762' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 657' ' ' MET . . . . . . . . . . . . . 64.3 mtt . . . . . 0 N--CA 1.488 1.472 0 CA-C-O 121.02 0.438 . . . . 63.32 110.991 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 658' ' ' GLY . . . . . . . . . . . . . . . 120.28 -51.66 0.76 Allowed Glycine 0 CA--C 1.523 0.538 0 N-CA-C 110.448 -1.061 . . . . 61.030000000000001 110.448 -169.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 659' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -110.4 98.51 7.71 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 109.582 -0.525 . . . . 74.200000000000003 109.582 168.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 660' ' ' GLY . . . . . . . . . . . . . . . -119.8 -129.78 3.9 Favored Glycine 0 CA--C 1.524 0.603 0 C-N-CA 121.011 -0.614 . . . . 74.349999999999994 113.333 -178.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 64.33 17.35 10.71 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.092 0.557 . . . . 65.439999999999998 112.184 -178.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 662' ' ' THR . . . . . . . . . . . . . 48.1 p -81.51 92.13 6.45 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 121.181 0.515 . . . . 74.540000000000006 110.169 174.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 663' ' ' SER . . . . . . . . . . . . . 41.1 t -55.3 134.28 49.93 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 115.735 -0.666 . . . . 64.109999999999999 112.558 -174.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 664' ' ' ASP . . . . . 0.416 ' OD2' ' HB2' ' A' ' 727' ' ' LYS . 24.5 t0 -74.65 122.94 23.97 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 121.272 0.558 . . . . 73.420000000000002 111.249 178.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 665' ' ' LEU . . . . . . . . . . . . . 84.3 mt -95.44 138.07 33.63 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 115.685 -0.689 . . . . 61.219999999999999 111.261 -179.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 666' ' ' GLU . . . . . 0.454 ' H ' ' CD ' ' A' ' 666' ' ' GLU . 1.3 pm0 -78.32 142.33 62.9 Favored Pre-proline 0 CA--C 1.54 0.596 0 CA-C-N 116.439 -0.346 . . . . 70.439999999999998 110.189 170.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 667' ' ' PRO . . . . . 0.414 ' HG3' ' HB2' ' A' ' 725' ' ' ASP . 38.2 Cg_exo -59.7 144.25 99.48 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 122.83 2.353 . . . . 33.200000000000003 114.467 -171.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 668' ' ' LYS . . . . . . . . . . . . . 49.9 tptt -82.3 97.37 8.26 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.658 -0.701 . . . . 72.239999999999995 109.745 171.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 669' ' ' LEU . . . . . 0.413 ' HG ' HG23 ' A' ' 671' ' ' VAL . 56.7 tp -90.19 105.86 18.09 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.002 -0.544 . . . . 65.530000000000001 110.527 179.188 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 670' ' ' THR . . . . . . . . . . . . . 96.8 m -88.58 110.22 20.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.265 0.555 . . . . 74.519999999999996 111.366 -178.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 671' ' ' VAL . . . . . 0.418 HG22 HG13 ' A' ' 689' ' ' VAL . 72.4 t -129.6 131.72 23.76 Favored Pre-proline 0 CA--C 1.535 0.396 0 CA-C-N 115.753 -0.658 . . . . 70.5 110.285 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 672' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -69.07 123.96 10.87 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 121.829 1.686 . . . . 75.340000000000003 111.693 176.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 673' ' ' VAL . . . . . . . . . . . . . 14.8 p -63.53 -29.52 47.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 N-CA-C 112.357 0.503 . . . . 71.530000000000001 112.357 -174.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 674' ' ' GLY . . . . . . . . . . . . . . . -150.88 143.9 11.14 Favored Glycine 0 CA--C 1.525 0.657 0 C-N-CA 120.741 -0.742 . . . . 72.329999999999998 113.177 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 675' ' ' ALA . . . . . 0.423 ' O ' ' HA ' ' A' ' 737' ' ' VAL . . . -148.63 143.89 26.84 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.729 0.299 . . . . 74.439999999999998 110.981 179.496 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 676' ' ' THR . . . . . . . . . . . . . 49.7 m -130.07 131.03 45.61 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.761 0.315 . . . . 70.519999999999996 111.509 -179.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 677' ' ' ILE . . . . . . . . . . . . . 25.6 pt -133.71 176.5 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 CA-C-O 120.882 0.373 . . . . 74.510000000000005 110.945 179.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 678' ' ' HIS . . . . . . . . . . . . . 76.2 m80 -118.67 158.82 24.77 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 121.08 0.467 . . . . 63.240000000000002 111.879 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 679' ' ' VAL . . . . . 0.402 HG21 HG22 ' A' ' 741' ' ' VAL . 98.8 t -60.45 112.1 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-N 116.142 -0.481 . . . . 75.530000000000001 111.172 176.295 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 114.49 -16.65 19.24 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 121.379 -0.438 . . . . 43.350000000000001 113.03 -175.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 681' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -73.96 -172.18 1.27 Allowed 'General case' 0 CA--C 1.546 0.809 0 CA-C-O 121.033 0.444 . . . . 70.239999999999995 111.723 178.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 682' ' ' SER . . . . . . . . . . . . . 25.4 m -129.07 155.12 45.95 Favored 'General case' 0 N--CA 1.478 0.94 0 O-C-N 122.211 -0.305 . . . . 62.530000000000001 111.007 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 683' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -159.2 120.35 3.28 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 120.821 0.343 . . . . 72.150000000000006 111.69 -179.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 684' ' ' VAL . . . . . . . . . . . . . 80.9 t -113.97 110.11 49.14 Favored Pre-proline 0 N--CA 1.471 0.588 0 CA-C-O 120.843 0.354 . . . . 62.299999999999997 111.544 177.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -58.09 -36.79 97.66 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 122.77 2.314 . . . . 71.409999999999997 113.665 -177.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 686' ' ' MET . . . . . 0.442 ' CE ' ' HA ' ' A' ' 686' ' ' MET . 1.0 OUTLIER -79.26 -11.78 59.95 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.424 0.527 . . . . 72.510000000000005 112.424 -177.374 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 687' ' ' ALA . . . . . . . . . . . . . . . -89.61 -32.68 16.99 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.215 0.531 . . . . 52.539999999999999 110.972 176.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 688' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -84.74 -17.54 38.0 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 116.137 -0.483 . . . . 72.310000000000002 111.683 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . 0.418 HG13 HG22 ' A' ' 671' ' ' VAL . 76.0 t -116.76 131.38 69.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 N-CA-C 112.695 0.628 . . . . 72.450000000000003 112.695 -175.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 690' ' ' LEU . . . . . 0.416 HD12 ' N ' ' A' ' 690' ' ' LEU . 5.2 mp -125.42 166.64 16.23 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 116.309 -0.405 . . . . 74.450000000000003 111.036 177.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 691' ' ' ALA . . . . . . . . . . . . . . . -148.97 122.7 9.25 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 120.905 0.384 . . . . 72.420000000000002 111.58 176.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 692' ' ' ILE . . . . . 0.548 HD13 ' HA ' ' A' ' 698' ' ' ASP . 37.2 mm -133.03 131.75 58.84 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 CA-C-N 116.475 -0.329 . . . . 55.340000000000003 111.481 -177.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 58.6 t0 -111.36 129.03 56.13 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 109.627 -0.508 . . . . 74.219999999999999 109.627 171.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -57.69 -28.05 63.47 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 112.619 0.6 . . . . 72.530000000000001 112.619 -173.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 695' ' ' GLU . . . . . 0.437 ' HG3' ' N ' ' A' ' 696' ' ' ASP . 12.6 pt-20 -82.91 -44.48 15.32 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 111.998 0.37 . . . . 54.020000000000003 111.998 -179.418 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 696' ' ' ASP . . . . . 0.437 ' N ' ' HG3' ' A' ' 695' ' ' GLU . 10.5 t70 -95.12 -48.86 5.77 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 121.181 0.515 . . . . 74.230000000000004 111.596 -170.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . 124.32 -137.46 10.68 Favored Glycine 0 CA--C 1.526 0.722 0 CA-C-N 116.179 -0.464 . . . . 55.420000000000002 112.352 -176.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 698' ' ' ASP . . . . . 0.548 ' HA ' HD13 ' A' ' 692' ' ' ILE . 18.0 t70 -70.92 118.21 13.4 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.339 0.59 . . . . 75.310000000000002 111.619 179.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 699' ' ' LEU . . . . . . . . . . . . . 80.3 mt -116.4 18.28 15.22 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 115.882 -0.599 . . . . 73.219999999999999 110.7 173.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 54.1 m -60.78 -27.56 68.09 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.114 0.483 . . . . 74.049999999999997 111.868 -178.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 701' ' ' SER . . . . . . . . . . . . . 25.3 t -78.55 -13.54 59.78 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.071 0.462 . . . . 72.439999999999998 111.513 178.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 702' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -90.03 7.64 36.59 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 116.42 -0.355 . . . . 74.540000000000006 111.436 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 703' ' ' ILE . . . . . 0.494 HG12 ' HB ' ' A' ' 723' ' ' VAL . 62.5 mt -85.39 138.41 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-O 121.336 0.589 . . . . 74.120000000000005 112.209 -177.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 704' ' ' LYS . . . . . . . . . . . . . 67.1 tttt -100.47 140.72 34.32 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.943 -0.571 . . . . 72.099999999999994 109.772 171.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 59.9 t -111.69 112.43 40.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-O 121.146 0.498 . . . . 74.099999999999994 111.807 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 706' ' ' ASP . . . . . 0.567 ' HB2' ' HB ' ' A' ' 720' ' ' THR . 9.2 m-20 -106.08 137.83 43.32 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 116.12 -0.491 . . . . 63.439999999999998 111.388 177.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 101.6 -177.93 27.23 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 121.35 -0.452 . . . . 71.209999999999994 113.509 177.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 708' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -161.79 145.94 12.67 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.959 0.409 . . . . 70.349999999999994 111.415 179.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 709' ' ' VAL . . . . . 0.508 HG22 ' HB2' ' A' ' 717' ' ' TYR . 96.5 t -117.56 120.12 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-N 116.283 -0.417 . . . . 53.399999999999999 110.882 177.016 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 710' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -77.66 135.92 38.15 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 120.912 0.387 . . . . 72.420000000000002 111.574 177.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 711' ' ' THR . . . . . . . . . . . . . 76.2 p -97.66 -1.35 43.83 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.911 0.386 . . . . 73.239999999999995 110.958 173.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 712' ' ' THR . . . . . . . . . . . . . 7.2 t -105.43 -13.47 15.63 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 116.219 -0.446 . . . . 63.329999999999998 111.952 178.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 713' ' ' LYS . . . . . . . . . . . . . 7.8 ttpm? -129.46 127.6 41.2 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.827 0.346 . . . . 62.439999999999998 111.662 -178.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 714' ' ' ALA . . . . . 0.462 ' HB2' HG23 ' A' ' 741' ' ' VAL . . . -72.0 144.89 48.67 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.199 -0.455 . . . . 75.239999999999995 111.735 177.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 152.76 171.87 20.62 Favored Glycine 0 CA--C 1.523 0.574 0 C-N-CA 121.027 -0.606 . . . . 63.329999999999998 113.029 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 716' ' ' THR . . . . . . . . . . . . . 56.3 m -100.3 122.23 42.76 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 122.36 -0.494 . . . . 72.400000000000006 111.327 179.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 717' ' ' TYR . . . . . 0.508 ' HB2' HG22 ' A' ' 709' ' ' VAL . 42.2 m-85 -118.92 134.94 54.84 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.139 -0.482 . . . . 73.140000000000001 110.582 -178.397 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 718' ' ' VAL . . . . . . . . . . . . . 49.5 t -101.27 113.97 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 CA-C-O 121.072 0.463 . . . . 72.530000000000001 111.58 -178.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 719' ' ' LEU . . . . . 0.467 HD21 HG23 ' A' ' 709' ' ' VAL . 92.3 mt -94.9 130.94 41.3 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.331 -0.395 . . . . 75.040000000000006 111.196 178.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . 0.567 ' HB ' ' HB2' ' A' ' 706' ' ' ASP . 25.0 m -113.29 132.71 55.44 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.753 0.311 . . . . 64.519999999999996 111.196 -178.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 721' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -124.58 140.69 52.71 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.664 0.269 . . . . 74.299999999999997 110.968 -179.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 56.8 m -140.61 123.5 16.39 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 120.513 0.197 . . . . 73.430000000000007 111.179 -179.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 723' ' ' VAL . . . . . 0.494 ' HB ' HG12 ' A' ' 703' ' ' ILE . 7.5 p -114.54 140.94 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 CA-C-O 121.056 0.455 . . . . 60.049999999999997 112.142 -176.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 27.3 m -102.44 144.93 30.27 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 116.136 -0.484 . . . . 63.310000000000002 111.798 -179.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 725' ' ' ASP . . . . . 0.414 ' HB2' ' HG3' ' A' ' 667' ' ' PRO . 5.7 t70 -103.63 150.77 23.67 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.323 0.649 . . . . 53.0 111.088 179.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 726' ' ' SER . . . . . . . . . . . . . 66.9 p -66.03 -14.65 62.04 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 112.522 0.564 . . . . 71.329999999999998 112.522 -175.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 727' ' ' LYS . . . . . 0.416 ' HB2' ' OD2' ' A' ' 664' ' ' ASP . 41.1 mmtm -105.36 -2.73 23.54 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 112.497 0.554 . . . . 63.009999999999998 112.497 -179.594 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 728' ' ' GLY . . . . . . . . . . . . . . . 112.21 12.42 13.77 Favored Glycine 0 CA--C 1.535 1.317 0 N-CA-C 115.384 0.914 . . . . 71.010000000000005 115.384 176.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 18.3 m80 -93.93 133.56 37.23 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 118.351 1.076 . . . . 74.040000000000006 111.241 173.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 730' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -134.24 112.54 11.15 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 122.075 -0.39 . . . . 72.340000000000003 111.263 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 34.1 m -112.47 160.44 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 N-CA-C 112.071 0.397 . . . . 73.420000000000002 112.071 -177.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 9.6 t -136.32 150.34 48.82 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 112.55 0.574 . . . . 75.319999999999993 112.55 -176.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -147.81 161.61 40.9 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.849 -0.614 . . . . 65.450000000000003 110.353 177.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 734' ' ' LYS . . . . . . . . . . . . . 33.2 mtmm -129.32 158.53 38.85 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 113.151 0.797 . . . . 63.439999999999998 113.151 -176.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 735' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -130.76 128.95 41.81 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 114.957 -1.019 . . . . 73.239999999999995 110.7 179.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 736' ' ' THR . . . . . . . . . . . . . 86.7 m -96.03 104.38 16.32 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.887 0.375 . . . . 74.209999999999994 111.205 178.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 737' ' ' VAL . . . . . 0.423 ' HA ' ' O ' ' A' ' 675' ' ' ALA . 46.7 t -97.69 140.84 17.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-O 120.821 0.343 . . . . 62.32 111.223 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 738' ' ' THR . . . . . . . . . . . . . 64.3 m -130.03 120.83 25.35 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 120.777 0.322 . . . . 55.109999999999999 111.147 179.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 739' ' ' VAL . . . . . . . . . . . . . 41.9 t -99.51 133.0 43.9 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-O 120.759 0.314 . . . . 73.409999999999997 111.355 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 740' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -121.97 151.84 40.34 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.39 -0.368 . . . . 75.150000000000006 111.571 -179.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 741' ' ' VAL . . . . . 0.462 HG23 ' HB2' ' A' ' 714' ' ' ALA . 25.1 t -100.47 121.35 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-O 120.771 0.32 . . . . 61.439999999999998 111.635 -179.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 742' ' ' ARG . . . . . 0.454 ' HG2' ' HG3' ' A' ' 743' ' ' GLU . 0.0 OUTLIER -89.09 -21.02 23.6 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.135 0.493 . . . . 63.32 110.539 176.665 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 743' ' ' GLU . . . . . 0.454 ' HG3' ' HG2' ' A' ' 742' ' ' ARG . 25.3 mt-10 -91.61 -174.09 3.76 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.927 -0.578 . . . . 74.129999999999995 111.406 -179.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 744' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -157.53 138.23 13.11 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.003 -0.544 . . . . 72.120000000000005 110.597 174.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 14.5 p -103.52 134.07 45.7 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 CA-C-O 121.008 0.432 . . . . 71.439999999999998 111.966 -174.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 746' ' ' LYS . . . . . 0.406 ' HG3' ' OD1' ' A' ' 747' ' ' ASN . 22.5 pttp -97.09 -36.42 10.49 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.033 0.444 . . . . 71.430000000000007 110.778 176.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 747' ' ' ASN . . . . . 0.406 ' OD1' ' HG3' ' A' ' 746' ' ' LYS . 15.5 m120 -113.37 108.71 17.6 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.166 -0.47 . . . . 54.329999999999998 110.123 174.288 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -53.26 102.3 0.05 Allowed 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 121.456 0.646 . . . . 75.129999999999995 111.947 -175.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 749' ' ' LYS . . . . . . . . . . . . . 53.1 mttp -57.81 143.87 75.59 Favored Pre-proline 0 CA--C 1.539 0.535 0 CA-C-N 115.891 -0.595 . . . . 74.349999999999994 111.491 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 750' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.6 93.61 0.68 Allowed 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 121.735 1.623 . . . . 75.400000000000006 110.54 168.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 751' ' ' ILE . . . . . . . . . . . . . 60.6 mt -65.56 88.37 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-O 121.392 0.615 . . . . 74.420000000000002 112.109 -173.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 752' ' ' LEU . . . . . . . . . . . . . 90.4 mt -83.22 99.04 9.71 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.889 -0.596 . . . . 74.409999999999997 110.83 176.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 753' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 . . . . . 0 C--O 1.239 0.515 0 CA-C-O 120.854 0.359 . . . . 71.150000000000006 111.433 -179.829 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 762' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 657' ' ' MET . . . . . 0.483 ' C ' ' SD ' ' A' ' 657' ' ' MET . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 120.953 0.406 . . . . 74.310000000000002 110.996 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 658' ' ' GLY . . . . . . . . . . . . . . . 111.54 -148.55 18.01 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 121.438 -0.41 . . . . 73.219999999999999 112.399 -177.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 659' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -149.31 165.89 30.62 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 122.457 -0.437 . . . . 73.310000000000002 111.025 177.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 660' ' ' GLY . . . . . . . . . . . . . . . 123.66 -73.59 0.4 Allowed Glycine 0 CA--C 1.522 0.497 0 C-N-CA 121.383 -0.437 . . . . 65.430000000000007 112.343 -178.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 50.8 mm-40 -76.8 129.61 36.51 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 122.593 -0.357 . . . . 73.420000000000002 110.765 176.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 662' ' ' THR . . . . . . . . . . . . . 94.1 m 61.27 88.15 0.09 Allowed 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 121.444 0.64 . . . . 64.329999999999998 111.186 -173.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 663' ' ' SER . . . . . . . . . . . . . 67.8 m -113.23 124.63 52.98 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 116.111 -0.495 . . . . 74.530000000000001 111.213 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 664' ' ' ASP . . . . . 0.444 ' OD2' ' HB2' ' A' ' 727' ' ' LYS . 18.7 t0 -93.31 124.49 37.33 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 121.255 0.55 . . . . 64.200000000000003 111.729 -179.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 665' ' ' LEU . . . . . . . . . . . . . 73.0 mt -91.08 133.47 35.31 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 115.866 -0.606 . . . . 71.049999999999997 109.814 173.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 666' ' ' GLU . . . . . 0.447 ' H ' ' CD ' ' A' ' 666' ' ' GLU . 1.5 pm0 -64.7 144.96 98.86 Favored Pre-proline 0 CA--C 1.539 0.545 0 CA-C-N 116.218 -0.446 . . . . 45.240000000000002 111.47 -179.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 667' ' ' PRO . . . . . 0.531 ' HD3' ' HB2' ' A' ' 725' ' ' ASP . 25.8 Cg_endo -60.91 145.12 99.51 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 122.785 2.323 . . . . 64.019999999999996 113.149 -174.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 668' ' ' LYS . . . . . . . . . . . . . 9.2 tmtm? -82.58 99.12 9.35 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.33 0.586 . . . . 61.420000000000002 110.384 179.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 669' ' ' LEU . . . . . . . . . . . . . 62.8 tp -89.8 109.27 20.27 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.726 -0.67 . . . . 64.5 110.736 179.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 670' ' ' THR . . . . . . . . . . . . . 60.7 m -87.08 110.42 20.09 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.827 0.346 . . . . 64.0 111.492 -178.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 671' ' ' VAL . . . . . 0.49 HG21 ' HB3' ' A' ' 733' ' ' ALA . 67.3 t -132.89 124.82 18.88 Favored Pre-proline 0 CA--C 1.542 0.668 0 CA-C-N 116.263 -0.426 . . . . 72.140000000000001 110.831 176.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 672' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.75 154.06 43.55 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.358 2.039 . . . . 71.439999999999998 112.537 178.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 673' ' ' VAL . . . . . . . . . . . . . 12.9 p -63.6 -32.25 56.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 N-CA-C 112.062 0.393 . . . . 61.450000000000003 112.062 -176.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 674' ' ' GLY . . . . . . . . . . . . . . . -170.4 173.14 44.3 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 120.685 -0.769 . . . . 73.299999999999997 114.204 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 675' ' ' ALA . . . . . . . . . . . . . . . -152.95 122.95 6.98 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.876 0.37 . . . . 74.209999999999994 111.308 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 676' ' ' THR . . . . . . . . . . . . . 82.7 m -102.29 124.93 48.74 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 112.158 0.429 . . . . 74.230000000000004 112.158 -177.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 677' ' ' ILE . . . . . 0.404 HD13 ' HB2' ' A' ' 683' ' ' PHE . 29.3 pt -126.4 177.0 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 CA-C-N 116.38 -0.373 . . . . 62.420000000000002 111.1 176.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 678' ' ' HIS . . . . . 0.443 ' CD2' ' HG3' ' A' ' 740' ' ' LYS . 68.6 m80 -117.02 156.16 27.97 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.732 0.641 . . . . 73.040000000000006 112.732 -178.085 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 679' ' ' VAL . . . . . 0.526 HG13 ' HA ' ' A' ' 712' ' ' THR . 85.0 t -61.53 121.27 9.32 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-N 115.536 -0.756 . . . . 73.349999999999994 111.375 175.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 110.94 -23.65 18.68 Favored Glycine 0 CA--C 1.526 0.751 0 CA-C-N 116.132 -0.485 . . . . 65.120000000000005 112.185 -177.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 681' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -83.38 -162.8 0.66 Allowed 'General case' 0 CA--C 1.543 0.707 0 CA-C-O 120.984 0.421 . . . . 70.230000000000004 111.687 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 682' ' ' SER . . . . . . . . . . . . . 74.0 m -141.47 173.97 11.0 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 122.156 -0.34 . . . . 74.120000000000005 111.703 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 683' ' ' PHE . . . . . 0.404 ' HB2' HD13 ' A' ' 677' ' ' ILE . 76.2 t80 -150.9 140.4 21.52 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.855 0.36 . . . . 65.329999999999998 111.759 -177.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 684' ' ' VAL . . . . . . . . . . . . . 99.0 t -118.12 105.78 46.36 Favored Pre-proline 0 CA--C 1.545 0.784 0 CA-C-O 120.728 0.299 . . . . 73.530000000000001 111.605 178.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.93 -38.43 78.96 Favored 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 122.745 2.297 . . . . 73.319999999999993 113.505 -178.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 686' ' ' MET . . . . . 0.563 ' HE1' ' HB ' ' A' ' 703' ' ' ILE . 0.3 OUTLIER -78.79 -9.46 59.45 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.759 0.651 . . . . 73.329999999999998 112.759 -175.977 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 687' ' ' ALA . . . . . . . . . . . . . . . -79.96 -44.9 19.46 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 120.9 0.381 . . . . 74.340000000000003 111.923 -179.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 688' ' ' GLU . . . . . . . . . . . . . 45.7 mm-40 -86.6 -8.22 57.68 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 113.0 0.741 . . . . 64.019999999999996 113.0 -174.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . 0.556 HG12 HD13 ' A' ' 703' ' ' ILE . 87.6 t -118.58 124.71 73.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-O 120.938 0.399 . . . . 72.430000000000007 111.956 -177.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 690' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -125.41 162.93 23.72 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 116.266 -0.425 . . . . 75.140000000000001 111.062 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 691' ' ' ALA . . . . . . . . . . . . . . . -142.69 121.71 12.86 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.057 0.456 . . . . 74.329999999999998 111.63 176.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 692' ' ' ILE . . . . . . . . . . . . . 45.6 mm -128.69 124.46 61.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-N 116.395 -0.366 . . . . 64.150000000000006 111.55 -178.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 693' ' ' ASP . . . . . 0.488 ' HB2' ' HB3' ' A' ' 667' ' ' PRO . 36.2 t70 -108.35 149.87 28.11 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 120.916 0.389 . . . . 61.43 110.883 173.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 8.3 mtpm? -65.84 -56.68 10.62 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 116.319 -0.401 . . . . 73.420000000000002 111.999 -176.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 695' ' ' GLU . . . . . 0.418 ' CD ' ' H ' ' A' ' 695' ' ' GLU . 0.6 OUTLIER -84.44 -51.76 6.68 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 112.149 0.426 . . . . 75.230000000000004 112.149 -174.856 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 696' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -72.23 -28.68 63.32 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-O 120.933 0.397 . . . . 64.150000000000006 111.397 -173.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . 103.73 -147.09 16.56 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 121.477 -0.392 . . . . 73.510000000000005 113.066 178.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -69.56 131.62 44.97 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 120.982 0.42 . . . . 75.420000000000002 110.995 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 699' ' ' LEU . . . . . 0.428 HD12 ' HB3' ' A' ' 667' ' ' PRO . 98.0 mt -125.45 15.76 8.25 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 120.973 0.416 . . . . 62.229999999999997 111.164 178.093 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 34.9 m -58.75 -38.34 78.21 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 121.064 0.459 . . . . 75.239999999999995 111.455 -178.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 701' ' ' SER . . . . . . . . . . . . . 33.7 m -61.44 -21.95 64.6 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 116.2 -0.454 . . . . 62.039999999999999 111.814 178.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 702' ' ' LYS . . . . . . . . . . . . . 64.0 mttm -91.31 1.28 57.22 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 112.607 0.595 . . . . 70.329999999999998 112.607 -178.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 703' ' ' ILE . . . . . 0.563 ' HB ' ' HE1' ' A' ' 686' ' ' MET . 74.5 mt -69.46 111.91 3.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-O 121.238 0.542 . . . . 72.329999999999998 111.559 -178.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 704' ' ' LYS . . . . . . . . . . . . . 24.3 tptm -85.02 118.91 24.87 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 115.549 -0.751 . . . . 70.420000000000002 110.508 178.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 51.7 t -96.42 138.25 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 CA-C-O 120.963 0.411 . . . . 64.040000000000006 111.823 -177.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 706' ' ' ASP . . . . . 0.584 ' HB3' ' HB ' ' A' ' 720' ' ' THR . 24.1 t70 -132.08 140.8 48.97 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 116.291 -0.413 . . . . 71.519999999999996 111.014 177.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 107.23 -176.79 21.27 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 121.331 -0.461 . . . . 73.109999999999999 113.067 -179.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 708' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -163.49 137.1 5.7 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.182 0.515 . . . . 72.510000000000005 111.734 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 709' ' ' VAL . . . . . 0.548 HG22 ' HB2' ' A' ' 717' ' ' TYR . 46.8 t -112.02 146.18 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-N 116.1 -0.5 . . . . 64.129999999999995 111.309 -178.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 710' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -83.81 156.79 22.32 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 121.396 0.617 . . . . 73.420000000000002 111.832 175.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 711' ' ' THR . . . . . 0.423 ' O ' ' HA ' ' A' ' 679' ' ' VAL . 47.2 p -117.75 -22.84 7.81 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.578 -0.737 . . . . 73.430000000000007 110.796 172.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 712' ' ' THR . . . . . 0.526 ' HA ' HG13 ' A' ' 679' ' ' VAL . 70.2 p -108.11 13.14 26.2 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 111.923 0.342 . . . . 63.43 111.923 178.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 713' ' ' LYS . . . . . . . . . . . . . 3.8 ttmp? -140.08 131.71 27.22 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.664 0.268 . . . . 74.040000000000006 111.132 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 714' ' ' ALA . . . . . . . . . . . . . . . -77.66 143.44 38.16 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 120.81 0.338 . . . . 63.329999999999998 111.284 177.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 155.47 -174.94 33.51 Favored Glycine 0 CA--C 1.525 0.657 0 C-N-CA 121.316 -0.469 . . . . 53.32 112.843 -178.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 716' ' ' THR . . . . . . . . . . . . . 38.7 m -123.55 123.02 39.68 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 117.097 0.449 . . . . 73.030000000000001 111.589 -178.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 717' ' ' TYR . . . . . 0.548 ' HB2' HG22 ' A' ' 709' ' ' VAL . 61.4 m-85 -128.03 128.95 45.91 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.185 -0.461 . . . . 55.240000000000002 110.778 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 718' ' ' VAL . . . . . . . . . . . . . 61.6 t -97.78 118.67 44.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-O 121.172 0.511 . . . . 65.140000000000001 111.942 -176.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 719' ' ' LEU . . . . . 0.407 HD21 HG23 ' A' ' 709' ' ' VAL . 91.0 mt -93.07 133.64 36.03 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.31 -0.404 . . . . 75.049999999999997 111.076 178.139 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . 0.584 ' HB ' ' HB3' ' A' ' 706' ' ' ASP . 17.0 m -100.96 144.75 29.53 Favored 'General case' 0 N--CA 1.473 0.714 0 O-C-N 122.214 -0.304 . . . . 73.120000000000005 111.101 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 721' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -134.86 113.85 11.98 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 122.449 0.3 . . . . 72.549999999999997 111.0 -178.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 60.4 m -114.23 137.92 51.15 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 111.7 0.259 . . . . 72.140000000000001 111.7 -179.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 8.2 p -138.13 136.17 44.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 CA-C-O 121.011 0.434 . . . . 71.140000000000001 111.446 177.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 42.4 m -113.13 129.58 56.46 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 120.864 0.364 . . . . 72.430000000000007 111.728 -178.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 725' ' ' ASP . . . . . 0.531 ' HB2' ' HD3' ' A' ' 667' ' ' PRO . 17.6 t0 -73.84 150.03 41.24 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-N 116.225 -0.443 . . . . 73.150000000000006 110.081 174.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 726' ' ' SER . . . . . . . . . . . . . 48.8 m -69.01 -27.24 65.5 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.692 0.282 . . . . 64.310000000000002 111.645 -178.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 727' ' ' LYS . . . . . 0.444 ' HB2' ' OD2' ' A' ' 664' ' ' ASP . 1.3 mptp? -89.19 5.22 45.73 Favored 'General case' 0 CA--C 1.546 0.827 0 N-CA-C 112.258 0.466 . . . . 71.150000000000006 112.258 -177.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 728' ' ' GLY . . . . . . . . . . . . . . . 113.31 -2.99 25.19 Favored Glycine 0 CA--C 1.537 1.409 0 N-CA-C 116.463 1.345 . . . . 54.520000000000003 116.463 169.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 63.0 m80 -94.72 119.54 33.51 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 118.941 1.37 . . . . 72.129999999999995 112.05 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 730' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -112.65 138.91 48.76 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 122.038 -0.414 . . . . 72.239999999999995 111.775 -178.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 29.4 m -138.54 152.36 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-O 120.786 0.327 . . . . 54.219999999999999 111.39 178.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 9.0 t -140.3 154.08 46.68 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.038 0.447 . . . . 45.030000000000001 111.653 179.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 733' ' ' ALA . . . . . 0.49 ' HB3' HG21 ' A' ' 671' ' ' VAL . . . -148.86 162.15 40.42 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 116.25 -0.432 . . . . 73.140000000000001 111.342 -179.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 734' ' ' LYS . . . . . . . . . . . . . 10.7 mtmp? -125.96 154.44 42.85 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 112.446 0.536 . . . . 73.219999999999999 112.446 -179.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 735' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -129.7 124.54 33.82 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.858 -0.61 . . . . 65.400000000000006 110.585 178.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 736' ' ' THR . . . . . . . . . . . . . 88.1 m -90.91 103.9 16.56 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.841 0.353 . . . . 74.430000000000007 111.633 -177.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 50.3 t -96.55 131.76 42.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 O-C-N 122.124 -0.36 . . . . 74.510000000000005 111.299 -178.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 738' ' ' THR . . . . . . . . . . . . . 88.5 m -122.68 122.75 39.51 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.028 0.442 . . . . 73.239999999999995 111.651 -178.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 739' ' ' VAL . . . . . . . . . . . . . 21.5 t -100.85 131.51 48.33 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 116.143 -0.48 . . . . 70.430000000000007 110.812 178.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 740' ' ' LYS . . . . . 0.443 ' HG3' ' CD2' ' A' ' 678' ' ' HIS . 16.9 ptpt -124.32 160.38 28.2 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.233 0.539 . . . . 74.230000000000004 111.705 177.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 741' ' ' VAL . . . . . 0.462 HG22 HG21 ' A' ' 679' ' ' VAL . 37.8 t -93.46 124.5 45.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 N-CA-C 112.507 0.558 . . . . 45.299999999999997 112.507 -172.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 742' ' ' ARG . . . . . . . . . . . . . 11.5 ptt85 -94.3 -48.42 6.18 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 120.994 0.426 . . . . 73.439999999999998 110.935 172.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 743' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -104.73 117.49 34.2 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.328 -0.396 . . . . 63.130000000000003 110.64 176.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 744' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -63.26 156.99 23.86 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 112.514 0.561 . . . . 55.399999999999999 112.514 -175.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 25.5 m -62.44 141.03 18.45 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-N 115.87 -0.605 . . . . 75.430000000000007 112.307 178.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -82.55 -177.64 6.77 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 121.31 0.576 . . . . 71.109999999999999 112.412 -173.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 747' ' ' ASN . . . . . 0.476 ' ND2' ' HG2' ' A' ' 749' ' ' LYS . 59.5 t30 -161.67 151.7 16.99 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 115.812 -0.631 . . . . 62.240000000000002 110.391 176.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -77.96 10.33 2.94 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 113.153 0.797 . . . . 75.420000000000002 113.153 -172.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 749' ' ' LYS . . . . . 0.476 ' HG2' ' ND2' ' A' ' 747' ' ' ASN . 19.8 ptmt -98.91 163.14 19.37 Favored Pre-proline 0 CA--C 1.542 0.652 0 O-C-N 122.307 -0.246 . . . . 74.230000000000004 110.637 175.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 750' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -65.37 97.78 0.31 Allowed 'Trans proline' 0 CA--C 1.543 0.972 0 C-N-CA 121.703 1.602 . . . . 74.430000000000007 111.347 170.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 751' ' ' ILE . . . . . . . . . . . . . 38.8 pt -90.1 173.95 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-O 121.21 0.528 . . . . 75.129999999999995 112.397 -175.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 752' ' ' LEU . . . . . . . . . . . . . 35.1 tp -102.1 127.01 49.19 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 116.122 -0.49 . . . . 74.340000000000003 111.033 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 753' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 . . . . . 0 C--O 1.24 0.567 0 CA-C-O 121.042 0.448 . . . . 70.430000000000007 111.879 -177.143 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 762' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 657' ' ' MET . . . . . . . . . . . . . 64.6 mtt . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 120.674 0.273 . . . . 72.400000000000006 111.348 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 658' ' ' GLY . . . . . . . . . . . . . . . 92.7 100.25 1.43 Allowed Glycine 0 CA--C 1.529 0.919 0 C-N-CA 121.051 -0.595 . . . . 61.210000000000001 113.734 175.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 659' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -94.63 -177.05 4.09 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 122.581 -0.364 . . . . 65.349999999999994 111.278 175.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 660' ' ' GLY . . . . . . . . . . . . . . . -147.36 160.09 28.19 Favored Glycine 0 CA--C 1.524 0.61 0 C-N-CA 120.7 -0.762 . . . . 70.129999999999995 113.292 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 661' ' ' GLU . . . . . 0.407 ' OE2' ' HE3' ' A' ' 727' ' ' LYS . 7.8 mm-40 -81.16 90.34 6.05 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.155 0.502 . . . . 70.219999999999999 110.868 -179.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 662' ' ' THR . . . . . . . . . . . . . 80.8 p -78.4 -173.52 3.35 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 116.019 -0.537 . . . . 72.510000000000005 112.082 -178.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 663' ' ' SER . . . . . . . . . . . . . 49.1 m -63.92 104.51 0.71 Allowed 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.078 0.466 . . . . 53.43 111.094 177.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 664' ' ' ASP . . . . . 0.448 ' HB3' ' HE1' ' A' ' 729' ' ' HIS . 12.8 t70 -86.02 126.75 34.38 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 116.061 -0.518 . . . . 72.340000000000003 111.89 -174.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 665' ' ' LEU . . . . . . . . . . . . . 80.7 mt -88.03 117.41 26.89 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 116.337 -0.392 . . . . 55.100000000000001 110.122 173.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 666' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -54.31 149.07 21.01 Favored Pre-proline 0 CA--C 1.54 0.559 0 CA-C-O 120.796 0.331 . . . . 64.129999999999995 111.444 178.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 667' ' ' PRO . . . . . 0.436 ' HA ' ' HA ' ' A' ' 693' ' ' ASP . 38.2 Cg_exo -57.77 140.48 93.77 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 122.422 2.081 . . . . 72.230000000000004 112.95 -173.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 668' ' ' LYS . . . . . 0.718 ' HA ' ' HE2' ' A' ' 668' ' ' LYS . 0.6 OUTLIER -82.88 102.96 12.0 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 120.932 0.396 . . . . 73.430000000000007 110.363 175.403 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 669' ' ' LEU . . . . . 0.502 ' HG ' HG23 ' A' ' 671' ' ' VAL . 61.9 tp -90.01 118.61 29.69 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.195 -0.457 . . . . 75.109999999999999 111.354 -179.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 670' ' ' THR . . . . . . . . . . . . . 89.3 m -93.85 109.85 21.53 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.732 0.301 . . . . 73.540000000000006 110.986 177.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 671' ' ' VAL . . . . . 0.502 HG23 ' HG ' ' A' ' 669' ' ' LEU . 95.7 t -139.74 122.19 10.13 Favored Pre-proline 0 CA--C 1.538 0.51 0 CA-C-N 116.151 -0.477 . . . . 72.230000000000004 110.583 177.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 672' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -76.37 151.88 33.96 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 122.119 1.879 . . . . 75.340000000000003 112.177 177.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 673' ' ' VAL . . . . . . . . . . . . . 8.0 p -64.27 -31.89 55.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 N-CA-C 112.325 0.491 . . . . 74.310000000000002 112.325 -175.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 674' ' ' GLY . . . . . . . . . . . . . . . -160.51 166.72 35.47 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 120.469 -0.872 . . . . 30.239999999999998 114.3 -177.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 675' ' ' ALA . . . . . . . . . . . . . . . -142.77 151.06 40.83 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.312 0.645 . . . . 71.129999999999995 109.849 177.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 676' ' ' THR . . . . . . . . . . . . . 91.5 m -137.93 119.23 14.66 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.105 0.479 . . . . 72.329999999999998 111.883 -177.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 677' ' ' ILE . . . . . . . . . . . . . 33.5 pt -130.75 176.48 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-N 116.032 -0.531 . . . . 75.150000000000006 111.097 -179.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 678' ' ' HIS . . . . . 0.524 ' HA ' ' O ' ' A' ' 740' ' ' LYS . 65.3 m80 -110.78 156.7 20.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.279 0.561 . . . . 75.230000000000004 111.815 177.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 679' ' ' VAL . . . . . 0.551 HG13 ' HA ' ' A' ' 712' ' ' THR . 85.2 t -58.31 126.16 15.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-N 115.899 -0.591 . . . . 55.420000000000002 110.98 174.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 94.82 4.6 61.69 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 121.153 -0.546 . . . . 40.140000000000001 113.568 -179.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 681' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -97.7 165.35 12.0 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.366 0.603 . . . . 62.420000000000002 112.152 178.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 682' ' ' SER . . . . . . . . . . . . . 46.5 m -93.9 137.14 33.45 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.887 -0.597 . . . . 65.420000000000002 111.739 -179.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 683' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -135.09 128.7 32.71 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 120.928 0.394 . . . . 72.219999999999999 111.531 -179.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 684' ' ' VAL . . . . . . . . . . . . . 48.9 t -125.07 97.99 36.9 Favored Pre-proline 0 CA--C 1.542 0.656 0 CA-C-O 120.856 0.36 . . . . 63.240000000000002 111.444 177.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -63.7 -34.19 63.44 Favored 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 122.491 2.127 . . . . 64.040000000000006 113.571 -178.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 686' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -79.34 -6.32 56.49 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.782 0.66 . . . . 62.409999999999997 112.782 -176.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 687' ' ' ALA . . . . . . . . . . . . . . . -92.37 -38.19 12.16 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.869 0.366 . . . . 74.439999999999998 111.924 179.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 688' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -98.69 13.08 33.42 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 112.384 0.513 . . . . 75.230000000000004 112.384 -176.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . 0.417 HG13 HG22 ' A' ' 671' ' ' VAL . 85.2 t -125.04 140.04 49.33 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-N 116.301 -0.409 . . . . 71.019999999999996 110.086 173.252 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 690' ' ' LEU . . . . . 0.55 HD21 HG12 ' A' ' 692' ' ' ILE . 9.2 tt -145.17 153.85 41.8 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 111.574 0.213 . . . . 62.130000000000003 111.574 -172.152 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 691' ' ' ALA . . . . . . . . . . . . . . . -147.4 125.12 11.83 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 112.049 0.389 . . . . 61.32 112.049 179.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 692' ' ' ILE . . . . . 0.55 HG12 HD21 ' A' ' 690' ' ' LEU . 47.5 mm -127.93 119.05 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 N-CA-C 112.032 0.382 . . . . 65.430000000000007 112.032 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 693' ' ' ASP . . . . . 0.436 ' HA ' ' HA ' ' A' ' 667' ' ' PRO . 14.6 t70 -94.81 147.7 23.07 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 109.789 -0.449 . . . . 70.299999999999997 109.789 171.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 64.9 tttm -58.31 -61.91 2.23 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.373 0.508 . . . . 75.040000000000006 112.373 -174.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -88.5 -39.77 13.94 Favored 'General case' 0 N--CA 1.479 1.002 0 O-C-N 121.846 -0.534 . . . . 64.409999999999997 112.242 -176.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 696' ' ' ASP . . . . . . . . . . . . . 34.3 t0 -70.99 -23.52 62.21 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.257 0.551 . . . . 61.109999999999999 110.826 -176.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . 90.3 -147.32 19.1 Favored Glycine 0 CA--C 1.525 0.665 0 CA-C-N 116.043 -0.526 . . . . 53.119999999999997 113.87 173.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 698' ' ' ASP . . . . . 0.454 ' HA ' HD13 ' A' ' 692' ' ' ILE . 14.4 t70 -67.9 123.03 19.46 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.058 0.456 . . . . 73.409999999999997 111.189 -179.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 699' ' ' LEU . . . . . . . . . . . . . 80.8 mt -122.25 24.95 9.2 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.993 -0.549 . . . . 74.549999999999997 110.782 178.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 88.4 m -61.96 -40.32 95.17 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.044 0.45 . . . . 75.010000000000005 112.032 -177.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 701' ' ' SER . . . . . . . . . . . . . 15.6 t -79.86 -3.69 49.01 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 121.048 0.451 . . . . 75.510000000000005 111.246 179.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 702' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -84.9 -11.43 55.6 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 120.988 0.423 . . . . 73.5 110.822 175.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 74.6 mt -68.57 117.71 11.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-O 121.588 0.709 . . . . 72.510000000000005 112.82 -173.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 704' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -83.67 121.58 27.46 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.397 -0.819 . . . . 64.530000000000001 110.627 174.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 41.7 t -99.61 116.38 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-O 120.82 0.343 . . . . 72.430000000000007 111.077 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 706' ' ' ASP . . . . . 0.55 ' HB3' ' HB ' ' A' ' 720' ' ' THR . 32.9 t70 -109.96 123.21 49.24 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 120.74 0.305 . . . . 70.25 110.993 179.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 130.11 173.92 13.54 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 121.397 -0.43 . . . . 53.140000000000001 113.07 -178.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 708' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -135.27 142.23 45.86 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 122.447 -0.443 . . . . 74.450000000000003 111.518 -178.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 709' ' ' VAL . . . . . 0.49 HG23 HD21 ' A' ' 719' ' ' LEU . 98.9 t -126.32 128.25 71.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-O 120.872 0.367 . . . . 74.329999999999998 111.424 -179.094 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 710' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -109.38 137.4 47.3 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 116.73 -0.214 . . . . 60.409999999999997 110.552 177.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 711' ' ' THR . . . . . . . . . . . . . 67.3 p -111.7 4.21 18.37 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 112.85 0.685 . . . . 73.129999999999995 112.85 -175.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 712' ' ' THR . . . . . 0.551 ' HA ' HG13 ' A' ' 679' ' ' VAL . 12.9 t -111.99 -10.47 13.94 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 112.163 0.431 . . . . 74.420000000000002 112.163 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 713' ' ' LYS . . . . . 0.431 ' HD3' ' N ' ' A' ' 714' ' ' ALA . 8.8 tmtt? -128.8 129.91 46.28 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 109.861 -0.422 . . . . 73.099999999999994 109.861 176.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 714' ' ' ALA . . . . . 0.431 ' N ' ' HD3' ' A' ' 713' ' ' LYS . . . -69.81 127.6 33.48 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 112.426 0.528 . . . . 74.049999999999997 112.426 -176.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 177.8 174.33 44.03 Favored Glycine 0 CA--C 1.524 0.6 0 CA-C-N 116.098 -0.501 . . . . 64.140000000000001 112.772 -179.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 716' ' ' THR . . . . . . . . . . . . . 38.6 m -100.01 121.9 42.08 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 122.532 -0.393 . . . . 63.310000000000002 111.056 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 717' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -122.39 109.58 14.58 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 120.646 0.26 . . . . 60.329999999999998 110.783 -177.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 718' ' ' VAL . . . . . 0.412 ' HA ' ' HA ' ' A' ' 736' ' ' THR . 42.6 t -93.79 126.96 46.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-O 120.941 0.4 . . . . 71.239999999999995 111.845 -175.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 719' ' ' LEU . . . . . 0.49 HD21 HG23 ' A' ' 709' ' ' VAL . 97.2 mt -105.32 153.01 22.2 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.955 0.407 . . . . 71.310000000000002 111.277 177.095 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . 0.55 ' HB ' ' HB3' ' A' ' 706' ' ' ASP . 28.8 m -120.82 129.74 53.68 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.487 -0.324 . . . . 63.340000000000003 110.809 177.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 721' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -115.18 119.79 37.58 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 120.824 0.345 . . . . 75.230000000000004 111.371 -178.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 87.0 m -124.05 140.41 53.0 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 116.54 -0.3 . . . . 70.040000000000006 111.209 -179.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 10.4 p -141.01 143.47 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 CA-C-O 120.866 0.365 . . . . 63.409999999999997 111.924 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 724' ' ' THR . . . . . 0.45 ' HA ' ' O ' ' A' ' 729' ' ' HIS . 23.7 m -123.01 142.2 51.11 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 116.392 -0.367 . . . . 61.119999999999997 111.603 -179.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -100.51 178.61 4.68 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.251 0.548 . . . . 74.239999999999995 112.316 -177.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 726' ' ' SER . . . . . . . . . . . . . 38.0 t -54.51 -31.92 57.03 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 113.323 0.86 . . . . 75.200000000000003 113.323 -179.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 727' ' ' LYS . . . . . 0.407 ' HE3' ' OE2' ' A' ' 661' ' ' GLU . 44.8 mmtm -86.63 -14.76 41.75 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 121.877 -0.514 . . . . 74.319999999999993 111.913 -179.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 728' ' ' GLY . . . . . . . . . . . . . . . 103.23 13.43 28.78 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 121.023 -0.608 . . . . 63.420000000000002 113.792 -178.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 729' ' ' HIS . . . . . 0.45 ' O ' ' HA ' ' A' ' 724' ' ' THR . 58.7 m80 -72.01 123.93 23.85 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 117.283 0.541 . . . . 72.109999999999999 110.54 174.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 730' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -122.25 108.47 13.32 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.137 0.494 . . . . 72.519999999999996 112.179 -174.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 34.9 m -107.72 155.67 8.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-N 116.036 -0.529 . . . . 65.109999999999999 110.737 176.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 5.4 t -152.51 136.86 16.67 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 112.819 0.674 . . . . 75.040000000000006 112.819 -175.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -141.87 146.87 36.28 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.09 -0.505 . . . . 75.120000000000005 111.214 -179.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 734' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -105.09 158.29 16.67 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.213 0.53 . . . . 74.310000000000002 112.188 -176.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 735' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -141.85 118.0 10.69 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.687 -0.688 . . . . 75.230000000000004 110.665 175.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 736' ' ' THR . . . . . 0.412 ' HA ' ' HA ' ' A' ' 718' ' ' VAL . 6.5 t -84.37 111.94 19.89 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.227 0.536 . . . . 53.450000000000003 111.73 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 43.5 t -96.63 103.84 15.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-O 121.282 0.563 . . . . 53.43 111.382 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 738' ' ' THR . . . . . . . . . . . . . 30.8 m -93.61 113.45 25.56 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.984 0.421 . . . . 74.209999999999994 111.344 -177.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 739' ' ' VAL . . . . . . . . . . . . . 45.8 t -96.41 116.4 38.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-N 116.297 -0.411 . . . . 72.120000000000005 111.037 178.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 740' ' ' LYS . . . . . 0.524 ' O ' ' HA ' ' A' ' 678' ' ' HIS . 11.7 ptmm? -111.59 159.11 18.47 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.027 0.442 . . . . 74.319999999999993 111.144 178.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 741' ' ' VAL . . . . . . . . . . . . . 38.3 t -70.72 154.69 7.91 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-O 120.798 0.333 . . . . 62.100000000000001 111.829 -175.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 742' ' ' ARG . . . . . . . . . . . . . 14.9 ptp180 -96.28 137.97 34.57 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 120.847 0.356 . . . . 74.430000000000007 110.423 174.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 743' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -83.1 92.38 7.4 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 120.767 0.318 . . . . 75.140000000000001 111.164 -177.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 744' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -131.58 172.94 11.64 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 112.44 0.533 . . . . 63.450000000000003 112.44 -177.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 31.1 m -134.17 29.31 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-N 115.817 -0.629 . . . . 74.420000000000002 110.747 178.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -81.1 19.86 0.86 Allowed 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 112.397 0.517 . . . . 51.200000000000003 112.397 -173.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 747' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -76.09 84.93 2.95 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.104 0.478 . . . . 61.229999999999997 110.904 179.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 -80.66 63.65 5.16 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 121.28 0.562 . . . . 74.230000000000004 112.088 -176.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 749' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm 48.53 66.46 5.68 Favored Pre-proline 0 CA--C 1.545 0.768 0 N-CA-C 113.116 0.784 . . . . 73.450000000000003 113.116 178.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 750' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -71.31 111.29 3.05 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 122.476 2.117 . . . . 65.239999999999995 111.804 175.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 751' ' ' ILE . . . . . . . . . . . . . 2.4 pp -92.35 13.26 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 N-CA-C 112.238 0.459 . . . . 61.549999999999997 112.238 -178.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 752' ' ' LEU . . . . . 0.488 HD13 ' N ' ' A' ' 753' ' ' GLU . 2.6 tm? -53.49 133.94 40.73 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-O 120.904 0.383 . . . . 73.340000000000003 110.749 176.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 753' ' ' GLU . . . . . 0.488 ' N ' HD13 ' A' ' 752' ' ' LEU . 42.3 mt-10 . . . . . 0 C--O 1.238 0.47 0 CA-C-O 120.768 0.318 . . . . 71.420000000000002 111.515 -177.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 762' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 657' ' ' MET . . . . . . . . . . . . . 22.0 ptt? . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 120.741 0.305 . . . . 73.420000000000002 111.111 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 658' ' ' GLY . . . . . . . . . . . . . . . 70.48 61.97 3.9 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 121.079 -0.581 . . . . 53.439999999999998 112.155 -175.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 659' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -60.02 106.51 0.51 Allowed 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 112.403 0.52 . . . . 70.329999999999998 112.403 -178.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 660' ' ' GLY . . . . . . . . . . . . . . . -96.44 62.23 1.2 Allowed Glycine 0 CA--C 1.525 0.689 0 N-CA-C 111.386 -0.686 . . . . 61.310000000000002 111.386 173.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -101.8 138.27 38.99 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 112.439 0.533 . . . . 63.119999999999997 112.439 -173.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 662' ' ' THR . . . . . . . . . . . . . 31.0 m -92.86 152.85 19.18 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 115.976 -0.556 . . . . 75.019999999999996 111.205 178.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 663' ' ' SER . . . . . . . . . . . . . 28.8 t -93.32 143.64 26.08 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 122.348 -0.22 . . . . 70.439999999999998 110.838 176.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 664' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -88.78 154.32 20.37 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 121.633 0.73 . . . . 72.439999999999998 112.356 -178.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 665' ' ' LEU . . . . . . . . . . . . . 44.8 mt -113.64 138.02 50.79 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.086 -0.961 . . . . 71.400000000000006 110.59 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 666' ' ' GLU . . . . . 0.484 ' H ' ' CD ' ' A' ' 666' ' ' GLU . 1.6 pm0 -54.01 139.23 54.15 Favored Pre-proline 0 CA--C 1.545 0.752 0 CA-C-O 120.762 0.315 . . . . 51.119999999999997 111.309 176.302 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 667' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -68.95 160.27 50.54 Favored 'Trans proline' 0 CA--C 1.545 1.045 0 C-N-CA 122.963 2.442 . . . . 64.099999999999994 115.124 -166.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 668' ' ' LYS . . . . . 0.442 ' HA ' ' HE3' ' A' ' 668' ' ' LYS . 0.2 OUTLIER -83.22 102.23 11.77 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 114.948 -1.024 . . . . 70.099999999999994 111.022 177.896 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 669' ' ' LEU . . . . . . . . . . . . . 57.9 tp -103.49 114.64 29.08 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 120.783 0.325 . . . . 63.299999999999997 111.096 176.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 670' ' ' THR . . . . . . . . . . . . . 99.4 m -101.67 112.1 24.56 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.875 0.369 . . . . 75.439999999999998 111.425 178.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 671' ' ' VAL . . . . . . . . . . . . . 90.2 t -125.98 132.84 24.45 Favored Pre-proline 0 CA--C 1.538 0.492 0 CA-C-N 116.3 -0.409 . . . . 75.120000000000005 110.776 177.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 672' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -66.47 138.43 50.25 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 122.128 1.886 . . . . 74.099999999999994 112.363 178.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 673' ' ' VAL . . . . . . . . . . . . . 11.7 p -73.17 -34.09 43.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 N-CA-C 112.326 0.491 . . . . 63.149999999999999 112.326 -175.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 674' ' ' GLY . . . . . . . . . . . . . . . -150.74 151.12 23.18 Favored Glycine 0 CA--C 1.523 0.533 0 C-N-CA 120.557 -0.83 . . . . 74.319999999999993 113.674 -176.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 675' ' ' ALA . . . . . 0.524 ' HB3' HG22 ' A' ' 737' ' ' VAL . . . -138.92 144.42 39.08 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 122.476 0.31 . . . . 63.329999999999998 110.978 179.136 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 676' ' ' THR . . . . . . . . . . . . . 36.5 m -131.42 118.61 20.48 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 120.596 0.236 . . . . 42.020000000000003 111.103 -178.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 677' ' ' ILE . . . . . . . . . . . . . 42.9 pt -136.67 177.58 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-O 121.091 0.472 . . . . 74.349999999999994 111.695 179.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 678' ' ' HIS . . . . . . . . . . . . . 79.2 m80 -129.57 140.29 51.25 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 111.924 0.342 . . . . 64.120000000000005 111.924 -178.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 679' ' ' VAL . . . . . . . . . . . . . 89.7 t -46.87 122.18 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 CA-C-N 115.753 -0.658 . . . . 70.219999999999999 112.558 -178.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 104.14 14.97 23.09 Favored Glycine 0 CA--C 1.528 0.883 0 CA-C-N 116.246 -0.433 . . . . 74.209999999999994 113.533 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 681' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -101.25 -161.94 0.9 Allowed 'General case' 0 CA--C 1.545 0.788 0 CA-C-O 121.407 0.622 . . . . 64.409999999999997 112.044 -179.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 682' ' ' SER . . . . . . . . . . . . . 40.1 m -134.62 111.1 9.75 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 115.938 -0.574 . . . . 73.329999999999998 110.394 175.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 683' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -118.7 136.24 54.04 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.582 0.23 . . . . 62.409999999999997 111.474 -177.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 684' ' ' VAL . . . . . 0.41 HG12 ' H ' ' A' ' 687' ' ' ALA . 86.5 t -121.38 111.8 33.23 Favored Pre-proline 0 CA--C 1.54 0.561 0 CA-C-O 120.553 0.216 . . . . 71.030000000000001 111.104 177.555 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -59.46 -50.62 7.89 Favored 'Trans proline' 0 CA--C 1.543 0.968 0 C-N-CA 122.723 2.282 . . . . 63.210000000000001 114.105 -176.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 686' ' ' MET . . . . . . . . . . . . . 53.9 mtp -79.73 -12.62 59.79 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 113.439 0.903 . . . . 74.340000000000003 113.439 -175.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 687' ' ' ALA . . . . . 0.41 ' H ' HG12 ' A' ' 684' ' ' VAL . . . -65.54 -21.17 66.58 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.845 0.355 . . . . 52.43 111.553 -178.412 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 688' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -107.37 0.73 23.2 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 112.346 0.498 . . . . 74.430000000000007 112.346 -178.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 25.4 t -99.55 151.11 4.94 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 O-C-N 122.098 -0.376 . . . . 74.120000000000005 111.528 -177.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 690' ' ' LEU . . . . . 0.446 HD21 HG12 ' A' ' 692' ' ' ILE . 9.1 tt -148.08 146.78 28.97 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 122.347 0.259 . . . . 72.519999999999996 111.025 -177.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 691' ' ' ALA . . . . . . . . . . . . . . . -145.73 128.46 16.24 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 111.994 0.368 . . . . 52.420000000000002 111.994 179.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 692' ' ' ILE . . . . . 0.529 HD13 ' HA ' ' A' ' 698' ' ' ASP . 45.4 mm -134.01 134.21 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 122.72 0.408 . . . . 63.229999999999997 111.737 -177.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 693' ' ' ASP . . . . . 0.454 ' HB2' ' CD1' ' A' ' 699' ' ' LEU . 35.0 t70 -106.95 144.77 33.1 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 122.077 -0.39 . . . . 63.420000000000002 111.01 173.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -59.33 -39.89 84.56 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 116.128 -0.487 . . . . 75.099999999999994 112.11 -177.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -83.01 -55.78 4.18 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 112.462 0.541 . . . . 73.230000000000004 112.462 -178.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 696' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -79.41 -48.27 14.27 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 112.445 0.535 . . . . 74.349999999999994 112.445 -169.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . 122.31 -112.26 1.96 Allowed Glycine 0 CA--C 1.522 0.47 0 C-N-CA 120.913 -0.66 . . . . 41.530000000000001 112.613 -176.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 698' ' ' ASP . . . . . 0.529 ' HA ' HD13 ' A' ' 692' ' ' ILE . 13.0 t70 -87.65 116.92 26.11 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 122.179 -0.601 . . . . 71.209999999999994 112.064 -176.271 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 699' ' ' LEU . . . . . 0.454 ' CD1' ' HB2' ' A' ' 693' ' ' ASP . 56.9 mt -112.37 21.2 15.98 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 116.287 -0.415 . . . . 75.420000000000002 111.32 175.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 29.6 m -60.14 -25.94 65.88 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 120.952 0.406 . . . . 70.040000000000006 111.603 -178.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 701' ' ' SER . . . . . . . . . . . . . 40.0 t -82.02 -18.21 44.06 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 121.163 0.506 . . . . 71.510000000000005 111.412 177.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 702' ' ' LYS . . . . . . . . . . . . . 48.6 mmtm -82.42 3.08 29.5 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 116.293 -0.412 . . . . 65.519999999999996 111.873 179.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 72.1 mt -78.37 138.98 19.24 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 CA-C-O 121.326 0.584 . . . . 73.439999999999998 112.438 -177.368 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 704' ' ' LYS . . . . . 0.471 ' O ' ' HA ' ' A' ' 721' ' ' TYR . 22.5 ttmm -104.84 139.33 39.76 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.783 -0.644 . . . . 65.530000000000001 110.267 178.149 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 60.8 t -115.59 111.09 34.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 N-CA-C 112.392 0.515 . . . . 73.450000000000003 112.392 -177.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 706' ' ' ASP . . . . . 0.571 ' HB3' ' HB ' ' A' ' 720' ' ' THR . 28.7 t70 -107.41 133.14 52.36 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.122 -0.49 . . . . 62.32 110.568 174.09 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 86.86 165.74 41.63 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 120.894 -0.67 . . . . 75.420000000000002 112.441 -176.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 708' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -159.37 148.78 18.44 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 122.283 -0.54 . . . . 64.510000000000005 111.153 -179.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 709' ' ' VAL . . . . . 0.451 HG23 HD11 ' A' ' 719' ' ' LEU . 58.7 t -96.45 137.58 23.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-N 116.094 -0.503 . . . . 64.319999999999993 111.665 -178.452 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 710' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -105.03 136.76 43.9 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 116.188 -0.46 . . . . 74.25 110.225 175.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 711' ' ' THR . . . . . . . . . . . . . 73.4 p -107.91 8.77 28.69 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 112.814 0.672 . . . . 74.120000000000005 112.814 -174.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 712' ' ' THR . . . . . . . . . . . . . 7.2 t -111.83 -9.73 14.05 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 122.078 -0.389 . . . . 50.549999999999997 111.61 176.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 713' ' ' LYS . . . . . . . . . . . . . 37.8 tttp -129.3 133.19 47.35 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 120.653 0.263 . . . . 74.439999999999998 110.885 177.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 714' ' ' ALA . . . . . . . . . . . . . . . -77.73 134.01 38.18 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 112.18 0.437 . . . . 74.129999999999995 112.18 -178.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 168.27 179.81 40.91 Favored Glycine 0 CA--C 1.524 0.625 0 CA-C-N 116.123 -0.49 . . . . 72.340000000000003 112.854 -179.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 716' ' ' THR . . . . . . . . . . . . . 41.0 m -108.64 122.67 47.59 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 120.999 0.428 . . . . 73.109999999999999 111.384 -178.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 717' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -114.06 124.09 51.28 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 116.284 -0.416 . . . . 71.319999999999993 111.036 -177.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 718' ' ' VAL . . . . . . . . . . . . . 49.3 t -97.36 114.65 35.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-O 121.111 0.481 . . . . 65.409999999999997 111.124 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 719' ' ' LEU . . . . . 0.451 HD11 HG23 ' A' ' 709' ' ' VAL . 47.4 mt -101.51 132.75 46.97 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 116.292 -0.413 . . . . 74.109999999999999 111.41 -177.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . 0.571 ' HB ' ' HB3' ' A' ' 706' ' ' ASP . 34.9 m -110.06 128.02 55.18 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 120.958 0.409 . . . . 60.119999999999997 111.501 178.083 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 721' ' ' TYR . . . . . 0.471 ' HA ' ' O ' ' A' ' 704' ' ' LYS . 75.3 m-85 -117.97 126.36 52.18 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.524 -0.307 . . . . 72.310000000000002 110.84 178.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 56.1 m -127.98 122.27 31.89 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 116.853 -0.158 . . . . 74.219999999999999 111.266 -178.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 12.9 p -111.11 142.14 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-O 120.903 0.382 . . . . 62.409999999999997 111.372 -179.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 52.3 m -113.79 126.5 55.28 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.083 0.468 . . . . 75.299999999999997 112.099 -178.368 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 725' ' ' ASP . . . . . 0.517 ' HB3' ' HB2' ' A' ' 729' ' ' HIS . 0.2 OUTLIER -84.5 158.81 20.88 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 115.953 -0.567 . . . . 75.319999999999993 111.483 176.22 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 726' ' ' SER . . . . . . . . . . . . . 49.8 m -58.21 -34.74 70.73 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.872 0.693 . . . . 71.129999999999995 112.872 -176.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 727' ' ' LYS . . . . . 0.489 ' HD2' ' N ' ' A' ' 727' ' ' LYS . 3.4 mptp? -90.45 13.45 15.62 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 122.09 -0.381 . . . . 72.120000000000005 111.59 -177.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 728' ' ' GLY . . . . . . . . . . . . . . . 91.54 10.84 61.46 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 121.118 -0.563 . . . . 52.130000000000003 114.224 174.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 729' ' ' HIS . . . . . 0.517 ' HB2' ' HB3' ' A' ' 725' ' ' ASP . 46.7 m80 -80.79 107.24 13.43 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 117.397 0.598 . . . . 74.109999999999999 111.203 178.36 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 730' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -111.39 124.69 52.77 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.982 -0.554 . . . . 43.25 111.271 -175.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 28.8 m -131.16 152.6 37.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 CA-C-O 120.739 0.304 . . . . 73.409999999999997 111.283 179.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 10.2 t -136.25 153.81 51.09 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 112.727 0.639 . . . . 63.140000000000001 112.727 -176.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -148.35 161.6 41.22 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.079 0.551 . . . . 52.039999999999999 110.704 177.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 734' ' ' LYS . . . . . . . . . . . . . 41.3 mttp -122.72 156.6 34.08 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 113.246 0.832 . . . . 74.120000000000005 113.246 -176.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 735' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -130.56 128.56 41.35 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 115.141 -0.936 . . . . 74.420000000000002 110.542 176.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 736' ' ' THR . . . . . . . . . . . . . 85.3 m -96.96 104.01 15.99 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.825 0.345 . . . . 71.510000000000005 111.37 178.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 737' ' ' VAL . . . . . 0.524 HG22 ' HB3' ' A' ' 675' ' ' ALA . 48.7 t -98.76 131.9 45.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-O 120.638 0.256 . . . . 44.149999999999999 111.414 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 738' ' ' THR . . . . . . . . . . . . . 90.7 m -121.36 117.9 28.12 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.042 0.449 . . . . 74.409999999999997 111.574 179.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 739' ' ' VAL . . . . . . . . . . . . . 27.4 t -98.94 125.14 52.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-N 116.244 -0.435 . . . . 73.340000000000003 111.043 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 740' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -114.1 152.34 31.23 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 112.142 0.423 . . . . 73.510000000000005 112.142 -177.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 741' ' ' VAL . . . . . 0.401 HG12 ' N ' ' A' ' 742' ' ' ARG . 23.7 t -79.94 156.4 4.56 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 CA-C-O 121.191 0.519 . . . . 74.409999999999997 112.307 -176.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 742' ' ' ARG . . . . . 0.401 ' N ' HG12 ' A' ' 741' ' ' VAL . 23.1 mmm180 -88.27 -177.37 5.66 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.032 0.444 . . . . 75.219999999999999 111.345 173.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 743' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -105.52 -15.52 14.98 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.859 0.362 . . . . 72.010000000000005 111.367 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 744' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -91.36 138.35 31.65 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.401 -0.363 . . . . 52.240000000000002 111.577 -176.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 4.0 p -75.83 106.03 5.29 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 CA-C-O 121.425 0.631 . . . . 62.25 111.713 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -103.86 130.08 51.4 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.117 0.484 . . . . 74.25 111.999 179.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 747' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 -102.35 12.17 36.99 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 115.926 -0.579 . . . . 63.130000000000003 110.166 173.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -67.66 83.48 0.18 Allowed 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.709 -0.678 . . . . 72.209999999999994 112.463 -177.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 749' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.04 131.93 24.33 Favored Pre-proline 0 N--CA 1.468 0.466 0 CA-C-N 116.177 -0.465 . . . . 74.530000000000001 110.117 171.456 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 750' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -63.89 118.51 5.45 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 122.407 2.072 . . . . 65.129999999999995 113.24 -178.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 751' ' ' ILE . . . . . . . . . . . . . 35.5 pt -77.34 24.39 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 N-CA-C 112.377 0.51 . . . . 63.329999999999998 112.377 -178.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 752' ' ' LEU . . . . . . . . . . . . . 2.7 pp -113.92 178.08 4.41 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 120.836 0.35 . . . . 65.209999999999994 111.424 -179.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 753' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 . . . . . 0 N--CA 1.469 0.504 0 CA-C-O 120.734 0.302 . . . . 75.409999999999997 111.782 -177.486 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 762' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 657' ' ' MET . . . . . . . . . . . . . 67.1 mtt . . . . . 0 N--CA 1.493 1.687 0 CA-C-O 120.912 0.387 . . . . 54.25 111.568 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 658' ' ' GLY . . . . . . . . . . . . . . . -93.43 -62.4 1.1 Allowed Glycine 0 CA--C 1.526 0.725 0 C-N-CA 121.286 -0.483 . . . . 43.229999999999997 112.026 176.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 659' ' ' ASN . . . . . . . . . . . . . 37.8 t30 -134.79 106.22 6.8 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 122.809 0.444 . . . . 72.030000000000001 109.871 173.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 660' ' ' GLY . . . . . . . . . . . . . . . -72.63 67.19 1.31 Allowed Glycine 0 CA--C 1.528 0.877 0 C-N-CA 121.226 -0.511 . . . . 71.209999999999994 113.179 -179.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -81.15 103.14 10.75 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.156 0.503 . . . . 72.420000000000002 110.623 178.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 662' ' ' THR . . . . . . . . . . . . . 4.4 t -144.8 173.05 12.18 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.886 -0.597 . . . . 63.340000000000003 110.374 -178.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 663' ' ' SER . . . . . . . . . . . . . 98.1 p -155.8 98.88 1.95 Allowed 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 112.896 0.702 . . . . 53.210000000000001 112.896 -176.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 664' ' ' ASP . . . . . 0.454 ' OD2' ' HB2' ' A' ' 727' ' ' LYS . 35.4 t0 -88.36 114.28 24.81 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 120.988 0.423 . . . . 74.030000000000001 109.916 169.448 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 665' ' ' LEU . . . . . 0.429 HD12 ' HD3' ' A' ' 694' ' ' LYS . 88.2 mt -90.6 137.32 32.45 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.165 -0.47 . . . . 73.219999999999999 110.463 175.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 666' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -57.01 131.96 80.05 Favored Pre-proline 0 CA--C 1.54 0.586 0 CA-C-N 116.496 -0.32 . . . . 71.030000000000001 110.557 172.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 667' ' ' PRO . . . . . 0.544 ' HB3' HD12 ' A' ' 699' ' ' LEU . 26.9 Cg_endo -60.37 148.61 89.8 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 122.433 2.089 . . . . 72.230000000000004 113.36 -172.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 668' ' ' LYS . . . . . . . . . . . . . 56.9 tptt -83.22 108.61 16.58 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.095 0.474 . . . . 72.219999999999999 111.213 177.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 669' ' ' LEU . . . . . 0.536 ' HG ' HG23 ' A' ' 671' ' ' VAL . 56.6 tp -96.65 111.97 23.9 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 116.281 -0.418 . . . . 70.310000000000002 111.335 -179.585 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 670' ' ' THR . . . . . . . . . . . . . 72.6 m -87.87 109.69 19.96 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.657 0.265 . . . . 52.140000000000001 110.927 179.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 671' ' ' VAL . . . . . 0.536 HG23 ' HG ' ' A' ' 669' ' ' LEU . 95.2 t -136.23 130.1 18.13 Favored Pre-proline 0 N--CA 1.472 0.663 0 CA-C-N 116.455 -0.339 . . . . 71.010000000000005 111.065 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 672' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -76.2 156.09 37.64 Favored 'Trans proline' 0 CA--C 1.542 0.882 0 C-N-CA 122.622 2.215 . . . . 74.140000000000001 112.759 176.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 673' ' ' VAL . . . . . . . . . . . . . 13.5 p -81.66 -33.59 12.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 N-CA-C 112.94 0.719 . . . . 55.329999999999998 112.94 -174.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 674' ' ' GLY . . . . . 0.401 ' HA2' ' O ' ' A' ' 736' ' ' THR . . . -175.08 139.55 4.85 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 119.926 -1.131 . . . . 52.109999999999999 114.35 -176.078 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 675' ' ' ALA . . . . . . . . . . . . . . . -139.96 151.33 45.45 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 122.654 0.382 . . . . 52.450000000000003 110.965 178.047 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 676' ' ' THR . . . . . . . . . . . . . 97.6 m -131.62 123.17 27.32 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-O 120.719 0.295 . . . . 74.510000000000005 111.576 -179.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 677' ' ' ILE . . . . . . . . . . . . . 29.8 pt -123.14 177.44 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 122.699 0.4 . . . . 72.450000000000003 111.405 -179.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 678' ' ' HIS . . . . . . . . . . . . . 74.2 m80 -107.37 161.66 14.61 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 121.326 0.584 . . . . 72.409999999999997 112.368 178.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 679' ' ' VAL . . . . . 0.607 HG13 ' HA ' ' A' ' 712' ' ' THR . 76.6 t -60.44 126.37 18.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-N 115.747 -0.661 . . . . 64.040000000000006 111.837 176.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 103.52 -2.69 46.15 Favored Glycine 0 CA--C 1.528 0.906 0 CA-C-N 116.129 -0.487 . . . . 64.209999999999994 113.389 -178.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 681' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -88.8 -175.74 4.99 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 116.91 0.355 . . . . 74.099999999999994 110.979 178.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 682' ' ' SER . . . . . . . . . . . . . 74.9 m -134.69 137.68 43.76 Favored 'General case' 0 N--CA 1.477 0.898 0 O-C-N 121.993 -0.442 . . . . 72.400000000000006 111.877 -178.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 683' ' ' PHE . . . . . . . . . . . . . 47.2 t80 -125.89 133.81 51.79 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 116.35 -0.386 . . . . 62.299999999999997 110.655 -178.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 684' ' ' VAL . . . . . . . . . . . . . 46.4 t -123.77 93.77 46.9 Favored Pre-proline 0 CA--C 1.546 0.791 0 CA-C-O 121.108 0.48 . . . . 72.109999999999999 112.089 -174.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -64.02 -29.58 66.26 Favored 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 122.706 2.271 . . . . 75.530000000000001 113.805 -178.17 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 686' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -79.3 -7.57 58.4 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.547 0.573 . . . . 72.140000000000001 112.547 -177.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 687' ' ' ALA . . . . . . . . . . . . . . . -110.26 -39.1 5.08 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.866 0.365 . . . . 62.340000000000003 111.655 177.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 688' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -77.38 -10.47 59.47 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 112.43 0.53 . . . . 54.439999999999998 112.43 -177.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . 0.476 HG12 HD13 ' A' ' 703' ' ' ILE . 88.7 t -119.03 125.01 74.13 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 CA-C-O 120.865 0.364 . . . . 73.510000000000005 111.565 178.089 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 690' ' ' LEU . . . . . 0.42 HD22 ' N ' ' A' ' 690' ' ' LEU . 2.7 mm? -122.36 161.77 22.81 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 120.863 0.364 . . . . 73.120000000000005 111.375 -177.223 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 691' ' ' ALA . . . . . . . . . . . . . . . -147.46 122.62 10.18 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 120.966 0.412 . . . . 63.420000000000002 111.896 177.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 692' ' ' ILE . . . . . . . . . . . . . 45.4 mm -123.9 135.01 64.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-N 116.349 -0.387 . . . . 74.239999999999995 111.25 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -120.44 149.91 41.64 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 120.823 0.344 . . . . 70.430000000000007 111.63 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 694' ' ' LYS . . . . . 0.429 ' HD3' HD12 ' A' ' 665' ' ' LEU . 37.8 ttpt -62.49 -61.2 2.6 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 112.314 0.487 . . . . 73.510000000000005 112.314 -177.465 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 695' ' ' GLU . . . . . 0.468 ' CD ' ' H ' ' A' ' 695' ' ' GLU . 0.1 OUTLIER -85.09 -53.11 5.48 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 111.868 0.321 . . . . 64.409999999999997 111.868 -174.664 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 696' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -66.52 -48.91 68.26 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 121.063 0.459 . . . . 71.140000000000001 111.052 -173.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . 122.49 -146.95 16.88 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 121.224 -0.513 . . . . 72.109999999999999 113.11 178.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -70.94 111.36 6.27 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.955 0.407 . . . . 62.32 110.921 179.078 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 699' ' ' LEU . . . . . 0.544 HD12 ' HB3' ' A' ' 667' ' ' PRO . 79.0 mt -104.77 17.41 24.18 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 120.85 0.357 . . . . 52.399999999999999 111.503 179.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 42.4 m -56.77 -37.12 70.65 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.177 0.513 . . . . 73.349999999999994 111.268 178.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 701' ' ' SER . . . . . . . . . . . . . 27.5 m -68.55 -12.48 61.33 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 116.207 -0.451 . . . . 73.150000000000006 111.982 178.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 702' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -100.69 3.18 42.18 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 111.813 0.301 . . . . 71.540000000000006 111.813 -176.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 703' ' ' ILE . . . . . 0.476 HD13 HG12 ' A' ' 689' ' ' VAL . 72.2 mt -73.7 118.5 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 120.964 0.411 . . . . 73.239999999999995 111.718 -178.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 704' ' ' LYS . . . . . 0.422 ' HB2' ' NZ ' ' A' ' 704' ' ' LYS . 5.2 ttmp? -84.33 115.59 22.58 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 116.169 -0.469 . . . . 53.25 110.329 176.277 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 67.8 t -95.87 106.57 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 121.161 0.505 . . . . 62.310000000000002 111.595 -178.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 706' ' ' ASP . . . . . 0.551 ' HB3' ' HB ' ' A' ' 720' ' ' THR . 25.2 t70 -101.82 125.57 48.52 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 116.177 -0.465 . . . . 51.229999999999997 111.099 179.378 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 112.04 163.81 17.02 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 121.067 -0.587 . . . . 52.409999999999997 113.335 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 708' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -149.62 145.72 26.92 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.019 0.438 . . . . 65.109999999999999 111.655 -177.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 709' ' ' VAL . . . . . 0.554 HG22 ' HB2' ' A' ' 717' ' ' TYR . 55.4 t -120.45 122.04 67.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 CA-C-N 116.28 -0.418 . . . . 72.019999999999996 111.607 -177.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 710' ' ' ASP . . . . . 0.533 ' HB2' ' HB3' ' A' ' 713' ' ' LYS . 10.1 m-20 -73.94 136.34 43.28 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 120.74 0.305 . . . . 60.539999999999999 110.816 174.35 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 711' ' ' THR . . . . . . . . . . . . . 81.2 p -96.48 0.99 51.1 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 120.932 0.396 . . . . 75.430000000000007 111.237 175.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 712' ' ' THR . . . . . 0.607 ' HA ' HG13 ' A' ' 679' ' ' VAL . 74.5 p -115.71 3.46 13.89 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 116.163 -0.472 . . . . 73.430000000000007 111.912 178.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 713' ' ' LYS . . . . . 0.533 ' HB3' ' HB2' ' A' ' 710' ' ' ASP . 5.6 tppp? -125.37 122.17 36.02 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 120.731 0.3 . . . . 65.239999999999995 111.586 -175.411 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 714' ' ' ALA . . . . . . . . . . . . . . . -70.36 112.46 6.68 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.928 0.394 . . . . 71.209999999999994 111.688 175.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 175.24 168.41 35.73 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 121.112 -0.566 . . . . 41.229999999999997 112.986 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 716' ' ' THR . . . . . . . . . . . . . 86.3 m -104.04 123.11 46.63 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 122.701 -0.293 . . . . 64.109999999999999 111.699 179.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 717' ' ' TYR . . . . . 0.554 ' HB2' HG22 ' A' ' 709' ' ' VAL . 86.0 m-85 -119.93 122.7 41.81 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.005 0.431 . . . . 73.120000000000005 111.164 177.012 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 718' ' ' VAL . . . . . . . . . . . . . 59.0 t -92.37 117.91 36.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-O 120.738 0.304 . . . . 52.240000000000002 111.139 177.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 719' ' ' LEU . . . . . 0.455 HD21 HG23 ' A' ' 709' ' ' VAL . 58.1 mt -94.45 148.26 22.42 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 116.671 -0.24 . . . . 74.420000000000002 111.111 -179.436 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . 0.551 ' HB ' ' HB3' ' A' ' 706' ' ' ASP . 25.0 m -114.98 133.15 56.28 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 120.615 0.245 . . . . 42.210000000000001 111.072 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 721' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -122.91 115.87 22.66 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.835 0.35 . . . . 61.32 111.07 179.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 46.2 m -123.95 123.1 39.67 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 120.654 0.264 . . . . 74.299999999999997 111.474 -178.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 8.7 p -119.0 136.88 54.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 CA-C-O 120.963 0.411 . . . . 73.109999999999999 111.529 179.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 18.0 m -117.58 128.49 55.0 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.144 0.424 . . . . 72.430000000000007 112.144 -175.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 725' ' ' ASP . . . . . 0.515 ' HB3' ' H ' ' A' ' 729' ' ' HIS . 9.9 t70 -74.59 152.14 39.31 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 116.334 -0.394 . . . . 74.219999999999999 110.624 176.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 726' ' ' SER . . . . . . . . . . . . . 48.7 m -62.52 -27.41 69.14 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 112.624 0.601 . . . . 63.109999999999999 112.624 -177.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 727' ' ' LYS . . . . . 0.478 ' N ' ' HD3' ' A' ' 727' ' ' LYS . 3.5 mppt? -95.04 4.01 54.22 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 112.19 0.441 . . . . 72.219999999999999 112.19 179.399 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 728' ' ' GLY . . . . . . . . . . . . . . . 101.84 34.27 4.4 Favored Glycine 0 CA--C 1.533 1.161 0 N-CA-C 115.563 0.985 . . . . 51.350000000000001 115.563 171.136 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 729' ' ' HIS . . . . . 0.515 ' H ' ' HB3' ' A' ' 725' ' ' ASP . 31.2 m80 -109.53 111.08 22.39 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 118.077 0.938 . . . . 74.319999999999993 110.926 170.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 730' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -113.82 118.45 34.28 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 112.004 0.372 . . . . 52.420000000000002 112.004 -174.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 30.7 m -117.17 155.11 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-O 120.671 0.272 . . . . 72.150000000000006 111.171 178.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 10.0 t -147.52 145.38 29.08 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 112.792 0.664 . . . . 72.200000000000003 112.792 -175.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -148.72 143.65 26.57 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.962 -0.563 . . . . 55.32 111.144 178.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 734' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -106.92 159.52 16.2 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.343 0.592 . . . . 74.129999999999995 112.41 -178.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 735' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -132.77 130.08 39.46 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.707 -0.679 . . . . 63.520000000000003 110.837 -179.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 736' ' ' THR . . . . . 0.401 ' O ' ' HA2' ' A' ' 674' ' ' GLY . 90.5 m -94.13 103.89 15.93 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 120.919 0.39 . . . . 74.340000000000003 111.865 -179.017 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 44.3 t -102.6 135.17 41.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-O 120.719 0.295 . . . . 65.209999999999994 111.473 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 738' ' ' THR . . . . . . . . . . . . . 92.5 m -125.36 131.6 52.96 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 120.723 0.297 . . . . 74.219999999999999 111.378 178.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 739' ' ' VAL . . . . . . . . . . . . . 51.6 t -109.73 128.03 66.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-O 120.829 0.347 . . . . 64.349999999999994 111.011 177.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 740' ' ' LYS . . . . . 0.514 ' NZ ' ' HB3' ' A' ' 740' ' ' LYS . 7.3 mtpm? -116.18 152.6 33.39 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.973 0.416 . . . . 74.239999999999995 111.374 179.141 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 741' ' ' VAL . . . . . . . . . . . . . 18.1 t -81.48 145.9 8.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-O 120.704 0.288 . . . . 53.140000000000001 111.033 -178.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 742' ' ' ARG . . . . . . . . . . . . . 4.0 ppt_? -83.43 158.88 21.91 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.151 0.5 . . . . 63.539999999999999 112.143 178.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 743' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -69.41 143.89 53.5 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.8 -0.636 . . . . 74.430000000000007 112.5 -177.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 744' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -109.4 135.62 50.15 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 116.164 -0.471 . . . . 75.409999999999997 110.017 172.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 30.3 m -84.23 177.42 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 N-CA-C 112.136 0.421 . . . . 71.0 112.136 -177.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -61.95 90.4 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.025 0.44 . . . . 64.430000000000007 111.86 179.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 747' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -93.8 170.53 9.5 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 121.275 0.56 . . . . 55.030000000000001 111.693 178.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -83.23 32.24 0.45 Allowed 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 115.971 -0.559 . . . . 70.519999999999996 111.62 -178.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 749' ' ' LYS . . . . . . . . . . . . . 46.4 tptt 54.87 73.74 0.84 Allowed Pre-proline 0 CA--C 1.543 0.678 0 C-N-CA 123.145 0.578 . . . . 75.540000000000006 111.281 -175.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 750' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -70.27 105.34 1.55 Allowed 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 122.662 2.241 . . . . 55.210000000000001 112.705 -178.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 751' ' ' ILE . . . . . . . . . . . . . 58.3 mt -75.59 78.12 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-O 121.356 0.598 . . . . 72.439999999999998 110.297 177.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 752' ' ' LEU . . . . . . . . . . . . . 39.1 tp -74.39 90.56 2.17 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.917 -0.583 . . . . 74.140000000000001 111.91 -173.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 753' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 . . . . . 0 C--O 1.239 0.51 0 CA-C-N 116.148 -0.478 . . . . 53.43 111.186 177.103 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 762' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 657' ' ' MET . . . . . . . . . . . . . 9.7 tpt . . . . . 0 N--CA 1.488 1.437 0 CA-C-O 121.077 0.465 . . . . 70.420000000000002 111.802 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 658' ' ' GLY . . . . . . . . . . . . . . . -156.42 29.44 0.57 Allowed Glycine 0 CA--C 1.527 0.805 0 CA-C-N 116.145 -0.48 . . . . 53.420000000000002 112.582 176.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 659' ' ' ASN . . . . . . . . . . . . . 60.6 m-20 -69.72 106.63 3.16 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 120.795 0.331 . . . . 73.140000000000001 111.522 -177.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 660' ' ' GLY . . . . . . . . . . . . . . . -80.74 56.71 4.78 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 121.129 -0.557 . . . . 71.510000000000005 113.279 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 37.3 mm-40 -105.26 142.76 34.47 Favored 'General case' 0 N--CA 1.468 0.456 0 O-C-N 122.65 -0.323 . . . . 62.329999999999998 111.337 -179.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 662' ' ' THR . . . . . . . . . . . . . 9.1 t -92.79 172.59 8.24 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.211 0.529 . . . . 64.329999999999998 112.097 -177.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 663' ' ' SER . . . . . . . . . . . . . 62.8 m -89.93 122.8 33.3 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 116.328 -0.396 . . . . 62.439999999999998 111.559 -178.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 664' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -73.55 143.86 46.32 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 121.406 0.622 . . . . 71.219999999999999 111.552 177.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 665' ' ' LEU . . . . . . . . . . . . . 86.9 mt -87.33 126.0 34.58 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.648 -0.706 . . . . 73.230000000000004 110.387 176.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 666' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -62.1 145.59 93.15 Favored Pre-proline 0 CA--C 1.542 0.661 0 CA-C-N 116.116 -0.493 . . . . 73.030000000000001 111.3 178.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 667' ' ' PRO . . . . . 0.463 ' HD3' ' HB2' ' A' ' 725' ' ' ASP . 80.4 Cg_endo -76.94 147.14 26.64 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 122.365 2.043 . . . . 72.019999999999996 112.872 -176.189 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 668' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -83.15 104.05 13.04 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.127 0.489 . . . . 74.549999999999997 110.901 179.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 669' ' ' LEU . . . . . 0.418 ' HG ' HG23 ' A' ' 671' ' ' VAL . 58.1 tp -89.91 105.87 18.09 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.065 -0.516 . . . . 74.510000000000005 110.707 177.392 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 670' ' ' THR . . . . . . . . . . . . . 73.5 m -88.18 110.97 21.11 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.162 -0.472 . . . . 74.430000000000007 111.273 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 671' ' ' VAL . . . . . 0.497 HG22 HG13 ' A' ' 689' ' ' VAL . 85.7 t -132.08 126.27 20.49 Favored Pre-proline 0 N--CA 1.47 0.53 0 CA-C-N 116.146 -0.479 . . . . 64.109999999999999 110.768 179.275 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 672' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -69.73 137.48 35.64 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 122.27 1.98 . . . . 71.329999999999998 112.297 179.097 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 673' ' ' VAL . . . . . . . . . . . . . 12.5 p -64.54 -35.89 75.83 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 N-CA-C 112.279 0.474 . . . . 63.329999999999998 112.279 -175.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 674' ' ' GLY . . . . . . . . . . . . . . . -162.22 161.62 33.63 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 120.647 -0.787 . . . . 33.310000000000002 113.699 -178.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 675' ' ' ALA . . . . . . . . . . . . . . . -151.17 157.82 43.17 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 122.299 0.24 . . . . 65.439999999999998 110.955 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 676' ' ' THR . . . . . . . . . . . . . 60.7 m -133.38 126.39 31.18 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 122.347 -0.221 . . . . 72.549999999999997 111.394 179.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 677' ' ' ILE . . . . . . . . . . . . . 23.9 pt -130.33 174.56 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-O 120.976 0.417 . . . . 72.019999999999996 111.311 177.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 678' ' ' HIS . . . . . 0.528 ' O ' ' HB2' ' A' ' 681' ' ' ASP . 72.3 m80 -121.3 171.35 8.8 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.324 0.583 . . . . 64.510000000000005 112.378 -178.1 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 679' ' ' VAL . . . . . 0.485 HG23 ' HA ' ' A' ' 741' ' ' VAL . 84.5 t -63.71 120.01 9.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-N 116.023 -0.535 . . . . 35.109999999999999 111.254 175.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 97.2 0.84 59.65 Favored Glycine 0 CA--C 1.528 0.895 0 CA-C-N 116.185 -0.461 . . . . 63.439999999999998 113.211 -175.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 681' ' ' ASP . . . . . 0.528 ' HB2' ' O ' ' A' ' 678' ' ' HIS . 0.9 OUTLIER -77.05 178.58 6.87 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-O 121.101 0.477 . . . . 53.039999999999999 111.116 -179.561 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 682' ' ' SER . . . . . . . . . . . . . 87.2 p -134.94 126.21 28.19 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 116.511 -0.313 . . . . 53.229999999999997 110.831 177.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 683' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -127.53 134.38 49.77 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.931 0.396 . . . . 71.530000000000001 111.647 -176.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 684' ' ' VAL . . . . . 0.435 ' HA ' ' HD2' ' A' ' 685' ' ' PRO . 61.8 t -124.26 101.6 34.52 Favored Pre-proline 0 CA--C 1.545 0.766 0 CA-C-O 121.089 0.471 . . . . 72.409999999999997 111.943 -179.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 685' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' A' ' 684' ' ' VAL . 21.6 Cg_endo -60.99 -36.58 82.1 Favored 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 122.871 2.381 . . . . 53.43 113.843 -178.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 686' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -78.64 -1.75 35.77 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 112.237 0.458 . . . . 73.310000000000002 112.237 -177.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 687' ' ' ALA . . . . . . . . . . . . . . . -95.27 -48.08 6.05 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.078 0.466 . . . . 72.120000000000005 110.808 174.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 688' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -66.01 -38.31 88.12 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.605 0.594 . . . . 71.310000000000002 112.605 179.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . 0.497 HG13 HG22 ' A' ' 671' ' ' VAL . 98.9 t -86.67 143.1 12.08 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-O 120.934 0.397 . . . . 64.430000000000007 111.884 -178.118 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 690' ' ' LEU . . . . . 0.435 HD12 ' OG1' ' A' ' 700' ' ' THR . 45.9 tp -141.97 151.87 42.94 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.058 -0.519 . . . . 64.209999999999994 110.683 -177.092 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 691' ' ' ALA . . . . . 0.488 ' HB2' HD11 ' A' ' 703' ' ' ILE . . . -139.78 121.53 15.39 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.235 0.541 . . . . 72.530000000000001 111.439 174.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 692' ' ' ILE . . . . . . . . . . . . . 46.7 mm -128.93 120.53 52.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-N 116.219 -0.446 . . . . 55.43 111.716 -177.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 693' ' ' ASP . . . . . 0.46 ' HB2' ' HB3' ' A' ' 667' ' ' PRO . 31.9 t70 -102.88 149.24 24.7 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 120.787 0.327 . . . . 63.240000000000002 110.611 174.255 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -67.33 -55.41 13.98 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 112.367 0.506 . . . . 73.129999999999995 112.367 -176.075 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -83.8 -52.03 6.73 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 112.433 0.531 . . . . 63.530000000000001 112.433 -176.415 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 696' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -72.12 -32.79 67.27 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 120.874 0.368 . . . . 75.450000000000003 111.697 -172.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . 109.57 -144.69 16.72 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 120.973 -0.632 . . . . 24.420000000000002 113.515 177.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -71.06 122.47 20.13 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 120.85 0.357 . . . . 74.150000000000006 111.459 -178.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 699' ' ' LEU . . . . . . . . . . . . . 90.3 mt -118.85 20.89 12.69 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 120.998 0.428 . . . . 75.310000000000002 111.348 178.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 700' ' ' THR . . . . . 0.435 ' OG1' HD12 ' A' ' 690' ' ' LEU . 26.3 m -62.18 -39.22 91.94 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 121.169 0.509 . . . . 72.430000000000007 111.611 -179.339 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 701' ' ' SER . . . . . . . . . . . . . 63.3 m -71.07 -9.51 58.17 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 116.211 -0.449 . . . . 71.530000000000001 111.637 177.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 702' ' ' LYS . . . . . . . . . . . . . 2.4 mmmp? -87.01 -9.66 55.01 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 120.668 0.271 . . . . 71.540000000000006 111.049 176.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 703' ' ' ILE . . . . . 0.489 HG12 ' HB ' ' A' ' 723' ' ' VAL . 67.7 mt -74.76 115.57 16.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-O 120.743 0.306 . . . . 63.200000000000003 111.531 -178.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 704' ' ' LYS . . . . . . . . . . . . . 30.2 ttpt -89.95 119.47 30.34 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 120.872 0.368 . . . . 55.219999999999999 110.375 174.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 45.2 t -97.3 137.59 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 112.238 0.459 . . . . 62.450000000000003 112.238 -174.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 706' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -131.78 134.63 46.04 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 120.932 0.396 . . . . 63.450000000000003 110.962 175.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 128.07 178.87 15.55 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 121.373 -0.442 . . . . 73.219999999999999 112.987 179.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 708' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -166.28 130.71 2.17 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.046 0.45 . . . . 72.349999999999994 111.721 179.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 709' ' ' VAL . . . . . . . . . . . . . 60.1 t -107.54 131.2 58.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-N 116.222 -0.444 . . . . 71.120000000000005 111.652 -178.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 710' ' ' ASP . . . . . 0.437 ' O ' HG21 ' A' ' 739' ' ' VAL . 7.4 m-20 -85.68 141.86 29.45 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.037 0.446 . . . . 73.120000000000005 111.757 178.518 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 711' ' ' THR . . . . . 0.446 ' O ' ' HA ' ' A' ' 679' ' ' VAL . 80.5 p -111.29 2.36 17.64 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.476 -0.329 . . . . 75.150000000000006 111.648 177.361 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 712' ' ' THR . . . . . . . . . . . . . 31.2 p -103.84 -28.68 11.46 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 120.951 0.405 . . . . 61.439999999999998 111.883 178.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 713' ' ' LYS . . . . . 0.403 ' HB2' ' NZ ' ' A' ' 713' ' ' LYS . 4.8 ttmp? -119.64 133.33 55.69 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.505 -0.316 . . . . 53.210000000000001 111.174 -178.404 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 714' ' ' ALA . . . . . . . . . . . . . . . -69.56 142.98 53.5 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 120.868 0.366 . . . . 71.340000000000003 111.435 178.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 160.84 157.83 8.95 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 120.995 -0.621 . . . . 73.430000000000007 113.107 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 716' ' ' THR . . . . . . . . . . . . . 86.3 m -99.07 123.26 43.23 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 122.496 -0.414 . . . . 74.5 111.67 -178.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 717' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -122.19 150.33 42.4 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 122.579 0.352 . . . . 65.239999999999995 111.204 -178.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 718' ' ' VAL . . . . . . . . . . . . . 57.6 t -113.7 125.44 70.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 CA-C-O 121.003 0.43 . . . . 73.019999999999996 111.642 178.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 719' ' ' LEU . . . . . . . . . . . . . 81.4 mt -102.41 141.69 34.83 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.444 -0.344 . . . . 54.119999999999997 110.95 179.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 86.5 m -112.29 139.68 47.64 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-O 120.994 0.426 . . . . 61.100000000000001 111.71 -178.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 721' ' ' TYR . . . . . . . . . . . . . 50.1 m-85 -132.56 122.38 24.7 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 116.191 -0.459 . . . . 71.109999999999999 110.937 -179.017 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 95.3 m -125.69 125.32 42.86 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 120.873 0.368 . . . . 72.129999999999995 111.883 -179.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 723' ' ' VAL . . . . . 0.489 ' HB ' HG12 ' A' ' 703' ' ' ILE . 14.9 p -121.56 152.14 25.11 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-N 116.297 -0.411 . . . . 71.430000000000007 111.005 178.312 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 87.0 m -133.08 132.11 41.37 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.058 0.456 . . . . 72.519999999999996 111.938 177.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 725' ' ' ASP . . . . . 0.475 ' HB3' ' H ' ' A' ' 729' ' ' HIS . 9.9 t0 -73.41 151.05 41.29 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 115.714 -0.676 . . . . 64.519999999999996 110.608 177.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 726' ' ' SER . . . . . . . . . . . . . 44.0 t -59.57 -31.66 69.65 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.328 -0.396 . . . . 44.520000000000003 111.786 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 727' ' ' LYS . . . . . . . . . . . . . 10.3 mptt -86.71 1.05 53.41 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 112.237 0.458 . . . . 54.439999999999998 112.237 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 728' ' ' GLY . . . . . . . . . . . . . . . 100.55 33.77 4.96 Favored Glycine 0 CA--C 1.534 1.23 0 N-CA-C 115.49 0.956 . . . . 71.530000000000001 115.49 171.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 729' ' ' HIS . . . . . 0.475 ' H ' ' HB3' ' A' ' 725' ' ' ASP . 52.3 m80 -109.45 112.08 23.98 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 118.062 0.931 . . . . 74.530000000000001 111.571 173.058 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 730' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -99.51 129.05 45.65 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 121.028 0.442 . . . . 71.549999999999997 111.825 -176.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 48.8 t -127.51 136.1 61.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-N 116.22 -0.445 . . . . 71.209999999999994 110.591 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 10.3 t -135.13 144.95 47.39 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 112.364 0.505 . . . . 74.209999999999994 112.364 -178.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 733' ' ' ALA . . . . . 0.489 ' HB3' HG21 ' A' ' 671' ' ' VAL . . . -148.86 162.1 40.5 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 116.222 -0.445 . . . . 64.400000000000006 111.71 -178.53 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 734' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -123.72 155.35 38.01 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 112.356 0.502 . . . . 74.140000000000001 112.356 -178.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 735' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -130.04 126.36 37.5 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 116.021 -0.536 . . . . 74.25 110.746 177.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 736' ' ' THR . . . . . . . . . . . . . 97.8 m -95.1 109.54 21.59 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 120.992 0.425 . . . . 73.319999999999993 111.726 -179.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 47.7 t -106.5 121.67 59.4 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 CA-C-O 120.897 0.379 . . . . 62.399999999999999 111.505 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 738' ' ' THR . . . . . . . . . . . . . 54.2 m -104.77 121.81 44.4 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.091 0.472 . . . . 71.349999999999994 111.986 179.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 739' ' ' VAL . . . . . 0.437 HG21 ' O ' ' A' ' 710' ' ' ASP . 24.4 t -98.09 136.3 29.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-N 116.063 -0.517 . . . . 51.25 111.047 178.11 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 740' ' ' LYS . . . . . 0.408 ' O ' ' HA ' ' A' ' 678' ' ' HIS . 96.0 mttt -131.38 156.01 46.29 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.259 0.552 . . . . 75.329999999999998 111.957 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 741' ' ' VAL . . . . . 0.485 ' HA ' HG23 ' A' ' 679' ' ' VAL . 28.2 t -80.86 146.43 7.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-N 116.266 -0.425 . . . . 74.140000000000001 111.485 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 742' ' ' ARG . . . . . 0.415 HH11 ' HD3' ' A' ' 742' ' ' ARG . 13.7 ptt180 -84.35 179.42 7.45 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 120.707 0.289 . . . . 75.140000000000001 111.081 179.147 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 743' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -69.52 101.92 1.7 Allowed 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 112.888 0.699 . . . . 61.210000000000001 112.888 -175.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 744' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -100.78 153.18 19.67 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 120.77 0.319 . . . . 73.109999999999999 110.397 174.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 31.9 m -93.23 -175.24 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 N-CA-C 112.826 0.676 . . . . 73.329999999999998 112.826 -173.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -60.85 125.24 22.97 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.221 0.534 . . . . 75.519999999999996 111.811 178.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 747' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -84.53 65.05 8.78 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-O 121.513 0.673 . . . . 55.530000000000001 110.33 175.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -87.52 -28.33 22.08 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 112.553 0.575 . . . . 64.209999999999994 112.553 -176.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 749' ' ' LYS . . . . . 0.481 ' NZ ' ' HB3' ' A' ' 749' ' ' LYS . 0.1 OUTLIER -48.73 111.16 1.73 Allowed Pre-proline 0 CA--C 1.549 0.937 0 CA-C-O 121.25 0.547 . . . . 74.239999999999995 112.321 -175.389 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 750' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -85.47 146.37 9.61 Favored 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 123.133 2.555 . . . . 74.340000000000003 114.838 -171.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 751' ' ' ILE . . . . . . . . . . . . . 57.9 mt 59.67 86.0 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 CA-C-N 115.589 -0.732 . . . . 65.239999999999995 112.59 175.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 752' ' ' LEU . . . . . . . . . . . . . 43.2 tp -177.57 146.83 0.47 Allowed 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 116.167 -0.47 . . . . 64.450000000000003 111.235 178.126 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 753' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 . . . . . 0 N--CA 1.47 0.565 0 CA-C-O 121.112 0.482 . . . . 71.010000000000005 111.447 175.951 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 762' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 657' ' ' MET . . . . . . . . . . . . . 86.9 mtp . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.026 0.441 . . . . 71.0 111.532 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 658' ' ' GLY . . . . . . . . . . . . . . . 84.53 -67.92 3.61 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 121.316 -0.468 . . . . 62.310000000000002 112.962 178.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 659' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -91.42 149.28 21.78 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 122.462 -0.434 . . . . 61.340000000000003 111.475 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 660' ' ' GLY . . . . . . . . . . . . . . . -156.3 -110.44 0.33 Allowed Glycine 0 CA--C 1.525 0.673 0 C-N-CA 121.124 -0.56 . . . . 71.409999999999997 112.877 177.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 70.16 -11.46 0.57 Allowed 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 113.042 0.756 . . . . 72.209999999999994 113.042 176.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 662' ' ' THR . . . . . . . . . . . . . 82.3 m -70.39 104.77 2.81 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.13 0.49 . . . . 74.430000000000007 111.928 -174.153 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 663' ' ' SER . . . . . . . . . . . . . 68.2 m -132.23 158.18 42.45 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 116.167 -0.469 . . . . 72.310000000000002 111.236 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 664' ' ' ASP . . . . . 0.406 ' OD2' ' HB2' ' A' ' 727' ' ' LYS . 27.3 t0 -84.84 122.53 29.29 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 121.096 0.474 . . . . 70.450000000000003 110.979 176.013 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 665' ' ' LEU . . . . . . . . . . . . . 86.2 mt -96.94 136.89 36.86 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.117 -0.492 . . . . 55.030000000000001 110.768 175.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 666' ' ' GLU . . . . . 0.47 ' H ' ' CD ' ' A' ' 666' ' ' GLU . 1.4 pm0 -56.83 139.59 77.21 Favored Pre-proline 0 CA--C 1.544 0.712 0 CA-C-O 120.79 0.329 . . . . 73.340000000000003 111.16 175.53 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 667' ' ' PRO . . . . . 0.584 ' HB3' HD12 ' A' ' 699' ' ' LEU . 58.3 Cg_endo -68.97 156.77 64.32 Favored 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 122.618 2.212 . . . . 73.409999999999997 113.737 -172.614 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 668' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -87.76 105.18 17.21 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.99 -0.55 . . . . 65.540000000000006 111.226 177.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 669' ' ' LEU . . . . . 0.518 ' HG ' HG23 ' A' ' 671' ' ' VAL . 62.1 tp -95.09 108.13 20.21 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 116.011 -0.54 . . . . 72.329999999999998 110.658 177.151 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 670' ' ' THR . . . . . . . . . . . . . 88.2 m -86.34 111.31 20.36 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.858 0.361 . . . . 73.109999999999999 111.244 179.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 671' ' ' VAL . . . . . 0.518 HG23 ' HG ' ' A' ' 669' ' ' LEU . 94.6 t -136.31 130.93 18.39 Favored Pre-proline 0 N--CA 1.47 0.555 0 CA-C-N 116.301 -0.409 . . . . 73.319999999999993 110.983 -179.668 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 672' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -76.24 143.73 25.58 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 122.248 1.965 . . . . 72.510000000000005 111.995 175.069 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 673' ' ' VAL . . . . . . . . . . . . . 15.0 p -77.87 -28.06 15.34 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 CA-C-O 120.874 0.369 . . . . 72.340000000000003 111.403 -176.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 674' ' ' GLY . . . . . . . . . . . . . . . -156.16 136.61 5.1 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 120.934 -0.65 . . . . 63.32 113.584 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 675' ' ' ALA . . . . . . . . . . . . . . . -131.29 158.91 39.39 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 122.68 0.392 . . . . 71.340000000000003 110.528 177.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 676' ' ' THR . . . . . . . . . . . . . 13.6 m -135.0 129.04 33.53 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 112.018 0.377 . . . . 72.549999999999997 112.018 -177.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 677' ' ' ILE . . . . . . . . . . . . . 24.4 pt -138.97 176.43 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 122.465 0.306 . . . . 52.43 111.032 177.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 678' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -124.73 165.46 17.92 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.976 0.417 . . . . 75.319999999999993 111.511 178.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 679' ' ' VAL . . . . . . . . . . . . . 63.6 t -60.01 112.58 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 CA-C-N 116.211 -0.449 . . . . 65.349999999999994 110.668 175.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 118.3 -26.13 7.92 Favored Glycine 0 CA--C 1.528 0.89 0 CA-C-N 116.164 -0.471 . . . . 33.43 112.808 -175.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 681' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -69.11 163.91 23.71 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.248 0.547 . . . . 74.540000000000006 112.058 178.097 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 682' ' ' SER . . . . . . . . . . . . . 67.2 m -120.69 121.67 38.77 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.13 -0.487 . . . . 72.439999999999998 111.246 -178.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 683' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -118.42 126.89 53.02 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.334 -0.394 . . . . 73.340000000000003 110.809 -177.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 684' ' ' VAL . . . . . . . . . . . . . 60.8 t -115.4 100.67 53.88 Favored Pre-proline 0 N--CA 1.47 0.572 0 CA-C-O 120.789 0.328 . . . . 71.209999999999994 111.429 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -54.53 -47.14 28.43 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 122.802 2.334 . . . . 64.219999999999999 113.692 -177.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 686' ' ' MET . . . . . . . . . . . . . 88.2 mmm -78.24 0.56 24.7 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.898 0.703 . . . . 74.239999999999995 112.898 -175.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 687' ' ' ALA . . . . . . . . . . . . . . . -94.02 -47.79 6.53 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 120.943 0.401 . . . . 75.430000000000007 110.907 175.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 688' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -80.84 -18.22 48.15 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 112.373 0.508 . . . . 70.430000000000007 112.373 -178.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . 0.498 HG21 ' CZ ' ' A' ' 721' ' ' TYR . 89.3 t -97.54 142.43 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-O 120.888 0.375 . . . . 74.310000000000002 111.227 177.031 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 690' ' ' LEU . . . . . 0.633 HD21 HG12 ' A' ' 692' ' ' ILE . 7.9 tt -146.02 150.69 36.47 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.385 -0.371 . . . . 64.040000000000006 111.357 -173.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 691' ' ' ALA . . . . . . . . . . . . . . . -142.44 120.93 12.45 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.091 0.472 . . . . 63.439999999999998 111.885 176.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 692' ' ' ILE . . . . . 0.633 HG12 HD21 ' A' ' 690' ' ' LEU . 39.3 mm -127.46 144.15 38.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-N 116.166 -0.47 . . . . 71.319999999999993 110.761 178.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 693' ' ' ASP . . . . . 0.452 ' HB2' ' HB3' ' A' ' 667' ' ' PRO . 36.5 t70 -125.02 149.3 47.9 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 120.949 0.404 . . . . 71.019999999999996 111.582 -178.137 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -57.99 -60.09 4.25 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 116.003 -0.544 . . . . 72.200000000000003 112.428 -177.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 695' ' ' GLU . . . . . 0.427 ' CD ' ' H ' ' A' ' 695' ' ' GLU . 0.3 OUTLIER -85.07 -53.58 5.19 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 112.096 0.406 . . . . 72.329999999999998 112.096 -176.283 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 696' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -70.23 -42.13 72.68 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.793 0.33 . . . . 73.0 111.863 -171.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . 108.56 -131.89 10.81 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 120.96 -0.638 . . . . 63.340000000000003 113.399 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -70.93 113.36 7.9 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 121.064 0.459 . . . . 74.409999999999997 111.523 -177.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 699' ' ' LEU . . . . . 0.584 HD12 ' HB3' ' A' ' 667' ' ' PRO . 89.6 mt -110.73 11.8 22.59 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.316 0.579 . . . . 72.219999999999999 110.397 172.532 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 21.1 m -59.89 -28.68 67.77 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.937 -0.574 . . . . 73.040000000000006 110.888 177.189 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 701' ' ' SER . . . . . . . . . . . . . 34.2 t -71.13 -24.42 62.27 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 116.244 -0.434 . . . . 64.099999999999994 111.456 175.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 702' ' ' LYS . . . . . 0.494 ' HB2' HG23 ' A' ' 723' ' ' VAL . 8.4 mmpt? -81.32 -13.75 58.05 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 111.87 0.322 . . . . 62.420000000000002 111.87 -178.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 703' ' ' ILE . . . . . . . . . . . . . 69.8 mt -65.44 115.48 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 N-CA-C 112.076 0.398 . . . . 54.399999999999999 112.076 -177.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 704' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -98.42 124.76 43.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.112 0.482 . . . . 64.450000000000003 110.797 172.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 61.5 t -96.2 111.35 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-N 115.813 -0.63 . . . . 73.109999999999999 111.852 -177.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 706' ' ' ASP . . . . . 0.454 ' HB3' ' HB ' ' A' ' 720' ' ' THR . 38.6 t70 -99.23 134.6 41.85 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.455 -0.339 . . . . 74.409999999999997 110.748 177.211 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 108.42 171.77 21.39 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 121.148 -0.548 . . . . 34.409999999999997 112.678 -176.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 708' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -144.34 148.33 34.6 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 122.58 -0.365 . . . . 74.120000000000005 111.572 -176.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 709' ' ' VAL . . . . . 0.521 HG23 HD21 ' A' ' 719' ' ' LEU . 84.5 t -126.56 118.14 50.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 CA-C-O 120.806 0.336 . . . . 64.140000000000001 111.298 178.428 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 710' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -87.19 136.57 32.88 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 121.101 0.477 . . . . 70.420000000000002 111.361 177.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 711' ' ' THR . . . . . . . . . . . . . 73.9 p -98.63 -13.47 20.33 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.927 0.394 . . . . 73.010000000000005 111.437 177.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 712' ' ' THR . . . . . . . . . . . . . 71.7 p -93.31 -27.68 16.66 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 116.271 -0.422 . . . . 64.530000000000001 111.535 178.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 713' ' ' LYS . . . . . . . . . . . . . 50.2 tptt -116.53 132.43 56.68 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.563 -0.29 . . . . 74.430000000000007 110.526 178.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 714' ' ' ALA . . . . . . . . . . . . . . . -86.59 144.93 26.95 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 112.786 0.662 . . . . 72.030000000000001 112.786 -176.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 163.41 176.31 35.27 Favored Glycine 0 CA--C 1.522 0.482 0 CA-C-N 115.424 -0.807 . . . . 63.0 111.959 -179.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 716' ' ' THR . . . . . . . . . . . . . 95.7 m -94.68 122.21 37.05 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 117.222 0.511 . . . . 63.039999999999999 110.978 177.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 717' ' ' TYR . . . . . 0.477 ' HB2' HG22 ' A' ' 709' ' ' VAL . 57.6 m-85 -121.95 119.45 31.54 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.463 -0.335 . . . . 61.32 110.94 -178.213 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 718' ' ' VAL . . . . . . . . . . . . . 60.3 t -91.42 123.23 43.48 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-O 120.809 0.338 . . . . 54.130000000000003 111.182 179.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 719' ' ' LEU . . . . . 0.521 HD21 HG23 ' A' ' 709' ' ' VAL . 88.0 mt -104.82 126.15 51.6 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.418 -0.356 . . . . 63.130000000000003 111.241 177.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . 0.454 ' HB ' ' HB3' ' A' ' 706' ' ' ASP . 95.1 m -101.08 127.48 47.59 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.988 0.423 . . . . 70.150000000000006 111.33 178.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 721' ' ' TYR . . . . . 0.498 ' CZ ' HG21 ' A' ' 689' ' ' VAL . 57.7 m-85 -113.47 113.91 25.81 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.685 0.279 . . . . 74.5 110.76 179.466 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 72.0 m -113.85 125.34 53.95 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.762 0.315 . . . . 54.549999999999997 111.469 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 723' ' ' VAL . . . . . 0.494 HG23 ' HB2' ' A' ' 702' ' ' LYS . 8.3 p -129.42 133.98 64.44 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-O 120.995 0.426 . . . . 74.310000000000002 111.224 179.015 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 73.5 m -116.44 136.25 53.15 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 120.934 0.397 . . . . 62.530000000000001 111.887 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 725' ' ' ASP . . . . . 0.428 ' HB2' ' HD3' ' A' ' 667' ' ' PRO . 10.7 t0 -73.28 150.9 41.59 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 109.675 -0.491 . . . . 73.439999999999998 109.675 174.297 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 726' ' ' SER . . . . . . . . . . . . . 34.9 t -56.15 -33.24 65.02 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.348 -0.387 . . . . 73.209999999999994 111.753 -179.191 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 727' ' ' LYS . . . . . 0.464 ' HD3' ' N ' ' A' ' 727' ' ' LYS . 3.6 mppt? -91.42 6.85 43.84 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 112.712 0.634 . . . . 72.200000000000003 112.712 -178.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 728' ' ' GLY . . . . . . . . . . . . . . . 101.69 35.2 4.13 Favored Glycine 0 CA--C 1.534 1.279 0 N-CA-C 116.122 1.209 . . . . 71.409999999999997 116.122 169.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 729' ' ' HIS . . . . . 0.411 ' H ' ' HB3' ' A' ' 725' ' ' ASP . 40.7 m80 -109.3 110.68 21.92 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 118.178 0.989 . . . . 73.030000000000001 111.49 172.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 730' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -96.89 128.5 43.91 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.277 0.56 . . . . 71.209999999999994 112.121 -177.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 57.6 t -126.4 129.48 71.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 CA-C-N 115.97 -0.559 . . . . 53.149999999999999 110.109 176.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 7.5 t -137.12 128.86 28.84 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.167 0.508 . . . . 65.349999999999994 112.296 -177.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -135.56 157.65 46.34 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 122.804 0.442 . . . . 73.230000000000004 110.863 -178.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 734' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -121.3 158.69 27.62 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.994 0.739 . . . . 61.109999999999999 112.994 -175.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 735' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -130.57 128.51 41.25 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.839 -0.619 . . . . 64.319999999999993 111.161 179.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 736' ' ' THR . . . . . . . . . . . . . 86.6 m -87.93 103.89 16.1 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 120.751 0.31 . . . . 63.520000000000003 110.991 175.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 47.8 t -96.73 108.39 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-O 120.924 0.392 . . . . 73.530000000000001 111.188 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 738' ' ' THR . . . . . . . . . . . . . 27.3 m -94.84 108.96 20.99 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.79 0.328 . . . . 75.209999999999994 111.342 -179.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 739' ' ' VAL . . . . . . . . . . . . . 43.0 t -94.22 125.34 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-O 120.729 0.3 . . . . 71.150000000000006 110.793 176.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 740' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -115.38 146.55 41.47 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.048 0.451 . . . . 73.310000000000002 111.979 -175.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 741' ' ' VAL . . . . . . . . . . . . . 24.3 t -85.29 144.75 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 CA-C-O 120.88 0.371 . . . . 54.210000000000001 111.914 -179.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 742' ' ' ARG . . . . . . . . . . . . . 21.9 mmm180 -94.08 137.33 33.4 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 109.731 -0.47 . . . . 74.420000000000002 109.731 168.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 743' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -77.83 36.0 0.21 Allowed 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 121.042 0.448 . . . . 73.140000000000001 111.891 -176.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 744' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -125.5 97.8 5.33 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 116.252 -0.431 . . . . 71.0 110.714 -179.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 15.8 m -72.04 75.56 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 CA-C-O 121.832 0.825 . . . . 73.140000000000001 111.323 179.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 64.7 pttt -143.29 131.66 22.15 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.739 -0.664 . . . . 75.549999999999997 111.95 -174.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 747' ' ' ASN . . . . . 0.51 ' N ' HD22 ' A' ' 747' ' ' ASN . 0.9 OUTLIER -113.44 151.78 30.95 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 109.505 -0.554 . . . . 75.510000000000005 109.505 168.294 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -77.86 35.42 0.2 Allowed 'General case' 0 CA--C 1.545 0.772 0 CA-C-O 121.175 0.512 . . . . 64.329999999999998 111.514 177.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 749' ' ' LYS . . . . . . . . . . . . . 49.9 mtpt 65.93 149.7 0.12 Allowed Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 123.867 0.867 . . . . 63.409999999999997 112.348 -179.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 750' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -57.83 160.64 14.52 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 122.489 2.126 . . . . 73.209999999999994 112.791 179.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 751' ' ' ILE . . . . . . . . . . . . . 60.0 mt -64.18 93.37 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-O 121.016 0.436 . . . . 71.209999999999994 110.994 -179.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 752' ' ' LEU . . . . . . . . . . . . . 87.4 mt -75.69 139.47 41.95 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.171 -0.468 . . . . 64.150000000000006 111.292 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 753' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 . . . . . 0 C--O 1.241 0.615 0 CA-C-O 121.118 0.485 . . . . 65.140000000000001 110.687 -177.542 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 762' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 657' ' ' MET . . . . . 0.526 ' N ' ' SD ' ' A' ' 657' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.473 0 CA-C-O 120.623 0.249 . . . . 65.219999999999999 111.336 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 658' ' ' GLY . . . . . . . . . . . . . . . 82.97 172.05 48.11 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 121.332 -0.461 . . . . 73.409999999999997 113.197 178.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 659' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -116.62 107.86 15.23 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.937 0.398 . . . . 52.43 111.17 177.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 660' ' ' GLY . . . . . . . . . . . . . . . -74.59 110.48 3.09 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 120.895 -0.669 . . . . 40.409999999999997 112.598 175.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -60.6 116.88 4.69 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.025 0.441 . . . . 74.439999999999998 111.57 -179.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 662' ' ' THR . . . . . . . . . . . . . 80.7 p -90.33 178.9 6.02 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 115.993 -0.549 . . . . 73.129999999999995 110.811 175.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 663' ' ' SER . . . . . . . . . . . . . 47.0 m -137.13 134.57 36.53 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 122.28 -0.263 . . . . 44.43 111.483 -178.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 664' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -98.19 112.68 24.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.154 0.502 . . . . 65.230000000000004 110.094 169.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 665' ' ' LEU . . . . . 0.524 HD12 ' HB2' ' A' ' 694' ' ' LYS . 86.6 mt -91.98 137.87 32.01 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.937 -0.574 . . . . 65.310000000000002 111.038 179.191 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 666' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -80.68 142.2 52.83 Favored Pre-proline 0 CA--C 1.541 0.612 0 CA-C-N 116.223 -0.444 . . . . 73.109999999999999 110.406 173.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 667' ' ' PRO . . . . . 0.595 ' HB3' HD12 ' A' ' 699' ' ' LEU . 64.4 Cg_endo -70.86 146.2 52.75 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 122.231 1.954 . . . . 53.409999999999997 113.734 -173.002 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 668' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -83.3 103.86 13.01 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.975 -0.557 . . . . 73.140000000000001 110.576 173.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 669' ' ' LEU . . . . . . . . . . . . . 52.3 tp -89.79 132.65 35.12 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.153 -0.476 . . . . 71.239999999999995 109.95 176.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 670' ' ' THR . . . . . . . . . . . . . 91.1 m -121.61 111.31 17.07 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.025 0.441 . . . . 74.140000000000001 111.124 -179.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 671' ' ' VAL . . . . . . . . . . . . . 88.8 t -128.77 134.55 26.42 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-N 115.82 -0.627 . . . . 51.43 110.628 -179.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 672' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.57 127.82 17.94 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 121.964 1.776 . . . . 43.32 111.903 177.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 673' ' ' VAL . . . . . 0.442 ' O ' HG22 ' A' ' 736' ' ' THR . 12.5 p -64.4 -23.78 34.17 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 N-CA-C 112.414 0.524 . . . . 72.430000000000007 112.414 -174.179 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 674' ' ' GLY . . . . . . . . . . . . . . . -169.02 154.27 23.73 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 120.61 -0.805 . . . . 63.140000000000001 113.591 179.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 675' ' ' ALA . . . . . . . . . . . . . . . -150.38 156.29 41.22 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 122.502 0.321 . . . . 72.340000000000003 110.859 177.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 676' ' ' THR . . . . . . . . . . . . . 70.4 m -134.42 127.43 31.55 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.784 0.326 . . . . 60.140000000000001 111.269 -179.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 677' ' ' ILE . . . . . . . . . . . . . 28.4 pt -130.33 176.62 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-O 120.824 0.345 . . . . 61.549999999999997 111.124 179.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 678' ' ' HIS . . . . . 0.513 ' O ' ' HB2' ' A' ' 681' ' ' ASP . 69.9 m80 -116.67 166.67 11.85 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 121.581 0.705 . . . . 75.5 112.311 -179.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 679' ' ' VAL . . . . . 0.473 HG13 ' HA ' ' A' ' 712' ' ' THR . 82.4 t -67.16 112.18 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-N 115.972 -0.558 . . . . 72.329999999999998 110.494 174.334 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 109.24 -2.48 31.22 Favored Glycine 0 CA--C 1.529 0.957 0 CA-C-N 115.891 -0.595 . . . . 73.329999999999998 112.41 -172.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 681' ' ' ASP . . . . . 0.513 ' HB2' ' O ' ' A' ' 678' ' ' HIS . 1.1 t70 -75.62 -168.43 0.85 Allowed 'General case' 0 CA--C 1.547 0.835 0 CA-C-O 120.954 0.407 . . . . 71.319999999999993 110.955 178.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 682' ' ' SER . . . . . . . . . . . . . 73.7 m -150.18 136.74 19.05 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 122.159 -0.338 . . . . 63.450000000000003 110.553 176.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 683' ' ' PHE . . . . . . . . . . . . . 36.0 t80 -138.66 127.38 23.51 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 120.614 0.245 . . . . 65.400000000000006 111.652 -174.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 684' ' ' VAL . . . . . . . . . . . . . 63.8 t -111.73 101.45 51.27 Favored Pre-proline 0 N--CA 1.476 0.85 0 CA-C-O 120.726 0.298 . . . . 71.150000000000006 111.771 179.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -52.82 -42.81 60.91 Favored 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 122.975 2.45 . . . . 70.209999999999994 113.772 179.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 686' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -78.13 3.84 14.04 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 112.79 0.663 . . . . 61.509999999999998 112.79 -176.083 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 687' ' ' ALA . . . . . . . . . . . . . . . -109.35 -14.77 14.39 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 122.2 -0.313 . . . . 74.239999999999995 111.82 176.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 688' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -97.62 -6.5 33.17 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 112.722 0.638 . . . . 71.420000000000002 112.722 -175.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . 0.413 HG12 HD13 ' A' ' 703' ' ' ILE . 49.7 t -121.67 154.83 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 N-CA-C 112.025 0.38 . . . . 43.32 112.025 -174.17 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 690' ' ' LEU . . . . . 0.563 HD23 ' N ' ' A' ' 691' ' ' ALA . 6.4 tt -150.57 143.82 24.9 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 116.509 -0.314 . . . . 71.150000000000006 110.827 -178.307 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 691' ' ' ALA . . . . . 0.563 ' N ' HD23 ' A' ' 690' ' ' LEU . . . -144.08 132.05 21.57 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 112.416 0.525 . . . . 42.439999999999998 112.416 -179.132 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 692' ' ' ILE . . . . . 0.473 HD13 ' HA ' ' A' ' 698' ' ' ASP . 38.6 mm -135.77 136.89 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 N-CA-C 112.116 0.413 . . . . 63.539999999999999 112.116 -179.289 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -115.68 141.82 47.56 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 109.005 -0.739 . . . . 73.140000000000001 109.005 167.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 694' ' ' LYS . . . . . 0.524 ' HB2' HD12 ' A' ' 665' ' ' LEU . 54.5 mttp -71.33 -28.97 64.46 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.289 0.478 . . . . 74.400000000000006 112.289 -177.408 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -83.38 -44.75 14.48 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-O 120.916 0.389 . . . . 75.329999999999998 111.974 -179.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 696' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -92.87 -30.3 15.5 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 120.851 0.358 . . . . 65.299999999999997 111.325 -173.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . 105.86 -135.17 12.48 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 121.325 -0.464 . . . . 53.5 112.769 179.096 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 698' ' ' ASP . . . . . 0.473 ' HA ' HD13 ' A' ' 692' ' ' ILE . 12.1 t70 -71.83 125.09 26.29 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 122.534 -0.392 . . . . 71.299999999999997 111.497 179.05 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 699' ' ' LEU . . . . . 0.632 HD22 ' HD2' ' A' ' 702' ' ' LYS . 45.7 mt -119.83 6.65 10.92 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.493 -0.321 . . . . 72.540000000000006 111.584 177.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 49.6 m -58.6 -40.13 82.36 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.201 0.524 . . . . 73.340000000000003 111.464 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 701' ' ' SER . . . . . . . . . . . . . 37.2 t -66.03 -13.78 60.54 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 121.072 0.463 . . . . 63.149999999999999 111.817 176.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 702' ' ' LYS . . . . . 0.632 ' HD2' HD22 ' A' ' 699' ' ' LEU . 97.4 mttt -99.11 6.62 46.43 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.217 0.451 . . . . 74.109999999999999 112.217 -178.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 703' ' ' ILE . . . . . 0.413 HD13 HG12 ' A' ' 689' ' ' VAL . 73.9 mt -80.02 117.45 25.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-O 121.044 0.45 . . . . 72.140000000000001 111.541 -179.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 704' ' ' LYS . . . . . 0.409 ' HE3' ' HB2' ' A' ' 704' ' ' LYS . 35.9 ttmt -91.34 136.64 32.96 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.212 -0.449 . . . . 72.019999999999996 111.039 176.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 46.6 t -109.27 140.55 27.6 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-O 121.129 0.49 . . . . 63.219999999999999 111.889 -177.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 706' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -132.36 126.02 32.26 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 116.273 -0.421 . . . . 64.010000000000005 110.253 174.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 102.97 152.94 24.1 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 121.141 -0.552 . . . . 51.420000000000002 112.404 -173.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 708' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -153.59 143.62 22.1 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 122.19 -0.594 . . . . 60.43 111.566 -176.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 709' ' ' VAL . . . . . 0.543 HG22 ' HB2' ' A' ' 717' ' ' TYR . 71.7 t -99.52 134.35 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-N 116.067 -0.515 . . . . 64.329999999999998 111.842 -177.231 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 710' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -100.54 150.78 22.32 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 121.027 0.442 . . . . 64.25 110.431 170.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 711' ' ' THR . . . . . . . . . . . . . 80.7 p -107.39 28.2 8.34 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.444 -0.344 . . . . 73.349999999999994 111.494 -178.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 712' ' ' THR . . . . . 0.473 ' HA ' HG13 ' A' ' 679' ' ' VAL . 7.5 t -115.9 -28.48 6.66 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 112.385 0.513 . . . . 74.230000000000004 112.385 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 713' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -115.67 122.37 45.35 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 120.733 0.301 . . . . 63.32 111.095 -176.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 714' ' ' ALA . . . . . 0.482 ' HB2' HG23 ' A' ' 741' ' ' VAL . . . -70.43 101.96 2.08 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 121.199 0.523 . . . . 71.239999999999995 111.718 -178.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . -164.18 168.45 38.61 Favored Glycine 0 CA--C 1.52 0.355 0 CA-C-N 115.99 -0.55 . . . . 71.349999999999994 112.843 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 716' ' ' THR . . . . . . . . . . . . . 73.2 m -95.52 122.7 38.54 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.05 0.452 . . . . 74.150000000000006 111.612 178.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 717' ' ' TYR . . . . . 0.543 ' HB2' HG22 ' A' ' 709' ' ' VAL . 57.6 m-85 -116.86 124.45 49.54 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 116.106 -0.497 . . . . 70.310000000000002 110.418 179.158 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 718' ' ' VAL . . . . . . . . . . . . . 45.6 t -96.28 110.88 25.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-O 121.09 0.471 . . . . 71.120000000000005 111.613 -178.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 719' ' ' LEU . . . . . 0.531 HD21 HG23 ' A' ' 709' ' ' VAL . 58.9 mt -88.41 130.5 35.16 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.131 -0.486 . . . . 75.450000000000003 111.227 -178.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 84.5 m -99.72 132.29 45.16 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.903 0.382 . . . . 75.150000000000006 111.496 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 721' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -122.01 134.27 54.8 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.838 0.351 . . . . 73.310000000000002 110.937 177.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 24.7 m -135.82 130.27 33.7 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 111.625 0.231 . . . . 73.5 111.625 -176.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 8.7 p -125.0 132.47 71.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-O 121.031 0.443 . . . . 73.200000000000003 111.286 178.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 22.7 m -108.4 120.5 42.57 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.945 0.403 . . . . 63.329999999999998 111.991 -176.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 725' ' ' ASP . . . . . 0.496 ' HB2' ' HD3' ' A' ' 667' ' ' PRO . 3.6 t70 -73.19 149.71 42.69 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 116.197 -0.456 . . . . 75.349999999999994 110.734 175.216 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 726' ' ' SER . . . . . . . . . . . . . 56.8 p -65.43 -26.3 67.91 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 112.287 0.477 . . . . 55.420000000000002 112.287 -174.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 727' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -93.76 -3.7 51.68 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 112.715 0.635 . . . . 72.129999999999995 112.715 178.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 728' ' ' GLY . . . . . . . . . . . . . . . 111.72 19.88 7.16 Favored Glycine 0 CA--C 1.532 1.096 0 N-CA-C 115.529 0.972 . . . . 63.329999999999998 115.529 172.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 27.7 m80 -97.13 104.96 17.02 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 118.241 1.02 . . . . 74.010000000000005 111.025 172.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 730' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -112.19 114.63 27.54 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 120.933 0.397 . . . . 64.219999999999999 111.665 -177.116 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 32.8 m -109.83 158.73 9.82 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-O 121.084 0.469 . . . . 64.530000000000001 111.582 179.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 5.6 t -135.56 145.39 46.92 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 121.204 0.526 . . . . 61.530000000000001 112.163 -176.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -148.59 161.12 42.34 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.997 -0.547 . . . . 53.149999999999999 110.791 176.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 734' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -133.52 157.49 45.51 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 112.509 0.559 . . . . 73.329999999999998 112.509 -176.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 735' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -130.61 125.98 35.48 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 115.623 -0.717 . . . . 71.530000000000001 110.794 178.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 736' ' ' THR . . . . . 0.442 HG22 ' O ' ' A' ' 673' ' ' VAL . 8.3 t -93.36 110.27 21.82 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.254 0.55 . . . . 74.040000000000006 111.588 178.298 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 46.8 t -106.69 115.69 48.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-N 116.474 -0.33 . . . . 74.109999999999999 111.339 -179.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 738' ' ' THR . . . . . . . . . . . . . 88.8 m -99.62 124.72 45.1 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 120.778 0.323 . . . . 42.399999999999999 111.503 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 739' ' ' VAL . . . . . . . . . . . . . 49.7 t -96.76 134.25 35.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-O 120.916 0.389 . . . . 74.129999999999995 111.429 178.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 740' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -121.55 144.96 48.43 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.4 -0.363 . . . . 60.130000000000003 111.188 178.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 741' ' ' VAL . . . . . 0.482 HG23 ' HB2' ' A' ' 714' ' ' ALA . 25.6 t -80.07 143.17 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 O-C-N 121.639 -0.663 . . . . 63.350000000000001 111.638 -178.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 742' ' ' ARG . . . . . . . . . . . . . 86.1 mtm180 -71.18 127.81 33.81 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 116.32 -0.4 . . . . 75.200000000000003 110.851 175.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 743' ' ' GLU . . . . . 0.462 ' H ' ' CD ' ' A' ' 743' ' ' GLU . 1.1 pm0 -52.66 139.39 26.24 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 121.497 0.665 . . . . 73.299999999999997 112.293 -177.025 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 744' ' ' GLU . . . . . 0.49 ' H ' ' CD ' ' A' ' 744' ' ' GLU . 0.6 OUTLIER -88.53 137.02 32.69 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.664 -0.698 . . . . 72.109999999999999 112.404 -173.347 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 35.9 m -129.11 168.05 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-N 116.164 -0.471 . . . . 73.439999999999998 110.716 176.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -65.08 124.89 23.3 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 122.112 -0.367 . . . . 72.329999999999998 110.214 175.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 747' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -65.65 107.31 1.71 Allowed 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 120.996 0.427 . . . . 73.239999999999995 110.929 -175.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -108.73 130.17 55.36 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.123 -0.489 . . . . 73.299999999999997 111.129 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 749' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -110.75 99.01 40.24 Favored Pre-proline 0 CA--C 1.541 0.625 0 CA-C-O 120.858 0.361 . . . . 74.340000000000003 110.999 179.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 750' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -78.24 -164.83 0.29 Allowed 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 122.769 2.313 . . . . 74.409999999999997 112.536 179.07 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 751' ' ' ILE . . . . . . . . . . . . . 52.8 mt -97.37 89.32 1.99 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-O 120.955 0.407 . . . . 63.439999999999998 110.687 177.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 752' ' ' LEU . . . . . . . . . . . . . 82.6 mt -66.64 99.86 0.63 Allowed 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.072 0.463 . . . . 74.150000000000006 110.518 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 753' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 . . . . . 0 C--O 1.238 0.449 0 CA-C-O 121.282 0.563 . . . . 64.040000000000006 111.999 -173.52 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 762' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 657' ' ' MET . . . . . . . . . . . . . 84.1 mtp . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 120.583 0.23 . . . . 63.109999999999999 111.261 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 658' ' ' GLY . . . . . . . . . . . . . . . -133.07 -75.55 0.1 Allowed Glycine 0 CA--C 1.527 0.839 0 C-N-CA 121.04 -0.6 . . . . 71.030000000000001 112.926 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 659' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -151.91 -65.41 0.17 Allowed 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 111.971 0.36 . . . . 52.240000000000002 111.971 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 660' ' ' GLY . . . . . . . . . . . . . . . 73.35 174.24 27.73 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 121.217 -0.516 . . . . 43.130000000000003 113.255 -178.077 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -135.22 -71.01 0.48 Allowed 'General case' 0 N--CA 1.469 0.488 0 O-C-N 122.503 -0.41 . . . . 62.439999999999998 111.058 178.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 662' ' ' THR . . . . . . . . . . . . . 99.8 m 61.21 88.51 0.08 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.899 -0.591 . . . . 64.420000000000002 111.604 -175.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 663' ' ' SER . . . . . . . . . . . . . 74.0 m -92.61 120.49 33.09 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.172 -0.467 . . . . 72.519999999999996 110.312 173.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 664' ' ' ASP . . . . . 0.493 ' CG ' ' HB2' ' A' ' 727' ' ' LYS . 45.0 t0 -73.45 117.5 15.28 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 121.132 0.491 . . . . 51.119999999999997 111.676 -176.115 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 665' ' ' LEU . . . . . . . . . . . . . 85.2 mt -81.57 116.86 21.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.007 -0.542 . . . . 55.420000000000002 109.78 175.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 666' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -77.37 137.74 64.02 Favored Pre-proline 0 CA--C 1.541 0.616 0 CA-C-O 120.898 0.38 . . . . 75.209999999999994 111.433 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 667' ' ' PRO . . . . . 0.558 ' HB3' HD12 ' A' ' 699' ' ' LEU . 65.8 Cg_endo -71.46 140.46 36.56 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 122.596 2.197 . . . . 71.219999999999999 113.182 -174.085 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 668' ' ' LYS . . . . . 0.402 ' O ' ' HA ' ' A' ' 691' ' ' ALA . 22.7 tptm -83.58 106.9 15.68 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.302 -0.408 . . . . 74.340000000000003 110.631 176.687 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 669' ' ' LEU . . . . . 0.464 ' HG ' HG23 ' A' ' 671' ' ' VAL . 58.7 tp -90.04 110.14 21.15 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 116.275 -0.421 . . . . 74.349999999999994 110.523 178.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 670' ' ' THR . . . . . . . . . . . . . 67.6 m -86.38 109.4 18.99 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.854 0.359 . . . . 73.209999999999994 111.126 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 671' ' ' VAL . . . . . 0.464 HG23 ' HG ' ' A' ' 669' ' ' LEU . 91.0 t -141.78 120.83 7.95 Favored Pre-proline 0 N--CA 1.473 0.684 0 CA-C-N 116.257 -0.429 . . . . 75.299999999999997 110.774 179.178 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 672' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -73.8 150.1 43.86 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 122.366 2.044 . . . . 74.409999999999997 112.529 -179.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 673' ' ' VAL . . . . . . . . . . . . . 7.7 p -64.36 -38.2 81.94 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 N-CA-C 112.16 0.43 . . . . 74.310000000000002 112.16 -178.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 674' ' ' GLY . . . . . . . . . . . . . . . -156.46 157.67 28.1 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 120.805 -0.712 . . . . 72.540000000000006 114.031 -177.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 675' ' ' ALA . . . . . 0.434 ' O ' ' HA ' ' A' ' 737' ' ' VAL . . . -151.88 135.09 15.89 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 122.831 0.453 . . . . 62.299999999999997 110.668 178.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 676' ' ' THR . . . . . . . . . . . . . 62.5 m -115.23 123.63 49.32 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 121.993 -0.442 . . . . 74.129999999999995 112.025 -178.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 677' ' ' ILE . . . . . . . . . . . . . 17.5 pt -127.36 176.55 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 CA-C-N 116.254 -0.43 . . . . 71.109999999999999 110.865 177.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 678' ' ' HIS . . . . . . . . . . . . . 63.1 m80 -117.05 157.74 25.34 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.429 0.633 . . . . 72.140000000000001 112.182 -178.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 679' ' ' VAL . . . . . . . . . . . . . 92.0 t -54.63 113.02 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-N 115.513 -0.767 . . . . 52.299999999999997 111.401 175.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 116.3 -18.79 13.58 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 121.162 -0.542 . . . . 63.25 113.705 -179.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 681' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -74.43 -179.77 4.18 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 121.495 0.664 . . . . 64.030000000000001 112.502 -179.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 682' ' ' SER . . . . . . . . . . . . . 57.5 m -122.67 151.27 41.68 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.754 -0.657 . . . . 72.319999999999993 111.401 -178.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 683' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -158.88 116.04 2.77 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 116.546 -0.297 . . . . 73.329999999999998 110.801 -178.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 684' ' ' VAL . . . . . . . . . . . . . 41.7 t -113.57 98.3 46.52 Favored Pre-proline 0 CA--C 1.54 0.564 0 CA-C-O 120.949 0.404 . . . . 62.109999999999999 111.333 -178.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 685' ' ' PRO . . . . . 0.42 ' HB3' ' HE1' ' A' ' 721' ' ' TYR . 77.7 Cg_exo -51.52 -43.68 48.7 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 122.873 2.382 . . . . 71.420000000000002 113.615 -178.472 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 686' ' ' MET . . . . . 0.554 ' HE2' ' HA ' ' A' ' 686' ' ' MET . 0.4 OUTLIER -78.25 -1.3 32.3 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 112.758 0.651 . . . . 74.530000000000001 112.758 -177.13 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 687' ' ' ALA . . . . . . . . . . . . . . . -112.32 -8.35 13.94 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.788 0.328 . . . . 74.439999999999998 111.634 176.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 688' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -121.35 -22.54 5.96 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 112.119 0.414 . . . . 75.239999999999995 112.119 -177.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 96.4 t -95.82 148.23 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-O 120.626 0.251 . . . . 71.230000000000004 110.681 175.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 690' ' ' LEU . . . . . 0.68 HD21 HG12 ' A' ' 692' ' ' ILE . 9.6 tt -144.81 152.1 39.8 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 112.037 0.384 . . . . 65.530000000000001 112.037 -171.441 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 691' ' ' ALA . . . . . 0.402 ' HA ' ' O ' ' A' ' 668' ' ' LYS . . . -150.33 123.04 8.61 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 120.813 0.339 . . . . 65.230000000000004 111.371 176.479 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 692' ' ' ILE . . . . . 0.68 HG12 HD21 ' A' ' 690' ' ' LEU . 46.5 mm -123.62 134.65 65.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 N-CA-C 112.467 0.543 . . . . 53.229999999999997 112.467 -178.299 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 693' ' ' ASP . . . . . 0.474 ' HB2' ' HB3' ' A' ' 667' ' ' PRO . 67.7 t0 -117.43 128.34 54.91 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 109.216 -0.661 . . . . 72.040000000000006 109.216 170.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -65.63 -26.7 67.94 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 112.96 0.726 . . . . 73.120000000000005 112.96 -173.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -82.8 -40.65 20.12 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 120.824 0.345 . . . . 71.310000000000002 111.526 -177.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 696' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -95.65 -49.31 5.43 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 121.253 0.549 . . . . 55.119999999999997 111.702 -176.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . 129.01 -131.51 6.82 Favored Glycine 0 CA--C 1.528 0.855 0 CA-C-N 116.34 -0.391 . . . . 63.299999999999997 112.654 -177.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 698' ' ' ASP . . . . . 0.454 ' HA ' HD13 ' A' ' 692' ' ' ILE . 20.7 t70 -75.5 109.15 8.82 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 121.055 0.455 . . . . 75.239999999999995 111.464 178.422 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 699' ' ' LEU . . . . . 0.558 HD12 ' HB3' ' A' ' 667' ' ' PRO . 23.3 mt -99.42 4.41 46.2 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 120.839 0.352 . . . . 71.25 110.787 173.044 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 25.1 m -55.39 -40.06 70.92 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.686 0.755 . . . . 74.099999999999994 109.972 171.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 701' ' ' SER . . . . . . . . . . . . . 21.6 m -66.91 -7.76 24.37 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 115.218 -0.901 . . . . 71.120000000000005 112.146 177.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 702' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -104.05 -7.73 20.06 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 111.884 0.328 . . . . 72.129999999999995 111.884 -179.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 703' ' ' ILE . . . . . 0.482 ' HB ' ' HE1' ' A' ' 686' ' ' MET . 63.2 mt -70.66 140.8 17.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-O 120.835 0.35 . . . . 74.0 111.707 -178.233 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 704' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -110.51 133.42 53.31 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 110.247 -0.279 . . . . 72.140000000000001 110.247 170.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 50.5 t -96.7 107.23 19.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-O 120.956 0.407 . . . . 63.020000000000003 110.831 178.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 706' ' ' ASP . . . . . 0.519 ' HB3' ' HB ' ' A' ' 720' ' ' THR . 13.2 t70 -100.1 127.52 46.33 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 116.283 -0.417 . . . . 74.349999999999994 110.392 179.44 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 123.11 -175.86 16.6 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 121.173 -0.537 . . . . 55.119999999999997 113.132 -178.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 708' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -155.63 141.33 17.97 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 120.783 0.325 . . . . 73.430000000000007 111.237 -178.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 709' ' ' VAL . . . . . 0.471 HG22 ' HB2' ' A' ' 717' ' ' TYR . 93.9 t -124.87 111.53 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-O 120.887 0.375 . . . . 63.32 111.184 178.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 710' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -69.19 134.86 49.8 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 121.054 0.454 . . . . 63.549999999999997 110.669 176.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 711' ' ' THR . . . . . . . . . . . . . 35.9 p -113.54 -0.76 14.29 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.883 0.373 . . . . 74.310000000000002 110.98 178.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 712' ' ' THR . . . . . . . . . . . . . 81.9 p -98.15 -17.81 18.83 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.15 -0.477 . . . . 62.219999999999999 111.505 178.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 713' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -138.52 139.36 38.7 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 120.864 0.364 . . . . 64.209999999999994 111.271 -178.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 714' ' ' ALA . . . . . . . . . . . . . . . -70.18 144.4 51.95 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 112.662 0.616 . . . . 65.319999999999993 112.662 -176.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 159.25 161.54 11.28 Favored Glycine 0 CA--C 1.525 0.683 0 CA-C-N 115.689 -0.687 . . . . 75.409999999999997 112.262 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 716' ' ' THR . . . . . 0.405 ' HA ' ' HA ' ' A' ' 738' ' ' THR . 97.4 m -96.88 122.53 39.95 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 117.312 0.556 . . . . 74.5 111.419 178.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 717' ' ' TYR . . . . . 0.471 ' HB2' HG22 ' A' ' 709' ' ' VAL . 22.6 m-85 -123.8 150.2 44.77 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 116.193 -0.458 . . . . 53.219999999999999 110.304 -178.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 718' ' ' VAL . . . . . . . . . . . . . 58.4 t -115.57 133.94 60.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 CA-C-O 121.002 0.43 . . . . 72.239999999999995 111.918 -176.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 719' ' ' LEU . . . . . 0.414 HD21 HG23 ' A' ' 709' ' ' VAL . 88.6 mt -112.09 125.95 54.65 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.304 -0.407 . . . . 73.230000000000004 111.416 178.043 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . 0.519 ' HB ' ' HB3' ' A' ' 706' ' ' ASP . 68.8 m -99.52 129.12 45.66 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.156 -0.474 . . . . 74.040000000000006 111.253 178.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 721' ' ' TYR . . . . . 0.42 ' HE1' ' HB3' ' A' ' 685' ' ' PRO . 77.1 m-85 -115.7 114.25 24.59 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.751 0.31 . . . . 65.239999999999995 111.002 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 45.7 m -117.22 131.92 56.74 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.57 -0.286 . . . . 73.030000000000001 111.517 -178.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 723' ' ' VAL . . . . . 0.471 ' HB ' HG12 ' A' ' 703' ' ' ILE . 7.1 p -137.16 137.25 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-O 121.066 0.46 . . . . 74.120000000000005 111.424 178.213 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 724' ' ' THR . . . . . 0.458 ' HA ' ' HA ' ' A' ' 730' ' ' GLU . 33.5 m -107.27 135.3 49.01 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.248 0.547 . . . . 72.329999999999998 112.059 -178.254 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 725' ' ' ASP . . . . . 0.537 ' HB3' ' H ' ' A' ' 729' ' ' HIS . 11.0 t0 -73.61 154.09 39.9 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 115.853 -0.612 . . . . 70.340000000000003 110.617 177.553 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 726' ' ' SER . . . . . . . . . . . . . 74.6 m -65.78 -21.98 66.54 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 116.626 -0.261 . . . . 61.219999999999999 111.572 177.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 727' ' ' LYS . . . . . 0.493 ' HB2' ' CG ' ' A' ' 664' ' ' ASP . 73.8 mmtt -106.81 4.67 27.77 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 112.495 0.554 . . . . 75.120000000000005 112.495 178.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 728' ' ' GLY . . . . . . . . . . . . . . . 114.1 -5.67 23.65 Favored Glycine 0 CA--C 1.54 1.624 0 N-CA-C 116.739 1.455 . . . . 70.439999999999998 116.739 171.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 729' ' ' HIS . . . . . 0.537 ' H ' ' HB3' ' A' ' 725' ' ' ASP . 15.1 m80 -73.16 98.17 2.55 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 119.414 1.607 . . . . 75.030000000000001 111.389 174.661 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 730' ' ' GLU . . . . . 0.458 ' HA ' ' HA ' ' A' ' 724' ' ' THR . 34.7 tt0 -98.63 106.96 19.3 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 122.188 -0.32 . . . . 73.030000000000001 111.095 179.325 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 26.9 m -111.71 152.23 13.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-O 120.942 0.401 . . . . 75.409999999999997 111.582 -176.074 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 7.2 t -146.57 151.87 38.02 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.065 0.459 . . . . 75.040000000000006 112.124 -179.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -148.35 154.29 39.75 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 115.996 -0.547 . . . . 73.109999999999999 110.722 178.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 734' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -114.95 155.3 27.17 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 112.389 0.515 . . . . 74.019999999999996 112.389 -176.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 735' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -131.36 125.98 34.07 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.081 -0.508 . . . . 75.329999999999998 110.977 178.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 736' ' ' THR . . . . . . . . . . . . . 87.7 m -90.73 104.11 16.73 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 116.475 -0.329 . . . . 61.109999999999999 111.287 178.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 737' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 675' ' ' ALA . 48.3 t -99.99 110.2 26.56 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-O 120.872 0.368 . . . . 71.549999999999997 111.756 -179.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 738' ' ' THR . . . . . 0.405 ' HA ' ' HA ' ' A' ' 716' ' ' THR . 51.8 m -95.57 123.74 39.27 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 121.036 0.446 . . . . 54.399999999999999 111.627 178.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 739' ' ' VAL . . . . . . . . . . . . . 48.1 t -104.26 128.61 57.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 CA-C-O 120.835 0.35 . . . . 75.510000000000005 111.404 178.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 740' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -116.56 160.78 20.15 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 120.858 0.361 . . . . 60.240000000000002 111.553 177.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 741' ' ' VAL . . . . . . . . . . . . . 43.6 t -84.62 156.02 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 CA-C-O 120.817 0.341 . . . . 75.450000000000003 111.582 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 742' ' ' ARG . . . . . . . . . . . . . 12.9 ptp180 -95.6 136.0 36.55 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 120.913 0.387 . . . . 65.420000000000002 110.661 175.138 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 743' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -94.47 152.93 18.19 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 121.144 0.497 . . . . 75.200000000000003 111.674 -178.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 744' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -108.7 173.52 6.28 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 112.557 0.577 . . . . 63.340000000000003 112.557 -173.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 33.7 m -125.53 160.05 32.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-N 115.749 -0.659 . . . . 74.400000000000006 110.916 176.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 49.4 mttp -133.27 143.16 48.9 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.075 0.464 . . . . 63.549999999999997 111.756 177.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 747' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -96.69 -6.51 36.3 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 121.349 0.595 . . . . 62.119999999999997 111.04 -178.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -77.65 62.83 2.63 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 116.037 -0.529 . . . . 71.530000000000001 111.237 -178.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 749' ' ' LYS . . . . . 0.429 ' HA ' ' HD3' ' A' ' 750' ' ' PRO . 95.6 mttt 65.38 143.2 0.08 OUTLIER Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 123.049 0.539 . . . . 72.430000000000007 111.568 -175.323 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 750' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 749' ' ' LYS . 31.4 Cg_exo -59.67 92.04 0.08 OUTLIER 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 122.58 2.186 . . . . 65.209999999999994 113.992 -175.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 751' ' ' ILE . . . . . . . . . . . . . 60.7 mt -79.36 82.39 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 CA-C-O 121.602 0.715 . . . . 71.219999999999999 109.789 171.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 752' ' ' LEU . . . . . 0.533 HD23 ' H ' ' A' ' 752' ' ' LEU . 2.4 pt? -87.07 25.91 1.26 Allowed 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 113.128 0.788 . . . . 64.519999999999996 113.128 -170.357 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 753' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 . . . . . 0 N--CA 1.47 0.565 0 CA-C-O 121.284 0.564 . . . . 63.399999999999999 111.707 176.381 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 762' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 657' ' ' MET . . . . . . . . . . . . . 26.3 ptt? . . . . . 0 N--CA 1.487 1.412 0 CA-C-O 120.997 0.427 . . . . 64.329999999999998 111.2 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 658' ' ' GLY . . . . . . . . . . . . . . . -139.99 157.47 25.4 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 121.373 -0.442 . . . . 75.239999999999995 112.722 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 659' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -86.9 62.66 7.52 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.409 0.623 . . . . 72.329999999999998 111.45 -178.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 660' ' ' GLY . . . . . . . . . . . . . . . -111.54 133.09 11.26 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-N 115.828 -0.623 . . . . 64.439999999999998 112.486 178.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -151.5 165.85 32.94 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 122.463 -0.434 . . . . 74.25 110.815 -179.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 662' ' ' THR . . . . . . . . . . . . . 80.9 p -60.05 143.31 52.3 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 120.956 0.408 . . . . 51.229999999999997 111.955 -179.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 663' ' ' SER . . . . . . . . . . . . . 31.6 m -69.77 104.45 2.45 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 116.208 -0.451 . . . . 74.010000000000005 110.533 177.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 664' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -73.99 117.18 15.48 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.607 0.718 . . . . 63.310000000000002 112.017 -176.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 665' ' ' LEU . . . . . . . . . . . . . 87.8 mt -101.82 138.72 38.42 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.266 -0.879 . . . . 65.230000000000004 110.779 175.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 666' ' ' GLU . . . . . 0.419 ' H ' ' CD ' ' A' ' 666' ' ' GLU . 1.3 pm0 -70.73 137.52 85.56 Favored Pre-proline 0 CA--C 1.542 0.638 0 N-CA-C 110.222 -0.288 . . . . 74.209999999999994 110.222 170.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 667' ' ' PRO . . . . . 0.537 ' HB3' ' HB2' ' A' ' 693' ' ' ASP . 59.9 Cg_endo -70.59 150.3 62.97 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 122.569 2.179 . . . . 74.420000000000002 113.769 -174.189 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 668' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -83.53 107.88 16.29 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 121.178 0.513 . . . . 62.549999999999997 110.635 175.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 669' ' ' LEU . . . . . . . . . . . . . 48.5 tp -90.62 112.47 24.2 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.95 -0.568 . . . . 63.229999999999997 109.828 175.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 670' ' ' THR . . . . . . . . . . . . . 83.6 m -95.11 110.48 22.42 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.175 0.512 . . . . 74.25 111.73 -176.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 671' ' ' VAL . . . . . 0.41 HG22 HG13 ' A' ' 689' ' ' VAL . 82.1 t -133.25 134.2 23.81 Favored Pre-proline 0 CA--C 1.542 0.638 0 CA-C-N 115.599 -0.728 . . . . 71.239999999999995 110.758 -178.106 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 672' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.42 136.66 26.69 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 122.201 1.934 . . . . 63.229999999999997 111.807 175.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 673' ' ' VAL . . . . . . . . . . . . . 14.3 p -64.5 -33.63 64.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 N-CA-C 112.093 0.405 . . . . 60.329999999999998 112.093 -176.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 674' ' ' GLY . . . . . 0.437 ' HA2' ' O ' ' A' ' 736' ' ' THR . . . -157.31 153.3 24.55 Favored Glycine 0 CA--C 1.523 0.554 0 C-N-CA 120.894 -0.67 . . . . 63.299999999999997 113.416 -178.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 675' ' ' ALA . . . . . . . . . . . . . . . -144.51 121.0 11.03 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.752 0.311 . . . . 61.409999999999997 111.169 179.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 676' ' ' THR . . . . . . . . . . . . . 84.8 m -96.98 121.6 39.04 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.92 0.39 . . . . 61.130000000000003 111.446 -179.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 677' ' ' ILE . . . . . . . . . . . . . 32.0 pt -130.79 176.68 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 CA-C-N 116.5 -0.318 . . . . 74.310000000000002 110.984 178.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 678' ' ' HIS . . . . . . . . . . . . . 78.0 m80 -121.55 153.72 37.64 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.231 0.538 . . . . 52.439999999999998 112.394 -179.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 679' ' ' VAL . . . . . . . . . . . . . 92.6 t -55.32 115.28 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 115.68 -0.691 . . . . 64.540000000000006 111.733 179.261 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 100.33 24.42 9.56 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 121.313 -0.47 . . . . 71.129999999999995 113.341 -177.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 681' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -108.59 176.03 5.26 Favored 'General case' 0 CA--C 1.546 0.826 0 O-C-N 122.516 -0.402 . . . . 52.350000000000001 110.883 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 682' ' ' SER . . . . . . . . . . . . . 84.4 p -114.94 129.57 56.74 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 122.334 0.254 . . . . 64.129999999999995 111.237 -179.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 683' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -139.4 126.1 20.68 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 120.821 0.343 . . . . 64.310000000000002 111.224 -178.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 684' ' ' VAL . . . . . . . . . . . . . 81.6 t -114.17 105.19 54.39 Favored Pre-proline 0 N--CA 1.474 0.753 0 N-CA-C 111.989 0.366 . . . . 55.409999999999997 111.989 -179.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_exo -53.37 -40.55 77.78 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 123.041 2.494 . . . . 71.120000000000005 113.727 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 686' ' ' MET . . . . . 0.552 ' HE3' ' HA ' ' A' ' 686' ' ' MET . 1.0 OUTLIER -78.24 -4.0 45.56 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 112.636 0.606 . . . . 73.439999999999998 112.636 -177.994 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 687' ' ' ALA . . . . . . . . . . . . . . . -98.74 -17.68 18.39 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.954 0.407 . . . . 63.130000000000003 111.385 177.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 688' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -98.67 -13.94 20.07 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 112.446 0.535 . . . . 74.420000000000002 112.446 -175.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . 0.59 HG12 HD13 ' A' ' 703' ' ' ILE . 94.9 t -122.49 132.93 70.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 N-CA-C 112.919 0.711 . . . . 75.140000000000001 112.919 -173.23 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 690' ' ' LEU . . . . . 0.514 ' HA ' HG23 ' A' ' 700' ' ' THR . 6.5 mp -124.93 165.0 18.87 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 116.274 -0.421 . . . . 71.540000000000006 111.021 177.392 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 691' ' ' ALA . . . . . . . . . . . . . . . -152.19 127.41 9.84 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 120.915 0.388 . . . . 44.340000000000003 111.909 178.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 692' ' ' ILE . . . . . . . . . . . . . 45.6 mm -135.28 139.07 47.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 N-CA-C 112.097 0.406 . . . . 73.310000000000002 112.097 -177.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 693' ' ' ASP . . . . . 0.537 ' HB2' ' HB3' ' A' ' 667' ' ' PRO . 45.5 t0 -120.29 137.93 53.98 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 109.589 -0.523 . . . . 75.519999999999996 109.589 171.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 52.9 tttp -57.33 -35.25 69.66 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 121.06 0.457 . . . . 74.129999999999995 112.1 -178.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -82.52 -46.16 13.76 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 112.294 0.479 . . . . 72.219999999999999 112.294 -176.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 696' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -94.33 -34.79 12.67 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 112.361 0.504 . . . . 51.100000000000001 112.361 -170.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . 105.26 -123.3 7.55 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 121.44 -0.409 . . . . 33.530000000000001 113.018 -178.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -75.96 118.41 18.7 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 121.272 0.558 . . . . 71.540000000000006 112.142 -178.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 699' ' ' LEU . . . . . 0.449 HD12 ' HB3' ' A' ' 667' ' ' PRO . 81.4 mt -118.33 8.13 12.15 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 115.719 -0.673 . . . . 62.420000000000002 110.408 171.742 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 700' ' ' THR . . . . . 0.514 HG23 ' HA ' ' A' ' 690' ' ' LEU . 37.8 m -59.1 -37.77 77.96 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.48 0.657 . . . . 54.229999999999997 110.568 175.343 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 701' ' ' SER . . . . . . . . . . . . . 54.8 p -73.4 -2.75 23.62 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 115.588 -0.733 . . . . 62.200000000000003 111.865 176.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 702' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -110.74 2.01 18.18 Favored 'General case' 0 CA--C 1.541 0.596 0 N-CA-C 111.859 0.318 . . . . 72.150000000000006 111.859 -179.067 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 703' ' ' ILE . . . . . 0.59 HD13 HG12 ' A' ' 689' ' ' VAL . 66.9 mt -71.12 129.67 34.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-O 121.179 0.514 . . . . 72.319999999999993 111.695 -179.169 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 704' ' ' LYS . . . . . . . . . . . . . 2.4 tppp? -104.88 127.26 52.64 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.192 -0.458 . . . . 71.049999999999997 110.244 177.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 50.1 t -97.94 134.8 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-O 120.825 0.345 . . . . 74.329999999999998 111.893 -177.115 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 706' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -128.56 147.63 50.71 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 116.133 -0.485 . . . . 74.349999999999994 110.351 175.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 106.13 -172.44 18.84 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 121.185 -0.531 . . . . 75.349999999999994 112.658 -177.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 708' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -165.18 130.62 2.61 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 116.925 0.363 . . . . 74.310000000000002 111.542 179.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 709' ' ' VAL . . . . . 0.553 HG22 ' HB2' ' A' ' 717' ' ' TYR . 98.8 t -110.63 116.6 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-O 120.792 0.329 . . . . 73.150000000000006 111.431 177.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 710' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -73.26 134.8 44.37 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 120.979 0.419 . . . . 72.129999999999995 110.584 175.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 711' ' ' THR . . . . . . . . . . . . . 75.8 p -105.97 -0.11 25.28 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 111.913 0.338 . . . . 75.120000000000005 111.913 -179.04 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 712' ' ' THR . . . . . . . . . . . . . 14.9 t -107.34 -1.86 21.21 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 112.47 0.544 . . . . 72.299999999999997 112.47 -177.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 713' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -143.58 134.94 26.0 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 122.021 -0.424 . . . . 73.010000000000005 111.174 -179.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 714' ' ' ALA . . . . . . . . . . . . . . . -70.23 140.79 52.49 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 112.343 0.498 . . . . 72.299999999999997 112.343 -176.16 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 153.39 167.08 15.31 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 121.124 -0.56 . . . . 61.439999999999998 112.856 -179.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 716' ' ' THR . . . . . . . . . . . . . 34.7 m -96.56 122.92 40.0 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 122.461 -0.435 . . . . 70.219999999999999 111.908 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 717' ' ' TYR . . . . . 0.553 ' HB2' HG22 ' A' ' 709' ' ' VAL . 27.3 m-85 -121.89 143.02 49.68 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 116.122 -0.49 . . . . 73.310000000000002 110.142 178.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 718' ' ' VAL . . . . . . . . . . . . . 53.8 t -109.75 127.49 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 N-CA-C 112.645 0.609 . . . . 60.340000000000003 112.645 -174.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 719' ' ' LEU . . . . . . . . . . . . . 96.3 mt -106.72 132.25 52.91 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 116.068 -0.515 . . . . 50.229999999999997 111.424 176.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 58.4 m -109.87 124.65 51.71 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 120.791 0.329 . . . . 74.040000000000006 111.261 179.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 721' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -110.94 129.63 55.82 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.507 -0.315 . . . . 73.25 110.718 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 99.5 m -132.65 125.37 30.19 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.554 0.216 . . . . 73.340000000000003 111.286 -179.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 8.1 p -117.62 142.53 31.42 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 CA-C-O 120.933 0.397 . . . . 51.229999999999997 111.773 -178.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 44.1 m -105.07 118.96 37.84 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.238 0.542 . . . . 74.439999999999998 112.429 -176.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 725' ' ' ASP . . . . . 0.525 ' HB2' ' HD3' ' A' ' 667' ' ' PRO . 5.7 t0 -73.79 150.94 40.76 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 115.798 -0.637 . . . . 75.209999999999994 110.804 174.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 726' ' ' SER . . . . . . . . . . . . . 59.8 p -74.19 -15.27 61.02 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 112.459 0.541 . . . . 65.450000000000003 112.459 -175.021 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 727' ' ' LYS . . . . . . . . . . . . . 65.2 mmtt -103.66 6.14 36.84 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 112.266 0.469 . . . . 72.120000000000005 112.266 177.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 728' ' ' GLY . . . . . . . . . . . . . . . 102.83 27.96 6.44 Favored Glycine 0 CA--C 1.532 1.103 0 N-CA-C 115.269 0.868 . . . . 54.219999999999999 115.269 173.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 729' ' ' HIS . . . . . 0.42 ' H ' ' HB3' ' A' ' 725' ' ' ASP . 21.1 m80 -109.14 104.01 13.11 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 117.897 0.849 . . . . 55.399999999999999 111.6 173.19 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 730' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -98.83 105.58 17.74 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 120.807 0.337 . . . . 72.109999999999999 110.867 177.172 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 33.9 m -106.79 153.59 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-O 120.822 0.344 . . . . 74.140000000000001 111.624 -178.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 9.8 t -134.94 147.86 49.88 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 112.415 0.524 . . . . 75.310000000000002 112.415 -176.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -148.56 149.6 31.87 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.08 0.552 . . . . 63.450000000000003 109.989 176.082 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 734' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -120.44 158.46 27.17 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 113.03 0.752 . . . . 73.420000000000002 113.03 -173.134 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 735' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -130.34 123.44 29.97 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.374 -0.83 . . . . 63.109999999999999 110.708 179.123 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 736' ' ' THR . . . . . 0.437 ' O ' ' HA2' ' A' ' 674' ' ' GLY . 62.2 m -92.49 103.67 16.07 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 121.056 0.455 . . . . 61.340000000000003 111.122 178.178 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 50.0 t -96.58 128.93 47.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-O 120.85 0.357 . . . . 74.409999999999997 111.411 -177.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 738' ' ' THR . . . . . . . . . . . . . 97.0 m -114.58 114.6 25.94 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.092 0.472 . . . . 75.120000000000005 111.642 -178.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 739' ' ' VAL . . . . . . . . . . . . . 39.3 t -93.06 135.14 28.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 CA-C-N 116.162 -0.472 . . . . 55.43 111.155 178.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 740' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -122.71 155.53 36.27 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.74 0.305 . . . . 71.150000000000006 111.594 -178.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 741' ' ' VAL . . . . . . . . . . . . . 24.1 t -75.79 148.06 7.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-O 120.69 0.281 . . . . 74.409999999999997 111.586 -178.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 742' ' ' ARG . . . . . 0.416 HH11 ' HD3' ' A' ' 742' ' ' ARG . 51.6 mtt-85 -87.4 -169.5 2.64 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 120.702 0.286 . . . . 74.409999999999997 110.724 175.564 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 743' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -125.89 123.9 39.67 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 113.62 0.97 . . . . 73.349999999999994 113.62 -170.226 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 744' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.25 170.15 16.36 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.18 -0.918 . . . . 73.409999999999997 109.761 170.394 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 59.7 t -116.82 125.26 73.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 CA-C-O 120.853 0.359 . . . . 73.239999999999995 111.96 -177.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -67.06 95.88 0.41 Allowed 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.172 0.511 . . . . 74.329999999999998 111.159 175.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 747' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -155.83 160.97 40.66 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 116.081 -0.509 . . . . 63.140000000000001 110.427 -178.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -69.01 130.2 42.09 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 121.646 0.736 . . . . 65.239999999999995 112.024 -177.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 749' ' ' LYS . . . . . 0.548 ' HD2' ' HD2' ' A' ' 750' ' ' PRO . 22.3 tptm -103.23 125.79 34.12 Favored Pre-proline 0 CA--C 1.543 0.678 0 CA-C-N 115.64 -0.709 . . . . 61.140000000000001 110.716 -178.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 750' ' ' PRO . . . . . 0.548 ' HD2' ' HD2' ' A' ' 749' ' ' LYS . 13.0 Cg_endo -55.6 109.13 0.38 Allowed 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 122.542 2.162 . . . . 65.430000000000007 113.068 179.221 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 751' ' ' ILE . . . . . . . . . . . . . 62.9 mt 60.31 96.39 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-O 121.44 0.638 . . . . 74.219999999999999 111.722 -178.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 752' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -73.41 109.89 7.28 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 116.073 -0.512 . . . . 74.299999999999997 110.682 -178.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 753' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 . . . . . 0 N--CA 1.472 0.658 0 CA-C-O 121.407 0.622 . . . . 63.420000000000002 111.696 -178.506 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 762' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 657' ' ' MET . . . . . . . . . . . . . 96.0 mmm . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 120.768 0.318 . . . . 71.430000000000007 111.51 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 658' ' ' GLY . . . . . . . . . . . . . . . 125.64 -61.21 0.62 Allowed Glycine 0 N--CA 1.465 0.614 0 C-N-CA 121.344 -0.455 . . . . 72.120000000000005 112.62 -178.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 659' ' ' ASN . . . . . . . . . . . . . 30.2 m-80 -125.66 95.75 4.55 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 121.154 0.502 . . . . 72.349999999999994 111.184 178.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 660' ' ' GLY . . . . . . . . . . . . . . . -92.16 -46.83 3.48 Favored Glycine 0 CA--C 1.523 0.59 0 C-N-CA 121.193 -0.527 . . . . 73.519999999999996 112.815 178.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -70.63 101.4 2.04 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 120.865 0.364 . . . . 74.0 111.358 178.091 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 662' ' ' THR . . . . . . . . . . . . . 10.2 t -89.21 157.26 18.32 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.074 0.464 . . . . 72.120000000000005 111.239 176.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 663' ' ' SER . . . . . . . . . . . . . 63.6 m -81.32 97.81 7.86 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.044 0.387 . . . . 53.350000000000001 112.044 -178.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 664' ' ' ASP . . . . . 0.463 ' OD2' ' HB2' ' A' ' 727' ' ' LYS . 16.2 t0 -90.21 132.21 35.62 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.266 0.555 . . . . 75.519999999999996 111.112 172.593 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 665' ' ' LEU . . . . . . . . . . . . . 67.7 mt -99.52 126.35 45.46 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.812 -0.631 . . . . 74.329999999999998 110.412 176.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 666' ' ' GLU . . . . . 0.519 ' H ' ' CD ' ' A' ' 666' ' ' GLU . 0.7 OUTLIER -58.69 156.33 24.81 Favored Pre-proline 0 CA--C 1.544 0.722 0 CA-C-N 115.872 -0.604 . . . . 71.409999999999997 112.28 -179.283 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 667' ' ' PRO . . . . . 0.421 ' HD3' ' HB2' ' A' ' 725' ' ' ASP . 72.0 Cg_endo -75.17 145.29 30.71 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.276 1.984 . . . . 75.349999999999994 112.861 -175.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 668' ' ' LYS . . . . . . . . . . . . . 52.6 tptt -82.37 104.3 12.57 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.105 0.478 . . . . 73.319999999999993 111.001 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 669' ' ' LEU . . . . . . . . . . . . . 51.2 tp -89.91 106.58 18.57 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.271 0.557 . . . . 62.109999999999999 110.762 177.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 670' ' ' THR . . . . . . . . . . . . . 33.0 m -91.75 110.92 22.27 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.089 -0.505 . . . . 72.019999999999996 111.246 -177.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 671' ' ' VAL . . . . . 0.437 HG21 ' HB3' ' A' ' 733' ' ' ALA . 84.7 t -131.66 139.72 36.1 Favored Pre-proline 0 N--CA 1.473 0.691 0 CA-C-N 116.092 -0.504 . . . . 74.409999999999997 111.161 -176.369 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 672' ' ' PRO . . . . . 0.404 ' HD2' HG13 ' A' ' 671' ' ' VAL . 74.3 Cg_endo -76.74 149.34 29.72 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 122.418 2.079 . . . . 75.319999999999993 112.595 175.129 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 673' ' ' VAL . . . . . . . . . . . . . 12.5 p -69.57 -34.75 63.02 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 N-CA-C 112.468 0.544 . . . . 72.129999999999995 112.468 -176.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 674' ' ' GLY . . . . . . . . . . . . . . . 179.85 169.39 40.04 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 120.396 -0.907 . . . . 64.209999999999994 113.949 -178.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 675' ' ' ALA . . . . . . . . . . . . . . . -154.99 140.2 17.56 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 122.625 0.37 . . . . 61.240000000000002 111.107 179.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 676' ' ' THR . . . . . . . . . . . . . 86.2 m -118.71 121.22 39.6 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-O 120.713 0.292 . . . . 72.140000000000001 111.398 -179.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 677' ' ' ILE . . . . . . . . . . . . . 30.0 pt -129.3 174.3 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-O 120.986 0.422 . . . . 74.040000000000006 111.886 -177.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 678' ' ' HIS . . . . . . . . . . . . . 53.0 m80 -115.84 166.3 12.11 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.312 0.577 . . . . 32.130000000000003 111.933 178.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 679' ' ' VAL . . . . . 0.585 HG13 ' HA ' ' A' ' 712' ' ' THR . 63.2 t -56.95 111.88 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-N 115.628 -0.714 . . . . 73.329999999999998 110.643 174.003 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 123.05 -33.2 4.13 Favored Glycine 0 CA--C 1.526 0.736 0 CA-C-N 116.256 -0.429 . . . . 44.439999999999998 112.815 -175.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 681' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -73.48 128.26 35.01 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.095 0.474 . . . . 74.329999999999998 111.659 179.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 682' ' ' SER . . . . . . . . . . . . . 50.4 m -85.34 144.42 28.06 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 120.849 0.357 . . . . 61.409999999999997 110.871 176.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 683' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -118.08 132.38 56.36 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 120.809 0.338 . . . . 74.450000000000003 111.263 -178.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 684' ' ' VAL . . . . . . . . . . . . . 52.4 t -116.84 96.98 49.89 Favored Pre-proline 0 CA--C 1.544 0.72 0 CA-C-N 116.461 -0.336 . . . . 61.210000000000001 111.326 -178.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -77.28 -31.62 3.48 Favored 'Trans proline' 0 CA--C 1.545 1.07 0 C-N-CA 122.783 2.322 . . . . 72.549999999999997 114.461 -174.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 686' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.35 -12.17 59.99 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 112.303 0.482 . . . . 74.209999999999994 112.303 -174.515 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 687' ' ' ALA . . . . . . . . . . . . . . . -94.22 -27.39 16.2 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 111.91 0.337 . . . . 62.130000000000003 111.91 178.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 688' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -91.35 -8.22 48.7 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 112.133 0.42 . . . . 75.109999999999999 112.133 -177.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . 0.515 HG12 HD13 ' A' ' 703' ' ' ILE . 62.7 t -114.21 127.64 71.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-O 120.987 0.422 . . . . 75.439999999999998 111.559 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 690' ' ' LEU . . . . . 0.412 HD22 ' C ' ' A' ' 689' ' ' VAL . 3.8 mm? -123.66 155.82 37.04 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 116.247 -0.433 . . . . 71.129999999999995 111.125 179.563 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 691' ' ' ALA . . . . . . . . . . . . . . . -141.5 122.86 14.9 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 120.659 0.266 . . . . 73.150000000000006 110.865 174.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 692' ' ' ILE . . . . . 0.431 HD13 ' HA ' ' A' ' 698' ' ' ASP . 48.1 mm -128.68 120.48 52.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 N-CA-C 112.087 0.403 . . . . 73.209999999999994 112.087 -177.034 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -95.05 149.94 20.71 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.09 0.472 . . . . 62.25 110.692 172.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 7.5 mtpm? -77.42 -34.56 54.68 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 112.665 0.617 . . . . 61.539999999999999 112.665 -173.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -84.86 -54.98 4.32 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 121.828 -0.545 . . . . 73.430000000000007 112.095 177.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 696' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -75.93 -50.48 14.85 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 112.125 0.417 . . . . 74.400000000000006 112.125 -173.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . 123.94 -139.44 12.03 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 121.37 -0.443 . . . . 74.25 112.65 -175.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 698' ' ' ASP . . . . . 0.431 ' HA ' HD13 ' A' ' 692' ' ' ILE . 14.3 t70 -67.53 122.57 18.28 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 122.369 -0.489 . . . . 73.329999999999998 111.961 -178.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 699' ' ' LEU . . . . . 0.405 HD22 ' HD2' ' A' ' 702' ' ' LYS . 83.5 mt -118.49 19.44 13.33 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 116.097 -0.502 . . . . 72.420000000000002 111.1 176.087 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 89.3 m -59.52 -31.96 69.87 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 120.954 0.407 . . . . 74.209999999999994 112.067 -176.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 701' ' ' SER . . . . . . . . . . . . . 46.7 m -72.03 -13.58 61.64 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 120.763 0.316 . . . . 40.299999999999997 111.833 179.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 702' ' ' LYS . . . . . 0.405 ' HD2' HD22 ' A' ' 699' ' ' LEU . 68.8 mttm -92.98 -2.74 55.48 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 112.09 0.404 . . . . 71.230000000000004 112.09 179.513 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 703' ' ' ILE . . . . . 0.515 HD13 HG12 ' A' ' 689' ' ' VAL . 69.8 mt -68.67 119.48 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-O 121.09 0.471 . . . . 71.420000000000002 111.763 -179.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 704' ' ' LYS . . . . . . . . . . . . . 51.1 tptt -89.76 126.62 35.74 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.246 -0.434 . . . . 54.039999999999999 110.177 175.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 51.7 t -95.99 130.07 45.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-O 121.046 0.451 . . . . 45.109999999999999 112.004 -177.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 706' ' ' ASP . . . . . 0.581 ' HB3' ' HB ' ' A' ' 720' ' ' THR . 14.4 t70 -123.29 145.69 48.49 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.185 -0.462 . . . . 64.150000000000006 110.484 176.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 119.96 -153.98 16.59 Favored Glycine 0 CA--C 1.524 0.651 0 C-N-CA 121.079 -0.582 . . . . 51.240000000000002 113.32 178.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 708' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -166.96 141.42 3.94 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.762 0.315 . . . . 71.530000000000001 111.118 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 709' ' ' VAL . . . . . . . . . . . . . 59.9 t -127.1 110.89 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-O 120.583 0.23 . . . . 75.230000000000004 110.918 174.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 710' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -94.29 135.77 35.32 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 109.882 -0.414 . . . . 63.109999999999999 109.882 176.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 711' ' ' THR . . . . . 0.431 ' O ' ' HA ' ' A' ' 679' ' ' VAL . 71.8 p -105.77 0.04 25.79 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 122.105 -0.372 . . . . 62.509999999999998 111.98 -177.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 712' ' ' THR . . . . . 0.585 ' HA ' HG13 ' A' ' 679' ' ' VAL . 72.0 p -116.24 -24.25 8.05 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 116.426 -0.352 . . . . 74.129999999999995 111.777 178.29 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 713' ' ' LYS . . . . . . . . . . . . . 61.2 tttm -111.9 121.29 44.62 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 120.899 0.381 . . . . 72.109999999999999 111.119 -178.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 714' ' ' ALA . . . . . . . . . . . . . . . -70.21 143.88 52.08 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 112.542 0.571 . . . . 71.510000000000005 112.542 -177.017 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 156.39 162.24 11.3 Favored Glycine 0 CA--C 1.526 0.722 0 CA-C-N 115.938 -0.574 . . . . 63.240000000000002 112.509 179.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 716' ' ' THR . . . . . . . . . . . . . 51.6 m -98.34 122.57 41.68 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 117.311 0.556 . . . . 73.129999999999995 111.093 177.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 717' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -119.49 137.33 53.87 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.431 -0.35 . . . . 72.329999999999998 110.71 -178.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 718' ' ' VAL . . . . . . . . . . . . . 48.4 t -95.15 131.36 42.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-O 121.079 0.466 . . . . 74.409999999999997 111.606 179.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 719' ' ' LEU . . . . . . . . . . . . . 86.6 mt -108.53 133.67 52.35 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.055 -0.52 . . . . 65.400000000000006 110.814 177.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . 0.581 ' HB ' ' HB3' ' A' ' 706' ' ' ASP . 77.3 m -117.53 130.92 56.72 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-O 120.634 0.254 . . . . 63.5 110.934 178.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 721' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -119.23 132.26 55.91 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 120.672 0.272 . . . . 63.420000000000002 111.118 -178.511 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 97.8 m -128.33 139.47 52.39 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 111.686 0.254 . . . . 62.109999999999999 111.686 -179.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 13.8 p -141.27 147.2 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 CA-C-O 120.937 0.399 . . . . 75.239999999999995 111.244 178.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 18.7 m -110.97 144.95 39.26 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.035 0.445 . . . . 73.510000000000005 111.999 -176.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 725' ' ' ASP . . . . . 0.723 ' HB3' ' H ' ' A' ' 729' ' ' HIS . 7.5 t70 -74.11 168.46 19.52 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.041 0.536 . . . . 50.229999999999997 111.222 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 726' ' ' SER . . . . . . . . . . . . . 34.1 t -68.65 -30.83 69.62 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 120.78 0.324 . . . . 74.019999999999996 110.985 174.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 727' ' ' LYS . . . . . 0.463 ' HB2' ' OD2' ' A' ' 664' ' ' ASP . 4.1 mptp? -96.47 -9.44 29.7 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 112.62 0.6 . . . . 71.430000000000007 112.62 177.423 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 728' ' ' GLY . . . . . . . . . . . . . . . 113.15 22.38 5.6 Favored Glycine 0 CA--C 1.535 1.332 0 N-CA-C 116.111 1.204 . . . . 50.140000000000001 116.111 173.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 729' ' ' HIS . . . . . 0.723 ' H ' ' HB3' ' A' ' 725' ' ' ASP . 46.5 m80 -83.67 119.98 25.43 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 118.117 0.958 . . . . 74.230000000000004 110.949 169.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 730' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -103.56 119.76 39.54 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 120.823 0.344 . . . . 73.510000000000005 111.692 -179.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 35.1 m -120.65 157.43 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-O 120.733 0.301 . . . . 55.149999999999999 111.234 179.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 9.6 t -146.91 147.88 31.22 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.545 0.572 . . . . 72.420000000000002 112.545 -177.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 733' ' ' ALA . . . . . 0.437 ' HB3' HG21 ' A' ' 671' ' ' VAL . . . -141.73 161.9 36.8 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 116.042 -0.527 . . . . 60.140000000000001 110.91 -179.677 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 734' ' ' LYS . . . . . . . . . . . . . 42.8 mtmt -128.9 150.8 50.2 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 112.872 0.693 . . . . 44.140000000000001 112.872 -173.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 735' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -130.75 140.65 50.33 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 115.423 -0.808 . . . . 73.409999999999997 110.662 177.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 736' ' ' THR . . . . . . . . . . . . . 92.4 m -109.85 107.76 17.83 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 112.221 0.452 . . . . 72.329999999999998 112.221 -178.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 57.5 t -102.47 131.67 50.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 O-C-N 122.16 -0.338 . . . . 71.109999999999999 111.787 -178.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 738' ' ' THR . . . . . . . . . . . . . 91.7 m -119.13 118.46 31.44 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 120.788 0.327 . . . . 60.119999999999997 111.522 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 739' ' ' VAL . . . . . . . . . . . . . 41.7 t -102.88 139.1 24.73 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 CA-C-O 120.67 0.271 . . . . 73.120000000000005 111.418 178.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 740' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -128.91 157.68 40.91 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 120.931 0.396 . . . . 73.329999999999998 111.76 179.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 741' ' ' VAL . . . . . 0.464 HG12 ' H ' ' A' ' 743' ' ' GLU . 9.6 t -79.37 153.12 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-N 116.551 -0.295 . . . . 71.420000000000002 111.585 -176.489 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 742' ' ' ARG . . . . . . . . . . . . . 23.4 ptt180 -83.62 -27.82 28.9 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 112.074 0.398 . . . . 73.129999999999995 112.074 -177.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 743' ' ' GLU . . . . . 0.464 ' H ' HG12 ' A' ' 741' ' ' VAL . 12.0 pt-20 -152.86 146.76 25.29 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 120.757 0.313 . . . . 73.230000000000004 111.339 -177.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 744' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -91.16 113.16 25.34 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.818 0.342 . . . . 74.430000000000007 111.336 177.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 745' ' ' VAL . . . . . 0.521 HG12 ' H ' ' A' ' 747' ' ' ASN . 57.8 t -91.44 122.38 42.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-O 120.882 0.372 . . . . 75.129999999999995 110.92 177.136 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -93.02 7.37 44.41 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 112.107 0.41 . . . . 74.010000000000005 112.107 -176.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 747' ' ' ASN . . . . . 0.521 ' H ' HG12 ' A' ' 745' ' ' VAL . 19.4 m120 -110.03 100.5 9.43 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 120.989 0.424 . . . . 72.420000000000002 111.462 177.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -78.47 156.06 29.54 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.126 0.488 . . . . 74.219999999999999 110.881 177.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 749' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -132.45 153.66 81.27 Favored Pre-proline 0 CA--C 1.538 0.496 0 CA-C-N 116.045 -0.525 . . . . 72.219999999999999 110.89 -177.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 750' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -51.8 100.56 0.05 OUTLIER 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 122.416 2.077 . . . . 62.340000000000003 112.674 176.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 751' ' ' ILE . . . . . . . . . . . . . 22.4 pt -89.48 160.56 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-N 116.237 -0.438 . . . . 71.409999999999997 112.006 -178.37 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 752' ' ' LEU . . . . . . . . . . . . . 55.3 tp -83.8 125.14 31.65 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.223 -0.444 . . . . 62.210000000000001 111.871 -177.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 753' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 . . . . . 0 N--CA 1.469 0.508 0 CA-C-N 116.445 -0.343 . . . . 73.109999999999999 111.522 178.279 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 762' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 657' ' ' MET . . . . . . . . . . . . . 25.6 ptt? . . . . . 0 N--CA 1.487 1.407 0 CA-C-O 120.63 0.252 . . . . 63.340000000000003 111.028 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 658' ' ' GLY . . . . . . . . . . . . . . . 79.33 159.22 15.67 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 121.072 -0.585 . . . . 65.340000000000003 112.638 -175.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 659' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -137.68 132.36 32.79 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 122.509 -0.406 . . . . 64.120000000000005 111.51 179.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 660' ' ' GLY . . . . . . . . . . . . . . . -177.51 61.1 0.09 OUTLIER Glycine 0 CA--C 1.527 0.786 0 C-N-CA 120.741 -0.742 . . . . 32.229999999999997 113.642 -177.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -85.09 90.69 7.92 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 121.374 0.607 . . . . 64.200000000000003 110.412 176.133 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 662' ' ' THR . . . . . . . . . . . . . 68.8 p -81.07 162.59 23.68 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 113.033 0.753 . . . . 74.420000000000002 113.033 -171.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 663' ' ' SER . . . . . . . . . . . . . 46.6 t -101.31 142.45 32.71 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.297 -0.865 . . . . 74.129999999999995 109.854 171.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 664' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -73.74 149.99 41.44 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.644 0.735 . . . . 73.430000000000007 112.504 -175.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 665' ' ' LEU . . . . . . . . . . . . . 72.6 mt -101.49 137.68 39.49 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-N 115.019 -0.991 . . . . 55.030000000000001 110.876 177.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 666' ' ' GLU . . . . . 0.502 ' HG3' ' HB3' ' A' ' 729' ' ' HIS . 19.7 mp0 -71.11 150.09 94.64 Favored Pre-proline 0 CA--C 1.538 0.497 0 CA-C-N 116.121 -0.491 . . . . 74.219999999999999 110.505 177.427 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 667' ' ' PRO . . . . . 0.559 ' HB3' HD12 ' A' ' 699' ' ' LEU . 37.5 Cg_endo -65.1 133.19 34.55 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 122.103 1.869 . . . . 73.519999999999996 112.345 179.092 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 668' ' ' LYS . . . . . . . . . . . . . 56.1 tptt -82.18 106.98 14.51 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 121.173 0.511 . . . . 73.340000000000003 110.56 179.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 669' ' ' LEU . . . . . 0.516 ' HG ' HG23 ' A' ' 671' ' ' VAL . 60.0 tp -89.39 106.04 18.19 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.709 -0.678 . . . . 53.409999999999997 110.912 -178.614 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 670' ' ' THR . . . . . . . . . . . . . 86.3 m -86.37 110.4 19.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.034 0.445 . . . . 74.25 110.828 179.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 671' ' ' VAL . . . . . 0.516 HG23 ' HG ' ' A' ' 669' ' ' LEU . 94.8 t -127.55 127.94 24.03 Favored Pre-proline 0 CA--C 1.536 0.418 0 CA-C-N 116.032 -0.531 . . . . 74.329999999999998 111.021 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 672' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -64.48 154.2 73.03 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 122.305 2.003 . . . . 72.420000000000002 111.929 178.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 673' ' ' VAL . . . . . . . . . . . . . 10.1 p -81.5 -34.39 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 O-C-N 122.145 -0.347 . . . . 74.239999999999995 111.89 -176.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 674' ' ' GLY . . . . . 0.418 ' HA2' ' O ' ' A' ' 736' ' ' THR . . . -162.54 163.88 35.36 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 121.094 -0.574 . . . . 64.430000000000007 113.579 -178.173 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 675' ' ' ALA . . . . . . . . . . . . . . . -156.3 118.28 3.97 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 120.694 0.283 . . . . 71.209999999999994 111.747 179.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 676' ' ' THR . . . . . . . . . . . . . 88.7 m -97.43 126.14 42.5 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 120.648 0.261 . . . . 73.049999999999997 111.591 178.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 677' ' ' ILE . . . . . 0.416 HG13 HG22 ' A' ' 739' ' ' VAL . 20.1 pt -138.52 176.44 6.62 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 C-N-CA 122.514 0.325 . . . . 71.430000000000007 111.288 179.391 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 678' ' ' HIS . . . . . 0.541 ' O ' ' HB2' ' A' ' 681' ' ' ASP . 72.1 m80 -114.93 177.21 4.73 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 121.396 0.617 . . . . 53.229999999999997 112.574 -179.6 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 679' ' ' VAL . . . . . 0.481 HG23 ' HA ' ' A' ' 741' ' ' VAL . 96.1 t -66.45 122.13 16.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-N 116.004 -0.544 . . . . 75.209999999999994 110.957 174.154 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 86.1 18.31 59.55 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 121.218 -0.515 . . . . 70.439999999999998 112.825 -176.028 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 681' ' ' ASP . . . . . 0.541 ' HB2' ' O ' ' A' ' 678' ' ' HIS . 1.1 t70 -83.09 -175.32 5.78 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-O 120.882 0.373 . . . . 70.109999999999999 111.295 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 682' ' ' SER . . . . . . . . . . . . . 69.7 m -123.12 140.66 52.8 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 122.418 0.287 . . . . 53.340000000000003 111.314 179.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 683' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -154.61 125.38 7.07 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 116.494 -0.321 . . . . 73.530000000000001 110.87 -178.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 684' ' ' VAL . . . . . . . . . . . . . 38.6 t -125.38 93.57 44.77 Favored Pre-proline 0 CA--C 1.546 0.789 0 CA-C-O 121.022 0.439 . . . . 65.510000000000005 111.926 -177.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -61.27 -36.81 77.78 Favored 'Trans proline' 0 CA--C 1.545 1.028 0 C-N-CA 122.725 2.283 . . . . 53.109999999999999 113.576 -177.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 686' ' ' MET . . . . . . . . . . . . . 1.9 mmt -78.82 4.08 14.98 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 112.573 0.582 . . . . 65.510000000000005 112.573 -176.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 687' ' ' ALA . . . . . . . . . . . . . . . -119.21 -40.65 2.8 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.18 0.514 . . . . 54.450000000000003 111.211 174.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 688' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -71.93 -24.91 61.71 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 116.2 -0.455 . . . . 75.540000000000006 111.998 179.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . 0.427 HG13 HG22 ' A' ' 671' ' ' VAL . 63.7 t -96.91 144.48 10.49 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 CA-C-O 120.677 0.275 . . . . 51.009999999999998 110.802 174.258 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 690' ' ' LEU . . . . . 0.45 HD23 ' N ' ' A' ' 691' ' ' ALA . 10.5 tt -142.66 149.55 39.04 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 120.475 0.178 . . . . 61.240000000000002 111.105 -174.302 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 691' ' ' ALA . . . . . 0.45 ' N ' HD23 ' A' ' 690' ' ' LEU . . . -144.22 132.78 22.21 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 112.085 0.402 . . . . 42.5 112.085 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 692' ' ' ILE . . . . . 0.576 HD13 ' HA ' ' A' ' 698' ' ' ASP . 43.7 mm -133.97 132.91 56.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 N-CA-C 112.039 0.385 . . . . 63.25 112.039 -178.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 693' ' ' ASP . . . . . 0.46 ' OD1' ' HG2' ' A' ' 695' ' ' GLU . 7.7 t70 -110.68 149.21 30.79 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 109.714 -0.476 . . . . 65.530000000000001 109.714 171.162 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -69.41 -29.3 67.0 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 111.894 0.331 . . . . 70.140000000000001 111.894 -177.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 695' ' ' GLU . . . . . 0.46 ' HG2' ' OD1' ' A' ' 693' ' ' ASP . 12.2 pt-20 -81.72 -46.37 14.38 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 112.189 0.441 . . . . 74.040000000000006 112.189 -175.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 696' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -95.53 -48.85 5.66 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.138 0.494 . . . . 73.349999999999994 111.683 -174.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . 119.22 -119.28 4.25 Favored Glycine 0 CA--C 1.525 0.658 0 CA-C-N 116.006 -0.543 . . . . 50.350000000000001 112.423 -175.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 698' ' ' ASP . . . . . 0.576 ' HA ' HD13 ' A' ' 692' ' ' ILE . 12.9 t70 -74.88 116.36 15.51 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 122.372 -0.487 . . . . 74.0 111.757 -178.082 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 699' ' ' LEU . . . . . 0.559 HD12 ' HB3' ' A' ' 667' ' ' PRO . 57.8 mt -114.54 22.95 13.17 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 116.108 -0.497 . . . . 63.310000000000002 110.944 174.25 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 37.7 m -60.54 -37.39 81.05 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 120.979 0.419 . . . . 55.530000000000001 111.823 -176.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 701' ' ' SER . . . . . . . . . . . . . 70.6 m -74.51 -10.9 60.0 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 120.848 0.356 . . . . 71.430000000000007 111.794 177.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 702' ' ' LYS . . . . . 0.458 ' HG3' HD22 ' A' ' 699' ' ' LEU . 48.0 mmtm -90.88 7.22 41.08 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 120.831 0.348 . . . . 72.340000000000003 111.433 -178.413 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 703' ' ' ILE . . . . . 0.423 HD13 HG12 ' A' ' 689' ' ' VAL . 66.4 mt -87.24 117.73 31.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 CA-C-O 121.234 0.54 . . . . 75.329999999999998 112.421 -177.37 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 704' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -84.68 135.39 34.18 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.959 -0.564 . . . . 55.130000000000003 110.546 173.033 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 56.2 t -107.98 143.58 18.19 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-O 120.844 0.354 . . . . 74.299999999999997 111.954 -177.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 706' ' ' ASP . . . . . 0.503 ' HB3' ' HB ' ' A' ' 720' ' ' THR . 24.7 t70 -129.05 143.5 50.89 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 122.713 0.405 . . . . 75.349999999999994 110.673 175.103 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 93.36 174.38 40.36 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 121.315 -0.469 . . . . 64.239999999999995 112.516 -174.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 708' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -152.07 137.9 18.01 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 122.259 -0.554 . . . . 73.140000000000001 112.157 -179.118 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 709' ' ' VAL . . . . . . . . . . . . . 89.3 t -106.68 114.97 47.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-O 120.94 0.4 . . . . 73.129999999999995 111.466 178.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 710' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -82.43 136.87 34.84 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 116.472 -0.331 . . . . 73.510000000000005 110.881 176.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 711' ' ' THR . . . . . . . . . . . . . 78.9 p -97.4 -31.88 12.15 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 112.326 0.491 . . . . 64.040000000000006 112.326 -176.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 712' ' ' THR . . . . . . . . . . . . . 51.0 p -85.42 -0.16 54.03 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.547 0.573 . . . . 60.100000000000001 112.547 -177.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 713' ' ' LYS . . . . . . . . . . . . . 23.0 tptp -140.3 132.4 27.97 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.705 0.288 . . . . 73.209999999999994 110.964 -178.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 714' ' ' ALA . . . . . . . . . . . . . . . -75.65 144.69 41.53 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 112.046 0.388 . . . . 63.229999999999997 112.046 -177.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 162.09 164.35 16.85 Favored Glycine 0 CA--C 1.523 0.591 0 C-N-CA 121.219 -0.515 . . . . 52.009999999999998 112.828 179.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 716' ' ' THR . . . . . . . . . . . . . 54.8 m -95.73 123.23 39.2 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.119 0.485 . . . . 52.229999999999997 111.434 178.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 717' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -120.75 110.59 16.56 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 116.109 -0.496 . . . . 75.219999999999999 110.659 -179.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 718' ' ' VAL . . . . . . . . . . . . . 48.8 t -90.58 107.82 18.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-O 121.082 0.467 . . . . 75.129999999999995 111.059 179.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 719' ' ' LEU . . . . . . . . . . . . . 59.9 mt -89.52 150.43 22.45 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.128 -0.487 . . . . 75.239999999999995 111.968 -176.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . 0.503 ' HB ' ' HB3' ' A' ' 706' ' ' ASP . 92.2 m -121.87 135.85 54.91 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 116.412 -0.358 . . . . 64.140000000000001 110.902 177.276 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 721' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -122.08 142.72 50.08 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.929 0.395 . . . . 62.399999999999999 111.463 -178.157 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 69.9 m -138.71 135.12 34.43 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 122.399 0.28 . . . . 72.019999999999996 111.138 -179.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 10.9 p -128.3 144.27 38.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 O-C-N 122.233 -0.292 . . . . 71.510000000000005 111.14 178.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 28.8 m -110.7 144.01 40.29 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.434 0.635 . . . . 73.239999999999995 112.214 -177.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 725' ' ' ASP . . . . . 0.449 ' HB3' ' H ' ' A' ' 729' ' ' HIS . 45.2 t0 -91.74 151.74 20.49 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.916 0.886 . . . . 73.530000000000001 110.25 -179.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 726' ' ' SER . . . . . 0.446 ' HB3' ' OE2' ' A' ' 695' ' ' GLU . 48.0 t -64.95 -22.71 67.04 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.161 0.505 . . . . 73.310000000000002 110.846 177.602 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 727' ' ' LYS . . . . . . . . . . . . . 27.5 mmtp -90.29 -6.33 55.26 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 116.187 -0.461 . . . . 73.329999999999998 111.885 177.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 728' ' ' GLY . . . . . . . . . . . . . . . 109.25 -5.84 31.94 Favored Glycine 0 CA--C 1.531 1.044 0 N-CA-C 114.776 0.671 . . . . 62.530000000000001 114.776 176.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 729' ' ' HIS . . . . . 0.502 ' HB3' ' HG3' ' A' ' 666' ' ' GLU . 39.7 m80 -68.91 138.35 54.57 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 117.933 0.866 . . . . 62.039999999999999 111.028 179.284 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 730' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -133.65 130.92 38.92 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 120.832 0.349 . . . . 75.219999999999999 111.77 -178.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 26.9 m -131.48 160.87 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-N 116.342 -0.39 . . . . 74.400000000000006 111.625 -179.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 2.8 t -142.64 146.91 34.96 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 112.771 0.656 . . . . 61.119999999999997 112.771 -174.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -148.66 154.45 39.68 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 116.103 -0.499 . . . . 65.010000000000005 110.741 178.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 734' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -123.02 159.66 27.93 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 113.367 0.877 . . . . 74.430000000000007 113.367 -174.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 735' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -138.25 137.7 37.76 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 115.326 -0.852 . . . . 71.030000000000001 110.988 179.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 736' ' ' THR . . . . . 0.418 ' O ' ' HA2' ' A' ' 674' ' ' GLY . 99.0 m -103.36 106.48 17.0 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 121.01 0.433 . . . . 70.120000000000005 111.934 178.619 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 45.1 t -96.64 140.91 16.41 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 116.626 -0.261 . . . . 73.209999999999994 110.643 177.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 738' ' ' THR . . . . . . . . . . . . . 87.5 m -132.88 114.14 13.7 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 122.001 -0.437 . . . . 24.350000000000001 111.645 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 739' ' ' VAL . . . . . 0.416 HG22 HG13 ' A' ' 677' ' ' ILE . 52.8 t -93.28 137.07 23.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-N 116.212 -0.449 . . . . 61.109999999999999 110.829 177.504 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 740' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -123.01 149.45 44.3 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.117 0.484 . . . . 73.209999999999994 111.559 179.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 741' ' ' VAL . . . . . 0.481 ' HA ' HG23 ' A' ' 679' ' ' VAL . 26.9 t -75.77 151.77 6.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 116.288 -0.415 . . . . 53.100000000000001 111.419 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 742' ' ' ARG . . . . . . . . . . . . . 16.2 ptt180 -105.38 155.27 19.28 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 121.061 0.457 . . . . 75.099999999999994 111.236 178.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 743' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -93.15 115.59 28.22 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 121.168 0.509 . . . . 70.140000000000001 110.168 171.113 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 744' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -117.35 173.72 6.54 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.277 0.561 . . . . 72.329999999999998 112.257 -172.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 18.8 m -109.43 -177.78 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-N 115.996 -0.547 . . . . 71.349999999999994 111.22 178.461 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 21.6 pttm -109.46 145.03 36.89 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.785 0.326 . . . . 53.140000000000001 110.485 173.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 747' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -154.65 160.23 41.29 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.449 -0.341 . . . . 71.340000000000003 111.039 -175.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -76.99 38.98 0.22 Allowed 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 112.35 0.5 . . . . 73.439999999999998 112.35 178.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 749' ' ' LYS . . . . . 0.451 ' HB3' HG12 ' A' ' 751' ' ' ILE . 53.1 mtpt 61.75 98.81 0.04 OUTLIER Pre-proline 0 CA--C 1.543 0.71 0 C-N-CA 123.063 0.545 . . . . 61.140000000000001 112.299 178.463 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 750' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -74.3 47.41 1.57 Allowed 'Trans proline' 0 CA--C 1.546 1.111 0 C-N-CA 123.134 2.556 . . . . 71.030000000000001 113.083 178.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 751' ' ' ILE . . . . . 0.451 HG12 ' HB3' ' A' ' 749' ' ' LYS . 15.5 mm -82.82 28.44 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.868 0 CA-C-O 121.652 0.739 . . . . 73.129999999999995 111.425 -177.206 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 752' ' ' LEU . . . . . 0.461 ' N ' HD12 ' A' ' 752' ' ' LEU . 6.2 mp -81.25 41.13 0.59 Allowed 'General case' 0 CA--C 1.544 0.713 0 O-C-N 121.819 -0.551 . . . . 74.010000000000005 111.357 -179.196 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 753' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 . . . . . 0 N--CA 1.468 0.465 0 CA-C-N 116.09 -0.505 . . . . 73.200000000000003 111.503 -177.727 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 762' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 657' ' ' MET . . . . . . . . . . . . . 28.1 ttt . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 120.759 0.314 . . . . 74.109999999999999 111.152 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 658' ' ' GLY . . . . . . . . . . . . . . . 74.66 -74.14 1.35 Allowed Glycine 0 CA--C 1.527 0.824 0 C-N-CA 121.201 -0.523 . . . . 73.140000000000001 113.344 178.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 659' ' ' ASN . . . . . . . . . . . . . 64.1 m-20 -75.52 130.6 39.13 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 122.594 -0.356 . . . . 75.120000000000005 111.604 -177.265 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 660' ' ' GLY . . . . . . . . . . . . . . . -57.03 142.98 41.27 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 121.484 -0.389 . . . . 70.540000000000006 113.641 178.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -117.88 169.11 9.89 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.312 0.577 . . . . 74.409999999999997 112.493 -177.656 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 662' ' ' THR . . . . . . . . . . . . . 62.6 p -106.82 153.68 22.12 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 115.935 -0.575 . . . . 74.310000000000002 111.677 -179.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 663' ' ' SER . . . . . . . . . . . . . 48.9 p -74.17 122.51 22.88 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 116.364 -0.38 . . . . 64.340000000000003 111.708 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 664' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -105.02 126.6 52.24 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.456 0.646 . . . . 73.200000000000003 111.995 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 665' ' ' LEU . . . . . . . . . . . . . 89.2 mt -96.04 138.32 33.83 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.749 -0.66 . . . . 74.319999999999993 111.196 178.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 666' ' ' GLU . . . . . 0.528 ' H ' ' CD ' ' A' ' 666' ' ' GLU . 0.8 OUTLIER -82.22 140.11 45.62 Favored Pre-proline 0 CA--C 1.541 0.625 0 CA-C-N 116.01 -0.541 . . . . 71.030000000000001 110.872 174.974 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 667' ' ' PRO . . . . . 0.536 ' HB3' HD12 ' A' ' 699' ' ' LEU . 42.3 Cg_endo -65.79 138.3 52.87 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 122.715 2.277 . . . . 71.239999999999995 113.869 -171.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 668' ' ' LYS . . . . . . . . . . . . . 28.9 ttpp -82.9 107.68 15.69 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.905 -0.588 . . . . 72.439999999999998 110.747 177.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 669' ' ' LEU . . . . . 0.443 ' HG ' HG23 ' A' ' 671' ' ' VAL . 55.3 tp -100.78 112.48 24.9 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 121.146 0.498 . . . . 74.530000000000001 111.176 -178.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 670' ' ' THR . . . . . . . . . . . . . 94.7 m -93.47 111.48 23.16 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.962 0.41 . . . . 53.43 111.115 179.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 671' ' ' VAL . . . . . 0.443 HG23 ' HG ' ' A' ' 669' ' ' LEU . 73.8 t -137.49 137.24 21.64 Favored Pre-proline 0 CA--C 1.54 0.569 0 CA-C-N 115.767 -0.651 . . . . 64.400000000000006 110.843 -178.237 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 672' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -73.93 139.56 27.48 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 122.098 1.865 . . . . 65.530000000000001 112.015 174.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 673' ' ' VAL . . . . . . . . . . . . . 10.9 p -79.9 -29.64 12.9 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 CA-C-O 120.955 0.407 . . . . 71.140000000000001 112.017 -177.058 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 674' ' ' GLY . . . . . . . . . . . . . . . -158.89 142.65 8.53 Favored Glycine 0 CA--C 1.523 0.563 0 C-N-CA 120.804 -0.713 . . . . 52.509999999999998 113.263 179.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 675' ' ' ALA . . . . . . . . . . . . . . . -142.7 121.14 12.41 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 120.844 0.354 . . . . 50.409999999999997 111.709 -178.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 676' ' ' THR . . . . . . . . . . . . . 62.4 m -101.41 119.0 38.1 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.701 0.286 . . . . 74.140000000000001 110.923 179.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 677' ' ' ILE . . . . . . . . . . . . . 32.1 pt -125.36 177.01 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-O 121.095 0.474 . . . . 54.210000000000001 111.333 -179.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 678' ' ' HIS . . . . . . . . . . . . . 65.6 m80 -116.99 157.94 24.94 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 121.133 0.492 . . . . 63.420000000000002 111.754 179.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 679' ' ' VAL . . . . . 0.478 HG13 ' HA ' ' A' ' 712' ' ' THR . 95.9 t -57.37 116.35 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 116.093 -0.503 . . . . 70.340000000000003 110.526 174.307 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 117.44 -22.36 10.24 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 121.294 -0.479 . . . . 55.43 112.682 -175.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 681' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -62.79 150.26 41.95 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.537 0.684 . . . . 73.340000000000003 112.697 178.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 682' ' ' SER . . . . . . . . . . . . . 99.9 p -90.64 146.07 24.33 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 115.373 -0.83 . . . . 50.439999999999998 110.162 171.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 683' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -150.1 112.26 4.63 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 120.974 0.416 . . . . 74.530000000000001 111.628 -178.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 684' ' ' VAL . . . . . . . . . . . . . 58.5 t -115.33 98.93 51.7 Favored Pre-proline 0 CA--C 1.543 0.679 0 CA-C-O 120.953 0.406 . . . . 73.150000000000006 111.198 178.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 685' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -63.44 -25.89 70.65 Favored 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 122.673 2.249 . . . . 74.340000000000003 113.144 -177.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 686' ' ' MET . . . . . 0.404 ' HA ' ' CE ' ' A' ' 686' ' ' MET . 0.0 OUTLIER -87.29 11.32 14.59 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.265 0.469 . . . . 74.219999999999999 112.265 179.57 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 687' ' ' ALA . . . . . . . . . . . . . . . -119.43 -32.43 4.35 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.908 0.385 . . . . 71.319999999999993 111.396 175.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 688' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -90.92 9.72 29.35 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 112.289 0.477 . . . . 75.140000000000001 112.289 -178.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 94.2 t -125.76 139.19 52.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 122.56 0.344 . . . . 73.420000000000002 110.93 177.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 690' ' ' LEU . . . . . 0.478 HD23 ' N ' ' A' ' 691' ' ' ALA . 2.3 tt -142.73 133.06 24.77 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-O 120.691 0.281 . . . . 73.200000000000003 111.121 -176.06 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 691' ' ' ALA . . . . . 0.478 ' N ' HD23 ' A' ' 690' ' ' LEU . . . -126.63 125.52 42.05 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 112.465 0.543 . . . . 63.329999999999998 112.465 -178.042 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 692' ' ' ILE . . . . . 0.528 HD13 ' HA ' ' A' ' 698' ' ' ASP . 43.4 mm -134.36 132.11 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 CA-C-N 116.418 -0.356 . . . . 75.209999999999994 111.813 -179.083 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -107.98 129.63 55.1 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 109.194 -0.669 . . . . 63.100000000000001 109.194 168.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -60.24 -29.12 68.57 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 112.362 0.504 . . . . 63.399999999999999 112.362 -173.338 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 695' ' ' GLU . . . . . 0.406 ' HG3' ' N ' ' A' ' 696' ' ' ASP . 12.1 pt-20 -78.84 -45.87 19.86 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 120.999 0.428 . . . . 74.400000000000006 111.909 -179.741 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 696' ' ' ASP . . . . . 0.406 ' N ' ' HG3' ' A' ' 695' ' ' GLU . 10.2 t70 -94.07 -48.57 6.17 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.993 0.425 . . . . 74.109999999999999 111.455 -171.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . 124.02 -131.98 8.19 Favored Glycine 0 CA--C 1.524 0.614 0 CA-C-N 116.263 -0.426 . . . . 71.439999999999998 112.977 -178.086 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 698' ' ' ASP . . . . . 0.528 ' HA ' HD13 ' A' ' 692' ' ' ILE . 32.0 t70 -72.33 119.8 17.04 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 112.301 0.482 . . . . 75.230000000000004 112.301 -178.577 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 699' ' ' LEU . . . . . 0.536 HD12 ' HB3' ' A' ' 667' ' ' PRO . 62.4 mt -118.06 14.59 14.09 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 120.981 0.42 . . . . 73.400000000000006 110.873 175.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 81.2 m -60.01 -33.77 72.44 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.293 0.479 . . . . 70.450000000000003 112.293 -178.043 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 701' ' ' SER . . . . . . . . . . . . . 32.2 t -70.29 -16.7 63.05 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.196 0.522 . . . . 73.099999999999994 111.377 177.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 702' ' ' LYS . . . . . 0.535 ' HD2' HD22 ' A' ' 699' ' ' LEU . 67.5 mttm -91.88 6.38 46.38 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.197 -0.456 . . . . 62.039999999999999 111.769 179.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 703' ' ' ILE . . . . . 0.447 HG12 ' HB ' ' A' ' 723' ' ' VAL . 67.0 mt -82.3 133.87 28.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-O 120.946 0.403 . . . . 70.329999999999998 111.326 177.361 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 704' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -112.74 126.93 55.95 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.474 -0.33 . . . . 73.239999999999995 110.534 174.189 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 61.7 t -98.66 124.29 51.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-O 120.914 0.388 . . . . 72.140000000000001 111.605 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 706' ' ' ASP . . . . . 0.46 ' HB3' ' HB ' ' A' ' 720' ' ' THR . 37.3 t70 -109.95 143.25 40.16 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 116.26 -0.427 . . . . 64.120000000000005 110.658 174.4 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 94.16 166.76 37.02 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 121.015 -0.612 . . . . 53.109999999999999 113.102 -178.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 708' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -149.52 152.61 35.85 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 120.925 0.393 . . . . 63.509999999999998 111.473 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 709' ' ' VAL . . . . . 0.458 HG22 ' HB2' ' A' ' 717' ' ' TYR . 67.2 t -121.63 135.71 60.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 CA-C-N 116.498 -0.319 . . . . 61.539999999999999 111.608 -177.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 710' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -86.82 136.13 33.09 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.805 0.336 . . . . 74.519999999999996 110.824 173.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 711' ' ' THR . . . . . . . . . . . . . 68.3 p -106.4 4.04 28.03 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.124 0.488 . . . . 64.349999999999994 110.758 176.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 712' ' ' THR . . . . . 0.478 ' HA ' HG13 ' A' ' 679' ' ' VAL . 71.2 p -112.2 -11.76 13.72 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.91 -0.586 . . . . 72.25 112.255 -178.152 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 713' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -132.63 132.57 42.61 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.619 -0.264 . . . . 72.409999999999997 110.711 -178.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 714' ' ' ALA . . . . . 0.471 ' HB2' HG23 ' A' ' 741' ' ' VAL . . . -70.38 141.78 52.16 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 112.244 0.461 . . . . 74.319999999999993 112.244 -178.429 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 152.56 170.38 18.93 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 121.072 -0.585 . . . . 61.200000000000003 113.452 179.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 716' ' ' THR . . . . . . . . . . . . . 91.8 m -93.5 130.47 39.33 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 120.961 0.41 . . . . 55.229999999999997 111.668 177.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 717' ' ' TYR . . . . . 0.458 ' HB2' HG22 ' A' ' 709' ' ' VAL . 45.2 m-85 -128.16 139.74 52.31 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 122.763 0.425 . . . . 73.510000000000005 110.398 179.693 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 718' ' ' VAL . . . . . . . . . . . . . 45.3 t -105.86 140.59 23.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 N-CA-C 112.316 0.488 . . . . 74.219999999999999 112.316 -175.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 719' ' ' LEU . . . . . 0.418 HD21 HG23 ' A' ' 709' ' ' VAL . 85.3 mt -128.22 139.33 52.51 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 116.126 -0.488 . . . . 73.319999999999993 111.536 178.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . 0.46 ' HB ' ' HB3' ' A' ' 706' ' ' ASP . 96.5 m -120.51 139.26 53.16 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 120.814 0.34 . . . . 64.340000000000003 111.218 178.003 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 721' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -128.13 126.77 41.75 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 116.676 -0.238 . . . . 74.400000000000006 110.825 -178.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 85.0 m -132.13 135.09 46.15 Favored 'General case' 0 N--CA 1.475 0.818 0 O-C-N 122.416 -0.178 . . . . 74.099999999999994 111.476 -178.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 723' ' ' VAL . . . . . 0.447 ' HB ' HG12 ' A' ' 703' ' ' ILE . 7.5 p -130.45 137.64 55.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-O 121.032 0.444 . . . . 74.340000000000003 111.529 179.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 24.1 m -106.56 127.91 53.7 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.129 0.418 . . . . 72.230000000000004 112.129 -177.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 725' ' ' ASP . . . . . 0.488 ' HB2' ' HD3' ' A' ' 667' ' ' PRO . 1.1 t70 -81.59 150.95 27.91 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 122.945 0.498 . . . . 73.010000000000005 111.569 176.373 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 726' ' ' SER . . . . . . . . . . . . . 48.9 m -58.24 -34.08 70.05 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 112.57 0.581 . . . . 72.010000000000005 112.57 -176.087 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 727' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -85.76 -8.54 58.08 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 112.501 0.556 . . . . 72.230000000000004 112.501 -178.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 728' ' ' GLY . . . . . . . . . . . . . . . 113.1 14.3 10.09 Favored Glycine 0 CA--C 1.535 1.294 0 N-CA-C 115.255 0.862 . . . . 74.310000000000002 115.255 175.443 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 729' ' ' HIS . . . . . 0.419 ' O ' ' HB3' ' A' ' 725' ' ' ASP . 13.5 m80 -89.79 108.51 19.74 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 117.908 0.854 . . . . 74.319999999999993 111.229 172.518 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 730' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -108.17 113.88 27.35 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 120.811 0.338 . . . . 72.329999999999998 111.292 -178.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 731' ' ' VAL . . . . . 0.446 HG22 ' HG2' ' A' ' 667' ' ' PRO . 17.8 m -112.45 159.15 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 CA-C-O 120.624 0.249 . . . . 63.009999999999998 111.517 -177.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 8.8 t -147.14 151.94 37.62 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 112.746 0.647 . . . . 55.409999999999997 112.746 -177.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -148.25 161.34 41.69 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.933 -0.576 . . . . 74.549999999999997 110.424 178.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 734' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -130.64 159.59 36.74 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 112.901 0.704 . . . . 72.310000000000002 112.901 -175.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 735' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -134.03 128.41 34.27 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.581 -0.736 . . . . 72.340000000000003 111.075 178.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 736' ' ' THR . . . . . . . . . . . . . 74.3 m -99.52 107.41 19.58 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 120.918 0.39 . . . . 54.219999999999999 111.108 175.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 47.4 t -97.04 141.11 16.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-O 120.71 0.291 . . . . 72.239999999999995 111.414 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 738' ' ' THR . . . . . . . . . . . . . 85.9 m -131.32 120.91 23.82 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 122.093 -0.379 . . . . 71.430000000000007 110.917 177.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 739' ' ' VAL . . . . . . . . . . . . . 38.4 t -101.18 133.6 43.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 N-CA-C 111.831 0.308 . . . . 62.549999999999997 111.831 -177.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 740' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -120.89 149.93 41.85 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 120.811 0.339 . . . . 70.239999999999995 111.509 177.158 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 741' ' ' VAL . . . . . 0.471 HG23 ' HB2' ' A' ' 714' ' ' ALA . 21.2 t -84.68 162.2 3.02 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 O-C-N 122.277 -0.264 . . . . 53.340000000000003 110.72 176.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 742' ' ' ARG . . . . . 0.436 ' N ' HG12 ' A' ' 741' ' ' VAL . 5.4 mpt_? -61.17 161.78 8.3 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.235 0.541 . . . . 74.140000000000001 111.455 175.051 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 743' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -66.92 90.19 0.18 Allowed 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.011 0.434 . . . . 70.310000000000002 111.837 178.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 744' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -72.02 101.18 2.66 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.106 0.479 . . . . 64.129999999999995 110.651 174.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 73.1 t -68.99 127.98 31.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-N 116.295 -0.411 . . . . 60.32 111.074 179.562 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 746' ' ' LYS . . . . . 0.429 ' O ' ' HG3' ' A' ' 746' ' ' LYS . 52.7 pttt -68.95 95.48 0.7 Allowed 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 121.516 0.674 . . . . 72.219999999999999 111.61 179.614 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 747' ' ' ASN . . . . . . . . . . . . . 13.4 p30 -76.74 -159.46 0.12 Allowed 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.086 -0.506 . . . . 63.039999999999999 110.981 175.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 748' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -54.44 91.58 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 112.861 0.689 . . . . 55.310000000000002 112.861 -178.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 749' ' ' LYS . . . . . 0.424 ' HB2' ' HE3' ' A' ' 749' ' ' LYS . 38.1 ttmt 53.41 84.1 0.22 Allowed Pre-proline 0 CA--C 1.545 0.787 0 N-CA-C 112.974 0.731 . . . . 61.509999999999998 112.974 174.2 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 750' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -68.18 110.6 2.25 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 122.482 2.121 . . . . 64.340000000000003 111.822 172.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 751' ' ' ILE . . . . . . . . . . . . . 60.5 mt -76.47 132.97 31.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-O 121.003 0.43 . . . . 62.229999999999997 111.788 -177.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 752' ' ' LEU . . . . . . . . . . . . . 1.9 pp -143.18 171.47 14.04 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 116.25 -0.432 . . . . 73.310000000000002 111.902 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 753' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 . . . . . 0 N--CA 1.47 0.542 0 CA-C-O 121.102 0.477 . . . . 72.239999999999995 111.401 179.685 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 762' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_